PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, H; Zhang, FL; Shi, WJ; Bai, XJ; Jia, SQ; Zhang, CG; Ding, W				Li, Hua; Zhang, Feng-Lan; Shi, Wen-Jie; Bai, Xue-Jia; Jia, Shu-Qin; Zhang, Chen-Guang; Ding, Wei			Immobilization of FLAG-Tagged Recombinant Adeno-Associated Virus 2 onto Tissue Engineering Scaffolds for the Improvement of Transgene Delivery in Cell Transplants	PLOS ONE			English	Article							GENE DELIVERY; MONOCLONAL-ANTIBODY; ADIPOSE-TISSUE; IMMUNE-RESPONSES; GELATIN SPONGE; CAPSID PROTEIN; VIRAL VECTORS; THERAPY; AAV; ADENOVIRUS	The technology of virus-based genetic modification in tissue engineering has provided the opportunity to produce more flexible and versatile biomaterials for transplantation. Localizing the transgene expression with increased efficiency is critical for tissue engineering as well as a challenge for virus-based gene delivery. In this study, we tagged the VP2 protein of type 2 adeno-associated virus (AAV) with a 3xFLAG plasmid at the N-terminus and packaged a FLAG-tagged recombinant AAV2 chimeric mutant. The mutant AAVs were immobilized onto the tissue engineering scaffolds with crosslinked anti-FLAG antibodies by N-succinimidyl-3-(2-pyridyldithiol) propionate (SPDP). Cultured cells were seeded to scaffolds to form 3D transplants, and then tested for viral transduction both in vitro and in vivo. The results showed that our FLAG-tagged AAV2 exerted similar transduction efficiency compared with the wild type AAV2 when infected cultured cells. Following immobilization onto the scaffolds of PLGA or gelatin sponge with anti-FLAG antibodies, the viral mediated transgene expression was significantly improved and more localized. Our data demonstrated that the mutation of AAV capsid targeted for antibody-based immobilization could be a practical approach for more efficient and precise transgene delivery. It was also suggested that the immobilization of AAV might have attractive potentials in applications of tissue engineering involving the targeted gene manipulation in 3D tissue cultures.	[Li, Hua] Capital Med Univ, Dept Oral & Maxillofacial Head & Neck Oncol, Beijing Stomatol Hosp, Beijing, Peoples R China; [Zhang, Feng-Lan] Natl Inst Food & Drug Controls, Beijing, Peoples R China; [Shi, Wen-Jie; Jia, Shu-Qin] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Shi, Wen-Jie; Bai, Xue-Jia; Zhang, Chen-Guang; Ding, Wei] Capital Med Univ, Dept Med Genet, Beijing, Peoples R China; [Ding, Wei] Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Capital Medical University	Zhang, CG (corresponding author), Capital Med Univ, Dept Med Genet, Beijing, Peoples R China.	chzhang@ccmu.edu.cn; weiding@ccmu.edu.cn			Chinese National Science Foundation (NSFC) [30970161, 81372284]	Chinese National Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Chinese National Science Foundation (NSFC 30970161 and 81372284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourdenx M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00050; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Day TP, 2014, ADV EXP MED BIOL, V801, P687, DOI 10.1007/978-1-4614-3209-8_86; Ding W, 2012, AAV2 FLAG LUC; Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Herzog Roland W, 2004, Methods Mol Biol, V246, P179; High KA, 2004, SEMIN THROMB HEMOST, V30, P257, DOI 10.1055/s-2004-825639; Hong L, 2005, ANN BIOMED ENG, V33, P511, DOI 10.1007/s10439-005-2510-7; Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940; Jang JH, 2010, GENE THER, V17, P1384, DOI 10.1038/gt.2010.81; Kachi S, 2009, HUM GENE THER, V20, P31, DOI 10.1089/hum.2008.046; Kim SG, 2013, BMB REP, V46, P328, DOI 10.5483/BMBRep.2013.46.6.231; Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576; Lai CM, 2002, DNA CELL BIOL, V21, P895, DOI 10.1089/104454902762053855; Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452; Lin SD, 2011, TISSUE ENG PT A, V17, P1489, DOI [10.1089/ten.tea.2010.0688, 10.1089/ten.TEA.2010.0688]; Luk KDK, 2003, BIOCHEM BIOPH RES CO, V308, P636, DOI 10.1016/S0006-291X(03)01429-3; Luo Yongxiang, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P279; McCraw DM, 2012, VIROLOGY, V431, P40, DOI 10.1016/j.virol.2012.05.004; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Nasu T, 2009, J ORTHOP RES, V27, P1162, DOI 10.1002/jor.20860; Ochiya T, 1999, NAT MED, V5, P707, DOI 10.1038/9560; Park BH, 2012, BONE, V51, P313, DOI 10.1016/j.bone.2012.05.019; Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139; Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049; Rodino-Klapac LR, 2011, METHODS MOL BIOL, V709, P287, DOI 10.1007/978-1-61737-982-6_19; Rogers GL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00194; Seo S, 2013, INVEST OPHTH VIS SCI, V54, P6118, DOI 10.1167/iovs.13-11673; Serra T, 2013, ACTA BIOMATER, V9, P5521, DOI 10.1016/j.actbio.2012.10.041; Song CX, 2005, P ANN INT IEEE EMBS, P4095; Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129; Strehblow C, 2005, J CONTROL RELEASE, V102, P737, DOI 10.1016/j.jconrel.2004.10.033; Su H, 2004, P NATL ACAD SCI USA, V101, P16280, DOI 10.1073/pnas.0407449101; Su H, 2000, P NATL ACAD SCI USA, V97, P13801, DOI 10.1073/pnas.250488097; Warrington KH, 2004, J VIROL, V78, P6595, DOI 10.1128/JVI.78.12.6595-6609.2004; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang QC, 1998, HUM GENE THER, V9, P1929, DOI 10.1089/hum.1998.9.13-1929; Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006; Zhang YD, 2012, HUM GENE THER, V23, P98, DOI 10.1089/hum.2011.131	43	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129013	10.1371/journal.pone.0129013	http://dx.doi.org/10.1371/journal.pone.0129013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035716	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100064
J	Mateos-Gonzalez, F; Sundstrom, LF; Schmid, M; Bjorklund, M				Mateos-Gonzalez, Fernando; Sundstrom, L. Fredrik; Schmid, Marian; Bjorklund, Mats			Rapid Evolution of Parasite Resistance in a Warmer Environment: Insights from a Large Scale Field Experiment	PLOS ONE			English	Article							PERCH PERCA-FLUVIATILIS; CLIMATE-CHANGE; DIPLOSTOMUM-SPATHACEUM; RAINBOW-TROUT; SELECTION; IMMUNITY; GENES; WATER	Global climate change is expected to have major effects on host-parasite dynamics, with potentially enormous consequences for entire ecosystems. To develop an accurate prognostic framework, theoretical models must be supported by empirical research. We investigated potential changes in host-parasite dynamics between a fish parasite, the eyefluke Diplostomum baeri, and an intermediate host, the European perch Perca fluviatilis, in a large-scale semi-enclosed area in the Baltic Sea, the Biotest Lake, which since 1980 receives heated water from a nuclear power plant. Two sample screenings, in two consecutive years, showed that fish from the warmer Biotest Lake were now less parasitized than fish from the Baltic Sea. These results are contrasting previous screenings performed six years after the temperature change, which showed the inverse situation. An experimental infection, by which perch from both populations were exposed to D. baeri from the Baltic Sea, revealed that perch from the Baltic Sea were successfully infected, while Biotest fish were not. These findings suggest that the elevated temperature may have resulted, among other outcomes, in an extremely rapid evolutionary change through which fish from the experimental Biotest Lake have gained resistance to the parasite. Our results confirm the need to account for both rapid evolutionary adaptation and biotic interactions in predictive models, and highlight the importance of empirical research in order to validate future projections.	[Mateos-Gonzalez, Fernando; Sundstrom, L. Fredrik; Bjorklund, Mats] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [Schmid, Marian] Univ Konstanz, Limnol Inst, Dept Fish Ecol, Constance, Germany	Uppsala University; University of Konstanz	Mateos-Gonzalez, F (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	fernandomateos@gmail.com	Sundstrom, Fred/E-6736-2011; Mateos-González, Fernando/A-7935-2011	Sundstrom, Fred/0000-0002-3157-7289; Mateos-González, Fernando/0000-0001-6765-8761; Bjorklund, Mats/0000-0001-5436-6989	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [214-2010-630]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	This study was supported by a grant from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (http://www.formas.se/) to MB (FORMAS 214-2010-630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrmann-Godel J, 2013, PARASITOLOGY, V140, P509, DOI 10.1017/S0031182012001989; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bjorklund M, 2015, ECOL EVOL, V5, P1440, DOI 10.1002/ece3.1426; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Bryan-Walker K, 2007, MAR BIOL, V152, P687, DOI 10.1007/s00227-007-0725-x; Callaway R, 2012, AQUAT CONSERV, V22, P389, DOI 10.1002/aqc.2247; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Dargent F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2371; Devleesschauwer B, 2015, **DATA OBJECT**; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Ehlin U., 2009, ENV EFFECTS LARGE RE; Eizaguirre C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1632; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HOGLUND J, 1990, J HELMINTHOL, V64, P139, DOI 10.1017/S0022149X00012050; JENSEN KT, 1992, HELGOLANDER MEERESUN, V46, P329, DOI 10.1007/BF02367103; JOHNSON KA, 1971, J PARASITOL, V57, P244, DOI 10.2307/3278021; Karas P., 2010, BIOL UNDERSOKNINGAR; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Macnab V, 2012, GLOBAL CHANGE BIOL, V18, P1540, DOI 10.1111/j.1365-2486.2011.02595.x; Moszczynska A, 2009, MOL ECOL RESOUR, V9, P75, DOI 10.1111/j.1755-0998.2009.02634.x; Pickles RSA, 2013, GLOBAL CHANGE BIOL, V19, P2645, DOI 10.1111/gcb.12255; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; R Development Core Team, 2014, R LANG ENV STAT COMP; Rauch G, 2006, BIOL LETT-UK, V2, P382, DOI 10.1098/rsbl.2006.0462; SANDSTROM O, 1995, J FISH BIOL, V47, P652, DOI 10.1006/jfbi.1995.0169; Scharsack JP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-109; Speybroeck N, 2013, INT J PUBLIC HEALTH, V58, P791, DOI 10.1007/s00038-012-0439-9; WHYTE SK, 1990, J FISH DIS, V13, P281, DOI 10.1111/j.1365-2761.1990.tb00784.x; WILLIAMS MO, 1966, PARASITOLOGY, V56, P693, DOI 10.1017/S0031182000071717; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004	30	9	9	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128860	10.1371/journal.pone.0128860	http://dx.doi.org/10.1371/journal.pone.0128860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035300	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100053
J	Myung, W; Lee, GH; Won, HH; Fava, M; Mischoulon, D; Nyer, M; Kim, DK; Heo, JY; Jeon, HJ				Myung, Woojae; Lee, Geung-Hee; Won, Hong-Hee; Fava, Maurizio; Mischoulon, David; Nyer, Maren; Kim, Doh Kwan; Heo, Jung-Yoon; Jeon, Hong Jin			Paraquat Prohibition and Change in the Suicide Rate and Methods in South Korea	PLOS ONE			English	Article							MEANS RESTRICTION; SWITZERLAND; ASSOCIATION; PREVENTION; HOMICIDE; IMPACT; GAS	The annual suicide rate in South Korea is the highest among the developed countries. Paraquat is a highly lethal herbicide, commonly used in South Korea as a means for suicide. We have studied the effect of the 2011 paraquat prohibition on the national suicide rate and method of suicide in South Korea. We obtained the monthly suicide rate from 2005 to 2013 in South Korea. In our analyses, we adjusted for the effects of celebrity suicides, and economic, meteorological, and seasonal factors on suicide rate. We employed change point analysis to determine the effect of paraquat prohibition on suicide rate over time, and the results were verified by structural change analysis, an alternative statistical method. After the paraquat prohibition period in South Korea, there was a significant reduction in the total suicide rate and suicide rate by poisoning with herbicides or fungicides in all age groups and in both genders. The estimated suicide rates during this period decreased by 10.0% and 46.1% for total suicides and suicides by poisoning of herbicides or fungicides, respectively. In addition, method substitution effect of paraquat prohibition was found in suicide by poisoning by carbon monoxide, which did not exceed the reduction in the suicide rate of poisoning with herbicides or fungicides. In South Korea, paraquat prohibition led to a lower rate of suicide by paraquat poisoning, as well as a reduction in the overall suicide rate. Paraquat prohibition should be considered as a national suicide prevention strategy in developing and developed countries alongside careful observation for method substitution effects.	[Myung, Woojae; Kim, Doh Kwan; Heo, Jung-Yoon; Jeon, Hong Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat,Depress Ctr, Seoul, South Korea; [Myung, Woojae; Lee, Geung-Hee] Korea Natl Open Univ, Dept Informat Stat, Seoul, South Korea; [Myung, Woojae; Won, Hong-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Fava, Maurizio; Mischoulon, David; Nyer, Maren; Jeon, Hong Jin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Depress Clin & Res Program, Boston, MA 02115 USA; [Jeon, Hong Jin] Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Jeon, Hong Jin] Samsung Adv Inst Hlth Sci & Technol, Dept Med Device Management & Res, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea National Open University; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat,Depress Ctr, Seoul, South Korea.	jeonhj@skku.edu	Kim, Doh Kwan/F-4616-2014; Won, Hong-Hee/D-2672-2011; Myung, Woojae/AAD-3016-2021; Fava, Maurizio/AAH-3548-2020	Kim, Doh Kwan/0000-0002-2302-6153; Won, Hong-Hee/0000-0001-5719-0552; Myung, Woojae/0000-0001-9985-2032; 	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0013064]; Korea Health Technology RAMP;D Project (HJJ) through the Korea Health Industry Development Institute (KHIDI); Samsung Medical Center Clinical Research Development Program (CRDP) [SMO1131461]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Health Technology RAMP;D Project (HJJ) through the Korea Health Industry Development Institute (KHIDI); Samsung Medical Center Clinical Research Development Program (CRDP)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2011-0013064, HJJ) and a grant of the Korea Health Technology R&D Project (HJJ) through the Korea Health Industry Development Institute (KHIDI). This study was also supported by the Samsung Medical Center Clinical Research Development Program (CRDP) Grant SMO1131461 (HJJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TIM SER STAFF SRD X; Bridges FS, 2004, PERCEPT MOTOR SKILL, V98, P594; Chan CH, 2014, J EPIDEMIOL COMMUN H, V68, P246, DOI 10.1136/jech-2013-202759; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Chen YY, 2014, ARCH SUICIDE RES, V18, P221, DOI 10.1080/13811118.2013.824840; Choi YR, 2014, J AFFECT DISORDERS, V167, P322, DOI 10.1016/j.jad.2014.06.026; Christensen J, 1996, PREV VET MED, V26, P53, DOI 10.1016/0167-5877(95)00520-X; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; Diekstra RFW, 1995, PREVENTIVE STRATEGIE; Eddleston M, 2006, CLIN TOXICOL, V44, P283, DOI 10.1080/15563650600584444; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Hong SY, 2002, TOXICOL LETT, V126, P51, DOI 10.1016/S0378-4274(01)00431-3; Jeon HJ, 2010, J AFFECT DISORDERS, V127, P274, DOI 10.1016/j.jad.2010.05.027; Jeon HJ, 2010, J NERV MENT DIS, V198, P643, DOI 10.1097/NMD.0b013e3181ef3ecf; Jia HM, 2009, PUBLIC HEALTH REP, V124, P692, DOI 10.1177/003335490912400511; Kallek S, 1979, SEASONAL ANAL EC TIM, P1; Kervegant M, 2013, J MED TOXICOL, V9, P144, DOI 10.1007/s13181-012-0283-6; Kim Y, 2011, PSYCHIAT RES, V186, P390, DOI 10.1016/j.psychres.2010.08.006; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Lee W.J., 2009, J RURAL MED, V4, P53, DOI [10.2185/jrm.4.53, DOI 10.2185/JRM.4.53]; LESTER D, 1990, ACTA PSYCHIAT SCAND, V82, P383, DOI 10.1111/j.1600-0447.1990.tb01406.x; LOFTIN C, 1991, NEW ENGL J MED, V325, P1615, DOI 10.1056/NEJM199112053252305; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; Reisch T, 2013, AM J PSYCHIAT, V170, P977, DOI 10.1176/appi.ajp.2013.12091256; Seok Su-Jin, 2009, Korean Journal of Internal Medicine, V24, P247, DOI 10.3904/kjim.2009.24.3.247; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Van der Hoek W, 1998, SOC SCI MED, V46, P495, DOI 10.1016/S0277-9536(97)00193-7; Won HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061809; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6	32	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128980	10.1371/journal.pone.0128980	http://dx.doi.org/10.1371/journal.pone.0128980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26035175	Green Published, gold			2022-12-27	WOS:000355699100060
J	Xu, L; Tang, HW; El-Naggar, AK; Wei, P; Sturgis, EM				Xu, Li; Tang, Hongwei; El-Naggar, Adel K.; Wei, Peng; Sturgis, Erich M.			Genetic Variants in DNA Double-Strand Break Repair Genes and Risk of Salivary Gland Carcinoma: A Case-Control Study	PLOS ONE			English	Article							CANCER; RECOMBINATION	DNA double strand break (DSB) repair is the primary defense mechanism against ionizing radiation-induced DNA damage. Ionizing radiation is the only established risk factor for salivary gland carcinoma (SGC). We hypothesized that genetic variants in DSB repair genes contribute to individual variation in susceptibility to SGC. To test this hypothesis, we conducted a case-control study in which we analyzed 415 single nucleotide polymorphisms (SNPs) in 45 DSB repair genes in 352 SGC cases and 598 controls. Multivariate logistic regression analysis was performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Rs3748522 in RAD52 and rs13180356 in XRCC4 were significantly associated with SGC after Bonferroni adjustment; ORs (95% CIs) for the variant alleles of these SNPs were 1.71 (1.40-2.09, P=1.70 x 10(-7)) and 0.58 (0.45-0.74, P=2.00 x 10(-5)) respectively. The genetic effects were modulated by histological subtype. The association of RAD52-rs3748522 with SGC was strongest for mucoepidermoid carcinoma (OR=2.21, 95%CI: 1.55-3.15, P=1.25 x 10(-5), n=74), and the association of XRCC4-rs13180356 with SGC was strongest for adenoid cystic carcinoma (OR=0.60, 95% CI: 0.42-0.87, P=6.91 x 10(-3), n=123). Gene-level association analysis revealed one gene, PRKDC, with a marginally significant association with SGC risk in non-Hispanic whites. To our knowledge, this study is the first to comprehensively evaluate the genetic effect of DSB repair genes on SGC risk. Our results indicate that genetic variants in the DSB repair pathways contribute to inter-individual differences in susceptibility to SGC and show that the impact of genetic variants differs by histological subtype. Independent studies are warranted to confirm these findings.	[Xu, Li; Sturgis, Erich M.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Tang, Hongwei] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wei, Peng] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA; [Wei, Peng] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Sch Publ Hlth, Houston, TX 77030 USA; [Sturgis, Erich M.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center	Sturgis, EM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	esturgis@mdanderson.org	Wei, Peng/X-2306-2019	Wei, Peng/0000-0001-7758-6116	University of Texas MD Anderson Cancer Center start-up fund; National Institutes of Health (NIH) grant [U01 DE019765-01]; Cancer Center Support Grant [CA016672]; NIH grant [R01CA169122]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA169122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE019765] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center start-up fund; National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by The University of Texas MD Anderson Cancer Center start-up funds (to EMS), National Institutes of Health (NIH) grant U01 DE019765-01 (to AKE, EMS is project 2 leader), and Cancer Center Support Grant CA016672 to The University of Texas MD Anderson Cancer Center (to Dr. Ronald DePinho). PW was partially supported by NIH grant R01CA169122.	Adelstein DJ, 2012, SEMIN RADIAT ONCOL, V22, P245, DOI 10.1016/j.semradonc.2012.03.009; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Convery E, 2005, P NATL ACAD SCI USA, V102, P1345, DOI 10.1073/pnas.0406466102; Do R, 2015, NAT GENET, V47, P126, DOI 10.1038/ng.3186; Forrest J, 2008, NUTR CANCER, V60, P469, DOI 10.1080/01635580802143851; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Horn-Ross PL, 1999, EPIDEMIOLOGY, V10, P528, DOI 10.1097/00001648-199909000-00011; HornRoss PL, 1997, EPIDEMIOLOGY, V8, P414, DOI 10.1097/00001648-199707000-00011; HORSMAN DE, 1995, CANCER GENET CYTOGEN, V80, P165, DOI 10.1016/0165-4608(94)00187-G; Howlader N, 2013, SEER CANCER STATISTI; Huang Y, 2014, SCI WORLD J, DOI 10.1155/2014/584910; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702; Muscat JE, 1998, OTOLARYNG HEAD NECK, V118, P195, DOI 10.1016/S0194-5998(98)80013-2; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rana BK, 2007, HYPERTENSION, V49, P96, DOI 10.1161/01.HYP.0000252029.35106.67; Saku T, 1997, CANCER-AM CANCER SOC, V79, P1465, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1465::AID-CNCR4>3.3.CO;2-7; Sonoda E, 2001, P NATL ACAD SCI USA, V98, P8388, DOI 10.1073/pnas.111006398; SPITZ MR, 1990, ARCH OTOLARYNGOL, V116, P1163; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Thompson DQ, 1987, FISH WILDL REP, V2, P1; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang L, 2013, AM J PATHOL, V182, P2048, DOI 10.1016/j.ajpath.2013.02.020	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128753	10.1371/journal.pone.0128753	http://dx.doi.org/10.1371/journal.pone.0128753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035306	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100045
J	Bhuvanalakshmi, G; Arfuso, F; Millward, M; Dharmarajan, A; Warrier, S				Bhuvanalakshmi, G.; Arfuso, Frank; Millward, Michael; Dharmarajan, Arun; Warrier, Sudha			Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties	PLOS ONE			English	Article							EPIGENETIC INACTIVATION; MULTIDRUG-RESISTANCE; GENE-EXPRESSION; PROSTATE-CANCER; BREAST-CANCER; WNT; MECHANISMS; ANGIOGENESIS; ACTIVATION; MIGRATION	The Wnt pathway is integrally involved in regulating self-renewal, proliferation, and maintenance of cancer stem cells (CSCs). We explored the effect of the Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), in modulating epithelial to mesenchymal transition (EMT) in CSCs from human glioblastoma cells lines, U87 and U373. sFRP4 chemo-sensitized CSC-enriched cells to the most commonly used anti-glioblastoma drug, temozolomide (TMZ), by the reversal of EMT. Cell movement, colony formation, and invasion in vitro were suppressed by sFRP4+TMZ treatment, which correlated with the switch of expression of markers from mesenchymal (Twist, Snail, N-cadherin) to epithelial (E-cadherin). sFRP4 treatment elicited activation of the Wnt-Ca-2(+) pathway, which antagonizes the Wnt/beta-catenin pathway. Significantly, the chemo-sensitization effect of sFRP4 was correlated with the reduction in the expression of drug resistance markers ABCG2, ABCC2, and ABCC4. The efficacy of sFRP4+TMZ treatment was demonstrated in vivo using nude mice, which showed minimum tumor engraftment using CSCs pretreated with sFRP4+TMZ. These studies indicate that sFRP4 treatment would help to improve response to commonly used chemotherapeutics in gliomas by modulating EMT via the Wnt/beta-catenin pathway. These findings could be exploited for designing better targeted strategies to improve chemo-response and eventually eliminate glioblastoma CSCs.	[Bhuvanalakshmi, G.; Warrier, Sudha] Manipal Univ, Manipal Inst Regenerat Med, Div Canc Stem Cells & Cardiovasc Regenerat, Bangalore 560065, Karnataka, India; [Arfuso, Frank; Dharmarajan, Arun; Warrier, Sudha] Curtin Univ, Sch Biomed Sci, Curtin Hlth Innovat Res Inst, Stem Cell & Canc Biol Lab, Perth, WA 6845, Australia; [Arfuso, Frank] Univ Western Australia, Fac Sci, Sch Anat Physiol & Human Biol, Crawley, WA 6009, Australia; [Millward, Michael] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia	Manipal Academy of Higher Education (MAHE); Curtin University; University of Western Australia; University of Western Australia	Dharmarajan, A (corresponding author), Curtin Univ, Sch Biomed Sci, Curtin Hlth Innovat Res Inst, Stem Cell & Canc Biol Lab, Perth, WA 6845, Australia.	a.dharmarajan@curtin.edu.au; sudha.warrier@manipal.edu	; Arfuso, Frank/H-8761-2014	Dharmarajan, Arun/0000-0002-6715-6005; Arfuso, Frank/0000-0001-7678-9472	Curtin University Commercialization Advisory Board; School of Biomedical Sciences Strategic Research Funds; India Research Initiative funds; Department of Biotechnology, India [BT/PR8493/MED/31/226/2013]; University of Western Australia, Perth, Western Australia	Curtin University Commercialization Advisory Board; School of Biomedical Sciences Strategic Research Funds; India Research Initiative funds; Department of Biotechnology, India(Department of Biotechnology (DBT) India); University of Western Australia, Perth, Western Australia	This work was supported by Curtin University Commercialization Advisory Board and School of Biomedical Sciences Strategic Research Funds, India Research Initiative funds (Prof Arun Dharmarajan), funding from the Department of Biotechnology, India (BT/PR8493/MED/31/226/2013) and funds provided by Prof Michael Millward, University of Western Australia, Perth, Western Australia.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Annabi B, 2008, MOL CANCER RES, V6, P907, DOI 10.1158/1541-7786.MCR-07-2184; Apuzzo MLJ, 1990, NEUROSURGICAL TOPICS, V2; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bhuvanalakshmi G, 2014, STEM CELL REV REP, V10, P856, DOI 10.1007/s12015-014-9530-3; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Chen CP, 2011, IEEJ T ELECTR ELECTR, V6, pS27, DOI 10.1002/tee.20617; Chen MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112915; Constantinou Thecla, 2008, J Mol Signal, V3, P10, DOI 10.1186/1750-2187-3-10; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Drake JM, 2003, APOPTOSIS, V8, P389, DOI 10.1023/A:1024181203729; Feng Han Q, 2006, CANC LETT; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Guo K, 1998, BIOL REPROD, V58, P739, DOI 10.1095/biolreprod58.3.739; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hewitt DP, 2006, BIOL REPROD, V75, P75, DOI 10.1095/biolreprod.105.047647; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Hsieh M, 2003, ENDOCRINOLOGY, V144, P4597, DOI 10.1210/en.2003-0048; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Jones SE, 2000, INVEST OPHTH VIS SCI, V41, P1297; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Lacher MD, 2003, CELL DEATH DIFFER, V10, P528, DOI 10.1038/sj.cdd.4401197; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin YC, 2014, J CELL SCI, V127, P85, DOI 10.1242/jcs.132779; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu YH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-85; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; Muley A, 2010, AM J PATHOL, V176, P1505, DOI 10.2353/ajpath.2010.090465; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Plasencia C, 2005, MOL CANCER THER, V4, P1105, DOI 10.1158/1535-7163.MCT-04-0288; Rampazzo E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.32; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Schiefer L, 2014, CANCER GENE THER, V21, P297, DOI 10.1038/cgt.2014.30; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Takagi H, 2008, J GASTROENTEROL, V43, P378, DOI 10.1007/s00535-008-2170-0; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Warrier S, 2014, CANCER GENE THER, V21, P381, DOI 10.1038/cgt.2014.42; Warrier S, 2013, ONCOL RES, V21, P93, DOI 10.3727/096504013X13786659070154; Wolf V, 1997, FEBS LETT, V417, P385, DOI 10.1016/S0014-5793(97)01324-0	49	53	55	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127517	10.1371/journal.pone.0127517	http://dx.doi.org/10.1371/journal.pone.0127517			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030909	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900055
J	Del Piccolo, L; Pietrolongo, E; Radice, D; Tortorella, C; Confalonieri, P; Pugliatti, M; Lugaresi, A; Giordano, A; Heesen, C; Solari, A				Del Piccolo, Lidia; Pietrolongo, Erika; Radice, Davide; Tortorella, Carla; Confalonieri, Paolo; Pugliatti, Maura; Lugaresi, Alessandra; Giordano, Andrea; Heesen, Christoph; Solari, Alessandra		AutoMS Project	Patient Expression of Emotions and Neurologist Responses in First Multiple Sclerosis Consultations	PLOS ONE			English	Article							VERONA CODING DEFINITIONS; SHARED DECISION-MAKING; HOSPITAL ANXIETY; CANCER-PATIENTS; SEQUENCE-ANALYSIS; DEPRESSION SCALE; COMMUNICATION; PHYSICIAN; HEALTH; DISTRESS	Background Anxiety and depression are common in people with multiple sclerosis (MS), but data on emotional communication during MS consultations are lacking. We assessed patient expressions of emotion and neurologist responses during first-ever MS consultations using the Verona Coding Definitions of Emotional Sequences (VR-CoDES). Methods We applied VR-CoDES to recordings/ transcripts of 88 outpatient consultations (10 neurologists, four MS Italian centers). Before consultation, patients completed the Hospital Anxiety and Depression Scale (HADS). Multilevel sequential analysis was performed on the number of cues/concerns expressed by patients, and the proportion of reduce space responses by neurologists. Results Patients expressed 492 cues and 45 concerns (median 4 cues and 1 concern per consultation). The commonest cues were verbal hints of hidden worries (cue type b, 41%) and references to stressful life events (type d, 26%). Variables independently associated with number of cues/concerns were: anxiety (HADS-Anxiety score >8) (incidence risk ratio, IRR 1.08, 95% CI 1.06-1.09; p<0.001); patient age (IRR 0.98, 95% CI 0.98-0.99; p<0.001); neurologist age (IRR 0.94, 95% CI 0.92-0.96; p=0.03); and second opinion consultation (IRR 0.72, 95% CI 0.60-0.86; p=0.007). Neurologists reacted to patient emotions by reducing space (changing subject, taking no notice, giving medical advice) for 58% of cues and 76% of concerns. Anxiety was the only variable significantly associated with 'reduce space' responses (odds ratio 2.17, 95% CI 1.32-3.57; p=0.003). Conclusions Patient emotional expressions varied widely, but VR-CoDES cues b and d were expressed most often. Patient anxiety was directly associated with emotional expressions; older age of patients and neurologists, and second opinion consultations were inversely associated with patient emotional expression. In over 50% of instances, neurologists responded to these expressions by reducing space, more so in anxious patients. These findings suggest that neurologists need to improve their skills in dealing with patient emotions.	[Del Piccolo, Lidia] Univ Verona, Dept Med & Publ Hlth, I-37100 Verona, Italy; [Pietrolongo, Erika; Lugaresi, Alessandra] G DAnnunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Radice, Davide] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Tortorella, Carla] Univ Bari, Dept Basic Med Sci, Dept Neurosci, Bari, Italy; [Tortorella, Carla] Univ Bari, Dept Sense Organs, Bari, Italy; [Confalonieri, Paolo] Fdn IRCCS Neurol Inst C Besta, Unit Neuroimmunol, Milan, Italy; [Giordano, Andrea; Solari, Alessandra] Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Hamburg, Germany	University of Verona; G d'Annunzio University of Chieti-Pescara; IRCCS European Institute of Oncology (IEO); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Hamburg; University Medical Center Hamburg-Eppendorf	Solari, A (corresponding author), Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy.	solari@istituto-besta.it	Radice, Davide/B-7462-2016; Confalonieri, Paolo/AAS-8513-2021; Lugaresi, Alessandra/C-7743-2012; Solari, Alessandra/AAO-1741-2021; DEL PICCOLO, LIDIA/E-8583-2010; Antozzi, Carlo/AAB-8787-2019; Pugliatti, Maura/K-4071-2016; Giordano, Andrea/AAN-3738-2021; pietrolongo, erika/AAC-5694-2020; tortorella, carla/J-2557-2012	Radice, Davide/0000-0002-5075-1895; Confalonieri, Paolo/0000-0001-8030-5725; Lugaresi, Alessandra/0000-0003-2902-5589; Solari, Alessandra/0000-0001-9930-7579; Antozzi, Carlo/0000-0001-9270-5224; Pugliatti, Maura/0000-0001-9396-8683; Giordano, Andrea/0000-0003-4466-9788; pietrolongo, erika/0000-0002-6311-5994; Trojano, Maria/0000-0002-6329-8946; tortorella, carla/0000-0001-9037-7300; Del Piccolo, Lidia/0000-0003-1735-9362; Gaissmaier, Wolfgang/0000-0001-6273-178X	Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/37]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM))	This study was supported by the Fondazione Italiana Sclerosi Multipla (FISM, www.aism.it, grant No. 2010/R/37 to AS). The funding sources had no role in study design, data collection, data analysis, data interpretation, or report writing.	Adams K, 2012, PATIENT EDUC COUNS, V89, P44, DOI 10.1016/j.pec.2012.04.005; Brown RF, 2009, PSYCHOL PSYCHOTHER-T, V82, P41, DOI 10.1348/147608308X345614; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Butow PN, 2002, PSYCHO-ONCOLOGY, V11, P47, DOI 10.1002/pon.556; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Dahl OP, 2009, MULT SCLER J, V15, P1495, DOI 10.1177/1352458509351542; DAVENPORT S, 1987, LANCET, V2, P439; Del Piccolo L, 2005, PATIENT EDUC COUNS, V58, P252, DOI 10.1016/j.pec.2005.01.001; Del Piccolo L, 2000, PSYCHOL MED, V30, P629, DOI 10.1017/S003329179900197X; Del Piccolo L, 2007, SOC SCI MED, V65, P2357, DOI 10.1016/j.socscimed.2007.07.010; Del Piccolo L, 2012, PATIENT EDUC COUNS, V88, P29, DOI 10.1016/j.pec.2012.01.010; Del Piccolo L, 2011, PATIENT EDUC COUNS, V82, P149, DOI 10.1016/j.pec.2010.02.024; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Eide H, 2004, SOC SCI MED, V59, P145, DOI 10.1016/j.socscimed.2003.10.011; Eide H, 2011, CLIN J PAIN, V27, P602, DOI 10.1097/AJP.0b013e3182102872; Eide H, 2011, PATIENT EDUC COUNS, V82, P156, DOI 10.1016/j.pec.2010.04.036; Epstein RM, 2007, J GEN INTERN MED, V22, P1731, DOI 10.1007/s11606-007-0416-9; Feinstein A, 2014, NAT REV NEUROL, V10, P507, DOI 10.1038/nrneurol.2014.139; Finset A, 2013, PATIENT EDUC COUNS, V93, P80, DOI 10.1016/j.pec.2013.04.023; Finset A, 2012, PATIENT EDUC COUNS, V88, P359, DOI 10.1016/j.pec.2012.06.022; Giordano A, 2013, EUR J NEUROL, V20, P681, DOI 10.1111/ene.12028; Giordano A, 2011, J NEUROL SCI, V307, P86, DOI 10.1016/j.jns.2011.05.008; Goossensen A, 2007, PATIENT EDUC COUNS, V67, P50, DOI 10.1016/j.pec.2007.01.017; Hall JA, 1996, MED CARE, V34, P1205, DOI 10.1097/00005650-199612000-00006; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Honarmand K, 2009, MULT SCLER J, V15, P1518, DOI 10.1177/1352458509347150; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; LERMAN CE, 1990, J GEN INTERN MED, V5, P29, DOI 10.1007/BF02602306; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; McGuigan C, 2006, J NEUROL, V253, P219, DOI 10.1007/s00415-005-0963-0; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Mjaaland TA, 2011, PATIENT EDUC COUNS, V84, P332, DOI 10.1016/j.pec.2011.02.001; Oguchi M, 2011, PATIENT EDUC COUNS, V82, P163, DOI 10.1016/j.pec.2010.04.006; Pietrolongo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060721; Pollak KI, 2007, J CLIN ONCOL, V25, P5748, DOI 10.1200/JCO.2007.12.4180; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Silverman J, 2013, SKILLS COMMUNICATING, V3rd; Simpson RJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-128; King JS, 2006, AM J LAW MED, V32, P429, DOI 10.1177/009885880603200401; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Vatne TM, 2010, PATIENT EDUC COUNS, V80, P399, DOI 10.1016/j.pec.2010.06.026; White Carmel Parker, 2007, J Neurosci Nurs, V39, P89; Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798; Zhou YF, 2015, EUR ARCH OTO-RHINO-L, V272, P2473, DOI 10.1007/s00405-014-3209-x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann C, 2011, PATIENT EDUC COUNS, V82, P141, DOI 10.1016/j.pec.2010.03.017	48	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127734	10.1371/journal.pone.0127734	http://dx.doi.org/10.1371/journal.pone.0127734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030822	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900078
J	Huseth, AS; Petersen, JD; Poveda, K; Szendrei, Z; Nault, BA; Kennedy, GG; Groves, RL				Huseth, Anders S.; Petersen, Jessica D.; Poveda, Katja; Szendrei, Zsofia; Nault, Brian A.; Kennedy, George G.; Groves, Russell L.			Spatial and Temporal Potato Intensification Drives Insecticide Resistance in the Specialist Herbivore, Leptinotarsa decemlineata	PLOS ONE			English	Article							AGRICULTURAL LANDSCAPE SIMPLIFICATION; BEETLE COLEOPTERA-CHRYSOMELIDAE; WESTERN CORN-ROOTWORM; NEONICOTINOID INSECTICIDES; SOLANUM-TUBEROSUM; CROP-ROTATION; BT CROPS; MANAGEMENT; HISTORY; FOOD	Landscape-scale intensification of individual crops and pesticide use that is associated with this intensification is an emerging, environmental problem that is expected to have unequal effects on pests with different lifecycles, host ranges, and dispersal abilities. We investigate if intensification of a single crop in an agroecosystem has a direct effect on insecticide resistance in a specialist insect herbivore. Using a major potato pest, Leptinotarsa decemlineata, we measured imidacloprid (neonicotinoid) resistance in populations across a spatiotemporal crop production gradient where potato production has increased in Michigan and Wisconsin, USA. We found that concurrent estimates of area and temporal frequency of potato production better described patterns of imidacloprid resistance among L. decemlineata populations than general measures of agricultural production (% cropland, landscape diversity). This study defines the effects individual crop rotation patterns can have on specialist herbivore insecticide resistance in an agroecosystem context, and how impacts of intensive production can be estimated with general estimates of insecticide use. Our results provide empirical evidence that variation in the intensity of neonicotinoid-treated potato in an agricultural landscape can have unequal impacts on L. decemlineata insecticide insensitivity, a process that can lead to resistance and locally intensive insecticide use. Our study provides a novel approach applicable in other agricultural systems to estimate impacts of crop rotation, increased pesticide dependence, insecticide resistance, and external costs of pest management practices on ecosystem health.	[Huseth, Anders S.; Petersen, Jessica D.; Nault, Brian A.] Cornell Univ, New York State Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Poveda, Katja] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Szendrei, Zsofia] Michigan State Univ, Dept Entomol, E Lansing, MI 48823 USA; [Kennedy, George G.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27607 USA; [Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	Cornell University; Cornell University; Michigan State University; University of North Carolina; North Carolina State University; University of Wisconsin System; University of Wisconsin Madison	Huseth, AS (corresponding author), Cornell Univ, New York State Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	andershuseth@gmail.com		Huseth, Anders/0000-0002-5273-8555	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program [FY11-13]	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program	This research was supported by the Wisconsin Potato Industry Board and the National Potato Council's State Cooperative Research Program FY11-13.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Alyokhin A, 2007, PEST MANAG SCI, V63, P32, DOI 10.1002/ps.1305; Alyokhin A, 2015, PEST MANAG SCI, V71, P343, DOI 10.1002/ps.3826; Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; [Anonymous], 2009, SUREHARVEST DAT FARM; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Boydston RA, 2005, WEED TECHNOL, V19, P443, DOI 10.1614/WT-04-223R; Bruce TJA, 2012, J EXP BOT, V63, P537, DOI 10.1093/jxb/err281; Bussan AJ, 2012, ROLE OF BIOTECHNOLOGY IN A SUSTAINABLE FOOD SUPPLY, P192; Carriere Y, 2012, P NATL ACAD SCI USA, V109, P775, DOI 10.1073/pnas.1117851109; Castle SJ, 1999, ANN ENTOMOL SOC AM, V92, P840, DOI 10.1093/aesa/92.6.840; Croft BA, 1983, PEST RESISTANCE PEST, P277; Crowder DW, 2005, J ECON ENTOMOL, V98, P534, DOI 10.1603/0022-0493-98.2.534; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Faraway J., 2004, LINEAR MODELS R; Fitt Gary, 2009, P507, DOI 10.1007/978-1-4020-8990-9_17; FORGASH AJ, 1984, PESTIC BIOCHEM PHYS, V22, P178, DOI 10.1016/0048-3575(84)90087-7; Fox J, 2008, APPL REGRESSION ANAL; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Georghiou G. P., 1983, Pest resistance to pesticides, P769; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Grafius E, 1997, J ECON ENTOMOL, V90, P1144, DOI 10.1093/jee/90.5.1144; HARE JD, 1990, ANNU REV ENTOMOL, V35, P81, DOI 10.1146/annurev.en.35.010190.000501; Head G, INSECT RESISTANCE MA, P89; Hoy CW, 1996, J ECON ENTOMOL, V89, P963, DOI 10.1093/jee/89.4.963; Huseth AS, 2013, J ECON ENTOMOL, V106, P2491, DOI 10.1603/EC13277; Huseth AS, 2014, PEST MANAG SCI, V70, P1863, DOI 10.1002/ps.3740; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Larsen AE, 2013, P NATL ACAD SCI USA, V110, P15330, DOI 10.1073/pnas.1301900110; McGarigal K., FRAGSTATS SPATIAL PA; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; NECK R W, 1983, Coleopterists Bulletin, V37, P177; Onstad D., 2013, INSECT RESISTANCE MA, V2nd edn, P327; Osteen CD, 2013, PEST MANAG SCI, V69, P1001, DOI 10.1002/ps.3529; Palumbo J.C., 2003, IPM SERIES, V17; Parsa S, 2014, P NATL ACAD SCI USA, V111, P3889, DOI 10.1073/pnas.1312693111; Piiroinen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-13; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; PREISLER HK, 1988, J ECON ENTOMOL, V81, P759, DOI 10.1093/jee/81.3.759; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; ROUSH RT, 1989, PESTIC SCI, V26, P423, DOI 10.1002/ps.2780260409; ROUSH RT, 1992, RESISTANCE 91 : ACHIEVEMENTS AND DEVELOPMENTS IN COMBATING PESTICIDE RESISTANCE, P61; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sexson D, 2005, P WISC ANN POT M 200, V25, P229; Shannon C. E., 1949, MATH THEORY COMMUNIC; Szalai M, 2014, AGR SYST, V124, P39, DOI 10.1016/j.agsy.2013.10.009; Szendrei Z, 2012, PEST MANAG SCI, V68, P941, DOI 10.1002/ps.3258; Tabashnik BE, 2014, J ECON ENTOMOL, V107, P496, DOI 10.1603/EC13458; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Team RDC, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turner MG, 2001, LANDSCAPE ECOLOGY TH, P93; United States Department of Agriculture, NAT AGR IM PROGR; USDA National Agricultural Statistics Service, CROPL DAT LAY; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; WEBER DC, 1993, ENTOMOL EXP APPL, V66, P191, DOI 10.1007/BF02382289; WEBER DC, 1995, ENVIRON ENTOMOL, V24, P608, DOI 10.1093/ee/24.3.608; Weisz R, 1996, J ECON ENTOMOL, V89, P435, DOI 10.1093/jee/89.2.435; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P5, DOI 10.1079/9781845933531.0005; Whitaker PM, 1994, THESIS U WISCONSIN M; Williams MM, 2005, WEED TECHNOL, V19, P1050, DOI 10.1614/WT-04-334R2.1; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhao JZ, 2000, J ECON ENTOMOL, V93, P1508, DOI 10.1603/0022-0493-93.5.1508	65	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127576	10.1371/journal.pone.0127576	http://dx.doi.org/10.1371/journal.pone.0127576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030877	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900062
J	Jacobsen, R; Hypponen, E; Sorensen, TIA; Vaag, AA; Heitmann, BL				Jacobsen, Ramune; Hypponen, Elina; Sorensen, Thorkild I. A.; Vaag, Allan A.; Heitmann, Berit L.			Gestational and Early Infancy Exposure to Margarine Fortified with Vitamin D through a National Danish Programme and the Risk of Type 1 Diabetes: The D-Tect Study	PLOS ONE			English	Article							EARLY-LIFE; D SUPPLEMENTATION; EARLY-CHILDHOOD; DIETARY-INTAKE; BIRTH-WEIGHT; D DEFICIENCY; IN-UTERO; METAANALYSIS; FORTIFICATION; PREGNANCY	The objective of the study was to assess whether gestational and early infancy exposure to low dose vitamin D froma mandatory margarine fortification programme in Denmark influenced the risk of developing type 1 diabetes (T1D) before age of 15 years. The study population included all individuals born in Denmark from 1983 to 1988 and consisted of 331,623 individuals. The 1st of June 1985, which was the date of issue of the new ministerial order cancelling mandatory fortification of margarine with vitamin D in Denmark, served as a reference point separating the studied population into various exposure groups. We further modelled birth cohort effects in children developing T1D as a linear spline, and compared the slopes between the birth cohorts with various prenatal and infancy exposures to vitamin D fortification. In total, 886 (0.26%) individuals developed T1D before the age of 15 years. The beta coefficients (95% CI), or slopes, for linear birth cohort effect in log Hazard Ratio (HR) per one month of birth in individuals born during the periods of gestational exposure, wash-out, and non-exposure were: 0.010 (-0.002/0.021), -0.010 (-0.035/0.018), and 0.008 (-0.017/0.032), respectively. The beta coefficients (95% CI) for individuals born during the periods of first postnatal year exposure, wash-out, and non-exposure were: 0.007 (-0.016/0.030), 0.006 (-0.004/0.016), and 0.007 (-0.002/0.016), respectively. In conclusion, we found no evidence to support that exposure to low dose vitamin D from the Danish mandatory margarine fortification regimen during gestational and first postnatal year of life changed the risk of developing T1D before the age of 15 years.	[Jacobsen, Ramune; Heitmann, Berit L.] Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Hypponen, Elina] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Jacobsen, Ramune; Sorensen, Thorkild I. A.; Heitmann, Berit L.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Vaag, Allan A.] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Vaag, Allan A.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Southren Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia	University of Copenhagen; Bispebjerg Hospital; University of South Australia; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Bristol; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Sydney	Jacobsen, R (corresponding author), Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.	ramune.jacobsen@regionh.dk	Hypponen, Elina/B-2596-2014; Jacobsen, Ramune/AAG-1887-2019	Hypponen, Elina/0000-0003-3670-9399; Vaag, Allan Arthur/0000-0002-3690-2191; Jacobsen, Ramune/0000-0002-8142-9807; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Programme Commission on Health, Food, and Welfare under Danish Council for Strategic research [0603-00453B]; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; MRC [MC_UU_12013/1] Funding Source: UKRI	Programme Commission on Health, Food, and Welfare under Danish Council for Strategic research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is a part of the 4 years project "D-tect" funded by the Programme Commission on Health, Food, and Welfare under the Danish Council for Strategic research (grant number 0603-00453B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1996, AUST VET J, V74, P311, DOI 10.1111/j.1751-0813.1996.tb13786.x; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Black LJ, 2012, J NUTR, V142, P1102, DOI 10.3945/jn.112.158014; Bowyer L, 2009, CLIN ENDOCRINOL, V70, P372, DOI 10.1111/j.1365-2265.2008.03316.x; Brot C, 2001, BRIT J NUTR, V86, pS97, DOI 10.1079/BJN2001345; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Cardwell CR, 2008, DIABETIC MED, V25, P261, DOI 10.1111/j.1464-5491.2007.02351.x; Cardwell CR, 2010, DIABETOLOGIA, V53, P641, DOI 10.1007/s00125-009-1648-5; Cardwell CR, 2005, DIABETIC MED, V22, P200, DOI 10.1111/j.1464-5491.2005.01369.x; Fagt S, 2001, FORSYNINGEN FODEVARE; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Haradsdottir J, 1989, TILSAETNING VITAMINE; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; Hollis BW, 2006, CAN MED ASSOC J, V174, P1287, DOI 10.1503/cmaj.060149; Hypponen E, 2011, ANN NUTR METAB, V59, P28, DOI 10.1159/000332072; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jensen CB, 2012, NUTRIENTS, V4, P259, DOI 10.3390/nu4040259; Laaksi IT, 2006, EUR J CLIN NUTR, V60, P1035, DOI 10.1038/sj.ejcn.1602414; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Madsen KH, 2013, AM J CLIN NUTR, V98, P374, DOI 10.3945/ajcn.113.059469; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; MEJBORN H, 2004, D VITAMINSTATUS DANS; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Piirainen T, 2007, EUR J CLIN NUTR, V61, P123, DOI 10.1038/sj.ejcn.1602506; Svensson J, 2005, EUR J EPIDEMIOL, V20, P429, DOI 10.1007/s10654-005-0878-1; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; Svensson J, 2009, PEDIATR DIABETES, V10, P248, DOI 10.1111/j.1399-5448.2008.00483.x; Thiele DK, 2013, J HUM LACT, V29, P163, DOI 10.1177/0890334413477916; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	32	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128631	10.1371/journal.pone.0128631	http://dx.doi.org/10.1371/journal.pone.0128631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030061	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000356630900177
J	Pan, HP; Yang, XW; Bidne, K; Hellmich, RL; Siegfried, BD; Zhou, XG				Pan, Huipeng; Yang, Xiaowei; Bidne, Keith; Hellmich, Richard L.; Siegfried, Blair D.; Zhou, Xuguo			Selection of Reference Genes for RT-qPCR Analysis in the Monarch Butterfly, Danaus plexippus (L.), a Migrating Bio-Indicator	PLOS ONE			English	Article							CORN POLLEN; PCR; EXPRESSION; ECOLOGY	Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) is a powerful technique to quantify gene expression. To facilitate gene expression study and obtain accurate results, normalization relative to stably expressed reference genes is crucial. The monarch butterfly, Danaus plexippus (L.), is one of the most recognized insect species for its spectacular annual migration across North America. Besides its great voyages, D. plexippus has drawn attention to its role as a bio-indicator, ranging from genetically modified organisms (GMOs) to natural ecosystems. In this study, nine reference genes from D. plexippus genome were selected as the candidate reference genes. The expression profiles of these candidates under various biotic and abiotic conditions were evaluated using the four readily available computational programs, BestKeeper, Normfinder, geNorm, and.Ct method, respectively. Moreover, RefFinder, a web-based computational platform integrating the four above mentioned algorisms, provided a comprehensive ranking of the stability of these reference genes. As a result, a suite of reference genes were recommended for each experimental condition. Specifically, elongation factor 1 alpha(EF1A) and ribosomal protein 49 (RP49) were the most stable reference genes, respectively, under biotic (development, tissue, and sex) and abiotic (photoperiod, temperature, and dietary RNAi) conditions. With the recent release of a 273-million base pair draft genome, results from this study allow us to establish a standardized RT-qPCR analysis and lay a foundation for the subsequent genomic and functional genomic research in D. plexippus, a major bio-indicator and an emerging model for migratory animals.	[Pan, Huipeng; Yang, Xiaowei; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Yang, Xiaowei] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Bidne, Keith; Hellmich, Richard L.] Iowa State Univ, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Bidne, Keith; Hellmich, Richard L.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Siegfried, Blair D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA	University of Kentucky; Cornell University; Iowa State University; Iowa State University; University of Nebraska System; University of Nebraska Lincoln	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu			University of Kentucky; USDA BRAG grant [3048108827]	University of Kentucky; USDA BRAG grant	This research was supported by a start-up fund from the University of Kentucky to XGZ, a grant from USDA BRAG grant (Award Agreement No.: 3048108827) to XGZ and BDS.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2008, ENVIRON ENTOMOL; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Guo JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07042; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jesse LCH, 2000, OECOLOGIA, V125, P241, DOI 10.1007/s004420000502; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Solensky MJ, 2004, J INSECT BEHAV, V17, P723, DOI 10.1023/B:JOIR.0000048985.58159.0d; Stensmyr MC, 2011, CELL, V147, P970, DOI 10.1016/j.cell.2011.11.009; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wraight CL, 2000, P NATL ACAD SCI USA, V97, P7700, DOI 10.1073/pnas.130202097; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Zangerl AR, 2001, P NATL ACAD SCI USA, V98, P11908, DOI 10.1073/pnas.171315698; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	35	26	29	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129482	10.1371/journal.pone.0129482	http://dx.doi.org/10.1371/journal.pone.0129482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030778	Green Published, gold			2022-12-27	WOS:000356630900221
J	Saif, AFMS; Prabuwono, AS; Mahayuddin, ZR				Saif, A. F. M. Saifuddin; Prabuwono, Anton Satria; Mahayuddin, Zainal Rasyid			Moment Feature Based Fast Feature Extraction Algorithm for Moving Object Detection Using Aerial Images	PLOS ONE			English	Article								Fast and computationally less complex feature extraction for moving object detection using aerial images from unmanned aerial vehicles (UAVs) remains as an elusive goal in the field of computer vision research. The types of features used in current studies concerningmoving object detection are typically chosen based on improving detection rate rather than on providing fast and computationally less complex feature extraction methods. Because moving object detection using aerial images from UAVs involves motion as seen from a certain altitude, effective and fast feature extraction is a vital issue for optimum detection performance. This research proposes a two-layer bucket approach based on a new feature extraction algorithm referred to as the moment-based feature extraction algorithm (MFEA). Because a moment represents thecoherent intensity of pixels and motion estimation is a motion pixel intensity measurement, this research used this relation to develop the proposed algorithm. The experimental results reveal the successful performance of the proposed MFEA algorithm and the proposed methodology.	[Saif, A. F. M. Saifuddin; Prabuwono, Anton Satria; Mahayuddin, Zainal Rasyid] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Ukm Bangi 43600, Selangor De, Malaysia; [Prabuwono, Anton Satria] King Abdulaziz Univ, Fac Comp & Informat Technol, Rabigh 21911, Saudi Arabia	Universiti Kebangsaan Malaysia; King Abdulaziz University	Saif, AFMS (corresponding author), Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Ukm Bangi 43600, Selangor De, Malaysia.	rashedcse25@yahoo.com	Saif, A F M Saifuddin/N-7238-2014; Prabuwono, Anton Satria/K-7555-2014; Mahayuddin, Zainal R/E-9064-2017	Saif, A F M Saifuddin/0000-0002-6163-4678; Prabuwono, Anton Satria/0000-0003-3337-6605; Mahayuddin, Zainal/0000-0002-9014-8599	Ministry of Higher Education Malaysia [FRGS/1/2012/SG05/UKM/02/12, ERGS/1/2012/STG07/UKM/02/7]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This research is supported by Ministry of Higher Education Malaysia research grant scheme of FRGS/1/2012/SG05/UKM/02/12 and ERGS/1/2012/STG07/UKM/02/7.	Bhuvaneswari K, 2009, CONTR AUT COMM EN CO; Cheng HY, 2012, IEEE T IMAGE PROCESS, V21, P2152, DOI 10.1109/TIP.2011.2172798; Cheraghi SA, 2012, CONTR SYST COMP ENG; Gaszczak A., 2011, REAL TIME PEOPLE VEH; Gleason J, 2011, VEHICLE DETECTION AE; Ibrahim AWN, 2010, IM VID TECHN PSIVT 2; Jiang Z, 2009, MICR EL 2009 PRIMEAS; Kembhavi A, 2011, IEEE T PATTERN ANAL, V33, P1250, DOI 10.1109/TPAMI.2010.182; Long C, 2012, COMP VIS REM SENS CV; Mofaddel MA, 2011, COMP ENG SYST ICCES; Moranduzzo T, 2012, GEOSC REM SENS S IGA; Oreifej O, 2010, HUMAN IDENTITY RECOG; Pingting L, 2012, INF SCI DIG CONT TEC; Pollard T, 2012, COMP VIS PATT REC WO; Saif A., 2013, INT J INFORM SYSTEM, V1, P50; Saif A. F. M. Saifuddin, 2013, International Journal of Advancements in Computing Technology, V5, P57; Saif AFMS, 2013, LECT NOTES COMPUT SC, V8237, P104, DOI 10.1007/978-3-319-02958-0_10; Sheng W, 2011, COMP INF TECHN CIT 2; Teutsch M, 2012, INF FUS FUSION 2012; Teutsch M, 2012, ADV VID SIGN BAS SUR; Wang X, 2011, COMP INT SEC CIS 201; Yingqian Y, 2012, VEH EL SAF ICVES 201; Zezhong Z, 2012, GEOSC REM SENS S IGA; Zhuoyi L, 2008, INT INF HID MULT SIG	24	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126212	10.1371/journal.pone.0126212	http://dx.doi.org/10.1371/journal.pone.0126212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030818	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900022
J	Usategui-Martin, R; Garcia-Aparicio, J; Corral-Gudino, L; Calero-Paniagua, I; Del Pino-Montes, J; Sarmiento, RG				Usategui-Martin, Ricardo; Garcia-Aparicio, Judith; Corral-Gudino, Luis; Calero-Paniagua, Ismael; Del Pino-Montes, Javier; Sarmiento, Rogelio Gonzalez			Polymorphisms in Autophagy Genes Are Associated with Paget Disease of Bone	PLOS ONE			English	Article							SQSTM1 MUTATIONS; CROHNS-DISEASE; PATHOGENESIS; PROTEIN; OSTEOCLASTOGENESIS; INTERLEUKIN-8; METAANALYSIS; DEGRADATION; BIOGENESIS; INCLUSIONS	Paget disease of bone (PDB) is a focal bone disorder affecting the skeleton segmentally. The main alteration resides in osteoclasts that increase in size, number and activity. Many osteoclasts have cytoplasmic inclusions that have been associated with protein aggregates, increasing the evidences of a possible deregulation of autophagy in the development of the PDB. Autophagy starts with encapsulation of the target into a double-membrane-bound structure called an "autophagosome." It has been reported that at least 18 ATG genes (autophagy-related genes) are involved in autophagosome formation. We have studied the distribution of genotypes of the ATG2B rs3759601, ATG16L1 rs2241880, ATG10 rs1864183 and ATG5 rs2245214 polymorphisms in a Spanish cohort of subjects with PDB and compared with healthy subjects. Our results show that being a carrier of the C allele of the ATG16L1 rs2241880 and the G allele of ATG5 rs2245214 polymorphisms were associated with an increased risk of developing PDB, whereas being a carrier of the T allele of ATG10 rs1864183 polymorphism decreased the risk of suffering the disease in our series. This is the first report that shows an association between autophagy and Paget Disease of Bone and requires further confirmation in other series.	[Usategui-Martin, Ricardo; Sarmiento, Rogelio Gonzalez] Univ Salamanca, Hosp Univ Salamanca, CSIC, Unidad Med Mol,IBSAL,Dept Med, E-37008 Salamanca, Spain; [Garcia-Aparicio, Judith; Corral-Gudino, Luis] Univ Salamanca, Hosp Univ Salamanca, CSIC, Serv Med Interna,IBSAL, E-37008 Salamanca, Spain; [Calero-Paniagua, Ismael; Del Pino-Montes, Javier] Univ Salamanca, Hosp Univ Salamanca, CSIC, Serv Reumatol,IBSAL, E-37008 Salamanca, Spain; [Sarmiento, Rogelio Gonzalez] Univ Salamanca, IBMCC, CSIC, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Sarmiento, RG (corresponding author), Univ Salamanca, Hosp Univ Salamanca, CSIC, Unidad Med Mol,IBSAL,Dept Med, E-37008 Salamanca, Spain.	gonzalez@usal.es	Gonzalez-Sarmiento, Rogelio/V-5526-2019; Corral-Gudino, Luis/K-4863-2019	Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; Corral-Gudino, Luis/0000-0003-0151-5420; Usategui-Martin, Ricardo/0000-0001-7699-4388	Carlos III Institute, Government of Spain [FIS PI 13/01741]	Carlos III Institute, Government of Spain	This work was supported by FIS PI 13/01741 (project belonging to Carlos III Institute, Government of Spain).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Bolland MJ, 2007, J BONE MINER RES, V22, P411, DOI 10.1359/JBMR.061204; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Chamoux E, 2009, MOL ENDOCRINOL, V23, P1668, DOI 10.1210/me.2009-0066; Cheng JF, 2010, WORLD J GASTROENTERO, V16, P1258, DOI 10.3748/wjg.v16.i10.1258; Collet C, 2007, J BONE MINER RES, V22, P310, DOI 10.1359/JBMR.061106; Corral-Gudino L, 2013, BONE, V55, P347, DOI 10.1016/j.bone.2013.04.024; Corral-Gudino L, 2010, CYTOKINE, V52, P146, DOI 10.1016/j.cyto.2010.07.008; Daroszewska A, 2011, HUM MOL GENET, V20, P2734, DOI 10.1093/hmg/ddr172; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Helfrich MH, 2000, J BONE MINER RES, V15, P2315, DOI 10.1359/jbmr.2000.15.12.2315; Hsu YL, 2010, CARCINOGENESIS, V31, P587, DOI 10.1093/carcin/bgq030; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ichimura Y, 2010, SEMIN IMMUNOPATHOL, V32, P431, DOI 10.1007/s00281-010-0220-1; Lacher M, 2009, ACTA PAEDIATR, V98, P1835, DOI 10.1111/j.1651-2227.2009.01438.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pyo JO, 2012, EXP MOL MED, V44, P73, DOI 10.3858/emm.2012.44.2.029; Ralston SH, 2012, CALCIFIED TISSUE INT, V91, P97, DOI 10.1007/s00223-012-9599-0; Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020; Roodman GD, 2010, ANN NY ACAD SCI, V1192, P176, DOI 10.1111/j.1749-6632.2009.05214.x; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Schleinitz D, 2011, METHODS MOL BIOL, V700, P77, DOI 10.1007/978-1-61737-954-3_6; Sieradzan KA, 1999, EXP NEUROL, V156, P92, DOI 10.1006/exnr.1998.7005; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	33	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128984	10.1371/journal.pone.0128984	http://dx.doi.org/10.1371/journal.pone.0128984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030385	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900203
J	Zhu, MY; Zhu, GW; Nurminen, L; Wu, TF; Deng, JM; Zhang, YL; Qin, BQ; Ventela, AM				Zhu, Mengyuan; Zhu, Guangwei; Nurminen, Leena; Wu, Tingfeng; Deng, Jianming; Zhang, Yunlin; Qin, Boqiang; Ventela, Anne-Mari			The Influence of Macrophytes on Sediment Resuspension and the Effect of Associated Nutrients in a Shallow and Large Lake (Lake Taihu, China)	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; WIND; PHOSPHORUS; DYNAMICS; LIGHT; RESTORATION; RELEASE; QUALITY; CHLOROPHYLL; VARIABILITY	A yearlong campaign to examine sediment resuspension was conducted in large, shallow and eutrophic Lake Taihu, China, to investigate the influence of vegetation on sediment resuspension and its nutrient effects. The study was conducted at 6 sites located in both phytoplankton-dominated zone and macrophyte-dominated zone of the lake, lasting for a total of 13 months, with collections made at two-week intervals. Sediment resuspension in Taihu, with a two-week high average rate of 1771 g.m(-2).d(-1) and a yearly average rate of 377 g.m(-2).d(-1), is much stronger than in many other lakes worldwide, as Taihu is quite shallow and contains a long fetch. The occurrence of macrophytes, however, provided quite strong abatement of sediment resuspension, which may reduce the sediment resuspension rate up to 29-fold. The contribution of nitrogen and phosphorus to the water column from sediment resuspension was estimated as 0.34 mg.L-1 and 0.051 mg.L-1 in the phytoplankton-dominated zone. Sediment resuspension also largely reduced transparency and then stimulated phytoplankton growth. Therefore, sediment resuspension may be one of the most important factors delaying the recovery of eutrophic Lake Taihu, and the influence of sediment resuspension on water quality must also be taken into account by the lake managers when they determine the restoration target.	[Zhu, Mengyuan; Zhu, Guangwei; Wu, Tingfeng; Deng, Jianming; Zhang, Yunlin; Qin, Boqiang] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Nurminen, Leena] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Ventela, Anne-Mari] Pyhajarvi Inst, Kauttua 27500, Finland	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Helsinki	Zhu, GW (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China.	gwzhu@niglas.ac.cn	Qin, Boqiang/E-5900-2013; Zhang, Yunlin/N-5464-2014	Zhang, Yunlin/0000-0002-3382-4570; Wu, Tingfeng/0000-0002-9985-7746	External Cooperation Program of the Chinese Academy of Sciences [GJHZ1214]; National Natural Science Foundation of China [41230744]; Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences [NIGLAS2012135002]; Finnish Academy of Science (FICCA) [256244, 256240]	External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences; Finnish Academy of Science (FICCA)	This work was funded by the External Cooperation Program of the Chinese Academy of Sciences (GJHZ1214, http://www.cas.cn/, received by GZ), the National Natural Science Foundation of China (grant 41230744, http://www.nsfc.gov.cn/, received by BQ), the Key Program of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (NIGLAS2012135002, http://niglas.ac.cn/, received by GZ), and the Finnish Academy of Science (FICCA, No. 256244 and No. 256240, http://www.acadsci.fi/, received by LN and AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFFRET G, 1994, DEEP-SEA RES PT I, V41, P925, DOI 10.1016/0967-0637(94)90084-1; Bachmann Roger W., 2000, Lake and Reservoir Management, V16, P281; Bachmann RW, 1999, HYDROBIOLOGIA, V394, P219, DOI 10.1023/A:1003638329772; BENGTSSON L, 1992, HYDROBIOLOGIA, V241, P163, DOI 10.1007/BF00028639; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chen FZ, 2013, HYDROBIOLOGIA, V718, P59, DOI 10.1007/s10750-013-1603-9; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Dong B.L., 2011, THESIS NANJING I GEO; Dzialowski AR, 2008, LAKE RESERV MANAGE, V24, P313, DOI 10.1080/07438140809354841; EVANS RD, 1994, HYDROBIOLOGIA, V284, P5, DOI 10.1007/BF00005727; Gasith A., 1975, VERH INT VEREIN LIMN, V19, P116; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Hawley N, 2014, J GREAT LAKES RES, V40, P18, DOI 10.1016/j.jglr.2013.11.010; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hofmann H, 2008, INT VER THEOR ANGEW, V30, P627; Horppila J, 2003, WATER RES, V37, P4468, DOI 10.1016/S0043-1354(03)00405-6; Horppila J, 2001, FRESHWATER BIOL, V46, P1447, DOI 10.1046/j.1365-2427.2001.00765.x; Horppila J, 2013, J HYDRODYN, V25, P288, DOI 10.1016/S1001-6058(13)60365-0; Huang PS, 2009, ECOL ENG, V35, P1619, DOI 10.1016/j.ecoleng.2008.10.007; Huang Z, 1997, BIOTECHNOL B, V4, P26; James RT, 2009, HYDROBIOLOGIA, V627, P211, DOI 10.1007/s10750-009-9729-5; James WF, 2004, HYDROBIOLOGIA, V515, P193, DOI 10.1023/B:HYDR.0000027328.00153.b2; Jeppesen E, 2003, LIMNOL OCEANOGR, V48, P1913, DOI 10.4319/lo.2003.48.5.1913; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Jiang Xia, 2011, Huanjing Kexue, V32, P1285; Jin KR, 2007, J ENG MECH, V133, P899, DOI 10.1061/(ASCE)0733-9399(2007)133:8(899); Jin X., 1990, STANDARD LAKE EUTROP; Kaitaranta J, 2013, BOREAL ENVIRON RES, V18, P473; Kelderman P, 2012, AQUAT SCI, V74, P301, DOI 10.1007/s00027-011-0222-7; LAPASIN R, 1992, CARBOHYD POLYM, V17, P1, DOI 10.1016/0144-8617(92)90017-K; [李一平 LI Yipin], 2007, [水利学报, Journal of Hydraulic Engineering], V38, P558; Liu XH, 2013, J GEOPHYS RES-BIOGEO, V118, P713, DOI 10.1002/jgrg.20054; Lowe EF, 2001, HYDROBIOLOGIA, V448, P11, DOI 10.1023/A:1017541010768; [罗潋葱 Luo Liancong], 2004, [海洋与湖沼, Oceanologia et Limnologia Sinica], V35, P491; Ma R. H, 2010, REMOTE SENSING WATER; Ma RH, 2008, SENSORS-BASEL, V8, P3988, DOI 10.3390/s8063988; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; McMullen KY, 2015, GEO-MAR LETT, V35, P135, DOI 10.1007/s00367-014-0392-0; Niemisto J, 2008, LIMNOL OCEANOGR, V53, P2407, DOI 10.4319/lo.2008.53.6.2407; Nurminen L, 2009, WATER RES, V43, P3217, DOI 10.1016/j.watres.2009.04.041; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Penning WE, 2013, HYDROBIOLOGIA, V710, P279, DOI 10.1007/s10750-012-1026-z; Qian J.L., 1990, SOILS, V22, P258; Qian J, 2011, J HYDRODYN, V23, P826, DOI 10.1016/S1001-6058(10)60182-5; Qin BQ, 2006, SCI CHINA SER D, V49, P38, DOI 10.1007/s11430-006-8104-x; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Qin BQ, 2004, CHINESE SCI BULL, V49, P54, DOI 10.1360/03wd0174; Qin BQ, 2008, LAKE TAIHU; Reardon KE, 2014, WATER RESOUR RES, V50, P8826, DOI 10.1002/2014WR015396; Schallenberg M, 2004, FRESHWATER BIOL, V49, P143, DOI 10.1046/j.1365-2426.2003.01172.x; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SONDERGAARD M, 1992, HYDROBIOLOGIA, V228, P91, DOI 10.1007/BF00006480; Tammeorg O, 2013, AQUAT SCI, V75, P559, DOI 10.1007/s00027-013-0300-0; Wu TF, 2013, INT J SEDIMENT RES, V28, P139, DOI 10.1016/S1001-6279(13)60026-8; Zhang W, 1984, STUDY METHODS FOREST; Zhang YL., 2003, J OCEANOL LIMNOL, V02, P30; Zhang YL, 2006, SCI CHINA SER D, V49, P114, DOI 10.1007/s11430-006-8111-y; Zhang YL, 2006, SCI CHINA SER D, V49, P431, DOI 10.1007/s11430-006-0431-4; [张运林 Zhang Yunlin], 2004, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V13, P266; Zhang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098055; Zhu MY, 2013, ENVIRON POLLUT, V173, P216, DOI 10.1016/j.envpol.2012.10.016	61	38	56	10	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127915	10.1371/journal.pone.0127915	http://dx.doi.org/10.1371/journal.pone.0127915			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030094	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900089
J	Coghlan, BA; Goldizen, AW; Thomson, VA; Seddon, JM				Coghlan, Brett A.; Goldizen, Anne W.; Thomson, Vicki A.; Seddon, Jennifer M.			Phylogeography of Eastern Grey Kangaroos, Macropus giganteus, Suggests a Mesic Refugium in Eastern Australia	PLOS ONE			English	Article							PERCHED LAKE-SEDIMENTS; MITOCHONDRIAL-DNA; RAIN-FOREST; HISTORICAL BIOGEOGRAPHY; CLIMATIC OSCILLATIONS; POPULATION-GENETICS; STATISTICAL TESTS; CONTROL REGION; FRASER ISLAND; EVOLUTION	Phylogeographic studies around the world have identified refugia where fauna were able to persist during unsuitable climatic periods, particularly during times of glaciation. In Australia the effects of Pleistocene climate oscillations on rainforest taxa have been well studied but less is known about the effects on mesic-habitat fauna, such as the eastern grey kangaroo (Macropus giganteus). The eastern grey kangaroo is a large mammal that is common and widespread throughout eastern Australia, preferring dry mesic habitat, rather than rainforest. As pollen evidence suggests that the central-eastern part of Australia (southeast Queensland and northern New South Wales) experienced cycles of expansion in mesic habitat with contraction in rainforests, and vice versa during glacial and interglacial periods, respectively, we hypothesise that the distribution of the eastern grey kangaroo was affected by these climate oscillations and may have contracted to mesic habitat refugia. From 375 mitochondrial DNA control region sequences from across the distribution of eastern grey kangaroos we obtained 108 unique haplotypes. Phylogenetic analysis identified two clades in Queensland, one of which is newly identified and restricted to a small coastal region in southern Queensland north of Brisbane, known as the Sunshine Coast. The relatively limited geographic range of this genetically isolated clade suggests the possibility of a mesic habitat refugium forming during rainforest expansion during wetter climate cycles. Other potential, although less likely, reasons for the genetic isolation of the highly distinct clade include geographic barriers, separate northward expansions, and strong local adaptation.	[Coghlan, Brett A.; Goldizen, Anne W.; Thomson, Vicki A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Seddon, Jennifer M.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	University of Queensland; University of Queensland	Coghlan, BA (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	brett.coghlan@uqconnect.edu.au	Goldizen, Anne/G-7366-2012; Thomson, Vicki A./B-9971-2014; Seddon, Jennifer/AAM-3827-2021; Seddon, Jennifer/A-1402-2010	Goldizen, Anne/0000-0003-0101-4108; Thomson, Vicki A./0000-0001-8368-9664; Seddon, Jennifer/0000-0003-3789-6878; Seddon, Jennifer/0000-0003-3789-6878	National Geograhic Society [8055-06]; Australian Research Council [DP120102693]	National Geograhic Society; Australian Research Council(Australian Research Council)	This study was funded by a grants from the National Geograhic Society (grant 8055-06; http://www.nationalgeographic.com/explorers/grantsprograms/cre/) to AWG and from the Australian Research Council (grant DP120102693; http://arc.gov.au/) to AWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Chapple DG, 2011, J BIOGEOGR, V38, P1761, DOI 10.1111/j.1365-2699.2011.02531.x; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Clegg SM, 1998, MOL ECOL, V7, P679, DOI 10.1046/j.1365-294x.1998.00376.x; Commonwealth of Australia, 2011, KANGAROO POPULATION; Commonwealth of Australia (Geoscience Australia), 2006, STATES INCLUDING COA; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp M, 1999, FLORA AUSTR, V1, P321; Davis NE, 2008, WILDLIFE RES, V35, P684, DOI 10.1071/WR08042; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Fumagalli L, 1997, MOL ECOL, V6, P1199, DOI 10.1046/j.1365-294X.1997.00298.x; Gallagher SJ, 2003, PALAEOGEOGR PALAEOCL, V193, P349, DOI 10.1016/S0031-0182(03)00231-1; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILL GJE, 1981, AUST WILDLIFE RES, V8, P245; Honnen AC, 2010, BIOL J LINN SOC, V99, P727, DOI 10.1111/j.1095-8312.2010.01373.x; JARMAN PJ, 1983, AUST WILDLIFE RES, V10, P33; Lee KE, 2010, CONSERV GENET, V11, P2091, DOI 10.1007/s10592-009-9987-9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longmore ME, 1999, QUATERN INT, V57-8, P35, DOI 10.1016/S1040-6182(98)00048-2; Longmore ME, 1997, AUST J BOT, V45, P507, DOI 10.1071/BT96109; Malekian M, 2010, MOL PHYLOGENET EVOL, V54, P122, DOI 10.1016/j.ympev.2009.07.026; McGrath R, 1998, AUST GEOGR, V29, P205, DOI 10.1080/00049189808703215; McGuigan K, 1998, MOL ECOL, V7, P175, DOI 10.1046/j.1365-294x.1998.00329.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Nauman R, 2010, QUEENSLAND AUSTRALIA; Neaves LE, 2009, MOL ECOL, V18, P3363, DOI 10.1111/j.1365-294X.2009.04293.x; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Pavlova A, 2010, CONSERV GENET, V11, P2393, DOI 10.1007/s10592-010-0125-5; Piggott MP, 2003, AUST J ZOOL, V51, P341, DOI 10.1071/ZO03012; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; POOLE W E, 1982, Mammalian Species, P1, DOI 10.2307/3504005; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, FIGTREE 1 3 1; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schauble CS, 2001, BIOL J LINN SOC, V74, P157, DOI 10.1006/bijl.2001.0562; Schneider C, 1999, P ROY SOC B-BIOL SCI, V266, P191, DOI 10.1098/rspb.1999.0621; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Sniderman JMK, 2011, J BIOGEOGR, V38, P1456, DOI 10.1111/j.1365-2699.2011.02518.x; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner Z, 2001, STATUS AND MANAGEMEN; TAYLOR RJ, 1983, AUST WILDLIFE RES, V10, P203; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Zenger KR, 2003, HEREDITY, V91, P153, DOI 10.1038/sj.hdy.6800293	55	4	4	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128160	10.1371/journal.pone.0128160	http://dx.doi.org/10.1371/journal.pone.0128160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024370	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400073
J	Li, X; Du, WJ; Ma, FX; Feng, XM; Bayard, F; Han, ZC				Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Bayard, Francis; Han, Zhong Chao			High Concentrations of TNF-alpha Induce Cell Death during Interactions between Human Umbilical Cord Mesenchymal Stem Cells and Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							STROMAL CELLS; IL-6; INTERLEUKIN-6; MACROPHAGES; IL-1-BETA; PROMOTE	Human umbilical cord mesenchymal stromal cells (hUC-MSCs) are currently being used as novel therapeutic agents in numerous clinical trials. Previous works have shown that hUC-MSCs possess profound immunomodulatory capacities through IL-1 stimulation produced by peripheral blood mononuclear cells (PBMCs), their main cellular partner in most pathophysiological and therapeutic situations. The present study was designed to explore the role of TNF-alpha in these interactions. In these experiments, we demonstrated that TNF-alpha originated from PBMCs under the influence of IL-1. We also showed that TNF-alpha acted differently depending upon the concentrations reached. At low concentrations it clearly contributed to IL-6 and monocyte chemotactic protein 1 (MCP-1) production. At high concentrations, used alone or in association with the TNF-related apoptosis-inducing ligand, TNF-alpha also stimulated hUC-MSC IL-6 but, more intensely, MCP-1 production. This stimulation was associated but independent of apoptosis induction in a process involving Inhibitor of Apoptosis Proteins. Interferon gamma (IFN-gamma), tested to stimulate PBMC and tissue activation, amplified IL-6 and MCP-1 production and cell death by, apparently, a different process involving necrosis. Our findings bring new insights into the complex interactions between hUC-MSCs and PBMCs, involving cytokines, chemokines and cell death, and are of fundamental importance for tissue homeostasis.	[Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Han, Zhong Chao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Han, Zhong Chao] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin, Peoples R China; [Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Han, Zhong Chao] Peking Union Med Coll, Tianjin, Peoples R China; [Bayard, Francis] Fac Med Toulouse, INSERM, Inst Med Mol Rangueil, F-31073 Toulouse, France; [Han, Zhong Chao] TEDA, AmCellGene Co Ltd, Natl Engn Res Ctr Cell Prod, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bayard, F (corresponding author), Fac Med Toulouse, INSERM, Inst Med Mol Rangueil, U317, F-31073 Toulouse, France.	bayardchine@yahoo.fr; hanzhongchao@hotmail.com	Han, Zhong Chao/D-7157-2016	Han, Zhong Chao/0000-0002-2687-7682; Du, Wenjing/0000-0002-4096-1549	National Basic Research Program of China (973 program of China) [2011CB964802, 2013CB966904]; National Natural Science Foundation of China [81330015]	National Basic Research Program of China (973 program of China)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 program of China), Grant no. 2011CB964802 and Grant no. 2013CB966904; ZCH and XMF received the funding, respectively; and the National Natural Science Foundation of China, Grant no. 81330015; ZCH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Benedict CA, 2012, J EXP MED, V209, P1903, DOI 10.1084/jem.20122235; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Flygare JA, 2012, J MED CHEM, V55, P4101, DOI 10.1021/jm300060k; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Titmarsh DM, 2014, STEM CELL TRANSL MED, V3, P81, DOI 10.5966/sctm.2013-0118; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wang D, 2012, CELL PHYSIOL BIOCHEM, V29, P551, DOI 10.1159/000338509; Wang D, 2010, EXP CELL RES, V316, P2414, DOI 10.1016/j.yexcr.2010.04.018	24	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128647	10.1371/journal.pone.0128647	http://dx.doi.org/10.1371/journal.pone.0128647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023782	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400100
J	Mutabazi, V; Bitega, JP; Ngeruka, LM; Karema, C; Binagwaho, A				Mutabazi, Vincent; Bitega, Jean Paul; Ngeruka, Leon Muyenzi; Karema, Corine; Binagwaho, Agnes			Assessing Odor Level when Using PrePex for HIV Prevention: A Prospective, Randomized, Open Label, Blinded Assessor Trial to Improve Uptake of Male Circumcision	PLOS ONE			English	Article							MEN	The PrePex is a WHO-prequalified medical device for adult male circumcision for HIV prevention. The Government of Rwanda was the first country to implement the PrePex device and acts as the leading center of excellence providing training and formal guidelines. As part of the Government's efforts to improve PrePex implementation, it made efforts to improve the psychological acceptability of device by men, thus increasing uptake with VMMC in sub-Saharan Africa. Some men who underwent the PrePex procedure complained of foreskin odor while wearing the PrePex 3-7 days after it was placed. This complaint was identified as potential risk for uptake of the device. Researchers from Rwanda assumed there is a possible relation between the level of foreskin odor and patient foreskin hygiene technique. The Government of Rwanda decided to investigate those assumptions in a scientific way and conduct a trial to test different hygiene-cleaning methods in order to increase the acceptability of PrePex and mitigate the odor concern. The main objective of the trial was to compare odor levels between three arms, having identical personal hygiene but different foreskin hygiene techniques using either clear water with soap during a daily shower, soapy water using a syringe, or chlorhexidine using a syringe. One hundred and one subjects were enrolled to the trial and randomly allocated into three trial arms. Using chlorhexidine solution daily almost completely eliminated odor, and was statistically significant more effective that the other two arms. The trial results suggest that odor from the foreskin, while wearing the PrePex device, could be related to the growth of anaerobic bacteria, which can be prevented by a chlorhexidine cleaning method. This finding can be used to increase acceptability by men when considering PrePex as one of the leading methods for HIV prevention in VMMC programs.	[Mutabazi, Vincent; Karema, Corine; Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Bitega, Jean Paul] Mil Med Insurance, Kigali, Rwanda; [Ngeruka, Leon Muyenzi] Rwanda Mil Hosp, Kigali, Rwanda		Mutabazi, V (corresponding author), Minist Hlth, Kigali, Rwanda.	mutabazivincent@yahoo.com			Government of Rwanda; Circ MedTech, Ltd (Tortola, British Virgin Islands)	Government of Rwanda; Circ MedTech, Ltd (Tortola, British Virgin Islands)	Sources of support: national study sponsored by the Government of Rwanda; Prepex devices and Nasal Ranger provided by Circ MedTech, Ltd (Tortola, British Virgin Islands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Krampe A, 2007, COMPUT STAT DATA AN, V51, P4124, DOI 10.1016/j.csda.2007.01.021; McGinley MA, 2004, WATER SCI TECHNOL, V50, P75, DOI 10.2166/wst.2004.0225; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; St. Croix Sensory Inc, 2008, NAS RANG FIELD OLF O; UNAIDS, 2013, UNAIDS WELC PREQ WHO; UNAIDS, 2011, INT PARTN CALL ACC A; World Health Organization, VOL MED MAL CIRC HIV	11	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126664	10.1371/journal.pone.0126664	http://dx.doi.org/10.1371/journal.pone.0126664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023772	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400016
J	State, B; Park, P; Weber, I; Macy, M				State, Bogdan; Park, Patrick; Weber, Ingmar; Macy, Michael			The Mesh of Civilizations in the Global Network of Digital Communication	PLOS ONE			English	Article							CLASH; TRADE	Conflicts fueled by popular religious mobilization have rekindled the controversy surrounding Samuel Huntington's theory of changing international alignments in the Post-Cold War era. In The Clash of Civilizations, Huntington challenged Fukuyama's "end of history" thesis that liberal democracy had emerged victorious out of Post-war ideological and economic rivalries. Based on a top-down analysis of the alignments of nation states, Huntington famously concluded that the axes of international geo-political conflicts had reverted to the ancient cultural divisions that had characterized most of human history. Until recently, however, the debate has had to rely more on polemics than empirical evidence. Moreover, Huntington made this prediction in 1993, before social media connected the world's population. Do digital communications attenuate or echo the cultural, religious, and ethnic "fault lines" posited by Huntington prior to the global diffusion of social media? We revisit Huntington's thesis using hundreds of millions of anonymized email and Twitter communications among tens of millions of worldwide users to map the global alignment of interpersonal relations. Contrary to the supposedly borderless world of cyberspace, a bottom-up analysis confirms the persistence of the eight culturally differentiated civilizations posited by Huntington, with the divisions corresponding to differences in language, religion, economic development, and spatial distance.	[State, Bogdan] Stanford Univ, Stanford, CA 94305 USA; [Park, Patrick; Macy, Michael] Cornell Univ, Ithaca, NY 14850 USA; [Weber, Ingmar] Qatar Comp Res Inst, Doha, Qatar	Stanford University; Cornell University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute	Macy, M (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.	m.macy@cornell.edu	Park, Patrick/K-5021-2019; Weber, Ingmar/AAE-6909-2020	Park, Patrick/0000-0003-3075-4519; Weber, Ingmar/0000-0003-4169-2579	U.S. National Science Foundation [SES 1226483, IIS 0910664]; National Research Foundation of Korea [NRF-2013S1A3A2055285]; Joan Butler Ford Stanford Graduate Fellowship; Amherst College Kellogg Fellowship; Google; Direct For Computer & Info Scie & Enginr [0910664] Funding Source: National Science Foundation; Direct For Social, Behav & Economic Scie [1226483] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); National Research Foundation of Korea(National Research Foundation of Korea); Joan Butler Ford Stanford Graduate Fellowship; Amherst College Kellogg Fellowship; Google(Google Incorporated); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	MM was supported by the U.S. National Science Foundation SES 1226483 and IIS 0910664, Google, and the National Research Foundation of Korea NRF-2013S1A3A2055285. BS was supported by the Joan Butler Ford Stanford Graduate Fellowship and by the Amherst College Kellogg Fellowship. PP was supported by the U.S. National Science Foundation SES 1226483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, P 6 INT AAAI C WEB S; Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI [10.18637/jss.v024.i06, DOI 10.18637/JSS.V024.I06, 10.18637/jss.v024.i02]; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dekker D, 2003, MULTICOLLINEARITY RO; Dekker D, 2007, PSYCHOMETRIKA, V72, P563, DOI 10.1007/s11336-007-9016-1; Festinger L, 1959, SOCIAL PRESSURES INF; Fox J., 2001, ETHNICITIES, V1, P295, DOI DOI 10.1177/146879680100100302; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fukuyama F., 1992, END HIST LAST MAN; Hagerstrand T., 1967, INNOVATION DIFFUSION; HEDSTROM P, 1994, AM J SOCIOL, V99, P1157, DOI 10.1086/230408; HUNTINGTON SP, 1993, FOREIGN AFF, V72, P22, DOI 10.2307/20045621; Johnson TM, 2008, WORLD RELIG DATABASE; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; Neumayer E, 2011, APPL GEOGR, V31, P901, DOI 10.1016/j.apgeog.2011.01.009; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reinhardt J, 2006, PHYS REV E, V74; Russett BM, 2000, J PEACE RES, V37, P583, DOI 10.1177/0022343300037005003; State Bogdan, 2013, P 6 ACM INT C WEB SE, P265, DOI DOI 10.1177/1753193412471107; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; Wallerstein I., 2006, WORLD SYSTEMS ANAL I; Weber Ingmar, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P290; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	24	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0122543	10.1371/journal.pone.0122543	http://dx.doi.org/10.1371/journal.pone.0122543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024487	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400002
J	Cattarino, L; Hermoso, V; Carwardine, J; Kennard, MJ; Linke, S				Cattarino, Lorenzo; Hermoso, Virgilio; Carwardine, Josie; Kennard, Mark J.; Linke, Simon			Multi-Action Planning for Threat Management: A Novel Approach for the Spatial Prioritization of Conservation Actions	PLOS ONE			English	Article							FRESH-WATER; MULTIPLE THREATS; CONNECTIVITY; RETURN; INVESTMENT; FRAMEWORK; TRAITS; TIME	Planning for the remediation of multiple threats is crucial to ensure the long term persistence of biodiversity. Limited conservation budgets require prioritizing which management actions to implement and where. Systematic conservation planning traditionally assumes that all the threats in priority sites are abated (fixed prioritization approach). However, abating only the threats affecting the species of conservation concerns may be more cost-effective. This requires prioritizing individual actions independently within the same site (independent prioritization approach), which has received limited attention so far. We developed an action prioritization algorithm that prioritizes multiple alternative actions within the same site. We used simulated annealing to find the combination of actions that remediate threats to species at the minimum cost. Our algorithm also accounts for the importance of selecting actions in sites connected through the river network (i.e., connectivity). We applied our algorithm to prioritize actions to address threats to freshwater fish species in the Mitchell River catchment, northern Australia. We compared how the efficiency of the independent and fixed prioritization approach varied as the importance of connectivity increased. Our independent prioritization approach delivered more efficient solutions than the fixed prioritization approach, particularly when the importance of achieving connectivity was high. By spatially prioritizing the specific actions necessary to remediate the threats affecting the target species, our approach can aid cost-effective habitat restoration and land-use planning. It is also particularly suited to solving resource allocation problems, where consideration of spatial design is important, such as prioritizing conservation efforts for highly mobile species, species facing climate change-driven range shifts, or minimizing the risk of threats spreading across different realms.	[Cattarino, Lorenzo; Hermoso, Virgilio; Kennard, Mark J.; Linke, Simon] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Hermoso, Virgilio; Kennard, Mark J.; Linke, Simon] Griffith Univ, Natl Environm Res Program Northern Australia Hub, Nathan, Qld 4111, Australia; [Carwardine, Josie] CSIRO Ecosyst Sci, Dutton Pk, Qld, Australia	Griffith University; Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cattarino, L (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia.	l.cattarino@gmail.com	Carwardine, Josie/A-5801-2011; Kennard, Mark James/C-3425-2008; Lopez, Virgilio Hermoso/H-8276-2015	Kennard, Mark James/0000-0003-4383-4999; Lopez, Virgilio Hermoso/0000-0003-3205-5033; Linke, Simon/0000-0002-1797-3947; Cattarino, Lorenzo/0000-0003-3975-550X	Australian Research Council [DP120103353, DE130100565]; Australian Government's National Environmental Research Program (NERP); Griffith University	Australian Research Council(Australian Research Council); Australian Government's National Environmental Research Program (NERP)(Australian Government); Griffith University(Griffith University)	This study was conducted with the support of funding from the Australian Research Council. The authors acknowledge the Australian Research Council (Discovery Grant No. DP120103353 to SL, MJK and JC and DECRA Grant No. DE130100565 to SL), the Australian Government's National Environmental Research Program (NERP) (SL, MJK and VH) and Griffith University (VH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, CATCHM SCAL LAND US; Adams VM, 2014, CONSERV LETT, V7, P425, DOI 10.1111/conl.12080; Auerbach NA, 2014, ECOL APPL, V24, P1357, DOI 10.1890/13-0711.1; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Billionnet A, 2013, SYST BIOL, V62, P147, DOI 10.1093/sysbio/sys081; Bond NR, 2014, DIVERS DISTRIB, V20, P931, DOI 10.1111/ddi.12213; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Chades I, 2015, CONSERV BIOL, V29, P525, DOI 10.1111/cobi.12413; ESRI, 2013, ARCGIS; Evans MC, 2011, DIVERS DISTRIB, V17, P437, DOI 10.1111/j.1472-4642.2011.00747.x; Faith DP, 1996, BIODIVERS CONSERV, V5, P417, DOI 10.1007/BF00056388; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2013, DIVERS DISTRIB, V19, P1031, DOI 10.1111/ddi.12082; Hermoso V, 2012, DIVERS DISTRIB, V18, P448, DOI 10.1111/j.1472-4642.2011.00879.x; HOF JG, 1993, FOREST SCI, V39, P816; Holzkamper A, 2007, BIOL CONSERV, V136, P117, DOI 10.1016/j.biocon.2006.11.011; Januchowski-Hartley SR, 2011, BIOL INVASIONS, V13, P1241, DOI 10.1007/s10530-011-9960-7; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Kennard MJ, 2010, TROPICAL RIVERS COAS; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Levin N, 2013, BIOL CONSERV, V158, P371, DOI 10.1016/j.biocon.2012.08.032; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A, 2011, CONSERV LETT, V4, P383, DOI 10.1111/j.1755-263X.2011.00190.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Pouzols FM, 2013, METHODS ECOL EVOL, V4, P426, DOI 10.1111/2041-210X.12040; Pressey RL, 2004, ECOL LETT, V7, P1035, DOI 10.1111/j.1461-0248.2004.00672.x; Pringle CM, 2001, ECOL APPL, V11, P981, DOI 10.1890/1051-0761(2001)011[0981:HCATMO]2.0.CO;2; Pusey Brad, 2011, P151; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Sternberg D, 2014, ECOGRAPHY, V37, P54, DOI 10.1111/j.1600-0587.2013.00362.x; Sternberg D, 2013, FRESHWATER BIOL, V58, P1767, DOI 10.1111/fwb.12166; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; van Teeffelen Astrid J.A., 2008, Biodiversity Informatics, V5, P1; van Teeffelen AJA, 2008, J APPL ECOL, V45, P1401, DOI 10.1111/j.1365-2664.2008.01514.x; Venter O, 2013, CONSERV LETT, V6, P116, DOI 10.1111/j.1755-263X.2012.00287.x; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wilson K.A., 2009, SPATIAL CONSERVATION; Wilson K, 2010, MEANJIN, V69, P20; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wilson KA, 2011, PHILOS T R SOC B, V366, P2670, DOI 10.1098/rstb.2011.0108; Wilson KA, 2011, J APPL ECOL, V48, P715, DOI 10.1111/j.1365-2664.2011.01975.x	51	28	28	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128027	10.1371/journal.pone.0128027	http://dx.doi.org/10.1371/journal.pone.0128027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020794	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300073
J	Caviezel, S; Dratva, J; Schaffner, E; Schindler, C; Endes, S; Autenrieth, CS; Wanner, M; Martin, B; de Groot, E; Gaspoz, JM; Kunzil, N; Probst-Hensch, N; Schmidt-Trucksass, A				Caviezel, Seraina; Dratva, Julia; Schaffner, Emmanuel; Schindler, Christian; Endes, Simon; Autenrieth, Christine S.; Wanner, Miriam; Martin, Brian; de Groot, Eric; Gaspoz, Jean-Michel; Kuenzil, Nino; Probst-Hensch, Nicole; Schmidt-Trucksass, Arno			Carotid Stiffness and Physical Activity in Elderly-A Short Report of the SAPALDIA 3 Cohort Study	PLOS ONE			English	Article							HABITUAL EXERCISE; ACTIVITY QUESTIONNAIRE; ARTERIAL PROPERTIES; LUNG-DISEASES; AIR-POLLUTION; SHEAR-STRESS; RISK; ATHEROSCLEROSIS; ULTRASOUND; SWISS	Introduction Regular physical activity has been shown to reduce cardiovascular disease risk in the general population. While smaller studies in specified groups (highly trained versus untrained individuals) indicate a certain dose-dependent effect of physical activity on the reduction of carotid stiffness (an indicator of subclinical vascular disease), it is unclear whether this association is present in a representative sample. Thus, we investigated this question cross-sectionally in participants from the population-based Swiss Cohort Study on Air Pollution And Lung and Heart Diseases In Adults (SAPALDIA). Methods Self-reported total, moderate and vigorous physical activity and distensibility as a measure of local arterial stiffness among 1636 participants aged 50 to 81 years without clinically manifest diseases were evaluated. Mixed regression models were used to examine associations of physical activity intensity with distensibility. Results Vigorous physical activity, but not total nor moderate physical activity, was significantly associated with increased distensibility (=reduced carotid stiffness) in univariate analyses (percent change in the geometric mean and 95% confidence interval per 1 standard deviation increment in vigorous physical activity = 2.54 (0.69; 4.43), p<0.01; in total physical activity = 1.62 (-0.22; 3.50), p = 0.08; in moderate physical activity = 0.70 (-1.12; 2.56), p = 0.45). These associations disappeared when we additionally adjusted for age. Conclusion After adjustment for the most important confounders and risk factors, we found no evidence for an association of physical activity with carotid stiffness in the general middle aged to elderly population.	[Caviezel, Seraina; Endes, Simon; Schmidt-Trucksass, Arno] Univ Basel, Dept Sport Exercise & Hlth, Div Sports & Exercise Med, Basel, Switzerland; [Caviezel, Seraina; Dratva, Julia; Schaffner, Emmanuel; Schindler, Christian; Autenrieth, Christine S.; Kuenzil, Nino; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Caviezel, Seraina; Dratva, Julia; Schaffner, Emmanuel; Schindler, Christian; Autenrieth, Christine S.; Kuenzil, Nino; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland; [Wanner, Miriam; Martin, Brian] Univ Zurich, Inst Social & Prevent Med, Phys Act & Hlth Unit, CH-8006 Zurich, Switzerland; [de Groot, Eric] Imagelabonline, Ctr Sci, Amsterdam, Netherlands; [Gaspoz, Jean-Michel] Univ Geneva, Dept Community Med & Primary Care, Univ Hosp Geneva, Geneva, Switzerland	University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich; University of Geneva	Schmidt-Trucksass, A (corresponding author), Univ Basel, Dept Sport Exercise & Hlth, Div Sports & Exercise Med, Basel, Switzerland.	arno.schmidt-trucksaess@unibas.ch	Martin, Brian W/H-3241-2012; Schmidt-Trucksäss, Arno/I-7673-2015; Kuenzli, Nino/F-7195-2014	Schmidt-Trucksäss, Arno/0000-0002-4662-3911; Kuenzli, Nino/0000-0001-8360-080X; Endes, Simon/0000-0002-2193-0114; Wanner, Miriam/0000-0003-0888-0690	Swiss National Science Foundation [33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, PMPDP3_129021/1, PMPDP3_141671/1]; Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Graubunden and Zurich; canton's Lung League of Stiftung ehemals Bundner Heilstatten; canton's Lung League of SUVA; canton's Lung League of Freiwillige Akademische Gesellschaft; canton's Lung League of UBS Wealth Foundation; canton's Lung League of Talecris Biotherapeutics GmbH; canton's Lung League of Abbott Diagnostics; canton's Lung League of European Commission 018996; canton's Lung League of Wellcome Trust [WT 084703MA]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Office for Forest, Environment and Landscape; Federal Office of Public Health; Federal Office of Roads and Transport; canton's government of Aargau; canton's government of Basel-Stadt; canton's government of Basel-Land; canton's government of Geneva; canton's government of Luzern; canton's government of Ticino; canton's government of Valais; canton's government of Zurich; Swiss Lung League; canton's Lung League of Basel Stadt/Basel Landschaft; canton's Lung League of Geneva; canton's Lung League of Ticino; canton's Lung League of Valais; canton's Lung League of Graubunden and Zurich; canton's Lung League of Stiftung ehemals Bundner Heilstatten; canton's Lung League of SUVA; canton's Lung League of Freiwillige Akademische Gesellschaft; canton's Lung League of UBS Wealth Foundation; canton's Lung League of Talecris Biotherapeutics GmbH; canton's Lung League of Abbott Diagnostics; canton's Lung League of European Commission 018996; canton's Lung League of Wellcome Trust	The Swiss Study on Air Pollution and Lung and Heart Diseases In Adults (SAPALDIA) was supported by the Swiss National Science Foundation (grants 33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099, PMPDP3_129021/1, and PMPDP3_141671/1), the Federal Office for Forest, Environment and Landscape, the Federal Office of Public Health, the Federal Office of Roads and Transport, and the canton's government of Aargau, Basel-Stadt, Basel-Land, Geneva, Luzern, Ticino, Valais, and Zurich. Additional funding came from the Swiss Lung League, the canton's Lung League of Basel Stadt/Basel Landschaft, Geneva, Ticino, Valais, Graubunden and Zurich, Stiftung ehemals Bundner Heilstatten, SUVA, Freiwillige Akademische Gesellschaft, UBS Wealth Foundation, Talecris Biotherapeutics GmbH, Abbott Diagnostics, European Commission 018996 (GABRIEL), and Wellcome Trust WT 084703MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Adji A, 2011, AM J HYPERTENS, V24, P5, DOI 10.1038/ajh.2010.192; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2005, GUID DAT PROC AN; Caviezel S, 2014, ATHEROSCLEROSIS, V235, P576, DOI 10.1016/j.atherosclerosis.2014.05.963; Caviezel S, 2013, ATHEROSCLEROSIS, V231, P448, DOI 10.1016/j.atherosclerosis.2013.10.010; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Cook JN, 2006, AM J PHYSIOL-HEART C, V290, pH1596, DOI 10.1152/ajpheart.01054.2005; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dabagh M, 2008, MED BIOL ENG COMPUT, V46, P649, DOI 10.1007/s11517-008-0338-7; Federal Office of Sport FOSPO Federal Office of Public Health FOPH Health Promotion Switzerland bfu-Swiss Council for Accident Prevention Swiss Accident Insurance Fund (Suva) Health and Physical Activity Network Switzerland, 2013, HLTH ENH PHYS ACT CO; Hambrecht R, 1998, CIRCULATION, V98, P2709, DOI 10.1161/01.CIR.98.24.2709; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; McDonnell BJ, 2013, AM J HYPERTENS, V26, P334, DOI 10.1093/ajh/hps055; Monahan KD, 2001, CIRCULATION, V104, P1627, DOI 10.1161/hc3901.096670; Nilsson PM, 2009, HYPERTENSION, V54, P3, DOI 10.1161/HYPERTENSIONAHA.109.129114; Nualnim N, 2011, AM J CARDIOL, V107, P783, DOI 10.1016/j.amjcard.2010.10.062; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schmidt-Trucksass A, 2000, J APPL PHYSIOL, V89, P1956, DOI 10.1152/jappl.2000.89.5.1956; Schmidt-Trucksass A, 1999, ATHEROSCLEROSIS, V145, P107, DOI 10.1016/S0021-9150(99)00020-9; Schmitz KH, 2001, MED SCI SPORT EXER, V33, P2065, DOI 10.1097/00005768-200112000-00014; Sugawara J, 2006, AM J HYPERTENS, V19, P1032, DOI 10.1016/j.amjhyper.2006.03.008; Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896; Tanaka H, 2000, CIRCULATION, V102, P1270, DOI 10.1161/01.CIR.102.11.1270; Teynor A, 2012, ULTRASOUND MED BIOL, V38, P1440, DOI 10.1016/j.ultrasmedbio.2012.03.015; Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3; van de Laar RJ, 2010, HYPERTENSION, V55, P33, DOI 10.1161/HYPERTENSIONAHA.109.138289; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128991	10.1371/journal.pone.0128991	http://dx.doi.org/10.1371/journal.pone.0128991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035590	Green Accepted, Green Published, gold			2022-12-27	WOS:000355699100063
J	Sheng, J; Yang, YP; Ma, YX; Yang, BJ; Zhang, YX; Kang, SY; Zhou, T; Hong, SD; Qin, T; Hu, ZH; Fang, WF; Huang, Y; Zhang, L				Sheng, Jin; Yang, Yunpeng; Ma, Yuxiang; Yang, Bijun; Zhang, Yaxiong; Kang, Shiyang; Zhou, Ting; Hong, Shaodong; Qin, Tao; Hu, Zhihuang; Fang, Wenfeng; Huang, Yan; Zhang, Li			The Efficacy of Combining Antiangiogenic Agents with Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer Who Failed First-Line Chemotherapy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PHASE-III TRIAL; ENDOTHELIAL PROGENITOR CELLS; PLATINUM-BASED CHEMOTHERAPY; VANDETANIB PLUS DOCETAXEL; DOUBLE-BLIND; 2ND-LINE TREATMENT; BEVACIZUMAB; ERLOTINIB; PLACEBO; CARBOPLATIN	Background The clinical outcomes of patients with NSCLC who progressed after first-line treatments remain poor. The purpose of this study was to assess the advantage of antiangiogenic therapy plus standard treatment versus standard treatment alone for this population of patients. Methods We conducted a rigorous search using electronic databases for eligible studies reporting antiangiogenic therapy combined with standard second-line chemotherapy versus standard second-line treatment for patient who progressed after front-line treatment. Pooled risk ratio and 95% confidence intervals were calculated using proper statistical method. Predefined subgroup analyses were conducted to identify the potential proper patients. Results Thirteen phase II/III RCTs which involved a total of 8358 participants were included. Overall, there was significant improvement in OS (HR 0.94, 95% CI: 0.89-0.99, p = 0.03), PFS (HR 0.80, 95% CI: 0.76-0.84, p < 0.00001), ORR (RR 1.75, 95% CI: 1.55-1.98, p < 0.00001) and DCR (RR 1.23, 95% CI: 1.18-1.28, p < 0.00001) in the group with antiangiogenic therapy plus standard treatment versus the group with standard treatment alone. Subgroup analysis showed that OS benefit was presented only in patients treated with docetaxel plus antiangiogenic agents (HR 0.92, 95% CI: 0.86-0.99, p = 0.02) and patients with non-squamous NSCLC (HR for OS 0.92, 95% CI: 0.86-0.99, p = 0.02). Conclusions This study revealed that the addition of antiangiogenic agents to the standard treatments could provide clinical benefit to NSCLC patients who failed their first-line therapy. Furthermore, proper selection of the combined standard cytotoxic agent, as well as the patient population by tumor histology, is warranted for future studies and clinical application of antiangiogenic therapy.	[Sheng, Jin; Yang, Yunpeng; Ma, Yuxiang; Zhou, Ting; Hong, Shaodong; Qin, Tao; Hu, Zhihuang; Fang, Wenfeng; Huang, Yan; Zhang, Li] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sheng, Jin; Yang, Yunpeng; Ma, Yuxiang; Zhou, Ting; Hong, Shaodong; Qin, Tao; Hu, Zhihuang; Fang, Wenfeng; Huang, Yan; Zhang, Li] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Sheng, Jin; Yang, Yunpeng; Ma, Yuxiang; Zhou, Ting; Hong, Shaodong; Qin, Tao; Hu, Zhihuang; Fang, Wenfeng; Huang, Yan; Zhang, Li] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Yang, Bijun; Zhang, Yaxiong; Kang, Shiyang] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Zhang, L (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.	zhangli6@mail.sysu.edu.cn			National High Technology Research and Development Program of China [2012AA02A502]; Innovative drug RD center [2013ZX09401003-002]; National Natural Science Funds of China [81372502]; Wu Jieping Medical Foundation Project [320.6750.131]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Innovative drug RD center; National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Wu Jieping Medical Foundation Project	1. National High Technology Research and Development Program of China (Grant No. 2012AA02A502). 2. Innovative drug R&D center based on real-time high-throughput cell-based screening platform and large capacity compound library (Grant No. 2013ZX09401003-002). 3. National Natural Science Funds of China (Grant No. 81372502). 4. Wu Jieping Medical Foundation Project (Grant No. 320.6750.131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108048; Bertolini F, 2003, CANCER RES, V63, P4342; Brauer MJ, 2013, CLIN CANCER RES, V19, P3681, DOI 10.1158/1078-0432.CCR-12-3635; Lima ABC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022681; de Boer RH, 2011, J CLIN ONCOL, V29, P1067, DOI 10.1200/JCO.2010.29.5717; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Groen HJM, 2013, ANN ONCOL, V24, P2382, DOI 10.1093/annonc/mdt212; Hanna NH, 2013, J CLIN ONCOL, V31; Heist RS, 2014, J THORAC ONCOL, V9, P214, DOI 10.1097/JTO.0000000000000071; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Herbst RS, 2010, LANCET ONCOL, V11, P619, DOI 10.1016/S1470-2045(10)70132-7; Heymach JV, 2007, J CLIN ONCOL, V25, P4270, DOI 10.1200/JCO.2006.10.5122; Hotta K, 2007, J THORAC ONCOL, V2, P402, DOI 10.1097/01.JTO.0000268673.95119.c7; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Leighl NB, 2012, CURR ONCOL, V19, pS52, DOI 10.3747/co.19.1114; Li TH, 2013, J CLIN ONCOL, V31, P1039, DOI 10.1200/JCO.2012.45.3753; Mok T, 2014, J THORAC ONCOL, V9, P848, DOI 10.1097/JTO.0000000000000160; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Ramlau R, 2012, J CLIN ONCOL, V30, P3640, DOI 10.1200/JCO.2012.42.6932; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993; Scagliotti GV, 2009, J THORAC ONCOL, V4, P1568, DOI 10.1097/JTO.0b013e3181c06980; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678	34	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127306	10.1371/journal.pone.0127306	http://dx.doi.org/10.1371/journal.pone.0127306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034985	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100011
J	Elias, JJ; Lacetera, N; Macis, M				Elias, Julio J.; Lacetera, Nicola; Macis, Mario			Markets and Morals: An Experimental Survey Study	PLOS ONE			English	Article							PROSTITUTION; INCENTIVES; ATTITUDES; DONATION; PAYMENT; KIDNEYS	Most societies prohibit some market transactions based on moral concerns, even when the exchanges would benefit the parties involved and would not create negative externalities. A prominent example is given by payments for human organs for transplantation, banned virtually everywhere despite long waiting lists and many deaths of patients who cannot find a donor. Recent research, however, has shown that individuals significantly increase their stated support for a regulated market for human organs when provided with information about the organ shortage and the potential beneficial effects a price mechanism. In this study we focused on payments for human organs and on another "repugnant" transaction, indoor prostitution, to address two questions: (A) Does providing general information on the welfare properties of prices and markets modify attitudes toward repugnant trades? (B) Does additional knowledge on the benefits of a price mechanism in a specific context affect attitudes toward price-based transactions in another context? By answering these questions, we can assess whether eliciting a market-oriented approach may lead to a relaxation of moral opposition to markets, and whether there is a cross-effect of information, in particular for morally controversial activities that, although different, share a reference to the "commercialization" of the human body. Relying on an online survey experiment with 5,324 U.S. residents, we found no effect of general information about market efficiency, consistent with morally controversial markets being accepted only when they are seen as a solution to a specific problem. We also found some cross-effects of information about a transaction on the acceptance of the other; however, the responses were mediated by the gender and (to a lesser extent) religiosity of the respondent-in particular, women exposed to information about legalizing prostitution reduced their stated support for regulated organ payments. We relate these findings to prior research and discuss implications for public policy.	[Elias, Julio J.] Univ CEMA, Buenos Aires, DF, Argentina; [Lacetera, Nicola] Univ Toronto, Inst Management & Innovat, Mississauga, ON L5L 1C6, Canada; [Macis, Mario] Johns Hopkins Univ, Baltimore, MD 21202 USA	University of Toronto; University Toronto Mississauga; Johns Hopkins University	Elias, JJ (corresponding author), Univ CEMA, Av Cordoba 374,C1054AAP, Buenos Aires, DF, Argentina.	je49@ucema.edu.ar; nicola.lacetera@utoronto.ca; mmacis@jhu.edu	Macis, Mario/H-4214-2013	Macis, Mario/0000-0001-6635-2752; Lacetera, Nicola/0000-0002-3191-8792	Research and Scholarly Activity Fund of University of Toronto	Research and Scholarly Activity Fund of University of Toronto	Funding came from the Research and Scholarly Activity Fund of the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLOBE MAIL; [Anonymous], 2014, NY TIMES; Arrow K. J., 1951, SOCIAL CHOICE INDIVI; BASOW SA, 1990, PSYCHOL WOMEN QUART, V14, P135, DOI 10.1111/j.1471-6402.1990.tb00009.x; Becker GS, 2007, J ECON PERSPECT, V21, P3, DOI 10.1257/jep.21.3.3; Becker GS, 2006, J POLIT ECON, V114, P38, DOI 10.1086/498918; Brehman BR, 2010, THESIS U NEVADA; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Coffman Katherine B., 2013, 19508 NBER; Cotton A, 2002, J APPL SOC PSYCHOL, V32, P1790, DOI 10.1111/j.1559-1816.2002.tb00259.x; Cunningham S., 2014, 20281 NBER; Delmonico FL, 2002, NEW ENGL J MED, V346, P2002, DOI 10.1056/NEJMsb013216; Elias JJ, 2015, AM EC REV P IN PRESS; Falk A, 2013, SCIENCE, V340, P707, DOI 10.1126/science.1231566; Friedman M, 1962, CAPITALISM FREEDOM, DOI DOI 10.2307/825316; Guiso L, 2006, J ECON PERSPECT, V20, P23, DOI 10.1257/jep.20.2.23; Hayek FA, 1945, AM ECON REV, V35, P519; HILL JL, 1994, CORNELL LAW REV, V79, P631; Jakobsson N, 2011, FEM ECON, V17, P31, DOI 10.1080/13545701.2010.541863; Kaplow L, 2007, J POLIT ECON, V115, P494, DOI 10.1086/519927; Kass L.R., 2002, LFE LIBERTY DEFENSE; Knight F. H., 1933, EC ORG; Leider S, 2010, AM J TRANSPLANT, V10, P1221, DOI 10.1111/j.1600-6143.2010.03019.x; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Matas A, 2012, AM J TRANSPLANT, V12, P1957, DOI 10.1111/j.1600-6143.2012.04117.x; Matas AJ, 2004, AM J TRANSPLANT, V4, P216, DOI 10.1046/j.1600-6143.2003.00290.x; Miller J.D., 1984, THESIS G WASHINGTON; Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017; Outshoorn J, 2004, POLITICS PROSTITUTIO, P1; Roth AE, 2004, Q J ECON, V119, P457, DOI 10.1162/0033553041382157; Roth AE, 2007, J ECON PERSPECT, V21, P37, DOI 10.1257/jep.21.3.37; Sandel M.J, 2012, WHAT MONEY CANT BUY; Satel S, 2008, ALTRUISM ISNT ENOUGH; Shrage L., 2007, STANFORD ENCY PHILOS; Smith A., 1776, INQUIRY NATURE CAUSE; Zelizer Viviana, 1979, MORALS MARKETS DEV L	36	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127069	10.1371/journal.pone.0127069	http://dx.doi.org/10.1371/journal.pone.0127069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030927	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900039
J	Gao, X; Chen, JJ; Tong, ZK; Yang, GD; Yao, YA; Xu, F; Zhou, JY				Gao, Xuan; Chen, Junjun; Tong, Zhongkai; Yang, Guangdie; Yao, Yinan; Xu, Fei; Zhou, Jianying			Interleukin-10 Promoter Gene Polymorphisms and Susceptibility to Tuberculosis: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PULMONARY TUBERCULOSIS; HOST SUSCEPTIBILITY; CYTOKINE PRODUCTION; INTERFERON-GAMMA; CANDIDATE GENE; ALPHA; PHENOTYPES; AFRICANS; ASTHMA	Objective As an update to other recent meta-analyses, the purpose of this study was to explore whether interleukin-10 (IL-10) polymorphisms and their haplotypes contribute to tuberculosis (TB) susceptibility. Methods We searched for published case-control studies examining IL-10 polymorphisms and TB in PubMed, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), Wanfang databases and the Chinese National Knowledge Infrastructure (CNKI). Odds ratios (ORs) with 95% confidence intervals (CIs) were used to calculate the strengths of the associations. Results A total of 28 studies comprising 8,242 TB patients and 9,666 controls were included in the present study. There were no significant associations between the -1082G/A, -819C/T, and -592A/C polymorphisms and TB in the pooled samples. Subgroup analyses revealed that the -819T allele was associated with an increased TB risk in Asians in all genetic models (T vs. C: OR=1.17, 95% CI=1.05-1.29, P=0.003; TT vs. CC: OR=1.37, 95% CI=1.09-1.72, P=0.006; CT+TT vs. CC: OR=1.33, 95% CI=1.09-1.63, P=0.006; TT vs. CT+CC: OR=1.17, 95% CI=1.02-1.35, P=0.03) and that the -592A/C polymorphism was significantly associated with TB in Europeans under two genetic models (A vs. C: OR=0.77, 95% CI=0.60-0.98, P=0.03; AA vs. CC: OR=0.53, 95% CI=0.30-0.95, P=0.03). Furthermore, the GCC IL-10 promoter haplotype was associated with an increased risk of TB (GCC vs. others: P=1.42, 95% CI=1.02-1.97, P=0.04). Subgroup analyses based on ethnicity revealed that the GCC haplotype was associated with a higher risk of TB in Europeans, whereas the ACC haplotype was associated with a lower TB risk in both Asians and Europeans. Conclusions This meta-analysis suggests that the IL-10-819T/C polymorphism is associated with the risk of TB in Asians and that the IL-10-592A/C polymorphism may be a risk factor for TB in Europeans. Furthermore, these data indicate that IL-10 promoter haplotypes play a vital role in the susceptibility to or protection against the development of TB.	[Gao, Xuan; Chen, Junjun; Tong, Zhongkai; Yang, Guangdie; Yao, Yinan; Xu, Fei; Zhou, Jianying] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Resp Dis, Hangzhou, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn			National Natural Science Foundation of China [81170038, 81300009]; Natural Science Foundation for the Youth of Zhejiang Province, China [Q13H010001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for the Youth of Zhejiang Province, China	This research is funded by grants from the National Natural Science Foundation of China (81170038&81300009), http://www.nsfc.gov.cn/, and by a grant from the Natural Science Foundation for the Youth of Zhejiang Province, China (Q13H010001), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgunes A, 2011, INDIAN J MED MICROBI, V29, P28, DOI 10.4103/0255-0857.76520; Amirzargar AA, 2006, EUR CYTOKINE NETW, V17, P84; Ates O, 2008, J CLIN IMMUNOL, V28, P232, DOI 10.1007/s10875-007-9155-2; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Bellamy R, 2000, CLIN SCI, V98, P245, DOI 10.1042/CS19990228; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Bellamy R, 2006, MICROBES INFECT, V8, P1119, DOI 10.1016/j.micinf.2005.10.025; Ben-Selma W, 2011, MICROBES INFECT, V13, P837, DOI 10.1016/j.micinf.2011.04.009; Bloom BR, 1998, NEW ENGL J MED, V338, P677, DOI 10.1056/NEJM199803053381008; Chatterjee R, 2005, CLIN EXP ALLERGY, V35, P914, DOI 10.1111/j.1365-2222.2005.02273.x; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Figueiredo JFD, 2008, BRAZ J INFECT DIS, V12, P278, DOI 10.1590/S1413-86702008000400004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Garcia-Elorriaga G, 2013, ASIAN PAC J TROP MED, V6, P505, DOI 10.1016/S1995-7645(13)60086-3; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffmann SC, 2001, TRANSPLANTATION, V72, P1444, DOI 10.1097/00007890-200110270-00019; Hyun MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053758; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Kalsdorf B, 2013, EUR J IMMUNOL, V43, P540, DOI 10.1002/eji.201242804; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088448; Liang L, 2011, FEMS IMMUNOL MED MIC, V62, P84, DOI 10.1111/j.1574-695X.2011.00791.x; Lindenau JD, 2014, INT J TUBERC LUNG D, V18, P952, DOI 10.5588/ijtld.14.0060; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069547; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Lyon H, 2004, GENET EPIDEMIOL, V26, P155, DOI 10.1002/gepi.10298; Ma H, 2012, THESIS FUDAN U; Ma M, 2012, THESIS ACAD MILITARY; [马志明 MA Zhiming], 2007, [广东医学, Guangdong Medical Journal], V28, P1243; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Meenakshi P, 2013, SCAND J IMMUNOL, V78, P92, DOI 10.1111/sji.12055; Meilang QuCuo, 2012, Modern Preventive Medicine, V39, P3607; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031; Moller M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-154; Nie W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056065; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Oh JH, 2007, RESPIROLOGY, V12, P594, DOI 10.1111/j.1440-1843.2007.01108.x; Oral HB, 2006, CYTOKINE, V35, P143, DOI 10.1016/j.cyto.2006.07.015; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Qidwai T, 2012, SCAND J IMMUNOL, V75, P568, DOI 10.1111/j.1365-3083.2012.02696.x; Qu HQ, 2011, J MED GENET, V48, P217, DOI 10.1136/jmg.2010.087361; Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011; Shin HD, 2005, EXP MOL MED, V37, P128, DOI 10.1038/emm.2005.17; Stein CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001189; Sunder SR, 2012, HUM IMMUNOL, V73, P605, DOI 10.1016/j.humimm.2012.03.012; Taype CA, 2010, INFECT GENET EVOL, V10, P495, DOI 10.1016/j.meegid.2010.02.011; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Thye T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005420; Trajkov Dejan, 2009, Indian J Tuberc, V56, P117; Tso HW, 2005, GENES IMMUN, V6, P358, DOI 10.1038/sj.gene.6364189; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075090; Wu F, 2008, J OCCUP HEALTH, V50, P445, DOI 10.1539/joh.L8006; Xin DS, 2012, CHINA HEALTHCARE NUT, V11, P68; Yang Hui, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P155; Zhang J, 2011, INT J TUBERC LUNG D, V15, P594, DOI 10.5588/ijtld.09.0703	64	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127496	10.1371/journal.pone.0127496	http://dx.doi.org/10.1371/journal.pone.0127496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030829	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900054
J	Goyden, J; Tawara, K; Hedeen, D; Willey, JS; Oxford, JT; Jorcyk, CL				Goyden, Jake; Tawara, Ken; Hedeen, Danielle; Willey, Jeffrey S.; Oxford, Julia Thom; Jorcyk, Cheryl L.			The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation	PLOS ONE			English	Article							NF-KAPPA-B; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN-M; IONIZING-RADIATION; RECEPTOR ACTIVATOR; BONE-RESORPTION; OSTEOCLAST FORMATION; SIGNAL-TRANSDUCTION; IN-VITRO; DIFFERENTIATION	Bone deterioration is a challenge in long-term spaceflight with significant connections to patients experiencing disuse bone loss. Prolonged unloading and radiation exposure, defining characteristics of space travel, have both been associated with changes in inflammatory signaling via IL-6 class cytokines in bone. While there is also evidence for perturbed IL-6 class signaling in spaceflight, there has been scant examination of the connections between microgravity, radiation, and inflammatory stimuli in bone. Our lab and others have shown that the IL-6 class cytokine oncostatin M (OSM) is an important regulator of bone remodeling. We hypothesize that simulated microgravity alters osteoblast OSM signaling, contributing to the decoupling of osteolysis and osteogenesis in bone homeostasis. To test this hypothesis, we induced OSM signaling in murine MC3T3-E1 pre-osteoblast cells cultured in modeled microgravity using a rotating wall vessel bioreactor with and without exposure to radiation typical of a solar particle event. We measured effects on inflammatory signaling, osteoblast activity, and mineralization. Results indicated time dependent interactions among all conditions in the regulation of IL-6 production. Furthermore, OSM induced the transcription of OSM receptor beta, IL 6 receptor a subunits, collagen alpha 1(I), osteocalcin, sclerostin, RANKL, and osteoprotegerin. Measurements of osteoid mineralization suggest that the spatial organization of the osteoblast environment is an important consideration in understanding bone formation. Taken together, these results support a role for altered OSM signaling in the mechanism of microgravity-induced bone loss.	[Goyden, Jake; Tawara, Ken; Hedeen, Danielle; Oxford, Julia Thom; Jorcyk, Cheryl L.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Willey, Jeffrey S.] Wake Forest Sch Med, Dept Radiat Oncol, Winston Salem, NC 27157 USA; [Willey, Jeffrey S.] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Oxford, Julia Thom; Jorcyk, Cheryl L.] Boise State Univ, Biomol Res Ctr, Boise, ID 83725 USA	Idaho; Boise State University; Wake Forest University; Wake Forest University; Idaho; Boise State University	Jorcyk, CL (corresponding author), Boise State Univ, Dept Biol Sci, 1910 Univ Dr, Boise, ID 83725 USA.	cjorcyk@boisestate.edu	Oxford, Julia Thom/AAH-2842-2019	Oxford, Julia Thom/0000-0002-4850-3569	National Aeronautics and Space Administration (NASA) [NNX10AN29A, NNX13AB10A]; National Space Biomedical Research Institute (NASA) [EO00008, NCC 9-58]; Idaho Experimental Program; National Institutes of Health NCI [R15CA137510]; National Institutes of Health [P20GM103408, P20GM109095]; Susan G. Komen Foundation [KG100513]; American Cancer Society [RSG-09-276-01-CSM]; NATIONAL CANCER INSTITUTE [R15CA137510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109095, P20GM103408] Funding Source: NIH RePORTER	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Space Biomedical Research Institute (NASA)(National Aeronautics & Space Administration (NASA)); Idaho Experimental Program; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Aeronautics and Space Administration (NASA) grant (NNX10AN29A and NNX13AB10A), www.nasa.gov; the National Space Biomedical Research Institute (#EO00008 through NASA NCC 9-58); Idaho Experimental Program to Stimulate Competitive Research (EPSCoR) Research Initiation Grant (no grant number), www.idahoepscor.org; National Institutes of Health NCI grant R15CA137510, deainfo.nci.nih.gov/funding.htm; National Institutes of Health IDeA grants P20GM103408 and P20GM109095, www.nigms.nih.gov/training/IDeA/Pages/default.aspx; Susan G. Komen Foundation grant KG100513, ww5.komen.org/ResearchGrants/GrantPrograms.html; and American Cancer Society grant RSG-09-276-01-CSM, www.cancer.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeronautics N, 2013, HUM RES PROGR, V3; Al-Dujaili SA, 2011, J CELL BIOCHEM, V112, P2412, DOI 10.1002/jcb.23164; Alexandre C, 2011, JOINT BONE SPINE, V78, P572, DOI 10.1016/j.jbspin.2011.04.007; Alwood JS, 2010, BONE, V47, P248, DOI 10.1016/j.bone.2010.05.004; Arena C, 2014, ACTA ASTRONAUT, V104, P419, DOI 10.1016/j.actaastro.2014.05.005; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Bellido T, 1996, J CLIN INVEST, V97, P431, DOI 10.1172/JCI118432; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Bolin Celeste, 2012, Genes Cancer, V3, P117, DOI 10.1177/1947601912458284; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; BRACH MA, 1993, J BIOL CHEM, V268, P8466; Bueno E.M., 2011, SYNTH LECT TISSUE EN, V3, P1, DOI DOI 10.2200/S00329ED1V01Y201101TIS007; Crockett JC, 2011, OSTEOPOROSIS INT, V22, P1, DOI 10.1007/s00198-010-1272-8; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Crucian B, 2013, J CLIN IMMUNOL, V33, P456, DOI 10.1007/s10875-012-9824-7; Crucian B, 2011, AVIAT SPACE ENVIR MD, V82, P857, DOI 10.3357/ASEM.3047.2011; Dare A, 1997, J DENT RES, V76, P658, DOI 10.1177/00220345970760020601; de Andres MC, 2011, BIOCHEM BIOPH RES CO, V407, P54, DOI 10.1016/j.bbrc.2011.02.101; de Hooge ASK, 2002, AM J PATHOL, V160, P1733, DOI 10.1016/S0002-9440(10)61120-0; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Fournier C, 2001, INT J RADIAT BIOL, V77, P713, DOI 10.1080/095530000110045025; GIMBLE JM, 1994, J CELL BIOCHEM, V54, P122, DOI 10.1002/jcb.240540113; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Hargens AR, 2013, EUR J APPL PHYSIOL, V113, P2183, DOI 10.1007/s00421-012-2523-5; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hu L, 2014, ACTA ASTRONAUT, V104, P1; Hu YY, 2014, RADIAT ENVIRON BIOPH, V53, P73, DOI 10.1007/s00411-013-0499-0; Hu YY, 2012, ADV SPACE RES, V49, P1422, DOI 10.1016/j.asr.2012.02.001; Hughes JH, 2001, IN VITRO CELL DEV-AN, V37, P209; Hutt JA, 2002, MOL CANCER THER, V1, P601; Jay PR, 1996, ENDOCRINOLOGY, V137, P1151, DOI 10.1210/en.137.4.1151; Kansara M, 2013, J CLIN INVEST, V123, P5351, DOI 10.1172/JCI70559; Kapitonova MY, 2014, B EXP BIOL MED+, V156, P393, DOI 10.1007/s10517-014-2357-8; Karim L, 2013, J BONE MINER METAB; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Kumei Y, 1996, J BIOTECHNOL, V47, P313, DOI 10.1016/0168-1656(96)01412-5; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lau RYC, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/293808; Li Y, 2008, CYTOKINE, V43, P165, DOI 10.1016/j.cyto.2008.05.007; Lloyd SAJ, 2008, ADV SPACE RES, V42, P1889, DOI 10.1016/j.asr.2008.08.006; Loomer PM, 2001, CRIT REV ORAL BIOL M, V12, P252, DOI 10.1177/10454411010120030401; Mehta SK, 2013, CYTOKINE, V61, P205, DOI 10.1016/j.cyto.2012.09.019; Nagaraja MP, 2013, J CELL BIOCHEM, V114, P1001, DOI 10.1002/jcb.24454; Nakahama K, 2010, CELL MOL LIFE SCI, V67, P4001, DOI 10.1007/s00018-010-0479-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; O'Brien CA, 2000, J CELL BIOCHEM, V79, P532, DOI 10.1002/1097-4644(20001215)79:4<532::AID-JCB20>3.0.CO;2-U; Oest ME, 2014, J ORTHOP RES; Orwoll ES, 2013, J BONE MINER RES, V28, P1243, DOI 10.1002/jbmr.1948; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Persson E, 2005, BIOCHEM BIOPH RES CO, V335, P705, DOI 10.1016/j.bbrc.2005.07.135; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120; Rucci N, 2007, J CELL BIOCHEM, V100, P464, DOI 10.1002/jcb.21059; Ryan RE, 2015, CYTOKINE, V72, P71, DOI 10.1016/j.cyto.2014.11.007; Sakurai T, 2007, J RADIAT RES, V48, P515, DOI 10.1269/jrr.07012; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Sims NA, 2009, MOL CELL ENDOCRINOL, V310, P30, DOI 10.1016/j.mce.2008.08.025; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; STEIN TP, 1994, AM J PHYSIOL, V266, pE448, DOI 10.1152/ajpendo.1994.266.3.E448; Stephens DL, 2005, ACTA ASTRONAUT, V56, P969, DOI 10.1016/j.actaastro.2005.01.024; Stross C, 2006, J BIOL CHEM, V281, P8458, DOI 10.1074/jbc.M511212200; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Tazi N, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-61; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Templin T, 2012, INT J RADIAT BIOL, V88, P531, DOI 10.3109/09553002.2012.690549; Tonna S, 2014, CALCIFIED TISSUE INT, V94, P35, DOI 10.1007/s00223-013-9738-2; Townsend LW, 2005, RADIAT PROT DOSIM, V115, P44, DOI 10.1093/rpd/nci141; Turner RT, 2013, BONE, V57, P164, DOI 10.1016/j.bone.2013.08.002; Walker EC, ONCOSTATIN M PROMOTE; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wernle JD, 2010, J BIOMECH, V43, P2738, DOI 10.1016/j.jbiomech.2010.06.017; Willey JS, 2011, CLIN REV BONE MINER, V9, P54, DOI 10.1007/s12018-011-9092-8; Wu X, 2013, MOL BIOTECHNOL, V54, P331, DOI 10.1007/s12033-012-9568-x; Xu W, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-94; Yang B, 2013, INT J MOL MED, V31, P698, DOI 10.3892/ijmm.2013.1255; Yumoto K, 2010, RADIAT RES, V173, P494, DOI 10.1667/RR1754.1; Zou LX, 2010, ADV SPACE RES, V46, P1237, DOI 10.1016/j.asr.2010.06.037	83	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127230	10.1371/journal.pone.0127230	http://dx.doi.org/10.1371/journal.pone.0127230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030441	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900043
J	Grgic, H; Costa, M; Friendship, RM; Carman, S; Nagy, E; Poljak, Z				Grgic, Helena; Costa, Marcio; Friendship, Robert M.; Carman, Susy; Nagy, Eva; Poljak, Zvonimir			Genetic Characterization of H1N1 and H1N2 Influenza A Viruses Circulating in Ontario Pigs in 2012	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; HEMAGGLUTININ MOLECULE; SWINE; ORIGIN; CANADA; EVOLUTION; HUMANS	The objective of this study was to characterize H1N1 and H1N2 influenza A virus isolates detected during outbreaks of respiratory disease in pig herds in Ontario (Canada) in 2012. Six influenza viruses were included in analysis using full genome sequencing based on the 454 platform. In five H1N1 isolates, all eight segments were genetically related to 2009 pandemic virus (A(H1N1)pdm09). One H1N2 isolate had hemagglutinin (HA), polymerase A (PA) and non-structural (NS) genes closely related to A(H1N1) pdm09, and neuraminidase (NA), matrix (M), polymerase B1 (PB1), polymerase B2 (PB2), and nucleoprotein (NP) genes originating from a triple-reassortant H3N2 virus (tr H3N2). The HA gene of five Ontario H1 isolates exhibited high identity of 99% with the human A(H1N1) pdm09 [A/Mexico/InDRE4487/09] from Mexico, while one Ontario H1N1 isolate had only 96.9% identity with this Mexican virus. Each of the five Ontario H1N1 viruses had between one and four amino acid (aa) changes within five antigenic sites, while one Ontario H1N2 virus had two aa changes within two antigenic sites. Such aa changes in antigenic sites could have an effect on antibody recognition and ultimately have implications for immunization practices. According to aa sequence analysis of the M2 protein, Ontario H1N1 and H1N2 viruses can be expected to offer resistance to adamantane derivatives, but not to neuraminidase inhibitors.	[Grgic, Helena; Friendship, Robert M.; Poljak, Zvonimir] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [Costa, Marcio; Nagy, Eva] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Carman, Susy] Univ Guelph, Lab Serv Div, Hlth Anim Lab, Guelph, ON N1H 6R8, Canada; [Grgic, Helena; Costa, Marcio; Friendship, Robert M.; Carman, Susy; Nagy, Eva; Poljak, Zvonimir] Univ Guelph, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph; University of Guelph; University of Guelph	Grgic, H (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada.	hgrgic@uoguelph.ca		Costa, Marcio/0000-0001-5067-7501	NSERC Collaborative Research and Development [428602-11]; Zoetis [428602-11]; OMAFRA [UofG2011-1159]	NSERC Collaborative Research and Development(Natural Sciences and Engineering Research Council of Canada (NSERC)); Zoetis; OMAFRA	The work was supported by the following: NSERC Collaborative Research and Development jointly with Zoetis: 428602-11 (to ZP); OMAFRA: UofG2011-1159, http://www.nserc-crsng.gc.ca/index_eng.asp http://www.omafra.gov.on.ca/english/ (to ZP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, WHO MAN AN INFL DIAG; Banyai K, 2012, J VIROL, V86, P13133, DOI 10.1128/JVI.02503-12; Berhane Y, 2010, AVIAN DIS, V54, P1275, DOI 10.1637/9422-061410-Reg.1; Boni A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/598732; CHAMBERS TM, 1991, ARCH VIROL, V116, P261, DOI 10.1007/BF01319247; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gibbs AJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-207; Grgic H, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0194-z; Howard AW, 2011, EMERG INFECT DIS, V17, P1049, DOI [10.3201/eid/1706.101886, DOI 10.3201/EID/1706.101886]; Howden KJ, 2009, CAN VET J, V50, P1153; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Karasin AI, 2006, J CLIN MICROBIOL, V44, P1123, DOI 10.1128/JCM.44.3.1123-1126.2006; Karasin AI, 2004, J CLIN MICROBIOL, V42, P4349, DOI 10.1128/JCM.42.9.4349-4354.2004; Kobayashi M, 2013, EMERG INFECT DIS, V19, P1972, DOI 10.3201/eid1912.120944; KODIHALLI S, 1995, J VIROL, V69, P4888, DOI 10.1128/JVI.69.8.4888-4897.1995; Koen J, 1919, J VET MED, V14, P468; Kozakov D, 2010, TRENDS BIOCHEM SCI, V35, P471, DOI 10.1016/j.tibs.2010.03.006; Lorusso A, 2011, J GEN VIROL, V92, P919, DOI 10.1099/vir.0.027557-0; Marjuki H, 2010, ARCH VIROL, V155, P925, DOI 10.1007/s00705-010-0666-4; McEwen B, 2009, NEWSLETTER, V13, P14, DOI [10.1038/laban0109-13, DOI 10.1038/LABAN0109-13]; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Nfon CK, 2011, J VIROL, V85, P8667, DOI 10.1128/JVI.00801-11; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049; Vincent AL, 2009, VIRUS GENES, V39, P176, DOI 10.1007/s11262-009-0386-6; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WOOD JM, 1989, VIROLOGY, V171, P214, DOI 10.1016/0042-6822(89)90528-X; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127840	10.1371/journal.pone.0127840	http://dx.doi.org/10.1371/journal.pone.0127840			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030614	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900084
J	Hwang, S; Bang, K; Lee, J; Cho, S				Hwang, Sejung; Bang, Kyeongrin; Lee, Jiae; Cho, Saeyoull			Circulating Hemocytes from Larvae of the Japanese Rhinoceros Beetle Allomyrina dichotoma (Linnaeus) (Coleoptera: Scarabaeidae) and the Cellular Immune Response to Microorganisms	PLOS ONE			English	Article							PHAGOCYTOSIS; AUTOPHAGY; HEMATOPOIESIS; DEFENSE	Hemocytes of the last larva of the Japanese rhinoceros beetle A. dichotoma (Linnaeus) (Coleoptera: Scarabaeidae) were classified as granulocytes, plasmatocytes, oenocytoids, spherulocytes, prohemocytes, and adipohemocytes. Among these cell types, only the granulocytes became immunologically activated with obvious morphological changes, displaying large amoeba-like, lobopodia-like, and fan-like structures. In addition, their cytoplasmic granules became larger and greatly increased in number. To explore whether these granules could be immunologically generated as phagosomes, total hemocytes were stained with LysoTracker. Greater than 90% of the granulocytes retained the LysoTracker dye at 4 h post-bacterial infection. In flow cytometry analysis, the red fluorescent signal was highly increased at 4 h post-bacterial infection (60.36%) compared to controls (5.08%), as was confirmed by fluorescent microscopy. After 12 h post-infection, these signals returned to basal levels. The uptake of pathogens by granulocytes rapidly triggered the translocation of the microtubule-associated protein 1 light chain 3 alpha (LC3) to the phagosome, which may result in enhanced pathogen killing.	[Hwang, Sejung; Bang, Kyeongrin; Lee, Jiae; Cho, Saeyoull] Kangwon Natl Univ, Dept Appl Biol, Coll Agr & Life Sci, Environm Friendly Agr Ctr, Chunchon, South Korea	Kangwon National University	Cho, S (corresponding author), Kangwon Natl Univ, Dept Appl Biol, Coll Agr & Life Sci, Environm Friendly Agr Ctr, Chunchon, South Korea.	saeyoullcho@kangwon.ac.kr			National Research Foundation of Korea [NRF-2014R1A1A4A01008545]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (Grant Number: NRF-2014R1A1A4A01008545).	Bang K, 2012, MOL BIOL REP, V39, P5151, DOI 10.1007/s11033-011-1311-3; Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010; Colombo MI, 2007, IUBMB LIFE, V59, P238, DOI 10.1080/15216540701230503; Garcia-Garcia E, 2009, DEV COMP IMMUNOL, V33, P728, DOI 10.1016/j.dci.2008.12.006; Gardiner EMM, 2000, ARCH INSECT BIOCHEM, V43, P147, DOI 10.1002/(SICI)1520-6327(200004)43:4&lt;147::AID-ARCH1&gt;3.0.CO;2-J; Giglio A, 2008, MICRON, V39, P552, DOI 10.1016/j.micron.2007.07.004; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gupta A. P., 1979, INSECT HEMOCYTES DEV; Gupta AP, 1985, COMPREHENSIVE INSECT, P85; JONES JC, 1962, AM ZOOL, V2, P209; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; Klippel N, 2007, ANAL LETT, V40, P1400, DOI 10.1080/00032710701327047; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kwon H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103620; Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396; Lamprou I, 2007, IMMUNOLOGY, V121, P314, DOI 10.1111/j.1365-2567.2007.02576.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Manachini B, 2011, J INVERTEBR PATHOL, V106, P360, DOI 10.1016/j.jip.2010.12.006; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Mihalache CC, 2012, EXP CELL RES, V318, P1187, DOI 10.1016/j.yexcr.2011.12.021; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Pandey J. P., 2012, American Journal of Biochemistry and Molecular Biology, V2, P82; Romao S, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13198; Rosales C, 2011, ISJ-INVERT SURVIV J, V8, P109; Shelby Kent S., 2012, Insects, V3, P743, DOI 10.3390/insects3030743; Soares T, 2013, MICRON, V48, P11, DOI 10.1016/j.micron.2013.02.002; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711	32	21	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128519	10.1371/journal.pone.0128519	http://dx.doi.org/10.1371/journal.pone.0128519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030396	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900163
J	Ingels, B; Van Hassel, P; Van Leeuwen, T; De Clercq, P				Ingels, Brecht; Van Hassel, Pieter; Van Leeuwen, Thomas; De Clercq, Patrick			Feeding History Affects Intraguild Interactions between Harmonia axyridis (Coleoptera: Coccinellidae) and Episyrphus balteatus (Diptera: Syrphidae)	PLOS ONE			English	Article							ASIAN LADY BEETLE; PALLAS COLEOPTERA; BIOLOGICAL-CONTROL; PREDATION; LIMITATION; EUROPE; SPREAD; DIET	While the effect of several factors such as predator and prey size, morphology and developmental stage on intraguild predation (IGP) is widely investigated, little is known about the influence of diet on the occurrence and outcome of IGP. In the present study, the effect of the diet experienced during larval development on IGP between the ladybird Harmonia axyridis and the syrphid Episyrphus balteatus is investigated. Four diets were tested for H. axyridis: eggs of the Mediterranean flour moth Ephestia kuehniella, pea aphids, Acyrthosiphon pisum, in an ad libitum amount, pea aphids in a limited amount, and honey bee pollen. For E. balteatus only the two aphid diets were tested. First, experiments were performed to determine the quality of the various diets for development of both predators. Second, IGP experiments between H. axyridis and E. balteatus were performed both in Petri dishes and on potted pepper plants. The diet of both species influenced the incidence of IGP between H. axyridis and E. balteatus both in Petri dishes and on potted plants. In general, smaller larvae of H. axyridis (those fed on poor or restricted diet) fed more on hoverflies than large (wellnourished) ladybird larvae. Further, poorly nourished (smaller) larvae of E. balteatus were more susceptible to predation than well-fed (larger) hoverfly larvae. The observed effects were not only due to the lower fitness of larvae of both predators reared on an inferior quality diet but also to changes in predator behaviour. The results from this study show that IGP interactions are influenced by a multitude of factors, including feeding history of the organisms involved, and emphasize the importance of taking these factors into account in order to fully understand the ecological relevance of IGP.	[Ingels, Brecht; Van Hassel, Pieter; Van Leeuwen, Thomas; De Clercq, Patrick] Univ Ghent, Lab Agrozool, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium; [Van Leeuwen, Thomas] Univ Amsterdam, IBED, Amsterdam, Netherlands	Ghent University; University of Amsterdam	Ingels, B (corresponding author), Univ Ghent, Lab Agrozool, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium.	ingels.brecht@gmail.com	De Clercq, Patrick/B-5721-2015	De Clercq, Patrick/0000-0003-0664-1602; Van Leeuwen, Thomas/0000-0003-4651-830X	Research Foundation Flanders (FWO Vlaanderen)	Research Foundation Flanders (FWO Vlaanderen)(FWO)	Brecht Ingels was supported by a PhD grant from the Research Foundation Flanders (FWO Vlaanderen). Thomas Van Leeuwen is a postdoctoral fellow of the Research Foundation Flanders, FWO Vlaanderen (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Alhmedi A, 2009, ENTOMOL SCI, V12, P349, DOI 10.1111/j.1479-8298.2009.00342.x; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; Berkvens N, 2008, BIOCONTROL, V53, P211, DOI 10.1007/s10526-007-9130-0; Berkvens N, 2008, BIOCONTROL, V53, P201, DOI 10.1007/s10526-007-9128-7; Brown PMJ, 2008, BIOCONTROL, V53, P5, DOI 10.1007/s10526-007-9132-y; Brown PMJ, 2011, BIOCONTROL, V56, P623, DOI 10.1007/s10526-011-9379-1; Brown PMJ, 2015, ENTOMOL SCI, V18, P130, DOI 10.1111/ens.12092; Colunga-Garcia M, 1998, ENVIRON ENTOMOL, V27, P1574, DOI 10.1093/ee/27.6.1574; De Clercq P, 2003, BIOCONTROL, V48, P39, DOI 10.1023/A:1021219714684; Denno RF, 2003, ECOLOGY, V84, P2522, DOI 10.1890/02-0370; Dmitriew C, 2007, J EVOLUTION BIOL, V20, P1298, DOI 10.1111/j.1420-9101.2007.01349.x; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Hautier L, 2011, BIOL INVASIONS, V13, P1805, DOI 10.1007/s10530-010-9935-0; Hindayana D, 2001, BIOL CONTROL, V20, P236, DOI 10.1006/bcon.2000.0895; Hodek I, 1996, ECOLOGY COCCINELLIDA; Ingels B, 2011, BIOCONTROL, V56, P871, DOI 10.1007/s10526-011-9363-9; Kagata H, 2006, ENTOMOL EXP APPL, V119, P239, DOI 10.1111/j.1570-7458.2006.00414.x; Koch R L, 2003, J Insect Sci, V3, P32; Koch RL, 2006, NEOTROP ENTOMOL, V35, P421, DOI 10.1590/S1519-566X2006000400001; Kutner M., 2005, APPL LINEAR STAT MOD; Lucas E, 2005, EUR J ENTOMOL, V102, P351, DOI 10.14411/eje.2005.052; Lucas E, 2009, BIOCONTROL SCI TECHN, V19, P555, DOI 10.1080/09583150902883460; McCullagh P, 1989, GEN LINEAR MODELS; Mendel D, 2011, J APPL ENTOMOL, V135, P311, DOI 10.1111/j.1439-0418.2010.01548.x; Michaud JP, 2002, ENVIRON ENTOMOL, V31, P827, DOI 10.1603/0046-225X-31.5.827; OSAWA N, 1992, HEREDITY, V69, P297, DOI 10.1038/hdy.1992.129; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Raubenheimer D, 2007, ECOLOGY, V88, P2598, DOI 10.1890/07-0012.1; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Sadeghi H, 2000, J ANIM ECOL, V69, P771, DOI 10.1046/j.1365-2656.2000.00433.x; Specty O, 2003, ARCH INSECT BIOCHEM, V52, P81, DOI 10.1002/arch.10070; SPSS, 2010, IBM SPSS STAT 19 COR; TENHUMBERG B, 1995, ENVIRON ENTOMOL, V24, P687, DOI 10.1093/ee/24.3.687; TENHUMBERG B, 1995, AGR ECOSYST ENVIRON, V52, P39, DOI 10.1016/0167-8809(94)09007-T; Thomas AP, 2013, INSECT CONSERV DIVER, V6, P20, DOI 10.1111/j.1752-4598.2012.00184.x; Ware RL, 2008, BIOCONTROL, V53, P169, DOI 10.1007/s10526-007-9135-8; Yasuda H, 2004, OECOLOGIA, V141, P722, DOI 10.1007/s00442-004-1680-6	40	9	10	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128518	10.1371/journal.pone.0128518	http://dx.doi.org/10.1371/journal.pone.0128518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030267	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900162
J	Sari, M; Bahceci, I; Dogrusoz, U; Sumer, SO; Aksoy, BA; Babur, O; Demir, E				Sari, Mecit; Bahceci, Istemi; Dogrusoz, Ugur; Sumer, Selcuk Onur; Aksoy, Buelent Arman; Babur, Oezguen; Demir, Emek			SBGNViz: A Tool for Visualization and Complexity Management of SBGN Process Description Maps	PLOS ONE			English	Article							GRAPH VISUALIZATION; CYTOSCAPE; INFORMATION; NETWORKS; GENE; WEB	Background Information about cellular processes and pathways is becoming increasingly available in detailed, computable standard formats such as BioPAX and SBGN. Effective visualization of this information is a key recurring requirement for biological data analysis, especially for -omic data. Biological data analysis is rapidly migrating to web based platforms; thus there is a substantial need for sophisticated web based pathway viewers that support these platforms and other use cases. Results Towards this goal, we developed a web based viewer named SBGNViz for process description maps in SBGN (SBGN-PD). SBGNViz can visualize both BioPAX and SBGN formats. Unique features of SBGNViz include the ability to nest nodes to arbitrary depths to represent molecular complexes and cellular locations, automatic pathway layout, editing and highlighting facilities to enable focus on sub-maps, and the ability to inspect pathway members for detailed information from EntrezGene. SBGNViz can be used within a web browser without any installation and can be readily embedded into web pages. SBGNViz has two editions built with ActionScript and JavaScript. The JavaScript edition, which also works on touch enabled devices, introduces novel methods for managing and reducing complexity of large SBGN-PD maps for more effective analysis. Conclusion SBGNViz fills an important gap by making the large and fast-growing corpus of rich pathway information accessible to web based platforms. SBGNViz can be used in a variety of contexts and in multiple scenarios ranging from visualization of the results of a single study in a web page to building data analysis platforms.	[Sari, Mecit; Bahceci, Istemi; Dogrusoz, Ugur] Bilkent Univ, Dept Comp Engn, Ankara, Turkey; [Dogrusoz, Ugur; Sumer, Selcuk Onur; Aksoy, Buelent Arman; Babur, Oezguen; Demir, Emek] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Aksoy, Buelent Arman] Triinst Training Program Computat Biol & Med, New York, NY USA	Ihsan Dogramaci Bilkent University; Memorial Sloan Kettering Cancer Center	Dogrusoz, U (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	dogrusoz@cbio.mskcc.org	Dogrusoz, Ugur/HGC-3914-2022; Dogrusoz, Ugur/ABI-7050-2020	Dogrusoz, Ugur/0000-0002-7153-0784	Scientific and Technological Research Council of Turkey [113E161]; UD Foundation for the National Institutes of Health (US) [U41HG006623, GM103504]; Defense Advanced Research Projects Agency United States Army Research Office (Big Mechanism Program) [W911NF14C0119]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); UD Foundation for the National Institutes of Health (US); Defense Advanced Research Projects Agency United States Army Research Office (Big Mechanism Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Scientific and Technological Research Council of Turkey (#113E161, http://www.tubitak.gov.tr/en), UD Foundation for the National Institutes of Health (US) (#U41HG006623 and #GM103504, http://www.fnih.org), and Defense Advanced Research Projects Agency United States Army Research Office (Big Mechanism Program) (http://www.darpa.mil, grant number: W911NF14C0119, grant recipient: ED (Dr. Emek Demir)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babur O, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-642; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Czauderna T, 2010, BIOINFORMATICS, V26, P2340, DOI 10.1093/bioinformatics/btq407; Demir E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003194; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Dogrusoz U, 2006, COMPUT GRAPH-UK, V30, P86, DOI 10.1016/j.cag.2005.10.015; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Goncalves E, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-17; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; Krause F, 2013, BIOINFORMATICS, V29, P1467, DOI 10.1093/bioinformatics/btt159; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; van Iersel MP, 2012, BIOINFORMATICS, V28, P2016, DOI 10.1093/bioinformatics/bts270; [No title captured], DOI DOI 10.1038/NBT.1558	14	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128985	10.1371/journal.pone.0128985	http://dx.doi.org/10.1371/journal.pone.0128985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030594	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900204
J	Yin, L; Xue, YF; Ma, YH				Yin, Liang; Xue, Yanfen; Ma, Yanhe			Global Microarray Analysis of Alkaliphilic Halotolerant Bacterium Bacillus sp N16-5 Salt Stress Adaptation	PLOS ONE			English	Article							SIGMA-FACTOR SIGMA(B); LISTERIA-MONOCYTOGENES; HIGH-SALINITY; HELICOBACTER-PYLORI; COMPATIBLE SOLUTES; ESCHERICHIA-COLI; PSEUDOFIRMUS OF4; SUBTILIS; MOTILITY; RESISTANCE	The alkaliphilic halotolerant bacterium Bacillus sp. N16-5 is often exposed to salt stress in its natural habitats. In this study, we used one-colour microarrays to investigate adaptive responses of Bacillus sp. N16-5 transcriptome to long-term growth at different salinity levels (0%, 2%, 8%, and 15% NaCl) and to a sudden salt increase from 0% to 8% NaCl. The common strategies used by bacteria to survive and grow at high salt conditions, such as K+ uptake, Na+ efflux, and the accumulation of organic compatible solutes (glycine betaine and ectoine), were observed in Bacillus sp. N16-5. The genes of SigB regulon involved in general stress responses and chaperone-encoding genes were also induced by high salt concentration. Moreover, the genes regulating swarming ability and the composition of the cytoplasmic membrane and cell wall were also differentially expressed. The genes involved in iron uptake were down-regulated, whereas the iron homeostasis regulator Fur was up-regulated, suggesting that Fur may play a role in the salt adaption of Bacillus sp. N16-5. In summary, we present a comprehensive gene expression profiling of alkaliphilic Bacillus sp. N16-5 cells exposed to high salt stress, which would help elucidate the mechanisms underlying alkaliphilic Bacillus spp. survival in and adaptation to salt stress.	[Yin, Liang; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Yin, Liang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, YH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	mayanhe@im.ac.cn	MA, YAN/HHN-2912-2022		Ministry of Sciences and Technology of China [2011CBA00800, 2013CBA733900, 2011AA02A206, 2012AA022100]	Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Ministry of Sciences and Technology of China (Grant No. 2011CBA00800, 2013CBA733900, 2011AA02A206 and 2012AA022100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; Becker LA, 1998, J BACTERIOL, V180, P4547, DOI 10.1128/JB.180.17.4547-4554.1998; Bowers Karen J, 2009, Saline Syst, V5, P9, DOI 10.1186/1746-1448-5-9; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Chan PF, 1998, J BACTERIOL, V180, P6082; Choi Y, 2015, INFECT IMMUN, V83, P197, DOI 10.1128/IAI.02633-14; Coker James A, 2007, Saline Syst, V3, P6, DOI 10.1186/1746-1448-3-6; Connelly MB, 2004, J BACTERIOL, V186, P4159, DOI 10.1128/JB.186.13.4159-4167.2004; Ferreira A, 2003, APPL ENVIRON MICROB, V69, P2692, DOI 10.1128/AEM.69.5.2692-2698.2003; Ferreira A, 2001, APPL ENVIRON MICROB, V67, P4454, DOI 10.1128/AEM.67.10.4454-4457.2001; Gancz H, 2011, J MICROBIOL, V49, P294, DOI 10.1007/s12275-011-0396-7; Gao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028148; Glaasker E, 1998, J BACTERIOL, V180, P4718, DOI 10.1128/JB.180.17.4718-4723.1998; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Hoffmann T, 2002, J BACTERIOL, V184, P718, DOI 10.1128/JB.184.3.718-727.2002; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Horsburgh MJ, 1999, MOL MICROBIOL, V32, P41, DOI 10.1046/j.1365-2958.1999.01323.x; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Ito M, 2001, BIOSCI BIOTECH BIOCH, V65, P2773, DOI 10.1271/bbb.65.2773; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; Jebbar M, 2005, J BACTERIOL, V187, P1293, DOI 10.1128/JB.187.4.1293-1304.2005; Kajiyama Y, 2007, J BACTERIOL, V189, P7511, DOI 10.1128/JB.00968-07; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; KITADA M, 1994, J BACTERIOL, V176, P6464, DOI 10.1128/JB.176.21.6464-6469.1994; KO R, 1994, J BACTERIOL, V176, P426, DOI 10.1128/JB.176.2.426-431.1994; Kosmaoglou M, 2008, PROG RETIN EYE RES, V27, P434, DOI 10.1016/j.preteyeres.2008.03.001; Krulwich TA, 2001, BBA-BIOENERGETICS, V1505, P158, DOI 10.1016/S0005-2728(00)00285-1; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; Li G, 2011, SCI CHINA LIFE SCI, V54, P90, DOI 10.1007/s11427-010-4106-1; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLORET J, 1995, APPL ENVIRON MICROB, V61, P3701, DOI 10.1128/AEM.61.10.3701-3704.1995; Lopez CS, 1998, CURR MICROBIOL, V36, P55; Lopez CS, 2006, MICROBIOL-SGM, V152, P605, DOI 10.1099/mic.0.28345-0; Lopez CS, 2000, INT J FOOD MICROBIOL, V55, P137, DOI 10.1016/S0168-1605(00)00171-9; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Palomino MM, 2009, RES MICROBIOL, V160, P117, DOI 10.1016/j.resmic.2008.10.011; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Schroeter R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080956; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Song YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054090; Sorokin DY, 2014, EXTREMOPHILES, V18, P791, DOI 10.1007/s00792-014-0670-9; Spohn G, 1999, J BACTERIOL, V181, P593, DOI 10.1128/JB.181.2.593-599.1999; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Tsuzuki M, 2011, APPL ENVIRON MICROB, V77, P7551, DOI 10.1128/AEM.05463-11; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; Volker U, 1999, J BACTERIOL, V181, P3942; Wick LM, 2004, ADV BIOCHEM ENG BIOT, V89, P1; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X	52	7	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128649	10.1371/journal.pone.0128649	http://dx.doi.org/10.1371/journal.pone.0128649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030352	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900179
J	Zheng, QL; Wu, HJ; Cao, J				Zheng, Qiaoli; Wu, Haijian; Cao, Jiang			Circulating Adiponectin and Risk of Endometrial Cancer	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; POSTMENOPAUSAL WOMEN; SERUM LEPTIN; OBESITY; ASSOCIATION; EXPRESSION; RECEPTORS; METAANALYSIS; HORMONES	Background Adiponectin is an insulin-sensitizing hormone produced by adipocytes. It has been suggested to be involved in endometrial tumorigenesis. Published data have shown inconsistent results for the association between circulating adiponectin levels and endometrial cancer. In this study, we conducted a meta-analysis to evaluate the predictive value of circulating adiponectin levels on the development of endometrial cancer. Methods PubMed, Embase, ISI web of knowledge, and Cochrane databases were searched for all eligible studies, and the summary relative risk (SRR) was calculated. Additionally, we performed dose-response analysis with eight eligible studies. Results A total of 1,955 cases and 3,458 controls from 12 studies were included. The SRR for the 'highest' vs 'lowest' adiponectin levels indicated high adiponectin level reduced the risk of endometrial cancer [SRR = 0.40, 95% confidence interval (CI), 0.33-0.66]. Results from the subgroup analyses were consistent with the overall analysis. The SRR for each 1 mu g/ml increase of adiponectin indicated a 3% reduction in endometrial cancer risk (95% CI: 2%-4%), and a 14% reduction for each increase of 5 mu g/ml (95% CI: 9%-19%). No evidence of publication bias was found. Conclusions This meta-analysis demonstrates that low level of circulating adiponectin is a risk factor for endometrial cancer.	[Zheng, Qiaoli; Cao, Jiang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Qiaoli] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Dermatol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Haijian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Cao, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Res Ctr, 88 Jiefang Rd, Hangzhou 310003, Zhejiang, Peoples R China.	caoj@zju.edu.cn						Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Arikoglu H, 2014, GENE, V534, P10, DOI 10.1016/j.gene.2013.10.039; Arita Y, 2012, BIOCHEM BIOPH RES CO, V425, P560, DOI 10.1016/j.bbrc.2012.08.024; Ashizawa N, 2010, GYNECOL ONCOL, V119, P65, DOI 10.1016/j.ygyno.2010.07.007; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Christiansen T, 2010, J CLIN ENDOCR METAB, V95, P911, DOI 10.1210/jc.2008-2505; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Cust AE, 2007, J CLIN ENDOCR METAB, V92, P255, DOI 10.1210/jc.2006-1371; Dal Maso L, 2004, J CLIN ENDOCR METAB, V89, P1160, DOI 10.1210/jc.2003-031716; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Dallal CM, 2013, ENDOCR-RELAT CANCER, V20, P151, DOI 10.1530/ERC-12-0229; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erdogan S, 2013, ENDOCR-RELAT CANCER, V20, P669, DOI 10.1530/ERC-13-0280; Friedenreich CM, 2012, ENDOCR-RELAT CANCER, V19, P785, DOI 10.1530/ERC-12-0211; Furberg AS, 2003, INT J CANCER, V104, P669, DOI 10.1002/ijc.10974; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Houde AA, 2014, ADIPOCYTE, V3, P132, DOI 10.4161/adip.28308; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Luhn P, 2013, CANCER EPIDEM BIOMAR, V22, P1304, DOI 10.1158/1055-9965.EPI-13-0258; Lukanova A, 2004, INT J CANCER, V108, P262, DOI 10.1002/ijc.11544; Ma Y, 2013, J GYNECOL ONCOL, V24, P336, DOI 10.3802/jgo.2013.24.4.336; Macis D, 2014, INT J EPIDEMIOL, V43, P1226, DOI 10.1093/ije/dyu088; MACMAHON B, 1974, Gynecologic Oncology, V2, P122, DOI 10.1016/0090-8258(74)90003-1; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Moon HS, 2011, MOL CANCER THER, V10, P2234, DOI 10.1158/1535-7163.MCT-11-0545; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Ohbuchi Y, 2013, INT J CLIN ONCOL; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Petridou E, 2003, J CLIN ENDOCR METAB, V88, P993, DOI 10.1210/jc.2002-021209; Soliman PT, 2006, CANCER-AM CANCER SOC, V106, P2376, DOI 10.1002/cncr.21866; Soliman PT, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.045; Takemura Y, 2006, ENDOCRINOLOGY, V147, P3203, DOI 10.1210/en.2005-1510; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Westerink J, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-13; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	52	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129824	10.1371/journal.pone.0129824	http://dx.doi.org/10.1371/journal.pone.0129824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030130	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900233
J	Zhou, C; Long, Y; Yang, HL; Zhu, CY; Ma, QL; Zhang, YG				Zhou, Cheng; Long, Yan; Yang, Hongling; Zhu, Chunyan; Ma, Qingling; Zhang, Yonggang			TRAIL Is Decreased Before 20 Weeks Gestation in Women with Hypertensive Disorders of Pregnancy	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; MATERNAL OBESITY; PREECLAMPSIA; RECEPTORS; PATHOGENESIS; POPULATION; MEMBER	Objective The present study evaluated maternal plasma protein profiles before the onset of hypertensive disorders of pregnancy (HDP) to assess the relationship between maternal plasma tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and HDP before 20 weeks gestation and to evaluate the discriminatory performance of plasma TRAIL levels for HDP. Methods A 2-phase discovery/validation study was designed. In the discovery phase, a nested case-controlled study was performed using plasma sampled at 8 to 20 weeks gestation from 20 women who later developed HDP and from 20 age-and gestational week-matched controls. Plasma was analyzed using a human protein microarray technology designed to simultaneously detect 507 proteins. The functional annotation and clustering of the differentially expressed proteins were performed using DAVID and the GO database. TRAIL levels were further validated in an independent study using plasma obtained at 8 to 20 weeks gestation from 53 women who later developed HDP and from 106 matched controls, and 62 clinical risk factors were investigated. Results In the protein microarray analysis, 23 proteins were differentially expressed between the two groups. The ELISA showed that women who later developed HDP had significantly lower TRAIL levels compared to women with uncomplicated pregnancies. The multivariable Cox regression analysis identified the following three factors that were entered into the final Cox regression model: gravidity (OR = 2.02, 95% CI 1.00-4.09), pre-pregnancy BMI (OR = 1.46, 95% CI 1.21-1.76) and TRAIL levels (OR = 0.97, 95% CI 0.94-0.99). The model had a significantly better discriminatory power (AUC = 0.83, 95% CI 0.75-0.88) compared to TRAIL alone as an independent predictor of HDP (AUC = 0.59, 95% CI 0.51-0.67). Conclusion Twenty-three differentially expressed proteins before 20 weeks gestation might be associated with the pathogenesis of HDP. Plasma TRAIL levels were associated with the development of HDP, and the combination of plasma TRAIL levels with pre-pregnancy BMI and gravidity had a good discriminatory performance for HDP before 20 weeks gestation.	[Zhou, Cheng; Long, Yan; Yang, Hongling; Ma, Qingling; Zhang, Yonggang] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China; [Zhu, Chunyan] Guangzhou Med Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Yang, HL (corresponding author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China.	hlyang62@163.com; zchyan@163.com			National Natural Science Fund of China [2012-81102197]; Science and Technology Fund of Guangzhou [201300000135]; Science and Technology Fund of Guangdong Province [20120318067]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Science and Technology Fund of Guangzhou; Science and Technology Fund of Guangdong Province	This study was supported by the National Natural Science Fund of China (2012-81102197, CYZ, http://www.nsfc.gov.cn/), the Science and Technology Fund of Guangzhou (201300000135, HLY, http://apply.gzkj.gov.cn/) and the Science and Technology Fund of Guangdong Province (20120318067, HLY, http://www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz A, 2012, ULTRASOUND OBST GYN, V40, P398, DOI 10.1002/uog.11205; Akolekar R, 2009, PRENATAL DIAG, V29, P1103, DOI 10.1002/pd.2375; Anderson UD, 2012, PLACENTA, V33, pS42, DOI 10.1016/j.placenta.2011.11.021; Bai X, 2009, PLACENTA, V30, P855, DOI 10.1016/j.placenta.2009.07.006; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Benirschke K, 1995, PATHOLOGY HUMAN PLAC, P182; Chaemsaithong P, 2014, J MATERN-FETAL NEO M, V27, P217, DOI 10.3109/14767058.2013.806906; Chen LH, 2004, LIFE SCI, V74, P1479, DOI 10.1016/j.lfs.2003.07.044; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Davidovich IA, 2004, CANCER LETT, V211, P189, DOI 10.1016/j.canlet.2004.03.026; Dildy GA, 2007, SEMIN PERINATOL, V31, P135, DOI 10.1053/j.semperi.2007.03.005; Keogh RJ, 2007, CIRC RES, V100, P834, DOI 10.1161/01.RES.0000261352.81736.37; Leeners B, 2006, CLIN SCI, V111, P81, DOI 10.1042/CS20060015; Leung TY, 2008, BJOG-INT J OBSTET GY, V115, P1529, DOI 10.1111/j.1471-0528.2008.01931.x; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Meads CA, 2008, HEALTH TECHNOL ASSES, V12, P261; Phillips TA, 1999, J IMMUNOL, V162, P6053; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Poon LCY, 2009, HYPERTENSION, V53, P812, DOI 10.1161/HYPERTENSIONAHA.108.127977; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Skrastad RB, 2014, ACTA OBSTET GYN SCAN, V93, P1238, DOI 10.1111/aogs.12479; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Stamatopoulou A, 2011, HYPERTENS PREGNANCY, V30, P384, DOI 10.3109/10641955.2010.484081; Tenenbaum A, 2004, INT J CARDIOL, V97, P167, DOI 10.1016/j.ijcard.2003.07.033; Thomas LR, 2004, J BIOL CHEM, V279, P32780, DOI 10.1074/jbc.M401680200; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; von Dadelszen P, 2011, BEST PRACT RES CL OB, V25, P389, DOI 10.1016/j.bpobgyn.2011.04.001; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Whitley GSJ, 2009, J ANAT, V215, P21, DOI 10.1111/j.1469-7580.2008.01039.x; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128425	10.1371/journal.pone.0128425	http://dx.doi.org/10.1371/journal.pone.0128425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030414	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900147
J	Hartmann, MD; Boichenko, I; Coles, M; Lupas, AN; Alvarez, BH				Hartmann, Marcus D.; Boichenko, Iuliia; Coles, Murray; Lupas, Andrei N.; Alvarez, Birte Hernandez			Structural Dynamics of the Cereblon Ligand Binding Domain	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; LENALIDOMIDE; COMPLEX; DEGRADATION; MOLSCRIPT; MUTATION; READERS; TARGET	Cereblon, a primary target of thalidomide and its derivatives, has been characterized structurally from both bacteria and animals. Especially well studied is the thalidomide binding domain, CULT, which shows an invariable structure across different organisms and in complex with different ligands. Here, based on a series of crystal structures of a bacterial representative, we reveal the conformational flexibility and structural dynamics of this domain. In particular, we follow the unfolding of large fractions of the domain upon release of thalidomide in the crystalline state. Our results imply that a third of the domain, including the thalidomide binding pocket, only folds upon ligand binding. We further characterize the structural effect of the C-terminal truncation resulting from the mental-retardation linked R419X nonsense mutation in vitro and offer a mechanistic hypothesis for its irresponsiveness to thalidomide. At 1.2 angstrom resolution, our data provide a view of thalidomide binding at atomic resolution.	[Hartmann, Marcus D.; Boichenko, Iuliia; Coles, Murray; Lupas, Andrei N.; Alvarez, Birte Hernandez] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany	Max Planck Society	Hartmann, MD (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany.	marcus.hartmann@tuebingen.mpg.de; birte.hernandez@tuebingen.mpg.de	Hartmann, Marcus/L-8759-2019	Hartmann, Marcus/0000-0001-6937-5677; Hernandez Alvarez, Birte/0000-0003-0635-8698				Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chang Xiu-Bao, 2011, Int J Biochem Mol Biol, V2, P287; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lupas AN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004023; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	23	15	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128342	10.1371/journal.pone.0128342	http://dx.doi.org/10.1371/journal.pone.0128342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024445	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400086
J	Li, HY; Lindquist, JL; Yang, YF				Li, Haiyan; Lindquist, John L.; Yang, Yunfei			Effects of Sowing Date on Phenotypic Plasticity of Fitness-Related Traits in Two Annual Weeds on the Songnen Plain of China	PLOS ONE			English	Article							PIGWEED AMARANTHUS-RETROFLEXUS; LIFE-HISTORY CHARACTERS; ARABIDOPSIS-THALIANA; REDROOT PIGWEED; PHENOLOGICAL DEVELOPMENT; POPULATIONS; PHOTOPERIOD; GERMINATION; REPRODUCTION; LIGHT	Background Phenotypic plasticity of fitness-related traits is vital for plant species to adapt to variable environments. Chenopodium glaucum L. and Amaranthus retroflexus L. are two common weed species globally. Understanding the plasticity in life-history traits, especially in reproductive allocation, within and among these species is important for predicting their success and for managing them in different environments. Methodology/Principal Findings Seeds of the two plant species were sown every 10 days from 26 Jun to 15 Aug. Life-history and fitness-related traits of both phenology and morphology were measured, and dry biomass of roots, stems, leaves, and reproductive tissues was determined at physiological maturity. Length of reproductive and total life period of the two species differed among six sowing-date treatments. Later germinating plants led to relatively reduced total life period, size, and earlier reproduction than earlier germinating plants. The ratio of reproductive biomass to total plant biomass increased with later planting dates in C. glaucum but declined in A. retroflexus. Mature plant height, crown diameter, and reproductive tissue biomass, and seed production of C. glaucum and A. retroflexus increased with delayed reproductive period. Both species displayed true plasticity in reproductive allocation. However, the sowing date had a far greater effect on rate of vegetative growth than on allocation to reproduction. Conclusions/Significance The fitness of both C. glaucum and A. retroflexus populations have an apparent increase when the period between germination and seed production is much longer. However, C. glaucum appears better adapted to later sowing than A. retroflexus. Controlling seedlings prior to reproduction will alleviate the negative effect not only in the present year but also in future years.	[Li, Haiyan; Yang, Yunfei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Lindquist, John L.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Northeast Normal University - China; University of Nebraska System; University of Nebraska Lincoln	Yang, YF (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	yangyf@nenu.edu.cn	Lindquist, John L/D-8656-2012		National Natural Science Foundation of China [31472134, 31170504, 30901049]; Doctoral Program of Higher Education Foundation of China [20110043110005]; Youth Foundation of Science and Technology Commission of Jilin Province, China [201101012]; Youth Foundation of Northeast Normal University of China [20090501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education Foundation of China; Youth Foundation of Science and Technology Commission of Jilin Province, China; Youth Foundation of Northeast Normal University of China	National Natural Science Foundation of China (31472134, www.nsfc.gov.cn, YFY) - decision to publish; National Natural Science Foundation of China (31170504, www.nsfc.gov.cn, YFY)-study design, data collection and analysis; National Natural Science Foundation of China (30901049, www.nsfc.gov.cn, HYL); -data collection and analysis, The Doctoral Program of Higher Education Foundation of China (20110043110005, http://www.moe.edu.cn, YFY);-preparation of the manuscript Youth Foundation of Science and Technology Commission of Jilin Province, China (201101012, www.kjt.jl.gov.cn, HYL); -preparation of the manuscript Youth Foundation of Northeast Normal University of China (20090501, www.nenu.edu.cn, HYL). -study design.	Chen MJ, 2002, FORAGE PLANTS CHINA; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2001, EVOLUTION, V55, P692, DOI 10.1554/0014-3820(2001)055[0692:ADIPIN]2.0.CO;2; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; HICKMAN JC, 1975, J ECOL, V63, P689, DOI 10.2307/2258745; Huang JZ, 2001, WEED SCI, V49, P500, DOI 10.1614/0043-1745(2001)049[0500:EOTAPO]2.0.CO;2; Jackson S, 1997, PLANT CELL ENVIRON, V20, P790, DOI 10.1046/j.1365-3040.1997.d01-110.x; Kantolic AG, 2005, FIELD CROP RES, V93, P212, DOI 10.1016/j.fcr.2004.10.001; KNEZEVIC SZ, 1994, WEED SCI, V42, P568, DOI 10.1017/S0043174500076967; KUDOH H, 1995, OECOLOGIA, V103, P148, DOI 10.1007/BF00329074; Li HY, 2008, J INTEGR PLANT BIOL, V50, P641, DOI 10.1111/j.1744-7909.2008.00646.x; Littell RC, 2002, SAS LINEAR MODELS; Manuel C., 2002, ECOLOGY CONCEPTS APP, V2nd, P279; Nicol JM, 2003, PLANT ECOL, V168, P191, DOI 10.1023/A:1024430919811; Pan R, 1997, PLANT PHYSIOL, P276; Pigliucci M, 1997, AM J BOT, V84, P887, DOI 10.2307/2446278; Rajcan I, 2002, CROP SCI, V42, P1930, DOI 10.2135/cropsci2002.1930; Ray J, 2006, WEED SCI, V54, P127, DOI 10.1614/WS-05-113R.1; SANS FX, 1994, CAN J BOT, V72, P10, DOI 10.1139/b94-003; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Silvertown JW, 2003, INTRO PLANT POPULATI; STEVENS O. A., 1957, Weeds, V5, P46, DOI 10.2307/4040327; SULTAN SE, 1993, EVOLUTION, V47, P1009, DOI 10.1111/j.1558-5646.1993.tb02132.x; SULTAN SE, 1987, EVOL BIOL, V21, P127; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sun Ju, 2007, Yingyong Shengtai Xuebao, V18, P771; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Wulff RD, 1999, CAN J BOT, V77, P1150, DOI 10.1139/cjb-77-8-1150; Zhou DW, 2005, CAN J BOT, V83, P28, DOI [10.1139/b04-148, 10.1139/B04-148]	33	4	4	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127795	10.1371/journal.pone.0127795	http://dx.doi.org/10.1371/journal.pone.0127795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023915	Green Published, gold			2022-12-27	WOS:000355319400053
J	Val-Cid, C; Biarnes, X; Faijes, M; Planas, A				Val-Cid, Cristina; Biarnes, Xevi; Faijes, Magda; Planas, Antoni			Structural-Functional Analysis Reveals a Specific Domain Organization in Family GH20 Hexosaminidases	PLOS ONE			English	Article							BETA-N-ACETYLHEXOSAMINIDASE; SUBSTRATE-ASSISTED CATALYSIS; HUMAN-MILK OLIGOSACCHARIDES; GLYCOSIDE HYDROLASE; TAY-SACHS; BIOSIDASE; PROTEIN; INHIBITION; SEQUENCE; INSIGHT	Hexosaminidases are involved in important biological processes catalyzing the hydrolysis of N-acetyl-hexosaminyl residues in glycosaminoglycans and glycoconjugates. The GH20 enzymes present diverse domain organizations for which we propose two minimal model architectures: Model A containing at least a non-catalytic GH20b domain and the catalytic one (GH20) always accompanied with an extra alpha-helix (GH20b-GH20-alpha), and Model B with only the catalytic GH20 domain. The large Bifidobacterium bifidum lacto-N-biosidase was used as a model protein to evaluate the minimal functional unit due to its interest and structural complexity. By expressing different truncated forms of this enzyme, we show that Model A architectures cannot be reduced to Model B. In particular, there are two structural requirements general to GH20 enzymes with Model A architecture. First, the non-catalytic domain GH20b at the N-terminus of the catalytic GH20 domain is required for expression and seems to stabilize it. Second, the substrate-binding cavity at the GH20 domain always involves a remote element provided by a long loop from the catalytic domain itself or, when this loop is short, by an element from another domain of the multidomain structure or from the dimeric partner. Particularly, the lacto-N-biosidase requires GH20b and the lectin-like domain at the N- and C-termini of the catalytic GH20 domain to be fully soluble and functional. The lectin domain provides this remote element to the active site. We demonstrate restoration of activity of the inactive GH20b-GH20-alpha construct (model A architecture) by a complementation assay with the lectin-like domain. The engineering of minimal functional units of multidomain GH20 enzymes must consider these structural requirements.	[Val-Cid, Cristina; Biarnes, Xevi; Faijes, Magda; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Faijes, M (corresponding author), Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona, Spain.	magda.faijes@iqs.edu	Biarnés, Xevi/AAA-3107-2019; Faijes, Magda/AAA-2468-2019; PLANAS, ANTONI/I-4803-2015	Biarnés, Xevi/0000-0003-4121-9474; PLANAS, ANTONI/0000-0001-7073-3320	NANO3BIO from the European Commission [FP7-KBBE-2013-7, 613931]; GLYCOZYMES from MEC, Spain [BIO2013-49022-C2-1-R]; Fundacion Instituto Danone	NANO3BIO from the European Commission; GLYCOZYMES from MEC, Spain; Fundacion Instituto Danone(Danone Nutricia)	This work was supported in part by grants NANO3BIO (FP7-KBBE-2013-7; # 613931) from the European Commission and GLYCOZYMES (BIO2013-49022-C2-1-R) from MEC, Spain. C. Val-Cid acknowledges financial support from the Fundacion Instituto Danone (2012-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; Garrido D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017315; Gravel R. A., 1995, METABOLIC MOL BASIS, P2839; Hattie M, 2012, CHEMBIOCHEM, V13, P1128, DOI 10.1002/cbic.201200135; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito T, 2013, J BIOL CHEM, V288, P11795, DOI 10.1074/jbc.M112.420109; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu T, 2013, CURR PHARM DES; Liu T, 2012, CURR DRUG TARGETS, V13, P512, DOI 10.2174/138945012799499730; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; MAHURAN D, 1985, ISOZYMES-CURR T BIOL, V12, P229; Mark BL, 1998, J BIOL CHEM, V273, P19618, DOI 10.1074/jbc.273.31.19618; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P42131, DOI 10.1074/jbc.M107154200; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Thi NN, 2014, BIOCHEMISTRY-US, V53, P1789, DOI 10.1021/bi401697j; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Rountree JSS, 2009, CHEMMEDCHEM, V4, P378, DOI 10.1002/cmdc.200800350; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Slamova K, 2010, BIOTECHNOL ADV, V28, P682, DOI 10.1016/j.biotechadv.2010.04.004; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200	38	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128075	10.1371/journal.pone.0128075	http://dx.doi.org/10.1371/journal.pone.0128075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024355	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400067
J	Ide, S; Nakamura, S; Yamamoto, Y; Kohno, Y; Fukuda, Y; Ikeda, H; Sasaki, E; Yanagihara, K; Higashiyama, Y; Hashiguchi, K; Futsuki, Y; Inoue, Y; Fukushima, K; Suyama, N; Kohno, S				Ide, Shotaro; Nakamura, Shigeki; Yamamoto, Yoshihiro; Kohno, Yoshihisa; Fukuda, Yuichi; Ikeda, Hideki; Sasaki, Eisuke; Yanagihara, Katsunori; Higashiyama, Yasuhito; Hashiguchi, Kohji; Futsuki, Yoji; Inoue, Yuichi; Fukushima, Kiyoyasu; Suyama, Naofumi; Kohno, Shigeru			Epidemiology and Clinical Features of Pulmonary Nontuberculous Mycobacteriosis in Nagasaki, Japan	PLOS ONE			English	Article							LUNG-DISEASE; AVIUM COMPLEX; PROGNOSTIC-FACTORS; BCG-VACCINATION; INFECTIONS; PREVALENCE; OUTCOMES	Background and Objectives Recent reports indicate that the incidence of nontuberculous mycobacterial- lung disease (NTM-LD) is increasing. This study aimed to investigate the epidemiology and clinical features of NTM-LD patients in Nagasaki prefecture, Japan to identify the negative prognostic factors for NTM-LD in Japan. Methods The medical records of patients newly diagnosed with NTM-LD in eleven hospitals in Nagasaki prefecture between January 2001 and February 2010 were reviewed. Data regarding the annual population of each region and the incidence of all forms of tuberculosis were collected to assess geographic variations in NTM-LD incidence, isolates, and radiological features. Results A total 975 patients were diagnosed with NTM-LD. The incidence increased over the study period and reached 11.0 and 10.1 per 100,000 population in 2008 and 2009, respectively. M. intracellulare was the most common pathogen in the southern region, and M. avium most common in other regions. The most common radiographic pattern was the nodular-bronchiectatic pattern. Age >60 years, body mass index <18.5 kg/m(2), underlying lung disease, and cavitary pattern were the negative prognostic factors at the 1-year follow-up. Conclusions The incidence of NTM-LD has been increasing in Nagasaki prefecture. The isolates and radiographic features of patients vary markedly by region.	[Ide, Shotaro; Nakamura, Shigeki; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, Nagasaki 852, Japan; [Ide, Shotaro] Nagasaki Univ, Grad Sch Biomed Sci, Unit Mol Microbiol & Immunol, Nagasaki 852, Japan; [Yanagihara, Katsunori] Nagasaki Univ Hosp, Dept Lab Med, Nagasaki, Japan; [Hashiguchi, Kohji] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan; [Futsuki, Yoji; Suyama, Naofumi] Nagasaki Municipal Hosp, Nagasaki, Japan; [Inoue, Yuichi] Isahaya Hlth Insurance Gen Hosp, Isahaya, Japan; [Fukushima, Kiyoyasu] Japanese Red Cross Nagasaki Genbaku Isahaya Hosp, Isahaya, Japan; [Fukuda, Yuichi] Sasebo City Gen Hosp, Sasebo, Japan; [Higashiyama, Yasuhito] Hokusho Cent Hosp, Sasebo, Japan; [Sasaki, Eisuke] Natl Hosp Org, Nagasaki Med Ctr, Omura, Japan; [Kohno, Yoshihisa] Izumikawa Hosp, Minami Shimabara, Japan; [Ikeda, Hideki] Nagasaki Goto Cent Hosp, Goto, Japan; [Nakamura, Shigeki] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, Tokyo, Japan; [Yamamoto, Yoshihiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Clin Infect Dis, Toyama 930, Japan	Nagasaki University; Nagasaki University; Nagasaki University; National Institute of Infectious Diseases (NIID); University of Toyama	Nakamura, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, Nagasaki 852, Japan.	moju516@nagasaki-u.ac.jp		Ide, Shotaro/0000-0001-7872-8147	Global Centers of Excellence Program; Japan Society for the Promotion of Science; Taisho Toyama Pharmaceutical Co. Ltd.	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Taisho Toyama Pharmaceutical Co. Ltd.	This study was partially supported by a grant from the Global Centers of Excellence Program (S.I., S.N., and S.K.). Funding source: Japan Society for the Promotion of Science. Website: https://www.jsps.go.jp/english/index.html. Funding source: Taisho Toyama Pharmaceutical Co. Ltd. Website: http://www.taishotoyama.co.jp. These funders paid for analysis and interpretation of data, but had no involvement in the study.	Adjemian J, 2012, AM J RESP CRIT CARE, V186, P553, DOI 10.1164/rccm.201205-0913OC; Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; Bodle EE, 2008, EMERG INFECT DIS, V14, P390, DOI 10.3201/eid1403.061143; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Chen CY, 2012, DIAGN MICR INFEC DIS, V72, P47, DOI 10.1016/j.diagmicrobio.2011.09.009; Chou MP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-279; Dailloux M, 2006, EUR RESPIR J, V28, P1211, DOI 10.1183/09031936.00063806; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Fujikane T, 2005, INT J TUBERC LUNG D, V9, P1281; Fujita K, 2013, CLIN MICROBIOL INFEC, V19, P537, DOI 10.1111/j.1469-0691.2012.03929.x; Fujiuchi S, 2003, RESPIRATION, V70, P76, DOI 10.1159/000068416; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hayashi M, 2012, AM J RESP CRIT CARE, V185, P575, DOI 10.1164/rccm.201107-1203OC; Hersh AL, 2003, INT J TUBERC LUNG D, V7, P22; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Kajiki Akira, 2011, Kekkaku, V86, P113; Kazumi Yuko, 2006, Kekkaku, V81, P551; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; Kobashi Yoshihiro, 2004, Journal of Infection and Chemotherapy, V10, P25, DOI 10.1007/s10156-003-0273-3; KUSUNOKI S, 1991, J CLIN MICROBIOL, V29, P1596, DOI 10.1128/JCM.29.8.1596-1603.1991; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Moore JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-612; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Reed C, 2006, AM J EPIDEMIOL, V164, P32, DOI 10.1093/aje/kwj159; ROMANUS V, 1995, TUBERCLE LUNG DIS, V76, P300, DOI 10.1016/S0962-8479(05)80028-0; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Singer J, 2000, INT J STD AIDS, V11, P212, DOI 10.1258/0956462001915732; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; TRNKA L, 1994, TUBERCLE LUNG DIS, V75, P348, DOI 10.1016/0962-8479(94)90080-9; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC; WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107	32	35	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128304	10.1371/journal.pone.0128304	http://dx.doi.org/10.1371/journal.pone.0128304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020948	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300099
J	Mhuantong, W; Wongwilaiwalin, S; Laothanachareon, T; Eurwilaichitr, L; Tangphatsornruang, S; Boonchayaanant, B; Limpiyakorn, T; Pattaragulwanit, K; Punmatharith, T; McEvoy, J; Khan, E; Rachakornkij, M; Champreda, V				Mhuantong, Wuttichai; Wongwilaiwalin, Sarunyou; Laothanachareon, Thanaporn; Eurwilaichitr, Lily; Tangphatsornruang, Sithichoke; Boonchayaanant, Benjaporn; Limpiyakorn, Tawan; Pattaragulwanit, Kobchai; Punmatharith, Thantip; McEvoy, John; Khan, Eakalak; Rachakornkij, Manaskorn; Champreda, Verawat			Survey of Microbial Diversity in Flood Areas during Thailand 2011 Flood Crisis Using High-Throughput Tagged Amplicon Pyrosequencing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SP-NOV; FRESH-WATER; GEN. NOV.; GEOBACTER-SULFURREDUCENS; BACTERIAL COMMUNITY; SEDIMENTS; REDUCTION; WETLAND; FUNGI	The Thailand flood crisis in 2011 was one of the largest recorded floods in modern history, causing enormous damage to the economy and ecological habitats of the country. In this study, bacterial and fungal diversity in sediments and waters collected from ten flood areas in Bangkok and its suburbs, covering residential and agricultural areas, were analyzed using high-throughput 454 pyrosequencing of 16S rRNA gene and internal transcribed spacer sequences. Analysis of microbial community showed differences in taxa distribution in water and sediment with variations in the diversity of saprophytic microbes and sulfate/nitrate reducers among sampling locations, suggesting differences in microbial activity in the habitats. Overall, Proteobacteria represented a major bacterial group in waters, while this group co-existed with Firmicutes, Bacteroidetes, and Actinobacteria in sediments. Anaeromyxobacter, Steroidobacter, and Geobacter were the dominant bacterial genera in sediments, while Sulfuricurvum, Thiovirga, and Hydrogenophaga predominated in waters. For fungi in sediments, Ascomycota, Glomeromycota, and Basidiomycota, particularly in genera Philipsia, Rozella, and Acaulospora, were most frequently detected. Chytridiomycota and Ascomycota were the major fungal phyla, and Rhizophlyctis and Mortierella were the most frequently detected fungal genera in water. Diversity of sulfate-reducing bacteria, related to odor problems, was further investigated using analysis of the dsrB gene which indicated the presence of sulfate-reducing bacteria of families Desulfobacteraceae, Desulfobulbaceae, Syntrobacteraceae, and Desulfoarculaceae in the flood sediments. The work provides an insight into the diversity and function of microbes related to biological processes in flood areas.	[Mhuantong, Wuttichai; Wongwilaiwalin, Sarunyou; Laothanachareon, Thanaporn; Eurwilaichitr, Lily; Champreda, Verawat] Natl Ctr Genet Engn & Biotechnol, Enzyme Technol Lab, Khlong Luang 12120, Pathum Thani, Thailand; [Tangphatsornruang, Sithichoke] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Khlong Luang 12120, Pathum Thani, Thailand; [Boonchayaanant, Benjaporn; Limpiyakorn, Tawan; Rachakornkij, Manaskorn] Chulalongkorn Univ, Fac Engn, Dept Environm Engn, Bangkok 10330, Thailand; [Boonchayaanant, Benjaporn; Limpiyakorn, Tawan; Punmatharith, Thantip; Rachakornkij, Manaskorn] Chulalongkorn Univ, Ctr Excellence HSM, Bangkok 10330, Thailand; [Pattaragulwanit, Kobchai] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok 10330, Thailand; [McEvoy, John] N Dakota State Univ, Dept Vet & Microbiol Sci, Fargo, ND 58108 USA; [Khan, Eakalak] N Dakota State Univ, Dept Civil & Environm Engn, Fargo, ND 58108 USA	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; North Dakota State University Fargo; North Dakota State University Fargo	Champreda, V (corresponding author), Natl Ctr Genet Engn & Biotechnol, Enzyme Technol Lab, 113 Thailand Sci Pk, Khlong Luang 12120, Pathum Thani, Thailand.	verawat@biotec.or.th	Suwannasilp, Benjaporn/S-1254-2019; Tangphatsornruang, Sithichoke/G-3633-2010	Tangphatsornruang, Sithichoke/0000-0003-2673-0012; McEvoy, John/0000-0001-6843-5551; Pattaragulwanit, Kobchai/0000-0003-3744-8370; Laothanachareon, Thanaporn/0000-0002-4565-8581; Boonchayaanant Suwannasilp, Benjaporn/0000-0003-4321-5370	National Science and Technology Development Agency (NSTDA); National Science Foundation [1219755]	National Science and Technology Development Agency (NSTDA); National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science and Technology Development Agency (NSTDA) (http://www.nstda.or.th) and the National Science Foundation (http://www.nsf.gov) under Grant No. 1219755. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSTDA and National Science Foundation.	Abbai NS, 2013, MOL BIOTECHNOL, V54, P900, DOI 10.1007/s12033-012-9639-z; ALONGI DM, 1994, HYDROBIOLOGIA, V285, P19, DOI 10.1007/BF00005650; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, STANDARD METHODS EXA; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bastida F, 2010, FEMS MICROBIOL ECOL, V73, P370, DOI 10.1111/j.1574-6941.2010.00889.x; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Caldwell ME, 2011, INT J SYST EVOL MICR, V61, P2659, DOI 10.1099/ijs.0.023853-0; Chaturongkasumrit Y, 2013, SCI TOTAL ENVIRON, V463, P959, DOI 10.1016/j.scitotenv.2013.06.071; Chiaramonte JB, 2013, MICROB ECOL, V66, P773, DOI 10.1007/s00248-013-0292-2; Coby AJ, 2011, APPL ENVIRON MICROB, V77, P6036, DOI 10.1128/AEM.00276-11; DEWEERD KA, 1990, ARCH MICROBIOL, V154, P23; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fahrbach M, 2008, INT J SYST EVOL MICR, V58, P2215, DOI 10.1099/ijs.0.65342-0; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; FischerRomero C, 1996, INT J SYST BACTERIOL, V46, P183, DOI 10.1099/00207713-46-1-183; Fu B, 2011, WORLD J MICROB BIOT, V27, P915, DOI 10.1007/s11274-010-0534-0; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Harmsen HJM, 1998, INT J SYST BACTERIOL, V48, P1383, DOI 10.1099/00207713-48-4-1383; Hubert CRJ, 2012, ENVIRON MICROBIOL, V14, P387, DOI 10.1111/j.1462-2920.2011.02521.x; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Kafle Gopi Krishna, 2014, Journal of Biosystems Engineering, V39, P76; Kanokratana P, 2013, MICROB ECOL, V66, P322, DOI 10.1007/s00248-013-0209-0; Kato S, 2012, GEOMICROBIOL J, V29, P896, DOI 10.1080/01490451.2011.635763; Kivlin SN, 2014, BIOGEOCHEMISTRY, V117, P23, DOI 10.1007/s10533-013-9852-2; Kjeldsen KU, 2010, INT J SYST EVOL MICR, V60, P1060, DOI 10.1099/ijs.0.014746-0; Kohout P, 2012, FEMS MICROBIOL ECOL, V80, P216, DOI 10.1111/j.1574-6941.2011.01291.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Lombard M, 2000, J BIOL CHEM, V275, P115, DOI 10.1074/jbc.275.1.115; Looper JK, 2013, ENVIRON SCI-PROC IMP, V15, P2068, DOI 10.1039/c3em00200d; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Mahadevan R, 2006, APPL ENVIRON MICROB, V72, P1558, DOI 10.1128/AEM.72.2.1558-1568.2006; Manohar CS, 2013, FEMS MICROBIOL LETT, V341, P69, DOI 10.1111/1574-6968.12087; Martin F, 2012, ENVIRON POLLUT, V162, P345, DOI 10.1016/j.envpol.2011.11.032; Medihala PG, 2012, CAN J MICROBIOL, V58, P1135, DOI [10.1139/w2012-087, 10.1139/W2012-087]; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Overmann J, 2000, FEMS MICROBIOL REV, V24, P591, DOI 10.1111/j.1574-6976.2000.tb00560.x; Page LH, 2015, J ENVIRON MANAGE, V152, P91, DOI 10.1016/j.jenvman.2015.01.024; Papanikolaou S, 2007, EUR J LIPID SCI TECH, V109, P1060, DOI 10.1002/ejlt.200700169; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pascoal C, 2004, APPL ENVIRON MICROB, V70, P5266, DOI 10.1128/AEM.70.9.5266-5273.2004; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sanford RA, 2002, APPL ENVIRON MICROB, V68, P893, DOI 10.1128/AEM.68.2.893-900.2002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schwarz AO, 2012, WATER RES, V46, P3283, DOI 10.1016/j.watres.2012.03.046; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Taylor J, 2011, ENVIRON INT, V37, P1019, DOI 10.1016/j.envint.2011.03.015; ten Veldhuis JAE, 2010, WATER RES, V44, P2910, DOI 10.1016/j.watres.2010.02.009; Thormann MN, 2007, FUNGAL DIVERS, V24, P241; Tu YT, 2014, J HYDROL, V510, P70, DOI 10.1016/j.jhydrol.2013.12.015; Wagner M, 1998, PHYLOGENY DISSIMILAT; WANG J, 2013, J BIOPHARM STAT, V23, P1677; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wongwongsee W, 2013, MAR POLLUT BULL, V74, P95, DOI 10.1016/j.marpolbul.2013.07.025; Wurzbacher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094643; Xia FF, 2014, LETT APPL MICROBIOL, V59, P26, DOI 10.1111/lam.12240; Zeng HY, 2014, ENVIRON EARTH SCI, V71, P1339, DOI 10.1007/s12665-013-2540-7; Zhang T, 2012, APPL ENVIRON MICROB, V78, P8304, DOI 10.1128/AEM.02469-12; Zhao HP, 2011, ENVIRON SCI TECHNOL, V45, P10155, DOI 10.1021/es202569b; Zhao L, 2012, WORLD J MICROB BIOT, V28, P2077, DOI 10.1007/s11274-012-1010-9; Zhu C, 2011, AFR J AGR RES, V6, P6107, DOI 10.5897/AJAR11.1159	71	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128043	10.1371/journal.pone.0128043	http://dx.doi.org/10.1371/journal.pone.0128043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020967	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300075
J	Persson, T; Battenberg, K; Demina, IV; Vigil-Stenman, T; Heuvel, BV; Pujic, P; Facciotti, MT; Wilbanks, EG; O'Brien, A; Fournier, P; Hernandez, MAC; Herrera, AM; Medigue, C; Normand, P; Pawlowski, K; Berry, AM				Persson, Tomas; Battenberg, Kai; Demina, Irina V.; Vigil-Stenman, Theoden; Heuvel, Brian Vanden; Pujic, Petar; Facciotti, Marc T.; Wilbanks, Elizabeth G.; O'Brien, Anna; Fournier, Pascale; Hernandez, Maria Antonia Cruz; Herrera, Alberto Mendoza; Medigue, Claudine; Normand, Philippe; Pawlowski, Katharina; Berry, Alison M.			Candidatus Frankia Datiscae Dg1, the Actinobacterial Microsymbiont of Datisca glomerata, Expresses the Canonical nod Genes nodABC in Symbiosis with Its Host Plant	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; FIXING ROOT-NODULES; RHIZOBIUM-LEGUMINOSARUM; MOLECULAR PHYLOGENY; ARBUSCULAR MYCORRHIZA; NITROGEN-FIXATION; GENUS FRANKIA; SP NOV.; EVOLUTION; STRAINS	Frankia strains are nitrogen-fixing soil actinobacteria that can form root symbioses with actinorhizal plants. Phylogenetically, symbiotic frankiae can be divided into three clusters, and this division also corresponds to host specificity groups. The strains of cluster II which form symbioses with actinorhizal Rosales and Cucurbitales, thus displaying a broad host range, show suprisingly low genetic diversity and to date can not be cultured. The genome of the first representative of this cluster, Candidatus Frankia datiscae Dg1 (Dg1), a microsymbiont of Datisca glomerata, was recently sequenced. A phylogenetic analysis of 50 different housekeeping genes of Dg1 and three published Frankia genomes showed that cluster II is basal among the symbiotic Frankia clusters. Detailed analysis showed that nodules of Datisca glomerata, independent of the origin of the inoculum, contain several closely related cluster II Frankia operational taxonomic units. Actinorhizal plants and legumes both belong to the nitrogen-fixing plant clade, and bacterial signaling in both groups involves the common symbiotic pathway also used by arbuscular mycorrhizal fungi. However, so far, no molecules resembling rhizobial Nod factors could be isolated from Frankia cultures. Alone among Frankia genomes available to date, the genome of Dg1 contains the canonical nod genes nodA, nodB and nodC known from rhizobia, and these genes are arranged in two operons which are expressed in Datisca glomerata nodules. Furthermore, Frankia Dg1 nodC was able to partially complement a Rhizobium leguminosarum A34 nodC::Tn5 mutant. Phylogenetic analysis showed that Dg1 Nod proteins are positioned at the root of both alpha- and beta-rhizobial NodABC proteins. NodA-like acyl transferases were found across the phylum Actinobacteria, but among Proteobacteria only in nodulators. Taken together, our evidence indicates an Actinobacterial origin of rhizobial Nod factors.	[Persson, Tomas; Demina, Irina V.; Vigil-Stenman, Theoden; Pawlowski, Katharina] Univ Stockholm, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Battenberg, Kai; Berry, Alison M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Heuvel, Brian Vanden] Colorado State Univ, Dept Biol, Pueblo, CO 81001 USA; [Pujic, Petar; Fournier, Pascale; Normand, Philippe] Univ Lyon 1, CNRS, Ecol Microbienne, UMR5557, F-69622 Villeurbanne, France; [Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Facciotti, Marc T.; Wilbanks, Elizabeth G.; O'Brien, Anna] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Hernandez, Maria Antonia Cruz; Herrera, Alberto Mendoza] Inst Politecn Nacl, Ctr Biotecnol Genom, Reynosa 88710, Tamaulipas, Mexico; [Medigue, Claudine] Genoscope, Evry, France	University of California System; University of California Davis; Colorado State University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of California System; University of California Davis; University of California System; University of California Davis; Instituto Politecnico Nacional - Mexico	Pawlowski, K (corresponding author), Univ Stockholm, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	katharina.pawlowski@su.se	Pujic, Petar/ACY-1850-2022; Facciotti, Marc/AAF-9227-2020; Pawlowski, Katharina/U-9955-2017; Normand, Philippe/ABD-2235-2020	Pujic, Petar/0000-0003-1957-8534; Facciotti, Marc/0000-0003-4453-3274; Pawlowski, Katharina/0000-0003-2693-885X; Normand, Philippe/0000-0002-2139-2141; O'Brien, Anna/0000-0002-8455-8620	Swedish Research Council [229-2005-679]; Swedish Research Council VR [2007-17840-52674-16]; CA Experiment Station project [PLS-2173-H]; UC Davis Plant Sciences Graduate Fellowship; NSF GRFP [DGE-1148897]; NSF [EF-0949453]; Sesam [ANR-10-BLAN-1708]; BugsInACell [ANR-13-BSV7-0013-03]; UC Mexus-Conacyt [05-24]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council VR(Swedish Research Council); CA Experiment Station project; UC Davis Plant Sciences Graduate Fellowship; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); Sesam; BugsInACell; UC Mexus-Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Swedish Research Council Formas (229-2005-679) to KP; Swedish Research Council VR (2007-17840-52674-16) to KP; CA Experiment Station project PLS-2173-H to AMB; UC Davis Plant Sciences Graduate Fellowship to KB; UC Mexus-Conacyt 05-24 to AMB and AMH; NSF GRFP DGE-1148897 to A'OB; NSF EF-0949453 to MTF; Sesam ANR-10-BLAN-1708 to PN; and BugsInACell ANR-13-BSV7-0013-03 to PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ABI PRISM 7700 Sequence Detection System, 2007, ABI US B, V2; Alloisio N, 2010, MOL PLANT MICROBE IN, V23, P593, DOI 10.1094/MPMI-23-5-0593; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aoki S, 2013, MOL BIOL EVOL, V30, P2494, DOI 10.1093/molbev/mst153; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BENSON DR, 1993, MICROBIOL REV, V57, P293, DOI 10.1128/MMBR.57.2.293-319.1993; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Berry AM, 2011, FUNCT PLANT BIOL, V38, P645, DOI 10.1071/FP11095; BERRY AM, 1993, P NATL ACAD SCI USA, V90, P6091, DOI 10.1073/pnas.90.13.6091; Berry AM, 2004, PLANT PHYSIOL, V135, P1849, DOI 10.1104/pp.103.031534; Bickhart DM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-468; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bond G., 1976, International Biological Programme, P443; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; BURLEIGH SH, 1995, CAN J BOT, V73, P1527, DOI 10.1139/b95-165; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Ceremonie H, 1999, CAN J BOT, V77, P1293, DOI 10.1139/cjb-77-9-1293; Chelius MK, 2000, INT J SYST EVOL MICR, V50, P751, DOI 10.1099/00207713-50-2-751; Chen WM, 2012, MICROBIOL-SGM, V158, P1758, DOI 10.1099/mic.0.058370-0; Chen WM, 2005, APPL ENVIRON MICROB, V71, P7461, DOI 10.1128/AEM.71.11.7461-7471.2005; Clark LC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01109; Clawson ML, 1998, APPL ENVIRON MICROB, V64, P3539; Daubin V, 2003, MOL BIOL EVOL, V20, P471, DOI 10.1093/molbev/msg022; Delignette-Muller ML, 2013, FITDISTRPLUS HELP FI; Demina IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072442; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; DOWNIE JA, 1985, MOL GEN GENET, V198, P255, DOI 10.1007/BF00383003; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edulamudi P, 2011, LETT APPL MICROBIOL, V53, P587, DOI 10.1111/j.1472-765X.2011.03151.x; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garg B, 1999, APPL ENVIRON MICROB, V65, P2802; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Ghodhbane-Gtari F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00085-13; Ghodhbane-Gtari F, 2010, MICROB ECOL, V60, P487, DOI 10.1007/s00248-010-9641-6; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Goedhart J, 1999, BIOCHEMISTRY-US, V38, P10898, DOI 10.1021/bi990714q; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heuvel BDV, 2004, CAN J MICROBIOL, V50, P989, DOI [10.1139/w04-079, 10.1139/W04-079]; Hocher V, 2011, PLANT PHYSIOL, V156, P700, DOI 10.1104/pp.111.174151; Hruska K, 2012, VET MED-CZECH, V57, P623, DOI 10.17221/6558-VETMED; Husnik F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-87; Huss-Danell K, 1997, PLANT SOIL, V197, P35, DOI 10.1023/A:1004268931699; Ivanova N, 2010, STAND GENOMIC SCI, V2, P158, DOI 10.4056/sigs.711311; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Labeda DP, 2011, INT J SYST EVOL MICR, V61, P2525, DOI 10.1099/ijs.0.028514-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAWRENCE DB, 1967, J ECOL, V55, P793, DOI 10.2307/2258426; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; LISTON A, 1989, Aliso, V12, P525; Madhaiyan M, 2009, INT J SYST EVOL MICR, V59, P2904, DOI 10.1099/ijs.0.009811-0; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Mansour SR, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01205-13; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; MIRZA MS, 1994, APPL ENVIRON MICROB, V60, P2371, DOI 10.1128/AEM.60.7.2371-2376.1994; MIRZA MS, 1994, PLANT SOIL, V160, P147, DOI 10.1007/BF00150356; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Munk C, 2009, STAND GENOMIC SCI, V1, P292, DOI 10.4056/sigs.47643; Normand P, 1997, PHYSIOL PLANTARUM, V99, P722, DOI 10.1034/j.1399-3054.1997.990426.x; Normand P, 1996, INT J SYST BACTERIOL, V46, P1, DOI 10.1099/00207713-46-1-1; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Nouioui I, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00468-13; Nouioui I, 2013, J BIOSCIENCES, V38, P695, DOI 10.1007/s12038-013-9366-z; Nouioui I, 2011, ANTON LEEUW INT J G, V100, P579, DOI 10.1007/s10482-011-9613-y; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pawlowski K, 2012, PROTOPLASMA, V249, P967, DOI 10.1007/s00709-012-0388-4; Persson T, 2011, J BACTERIOL, V193, P7017, DOI 10.1128/JB.06208-11; Peterson SB, 2006, APPL ENVIRON MICROB, V72, P5421, DOI 10.1128/AEM.02928-05; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; R Core Team, 2021, R LANGUAGE ENV STAT; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHLAMAN HRM, 1991, J BACTERIOL, V173, P4277, DOI 10.1128/JB.173.14.4277-4287.1991; Sedzielewska KA, 2011, NEW PHYTOL, V192, P794, DOI 10.1111/j.1469-8137.2011.03937.x; Sen A, 2014, INT J SYST EVOL MICR, V64, P3821, DOI 10.1099/ijs.0.063966-0; Sen A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00103-13; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Svistoonoff S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064515; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Tice H, 2010, STAND GENOMIC SCI, V2, P168, DOI 10.4056/sigs.721316; Tisa LS, 2013, J BIOSCIENCES, V38, P719, DOI 10.1007/s12038-013-9364-1; Udwary DW, 2011, APPL ENVIRON MICROB, V77, P3617, DOI 10.1128/AEM.00038-11; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vigil-Stenman V, 2014, BMC GENOMIC IN PRESS; Wall LG, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00503-13; Werner GDA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5087; Yokoyama J, 2000, MOL PHYLOGENET EVOL, V14, P11, DOI 10.1006/mpev.1999.0672; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183	117	56	57	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127630	10.1371/journal.pone.0127630	http://dx.doi.org/10.1371/journal.pone.0127630			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020781	Green Published, gold			2022-12-27	WOS:000355187300049
J	Gauthier, T; Claude-Taupin, A; Delage-Mourroux, R; Boyer-Guittaut, M; Hervouet, E				Gauthier, Thierry; Claude-Taupin, Aurore; Delage-Mourroux, Regis; Boyer-Guittaut, Michael; Hervouet, Eric			Proximity Ligation In situ Assay is a Powerful Tool to Monitor Specific ATG Protein Interactions following Autophagy Induction	PLOS ONE			English	Article							SELECTIVE AUTOPHAGY; MITOPHAGY; LC3; P62/SQSTM1; NEURONS; DISEASE; SYSTEM; CELLS; P62	Macroautophagy is a highly regulated intracellular degradation process which has been extensively studied over the last decade. This pathway has been initially described as a non selective process inducing the degradation of parts of the cytoplasm as well as organelles at random. Nevertheless, over the last few years, new research highlighted the existence of a more selective autophagy pathway specifically recruiting some organelles or aggregates to the autophagosomes in order to induce their degradation. These selective autophagy pathways such as aggrephagy, mitophagy, pexophagy or xenophagy, involve the intervention of a cargo, the material to be degraded, cargo adapters, the molecules allowing the recruitment of the cargo to the autophagosome, and the proteins of the ATG8 family which link the cargo adapters to the autophagosome. One of the main questions which now remain is to develop new techniques and protocols able to discriminate between these different types of induced autophagy. In our work, we studied the possibility to use the P-LISA technique, which has been recently developed to study endogenous in vivo protein interactions, as a new technique to characterize the ATG proteins specifically involved in bulk or selective autophagy. In this manuscript, we indeed demonstrate that this technique allows the study of endogenous ATG protein interactions in cells following autophagy induction, but more interestingly that this technique might be used to characterize the ATG proteins involved in selective autophagy.	[Gauthier, Thierry; Claude-Taupin, Aurore; Delage-Mourroux, Regis; Boyer-Guittaut, Michael; Hervouet, Eric] Univ Franche Comte, Biochim Lab, Estrogenes Express Genique & Pathol Syst Nerveux, UFR Sci & Tech,SFR IBCT FED4234, F-25030 Besancon, France	Universite de Franche-Comte	Hervouet, E (corresponding author), Univ Franche Comte, Biochim Lab, Estrogenes Express Genique & Pathol Syst Nerveux, UFR Sci & Tech,SFR IBCT FED4234, F-25030 Besancon, France.	eric.hervouet@univ-fcomte.fr	Hervouet, Eric/U-5784-2019; Claude-Taupin, Aurore/GQW-6605-2022; Gauthier, Thierry/GQZ-4264-2022; DELAGE-MOURROUX, Régis/ABE-1424-2021; Guittaut, Michael/ABE-4274-2021	Claude-Taupin, Aurore/0000-0002-0792-4295; DELAGE-MOURROUX, Régis/0000-0002-7145-5948; Guittaut, Michael/0000-0001-9540-5593; Hervouet, Eric/0000-0002-4841-7812	University of Franche-Comte; "Ministere de l'Enseignement Superieur et de la Recherche" (MESR); Region de Franche-Comte; fellowship of "Region de Franche-Comte"; Conference de Coordination Interregional du Grand-Est "Ligue Contre le Cancer" [007.Y-2014]	University of Franche-Comte; "Ministere de l'Enseignement Superieur et de la Recherche" (MESR)(Ministry of Research, France); Region de Franche-Comte(Region Bourgogne-Franche-Comte); fellowship of "Region de Franche-Comte"(Region Bourgogne-Franche-Comte); Conference de Coordination Interregional du Grand-Est "Ligue Contre le Cancer"	This work was supported by 1) the University of Franche-Comte, 2) "Ministere de l'Enseignement Superieur et de la Recherche" (MESR) and fundings from 1) "Region de Franche-Comte" 2013 : EH 2) fellowship of "Region de Franche-Comte". : ACT 3) Conference de Coordination Interregional du Grand-Est "Ligue Contre le Cancer" 2014 (#007.Y-2014) : EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; [Anonymous], 2014, Cancer Discov, V4, pOF17, DOI [10.1158/2159-8290.CD-RW2014-196, 10.1158/2159-8290.CD-RW2014-152]; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390; Buckingham EM, 2014, BIOTECHNIQUES, V57, P241, DOI 10.2144/000114226; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Cieehomska IA, 2007, AUTOPHAGY, V3, P586, DOI 10.4161/auto.4843; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korkhov VM, 2009, J CELL BIOCHEM, V107, P86, DOI 10.1002/jcb.22103; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Nyfeler B, 2012, METHODS MOL BIOL, V821, P239, DOI 10.1007/978-1-61779-430-8_14; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Park S, 2014, AUTOPHAGY, V10, P1906, DOI 10.4161/auto.32177; Shvets E, 2011, AUTOPHAGY, V7, P683, DOI 10.4161/auto.7.7.15279; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi Y, 2013, AUTOPHAGY, V9, P1107, DOI 10.4161/auto.24817; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74	28	11	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128701	10.1371/journal.pone.0128701	http://dx.doi.org/10.1371/journal.pone.0128701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034986	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100043
J	Jalali, S; Kohli, S; Latka, C; Bhatia, S; Vellarikal, SK; Sivasubbu, S; Scaria, V; Ramachandran, S				Jalali, Saakshi; Kohli, Samantha; Latka, Chitra; Bhatia, Sugandha; Vellarikal, Shamsudheen Karuthedath; Sivasubbu, Sridhar; Scaria, Vinod; Ramachandran, Srinivasan			Screening Currency Notes for Microbial Pathogens and Antibiotic Resistance Genes Using a Shotgun Metagenomic Approach	PLOS ONE			English	Article							BACTERIAL-CONTAMINATION; FOMITES; IDENTIFICATION; ASPERGILLOSIS; DISCOVERY; SEQUENCES; RESERVOIR; ENZYMES; COINS	Fomites are a well-known source of microbial infections and previous studies have provided insights into the sojourning microbiome of fomites from various sources. Paper currency notes are one of the most commonly exchanged objects and its potential to transmit pathogenic organisms has been well recognized. Approaches to identify the microbiome associated with paper currency notes have been largely limited to culture dependent approaches. Subsequent studies portrayed the use of 16S ribosomal RNA based approaches which provided insights into the taxonomical distribution of the microbiome. However, recent techniques including shotgun sequencing provides resolution at gene level and enable estimation of their copy numbers in the metagenome. We investigated the microbiome of Indian paper currency notes using a shotgun metagenome sequencing approach. Metagenomic DNA isolated from samples of frequently circulated denominations of Indian currency notes were sequenced using Illumina Hiseq sequencer. Analysis of the data revealed presence of species belonging to both eukaryotic and prokaryotic genera. The taxonomic distribution at kingdom level revealed contigs mapping to eukaryota (70%), bacteria (9%), viruses and archae (similar to 1%). We identified 78 pathogens including Staphylococcus aureus, Corynebacterium glutamicum, Enterococcus faecalis, and 75 cellulose degrading organisms including Acidothermus cellulolyticus, Cellulomonas flavigena and Ruminococcus albus. Additionally, 78 antibiotic resistance genes were identified and 18 of these were found in all the samples. Furthermore, six out of 78 pathogens harbored at least one of the 18 common antibiotic resistance genes. To the best of our knowledge, this is the first report of shotgun metagenome sequence dataset of paper currency notes, which can be useful for future applications including as bio-surveillance of exchangeable fomites for infectious agents.	[Jalali, Saakshi; Scaria, Vinod; Ramachandran, Srinivasan] CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi 110020, India; [Kohli, Samantha] CSIR, Inst Genom & Integrat Biol, Funct Genom Unit, New Delhi 110001, India; [Latka, Chitra] CSIR, Inst Genom & Integrat Biol, Struct Biol Unit, New Delhi 110020, India; [Bhatia, Sugandha] CSIR, Inst Genom & Integrat Biol, Resp Dis Biol Unit, Delhi 110007, India; [Vellarikal, Shamsudheen Karuthedath; Sivasubbu, Sridhar] CSIR, Inst Genom & Integrat Biol, Genom & Mol Med Unit, Delhi, India; [Jalali, Saakshi; Kohli, Samantha; Latka, Chitra; Bhatia, Sugandha; Vellarikal, Shamsudheen Karuthedath; Sivasubbu, Sridhar; Scaria, Vinod; Ramachandran, Srinivasan] Acad Sci & Innovat Res AcSIR, Delhi 110020, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR)	Sivasubbu, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Genom & Mol Med Unit, Mathura Rd, Delhi, India.	sridhar@igib.res.in; vinods@igib.res.in; ramu@igib.in	Scaria, Vinod/AAS-3151-2021; Sharma, Dr. Samantha/AAY-7184-2021; Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022	Sharma, Dr. Samantha/0000-0001-9599-4455; Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Scaria, Vinod/0000-0001-7644-7181; Bhatia, Sugandha/0000-0003-3092-8283	Council of Scientific and Industrial Research [OLP1105]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The project was funded by The Council of Scientific and Industrial Research through grant OLP1105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS BL, 1972, J AMER MED ASSOC, V219, P1202, DOI 10.1001/jama.219.9.1202; Akoachere Jane-Francis Tatah Kihla, 2014, BMC Res Notes, V7, P16, DOI 10.1186/1756-0500-7-16; Al-Ghamdi AK, 2011, SE ASIAN J TROP MED, V42, P711; Andrews S., 2010, FASTQC QUALITY CONTR; Angelakis E, 2014, FUTURE MICROBIOL, V9, P249, DOI 10.2217/fmb.13.161; [Anonymous], 2014, PATH MICR; [Anonymous], 2014, VIRUS PATHOGEN RESOU; [Anonymous], 2011, INDIAN POPULATION ST; [Anonymous], 2013, ONLINE TEXTBOOK OF B; Awodi NO, 2000, NIGERIAN J PARASITOL, V122, P137; Basavarajappa K G, 2005, Indian J Pathol Microbiol, V48, P278; Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Brady G, 2000, ASSESSMENT PUBLIC HL; Bragg L, 2014, METHODS MOL BIOL, V1096, P183, DOI 10.1007/978-1-62703-712-9_15; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Charnock C, 2005, BRIT J GEN PRACT, V55, P37; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Daniel R, 2004, CURR OPIN BIOTECH, V15, P199, DOI 10.1016/j.copbio.2004.04.005; De Filippo C, 2012, BRIEF BIOINFORM, V13, P696, DOI 10.1093/bib/bbs070; Denning DW, 2006, MED MYCOL, V44, pS1, DOI 10.1080/13693780600931192; El-Dars FMSE, 2005, INT J ENVIRON HEAL R, V15, P235, DOI 10.1080/09603120500105976; Elumalai EK, 2012, INT J OCCUP ENV MED, V3, P204; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; EuPathDB, 2014, EU PATH DAT RES; FELSENFELD O, 1965, B WORLD HEALTH ORGAN, V33, P725; Goktas Pasa, 1992, Mikrobiyoloji Bulteni, V26, P344; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Julian TR, 2011, APPL ENVIRON MICROB, V77, P6918, DOI 10.1128/AEM.05709-11; Kalita M, 2013, POL J MICROBIOL, V62, P281, DOI 10.33073/pjm-2013-036; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kennedy J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-27; Khin Nwe O o, 1989, J Diarrhoeal Dis Res, V7, P92; Knudsen T, 2014, CLC GENOMICS BENCHWO, V6; Kulahoglu C, 2014, METHODS MOL BIOL, V1158, P71, DOI 10.1007/978-1-4939-0700-7_5; Kuria J K N, 2009, East Afr Med J, V86, P151; Lalonde M, 2007, THE GAZETTE, V1, P1; Lamichhane J., 2009, NEPAL J SCI TECHNOL, V10, P161; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Markowitz VM, 2006, BIOINFORMATICS, V22, pE359, DOI 10.1093/bioinformatics/btl217; Michaels B., 2002, Food Service Technology, V2, P1, DOI 10.1046/j.1471-5740.2002.00030.x; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Pope CTW, 2002, SOUTH MED J, V95, P1408, DOI 10.1097/00007611-200295120-00011; Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; SATTAR SA, 1986, J HYG-CAMBRIDGE, V96, P277, DOI 10.1017/S0022172400066055; Schmieder R, 2012, FUTURE MICROBIOL, V7, P73, DOI [10.2217/fmb.11.135, 10.2217/FMB.11.135]; Siddique S, 2003, MANILA PHILIPPINE HE; Singh N, 2006, MED MYCOL, V44, P445, DOI 10.1080/13693780600684494; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Talaro KP, 2013, FDN MICROBIOLOGY; Tu QC, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku138; Uneke CJ, 2007, J ENVIRON HEALTH, V69, P54; Wamae C N, 2009, East Afr Med J, V86, P149; Wanule Dinesh, 2011, Journal of Environmental Science & Engineering, V53, P515; Xu JR, 2005, J ENVIRON HEALTH, V67, P51; Yildiran ST, 2006, MED MYCOL, V44, P665, DOI 10.1080/13693780600717161; Yoon SH, 2007, NUCL ACIDS RES; Yun J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-8; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	65	15	16	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128711	10.1371/journal.pone.0128711	http://dx.doi.org/10.1371/journal.pone.0128711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035208	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100044
J	Ansbro, EM; Gill, MM; Reynolds, J; Shelley, KD; Strasser, S; Sripipatana, T; Ncube, AT; Mumba, GT; Terris-Prestholt, F; Peeling, RW; Mabey, D				Ansbro, Eimhin M.; Gill, Michelle M.; Reynolds, Joanna; Shelley, Katharine D.; Strasser, Susan; Sripipatana, Tabitha; Ncube, Alexander Tshaka; Mumba, Grace Tembo; Terris-Prestholt, Fern; Peeling, Rosanna W.; Mabey, David			Introduction of Syphilis Point-of-Care Tests, from Pilot Study to National Programme Implementation in Zambia: A Qualitative Study of Healthcare Workers' Perspectives on Testing, Training and Quality Assurance	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; ANTENATAL SYPHILIS; CONGENITAL-SYPHILIS; MALARIA DIAGNOSIS; MATERNAL SYPHILIS; HIV; PREGNANCY; OPPORTUNITIES	Syphilis affects 1.4 million pregnant women globally each year. Maternal syphilis causes congenital syphilis in over half of affected pregnancies, leading to early foetal loss, pregnancy complications, stillbirth and neonatal death. Syphilis is under-diagnosed in pregnant women. Point-of-care rapid syphilis tests (RST) allow for same-day treatment and address logistical barriers to testing encountered with standard Rapid Plasma Reagin testing. Recent literature emphasises successful introduction of new health technologies requires healthcare worker (HCW) acceptance, effective training, quality monitoring and robust health systems. Following a successful pilot, the Zambian Ministry of Health (MoH) adopted RST into policy, integrating them into prevention of mother-to-child transmission of HIV clinics in four underserved Zambian districts. We compare HCW experiences, including challenges encountered in scaling up from a highly supported NGO-led pilot to a large-scale MoH-led national programme. Questionnaires were administered through structured interviews of 16 HCWs in two pilot districts and 24 HCWs in two different rollout districts. Supplementary data were gathered via stakeholder interviews, clinic registers and supervisory visits. Using a conceptual framework adapted from health technology literature, we explored RST acceptance and usability. Quantitative data were analysed using descriptive statistics. Key themes in qualitative data were explored using template analysis. Overall, HCWs accepted RST as learnable, suitable, effective tools to improve antenatal services, which were usable in diverse clinical settings. Changes in training, supervision and quality monitoring models between pilot and rollout may have influenced rollout HCW acceptance and compromised testing quality. While quality monitoring was integrated into national policy and training, implementation was limited during rollout despite financial support and mentorship. We illustrate that new health technology pilot research can rapidly translate into policy change and scale-up. However, training, supervision and quality assurance models should be reviewed and strengthened as rollout of the Zambian RST programme continues.	[Ansbro, Eimhin M.; Peeling, Rosanna W.; Mabey, David] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Gill, Michelle M.] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA; [Reynolds, Joanna] London Sch Hyg & Trop Med, Dept Social & Environm Hlth, London WC1, England; [Shelley, Katharine D.] George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA; [Strasser, Susan; Ncube, Alexander Tshaka] Elizabeth Glaser Pediat AIDS Fdn, Lusaka, Zambia; [Sripipatana, Tabitha] US Agcy Int Dev, Off Populat & Reprod Hlth, Washington, DC 20523 USA; [Mumba, Grace Tembo] Minist Hlth, HIV AIDS STI Programme, Lusaka, Zambia; [Terris-Prestholt, Fern] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; George Washington University; United States Agency for International Development (USAID); University of London; London School of Hygiene & Tropical Medicine	Ansbro, EM (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.	ansbroe@yahoo.co.uk		Mabey, David/0000-0002-0031-8276; Terris-Prestholt, Fern/0000-0003-1693-5196	UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases through a grant from the Bill & Melinda Gates Foundation [OPP 47697]	UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases through a grant from the Bill & Melinda Gates Foundation	Funding for the pilot study was from UNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases through a grant from the Bill & Melinda Gates Foundation (grant no. OPP 47697). The authors received no specific funding for the rollout evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance GHW, 2008, SCALING SAVING LIVES; Ansah EK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-258; Asiimwe C, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-5; Bates I, 2006, CLIN INFECT DIS, V42, P383, DOI 10.1086/499368; Blandford JM, 2007, SEX TRANSM DIS, V34, pS61, DOI 10.1097/01.olq.0000258314.20752.5f; Blattner K, 2010, J PRIM HEALTH CARE, V2, P54, DOI 10.1071/HC10054; Bristow CC, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu015; Broome C, 2005, MED INFORM INTERNET, V30, P83, DOI 10.1080/14639230500298750; Central Statistical Office (CSO), 2007, ZAMB DEM HLTH SURV 2; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2012, SOC SCI MED, V74, P1528, DOI 10.1016/j.socscimed.2012.01.025; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Chuttur MY, 2009, SPROUTS WORKING PAPE; Department of Reproductive Health and Research World Health Organization, 2007, WHO GLOB EL CONG SYP; Deperthes BD, 2004, B WORLD HEALTH ORGAN, V82, P410; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Ferrinho P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-30; Finelli L, 1998, Bull World Health Organ, V76 Suppl 2, P126; Garcia SG, 2007, SEX TRANSM DIS, V34, pS37, DOI 10.1097/olq.0000251236.48770.35; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gloyd S, 2007, SEX TRANSM DIS, V34, pS31, DOI 10.1097/01.olq.0000264586.49616.72; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Herring A, 2006, NAT REV MICROBIOL, pS33, DOI 10.1038/nrmicro1563; Jafari Y, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/465932; Jeng J, 2005, INFORM TECHNOL LIBR, V24, P47, DOI 10.6017/ital.v24i2.3365; King N., 2012, TEMPLATE ANAL; Kyabayinze DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-291; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Loubiere S, 2010, CLIN MICROBIOL INFEC, V16, P1070, DOI 10.1111/j.1469-0691.2010.03280.x; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Observatory GH, 2012, ZAMBIA COUNTRY HLTH; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Parekh BS, 2010, AM J CLIN PATHOL, V134, P573, DOI 10.1309/AJCPTDIMFR00IKYX; Pearce J, 2012, J CONTIN EDUC HEALTH, V32, P215, DOI 10.1002/chp.21148; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peeling RW, 2004, LANCET, V364, P1561, DOI 10.1016/S0140-6736(04)17327-3; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Potter D, 2006, SEX TRANSM DIS, V33, P604, DOI 10.1097/01.olq.0000216029.00424.ae; Rafi M., 2010, ED RES REV, V5, P64; Reynolds J, 2013, QUAL HEALTH RES, V23, P579, DOI 10.1177/1049732312470761; Ridde Valery, 2010, TROP MED INT HEALTH, DOI [10.1111/j.1365-3156.2010.02607.x, DOI 10.1111/J.1365-3156.2010.02607.X]; Schito M, 2012, J INFECT DIS, V205, pS169, DOI 10.1093/infdis/jis044; Schmid GP, 2007, SEX TRANSM DIS, V34, pS5, DOI 10.1097/01.olq.0000261456.09797.1b; Shelley KD, 2015, REV; Shott JP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/651927; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; Sweeney S, 2014, HEALTH POLICY PLANN, V29, P633, DOI 10.1093/heapol/czt049; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Vian T, 2013, HEALTH POLICY PLANN, V28, P237, DOI 10.1093/heapol/czs056; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; WHO, 2014, COUNTR STAT; Wilkinson D, 1997, TROP MED INT HEALTH, V2, P57, DOI 10.1046/j.1365-3156.1997.d01-127.x; World Health Organization, 2002, PROV EFF ANT CAR INT; World Health Organization, 2012, INV CAS EL MOTH TO C; Yamey G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001049; Yao K, 2010, AM J CLIN PATHOL, V134, P568, DOI 10.1309/AJCPOPXR8MNTZ5PY; Zambian MoH, 2011, NATL PROGRAMME PREVE	62	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127728	10.1371/journal.pone.0127728	http://dx.doi.org/10.1371/journal.pone.0127728			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030741	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000356630900077
J	Chen, JP; Burke, JJ				Chen, Junping; Burke, John J.			Developing Fiber Specific Promoter-Reporter Transgenic Lines to Study the Effect of Abiotic Stresses on Fiber Development in Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM-L; GENE-EXPRESSION; HIGHER-PLANTS; ELONGATION; QUALITY; BINDING; PROTEIN; CLONING; TEMPERATURES; SYNTHASE	Cotton is one of the most important cash crops in US agricultural industry. Environmental stresses, such as drought, high temperature and combination of both, not only reduce the overall growth of cotton plants, but also greatly decrease cotton lint yield and fiber quality. The impact of environmental stresses on fiber development is poorly understood due to technical difficulties associated with the study of developing fiber tissues and lack of genetic materials to study fiber development. To address this important question and provide the need for scientific community, we have generated transgenic cotton lines harboring cotton fiber specific promoter (CFSP)-reporter constructs from six cotton fiber specific genes (Expansin, E6, Rac13, CelA1, LTP, and Fb late), representing genes that are expressed at different stages of fiber development. Individual CFSP::GUS or CFSP::GFP construct was introduced into Coker 312 via Agrobacterium mediated transformation. Transgenic cotton lines were evaluated phenotypically and screened for the presence of selectable marker, reporter gene expression, and insertion numbers. Quantitative analysis showed that the patterns of GUS reporter gene activity during fiber development in transgenic cotton lines were similar to those of the native genes. Greenhouse drought and heat stress study showed a correlation between the decrease in promoter activities and decrease in fiber length, increase in micronaire and changes in other fiber quality traits in transgenic lines grown under stressed condition. These newly developed materials provide new molecular tools for studying the effects of abiotic stresses on fiber development and may be used in study of cotton fiber development genes and eventually in the genetic manipulation of fiber quality.	[Chen, Junping; Burke, John J.] ARS, Plant Stress & Germplasm Dev Unit, Cropping Syst Res Lab, USDA, Lubbock, TX 79415 USA	United States Department of Agriculture (USDA)	Chen, JP (corresponding author), ARS, Plant Stress & Germplasm Dev Unit, Cropping Syst Res Lab, USDA, Lubbock, TX 79415 USA.	junping.chen@ars.usda.gov			Cotton Incorporated [05-711]	Cotton Incorporated(Cotton R&D Corp)	This work was supported by the Cotton Incorporated, http://www.cottoninc.com/ Project No. 05-711 to JB and JC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RD, 2011, STRESS PHYSL COTTON, P149; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BAYLEY C, 1992, THEOR APPL GENET, V83, P645, DOI 10.1007/BF00226910; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIOU GT, 1993, AM J AGR ECON, V75, P467, DOI 10.2307/1242931; DELMER DP, 1995, MOL GEN GENET, V248, P43, DOI 10.1007/BF02456612; Fleming AJ, 1996, PLANT J, V10, P745, DOI 10.1046/j.1365-313X.1996.10040745.x; GIPSON JR, 1969, CROP SCI, V9, P127, DOI 10.2135/cropsci1969.0011183X000900020004x; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Indrais E, 2011, INT J AGRIC BIOL, V13, P89; JEFFERSON RA, 1987, EMBO J, V6, P3901; JOHN ME, 1992, P NATL ACAD SCI USA, V89, P5769, DOI 10.1073/pnas.89.13.5769; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Kristiansson E, 2009, MOL BIOL EVOL, V26, P1299, DOI 10.1093/molbev/msp040; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lokhande S, 2014, AGRON J, V106, P1060, DOI 10.2134/agronj13.0537; Orford SJ, 1998, BBA-GENE STRUCT EXPR, V1398, P342, DOI 10.1016/S0167-4781(98)00065-7; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Pettigrew WT, 2008, CROP SCI, V48, P278, DOI 10.2135/cropsci2007.05.0261; Rinehart JA, 1996, PLANT PHYSIOL, V112, P1331, DOI 10.1104/pp.112.3.1331; ROBERTS EM, 1992, PLANT PHYSIOL, V100, P979, DOI 10.1104/pp.100.2.979; Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Santamaria M, 2001, PLANT MOL BIOL, V47, P641, DOI 10.1023/A:1012410009930; SCHWOB E, 1993, PLANT J, V4, P423, DOI 10.1046/j.1365-313X.1993.04030423.x; Shahmuradov IA, 2005, NUCLEIC ACIDS RES, V33, P1069, DOI 10.1093/nar/gki247; Snowden MC, 2014, AGRON J, V106, P452, DOI 10.2134/agronj2013.0325; TROLINDER NL, 1987, PLANT CELL REP, V6, P231, DOI 10.1007/BF00268487; Xin Z, 2006, DNA SEQUENCING, P47; Zhu HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-40	30	7	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129870	10.1371/journal.pone.0129870	http://dx.doi.org/10.1371/journal.pone.0129870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030401	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900235
J	Gordo-Remartinez, S; Calderon-Moreno, M; Fernandez-Herranz, J; Castuera-Gil, A; Gallego-Alonso-Colmenares, M; Puertas-Lopez, C; Nuevo-Gonzalez, JA; Sanchez-Sendin, D; Garcia-Gamiz, M; Sevillano-Fernandez, JA; Alvarez-Sala, LA; Andueza-Lillo, JA; de Miguel-Yanes, JM				Gordo-Remartinez, Susana; Calderon-Moreno, Mara; Fernandez-Herranz, Juan; Castuera-Gil, Ana; Gallego-Alonso-Colmenares, Mar; Puertas-Lopez, Carolina; Nuevo-Gonzalez, Jose A.; Sanchez-Sendin, Domingo; Garcia-Gamiz, Mercedes; Sevillano-Fernandez, Jose A.; Alvarez-Sala, Luis A.; Andueza-Lillo, Juan A.; de Miguel-Yanes, Jose M.			Usefulness of Midregional Proadrenomedullin to Predict Poor Outcome in Patients with Community Acquired Pneumonia	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; SEVERITY INDEX; GUIDELINES; MANAGEMENT; RISK; ADRENOMEDULLIN; PROCALCITONIN; INFLAMMATION; BIOMARKERS; DISEASES	Background midregional proadrenomedullin (MR-proADM) is a prognostic biomarker in patients with community-acquired pneumonia (CAP). We sought to confirm whether MR-proADM added to Pneumonia Severity Index (PSI) improves the potential prognostic value of PSI alone, and tested to what extent this combination could be useful in predicting poor outcome of patients with CAP in an Emergency Department (ED). Methods Consecutive patients diagnosed with CAP were enrolled in this prospective, single-centre, observational study. We analyzed the ability of MR-proADM added to PSI to predict poor outcome using receiver operating characteristic (ROC) curves, logistic regression and risk reclassification and comparing it with the ability of PSI alone. The primary outcome was "poor outcome", defined as the incidence of an adverse event (ICU admission, hospital readmission, or mortality at 30 days after CAP diagnosis). Results 226 patients were included; 33 patients (14.6%) reached primary outcome. To predict primary outcome the highest area under curve (AUC) was found for PSI (0.74 [0.64-0.85]), which was not significantly higher than for MR-proADM (AUC 0.72 [0.63-0.81, p > 0.05]). The combination of PSI and MR-proADM failed to improve the predictive potential of PSI alone (AUC 0.75 [0.65-0.85, p=0.56]). Ten patients were appropriately reclassified when the combined PSI and MR-proADM model was used as compared with the model of PSI alone. Net reclassification improvement (NRI) index was statistically significant (7.69%, p = 0.03) with an improvement percentage of 3.03% (p = 0.32) for adverse event, and 4.66% (P = 0.02) for no adverse event. Conclusion MR-proADM in combination with PSI may be helpful in individual risk stratification for short-term poor outcome of CAP patients, allowing a better reclassification of patients compared with PSI alone.	[Gordo-Remartinez, Susana; Calderon-Moreno, Mara; Fernandez-Herranz, Juan; Castuera-Gil, Ana; Gallego-Alonso-Colmenares, Mar; Nuevo-Gonzalez, Jose A.; Sanchez-Sendin, Domingo; Garcia-Gamiz, Mercedes; Sevillano-Fernandez, Jose A.; Andueza-Lillo, Juan A.] Hosp Gen Univ Gregorio Maranon, Emergency Dept, Madrid, Spain; [Puertas-Lopez, Carolina] Hosp Gen Univ Gregorio Maranon, Dept Biochem, Madrid, Spain; [Alvarez-Sala, Luis A.; de Miguel-Yanes, Jose M.] Hosp Gen Univ Gregorio Maranon, Dept Internal Med, Madrid, Spain; [Alvarez-Sala, Luis A.; Andueza-Lillo, Juan A.] Univ Complutense Madrid, Fac Med, Dept Med, E-28040 Madrid, Spain	General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Complutense University of Madrid	Gordo-Remartinez, S (corresponding author), Hosp Gen Univ Gregorio Maranon, Emergency Dept, Madrid, Spain.	susanagordo79@gmail.com	Calderon-Moreno, Maria/E-9028-2018	Calderon-Moreno, Maria/0000-0002-5032-0331; de Miguel-Yanes, Jose M./0000-0003-2802-033X	Thermo Scientific	Thermo Scientific	Susana Gordo-Remartinez and Juan Andueza-Lillo received modest honoraria (500 [SIC] each) for a lecture in one meeting sponsored by Thermo Scientific. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Albrich WC, 2013, EUR RESPIR J, V42, P1064, DOI 10.1183/09031936.00113612; Albrich WC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-112; Almirall J, 2000, EUR RESPIR J, V15, P757, DOI 10.1034/j.1399-3003.2000.15d21.x; Aujesky D, 2008, CLIN INFECT DIS, V47, pS133, DOI 10.1086/591394; Aujesky D, 2009, CLIN INFECT DIS, V49, pE100, DOI 10.1086/644741; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Bello S, 2012, EUR RESPIR J, V39, P1144, DOI 10.1183/09031936.00080411; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Chalmers JD, 2010, J ANTIMICROB CHEMOTH, V65, P608, DOI 10.1093/jac/dkq038; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christ-Crain M, 2005, CRIT CARE, V9, pR816, DOI 10.1186/cc3885; Courtais C, 2013, AM J EMERG MED, V31, P215, DOI 10.1016/j.ajem.2012.07.017; Ewig S, 2011, EUR RESPIR J, V38, P253, DOI 10.1183/09031936.00199810; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Grupo de estudio de las infecciones en urgencias, 2000, EMERGENCIAS, V12, P80; Gutierrez Macias A, 2000, EMERGENCIAS, V12, P77; Huang DT, 2009, CHEST, V136, P823, DOI 10.1378/chest.08-1981; Julian-Jimenez A, 2014, ENFERM INFEC MICR CL, V32, P225, DOI 10.1016/j.eimc.2013.04.015; Kruger S, 2010, AM J RESP CRIT CARE, V182, P1426, DOI 10.1164/rccm.201003-0415OC; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Linscheid P, 2005, ENDOCRINOLOGY, V146, P2699, DOI 10.1210/en.2004-1424; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Menendez R, 2010, ARCH BRONCONEUMOL, V46, P543, DOI 10.1016/j.arbres.2010.06.014; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Renaud B, 2012, CHEST, V142, P1447, DOI 10.1378/chest.11-2574; Schuetz P, 2010, CRIT CARE, V14, DOI 10.1186/cc9055; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Seligman R, 2012, CLINICS, V67, P1321, DOI 10.6061/clinics/2012(11)17; Welte T, 2004, INFECTION, V32, P234, DOI 10.1007/s15010-004-3107-z; Yealy DM, 2005, ANN INTERN MED, V143, P881, DOI 10.7326/0003-4819-143-12-200512200-00006	34	20	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0125212	10.1371/journal.pone.0125212	http://dx.doi.org/10.1371/journal.pone.0125212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030588	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900012
J	Hayward, AD; Lummaa, V; Bazykin, GA				Hayward, Adam D.; Lummaa, Virpi; Bazykin, Georgii A.			Fitness Consequences of Advanced Ancestral Age over Three Generations in Humans	PLOS ONE			English	Article							DE-NOVO MUTATIONS; COPY NUMBER VARIATION; LIFE-HISTORY TRAITS; PATERNAL-AGE; PARENTAL AGE; PREINDUSTRIAL HUMANS; NATURAL-SELECTION; EPIGENETIC MECHANISMS; REPRODUCTIVE SUCCESS; HUMAN-POPULATIONS	A rapid rise in age at parenthood in contemporary societies has increased interest in reports of higher prevalence of de novo mutations and health problems in individuals with older fathers, but the fitness consequences of such age effects over several generations remain untested. Here, we use extensive pedigree data on seven pre-industrial Finnish populations to show how the ages of ancestors for up to three generations are associated with fitness traits. Individuals whose fathers, grandfathers and great-grandfathers fathered their lineage on average under age 30 were similar to 13% more likely to survive to adulthood than those whose ancestors fathered their lineage at over 40 years. In addition, females had a lower probability of marriage if their male ancestors were older. These findings are consistent with an increase of the number of accumulated de novo mutations with male age, suggesting that deleterious mutations acquired from recent ancestors may be a substantial burden to fitness in humans. However, possible non-mutational explanations for the observed associations are also discussed.	[Hayward, Adam D.; Lummaa, Virpi] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Hayward, Adam D.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Bazykin, Georgii A.] Russian Acad Sci, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow 127994, Russia; [Bazykin, Georgii A.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow 119992, Russia; [Bazykin, Georgii A.] Moscow MV Lomonosov State Univ, Belozersky Inst Phys & Chem Biol, Moscow 119992, Russia; [Bazykin, Georgii A.] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia	University of Sheffield; University of Edinburgh; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; Pirogov Russian National Research Medical University	Lummaa, V (corresponding author), Russian Acad Sci, Kharkevich Inst, Inst Informat Transmiss Problems, Bolshoy Karetny Pereulok 19, Moscow 127994, Russia.	v.lummaa@sheffield.ac.uk; gbazykin@iitp.ru	Lummaa, Virpi/AHB-0181-2022; Bazykin, Georgii/E-4601-2012; Hayward, Adam/B-7659-2016	Bazykin, Georgii/0000-0003-2334-2751; Hayward, Adam/0000-0001-6953-7509	European Research Council (ERC) grant; Russian Foundation for Basic Research grant [15-34-21135-mol_a_ved]	European Research Council (ERC) grant(European Research Council (ERC)); Russian Foundation for Basic Research grant(Russian Foundation for Basic Research (RFBR))	This work was partially supported by the European Research Council (ERC) grant to ADH and VL; and by the Russian Foundation for Basic Research grant #15-34-21135-mol_a_ved to GAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KG, 2006, CURR ANTHROPOL, V47, P513, DOI 10.1086/504167; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Buizer-Voskamp JE, 2011, SCHIZOPHR RES, V129, P128, DOI 10.1016/j.schres.2011.03.021; Courtiol A, 2012, P NATL ACAD SCI USA, V109, P8044, DOI 10.1073/pnas.1118174109; Crabtree GR, 2013, TRENDS GENET, V29, P1, DOI 10.1016/j.tig.2012.10.002; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Crow TJ, 2012, SCHIZOPHR RES, V139, P267, DOI 10.1016/j.schres.2012.03.010; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Eory L, 2010, MOL BIOL EVOL, V27, P177, DOI 10.1093/molbev/msp219; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Faurie C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005680; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frans EM, 2013, JAMA PSYCHIAT, V70, P516, DOI 10.1001/jamapsychiatry.2013.1180; Frans EM, 2011, SCHIZOPHR RES, V133, P120, DOI 10.1016/j.schres.2011.09.027; Gavrilov LA, 2001, SEX AND LONGEVITY: SEXUALITY, GENDER, REPRODUCTION, PARENTHOOD, P7; Gavrilov LA, 1997, SCIENCE, V277, P17; Gavrilov LA, 2012, BIODEMOGR SOC BIOL, V58, P14, DOI 10.1080/19485565.2012.666121; Gillespie DOS, 2013, EVOLUTION, V67, P1964, DOI 10.1111/evo.12078; GOURBIN C, 1999, GENUS, V55, P61, DOI DOI 10.2307/29788590; Guinchat V, 2012, ACTA OBSTET GYN SCAN, V91, P287, DOI 10.1111/j.1600-0412.2011.01325.x; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Hayward AD, 2013, P NATL ACAD SCI USA, V110, P13886, DOI 10.1073/pnas.1301817110; Hayward AD, 2012, P ROY SOC B-BIOL SCI, V279, P4165, DOI 10.1098/rspb.2012.1190; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hubbard RE, 2009, AGE AGEING, V38, P380, DOI 10.1093/ageing/afp035; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Hurles M, 2012, NAT GENET, V44, P1174, DOI 10.1038/ng.2448; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Keightley PD, 2012, GENETICS, V190, P295, DOI 10.1534/genetics.111.134668; Kemkes-Grottenthaler A, 2004, ANN HUM BIOL, V31, P139, DOI 10.1080/03014460410001663407; Kondrashov A, 2012, NATURE, V488, P467, DOI 10.1038/488467a; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lahdenpera M, 2007, P ROY SOC B-BIOL SCI, V274, P2437, DOI 10.1098/rspb.2007.0688; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lahdenpera M, 2011, EVOLUTION, V65, P476, DOI 10.1111/j.1558-5646.2010.01142.x; Larmuseau MHD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2400; LIAN ZH, 1986, AM J HUM GENET, V39, P648; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu YS, 2011, AGEING RES REV, V10, P115, DOI 10.1016/j.arr.2010.09.004; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; Lummaa V, 2001, J ANIM ECOL, V70, P739, DOI 10.1046/j.0021-8790.2001.00537.x; Lummaa V, 1998, J EVOLUTION BIOL, V11, P147; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McGrath J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077444; McRae AF, 2013, BEHAV GENET, V43, P202, DOI 10.1007/s10519-013-9587-9; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Moring B, 1996, CONTINUITY CHANGE, V11, P91, DOI 10.1017/S0268416000003106; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Nelson SM, 2013, HUM REPROD UPDATE, V19, P67, DOI 10.1093/humupd/dms043; Nitsch A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2313; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100; Parner ET, 2012, ANN EPIDEMIOL, V22, P143, DOI 10.1016/j.annepidem.2011.12.006; Perrin MC, 2007, SCHIZOPHRENIA BULL, V33, P1270, DOI 10.1093/schbul/sbm093; Pettay JE, 2005, P NATL ACAD SCI USA, V102, P2838, DOI 10.1073/pnas.0406709102; Pettay JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000606; Power RA, 2014, EUR J HUM GENET, V22, P386, DOI 10.1038/ejhg.2013.155; Rahbar MH, 2012, J AUTISM DEV DISORD, V42, P1928, DOI 10.1007/s10803-011-1438-z; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rickard IJ, 2010, ECOLOGY, V91, P3515, DOI 10.1890/10-0019.1; Robine JM, 2003, EXP GERONTOL, V38, P361, DOI 10.1016/S0531-5565(02)00245-0; Rutten BPF, 2009, SCHIZOPHRENIA BULL, V35, P1045, DOI 10.1093/schbul/sbp104; Salihu HM, 2003, OBSTET GYNECOL, V102, P1006, DOI 10.1016/S0029-7844(03)00739-7; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Schmidt L, 2012, HUM REPROD UPDATE, V18, P29, DOI 10.1093/humupd/dmr040; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Shabalina SA, 1997, P NATL ACAD SCI USA, V94, P13034, DOI 10.1073/pnas.94.24.13034; Sigle-Rushton W., 2004, FUTURE FAMILY, P116; Smith CL, 2010, CURR GENOMICS, V11, P447, DOI 10.2174/138920210793176001; Smith KR, 2009, SOC SCI MED, V68, P1649, DOI 10.1016/j.socscimed.2009.02.010; Spuhler JN, 1976, DEMOGRAPHIC ANTHR QU, P185; SUNDIN J, 1992, SOC SCI HIST, V16, P99, DOI 10.2307/1171323; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Weaver JR, 2009, MAMM GENOME, V20, P532, DOI 10.1007/s00335-009-9225-2; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7; Zhu JL, 2008, EUR J EPIDEMIOL, V23, P443, DOI 10.1007/s10654-008-9253-3	90	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128197	10.1371/journal.pone.0128197	http://dx.doi.org/10.1371/journal.pone.0128197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030274	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000356630900122
J	Joozdani, FA; Yari, F; Joozdani, PA; Nafisi, S				Joozdani, Farzaneh Abassi; Yari, Faramarz; Joozdani, Parvaneh Abassi; Nafisi, Shohreh			Interaction of Sulforaphane with DNA and RNA	PLOS ONE			English	Article							FORCE-FIELD; CRUCIFEROUS VEGETABLES; STRUCTURAL-ANALYSIS; CANCER; BINDING; ISOTHIOCYANATES; BROCCOLI; POLYMORPHISMS; INDUCTION; ENZYMES	Sulforaphane (SFN) is an isothiocyanate found in cruciferous vegetables with anti-inflammatory, anti-oxidant and anti-cancer activities. However, the antioxidant and anticancer mechanism of sulforaphane is not well understood. In the present research, we reported binding modes, binding constants and stability of SFN-DNA and -RNA complexes by Fourier transform infrared (FTIR) and UV-Visible spectroscopic methods. Spectroscopic evidence showed DNA intercalation with some degree of groove binding. SFN binds minor and major grooves of DNA and backbone phosphate (PO2), while RNA binding is through G, U, A bases with some degree of SFN-phosphate (PO2) interaction. Overall binding constants were estimated to be K(SFN-DNA)= 3.01 (+/- 0.035) x 10(4) M-1 and K(SFN-RNA) = 6.63 (+/- 0.042) x 10(3) M-1. At high SFN concentration (SFN/RNA = 1/1), DNA conformation changed from B to A occurred, while RNA remained in A-family structure.	[Joozdani, Farzaneh Abassi; Yari, Faramarz; Joozdani, Parvaneh Abassi] IAU, Sci & Res Branch, Dept Biol, Tehran, Iran; [Nafisi, Shohreh] IAU, Cent Tehran Branch, Dept Chem, Tehran, Iran; [Nafisi, Shohreh] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Nafisi, S (corresponding author), IAU, Cent Tehran Branch, Dept Chem, Tehran, Iran.	drshnafisi@gmail.com			Iran National Science Foundation, Tehran, Iran	Iran National Science Foundation, Tehran, Iran(Iran National Science Foundation (INSF))	Authors appreciate Iran National Science Foundation, Tehran, Iran for support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Ali HI, 2010, J COMPUT AID MOL DES, V24, P57, DOI 10.1007/s10822-009-9314-z; Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Andrushchenko V, 2002, J PHYS CHEM B, V106, P12623, DOI 10.1021/jp0262721; [Anonymous], 1987, BINDING CONSTANTS ME; Arakawa H, 2000, J BIOL CHEM, V275, P10150, DOI 10.1074/jbc.275.14.10150; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bryant CS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-47; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Couch GS, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj031; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Herr I, 2010, CANCER TREAT REV, V36, P377, DOI 10.1016/j.ctrv.2010.01.002; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Joseph MA, 2004, NUTR CANCER, V50, P206, DOI 10.1207/s15327914nc5002_11; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kanakis CD, 2007, CELL BIOCHEM BIOPHYS, V49, P29, DOI 10.1007/s12013-007-0037-2; Kanakis CD, 2005, J BIOMOL STRUCT DYN, V22, P719, DOI 10.1080/07391102.2005.10507038; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; LARSEN TA, 1989, J BIOMOL STRUCT DYN, V7, P477, DOI 10.1080/07391102.1989.10508505; LOPRETE DM, 1993, BIOCHEMISTRY-US, V32, P4077, DOI 10.1021/bi00066a032; MARMUR J, 1961, J MOL BIOL, V3, P585, DOI 10.1016/S0022-2836(61)80023-5; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; N'soukpoe-Kossi CN, 2008, DNA CELL BIOL, V27, P337, DOI 10.1089/dna.2008.0727; Nafisi S, 2008, J MOL STRUCT, V875, P392, DOI 10.1016/j.molstruc.2007.05.010; Nafisi S, 2009, DNA CELL BIOL, V28, P201, DOI 10.1089/dna.2008.0840; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Ouameur AA, 2004, DNA CELL BIOL, V23, P783, DOI 10.1089/dna.2004.23.783; Ouameur AA, 2004, CAN J CHEM, V82, P1112, DOI 10.1139/V04-061; Polyanichko AM, 2004, NUCLEIC ACIDS RES, V32, P989, DOI 10.1093/nar/gkh242; POSNER GH, 1994, J MED CHEM, V37, P170, DOI 10.1021/jm00027a021; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Shan Y, 2006, INT J ONCOL, V29, P883; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; TAILLANDIER E, 1992, METHOD ENZYMOL, V211, P307; Tajmir-Riahi HA, 2009, SPECTROSC-INT J, V23, P81, DOI 10.1155/2009/587956; TAJMIRRIAHI HA, 1995, FEBS LETT, V370, P105, DOI 10.1016/0014-5793(95)00802-G; Vijayalakshmi R, 2000, BIOCHEM BIOPH RES CO, V271, P731, DOI 10.1006/bbrc.2000.2707; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, CANCER RES, V54, pS1976; Zhang Y, 2007, ACTA PHARMACOL SIN, V28, P1343, DOI 10.1111/j.1745-7254.2007.00679.x; Zhao H, 2007, INT J CANCER, V120, P2208, DOI 10.1002/ijc.22549	51	16	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127541	10.1371/journal.pone.0127541	http://dx.doi.org/10.1371/journal.pone.0127541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030290	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900058
J	Van Der Gucht, A; Sebaiti, MA; Itti, E; Aouizerate, J; Evangelista, E; Chalaye, J; Gherardi, RK; Ragunathan-Thangarajah, N; Bachoud-Levi, AC; Authier, FJ				Van Der Gucht, Axel; Sebaiti, Mehdi Aoun; Itti, Emmanuel; Aouizerate, Jessie; Evangelista, Eva; Chalaye, Julia; Gherardi, Romain K.; Ragunathan-Thangarajah, Nilusha; Bachoud-Levi, Anne-Catherine; Authier, Francois-Jerome			Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis	PLOS ONE			English	Article							POSTERIOR CINGULATE CORTEX; ALZHEIMERS-DISEASE; ALUMINUM HYDROXIDE; FOLLOW-UP; CEREBELLUM; MUSCLE; CNS	Background Patients with aluminum hydroxide adjuvant-induced macrophagic myofasciitis (MMF) complain of arthromyalgias, chronic fatigue and cognitive deficits. This study aimed to characterize brain perfusion in these patients. Methods Brain perfusion SPECT was performed in 76 consecutive patients (aged 49 +/- 10 y) followed in the Garches-Necker-Mondor-Hendaye reference center for rare neuromuscular diseases. Images were acquired 30 min after intravenous injection of 925 MBq Tc-99m-ethylcysteinate dimer (ECD) at rest. All patients also underwent a comprehensive battery of neuropsychological tests, within 1.3 +/- 5.5 mo from SPECT. Statistical parametric maps (SPM12) were obtained for each test using linear regressions between each performance score and brain perfusion, with adjustment for age, sex, socio-cultural level and time delay between brain SPECT and neuropsychological testing. Results SPM analysis revealed positive correlation between neuropsychological scores (mostly exploring executive functions) and brain perfusion in the posterior associative cortex, including cuneus/precuneus/occipital lingual areas, the periventricular white matter/corpus callosum, and the cerebellum, while negative correlation was found with amygdalo-hippocampal/entorhinal complexes. A positive correlation was also observed between brain perfusion and the posterior associative cortex when the time elapsed since last vaccine injection was investigated. Conclusions Brain perfusion SPECT showed a pattern of cortical and subcortical changes in accordance with the MMF-associated cognitive disorder previously described. These results provide a neurobiological substrate for brain dysfunction in aluminum hydroxide adjuvant-induced MMF patients.	[Van Der Gucht, Axel; Itti, Emmanuel; Evangelista, Eva; Chalaye, Julia] Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, F-94010 Creteil, France; [Aouizerate, Jessie; Authier, Francois-Jerome] Paris Est Univ, H Mondor Hosp, AP HP, Dept Neurol, F-94010 Creteil, France; [Aouizerate, Jessie; Gherardi, Romain K.; Authier, Francois-Jerome] Paris Est Univ, H Mondor Hosp, AP HP, Dept Pathol, F-94010 Creteil, France; [Aouizerate, Jessie; Gherardi, Romain K.; Ragunathan-Thangarajah, Nilusha; Authier, Francois-Jerome] Paris Est Univ, H Mondor Hosp, Reference Ctr Neuromuscular Disorders, F-94010 Creteil, France; [Aouizerate, Jessie; Gherardi, Romain K.; Ragunathan-Thangarajah, Nilusha; Authier, Francois-Jerome] INSERM, Team 10, U955, F-94010 Creteil, France; [Bachoud-Levi, Anne-Catherine] INSERM, Team 1, U955, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Itti, E (corresponding author), Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, F-94010 Creteil, France.	emmanuel.itti@hmn.aphp.fr	Bachoud-Lévi, Anne-Catherine/GYU-8680-2022	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; AUTHIER, Francois Jerome/0000-0002-0182-2052; Itti, Emmanuel/0000-0003-1578-4058; Van Der Gucht, Axel/0000-0002-2060-4210	French research program "Partenariats Institutions-Citoyens pour la Recherche et l'Innovation" (PICRI); French patients' association "Entraide des Malades de la Myofasciite a Macrophages" (E3M); "Association Francaise contre les Myopathies" (AFM)	French research program "Partenariats Institutions-Citoyens pour la Recherche et l'Innovation" (PICRI); French patients' association "Entraide des Malades de la Myofasciite a Macrophages" (E3M); "Association Francaise contre les Myopathies" (AFM)(Association Francaise contre les Myopathies)	N. Ranganuthan-Thangarajah was recipient of a fellowship from French research program "Partenariats Institutions-Citoyens pour la Recherche et l'Innovation" (PICRI) 2010. M. Aoun Sebaiti was recipient of a grant from the French patients' association "Entraide des Malades de la Myofasciite a Macrophages" (E3M). GNMH reference center (Centre de reference Maladies Neuromusculaires : Garches - Necker - Mondor Hendaye) is supported by grants from the "Association Francaise contre les Myopathies" (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authier FJ, 2003, ARTHRITIS RHEUM-US, V48, P569, DOI 10.1002/art.10740; Cadusseau J, 2014, CURR MED CHEM, V21, P511; Couette M, 2009, J INORG BIOCHEM, V103, P1571, DOI 10.1016/j.jinorgbio.2009.08.005; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Gadea M, 2009, BRAIN LANG, V110, P101, DOI 10.1016/j.bandl.2009.03.006; Gherardi RK, 1998, LANCET, V352, P347, DOI 10.1016/S0140-6736(98)02326-5; Gherardi RK, 2003, IMMUNOL ALLERGY CLIN, V23, P699, DOI 10.1016/S0889-8561(03)00095-X; Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Guedj E, 2008, J NUCL MED, V49, P1798, DOI 10.2967/jnumed.108.053264; Ichise M, 1997, J NUCL MED, V38, P1253; Khan Z, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-99; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Passeri E, 2011, J INORG BIOCHEM, V105, P1457, DOI 10.1016/j.jinorgbio.2011.08.006; Ragunathan-Thangarajah N, 2013, J INORG BIOCHEM, V128, P262, DOI 10.1016/j.jinorgbio.2013.07.020; REDHEAD K, 1992, PHARMACOL TOXICOL, V70, P278, DOI 10.1111/j.1600-0773.1992.tb00471.x; Rigolet M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00230; SAHIN G, 1994, BIOL TRACE ELEM RES, V41, P129, DOI 10.1007/BF02917223; Santiago T, 2015, RHEUMATOL INT, V35, P189, DOI 10.1007/s00296-014-3065-4; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; WEN GY, 1985, ACTA NEUROPATHOL, V68, P175, DOI 10.1007/BF00690191; Westerhausen R, 2009, CEREB CORTEX, V19, P1322, DOI 10.1093/cercor/bhn173	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128353	10.1371/journal.pone.0128353	http://dx.doi.org/10.1371/journal.pone.0128353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030650	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900140
J	Inohara, T; Kohsaka, S; Goto, M; Furukawa, Y; Fukushima, M; Sakata, R; Elayda, M; Wilson, JM; Kimura, T				Inohara, Taku; Kohsaka, Shun; Goto, Masashi; Furukawa, Yutaka; Fukushima, Masanori; Sakata, Ryuzo; Elayda, MacArthur; Wilson, James M.; Kimura, Takeshi			Hypothesis of Long-Term Outcome after Coronary Revascularization in Japanese Patients Compared to Multiethnic Groups in the US	PLOS ONE			English	Article							BASE-LINE CHARACTERISTICS; IN-HOSPITAL MORTALITY; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; CLINICAL-OUTCOMES; MEDICAL THERAPY; INTERVENTION; AMERICANS; WHITE; IMPACT	Background Ethnicity has a significant impact on coronary artery disease (CAD). This study investigated the long-term outcomes of Japanese patients undergoing revascularization compared with US patients belonging to multiple ethnic groups. Methods and Results We evaluated clinical outcomes, based on ethnicity, of patients included in the Coronary Revascularization Demonstrating Outcome (CREDO-Kyoto) and the Texas (US) Heart Institute Research Database (THIRDBase) registries. For the analysis, we included 8871 patients from the CREDO-Kyoto registry (median follow-up period [FU], 3.5 years; interquartile range [IQR], 2.6-4.3) and 6717 patients from the THIRDBase registry (FU, 5.2 years; IQR, 3.8-6.5) who underwent percutaneous coronary intervention or bypass surgery. Cox proportional hazard models were constructed to compare the adjusted long-term outcomes for each ethnic group. A total of 8871 Japanese, 5170 Caucasians, 648 African-Americans, 817 Hispanics, and 82 Asian-Americans were identified. When adjusted, Japanese patients had significantly better outcomes than US patients, classified by ethnicity (Caucasians: hazard ratio [HR], 1.56; 95% confidence interval [CI], 1.35-1.79; Hispanics: HR, 1.53; 95% CI, 1.22-1.93; African-Americans: HR, 2.03; 95% CI, 1.62-2.56), except for Asian-Americans (HR, 0.84; 95% CI. 0.38-1.89) who had outcomes similar to Japanese patients. Conclusion Our findings indicate better survival outcomes in re-vascularized Japanese CAD patients compared to major ethnic groups in the US, including Caucasian, Hispanic, and African-American CAD patients. The characteristics and outcomes of Japanese CAD patients were similar to those of Asian-Americans, despite the sample size limitations in the US dataset.	[Inohara, Taku; Kohsaka, Shun] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Goto, Masashi] Kyoto Univ Hlth Serv, Kyoto, Japan; [Furukawa, Yutaka] Kobe City Med Ctr Gen Hosp, Div Cardiol, Kobe, Hyogo, Japan; [Fukushima, Masanori] Kyoto Univ Hosp, Translat Res Ctr, Kyoto 606, Japan; [Sakata, Ryuzo] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Surg, Kyoto, Japan; [Elayda, MacArthur] Baylor St Lukes Med Ctr, Texas Heart Inst, Div Biostat, Houston, TX USA; [Wilson, James M.] Baylor St Lukes Med Ctr, Div Cardiol, Texas Heart Inst, Houston, TX USA; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Keio University; Kyoto University; Kobe City Medical Center General Hospital; Kyoto University; Kyoto University; Texas Heart Institute; Texas Heart Institute; Kyoto University	Kohsaka, S (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	kohsaka@cpnet.med.keio.ac.jp		Kohsaka, Shun/0000-0003-3779-2972	KAKENHI [25460630, 25460777]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research KAKENHI (No. 25460630 and 25460777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano J, 2011, GEN THORAC CARDIOVAS, V2013, P578, DOI [DOI 10.1007/S11748-013-0289-2, 10.1007/s11748-013-0289-2]; Berger JS, 2004, AM J CARDIOL, V94, P647, DOI 10.1016/j.amjcard.2004.05.033; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; EGUSA G, 1993, ATHEROSCLEROSIS, V100, P249, DOI 10.1016/0021-9150(93)90211-C; Endo A, 2013, AM J CARDIOVASC DRUG, V13, P103, DOI 10.1007/s40256-013-0021-8; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Hulten E, 2013, AM J CARDIOL, V111, P479, DOI 10.1016/j.amjcard.2012.10.028; Khambatta S, 2013, AM HEART J, V165, P893, DOI 10.1016/j.ahj.2013.02.030; Kim SW, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.07.012; Kohsaka S, 2008, J THORAC CARDIOV SUR, V136, P500, DOI 10.1016/j.jtcvs.2007.11.050; Kohsaka S, 2012, DIABETES CARE, V35, P654, DOI 10.2337/dc11-1547; Kohsaka S, 2010, AM J CARDIOL, V105, P1698, DOI 10.1016/j.amjcard.2010.01.349; Kumar RS, 2013, CIRCULATION, V127, P1395, DOI 10.1161/CIRCULATIONAHA.113.001437; Marks DS, 2000, AM HEART J, V140, P162, DOI 10.1067/mhj.2000.106645; Mehta RH, 2012, AM J CARDIOL, V109, P925, DOI 10.1016/j.amjcard.2011.11.019; Nakamura Y, 2008, AM J CLIN NUTR, V88, P424, DOI 10.1093/ajcn/88.2.424; Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001; Nishigaki K, 2008, JACC-CARDIOVASC INTE, V1, P469, DOI 10.1016/j.jcin.2008.08.002; Nishiyama K, 2010, INT J CARDIOL, V143, P178, DOI 10.1016/j.ijcard.2009.02.010; Palaniappan L, 2004, ANN EPIDEMIOL, V14, P499, DOI 10.1016/j.annepidem.2003.12.001; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; Pradhan J, 2008, CATHETER CARDIO INTE, V72, P36, DOI 10.1002/ccd.21556; Rusinova RP, 2013, AM J CARDIOL, V111, P979, DOI 10.1016/j.amjcard.2012.12.014; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Sekikawa A, 2011, STROKE, V42, P2538, DOI 10.1161/STROKEAHA.110.613042; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Slater J, 2003, AM J CARDIOL, V92, P773, DOI 10.1016/S0002-9149(03)00881-6; The Japanese Circulation Society, 2011, JCS NAT SURV MAN CAR; Thomas KL, 2010, AM HEART J, V160, P744, DOI 10.1016/j.ahj.2010.06.014; US Department of Health and Human Services Centers for Disease Ccontrol and Prevention National Center for Health Statistics, 2005, HLTH US 2005 CHARTB; Wang TY, 2007, AM J CARDIOL, V100, P391, DOI 10.1016/j.amjcard.2007.03.035; Watanabe H, 2003, ATHEROSCLEROSIS, V166, P67, DOI 10.1016/S0021-9150(02)00304-0; Xu WX, 2013, AM HEART J, V166, P1050, DOI 10.1016/j.ahj.2013.10.001	33	10	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128252	10.1371/journal.pone.0128252	http://dx.doi.org/10.1371/journal.pone.0128252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023784	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400076
J	Ming, YZ; Hu, J; Luo, QZ; Ding, X; Luo, WG; Zhuang, Q; Zou, YZ				Ming, Yingzi; Hu, Juan; Luo, Qizhi; Ding, Xiang; Luo, Weiguang; Zhuang, Quan; Zou, Yizhou			Acute Antibody-Mediated Rejection in Presence of MICA-DSA and Successful Renal Re-Transplant with Negative-MICA Virtual Crossmatch	PLOS ONE			English	Article							HLA ANTIBODIES; AUTOANTIBODIES	The presence of donor-specific alloantibodies (DSAs) against the MICA antigen results in high risk for antibody-mediated rejection (AMR) of a transplanted kidney, especially in patients receiving a re-transplant. We describe the incidence of acute C4d+ AMR in a patient who had received a first kidney transplant with a zero HLA antigen mismatch. Retrospective analysis of post-transplant T and B cell crossmatches were negative, but a high level of MICA alloantibody was detected in sera collected both before and after transplant. The DSA against the first allograft mismatched MICA*018 was in the recipient. Flow cytometry and cytotoxicity tests with five samples of freshly isolated human umbilical vein endothelial cells demonstrated the alloantibody nature of patient's MICA-DSA. Prior to the second transplant, a MICA virtual crossmatch and T and B cell crossmatches were used to identify a suitable donor. The patient received a second kidney transplant, and allograft was functioning well at one-year follow-up. Our study indicates that MICA virtual crossmatch is important in selection of a kidney donor if the recipient has been sensitized with MICA antigens.	[Ming, Yingzi; Zhuang, Quan] Ctr South Univ, Xiangya Hosp 3, Ctr Organ Transplantat, Changsha, Hunan, Peoples R China; [Hu, Juan; Luo, Qizhi; Luo, Weiguang; Zou, Yizhou] Ctr South Univ, Xiangya Sch Med, Dept Immunol, HLA Histocompatibil Lab, Changsha, Hunan, Peoples R China; [Ding, Xiang] Ctr South Univ, Xiangya Hosp, Dept Urol Surg, Changsha, Hunan, Peoples R China; [Zou, Yizhou] Cooperat Innovat Ctr Engn & New Prod Dev Biol Hun, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Zou, YZ (corresponding author), Ctr South Univ, Xiangya Sch Med, Dept Immunol, HLA Histocompatibil Lab, Changsha, Hunan, Peoples R China.	zouyizhou@hotmail.com	LUO, QI/GQH-7209-2022		National Natural Science Fund of China [81273265]; Hunan Science and Technology Fund [2013FJ2005]; Hunan Health Science Fund [B2013-003]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Hunan Science and Technology Fund; Hunan Health Science Fund	This study was supported in part by research funds provided by the National Natural Science Fund of China (No. 81273265), Hunan Science and Technology Fund (No. 2013FJ2005) and Hunan Health Science Fund (B2013-003).	Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Crespo M, 2001, TRANSPLANTATION, V71, P652, DOI 10.1097/00007890-200103150-00013; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; Duquesnoy RJ, 2008, HUM IMMUNOL, V69, P826, DOI 10.1016/j.humimm.2008.10.003; Goers TA, 2008, J IMMUNOL, V180, P4487, DOI 10.4049/jimmunol.180.7.4487; Leong HS, 2008, J LEUKOCYTE BIOL, V83, P263, DOI 10.1189/jlb.0607339; Molinero LL, 2006, HUM IMMUNOL, V67, P170, DOI 10.1016/j.humimm.2006.02.010; Montgomery RA, 2004, TRANSPLANTATION, V78, P181, DOI 10.1097/01.tp.0000129256.84027.d6; Qin ZQ, 2013, HUM IMMUNOL, V74, P1445, DOI 10.1016/j.humimm.2013.05.002; Reinsmoen NL, 2010, TRANSPLANTATION, V90, P1473, DOI 10.1097/TP.0b013e3181fd97f1; Stastny P, 2013, INT J IMMUNOGENET, V40, P11, DOI 10.1111/iji.12016; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Vasilescu ER, 2004, TRANSPL IMMUNOL, V12, P177, DOI 10.1016/j.trim.2003.08.002; Warraich RS, 2000, TRANSPLANTATION, V69, P1609; Zou Y, 2010, TISSUE ANTIGENS, V76, P171, DOI 10.1111/j.1399-0039.2010.01527.x; Zou YZ, 2006, HUM IMMUNOL, V67, P145, DOI 10.1016/j.humimm.2006.02.016; Zou YZ, 2006, HUM IMMUNOL, V67, P230, DOI 10.1016/j.humimm.2006.02.017; Zou YZ, 2009, IMMUNOGENETICS, V61, P91, DOI 10.1007/s00251-008-0344-9; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	19	14	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127861	10.1371/journal.pone.0127861	http://dx.doi.org/10.1371/journal.pone.0127861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024219	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400054
J	Page, CM; Patel, A; Hibberd, PL				Page, Charlotte M.; Patel, Archana; Hibberd, Patricia L.			Does Smoke from Biomass Fuel Contribute to Anemia in Pregnant Women in Nagpur, India? A Cross-Sectional Study	PLOS ONE			English	Article							BIOFUEL SMOKE; RISK-FACTORS; PREVALENCE; COOKING	Background Anemia affects upwards of 50% of pregnant women in developing countries and is associated with adverse outcomes for mother and child. We hypothesized that exposure to smoke from biomass fuel - which is widely used for household energy needs in resource-limited settings - could exacerbate anemia in pregnancy, possibly as a result of systemic inflammation. Objective To evaluate whether exposure to smoke from biomass fuel (wood, straw, crop residues, or dung) as opposed to clean fuel (electricity, liquefied petroleum gas, natural gas, or biogas) is an independent risk factor for anemia in pregnancy, classified by severity. Methods A secondary analysis was performed using data collected from a rural pregnancy cohort (N = 12,782) in Nagpur, India in 2011-2013 as part of the NIH-funded Maternal and Newborn Health Registry Study. Multinomial logistic regression was used to estimate the effect of biomass fuel vs. clean fuel use on anemia in pregnancy, controlling for maternal age, body mass index, education level, exposure to household tobacco smoke, parity, trimester when hemoglobin was measured, and receipt of prenatal iron and folate supplements. Results The prevalence of any anemia (hemoglobin <11 g/dl) was 93% in biomass fuel users and 88% in clean fuel users. Moderate-to-severe anemia (hemoglobin <10 g/dl) occurred in 53% and 40% of the women, respectively. Multinomial logistic regression showed higher relative risks of mild anemia in pregnancy (hemoglobin 10-11 g/dl; RRR = 1.38, 95% CI = 1.19-1.61) and of moderate-to-severe anemia in pregnancy (RRR = 1.79, 95% CI = 1.53-2.09) in biomass fuel vs. clean fuel users, after adjusting for covariates. Conclusion In our study population, exposure to biomass smoke was associated with higher risks of mild and moderate-to-severe anemia in pregnancy, independent of covariates.	[Page, Charlotte M.; Hibberd, Patricia L.] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Patel, Archana] Lata Med Res Fdn, Nagpur, Maharashtra, India; [Hibberd, Patricia L.] Massachusetts Gen Hosp Children, Div Global Hlth, Boston, MA USA	Harvard University; Harvard Medical School	Page, CM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	charlotte_page@hms.harvard.edu		Hibberd, Patricia/0000-0002-7455-8117; Page, Charlotte/0000-0002-8038-9487	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01HD058322]; South Asia Institute at Harvard University; National Center for Research Resources; National Center for Advancing Translational Sciences (National Institutes of Health) [UL1 TR001102]; Harvard University and its affiliated academic healthcare centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD078439, U01HD058322] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT003683] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); South Asia Institute at Harvard University; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University and its affiliated academic healthcare centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Maternal and Newborn Health Registry Study is funded by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) (U01HD058322 [PLH]). This secondary data analysis was funded by grants received by CP from the South Asia Institute at Harvard University (southasiainstitute.harvard.edu) and the Scholars in Medicine Office at Harvard Medical School (http://hms.harvard.edu/departments/medical-education/student-services/scholars-medicine-sim). Dr. Bernard Rosner of Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (catalyst.harvard.edu) was consulted about statistical models. Harvard Catalyst is funded by the National Center for Research Resources and the National Center for Advancing Translational Sciences (National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Farsi YM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-7; Al-Mehaisen L, 2011, MATERNAL ANEMIA RURA; American College of Obstetrics & Gynecology, 2008, OBSTET GYNECOL, V112, P201, DOI [DOI 10.1097/AOG.0B013E3181809C0D, 10.1097/AOG.0b013e3181809c0d]; [Anonymous], 2012, GUID DAIL IR FOL AC; Balakrishnan K., 2004, INDOOR AIR POLLUTION; Bencaiova G, 2012, EUR J INTERN MED, V23, P529, DOI 10.1016/j.ejim.2012.04.008; Bora R, 2014, J MATERN-FETAL NEO M, V27, P887, DOI 10.3109/14767058.2013.845161; Charles AM, 2010, HEALTH CARE WOMEN IN, V31, P585, DOI 10.1080/07399331003710541; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Dutta A, 2012, TOXICOL APPL PHARM, V261, P255, DOI 10.1016/j.taap.2012.04.004; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Gall ET, AM J PUBLIC HLTH, V201, pe67, DOI 10.2105/AJPH.2012.300955; Ghio AJ, 2012, OCCUP ENVIRON MED, V69, P170, DOI 10.1136/oem.2011.065276; Goonewardene M, 2012, BEST PRACT RES CL OB, V26, P3, DOI 10.1016/j.bpobgyn.2011.10.010; Goudar SS, 2012, INT J GYNECOL OBSTET, V118, P190, DOI 10.1016/j.ijgo.2012.04.022; Gould William, 2000, STATA TECHNICAL B, V9, P19; Hertel S, 2010, EUR J EPIDEMIOL, V25, P581, DOI 10.1007/s10654-010-9477-x; Kalaivani K, 2009, INDIAN J MED RES, V130, P627; Kyu HH, 2010, ANN EPIDEMIOL, V20, P811, DOI 10.1016/j.annepidem.2010.07.096; Lone F W, 2004, East Mediterr Health J, V10, P801; Machisa M, 2013, T ROY SOC TROP MED H, V107, P535, DOI 10.1093/trstmh/trt055; Makhoul Z, 2012, SE ASIAN J TROP MED, V43, P735; Martin WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001455; Mishra V, 2007, INT J EPIDEMIOL, V36, P117, DOI 10.1093/ije/dyl234; Patel AB, 2013, INT J OCCUP ENV HEAL, V19, P35, DOI 10.1179/2049396712Y.0000000013; Singh LL, 2006, DISTRICT LEVEL HOUSE, P2002; Tripathi R, 2012, J OBSTET GYNAECOL RE, V38, P203, DOI 10.1111/j.1447-0756.2011.01679.x; Tsai DH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-24; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, SER FERR CONC ASS IR	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127890	10.1371/journal.pone.0127890	http://dx.doi.org/10.1371/journal.pone.0127890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024473	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400056
J	Suwansa-ard, S; Thongbuakaew, T; Wang, T; Zhao, M; Elizur, A; Hanna, PJ; Sretarugsa, P; Cummins, SF; Sobhon, P				Suwansa-ard, Saowaros; Thongbuakaew, Tipsuda; Wang, Tianfang; Zhao, Min; Elizur, Abigail; Hanna, Peter J.; Sretarugsa, Prapee; Cummins, Scott F.; Sobhon, Prasert			In silico Neuropeptidome of Female Macrobrachium rosenbergii Based on Transcriptome and Peptide Mining of Eyestalk, Central Nervous System and Ovary	PLOS ONE			English	Article							CRUSTACEAN CARDIOACTIVE-PEPTIDE; GONADOTROPIN-RELEASING-HORMONE; EGG-LAYING HORMONE; FRESH-WATER PRAWN; CUTICLE-HARDENING HORMONE; BLACK TIGER SHRIMP; HYPERGLYCEMIC HORMONE; SHORE CRAB; DECAPOD CRUSTACEANS; FOOD-INTAKE	Macrobrachium rosenbergii is the most economically important of the cultured freshwater crustacean species, yet there is currently a deficiency in genomic and transcriptomic information for research requirements. In this study, we present an in silico analysis of neuropeptide genes within the female M. rosenbergii eyestalk, central nervous system, and ovary. We could confidently predict 37 preproneuropeptide transcripts, including those that encode bursicons, crustacean cardioactive peptide, crustacean hyperglycemic hormones, eclosion hormone, pigment-dispersing hormones, diuretic hormones, neuropeptide F, neuroparsins, SIFamide, and sulfakinin. These transcripts are most prominent within the eyestalk and central nervous system. Transcript tissue distribution as determined by reverse transcription-polymerase chain reaction revealed the presence of selected neuropeptide genes of interest mainly in the nervous tissues while others were additionally present in the non-nervous tissues. Liquid chromatography-mass spectrometry analysis of eyestalk peptides confirmed the presence of the crustacean hyperglycemic hormone precursor. This data set provides a strong foundation for further studies into the functional roles of neuropeptides in M. rosenbergii, and will be especially helpful for developing methods to improve crustacean aquaculture.	[Suwansa-ard, Saowaros; Thongbuakaew, Tipsuda; Hanna, Peter J.; Sretarugsa, Prapee; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Wang, Tianfang; Zhao, Min; Elizur, Abigail; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth,Educ & Engn, Maroochydore, Qld, Australia; [Hanna, Peter J.] Deakin Univ, Fac Sci Engn & Built Environm, Pro Vice Chancellors Off, Geelong, Vic 3217, Australia	Mahidol University; University of the Sunshine Coast; Deakin University	Cummins, SF (corresponding author), Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand.	scummins@usc.edu.au; prasert.sob@mahidol.ac.th	Wang, Tianfang/L-5192-2016; Zhao, Min/J-6588-2019; Wang, Tianfang/AAG-4290-2020; Suwansa-ard, Saowaros Mai/ABB-2227-2021; Wang, Tianfang/GRO-0844-2022; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Zhao, Min/0000-0001-5498-3434; Wang, Tianfang/0000-0002-4876-7767; Suwansa-ard, Saowaros Mai/0000-0002-9129-2082; Wang, Tianfang/0000-0002-4876-7767; Cummins, Scott/0000-0002-1454-2076; Elizur, Abigail/0000-0002-2960-302X; Thongbuakaew, Tipsuda/0000-0001-9643-8477	Office of the Higher Education Commission under the National Research Universities Initiatives; Distinguished Research Professor Grant (Thailand Research Fund); Distinguished Research Professor Grant (Office of the Higher Education Commission); Distinguished Research Professor Grant (Mahidol University); TRF-RGJ; ARC; University of the Sunshine Coast	Office of the Higher Education Commission under the National Research Universities Initiatives; Distinguished Research Professor Grant (Thailand Research Fund); Distinguished Research Professor Grant (Office of the Higher Education Commission); Distinguished Research Professor Grant (Mahidol University); TRF-RGJ; ARC(Australian Research Council); University of the Sunshine Coast	This work was funded by: 1. A grant from the Office of the Higher Education Commission under the National Research Universities Initiatives (http://www.op.mahidol.ac.th/orra/MU_NRU.html) and a Distinguished Research Professor Grant (co-funded by the Thailand Research Fund, the Office of the Higher Education Commission, and Mahidol University) (http://www.trf.or.th) to P. Sobhon. 2. TRF-RGJ Ph.D. Scholarship to P. Sretarugsa TT P. Sobhon SS (http://rgj.trf.or.th). 3. ARC grant to SFC (http://www.arc.gov.au). 4. University of the Sunshine Coast internal grant to SFC (http://www.usc.edu.au/university/learning-and-teaching/grants-and-awards-for-learning-and-teaching). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDEHM U, 1993, CELL TISSUE RES, V272, P473, DOI 10.1007/BF00318553; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Baker JD, 2002, J EXP BIOL, V205, P2555; Behrens HL, 2008, ANAL CHEM, V80, P6949, DOI 10.1021/ac800798h; BERNHEIM SM, 1995, J COMP PHYSIOL A, V176, P131; Chang ES, 2001, AM ZOOL, V41, P380, DOI 10.1668/0003-1569(2001)041[0380:CHHFOP]2.0.CO;2; Chen SH, 2004, MAR BIOTECHNOL, V6, P83, DOI 10.1007/s10126-003-0014-8; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Christie AE, 2008, GEN COMP ENDOCR, V156, P246, DOI 10.1016/j.ygcen.2008.01.018; Christie AE, 2008, GEN COMP ENDOCR, V155, P526, DOI 10.1016/j.ygcen.2007.09.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Christie AE, 2012, J EXP BIOL, V215, P2535, DOI 10.1242/jeb.070565; Christie AE, 2011, J EXP BIOL, V214, P1386, DOI 10.1242/jeb.053173; Christie AE, 2011, GEN COMP ENDOCR, V171, P131, DOI 10.1016/j.ygcen.2011.01.002; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Christie AE, 2010, GEN COMP ENDOCR, V167, P164, DOI 10.1016/j.ygcen.2010.01.005; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Cooke IM, 2002, BIOL BULL-US, V202, P108, DOI 10.2307/1543649; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; DeKeyser SS, 2007, J PROTEOME RES, V6, P1782, DOI 10.1021/pr060603v; Dickinson PS, 2007, J EXP BIOL, V210, P2278, DOI 10.1242/jeb.004770; Dickinson PS, 2009, J EXP BIOL, V212, P1140, DOI 10.1242/jeb.028621; DIRCKSEN H, 1988, CELL TISSUE RES, V254, P347; Dircksen H, 1998, CONSERVED CRUSTACEAN; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Donini A, 2001, J INSECT PHYSIOL, V47, P277, DOI 10.1016/S0022-1910(00)00112-8; Ernest SC, 2008, REPRODUCTIVE BIOL CR, P299; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fort TJ, 2007, J NEUROPHYSIOL, V97, P3407, DOI 10.1152/jn.00939.2006; Fu Q, 2005, BIOCHEM BIOPH RES CO, V337, P765, DOI 10.1016/j.bbrc.2005.09.111; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Gallus L, 2001, EUR J HISTOCHEM, V45, P95; Gard AL, 2009, GEN COMP ENDOCR, V160, P271, DOI 10.1016/j.ygcen.2008.12.014; GIRARDIE J, 1987, INSECT BIOCHEM, V17, P977, DOI 10.1016/0020-1790(87)90106-5; GOVIND CK, 1975, J COMP PHYSIOL, V96, P185, DOI 10.1007/BF00612694; Granato FC, 2004, COMP BIOCHEM PHYS A, V138, P313, DOI 10.1016/j.cbpb.2004.04.009; Guan ZB, 2014, AQUACULTURE, V418, P67, DOI 10.1016/j.aquaculture.2013.10.010; Harshini S, 2002, PEPTIDES, V23, P1759, DOI 10.1016/S0196-9781(02)00152-3; Harzsch S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-58; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Horodyski FM, 1996, J INSECT PHYSIOL, V42, P917, DOI 10.1016/0022-1910(96)00035-2; Hsu YWA, 2010, J COMP NEUROL, V518, P4674, DOI 10.1002/cne.22474; Hui LM, 2012, PEPTIDES, V36, P230, DOI 10.1016/j.peptides.2012.05.007; Hull JJ, 2009, BIOCHEMISTRY-US, V48, P9047, DOI 10.1021/bi901078y; Jia CX, 2013, J PROTEOMICS, V91, P1, DOI 10.1016/j.jprot.2013.06.021; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Johnsen AH, 2000, EUR J BIOCHEM, V267, P1153, DOI 10.1046/j.1432-1327.2000.01113.x; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; KONO T, 1990, FEBS LETT, V263, P358, DOI 10.1016/0014-5793(90)81413-I; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Liu Zhipeng, 2006, Invertebrate Neuroscience, V6, P41, DOI 10.1007/s10158-006-0016-0; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Maestro JL, 2001, EUR J BIOCHEM, V268, P5824, DOI 10.1046/j.0014-2956.2001.02527.x; Marco HG, 2014, PEPTIDES, V53, P97, DOI 10.1016/j.peptides.2013.10.013; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Meeratana P, 2007, AQUACULTURE, V270, P249, DOI 10.1016/j.aquaculture.2007.03.009; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nachman RJ, 2005, PEPTIDES, V26, P115, DOI 10.1016/j.peptides.2004.07.018; Nagaraju GPC, 2011, INTEGR BIOL-UK, V3, P218, DOI 10.1039/c0ib00086h; Nagaraju GPC, 2010, COMP BIOCHEM PHYS D, V5, P317, DOI 10.1016/j.cbd.2010.09.002; Nagaraju GPC, 2011, J ENDOCRINOL, V210, P379, DOI 10.1530/JOE-11-0154; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Nagaraju GP, 2005, INT J APPL SCI ENG, V3, P61; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2013, NEUROSCIENCES MOL BE, P213, DOI DOI 10.1007/978-3-642-10769-6_11; Ngernsoungnern Apichart, 2008, Invertebrate Neuroscience, V8, P49, DOI 10.1007/s10158-008-0067-5; Ngernsoungnern P, 2008, GEN COMP ENDOCR, V155, P613, DOI 10.1016/j.ygcen.2007.08.012; Ngernsoungnern P, 2009, AQUACULTURE, V296, P143, DOI 10.1016/j.aquaculture.2009.08.011; Palasoon R, 2011, INVERTEBR NEUROSCI, V11, P29, DOI 10.1007/s10158-011-0115-4; Panchan N, 2003, PEPTIDES, V24, P1563, DOI 10.1016/j.peptides.2003.08.015; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phlippen MK, 2000, J EXP BIOL, V203, P521; Polanska MA, 2007, CELL TISSUE RES, V330, P331, DOI 10.1007/s00441-007-0473-8; Rao KR, 2001, AM ZOOL, V41, P364, DOI 10.1668/0003-1569(2001)041[0364:CPEHCA]2.0.CO;2; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; ROTHMAN BS, 1983, GEN COMP ENDOCR, V52, P134, DOI 10.1016/0016-6480(83)90166-1; Ruder T, 2013, J MOL EVOL, V76, P192, DOI 10.1007/s00239-013-9552-5; Saver MA, 1998, COMP BIOCHEM PHYS A, V120, P301, DOI 10.1016/S1095-6433(98)00033-6; Schoofs L, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P183, DOI 10.1016/B978-012369442-3/50031-3; Schooley D.A., 2012, INSECT ENDOCRINOLOGY, P366, DOI DOI 10.1016/B978-0-12-384749-2.10009-3; Shang YH, 2013, NEURON, V80, P171, DOI 10.1016/j.neuron.2013.07.029; Shmulik P, 2008, REPRODUCTIVE BIOL CR, P427; Song Qisheng, 2011, P132; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatemoto K, 2004, HANDB EXP PHARM, V162, P1; Tinikul Y, 2011, CELL TISSUE RES, V343, P579, DOI 10.1007/s00441-010-1112-3; Torfs P, 2002, BIOCHEM BIOPH RES CO, V299, P312, DOI 10.1016/S0006-291X(02)02624-4; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Tsai PS, 2006, GEN COMP ENDOCR, V148, P48, DOI 10.1016/j.ygcen.2005.09.016; Turner LM, 2013, J EXP BIOL, V216, P1191, DOI 10.1242/jeb.078527; Van Wielendaele P, 2013, J INSECT PHYSIOL, V59, P624, DOI 10.1016/j.jinsphys.2013.03.005; Van Wielendaele P, 2013, INSECT BIOCHEM MOLEC, V43, P102, DOI 10.1016/j.ibmb.2012.10.002; Vazquez-Acevedo N, 2009, BIOL BULL-US, V217, P313, DOI 10.1086/BBLv217n3p313; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Vehovszky A, 2005, NEUROSCI LETT, V373, P200, DOI 10.1016/j.neulet.2004.10.020; Ventura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097323; Verleyen P, 2009, GEN COMP ENDOCR, V162, P27, DOI 10.1016/j.ygcen.2008.10.020; Webster SG, 2013, GEN COMP ENDOCR, V182, P54, DOI 10.1016/j.ygcen.2012.11.018; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Weimann JM, 1997, J NEUROSCI, V17, P1748; Wilcockson DC, 2008, GEN COMP ENDOCR, V156, P113, DOI 10.1016/j.ygcen.2007.12.003; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yin GL, 2006, PEPTIDES, V27, P1241, DOI 10.1016/j.peptides.2005.11.015; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P816, DOI 10.1016/j.ibmb.2012.06.006; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581	125	77	78	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0123848	10.1371/journal.pone.0123848	http://dx.doi.org/10.1371/journal.pone.0123848			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023789	Green Published, gold			2022-12-27	WOS:000355319400004
J	Tomita, J; Ueno, T; Mitsuyoshi, M; Kume, S; Kume, K				Tomita, Jun; Ueno, Taro; Mitsuyoshi, Madoka; Kume, Shoen; Kume, Kazuhiko			The NMDA Receptor Promotes Sleep in the Fruit Fly, Drosophila melanogaster	PLOS ONE			English	Article							PAN-NEURONAL KNOCKDOWN; TERM-MEMORY; OLFACTORY MEMORY; MUSHROOM BODIES; REDUCED SLEEP; WAKEFULNESS; DOPAMINE; IDENTIFICATION; HOMEOSTASIS; AROUSAL	Considerable evidence indicates that sleep is essential for learning and memory. Drosophila melanogaster has emerged as a novel model for studying sleep. We previously found a short sleeper mutant, fumin (fmn), and identified its mutation in the dopamine transporter gene. We reported similarities in the molecular basis of sleep and arousal regulation between mammals and Drosophila. In aversive olfactory learning tasks, fmn mutants demonstrate defective memory retention, which suggests an association between sleep and memory. In an attempt to discover additional sleep related genes in Drosophila, we carried out a microarray analysis comparing mRNA expression in heads of fmn and control flies and found that 563 genes are differentially expressed. Next, using the pan-neuronal Gal4 driver elav-Gal4 and UAS-RNA interference (RNAi) to knockdown individual genes, we performed a functional screen. We found that knockdown of the NMDA type glutamate receptor channel gene (Nmdar1) (also known as dNR1) reduced sleep. The NMDA receptor (NMDAR) plays an important role in learning and memory both in Drosophila and mammals. The application of the NMDAR antagonist, MK-801, reduced sleep in control flies, but not in fmn. These results suggest that NMDAR promotes sleep regulation in Drosophila.	[Tomita, Jun; Ueno, Taro; Mitsuyoshi, Madoka; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan; [Ueno, Taro] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Tokyo 113, Japan; [Tomita, Jun; Kume, Kazuhiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Nagoya, Aichi, Japan	Kumamoto University; Tokyo Metropolitan Institute of Medical Science; Nagoya City University	Kume, K (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan.	kume@phar.nagoya-cu.ac.jp	Kume, Shoen/M-4356-2016; Ueno, Taro/AAN-7260-2021	Kume, Shoen/0000-0002-4292-205X; Ueno, Taro/0000-0003-3697-4301; Kume, Kazuhiko/0000-0003-4232-1657	Japan Society for the Promotion of Science (JSPS) [22300132, 25290007, 22700433, 24700413]; Grants-in-Aid for Scientific Research [26507008, 26253059] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (22300132, 25290007, K.K., 22700433, 24700413, J.T.). T.U. was supported by Grant-in-Aid for JSPS Fellows.	Borbely A A, 1982, Hum Neurobiol, V1, P195; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Seugnet L, 2009, J NEUROSCI, V29, P7148, DOI 10.1523/JNEUROSCI.5629-08.2009; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Takahama K, 2012, BIOCHEM BIOPH RES CO, V417, P807, DOI 10.1016/j.bbrc.2011.12.040; TOBLER I, 1983, BEHAV BRAIN RES, V8, P351, DOI 10.1016/0166-4328(83)90180-8; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Ueno T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00303; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032007; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031513; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Zachepilo T G, 2008, Neurosci Behav Physiol, V38, P369, DOI 10.1007/s11055-008-0052-9; Zhang S, 2008, BIOCHEM BIOPH RES CO, V370, P82, DOI 10.1016/j.bbrc.2008.03.015	39	43	44	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128101	10.1371/journal.pone.0128101	http://dx.doi.org/10.1371/journal.pone.0128101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023770	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400070
J	Wang, H; Liu, Z; Sun, L; Luo, Q				Wang, Hui; Liu, Zhe; Sun, Lina; Luo, Qing			Optimal Design of River Monitoring Network in Taizihe River by Matter Element Analysis	PLOS ONE			English	Article							CRITICAL SAMPLING POINTS; WATER; METHODOLOGY; SELECTION	The objective of this study is to optimize the river monitoring network in Taizihe River, Northeast China. The situation of the network and water characteristics were studied in this work. During this study, water samples were collected once a month during January 2009 - December 2010 from seventeen sites. Futhermore, the 16 monitoring indexes were analyzed in the field and laboratory. The pH value of surface water sample was found to be in the range of 6.83 to 9.31, and the average concentrations of NH4+-N, chemical oxygen demand (COD), volatile phenol and total phosphorus (TP) were found decreasing significantly. The water quality of the river has been improved from 2009 to 2010. Through the calculation of the data availability and the correlation between adjacent sections, it was found that the present monitoring network was inefficient as well as the optimization was indispensable. In order to improve the situation, the matter element analysis and gravity distance were applied in the optimization of river monitoring network, which were proved to be a useful method to optimize river quality monitoring network. The amount of monitoring sections were cut from 17 to 13 for the monitoring network was more cost-effective after being optimized. The results of this study could be used in developing effective management strategies to improve the environmental quality of Taizihe River. Also, the results show that the proposed model can be effectively used for the optimal design of monitoring networks in river systems.	[Wang, Hui; Sun, Lina; Luo, Qing] Shenyang Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110044, Liaoning, Peoples R China; [Liu, Zhe] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Liaoning, Peoples R China	Shenyang University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Sun, L (corresponding author), Shenyang Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110044, Liaoning, Peoples R China.	sln629@163.com	Wang, Hui/AAB-7016-2021; Luo, Qing/ABD-4148-2020	Luo, Qing/0000-0002-4306-6283; Wang, Hui/0000-0002-2237-720X	Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07202-004-05]; National Basic Research Program of China (973 Program) [2014CB441106]; Shenyang Science and Technology plan project [F14-133-9-00]	Major Science and Technology Program for Water Pollution Control and Treatment; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenyang Science and Technology plan project	This study was financially supported by Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07202-004-05), the National Basic Research Program of China (973 Program) (2014CB441106), and Shenyang Science and Technology plan project (F14-133-9-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association A. P. H., 2005, STANDARD METHODS EXA, P521; Ayenimo JG., 2005, KRAGUJEVAC J SCI, V27, P43; Beckers CV, 1974, DESIGN COST EFFECTIV; Chilundo M, 2008, PHYS CHEM EARTH, V33, P655, DOI 10.1016/j.pce.2008.06.055; CIENIAWSKI SE, 1995, WATER RESOUR RES, V31, P399, DOI 10.1029/94WR02039; Cong NV, 1999, THESIS CHIANG MAI U; Diagomanolin V, 2004, TOXICOL LETT, V151, P63, DOI 10.1016/j.toxlet.2004.02.018; Dixon W, 1996, WATER RES, V30, P1935, DOI 10.1016/0043-1354(96)00087-5; Dong C., 2004, THESIS SHANDONG U CH, P19; Gao M., 1997, ADV ENV SCI, V5, P77; GROOT S, 1984, WATER SCI TECHNOL, V16, P275, DOI 10.2166/wst.1984.0137; Guo SP, 2008, WATER RESOURCES HYDR, V26, P50; [郭小青 Guo Xiaoqing], 2005, [科技通报, Bulletin of Science and Technology], V21, P360; HARMANCIOGLU NB, 1992, WATER RESOUR BULL, V28, P179; Harmancioglu NB, 1992, J AM WATER RESOUR AS, V28, P179; HUDAK PF, 1995, J HYDROL, V164, P153, DOI 10.1016/0022-1694(94)02559-T; Jiang X, 2006, HEILONGJIANG ENV J, V30, P44; Junshum P., 2007, Journal of Agriculture and Social Sciences, V3, P91; Kar D, 2008, INT J ENVIRON SCI TE, V5, P119, DOI 10.1007/BF03326004; Li GX, 2010, J ANHUI AGR SCI, V38, P18337; Li S, 2011, J WATER RESOURCES WA, V22, P111; [李文生 LI Wensheng], 2007, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V5, P51; Li X., 1996, THESIS NE NORMAL U C, P18; Markus M, 2003, J HYDROL, V283, P107, DOI 10.1016/S0022-1694(03)00244-0; Strobl RO, 2006, ENVIRON MONIT ASSESS, V122, P319, DOI 10.1007/s10661-006-0358-4; Strobl RO, 2006, ENVIRON MONIT ASSESS, V112, P137, DOI 10.1007/s10661-006-0774-5; Strobl RO, 2008, J ENVIRON MANAGE, V87, P639, DOI 10.1016/j.jenvman.2007.03.001; Ward RC, 1996, J AM WATER RESOUR AS, V32, P673, DOI [10.1111/j.1752-1688.1996.tb03465.x, DOI 10.1111/J.1752-1688.1996.TB03465.X]; Xiao ZX., 2008, THESIS HEFEI U TECHN, P8; [杨文艳 YANG Wenyan], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P9197; Yang WY, 2008, J ANHUI AGR SCI, V36, P9209; Yang YJ, 2002, WATER RESOURCES PROT, V2, P15; Yang YJ, 2002, WATER RESOURCES PROT, V2, P14; Zhang Y, 2005, ENVIRON SCI TECHNOL, V28, P114; Zhu HJ, 1998, YUNNAN ENV SCI, V17, P51	35	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127535	10.1371/journal.pone.0127535	http://dx.doi.org/10.1371/journal.pone.0127535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023785	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400040
J	Graziano, TS; Cuzzullin, MC; Franco, GC; Schwartz, HO; de Andrade, ED; Groppo, FC; Cogo-Muller, K				Graziano, Talita Signoreti; Cuzzullin, Maria Claudia; Franco, Gilson Cesar; Schwartz-Filho, Humberto Osvaldo; de Andrade, Eduardo Dias; Groppo, Francisco Carlos; Cogo-Mueller, Karina			Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm	PLOS ONE			English	Article							REDUCTASE INHIBITORS; COMBINATION; RESISTANCE; BACTERIAL; THERAPY; AGENTS	Statins are important lipid-lowering agents with other pleiotropic effects. Several studies have explored a possible protective effect of statins to reduce the morbidity and mortality of many infectious diseases. Staphylococcus aureus is one of the main pathogens implicated in nosocomial infections; its ability to form biofilms makes treatment difficult. The present study observed the MIC of atorvastatin, pravastatin and simvastatin against S. aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus faecalis. Simvastatin was the only agent with activity against clinical isolates and reference strains of methicilin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). Thus, the effects of simvastatin on the growth, viability and biofilm formation of S. aureus were tested. In addition, a possible synergistic effect between simvastatin and vancomycin was evaluated. Simvastatin's MIC was 15.65 mu g/mL for S. aureus 29213 and 31.25 mu g/mL for the other strains of S. aureus. The effect of simvastatin was bactericidal at 4xMIC and bacteriostatic at the MIC concentration. No synergistic effect was found between simvastatin and vancomycin. However, the results obtained against S. aureus biofilms showed that, in addition to inhibiting adhesion and biofilm formation at concentrations from 1/16xMIC to 4xMIC, simvastatin was also able to act against mature biofilms, reducing cell viability and extra-polysaccharide production. In conclusion, simvastatin showed pronounced antimicrobial activity against S. aureus biofilms, reducing their formation and viability.	[Graziano, Talita Signoreti; Cuzzullin, Maria Claudia; de Andrade, Eduardo Dias; Groppo, Francisco Carlos; Cogo-Mueller, Karina] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Pharmacol Anesthesiol & Therapeut, Piracicaba, SP, Brazil; [Franco, Gilson Cesar] Univ Estadual Ponta Grossa, Dept Gen Biol, Area Physiol & Pathophysiol, Ponta Grossa, Parana, Brazil; [Schwartz-Filho, Humberto Osvaldo; Cogo-Mueller, Karina] Univ Santo Amaro, Dept Dent, Implantol Area, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Ponta Grossa; Universidade de Santo Amaro (UNISA)	Cogo-Muller, K (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Pharmacol Anesthesiol & Therapeut, Piracicaba, SP, Brazil.	karicogo@hotmail.com	groppo, francisco carlos/HIK-2053-2022; Muller, Karina Cogo/H-2365-2012; Muller, Karina/ABA-1819-2021; Schwartz, Humberto/C-6405-2012	groppo, francisco carlos/0000-0002-8513-773X; Muller, Karina Cogo/0000-0002-9048-8702; Schwartz, Humberto/0000-0002-3873-4945	FAPESP -Sao Paulo Research Foundation [2013/06570-3, 2011/15795-3]; Brazilian National Council for Scientific and Technological Development - CNPq	FAPESP -Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by http://www.fapesp.br/en/, FAPESP -Sao Paulo Research Foundation Grant - 2013/06570-3 (KCM) and Master fellowship - 2011/15795-3 (TSG); http://www.cnpq.br/, The Brazilian National Council for Scientific and Technological Development - CNPq Graduation fellowship-PIBIC (MCC).	Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Alla VM, 2013, DRUGS, V73, P1025, DOI 10.1007/s40265-013-0072-9; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Bergman P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024394; Bjorkhem-Bergman L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010702; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Busuioc M, 2009, J BACTERIOL, V191, P7315, DOI 10.1128/JB.00425-09; Ccahuana-Vásquez Renzo Alberto, 2010, Braz. oral res., V24, P135, DOI 10.1590/S1806-83242010000200002; Chamilos G, 2006, ANTIMICROB AGENTS CH, V50, P96, DOI 10.1128/AAC.50.1.96-103.2006; Clinical and Laboratory Standards Institute (CLSI), 2006, METH DIL ANT SUSC TE; CRAIG WA, 1996, ANTIBIOTICS LAB MED; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Galgoczy L, 2009, MYCOSES, V52, P447, DOI 10.1111/j.1439-0507.2008.01634.x; Ganeshnarayan K, 2009, APPL ENVIRON MICROB, V75, P1308, DOI 10.1128/AEM.01900-08; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; HOFFMAN WF, 1986, J MED CHEM, V29, P849, DOI 10.1021/jm00155a040; Horn MP, 2008, J PHARMACOL EXP THER, V326, P135, DOI 10.1124/jpet.108.137927; Janda S, 2010, J CRIT CARE, V25; Jerwood S, 2008, J ANTIMICROB CHEMOTH, V61, P362, DOI 10.1093/jac/dkm496; Khan AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052929; Kozarov E, 2014, CARDIOVASC RES, V102, P362, DOI 10.1093/cvr/cvu058; Lefer DJ, 2002, CIRCULATION, V106, P2041, DOI 10.1161/01.CIR.0000033635.42612.88; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lopez-Cortes LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082958; Mah TF, 2012, FUTURE MICROBIOL, V7, P1061, DOI [10.2217/FMB.12.76, 10.2217/fmb.12.76]; Masadeh M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-13; Mason RP, 2005, AM J CARDIOL, V96, p11F, DOI 10.1016/j.amjcard.2005.06.008; McTaggart F, 2001, AM J CARDIOL, V87, p28B; Nyilasi I, 2010, FEMS MICROBIOL LETT, V307, P175, DOI 10.1111/j.1574-6968.2010.01972.x; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pillai Jr SK, 2005, ANTIBIOTICS LAB MED, P366; Raja AF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-54; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Smith SC, 2014, J AM COLL CARDIOL, V64, P601, DOI 10.1016/j.jacc.2014.06.1159; Sun LM, 2009, ANTIMICROB AGENTS CH, V53, P1586, DOI 10.1128/AAC.00940-08; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; Wan YD, 2014, CRIT CARE, V18, DOI 10.1186/cc13828; Welsh AM, 2009, PATHOLOGY, V41, P689, DOI 10.3109/00313020903305860; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; Wu WS, 2013, J MICROBIOL IMMUNOL, V46, P89, DOI 10.1016/j.jmii.2012.03.009	49	67	71	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128098	10.1371/journal.pone.0128098	http://dx.doi.org/10.1371/journal.pone.0128098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020797	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300079
J	Kadivar, A; Kamalidehghan, B; Javar, HA; Davoudi, ET; Zaharuddin, ND; Sabeti, B; Chung, LY; Noordin, MI				Kadivar, Ali; Kamalidehghan, Behnam; Javar, Hamid Akbari; Davoudi, Ehsan Taghizadeh; Zaharuddin, Nurul Dhania; Sabeti, Bahareh; Chung, Lip Yong; Noordin, Mohamed Ibrahim			Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; GASTROINTESTINAL STROMAL TUMORS; CHRONIC MYELOID-LEUKEMIA; MATRIX TABLETS; HEALTHY-VOLUNTEERS; GASTRIC RETENTION; HYDROCHLORIDE; COMBINATION; PERFORMANCE; STABILITY	Introduction Imatinib mesylate is an antineoplastic agent which has high absorption in the upper part of the gastrointestinal tract (GIT). Conventional imatinib mesylate (Gleevec) tablets produce rapid and relatively high peak blood levels and requires frequent administration to keep the plasma drug level at an effective range. This might cause side effects, reduced effectiveness and poor therapeutic management. Therefore, floating sustained-release Imatinib tablets were developed to allow the tablets to be released in the upper part of the GIT and overcome the inadequacy of conventional tablets. Methodology Floating sustained-release Imatinib mesylate tablets were prepared using the wet granulation method. Tablets were formulated using Hydroxypropyl Methylcellulose (HPMC K4M), with Sodium alginate (SA) and Carbomer 934P (CP) as release-retarding polymers, sodium bicarbonate (NaHCO3) as the effervescent agent and lactose as a filler. Floating behavior, in vitro drug release, and swelling index studies were conducted. Initial and total drug release duration was compared with a commercial tablet (Gleevec) in 0.1 N HCl (pH 1.2) at 37 +/- 0.5 degrees C for 24 hours. Tablets were then evaluated for various physical parameters, including weight variation, thickness, hardness, friability, and drug content. Consequently, 6 months of physical stability studies and in vitro gastro-retentive studies were conducted. Results and Discussion Statistical data analysis revealed that tablets containing a composition of 14.67% w/w HPMC K4M, 10.67%, w/w Na alginate, 1.33%, w/w Carbomer 934P and 9.33%, w/w NaHCO3 produced the most favorable formulation to develop 24-hour sustained-release tablets with optimum floating behavior and satisfactory physicochemical characteristics. Furthermore, in vitro release study revealed that the formulated SR tablet had significantly lower C-max and higher T-max compared to the conventional tablet (Gleevec). Thus, formulated SR tablets preserved persistent concentration of plasma up to 24 hours. Conclusion In conclusion, in order to suggest a better drug delivery system with constant favorable release, resulting in optimized absorption and less side effects, formulated CP-HPMC-SA based imatinib mesylate floating sustained-release tablets can be a promising candidate for cancer chemotherapy.	[Kadivar, Ali; Kamalidehghan, Behnam; Davoudi, Ehsan Taghizadeh; Zaharuddin, Nurul Dhania; Sabeti, Bahareh; Chung, Lip Yong; Noordin, Mohamed Ibrahim] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Javar, Hamid Akbari] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut, Tehran, Iran	Universiti Malaya; Tehran University of Medical Sciences	Noordin, MI (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	ibrahimn@um.edu.my	Noordin, Mohamed/AAK-4152-2021; CHUNG, LIP YONG/B-7764-2010; javar, hamid akbari/B-1928-2018; Kamalidehghan, Behnam/B-5401-2013	CHUNG, LIP YONG/0000-0002-3596-768X; javar, hamid akbari/0000-0003-4137-6939; Kamalidehghan, Behnam/0000-0001-8530-8124; akbari javar, hamid/0000-0001-6036-1084; Noordin, Mohamed Ibrahim/0000-0002-9424-8925	University of Malaya through IPPP research Grant [PV047/2011A]; Malaysian Ministry of Higher Education's MOHE-HIR [UM.C/625/1/MOHE/MED/17, UM.C/625/1/MOHE/MED/33]	University of Malaya through IPPP research Grant; Malaysian Ministry of Higher Education's MOHE-HIR	The authors would like to express their utmost gratitude and appreciation to University of Malaya through IPPP research Grant (Grant no. PV047/2011A), and Malaysian Ministry of Higher Education's MOHE-HIR Grants (UM.C/625/1/MOHE/MED/17 and UM.C/625/1/MOHE/MED/33) for providing financial supports to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjali Devi N., 2013, INT J PHARM PHARM SC, V5, P271; Asnaashari S, 2011, PHARM DEV TECHNOL, V16, P400, DOI 10.3109/10837451003774393; Berry MR, 2007, J PHARMACEUT BIOMED, V45, P194, DOI 10.1016/j.jpba.2007.05.021; Boyapally H, 2010, COLLOID SURFACE B, V77, P227, DOI 10.1016/j.colsurfb.2010.01.031; Center for Drug Evaluation and Research of the U. S. Department of Health and Human Services Food and Drug Administration Guidance for Industry, 2001, GUID IND BIOAN METH; Chavanpatil MD, 2006, INT J PHARMACEUT, V316, P86, DOI 10.1016/j.ijpharm.2006.02.038; Chen RN, 2010, EUR J PHARM SCI, V39, P82, DOI 10.1016/j.ejps.2009.10.015; Chen YC, 2013, INT J PHARMACEUT, V441, P162, DOI 10.1016/j.ijpharm.2012.12.002; Cohen MH, 2002, ONCOLOGIST, V7, P393, DOI 10.1634/theoncologist.7-5-393; Dash S, 2010, ACTA POL PHARM, V67, P217; Davoudi ET, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/495319; De Kogel CE, 2007, ONCOLOGIST, V12, P1390, DOI 10.1634/theoncologist.12-12-1390; de Lemos ML, 2015, J ONCOL PHARM PRACT, V21, P76, DOI 10.1177/1078155214522143; de Wit D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-575; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Deshpande AA, 1997, PHARMACEUT RES, V14, P815, DOI 10.1023/A:1012171010492; Dorozynski P, 2004, DRUG DEV IND PHARM, V30, P947, DOI 10.1081/DDC-200037179; Druker BJ, 2003, SEMIN HEMATOL, V40, P50, DOI 10.1053/shem.2003.50000; Gambhire MN, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0803073; Gande S, 2011, DARU, V19, P202; Genc L, 1999, Pharm Acta Helv, V74, P43, DOI 10.1016/S0031-6865(99)00017-5; Guguloth Mohan, 2011, PDA J Pharm Sci Technol, V65, P198, DOI 10.5731/pdajpst.2011.00685; HODSDON AC, 1995, J CONTROL RELEASE, V33, P143, DOI 10.1016/0168-3659(94)00076-7; Hwang SJ, 1998, CRIT REV THER DRUG, V15, P243; Jagdale SC, 2009, AAPS PHARMSCITECH, V10, P1071, DOI 10.1208/s12249-009-9300-8; Khan GM, 1998, J CONTROL RELEASE, V54, P185, DOI 10.1016/S0168-3659(97)00225-3; Kose-Ozkan C, 2010, COMB CHEM HIGH T SCR, V13, P683, DOI 10.2174/138620710791920347; Kuu WY, 1998, INT J PHARM, V166, P167, DOI 10.1016/S0378-5173(98)00049-0; Macdonald JB, 2015, J AM ACAD DERMATOL, V72, P203, DOI 10.1016/j.jaad.2014.07.032; Matthews BR, 1999, DRUG DEV IND PHARM, V25, P831, DOI 10.1081/DDC-100102245; Meco D, 2005, CANCER LETT, V228, P211, DOI 10.1016/j.canlet.2005.02.054; Moen MD, 2007, DRUGS, V67, P299, DOI 10.2165/00003495-200767020-00010; Mortazavi SA, 2014, IRAN J PHARM RES, V13, P19; Newell DR, 2005, EUR J CANCER, V41, P676, DOI 10.1016/j.ejca.2004.12.024; Novartis FDA, 2003, GLEEV IM MES; Nunthanid J, 2004, J CONTROL RELEASE, V99, P15, DOI 10.1016/j.jconrel.2004.06.008; Parise RA, 2003, J CHROMATOGR B, V791, P39, DOI 10.1016/S1570-0232(03)00206-X; Pather SI, 1998, INT J PHARM, V164, P1, DOI 10.1016/S0378-5173(97)00348-7; Pharmacopoeia TB, 2007, BRIT PHARMACOPOEIA; RAO KVR, 1988, INT J PHARM, V48, P1; Rehman AU, 2013, TROP J PHARM RES, V12, P169, DOI 10.4314/tjpr.v12i2.6; Sauzet C, 2009, INT J PHARMACEUT, V378, P23, DOI 10.1016/j.ijpharm.2009.05.027; SHAW JE, 1980, ANNU REP MED CHEM, V15, P302; Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7; Srinatha A, 2008, DRUG DELIV, V15, P471, DOI [10.1080/10717540802329282, 10.1080/10717540802329282 ]; Tadros MI, 2010, EUR J PHARM BIOPHARM, V74, P332, DOI 10.1016/j.ejpb.2009.11.010; Teng JFT, 2012, THER DRUG MONIT, V34, P85, DOI 10.1097/FTD.0b013e31823cdec9; Titier K, 2005, THER DRUG MONIT, V27, P634, DOI 10.1097/01.ftd.0000175973.71140.91; USP, 2004, US PHARM, VXXVII; Varshosaz J, 2006, DRUG DELIV, V13, P277, DOI 10.1080/10717540500395106; Vilches AP, 2002, INT J PHARM, V246, P17, DOI 10.1016/S0378-5173(02)00333-2; Wadher KJ, 2011, INDIAN J PHARM SCI, V73, P208; Weigel MT, 2009, CANCER LETT, V273, P70, DOI 10.1016/j.canlet.2008.07.040; Wong DWY, 2008, CLIN ONCOL-UK, V20, P517, DOI 10.1016/j.clon.2008.04.008; Xu XQ, 2006, INT J PHARMACEUT, V310, P139, DOI 10.1016/j.ijpharm.2005.12.003; Yin LF, 2013, INT J PHARMACEUT, V452, P241, DOI 10.1016/j.ijpharm.2013.05.011; Zahaby EI- SA, SAUDI PHARM J; Zaharuddin ND, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/735891; Zhang CG, 2012, INT J PHARMACEUT, V430, P141, DOI 10.1016/j.ijpharm.2012.04.013	59	17	17	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0126874	10.1371/journal.pone.0126874	http://dx.doi.org/10.1371/journal.pone.0126874			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035710	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100008
J	Yu, L; Tian, YL; Gao, AX; Shi, ZZ; Liu, YS; Li, CM				Yu, Ling; Tian, YunLi; Gao, AnXiu; Shi, ZhuanZhuan; Liu, YingShuai; Li, ChangMing			Bi-Module Sensing Device to In Situ Quantitatively Detect Hydrogen Peroxide Released from Migrating Tumor Cells	PLOS ONE			English	Article							GROWTH-FACTOR; ENDOTHELIAL-CELLS; LIVING CELLS; CANCER CELLS; ADHESION; ACTIVATION; APOPTOSIS; H2O2; SUPEROXIDE; EXPRESSION	Cell migration is one of the key cell functions in physiological and pathological processes, especially in tumor metastasis. However, it is not feasible to monitor the important biochemical molecules produced during cell migrations in situ by conventional cell migration assays. Herein, for the first time a device containing both electrochemical sensing and trans-well cell migration modules was fabricated to sensitively quantify biochemical molecules released from the cell migration process in situ. The fully assembled device with a multi-wall carbon nanotube/graphene/MnO2 nanocomposite functionalized electrode was able to successfully characterize hydrogen peroxide (H2O2) production from melanoma A375 cells, larynx carcinoma HEp-2 cells and liver cancer Hep G2 under serum established chemotaxis. The maximum concentration of H2O2 produced from A375, HEp-2 and Hep G2 in chemotaxis was 130 +/- 1.3 nM, 70 +/- 0.7 nM and 63 +/- 0.7 nM, respectively. While the time required reaching the summit of H2O2 production was 3.0, 4.0 and 1.5 h for A375, HEp-2 and Hep G2, respectively. By staining the polycarbonate micropore membrane disassembled from the device, we found that the average migration rate of the A375, HEp-2 and Hep G2 cells were 98 +/- 6%, 38 +/- 4% and 32 +/- 3%, respectively. The novel bi-module cell migration platform enables in situ investigation of cell secretion and cell function simultaneously, highlighting its potential for characterizing cell motility through monitoring H2O2 production on rare samples and for identifying underlying mechanisms of cell migration.	[Yu, Ling; Tian, YunLi; Gao, AnXiu; Shi, ZhuanZhuan; Liu, YingShuai; Li, ChangMing] Southwest Univ, Fac Mat & Energy, Inst Clean Energy & Adv Mat, Chongqing 400715, Peoples R China; [Yu, Ling; Tian, YunLi; Gao, AnXiu; Shi, ZhuanZhuan; Liu, YingShuai; Li, ChangMing] Chongqing Key Lab Adv Mat & Technol Clean Energie, Chongqing 400715, Peoples R China; [Yu, Ling; Tian, YunLi; Gao, AnXiu; Shi, ZhuanZhuan; Liu, YingShuai; Li, ChangMing] Chongqing Engn Res Ctr Rapid Diag Fatal Dis, Chongqing 400715, Peoples R China	Southwest University - China	Yu, L (corresponding author), Southwest Univ, Fac Mat & Energy, Inst Clean Energy & Adv Mat, Chongqing 400715, Peoples R China.	lingyu12@swu.edu.cn; ysliu@swu.edu.cn	Li, Chang Ming/N-8811-2019; Yu, Ling/J-4286-2016; Li, Chang Ming/F-9340-2017	Li, Chang Ming/0000-0002-4041-2574; Yu, Ling/0000-0002-6726-281X; Li, Chang Ming/0000-0002-4041-2574	Chongqing Key Laboratory for Advanced Materials and Technologies of Clean Energies; Southwest University [SWU111071]; National Science Foundation of China [31200700, 21375108]; Chongqing Key Natural Science Foundation [cstc2014jcyjA10070]	Chongqing Key Laboratory for Advanced Materials and Technologies of Clean Energies; Southwest University(Southwest University - China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Key Natural Science Foundation	This work is financially supported by Chongqing Key Laboratory for Advanced Materials and Technologies of Clean Energies, Start-up grant under SWU111071 from Southwest University, the National Science Foundation of China (No. 31200700,21375108), and Chongqing Key Natural Science Foundation (cstc2014jcyjA10070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuta AKH, 2010, LANGMUIR, V26, P4160, DOI 10.1021/la903441u; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Basuroy S, 2010, AM J PHYSIOL-GASTR L, V299, pG186, DOI 10.1152/ajpgi.00368.2009; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chen YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044937; DeGennaro M, 2011, DEV CELL, V20, P233, DOI 10.1016/j.devcel.2010.12.007; Dinic J, 2013, BBA-BIOMEMBRANES, V1828, P1102, DOI 10.1016/j.bbamem.2012.12.004; Eklund SE, 2006, J ELECTROANAL CHEM, V587, P333, DOI 10.1016/j.jelechem.2005.11.024; Eklund SE, 2003, ANAL CHIM ACTA, V496, P93, DOI 10.1016/S0003-2670(03)00992-9; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Grisham MB, 2013, COMP BIOCHEM PHYS A, V165, P429, DOI 10.1016/j.cbpa.2013.02.003; Guo CX, 2010, ADV MATER, V22, P5164, DOI 10.1002/adma.201001699; Hu TS, 2005, AM J PHYSIOL-RENAL, V289, pF816, DOI 10.1152/ajprenal.00024.2005; Hung WY, 2012, BBA-GEN SUBJECTS, V1820, P1102, DOI 10.1016/j.bbagen.2012.04.016; Im YS, 2012, BIOMOL THER, V20, P165, DOI 10.4062/biomolther.2012.20.2.165; Jeong GS, 2011, BIOMED MICRODEVICES, V13, P717, DOI 10.1007/s10544-011-9541-7; Jiang Q, 2006, J OCUL PHARMACOL TH, V22, P93, DOI 10.1089/jop.2006.22.93; Kohn E C, 1993, Oncology (Williston Park), V7, P47; Lahdesmaki I, 2007, ANALYST, V132, P811, DOI 10.1039/b704188h; Lauffenburger DA, 1996, NATURE, V383, P390, DOI 10.1038/383390a0; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee DJ, 2013, MOL CELLS, V35, P93, DOI 10.1007/s10059-013-0034-9; Lee ER, 2007, BIOL PHARM BULL, V30, P32, DOI 10.1248/bpb.30.32; Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002; Li NY, 2003, FREE RADICAL BIO MED, V34, P465, DOI 10.1016/S0891-5849(02)01325-4; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Longpre JM, 2008, FREE RADICAL RES, V42, P533, DOI 10.1080/10715760802126692; Luanpitpong S, 2010, J BIOL CHEM, V285, P38832, DOI 10.1074/jbc.M110.124958; Manning P, 2011, BIOCHEM SOC T, V39, P1288, DOI 10.1042/BST0391288; Nie FQ, 2007, BIOMATERIALS, V28, P4017, DOI 10.1016/j.biomaterials.2007.05.037; Pan Q, 2011, INVEST OPHTH VIS SCI, V52, P1723, DOI 10.1167/iovs.10-5866; Park SE, 2007, FEBS LETT, V581, P180, DOI 10.1016/j.febslet.2006.12.006; Park WH, 2013, INT J MOL MED, V31, P471, DOI 10.3892/ijmm.2012.1215; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; Polacheck WJ, 2013, CELL MOL LIFE SCI, V70, P1335, DOI 10.1007/s00018-012-1115-1; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; Rabinowitz JD, 1998, J AM CHEM SOC, V120, P2464, DOI 10.1021/ja973560f; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Shi ZZ, 2014, ANAL METHODS-UK, V6, P4446, DOI 10.1039/c4ay00695j; Snider RM, 2008, ANAL CHIM ACTA, V609, P44, DOI 10.1016/j.aca.2007.12.032; Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013; Nguyen TA, 2013, ANAL CHEM, V85, P11068, DOI 10.1021/ac402761s; Tobar N, 2010, BRIT J CANCER, V103, P1040, DOI 10.1038/sj.bjc.6605847; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; van der Meer AD, 2010, AM J PHYSIOL-HEART C, V298, pH719, DOI 10.1152/ajpheart.00933.2009; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Wu WS, 2006, MOL CANCER RES, V4, P747, DOI 10.1158/1541-7786.MCR-06-0096; Yu L, 2014, INTEGR BIOL-UK, V6, P1211, DOI 10.1039/c4ib00170b; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109	55	5	5	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127610	10.1371/journal.pone.0127610	http://dx.doi.org/10.1371/journal.pone.0127610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035641	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100015
J	Afzal, M; Shafeeq, S; Manzoor, I; Kuipers, OP				Afzal, Muhammad; Shafeeq, Sulman; Manzoor, Irfan; Kuipers, Oscar P.			Maltose-Dependent Transcriptional Regulation of the mal Regulon by MalR in Streptococcus pneumoniae	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; MALTOSACCHARIDE UTILIZATION; BACILLUS-SUBTILIS; ASCORBIC-ACID; GALR FAMILY; METABOLISM; SYSTEM; PROMOTER	The maltose regulon (mal regulon) has previously been shown to consist of the mal gene cluster (malMP, malXCD and malAR operons) in Streptococcus pneumoniae. In this study, we have further elucidated the complete mal regulon in S. pneumoniae D39 using microarray analyses and beta-galactosidase assays. In addition to the mal gene cluster, the complete mal regulon of S. pneumoniae D39 consists of a pullulanase (PulA), a glucosidase (DexB), a glucokinase (RokB), a PTS component (PtsG) and an amylase (AmyA2). Our microarray studies and beta-galactosidase assays further showed that the LacI-family transcriptional regulator MalR represses the expression of the mal regulon in the absence of maltose. Furthermore, the role of the pleiotropic transcriptional regulator CcpA in the regulation of the mal regulon in the presence of maltose was explored. Our microarray analysis with a Delta ccpA strain showed that CcpA only represses the expression of the malXCD operon and the pulA gene in the presence of maltose. Hence, we extend the mal regulon now consisting of pulA, dexB, rokB, ptsG and amyA2 in addition to malMP, malXCD and malAR operons.	[Afzal, Muhammad; Shafeeq, Sulman; Manzoor, Irfan; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Afzal, Muhammad; Manzoor, Irfan] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Shafeeq, Sulman] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	University of Groningen; Government College University Faisalabad; Karolinska Institutet	Kuipers, OP (corresponding author), Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	o.p.kuipers@rug.nl	Shafeeq, Sulman/P-4473-2014; Kuipers, Oscar/B-6752-2009	Shafeeq, Sulman/0000-0003-1152-526X; Manzoor, Irfan/0000-0003-3850-2690; Kuipers, Oscar/0000-0001-5596-7735	University of Groningen	University of Groningen	This work was supported by University of Groningen.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Afzal M, 2015, JOVE-J VIS EXP, DOI 10.3791/52649; Afzal M, 2015, APPL ENVIRON MICROB, V81, P3121, DOI 10.1128/AEM.00499-15; Afzal M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00072; Afzal M, 2015, MICROBIOL-SGM, V161, P41, DOI 10.1099/mic.0.083899-0; Afzal M, 2014, APPL ENVIRON MICROB, V80, P5349, DOI 10.1128/AEM.01370-14; Andersson U, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-28; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bender David A., 2005, DICT FOOD NUTR; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Bloch M A, 1987, J BACTERIOL, V168, P1220; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Brown WH, 2005, INTRO ORGANIC CHEM; Buckwalter CM, 2012, TRENDS MICROBIOL, V20, P517, DOI 10.1016/j.tim.2012.08.008; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; EHRMANN M, 1987, J BACTERIOL, V169, P3539, DOI 10.1128/jb.169.8.3539-3545.1987; Halfmann A, 2007, FEMS MICROBIOL LETT, V268, P217, DOI 10.1111/j.1574-6968.2006.00584.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kilic AO, 2007, FEMS MICROBIOL LETT, V266, P218, DOI 10.1111/j.1574-6968.2006.00522.x; Kilic AO, 2004, J BACTERIOL, V186, P4246, DOI 10.1128/JB.186.13.4246-4253.2004; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Krause FS, 2010, APPL ENVIRON MICROB, V76, P370, DOI 10.1128/AEM.01553-09; LACKS S, 1968, GENETICS, V60, P685; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Nguyen CC, 1995, FEBS LETT, V377, P98, DOI 10.1016/0014-5793(95)01344-X; Nieto C, 1997, J BIOL CHEM, V272, P30860, DOI 10.1074/jbc.272.49.30860; Nieto C, 2001, J BIOL CHEM, V276, P14946, DOI 10.1074/jbc.M010911200; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; PUYET A, 1993, J MOL BIOL, V230, P800, DOI 10.1006/jmbi.1993.1202; REIDL J, 1989, J BACTERIOL, V171, P4888, DOI 10.1128/jb.171.9.4888-4899.1989; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; Ryan KJ., 2004, SHERRIS MED MICROBIO; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; Sato Y, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.21285; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz M, 1987, MALTOSE REGULON ESCH; Shafeeq S, 2015, GENOM DATA, V4, P57, DOI 10.1016/j.gdata.2015.02.004; Shafeeq S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057586; Shafeeq S, 2012, MICROBIOL-SGM, V158, P2917, DOI 10.1099/mic.0.062919-0; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Shelburne SA, 2009, MOL MICROBIOL, V74, P159, DOI 10.1111/j.1365-2958.2009.06858.x; STASSI DL, 1982, GENE, V20, P359, DOI 10.1016/0378-1119(82)90204-9; SUGISAWA H, 1966, J FOOD SCI, V31, P561, DOI 10.1111/j.1365-2621.1966.tb01905.x; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; vanWezel GP, 1997, MOL MICROBIOL, V23, P537, DOI 10.1046/j.1365-2958.1997.d01-1878.x; VIDALINGIGLIARDI D, 1991, J MOL BIOL, V218, P323, DOI 10.1016/0022-2836(91)90715-I; Wagner M, 2014, APPL ENVIRON MICROB, V80, P1072, DOI 10.1128/AEM.03050-13; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; WEINRAUCH Y, 1981, MOL GEN GENET, V183, P7, DOI 10.1007/BF00270130; Yesilkaya H, 2008, FEMS MICROBIOL LETT, V278, P231, DOI 10.1111/j.1574-6968.2007.01003.x; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	64	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127579	10.1371/journal.pone.0127579	http://dx.doi.org/10.1371/journal.pone.0127579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030923	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900063
J	Bridwell, DA; Roth, C; Gupta, CN; Calhoun, VD				Bridwell, David A.; Roth, Cullen; Gupta, Cota Navin; Calhoun, Vince D.			Cortical Response Similarities Predict which Audiovisual Clips Individuals Viewed, but Are Unrelated to Clip Preference	PLOS ONE			English	Article							INTERSUBJECT CORRELATIONS; WAVELET ANALYSIS; TEMPORAL CORTEX; BRAIN; SYNCHRONIZATION; FMRI; SCHIZOPHRENIA; OSCILLATIONS; VARIABILITY; POTENTIALS	Cortical responses to complex natural stimuli can be isolated by examining the relationship between neural measures obtained while multiple individuals view the same stimuli. These inter-subject correlation's (ISC's) emerge from similarities in individual's cortical response to the shared audiovisual inputs, which may be related to their emergent cognitive and perceptual experience. Within the present study, our goal is to examine the utility of using ISC's for predicting which audiovisual clips individuals viewed, and to examine the relationship between neural responses to natural stimuli and subjective reports. The ability to predict which clips individuals viewed depends on the relationship of the EEG response across subjects and the nature in which this information is aggregated. We conceived of three approaches for aggregating responses, i.e. three assignment algorithms, which we evaluated in Experiment 1A. The aggregate correlations algorithm generated the highest assignment accuracy (70.83% chance = 33.33%) and was selected as the assignment algorithm for the larger sample of individuals and clips within Experiment 1B. The overall assignment accuracy was 33.46% within Experiment 1B (chance = 06.25%), with accuracies ranging from 52.9% (Silver Linings Playbook) to 11.75% (Seinfeld) within individual clips. ISC's were significantly greater than zero for 15 out of 16 clips, and fluctuations within the delta frequency band (i.e. 0-4 Hz) primarily contributed to response similarities across subjects. Interestingly, there was insufficient evidence to indicate that individuals with greater similarities in clip preference demonstrate greater similarities in cortical responses, suggesting a lack of association between ISC and clip preference. Overall these results demonstrate the utility of using ISC's for prediction, and further characterize the relationship between ISC magnitudes and subjective reports.	[Bridwell, David A.; Roth, Cullen; Gupta, Cota Navin; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM 87123 USA; [Roth, Cullen] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Roth, Cullen] Univ New Mexico, Dept Biol, IMSD, Albuquerque, NM 87131 USA; [Roth, Cullen] Duke Univ, Program Genet & Gen, Durham, NC 27706 USA; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; Duke University; University of New Mexico	Bridwell, DA (corresponding author), Mind Res Network, Albuquerque, NM 87123 USA.	dbridwell@mrn.org	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747	NIH [1R01EB006841, GM-060201]; Mind Research Network; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201, T32GM007754] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mind Research Network; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH (http://www.nih.gov/) grant 1R01EB006841 (awarded to VC), GM-060201 (to CR), and a pilot grant awarded by the Mind Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2013, EUR J NEUROSCI, V37, P1458, DOI 10.1111/ejn.12173; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; Bradley AP, 2004, CLIN NEUROPHYSIOL, V115, P1114, DOI 10.1016/j.clinph.2003.11.016; Bridwell DA, 2014, SCHIZOPHR RES, V2014; Bridwell DA, 2014, MEG SIGNALS DYNAMIC; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; COHEN A, 1992, COMMUN PUR APPL MATH, V45, P485, DOI 10.1002/cpa.3160450502; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; Demiralp T, 2001, INT J PSYCHOPHYSIOL, V39, P221, DOI 10.1016/S0167-8760(00)00143-4; Dmochowski JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5567; Dmochowski JP, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00112; Doelling KB, 2014, NEUROIMAGE, V85, P761, DOI 10.1016/j.neuroimage.2013.06.035; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gaebler M, 2014, NEUROIMAGE, V100, P427, DOI 10.1016/j.neuroimage.2014.06.008; Glerean E, 2012, BRAIN CONNECT, V2, P91, DOI 10.1089/brain.2011.0068; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Good P, 2005, PERMUTATION PARAMETR; Gross J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001752; Hanson SJ, 2009, J COMPUT NEUROSCI, V27, P103, DOI 10.1007/s10827-008-0129-z; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hasson U, 2008, PROJECTIONS, V2, P1, DOI 10.3167/proj.2008.020102; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Hejnar MR, 2007, HUM BRAIN MAPP, V28, P860, DOI 10.1002/hbm.20321; Horton C, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046015; Huttunen H, 2013, MACH VISION APPL, V24, P1311, DOI 10.1007/s00138-012-0464-y; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Joormann J, 2004, COGNITION EMOTION, V18, P125, DOI 10.1080/02699930244000480; Kauppi J- P, 2010, INF TECHN APPL BIOM, P1, DOI [10.1109/ITAB.2010.5687650, DOI 10.1109/ITAB.2010.5687650]; Kauppi Jukka-Pekka, 2010, Front Neuroinform, V4, P5, DOI 10.3389/fninf.2010.00005; Kim D, 2008, NEUROIMAGE, V39, P1129, DOI 10.1016/j.neuroimage.2007.09.042; Konvalinka I, 2014, NEUROIMAGE, V94, P79, DOI 10.1016/j.neuroimage.2014.03.003; Koskinen M, 2014, NEUROIMAGE, V100, P263, DOI 10.1016/j.neuroimage.2014.06.018; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lahnakoski JM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00233; Lankinen K, 2014, NEUROIMAGE, V92, P217, DOI 10.1016/j.neuroimage.2014.02.004; Lee YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095415; Lessa PS, 2011, J NEUROSCI METH, V194, P350, DOI 10.1016/j.jneumeth.2010.09.005; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Nummenmaa L, 2012, P NATL ACAD SCI USA, V109, P9599, DOI 10.1073/pnas.1206095109; Pajula J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041196; Porbadnigk AK, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056003; Quiroga RQ, 2001, BRAIN RES PROTOC, V8, P16, DOI 10.1016/S1385-299X(01)00077-0; Quiroga RQ, 2000, PHYSICA D, V145, P278, DOI 10.1016/S0167-2789(00)00116-0; Roth A, 2007, INT J PSYCHOPHYSIOL, V66, P244, DOI 10.1016/j.ijpsycho.2007.08.005; Roth C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00370; Sanger J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00234; Salmi J, 2013, NEUROIMAGE-CLIN, V3, P489, DOI 10.1016/j.nicl.2013.10.011; Salmi J, 2014, HUM BRAIN MAPP, V35, P4767, DOI 10.1002/hbm.22510; SAMAR VJ, 1995, BRAIN COGNITION, V27, P398, DOI 10.1006/brcg.1995.1028; Scholler S, 2012, IEEE T IMAGE PROCESS, V21, P2619, DOI 10.1109/TIP.2012.2187672; Seghier ML, 2009, NEUROIMAGE, V45, P349, DOI 10.1016/j.neuroimage.2008.12.017; Strang G, 1996, WAVELETS FILTERBANKS; Sur Shravani, 2009, Ind Psychiatry J, V18, P70, DOI 10.4103/0972-6748.57865; Unser M, 1992, IEEE T INF THEORY, V38; von Borries AKL, 2013, COGN AFFECT BEHAV NE, V13, P737, DOI 10.3758/s13415-013-0150-1; Whittingstall K, 2010, MAGN RESON IMAGING, V28, P1135, DOI 10.1016/j.mri.2010.03.042; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Yazdani A, 2012, ACM T INTERACT INTEL, V2, DOI 10.1145/2133366.2133373; Ylipaavalniemi J, 2009, NEUROIMAGE, V48, P176, DOI 10.1016/j.neuroimage.2009.03.056	70	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128833	10.1371/journal.pone.0128833	http://dx.doi.org/10.1371/journal.pone.0128833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030422	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900195
J	De Pascalis, V; Varriale, V; Cacace, I				De Pascalis, Vilfredo; Varriale, Vincenzo; Cacace, Immacolata			Pain Modulation in Waking and Hypnosis in Women: Event-Related Potentials and Sources of Cortical Activity	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; POSTTRAUMATIC-STRESS-DISORDER; SELECTIVE SPATIAL ATTENTION; HUMAN ANTERIOR CINGULATE; ELECTROMAGNETIC TOMOGRAPHY; HYPNOTIC ANALGESIA; HUMAN BRAIN; SEX-DIFFERENCES; FOCUSED ANALGESIA; LASER STIMULI	Using a strict subject selection procedure, we tested in High and Low Hypnotizable subjects (HHs and LHs) whether treatments of hypoalgesia and hyperalgesia, as compared to a relaxation-control, differentially affected subjective pain ratings and somatosensory event-related potentials (SERPs) during painful electric stimulation. Treatments were administered in waking and hypnosis conditions. LHs showed little differentiation in pain and distress ratings between hypoalgesia and hyperalgesia treatments, whereas HHs showed a greater spread in the instructed direction. HHs had larger prefrontal N140 and P200 waves of the SERPs during hypnotic hyperalgesia as compared to relaxation-control treatment. Importantly, HHs showed significant smaller frontocentral N140 and frontotemporal P200 waves during hypnotic hypoalgesia. LHs did not show significant differences for these SERP waves among treatments in both waking and hypnosis conditions. Source localization (sLORETA) method revealed significant activations of the bilateral primary somatosensory (BA3), middle frontal gyrus (BA6) and anterior cingulate cortices (BA24). Activity of these contralateral regions significantly correlated with subjective numerical pain scores for control treatment in waking condition. Moreover, multivariate regression analyses distinguished the contralateral BA3 as the only region reflecting a stable pattern of pain coding changes across all treatments in waking and hypnosis conditions. More direct testing showed that hypnosis reduced the strength of the association of pain modulation and brain activity changes at BA3. sLORETA in HHs revealed, for the N140 wave, that during hypnotic hyperalgesia, there was an increased activity within medial, supramarginal and superior frontal gyri, and cingulated gyrus (BA32), while for the P200 wave, activity was increased in the superior (BA22), middle (BA37), inferior temporal (BA19) gyri and superior parietal lobule (BA7). Hypnotic hypoalgesia in HHs, for N140 wave, showed reduced activity within medial and superior frontal gyri (BA9,8), paraippocampal gyrus (BA34), and postcentral gyrus (BA1), while for the P200, activity was reduced within middle and superior frontal gyri (BA9 and BA10), anterior cingulate (BA33), cuneus (BA19) and sub-lobar insula (BA13). These findings demonstrate that hypnotic suggestions can exert a top-down modulatory effect on attention/preconscious brain processes involved in pain perception.	[De Pascalis, Vilfredo; Varriale, Vincenzo; Cacace, Immacolata] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy	Sapienza University Rome	De Pascalis, V (corresponding author), Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	vilfredo.depascalis@uniroma1.it	De Pascalis, Vilfredo/ABC-5534-2021; Varriale, Vincenzo/AAQ-9419-2020	Varriale, Vincenzo/0000-0002-1609-9282; DE PASCALIS, Vilfredo/0000-0003-4594-8877	University of Rome "La Sapienza" [C26A08B8BP]	University of Rome "La Sapienza"	This research was supported by a grant from the University of Rome "La Sapienza" (2008, prot. C26A08B8BP) to V. DePascalis for a research project titled "Suggestioni di analgesia e iperalgesia in veglia e ipnosi: effetto sui potenziali somatosensoriali evento-correlati". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen R, 2010, PAIN, V151, P825, DOI 10.1016/j.pain.2010.09.020; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BECKER DE, 1993, ELECTROEN CLIN NEURO, V88, P290, DOI 10.1016/0168-5597(93)90053-R; Becker DE, 2000, PAIN, V84, P37, DOI 10.1016/S0304-3959(99)00182-7; Bromm B, 1998, ELECTROEN CLIN NEURO, V107, P227, DOI 10.1016/S0013-4694(98)00075-3; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Buchel C, 1999, J NEUROSCI, V19, P10869; Bushnell M, 2006, WALL MELZACKS TXB PA, P107; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Cardena E., 2007, CONT HYPNOSIS, V24, P154, DOI [10.1002/ch.340, DOI 10.1002/CH.340]; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; Caruana F, 2011, CURR BIOL, V21, P195, DOI 10.1016/j.cub.2010.12.042; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; Chaves JF, 1997, INT J CLIN EXP HYP, V45, P356, DOI 10.1080/00207149708416138; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Clark WC, 2002, PAIN, V98, P241, DOI 10.1016/S0304-3959(01)00474-2; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Congedo M, 2009, HDB NEUROFEEDBACK DY, P85; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; CRAWFORD HJ, 1994, INT J CLIN EXP HYP, V42, P204, DOI 10.1080/00207149408409352; Crawford HJ., 1992, CONT HYPNOSIS RES, P227; Croft RJ, 2002, INT J PSYCHOPHYSIOL, V46, P101, DOI 10.1016/S0167-8760(02)00118-6; Danziger N, 1998, PAIN, V75, P85, DOI 10.1016/S0304-3959(97)00208-X; De Pascalis V, 1999, PAIN, V83, P499, DOI 10.1016/S0304-3959(99)00157-8; De Pascalis V, 2005, INT J PSYCHOPHYSIOL, V56, P157, DOI 10.1016/j.ijpsycho.2004.11.004; De Pascalis V, 2001, CLIN NEUROPHYSIOL, V112, P1475, DOI 10.1016/S1388-2457(01)00586-7; De Pascalis V, 2000, INT J CLIN EXP HYP, V48, P44, DOI 10.1080/00207140008410360; De Pascalis V, 2002, SUGGESTION SUGGESTIB, P157; De Pascalis V, 2008, PAIN, V134, P197, DOI 10.1016/j.pain.2007.09.005; De Pascalis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079605; DEPASCALIS V, 2000, INT J CLIN EXP HYP, V48, P15; Derbyshire SWG, 2009, EUR J PAIN, V13, P542, DOI 10.1016/j.ejpain.2008.06.010; DESMEDT JE, 1989, ELECTROEN CLIN NEURO, V74, P321, DOI 10.1016/0168-5597(89)90001-4; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Duncan Gary H, 2003, Adv Neurol, V93, P69; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Eimer M, 2002, PSYCHOPHYSIOLOGY, V39, P437, DOI 10.1017/S0048577201393162; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Emdad R, 2006, PSYCHOTHER PSYCHOSOM, V75, P122, DOI 10.1159/000090897; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Faymonville ME, 2006, J PHYSIOL-PARIS, V99, P463, DOI 10.1016/j.jphysparis.2006.03.018; Faymonville ME, 2000, ANESTHESIOLOGY, V92, P1257, DOI 10.1097/00000542-200005000-00013; Faymonville ME, 2003, COGNITIVE BRAIN RES, V17, P255, DOI 10.1016/S0926-6410(03)00113-7; Frot M, 1999, CLIN NEUROPHYSIOL, V110, P133, DOI 10.1016/S0168-5597(98)00054-9; Frot M, 2013, HUM BRAIN MAPP, V34, P2655, DOI 10.1002/hbm.22097; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 2012, NEUROPHYSIOL CLIN, V42, P299, DOI 10.1016/j.neucli.2012.06.001; Garcia-Larrea L, 2013, PAIN, V154, pS29, DOI 10.1016/j.pain.2013.09.001; Garcia-Larrea L, 2012, NEUROSCI LETT, V520, P188, DOI 10.1016/j.neulet.2012.05.007; GARCIALARREA L, 1995, PSYCHOPHYSIOLOGY, V32, P526, DOI 10.1111/j.1469-8986.1995.tb01229.x; GARCIALARREA L, 1991, ELECTROEN CLIN NEURO, V80, P201, DOI 10.1016/0168-5597(91)90122-E; GarciaLarrea L, 1997, NEUROREPORT, V8, P3785, DOI 10.1097/00001756-199712010-00026; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; GIBSON SJ, 1991, PAIN, V47, P173, DOI 10.1016/0304-3959(91)90202-9; GLASS A, 1984, BIOL PSYCHOL, V19, P169, DOI 10.1016/0301-0511(84)90035-8; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; Gruzelier JH., 2000, CONT HYPNOSIS, V17, P51, DOI DOI 10.1002/CH.193; Hagen MC, 2002, J NEUROPHYSIOL, V88, P1400, DOI 10.1152/jn.2002.88.3.1400; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; HARI R, 1983, NEUROSCI LETT, V42, P77, DOI 10.1016/0304-3940(83)90425-1; Hofbauer RK, 2001, J NEUROPHYSIOL, V86, P402, DOI 10.1152/jn.2001.86.1.402; Horton JE, 2004, BRAIN, V127, P1741, DOI 10.1093/brain/awh196; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Iannetti GD, 2004, CLIN NEUROPHYSIOL, V115, P2629, DOI 10.1016/j.clinph.2004.05.023; Jensen M, 2006, J BEHAV MED, V29, P95, DOI 10.1007/s10865-005-9031-6; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; KUNDE V, 1993, ELECTROEN CLIN NEURO, V88, P280, DOI 10.1016/0168-5597(93)90052-Q; Lee MC, 2009, J NEUROSCI, V29, P7909, DOI 10.1523/JNEUROSCI.0014-09.2009; Legrain V, 2005, CLIN NEUROPHYSIOL, V116, P2165, DOI 10.1016/j.clinph.2005.05.019; Legrain V, 2012, NEUROPHYSIOL CLIN, V42, P325, DOI 10.1016/j.neucli.2012.06.003; Legrain V, 2003, PAIN, V103, P237, DOI 10.1016/S0304-3959(02)00451-7; Legrain V, 2002, PAIN, V99, P21, DOI 10.1016/S0304-3959(02)00051-9; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Leknes S, 2013, PAIN, V154, P402, DOI 10.1016/j.pain.2012.11.018; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Lorenz J, 2003, NEUROPHYSIOL CLIN, V33, P293, DOI 10.1016/j.neucli.2003.10.004; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Mancini F, 2012, J NEUROSCI, V32, P17155, DOI 10.1523/JNEUROSCI.3059-12.2012; May A, 1998, PAIN, V74, P61, DOI 10.1016/S0304-3959(97)00144-9; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MELZACK R, 1968, P423; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MIRON D, 1989, PAIN, V39, P345, DOI 10.1016/0304-3959(89)90048-1; Mohr C, 2012, EUR J PAIN, V16, P496, DOI 10.1016/j.ejpain.2011.07.010; MORGAN AH, 1979, AM J CLIN HYPN, V21, P134; Mouraux A, 2007, NEUROSCIENCE, V150, P72, DOI 10.1016/j.neuroscience.2007.08.035; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir RR, 2008, J PAIN, V9, P1058, DOI 10.1016/j.jpain.2008.06.008; Omori S, 2013, CLIN NEUROPHYSIOL, V124, P1422, DOI 10.1016/j.clinph.2013.01.006; Page RA, 2007, AM J CLIN HYPN, V49, P283, DOI 10.1080/00029157.2007.10524505; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 2000, PAIN, V84, P77, DOI 10.1016/S0304-3959(99)00190-6; Pomares FB, 2013, NEUROIMAGE, V64, P466, DOI 10.1016/j.neuroimage.2012.09.038; Price D.D., 1999, PROGR PAIN RES MANAG; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Ray AL, 2002, PRACTICAL PAIN MANAG; RAY WJ, 1976, NEUROPSYCHOLOGIA, V14, P391, DOI 10.1016/0028-3932(76)90035-X; Ray WJ, 2002, BIOL PSYCHOL, V60, P17, DOI 10.1016/S0301-0511(02)00029-7; Raz A., 2004, COGNITIVE NEUROSCIEN, P420; Rudski JM, 2004, INT J CLIN EXP HYP, V52, P39, DOI 10.1076/iceh.52.1.39.23924; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Sharav Y, 2004, INT J PSYCHOPHYSIOL, V52, P187, DOI 10.1016/j.ijpsycho.2003.10.001; Sharav Y, 2006, PAIN, V124, P280, DOI 10.1016/j.pain.2006.04.016; Shor RE, 1962, HARVASRD GROUP SCALE; Straube T, 2009, HUM BRAIN MAPP, V30, P689, DOI 10.1002/hbm.20536; Talairach J., 1988, COPLANAR STEREOTAXIC; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Terhune DB, 2010, CONSCIOUS COGN, V19, P1140, DOI 10.1016/j.concog.2010.03.006; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Valentini E, 2013, CORTEX, V49, P446, DOI 10.1016/j.cortex.2012.02.005; Valeriani M, 2000, CLIN NEUROPHYSIOL, V111, P1103, DOI 10.1016/S1388-2457(00)00273-X; Valet M, 2009, PSYCHOSOM MED, V71, P49, DOI 10.1097/PSY.0b013e31818d1e02; Vanhaudenhuyse A, 2009, NEUROIMAGE, V47, P1047, DOI 10.1016/j.neuroimage.2009.05.031; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wiech K, 2008, PAIN, V139, P467, DOI 10.1016/j.pain.2008.07.030; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Zachariae R, 1998, EUR J PAIN, V2, P25, DOI 10.1016/S1090-3801(98)90043-X	143	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128474	10.1371/journal.pone.0128474	http://dx.doi.org/10.1371/journal.pone.0128474			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030417	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900155
J	Gobbi, A; Jurman, G				Gobbi, Andrea; Jurman, Giuseppe			A Null Model for Pearson Coexpression Networks	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; CORRELATION-COEFFICIENT; MICROARRAY; INFERENCE; CLASSIFICATION; FRAMEWORK; COXPRESDB; DATABASE; PROVIDES	Gene coexpression networks inferred by correlation from high-throughput profiling such as microarray data represent simple but effective structures for discovering and interpreting linear gene relationships. In recent years, several approaches have been proposed to tackle the problem of deciding when the resulting correlation values are statistically significant. This is most crucial when the number of samples is small, yielding a non-negligible chance that even high correlation values are due to random effects. Here we introduce a novel hard thresholding solution based on the assumption that a coexpression network inferred by randomly generated data is expected to be empty. The threshold is theoretically derived by means of an analytic approach and, as a deterministic independent null model, it depends only on the dimensions of the starting data matrix, with assumptions on the skewness of the data distribution compatible with the structure of gene expression levels data. We show, on synthetic and array datasets, that the proposed threshold is effective in eliminating all false positive links, with an offsetting cost in terms of false negative detected edges.	[Gobbi, Andrea; Jurman, Giuseppe] Fdn Bruno Kessler, Trento, Italy	Fondazione Bruno Kessler	Jurman, G (corresponding author), Fdn Bruno Kessler, Trento, Italy.	jurman@fbk.eu	Jurman, Giuseppe/GRS-8221-2022	Gobbi, Andrea/0000-0003-1709-7542; Jurman, Giuseppe/0000-0002-2705-5728	Fondazione Bruno Kessler	Fondazione Bruno Kessler	The work has been funded by Fondazione Bruno Kessler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1908, BIOMETRIKA, V6, P1; Azuaje FJ, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-12; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Baralla A, 2009, ANN NY ACAD SCI, V1158, P246, DOI 10.1111/j.1749-6632.2008.04099.x; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Bevington PR, 1969, DATA REDUCTION AND E; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Borate Bhavesh R, 2009, BMC Res Notes, V2, P240, DOI 10.1186/1756-0500-2-240; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Butte A J, 2000, Pac Symp Biocomput, P418; Caraiani P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058109, 10.1371/journal.pone.0056767]; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Casellas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038919; Chen H, 2011, THESIS; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Davidson GS, 2001, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2001, PROCEEDINGS, P23, DOI 10.1109/INFVIS.2001.963275; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Dempsey K, 2011, P 44 HAW INT C SYST, P1; Doig TN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-469; Dudoit S, 2008, SPRINGER SER STAT, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290; Feltus FA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-44; Filosi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089815; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fisher R.A., 1925, METRON, V5, P90; Fisher RA, 1914, BIOMETRIKA, V10, P507; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Fukushima A, 2013, GENE, V518, P209, DOI 10.1016/j.gene.2012.11.028; Furlotte NA, 2011, BIOINFORMATICS, V27, pI288, DOI 10.1093/bioinformatics/btr221; Gaiteri C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00095; GAYEN AK, 1951, BIOMETRIKA, V38, P219, DOI 10.1093/biomet/38.1-2.219; Gibbs David L, 2013, J Clin Bioinforma, V3, P11, DOI 10.1186/2043-9113-3-11; Gibson SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055871; Giorgi FM, 2011, THESIS; Good P., 2000, PERMUTATION TESTS; HALDANE JBS, 1949, BIOMETRIKA, V36, P467, DOI 10.1093/biomet/36.3-4.467; HAMZA K, 1995, STAT PROBABIL LETT, V23, P21, DOI 10.1016/0167-7152(94)00090-U; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Hey GB, 1938, BIOMETRIKA, V30, P68; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jurman G, 2013, ARXIV12012931MATHCO; Kendall M.G., 1973, ADV THEORY STAT, V2; Kendall MG, 1977, THE ADVANCED THEORY; Kenney JF, 1962, MATHEMATICS OF STATI; Kenney JF, 1951, MATHEMATICS OF STATI; Khanin R, 2007, METHODS OF MICROARRAY DATA ANALYSIS V, P75, DOI 10.1007/978-0-387-34569-7_6; KOWALSKI CJ, 1972, J ROY STAT SOC C-APP, V21, P1; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050411; Lavi O, 2012, J COMPUT BIOL, V19, P694, DOI 10.1089/cmb.2012.0065; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Liang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116776; Lopez-Kleine L, 2013, BRIEF FUNCT GENOMICS, V12, P457, DOI 10.1093/bfgp/elt003; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Ma C, 2012, PLANT PHYSIOL, V160, P192, DOI 10.1104/pp.112.201962; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Meyer P, 2011, NAT BIOTECHNOL, V29, P811, DOI 10.1038/nbt.1968; Miller R.G., 1981, SIMULTANEOUS STAT IN, Ved 2nd, DOI DOI 10.1007/s11263-015-0816-y; Mistry M, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-105; Numata Jorge, 2008, Genome Inform, V20, P112; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; OLKIN I, 1958, ANN MATH STAT, V29, P201, DOI 10.1214/aoms/1177706717; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pearson ES, 1929, BIOMETRIKA, V21, P259, DOI 10.2307/2332560; Perkins AD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S4; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PRICE DJD, 1965, SCIENCE, V149, P510; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Pugh EM, 1966, THE ANALYSIS OF PHYS; Rahman N.A., 1968, COURSE THEORETICAL S; Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Rau A, 2015, BIOINFORMATICS, V31, P1420, DOI 10.1093/bioinformatics/btu845; Rider AK, 2014, NETW SCI, V2, P139, DOI 10.1017/nws.2014.13; Rider PR, 1932, BIOMETRIKA, V24, P382, DOI 10.1093/biomet/24.3-4.382; Rotival M, 2014, BRIEF FUNCT GENOMICS, V13, P66, DOI 10.1093/bfgp/elt030; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Scholz M., 2006, THESIS U POTSDAM POT; Soheila K, 2013, ASIAN PAC J CANCER P, V14, P1629, DOI 10.7314/APJCP.2013.14.3.1629; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Song QF, 2015, MOL MED REP, V11, P21, DOI 10.3892/mmr.2014.2695; Soper HE, 1915, BIOMETRIKA, V11, P328; Stathias V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115842; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Szederkenyi G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-177; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Wang HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077429; Wang SC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0351-9; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Yuan Ao, 2010, J Biomed Sci Eng, V3, P977, DOI 10.4236/jbise.2010.310128; Zhang A, 2006, ADVANCED ANALYSIS OF; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002656; Zheng ZL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-27; Zhi Wei, 2013, Methods Mol Biol, V972, P121, DOI 10.1007/978-1-60327-337-4_8; Zhu DX, 2005, J COMPUT BIOL, V12, P1029, DOI 10.1089/cmb.2005.12.1029; Zucknick M, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1307	112	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128115	10.1371/journal.pone.0128115	http://dx.doi.org/10.1371/journal.pone.0128115			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030917	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900111
J	Thielen, K; Kolodziejczyk, C; Andersen, I; Heinesen, E; Diderichsen, F				Thielen, Karsten; Kolodziejczyk, Christophe; Andersen, Ingelise; Heinesen, Eskil; Diderichsen, Finn			Cancer Stage, Comorbidity, and Socioeconomic Differences in the Effect of Cancer on Labour Market Participation: A Danish Register-Based Follow-Up Study	PLOS ONE			English	Article							BREAST-CANCER; SOCIAL-INEQUALITY; EARLY RETIREMENT; EMPLOYMENT; SURVIVORS; COHORT; IMPACT; DIAGNOSIS; POLICIES; DENMARK	Purpose Socioeconomic inequality in return to work after cancer treatment and rehabilitation have been documented, but less is known about its causes. This paper investigates the role played by breast cancer stage at diagnosis and comorbidity. Methods We used the comprehensive Danish Cancer Registry to follow 7372 women aged 30-60, who were in the labour force when diagnosed with breast cancer in 2000-06 and survived at least three years. Controls were 213,276 women without breast cancer. Inequalities in employment outlook were estimated as interaction effects in linear regression between educational attainment and disease on employment. Results There is significant interaction between education and breast cancer, but it is only marginally affected by including stage and comorbidity in the regression models. Education, breast cancer stage, and comorbidity all have strong effects on later employment, and a considerable amount of the educational effect is mediated by comorbidity and pre-cancer labour market participation and income. Conclusion The result of the study is negative in the sense that the stronger effect of breast cancer on employment among low-educated compared to highly educated individuals is not explained by cancer stage or comorbidity. The fact that comorbidity has little impact on inequality may be due to a different social patterning of most comorbidity compared to breast cancer.	[Thielen, Karsten; Andersen, Ingelise; Diderichsen, Finn] Univ Copenhagen, Inst Publ Hlth, Sect Social Med, Copenhagen K, Denmark; [Kolodziejczyk, Christophe] KORA, Danish Inst Local & Reg Govt Res, Copenhagen K, Denmark; [Heinesen, Eskil] Rockwool Fdn Res Unit, Copenhagen K, Denmark	University of Copenhagen	Andersen, I (corresponding author), Univ Copenhagen, Inst Publ Hlth, Sect Social Med, Copenhagen K, Denmark.	inan@sund.ku.dk	Diderichsen, Finn/P-4654-2019	Diderichsen, Finn/0000-0002-9998-4972; Heinesen, Eskil/0000-0001-8953-1403; Thielen, Karsten/0000-0003-0505-5986; Andersen, Ingelise/0000-0002-0076-265X	Danish Cancer Society [SU08004]	Danish Cancer Society(Danish Cancer Society)	The study was supported by a grant from The Danish Cancer Society, grant number SU08004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn E, 2009, BREAST CANCER RES TR, V116, P609, DOI 10.1007/s10549-008-0209-9; Carlsen K, 2008, SCAND J PUBLIC HEALT, V36, P117, DOI 10.1177/1403494807085192; Carlsen K, 2014, SCAND J PUBLIC HEALT, V42, P319, DOI 10.1177/1403494813520354; Dalton SO, 2006, BRIT J CANCER, V95, P653, DOI 10.1038/sj.bjc.6603294; Dalton SO, 2008, EUR J CANCER, V44, P2074, DOI 10.1016/j.ejca.2008.06.018; Davidson R, 1993, ESTIMATION INFERENCE; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P12, DOI 10.1177/1403494812457734; Hansen RP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-49; Heinesen E, 2013, J HEALTH ECON, V32, P1028, DOI 10.1016/j.jhealeco.2013.08.004; Holland P, 2011, INT J HEALTH SERV, V41, P395, DOI 10.2190/HS.41.3.a; Holm LV, 2013, ACTA ONCOL, V52, P410, DOI 10.3109/0284186X.2012.745014; Jensen LF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-518; Kaikkonen R, 2009, EUR J PUBLIC HEALTH, V19, P458, DOI 10.1093/eurpub/ckp095; Krieger N, 2005, CANCER CAUSE CONTROL, V16, P5, DOI 10.1007/s10552-004-1251-5; Lietzen Lone Winther, 2011, Clin Epidemiol, V3 Suppl 1, P35, DOI 10.2147/CLEP.S20627; Lindbohm ML, 2014, PSYCHO-ONCOLOGY, V23, P634, DOI 10.1002/pon.3459; Ording Anne Gulbech, 2012, Clin Epidemiol, V4 Suppl 2, P11, DOI 10.2147/CLEP.S31574; Saito N, 2014, J OCCUP HEALTH, V56, P49, DOI 10.1539/joh.13-0140-OA; Suicide, 2012, HLTH GLANC EUR 2012, P28; Torp S, 2013, EUR J PUBLIC HEALTH, V23, P116, DOI 10.1093/eurpub/ckr192; van Muijen P, 2013, EUR J CANCER CARE, V22, P144, DOI 10.1111/ecc.12033; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007	22	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128621	10.1371/journal.pone.0128621	http://dx.doi.org/10.1371/journal.pone.0128621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030914	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900175
J	Zhang, JQ; Liu, FZ; Cao, JT; Liu, XL				Zhang, Jianqin; Liu, Fuzhu; Cao, Junting; Liu, Xiaolin			Skin Transcriptome Profiles Associated with Skin Color in Chickens	PLOS ONE			English	Article							COAT-COLOR; MELANOCORTIN SYSTEM; PIGMENTATION GENES; SOAY SHEEP; MITF GENE; MC1R; EXPRESSION; VARIANTS; MUTATION; JAPANESE	Nutritional and medicinal benefits have been attributed to the consumption of tissues from the black-boned chickens in oriental countries. Lueyang black-boned chicken is one of the native chicken breeds. However, some birds may instead have white or lighter skin, which directly causes economic losses every year. Previous studies of pigmentation have focused on a number of genes that may play important roles in coat color regulation. Illumina2000 sequencing technology was used to catalog the global gene expression profiles in the skin of the Lueyang chicken with white versus black skin. A total of 18,608 unigenes were assembled from the reads obtained from the skin of the white and black chickens. A total of 649 known genes were differentially expressed in the black versus white chickens, with 314 genes that were up regulated and 335 genes that were down-regulated, and a total of 162 novel genes were differentially expressed in the black versus white chickens, consisting of 73 genes that were up-regulated (including 4 highly expressed genes that were expressed exclusively in the skin of the black chickens) and 89 genes that were down-regulated. There were also a total of 8 known coat-color genes expressed in previous studies (ASIP, TYR, KIT, TYRP1, OCA2, KITLG, MITF and MC1R). In this study, 4 of which showed greater expression in the black chickens, and several were up-regulated, such as KIT, ASIP, TYR and OCA2. To our surprise, KITLG, MITF and MC1R showed no significant difference in expression between the black-and white-skinned chickens, and the expression of TYRP1 was not detected in either skin color. The expression of ASIP, TYR, KIT, TYRP1, OCA2, KITLG, MITF and MC1R was validated by real-time quantitative polymerase chain reaction (qPCR), and the results of the qPCR were consistent with the RNA-seq. This study provides several candidate genes that may be associated with the development of black versus white skin. More importantly, the fact that the MC1R gene showed no significant difference in expression between the black and white chickens is of particular interest for future studies that aim to elucidate its functional role in the regulation of skin color.	[Zhang, Jianqin; Liu, Fuzhu; Cao, Junting; Liu, Xiaolin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhang, Jianqin; Liu, Fuzhu; Cao, Junting; Liu, Xiaolin] Shaanxi Key Lab Mol Biol Agr, Yanging, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zhang, JQ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zhangjianqin1356@126.com			Shaanxi Nature Science Foundation; University Basic Research Project	Shaanxi Nature Science Foundation; University Basic Research Project	This work was supported by the Shaanxi Nature Science Foundation (2012) and the University Basic Research Project (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2013, J DERMATOL SCI, V69, P167, DOI 10.1016/j.jdermsci.2012.10.016; Barrett RDH, 2012, MOL ECOL, V21, P2833, DOI 10.1111/j.1365-294X.2012.05560.x; Bradley BJ, 2013, J MAMM EVOL, V20, P263, DOI 10.1007/s10914-012-9212-3; Chen W, 2013, MOL BIOL REP, V40, P1987, DOI 10.1007/s11033-012-2256-x; Dereure O, 2001, Am J Clin Dermatol, V2, P253, DOI 10.2165/00128071-200102040-00006; Dessinioti C, 2011, PHOTOCHEM PHOTOBIOL, V87, P978, DOI 10.1111/j.1751-1097.2011.00970.x; Drogemuller C, 2006, MAMM GENOME, V17, P58, DOI 10.1007/s00335-005-0104-1; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Emaresi G, 2013, MOL ECOL, V22, P4915, DOI 10.1111/mec.12438; Fan RW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-389; Gangoso L, 2011, J EVOLUTION BIOL, V24, P2055, DOI 10.1111/j.1420-9101.2011.02336.x; Gratten J, 2007, P ROY SOC B-BIOL SCI, V274, P619, DOI 10.1098/rspb.2006.3762; Gruber JV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/702120; Hart KL, 2013, CROAT MED J, V54, P248, DOI 10.3325/cmj.2013.54.248; Hawkes JE, 2013, J DERMATOL SCI, V69, P30, DOI 10.1016/j.jdermsci.2012.09.016; Hoffman JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086519; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Kinsler VA, 2012, J INVEST DERMATOL, V132, P2026, DOI 10.1038/jid.2012.95; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Li YL, 2011, MOL BIOL REP, V38, P1433, DOI 10.1007/s11033-010-0248-2; Minvielle F, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-15; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Parvez S, 2006, PHYTOTHER RES, V20, P921, DOI 10.1002/ptr.1954; Penagaricano F, 2012, J APPL GENET, V53, P99, DOI 10.1007/s13353-011-0066-9; Plonka PM, 2009, EXP DERMATOL, V18, P1096, DOI 10.1111/j.1600-0625.2009.00985.x; Roberts DW, 2006, PIGM CELL RES, V19, P76, DOI 10.1111/j.1600-0749.2005.00286.x; Saravanaperumal SA, 2014, GENE, V552, P165, DOI 10.1016/j.gene.2014.09.031; Schaaffler A, 2006, NAT CLIN PRACT ENDOC, V2, P374, DOI 10.1038/ncpendmet0197; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Sturm RA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-248; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Yamada T, 2013, J INVEST DERMATOL, V133, P2753, DOI 10.1038/jid.2013.235; Yamaguchi K, 2012, J HUM GENET, V57, P700, DOI 10.1038/jhg.2012.96; Yang GL, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/675382, DOI 10.1155/2013/675382]; Yang YJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/689756	39	46	54	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127301	10.1371/journal.pone.0127301	http://dx.doi.org/10.1371/journal.pone.0127301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030885	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900046
J	Eichelberger, L; Murphy, G; Etemadi, A; Abnet, CC; Islami, F; Shakeri, R; Malekzadeh, R; Dawsey, SM				Eichelberger, Laura; Murphy, Gwen; Etemadi, Arash; Abnet, Christian C.; Islami, Farhad; Shakeri, Ramin; Malekzadeh, Reza; Dawsey, Sanford M.			Risk of Gastric Cancer by Water Source: Evidence from the Golestan Case-Control Study	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; STOMACH-CANCER; ESOPHAGEAL CANCER; DRINKING-WATER; EPIDEMIOLOGY; TRANSMISSION; SEROPREVALENCE; VEGETABLES; COHORT	Background Gastric cancer (GC) is the world's fifth most common cancer, and the third leading cause of cancer-related death. Over 70% of incident cases and deaths occur in developing countries. We explored whether disparities in access to improved drinking water sources were associated with GC risk in the Golestan Gastric Cancer Case Control Study. Methods and Findings 306 cases and 605 controls were matched on age, gender, and place of residence. We conducted unconditional logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CI), adjusted for age, gender, ethnicity, marital status, education, head of household education, place of birth and residence, homeownership, home size, wealth score, vegetable consumption, and H. pylori seropositivity. Fully-adjusted ORs were 0.23 (95% CI: 0.05-1.04) for chlorinated well water, 4.58 (95% CI: 2.07-10.16) for unchlorinated well water, 4.26 (95% CI: 1.81-10.04) for surface water, 1.11 (95% CI: 0.61-2.03) for water from cisterns, and 1.79 (95% CI: 1.20-2.69) for all unpiped sources, compared to in-home piped water. Comparing unchlorinated water to chlorinated water, we found over a two-fold increased GC risk (OR 2.37, 95% CI: 1.56-3.61). Conclusions Unpiped and unchlorinated drinking water sources, particularly wells and surface water, were significantly associated with the risk of GC.	[Eichelberger, Laura] Univ Texas San Antonio, Dept Anthropol, San Antonio, TX 78249 USA; [Eichelberger, Laura; Murphy, Gwen; Etemadi, Arash; Abnet, Christian C.; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Etemadi, Arash; Islami, Farhad; Shakeri, Ramin; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Oncol Res Ctr, Digest Dis Res Inst, Tehran, Iran; [Islami, Farhad] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30303 USA	University of Texas System; University of Texas at San Antonio (UTSA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tehran University of Medical Sciences; American Cancer Society	Eichelberger, L (corresponding author), Univ Texas San Antonio, Dept Anthropol, One UTSA Circle, San Antonio, TX 78249 USA.	laura.eichelberger@utsa.edu	Etemadi, Arash/C-1386-2016; Malekzadeh, Reza/U-1382-2017; Abnet, Christian C/C-4111-2015; Etemadi, Arash/Y-7082-2018; Murphy, Gwen/AFR-8275-2022; Murphy, Gwen/GQB-3897-2022; Murphy, Gwen/G-7443-2015	Etemadi, Arash/0000-0002-3458-1072; Malekzadeh, Reza/0000-0002-9820-6335; Abnet, Christian C/0000-0002-3008-7843; Etemadi, Arash/0000-0002-3458-1072; Murphy, Gwen/0000-0003-0118-5337; , Ramin/0000-0003-0487-3629; Islami, Farhad/0000-0002-7357-5994	Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; Digestive Disease Research Institute of Tehran University of Medical Sciences [82-603]; Cancer Research UK [C20/A5860]; International Agency for Research on Cancer; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; Digestive Disease Research Institute of Tehran University of Medical Sciences; Cancer Research UK(Cancer Research UK); International Agency for Research on Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; the Digestive Disease Research Institute of Tehran University of Medical Sciences (grant No 82-603); Cancer Research UK (C20/A5860); and by the International Agency for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GLOBOCAN 2012 STOM C; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Bellack NR, 2006, EPIDEMIOL INFECT, V134, P439, DOI 10.1017/S0950268806006005; BOEING H, 1991, INT J CANCER, V47, P858, DOI 10.1002/ijc.2910470612; BOEING H, 1991, J CANCER RES CLIN, V117, P133, DOI 10.1007/BF01613137; Brown LM, 2000, EPIDEMIOL REV, V22, P283, DOI 10.1093/oxfordjournals.epirev.a018040; Camargo MC, 2004, HELICOBACTER, V9, P106, DOI 10.1111/j.1083-4389.2004.00206.x; Cantor KP, 1997, CANCER CAUSE CONTROL, V8, P292, DOI 10.1023/A:1018444902486; Cantor KP, 2006, CANC EPIDEMIOLOGY PR, P382; Carballo F, 1997, GUT, V41, pA39; Cover TL, 2013, GUT MICROBES, V4, P482, DOI 10.4161/gmic.26262; CUELLO C, 1976, JNCI-J NATL CANCER I, V57, P1015, DOI 10.1093/jnci/57.5.1015; D'Elia L, 2012, CLIN NUTR, V31, P489, DOI 10.1016/j.clnu.2012.01.003; Engstrand L, 2013, BEST PRACT RES CL GA, V27, P39, DOI 10.1016/j.bpg.2013.03.016; Epplein M, 2012, CANCER EPIDEM BIOMAR, V21, P2185, DOI 10.1158/1055-9965.EPI-12-0792-T; Gao L, 2009, CANCER RES, V69, P6164, DOI 10.1158/0008-5472.CAN-09-0596; Gao L, 2009, CANCER RES, V69, P2973, DOI 10.1158/0008-5472.CAN-08-3477; Goodman KJ, 1996, AM J EPIDEMIOL, V144, P290, DOI 10.1093/oxfordjournals.aje.a008924; Goodwin CS, 1997, LANCET, V349, P265, DOI 10.1016/S0140-6736(96)07023-7; HAENSZEL W, 1976, JNCI-J NATL CANCER I, V56, P265, DOI 10.1093/jnci/56.2.265; Hegarty JP, 1999, J APPL MICROBIOL, V87, P697, DOI 10.1046/j.1365-2672.1999.00912.x; HOPKINS RJ, 1993, J INFECT DIS, V168, P222, DOI 10.1093/infdis/168.1.222; Howard G., 2003, DOMESTIC WATER QUANT; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Islami F, 2009, EUR J CANCER, V45, P3156, DOI 10.1016/j.ejca.2009.09.018; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Javanparast S, 2011, J PUBLIC HEALTH POL, V32, P263, DOI 10.1057/jphp.2011.7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Keshavarzi B, 2012, ENVIRON GEOCHEM HLTH, V34, P15, DOI 10.1007/s10653-011-9377-3; KLEIN PD, 1991, LANCET, V337, P1503, DOI 10.1016/0140-6736(91)93196-G; Leon DA, 2000, BRIT MED J, V320, P1705, DOI 10.1136/bmj.320.7251.1705; Malekzadeh R, 2009, ARCH IRAN MED, V12, P576; Mazari-Hiriart M, 2001, WATER SCI TECHNOL, V43, P93, DOI 10.2166/wst.2001.0718; MENDALL MA, 1992, LANCET, V339, P896, DOI 10.1016/0140-6736(92)90931-R; MENDALL MA, 1995, GUT, V37, P1, DOI 10.1136/gut.37.1.1; Nouraie M, 2005, CANCER EPIDEM BIOMAR, V14, P2087, DOI 10.1158/1055-9965.EPI-05-0038; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; RISCH HA, 1985, AM J EPIDEMIOL, V122, P947, DOI 10.1093/oxfordjournals.aje.a114199; Shakeri R, 2013, INT J CANCER, V133, P455, DOI 10.1002/ijc.28018; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Ueda M, 2003, CANCER SCI, V94, P914, DOI 10.1111/j.1349-7006.2003.tb01375.x; Ward MH, 2008, INT J OCCUP ENV HEAL, V14, P193, DOI 10.1179/oeh.2008.14.3.193; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; World Health Organization, HLTH SAF DRINK WAT B; World Health Organization, 2012, PROGR DRINK WAT SAN	49	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128491	10.1371/journal.pone.0128491	http://dx.doi.org/10.1371/journal.pone.0128491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023788	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400094
J	Kim, ES; Jeon, HB; Lim, H; Shin, JH; Park, SJ; Jo, YK; Oh, W; Yang, YS; Cho, DH; Kim, JY				Kim, Eun Sung; Jeon, Hong Bae; Lim, Hoon; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Oh, Wonil; Yang, Yoon Sun; Cho, Dong-Hyung; Kim, Ju-Yeon			Conditioned Media from Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Inhibits Melanogenesis by Promoting Proteasomal Degradation of MITF	PLOS ONE			English	Article							BONE-MARROW; MELANOMA; ACTIVATION; SUMOYLATION; MELANOCYTES; EXPANSION; PATHWAY	Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) secrete various beneficial molecules, which have anti-apoptotic activity and cell proliferation. However, the effect of hUCB-MSCs in melanogenesis is largely unclear. In this study, we show that conditioned media (CM) derived from hUCB-MSCs inhibit melanogenesis by regulating microphthalmia-associated transcription factor (MITF) expression via the ERK signalling pathway. Treatment of hUCB-MSC-CM strongly inhibited the alpha-melanocyte stimulating hormone-induced hyperpigmentation in melanoma cells as well as melanocytes. Treatment of hUCB-MSC-CM induced ERK1/2 activation in melanocytes. In addition, inhibition of ERK1/2 suppressed the anti-pigmentation activity of the hUCB-MSC-CM in melanocytes and in vitro artificial skin models. We also found that the expression of MITF was appreciably diminished while expression of phosphorylated MITF, which leads to its proteasomal degradation, was increased in cells treated with hUCB-MSC-CM. These results suggested that hUCB-MSC-CM significantly suppresses melanin synthesis via MITF degradation by the ERK pathway activation.	[Kim, Eun Sung; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi Do, South Korea; [Jeon, Hong Bae; Lim, Hoon; Oh, Wonil; Yang, Yoon Sun; Kim, Ju-Yeon] MEDIPOST Co Ltd, Biomed Res Inst, Songnam, Gyeonggi Do, South Korea	Kyung Hee University; MEDIPOST	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi Do, South Korea.	dhcho@khu.ac.kr; msc@medi-post.co.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A1058361]; MOTIE; KEIT [10048038]; MEDIPOST Co., Ltd.	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); MOTIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); KEIT; MEDIPOST Co., Ltd.	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A1058361) (www.nrf.re.kr), and was supported by industrial technology development program funded by the MOTIE and KEIT (10048038) (www.motie.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEDIPOST Co., Ltd. provided support in the form of salaries for authors (BH Jeon, H Lim, W Oh, YS Yang, JY Kim), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Bellei B, 2011, PIGM CELL MELANOMA R, V24, P309, DOI 10.1111/j.1755-148X.2010.00800.x; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Chakraborty AK, 1998, PIGM CELL RES, V11, P206, DOI 10.1111/j.1600-0749.1998.tb00731.x; Choi H, 2013, J INVEST DERMATOL, V133, P528, DOI 10.1038/jid.2012.331; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Flynn A, 2007, CYTOTHERAPY, V9, P717, DOI 10.1080/14653240701584578; Hwang I, 2013, J DERMATOL SCI, V72, P274, DOI 10.1016/j.jdermsci.2013.08.006; Jenhani F, 2011, TRANSPL P, V43, P639, DOI 10.1016/j.transproceed.2011.01.021; Jeong SY, 2013, STEM CELLS, V31, P2136, DOI 10.1002/stem.1471; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kim HS, 2013, GASTROENTEROLOGY, V145, P1392, DOI 10.1053/j.gastro.2013.08.033; Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140; Kim JY, 2010, FEBS LETT, V584, P3601, DOI 10.1016/j.febslet.2010.07.028; Kim WS, 2008, BIOL PHARM BULL, V31, P606, DOI 10.1248/bpb.31.606; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu JJ, 2010, PIGM CELL MELANOMA R, V23, P741, DOI 10.1111/j.1755-148X.2010.00775.x; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Okazaki M, 2005, BRIT J DERMATOL, V153, P23, DOI 10.1111/j.1365-2133.2005.06966.x; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; TAMAGAWA T, 1985, FEBS LETT, V183, P433, DOI 10.1016/0014-5793(85)80825-5; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wu M, 2000, GENE DEV, V14, P301; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yoshida Y, 2007, AM J PHYSIOL-GASTR L, V293, pG1089, DOI 10.1152/ajpgi.00187.2007; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	39	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128078	10.1371/journal.pone.0128078	http://dx.doi.org/10.1371/journal.pone.0128078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024475	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400068
J	Kumar, S; Bhatia, S				Kumar, Santosh; Bhatia, Sabhyata			Isolation of Catharanthus roseus (L.) G. Don Nuclei and Measurement of Rate of Tryptophan decarboxylase Gene Transcription Using Nuclear Run-On Transcription Assay	PLOS ONE			English	Article							FERREDOXIN-1 MESSENGER-RNA; MOLECULAR-CLONING; EXPRESSION; ALKALOIDS; PATHWAY; YEAST	Background An accurate assessment of transcription 'rate' is often desired to describe the promoter activity. In plants, isolation of transcriptionally active nuclei and their subsequent use in nuclear run-on assays has been challenging and therefore limit an accurate measurement of gene transcription 'rate'. Catharanthus roseus has emerged as a model medicinal plant as it exhibits an unsurpassed spectrum of chemodiversity, producing over 130 alkaloids through the terpenoid indole alkaloid (TIA) pathway and therefore serves as a 'molecular hub' to understand gene expression profiles. Results The protocols presented here streamline, adapt and optimize the existing methods of nuclear run-on assay for use in C. roseus. Here, we fully describe all the steps to isolate transcriptionally active nuclei from C. roseus leaves and utilize them to perform nuclear run-on transcription assay. Nuclei isolated by this method transcribed at a level consistent with their response to external stimuli, as transcription rate of TDC gene was found to be higher in response to external stimuli i.e. when seedlings were subjected to UV-B light or to methyl jasmonate (MeJA). However, the relative transcript abundance measured parallel through qRT-PCR was found to be inconsistent with the synthesis rate indicating that some post transcriptional events might have a role in transcript stability in response to stimuli. Conclusions Our study provides an optimized, efficient and inexpensive method of isolation of intact nuclei and nuclear 'run-on' transcription assay to carry out in-situ measurement of gene transcription rate in Catharanthus roseus. This would be valuable in investigating the transcriptional and post transcriptional response of other TIA pathway genes in C. roseus. Isolated nuclei may also provide a resource that could be used for performing the chip assay as well as serve as the source of nuclear proteins for in-vitro EMSA studies. Moreover, nascent nuclear run-on transcript could be further subjected to RNA-Seq for global nuclear run-on assay (GNRO-Seq) for genome wide in-situ measurement of transcription rate of plant genes.	[Kumar, Santosh; Bhatia, Sabhyata] Natl Inst Plant Genome Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg,POB 10531, New Delhi 110067, India.	sabhyatabhatia@nipgr.ac.in		Bhatia, Sabhyata/0000-0003-0811-219X	National Institute of Plant Genome Research (NIPGR); Council for Scientific and Industrial Research (CSIR)	National Institute of Plant Genome Research (NIPGR)(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by the National Institute of Plant Genome Research (NIPGR) for the funding support and the Council for Scientific and Industrial Research (CSIR) for fellowship grant to SK.	AERTS RJ, 1994, PLANT J, V5, P635, DOI 10.1111/j.1365-313X.1994.00635.x; ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Anderson MB, 1999, PLANT CELL, V11, P1579, DOI 10.1105/tpc.11.8.1579; BAERSON SR, 1990, MOL CELL BIOL, V10, P842, DOI 10.1128/MCB.10.2.842; Chan MT, 1998, PLANT J, V15, P685, DOI 10.1046/j.1365-313x.1998.00244.x; COX KH, 1988, PLANT MOL BIOL PRACT, P1; DEAMER DW, 1967, J CELL BIOL, V33, P395, DOI 10.1083/jcb.33.2.395; DELIDOW BC, 1989, GENE ANAL TECH, V6, P120, DOI 10.1016/0735-0651(89)90002-2; DELUCA V, 1989, P NATL ACAD SCI USA, V86, P2582; DELUCA V, 1986, J PLANT PHYSIOL, V125, P147, DOI 10.1016/S0176-1617(86)80252-8; FEINBAUM RL, 1988, MOL CELL BIOL, V8, P1985, DOI 10.1128/MCB.8.5.1985; FENNOY SL, 1995, PLANT J, V7, P287, DOI 10.1046/j.1365-313X.1995.7020287.x; Folta KM, 2006, NAT PROTOC, V1, P3094, DOI 10.1038/nprot.2006.471; Folta KM, 2000, PLANT CELL REP, V19, P504, DOI 10.1007/s002990050764; Folta KM, 2003, PLANT MOL BIOL, V51, P609, DOI 10.1023/A:1022393406204; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GALLAGHER TF, 1982, EMBO J, V1, P1493, DOI 10.1002/j.1460-2075.1982.tb01345.x; GRUMMT I, 1976, CELL, V7, P447, DOI 10.1016/0092-8674(76)90175-6; HAJELA RK, 1990, PLANT PHYSIOL, V93, P1246, DOI 10.1104/pp.93.3.1246; Hansen ER, 2001, PLANT PHYSIOL, V125, P770, DOI 10.1104/pp.125.2.770; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; HONDA SI, 1966, J EXP BOT, V17, P460, DOI 10.1093/jxb/17.3.460; Jaggi M, 2011, APPL MICROBIOL BIOT, V90, P1005, DOI 10.1007/s00253-011-3131-8; Kanazawa A, 2000, PLANT MOL BIOL REP, V18, P377, DOI 10.1007/BF02825066; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Laflamme P, 2001, PLANT PHYSIOL, V125, P189, DOI 10.1104/pp.125.1.189; LESCURE B, 1981, NUCLEIC ACIDS RES, V9, P31, DOI 10.1093/nar/9.1.31; LUTHE DS, 1980, PLANT PHYSIOL, V65, P305, DOI 10.1104/pp.65.2.305; MARRS KA, 1989, P NATL ACAD SCI USA, V86, P4492, DOI 10.1073/pnas.86.12.4492; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MCCLURE BA, 1989, PLANT CELL, V1, P229, DOI 10.1105/tpc.1.2.229; Meng L, 2003, PLANT MOL BIOL REP, V21, P65, DOI 10.1007/BF02773398; Menke FLH, 1999, PLANT PHYSIOL, V119, P1289, DOI 10.1104/pp.119.4.1289; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Murata J, 2008, PLANT CELL, V20, P524, DOI 10.1105/tpc.107.056630; Ouwerkerk PBF, 1999, PLANT MOL BIOL, V41, P491, DOI 10.1023/A:1006321100550; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Petracek ME, 1998, P NATL ACAD SCI USA, V95, P9009, DOI 10.1073/pnas.95.15.9009; Pollier J, 2014, PLANT PHYSIOL BIOCH, V83, P20, DOI 10.1016/j.plaphy.2014.07.004; Roepke J, 2010, P NATL ACAD SCI USA, V107, P15287, DOI 10.1073/pnas.0911451107; Sambrook J., 1989, MOLECULAR CLONING A; STRAND R, 1994, MOL CELL BIOCHEM, V139, P149, DOI 10.1007/BF01081738; Van Breukelen F, 2000, J EXP BIOL, V203, P1123; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Van Moerkercke A, 2013, PLANT CELL PHYSIOL, V54, P673, DOI 10.1093/pcp/pct039; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; WEBER J, 1977, CELL, V10, P611, DOI 10.1016/0092-8674(77)90093-9	49	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127892	10.1371/journal.pone.0127892	http://dx.doi.org/10.1371/journal.pone.0127892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024519	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400057
J	Niessen, SJM; Forcada, Y; Mantis, P; Lamb, CR; Harrington, N; Fowkes, R; Korbonits, M; Smith, K; Church, DB				Niessen, Stijn J. M.; Forcada, Yaiza; Mantis, Panagiotis; Lamb, Christopher R.; Harrington, Norelene; Fowkes, Rob; Korbonits, Marta; Smith, Ken; Church, David B.			Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter	PLOS ONE			English	Article							GROWTH-HORMONE; DOMESTIC CATS; RISK-FACTORS; MELLITUS; PREVALENCE; DIAGNOSIS; INSULIN; DISEASE; COMPLEX; PLASMA	Naturally occurring diabetes mellitus (DM) is common in domestic cats (Felis catus). It has been proposed as a model for human Type 2 DM given many shared features. Small case studies demonstrate feline DM also occurs as a result of insulin resistance due to a somatotrophinoma. The current study estimates the prevalence of hypersomatotropism or acromegaly in the largest cohort of diabetic cats to date, evaluates clinical presentation and ease of recognition. Diabetic cats were screened for hypersomatotropism using serum total insulin-like growth factor-1 (IGF-1; radioimmunoassay), followed by further evaluation of a subset of cases with suggestive IGF-1 (>1000 ng/ml) through pituitary imaging and/or histopathology. Clinicians indicated pre-test suspicion for hypersomatotropism. In total 1221 diabetic cats were screened; 319 (26.1%) demonstrated a serum IGF-1>1000 ng/ml (95% confidence interval: 23.6-28.6%). Of these cats a subset of 63 (20%) underwent pituitary imaging and 56/63 (89%) had a pituitary tumour on computed tomography; an additional three on magnetic resonance imaging and one on necropsy. These data suggest a positive predictive value of serum IGF-1 for hypersomatotropism of 95% (95% confidence interval: 90-100%), thus suggesting the overall hypersomatotropism prevalence among UK diabetic cats to be 24.8% (95% confidence interval: 21.2-28.6%). Only 24% of clinicians indicated a strong pre-test suspicion; most hypersomatotropism cats did not display typical phenotypical acromegaly signs. The current data suggest hypersomatotropism screening should be considered when studying diabetic cats and opportunities exist for comparative acromegaly research, especially in light of the many detected communalities with the human disease.	[Niessen, Stijn J. M.; Forcada, Yaiza; Mantis, Panagiotis; Lamb, Christopher R.; Church, David B.] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, London, England; [Niessen, Stijn J. M.] Univ Newcastle, Inst Cellular Med, Diabet Res Grp, Newcastle, Tyne & Wear, England; [Harrington, Norelene; Smith, Ken] Univ London, Royal Vet Coll, Dept Pathol & Pathogen Biol, London, England; [Fowkes, Rob] Univ London, Royal Vet Coll, Dept Comparat Biol, London, England; [Korbonits, Marta] Queen Mary Univ London, WHRI, Barts & Royal London Sch Med & Dent, Dept Endocrinol, London, England	University of London; University of London Royal Veterinary College; Newcastle University - UK; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; Queen Mary University London	Niessen, SJM (corresponding author), Univ London, Royal Vet Coll, Dept Clin Sci & Serv, London, England.	sniessen@rvc.ac.uk	Fowkes, Robert/HHT-0664-2022; Harrington, Norelene/AAQ-4669-2020; Fowkes, Robert/AAI-4756-2020	Fowkes, Robert/0000-0002-2222-2056; Mantis, Panagiotis/0000-0003-0799-5330; Korbonits, Marta/0000-0002-4101-9432				Aflorei ED, 2014, J NEURO-ONCOL, V117, P379, DOI 10.1007/s11060-013-1354-5; Alexopoulou O, 2014, PITUITARY, V17, P81, DOI 10.1007/s11102-013-0471-7; Alt N, 2007, RES VET SCI, V83, P331, DOI 10.1016/j.rvsc.2007.01.014; Biering H, 2000, ACTA MED AUST, V27, P27, DOI 10.1046/j.1563-2571.2000.00106.x; Brearley MJ, 2006, VET COMP ONCOL, V4, P209, DOI 10.1111/j.1476-5829.2006.00108.x; CAPEN CC, 1989, TOXICOL PATHOL, V17, P234, DOI 10.1177/019262338901700202; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P4769, DOI 10.1210/jc.2006-1668; De Decker S, 2015, J VET INTERN MED, V29, P405, DOI 10.1111/jvim.12522; Dirtu AC, 2013, ENVIRON INT, V57-58, P60, DOI 10.1016/j.envint.2013.04.004; Forcada Y, 2014, J VET INTERN MED, V28, P458, DOI 10.1111/jvim.12275; Gostelow R, 2014, J VET INTERN MED, V28, P1030; Hoenig M, 2000, AM J PATHOL, V157, P2143, DOI 10.1016/S0002-9440(10)64852-3; Hoenig M, 2002, MOL CELL ENDOCRINOL, V197, P221, DOI 10.1016/S0303-7207(02)00264-2; Hoppener JWM, 2006, INT J BIOCHEM CELL B, V38, P726, DOI 10.1016/j.biocel.2005.12.009; JOHNSON KH, 1986, AM J PATHOL, V125, P416; KOKKA N, 1971, ENDOCRINOLOGY, V88, P359, DOI 10.1210/endo-88-2-359; Lamb CR, 2014, J FELINE MED SURG, V16, P99, DOI 10.1177/1098612X13497212; Lederer R, 2009, VET J, V179, P254, DOI 10.1016/j.tvjl.2007.09.019; Lewitt MS, 2000, J ENDOCRINOL, V166, P21, DOI 10.1677/joe.0.1660021; McCann TM, 2007, J FELINE MED SURG, V9, P289, DOI 10.1016/j.jfms.2007.02.001; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; NABARRO JDN, 1987, CLIN ENDOCRINOL, V26, P481, DOI 10.1111/j.1365-2265.1987.tb00805.x; Niessen SJM, 2007, J VET INTERN MED, V21, P899, DOI 10.1892/0891-6640(2007)21[899:FAAUE]2.0.CO;2; Niessen SJM, 2007, VET REC, V160, P902, DOI 10.1136/vr.160.26.902; Niessen S, 2010, J FELINE MED SURG, V12, P15, DOI 10.1016/j.jfms.2009.12.003; Niessen SJM, 2013, VET CLIN N AM-SMALL, V43, P319, DOI 10.1016/j.cvsm.2012.12.004; O'Brien TD, 2002, MOL CELL ENDOCRINOL, V197, P213, DOI 10.1016/S0303-7207(02)00265-4; Prahl A, 2007, J FELINE MED SURG, V9, P351, DOI 10.1016/j.jfms.2007.02.004; Resmini E, 2009, ACTA DIABETOL, V46, P85, DOI 10.1007/s00592-009-0112-9; Reusch CE, 2006, VET REC, V158, P195, DOI 10.1136/vr.158.6.195; Rosario PW, 2011, PITUITARY, V14, P217, DOI 10.1007/s11102-010-0281-0; Scacchi Massimo, 2006, Pituitary, V9, P297, DOI 10.1007/s11102-006-0409-4; SHISHKO PI, 1994, DIABETES RES CLIN PR, V25, P1, DOI 10.1016/0168-8227(94)90155-4; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; Tyson R, 2005, VET RADIOL ULTRASOUN, V46, P33, DOI 10.1111/j.1740-8261.2005.00006.x	35	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127794	10.1371/journal.pone.0127794	http://dx.doi.org/10.1371/journal.pone.0127794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023776	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000355319400052
J	Schneider, A; Schneider, MP; Krieter, DH; Genser, B; Scharnagl, H; Stojakovic, T; Wanner, C; Drechsler, C				Schneider, Andreas; Schneider, Markus P.; Krieter, Detlef H.; Genser, Bernd; Scharnagl, Hubert; Stojakovic, Tatjana; Wanner, Christoph; Drechsler, Christiane			Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; CARDIOVASCULAR EVENTS; MINERAL METABOLISM; MORTALITY; FIBROBLAST-GROWTH-FACTOR-23; HEMODIAFILTRATION; HEMODIALYSIS; ASSOCIATION; REMOVAL; FGF23	Background In patients undergoing maintenance hemodialysis (HD), increased levels of circulating fibroblast growth factor-23 (FGF-23) are independently associated with cardiovascular events and mortality. Interventional strategies aiming to reduce levels of FGF-23 in HD patients are of particular interest. The purpose of the current study was to compare the impact of high-flux versus low-flux HD on circulating FGF-23 levels. Methods We conducted a post-hoc analysis of the MINOXIS study, including 127 dialysis patients randomized to low-flux (n = 62) and high-flux (n = 65) HD for 52 weeks. Patients with valid measures for FGF-23 investigated baseline and after 52 weeks were included. Results Compared to baseline, a significant increase in FGF-23 levels after one year of low-flux HD was observed (Delta plasma FGF-23: +4026 RU/ml; p < 0.001). In contrast, FGF-23 levels remained stable in the high flux group (Delta plasma FGF-23: +373 RU/ml, p = 0.70). The adjusted difference of the absolute change in FGF-23 levels between the two treatment groups was statistically significant (p < 0.01). Conclusions Over a period of 12 months, high-flux HD was associated with stable FGF-23 levels, whereas the low-flux HD group showed an increase of FGF-23. However, the implications of the different FGF 23 time-trends in patients on high flux dialysis, as compared to the control group, remain to be explored in specifically designed clinical trials.	[Schneider, Andreas; Krieter, Detlef H.; Wanner, Christoph; Drechsler, Christiane] Univ Hosp, Div Nephrol, Dept Med, Wurzburg, Germany; [Schneider, Markus P.] Univ Hosp, Dept Hypertens & Nephrol, Erlangen, Germany; [Genser, Bernd] Mannheim Inst Publ Hlth Social & Prevent Med, Fac Med, Mannheim, Germany; [Genser, Bernd] BGStats Consulting, Vienna, Austria; [Scharnagl, Hubert; Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	University of Wurzburg; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Medical University of Graz	Schneider, A (corresponding author), Univ Hosp, Div Nephrol, Dept Med, Wurzburg, Germany.	schneider_a6@ukw.de		Genser, Bernd/0000-0001-5787-0902; Schneider, Markus/0000-0002-5265-8088	University of Wuerzburg	University of Wuerzburg	B.G. received an unrestricted educational grant from University of Wuerzburg to provide statistical support for the study. Co-author Bernd Genser is employed by BGStats Consulting, which provided support in the form of salary for author BG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cornelis T, 2014, AM J KIDNEY DIS, V64, P247, DOI 10.1053/j.ajkd.2014.02.016; Covic A, 2009, NEPHROL DIAL TRANSPL, V24, P1506, DOI 10.1093/ndt/gfn613; Diniz H, 2013, NEFROLOGIA, V33, P835, DOI 10.3265/Nefrologia.pre2013.Jul.12091; Drechsler C, 2009, NEPHROL DIAL TRANSPL, V24, P3151, DOI 10.1093/ndt/gfp260; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Khan AM, 2012, CLIN J AM SOC NEPHRO, V7, P2017, DOI 10.2215/CJN.02160212; Kovesdy CP, 2013, NEPHRON CLIN PRACT, V123, P194, DOI 10.1159/000353593; Makar SH, 2010, IRAN J KIDNEY DIS, V4, P327; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Neirynck N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044201; Palmer SC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005016.pub2; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Patrier L, 2013, J NEPHROL, V26, P342, DOI 10.5301/jn.5000150; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Quarles LD, 2012, EXP CELL RES, V318, P1040, DOI 10.1016/j.yexcr.2012.02.027; Schneider A, 2012, CLIN J AM SOC NEPHRO, V7, P52, DOI 10.2215/CJN.02710311; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x	23	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128079	10.1371/journal.pone.0128079	http://dx.doi.org/10.1371/journal.pone.0128079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024521	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400069
J	Taus, F; Santucci, MB; Greco, E; Morandi, M; Palucci, I; Mariotti, S; Poerio, N; Nisini, R; Delogu, G; Fraziano, M				Taus, Francesco; Santucci, Marilina B.; Greco, Emanuela; Morandi, Matteo; Palucci, Ivana; Mariotti, Sabrina; Poerio, Noemi; Nisini, Roberto; Delogu, Giovanni; Fraziano, Maurizio			Monosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against Tuberculosis	PLOS ONE			English	Article							URIC-ACID; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATION; REINFECTION; MACROPHAGES; PROTECTION; RESPONSES; FUSION	A safer and more effective anti-Tuberculosis vaccine is still an urgent need. We probed the effects of monosodium urate crystals (MSU) on innate immunity to improve the Bacille Calmette-Guerin (BCG) vaccination. Results showed that in vitro MSU cause an enduring macrophage stimulation of the anti-mycobacterial response, measured as intracellular killing, ROS production and phagolysosome maturation. The contribution of MSU to anti-mycobacterial activity was also shown in vivo. Mice vaccinated in the presence of MSU showed a lower number of BCG in lymph nodes draining the vaccine inoculation site, in comparison to mice vaccinated without MSU. Lastly, we showed that MSU improved the efficacy of BCG vaccination in mice infected with Mycobacterium tuberculosis (MTB), measured in terms of lung and spleen MTB burden. These results demonstrate that the use of MSU as adjuvant may represent a novel strategy to enhance the efficacy of BCG vaccination.	[Taus, Francesco; Santucci, Marilina B.; Greco, Emanuela; Poerio, Noemi; Fraziano, Maurizio] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Morandi, Matteo; Palucci, Ivana; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy; [Mariotti, Sabrina; Nisini, Roberto] Ist Super Sanita, Dept Infect Parasit & Immunomediated, I-00161 Rome, Italy	University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS)	Fraziano, M (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	fraziano@bio.uniroma2.it	Poerio, Noemi/AAB-4835-2022; MARIOTTI, SABRINA/M-4361-2015; Nisini, Roberto/M-4363-2015; Fraziano, Maurizio/F-1425-2013; palucci, ivana/J-8542-2018	Poerio, Noemi/0000-0002-7025-6496; MARIOTTI, SABRINA/0000-0002-7009-7616; Nisini, Roberto/0000-0003-1077-423X; Fraziano, Maurizio/0000-0002-5643-0769; Delogu, Giovanni/0000-0003-0182-8267; Taus, Francesco/0000-0003-4728-6686; palucci, ivana/0000-0003-2106-1761	EU [N. 643558]; Italian Ministry of University [2008L57JXW 005, 2009N98ST4_003]	EU(European Commission); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	EU framework programme for research and innovation Horizon 2020 "Eliciting Mucosal Immunity to tuberculosis" (EMI-TB), Grant N. 643558. Italian Ministry of University (grant number 2008L57JXW 005). EG was supported by the Italian Ministry of University (grant number 2009N98ST4_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON S, 1982, ARTHRITIS RHEUM, V25, P174, DOI 10.1002/art.1780250210; Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Bieber JD, 2004, ARTHRITIS RHEUM-US, V50, P2400, DOI 10.1002/art.20438; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Conforti-Andreoni C, 2011, J IMMUNOL, V187, P5842, DOI 10.4049/jimmunol.1101408; Desaulniers P, 2001, J LEUKOCYTE BIOL, V70, P659; Greco E, 2012, P NATL ACAD SCI USA, V109, pE1360, DOI 10.1073/pnas.1200484109; Greco E, 2010, IMMUNOLOGY, V129, P125, DOI 10.1111/j.1365-2567.2009.03145.x; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Ma XJ, 2007, WORLD J GASTROENTERO, V13, P1060, DOI 10.3748/wjg.v13.i7.1060; Mak TK, 2008, LANCET, V372, P786, DOI 10.1016/S0140-6736(08)61318-5; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, IMMUNOL REV, V233, P218, DOI 10.1111/j.0105-2896.2009.00860.x; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Pitt JM, 2013, MICROB PATHOGENESIS, V58, P2, DOI 10.1016/j.micpath.2012.12.002; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; Saiga H., 2014, J INFECT DIS; Sakamaki I, 2011, NUCLEOS NUCLEOT NUCL, V30, P1077, DOI 10.1080/15257770.2011.597368; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; von Reyn CF, 2012, INT J TUBERC LUNG D, V16, P718, DOI 10.5588/ijtld.11.0444; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	37	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127279	10.1371/journal.pone.0127279	http://dx.doi.org/10.1371/journal.pone.0127279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023779	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400034
J	Wolff, M; Unuchek, D; Zhang, B; Gordeliy, V; Willbold, D; Nagel-Steger, L				Wolff, Martin; Unuchek, Dmitry; Zhang, Bo; Gordeliy, Valentin; Willbold, Dieter; Nagel-Steger, Luitgard			Amyloid beta Oligomeric Species Present in the Lag Phase of Amyloid Formation	PLOS ONE			English	Article							SEDIMENTATION-VELOCITY EXPERIMENTS; PROTEIN-PROTEIN INTERACTIONS; ANALYTICAL ULTRACENTRIFUGATION; ALZHEIMERS-DISEASE; SOLUBLE OLIGOMERS; MOLECULAR-WEIGHT; PEPTIDE; HETEROGENEITY; DISTRIBUTIONS; A-BETA-40	Alzheimer's disease (AD)-associated amyloid beta peptide (A beta) is one of the main actors in AD pathogenesis. A beta is characterized by its high tendency to self-associate, leading to the generation of oligomers and amyloid fibrils. The elucidation of pathways and intermediates is crucial for the understanding of protein assembly mechanisms in general and in conjunction with neurodegenerative diseases, e.g., for the identification of new therapeutic targets. Our study focused on A beta 42 and its oligomeric assemblies in the lag phase of amyloid formation, as studied by sedimentation velocity (SV) centrifugation. The assembly state of A beta during the lag phase, the time required by an A beta solution to reach the exponential growth phase of aggregation, was characterized by a dominant monomer fraction below 1 S and a population of oligomeric species between 4 and 16 S. From the oligomer population, two major species close to a 12-mer and an 18-mer with a globular shape were identified. The recurrence of these two species at different initial concentrations and experimental conditions as the smallest assemblies present in solution supports the existence of distinct, energetically favored assemblies in solution. The sizes of the two species suggest an A beta 42 aggregation pathway that is based on a basic hexameric building block. The study demonstrates the potential of SV analysis for the evaluation of protein aggregation pathways.	[Wolff, Martin; Willbold, Dieter; Nagel-Steger, Luitgard] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Wolff, Martin; Zhang, Bo; Gordeliy, Valentin; Willbold, Dieter; Nagel-Steger, Luitgard] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, Julich, Germany; [Unuchek, Dmitry; Gordeliy, Valentin] Moscow Inst Phys & Technol, Dep Mol & Chem Phys, Dolgoprudnyi, Russia; [Zhang, Bo] Res Ctr Julich, Inst Complex Syst, Neutron Scattering ICS 1, Julich, Germany; [Gordeliy, Valentin] Univ Grenoble Alpes, Inst Biol Struct JP Ebel, Grenoble, France; [Gordeliy, Valentin] CNRS, Inst Biol Struct JP Ebel, Grenoble, France; [Gordeliy, Valentin] CEA Grenoble, Direct Sci Vivant, Inst Biol Struct JP Ebel, F-38054 Grenoble, France	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Moscow Institute of Physics & Technology; Helmholtz Association; Research Center Julich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Nagel-Steger, L (corresponding author), Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany.		Gordeliy, Valentin I/J-3636-2013; Willbold, Dieter/A-6280-2013; Nagel-Steger, Luitgard/H-6415-2013	Gordeliy, Valentin I/0000-0001-5782-5896; Willbold, Dieter/0000-0002-0065-7366; Nagel-Steger, Luitgard/0000-0001-5232-2149; Unuchek, Dmitrii/0000-0003-2590-2644	NSF Teragrid Allocation grant [TGMCB070038]; Helmholtz Association	NSF Teragrid Allocation grant; Helmholtz Association(Helmholtz Association)	Computing time and computational support for UltraScan III software was provided by the Texas Advanced Computing Centre from UT Austin, and is supported by an NSF Teragrid Allocation grant, TGMCB070038. Helmholtz Association funded this work through the Helmholtz-Portfolio Topics "Technology and Medicine" and "Drug Research". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Correia JJ, 2010, METHOD CELL BIOL, V95, P275, DOI 10.1016/S0091-679X(10)95015-2; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Demeler B, 2014, ULTRASCAN SOFTWARE C; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Demeler B, 2009, METHOD ENZYMOL, V454, P87, DOI 10.1016/S0076-6879(08)03804-4; Durchschlag H., 1986, THERMODYNAMIC DATA B; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Gabrielson JP, 2011, METHODS, V54, P83, DOI 10.1016/j.ymeth.2010.12.030; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gu L, 2013, J BIOL CHEM, V288, P18673, DOI 10.1074/jbc.M113.457739; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; Hayden EY, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt226; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hosszu LLP, 2009, J BIOL CHEM, V284, P21981, DOI 10.1074/jbc.M809173200; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Jang H, 2013, J PHYS CHEM B; Kar SR, 2000, ANAL BIOCHEM, V285, P135, DOI 10.1006/abio.2000.4748; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 2014, SEDNTERP; Legleiter J, 2011, METHODS MOL BIOL, V670, P57, DOI 10.1007/978-1-60761-744-0_5; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu J, 2006, AAPS J, V8, pE580, DOI 10.1208/aapsj080367; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mok YF, 2006, METHOD ENZYMOL, V413, P199, DOI 10.1016/S0076-6879(06)13011-6; Mok YF, 2011, METHODS, V54, P67, DOI 10.1016/j.ymeth.2010.10.004; Nagel-Steger L, 2010, EUR BIOPHYS J BIOPHY, V39, P415, DOI 10.1007/s00249-009-0416-2; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Roychaudhuri R, 2013, J MOL BIOL, V425, P292, DOI 10.1016/j.jmb.2012.11.006; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2014, SEDFIT; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Trevitt CR, 2014, J BIOL CHEM, V289, P25497, DOI 10.1074/jbc.M114.566588; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200	58	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127865	10.1371/journal.pone.0127865	http://dx.doi.org/10.1371/journal.pone.0127865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024352	Green Published, gold			2022-12-27	WOS:000355319400055
J	Guerin, F; Wagner, M; Line, A; Zappa, M; Fasseu, M; Paradis, V; Vilgrain, V; Van Beers, BE; Legagneux, J; Moreau, R; Letteron, P				Guerin, Florent; Wagner, Mathilde; Line, Antoine; Zappa, Magaly; Fasseu, Magali; Paradis, Valerie; Vilgrain, Valerie; Van Beers, Bernard E.; Legagneux, Josette; Moreau, Richard; Letteron, Philippe			Hepatic Proliferation and Angiogenesis Markers Are Increased after Portal Deprivation in Rats: A Study of Molecular, Histological and Radiological Changes	PLOS ONE			English	Article							CONGENITAL PORTOSYSTEMIC SHUNTS; CHRONIC LIVER-DISEASE; PORTACAVAL-SHUNT; BUFFER RESPONSE; BRANCH LIGATION; VEIN; TISSUE; BLOOD; COMPLICATIONS; REGENERATION	Background & Aims To determine the pathogenesis of liver nodules, and lesions similar to obliterative portal venopathy, observed after portosystemic shunts or portal vein thrombosis in humans. Methods We conducted an experimental study comparing portacaval shunt (PCS), total portal vein ligation (PVL), and sham (S) operated rats. Each group were either sacrificed at 6 weeks (early) or 6 months (late). Arterial liver perfusion was studied in vivo using CT, and histopathological changes were noted. Liver mRNA levels were quantified by RT-QPCR for markers of inflammation (Il10, Tnfa), proliferation (Il6st, Mki67, Hgf, Hnf4a), angiogenesis: (Vegfa, Vegfr 1, 2 and 3; Pgf), oxidative stress (Nos2, and 3, Hif1a), and fibrosis (Tgfb). PCS and PVL were compared to the S group. Results Periportal fibrosis and arterial proliferation was observed in late PCS and PVL groups. CT imaging demonstrated increased arterial liver perfusion in the PCS group. RT-QPCR showed increased inflammatory markers in PCS and PVL early groups. Tnfa and Il10 were increased in PCS and PVL late groups respectively. All proliferative markers increased in the PCS, and Hnf4a in the PVL early groups. Mki67 and Hnf4a were increased in the PCS late group. Nos3 was increased in the early and late PCS groups, and Hif1a was decreased in the PVL groups. Markers of angiogenesis were all increased in the early PCS group, and Vegfr3 and Pgf in the late PCS group. Only Vegfr3 was increased in the PVL groups. Tgf was increased in the PCS groups. Conclusions Portal deprivation in rats induces a sustained increase in intrahepatic markers of inflammation, angiogenesis, proliferation, and fibrosis.	[Guerin, Florent] Univ Paris 11, Hop Univ Paris Sud Bicetre, AP HP, Dept Pediat Surg, Le Kremlin Bicetre, France; [Guerin, Florent; Wagner, Mathilde; Line, Antoine; Zappa, Magaly; Fasseu, Magali; Paradis, Valerie; Vilgrain, Valerie; Van Beers, Bernard E.; Moreau, Richard; Letteron, Philippe] Univ Paris 07, Fac Med Xavier Bichat, INSERM, Ctr Rech Inflammat,UMR 1149, Paris, France; [Guerin, Florent; Line, Antoine; Legagneux, Josette] AP HP, AGEPS, Lab Microchirurg, Paris, France; [Wagner, Mathilde; Zappa, Magaly; Vilgrain, Valerie; Van Beers, Bernard E.] Univ Paris 07, Hop Univ Paris Nord Val Seine Beaujon, AP HP, Dept Radiol, Clichy, France; [Paradis, Valerie] Univ Paris 07, Hop Univ Paris Nord Val Seine Beaujon, AP HP, Dept Pathol, Clichy, France; [Moreau, Richard] Univ Paris 07, Hop Univ Paris Nord Val Seine Beaujon, AP HP, Dept Hepatol, Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); AGEPS Agence Generale des Equipements et Produits de Sante - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Guerin, F (corresponding author), Univ Paris 11, Hop Univ Paris Sud Bicetre, AP HP, Dept Pediat Surg, Le Kremlin Bicetre, France.	florent.guerin@bct.aphp.fr	Moreau, Richard/N-2197-2017; Paradis, Valerie/X-9097-2019; Van Beers, Bernard/N-2816-2016; Moreau, Richard/S-1300-2019	Moreau, Richard/0000-0003-0862-403X; Van Beers, Bernard/0000-0001-6429-1140; Moreau, Richard/0000-0003-0862-403X; Wagner, Mathilde/0000-0003-1172-4592; Paradis, Valerie/0000-0003-3142-3762	FONDS D'ETUDES ET DE RECHERCHE DU CORPS MEDICAL (Assistance Publique-Hopitaux de Paris)	FONDS D'ETUDES ET DE RECHERCHE DU CORPS MEDICAL (Assistance Publique-Hopitaux de Paris)	All this work was supported with the grant from FONDS D'ETUDES ET DE RECHERCHE DU CORPS MEDICAL (Assistance Publique-Hopitaux de Paris). There were no additional funding sources for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2012, LIVER INT, V32, P531, DOI 10.1111/j.1478-3231.2012.02755.x; BARTON JW, 1989, PEDIATR RADIOL, V20, P113, DOI 10.1007/BF02010653; BIOULACSAGE P, 1985, HEPATOLOGY, V5, P1183, DOI 10.1002/hep.1840050620; Cazals-Hatem D, 2011, J HEPATOL, V54, P455, DOI 10.1016/j.jhep.2010.07.038; Cohen MM, 2003, AM J MED GENET A, V116A, P1, DOI 10.1002/ajmg.a.10750; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Franchi-Abella S, 2010, J PEDIATR GASTR NUTR, V51, P322, DOI 10.1097/MPG.0b013e3181d9cb92; Gandhi CR, 2002, J HEPATOL, V37, P340, DOI 10.1016/S0168-8278(02)00165-4; Garcia C, 2011, CYTOKINE, V56, P680, DOI 10.1016/j.cyto.2011.08.033; Glatard AS, 2012, RADIOLOGY, V263, P741, DOI 10.1148/radiol.12111785; Gock M, 2011, MICROVASC RES, V81, P274, DOI 10.1016/j.mvr.2011.03.005; Guerin F, 2009, J PEDIATR SURG, V44, P1337, DOI 10.1016/j.jpedsurg.2008.11.003; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; JOHNSON JA, 1966, AM J PHYSIOL, V210, P1299, DOI 10.1152/ajplegacy.1966.210.6.1299; Kollmar O, 2007, AM J PHYSIOL-GASTR L, V292, pG1534, DOI 10.1152/ajpgi.00503.2006; KOSHY A, 1988, J PHARMACOL METHOD, V20, P265, DOI 10.1016/0160-5402(88)90068-X; Kurinna S, 2011, INT J BIOCHEM CELL B, V43, P189, DOI 10.1016/j.biocel.2010.03.013; Lee KCL, 2011, JAVMA-J AM VET MED A, V239, P638, DOI 10.2460/javma.239.5.638; LEE SH, 1961, SURGERY, V50, P668; Lisovsky M, 2011, AM J SURG PATHOL, V35, P1381, DOI 10.1097/PAS.0b013e3182230ce4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCUSKEY RS, 1983, HEPATOLOGY, V3, P96; Moreau R, 2005, J HEPATOL, V43, P6, DOI 10.1016/j.jhep.2005.04.002; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Pupulim LF, 2013, CLIN RADIOL, V68, pE362, DOI 10.1016/j.crad.2013.01.024; Reiberger T, 2009, J HEPATOL, V51, P865, DOI 10.1016/j.jhep.2009.06.024; Rocheleau B, 1999, AM J PHYSIOL-GASTR L, V277, pG1000, DOI 10.1152/ajpgi.1999.277.5.G1000; ROZGA J, 1986, EUR SURG RES, V18, P302, DOI 10.1159/000128539; Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004; Tivers MS, 2012, J COMP PATHOL, V147, P55, DOI 10.1016/j.jcpa.2011.09.001; UM SH, 1994, HEPATOLOGY, V19, P202, DOI 10.1002/hep.1840190130; WEINBREN K, 1976, NATURE, V264, P440, DOI 10.1038/264440a0; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Zaitoun AA, 2006, J SURG RES, V131, P225, DOI 10.1016/j.jss.2005.11.587; Zipprich A, 2008, AM J PHYSIOL-GASTR L, V295, pG197, DOI 10.1152/ajpgi.00190.2007	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125493	10.1371/journal.pone.0125493	http://dx.doi.org/10.1371/journal.pone.0125493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020934	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300014
J	Liu, SM; Lacape, JM; Constable, GA; Llewellyn, DJ				Liu, Shiming; Lacape, Jean-Marc; Constable, Greg A.; Llewellyn, Danny J.			Inheritance and QTL Mapping of Leaf Nutrient Concentration in a Cotton Inter-Specific Derived RIL Population	PLOS ONE			English	Article							SEED MINERAL CONCENTRATIONS; QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; POTASSIUM NUTRITION; GENOME SEQUENCE; USE-EFFICIENCY; PHOSPHORUS; CULTIVARS; GROWTH; MECHANISM	Developing and deploying cotton cultivars with high nutrient uptake, use efficiency and tolerance to nutrient related soil stresses is desirable to assist sustainable soil management. Genetic variation, heritability, selection response and quantitative trait loci (QTLs) were investigated for five macronutrients (P, K, Ca, Mg, S) and five micronutrients (Fe, Mn, B, Zn, and Cu) in a recombinant inbred line (RIL) population from an inter-specific cross between Gossypium hirsutum cv. Guazuncho 2, and G. barbadense accession VH8-4602. Na and K/Na ratio were also studied as the imbalance between Na and other nutrients is detrimental to cotton growth and development. The concentrations of nutrients were measured for different plant parts of the two parents and for leaf samples of the whole population collected at early to peak flowering in field experiments over two years in a sodic Vertosol soil. Parental contrast was large for most nutrient concentrations in leaves when compared with other plant parts. Segregation for leaf nutrient concentration was observed within the population with transgression for P, K, K/Na ratio and all micronutrients. Genotypic difference was the major factor behind within-population variation for most nutrients, while narrow sense heritability was moderate (0.27 for Mn and Cu, and 0.43 for B). At least one significant QTL was identified for each nutrient except K and more than half of those QTLs were clustered on chromosomes 14, 18 and 22. Selection response was predicted to be low for P and all micronutrients except B, high for K, Na and B, and very high for K/Na ratio. Correlations were more common between macronutrients, Na and K/Na ratio where the nature and strength of the relations varied (r=-0.69 to 0.76). We conclude that there is sufficient genetic diversity between these two tetraploid cotton species that could be exploited to improve cotton nutrient status by introgressing species-unique favourable alleles.	[Liu, Shiming; Constable, Greg A.] CSIRO, Agr Flagship, Narrabri, NSW 2390, Australia; [Lacape, Jean-Marc] CIRAD, UMR AGAP, F-34398 Montpellier, France; [Llewellyn, Danny J.] CSIRO, Agr Flagship, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); CIRAD; Universite de Montpellier; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Liu, SM (corresponding author), CSIRO, Agr Flagship, Narrabri, NSW 2390, Australia.	shiming.liu@csiro.au	Llewellyn, Danny J/D-5230-2009; Liu, Shiming/F-2557-2011; Lacape, Jean-Marc/B-4326-2008; Lacape, JM/Y-1806-2019	Llewellyn, Danny J/0000-0001-9535-8707; Lacape, Jean-Marc/0000-0003-0891-8329; 	French National Research Agency, ANR [ANR-06-GPLA-018]; Cotton Breeding Australia Joint Venture	French National Research Agency, ANR(French National Research Agency (ANR)); Cotton Breeding Australia Joint Venture(Cotton R&D Corp)	The French National Research Agency, ANR, through its program specialized in plant genomics, Genoplante, has sponsored the QTL aspects of this research (project nr ANR-06-GPLA-018). Field studies in Australia were funded through the Cotton Breeding Australia Joint Venture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2002, TASKS VEG SCI, V37, P199; Ashraf M, 2002, CRIT REV PLANT SCI, V21, P1, DOI 10.1016/S0735-2689(02)80036-3; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Basten C. J., 2003, QTL CARTOGRAPHER VER; BENNETT O. L., 1965, AGRON J, V57, P296; Bernardo R., 2010, BREEDING QUANTITATIV; Bienert S., 2005, PROJEKTFINANZIERUNG; BLAND WL, 1989, SOIL SCI SOC AM J, V53, P1850, DOI 10.2136/sssaj1989.03615995005300060039x; BLEVINS DG, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P259; Boyce Chartered Accountants, 2012, AUSTR COTT COMP AN 2, P50; BRAUD M, 1974, Coton et Fibres Tropicales, V29, P215; BROUDER SM, 1990, FIELD CROP RES, V23, P187, DOI 10.1016/0378-4290(90)90054-F; Brown JF, 1990, P 5 AUSTR COTT C, P67; Butler DG, 2009, QUEENSLAND DEP PRIMA; CAKMAK I, 1986, PHYSIOL PLANTARUM, V68, P483, DOI 10.1111/j.1399-3054.1986.tb03386.x; CASSMAN KG, 1989, AGRON J, V81, P870, DOI 10.2134/agronj1989.00021962008100060006x; CHHIPA BR, 1995, AUST J AGR RES, V46, P533, DOI 10.1071/AR9950533; CONSTABLE GA, 1988, AUST J EXP AGR, V28, P351, DOI 10.1071/EA9880351; CRAMER GR, 1987, PLANT PHYSIOL, V83, P510, DOI 10.1104/pp.83.3.510; Ding GD, 2010, ANN BOT-LONDON, V105, P1221, DOI 10.1093/aob/mcq050; EVANS LT, 1993, CROP EVOLUTION ADAPT, P317; Fageria N.K., 2009, USE NUTR CROP PLANTS; Falconer D. S., 1996, INTRO QUANTITATIVE G; Foolad MR, 1999, PLANT BREEDING, V118, P167, DOI 10.1046/j.1439-0523.1999.118002167.x; Foolad MR, 1997, PLANT BREEDING, V116, P53, DOI 10.1111/j.1439-0523.1997.tb00974.x; FOY CD, 1981, AGRON J, V73, P107, DOI 10.2134/agronj1981.00021962007300010024x; FOY CD, 1969, AGRON J, V61, P690, DOI 10.2134/agronj1969.00021962006100050012x; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Gholamhossein H., 2011, World Cotton Research Conference-5, Mumbai, India, 7-11 November 2011, P85; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Girma K, 2007, J COTTON SCI, V11, P12; Gorham J, 2010, PHYSIOLOGY OF COTTON, P129, DOI 10.1007/978-90-481-3195-2_13; Hearn A. B., 1981, Field Crop Abstracts, V34, P11; Hodges SC, 2010, PHYSIOLOGY OF COTTON, P142, DOI 10.1007/978-90-481-3195-2_14; Holland JB, 2002, PL BRED RE, V22, P9; Iqbal R. J., 2001, International Journal of Agriculture and Biology, V3, P186; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; JOHAM HE, 1955, PLANT PHYSIOL, V30, P4, DOI 10.1104/pp.30.1.4; Kerby T. A., 1985, Potassium in Agriculture, P843; Lacape JM, 2013, FIELD CROP RES, V144, P256, DOI 10.1016/j.fcr.2013.01.001; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liu SM, 2015, EUPHYTICA, V201, P253, DOI 10.1007/s10681-014-1205-2; Liu SM, 2011, EUPHYTICA, V178, P309, DOI 10.1007/s10681-010-0289-6; Lopez M, 2008, J PLANT NUTR, V31, P1947, DOI 10.1080/01904160802402963; Mullins GL, 2010, PHYSIOLOGY OF COTTON, P97, DOI 10.1007/978-90-481-3195-2_9; OHKI K, 1975, AGRON J, V67, P30, DOI 10.2134/agronj1975.00021962006700010008x; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Rana RS, 1980, P INT S SALT AFF SOI, P487; RATHERT G, 1982, J PLANT NUTR, V5, P183, DOI 10.1080/01904168209362948; REUTER DJ, 1986, PLANT ANAL INTERPRET, P38; Rochester I., 2012, FLOWERING FRUITING C, V8, P35; Rochester IJ, 2015, FIELD CROP RES, V173, P14, DOI 10.1016/j.fcr.2015.01.001; Rochester IJ, 2010, CROP PASTURE SCI, V61, P825, DOI 10.1071/CP10043; Rochester IJ, 2003, P WORLD COTT RES C 3, V3, P681; ROTHWELL A., 1967, Coir. Grow. Rev., V44, P23; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Schwab GJ, 2000, COMMUN SOIL SCI PLAN, V31, P149, DOI 10.1080/00103620009370426; Soil Survey Staff, 1996, KEYS SOIL TAX; THENABADU MW, 1966, NATURE, V209, P165, DOI 10.1038/209165a0; Tiwari RS, 2013, EUPHYTICA, V194, P1, DOI 10.1007/s10681-013-0927-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waddle BA, 1984, COTTON AGRONOMY MONO, V24, P233; Wang ZN, 2013, G3-GENES GENOM GENET, V3, P1759, DOI 10.1534/g3.113.006890; Ward WT, 1999, 2199 CSIRO; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; WHITENBERG D. C, 1964, BOT GAZ, V125, P56, DOI 10.1086/336245; Wright PR, 1999, PLANT SOIL, V211, P231, DOI 10.1023/A:1004652728420; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Zia-ul-hassan, 2011, J PLANT NUTR, V34, P1957, DOI 10.1080/01904167.2011.610483	74	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128100	10.1371/journal.pone.0128100	http://dx.doi.org/10.1371/journal.pone.0128100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020945	Green Published, gold			2022-12-27	WOS:000355187300080
J	Long, JA; Burrow, CJ; Ginter, M; Maisey, JG; Trinajstic, KM; Coates, MI; Young, GC; Senden, TJ				Long, John A.; Burrow, Carole J.; Ginter, Michal; Maisey, John G.; Trinajstic, Kate M.; Coates, Michael I.; Young, Gavin C.; Senden, Tim J.			First Shark from the Late Devonian (Frasnian) Gogo Formation, Western Australia Sheds New Light on the Development of Tessellated Calcified Cartilage	PLOS ONE			English	Article							PRIMITIVE CHONDRICHTHYAN BRAINCASE; PLACODERM FISH; TRIBODUS-LIMAE; ARTHRODIRE; ORIGIN; ELASMOBRANCHII; PRESERVATION; JAWS; SKELETON; REVEALS	Background Living gnathostomes (jawed vertebrates) comprise two divisions, Chondrichthyes (cartilaginous fishes, including euchondrichthyans with prismatic calcified cartilage, and extinct stem chondrichthyans) and Osteichthyes (bony fishes including tetrapods). Most of the early chondrichthyan ('shark') record is based upon isolated teeth, spines, and scales, with the oldest articulated sharks that exhibit major diagnostic characters of the group-prismatic calcified cartilage and pelvic claspers in males-being from the latest Devonian, c. 360 Mya. This paucity of information about early chondrichthyan anatomy is mainly due to their lack of endoskeletal bone and consequent low preservation potential. Methodology/Principal Findings Here we present new data from the first well-preserved chondrichthyan fossil from the early Late Devonian (ca. 380-384 Mya) Gogo Formation Legerstatte of Western Australia. The specimen is the first Devonian shark body fossil to be acid-prepared, revealing the endoskeletal elements as three-dimensional undistorted units: Meckel's cartilages, nasal, ceratohyal, basibranchial and possible epibranchial cartilages, plus left and right scapulocoracoids, as well as teeth and scales. This unique specimen is assigned to Gogoselachus lynnbeazleyae n. gen. n. sp. Conclusions/Significance The Meckel's cartilages show a jaw articulation surface dominated by an expansive cotylus, and a small mandibular knob, an unusual condition for chondrichthyans. The scapulocoracoid of the new specimen shows evidence of two pectoral fin basal articulation facets, differing from the standard condition for early gnathostomes which have either one or three articulations. The tooth structure is intermediate between the 'primitive' ctenacanthiform and symmoriiform condition, and more derived forms with a euselachian-type base. Of special interest is the highly distinctive type of calcified cartilage forming the endoskeleton, comprising multiple layers of nonprismatic subpolygonal tesserae separated by a cellular matrix, interpreted as a transitional step toward the tessellated prismatic calcified cartilage that is recognized as the main diagnostic character of the chondrichthyans.	[Long, John A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Long, John A.; Young, Gavin C.] Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT, Australia; [Long, John A.] Museum Victoria, Geosci, Melbourne, Vic, Australia; [Burrow, Carole J.] Queensland Museum, Ancient Environm, Hendra, Qld, Australia; [Ginter, Michal] Univ Warsaw, Palaeontol Sect, Warsaw, Poland; [Maisey, John G.] Amer Museum Nat Hist, New York, NY 10024 USA; [Trinajstic, Kate M.] Curtin Univ, Environm & Agr, Perth, WA 6845, Australia; [Trinajstic, Kate M.] Western Australian Museum, Earth & Planetary Sci, Perth, WA 6000, Australia; [Coates, Michael I.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Senden, Tim J.] Australian Natl Univ, Dept Appl Math, Canberra, ACT, Australia	Flinders University South Australia; Australian National University; Museum Victoria; Queensland Museum; University of Warsaw; American Museum of Natural History (AMNH); Curtin University; Western Australian Museum; University of Chicago; Australian National University	Long, JA (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	john.long@flinders.edu.au	Burrow, Carole J./AAG-4327-2021; Coates, Michael/AAO-3810-2020; Senden, Tim J/A-7319-2008	Coates, Michael/0000-0003-2843-1075; Senden, Tim J/0000-0001-6808-7219; Trinajstic, Kate/0000-0002-6519-6396; Ginter, Michal/0000-0002-7210-7312; Long, John/0000-0001-8012-0114	Australian Research Council [DP 0772138, DP1092870]	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council DP 0772138 awarded to GCY and JAL for travel and scanning of specimens at the ANU; and DP1092870 awarded to KMT for travel to collaborate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 2008, ACTA GEOL POL, V58, P155; Burrow Carole J., 2004, Fossils and Strata, V50, P8; Burrow CJ, 2009, ANTARCT SCI, V21, P71, DOI 10.1017/S0954102008001521; Burrow CJ, 2005, LETHAIA, V38, P205, DOI 10.1080/00241160510013286; Burrow CJ, 2012, HIST BIOL, V21, P71; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Coates MI, 1998, NATURE, V396, P729, DOI 10.1038/25467; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Coates MI, 2007, PALAEONTOLOGY, V50, P1421, DOI 10.1111/j.1475-4983.2007.00719.x; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dean MN, 2009, J ANAT, V215, P227, DOI 10.1111/j.1469-7580.2009.01116.x; DENNIS K, 1979, ZOOL J LINN SOC-LOND, V67, P1, DOI 10.1111/j.1096-3642.1979.tb01102.x; DENNIS K, 1981, ZOOL J LINN SOC-LOND, V73, P213, DOI 10.1111/j.1096-3642.1981.tb01594.x; DICK J R F, 1978, Transactions of the Royal Society of Edinburgh, V70, P63; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Eames BF, 2007, J ANAT, V210, P542, DOI 10.1111/j.1469-7580.2007.00723.x; Furbringer P, 1903, MORPHOLOGISCHES JB, V31, P360; Gardiner B. G., 1984, B BRIT MUS NAT HIST, V37, P1; Gardiner B.G., 1977, PROBLEMS EARLY VERTE, P227; Gegenbaur C., 1872, UNTERSUCHUNGEN VERGL; Ginter M., 2010, HDB PALEOICHTHYOLOGY; Ginter M., 2005, ICHTHYOL ISSUES SPEC, V8, P11; Ginter Michal, 2010, P145; Ginter Michal, 2002, Acta Geologica Polonica, V52, P169; Gross W., 1973, Palaeontographica Abt A, V142, P51; Gross W., 1971, Palaeontographica A, V136, P1; Gross W, 1937, SENCKENBERGIANIA, V20, P123; Hairapetian V, 2006, ACTA PALAEONTOL POL, V51, P499; Hairapetian V, 2009, ACTA GEOL POL, V59, P173; HOTTON NICHOLAS, 1952, JOUR PALEONTOL, V26, P489; Jaekel O., 1921, Palaeontologische Zeitschrift Berlin, V3, P213; Janvier P., 1996, EARLY VERTEBRATES; Janvier Philippe, 2010, P431; KEMP NE, 1979, J MORPHOL, V160, P75, DOI 10.1002/jmor.1051600106; Lane JA, 2012, J PALEONTOL, V86, P886, DOI 10.1666/11-139.1; Lane JA, 2009, J VERTEBR PALEONTOL, V29, P25, DOI 10.1080/02724634.2009.10010359; Long J., 2006, SWIMMING STONE AMAZI; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; LONG JA, 1995, PALAEONTOLOGY, V38, P39; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Long JA, 2009, NATURE, V457, P1124, DOI 10.1038/nature07732; Maisey J.G., 1989, Journal of Vertebrate Paleontology, V9, P174; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P807, DOI 10.1671/0272-4634(2001)021[0807:CSRNCF]2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey JG, 1989, AM MUSEUM NOVITATES, V2931; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey John G., 2013, Revue de Paleobiologie, V32, P355; Martinez-Perez C, 2010, J VERTEBR PALEONTOL, V30, P1622, DOI 10.1080/02724634.2010.501451; Melendez I, 2013, GEOLOGY, V41, P123, DOI 10.1130/G33492.1; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Newberry J.S., 1875, REPORT GEOLOGICAL SU, V2, P1; Orvig T., 1951, Arkiv for Zoologi (2), V2, P321; Pradel A, 2014, NATURE, V509, P608, DOI 10.1038/nature13195; REIF W-E, 1978, Palaeontologische Zeitschrift, V52, P110; Rucklin M, 2012, NATURE, V491, P748, DOI 10.1038/nature11555; Schaeffer B., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P101; Soares MC, 2013, J MORPHOL, V274, P1111, DOI 10.1002/jmor.20166; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Trinajstic K, 2009, PALAEONTOLOGY, V52, P641, DOI 10.1111/j.1475-4983.2009.00870.x; Turner S., 1993, P174; TURNER S, 1982, Journal of Vertebrate Paleontology, V2, P117; Turner Susan, 2000, Courier Forschungsinstitut Senckenberg, V223, P487; Wells J. W., 1944, PALAEONTOGRAPH AMER, V3, P99; Williams ME, 2001, J VERTEBR PALEONTOL, V21, P214, DOI 10.1671/0272-4634(2001)021[0214:TRICSW]2.0.CO;2; Williams ME, 1998, J VERTEBR PALEONTOL, V18, P251, DOI 10.1080/02724634.1998.10011054; Woodward A.S., 1892, GEOL MAG, P1, DOI [10.1017/S0016756800188533, DOI 10.1017/S0016756800188533]; YOUNG GC, 1982, PALAEONTOLOGY, V25, P817; YOUNG GC, 1984, PALAEONTOLOGY, V27, P635; Zangerl R., 1981, HDB PALEOICHTHYOLOGY; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	83	23	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126066	10.1371/journal.pone.0126066	http://dx.doi.org/10.1371/journal.pone.0126066			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020788	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300019
J	Moghimi, E; Solomon, JA; Gianforcaro, A; Hamadeh, MJ				Moghimi, Elnaz; Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.			Dietary Vitamin D-3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; MANGANESE SUPEROXIDE-DISMUTASE; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; CU/ZN-SUPEROXIDE; D DEFICIENCY; AUTOIMMUNE ENCEPHALOMYELITIS; CYTOKINE PRODUCTION; GONADAL-STEROIDS; SEX-DIFFERENCES	Background Dietary vitamin D-3 (D-3) restriction reduces paw grip endurance and motor performance in G93A mice, and increases inflammation and apoptosis in the quadriceps of females. ALS, a neuromuscular disease, causes progressive degeneration of motor neurons in the brain and spinal cord. Objective We analyzed the spinal cords of G93A mice following dietary D-3 restriction at 2.5% the adequate intake (AI) for oxidative damage (4-HNE, 3-NY), antioxidant enzymes (SOD2, catalase, GPx1), inflammation (TNF-alpha, IL-6, IL-10), apoptosis (bax/bcl-2 ratio, cleaved/procaspase 3 ratio), neurotrophic factor (GDNF) and neuron count (ChAT, SMI-36/SMI-32 ratio). Methods Beginning at age 25 d, 42 G93A mice were provided food ad libitum with either adequate (AI; 1 IU D-3/g feed; 12 M, 11 F) or deficient (DEF; 0.025 IU D-3/g feed; 10 M, 9 F) D3. At age 113 d, the spinal cords were analyzed for protein content. Differences were considered significant at P <= 0.10, since this was a pilot study. Results DEF mice had 16% higher 4-HNE (P = 0.056), 12% higher GPx1 (P = 0.057) and 23% higher Bax/Bcl2 ratio (P = 0.076) vs. AI. DEF females had 29% higher GPx1 (P = 0.001) and 22% higher IL-6 (P = 0.077) vs. AI females. DEF males had 23% higher 4-HNE (P = 0.066) and 18% lower SOD2 (P = 0.034) vs. AI males. DEF males had 27% lower SOD2 (P = 0.004), 17% lower GPx1 (P = 0.070), 29% lower IL-6 (P = 0.023) and 22% lower ChAT (P = 0.082) vs. DEF females. Conclusion D-3 deficiency exacerbates disease pathophysiology in the spinal cord of G93A mice, the exact mechanisms are sex-specific. This is in accord with our previous results in the quadriceps, as well as functional and disease outcomes.	[Moghimi, Elnaz; Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Moghimi, Elnaz; Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Hamadeh, MJ (corresponding author), York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (http://www.nserccrsng.gc.ca/Index_eng.asp) received by MJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, J Nutr, V107, P1340; [Anonymous], 2005, EST SAF START DOS CL; Barp J, 2012, CAN J PHYSIOL PHARM, V90, P1229, DOI [10.1139/y2012-078, 10.1139/Y2012-078]; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Berthod F, IN VIVO IN VITRO MOD; Bishop A, 2009, J NEUROCHEM, V109, P74, DOI 10.1111/j.1471-4159.2009.05884.x; Bobjer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061466; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Camu W, 2014, NEUROBIOL AGING, V35, P1198, DOI 10.1016/j.neurobiolaging.2013.11.005; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Cervetto C, 2013, TOXICOLOGY, V311, P69, DOI 10.1016/j.tox.2013.04.004; Chakrabarti S, 2012, AM J PHYSIOL-CELL PH, V302, pC666, DOI 10.1152/ajpcell.00181.2011; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Coletta RD, 2002, ORAL MICROBIOL IMMUN, V17, P186, DOI 10.1034/j.1399-302X.2002.170309.x; Czlonkowska A, 2005, CURR PHARM DESIGN, V11, P1017, DOI 10.2174/1381612053381693; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; de Aguilar JLG, 2000, NEUROBIOL DIS, V7, P406, DOI 10.1006/nbdi.2000.0295; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; GALLAGHER JC, 1980, J CLIN ENDOCR METAB, V51, P1359, DOI 10.1210/jcem-51-6-1359; Gan XF, 2014, INT J CLIN EXP MED, V7, P2530; Garcia-Segura LM, 2003, PROG NEUROBIOL, V71, P31, DOI 10.1016/j.pneurobio.2003.09.005; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Gianforcaro A, 2014, CNS NEUROSCI THER, V20, P101, DOI 10.1111/cns.12204; Gianforcaro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0030243; Gianforcaro A, 2012, CNS NEUROSCI THER, V18, P547, DOI 10.1111/j.1755-5949.2012.00316.x; Groeneveld GJ, 2004, BRAIN RES, V1021, P128, DOI 10.1016/j.brainres.2004.06.024; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Halhali A, 2010, J STEROID BIOCHEM, V121, P448, DOI 10.1016/j.jsbmb.2010.03.008; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Ibi M, 2001, NEUROPHARMACOLOGY, V40, P761, DOI 10.1016/S0028-3908(01)00009-0; Isse K, 2010, HEPATOLOGY, V51, P869, DOI 10.1002/hep.23386; Jardim BV, 2013, ONCOL REP, V30, P1119, DOI 10.3892/or.2013.2540; Jennum P, 2013, J NEUROL, V260, P785, DOI 10.1007/s00415-012-6706-0; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Karam C, 2013, J CLIN NEUROSCI; Keeney JTR, 2013, FREE RADICAL BIO MED, V65, P324, DOI 10.1016/j.freeradbiomed.2013.07.019; Luong KVQ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-16; Kiaei M, 2007, EXP NEUROL, V205, P74, DOI 10.1016/j.expneurol.2007.01.036; Kinuta K, 2000, ENDOCRINOLOGY, V141, P1317, DOI 10.1210/en.141.4.1317; Knippenberg S, 2011, ACTA NEUROL SCAND, V124, P171, DOI 10.1111/j.1600-0404.2010.01447.x; Laird E, 2014, J CLIN ENDOCR METAB, V99, P1807, DOI 10.1210/jc.2013-3507; Lechtzin N, 2006, RESP CARE, V51, P871; LI ZG, 1993, CLIN EXP RHEUMATOL, V11, P157; Lim S, 2013, AM J CLIN NUTR, V97, P524, DOI 10.3945/ajcn.112.048496; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; de Almeida JPL, 2012, NEUROL SCI, V33, P9, DOI 10.1007/s10072-011-0921-9; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Maggio M, 2006, J CLIN ENDOCR METAB, V91, P345, DOI 10.1210/jc.2005-1097; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Milionis A, 2012, FASEB J, V26; Miller RR, 2007, J GERONTOL A-BIOL, V62, P1402, DOI 10.1093/gerona/62.12.1402; Mitchell JD, 2000, AMYOTROPH LATERAL SC, V1, P235, DOI 10.1080/14660820050515061; Moghimi E, 2015, PLOS ONE UNPUB; Nakamizo T, 2000, NEUROREPORT, V11, P3493, DOI 10.1097/00001756-200011090-00019; Nashold FE, 2009, J IMMUNOL, V183, P3672, DOI 10.4049/jimmunol.0901351; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Numakawa T, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/405194; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Parkhomenko E, 2012, FASEB J, V26; Parkhomenko EA, 2011, DIETARY VITAMIN D3 5, P329; Parkhomenko EA, 2011, VITAMIN D DEFICIENCY, V328; Patel BP, 2009, CLIN NUTR, V28, P604, DOI 10.1016/j.clnu.2009.06.002; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Pierrot-Deseilligny C, 2009, J NEUROL, V256, P1468, DOI 10.1007/s00415-009-5139-x; Rao AK, 2011, J STEROID BIOCHEM, V127, P382, DOI 10.1016/j.jsbmb.2011.06.008; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saedisomeolia A, 2013, Indian J Med Sci, V67, P29; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Shahsavar S, 2013, FASEB J, V27; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Siddiqui MA, 2011, HUM EXP TOXICOL, V30, P860, DOI 10.1177/0960327110382130; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020582; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Summerday Nicole Marie, 2012, J Pharm Pract, V25, P75, DOI 10.1177/0897190011421839; Suzuki M, 2007, AMYOTROPH LATERAL SC, V8, P20, DOI 10.1080/17482960600982447; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Taheri-Shalmani S, 2013, FASEB J, V27; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V258, P685, DOI 10.1006/bbrc.1999.0577; Tripanichkul W, 2007, BRAIN RES, V1164, P24, DOI 10.1016/j.brainres.2007.05.076; Tripodoro Vilma Adriana, 2008, Curr Opin Support Palliat Care, V2, P173, DOI 10.1097/SPC.0b013e32830c9049; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; UCHINO M, 1994, J NEUROL SCI, V127, P61, DOI 10.1016/0022-510X(94)90136-8; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Willis KS, 2012, OPEN ACCESS J SPORTS, V3, P35, DOI 10.2147/OAJSM.S31022; WOODROOFE MN, 1995, NEUROLOGY, V45, pS6, DOI 10.1212/WNL.45.6_Suppl_6.S6; Wrzosek M, 2013, PHARMACOL REP, V65, P271, DOI 10.1016/S1734-1140(13)71003-X; Wu SP, 2011, DISCOV MED, V11, P325; YANAGIHARA R, 1984, ANN NEUROL, V15, P42, DOI 10.1002/ana.410150108; Zaldivar V, 2011, NEUROENDOCRINOLOGY, V93, P106, DOI 10.1159/000323760; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhao L, 2004, J BIOL CHEM, V279, P44093, DOI 10.1074/jbc.M313131200	110	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126355	10.1371/journal.pone.0126355	http://dx.doi.org/10.1371/journal.pone.0126355			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020962	gold, Green Published			2022-12-27	WOS:000355187300021
J	Bian, YQ; Zhang, J; Wang, J; Wang, JH; Wang, W				Bian, Yunqiang; Zhang, Jian; Wang, Jun; Wang, Jihua; Wang, Wei			Free Energy Landscape and Multiple Folding Pathways of an H-Type RNA Pseudoknot	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; STABILITY; KINETICS; HAIRPIN; IONS; BINDING; SWITCH; VIRUS	How RNA sequences fold to specific tertiary structures is one of the key problems for understanding their dynamics and functions. Here, we study the folding process of an H-type RNA pseudoknot by performing a large-scale all-atom MD simulation and bias-exchange metadynamics. The folding free energy landscapes are obtained and several folding intermediates are identified. It is suggested that the folding occurs via multiple mechanisms, including a step-wise mechanism starting either from the first helix or the second, and a cooperative mechanism with both helices forming simultaneously. Despite of the multiple mechanism nature, the ensemble folding kinetics estimated from a Markov state model is single-exponential. It is also found that the correlation between folding and binding of metal ions is significant, and the bound ions mediate long-range interactions in the intermediate structures. Non-native interactions are found to be dominant in the unfolded state and also present in some intermediates, possibly hinder the folding process of the RNA.	[Bian, Yunqiang; Zhang, Jian; Wang, Jun; Wang, Wei] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Bian, Yunqiang; Zhang, Jian; Wang, Jun; Wang, Wei] Nanjing Univ, Dept Phys, Nanjing 210093, Jiangsu, Peoples R China; [Bian, Yunqiang; Wang, Jihua] Dezhou Univ, Inst Biophys, Shandong Prov Key Lab Funct Macromol Biophys, Dezhou 253023, Peoples R China	Nanjing University; Nanjing University; Dezhou University	Zhang, J (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China.	jzhang@nju.edu.cn; wangwei@nju.edu.cn	Zhang, Jian/A-5886-2017; Wang, Jun/E-6642-2011	Zhang, Jian/0000-0003-2338-0395; 	National Natural Science Foundation of China (NSFC) [11274157, 11334004]; National Natural Science Foundation of China [11174133]; National Basic Research Program of China (NBRPC) [2012CB921502, 2013CB834100]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (NBRPC)(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC) Grants No. 11274157 JZ http://nsfc.pubmed.cn, National Natural Science Foundation of China (NSFC) Grants No. 11174133 JW http://nsfc.pubmed.cn, National Basic Research Program of China (NBRPC) Grants No. 2012CB921502 JZ http://www.973.gov.cn, National Basic Research Program of China (NBRPC) Grants No. 2013CB834100 WW http://www.973.gov.cn, National Natural Science Foundation of China (NSFC) Grants No. 11334004 WW http://nsfc.pubmed.cn, Priority Academic Program Development of Jiangsu Higher Education Institutions JZ http://jsycw.ec.js.edu.cn.	Bian YQ, 2015, MOL SIMULAT, V41, P752, DOI 10.1080/08927022.2014.931680; Bian YQ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003562; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bowman GR, 2008, J AM CHEM SOC, V130, P9676, DOI 10.1021/ja8032857; Cao S, 2007, J MOL BIOL, V367, P909, DOI 10.1016/j.jmb.2007.01.006; Cao S, 2006, NUCLEIC ACIDS RES, V34, P2634, DOI 10.1093/nar/gkl346; Cao S, 2010, RNA, V16, P538, DOI 10.1261/rna.1800210; Chen AA, 2013, P NATL ACAD SCI USA, V110, P16820, DOI 10.1073/pnas.1309392110; Chen G, 2007, RNA, V13, P2175, DOI 10.1261/rna.676707; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Cho SS, 2009, P NATL ACAD SCI USA, V106, P17349, DOI 10.1073/pnas.0906625106; Cossio P, 2010, J PHYS CHEM B, V114, P3259, DOI 10.1021/jp907464b; Csaszar K, 2001, J MOL BIOL, V313, P1073, DOI 10.1006/jmbi.2001.5100; de Messieres M, 2014, BIOPHYS J, V106, P244, DOI 10.1016/j.bpj.2013.09.036; Denesyuk NA, 2011, J AM CHEM SOC, V133, P11858, DOI 10.1021/ja2035128; Draper DE, 2008, BIOPHYS J, V95, P5489, DOI 10.1529/biophysj.108.131813; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Garcia AE, 2008, J AM CHEM SOC, V130, P815, DOI 10.1021/ja074191i; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Gluick TC, 1997, BIOCHEMISTRY-US, V36, P16173, DOI 10.1021/bi971362v; Green L, 2008, J MOL BIOL, V375, P511, DOI 10.1016/j.jmb.2007.05.058; Guy AT, 2012, BIOPHYS J, V103, P1028, DOI 10.1016/j.bpj.2012.08.012; Hengesbach M, 2012, ANGEW CHEM INT EDIT, V51, P5876, DOI 10.1002/anie.201200526; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Isambert H, 2000, P NATL ACAD SCI USA, V97, P6515, DOI 10.1073/pnas.110533697; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048460; Liu LA, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3447385; Marinelli F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000452; Narayanan R, 2011, J AM CHEM SOC, V133, P18767, DOI 10.1021/ja205737v; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Piana S, 2007, J PHYS CHEM B, V111, P4553, DOI 10.1021/jp067873l; Santner T, 2012, J AM CHEM SOC, V134, P11928, DOI 10.1021/ja3049964; Shi YZ, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4894752; Smith AW, 2005, J PHYS CHEM B, V109, P17025, DOI 10.1021/jp053949m; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Soto AM, 2007, BIOCHEMISTRY-US, V46, P2973, DOI 10.1021/bi0616753; Staple DW, 2005, PLOS BIOL, V3, P956, DOI 10.1371/journal.pbio.0030213; Tan ZJ, 2007, BIOPHYS J, V92, P3615, DOI 10.1529/biophysj.106.100388; Tan ZJ, 2006, BIOPHYS J, V91, P518, DOI 10.1529/biophysj.106.084285; Tan ZJ, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1842059; Thirumalai D, 1996, ACCOUNTS CHEM RES, V29, P433, DOI 10.1021/ar9500933; Wang J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001118; Woodson SA, 2005, CURR OPIN CHEM BIOL, V9, P104, DOI 10.1016/j.cbpa.2005.02.004; Wu YJ, 2014, NUCLEIC ACIDS RES, V42, P4505, DOI 10.1093/nar/gkt1396; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Xu XJ, 2012, J AM CHEM SOC, V134, P12499, DOI 10.1021/ja3013819; Zagrovic B, 2002, J MOL BIOL, V323, P153, DOI 10.1016/S0022-2836(02)00888-4; Zhang J, 2009, RNA, V15, P2248, DOI 10.1261/rna.1723609; Zhang J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2895050; Zhang YJ, 2011, J AM CHEM SOC, V133, P6882, DOI 10.1021/ja1109425; Zhao YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00734	52	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129089	10.1371/journal.pone.0129089	http://dx.doi.org/10.1371/journal.pone.0129089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030098	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900209
J	Blaak, H; Lynch, G; Italiaander, R; Hamidjaja, RA; Schets, FM; Husman, AMD				Blaak, Hetty; Lynch, Gretta; Italiaander, Ronald; Hamidjaja, Raditijo A.; Schets, Franciska M.; Husman, Ana Maria de Roda			Multidrug-Resistant and Extended Spectrum Beta-Lactamase-Producing Escherichia coli in Dutch Surface Water and Wastewater	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; SOURCE ATTRIBUTION; RISK-ASSESSMENT; ENTEROBACTERIACEAE; DISSEMINATION; VEGETABLES; EFFLUENT; BACTERIA; METAANALYSIS	Objective The goal of the current study was to gain insight into the prevalence and concentrations of antimicrobial resistant (AMR) Escherichia coli in Dutch surface water, and to explore the role of wastewater as AMR contamination source. Methods The prevalence of AMR E. coli was determined in 113 surface water samples obtained from 30 different water bodies, and in 33 wastewater samples obtained at five health care institutions (HCIs), seven municipal wastewater treatment plants (mWWTPs), and an airport WWTP. Overall, 846 surface water and 313 wastewater E. coli isolates were analysed with respect to susceptibility to eight antimicrobials (representing seven different classes): ampicillin, cefotaxime, tetracycline, ciprofloxacin, streptomycin, sulfamethoxazole, trimethoprim, and chloramphenicol. Results Among surface water isolates, 26% were resistant to at least one class of antimicrobials, and 11% were multidrug-resistant (MDR). In wastewater, the proportions of AMR/MDR E. coli were 76%/62% at HCIs, 69%/19% at the airport WWTP, and 37%/27% and 31%/20% in mWWTP influents and effluents, respectively. Median concentrations of MDR E. coli were 2.2x10(2), 4.0x10(4), 1.8x10(7), and 4.1x10(7) cfu/l in surface water, WWTP effluents, WWTP influents and HCI wastewater, respectively. The different resistance types occurred with similar frequencies among E. coli from surface water and E. coli from municipal wastewater. By contrast, among E. coli from HCI wastewater, resistance to cefotaxime and resistance to ciprofloxacin were significantly overrepresented compared to E. coli from municipal wastewater and surface water. Most cefotaxime-resistant E. coliisolates produced ESBL. In two of the mWWTP, ESBL-producing variants were detected that were identical with respect to phylogenetic group, sequence type, AMR-profile, and ESBL-genotype to variants from HCI wastewater discharged onto the same sewer and sampled on the same day (A(1)/ST23/CTX-M-1, B2(3)/ST131/CTX-M-15, D-2/ST405/CTX-M-15). Conclusion In conclusion, our data show that MDR E. coli are omnipresent in Dutch surface water, and indicate that municipal wastewater significantly contributes to this occurrence.	[Blaak, Hetty; Lynch, Gretta; Italiaander, Ronald; Hamidjaja, Raditijo A.; Schets, Franciska M.; Husman, Ana Maria de Roda] Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Husman, Ana Maria de Roda] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University	Blaak, H (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands.	hetty.blaak@rivm.nl		Hamidjaja, Raditijo/0000-0002-5655-2299	Dutch Ministry of Infrastructure and the Environment	Dutch Ministry of Infrastructure and the Environment	This study was in part financed by the Dutch Ministry of Infrastructure and the Environment, and the research institute where the work was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2008, INT J FOOD MICROBIOL, V123, P38, DOI 10.1016/j.ijfoodmicro.2007.11.067; Amos GCA, 2014, J ANTIMICROB CHEMOTH, V69, P1785, DOI 10.1093/jac/dku079; [Anonymous], 2007, 19458 NENENISO; [Anonymous], 2001, 166492 ISO; [Anonymous], 2000, 93081 NENENISO; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Blaak H, 2014, VET MICROBIOL; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; Boehme S, 2004, MOL NUTR FOOD RES, V48, P522, DOI 10.1002/mnfr.200400030; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P959, DOI 10.1017/S0950268811002172; EFSA - European Food Safety Authority, 2014, EFSA J, V12, P3590; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; Evers E. G., 2008, International Journal of Risk Assessment & Management, V8, P174, DOI 10.1504/IJRAM.2008.016151; Franz E, 2008, CRIT REV MICROBIOL, V34, P143, DOI [10.1080/10408410802357432, 10.1080/10408410802357432 ]; Galvin S, 2010, APPL ENVIRON MICROB, V76, P4772, DOI 10.1128/AEM.02898-09; George I, 2002, WATER RES, V36, P2607, DOI 10.1016/S0043-1354(01)00475-4; Gomez M, 2010, WIT TRANS ECOL ENVIR, V135, P83, DOI 10.2495/WP100081; Goni-Urriza M, 2000, APPL ENVIRON MICROB, V66, P125, DOI 10.1128/AEM.66.1.125-132.2000; Guardabassi L, 2004, APPL ENVIRON MICROB, V70, P984, DOI 10.1128/AEM.70.2.984-990.2004; HAAS CN, 1993, RISK ANAL, V13, P545, DOI 10.1111/j.1539-6924.1993.tb00013.x; Iwane T, 2001, WATER SCI TECHNOL, V43, P91; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Koczura R, 2012, SCI TOTAL ENVIRON, V414, P680, DOI 10.1016/j.scitotenv.2011.10.036; Korzeniewska E, 2013, ECOTOX ENVIRON SAFE, V91, P96, DOI 10.1016/j.ecoenv.2013.01.014; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; MARAN, 2012, MON ANT RES ANT US A; MARAN, 2013, MON ANT RES ANT US A; McGowan LL, 2006, J FOOD PROTECT, V69, P2976, DOI 10.4315/0362-028X-69.12.2976; Nauta M, 2009, INT J FOOD MICROBIOL, V129, P107, DOI 10.1016/j.ijfoodmicro.2008.12.001; NETHMAP, 2013, CONS ANT AG ANT RES; Novais C, 2005, APPL ENVIRON MICROB, V71, P3364, DOI 10.1128/AEM.71.6.3364-3368.2005; Ojer-Usoz E, 2014, WATER RES, V56, P37, DOI 10.1016/j.watres.2014.02.041; Osterblad M, 1999, J ANTIMICROB CHEMOTH, V43, P503, DOI 10.1093/jac/43.4.503; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Schets FM, 2011, WATER RES, V45, P2392, DOI 10.1016/j.watres.2011.01.025; Schijven JF, 2011, WATER RES, V45, P5564, DOI 10.1016/j.watres.2011.08.024; Schwaiger K, 2011, INT J FOOD MICROBIOL, V148, P191, DOI 10.1016/j.ijfoodmicro.2011.06.001; Schwaiger K, 2011, INT J ENVIRON HEAL R, V21, P161, DOI 10.1080/09603123.2010.515672; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; Servais P, 2009, SCI TOTAL ENVIRON, V408, P365, DOI 10.1016/j.scitotenv.2009.09.042; Smet A, 2010, MICROB DRUG RESIST, V16, P129, DOI 10.1089/mdr.2009.0132; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Soraas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069581; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; Veldman K, 2014, INT J FOOD MICROBIOL, V177, P72, DOI 10.1016/j.ijfoodmicro.2014.02.014; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y	56	80	84	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127752	10.1371/journal.pone.0127752	http://dx.doi.org/10.1371/journal.pone.0127752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030904	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900079
J	Chandrasekar, BS; Yadav, S; Victor, ES; Majumdar, S; Deobagkar-Lele, M; Wadhwa, N; Podder, S; Das, M; Nandi, D				Chandrasekar, Bhagawat S.; Yadav, Shikha; Victor, Emmanuel S.; Majumdar, Shamik; Deobagkar-Lele, Mukta; Wadhwa, Nitin; Podder, Santosh; Das, Mrinmoy; Nandi, Dipankar			Interferon-Gamma and Nitric Oxide Synthase 2 Mediate the Aggregation of Resident Adherent Peritoneal Exudate Cells: Implications for the Host Response to Pathogens	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LEUKOCYTE ADHESION; IFN-GAMMA; MACROPHAGE ACTIVATION; FUNCTIONAL-RESPONSES; MAC-1 CD11B/CD18; SALMONELLA; INFECTION; EXPRESSION; ACTIN	Interferon-gamma (Ifn gamma), a key macrophage activating cytokine, plays pleiotropic roles in host immunity. In this study, the ability of Ifn gamma to induce the aggregation of resident mouse adherent peritoneal exudate cells (APECs), consisting primarily of macrophages, was investigated. Cell-cell interactions involve adhesion molecules and, upon addition of Ifn gamma, CD11b re-localizes preferentially to the sites of interaction on APECs. A functional role of CD11b in enhancing aggregation is demonstrated using Reopro, a blocking reagent, and siRNA to Cd11b. Studies with NG-methyl-L-arginine (LNMA), an inhibitor of Nitric oxide synthase (Nos), NO donors, e.g., S-nitroso-N-acetyl-DL-penicillamine (SNAP) or Diethylenetriamine/ nitric oxide adduct (DETA/NO), and Nos2(-/-) mice identified Nitric oxide (NO) induced by Ifn gamma as a key regulator of aggregation of APECs. Further studies with Nos2(-/-) APECs revealed that some Ifn. responses are independent of NO: induction of MHC class II and CD80. On the other hand, Nos2 derived NO is important for other functions: motility, phagocytosis, morphology and aggregation. Studies with cytoskeleton depolymerizing agents revealed that Ifn gamma and NO mediate the cortical stabilization of Actin and Tubulin which contribute to aggregation of APECs. The biological relevance of aggregation of APECs was delineated using infection experiments with Salmonella Typhimurium (S. Typhimurium). APECs from orally infected, but not uninfected, mice produce high amounts of NO and aggregate upon ex vivo culture in a Nos2-dependent manner. Importantly, aggregated APECs induced by Ifn gamma contain fewer intracellular S. Typhimurium compared to their single counterparts post infection. Further experiments with LNMA or Reopro revealed that both NO and CD11b are important for aggregation; in addition, NO is bactericidal. Overall, this study elucidates novel roles for Ifn gamma and Nos2 in regulating Actin, Tubulin, CD11b, motility and morphology during the aggregation response of APECs. The implications of aggregation or "group behavior" of APECs are discussed in the context of host resistance to infectious organisms.	[Chandrasekar, Bhagawat S.; Yadav, Shikha; Victor, Emmanuel S.; Majumdar, Shamik; Deobagkar-Lele, Mukta; Wadhwa, Nitin; Das, Mrinmoy; Nandi, Dipankar] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Podder, Santosh; Nandi, Dipankar] Indian Inst Sci, CIDR, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Nandi, D (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nandi@biochem.iisc.ernet.in	Majumdar, Shamik/ABE-2032-2021; Stephen Victor, Emmanuel/HDN-0252-2022; Nandi, Dipankar/O-1363-2019; PODDER, SANTOSH/AHE-0982-2022; Das, Mrinmoy/AAS-5750-2021	Majumdar, Shamik/0000-0002-3458-816X; Stephen Victor, Emmanuel/0000-0001-5049-7017; Nandi, Dipankar/0000-0002-5221-9712; Das, Mrinmoy/0000-0002-5785-5697; PODDER, SANTOSH/0000-0003-0576-4598; Deobagkar, Mukta/0000-0002-8543-6801	Department of Biotechnology, Government of India [BT/01/CEIB/09/IV/05]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Government of India, grant BT/01/CEIB/09/IV/05. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhosle M, 2012, IMMUNOBIOLOGY, V217, P354, DOI 10.1016/j.imbio.2011.07.010; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brindicci C, 2010, AM J RESP CRIT CARE, V181, P21, DOI 10.1164/rccm.200904-0493OC; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Chandrasekar B, 2013, J INFECT DIS, V207, P1556, DOI 10.1093/infdis/jit067; Clements MK, 2003, J LEUKOCYTE BIOL, V73, P344, DOI 10.1189/jlb.0802401; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Ferroni P, 2012, ANTIOXID REDOX SIGN, V17, P1447, DOI 10.1089/ars.2011.4324; Fuseler JW, 2012, BIOMATERIALS, V33, P1032, DOI 10.1016/j.biomaterials.2011.10.029; Gross TJ, 2014, J IMMUNOL, V192, P2326, DOI 10.4049/jimmunol.1301758; Hanspal M, 1997, Curr Opin Hematol, V4, P142; HARBRECHT BG, 1995, SHOCK, V3, P79, DOI 10.1097/00024382-199503020-00001; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jun CD, 1996, CELL IMMUNOL, V174, P25, DOI 10.1006/cimm.1996.0290; Ke XC, 2001, BBA-MOL CELL RES, V1539, P101, DOI 10.1016/S0167-4889(01)00090-8; KUIJPERS TW, 1994, J IMMUNOL, V152, P5060; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Linder S, 2000, J CELL SCI, V113, P4165; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MacPherson M, 2011, J BIOL CHEM, V286, P17303, DOI 10.1074/jbc.M110.182998; Malu S, 2003, J IMMUNOL METHODS, V272, P55, DOI 10.1016/S0022-1759(02)00424-6; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; MATUSLEIBOVITCH N, 1993, CELL MOL NEUROBIOL, V13, P625, DOI 10.1007/BF00711562; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Norman MU, 2008, EUR J IMMUNOL, V38, P1368, DOI 10.1002/eji.200737847; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Ottenhoff THM, 1998, IMMUNOL TODAY, V19, P491, DOI 10.1016/S0167-5699(98)01321-8; PALLER AS, 1994, J AM ACAD DERMATOL, V31, P316, DOI 10.1016/S0190-9622(94)70162-8; Prasanna SJ, 2007, INT IMMUNOL, V19, P867, DOI 10.1093/intimm/dxm058; Rakshit S, 2014, BBA-MOL CELL RES, V1843, P2645, DOI 10.1016/j.bbamcr.2014.06.014; Raza MW, 1999, FEMS IMMUNOL MED MIC, V24, P387, DOI 10.1016/S0928-8244(99)00019-X; Roberts TL, 2005, J IMMUNOL, V175, P3569, DOI 10.4049/jimmunol.175.6.3569; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Russo E, 2013, J ENDOCRINOL INVEST, V36, P375, DOI 10.3275/8649; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Schwalm S, 2010, BRIT J PHARMACOL, V160, P1641, DOI 10.1111/j.1476-5381.2010.00818.x; Schwarz M, 2002, THROMB RES, V107, P121, DOI 10.1016/S0049-3848(02)00207-4; Soriano SG, 1999, STROKE, V30, P134, DOI 10.1161/01.STR.30.1.134; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Tamma Roberto, 2012, Inflammation & Allergy Drug Targets, V11, P196; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2013, J BIOL CHEM, V288, P4810, DOI 10.1074/jbc.M112.426353; Wahl SM, 1996, J LEUKOCYTE BIOL, V59, P789, DOI 10.1002/jlb.59.6.789; Wang XS, 2007, J INTERF CYTOK RES, V27, P329, DOI 10.1089/jir.2006.0154; Webb JL, 2001, INFECT IMMUN, V69, P6391, DOI 10.1128/IAI.69.10.6391-6400.2001; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie JM, 2013, IMMUNOL REV, V251, P65, DOI 10.1111/imr.12017	60	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128301	10.1371/journal.pone.0128301	http://dx.doi.org/10.1371/journal.pone.0128301			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029930	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900136
J	Cheng, Y; Qu, JF; Chen, Y; Zhao, MW; Li, XX				Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin			Anterior Segment Neovascularization in Diabetic Retinopathy: A Masquerade	PLOS ONE			English	Article							OCULAR ISCHEMIC SYNDROME; CAROTID-ENDARTERECTOMY; BLOOD-FLOW; ARTERY; CIRCULATION; STENOSIS; DISEASE; ORBIT; EYE	Purpose Anterior segment neovascularization (ASNV) could be a masquerade for ocular ischemic syndrome (OIS) in diabetic patients which misleads diagnosis and treatment. The purpose of our study is to find the relationship between blood flow velocity in carotid siphon and the development of ASNV in diabetic. Methods We reviewed 34 eyes of 17 diabetic patients who had Transcranial Color Doppler (TCD) examination with unilateral ASNV. The circulatory parameters of both eyes of each patient were compared and analyzed. In addition, 9 patients with more than 50% stenosis of extracranial internal carotid artery (ICA) and low velocity flow through TCD had been treated by carotid revascularization surgery. Results The maximal velocity in systole (Vmax) of carotid siphon (SCA) was lower in the eyes with ASNV than in the eyes without ASNV (P<0.05). ASNV of all the 9 patients regressed totally and BCVA improved significantly (P<0.05). Stenosis of ICA and arm-retina time (ART) decreased significantly (P<0.01) and SCA and ophthalmic artery (OA) increased significantly (P<0.01). Conclusions Our study showed ASNV could be a masquerade for OIS in patients with diabetic retinopathy. The decreased blood flow velocity in carotid siphon is related to the development of ASNV. Circulatory parameters screening of SCA by TCD is important to help us to evaluate the blood flow in SCA, the possibility of development of ASNV, and the prognosis of the patient. Interference such as carotid endarterectomy (CEA) or carotid artery stenting (CAS) can be performed if necessary to improve the blood flow in SCA and make ASNV regression.	[Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China	Peking University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com						Baumgartner RW, 2006, FRONT NEUROL NEUROSC, V21, P105, DOI 10.1159/000092393; Biller J, 1998, CIRCULATION, V97, P501; CARTER JE, 1985, STROKE, V16, P721, DOI 10.1161/01.STR.16.4.721; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Chen Celia S, 2007, Compr Ophthalmol Update, V8, P17; Dimitrova G, 2010, SURV OPHTHALMOL, V55, P193, DOI 10.1016/j.survophthal.2009.06.010; GOEBEL W, 1995, INVEST OPHTH VIS SCI, V36, P864; Hayreh SS, 2007, PROG RETIN EYE RES, V26, P470, DOI 10.1016/j.preteyeres.2007.06.001; Hazin R, 2009, CURR OPIN OPHTHALMOL, V20, P430, DOI 10.1097/ICU.0b013e3283313d38; HU HH, 1995, ACTA NEUROL SCAND, V92, P242; Ishikawa K, 2002, AM J OPHTHALMOL, V134, P295, DOI 10.1016/S0002-9394(02)01531-3; Kawaguchi S, 2001, NEUROSURGERY, V48, P328, DOI 10.1097/00006123-200102000-00016; Kawaguchi S, 2006, CEREBROVASC DIS, V22, P402, DOI 10.1159/000094859; Klein R, 2012, ARCH OPHTHALMOL-CHIC, V130, P749, DOI 10.1001/archophthalmol.2011.2560; Kodama A, 2010, CLIN OPHTHALMOL, V4, P1177, DOI 10.2147/OPTH.S13899; Lieb WE, 1998, RADIOL CLIN N AM, V36, P1059, DOI 10.1016/S0033-8389(05)70231-1; Mendrinos E, 2010, SURV OPHTHALMOL, V55, P2, DOI 10.1016/j.survophthal.2009.02.024; Miyajima Yoshiyasu, 2011, Rinsho Byori, V59, P1043; Mizener JB, 1997, OPHTHALMOLOGY, V104, P859, DOI 10.1016/S0161-6420(97)30221-8; Nagahara M, 2002, AM J OPHTHALMOL, V133, P270, DOI 10.1016/S0002-9394(01)01312-5; Nagaoka T, 2010, INVEST OPHTH VIS SCI, V51, P6729, DOI 10.1167/iovs.10-5364; Picard Francois, 2013, Rev Prat, V63, P759; Senn B C, 1996, Ger J Ophthalmol, V5, P386; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Terelak-Borys B, 2012, MED SCI MONITOR, V18, pRA138, DOI 10.12659/MSM.883260; Vandamme H, 2005, Rev Med Liege, V60, P737; Williamson TH, 1996, SURV OPHTHALMOL, V40, P255, DOI 10.1016/S0039-6257(96)82001-7	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0123627	10.1371/journal.pone.0123627	http://dx.doi.org/10.1371/journal.pone.0123627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029908	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900008
J	Chu, MP; Lieffers, J; Ghosh, S; Belch, AR; Chua, NS; Fontaine, A; Sangha, R; Turner, AR; Baracos, VE; Sawyer, MB				Chu, Michael P.; Lieffers, Jessica; Ghosh, Sunita; Belch, Andrew R.; Chua, Neil S.; Fontaine, Amelie; Sangha, Randeep; Turner, A. Robert; Baracos, Vickie E.; Sawyer, Michael B.			Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy	PLOS ONE			English	Article							INTERNATIONAL PROGNOSTIC INDEX; RANDOMIZED CONTROLLED-TRIAL; COMPUTED-TOMOGRAPHY; 1ST-LINE TREATMENT; ELDERLY-PATIENTS; CELL LYMPHOMAS; PLUS RITUXIMAB; OPEN-LABEL; CHEMOTHERAPY; CHOP	Skeletal muscle radio-density (SMD) measures muscle radiation attenuation (in Hounsfield Units, HU) on computed tomography (CT) scans. Low SMD is prognostic of poor survival in melanoma, however its significance is unknown for hematologic malignancies. We performed a single institution, retrospective review of all follicular lymphoma (FL) patients who received chemoimmunotherapy from 2004-2009. Patient demographics, FL International Prognostic Index 1 (FLIPI-1), progression free (PFS) and overall survival (OS) were collected as primary endpoints. Objective response rates (ORR) were secondary. SMD was calculated using pre-treatment CT scans. In 145 patients reviewed, median values were age 59, FLIPI-1 of 2, stage III, and 8 chemoimmunotherapy cycles received. Median PFS for those with low SMD (<36.6 and <33.1 HU for patients with BMI <= 25 and > 25 kg/m(2), respectively) compared to those with high SMD was profoundly worse, 69.6 vs. 106.7 months (hazard ratio [HR] 1.85; p = 0.01), respectively. Median OS was not reached in patients with high SMD vs. 92.7 months in low SMD patients (HR 4.02; p = 0.0002). Multivariate analysis supported lower SMD's OS detriment (HR = 3.40; p = 0.002) independent of FLIPI-1 (HR 1.46-2.76, p = 0.05) or gender. Low SMD predicted lower ORR, 83 vs. 96% (p = 0.01). SMD predicts survival independent of FLIPI-1 and potentially chemoimmunotherapy response. SMD is an inexpensive and powerful tool that can complement FLIPI-1.	[Chu, Michael P.; Lieffers, Jessica; Ghosh, Sunita; Belch, Andrew R.; Chua, Neil S.; Fontaine, Amelie; Sangha, Randeep; Turner, A. Robert; Baracos, Vickie E.; Sawyer, Michael B.] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada	University of Alberta	Sawyer, MB (corresponding author), Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada.	michael.sawyer@albertahealthservices.ca						Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Federico M, 2000, BLOOD, V95, P783; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Itchaki G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008909.pub2; Jager U, 2012, HAEMATOL-HEMATOL J, V97, P1431, DOI 10.3324/haematol.2011.059246; Lanic H, 2014, LEUKEMIA LYMPHOMA, V55, P817, DOI 10.3109/10428194.2013.816421; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Miljkovic I, 2011, METAB SYNDR RELAT D, V9, P319, DOI 10.1089/met.2010.0133; Miljkovic I, 2010, CURR OPIN CLIN NUTR, V13, P260, DOI 10.1097/MCO.0b013e328337d826; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Muller C, 2012, BLOOD, V119, P3276, DOI 10.1182/blood-2011-09-380949; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Riihijarvi S, 2011, EUR J HAEMATOL, V86, P124, DOI 10.1111/j.1600-0609.2010.01541.x; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Williams BA, 2006, TECHNICAL REPORT SER	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127589	10.1371/journal.pone.0127589	http://dx.doi.org/10.1371/journal.pone.0127589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030144	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900065
J	Huang, XJ; Deng, X; Xu, HB; Wu, S; Yuan, LM; Yang, ZJ; Yang, Y; Deng, H				Huang, Xiangjun; Deng, Xiong; Xu, Hongbo; Wu, Song; Yuan, Lamei; Yang, Zhijian; Yang, Yan; Deng, Hao			Identification of a Novel Mutation in the COL2A1 Gene in a Chinese Family with Spondyloepiphyseal Dysplasia Congenita	PLOS ONE			English	Article							PHENOTYPIC SPECTRUM; PROCOLLAGEN; EXPRESSION; PATIENT	Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominant chondrodysplasia characterized by disproportionate short-trunk dwarfism, skeletal and vertebral deformities. Exome sequencing and Sanger sequencing were performed in a Chinese Han family with typical SEDC, and a novel mutation, c.620G>A (p.Gly207Glu), in the collagen type II alpha-1 gene (COL2A1) was identified. The mutation may impair protein stability, and lead to dysfunction of type II collagen. Family-based study suggested that the mutation is a de novo mutation. Our study extends the mutation spectrum of SEDC and confirms genotype- phenotype relationship between mutations at glycine in the triple helix of the alpha-1 (II) chains of the COL2A1 and clinical findings of SEDC, which may be helpful in the genetic counseling of patients with SEDC.	[Huang, Xiangjun; Deng, Xiong; Xu, Hongbo; Yuan, Lamei; Yang, Zhijian; Yang, Yan; Deng, Hao] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China; [Wu, Song] Cent S Univ, Xiangya Hosp 3, Dept Orthoped, Changsha, Hunan, Peoples R China	Central South University; Central South University	Deng, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China.	hdeng008@yahoo.com	Yuan, Lamei/O-6331-2017; Deng, Hao/O-6340-2017	Yuan, Lamei/0000-0001-7558-0669; Deng, Hao/0000-0003-3240-4352	National Natural Science Foundation of China [81101339, 81001476, 81441033]; Natural Science Foundation of Hunan Province, China [10JJ4020, 10JJ5029]; Postgraduates Innovative Pilot Scheme of Hunan Province, China [7138000008]; Fundamental Research Funds for the Central Universities of Central South University [2014zzts368]; Construction Fund for Key Subjects of the Third Xiangya Hospital, Central South University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Postgraduates Innovative Pilot Scheme of Hunan Province, China; Fundamental Research Funds for the Central Universities of Central South University; Construction Fund for Key Subjects of the Third Xiangya Hospital, Central South University, China	This work was supported by National Natural Science Foundation of China (81101339, 81001476, 81441033); Natural Science Foundation of Hunan Province, China (10JJ4020, 10JJ5029); Postgraduates Innovative Pilot Scheme of Hunan Province (7138000008), China; Fundamental Research Funds for the Central Universities of Central South University (2014zzts368); and the Construction Fund for Key Subjects of the Third Xiangya Hospital, Central South University, China.	CHAN D, 1993, J BIOL CHEM, V268, P15238; Desir J, 2012, AM J MED GENET A, V158A, P1948, DOI 10.1002/ajmg.a.35301; FREISINGER P, 1994, J BIOL CHEM, V269, P13663; Guo Y, 2014, MOL BIOL REP, V41, P3631, DOI 10.1007/s11033-014-3227-1; Hoornaert KP, 2006, J MED GENET, V43, P406, DOI 10.1136/jmg.2005.035717; Husar-Memmer E, 2013, SEMIN ARTHRITIS RHEU, V42, P355, DOI 10.1016/j.semarthrit.2012.05.002; Jamieson SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002285; Jung SC, 2004, J PEDIATR ORTHOP B, V13, P63, DOI 10.1097/00009957-200403000-00001; Kannu P, 2012, J PAEDIATR CHILD H, V48, pE38, DOI 10.1111/j.1440-1754.2010.01979.x; Kozlowski K, 2004, AM J MED GENET A, V129A, P87, DOI 10.1002/ajmg.a.30132; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li S, 2014, JOINT BONE SPINE, V81, P86, DOI 10.1016/j.jbspin.2013.06.010; Mark PR, 2011, AM J MED GENET A, V155A, P174, DOI 10.1002/ajmg.a.33762; Nagendran S, 2012, AM J MED GENET A, V158A, P1204, DOI 10.1002/ajmg.a.35303; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; SPRANGER J, 1966, HELV PAEDIATR ACTA, V21, P598; STROM CM, 1984, NUCLEIC ACIDS RES, V12, P1025, DOI 10.1093/nar/12.2.1025; TILLER GE, 1995, AM J HUM GENET, V56, P388; Turner LM, 2010, FETAL PEDIATR PATHOL, V29, P57, DOI 10.3109/15513810903266310; Unger S, 2001, AM J MED GENET, V104, P140, DOI 10.1002/ajmg.10062; Veeravagu A, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.01.030; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289; Xia XY, 2008, CLIN CHIM ACTA, V387, P153, DOI 10.1016/j.cca.2007.09.006; Xiu XF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186048; Xu LL, 2014, EUR SPINE J, V23, pS271, DOI 10.1007/s00586-014-3292-0; Zhang L, 2012, MOL VIS, V18, P2114; Zhang Z, 2011, BIOCHEM BIOPH RES CO, V413, P504, DOI 10.1016/j.bbrc.2011.08.090	31	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127529	10.1371/journal.pone.0127529	http://dx.doi.org/10.1371/journal.pone.0127529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030151	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900057
J	Kinkel, S; Nadorf, J; Graage, JD; Jakubowitz, E; Kretzer, JP				Kinkel, Stefan; Nadorf, Jan; Graage, Jan Dennis; Jakubowitz, Eike; Kretzer, Jan Philippe			Primary Rotational Stability of Various Megaprostheses in a Biomechanical Sawbone Model with Proximal Femoral Defects Extending to the Isthmus	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; BONE INGROWTH; TUMOR ENDOPROSTHESES; CLASSIFICATION; IMPLANTS; STEM; REPLACEMENT; DESIGN; FEMUR; LOADS	Purpose Fixation of proximal femoral megaprostheses is achieved in the diaphyseal isthmus. We hypothesized that after extended bone resection including the proximal part of the isthmus a reduced length of fixation will affect the stability and fixation characteristics of these megaprostheses. The aim of this study was to analyze in a validated sawbone model with extended proximal femoral defects which types of implants have sufficient primary stability to allow osteointegration and to describe their fixation characteristics. Methods Four different cementless megaprostheses were implanted into 16 Sawbones with an AAOS type III defect after resection 11cm below the lesser trochanter involving the proximal isthmus. To determine the primary implant stability relative micromotions between bone and implant were measured in relation to a cyclic torque of 7Nm applied on the longitudinal axis of the implant. We determined the fixation characteristics of the different implant designs by comparing these relative micromotions along the longitudinal stem axis. Results In the tested sawbones all studied implants showed sufficient primary stability to admit bone integration with relative micromotions below 150 mu m after adapting our results to physiologic hip joint loadings. Different fixation characteristics of the megaprostheses were determined, which could be explained by their differing design and fixation concepts. Conclusions Cementless megaprostheses of different designs seem to provide sufficient primary stability to bridge proximal femoral defects if the diaphyseal isthmus is partially preserved. In our sawbone model the different implant fixation patterns can be related to their stem designs. No evidence can be provided to favor one of the studied implants in this setting. However, femoral morphology is variable and in different isthmus configurations specific implant designs might be appropriate to achieve the most favorable primary stability, which enables bone integration and consequently long term implant stability.	[Kinkel, Stefan; Nadorf, Jan; Graage, Jan Dennis; Kretzer, Jan Philippe] Univ Heidelberg Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany; [Jakubowitz, Eike] Hannover Med Sch, Dept Orthopaed Surg, Lab Biomech & Biomat, Hannover, Germany	Ruprecht Karls University Heidelberg; Hannover Medical School	Kinkel, S (corresponding author), Univ Heidelberg Hosp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany.	stefan.kinkel@med.uni-heidelberg.de			LINK GmbH; Deutsche Forschungsgemeinschaft; RuprechtKarls-Universitat Heidelberg	LINK GmbH; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); RuprechtKarls-Universitat Heidelberg	The work was partly funded through LINK GmbH (http://www.link-gmbh.com). LINK GmbH provided the tested implants but no further financial support. Therefore no grant number exists. The other tested implants were purchased from the manufacturers with an internal research budget of our biomechanical department. We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and RuprechtKarls-Universitat Heidelberg within the funding programme Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensmann G, 1990, Biomed Tech (Berl), V35 Suppl 3, P44; BERGMANN G, 1993, J BIOMECH, V26, P969, DOI 10.1016/0021-9290(93)90058-M; Bergmann G, 2010, BIO-MED MATER ENG, V20, P65, DOI 10.3233/BME-2010-0616; Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283; Bolognesi MP, 2004, J BONE JOINT SURG AM, V86A, P2720, DOI 10.2106/00004623-200412000-00020; Cristofolini L, 1996, J BIOMECH, V29, P525, DOI 10.1016/0021-9290(95)00084-4; DANTONIO J, 1993, CLIN ORTHOP RELAT R, P133; DUCHEYNE P, 1977, J BIOMED MATER RES, V11, P811, DOI 10.1002/jbm.820110603; ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45, DOI 10.1302/0301-620X.69B1.3818732; Gortz W, 2002, J BIOMECH ENG-T ASME, V124, P706, DOI 10.1115/1.1517565; Haddad FS, 1999, J BONE JOINT SURG AM, V81A, P1483, DOI 10.2106/00004623-199910000-00013; Heiner AD, 2001, J BIOMECH, V34, P773, DOI 10.1016/S0021-9290(01)00015-X; Heisel C, 2006, INT ORTHOP, V30, P452, DOI 10.1007/s00264-006-0207-7; Henderson ER, 2011, J BONE JOINT SURG AM, V93A, P418, DOI 10.2106/JBJS.J.00834; Ilyas I, 2002, INT ORTHOP, V26, P170, DOI 10.1007/s00264-002-0335-7; Jakubowitz E, 2008, J BIOMECH, V41, P3078, DOI 10.1016/j.jbiomech.2008.06.002; Jakubowitz E, 2011, CLIN BIOMECH, V26, P257, DOI 10.1016/j.clinbiomech.2010.11.004; Kinkel S, 2010, J SURG ONCOL, V101, P166, DOI 10.1002/jso.21441; Kinkel S, 2013, INT ORTHOP, V37, P1877, DOI 10.1007/s00264-013-2052-9; Laine HJ, 2000, J ARTHROPLASTY, V15, P86, DOI 10.1016/S0883-5403(00)91311-1; Merle C, 2014, J ORTHOP RES, V32, P413, DOI 10.1002/jor.22518; Mittermayer F, 2001, CLIN ORTHOP RELAT R, P167; Pepke W, 2014, INT ORTHOP, V38, P483, DOI 10.1007/s00264-013-2138-4; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; Shin DS, 1999, CLIN ORTHOP RELAT R, P53	25	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129149	10.1371/journal.pone.0129149	http://dx.doi.org/10.1371/journal.pone.0129149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030460	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900211
J	Palmer-Young, EC; Veit, D; Gershenzon, J; Schuman, MC				Palmer-Young, Evan C.; Veit, Daniel; Gershenzon, Jonathan; Schuman, Meredith C.			The Sesquiterpenes(E)-beta-Farnesene and (E)-alpha-Bergamotene Quench Ozone but Fail to Protect the Wild Tobacco Nicotiana attenuata from Ozone, UVB, and Drought Stresses	PLOS ONE			English	Article							ISOPRENE EMISSION; SESQUITERPENE EMISSIONS; VOLATILE EMISSIONS; PLANTS; THERMOTOLERANCE; BIOSYNTHESIS; LEAVES; TREES; HEAT; ARABIDOPSIS	Among the terpenes, isoprene (C-5) and monoterpene hydrocarbons (C-10) have been shown to ameliorate abiotic stress in a number of plant species via two proposed mechanisms: membrane stabilization and direct antioxidant effects. Sesquiterpene hydrocarbons (C-15) not only share the structural properties thought to lend protective qualities to isoprene and monoterpene hydrocarbons, but also react rapidly with ozone, suggesting that sesquiterpenes may similarly enhance tolerance of abiotic stresses. To test whether sesquiterpenes protect plants against ozone, UVB light, or drought, we used transgenic lines of the wild tobacco Nicotiana attenuata. The transgenic plants expressed a maize terpene synthase gene (ZmTPS10) which produced a blend of (E)-beta-farnesene and (E)-alpha-bergamotene, or a point mutant of the same gene (ZmTPS10M) which produced (E)-beta-farnesene alone,. (E)-beta-farnesene exerted a local, external, and transient ozone-quenching effect in ozone-fumigated chambers, but we found no evidence that enhanced sesquiterpene production by the plant inhibited oxidative damage, or maintained photosynthetic function or plant fitness under acute or chronic stress. Although the sesquiterpenes (E)-beta-farnesene and (E)-alpha-bergamotene might confer benefits under intermittent heat stress, which was not tested, any roles in relieving abiotic stress may be secondary to their previously demonstrated functions in biotic interactions.	[Palmer-Young, Evan C.; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany; [Veit, Daniel] Max Planck Inst Chem Ecol, Tech Serv, Jena, Germany; [Schuman, Meredith C.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Palmer-Young, EC (corresponding author), Univ Massachusetts, Organism & Evolutionary Biol Program, Amherst, MA 01003 USA.	epalmery@cns.umass.edu	Gershenzon, Jonathan/K-1331-2013; Palmer-Young, Evan/AFL-1225-2022; Schuman, Meredith C./A-5529-2013	Gershenzon, Jonathan/0000-0002-1812-1551; Palmer-Young, Evan/0000-0002-9258-2073; Schuman, Meredith C./0000-0003-3159-3534	Max Planck Society; International Max Planck Research School; National Science Foundation [S121000000211]; European Research Council [293926]	Max Planck Society(Max Planck SocietyFoundation CELLEX); International Max Planck Research School; National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Max Planck Society (http://www.mpg.de/en) (JG), by the International Max Planck Research School (http://www.mpg.de/en/imprs) (MCS), by the National Science Foundation Graduate Research Fellowship Program (http://www.nsf.gov/) (grant no. S121000000211 to EPY), and by the European Research Council (http://erc.europa.eu/, Clockwork Green advanced grant no. 293926 to Ian T. Baldwin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2009, PLANT PHYSIOL, V129, P269, DOI [10.1104/pp.010909.Plant, DOI 10.1104/PP.010909.PLANT]; Agelopoulos NG, 2000, J CHEM ECOL, V26, P497, DOI 10.1023/A:1005473825335; Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Arora A, 2002, CURR SCI INDIA, V82, P1227; Atkinson R, 2003, ATMOS ENVIRON, V37, pS197, DOI 10.1016/S1352-2310(03)00391-1; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Behnke K, 2010, PHOTOSYNTH RES, V104, P5, DOI 10.1007/s11120-010-9528-x; Behnke K, 2009, TREE PHYSIOL, V29, P725, DOI 10.1093/treephys/tpp009; Calogirou A, 1996, ANAL CHEM, V68, P1499, DOI 10.1021/ac950803i; Degen T, 2004, PLANT PHYSIOL, V135, P1928, DOI 10.1104/pp.104.039891; Duhl TR, 2008, BIOGEOSCIENCES, V5, P761, DOI 10.5194/bg-5-761-2008; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Frohnmeyer H, 2009, PLANT PHYSIOL, V133, P1420, DOI [10.1104/pp.103.030049.1420, DOI 10.1104/PP.103.030049.1420]; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Gase K, 2011, MOL ECOL RESOUR, V11, P890, DOI 10.1111/j.1755-0998.2011.03017.x; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Gregg JW, 2006, ECOL APPL, V16, P2368, DOI 10.1890/1051-0761(2006)016[2368:PADEOO]2.0.CO;2; Halitschke R, 2000, OECOLOGIA, V124, P408, DOI 10.1007/s004420000389; Hansen U, 1999, PHYS CHEM EARTH PT B, V24, P681, DOI 10.1016/S1464-1909(99)00065-9; Heath RL, 2008, ENVIRON POLLUT, V155, P453, DOI 10.1016/j.envpol.2008.03.010; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Helmig D, 2007, ENVIRON SCI TECHNOL, V41, P1545, DOI 10.1021/es0618907; Helmig D, 2006, ATMOS ENVIRON, V40, P4150, DOI 10.1016/j.atmosenv.2006.02.035; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kollner TG, 2009, PHYTOCHEMISTRY, V70, P1139, DOI 10.1016/j.phytochem.2009.06.011; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; Kourtchev I, 2009, ATMOS ENVIRON, V43, P3182, DOI 10.1016/j.atmosenv.2009.03.048; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lavoir AV, 2009, BIOGEOSCI DISC, V6, P863, DOI DOI 10.5194/BGD-6-863-2009; Logan BA, 1999, PLANT BIOLOGY, V1, P602, DOI 10.1111/j.1438-8677.1999.tb00269.x; Logan BA, 1999, PLANT PHYSIOL, V120, P821, DOI 10.1104/pp.120.3.821; Loivamaki M, 2007, PLANT PHYSIOL, V144, P1066, DOI 10.1104/pp.107.098509; Loreto F, 1998, PLANT CELL ENVIRON, V21, P101, DOI 10.1046/j.1365-3040.1998.00268.x; Loreto F, 2001, PLANT PHYSIOL, V126, P993, DOI 10.1104/pp.126.3.993; Loreto F, 2004, TREE PHYSIOL, V24, P361, DOI 10.1093/treephys/24.4.361; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Niinemets U, 2002, PLANT PHYSIOL, V130, P1371, DOI 10.1104/pp.009670; Pandey SP, 2008, PLANT J, V54, P845, DOI 10.1111/j.1365-313X.2008.03450.x; Pasqualini S, 2003, PLANT PHYSIOL, V133, P1122, DOI 10.1104/pp.103.026591; Penuelas J, 2005, PLANT CELL ENVIRON, V28, P278, DOI 10.1111/j.1365-3040.2004.01250.x; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Riedel T, 2008, PLANT CELL ENVIRON, V31, P1203, DOI 10.1111/j.1365-3040.2008.01827.x; Rivoal A, 2010, CHEMOSPHERE, V78, P942, DOI 10.1016/j.chemosphere.2009.12.047; Sasaki K, 2007, PLANT CELL PHYSIOL, V48, P1254, DOI 10.1093/pcp/pcm104; Schmelz EA, 2001, PLANTA, V214, P171, DOI 10.1007/s004250100603; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Schnitzler JP, 2010, PLANT BIOLOGY, V12, P302, DOI 10.1111/j.1438-8677.2009.00284.x; Schnitzler JP, 2004, PLANT PHYSIOL, V135, P152, DOI 10.1104/pp.103.037374; Schuman MC, ELIFE IN PRESS; Schuman MC, 2014, PLANT PHYSIOL, V166, P779, DOI 10.1104/pp.114.247130; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; Sharkey TD, 2001, PLANT PHYSIOL, V125, P2001, DOI 10.1104/pp.125.4.2001; Sharkey TD, 1996, TREE PHYSIOL, V16, P649; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; SHU YG, 1994, INT J CHEM KINET, V26, P1193, DOI 10.1002/kin.550261207; Siwko ME, 2007, BBA-BIOMEMBRANES, V1768, P198, DOI 10.1016/j.bbamem.2006.09.023; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Tsarouhas V, 2000, BIOMASS BIOENERG, V19, P165, DOI 10.1016/S0961-9534(00)00030-1; Velikova V, 2005, PLANT CELL ENVIRON, V28, P318, DOI 10.1111/j.1365-3040.2004.01314.x; Velikova V, 2011, PLANT PHYSIOL, V157, P905, DOI 10.1104/pp.111.182519; Vickers CE, 2009, PLANT CELL ENVIRON, V32, P520, DOI 10.1111/j.1365-3040.2009.01946.x; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; Wang L, 2007, PLANTA, V226, P159, DOI 10.1007/s00425-007-0477-3; Young-Pyo L, 2007, PLANT CELL REP, V26, P591, DOI 10.1007/s00299-006-0253-z	70	29	31	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127296	10.1371/journal.pone.0127296	http://dx.doi.org/10.1371/journal.pone.0127296			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030663	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900044
J	Soto, MCR				Ramirez Soto, Max Carlos			Sporotrichosis: The Story of an Endemic Region in Peru over 28 Years (1985 to 2012)	PLOS ONE			English	Article							RIO-DE-JANEIRO; CUTANEOUS SPOROTRICHOSIS; CATS	Background Abancay province is a long-standing geographical focus of sporotrichosis in the south central highlands of Peru. Therefore, we examined the features of 36 newly identified cases of sporotrichosis from two hospital centers in Abancay province. We also performed a literature review of studies conducted in this endemic geographical focus over a period of 28 years (1998 to 2012), and analyzed the demographic, clinical and epidemiological features of sporotrichosis in the cases reported in these studies. Methodology We examined the features of 36 new cases of sporotrichosis identified from two hospital centers in Abancay. Furthermore, we searched for relevant studies of cases of sporotrichosis in the endemic region using healthcare databases and literature sources. We analyzed a detailed subset of data on cases collected in Abancay, neighboring provinces, and other regions of Peru. Results A total of nine studies were identified, with 1467 cases included in the final analysis. We also analyzed 36 new cases found in the two hospital centers. Therefore, the combined total of cases analyzed was 1503. Of this total, 58% were male, and approximately 62% were aged <= 14 years. As expected, most cases were from Abancay province (88%), although 12% were from neighboring provinces and other regions of Peru. The lymphocutaneous form (939 cases) was the commonest. The face was the most commonly affected region (647 cases). A total of 1224 patients (81.4%) received treatment: 95.8% received potassium iodide, 2.6% ketoconazole and 1.6% itraconazole. The overall success rates were 60.7% with potassium iodide, 32.2% with ketoconazole and 85% with itraconazole. Conclusions The epidemic of sporotrichosis has been occurring for three decades in the province of Abancay in Peru. This mycosis affects primarily the pediatric population, with predominantly the lymphocutaneous form in the facial region. Although treatment with potassium iodide is safe and effective, response and adherence to treatment are influenced by its duration, cost, accessibility, and side effects.	[Ramirez Soto, Max Carlos] Hosp Reg Guillermo Diaz de la Vega, Clin Pathol Serv, Abancay, Peru; [Ramirez Soto, Max Carlos] Santa Teresa Clin, Clin Pathol Serv, Abancay, Peru		Soto, MCR (corresponding author), Hosp Reg Guillermo Diaz de la Vega, Clin Pathol Serv, Abancay, Peru.	maxcrs22@gmail.com	Ramírez-Soto, Max Carlos BSc, MPH, FRSPH, MACE/O-7824-2018	Ramírez-Soto, Max Carlos BSc, MPH, FRSPH, MACE/0000-0003-0471-6746				Aguilera S, 2005, AN PEDIAT BARC S2, V62, P1; Al-Tawfiq JA, 1998, CLIN INFECT DIS, V26, P1403, DOI 10.1086/516356; Arenas R, 2008, MICOLOGIA MED ILUSTR, P149; Barros MBD, 2003, INT J DERMATOL, V42, P677, DOI 10.1046/j.1365-4362.2003.01813.x; Bunce PE, 2012, MED MYCOL, V50, P197, DOI 10.3109/13693786.2011.584074; Cabezas C, 1996, PEDIATR INFECT DIS J, V15, P352, DOI 10.1097/00006454-199604000-00014; Barros MBD, 2011, CLIN INFECT DIS, V52, pE200, DOI 10.1093/cid/cir245; Barros MBD, 2010, REV PANAM SALUD PUBL, V27, P455; Flores A, 1991, REV PERU EPIDEMIOL, V4, P5; Garcia M, 2004, DERMATOL PERU, V14, P104; Garcia R, 1998, FOLIA DERMATOL PERU, V9, P59; GELDRES JJ, 1973, MYCOPATH MYCOL APPL, V51, P33, DOI 10.1007/BF02141284; Ghosh A, 1999, T ROY SOC TROP MED H, V93, P41, DOI 10.1016/S0035-9203(99)90173-6; Holechek Susan, 2004, Rev. perú. med. exp. salud publica, V21, P87; INEI, 2008, CENS NAC 2007 11 POB; Kovarik CL, 2008, MED MYCOL, V46, P53, DOI 10.1080/13693780701567481; Lyon GM, 2003, CLIN INFECT DIS, V36, P34, DOI 10.1086/345437; Marimon R, 2008, MED MYCOL, V46, P621, DOI 10.1080/13693780801992837; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; Meneses G, 1991, 5 PAN AM C INF DIS 7; Meneses G, 1992, BOL SOC PERU MED INT, V5, P2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Pappas PG, 2000, CLIN INFECT DIS, V30, P65, DOI 10.1086/313607; Ramirez-Soto M., 2012, Revista Peruana de Epidemiologia, V16, P121; Ramirez-Soto M, 2013, REV CHIL INFECTOL, V30, P548, DOI 10.4067/S0716-10182013000500013; Santa Teresa Medical Center, 1985, PAT REG REP 1985; Freitas DFS, 2012, MED MYCOL, V50, P170, DOI 10.3109/13693786.2011.596288; Freitas DFS, 2010, CLIN INFECT DIS, V50, DOI 10.1086/649891; Servicio Nacional de Metereologia e Hidrologia (SENAMHI), 2012, CAR CLIM REG CUSC AP; Verma S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001673	30	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127924	10.1371/journal.pone.0127924	http://dx.doi.org/10.1371/journal.pone.0127924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030742	gold, Green Published			2022-12-27	WOS:000356630900093
J	Wang, Y; Ding, H; Stell, WK; Liu, LP; Li, SQ; Liu, HS; Zhong, XW				Wang, Yong; Ding, Hui; Stell, William K.; Liu, Liangping; Li, Saiqun; Liu, Hongshan; Zhong, Xingwu			Exposure to Sunlight Reduces the Risk of Myopia in Rhesus Monkeys	PLOS ONE			English	Article							FORM-DEPRIVATION MYOPIA; LENS-INDUCED MYOPIA; REFRACTIVE DEVELOPMENT; EYE-GROWTH; OUTDOOR ACTIVITY; CHROMATIC ABERRATION; OPTICAL DEFOCUS; INFANT MONKEYS; TREE SHREWS; CHICK EYES	Exposure to sunlight has recently been postulated as responsible for the effect that more time spent outdoors protects children from myopia, while early life exposure to natural light was reported to be possibly related to onset of myopia during childhood. In this study, we had two aims: to determine whether increasing natural light exposure has a protective effect on hyperopic defocus-induced myopia, and to observe whether early postnatal exposure to natural light causes increased risk of refractive error in adolescence. Eight rhesus monkeys (aged 20-30 days) were treated monocularly with hyperopic-defocus (-3.0D lens) and divided randomly into two groups: AL group (n=4), reared under Artificial (indoor) Lighting (08: 0020: 00); and NL group (n=4), exposed to Natural (outdoor) Light for 3 hours per day (11: 0014: 00), and to indoor lighting for the rest of the light phase. After being reared with lenses for ca. 190 days, all monkeys were returned to unrestricted vision until the age of 3 years. Another eight age-matched monkeys, reared with unrestricted vision under artificial lighting since birth, were employed as controls. The ocular refraction, corneal curvature and axial dimensions were measured before lens-wearing (at 23 +/- 3 days of age), monthly during the light phase, and at the age of puberty (at 1185+3 days of age). During the lens-wearing treatment, infant monkeys in the NL group were more hyperopic than those in the AL group (F=5.726, P=0.032). Furthermore, the two eyes of most NL monkeys remained isometropic, whereas 3 of 4 AL monkeys developed myopic anisometropia more than -2.0D. At adolescence, eyes of AL monkeys showed significant myopic anisometropia compared with eyes of NL monkeys (AL vs NL: -1.66 +/- 0.87D vs -0.22 +/- 0.44D; P=0.002) and controls (AL vs Control: -1.66 +/- 0.87D vs -0.05 +/- 0.85D; P<0.0001). All differences in refraction were associated with parallel changes in axial dimensions. Our results suggest that exposure to natural outdoor light might have an effect to reduced hyperopic defocus-induced myopia. Also, the data imply that early life exposure to sunlight may help to maintain normal development of emmetropization later in life, and thus lower the risk of myopic anisometropia in adolescent monkey.	[Wang, Yong; Ding, Hui; Liu, Liangping; Li, Saiqun; Zhong, Xingwu] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yong; Ding, Hui; Liu, Liangping; Li, Saiqun; Zhong, Xingwu] Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Ding, Hui; Liu, Hongshan; Zhong, Xingwu] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Hainan Eye Hosp, Haikou, Hainan Province, Peoples R China; [Stell, William K.] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Stell, William K.] Univ Calgary, Cumming Sch Med, Dept Surg, Calgary, AB, Canada	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Calgary; University of Calgary	Zhong, XW (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhongxwu@mail.sysu.edu.cn		liangping, Liu/0000-0002-8041-0741	National Natural Science Foundation of China [81371046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81371046).	Amedo AO, 2012, OPHTHAL PHYSL OPT, V32, P89, DOI 10.1111/j.1475-1313.2011.00875.x; Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P5247, DOI 10.1167/iovs.09-4689; Beuerman RW, 2010, MYOPIA ANIMAL MODELS; Bradley DV, 1999, VISION RES, V39, P1749, DOI 10.1016/S0042-6989(98)00177-1; Chia A, 2008, CLIN EXP OPHTHALMOL, V36, P464, DOI 10.1111/j.1442-9071.2008.01799.x; Cho P, 2005, CURR EYE RES, V30, P71, DOI 10.1080/02713680590907256; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Cohen Y, 2011, EXP EYE RES, V92, P40, DOI 10.1016/j.exer.2010.10.012; Deng L, 2011, OPTOMETRY VISION SCI, V88, P383, DOI 10.1097/OPX.0b013e31820b0517; Diether S, 1997, VISION RES, V37, P659, DOI 10.1016/S0042-6989(96)00224-6; Foulds WS, 2013, INVEST OPHTH VIS SCI, V54, P8004, DOI 10.1167/iovs.13-12476; Graham B, 1999, VISION RES, V39, P189, DOI 10.1016/S0042-6989(98)00189-8; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; HARWERTH RS, 1986, SCIENCE, V232, P235, DOI 10.1126/science.3952507; HOOGERHEIDE J, 1971, OPHTHALMOLOGICA, V163, P209, DOI 10.1159/000306646; Jiang LQ, 2014, VISION RES, V94, P24, DOI 10.1016/j.visres.2013.10.020; Kroger RHH, 2000, BRIT J OPHTHALMOL, V84, P890, DOI 10.1136/bjo.84.8.890; Kroger RHH, 1996, J COMP PHYSIOL A, V179, P837; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Mandel Y, 2008, OPHTHALMOLOGY, V115, P686, DOI 10.1016/j.ophtha.2007.05.040; McMahon G, 2009, OPHTHALMOLOGY, V116, P468, DOI 10.1016/j.ophtha.2008.10.004; Michaelides M, 2005, EYE, V19, P2, DOI 10.1038/sj.eye.6701391; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ngo C, 2013, OPHTHAL PHYSL OPT, V33, P368, DOI 10.1111/opo.12051; Parssinen O, 2012, ACTA OPHTHALMOL, V90, P497, DOI 10.1111/j.1755-3768.2011.02210.x; Qian YS, 2009, INVEST OPHTH VIS SCI, V50, P1598, DOI 10.1167/iovs.07-1362; Qiao-Grider Y, 2004, INVEST OPHTH VIS SCI, V45, P3361, DOI 10.1167/iovs.04-0080; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Rovamo JM, 1999, VISION RES, V39, P2387, DOI 10.1016/S0042-6989(98)00273-9; Rucker FJ, 2012, J VISION, V12, DOI 10.1167/12.6.23; Rucker FJ, 2009, VISION RES, V49, P1775, DOI 10.1016/j.visres.2009.04.014; SCHAEFFEL F, 1991, VISION RES, V31, P717, DOI 10.1016/0042-6989(91)90011-S; Schwahn HN, 1997, VISION RES, V37, P2661, DOI 10.1016/S0042-6989(97)00114-4; Shaikh AW, 1999, OPTOMETRY VISION SCI, V76, P308, DOI 10.1097/00006324-199905000-00019; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Siegwart JT, 2012, ARVO M ABSTR INV OPH, V53, P3457; Smith EL, 2007, INVEST OPHTH VIS SCI, V48, P3914, DOI 10.1167/iovs.06-1264; Smith EL, 2013, INVEST OPHTH VIS SCI, V54, P2959, DOI 10.1167/iovs.13-11713; Smith EL, 2012, INVEST OPHTH VIS SCI, V53, P421, DOI 10.1167/iovs.11-8652; Smith EL, 2010, INVEST OPHTH VIS SCI, V51, P3864, DOI 10.1167/iovs.09-4969; Smith EL, 2002, INVEST OPHTH VIS SCI, V43, P291; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; Stell WK DH, 2013, INT MYOP C IMC 2013, P28; Tepelus TC, 2012, VISION RES, V54, P12, DOI 10.1016/j.visres.2011.11.014; Tepelus TC, 2010, VISION RES, V50, P57, DOI 10.1016/j.visres.2009.10.006; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI DOI 10.1001/ARCH0PHTHALM0L.2009.303; Weiss A H, 1989, J Pediatr Ophthalmol Strabismus, V26, P218; Wildsoet CE, 2003, CURR EYE RES, V27, P371, DOI 10.1076/ceyr.27.6.371.18188; Wildsoet CF, 2000, VISION RES, V40, P3273, DOI 10.1016/S0042-6989(00)00138-3; Winawer J, 2002, VISION RES, V42, P2651, DOI 10.1016/S0042-6989(02)00300-0; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P3806, DOI 10.1167/iovs.03-0326; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P3373, DOI 10.1167/iovs.04-0226; Zhu XY, 2009, INVEST OPHTH VIS SCI, V50, P37, DOI 10.1167/iovs.08-2102	59	34	39	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127863	10.1371/journal.pone.0127863	http://dx.doi.org/10.1371/journal.pone.0127863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030845	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900086
J	Weber, CS; Hainz, K; Deressa, T; Strandt, H; Pinheiro, DF; Mittermair, R; Pesado, JP; Thalhamer, J; Hammerl, P; Stoecklinger, A				Weber, Corinna Stefanie; Hainz, Katrina; Deressa, Tekalign; Strandt, Helen; Pinheiro, Douglas Florindo; Mittermair, Roberta; Pesado, Jennifer Pizarro; Thalhamer, Josef; Hammerl, Peter; Stoecklinger, Angelika			Immune Reactions against Gene Gun Vaccines Are Differentially Modulated by Distinct Dendritic Cell Subsets in the Skin	PLOS ONE			English	Article							EPIDERMAL LANGERHANS CELLS; REGULATORY T-CELLS; CONTACT HYPERSENSITIVITY; IN-VIVO; CUTTING EDGE; ANTIGENS; RESPONSES; ABLATION; PROTEIN; IDENTIFICATION	The skin accommodates multiple dendritic cell (DC) subsets with remarkable functional diversity. Immune reactions are initiated and modulated by the triggering of DC by pathogen-associated or endogenous danger signals. In contrast to these processes, the influence of intrinsic features of protein antigens on the strength and type of immune responses is much less understood. Therefore, we investigated the involvement of distinct DC subsets in immune reactions against two structurally different model antigens, E. coli beta-galactosidase (betaGal) and chicken ovalbumin (OVA) under otherwise identical conditions. After epicutaneous administration of the respective DNA vaccines with a gene gun, wild type mice induced robust immune responses against both antigens. However, ablation of langerin(+) DC almost abolished IgG1 and cytotoxic T lymphocytes against betaGal but enhanced T cell and antibody responses against OVA. We identified epidermal Langerhans cells (LC) as the subset responsible for the suppression of anti-OVA reactions and found regulatory T cells critically involved in this process. In contrast, reactions against betaGal were not affected by the selective elimination of LC, indicating that this antigen required a different langerin(+) DC subset. The opposing findings obtained with OVA and betaGal vaccines were not due to immune-modulating activities of either the plasmid DNA or the antigen gene products, nor did the differential cellular localization, size or dose of the two proteins account for the opposite effects. Thus, skin-borne protein antigens may be differentially handled by distinct DC subsets, and, in this way, intrinsic features of the antigen can participate in immune modulation.	[Weber, Corinna Stefanie; Hainz, Katrina; Deressa, Tekalign; Strandt, Helen; Pinheiro, Douglas Florindo; Mittermair, Roberta; Pesado, Jennifer Pizarro; Thalhamer, Josef; Hammerl, Peter; Stoecklinger, Angelika] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Hammerl, Peter] Salzburg Univ, Cent Anim Labs, A-5020 Salzburg, Austria; [Stoecklinger, Angelika] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria	Salzburg University; Salzburg University; Salzburg University	Stoecklinger, A (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	angelika.stoecklinger@sbg.ac.at	Stoecklinger, Angelika/C-7616-2016; Thalhamer, Josef/E-5787-2011; Florindo-Pinheiro, Douglas/G-8397-2016	Stoecklinger, Angelika/0000-0002-0351-8142; Thalhamer, Josef/0000-0003-2285-6400; Florindo-Pinheiro, Douglas/0000-0003-1051-0306; Strandt, Helen/0000-0002-1488-1633	Christian Doppler Research Association (CDG); Austrian Science Fund (FWF) [P25243-B22, W1213]	Christian Doppler Research Association (CDG); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work was supported by Christian Doppler Research Association (CDG) and Austrian Science Fund (FWF), projects #P25243-B22 and #W1213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, BLOOD DERIVED DERMAL; Bachy V, 2013, P NATL ACAD SCI USA, V110, P3041, DOI 10.1073/pnas.1214449110; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Brtko J, 1999, MOL CELL ENDOCRINOL, V152, P85, DOI 10.1016/S0303-7207(99)00054-4; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Byers AM, 2003, J IMMUNOL, V171, P17, DOI 10.4049/jimmunol.171.1.17; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Deressa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102280; Ettinger M, 2012, J INVEST DERMATOL, V132, P1665, DOI 10.1038/jid.2012.19; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gratz IK, 2014, J IMMUNOL, V192, P1351, DOI 10.4049/jimmunol.1301777; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Henri S, 2010, IMMUNOL CELL BIOL, V88, P366, DOI 10.1038/icb.2010.34; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kautz-Neu K, 2011, J EXP MED, V208, P885, DOI 10.1084/jem.20102318; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Nizza ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091054; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Ohkuri T, 2010, J IMMUNOL, V185, P4199, DOI 10.4049/jimmunol.0902249; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Stoecklinger A, 2007, J IMMUNOL, V179, P886, DOI 10.4049/jimmunol.179.2.886; Stoecklinger A, 2011, J IMMUNOL, V186, P1377, DOI 10.4049/jimmunol.1002557; TABE L, 1984, J MOL BIOL, V180, P645, DOI 10.1016/0022-2836(84)90031-7; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; van der Aar AMG, 2013, J INVEST DERMATOL, V133, P1240, DOI 10.1038/jid.2012.500	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128722	10.1371/journal.pone.0128722	http://dx.doi.org/10.1371/journal.pone.0128722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030383	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900187
J	Fan, T; Li, XM; Yang, W; Xia, KF; Jie, OY; Zhang, MY				Fan, Tian; Li, Xiumei; Yang, Wu; Xia, Kuaifei; Jie Ouyang; Zhang, Mingyong			Rice osa-miR171c Mediates Phase Change from Vegetative to Reproductive Development and Shoot Apical Meristem Maintenance by Repressing Four OsHAM Transcription Factors	PLOS ONE			English	Article							GRAS GENE FAMILY; FUNCTIONAL DIVERSIFICATION; OVER-EXPRESSION; PLANT MICRORNAS; FLORAL MERISTEM; JUVENILE-ADULT; PHYTOCHROME-C; SMALL RNAS; ARABIDOPSIS; ORTHOLOG	Phase change from vegetative to reproductive development is one of the critical developmental steps in plants, and it is regulated by both environmental and endogenous factors. The maintenance of shoot apical meristem (SAM) identity, miRNAs and flowering integrators are involved in this phase change process. Here, we report that the miRNA osa-miR171c targets four GRAS (GAI-RGA-SCR) plant-specific transcription factors (OsHAM1, OsHAM2, OsHAM3, and OsHAM4) to control the floral transition and maintenance of SAM indeterminacy in rice (Oryza sativa). We characterized a rice T-DNA insertion delayed heading (dh) mutant, where the expression of OsMIR171c gene is up-regulated. This mutant showed pleiotropic phenotypic defects, including especially prolonged vegetative phase, delayed heading date, and bigger shoot apex. Parallel expression analysis showed that osa-miR171c controlled the expression change of four OsHAMs in the shoot apex during floral transition, and responded to light. In the dh mutant, the expression of the juvenile-adult phase change negative regulator osa-miR156 was up-regulated, expression of the flowering integrators Hd3a and RFT1 was inhibited, and expression of FON4 negative regulators involved in the maintenance of SAM indeterminacy was also inhibited. From these data, we propose that the inhibition of osa-miR171c-mediated OsHAM transcription factors regulates the phase transition from vegetative to reproductive development by maintaining SAM indeterminacy and inhibiting flowering integrators.	[Fan, Tian; Yang, Wu; Xia, Kuaifei; Zhang, Mingyong] Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou, Guangdong, Peoples R China; [Fan, Tian; Yang, Wu; Xia, Kuaifei; Zhang, Mingyong] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, Guangzhou, Guangdong, Peoples R China; [Fan, Tian; Li, Xiumei; Yang, Wu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Xiumei] Chinese Acad Sci, Suth China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Jie Ouyang] Chongqing Acad Agr Sci, Rice Inst, Chongqing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Zhang, MY (corresponding author), Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou, Guangdong, Peoples R China.	zhangmy@scbg.ac.cn	Zhang, Mingyong/GQZ-6217-2022; li, xiu/GXV-1745-2022		National Science Foundation of China [31272240/31371604]; Natural Science Foundation of Guangdong [S2013020012830]; South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	This work was supported by the National Science Foundation of China (31272240/31371604), the Natural Science Foundation of Guangdong (S2013020012830), and South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund.	Asai K, 2002, DEVELOPMENT, V129, P265; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chu HW, 2006, PLANT PHYSIOL, V142, P1039, DOI 10.1104/pp.106.086736; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Day RB, 2004, PLANT MOL BIOL, V54, P261, DOI 10.1023/B:PLAN.0000028792.72343.ee; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Engstrom EM, 2012, PLANT SIGNAL BEHAV, V7, P227, DOI 10.4161/psb.18958; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; Ikeda-Kawakatsu K, 2012, PLANT J, V69, P168, DOI 10.1111/j.1365-313X.2011.04781.x; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Li WF, 2014, TREE GENET GENOMES, V10, P223, DOI 10.1007/s11295-013-0668-y; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu XY, 2008, BIOCHEM BIOPH RES CO, V368, P458, DOI 10.1016/j.bbrc.2008.02.007; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; Mu CS, 2005, PLANT PROD SCI, V8, P51, DOI 10.1626/pps.8.51; Nelson T, 1997, PLANT CELL, V9, P1121, DOI 10.1105/tpc.9.7.1121; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; Ohmori Y, 2013, PLANT CELL, V25, P229, DOI 10.1105/tpc.112.103432; Okano Y, 2008, PLANT J, V53, P65, DOI 10.1111/j.1365-313X.2007.03313.x; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Sablowski R, 2011, CURR OPIN PLANT BIOL, V14, P4, DOI 10.1016/j.pbi.2010.08.001; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Song CNA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010861; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Suzaki T, 2004, DEVELOPMENT, V131, P5649, DOI 10.1242/dev.01441; Suzaki T, 2008, PLANT CELL, V20, P2049, DOI 10.1105/tpc.107.057257; Suzaki T, 2006, PLANT CELL PHYSIOL, V47, P1591, DOI 10.1093/pcp/pcl025; Tabuchi H, 2011, PLANT CELL, V23, P3276, DOI 10.1105/tpc.111.088765; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Tsuda K, 2011, PLANT CELL, V23, P4368, DOI 10.1105/tpc.111.090050; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xue XY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004266; Yokota K, 2010, PLANT CELL PHYSIOL, V51, P1436, DOI 10.1093/pcp/pcq124; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yoshida A, 2012, PLANT J, V70, P327, DOI 10.1111/j.1365-313X.2011.04872.x; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	79	51	55	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125833	10.1371/journal.pone.0125833	http://dx.doi.org/10.1371/journal.pone.0125833			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023934	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400011
J	Hu, CH; Cheng, L; Sepulcre, J; Johnson, KA; Fakhri, GE; Lu, M; Li, QZ				Hu, Chenhui; Cheng, Lin; Sepulcre, Jorge; Johnson, Keith A.; Fakhri, Georges E.; Lu, M.; Li, Quanzheng			A Spectral Graph Regression Model for Learning Brain Connectivity of Alzheimer's Disease	PLOS ONE			English	Article							CORTICAL HUBS; NETWORK; ORGANIZATION; DEMENTIA; PET	Understanding network features of brain pathology is essential to reveal underpinnings of neurodegenerative diseases. In this paper, we introduce a novel graph regression model (GRM) for learning structural brain connectivity of Alzheimer's disease (AD) measured by amyloid-beta deposits. The proposed GRM regards C-11-labeled Pittsburgh Compound-B (PiB) positron emission tomography (PET) imaging data as smooth signals defined on an unknown graph. This graph is then estimated through an optimization framework, which fits the graph to the data with an adjustable level of uniformity of the connection weights. Under the assumed data model, results based on simulated data illustrate that our approach can accurately reconstruct the underlying network, often with better reconstruction than those obtained by both sample correlation and l1-regularized partial correlation estimation. Evaluations performed upon PiB-PET imaging data of 30 AD and 40 elderly normal control (NC) subjects demonstrate that the connectivity patterns revealed by the GRM are easy to interpret and consistent with known pathology. Moreover, the hubs of the reconstructed networks match the cortical hubs given by functional MRI. The discriminative network features including both global connectivity measurements and degree statistics of specific nodes discovered from the AD and NC amyloid-beta networks provide new potential biomarkers for preclinical and clinical AD.	[Hu, Chenhui; Lu, M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Cheng, Lin] Trinity Coll, Dept Engn, Hartford, CT 06106 USA; [Sepulcre, Jorge; Johnson, Keith A.] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA; [Fakhri, Georges E.; Li, Quanzheng] Massachusetts Gen Hosp, Ctr Adv Med Imaging Sci, Div Nucl Med & Mol Imaging, Dept Radiol, Boston, MA 02114 USA	Harvard University; Trinity College; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Li, QZ (corresponding author), Massachusetts Gen Hosp, Ctr Adv Med Imaging Sci, Div Nucl Med & Mol Imaging, Dept Radiol, Boston, MA 02114 USA.	Li.Quanzheng@mgh.harvard.edu	Sepulcre, Jorge/ABE-6375-2020	Sepulcre, Jorge/0000-0002-4199-2304	National Institutes of Health [R01EB013293, 1K23EB19023-01]; National Institute on Aging [P01AG036694, R01AG034556, R01AG037497]; Alzheimer's Association Zenith Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K23EB019023, R01EB013293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034556, P01AG036694, R01AG037497, P50AG005134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association Zenith Award(Alzheimer's Association); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the National Institutes of Health (R01EB013293 and 1K23EB19023-01), the National Institute on Aging Grants (P01AG036694, R01AG034556, and R01AG037497), and the Alzheimer's Association Zenith Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Agaskar A, 2013, IEEE T INFORM THEORY, V59, P4338, DOI 10.1109/TIT.2013.2252233; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; [Anonymous], 1992, NEURODEGENERATION; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Boyd S., 2004, CONVEX OPTIMIZATION; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; CALAMAI PH, 1987, MATH PROGRAM, V39, P93, DOI 10.1007/BF02592073; Cover T. M., 1991, ELEMENTS INFORM THEO; Drzezga A, 2011, BRAIN, V134, P1635, DOI 10.1093/brain/awr066; Fan RK, 1997, SPECTRAL GRAPH THEOR, V92; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Golub GH, 1999, SIAM J MATRIX ANAL A, V21, P185, DOI 10.1137/S0895479897326432; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hu C, 2013, P INT S BIOM IM; Huang SA, 2010, NEUROIMAGE, V50, P935, DOI 10.1016/j.neuroimage.2009.12.120; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lee H, 2011, IEEE T MED IMAGING, V30, P1154, DOI 10.1109/TMI.2011.2140380; Manning C. D., 2008, INTRO INFORM RETRIEV, V1; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Mathis CA, 2002, BIOORG MED CHEM LETT, V12, P295, DOI 10.1016/S0960-894X(01)00734-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meunier D., 2010, FRONTIERS NEUROSCIEN; Meyer FG, 2012, ARXIV12026666; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Sandryhaila A, 2012, ARXIV12104752; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sepulcre J, 2013, BRAIN, V136, P2239, DOI 10.1093/brain/awt146; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Shuman DI, 2013, IEEE SIGNAL PROC MAG, V30, P83, DOI 10.1109/MSP.2012.2235192; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Spielman DA, 2007, ANN IEEE SYMP FOUND, P29, DOI 10.1109/FOCS.2007.56; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Varoquaux G., 2010, ADV NEURAL INFORM PR; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang F, 2008, PATTERN RECOGN, V41, P3328, DOI 10.1016/j.patcog.2008.05.007; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	58	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128136	10.1371/journal.pone.0128136	http://dx.doi.org/10.1371/journal.pone.0128136			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024224	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400072
J	Joosten, A; van Dijke, M; Van Hiel, A; De Cremer, D				Joosten, Anne; van Dijke, Marius; Van Hiel, Alain; De Cremer, David			Out of Control!? How Loss of Self-Control Influences Prosocial Behavior: The Role of Power and Moral Values	PLOS ONE			English	Article							ORGANIZATIONAL CITIZENSHIP BEHAVIORS; EGO-DEPLETION; LIMITED-RESOURCE; INTERESTED BEHAVIOR; SANCTIONING SYSTEMS; WORKPLACE DEVIANCE; ETHICAL LEADERSHIP; STRENGTH MODEL; IDENTITY; COOPERATION	Lack of self-control has been suggested to facilitate norm-transgressing behaviors because of the operation of automatic selfish impulses. Previous research, however, has shown that people having a high moral identity may not show such selfish impulses when their self-control resources are depleted. In the present research, we extended this effect to prosocial behavior. Moreover, we investigated the role of power in the interaction between moral identity and self-control depletion. More specifically, we expected that power facilitates the externalization of internal states, which implies that for people who feel powerful, rather than powerless, depletion decreases prosocial behavior especially for those low in moral identity. A laboratory experiment and a multisource field study supported our predictions. The present finding that the interaction between self-control depletion and moral identity is contingent upon people's level of power suggests that power may enable people to refrain from helping behavior. Moreover, the findings suggest that if organizations want to improve prosocial behaviors, it may be effective to situationally induce moral values in their employees.	[Joosten, Anne; Van Hiel, Alain] Univ Ghent, Dept Dev Personal & Social Psychol, B-9000 Ghent, Belgium; [van Dijke, Marius] Erasmus Univ, Rotterdam Sch Management, Rotterdam, Netherlands; [De Cremer, David] Univ Cambridge, Judge Business Sch, Cambridge, England	Ghent University; Erasmus University Rotterdam; University of Cambridge	Joosten, A (corresponding author), Univ Ghent, Dept Dev Personal & Social Psychol, B-9000 Ghent, Belgium.	anne.joosten@ugent.be	van Dijke, Marius/ABD-8645-2020; van Dijke, Marius/C-8940-2013	Joosten, Anne/0000-0003-1328-9053; van Dijke, Marius/0000-0001-9974-5050	Fund for Scientific Research-Flanders (FWO-Vlaanderen) [G063610N]	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO)	This research was supported by grant G063610N from the Fund for Scientific Research-Flanders (FWO-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Allen T. D., 2000, HUM RESOUR MANAGE R, V10, P97, DOI [10.1016/s1053-4822(99)00041-8, DOI 10.1016/S1053-4822(99)00041-8]; Anderson C, 2006, EUR J SOC PSYCHOL, V36, P511, DOI 10.1002/ejsp.324; Anderson C, 2012, J PERS, V80, P313, DOI 10.1111/j.1467-6494.2011.00734.x; Aquino K, 2002, J PERS SOC PSYCHOL, V83, P1423, DOI 10.1037//0022-3514.83.6.1423; Aquino K, 2009, J PERS SOC PSYCHOL, V97, P123, DOI 10.1037/a0015406; Balliet D, 2010, GROUP PROCESS INTERG, V13, P227, DOI 10.1177/1368430209353634; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura Albert, 1977, SOCIAL LEARNING THEO; Barnes CM, 2011, ORGAN BEHAV HUM DEC, V115, P169, DOI 10.1016/j.obhdp.2011.01.009; Barriga AQ, 2001, MERRILL PALMER QUART, V47, P532, DOI 10.1353/mpq.2001.0020; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P1335, DOI 10.1037/0022-3514.72.6.1335; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 1999, J PERS, V67, P1165, DOI 10.1111/1467-6494.00086; Baumeister RF, 1994, LOSING CONTROL WHY P, DOI 10.5860/choice.32-6508; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Bell SJ, 2002, J RETAILING, V78, P131, DOI 10.1016/S0022-4359(02)00069-6; BLASI A, 1980, PSYCHOL BULL, V88, P1, DOI 10.1037/0033-2909.88.1.1; Brinol P, 2007, J PERS SOC PSYCHOL, V93, P1040, DOI 10.1037/0022-3514.93.6.1040; Chen S, 2001, J PERS SOC PSYCHOL, V80, P173, DOI 10.1037//0022-3514.80.2.173; Christian MS, 2011, ACAD MANAGE J, V54, P913, DOI 10.5465/amj.2010.0179; DeCelles KA, 2012, J APPL PSYCHOL, V97, P681, DOI 10.1037/a0026811; DeWall CN, 2007, J EXP SOC PSYCHOL, V43, P62, DOI 10.1016/j.jesp.2005.12.005; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Fischer P, 2007, PERS SOC PSYCHOL B, V33, P1306, DOI 10.1177/0146167207303025; FISKE ST, 1993, AM PSYCHOL, V48, P621, DOI 10.1037/0003-066X.48.6.621; French J. R. P., 1959, STUD SOC POWER, P150, DOI DOI 10.1007/BF00228551; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Galinsky AD, 2008, J PERS SOC PSYCHOL, V95, P1450, DOI 10.1037/a0012633; Gino F, 2011, ORGAN BEHAV HUM DEC, V115, P191, DOI 10.1016/j.obhdp.2011.03.001; GRUSEC JE, 1991, DEV PSYCHOL, V27, P338, DOI 10.1037/0012-1649.27.2.338; Guinote A, 2012, PSYCHOL SCI, V23, P475, DOI 10.1177/0956797611428472; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hardy SA, 2005, HUM DEV, V48, P232, DOI 10.1159/000086859; Hoogervorst N, 2012, LEADERSHIP QUART, V23, P883, DOI 10.1016/j.leaqua.2012.05.006; Joosten A, 2014, J BUS ETHICS, V121, P1, DOI 10.1007/s10551-013-1686-2; Kant, 1994, MORAL LAW GROUNDWORK; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; KIPNIS D, 1972, J PERS SOC PSYCHOL, V24, P33, DOI 10.1037/h0033390; Lee K, 2002, J APPL PSYCHOL, V87, P131, DOI 10.1037/0021-9010.87.1.131; Magee JC, 2013, PERS SOC PSYCHOL REV, V17, P158, DOI 10.1177/1088868312472732; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; Martin KD, 2006, J BUS ETHICS, V69, P175, DOI 10.1007/s10551-006-9084-7; Mayer DM, 2012, ACAD MANAGE J, V55, P151, DOI 10.5465/amj.2008.0276; Mayer DM, 2010, J BUS ETHICS, V95, P7, DOI 10.1007/s10551-011-0794-0; Mayer DM, 2009, ORGAN BEHAV HUM DEC, V108, P1, DOI 10.1016/j.obhdp.2008.04.002; Mead NL, 2009, J EXP SOC PSYCHOL, V45, P594, DOI 10.1016/j.jesp.2009.02.004; Mischel W., 1974, ADV EXP SOC PSYCHOL, V7, P249, DOI [10.1016/S0065-2601(08)60039-8, DOI 10.1016/S0065-2601(08)60039-8]; MOORMAN RH, 1995, J ORGAN BEHAV, V16, P127, DOI 10.1002/job.4030160204; Morrison EW, 2006, J MANAGE, V32, P5, DOI 10.1177/0149206305277790; Mulder LB, 2006, J EXP SOC PSYCHOL, V42, P147, DOI 10.1016/j.jesp.2005.03.002; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Muraven M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI 10.1177/0146167203029007008; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Narvaez D, 2006, J RES PERS, V40, P966, DOI 10.1016/j.jrp.2005.10.003; Nozick R., 1971, ANARCHY STATE UTOPIA; Organ D. W., 1988, ORGANISATIONAL CITIZ; Podsakoff NP, 2009, J APPL PSYCHOL, V94, P122, DOI 10.1037/a0013079; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Podsakoff PM, 2000, J MANAGE, V26, P513, DOI 10.1177/014920630002600306; Rawls J., 1971, THEORY JUSTICE; Reed A, 2003, J PERS SOC PSYCHOL, V84, P1270, DOI 10.1037/0022-3514.84.6.1270; Reed A, 2007, J MARKETING, V71, P178, DOI 10.1509/jmkg.71.1.178; Reynolds SJ, 2007, J APPL PSYCHOL, V92, P1610, DOI 10.1037/0021-9010.92.6.1610; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sage L, 2006, J SPORT SCI, V24, P455, DOI 10.1080/02640410500244531; Seeley EA, 2003, SELF IDENTITY, V2, P103, DOI 10.1080/15298860309034; Shalvi S, 2012, PSYCHOL SCI, V23, P1264, DOI 10.1177/0956797612443835; Shao RD, 2008, BUS ETHICS Q, V18, P513, DOI 10.5840/beq200818436; SMITH KD, 1989, J PERS SOC PSYCHOL, V57, P641, DOI 10.1037/0022-3514.57.4.641; Spector PE, 2011, ORGAN RES METHODS, V14, P287, DOI 10.1177/1094428110369842; Stucke TS, 2006, EUR J SOC PSYCHOL, V36, P1, DOI 10.1002/ejsp.285; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tenbrunsel AE, 1999, ADMIN SCI QUART, V44, P684, DOI 10.2307/2667052; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Van Dijke M, 2013, J MANAGEME IN PRESS; van Kleef GA, 2008, PSYCHOL SCI, V19, P1315, DOI 10.1111/j.1467-9280.2008.02241.x; Vohs KD, 2008, J PERS SOC PSYCHOL, V94, P883, DOI 10.1037/0022-3514.94.5.883; Wheeler SC, 2007, J EXP SOC PSYCHOL, V43, P150, DOI 10.1016/j.jesp.2006.01.001; Wisse B, 2012, J PERS PSYCHOL, V11, P40, DOI 10.1027/1866-5888/a000054; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	82	26	27	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126377	10.1371/journal.pone.0126377	http://dx.doi.org/10.1371/journal.pone.0126377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024380	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400013
J	Ma, C; Zhang, Y; Li, YQ; Chen, C; Cai, W; Zeng, YL				Ma, Chi; Zhang, Ying; Li, Yu-qing; Chen, Cheng; Cai, Wei; Zeng, Yue-lin			The Role of PPAR gamma in Advanced Glycation End Products-Induced Inflammatory Response in Human Chondrocytes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HUMAN OSTEOARTHRITIC CHONDROCYTES; EXPRESSION; PIOGLITAZONE; AGONIST; ALPHA; CELLS; MODEL; RAGE; BETA	Objective Advances made in the past ten years highlight the notion that peroxisome proliferator-activated receptors gamma (PPAR gamma) has protective properties in the pathophysiology of osteoarthritis (OA). The aim of this study was to define the roles of PPAR gamma in AGEs-induced inflammatory response in human chondrocytes. Methods Primary human chondrocytes were stimulated with AGEs in the presence or absence of neutralizing antibody against RAGE (anti-RAGE), MAPK specific inhibitors and PPAR gamma agonist pioglitazone. The expression of IL-1, MMP-13, TNF-alpha, PPAR gamma, nuclear NF-kappa B p65 and cytosol I kappa B alpha was determined by western blotting and real-time PCR. Results AGEs could enhance the expression of IL-1, TNF-alpha, and MMP-13, but the level of PPAR gamma was decreased in a time-and dose-dependent manner, which was inhibited by anti-RAGE, SB203580 (P38 MAPK specific inhibitor) and SP600125 (a selective inhibitor of JNK). PPAR gamma agonist pioglitazone could inhibit the effects of AGEs-induced inflammatory response and PPAR gamma down-regulation. In human chondrocytes, AGEs could induce cytosol I kappa B alpha degradation and increase the level of nuclear NF-kappa B p65, which was inhibited by PPAR gamma agonist pioglitazone. Conclusions In primary human chondrocytes, AGEs could down-regulate PPAR gamma expression and increase the inflammatory mediators, which could be reversed by PPAR gamma agonist pioglitazone. Activation of RAGE by AGEs triggers a cascade of downstream signaling, including MAPK JNK/p38, PPAR gamma and NF-kappa B. Taken together, PPAR gamma could be a potential target for pharmacologic intervention in the treatment of OA.	[Ma, Chi; Zhang, Ying; Li, Yu-qing; Chen, Cheng; Cai, Wei; Zeng, Yue-lin] Hunan Normal Univ, Affiliated Hosp 2, Peoples Liberat Army, Cent Hosp 163,Dept Orthoped, Changsha 410003, Hunan, Peoples R China	Hunan Normal University	Chen, C (corresponding author), Hunan Normal Univ, Affiliated Hosp 2, Peoples Liberat Army, Cent Hosp 163,Dept Orthoped, Changsha 410003, Hunan, Peoples R China.	jc163yy@163.com			National Natural Science Foundation of China [81201432]; Army Medical Research Subject of the "12th Five-Year-Plan" [CWS11J275]; Scientific Research Fund of Hunan Provincial Education Department [10B066]; Hunan Provincial Innovation Foundation for Postgraduate [CX2013B236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Army Medical Research Subject of the "12th Five-Year-Plan"; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Hunan Provincial Innovation Foundation for Postgraduate	The study was supported by National Natural Science Foundation of China (NO. 81201432), Army Medical Research Subject of the "12th Five-Year-Plan" (NO. CWS11J275), Scientific Research Fund of Hunan Provincial Education Department (NO. 10B066), and Hunan Provincial Innovation Foundation for Postgraduate (NO. CX2013B236).	Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Boileau C, 2007, ARTHRITIS RHEUM-US, V56, P2288, DOI 10.1002/art.22726; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Chen JR, 1999, RHEUMATOLOGY, V38, P1275, DOI 10.1093/rheumatology/38.12.1275; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; Cho MC, 2008, PPAR RES, V2008, DOI 10.1155/2008/679137; Cortizo AM, 2003, MOL CELL BIOCHEM, V250, P1, DOI 10.1023/A:1024934008982; Dukic-Stefanovic S, 2003, J NEUROCHEM, V87, P44, DOI 10.1046/j.1471-4159.2003.01988.x; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; Ishibashi Y, 2013, MICROVASC RES, V85, P54, DOI 10.1016/j.mvr.2012.10.007; Ji JD, 2001, J AUTOIMMUN, V17, P215, DOI 10.1006/jaut.2001.0542; Jiang LY, 2012, CNS NEUROSCI THER, V18, P659, DOI 10.1111/j.1755-5949.2012.00341.x; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Li F, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0306-0; Liang C, 2009, BRIT J PHARMACOL, V158, P1865, DOI 10.1111/j.1476-5381.2009.00450.x; Lin JG, 2012, BRIT J PHARMACOL, V166, P2212, DOI 10.1111/j.1476-5381.2012.01910.x; Lin TH, 2011, J CELL PHYSIOL, V226, P3242, DOI 10.1002/jcp.22685; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; Mahali SK, 2012, BIOCHEM PHARMACOL, V84, P1681, DOI 10.1016/j.bcp.2012.09.033; Monemdjou R, 2012, ARTHRITIS RHEUM-US, V64, P1551, DOI 10.1002/art.33490; Nah SS, 2008, RHEUMATOLOGY, V47, P425, DOI 10.1093/rheumatology/kem376; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; Nebbaki SS, 2013, J RHEUMATOL, V40, P877, DOI 10.3899/jrheum.120738; Puddu A, 2012, REGUL PEPTIDES, V177, P79, DOI 10.1016/j.regpep.2012.05.089; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Reiser KM, 1998, P SOC EXP BIOL MED, V218, P23; SCHMIDT AM, 1995, NAT MED, V1, P1002, DOI 10.1038/nm1095-1002; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vasheghani F, 2013, AM J PATHOL, V182, P1099, DOI 10.1016/j.ajpath.2012.12.012; Yamagishi S, 2009, PHARMACOL RES, V60, P174, DOI 10.1016/j.phrs.2009.01.006; Yang QS, 2010, EUR J PHARMACOL, V649, P108, DOI 10.1016/j.ejphar.2010.09.025; Yuan XC, 2011, J GENET GENOMICS, V38, P193, DOI 10.1016/j.jgg.2011.04.001; Zhang YH, 2010, INT J MOL MED, V25, P729, DOI 10.3892/ijmm_00000398	36	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125776	10.1371/journal.pone.0125776	http://dx.doi.org/10.1371/journal.pone.0125776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024533	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400009
J	Zhu, YX; Abdullah, LH; Doyle, SP; Nguyen, K; Ribeiro, CMP; Vasquez, PA; Forest, MG; Lethem, MI; Dickey, BF; Davis, CW				Zhu, Yunxiang; Abdullah, Lubna H.; Doyle, Sean P.; Nguyen, Kristine; Ribeiro, Carla M. P.; Vasquez, Paula A.; Forest, M. Gregory; Lethem, Michael I.; Dickey, Burton F.; Davis, C. William			Baseline Goblet Cell Mucin Secretion in the Airways Exceeds Stimulated Secretion over Extended Time Periods, and Is Sensitive to Shear Stress and Intracellular Mucin Stores	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; VON-WILLEBRAND-FACTOR; CYSTIC-FIBROSIS; GENE-EXPRESSION; ATP RELEASE; NUCLEOTIDE REGULATION; MUCUS GLYCOPROTEINS; GRANULE EXOCYTOSIS; OLIGOMERIC MUCINS; LUNG	Airway mucin secretion studies have focused on goblet cell responses to exogenous agonists almost to the exclusion of baseline mucin secretion ( BLMS). In human bronchial epithelial cell cultures (HBECCs), maximal agonist-stimulated secretion exceeds baseline by similar to 3-fold as measured over hour-long periods, but mucin stores are discharged completely and require 24 h for full restoration. Hence, over 24 h, total baseline exceeds agonist-induced secretion by several-fold. Studies with HBECCs and mouse tracheas showed that BLMS is highly sensitive to mechanical stresses. Harvesting three consecutive 1 h baseline luminal incubations with HBECCs yielded equal rates of BLMS; however, lengthening the middle period to 72 h decreased the respective rate significantly, suggesting a stimulation of BLMS by the gentle washes of HBECC luminal surfaces. BLMS declined exponentially after washing HBECCs (t(1/2) = 2.75 h), to rates approaching zero. HBECCs exposed to low perfusion rates exhibited spike-like increases in BLMS when flow was jumped 5-fold: BLMS increased >4 fold, then decreased within 5 min to a stable plateau at 1.5-2-fold over control. Higher flow jumps induced proportionally higher BLMS increases. Inducing mucous hyperplasia in HBECCs increased mucin production, BLMS and agonist-induced secretion. Mouse tracheal BLMS was similar to 6-fold higher during perfusion, than when flow was stopped. Munc13-2 null mouse tracheas, with their defect of accumulated cellular mucins, exhibited similar BLMS as WT, contrary to predictions of lower values. Graded mucous metaplasia induced in WT and Munc13-2 null tracheas with IL-13, caused proportional increases in BLMS, suggesting that naive Munc13-2 mouse BLMS is elevated by increased mucin stores. We conclude that BLMS is, [i] a major component of mucin secretion in the lung, [ii] sustained by the mechanical activity of a dynamic lung, [iii] proportional to levels of mucin stores, and [iv] regulated differentially from agonist-induced mucin secretion.	[Zhu, Yunxiang; Abdullah, Lubna H.; Doyle, Sean P.; Nguyen, Kristine; Ribeiro, Carla M. P.; Davis, C. William] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Davis, C. William] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Vasquez, Paula A.; Forest, M. Gregory] Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA; [Lethem, Michael I.] Univ Brighton, Pharm & Biomol Sci, Brighton BN2 4GJ, Moulsecoomb, England; [Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Brighton; University of Texas System; UTMD Anderson Cancer Center	Davis, CW (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA.	cwdavis@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009		National Institutes of Health [R01 HL097000]; Cystic Fibrosis Foundation [MCC DAVIS07XX0]; Cystic Fibrosis Foundation RDP grant [R026-CR11]; National Institutes of Health Molecular Therapy Core Center grant [P30 DK065988]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129795, R01HL097000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1412844] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1462992] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Foundation RDP grant; National Institutes of Health Molecular Therapy Core Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The studies described in this paper were supported by grants from the National Institutes of Health (R01 HL097000) and the Cystic Fibrosis Foundation (MCC DAVIS07XX0). Additionally, the authors' acknowledge the use of UNC Cystic Fibrosis/Pulmonary Research and Treatment Center Tissue Culture and Imaging/Histology Cores, which both received support from a Cystic Fibrosis Foundation RDP grant (R026-CR11) and a National Institutes of Health Molecular Therapy Core Center grant (P30 DK065988). NIH Grants website: http://grants.nih.gov/grants/guide/index.html?CFID=163646478&CFTOKEN=34654896&jsessionid=f630cf6c020e432511b04b3d7a1126d160f1 Cystic Fibrosis Foundation Grants website: http://www.cff.org/research/ForResearchers/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LH, 1996, BIOCHEM J, V316, P943, DOI 10.1042/bj3160943; Abdullah LH, 2007, AM J PHYSIOL-LUNG C, V293, pL591, DOI 10.1152/ajplung.00150.2007; Abdullah LH, 2012, METHODS MOL BIOL, V842, P259, DOI 10.1007/978-1-61779-513-8_16; Adler Kenneth B, 2013, Front Endocrinol (Lausanne), V4, P129, DOI 10.3389/fendo.2013.00129; Belvisi MG, 2002, CURR OPIN PHARMACOL, V2, P211, DOI 10.1016/S1471-4892(02)00145-5; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Button B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003755; CARLSTEDT I, 1983, BIOCHEM J, V211, P13, DOI 10.1042/bj2110013; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; Choi JY, 2003, ACTA OTO-LARYNGOL, V123, P1080, DOI 10.1080/00016480310002528; Clancy SM, 2004, AM J RESP CELL MOL, V31, P663, DOI 10.1165/rcmb.2003-0331OC; Conway JD, 2003, AM J PHYSIOL-LUNG C, V284, pL945, DOI 10.1152/ajplung.00410.2002; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Cressman VL, 1998, AM J RESP CELL MOL, V19, P853, DOI 10.1165/ajrcmb.19.6.3194; Dang LT, 2011, J BIOL CHEM, V286, P25763, DOI 10.1074/jbc.M111.249151; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; DAVIS CW, 1992, AM J PHYSIOL, V262, pC1313, DOI 10.1152/ajpcell.1992.262.5.C1313; Davis CW, 2008, RESP PHYSL NEUROBIOL; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; FREDBERG JJ, 1978, J ACOUST SOC AM, V63, P954, DOI 10.1121/1.381775; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Grygorczyk R, 2013, J PHYSIOL-LONDON, V591, P1195, DOI 10.1113/jphysiol.2012.244145; HARKEMA JR, 1987, J HISTOCHEM CYTOCHEM, V35, P279, DOI 10.1177/35.3.2434556; Herschlag G, 2013, J THEOR BIOL, V325, P42, DOI 10.1016/j.jtbi.2013.01.023; Holmen JM, 2004, AM J PHYSIOL-LUNG C, V287, pL824, DOI 10.1152/ajplung.00108.2004; Huang AY, 2001, J BIOL CHEM, V276, P22296, DOI 10.1074/jbc.M100211200; Jones LC, 2011, J PHYSL, V2011; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Kesimer M, 2013, MUCOSAL IMMUNOL, V6, P379, DOI 10.1038/mi.2012.81; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Kogel T, 2010, RESULTS PROBL CELL D, V50, P1, DOI 10.1007/400_2009_31; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Lazarowski ER, 2011, ADV PHARMACOL, V61, P221, DOI 10.1016/B978-0-12-385526-8.00008-4; LETHEM MI, 1993, AM J RESP CELL MOL, V9, P315, DOI 10.1165/ajrcmb/9.3.315; Livraghi A, 2009, J IMMUNOL, V182, P4357, DOI 10.4049/jimmunol.0802557; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; McGookin R, 1985, METHOD MOL BIOL, V2, P116, DOI [10.1385/0-89603-064-4:113, DOI 10.1385/0-89603-064-4:113]; Okada SF, 2013, AM J RESP CELL MOL, V49, P814, DOI 10.1165/rcmb.2012-0493OC; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Ramsingh R, 2011, AM J PHYSIOL-LUNG C, V300, pL587, DOI 10.1152/ajplung.00345.2010; Ribeiro CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005806; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rossi AH, 2004, J PHYSIOL-LONDON, V559, P555, DOI 10.1113/jphysiol.2004.070433; Rousseau K, 2003, HYBRIDOMA HYBRIDOM, V22, P293, DOI 10.1089/153685903322538818; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Roy MG, 2011, AM J RESP CELL MOL, V44, P755, DOI 10.1165/rcmb.2010-0020OC; Saegusa C, 2006, GENES CELLS, V11, P623, DOI 10.1111/j.1365-2443.2006.00964.x; SHEEHAN JK, 1991, BIOCHEM J, V274, P293, DOI 10.1042/bj2740293; Shimura S, 1994, AIRWAY SECRETION PHY, P325; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Turner MD, 2000, J BIOL CHEM, V275, P14025, DOI 10.1074/jbc.275.19.14025; Tuvim MJ, 2009, J BIOL CHEM, V284, P9781, DOI 10.1074/jbc.M807849200; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Young HWJ, 2006, AM J RESP CELL MOL, V35, P549, DOI 10.1165/rcmb.2006-0060OC; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	67	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127267	10.1371/journal.pone.0127267	http://dx.doi.org/10.1371/journal.pone.0127267			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024524	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400033
J	Gong, XC; Li, Y; Chen, HL; Qu, HB				Gong, Xingchu; Li, Yao; Chen, Huali; Qu, Haibin			Design Space Development for the Extraction Process of Danhong Injection Using a Monte Carlo Simulation Method	PLOS ONE			English	Article							ICH Q8 DEFINITION; OPTIMIZATION STRATEGY; ETHANOL PRECIPITATION; QUALITY; IMPLEMENTATION; CHROMATOGRAPHY; PURIFICATION; SEPARATION; SUGAR; WATER	A design space approach was applied to optimize the extraction process of Danhong injection. Dry matter yield and the yields of five active ingredients were selected as process critical quality attributes (CQAs). Extraction number, extraction time, and the mass ratio of water and material (W/M ratio) were selected as critical process parameters (CPPs). Quadratic models between CPPs and CQAs were developed with determination coefficients higher than 0.94. Active ingredient yields and dry matter yield increased as the extraction number increased. Monte-Carlo simulation with models established using a stepwise regression method was applied to calculate the probability-based design space. Step length showed little effect on the calculation results. Higher simulation number led to results with lower dispersion. Data generated in a Monte Carlo simulation following a normal distribution led to a design space with a smaller size. An optimized calculation condition was obtained with 10000 simulation times, 0.01 calculation step length, a significance level value of 0.35 for adding or removing terms in a stepwise regression, and a normal distribution for data generation. The design space with a probability higher than 0.95 to attain the CQA criteria was calculated and verified successfully. Normal operating ranges of 8.2-10 g/g of W/M ratio, 1.25-1.63 h of extraction time, and two extractions were recommended. The optimized calculation conditions can conveniently be used in design space development for other pharmaceutical processes.	[Gong, Xingchu; Li, Yao; Chen, Huali; Qu, Haibin] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Qu, HB (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China.	quhb@zju.edu.cn			National Natural Science Foundation of China [81273992]; Zhejiang Provincial Natural Science Foundation [LQ12H29004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (No. 81273992) and Zhejiang Provincial Natural Science Foundation (LQ12H29004). Haibin Qu received the first fund. The website is http://www.nsfc.gov.cn/. Xingchu Gong received the second fund. The website is http://www.zjnsf.gov.cn/. Funds were used to buy materials, chemicals, and pay labor costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard A, 2007, J CHEM ENG DATA, V52, P1838, DOI 10.1021/je700190m; [初阳 CHU Yang], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1161; Debrus B, 2011, J CHROMATOGR A, V1218, P5205, DOI 10.1016/j.chroma.2011.05.102; Debrus B, 2011, ANAL CHIM ACTA, V691, P33, DOI 10.1016/j.aca.2011.02.035; [杜中良 Du Zhongliang], 2010, [中国药房, China Pharmacy], V21, P2911; Fan L, 2011, J CHIN PHARM SCI, V20, P47, DOI DOI 10.5246/JCPS.2011.01.007; Getaz D, 2013, J CHROMATOGR A, V1284, P80, DOI 10.1016/j.chroma.2013.01.117; Gong XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092961; Gong XC, 2014, SEP PURIF TECHNOL, V132, P126, DOI 10.1016/j.seppur.2014.05.014; Gong XC, 2011, IND ENG CHEM RES, V50, P7542, DOI 10.1021/ie2004972; Gong XC, 2011, CHINESE J CHEM ENG, V19, P217, DOI 10.1016/S1004-9541(11)60157-2; [顾娟 GU Juan], 2005, [广东微量元素科学, Guangdong Weiliang Yuansu Kexue], V12, P61; Guo YX, 2007, J PHARMACEUT BIOMED, V43, P435, DOI 10.1016/j.jpba.2006.07.046; He Y, 2012, J ETHNOPHARMACOL, V144, P387, DOI 10.1016/j.jep.2012.09.025; ICH, 2009, PHARM DEV Q8 R2; Ingvarsson PT, 2013, PHARM RES-DORDR, V30, P2772, DOI 10.1007/s11095-013-1096-2; Korakianiti E, 2011, PHARM RES-DORDR, V28, P1465, DOI 10.1007/s11095-010-0315-3; Li HL, 2008, J MASS SPECTROM, V43, P1545, DOI 10.1002/jms.1441; Li Yao, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1653; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Liu Shuang-Yue, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1657; Mbinze JK, 2012, J CHROMATOGR A, V1263, P113, DOI 10.1016/j.chroma.2012.09.038; Nistor I, 2011, J PHARMACEUT BIOMED, V56, P30, DOI 10.1016/j.jpba.2011.04.027; Nistor I, 2013, J PHARMACEUT BIOMED, V74, P273, DOI 10.1016/j.jpba.2012.10.015; Pan JY, 2013, J PHARMACEUT BIOMED, V85, P28, DOI 10.1016/j.jpba.2013.06.020; Peterson JJ, 2008, J BIOPHARM STAT, V18, P959, DOI 10.1080/10543400802278197; Peterson JJ, 2010, STAT BIOPHARM RES, V2, P249, DOI 10.1198/sbr.2009.08065; Ren XP, 2013, CNS NEUROSCI THER, V19, P1, DOI 10.1111/cns.12029; Rozet E, 2013, TRAC-TREND ANAL CHEM, V42, P157, DOI 10.1016/j.trac.2012.09.007; Tsavas P, 2004, IND ENG CHEM RES, V43, P8391, DOI 10.1021/ie049353n; Xu XM, 2012, INT J PHARMACEUT, V434, P349, DOI 10.1016/j.ijpharm.2012.06.002; Xu ZH, 2012, PREP BIOCHEM BIOTECH, V42, P183, DOI 10.1080/10826068.2012.654572; Yan Bin-Jun, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1676; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8	35	12	18	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128236	10.1371/journal.pone.0128236	http://dx.doi.org/10.1371/journal.pone.0128236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020778	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300091
J	van der Walt, A; Kolbe, S; Mitchell, P; Wang, YJ; Butzkueven, H; Egan, G; Yiannikas, C; Graham, S; Kilpatrick, T; Klistorner, A				van der Walt, Anneke; Kolbe, Scott; Mitchell, Peter; Wang, Yejun; Butzkueven, Helmut; Egan, Gary; Yiannikas, Con; Graham, Stuart; Kilpatrick, Trevor; Klistorner, Alexander			Parallel Changes in Structural and Functional Measures of Optic Nerve Myelination after Optic Neuritis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; VISUAL-EVOKED POTENTIALS; AXONAL LOSS; REMYELINATION; MRI; ASSOCIATION; ATROPHY; CELLS	Introduction Visual evoked potential (VEP) latency prolongation and optic nerve lesion length after acute optic neuritis (ON) corresponds to the degree of demyelination, while subsequent recovery of latency may represent optic nerve remyelination. We aimed to investigate the relationship between multifocal VEP (mfVEP) latency and optic nerve lesion length after acute ON. Methods Thirty acute ON patients were studied at 1,3,6 and 12 months using mfVEP and at 1 and 12 months with optic nerve MRI. LogMAR and low contrast visual acuity were documented. By one month, the mfVEP amplitude had recovered sufficiently for latency to be measured in 23 (76.7%) patients with seven patients having no recordable mfVEP in more than 66% of segments in at least one test. Only data from these 23 patients was analysed further. Results Both latency and lesion length showed significant recovery during the follow-up period. Lesion length and mfVEP latency were highly correlated at 1 (r = 0.94, p = <0.0001) and 12 months (r = 0.75, p < 0.001). Both measures demonstrated a similar trend of recovery. Speed of latency recovery was faster in the early follow-up period while lesion length shortening remained relatively constant. At 1 month, latency delay was worse by 1.76ms for additional 1mm of lesion length while at 12 months, 1mm of lesion length accounted for 1.94ms of latency delay. Conclusion A strong association between two putative measures of demyelination in early and chronic ON was found. Parallel recovery of both measures could reflect optic nerve remyelination.	[Graham, Stuart; Klistorner, Alexander] Univ Sydney, Save Sight Inst, Dept Ophthalmol, Sydney, NSW, Australia; [van der Walt, Anneke; Kolbe, Scott; Wang, Yejun; Kilpatrick, Trevor] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [van der Walt, Anneke; Butzkueven, Helmut; Kilpatrick, Trevor] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [van der Walt, Anneke; Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Butzkueven, Helmut] Box Hill Hosp, Dept Neurol, Melbourne, Vic, Australia; [Egan, Gary] Monash Univ, Melbourne, Vic 3004, Australia; [Mitchell, Peter] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Yiannikas, Con] Concord Hosp, Dept Neurol, Sydney, NSW, Australia; [Graham, Stuart] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	University of Sydney; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Box Hill Hospital; Monash University; Royal Melbourne Hospital; Concord Repatriation General Hospital; Macquarie University	van der Walt, A (corresponding author), Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia.	anneke.vanderwalt@mh.org.au	Egan, Gary F./A-1381-2013	Egan, Gary/0000-0002-3186-4026; Kolbe, Scott/0000-0003-4685-1380; Butzkueven, Helmut/0000-0003-3940-8727; Kilpatrick, Trevor/0000-0003-3999-085X; Graham, Stuart/0000-0001-7519-969X; Klistorner, Alexander/0000-0003-0361-6399	National Health and Medical Research Council; Multiple Sclerosis Research Australia; Sydney Foundation for Medical Research	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia; Sydney Foundation for Medical Research	This work was supported by the National Health and Medical Research Council (AK, GFE, AV, HB, SCK), Multiple Sclerosis Research Australia grant (AK) and Sydney Foundation for Medical Research (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi Rohit, 2005, NeuroRx, V2, P277, DOI 10.1007/BF03206672; Balcer LJ, 2000, MULT SCLER J, V6, P163, DOI 10.1191/135245800701566025; BARNES D, 1991, BRAIN, V114, P1271, DOI 10.1093/brain/114.3.1271; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Bruck W, 2003, J NEUROL SCI, V206, P181, DOI 10.1016/s0022-510x(02)00191-0; Brusa A, 2001, BRAIN, V124, P468, DOI 10.1093/brain/124.3.468; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Davies MB, 1998, NEURORADIOLOGY, V40, P765, DOI 10.1007/s002340050681; Dubois-Dalcq M, 2008, BRAIN, V131, P1686, DOI 10.1093/brain/awn076; Fahle M., 2006, PRINCIPLES PRACTICE, P207; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Franklin R, 2008, NAT REV NEUROSCI; GUTTMANN CRG, 1995, AM J NEURORADIOL, V16, P1481; Hickman SJ, 2004, BRAIN, V127, P692, DOI 10.1093/brain/awh076; Jennings AR, 2002, J NEUROCYTOL, V31, P27, DOI 10.1023/A:1022567414294; Klistorner AI, 2001, INVEST OPHTH VIS SCI, V42, P2145; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2008, DOC OPHTHALMOL, V116, P19, DOI 10.1007/s10633-007-9072-y; Klistorner A, 2010, MULT SCLER J, V16, P786, DOI 10.1177/1352458510371408; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Lassmann H, 2005, MULTIPLE SCLEROSIS N, P153; Martin M, 2006, MYELIN DEFICIENCIES; McDonald WI, 1977, VISUAL EVOKED POTENT, P427; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; O'riordan J, 1998, PROGNOSTIC VALUE BRA; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Perier O, 1965, ELECT MICROSCOPIC FE, P937; PRINEAS JW, 1978, NEUROLOGY, V28, P68, DOI 10.1212/WNL.28.9_Part_2.68; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; PRINEAS JW, 1989, LAB INVEST, V61, P489; Rodriguez M, 2003, BRAIN, V126, P751, DOI 10.1093/brain/awg070; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Smith KJ, 2005, MULTIPLE SCLEROSIS N, P85, DOI [10.1016/B978-012738761-1/50007-9, DOI 10.1016/B978-012738761-1/50007-9]; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Wang C, 2013, LESION LENGTH ALONG; Waxman SG., 2005, MULTIPLE SCLEROSIS N, P165; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; Zhao C, 2005, J NEUROL SCI, V233, P87, DOI 10.1016/j.jns.2005.03.008	49	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0121084	10.1371/journal.pone.0121084	http://dx.doi.org/10.1371/journal.pone.0121084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020925	Green Published, gold			2022-12-27	WOS:000355187300002
J	Wang, LF; Chen, J; Shangguan, ZP				Wang, Li-fang; Chen, Juan; Shangguan, Zhou-ping			Yield Responses of Wheat to Mulching Practices in Dryland Farming on the Loess Plateau	PLOS ONE			English	Article							WATER-USE EFFICIENCY; GRAVEL-SAND MULCH; GRAIN-YIELD; SUPPLEMENTAL IRRIGATION; SOIL-WATER; CONSERVATION TILLAGE; SPRING WHEAT; PRODUCTIVITY; MANAGEMENT; SYSTEMS	Improving farming practices of soil and water conservation has profound effects on the yield of wheat (Triticum aestivum L.) in dryland farming regions of the Loess Plateau in China. Mulching has proven to be an effective practice to increase crop yield, and possibly contribute to replenishing groundwater. This evaluation study collected and analyzed the data of 1849 observations published in 38 papers using meta-analysis to investigate effects of the mulching practices on wheat yield in terms of different rainfall and regions in comparison with conventional tillage. The main results of the study follow. The effects of the mulching practices were ranked in the order of RFM (ridge-furrow mulching) > MTMC (mulching with two materials combined) > MOM (mulching with other materials) > WSM (wheat straw mulching) > FM (flat mulching). The effects of the mulching practices at the different levels of rainfall during the wheat growing season were in the order: (< 150 mm) > (> 250 mm) > (150-250 mm). The effects of the mulching practices in the different regions were in the order of Henan > Shanxi > Shaanxi > Gansu. WSM, MTMC and FM performed better in improving wheat yield for rainfall of < 150, 150-250 and > 250 mm during the growing season, respectively. The wheat yield with FM, MTMC, MOM and MOM was higher than those with the other mulching practices in Shaanxi, Gansu, Henan and Shanxi. The wheat yield with RFM was 27.4% higher than that with FM, indicating that RFM was the most effective practice to improve wheat yield among all the practices. These findings have important implications for choosing appropriate crop field management to improve wheat yield.	[Wang, Li-fang; Chen, Juan; Shangguan, Zhou-ping] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Shangguan, ZP (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	shangguan@ms.iswc.ac.cn	Chen, Juan/GXF-5536-2022		National Natural Science Foundation of China [41390463]; National Key Technology RD Program [2015BAC01B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	The study was financially supported by the National Natural Science Foundation of China (41390463) and the National Key Technology R&D Program (2015BAC01B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011780; Banerjee MJ, 2006, RESTOR ECOL, V14, P339, DOI 10.1111/j.1526-100X.2006.00142.x; Baumhardt RL, 2002, SOIL TILL RES, V68, P71, DOI 10.1016/S0167-1987(02)00097-1; Chen SY, 2010, AGR WATER MANAGE, V97, P1126, DOI 10.1016/j.agwat.2009.09.005; Fan TL, 2005, AGR WATER MANAGE, V76, P36, DOI 10.1016/j.agwat.2005.01.003; Fan TL, 2005, AGRON J, V97, P177; Fan XL, 2000, J PLANT NUTR SOIL SC, V163, P107, DOI 10.1002/(SICI)1522-2624(200002)163:1<107::AID-JPLN107>3.0.CO;2-W; Gan YT, 2013, ADV AGRON, V118, P429, DOI 10.1016/B978-0-12-405942-9.00007-4; Gao YaJun, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P15; He J, 2007, SOIL TILL RES, V94, P493, DOI 10.1016/j.still.2006.10.005; Hedges V., 1985, STAT METHODS METAANA; Huang GB, 2008, FIELD CROP RES, V107, P43, DOI 10.1016/j.fcr.2007.12.011; Huang MB, 2003, SOIL TILL RES, V72, P95, DOI 10.1016/S0167-1987(03)00065-5; Huang YL, 2005, AGR WATER MANAGE, V72, P209, DOI 10.1016/j.agwat.2004.09.012; Jabran K, 2015, J AGRON CROP SCI, V201, P389, DOI 10.1111/jac.12099; Jiao F, 2011, CATENA, V86, P110, DOI 10.1016/j.catena.2011.03.001; Jin K, 2007, SOIL TILL RES, V96, P131, DOI 10.1016/j.still.2007.05.002; Li FM, 2004, SOIL TILL RES, V78, P9, DOI 10.1016/j.still.2003.12.009; Li FM, 1999, FIELD CROP RES, V63, P79, DOI 10.1016/S0378-4290(99)00027-1; Li FM, 2001, AGR WATER MANAGE, V47, P25, DOI 10.1016/S0378-3774(00)00097-4; Li JM, 2007, J SUSTAIN AGR, V31, P133, DOI 10.1300/J064v31n03_09; Li XY, 2003, CATENA, V52, P105, DOI 10.1016/S0341-8162(02)00181-9; Li XY, 2002, AGR WATER MANAGE, V54, P243, DOI 10.1016/S0378-3774(01)00172-X; Liang YL, 2002, J PLANT NUTR, V25, P945, DOI 10.1081/PLN-120003930; Makurira H, 2011, AGR WATER MANAGE, V98, P1696, DOI 10.1016/j.agwat.2011.05.003; Rahman MA, 2005, FIELD CROP RES, V91, P71, DOI 10.1016/j.fcr.2004.06.010; Richter GM, 2005, AGR SYST, V84, P77, DOI 10.1016/j.agsy.2004.06.011; Schillinger WF, 2008, FIELD CROP RES, V109, P45, DOI 10.1016/j.fcr.2008.06.008; Shangguan ZP, 2002, INT J SUST DEV WORLD, V9, P341, DOI 10.1080/13504500209470129; Shao HB, 2008, CR BIOL, V331, P215, DOI 10.1016/j.crvi.2008.01.002; Sharma SP, 2014, AGR WATER MANAGE, V136, P75, DOI 10.1016/j.agwat.2014.01.008; Sidhu HS, 2007, AUST J EXP AGR, V47, P844, DOI 10.1071/EA06225; Smithers LG, 2008, AM J CLIN NUTR, V87, P912, DOI 10.1093/ajcn/87.4.912; Wang HX, 2001, AGR WATER MANAGE, V48, P151, DOI 10.1016/S0378-3774(00)00118-9; Wang TC, 2011, FIELD CROP RES, V124, P223, DOI 10.1016/j.fcr.2011.06.014; Xie ZK, 2006, SOIL TILL RES, V89, P35, DOI 10.1016/j.still.2005.06.013; Zhang HP, 1998, PLANT SOIL, V201, P295, DOI 10.1023/A:1004328004860; [张建军 ZHANG Jian-jun], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P247; Zhou LM, 2009, FIELD CROP RES, V113, P41, DOI 10.1016/j.fcr.2009.04.005; Zhu K, 2004, J ARID ENVIRON, V57, P487, DOI 10.1016/S0140-1963(03)00118-6	40	15	19	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127402	10.1371/journal.pone.0127402	http://dx.doi.org/10.1371/journal.pone.0127402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020965	gold, Green Submitted, Green Published			2022-12-27	WOS:000355187300039
J	Amigo, N; Mercado, E; Bentancor, A; Singh, P; Vilte, D; Gerhardt, E; Zotta, E; Ibarra, C; Manning, SD; Larzabal, M; Cataldi, A				Amigo, Natalia; Mercado, Elsa; Bentancor, Adriana; Singh, Pallavi; Vilte, Daniel; Gerhardt, Elisabeth; Zotta, Elsa; Ibarra, Cristina; Manning, Shannon D.; Larzabal, Mariano; Cataldi, Angel			Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 from Cattle in Argentina have Hypervirulent-Like Phenotypes	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SHIGA TOXIN 2; MASSIVE OUTBREAK; O157-H7 STRAINS; SAKAI CITY; VIRULENCE; DISEASE; INFECTION; WATER; COIL	The hemolytic uremic syndrome (HUS) whose main causative agent is enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a disease that mainly affects children under 5 years of age. Argentina is the country with the highest incidence of HUS in the world. Cattle are a major reservoir and source of infection with E. coli O157:H7. To date, the epidemiological factors that contribute to its prevalence are poorly understood. Single nucleotide polymorphism (SNP) typing has helped to define nine E. coli O157:H7 clades and the clade 8 strains were associated with most of the cases of severe disease. In this study, eight randomly selected isolates of EHEC O157:H7 from cattle in Argentina were studied as well as two human isolates. Four of them were classified as clade 8 through the screening for 23 SNPs; the two human isolates grouped in this clade as well, while two strains were closely related to strains representing clade 6. To assess the pathogenicity of these strains, we assayed correlates of virulence. Shiga toxin production was determined by an ELISA kit. Four strains were high producers and one of these strains that belonged to a novel genotype showed high verocytotoxic activity in cultured cells. Also, these clade 8 and 6 strains showed high RBC lysis and adherence to epithelial cells. One of the clade 6 strains showed stronger inhibition of normal water absorption than E. coli O157:H7 EDL933 in human colonic explants. In addition, two of the strains showing high levels of Stx2 production and RBC lysis activity were associated with lethality and uremia in a mouse model. Consequently, circulation of such strains in cattle may partially contribute to the high incidence of HUS in Argentina.	[Amigo, Natalia; Larzabal, Mariano; Cataldi, Angel] Inst Nacl Tecnol Agr, CICVyA, Inst Biotecnol, Hurlingham, Argentina; [Mercado, Elsa; Vilte, Daniel] Inst Nacl Tecnol Agr, CICVyA, Inst Patobiol, Hurlingham, Argentina; [Bentancor, Adriana] Univ Buenos Aires, Fac Ciencias Vet, Microbiol, Buenos Aires, DF, Argentina; [Gerhardt, Elisabeth; Zotta, Elsa; Ibarra, Cristina] Univ Buenos Aires, Fac Med, Dept Fisiol, IFIBIO CONICET, RA-1425 Buenos Aires, DF, Argentina; [Singh, Pallavi; Manning, Shannon D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Buenos Aires; University of Buenos Aires; Michigan State University	Cataldi, A (corresponding author), Inst Nacl Tecnol Agr, CICVyA, Inst Biotecnol, Hurlingham, Argentina.	cataldi.angeladrian@inta.gob.ar	Ibarra, Cristina/D-6242-2016; Singh, Pallavi/H-2975-2019; Manning, Shannon/GXA-0622-2022	Singh, Pallavi/0000-0002-0283-7459; Manning, Shannon/0000-0001-9581-0660; zotta, elsa/0000-0002-8763-5046; Larzabal, Mariano/0000-0002-1358-6982; Ibarra, Cristina/0000-0001-8182-501X	PICT from National Fund in Science and Technology (FONCYT), Argentina [0211]	PICT from National Fund in Science and Technology (FONCYT), Argentina	This work was partially funded by PICT grant #0211 from National Fund in Science and Technology (FONCYT), Argentina. Partially refers to the fact reagents from older finished grants were used. CI, ML and AC are CONICET fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ali GS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010167; Albanese A, 2015, INT J MED MICROBIOL; Baker DR, 2007, APPL ENVIRON MICROB, V73, P7338, DOI 10.1128/AEM.00755-07; Besser TE, 2007, APPL ENVIRON MICROB, V73, P671, DOI 10.1128/AEM.01035-06; Beutin L, 2007, J APPL MICROBIOL, V102, P630, DOI 10.1111/j.1365-2672.2006.03139.x; Brando R J F, 2008, Clin Exp Immunol, V153, P297, DOI 10.1111/j.1365-2249.2008.03698.x; CDC, 2006, 10451046 CDC MMWR, P1045; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P258; Dorr RA, 1997, COMPUT METH PROG BIO, V53, P9, DOI 10.1016/S0169-2607(96)01801-9; Eaton KA, 2008, INFECT IMMUN, V76, P3054, DOI 10.1128/IAI.01626-07; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez D, 2007, 11 C ARG MICR COR S1, V39, P178; Fiorito P, 2000, DIGEST DIS SCI, V45, P480, DOI 10.1023/A:1005480720832; Fukushima H, 1999, PEDIATR INT, V41, P213, DOI 10.1046/j.1442-200X.1999.4121041.x; Gerhardt E, 2013, INFECT IMMUN, V81, P2931, DOI 10.1128/IAI.00287-13; Gioffre A, 2002, VET MICROBIOL, V87, P301, DOI 10.1016/S0378-1135(02)00079-2; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Kim J, 1999, P NATL ACAD SCI USA, V96, P13288, DOI 10.1073/pnas.96.23.13288; Kudva IT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-103; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Larzabal M, 2010, DETECCION ESCHERICHI; Larzabal M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009046; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Matheus-Guimaraes C, 2014, FOODBORNE PATHOG DIS, V11, P248, DOI 10.1089/fpd.2013.1653; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mcwilliams BD, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0003-2013; Meichtri L, 2004, INT J FOOD MICROBIOL, V96, P189, DOI 10.1016/j.ijfoodmicro.2004.03.018; Mellor GE, 2012, APPL ENVIRON MICROB, V78, P4724, DOI 10.1128/AEM.00365-12; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Mora A, 2009, INT MICROBIOL, V12, P243, DOI 10.2436/20.1501.01.104; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; Noller AC, 2003, J CLIN MICROBIOL, V41, P675, DOI 10.1128/JCM.41.2.675-679.2003; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Repetto HA, 1997, KIDNEY INT, V52, P1708, DOI 10.1038/ki.1997.508; Riordan JT, 2008, J CLIN MICROBIOL, V46, P2070, DOI 10.1128/JCM.00203-08; Rivas M, 2003, EMERG INFECT DIS, V9, P1184; Rivas M, 2010, PATHOGENIC ESCHERICH, P142; Rivero MA, 2004, MEDICINA-BUENOS AIRE, V64, P352; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Shimizu E, 2014, MEM I OSWALDO CRUZ, V109, P236, DOI 10.1590/0074-0276140292; Shringi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051572; Shringi S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438, DOI 10.1128/IAI.58.8.2438-2445.1990; Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999	55	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127710	10.1371/journal.pone.0127710	http://dx.doi.org/10.1371/journal.pone.0127710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030198	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900074
J	Blakeslee, AMH; Keogh, CL; Fowler, AE; Griffen, BD				Blakeslee, April M. H.; Keogh, Carolyn L.; Fowler, Amy E.; Griffen, Blaine D.			Assessing the Effects of Trematode Infection on Invasive Green Crabs in Eastern North America	PLOS ONE			English	Article							CHARYBDIS-LONGICOLLIS LEENE; CARCINUS-MAENAS L.; SHORE CRAB; PREY SELECTION; METACERCARIAE DIGENEA; SACCULINA-CARCINI; INTERMEDIATE HOST; BURYING BEHAVIOR; LIFE-HISTORY; PARASITES	A common signature of marine invasions worldwide is a significant loss of parasites (= parasite escape) in non-native host populations, which may confer a release from some of the harmful effects of parasitism (e.g., castration, energy extraction, immune activation, behavioral manipulation) and possibly enhance the success of non-indigenous species. In eastern North America, the notorious invader Carcinus maenas (European green crab) has escaped more than two-thirds its native parasite load. However, one of its parasites, a trematode (Microphallus similis), can be highly prevalent in the non-native region; yet little is known about its potential impacts. We employed a series of laboratory experiments to determine whether and how M. similis infection intensity influences C. maenas, focusing on physiological assays of body mass index, energy storage, and immune activation, as well as behavioral analyses of foraging, shelter utilization, and conspicuousness. We found little evidence for enduring physiological or behavioral impacts four weeks after experimental infection, with the exception of mussel handling time which positively correlated with cyst intensity. However, we did find evidence for a short-term effect of M. similis infection during early stages of infection (soon after cercarial penetration) via a significant drop in circulating immune cells, and a significant increase in the crabs' righting response time. Considering M. similis is the only common parasite infecting C. maenas in eastern North America, our results for minimal lasting effects of the trematode on the crab's physiology and behavior may help explain the crab's continued prominence as a strong predator and competitor in the region.	[Blakeslee, April M. H.] Long Isl Univ, Brookville, NY 11548 USA; [Blakeslee, April M. H.; Fowler, Amy E.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Keogh, Carolyn L.] Univ Georgia, Athens, GA 30602 USA; [Fowler, Amy E.] Marine Resources Res Inst, South Carolina Dept Nat Resources, Charleston, SC 29422 USA; [Griffen, Blaine D.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Griffen, Blaine D.] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA	Smithsonian Institution; Smithsonian Environmental Research Center; University System of Georgia; University of Georgia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Blakeslee, AMH (corresponding author), Long Isl Univ, 720 Northern Blvd, Brookville, NY 11548 USA.	april.blakeslee@liu.edu	Griffen, Blaine/AAC-6384-2021	Fowler, Amy/0000-0003-4876-597X; Blakeslee, April/0000-0001-9667-2175	Research Opportunity Award; National Science Foundation award (NSF) [OCE-1129166]; Division Of Ocean Sciences [1129166] Funding Source: National Science Foundation	Research Opportunity Award; National Science Foundation award (NSF)(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a Research Opportunity Award to AMHB and BDG as a supplemental to BDG's National Science Foundation award (NSF #OCE-1129166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber I, 1997, FOLIA PARASIT, V44, P19; BATIE RE, 1983, NORTHWEST SCI, V57, P49; Blakeslee AMH, 2008, ECOLOGY, V89, P1068, DOI 10.1890/07-0832.1; Blakeslee AMH, 2013, ADV MAR BIOL, V66, P87, DOI 10.1016/B978-0-12-408096-6.00002-X; Blakeslee AMH, 2009, MAR ECOL PROG SER, V393, P83, DOI 10.3354/meps08225; Brawley SH, 2009, P NATL ACAD SCI USA, V106, P8239, DOI 10.1073/pnas.0812300106; Brousseau DJ, 2001, J EXP MAR BIOL ECOL, V262, P199, DOI 10.1016/S0022-0981(01)00290-8; Byers JE, 2008, ECOLOGY, V89, P439, DOI 10.1890/06-1036.1; Carlton JT, 2003, J BIOGEOGR, V30, P1809, DOI 10.1111/j.1365-2699.2003.00962.x; Choisy M, 2003, AM NAT, V162, P172, DOI 10.1086/375681; Chubb JC, 2010, TRENDS PARASITOL, V26, P93, DOI 10.1016/j.pt.2009.11.008; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; COMBES C, 1994, PARASITOLOGY, V109, pS3, DOI 10.1017/S0031182000085048; de Montaudouin X, 2005, J MAR BIOL ASSOC UK, V85, P809, DOI 10.1017/S0025315405011744; Dissanayake A, 2010, MAR ENVIRON RES, V70, P368, DOI 10.1016/j.marenvres.2010.07.004; Dittmer J, 2011, PARASITOL RES, V109, P759, DOI 10.1007/s00436-011-2319-2; Ellis JC, 2005, J EXP MAR BIOL ECOL, V324, P31, DOI 10.1016/j.jembe.2005.04.001; ELNER RW, 1980, J EXP MAR BIOL ECOL, V43, P151, DOI 10.1016/0022-0981(80)90022-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fredensborg BL, 2005, INT J PARASITOL, V35, P1061, DOI 10.1016/j.ijpara.2005.05.005; Fredensborg BL, 2004, J EXP MAR BIOL ECOL, V311, P253, DOI 10.1016/j.jembe.2004.05.011; FRIED B, 1986, J CHEM ECOL, V12, P1659, DOI 10.1007/BF01022372; Glude JB, 1955, T AM FISH SOC, V84, P13, DOI DOI 10.1577/1548-8659(1954)84[13:TEOTAP]2.0.CO;2; Goddard JHR, 2005, BIOL INVASIONS, V7, P895, DOI 10.1007/s10530-003-2981-0; Griffen BD, 2009, BIOL INVASIONS, V11, P027; Griffen BD, 2011, J EXP MAR BIOL ECOL, V406, P6, DOI 10.1016/j.jembe.2011.06.005; GROSHOLZ ED, 1995, MAR BIOL, V122, P239; Grosholz ED, 1996, BIOL CONSERV, V78, P59, DOI 10.1016/0006-3207(94)00018-2; Haas W, 2003, ZOOLOGY, V106, P349, DOI 10.1078/0944-2006-00125; Haas W, 2002, INT J PARASITOL, V32, P1145, DOI 10.1016/S0020-7519(02)00089-9; Hansen EK, 2005, PARASITOL RES, V97, P242, DOI 10.1007/s00436-005-1435-2; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HEARD RW, 1983, P HELM SOC WASH, V50, P170; Hollebone AL, 2008, BIOL INVASIONS, V10, P347, DOI 10.1007/s10530-007-9134-9; HUGHES RN, 1984, J EXP MAR BIOL ECOL, V77, P45, DOI 10.1016/0022-0981(84)90050-9; Innocenti G, 2003, CAN J ZOOL, V81, P173, DOI 10.1139/Z02-226; Innocenti G, 2007, HYDROBIOLOGIA, V590, P95, DOI 10.1007/s10750-007-0761-z; Innocenti G, 2009, J PARASITOL, V95, P1387, DOI 10.1645/GE-2026.1; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Kaplan AT, 2009, J PARASITOL, V95, P477, DOI 10.1645/GE-1737.1; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Koehler AV, 2010, J PARASITOL, V96, P862, DOI 10.1645/GE-2460.1; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lafferty KD, 1996, ECOLOGY, V77, P1390, DOI 10.2307/2265536; Lafferty KD, 1999, PARASITOL TODAY, V15, P111, DOI 10.1016/S0169-4758(99)01397-6; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; LINDBERG WJ, 1980, CRUSTACEANA, V39, P263, DOI 10.1163/156854080X00724; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Lohrer AM, 2002, ECOLOGY, V83, P719, DOI 10.2307/3071876; MARTORELLI SR, 1990, REV BIOL TROP, V38, P295; McCarthy HO, 2002, J PARASITOL, V88, P910, DOI 10.1645/0022-3395(2002)088[0910:LHALCP]2.0.CO;2; Meissner K, 1999, DIS AQUAT ORGAN, V35, P47, DOI 10.3354/dao035047; MENGE JL, 1974, OECOLOGIA, V17, P293, DOI 10.1007/BF00345748; Milinski M., 1990, P95; Mouritsen KN, 2006, MAR BIOL RES, V2, P270, DOI 10.1080/17451000600874752; Neal AT, 2012, J PARASITOL, V98, P293, DOI [10.1645/JP-GE-2969, 10.1645/JP-GE-2969.1]; Pina S, 2011, FOLIA PARASIT, V58, P48, DOI 10.14411/fp.2011.005; Poulin R, 2000, J FISH BIOL, V56, P123, DOI 10.1111/j.1095-8649.2000.tb02090.x; REBACH S, 1974, ECOLOGY, V55, P195, DOI 10.2307/1934636; Richards MG, 1999, J EXP MAR BIOL ECOL, V241, P159, DOI 10.1016/S0022-0981(99)00075-1; RICHARDSON TD, 1990, J EXP MAR BIOL ECOL, V142, P105, DOI 10.1016/0022-0981(90)90140-8; Robaldo RB, 1999, DIS AQUAT ORGAN, V37, P153, DOI 10.3354/dao037153; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Roman J, 2009, P ROYAL SOC B, V273, P2453; Ross DJ, 2004, MAR BIOL, V144, P747, DOI 10.1007/s00227-003-1223-4; Rudnick DA, 2005, CRUSTACEANA, V78, P787, DOI 10.1163/156854005774445500; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Saigusa M, 1997, MAR BIOL, V129, P87, DOI 10.1007/s002270050149; Saville DH, 2005, PARASITOLOGY, V131, P521, DOI 10.1017/S0031182005008048; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Small D, 2010, AQUAT BIOL, V10, P11, DOI 10.3354/ab00266; SPARKS AK, 1981, J INVERTEBR PATHOL, V38, P88, DOI 10.1016/0022-2011(81)90038-0; Stentiford GD, 2000, J EXP MAR BIOL ECOL, V247, P169, DOI 10.1016/S0022-0981(00)00146-5; Stentiford GD, 2005, J INVERTEBR PATHOL, V88, P136, DOI 10.1016/j.jip.2005.01.006; STRONG PL, 1972, J PARASITOL, V58, P92, DOI 10.2307/3278248; STUNKARD HW, 1957, BIOL BULL-US, V112, P254, DOI 10.2307/1539203; Thieltges DW, 2006, MAR ECOL PROG SER, V319, P129, DOI 10.3354/meps319129; Threlfall W, 1986, J EXP MAR BIOL ECOL, V2, P154; Torchin ME, 2001, BIOL INVASIONS, V3, P333, DOI 10.1023/A:1015855019360; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; TRUSCOTT R, 1990, FUNCT ECOL, V4, P455, DOI 10.2307/2389609; Walton WC, 2002, J EXP MAR BIOL ECOL, V272, P171, DOI 10.1016/S0022-0981(02)00127-2; Warrenchuk JJ, 2002, LOW WAKE FI, V19, P81; Werner M, 2001, OPHELIA, V55, P101, DOI 10.1080/00785236.2001.10409477; Whitlow WL, 2003, BIOL INVASIONS, V5, P23, DOI 10.1023/A:1024059025890; WILLIAMS IC, 1975, J EXP MAR BIOL ECOL, V17, P47, DOI 10.1016/0022-0981(75)90079-9; Wood CL, 2007, P NATL ACAD SCI USA, V104, P9335, DOI 10.1073/pnas.0700062104; Zetlmeisl C, 2011, PARASITOLOGY, V138, P394, DOI 10.1017/S0031182010001344	93	19	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128674	10.1371/journal.pone.0128674	http://dx.doi.org/10.1371/journal.pone.0128674			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030816	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900182
J	Hatipoglu, M; Saglam, M; Koseoglu, S; Koksal, E; Keles, A; Esen, HH				Hatipoglu, Mukerrem; Saglam, Mehmet; Koseoglu, Serhat; Koksal, Ekrem; Keles, Ali; Esen, Haci Hasan			The Effectiveness of Crataegus orientalis M Bieber. (Hawthorn) Extract Administration in Preventing Alveolar Bone Loss in Rats with Experimental Periodontitis	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; GINGIVAL CREVICULAR FLUID; REACTIVE OXYGEN; BORIC-ACID; SERUM; CONSTITUENTS; DISEASE; OXIDANT; FRUIT	The purpose of this animal study was to evaluate the effects of hawthorn (Crataeus orientalis M Bieber.) extract on serum oxidative status and alveolar bone loss in experimental periodontitis. Twenty-seven Wistar rats were assigned to one of the following groups: nonligated+placebo (saline) (NL, n = 9), ligature only+placebo (saline) (LO, n = 9), and ligature and treated with hawthorn extract in saline (H, n = 9) (100 mg/kg orogastrically, once a day for 11 days). Periodontitis was induced by submerging a 4/0 silk ligature in the sulcus of the mandibular right first molars of rats, and the animals were sacrificed after 11 days. Micro-CT examinations were performed for linear and volumetric parameter assessment of alveolar bone. Periodontal tissues were histopathologically examined to assess the differences among the study groups. Levels of serum total antioxidant status (TAS)/total oxidant status (TOS), and oxidative stress index (OSI) were also analyzed. Alveolar bone loss was significantly reduced by hawthorn administration compared to LO group (p<0.05). The number of inflammatory cells and osteoclasts in the LO group was significantly higher than that of the NL and H groups (p<0.05). The number of osteoblasts in the LO and H groups was significantly higher than that of the NL group (p<0.05). TOS and OSI levels were significantly reduced in H group compared to LO group (P < 0.05) and TAS levels were similar in H and NL group (p < 0.05). Hawthorn extract showed inhibitory effect on periodontal inflammation and alveolar bone loss by regulating TAS, TOS and OSI levels in periodontal disease in rats when administered systemically.	[Hatipoglu, Mukerrem] Akdeniz Univ, Sch Dent, Dept Periodontol, TR-07058 Antalya, Turkey; [Saglam, Mehmet; Koseoglu, Serhat] Izmir Katip Celebi Univ, Sch Dent, Dept Periodontol, Izmir, Turkey; [Koksal, Ekrem] Ondokuz Mayis Univ, Fac Sci & Arts, Dept Chem, Erzincan, Turkey; [Keles, Ali] Ondokuz Mayis Univ, Sch Dent, Dept Endodont, Samsun, Turkey; [Esen, Haci Hasan] Necmettin Erbakan Univ, Sch Med, Dept Pathol, Konya, Turkey	Akdeniz University; Izmir Katip Celebi University; Ondokuz Mayis University; Ondokuz Mayis University; Necmettin Erbakan University	Saglam, M (corresponding author), Izmir Katip Celebi Univ, Sch Dent, Dept Periodontol, Izmir, Turkey.	dtmehmetsaglam@gmail.com	sağlam, mehmet/HGB-1702-2022; Hatipoglu, Mukerrem/C-5431-2016; Hatipoglu, Mükerrem/HII-2944-2022; Keles, Ali/J-5897-2015	Keles, Ali/0000-0003-2835-767X				Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9; Bahorun T, 2003, NAHRUNG, V47, P191, DOI 10.1002/food.200390045; Baltacioglu E, 2006, J CLIN PERIODONTOL, V33, P385, DOI 10.1111/j.1600-051X.2006.00923.x; Benli M, 2008, CELL BIOCHEM FUNCT, V26, P844, DOI 10.1002/cbf.1515; Bor Z, 2012, TURK J MED SCI, V42, P315, DOI 10.3906/sag-1011-1304; Bostanci V, 2014, J PERIODONTOL, V85, P706, DOI 10.1902/jop.2013.130230; Buduneli E, 2004, J PERIODONTOL, V75, P1516, DOI 10.1902/jop.2004.75.11.1516; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Chapple ILC, 1997, J CLIN PERIODONTOL, V24, P287, DOI 10.1111/j.1600-051X.1997.tb00760.x; de Lima V, 2000, EUR J ORAL SCI, V108, P123, DOI 10.1034/j.1600-0722.2000.00766.x; Demirer S, 2012, ARCH ORAL BIOL, V57, P60, DOI 10.1016/j.archoralbio.2011.07.012; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Flemmig T F, 1999, Ann Periodontol, V4, P32, DOI 10.1902/annals.1999.4.1.32; Greenstein G, 1998, J PERIODONTOL, V69, P507, DOI 10.1902/jop.1998.69.5.507; Hosseinimehr SJ, 2007, J RADIAT RES, V48, P63, DOI 10.1269/jrr.06032; Kao ES, 2005, J AGR FOOD CHEM, V53, P430, DOI 10.1021/jf040231f; Keser Serhat, 2012, CHEM J, V2, P9; Kumar D, 2012, REV BRAS FARMACOGN, V22, P1187, DOI 10.1590/S0102-695X2012005000094; Lima V, 2004, J PERIODONTOL, V75, P162, DOI 10.1902/jop.2004.75.1.162; Ljubuncic P, 2005, J ETHNOPHARMACOL, V101, P153, DOI 10.1016/j.jep.2005.04.024; Luqman S, 2006, PHYTOTHER RES, V20, P303, DOI 10.1002/ptr.1861; Malekinejad H, 2013, J MED FOOD, V16, P593, DOI 10.1089/jmf.2012.2672; Niu Y, 2013, AFR J TRADIT COMPLEM, V10, P567; Oz HS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/754857; Ozdemir H, 2012, J PERIODONTAL RES, V47, P74, DOI 10.1111/j.1600-0765.2011.01406.x; Popovic-Milenkovic MT, 2014, ACTA POL PHARM, V71, P279; ROBINSON M, 1991, LAB ANIM, V25, P247, DOI 10.1258/002367791780808374; Saglam M, 2014, J PERIODONTAL RES, V49, P472, DOI 10.1111/jre.12126; Saglam M, 2015, J APPL ORAL SCI, V23, P33, DOI 10.1590/1678-775720140288; Sozer U, 2006, SCI PHARM, V74, P189; Struillou X, 2010, OPEN DENT J, V4, P37, DOI 10.2174/1874210601004010037; Tadic VM, 2008, J AGR FOOD CHEM, V56, P7700, DOI 10.1021/jf801668c; Toker H, 2008, J PERIODONTOL, V79, P1089, DOI [10.1902/jop.2008.070462, 10.1902/jop.2008.070462 ]; Toker H, 2009, J PERIODONTOL, V80, P672, DOI 10.1902/jop.2009.080509; Yao M, 2008, J ETHNOPHARMACOL, V118, P127, DOI 10.1016/j.jep.2008.03.020	36	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128134	10.1371/journal.pone.0128134	http://dx.doi.org/10.1371/journal.pone.0128134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030160	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900113
J	Huang, Y; Powers, C; Madala, SK; Greis, KD; Haffey, WD; Towbin, JA; Purevjav, E; Javadov, S; Strauss, AW; Khuchua, Z				Huang, Yan; Powers, Corey; Madala, Satish K.; Greis, Kenneth D.; Haffey, Wendy D.; Towbin, Jeffrey A.; Purevjav, Enkhsaikhan; Javadov, Sabzali; Strauss, Arnold W.; Khuchua, Zaza			Cardiac Metabolic Pathways Affected in the Mouse Model of Barth Syndrome	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; FATTY-ACID OXIDATION; PROTEIN; CARDIOLIPIN; MYOPATHY; FOLATE; SUPERCOMPLEXES; ORGANIZATION; DEFICIENCY; POLYMORPHISMS	Cardiolipin (CL) is a mitochondrial phospholipid essential for electron transport chain (ETC) integrity. CL-deficiency in humans is caused by mutations in the tafazzin (Taz) gene and results in a multisystem pediatric disorder, Barth syndrome (BTHS). It has been reported that tafazzin deficiency destabilizes mitochondrial respiratory chain complexes and affects supercomplex assembly. The aim of this study was to investigate the impact of Taz-knockdown on the mitochondrial proteomic landscape and metabolic processes, such as stability of respiratory chain supercomplexes and their interactions with fatty acid oxidation enzymes in cardiac muscle. Proteomic analysis demonstrated reduction of several polypeptides of the mitochondrial respiratory chain, including Rieske and cytochrome c1 subunits of complex III, NADH dehydrogenase alpha subunit 5 of complex I and the catalytic core-forming subunit of F0F1-ATP synthase. Taz gene knockdown resulted in upregulation of enzymes of folate and amino acid metabolic pathways in heart mitochondria, demonstrating that Taz-deficiency causes substantive metabolic remodeling in cardiac muscle. Mitochondrial respiratory chain supercomplexes are destabilized in CL-depleted mitochondria from Taz knockdown hearts resulting in disruption of the interactions between ETC and the fatty acid oxidation enzymes, very long-chain acyl-CoA dehydrogenase and long-chain 3-hydroxyacyl-CoA dehydrogenase, potentially affecting the metabolic channeling of reducing equivalents between these two metabolic pathways. Mitochondria-bound myoglobin was significantly reduced in Taz-knockdown hearts, potentially disrupting intracellular oxygen delivery to the oxidative phosphorylation system. Our results identify the critical pathways affected by the Taz-deficiency in mitochondria and establish a future framework for development of therapeutic options for BTHS.	[Huang, Yan; Powers, Corey; Towbin, Jeffrey A.; Purevjav, Enkhsaikhan; Strauss, Arnold W.; Khuchua, Zaza] Univ Cincinnati, Coll Med, Inst Heart, Dept Pediat, Cincinnati, OH 45220 USA; [Huang, Yan; Powers, Corey; Madala, Satish K.; Towbin, Jeffrey A.; Purevjav, Enkhsaikhan; Strauss, Arnold W.; Khuchua, Zaza] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Madala, Satish K.] Univ Cincinnati, Coll Med, Dept Pediat, Div Pulm Med, Cincinnati, OH USA; [Greis, Kenneth D.; Haffey, Wendy D.] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA; [Javadov, Sabzali] Univ Puerto Rico, Sch Med, Dept Physiol, San Juan, PR 00936 USA; [Towbin, Jeffrey A.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Towbin, Jeffrey A.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Towbin, Jeffrey A.] Le Bonheur Childrens Hosp, Memphis, TN USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Khuchua, Z (corresponding author), Univ Cincinnati, Coll Med, Inst Heart, Dept Pediat, Cincinnati, OH 45220 USA.	zaza.khuchua@cchmc.org	Javadov, Sabzali/J-9594-2017; Huang, Yan/C-8202-2014; Towbin, Jeffrey A./J-5595-2019; Khuchua, Zaza/J-6536-2016	Huang, Yan/0000-0001-9464-6889; Towbin, Jeffrey A./0000-0002-6585-714X; Khuchua, Zaza/0000-0003-3582-5670; Javadov, Sabzali/0000-0002-7024-5383; Greis, Kenneth/0000-0002-5316-3351	National Institute of Health (NIH) [1R01HL108867]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108867] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Study was funded by National Institute of Health (NIH) grant 1R01HL108867.	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Acehan D, 2009, MITOCHONDRION, V9, P86, DOI 10.1016/j.mito.2008.12.001; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Bottinger L, 2016, J BIOENERG BIOMEMBR, V48, P125, DOI 10.1007/s10863-015-9599-7; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Christensen KE, 2013, HUM MOL GENET, V22, P3705, DOI 10.1093/hmg/ddt223; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Diaz F., 2009, CURR PROTOC HUM GENE, V19, P4, DOI [DOI 10.1002/0471142905.HG1904S63, 10.1002/0471142905.hg1904s63]; Eismann T, 2009, AM J PHYSIOL-GASTR L, V296, pG266, DOI 10.1152/ajpgi.90583.2008; Eriksson M, 2009, J MOL DIAGN, V11, P257, DOI 10.2353/jmoldx.2009.080161; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Jalba MS, 2008, OBESITY, V16, P2096, DOI 10.1038/oby.2008.327; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5; Liu TT, 2014, LIFE SCI, V101, P27, DOI 10.1016/j.lfs.2014.02.004; Lutucuta S, 2001, CIRC RES, V88, P969, DOI 10.1161/hh0901.090301; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Meeson AP, 2001, CIRC RES, V88, P713, DOI 10.1161/hh0701.089753; Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nouws J, 2014, HUM MOL GENET, V23, P1311, DOI 10.1093/hmg/ddt521; Padmanabhan N, 2013, CELL, V155, P81, DOI 10.1016/j.cell.2013.09.002; Peralta S, 2014, HUM MOL GENET, V23, P1399, DOI 10.1093/hmg/ddt526; Phoon CKL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000455; Powers C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00074; Rak M, 2014, FEBS LETT, V588, P1832, DOI 10.1016/j.febslet.2014.03.046; Rodriguez RMG, 2013, INT J CARDIOL, V167, P768, DOI 10.1016/j.ijcard.2012.03.047; Rosenquist TH, 2013, DEV DYNAM, V242, P201, DOI 10.1002/dvdy.23922; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Shin M, 2014, J BIOL CHEM, V289, P15507, DOI 10.1074/jbc.M114.555573; Soustek MS, 2011, HUM GENE THER, V22, P865, DOI 10.1089/hum.2010.199; Spencer CT, 2011, AM J PHYSIOL-HEART C, V301, pH2122, DOI 10.1152/ajpheart.00479.2010; Taylor WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048628; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004; Vlecken DH, 2009, INT J DEV BIOL, V53, P517, DOI 10.1387/ijdb.082651dv; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wang W, 2014, MOL GENET METAB, V112, P30, DOI 10.1016/j.ymgme.2014.02.014; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Yasuda N, 2002, LIFE SCI, V71, P227, DOI 10.1016/S0024-3205(02)01637-5; Zhang BY, 2014, J PROTEOMICS, V101, P154, DOI 10.1016/j.jprot.2014.02.017	59	47	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128561	10.1371/journal.pone.0128561	http://dx.doi.org/10.1371/journal.pone.0128561			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030409	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900171
J	Myer, PR; Smith, TPL; Wells, JE; Kuehn, LA; Freetly, HC				Myer, Phillip R.; Smith, Timothy P. L.; Wells, James E.; Kuehn, Larry A.; Freetly, Harvey C.			Rumen Microbiome from Steers Differing in Feed Efficiency	PLOS ONE			English	Article							ACIDOSIS SARA ADAPTATION; BACTERIAL DIVERSITY; RUMINAL ACIDOSIS; BEEF-CATTLE; PHYLOGENETIC DIVERSITY; BOVINE RUMEN; DAIRY-COWS; COMMUNITY; ECOLOGY; IMPACT	The cattle rumen has a diverse microbial ecosystem that is essential for the host to digest plant material. Extremes in body weight (BW) gain in mice and humans have been associated with different intestinal microbial populations. The objective of this study was to characterize the microbiome of the cattle rumen among steers differing in feed efficiency. Two contemporary groups of steers (n=148 and n=197) were fed a ration (dry matter basis) of 57.35% dry-rolled corn, 30% wet distillers grain with solubles, 8% alfalfa hay, 4.25% supplement, and 0.4% urea for 63 days. Individual feed intake (FI) and BW gain were determined. Within contemporary group, the four steers within each Cartesian quadrant were sampled (n=16/group) from the bivariate distribution of average daily BW gain and average daily FI. Bacterial 16S rRNA gene amplicons were sequenced from the harvested bovine rumen fluid samples using next-generation sequencing technology. No significant changes in diversity or richness were indicated, and UniFrac principal coordinate analysis did not show any separation of microbial communities within the rumen. However, the abundances of relative microbial populations and operational taxonomic units did reveal significant differences with reference to feed efficiency groups. Bacteroidetes and Firmicutes were the dominant phyla in all ruminal groups, with significant population shifts in relevant ruminal taxa, including phyla Firmicutes and Lentisphaerae, as well as genera Succiniclasticum, Lactobacillus, Ruminococcus, and Prevotella. This study suggests the involvement of the rumen microbiome as a component influencing the efficiency of weight gain at the 16S level, which can be utilized to better understand variations in microbial ecology as well as host factors that will improve feed efficiency.	[Myer, Phillip R.; Smith, Timothy P. L.; Wells, James E.; Kuehn, Larry A.; Freetly, Harvey C.] USDA ARS, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA	United States Department of Agriculture (USDA)	Freetly, HC (corresponding author), USDA ARS, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA.	Harvey.Freetly@ars.usda.gov		Kuehn, Larry/0000-0002-7573-5365; Myer, Phillip/0000-0002-1980-2105	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food Agriculture [2011-68004-30214]; USDA, Agricultural Research Service; ARS [ARS-0422392] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food Agriculture; USDA, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by Agriculture and Food Research Initiative Competitive Grant No. 2011-68004-30214 from the USDA National Institute of Food Agriculture as well as the USDA, Agricultural Research Service.	Aronesty E., 2011, EA UTILS COMMAND LIN; Arthur PF, 2005, AUST J EXP AGR, V45, P985, DOI 10.1071/EA05052; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Canibe N, 2005, J ANIM SCI, V83, P1287; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; COOK GM, 1994, INT J SYST BACTERIOL, V44, P576, DOI 10.1099/00207713-44-3-576; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hales KE, 2014, J ANIM SCI, V92, P264, DOI 10.2527/jas.2013-6994; Hernandez-Sanabria E, 2012, APPL ENVIRON MICROB, V78, P1203, DOI 10.1128/AEM.05114-11; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hook SE, 2011, FEMS MICROBIOL ECOL, V78, P275, DOI 10.1111/j.1574-6941.2011.01154.x; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Jing L, 2014, BR J NUTR, V28, P1; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kishimoto A, 2006, CURR MICROBIOL, V53, P173, DOI 10.1007/s00284-005-0219-3; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lindholm-Perry AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080882; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mao SY, 2013, ANAEROBE, V24, P12, DOI 10.1016/j.anaerobe.2013.08.003; McCann JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091864; Nyonyo T, 2014, FEMS MICROBIOL ECOL, V88, P528, DOI 10.1111/1574-6941.12318; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prive F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069076; Ross EM, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-53; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Suen G, 2011, J BACTERIOL, V193, P5574, DOI 10.1128/JB.05621-11; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Wells JE, 1997, FEMS MICROBIOL ECOL, V22, P237, DOI 10.1111/j.1574-6941.1997.tb00376.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	46	182	197	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129174	10.1371/journal.pone.0129174	http://dx.doi.org/10.1371/journal.pone.0129174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030887	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900214
J	Shi, JW; Wang, S; Zhou, P; Shi, LY; Zhang, Y; Bai, F; Xue, D; Zhang, XK				Shi, Jianwei; Wang, Sheng; Zhou, Ping; Shi, Leiyu; Zhang, Yu; Bai, Fei; Xue, Di; Zhang, Xinkai			The Frequency of Patient-Initiated Violence and Its Psychological Impact on Physicians in China: A Cross-Sectional Study	PLOS ONE			English	Article							WORKPLACE VIOLENCE; JOB-SATISFACTION; OCCUPATIONAL VIOLENCE; EMERGENCY-DEPARTMENTS; GENERAL-PRACTICE; AGGRESSION; PREVALENCE; DOCTORS; GPS	Introduction In China, the severity of medical disputes has greatly increased during the past two decades, which has caused various adverse outcomes for health professionals. Previous research on violence in healthcare settings has primarily examined the occurrence of patient-initiated violence and its effects on physicians, but few studies have focused on the impact of the extent of physicians' exposure to violence. This study examined the different frequency levels of specific types of violence and their relationships to physicians' psychological wellbeing, including emotional exhaustion (EE), job satisfaction (JS), and intention to leave (IL). Methods Using a stratified random sampling method, the participants were drawn from 123 public hospitals in Shanghai, Hubei Province, and Gansu Province in China, and 1,656 completed questionnaires were collected. Chi-square test, analysis of variance, and mixed linear model were employed in the analysis. Results The results showed that the rate of exposure to verbal abuse (VA) was the highest (92.75%), followed by threats of assault (TA, 88.10%) and physical assaults (PA, 81.04%). Physicians' reported high-frequency exposure to VA, TA, and PA was 35.14%, 27.72%, and 19.32%, respectively. The results indicated that exposure to violence significantly affected EE, JS, and IL, and the intensity of the harm of high-frequency exposure was several times stronger than that of low-frequency exposure. Interestingly, we found that VA produced a greater adverse impact on physicians' EE and satisfaction with work (JS-1) than did TA or PA. This finding may be attributed to the fact that physicians are more likely to be exposed to a high frequency of VA, and the effect of high-frequency exposure is much stronger. Conclusion The results indicated that decreasing violent incidents and creating a safer work environment for physicians should be a top priority for both government and society.	[Shi, Jianwei; Zhou, Ping; Xue, Di] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Sch Publ Hlth, Key Lab Hlth Technol Assessment,Minist Hlth, Shanghai 200032, Peoples R China; [Wang, Sheng] E China Normal Univ, Sch Business, Shanghai 200241, Peoples R China; [Shi, Leiyu] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Zhang, Yu] Hlth & Family Planning Commiss Hubei Prov, Wuhan 430079, Hubei, Peoples R China; [Bai, Fei] Hlth & Family Planning Commiss Gansu Prov, Lanzhou 730030, Gansu, Peoples R China; [Zhang, Xinkai] Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Fudan University; East China Normal University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhou, P (corresponding author), Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Sch Publ Hlth, Key Lab Hlth Technol Assessment,Minist Hlth, Shanghai 200032, Peoples R China.	zhouping@fudan.edu.cn			National Natural Science Foundation of China [71203032]; Shanghai Planning Project of Philosophy and Social Science [2014EGL005]; Fudan University Scientific Research Capability Promotion for Youth	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Planning Project of Philosophy and Social Science; Fudan University Scientific Research Capability Promotion for Youth	Study design, data collection and analysis, preparation of the manuscript and decision to publish: Supported by the National Natural Science Foundation of China (Grant number 71203032), http://www.nsfc.gov.cn/. Preparation of the manuscript and decision to publish: Supported by the Shanghai Planning Project of Philosophy and Social Science (Grant number 2014EGL005), http://www.sh-popss.gov.cn/newsInfo.asp?idval=5869. Preparation of the manuscript and decision to publish: Supported by the Fudan University Scientific Research Capability Promotion for Youth.	Abualrub RF, 2007, J NURS SCHOLARSHIP, V39, P281, DOI 10.1111/j.1547-5069.2007.00181.x; [Anonymous], 2012, LANCET, V379, P1764, DOI 10.1016/S0140-6736(12)60729-6; Arnetz JE, 2011, AM J IND MED, V54, P925, DOI 10.1002/ajim.20984; Belayachi J, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-27; Carmi-Iluz T, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-54; Ceramidas DM, 2010, AUST J PRIM HEALTH, V16, P252, DOI 10.1071/PY09074; Coles J, 2007, AUST FAM PHYSICIAN, V36, P189; Driscoll R.J., 1995, CONSULTING PSYCHOL J, V47, P205, DOI DOI 10.1037/1061-4087.47.4.205; Elston MA, 2002, SOCIOL HEALTH ILL, V24, P575, DOI 10.1111/1467-9566.00309; EMANUEL EJ, 1995, JAMA-J AM MED ASSOC, V273, P323, DOI 10.1001/jama.273.4.323; Ergun FS, 2005, INT NURS REV, V52, P154; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gates DM, 2006, J EMERG MED, V31, P331, DOI 10.1016/j.jemermed.2005.12.028; Gong YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103242, 10.1371/journal.pone.0095597]; Heponiemi T, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-19; Jie L, 2012, LANCET, V379, P1878, DOI 10.1016/S0140-6736(12)60774-0; Kadra G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093660; Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P779, DOI 10.1136/oem.60.10.779; Konrad TR, 1999, MED CARE, V37, P1174, DOI 10.1097/00005650-199911000-00010; Koritsas S, 2007, BRIT J GEN PRACT, V57, P967, DOI 10.3399/096016407782604848; Kowalenko T, 2005, ANN EMERG MED, V46, P142, DOI 10.1016/j.annemergmed.2004.10.010; Lu GH., 2008, STUDIES PSYCHOL BEHA, V6, P103; Magin PJ, 2005, MED J AUSTRALIA, V183, P352, DOI 10.5694/j.1326-5377.2005.tb07082.x; Marilym J, 1998, ETHICAL CONDUCT CLIN, P114; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; MCANENEY CM, 1994, ANN EMERG MED, V23, P1248, DOI 10.1016/S0196-0644(94)70349-3; Quine L, 2001, J HEALTH PSYCHOL, V6, P73, DOI 10.1177/135910530100600106; Rid A, 2010, JAMA-J AM MED ASSOC, V304, P1472, DOI 10.1001/jama.2010.1414; Sherman MF, 2008, J OCCUP ENVIRON MED, V50, P1430, DOI 10.1097/JOM.0b013e31818a388e; Shields Margot, 2009, Health Rep, V20, P7; Simons Shellie, 2008, ANS Adv Nurs Sci, V31, pE48, DOI 10.1097/01.ANS.0000319571.37373.d7; Tolhurst Helen, 2003, Aust J Rural Health, V11, P231, DOI 10.1111/j.1440-1584.2003.00525.x; Wang XQ, 2012, LANCET, V380, P647, DOI 10.1016/S0140-6736(12)61367-1; Warren MG, 1998, J HEALTH SOC BEHAV, V39, P356, DOI 10.2307/2676344; Westra AE, 2011, J PEDIATR-US, V159, P496, DOI 10.1016/j.jpeds.2011.05.034; Williams ES, 2001, HEALTH CARE MANAGE R, V26, P7, DOI 10.1097/00004010-200101000-00002; World Health Organization, 2002, NEW RES SHOWS WORKPL; Wu SY, 2014, ARCH ENVIRON OCCUP H, V69, P81, DOI 10.1080/19338244.2012.732124; Wynne R., 1997, GUIDANCE PREVENTION	39	59	60	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128394	10.1371/journal.pone.0128394	http://dx.doi.org/10.1371/journal.pone.0128394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030143	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900145
J	Tao, JJ; Qi, QW; Kang, M; Huang, HW				Tao, Junjie; Qi, Qingwen; Kang, Ming; Huang, Hongwen			Adaptive Molecular Evolution of PHYE in Primulina, a Karst Cave Plant	PLOS ONE			English	Article							FLOWERING TIME; PHYLOGENETIC ANALYSIS; POSITIVE SELECTION; NATURAL VARIATION; PHYTOCHROME-C; ARABIDOPSIS; LIGHT; EXPRESSION; FAMILY; GROWTH	Limestone Karst areas possess high levels of biodiversity and endemism. Primulina is a typical component of Karst endemic floras. The high species richness and wide distribution in various Karst microenvironments make the genus an idea model for studying speciation and local adaptation. In this study, we obtained 10 full-length sequences of the phytochrome PHYE from available transcriptome resources of Primulina and amplified partial sequences of PHYE from the genomic DNA of 74 Primulina species. Then, we used maximum-likelihood approaches to explore molecular evolution of PHYE in this Karst cave plant. The results showed that PHYE was dominated by purifying selection in both data sets, and two sites were identified as potentially under positive selection. Furthermore, the. ratio varies greatly among different functional domains of PHYE and among different species lineages. These results suggest that potential positive selection in PHYE might have played an important role in the adaption of Primulina to heterogeneous light environments in Karst regions, and different species lineages might have been subjected to different selective pressures.	[Tao, Junjie; Qi, Qingwen; Kang, Ming; Huang, Hongwen] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Tao, Junjie; Qi, Qingwen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kang, M (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	mingkang@scbg.ac.cn; huanghw@mail.scbg.ac.cn	Kang, Ming/M-2368-2019		Natural Science Foundation of China [31270427]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (31270427).	Ai B, 2015, MOL ECOL RESOUR, V15, P619, DOI 10.1111/1755-0998.12333; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Arana MV, 2014, PLANT CELL ENVIRON, V37, P2014, DOI 10.1111/pce.12286; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Carvalho RF, 2011, J INTEGR PLANT BIOL, V53, P920, DOI 10.1111/j.1744-7909.2011.01081.x; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Davis S.D., 1995, CTR PLANT DIVERSITY, V2; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Halliday KJ, 2003, PLANT PHYSIOL, V131, P1913, DOI 10.1104/pp.102.018135; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Hennig L, 2002, PLANT PHYSIOL, V128, P194, DOI 10.1104/pp.010559; Heschel MS, 2007, NEW PHYTOL, V174, P735, DOI 10.1111/j.1469-8137.2007.02044.x; Ikeda H, 2010, MOL ECOL, V19, P2779, DOI 10.1111/j.1365-294X.2010.04700.x; Ikeda H, 2009, GENETICS, V182, P603, DOI 10.1534/genetics.109.102152; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Ingvarsson PK, 2006, GENETICS, V172, P1845, DOI 10.1534/genetics.105.047522; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kang M, 2014, NEW PHYTOL, V202, P1371, DOI 10.1111/nph.12726; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Liang KM, 2010, PHOTOSYNTHETICA, V48, P494, DOI 10.1007/s11099-010-0066-8; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; Mathews S, 2003, MOL BIOL EVOL, V20, P1087, DOI 10.1093/molbev/msg123; Mathews S, 2008, MOL PHYLOGENET EVOL, V49, P411, DOI 10.1016/j.ympev.2008.07.026; Mathews S, 2010, PLANT CELL, V22, P4, DOI 10.1105/tpc.109.072280; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nylander JAA., 2004, BIOINFORMATICS; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Pride D., 2000, SWAPP VERSION 1 0 2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Samis KE, 2008, EVOLUTION, V62, P2971, DOI 10.1111/j.1558-5646.2008.00484.x; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang J, 2010, BIOCHEM GENET, V48, P236, DOI 10.1007/s10528-009-9313-8; White GM, 2004, MOL BIOL EVOL, V21, P716, DOI 10.1093/molbev/msh067; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	50	6	11	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127821	10.1371/journal.pone.0127821	http://dx.doi.org/10.1371/journal.pone.0127821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030408	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900083
J	Xing, HJ; Jia, K; He, J; Shi, CZ; Fang, MX; Song, LL; Zhang, P; Zhao, Y; Fu, JN; Li, SJ				Xing, Huijie; Jia, Kun; He, Jun; Shi, Changzheng; Fang, Meixia; Song, Linliang; Zhang, Pu; Zhao, Yue; Fu, Jiangnan; Li, Shoujun			Establishment of the Tree Shrew as an Alcohol-Induced Fatty Liver Model for the Study of Alcoholic Liver Diseases	PLOS ONE			English	Article							OXIDATIVE STRESS; INJURY; MICE; CYP2E1; METABOLISM; ACTIVATION; STEATOSIS; INDUCTION; ADDUCTS; GENES	Currently, the pathogenesis of alcoholic liver diseases (ALDs) is not clear. As a result, there is no effective treatment for ALDs. One limitation is the lack of a suitable animal model for use in studying ALDs. The tree shrew is a lower primate animal, characterized by a high-alcohol diet. This work aimed to establish a fatty liver model using tree shrews and to assess the animals' suitability for the study of ALDs. Tree shrews were treated with alcohol solutions (10% and 20%) for two weeks. Hemophysiology, blood alcohol concentrations (BACs), oxidative stress factors, alcohol metabolic enzymes and hepatic pathology were checked and assayed with an automatic biochemical analyzer, enzyme-linked immunosorbent assay (ELISA), western blot, hematoxylin-eosin (HE) staining and oil red O staining, and magnetic resonance imaging (MRI). Compared with the normal group, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transpeptidase (GGT), total cholesterol (TC), triglyceride (TG), reactive oxygen species (ROS), and malondialdehyde (MDA) were significantly enhanced in alcohol-treated tree shrews. However, the activity of reduced glutathione hormone (GSH) and superoxide dismutase (SOD) declined. Notable changes in alcohol dehydrogenase (ADH1), aldehyde dehydrogenase(ALDH2), CYP2E1, UDP-glucuronosyl transferase 1A1 (UGT1A1) and nuclear factor erythroid-related factor 2 (Nrf2) were observed. HE and oil red O staining showed that hepatocyte swelling, hydropic degeneration, and adipohepatic syndrome occurred in the tree shrews. Alcohol can induce fatty liver-like pathological changes and result in alterations in liver function, oxidative stress factors, alcohol metabolism enzymes and Nrf2. Therefore, the established fatty liver model of tree shrews induced by alcohol should be a promising tool for the study of ALDs.	[Xing, Huijie; Jia, Kun; Li, Shoujun] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Xing, Huijie; Jia, Kun; Li, Shoujun] Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China; [Xing, Huijie; He, Jun; Fang, Meixia; Song, Linliang; Zhang, Pu; Zhao, Yue; Fu, Jiangnan] Jinan Univ, Inst Lab Anim, Guangzhou, Guangdong, Peoples R China; [Shi, Changzheng] Jinan Univ, Attached Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Jinan University; Jinan University	Fu, JN (corresponding author), Jinan Univ, Inst Lab Anim, Guangzhou, Guangdong, Peoples R China.	fujiangnan126@126.com; shoujunli@scau.edu.cn			Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases [2013A061401013]; Special Fund for Agro-scientific Research in the Public Interest [201303042]; Natural Science Foundation of Guangdong Province [S2013040016474]	Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases; Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported in part by the Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (2013A061401013), Special Fund for Agro-scientific Research in the Public Interest (201303042) and Natural Science Foundation of Guangdong Province (S2013040016474).	Adachi M, 2002, FREE RADICAL BIO MED, V32, P487, DOI 10.1016/S0891-5849(02)00740-2; Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243; Asare GA, 2008, TOXICOLOGY, V254, P11, DOI 10.1016/j.tox.2008.08.024; Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532; Buckley DB, 2009, DRUG METAB DISPOS, V37, P847, DOI 10.1124/dmd.108.024190; Cao J, 2003, J MED PRIMATOL, V32, P123, DOI 10.1034/j.1600-0684.2003.00022.x; Curry-McCoy TV, 2010, ALCOHOL CLIN EXP RES, V34, P251, DOI 10.1111/j.1530-0277.2009.01088.x; Donohue TM, 2004, ALCOHOL CLIN EXP RES, V28, P1257, DOI 10.1097/01.ALC.0000134233.89896.19; El-Guindy NBD, 2010, ALCOHOL CLIN EXP RES, V34, P1489, DOI 10.1111/j.1530-0277.2010.01234.x; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Foti RS, 2005, FORENSIC SCI INT, V153, P109, DOI 10.1016/j.forsciint.2004.12.003; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Gregory PA, 2004, TOXICOL APPL PHARM, V199, P354, DOI 10.1016/j.taap.2004.01.008; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Pateria P, 2013, BEST PRACT RES CL GA, V27, P577, DOI 10.1016/j.bpg.2013.08.001; Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209; Siegmund S, 2003, BEST PRACT RES CL GA, V17, P519, DOI 10.1016/S1521-6918(03)00033-7; Smathers RL, 2011, CHEM-BIOL INTERACT, V192, P107, DOI 10.1016/j.cbi.2011.02.021; Sofair AN, 2010, J CLIN GASTROENTEROL, V44, P301, DOI 10.1097/MCG.0b013e3181b3f760; Tsedensodnom O, 2013, DIS MODEL MECH, V6, P1213, DOI 10.1242/dmm.012195; Tuma DJ, 2002, FREE RADICAL BIO MED, V32, P303, DOI 10.1016/S0891-5849(01)00742-0; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P157, DOI 10.1111/j.1600-0714.2007.00605.x; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105; Zakhari S, 2013, ALCOHOL RES-CURR REV, V35, P6; Zhou ZX, 2005, AM J PATHOL, V166, P1681, DOI 10.1016/S0002-9440(10)62478-9	34	17	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128253	10.1371/journal.pone.0128253	http://dx.doi.org/10.1371/journal.pone.0128253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030870	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900134
J	Yang, YC; Zhang, N; Van Crombruggen, K; Lan, F; Hu, GH; Hong, SL; Bachert, C				Yang, Yucheng; Zhang, Nan; Van Crombruggen, Koen; Lan, Feng; Hu, Guohua; Hong, Suling; Bachert, Claus			Differential Expression and Release of Activin A and Follistatin in Chronic Rhinosinusitis with and without Nasal Polyps	PLOS ONE			English	Article							ALLERGIC-ASTHMA; BINDING-PROTEIN; INFLAMMATION; DISEASE; ACTIVATION; REGULATOR; PATHWAYS	Background Chronic rhinosinusitis with (CRSwNP) and without nasal polyps (CRSsNP) should be regarded as distinct clinical entities based on differential inflammatory mediator and remodeling profiles. Activin A, a member of the TGF-beta superfamily, plays an important role in inflammation and remodeling in the lower airways, although its expression and release in the upper airways remain undescribed. Objective To investigate the expression of activin A and its inhibitor follistatin in nasal tissue samples from CRSsNP and CRSwNP patients, and to monitor the spontaneous release of these molecules in a human mucosal model. Methods Protein levels were determined using ELISA for activin A, follistatin, TGF-beta 1 and indicator proteins (IL-5, ECP, IFN gamma) in 13 CRSsNP, 23 CRSwNP, and 10 control samples. The spontaneous release rate and the release ratios of activin A, follistatin and TGF-beta 1 were determined in 9 CRSsNP and 7 CRSwNP tissue fragments cultured ex-vivo. The induction of activin A and TGF-beta 1 by one another was studied in 7 CRSsNP tissue fragments cultured ex-vivo. Results Significantly higher concentrations of activin A, follistatin, TGF-beta 1, and IFN. were observed in CRSsNP compared with CRSwNP samples, whereas the concentrations of IL-5 and ECP were significantly lower. Follistatin was positively and linearly correlated with activin A in CRSsNP and CRSwNP. Activin A, follistatin and TGF-beta 1 were all spontaneously released by the samples, although the relative ratios released by tissue fragments from CRSsNP and CRSwNP samples were significantly different, with a higher follistatin/activin A-ratio and a follistatin/TGF beta 1-ratio (with less overall TGF-beta 1) in CRSwNP than in CRSsNP. Furthermore, TGF-beta 1 enhanced activin A secretion in CRSsNP tissue fragments cultured ex-vivo. Conclusion The differences in tissue concentrations and spontaneous release rates for activin A and follistatin in different CRS samples support the hypothesis that CRSsNP and CRSwNP are two distinct disease entities with respect to remodeling patterns.	[Yang, Yucheng; Hu, Guohua; Hong, Suling] Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China; [Zhang, Nan; Van Crombruggen, Koen; Lan, Feng; Bachert, Claus] Univ Ghent, Dept Otorhinolaryngol, Upper Airway Res Lab, B-9000 Ghent, Belgium; [Bachert, Claus] Karolinska Inst, Clintec, Div Nose Throat & Ear Dis, Stockholm, Sweden	Chongqing Medical University; Ghent University; Karolinska Institutet	Yang, YC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China.	yychxh@163.com	Bachert, Claus/J-8825-2012; Zhang, Nan/AAQ-3944-2020		European Commission's Seventh Framework program [43 260895]; Flemish Scientific Research Board (FWO grant) [8.417.08.N.01, G039412]; Interuniversity Attraction Poles program (IUAP) (Belgian Science Policy) [IAP7/30]; Fund for Scientific Research Flanders (FWO-Vlaanderen) [G.0641.10]; Special Research Fund (BOF) [01J01113]; Natural Science Foundation of Chongqing (China) [cstc2013jcyjA10036]; medical research projects of Chongqing Health Bureau (China) [2012-2-024]; National Key Clinical Specialist Construction Programs of China [2012-649]	European Commission's Seventh Framework program; Flemish Scientific Research Board (FWO grant); Interuniversity Attraction Poles program (IUAP) (Belgian Science Policy)(Belgian Federal Science Policy Office); Fund for Scientific Research Flanders (FWO-Vlaanderen)(FWO); Special Research Fund (BOF); Natural Science Foundation of Chongqing (China)(Natural Science Foundation of Chongqing); medical research projects of Chongqing Health Bureau (China); National Key Clinical Specialist Construction Programs of China	This work was supported by the European Commission's Seventh Framework program (No. 43 260895, PREDICTA, to CB), the Flemish Scientific Research Board (FWO grant no. 8.417.08.N.01, G039412 to CB), the Interuniversity Attraction Poles program (IUAP) (Belgian Science Policy IAP7/30 to CB), the Fund for Scientific Research Flanders (FWO-Vlaanderen - Projects G.0641.10 to CB and KVC), the Special Research Fund (BOF Nr. 01J01113 to KVC); the Natural Science Foundation of Chongqing (cstc2013jcyjA10036 - China to YY), the medical research projects of Chongqing Health Bureau (2012-2-024 - China to YY), and the National Key Clinical Specialist Construction Programs of China (No. 2012-649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2012, PEDIAT ALLERG IMM-UK, V23, P2, DOI 10.1111/j.1399-3038.2012.01318.x; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; FOKKENS WJ, 2012, RHINOLOGY, V50, P1, DOI DOI 10.4193/RHINO12.000; Forrester HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077119; Hardy CL, 2013, THORAX, V68, P9, DOI 10.1136/thoraxjnl-2011-201128; Hardy CL, 2006, CLIN EXP ALLERGY, V36, P941, DOI 10.1111/j.1365-2222.2006.02523.x; Hedger MP, 2013, CYTOKINE GROWTH F R, V24, P285, DOI 10.1016/j.cytogfr.2013.03.003; Kariyawasam HH, 2011, CLIN EXP ALLERGY, V41, P1505, DOI 10.1111/j.1365-2222.2011.03784.x; Kariyawasam HH, 2009, J ALLERGY CLIN IMMUN, V124, P454, DOI 10.1016/j.jaci.2009.06.022; Klingberg F, 2014, J CELL BIOL, V207, P283, DOI 10.1083/jcb.201402006; Mayer AK, 2008, EUR J IMMUNOL, V38, P1689, DOI 10.1002/eji.200737936; Naf S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092175; Patou J, 2011, RHINOLOGY, V49, P100, DOI 10.4193/Rhino09.147; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shoham T, 2001, J HISTOCHEM CYTOCHEM, V49, P1245, DOI 10.1177/002215540104901006; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Tomassen P, 2011, ALLERGY, V66, P556, DOI 10.1111/j.1398-9995.2010.02503.x; Van Bruaene N, 2012, CLIN EXP ALLERGY, V42, P883, DOI 10.1111/j.1365-2222.2011.03898.x; Van Bruaene N, 2011, CURR OPIN ALLERGY CL, V11, P8, DOI 10.1097/ACI.0b013e32834233ef; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Van Crombruggen K, 2010, RHINOLOGY, V48, P54, DOI 10.4193/Rhin09.078; Yang Y, 2014, ALLERGY, V69, P699, DOI 10.1111/all.12403; Yang YC, 2012, ALLERGY, V67, P1193, DOI 10.1111/j.1398-9995.2012.02880.x; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093754	26	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128564	10.1371/journal.pone.0128564	http://dx.doi.org/10.1371/journal.pone.0128564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030615	Green Published, gold			2022-12-27	WOS:000356630900172
J	Fujii, K; Yamashita, D; Kimura, T; Isaka, T; Kouzaki, M				Fujii, Keisuke; Yamashita, Daichi; Kimura, Tetsuya; Isaka, Tadao; Kouzaki, Motoki			Preparatory Body State before Reacting to an Opponent: Short-Term Joint Torque Fluctuation in Real-Time Competitive Sports	PLOS ONE			English	Article							BASKETBALL DEFENDERS; CUTTING MANEUVERS; MOVEMENT SYSTEMS; KNEE-JOINT; DYNAMICS; ANTICIPATION; MODEL; INFORMATION; INTEGRATION; DIRECTIONS	In a competitive sport, the outcome of a game is determined by an athlete's relationship with an unpredictable and uncontrolled opponent. We have previously analyzed the preparatory state of ground reaction forces (GRFs) dividing non-weighted and weighted states (i.e., vertical GRFs below and above 120% of body weight, respectively) in a competitive ballgame task and demonstrated that the non-weighted state prevented delay of the defensive step and promoted successful guarding. However, the associated kinetics of lower extremity joints during a competitive sports task remains unknown. The present study aims to investigate the kinetic characteristics of a real-time competitive sport before movement initiation. As a first kinetic study on a competitive sport, we initially compared the successful defensive kinetics with a relatively stable preparatory state and the choice-reaction sidestep as a control movement. Then, we investigated the kinetic cause of the outcome in a 1-on-1 dribble in terms of the preparatory states according to our previous study. The results demonstrated that in successful defensive motions in the non-weighted state guarding trial, the times required for the generation of hip abduction and three extension torques for the hip, knee, and ankle joints were significantly shortened compared with the choice-reaction sidestep, and hip abduction and hip extension torques were produced almost simultaneously. The sport-specific movement kinetics emerges only in a more-realistic interactive experimental setting. A comparison of the outcomes in the 1-on-1 dribble and preparatory GRF states showed that, in the non-weighted state, the defenders guarded successfully in 68.0% of the trials, and the defender's initiation time was earlier than that in the weighted state (39.1%). In terms of kinetics, the root mean squares of the derivative of hip abduction and three extension torques in the non-weighted state were smaller than those in the weighted state, irrespective of the outcome. These results indicate that the preparatory body state as explained by short-term joint torque fluctuations before the defensive step would help explain the performance in competitive sports, and will give insights into understanding human adaptive behavior in unpredicted and uncontrolled environments.	[Fujii, Keisuke] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Fujii, Keisuke] Japan Soc Promot Sci, Tokyo, Japan; [Yamashita, Daichi] Japan Inst Sports Sci, Tokyo, Japan; [Kimura, Tetsuya] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Isaka, Tadao] Ritsumeikan Univ, Fac Sports & Hlth Sci, Kyoto, Shiga, Japan; [Kouzaki, Motoki] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Nagoya University; Japan Society for the Promotion of Science; Kobe University; Ritsumeikan University; Kyoto University	Fujii, K (corresponding author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan.	keisuke198619@gmail.com	Yamashita, Daichi/ADG-4449-2022	Yamashita, Daichi/0000-0002-4920-2063; Fujii, Keisuke/0000-0001-5487-4297	Yamaha Motor Foundation for Sports	Yamaha Motor Foundation for Sports	This research was supported by the Yamaha Motor Foundation for Sports, (http://www.ymfs.jp/). KF and TI received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ae M., 1992, BIOMECHANISM, V11, P23; Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; Araujo D, 2006, PSYCHOL SPORT EXERC, V7, P653, DOI 10.1016/j.psychsport.2006.07.002; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; Besier TF, 2001, MED SCI SPORT EXER, V33, P1168; Brault S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037494; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; Davids K, 2006, ADAPT BEHAV, V14, P73, DOI 10.1177/105971230601400103; Esteves PT, 2012, J SPORT SCI, V30, P1285, DOI 10.1080/02640414.2012.707327; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Fu CJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0958; Fujii K, SPORTS BIOM IN PRESS; Fujii K, 2014, SPORT BIOMECH, V13, P204, DOI 10.1080/14763141.2014.953983; Fujii K, 2014, EUR J SPORT SCI, V14, P538, DOI 10.1080/17461391.2013.876104; Fujii K, 2014, EUR J SPORT SCI, V14, P209, DOI 10.1080/17461391.2013.780098; Fujii K, 2013, J ELECTROMYOGR KINES, V23, P1467, DOI 10.1016/j.jelekin.2013.08.001; Harald C, 1999, MATH METHODS STAT; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hristovski R, 2006, J SPORT SCI MED, V5, P60; Hristovski Robert, 2006, Nonlinear Dynamics Psychol Life Sci, V10, P409; Inaba Y, 2013, J APPL BIOMECH, V29, P336, DOI 10.1123/jab.29.3.336; Jackson RC, 2006, ACTA PSYCHOL, V123, P355, DOI 10.1016/j.actpsy.2006.02.002; Khalaj N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092270; Kijima A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047911; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lames M, 2006, J SPORT SCI MED, V5, P556; Latash M.L., 1996, DEXTERITY ITS DEV; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; McGee K., 2007, COACHING BASKETBALL, P94; Mirelman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040297; Okumura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051877; Palut Y, 2005, J SPORT SCI, V23, P1021, DOI 10.1080/02640410400021682; Passos P, 2008, J SPORT SCI, V26, P1421, DOI 10.1080/02640410802208986; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; Rand MK, 2000, GAIT POSTURE, V12, P169, DOI 10.1016/S0966-6362(00)00073-4; SEERING WP, 1980, J BIOMECH, V13, P785, DOI 10.1016/0021-9290(80)90240-7; Sekine M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-118; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Yamamoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072436; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220; Yoshihara Y, 2007, J ROBOT MECHATRON, V19, P448, DOI 10.20965/jrm.2007.p0448; Zelik KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031143	46	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128571	10.1371/journal.pone.0128571	http://dx.doi.org/10.1371/journal.pone.0128571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024485	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400098
J	Bosco, DB; Kenworthy, R; Zorio, DAR; Sang, QXA				Bosco, Dale B.; Kenworthy, Rachael; Zorio, Diego A. R.; Sang, Qing-Xiang Amy			Human Mesenchymal Stem Cells Are Resistant to Paclitaxel by Adopting a Non-Proliferative Fibroblastic State	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; 1ST TOTAL-SYNTHESIS; HUMAN BONE-MARROW; STROMAL CELLS; MULTIDRUG-RESISTANCE; ANTITUMOR-ACTIVITY; DRUG-RESISTANCE; CANCER; CHEMOTHERAPY; SURVIVAL	Human mesenchymal stem cell (hMSC) resistance to the apoptotic effects of chemotherapeutic drugs has been of major interest, as these cells can confer this resistance to tumor microenvironments. However, the effects of internalized chemotherapeutics upon hMSCs remain largely unexplored. In this study, cellular viability and proliferation assays, combined with different biochemical approaches, were used to investigate the effects of Paclitaxel exposure upon hMSCs. Our results indicate that hMSCs are highly resistant to the cytotoxic effects of Paclitaxel treatment, even though there was no detectable expression of the efflux pump P-glycoprotein, the usual means by which a cell resists Paclitaxel treatment. Moreover, Paclitaxel treatment induces hMSCs to adopt a non-proliferative fibroblastic state, as evidenced by changes to morphology, cellular markers, and a reduction in differentiation potential that is not directly coupled to the cytoskeletal effects of Paclitaxel. Taken together, our results show that Paclitaxel treatment does not induce apoptosis in hMSCs, but does induce quiescence and phenotypic changes.	[Bosco, Dale B.; Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Kenworthy, Rachael; Zorio, Diego A. R.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zorio, DAR (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	zorio@chem.fsu.edu; qxsang@chem.fsu.edu			Florida State University; Florida State University Research Foundation; Endowed Professorship in Cancer Research	Florida State University; Florida State University Research Foundation; Endowed Professorship in Cancer Research	This work was supported by internal grants from Florida State University. Bosco and Sang salaries are supported by Florida State University; Kenworthy and Zorio salaries are supported by the Florida State University Research Foundation. This work was supported in part by an Endowed Professorship in Cancer Research to Dr. Sang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117; Barbet R, 2012, CELL CYCLE, V11, P1611, DOI 10.4161/cc.20023; Bergfeld SA, 2014, MOL CANCER THER, V13, P962, DOI 10.1158/1535-7163.MCT-13-0400; Bian ZY, 2010, CANCER SCI, V101, P2554, DOI 10.1111/j.1349-7006.2010.01731.x; Carcamo-Orive I, 2008, EXP CELL RES, V314, P1777, DOI 10.1016/j.yexcr.2008.01.020; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Chen DR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/532161; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Conforti A, 2014, CYTOTHERAPY, V16, P868, DOI 10.1016/j.jcyt.2014.01.414; De Boeck A, 2013, GUT, V62, P550, DOI 10.1136/gutjnl-2011-301393; DELSAL G, 1995, MOL CELL BIOL, V15, P7152; Dittmer J, 2010, THESCIENTIFICWORLDJO, V10, P1234, DOI 10.1100/tsw.2010.119; Duchi S, 2014, BIOCONJUGATE CHEM, V25, P649, DOI 10.1021/bc5000498; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo BQ, 2004, BREAST CANCER RES TR, V85, P31, DOI 10.1023/B:BREA.0000021046.29834.12; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; HOLTON RA, 1994, J AM CHEM SOC, V116, P1597, DOI 10.1021/ja00083a066; HOLTON RA, 1994, J AM CHEM SOC, V116, P1599, DOI 10.1021/ja00083a067; Houthuijzen J, 2012, BRIT J CANCER, V106, P1901, DOI 10.1038/bjc.2012.201; Hurst DR, 2007, NAT MED, V13, P1289, DOI 10.1038/nm1107-1289; Ishii M, 2005, BIOCHEM BIOPH RES CO, V332, P297, DOI 10.1016/j.bbrc.2005.04.118; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lee EA, 2004, MOL CANCER THER, V3, P661; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONG BH, 1994, CANCER RES, V54, P4355; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Moitra K, 2011, CLIN PHARMACOL THER, V89, P491, DOI 10.1038/clpt.2011.14; Mueller LP, 2006, STEM CELLS, V24, P2753, DOI 10.1634/stemcells.2006-0108; Pessina A, 2013, BRIT J HAEMATOL, V160, P766, DOI 10.1111/bjh.12196; Pessina A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028321; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polioudaki H, 2009, CELL PROLIFERAT, V42, P434, DOI 10.1111/j.1365-2184.2009.00607.x; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Scherzed A, 2011, CANCER BIOL THER, V11, P349, DOI 10.4161/cbt.11.3.14179; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Shinojima N, 2013, CANCER RES, V73, P2333, DOI 10.1158/0008-5472.CAN-12-3086; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Straubinger R M, 1993, J Natl Cancer Inst Monogr, P69; Takeda M, 2007, PROSTATE, V67, P955, DOI 10.1002/pros.20581; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Wang Y, 2012, SCAND J GASTROENTERO, V47, P802, DOI 10.3109/00365521.2012.683042; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Xu S, 2012, STEM CELLS, V30, P266, DOI 10.1002/stem.787; Yang X, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-5; Zhao JS, 2005, INT J ONCOL, V27, P247	49	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128511	10.1371/journal.pone.0128511	http://dx.doi.org/10.1371/journal.pone.0128511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029917	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900160
J	Creis, E; Delage, L; Charton, S; Goulitquer, S; Leblanc, C; Potin, P; Gall, EA				Creis, Emeline; Delage, Ludovic; Charton, Sophie; Goulitquer, Sophie; Leblanc, Catherine; Potin, Philippe; Gall, Erwan Ar			Constitutive or Inducible Protective Mechanisms against UV-B Radiation in the Brown Alga Fucus vesiculosus? A Study of Gene Expression and Phlorotannin Content Responses	PLOS ONE			English	Article							PHENOLIC SUBSTANCES; STRESS; INDUCTION; TOLERANCE; SERRATUS; POLYSACCHARIDES; PHOTOSYNTHESIS; MACROALGAE; RESISTANCE; EUKARYOTES	A role as UV sunscreens has been suggested for phlorotannins, the phenolic compounds that accumulate in brown algae in response to a number of external stimuli and take part in cell wall structure. After exposure of the intertidal brown alga Fucus vesiculosus to artificial UV-B radiation, we examined its physiological responses by following the transcript level of the pksIII gene encoding a phloroglucinol synthase, likely to be involved in the first step of phlorotannins biosynthesis. We also monitored the expression of three targeted genes, encoding a heat shock protein (hsp70), which is involved in global stress responses, an aryl sulfotransferase (ast), which could be involved in the sulfation of phlorotannins, and a vanadium bromoperoxidase (vbpo), which can potentially participate in the scavenging of Reactive Oxygen Species (ROS) and in the cross-linking and condensation of phlorotannins. We investigated whether transcriptional regulation of these genes is correlated with an induction of phlorotannin accumulation by establishing metabolite profiling of purified fractions of low molecular weight phlorotannins. Our findings demonstrated that a high dose of UV-B radiation induced a significant overexpression of hsp70 after 12 and 24 hours following the exposure to the UV-B treatment, compared to control treatment. The physiological performance of algae quantified by the photosynthetic efficiency (Fv/Fm) was slightly reduced. However UV-B treatment did not induce the accumulation of soluble phlorotannins in F. vesiculosus during the kinetics of four weeks, a result that may be related to the lack of induction of the pksIII gene expression. Taken together these results suggest a constitutive accumulation of phlorotannins occurring during the development of F. vesiculosus, rather than inducible processes. Gene expression studies and phlorotannin profiling provide here complementary approaches to global quantifications currently used in studies of phenolic compounds in brown algae.	[Creis, Emeline; Delage, Ludovic; Charton, Sophie; Leblanc, Catherine; Potin, Philippe] Univ Paris 06, Sorbonne Univ, CNRS,CS 90074, UMR Integrat Biol Marine Models 8227,Stn Biol Ros, F-29688 Roscoff, France; [Goulitquer, Sophie] CNRS, Ctr Ressources Biol Marine, MetaboMer Mass Spectrometry Core Facil, Stn Biol Roscoff,FR2424, F-29688 Roscoff, Brittany, France; [Gall, Erwan Ar] Univ Bretagne Occidentale, Univ Europeenne Bretagne, CNRS 6539,Unite Mixte Rech, Inst Europeen Etud Marines IUEM,Lab Sci Environm, F-29280 Plouzane, Brittany, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Potin, P (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS,CS 90074, UMR Integrat Biol Marine Models 8227,Stn Biol Ros, F-29688 Roscoff, France.	potin@sb-roscoff.fr; erargall@univ-brest.fr	CHARTON, Sophie/GZH-0766-2022	Charton, Sophie AB/0000-0002-7941-4657	Groupement d'Interet Scientifique (GIS) Europole MER; project IDEALG "Investissements d'avenir, Biotechnologies-Bioressources" [ANR-10-BTBR-04]; Conseil Regional de Bretagne ARED SYNTHALG [7010]	Groupement d'Interet Scientifique (GIS) Europole MER; project IDEALG "Investissements d'avenir, Biotechnologies-Bioressources"(French National Research Agency (ANR)); Conseil Regional de Bretagne ARED SYNTHALG(Region Bretagne)	This project was initiated through a Grant-in-Aid for Scientific Research from Groupement d'Interet Scientifique (GIS) Europole MER to E.A.G and P.P. (Phlorotann'ING). S.G. was also supported by the project IDEALG (ANR-10-BTBR-04) "Investissements d'avenir, Biotechnologies-Bioressources". E.C. was supported by a Ph.D. fellowship from the Conseil Regional de Bretagne ARED SYNTHALG no7010.	Allen DJ, 1997, PLANT CELL ENVIRON, V20, P633, DOI 10.1111/j.1365-3040.1997.00093.x; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; [Anonymous], 2010, R LANG ENV STAT COMP; APT KE, 1993, PLANT MOL BIOL, V21, P27, DOI 10.1007/BF00039615; APT KE, 1995, MOL GEN GENET, V246, P455, DOI 10.1007/BF00290449; Arnold TM, 2000, J CHEM ECOL, V26, P1393, DOI 10.1023/A:1005588023887; Arnold TM, 1998, J CHEM ECOL, V24, P577, DOI 10.1023/A:1022373121596; Baldauf SL, 2008, J SYST EVOL, V46, P263, DOI 10.3724/SP.J.1002.2008.08008; Berglin M, 2004, BIOMACROMOLECULES, V5, P2376, DOI 10.1021/bm0496864; Bieza K, 2001, PLANT PHYSIOL, V126, P1105, DOI 10.1104/pp.126.3.1105; Bischof Kai, 2006, Reviews in Environmental Science and Bio/Technology, V5, P141, DOI 10.1007/s11157-006-0002-3; Bitton R, 2006, MACROMOL BIOSCI, V6, P737, DOI 10.1002/mabi.200600073; Breton F, 2011, J EXP MAR BIOL ECOL, V399, P167, DOI 10.1016/j.jembe.2011.01.002; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Connan S, 2004, BOT MAR, V47, P410, DOI 10.1515/BOT.2004.057; Davison IR, 1996, J PHYCOL, V32, P197, DOI 10.1111/j.0022-3646.1996.00197.x; FANG G, 1992, BIOTECHNIQUES, V13, P52; Flothe CR, 2014, EUR J PHYCOL, V49, P356, DOI 10.1080/09670262.2014.946452; Flothe CR, 2014, J PHYCOL, V50, P564, DOI 10.1111/jpy.12186; Gomez I, 2010, PHOTOCHEM PHOTOBIOL, V86, P1056, DOI 10.1111/j.1751-1097.2010.00786.x; Hader DP, 1997, PHOTOCHEM PHOTOBIOL, V66, P1, DOI 10.1111/j.1751-1097.1997.tb03132.x; HARBORNE JB, 1975, PHYTOCHEMISTRY, V14, P1147, DOI 10.1016/S0031-9422(00)98585-6; Henry BE, 2004, J PHYCOL, V40, P527, DOI 10.1111/j.1529-8817.2004.03103.x; Herve Maxime, 2014, RVAIDEMEMOIRE DIV BA; Hupel M, 2011, TALANTA, V86, P362, DOI 10.1016/j.talanta.2011.09.029; Hupel M, 2011, J EXP MAR BIOL ECOL, V401, P36, DOI 10.1016/j.jembe.2011.03.004; Jansen MAK, 2010, PHYSIOL PLANTARUM, V138, P22, DOI 10.1111/j.1399-3054.2009.01293.x; Jormalainen V, 2003, OIKOS, V103, P640, DOI 10.1034/j.1600-0706.2003.12635.x; Jueterbock A, 2014, MAR GENOM, V13, P27, DOI 10.1016/j.margen.2013.12.008; Koivikko R, 2008, J CHEM ECOL, V34, P57, DOI 10.1007/s10886-007-9410-2; Koivikko R, 2005, J CHEM ECOL, V31, P195, DOI 10.1007/s10886-005-0984-2; Lenth RV, 2014, LSMEANS LEAST SQUARE; Lesser MP, 1996, MAR ECOL PROG SER, V132, P287, DOI 10.3354/meps132287; Meslet-Cladiere L, 2013, PLANT CELL, V25, P3089, DOI 10.1105/tpc.113.111336; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Nielsen HD, 2003, NEW PHYTOL, V160, P157, DOI 10.1046/j.1469-8137.2003.00864.x; Pavia H, 1997, MAR ECOL PROG SER, V157, P139, DOI 10.3354/meps157139; Pearson G, 2006, EUR J PHYCOL, V41, P97, DOI 10.1080/09670260500505011; Pearson GA, 2010, MAR BIOTECHNOL, V12, P195, DOI 10.1007/s10126-009-9208-z; Ragan Glombitza, 1986, PROG PHYCOL RES, P129; RAGAN MA, 1976, BOT MAR, V19, P145, DOI 10.1515/botm.1976.19.3.145; RENGER G, 1989, PHOTOCHEM PHOTOBIOL, V49, P97, DOI 10.1111/j.1751-1097.1989.tb04083.x; Roeder V, 2005, J PHYCOL, V41, P1227, DOI 10.1111/j.1529-8817.2005.00150.x; Salgado LT, 2009, J PHYCOL, V45, P193, DOI 10.1111/j.1529-8817.2008.00642.x; Schoenwaelder Monica E. A., 2008, Algae, V23, P163; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Shibata T, 2006, J APPL PHYCOL, V18, P787, DOI 10.1007/s10811-006-9094-y; Steevensz AJ, 2012, PHYTOCHEM ANALYSIS, V23, P547, DOI 10.1002/pca.2354; Swanson AK, 2002, AQUAT BOT, V73, P241, DOI 10.1016/S0304-3770(02)00035-9; VANALSTYNE KL, 1988, ECOLOGY, V69, P655; VANALSTYNE KL, 1995, J CHEM ECOL, V21, P45, DOI 10.1007/BF02033661; Wahl M, 2011, ADV MAR BIOL, V59, P37, DOI 10.1016/B978-0-12-385536-7.00002-9	52	15	16	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128003	10.1371/journal.pone.0128003	http://dx.doi.org/10.1371/journal.pone.0128003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030665	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900100
J	Liu, QM; Qin, JC; Li, TW; Liu, EB; Fan, DJ; Edzesi, WM; Liu, JH; Jiang, JH; Liu, XL; Xiao, LJ; Liu, LL; Hong, DL				Liu, Qiangming; Qin, Jiancai; Li, Tianwei; Liu, Erbao; Fan, Dejia; Edzesi, Wisdom Mawuli; Liu, Jianhai; Jiang, Jianhua; Liu, Xiaoli; Xiao, Lianjie; Liu, Linglong; Hong, Delin			Fine Mapping and Candidate Gene Analysis of qSTL3, a Stigma Length-Conditioning Locus in Rice (Oryza sativaL.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; FLORAL CHARACTERISTICS; ENDOSPERM DEVELOPMENT; SEED PRODUCTION; CENTRAL CELL; GRAIN WIDTH; MAJOR QTL; G-PATCH; PROTEIN; ARABIDOPSIS	The efficiency of hybrid seed production can be improved by increasing the percentage of exserted stigma, which is closely related to the stigma length in rice. In the chromosome segment substitute line (CSSL) population derived from Nipponbare (recipient) and Kasalath (donor), a single CSSL (SSSL14) was found to show a longer stigma length than that of Nipponbare. The difference in stigma length between Nipponbare and SSSL14 was controlled by one locus (qSTL3). Using 7,917 individuals from the SSSL14/Nipponbare F-2 population, the qSTL3 locus was delimited to a 19.8-kb region in the middle of the short arm of chromosome 3. Within the 19.8-kb chromosome region, three annotated genes (LOC_Os03g14850, LOC_Os03g14860 and LOC_Os03g14880) were found in the rice genome annotation database. According to gene sequence alignments in LOC_Os03g14850, a transition of G (Nipponbare) to A (Kasalath) was detected at the 474-bp site in CDS. The transition created a stop codon, leading to a deletion of 28 amino acids in the deduced peptide sequence in Kasalath. A T-DNA insertion mutant (05Z11CN28) of LOC_Os03g14850-showed a longer stigma length than that of wild type (Zhonghua 11), validating that LOC_Os03g14850 is the gene controlling stigma length. However, the Kasalath allele of LOC_Os03g14850 is unique because all of the alleles were the same as that of Nipponbare at the 474-bp site in the CDS of LOC_Os03g14850 among the investigated accessions with different stigma lengths. A gene-specific InDel marker LQ30 was developed for improving stigma length during rice hybrid breeding by marker-assisted selection.	[Liu, Qiangming; Qin, Jiancai; Li, Tianwei; Liu, Erbao; Fan, Dejia; Edzesi, Wisdom Mawuli; Liu, Jianhai; Jiang, Jianhua; Liu, Xiaoli; Xiao, Lianjie; Liu, Linglong; Hong, Delin] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Jiang, Jianhua] Anhui Acad Agr Sci, Rice Res Inst, Hefei 230031, Peoples R China	Nanjing Agricultural University; Anhui Academy of Agricultural Sciences	Hong, DL (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	delinhong@njau.edu.cn	hong, delin/R-3398-2017; Liu, Xiaoli/HGE-7614-2022	hong, delin/0000-0002-2899-9739; Edzesi, Wisdom Mawuli/0000-0002-5033-3423; Liu, Qiangming/0000-0002-2426-8314	China national '863' program [B0201100690, B0201300662]; doctoral fund of Educational Ministry;  [2010AA101301]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD008958] Funding Source: NIH RePORTER	China national '863' program; doctoral fund of Educational Ministry; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by 2010AA101301, the China national '863' program B0201100690, B0201300662, doctoral fund of Educational Ministry.	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Bemer M, 2008, PLANT CELL, V20, P2088, DOI 10.1105/tpc.108.058958; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Hua ZT, 2009, ACCELERATING HYBRID, P139; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Kang IH, 2008, PLANT CELL, V20, P635, DOI 10.1105/tpc.107.055137; KATO H, 1987, JPN J BREED, V37, P318; KATO H, 1987, JPN J BREED, V37, P75; Krizova I, 2012, J VIROL, V86, P1988, DOI 10.1128/JVI.06638-11; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miyata M, 2007, THEOR APPL GENET, V114, P539, DOI 10.1007/s00122-006-0454-4; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Oh MW, 2014, PROTEIN PEPTIDE LETT, V21, P458, DOI 10.2174/09298665113206660120; Parsons BJ, 1999, GENET RESOUR CROP EV, V46, P587, DOI 10.1023/A:1008749532171; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Qiao BaoJian, 2007, Journal of Nanjing Agricultural University, V30, P1; Takano-Kai N, 2011, BREEDING SCI, V61, P244, DOI 10.1270/jsbbs.61.244; Tang ShuZhu, 2008, Hybrid Rice, V23, P1; Uga Y, 2003, THEOR APPL GENET, V107, P218, DOI 10.1007/s00122-003-1227-y; Uga Y, 2010, PLANT BREEDING, V129, P657, DOI 10.1111/j.1439-0523.2009.01765.x; VIRMANI SS, 1974, CROP SCI, V14, P350, DOI 10.2135/cropsci1974.0011183X001400030002x; VIRMANI SS, 1973, CROP SCI, V13, P66, DOI 10.2135/cropsci1973.0011183X001300010019x; Virmani SS, 1994, MONOGRA THEOR APPL G; Wang JianKang, 2009, Acta Agronomica Sinica, V35, P239, DOI 10.3724/SP.J.1006.2009.00239; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xing YZ, 2008, THEOR APPL GENET, V116, P789, DOI 10.1007/s00122-008-0711-9; Yamamoto T.T., 2003, RICE GENET NEWSLETT, V10, P33; Yan WG, 2009, MOL BREEDING, V24, P277, DOI 10.1007/s11032-009-9290-y; Yu Xin-Qiao, 2006, Acta Genetica Sinica, V33, P542, DOI 10.1016/S0379-4172(06)60083-8; Zhang JW, 2006, NUCLEIC ACIDS RES, V34, pD745, DOI 10.1093/nar/gkj016; Zhang YL, 2005, CURR BIOL, V15, P1936, DOI 10.1016/j.cub.2005.09.038	37	21	27	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127938	10.1371/journal.pone.0127938	http://dx.doi.org/10.1371/journal.pone.0127938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030903	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900095
J	Nair, MS; Lee, MM; Bonnegarde-Bernard, A; Wallace, JA; Dean, DH; Ostrowski, MC; Burry, RW; Boyaka, PN; Chan, MK				Nair, Manoj S.; Lee, Marianne M.; Bonnegarde-Bernard, Astrid; Wallace, Julie A.; Dean, Donald H.; Ostrowski, Michael C.; Burry, Richard W.; Boyaka, Prosper N.; Chan, Michael K.			Cry Protein Crystals: A Novel Platform for Protein Delivery	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; DELTA-ENDOTOXIN; BIODEGRADABLE MICROSPHERES; INFLUENZA-VIRUS; CELLS; RESPONSES; CRYIIIA; DISPLAY; GENE; MICROPARTICLES	Protein delivery platforms are important tools in the development of novel protein therapeutics and biotechnologies. We have developed a new class of protein delivery agent based on sub-micrometer-sized Cry3Aa protein crystals that naturally form within the bacterium Bacillus thuringiensis. We demonstrate that fusion of the cry3Aagene to that of various reporter proteins allows for the facile production of Cry3Aa fusion protein crystals for use in subsequent applications. These Cry3Aa fusion protein crystals are efficiently taken up and retained by macrophages and other cell lines in vitro, and can be delivered to mice in vivo via multiple modes of administration. Oral delivery of Cry3Aa fusion protein crystals to C57BL/6 mice leads to their uptake by MHC class II cells, including macrophages in the Peyer's patches, supporting the notion that the Cry3Aa framework can be used to stabilize cargo protein against degradation for delivery to gastrointestinal lymphoid tissues.	[Nair, Manoj S.; Lee, Marianne M.; Dean, Donald H.; Chan, Michael K.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH USA; [Bonnegarde-Bernard, Astrid; Boyaka, Prosper N.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Wallace, Julie A.; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biol, Columbus, OH 43210 USA; [Wallace, Julie A.; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Tumor Microenvironm Program, Columbus, OH 43210 USA; [Burry, Richard W.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chan, MK (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	michaelkchan88@cuhk.edu.hk	Nair, Manoj/B-4389-2009; Ostrowski, Michael/H-3108-2011	Nair, Manoj/0000-0002-5994-3957; Boyaka, Prosper/0000-0001-6857-9088; Ostrowski, Michael/0000-0003-2948-6297	US National Institute of Health [AI081291, AI043197]; American Heart Association Great Rivers Postdoctoral Fellowship [GRT00019207]; US Department of Defense Breast Cancer Predoctoral Fellowship [GRANT10578047]; NATIONAL CANCER INSTITUTE [P01CA097189, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043197, R21AI081291] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers Postdoctoral Fellowship(American Heart Association); US Department of Defense Breast Cancer Predoctoral Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institute of Health grant AI081291 (to MKC and DHD) and AI043197 (to PNB), an American Heart Association Great Rivers Postdoctoral Fellowship GRT00019207 (to MSN), and a US Department of Defense Breast Cancer Predoctoral Fellowship GRANT10578047 (to JAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale SS, 2010, ACS NANO, V4, P1493, DOI 10.1021/nn901586e; Banerjee D, 2010, CHEMBIOCHEM, V11, P1273, DOI 10.1002/cbic.201000125; Bauer-Kreisel P, 2010, ADV DRUG DELIVER REV, V62, P798, DOI 10.1016/j.addr.2010.04.003; Chowdhury EH, 2003, VET HUM TOXICOL, V45, P72; Clark Jason R, 2004, Expert Rev Vaccines, V3, P463, DOI 10.1586/14760584.3.4.463; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Crespo ALB, 2008, APPL ENVIRON MICROB, V74, P130, DOI 10.1128/AEM.01855-07; Deist BR, 2014, TOXINS, V6, P3005, DOI 10.3390/toxins6103005; Dey D, 2011, BIOMATERIALS, V32, P4647, DOI 10.1016/j.biomaterials.2011.03.016; ELDRIDGE JH, 1990, J CONTROL RELEASE, V11, P205, DOI 10.1016/0168-3659(90)90133-E; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Gu Z, 2011, CHEM SOC REV, V40, P3638, DOI 10.1039/c0cs00227e; Hasadsri L, 2009, J BIOL CHEM, V284, P6972, DOI 10.1074/jbc.M805956200; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Jay SM, 2008, FASEB J, V22, P2949, DOI 10.1096/fj.08-108803; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Kaczmarczyk SJ, 2011, P NATL ACAD SCI USA, V108, P16998, DOI 10.1073/pnas.1101874108; KOLLER CN, 1992, BIOCHEM BIOPH RES CO, V184, P692, DOI 10.1016/0006-291X(92)90645-2; Kunisawa J, 2002, EUR J IMMUNOL, V32, P2347, DOI 10.1002/1521-4141(200208)32:8<2347::AID-IMMU2347>3.0.CO;2-V; Lee LA, 2006, NANOMED-NANOTECHNOL, V2, P137, DOI 10.1016/j.nano.2006.07.009; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; Liu M, 2008, APPL MICROBIOL BIOT, V78, P669, DOI 10.1007/s00253-008-1345-1; Liu Y, 2011, ANGEW CHEM INT EDIT, V50, P3058, DOI 10.1002/anie.201005740; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; MALVAR T, 1994, J BACTERIOL, V176, P4750, DOI 10.1128/JB.176.15.4750-4753.1994; Mauriello EMF, 2004, VACCINE, V22, P1177, DOI 10.1016/j.vaccine.2003.09.031; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; MURTY MG, 1994, J MICROBIOL METH, V19, P103, DOI 10.1016/0167-7012(94)90041-8; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Park HW, 1998, APPL ENVIRON MICROB, V64, P3932; Park K, 2011, REACT FUNCT POLYM, V71, P280, DOI 10.1016/j.reactfunctpolym.2010.10.002; Patrick CW, 1998, FRONTIERS TISSUE ENG; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Ricca Ezio, 2003, J Nanobiotechnology, V1, P6, DOI 10.1186/1477-3155-1-6; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Sanchis V, 1996, J BIOTECHNOL, V48, P81, DOI 10.1016/0168-1656(96)01404-6; Sawaya MR, 2014, P NATL ACAD SCI USA, V111, P12769, DOI 10.1073/pnas.1413456111; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Nobuaki S, 2006, IN VITRO CELL DEV-AN, V42, P45; Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9; Tajne S, 2014, J BIOTECHNOL, V171, P71, DOI 10.1016/j.jbiotec.2013.11.029; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Ujwal R, 2011, METHODS, V55, P337, DOI 10.1016/j.ymeth.2011.09.020; Wang DA, 2010, ADV DRUG DELIVER REV, V62, P669, DOI 10.1016/j.addr.2010.04.008; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; WHITELEY HR, 1986, ANNU REV MICROBIOL, V40, P549, DOI 10.1146/annurev.mi.40.100186.003001; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wu SJ, 1996, J MOL BIOL, V255, P628, DOI 10.1006/jmbi.1996.0052; Yamamoto M, 2000, J IMMUNOL, V164, P5184, DOI 10.4049/jimmunol.164.10.5184; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Yeh MK, 1996, PHARMACEUT RES, V13, P1693, DOI 10.1023/A:1016496824839; Zhang H, 2002, CLIN PHARMACOKINET, V41, P661, DOI 10.2165/00003088-200241090-00003	61	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127669	10.1371/journal.pone.0127669	http://dx.doi.org/10.1371/journal.pone.0127669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030844	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900070
J	Valsecchi, V; Boido, M; De Amicis, E; Piras, A; Vercelli, A				Valsecchi, Valeria; Boido, Marina; De Amicis, Elena; Piras, Antonio; Vercelli, Alessandro			Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON PROTEIN; MOUSE MODEL; SELECTIVE VULNERABILITY; NEUROMUSCULAR-JUNCTION; SINGLE NUCLEOTIDE; NERVE-TERMINALS; GENE-PRODUCT; SURVIVAL	Spinal muscular atrophy (SMA) is a severe neuromuscular disease, the most common in infancy, and the third one among young people under 18 years. The major pathological landmark of SMA is a selective degeneration of lower motor neurons, resulting in progressive skeletal muscle denervation, atrophy, and paralysis. Recently, it has been shown that specific or general changes in the activity of ribonucleoprotein containing micro RNAs (miRNAs) play a role in the development of SMA. Additionally miRNA-206 has been shown to be required for efficient regeneration of neuromuscular synapses after acute nerve injury in an ALS mouse model. Therefore, we correlated the morphology and the architecture of the neuromuscular junctions (NMJs) of quadriceps, a muscle affected in the early stage of the disease, with the expression levels of miRNA-206 in a mouse model of intermediate SMA (SMAII), one of the most frequently used experimental model. Our results showed a decrease in the percentage of type II fibers, an increase in atrophic muscle fibers and a remarkable accumulation of neurofilament (NF) in the pre-synaptic terminal of the NMJs in the quadriceps of SMAII mice. Furthermore, molecular investigation showed a direct link between miRNA-206-HDAC4-FGFBP1, and in particular, a strong up-regulation of this pathway in the late phase of the disease. We propose that miRNA-206 is activated as survival endogenous mechanism, although not sufficient to rescue the integrity of motor neurons. We speculate that early modulation of miRNA-206 expression might delay SMA neurodegenerative pathway and that miRNA-206 could be an innovative, still relatively unexplored, therapeutic target for SMA.	[Valsecchi, Valeria; Boido, Marina; De Amicis, Elena; Piras, Antonio; Vercelli, Alessandro] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Dept Neurosci, Turin, Italy	University of Turin	Valsecchi, V (corresponding author), Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Dept Neurosci, Turin, Italy.	valeria.valsecchi@unito.it	Vercelli, Alessandro/A-1926-2012	Vercelli, Alessandro/0000-0002-5909-2128; Boido, Marina/0000-0003-1211-1552	Girotondo/ONLUS association; Smarathon-ONLUS association; University of Turin	Girotondo/ONLUS association; Smarathon-ONLUS association; University of Turin	This work was supported by funds from Girotondo/ONLUS and Smarathon-ONLUS associations to AV, and by University of Turin (ex 60% Linea B 2013) grant to MB.	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; [Anonymous], 1978, MAJOR PROBL CLIN PED; Arnold WD, 2013, ANN NEUROL, V74, P348, DOI 10.1002/ana.23995; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Beer HD, 2005, ONCOGENE, V24, P5269, DOI 10.1038/sj.onc.1208560; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Bruneteau G, 2013, BRAIN, V136, P2359, DOI 10.1093/brain/awt164; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Cifuentes-Diaz Carmen, 2002, Semin Pediatr Neurol, V9, P145, DOI 10.1053/spen.2002.33801; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; d'Errico P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082654; Deymeer F, 2008, NEUROLOGY, V71, P644, DOI 10.1212/01.wnl.0000324623.89105.c4; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Giavazzi A, 2006, J NEUROPATH EXP NEUR, V65, P267, DOI 10.1097/01.jnen.0000205144.54457.a3; Gokhin DS, 2008, J EXP BIOL, V211, P837, DOI 10.1242/jeb.014340; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Janssen HLA, 2013, NEW ENGL J MED, V369, P878, DOI 10.1056/NEJMc1307787; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kubota M, 2000, DEV MED CHILD NEUROL, V42, P61, DOI 10.1017/S0012162200000116; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LIEBER RL, 1992, J HAND SURG-AM, V17A, P787, DOI 10.1016/0363-5023(92)90444-T; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; MACDOUGALL JD, 1982, EUR J APPL PHYSIOL O, V48, P117, DOI 10.1007/BF00421171; MACDOUGALL JD, 1984, J APPL PHYSIOL, V57, P1399, DOI 10.1152/jappl.1984.57.5.1399; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Nicole S, 2002, MUSCLE NERVE, V26, P4, DOI 10.1002/mus.10110; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; PEARN J, 1980, LANCET, V1, P919; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Ruiz-Rosado A, 2013, J HISTOCHEM CYTOCHEM, V61, P372, DOI 10.1369/0022155413480149; SCHMIDT R, 1993, NEUROPEDIATRICS, V24, P36, DOI 10.1055/s-2008-1071510; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Sproule Douglas M, 2010, Ther Adv Neurol Disord, V3, P173, DOI 10.1177/1756285610369026; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Valsecchi V, 2013, HEALTH, V5, P1712, DOI DOI 10.4236/HEALTH.2013.510231; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Winbanks CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073589; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	86	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128560	10.1371/journal.pone.0128560	http://dx.doi.org/10.1371/journal.pone.0128560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030275	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900170
J	Wang, ZZ; Koenig, HG; Zhang, YH; Ma, WR; Huang, YQ				Wang, Zhizhong; Koenig, Harold G.; Zhang, Yuhong; Ma, Wanrui; Huang, Yueqin			Religious Involvement and Mental Disorders in Mainland China	PLOS ONE			English	Article							MAJOR DEPRESSION; SPIRITUALITY; HEALTH; PREVALENCE; ATTENDANCE; RISK; PARTICIPATION; MORTALITY; STRESS; ADULTS	Purpose The present study aims to examine the association between religious involvement and mental disorder (anxiety disorder, mood disorder, alcohol use disorder) in a general Chinese population, and explore connections between religious belief and mental disorders in the Hui and Han ethnic groups. Method Data were examined from a representative sample of 2,770 community-dwelling adults in the province of Ningxia located in western China. Self-reported religious attendance and the importance of religious in daily life were measured. The WHO Composite International Diagnostic Interview was used to diagnose mental disorders. Results In the overall sample, the importance of religious affiliation was positively associated with mental disorders (especially anxiety) (p<0.01). No association was found between any religious characteristic and mood disorders or alcohol use disorders. With regard to analyses within different ethnic groups, religious affiliation was positively associated with mental disorder in Han ethnicity (p<0.01), but not in Hui ethnicity. When stratified by age and ethnic group, religious affiliation was associated positively with mental disorder in younger Han (p<0.01); whereas high religiosity was associated positively with mental disorder in older Hui (p<0.05). Among older Hui, however, religious affiliation was inversely associated with mood disorder (p<0.05). Conclusions In contrast to most previous studies in Western populations, religious involvement is less likely to be inversely related to mental disorder in Mainland China, although this association varies by age and ethnic group.	[Wang, Zhizhong; Zhang, Yuhong] Ningxia Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Yinchuan, Peoples R China; [Koenig, Harold G.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Koenig, Harold G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Koenig, Harold G.] King Abdulaziz Univ, Dept Med, Jeddah 21413, Saudi Arabia; [Ma, Wanrui] Ningxia Med Univ, Gen Hosp, Comprehens Dept, Yinchuan, Peoples R China; [Huang, Yueqin] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Inst Mental Hlth,Hosp 6, Beijing 100871, Peoples R China	Ningxia Medical University; Duke University; Duke University; King Abdulaziz University; Ningxia Medical University; Peking University	Huang, YQ (corresponding author), Peking Univ, Minist Hlth, Key Lab Mental Hlth, Inst Mental Hlth,Hosp 6, Beijing 100871, Peoples R China.	huangyq@bjmu.edu.cn	Wang, Zhizhong/S-9508-2019; Zhang, Yuhong/I-5056-2012	Zhang, Yuhong/0000-0002-7110-8401; Wang, zhizhong/0000-0002-0612-3218	National Natural Science Funds of China [81060242]; Special Research Project of Ministry of Health [201202022]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Special Research Project of Ministry of Health	This study partly supported by the National Natural Science Funds of China (81060242) and Special Research Project of Ministry of Health (201202022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badham P, 2008, MODERN BELIEVING, V49, P50, DOI DOI 10.3828/MB.49.1.50; Baetz M, 2009, CAN J PSYCHIAT, V54, P292, DOI 10.1177/070674370905400503; Baker R. P., 1992, Social Science Computer Review, V10, P145; Balbuena L, 2013, CAN J PSYCHIAT, V58, P225, DOI 10.1177/070674371305800408; Behere PB, 2013, INDIAN J PSYCHIAT, V55, pS187, DOI 10.4103/0019-5545.105526; Bonelli RM, 2013, J RELIG HEALTH, V52, P657, DOI 10.1007/s10943-013-9691-4; Braam AW, 2010, J AFFECT DISORDERS, V125, P269, DOI 10.1016/j.jad.2010.02.116; Brown P. H., 2009, J SOCIO-ECON, V38, P310, DOI DOI 10.1016/J.SOCEC.2008.07.014; Chen Y, 2010, THEORY RES, V10, P102, DOI [10.1186/1471-2458-10-102, DOI 10.1186/1471-2458-10-102]; Chuah O, 2004, J MUSLIM AFFAIRS, V24, P155, DOI [10.1080/1360200042000212133, DOI 10.1080/1360200042000212133]; Dein S, 2012, J NERV MENT DIS, V200, P852, DOI 10.1097/NMD.0b013e31826b6dle; Fan LZ, 2003, SOC COMPASS, V50, P449; Freud S., 1981, FUTURE ILLUSION STAN, V21; Gladney D, 2003, RELIG CHINA TODAY, P145, DOI DOI 10.1177/0002716286483001013; Greenberg D, 2013, WORLD PSYCHIATRY, V12, P40, DOI 10.1002/wps.20012; Ho Wai-Yip, 2013, J COMP ASIAN DEV, V12, P84, DOI DOI 10.1080/15339114.2012.749119; Huang B., 2012, ASIAN CULTURE HIST, V4, P2, DOI DOI 10.5539/ACH.V4N1P2; Huang Y, 2008, WHO WORLD MENTAL HLT; [黄悦勤 HUANY Yue-Qin], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P21; Irfaeya M, 2008, J IMMIGR MINOR HEALT, V10, P337, DOI 10.1007/s10903-007-9091-5; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kidwai R, 2014, SOC PSYCH PSYCH EPID, V49, P487, DOI 10.1007/s00127-013-0723-x; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Koenig Harold G, 2012, Depress Res Treat, V2012, P460419, DOI 10.1155/2012/460419; Koenig HG, 2012, ASIAN J PSYCHIATR, V5, P180, DOI 10.1016/j.ajp.2012.04.004; Koenig HG, 2012, HDB RELIG HLTH; Koenig HG, 2011, SPIRITUALITY HLTH RE, P47; Lee S, 2007, PSYCHOL MED, V37, P61, DOI 10.1017/S0033291706008993; Linden SC, 2010, PSYCHOL MED, V40, P1317, DOI 10.1017/S0033291709991917; Liu EY, 2013, MENT HEALTH RELIG CU, V16, P215, DOI 10.1080/13674676.2012.672404; Lu J, 2008, J AFFECT DISORDERS, V111, P221, DOI 10.1016/j.jad.2008.02.018; Luo Y, 2004, J S CENTRAL U NATL, V24, P53; Miller L, 2014, JAMA PSYCHIAT, V71, P128, DOI 10.1001/jamapsychiatry.2013.3067; Miller L, 2012, AM J PSYCHIAT, V169, P89, DOI 10.1176/appi.ajp.2011.10121823; Miller T, 2008, PEW FORUM RELIG PUBL; Mueller PS, 2001, MAYO CLIN PROC, V76, P1225, DOI 10.4065/76.12.1225; Overmyer DL, 2003, CHINA QUART, P307, DOI 10.1017/S0009443903000196; Pargament K.I., 1997, PSYCHOL RELIG COPING; PEW RESEARCH CENTER, 2012, MOR 600 MILL CHIN AR; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Presser S, 2007, J SCI STUD RELIG, V46, P417, DOI 10.1111/j.1468-5906.2007.00367.x; RAJ D, 1964, J AM STAT ASSOC, V59, P251; Schnittker J, 2001, J SCI STUD RELIG, V40, P393, DOI 10.1111/0021-8294.00065; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; Shenzhen Statistics Bureau, 2021, SHENZH 7 NAT POP CEN; Stark R, 2011, REV RELIG RES, V52, P282; Su XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083217; Vail KE, 2012, PERS SOC PSYCHOL B, V38, P1288, DOI 10.1177/0146167212449361; Wang Zhizhong, 2013, Shanghai Arch Psychiatry, V25, P287, DOI 10.3969/j.issn.1002-0829.2013.05.004; Wei DD, 2013, J SCI STUD RELIG, V52, P349, DOI 10.1111/jssr.12031; WITZTUM E, 1990, BRIT J MED PSYCHOL, V63, P33, DOI 10.1111/j.2044-8341.1990.tb02854.x; Yao Xinzhong, 2006, MODERN BELIEVING, V47, P44, DOI [10.3828/MB.47.2.44, DOI 10.3828/MB.47.2.44]; Yeager DM, 2006, SOC SCI MED, V63, P2228, DOI 10.1016/j.socscimed.2006.05.007; Zeng Y, 2011, RES AGING, V33, P51, DOI 10.1177/0164027510383584; Zhang W., 2010, J AGING RES, V2010, P1, DOI [10.4061/2010/160294, DOI 10.4061/2010/160294]; Zhang W, 2008, J GERONTOL B-PSYCHOL, V63, pS293, DOI 10.1093/geronb/63.5.S293	58	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128800	10.1371/journal.pone.0128800	http://dx.doi.org/10.1371/journal.pone.0128800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030906	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900191
J	Zandvakili, I; Davis, AK; Hu, GD; Zheng, Y				Zandvakili, Inuk; Davis, Ashley Kuenzi; Hu, Guodong; Zheng, Yi			Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice	PLOS ONE			English	Article							TUMOR PROGRESSION; RATIONAL DESIGN; C-RAF; B-RAF; CANCER; EXPRESSION; ACTIVATION; GTPASES; MOUSE; CELLS	Numerous cellular studies have indicated that RhoA signaling is required for oncogenic Ras-induced transformation, suggesting that RhoA is a useful target in Ras induced neoplasia. However, to date very limited data exist to genetically attribute RhoA function to Ras-mediated tumorigenesis in mammalian models. In order to assess whether RhoA is required for K-Ras-induced lung cancer initiation, we utilized the K-Ras(G12D) Lox-Stop-Lox murine lung cancer model in combination with a conditional RhoA(flox/flox) and RhoC(-/-) knockout mouse models. Deletion of the floxed Rhoa gene and expression of K-Ras(G12)D was achieved by either CCSP-Cre or adenoviral Cre, resulting in simultaneous expression of K-Ras(G12D) and deletion of RhoA from the murine lung. We found that deletion of RhoA, RhoC or both did not adversely affect normal lung development. Moreover, we found that deletion of either RhoA or RhoC alone did not suppress K-Ras(G12D) induced lung adenoma initiation. Rather, deletion of RhoA alone exacerbated lung adenoma formation, whereas dual deletion of RhoA and RhoC together significantly reduced K-Ras(G12D) induced adenoma formation. Deletion of RhoA appears to induce a compensatory mechanism that exacerbates adenoma formation. The compensatory mechanism is at least partly mediated by RhoC. This study suggests that targeting of RhoA alone may allow for compensation and a paradoxical exacerbation of neoplasia, while simultaneous targeting of both RhoA and RhoC is likely to lead to more favorable outcomes.	[Zandvakili, Inuk; Davis, Ashley Kuenzi; Hu, Guodong; Zheng, Yi] Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Zandvakili, Inuk; Zheng, Yi] Cincinnati Childrens Hosp Med Ctr, Mol & Dev Biol Grad Program, Cincinnati, OH 45229 USA; [Zandvakili, Inuk; Zheng, Yi] Univ Cincinnati, Coll Med, Med Scientist Training Program, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zandvakili, Inuk/P-7241-2019; Zheng, Yi/J-7235-2015; Zandvakili, Inuk/C-8496-2011	Zandvakili, Inuk/0000-0003-3409-0019; Zheng, Yi/0000-0001-7089-6074; Kuenzi Davis, Ashley/0000-0003-1162-3994	National Institutes of Health [R01CA150547, R01CA141341, 5T32GM063483]; NATIONAL CANCER INSTITUTE [R01CA141341, R01CA150547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health through the following grants: R01CA150547 (YZ), R01CA141341 (YZ) and 5T32GM063483 (IZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAHAM H, 1989, MOL CELL BIOL, V9, P2058, DOI 10.1128/MCB.9.5.2058; Bellizzi A, 2008, INT J MOL MED, V22, P25; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Chew TW, 2013, ONCOGENE, P1, DOI 10.1038/onc.2013.34; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Du JG, 2004, MOL CANCER RES, V2, P233; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Faried A, 2005, EJSO, V31, P410, DOI 10.1016/j.ejso.2004.12.014; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Konstantinidou G, 2013, CANCER DISCOV, V3, P444, DOI 10.1158/2159-8290.CD-12-0388; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Li XR, 2006, EJSO-EUR J SURG ONC, V32, P1130, DOI 10.1016/j.ejso.2006.05.012; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; PERONA R, 1993, ONCOGENE, V8, P1285; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Rawlins EL, 2012, AM J RESP CELL MOL, V46, P269, DOI 10.1165/rcmb.2011-0372PS; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rodrigues P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6458; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Sato N, 2007, INT J CANCER, V120, P543, DOI 10.1002/ijc.22328; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vigil D, 2012, CANCER RES, V72, P5338, DOI 10.1158/0008-5472.CAN-11-2373; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; Zhou C, 2012, ONCOGENE, P1, DOI [10.1038/onc.2012.253, DOI 10.1038/0NC.2012.253]	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127923	10.1371/journal.pone.0127923	http://dx.doi.org/10.1371/journal.pone.0127923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030593	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900092
J	Dickie, DA; Job, DE; Gonzalez, DR; Shenkin, SD; Wardlaw, JM				Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Wardlaw, Joanna M.			Use of Brain MRI Atlases to Determine Boundaries of Age-Related Pathology: The Importance of Statistical Method	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; OLDER-ADULTS; RANDOM-FIELDS; GRAY-MATTER; ATROPHY; IMAGES; REGISTRATION; AD	Introduction Neurodegenerative disease diagnoses may be supported by the comparison of an individual patient's brain magnetic resonance image (MRI) with a voxel-based atlas of normal brain MRI. Most current brain MRI atlases are of young to middle-aged adults and parametric, e. g., mean +/- standard deviation (SD); these atlases require data to be Gaussian. Brain MRI data, e. g., grey matter (GM) proportion images, from normal older subjects are apparently not Gaussian. We created a nonparametric and a parametric atlas of the normal limits of GM proportions in older subjects and compared their classifications of GM proportions in Alzheimer's disease (AD) patients. Methods Using publicly available brain MRI from 138 normal subjects and 138 subjects diagnosed with AD (all 55-90 years), we created: a mean +/- SD atlas to estimate parametrically the percentile ranks and limits of normal ageing GM; and, separately, a nonparametric, rank order-based GM atlas from the same normal ageing subjects. GM images from AD patients were then classified with respect to each atlas to determine the effect statistical distributions had on classifications of proportions of GM in AD patients. Results The parametric atlas often defined the lower normal limit of the proportion of GM to be negative (which does not make sense physiologically as the lowest possible proportion is zero). Because of this, for approximately half of the AD subjects, 25-45% of voxels were classified as normal when compared to the parametric atlas; but were classified as abnormal when compared to the nonparametric atlas. These voxels were mainly concentrated in the frontal and occipital lobes. Discussion To our knowledge, we have presented the first nonparametric brain MRI atlas. In conditions where there is increasing variability in brain structure, such as in old age, nonparametric brain MRI atlases may represent the limits of normal brain structure more accurately than parametric approaches. Therefore, we conclude that the statistical method used for construction of brain MRI atlases should be selected taking into account the population and aim under study. Parametric methods are generally robust for defining central tendencies, e.g., means, of brain structure. Nonparametric methods are advisable when studying the limits of brain structure in ageing and neurodegenerative disease.	[Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Wardlaw, Joanna M.] Univ Edinburgh, Sch Med, Ctr Clin Brain Sci, Neuroimaging Sci, Edinburgh, Midlothian, Scotland; [Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Wardlaw, Joanna M.] Univ Edinburgh, Royal Infirm Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Shenkin, Susan D.] Scottish Imaging Network, Glasgow, Lanark, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Dickie, DA (corresponding author), Univ Edinburgh, Sch Med, Ctr Clin Brain Sci, Neuroimaging Sci, Edinburgh, Midlothian, Scotland.	ddickie1@staffmail.ed.ac.uk	Wardlaw, Joanna M/Y-3456-2019; Shenkin, Susan/GWZ-3174-2022; Rodriguez Gonzalez, David/AAA-1966-2019; Hernandez, María/GYU-3543-2022	Wardlaw, Joanna M/0000-0002-9812-6642; Rodriguez Gonzalez, David/0000-0002-9160-5106; Shenkin, Susan/0000-0001-7375-4776; Job, Dominic/0000-0002-7829-7217; Dickie, David Alexander/0000-0002-9443-8403	Scottish Funding Council; Scottish Executive Chief Scientist Office; Scottish Executive Chief Scientist Office through the SINAPSE collaboration; SINAPSE industrial collaboration (SPIRIT) PhD scholarship; Medical Research Council (MRC) scholarship; Tony Watson Scholarship; Wellcome Trust [007393/Z/05/Z]; BBSRC; EPSRC; ESRC; MRC; National Institutes of Health (NIH) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Open Access Series of Imaging Studies (OASIS) [P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, P50AG005681, R01AG021910, K01AG030514, U01AG024904, P01AG003991] Funding Source: NIH RePORTER; Medical Research Council [G0700704, MR/K026992/1] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	Scottish Funding Council; Scottish Executive Chief Scientist Office; Scottish Executive Chief Scientist Office through the SINAPSE collaboration; SINAPSE industrial collaboration (SPIRIT) PhD scholarship; Medical Research Council (MRC) scholarship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tony Watson Scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Access Series of Imaging Studies (OASIS); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge and thank the following centres and funders. This work was carried out in The University of Edinburgh Brain Research Imaging Centre (BRIC; http://www.bric.ed.ac.uk/). BRIC is part of the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) collaboration (http://www.sinapse.ac.uk/), funded by the Scottish Funding Council, Scottish Executive Chief Scientist Office, and the six collaborator Universities. Professor Joanna M. Wardlaw was funded by the Scottish Funding Council and Scottish Executive Chief Scientist Office through the SINAPSE collaboration. David Alexander Dickie was funded by a SINAPSE industrial collaboration (SPIRIT) PhD scholarship, a Medical Research Council (MRC) scholarship, and the Tony Watson Scholarship bequest to The University of Edinburgh. Dr Dominic E. Job was funded by Wellcome Trust Grant 007393/Z/05/Z. Dr Susan D. Shenkin and Professor Joanna M. Wardlaw are members of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the BBSRC, EPSRC, ESRC, and MRC is gratefully acknowledged. The Alzheimer's Disease Neuroimaging Initiative (ADNI - PI Michael W. Weiner, MD) data were acquired through the National Institutes of Health (NIH) Grant U01 AG024904, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, Abbott, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Amorfix Life Sciences Ltd., AstraZeneca, Bayer HealthCare, BioClinica, Inc., Biogen Idec Inc., Bristol-Myers Squibb Company, Eisai Inc., Elan Pharmaceuticals Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc., GE Healthcare, Innogenetics, N.V., IXICO Ltd., Janssen Alzheimer Immunotherapy Research & Development, LLC., Johnson & Johnson Pharmaceutical Research & Development LLC., Medpace, Inc., Merck & Co., Inc., Meso Scale Diagnostics, LLC., Novartis Pharmaceuticals Corporation, Pfizer Inc., Servier, Synarc Inc., Takeda Pharmaceutical Company, Canadian Institutes of Health Research, Foundation for the National Institutes of Health (www.fnih.org), Northern California Institute for Research and Education, Alzheimer's Disease Cooperative Study at the University of California, San Diego, Laboratory for Neuro Imaging at the University of California, Los Angeles, and NIH grants P30 AG010129 and K01 AG030514. The Open Access Series of Imaging Studies (OASIS) data were acquired through grants: P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382.	Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Aribisala BS, 2012, EUR RADIOL, DOI [10.1007/s00330-00012-02677-x, DOI 10.1007/S00330-00012-02677-X]; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Aubert-Broche B, 2011, NEUROIMAGE, V58, P409, DOI 10.1016/j.neuroimage.2011.03.025; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; BRODY JA, 1985, NATURE, V315, P463, DOI 10.1038/315463a0; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; Dickie DA, 2014, PRETERM INFANT BRAIN; Dickie DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084093; Dickie DA, 2012, EUR RADIOL, V22, P1385, DOI 10.1007/s00330-012-2392-7; ELVEBACK LR, 1970, J AMER MED ASSOC, V211, P69, DOI 10.1001/jama.211.1.69; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Ferguson KJ, 2010, J NEUROIMAGING, V20, P157, DOI 10.1111/j.1552-6569.2009.00368.x; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Freedman D., 2010, STAT MODELS CAUSAL I; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hill DLG, 2002, LECT NOTES COMPUT SC, V2488, P532; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim N, 2014, FRONTIERS PUBLIC HLT, V2; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Pernet CR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-67; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rorden C, 2007, NEUROIMAGE, V35, P1531, DOI 10.1016/j.neuroimage.2006.12.043; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Thompson PM, 2003, J NEUROSCI, V23, P994; Viviani R, 2007, HUM BRAIN MAPP, V28, P1075, DOI 10.1002/hbm.20332; Viviani R, 2007, NEUROIMAGE, V35, P121, DOI 10.1016/j.neuroimage.2006.11.037; Wardlaw JM, 2011, INT J STROKE, V6, P547, DOI 10.1111/j.1747-4949.2011.00683.x; Watts R, 2014, RADIOLOGY; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhao L, 2013, HUM BRAIN MAPP, V34, P2113, DOI 10.1002/hbm.22050; Ziegler G, 2014, NEUROIMAGE IN PRESS	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127939	10.1371/journal.pone.0127939	http://dx.doi.org/10.1371/journal.pone.0127939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023913	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000355319400059
J	Lim, C; Paris, DH; Blacksell, SD; Laongnualpanich, A; Kantipong, P; Chierakul, W; Wuthiekanun, V; Day, NPJ; Cooper, B; Limmathurotsakul, D				Lim, Cherry; Paris, Daniel H.; Blacksell, Stuart D.; Laongnualpanich, Achara; Kantipong, Pacharee; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Day, Nicholas P. J.; Cooper, Ben S.; Limmathurotsakul, Direk			How to Determine the Accuracy of an Alternative Diagnostic Test when It Is Actually Better than the Reference Tests: A Re-Evaluation of Diagnostic Tests for Scrub Typhus Using Bayesian LCMs	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PROTEIN ANTIGEN R56; ORIENTIA-TSUTSUGAMUSHI; PCR ASSAY; MURINE TYPHUS; GOLD STANDARD; INFECTION; LAOS; RICKETTSIOSES; COMBINATION	Background The indirect immunofluorescence assay (IFA) is considered a reference test for scrub typhus. Recently, the Scrub Typhus Infection Criteria (STIC; a combination of culture, PCR assays and IFA IgM) were proposed as a reference standard for evaluating alternative diagnostic tests. Here, we use Bayesian latent class models (LCMs) to estimate the true accuracy of each diagnostic test, and of STIC, for diagnosing scrub typhus. Methods/Principal Findings Data from 161 patients with undifferentiated fever were re-evaluated using Bayesian LCMs. Every patient was evaluated for the presence of an eschar, and tested with blood culture for Orientia tsutsugamushi, three different PCR assays, IFA IgM, and the Panbio IgM immunochromatographic test (ICT). True sensitivity and specificity of culture (24.4% and 100%), 56kDa PCR assay (56.8% and 98.4%), 47kDa PCR assay (63.2% and 96.1%), groEL PCR assay (71.4% and 93.0%), IFA IgM (70.0% and 83.8%), PanBio IgM ICT (72.8% and 96.8%), presence of eschar (42.7% and 98.9%) and STIC (90.5% and 82.5%) estimated by Bayesian LCM were considerably different from those obtained when using STIC as a reference standard. The IgM ICT had comparable sensitivity and significantly higher specificity compared to IFA (p=0.34 and p<0.001, respectively). Conclusions The low specificity of STIC was caused by the low specificity of IFA IgM. Neither STIC nor IFA IgM can be used as reference standards against which to evaluate alternative diagnostic tests. Further evaluation of new diagnostic tests should be done with a carefully selected set of diagnostic tests and appropriate statistical models.	[Lim, Cherry; Paris, Daniel H.; Blacksell, Stuart D.; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Day, Nicholas P. J.; Cooper, Ben S.; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Paris, Daniel H.; Blacksell, Stuart D.; Day, Nicholas P. J.; Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Laongnualpanich, Achara; Kantipong, Pacharee] Chiang Rai Prachanukroh Hosp, Chiang Rai, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol University	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	direk@tropmedres.ac	Chierakul, Wirongrong/AAC-3226-2020; Paris, Daniel/AFV-4762-2022; Paris, Daniel/GLN-7566-2022; Blacksell, Stuart/D-5530-2018	Chierakul, Wirongrong/0000-0003-2103-9425; Blacksell, Stuart/0000-0001-6576-726X; PARIS, Daniel/0000-0003-4743-5987; Limmathurotsakul, Direk/0000-0001-7240-5320; Cooper, Ben/0000-0002-9445-7217; Lim, Cherry/0000-0003-2555-6980	Wellcome Trust [100484/Z/12Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [100484/Z/12Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P391, DOI 10.1128/CVI.05478-11; Blacksell SD, 2010, AM J TROP MED HYG, V83, P365, DOI 10.4269/ajtmh.2010.09-0534; Ching WM, 2001, CLIN DIAGN LAB IMMUN, V8, P409, DOI 10.1128/CDLI.8.2.409-414.2001; Ching WM, 1998, CLIN DIAGN LAB IMMUN, V5, P519, DOI 10.1128/CDLI.5.4.519-526.1998; Choi YJ, 2005, EMERG INFECT DIS, V11, P237, DOI 10.3201/eid1102.040603; Coleman RE, 2002, AM J TROP MED HYG, V67, P497, DOI 10.4269/ajtmh.2002.67.497; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Horinouchi H, 1996, AM J TROP MED HYG, V54, P647, DOI 10.4269/ajtmh.1996.54.647; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Kim DM, 2007, AM J TROP MED HYG, V76, P806; Kim DM, 2011, J CLIN MICROBIOL, V49, P607, DOI 10.1128/JCM.01216-09; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Lim C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079489; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; Limmathurotsakul D, 2011, CLIN INFECT DIS, V52, P1024, DOI 10.1093/cid/cir080; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Liu YX, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-82; Luksameetanasan Rungnapa, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P91; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Paris DH, 2009, CLIN MICROBIOL INFEC, V15, P488, DOI 10.1111/j.1469-0691.2008.02671.x; Paris DH, 2008, T ROY SOC TROP MED H, V102, P186, DOI 10.1016/j.trstmh.2007.11.001; Paris DH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001307; Parola P, 2003, EMERG INFECT DIS, V9, P592, DOI 10.3201/eid0905.020511; Phetsouvanh R, 2013, AM J TROP MED HYG, V88, P932, DOI 10.4269/ajtmh.12-0325; Phommasone K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002163; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Prakash JAJ, 2011, INDIAN J MED MICROBI, V29, P47, DOI 10.4103/0255-0857.76524; Reisner BS, 1999, AM J CLIN PATHOL, V111, P503; Shiao CC, 2011, CAN MED ASSOC J, V183, pE1152, DOI 10.1503/cmaj.101929; Sonthayanon P, 2013, AM J TROP MED HYG, V89, P797, DOI 10.4269/ajtmh.13-0402; Tay S. T., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P171; Thap Lon Chan, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P780; Trikalinos TA, 2012, OPTIONS SUMMARIZING; Wang CC, 2007, AM J TROP MED HYG, V76, P1148, DOI 10.4269/ajtmh.2007.76.1148; Yasunaga H, 2011, INTERNAL MED, V50, P37, DOI 10.2169/internalmedicine.50.4220; Zhuo X, 2008, STAT METHODS DIAGNOS, P359	38	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0114930	10.1371/journal.pone.0114930	http://dx.doi.org/10.1371/journal.pone.0114930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024375	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400001
J	Hartmann, JA; Wichers, M; Menne-Lothmann, C; Kramer, I; Viechtbauer, W; Peeters, F; Schruers, KRJ; van Bemmel, AL; Myin-Germeys, I; Delespaul, P; van Os, J; Simons, CJP				Hartmann, Jessica A.; Wichers, Marieke; Menne-Lothmann, Claudia; Kramer, Ingrid; Viechtbauer, Wolfgang; Peeters, Frenk; Schruers, Koen R. J.; van Bemmel, Alex L.; Myin-Germeys, Inez; Delespaul, Philippe; van Os, Jim; Simons, Claudia J. P.			Experience Sampling-Based Personalized Feedback and Positive Affect: A Randomized Controlled Trial in Depressed Patients	PLOS ONE			English	Article							REWARD EXPERIENCE; EMOTIONS; SENSITIVITY; PSYCHOLOGY; VALIDITY; MOOD	Objectives Positive affect (PA) plays a crucial role in the development, course, and recovery of depression. Recently, we showed that a therapeutic application of the experience sampling method (ESM), consisting of feedback focusing on PA in daily life, was associated with a decrease in depressive symptoms. The present study investigated whether the experience of PA increased during the course of this intervention. Design Multicentre parallel randomized controlled trial. An electronic random sequence generator was used to allocate treatments. Settings University, two local mental health care institutions, one local hospital. Participants 102 pharmacologically treated outpatients with a DSM-IV diagnosis of major depressive disorder, randomized over three treatment arms. Intervention Six weeks of ESM self-monitoring combined with weekly PA-focused feedback sessions (experimental group); six weeks of ESM self-monitoring combined with six weekly sessions without feedback (pseudo-experimental group); or treatment as usual (control group). Main outcome The interaction between treatment allocation and time in predicting positive and negative affect (NA) was investigated in multilevel regression models. Results 102 patients were randomized (mean age 48.0, SD 10.2) of which 81 finished the entire study protocol. All 102 patients were included in the analyses. The experimental group did not show a significant larger increase in momentary PA during or shortly after the intervention compared to the pseudo-experimental or control groups (chi(2) (2) = 0.33, p = .846). The pseudo-experimental group showed a larger decrease in NA compared to the control group (chi(2) (1) = 6.29, p = .012). Conclusion PA-focused feedback did not significantly impact daily life PA during or shortly after the intervention. As the previously reported reduction in depressive symptoms associated with the feedback unveiled itself only after weeks, it is conceivable that the effects on daily life PA also evolve slowly and therefore were not captured by the experience sampling procedure immediately after treatment.	[Hartmann, Jessica A.; Wichers, Marieke; Menne-Lothmann, Claudia; Kramer, Ingrid; Viechtbauer, Wolfgang; Peeters, Frenk; Schruers, Koen R. J.; van Bemmel, Alex L.; Myin-Germeys, Inez; Delespaul, Philippe; van Os, Jim; Simons, Claudia J. P.] Maastricht Univ, Med Ctr, European Grad Sch Neurosci, Dept Psychiat & Psychol,SEARCH, NL-6200 MD Maastricht, Netherlands; [Hartmann, Jessica A.; Kramer, Ingrid; van Bemmel, Alex L.; Simons, Claudia J. P.] Inst Mental Hlth Care Eindhoven & Kempen, GGzE, Eindhoven, Netherlands; [Hartmann, Jessica A.] Univ Melbourne, Natl Ctr Excellence Youth Mental Hlth, Orygen, Melbourne, Vic, Australia; [Schruers, Koen R. J.] Leuven Univ, Fac Psychol, Ctr Learning & Expt Psychol, Leuven, Belgium; [Delespaul, Philippe] Mondriaan Mental Hlth Trust, South Limburg, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England	Maastricht University; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; KU Leuven; University of London; King's College London	Hartmann, JA (corresponding author), Maastricht Univ, Med Ctr, European Grad Sch Neurosci, Dept Psychiat & Psychol,SEARCH, NL-6200 MD Maastricht, Netherlands.	jessica.hartmann@orygen.org.au	van Os, Jim/V-8884-2019; Myin Germeys, Inez/HIR-3364-2022; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Delespaul, Philippe/E-8982-2011; van Os, Jim/C-2113-2014; Hartmann, Jessica A/N-7771-2013; Myin-Germeys, Inez/L-5106-2014; Viechtbauer, Wolfgang/M-1549-2013; Schruers, Koen/AAV-2922-2021; Delespaul, Philippe/L-1396-2019; Wichers, Marieke/N-6667-2014	van Os, Jim/0000-0002-7245-1586; Myin Germeys, Inez/0000-0002-3731-4930; Delespaul, Philippe/0000-0001-7420-0898; Hartmann, Jessica A/0000-0001-7662-6155; Viechtbauer, Wolfgang/0000-0003-3463-4063; Schruers, Koen/0000-0003-0134-406X; Delespaul, Philippe/0000-0001-7420-0898; Wichers, Marieke/0000-0001-5024-9064; Peeters, F/0000-0002-6167-8582	Netherlands Organization for Scientific Research; Dutch Health Research Council (ZON-MW) [171001002, 91501003]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Health Research Council (ZON-MW)(Netherlands Organization for Health Research and Development)	MW was supported by the Netherlands Organization for Scientific Research (Aspasia Grant). The study was funded by the Dutch Health Research Council (ZON-MW grants nos. 171001002 and 91501003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GGzE, Institute of Mental Health Care Eindhoven and the Kempen and Mondriaan Mental Health Trust provided support in the form of salaries for authors JAH, IK, ALvB, PhD, and CJPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barge-Schaapveld DQ, 2002, J CLIN PSYCHIAT; Beck A, 1979, COGNITIVE THERAPY DE; Ben-Zeev D, 2012, SCHIZOPHRENIA BULL, V38, P384, DOI 10.1093/schbul/sbr179; CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; Dunn BD, 2012, CLIN PSYCHOL PSYCHOT, V19, P326, DOI 10.1002/cpp.1799; First MB, 2002, STRUCTURED CLIN INTE; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Garland EL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00015; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Geschwind N, 2011, EUR NEUROPSYCHOPHARM, V21, P241, DOI 10.1016/j.euroneuro.2010.11.004; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hegerl U, 2010, J PSYCHOPHARMACOL, V24, P445, DOI 10.1177/0269881109106930; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; National Institute for Health and Clinical Excellence (NICE), 2018, DEPR AD REC MAN; Palmier-Claus JE, 2011, ACTA PSYCHIAT SCAND, V123, P12, DOI 10.1111/j.1600-0447.2010.01596.x; Peeters F, 2003, J ABNORM PSYCHOL, V112, P203, DOI 10.1037/0021-843X.112.2.203; Snijders TAB, 1999, MULTILEVEL ANALYSIS; StataCorp, 2012, STAT STAT SOFTW REL; Telford C, 2012, PSYCHOL MED, V42, P1119, DOI 10.1017/S0033291711002200; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; Wichers M, 2011, ACTA PSYCHIAT SCAND, V123, P402, DOI 10.1111/j.1600-0447.2011.01684.x; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66; Wichers M, 2008, J ABNORM PSYCHOL, V117, P699, DOI 10.1037/a0012909; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x	32	33	33	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128095	10.1371/journal.pone.0128095	http://dx.doi.org/10.1371/journal.pone.0128095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26034983	Green Published, gold			2022-12-27	WOS:000355699100027
J	Jiang, JX; Zhang, SJ; Xiong, YK; Jia, YL; Sun, YH; Lin, XX; Shen, HJ; Xie, QM; Yan, XF				Jiang, Jun-xia; Zhang, Shui-juan; Xiong, Yao-kang; Jia, Yong-liang; Sun, Yan-hong; Lin, Xi-xi; Shen, Hui-juan; Xie, Qiang-min; Yan, Xiao-feng			EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OBSTRUCTIVE SLEEP-APNEA; EPOXYEICOSATRIENOIC ACIDS; LEUKOTRIENE B-4; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ATHEROSCLEROSIS; INFLAMMATION; PATHWAY; HYPERTENSION; DISEASE	Cytochrome P-450 epoxygenase (EPOX)-derived epoxyeicosatrienoic acids (EETs), 5-lipoxygenase (5-LO), and leukotriene B-4 (LTB4), the product of 5-LO, all play a pivotal role in the vascular inflammatory process. We have previously shown that EETs can alleviate oxidized low-density lipoprotein (ox-LDL)-induced endothelial inflammation in primary rat pulmonary artery endothelial cells (RPAECs). Here, we investigated whether ox-LDL can promote LTB4 production through the 5-LO pathway. We further explored how exogenous EETs influence ox-LDL-induced LTB4 production and activity. We found that treatment with ox-LDL increased the production of LTB4 and further led to the expression and release of both monocyte chemoattractant protein-1 (MCP-1/CCL2) and intercellular adhesion molecule-1 (ICAM-1). All of the above ox-LDL-induced changes were attenuated by the presence of 11,12-EET and 14,15-EET, as these molecules inhibited the 5-LO pathway. Furthermore, the LTB4 receptor 1 (BLT1 receptor) antagonist U75302 attenuated ox-LDL-induced ICAM-1 and MCP-1/CCL2 expression and production, whereas LY255283, a LTB4 receptor 2 (BLT2 receptor) antagonist, produced no such effects. Moreover, in RPAECs, we demonstrated that the increased expression of 5-LO and BLT1 following ox-LDL treatment resulted from the activation of nuclear factor-kappa B (NF-kappa B) via the p38 mitogen-activated protein kinase (MAPK) pathway. Our results indicated that EETs suppress ox-LDL-induced LTB4 production and subsequent inflammatory responses by downregulating the 5-LO/BLT1 receptor pathway, in which p38 MAPK phosphorylation activates NF-kappa B. These results suggest that the metabolism of arachidonic acid via the 5-LO and EPOX pathways may present a mutual constraint on the physiological regulation of vascular endothelial cells.	[Jiang, Jun-xia; Shen, Hui-juan; Yan, Xiao-feng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Yong-liang; Sun, Yan-hong; Lin, Xi-xi; Xie, Qiang-min] Zhejiang Univ, Sch Med, Zhejiang Resp Drugs Res Lab China FDA, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Shui-juan; Xiong, Yao-kang] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University	Xie, QM (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Resp Drugs Res Lab China FDA, Hangzhou 310003, Zhejiang, Peoples R China.	xieqm@zju.edu.cn; yanxiaofeng0804@sina.com	lin, xi/GZL-4959-2022; Xie, Qiang-min/AAV-7711-2021		Natural Science Foundation of Zhejiang Province of China [Y2100218]; National Science Foundation of China [81270095]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of Zhejiang Province of China (No. Y2100218, http://www.zjnsf.gov.cn/) and the National Science Foundation of China (No. 81270095, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison JB, 2006, MICROVASC RES, V71, P175, DOI 10.1016/j.mvr.2006.02.007; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Back M, 2007, PROSTAG OTH LIPID M, V83, P209, DOI 10.1016/j.prostaglandins.2007.01.008; Back M, 2009, CARDIOVASC DRUG THER, V23, P41, DOI 10.1007/s10557-008-6140-9; Bao MH, 2013, J ETHNOPHARMACOL, V146, P543, DOI 10.1016/j.jep.2013.01.019; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Charo IF, 2011, NAT REV DRUG DISCOV, V10, P365, DOI 10.1038/nrd3444; Chu SJ, 2000, J IMMUNOL, V165, P4640, DOI 10.4049/jimmunol.165.8.4640; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; Coffey MJ, 2007, J LEUKOCYTE BIOL, V82, P1585, DOI 10.1189/jlb.0107019; Di Gennaro A, 2012, ADV IMMUNOL, V116, P51, DOI 10.1016/B978-0-12-394300-2.00002-8; Fleming I, 2007, TRENDS PHARMACOL SCI, V28, P448, DOI 10.1016/j.tips.2007.08.002; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hofmann B, 2013, EXPERT OPIN THER PAT, V23, P895, DOI 10.1517/13543776.2013.791678; Jiang JX, 2014, EUR J PHARMACOL, V727, P43, DOI 10.1016/j.ejphar.2014.01.045; KARARA A, 1993, J BIOL CHEM, V268, P13565; Kim ND, 2007, THESCIENTIFICWORLDJO, V7, P1307, DOI 10.1100/tsw.2007.181; Le Bel M, 2014, J INNATE IMMUN, V6, P159, DOI 10.1159/000353694; Lee SJ, 2010, CARDIOVASC RES, V88, P352, DOI 10.1093/cvr/cvq194; Lefebvre B, 2008, EUR RESPIR J, V32, P113, DOI 10.1183/09031936.00137107; Liu JY, 2010, BIOCHEM PHARMACOL, V79, P880, DOI 10.1016/j.bcp.2009.10.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Okunishi K, 2011, BBA-GEN SUBJECTS, V1810, P1096, DOI 10.1016/j.bbagen.2011.02.005; Papierniak ES, 2013, AM J THER, V20, P79, DOI 10.1097/MJT.0b013e31826915c2; Pfister SL, 2010, ADV PHARMACOL, V60, P27, DOI [10.1016/B978-0-12-385061-4.00002-7, 10.1016/S1054-3589(10)60008-7]; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Revermann M, 2011, BRIT J PHARMACOL, V163, P1721, DOI 10.1111/j.1476-5381.2011.01321.x; Riccioni G, 2012, SCI WORLD J, DOI 10.1100/2012/490968; Riccioni G, 2010, CURR DRUG TARGETS, V11, P882, DOI 10.2174/138945010791320881; Sanchez-Galan E, 2009, CARDIOVASC RES, V81, P216, DOI 10.1093/cvr/cvn277; Stanke-Labesque F, 2012, J LIPID RES, V53, P1944, DOI 10.1194/jlr.P022814; Steinhilber D, 2014, BASIC CLIN PHARMACOL, V114, P70, DOI 10.1111/bcpt.12114; Thomson SJ, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/605101; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; Wang GF, 2013, CARDIOVASC DRUG THER, V27, P199, DOI 10.1007/s10557-013-6440-6; Williams JM, 2010, J CARDIOVASC PHARM, V56, P336, DOI 10.1097/FJC.0b013e3181f04b1c; Wright L, 1998, AM J RESP CRIT CARE, V157, P219, DOI 10.1164/ajrccm.157.1.9704003; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Zhang H, 2012, INT J MOL SCI, V13, P1512, DOI 10.3390/ijms13021512	43	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128278	10.1371/journal.pone.0128278	http://dx.doi.org/10.1371/journal.pone.0128278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035589	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100031
J	Monteagudo, C; Mariscal-Arcas, M; Rivas, A; Lorenzo-Tovar, ML; Tur, JA; Olea-Serrano, F				Monteagudo, Celia; Mariscal-Arcas, Miguel; Rivas, Ana; Luisa Lorenzo-Tovar, Maria; Tur, Josep A.; Olea-Serrano, Fatima			Proposal of a Mediterranean Diet Serving Score	PLOS ONE			English	Article							QUALITY INDEX; REPRESENTATIVE SAMPLE; GLYCEMIC LOAD; LIFE-STYLE; ADHERENCE; POPULATION; CHILDREN; OLDER; FOOD; PATTERN	Background and Aims Numerous studies have demonstrated a relationship between Mediterranean Diet (MD) adherence and the prevention of cardiovascular diseases, cancer, and diabetes, etc. The study aim was to validate a novel instrument to measure MD adherence based on the consumption of food servings and food groups, and apply it in a female population from southern Spain and determining influential factors. Methods and Results The study included 1,155 women aged 12-83 yrs, classified as adolescents, adults, and over-60-yr-olds. All completed a validated semi-quantitative food frequency questionnaire (FFQ). The Mediterranean Dietary Serving Score (MDSS) is based on the latest update of the Mediterranean Diet Pyramid, using the recommended consumption frequency of foods and food groups; the MDSS ranges from 0 to 24. The discriminative power or correct subject classification capacity of the MDSS was analyzed with the Receiver Operating Characteristic (ROC) curve, using the MDS as reference method. Predictive factors for higher MDSS adherence were determined with a logistic regression model, adjusting for age. According to ROC curve analysis, MDSS evidenced a significant discriminative capacity between adherents and non-adherents to the MD pattern (optimal cutoff point=13.50; sensitivity=74%; specificity=48%). The mean MDSS was 12.45 (2.69) and was significantly higher with older age (p<0.001). Logistic regression analysis showed highest MD adherence by over 60-year-olds with low BMI and no habit of eating between meals. Conclusions The MDSS is an updated, easy, valid, and accurate instrument to assess MD adherence based on the consumption of foods and food groups per meal, day, and week. It may be useful in future nutritional education programs to prevent the early onset of chronic non-transmittable diseases in younger populations.	[Monteagudo, Celia; Rivas, Ana; Luisa Lorenzo-Tovar, Maria; Olea-Serrano, Fatima] Univ Granada, Dept Nutr & Food Sci, Res Grp Nutr Diet & Risk Assessment AGR 255, E-18071 Granada, Spain; [Mariscal-Arcas, Miguel] Univ Murcia, Dept Food Technol Nutr & Food Sci, Lorca 30800, Spain; [Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma De Mallorca, Spain; [Tur, Josep A.] CIBEROBN Physiopathol Obes & Nutr, E-07122 Palma De Mallorca, Spain	University of Granada; University of Murcia; Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma De Mallorca, Spain.	pep.tur@uib.es	Olea-Serrano, Fatima/I-4584-2017; Mariscal-Arcas, Miguel/R-3406-2019; Tur, Josep Antoni/F-5576-2014; Tur, Josep/AAE-5748-2020; Mariscal, Miguel/N-6543-2019; Stefanadis, Christodoulos/ABH-2232-2020; Rivas, Ana/D-7841-2018; Sánchez, Celia Monteagudo/M-1460-2014; Mariscal-Arcas, Miguel/K-4150-2017	Mariscal-Arcas, Miguel/0000-0001-9852-4950; Tur, Josep Antoni/0000-0002-6940-0761; Tur, Josep/0000-0002-6940-0761; Stefanadis, Christodoulos/0000-0001-5974-6454; Rivas, Ana/0000-0002-2143-0750; Sánchez, Celia Monteagudo/0000-0003-0529-379X; Mariscal-Arcas, Miguel/0000-0001-9852-4950	Spanish Ministry of Education and Science (FPU Program, PhD fellowship) [AP2008-03703]; European Union Commission [QLK4-1999-01 422, FOOD-CT-2004-506319]; Health Department of Granada City Council-University of Granada [2260]; Andalusian Regional Government (Research Group AGR-255), Spain; Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences) [11/01791, Red Predimed-RETIC RD06/0045/1004, CIBEROBN CB12/03/30038]; Balearic Islands Gov. [35/2011]; EU FEDER fund [35/2011]	Spanish Ministry of Education and Science (FPU Program, PhD fellowship)(German Research Foundation (DFG)); European Union Commission(European Commission); Health Department of Granada City Council-University of Granada; Andalusian Regional Government (Research Group AGR-255), Spain; Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences); Balearic Islands Gov.; EU FEDER fund	This study was supported by the Spanish Ministry of Education and Science (FPU Program, AP2008-03703, PhD fellowship for Celia Monteagudo), the European Union Commission (QLK4-1999-01 422 and FOOD-CT-2004-506319), the Health Department of Granada City Council-University of Granada (Contract n<SUP>o</SUP> 2260), Andalusian Regional Government (Research Group AGR-255), Spain, the Spanish Ministry of Health and Consumer Affairs (Programme for Promotion of Biomedical Research and Health Sciences, Projects 11/01791, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038), and a Grant of support to research groups no. 35/2011 (Balearic Islands Gov. and EU FEDER funds).	Babio N, 2014, CAN MED ASSOC J, V186, pE649, DOI 10.1503/cmaj.140764; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Baldini M, 2009, PUBLIC HEALTH NUTR, V12, P148, DOI 10.1017/S1368980008002759; Bonaccio M, 2012, BMJ OPEN, V2; Buckland G, 2011, BRIT J NUTR, V106, P1581, DOI 10.1017/S0007114511002078; Filippidis FT, 2011, PUBLIC HEALTH, V125, P436, DOI 10.1016/j.puhe.2011.03.009; Howarth NC, 2007, INT J OBESITY, V31, P675, DOI 10.1038/sj.ijo.0803456; Inelmen EM, 2008, J NUTR HEALTH AGING, V12, P3, DOI 10.1007/BF02982157; Beunza JJ, 2010, AM J CLIN NUTR, V92, P1484, DOI 10.3945/ajcn.2010.29764; Kourlaba G, 2009, ANN EPIDEMIOL, V19, P692, DOI 10.1016/j.annepidem.2009.03.019; Marisca-Arcas M, 2011, J NUTR HEALTH AGING, V15, P739, DOI 10.1007/s12603-011-0136-z; Mariscal-Arcas M, 2010, NUTR HOSP, V25, P1006, DOI 10.3305/nh.2010.25.6.4889; Mariscal-Arcas M, 2009, BRIT J NUTR, V102, P744, DOI 10.1017/S0007114509274769; Mariscal-Arcas M, 2009, PUBLIC HEALTH NUTR, V12, P1408, DOI 10.1017/S1368980008004126; Martinez-Gonzalez MA, 2004, EUR J CLIN NUTR, V58, P1550, DOI 10.1038/sj.ejcn.1602004; Martinez-Gonzalez MA, DIAZ SANTOS, V16, P837, DOI [10.1016/j.jpurol.2014.06.011, DOI 10.1016/J.JPUROL.2014.06.011]; Misirli G, 2012, AM J EPIDEMIOL, V176, P1185, DOI 10.1093/aje/kws205; Monteagudo C, 2013, PUBLIC HEALTH NUTR, V16, P639, DOI 10.1017/S1368980012003175; Naska A, 2014, NUTR METAB CARDIOVAS, V24, P216, DOI 10.1016/j.numecd.2013.11.007; Olmedo-Requena R, 2014, PUBLIC HEALTH NUTR, V17, P648, DOI 10.1017/S1368980013000657; Panagiotakos DB, 2007, PREV MED, V44, P335, DOI 10.1016/j.ypmed.2006.12.009; Patino-Alonso MC, 2014, J ACAD NUTR DIET, V114, P583, DOI 10.1016/j.jand.2013.07.038; Rathnayake Kumari Malkanthi, 2012, BMC Res Notes, V5, P469, DOI 10.1186/1756-0500-5-469; Rivas A, 2009, NUTR HOSP, V24, P521, DOI 10.3305/nh.2009.24.5.4462; Ros E, 2014, ADV NUTR, V5, p330S, DOI 10.3945/an.113.005389; Rossi M, 2013, DIABETOLOGIA, V56, P2405, DOI 10.1007/s00125-013-3013-y; Sanchez-Villegas A, 2002, EUR J NUTR, V41, P249, DOI 10.1007/s00394-002-0382-2; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Serra-Majem L, 2004, PUBLIC HEALTH NUTR, V7, P931, DOI 10.1079/PHN2004556; Sofi F, 2012, EUR J NUTR, V51, P167, DOI 10.1007/s00394-011-0202-7; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tur JA, 2005, BRIT J NUTR, V93, P369, DOI 10.1079/BJN20041363; Tur JA, 2004, BRIT J NUTR, V92, P341, DOI 10.1079/BJN20041209; Turati F, 2015, NUTR METAB CARDIOVAS, V25, P336, DOI 10.1016/j.numecd.2014.12.002; Velasco J, 2009, NUTR HOSP, V24, P193; W. H. Organization and Food and Agriculture Organization, 2003, DIET NUTR PREV CHRON, P147; WHO, 2010, GLOB STAT REP NONC D; Willett W., 2012, NUTR EPIDEMIOLOGY	40	64	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128594	10.1371/journal.pone.0128594	http://dx.doi.org/10.1371/journal.pone.0128594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035442	Green Published, gold			2022-12-27	WOS:000355699100038
J	Fujita, M; Sato, Y; Nagashima, K; Takahashi, S; Hata, A				Fujita, Misuzu; Sato, Yasunori; Nagashima, Kengo; Takahashi, Sho; Hata, Akira			Predictive Power of a Body Shape Index for Development of Diabetes, Hypertension, and Dyslipidemia in Japanese Adults: A Retrospective Cohort Study	PLOS ONE			English	Article							MASS INDEX; RISK-FACTORS; OBESITY; MORTALITY; ASSOCIATION; CLASSIFICATION; MELLITUS	Background/Objectives Recently, a body shape index (ABSI) was reported to predict all-cause mortality independently of body mass index (BMI) in Americans. This study aimed to evaluate whether ABSI is applicable to Japanese adults as a predictor for development of diabetes, hypertension, and dyslipidemia. Subjects/Methods We evaluated the predictive power of ABSI in a retrospective cohort study using annual health examination data from Chiba City Hall in Japan, for the period 2008 to 2012. Subjects included 37,581 without diabetes, 23,090 without hypertension, and 20,776 without dyslipidemia at baseline who were monitored for disease incidence for 4 years. We examined the associations of standardized ABSI, BMI, and waist circumference (WC) at baseline with disease incidence by logistic regression analyses. Furthermore, we conducted a case-matched study using the propensity score matching method. Results Elevated BMI, WC, and ABSI increased the risks of diabetes and dyslipidemia [BMI-diabetes: odds ratio (OR) = 1.26, 95% confidence interval (95% CI) = 1.20-1.32; BMI-dyslipidemia: OR = 1.15, 95% CI = 1.12-1.19; WC-diabetes: OR = 1.24, 95% CI = 1.18-1.31; WC-dyslipidemia: OR = 1.15, 95% CI = 1.11-1.19; ABSI-diabetes: OR = 1.06, 95% CI = 1.01-1.11; ABSI-dyslipidemia: OR = 1.04, 95% CI = 1.01-1.07]. Elevated BMI and WC, but not higher ABSI, also increased the risk of hypertension [BMI: OR = 1.32, 95% CI = 1.27-1.37; WC: OR = 1.22, 95% CI = 1.18-1.26; ABSI: OR = 1.00, 95% CI = 0.97-1.02]. Areas under the curve (AUCs) in regression models with ABSI were significantly smaller than in models with BMI or WC for all three diseases. In case-matched subgroups, the power of ABSI was weaker than that of BMI and WC for predicting the incidence of diabetes, hypertension, and dyslipidemia. Conclusions Compared with BMI or WC, ABSI was not a better predictor of diabetes, hypertension, and dyslipidemia in Japanese adults.	[Fujita, Misuzu; Hata, Akira] Chiba Univ, Dept Publ Hlth, Chiba, Chiba, Japan; [Sato, Yasunori; Nagashima, Kengo; Takahashi, Sho] Chiba Univ, Hosp Clin Res Ctr, Chiba, Chiba, Japan	Chiba University; Chiba University	Fujita, M (corresponding author), Chiba Univ, Dept Publ Hlth, Chiba, Chiba, Japan.	fujitam@chiba-u.jp	Nagashima, Kengo/I-1726-2013; Nagashima, Kengo/I-4258-2019	Nagashima, Kengo/0000-0003-4529-9045; Nagashima, Kengo/0000-0003-4529-9045; Fujita, Misuzu/0000-0001-5308-4744; HATA, AKIRA/0000-0003-0867-3704	Chiba City; Chiba Universities; Chiba Foundation for Health Promotion & Disease Prevention; MEXT KAKENHI [26460826]	Chiba City; Chiba Universities; Chiba Foundation for Health Promotion & Disease Prevention; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by a Grant for Joint Research Projects between Chiba City and Universities, 2013. URL:http://www.city.chiba.jp/sogoseisaku/sogoseisaku/kikaku/kyoudoukenkyuu.html. Grants from Chiba Foundation for Health Promotion & Disease Prevention. URL:http://www.kenko-chiba.or.jp/05kouhou/09cyousakenkyuu_h26.html. MEXT KAKENHI Grant Number 26460826. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2014, EUR J NUTR IN PRESS; Afsar B, 2013, NUTRITION, V29, P1214, DOI 10.1016/j.nut.2013.03.012; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Cheung YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085421; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dongsheng Y, 2014, UNIFIED APPROACH MEA; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fujita M, 2009, EXP BIOL MED, V234, P750, DOI 10.3181/0810-RM-292; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Ishikawa-Takata K, 2002, EUR J CLIN NUTR, V56, P601, DOI 10.1038/sj.ejcn.1601364; Jiang JY, 2013, PREV MED, V57, P60, DOI 10.1016/j.ypmed.2013.04.014; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Moore SC, 2009, AM J CLIN NUTR, V89, P1003, DOI 10.3945/ajcn.2009.27598; Nevill AM, 2006, AM J PHYS ANTHROPOL, V129, P151, DOI 10.1002/ajpa.20262; Oka R, 2010, OBESITY, V18, P153, DOI 10.1038/oby.2009.180; Parsons LS, RED BIAS PROP SCOR M; Pereira M, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-114; Ruhl CE, 2010, GASTROENTEROLOGY, V138, P1346, DOI 10.1053/j.gastro.2009.12.053; Schmiegelow MD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000672; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Song X, 2013, EUR J CLIN NUTR, V67, P1298, DOI 10.1038/ejcn.2013.203; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; The Japanese Society of Hypertension, 2009, GUID MAN HYP 2009; Welborn TA, 2007, EUR J CLIN NUTR, V61, P1373, DOI 10.1038/sj.ejcn.1602656; World Health Organization, 2013, WORLD HLTH STAT	30	54	59	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128972	10.1371/journal.pone.0128972	http://dx.doi.org/10.1371/journal.pone.0128972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030122	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900201
J	Gomez, C; Williams, AJ; Nicol, SJ; Mellin, C; Loeun, KL; Bradshaw, CJA				Gomez, Celine; Williams, Ashley J.; Nicol, Simon J.; Mellin, Camille; Loeun, Kim L.; Bradshaw, Corey J. A.			Species Distribution Models of Tropical Deep-Sea Snappers	PLOS ONE			English	Article							MARINE PROTECTED AREAS; GREAT-BARRIER-REEF; VULNERABILITY; PREDICTION; SEAMOUNT; FISH; CONSERVATION; BIODIVERSITY; BATHYMETRY; FISHERIES	Deep-sea fisheries provide an important source of protein to Pacific Island countries and territories that are highly dependent on fish for food security. However, spatial management of these deep-sea habitats is hindered by insufficient data. We developed species distribution models using spatially limited presence data for the main harvested species in the Western Central Pacific Ocean. We used bathymetric and water temperature data to develop presence-only species distribution models for the commercially exploited deep-sea snappers Etelis Cuvier 1828, Pristipomoides Valenciennes 1830, and Aphareus Cuvier 1830. We evaluated the performance of four different algorithms (CTA, GLM, MARS, and MAXENT) within the BIOMOD framework to obtain an ensemble of predicted distributions. We projected these predictions across the Western Central Pacific Ocean to produce maps of potential deep-sea snapper distributions in 32 countries and territories. Depth was consistently the best predictor of presence for all species groups across all models. Bathymetric slope was consistently the poorest predictor. Temperature at depth was a good predictor of presence for GLM only. Model precision was highest for MAXENT and CTA. There were strong regional patterns in predicted distribution of suitable habitat, with the largest areas of suitable habitat (> 35% of the Exclusive Economic Zone) predicted in seven South Pacific countries and territories (Fiji, Matthew & Hunter, Nauru, New Caledonia, Tonga, Vanuatu and Wallis & Futuna). Predicted habitat also varied among species, with the proportion of predicted habitat highest for Aphareus and lowest for Etelis. Despite data paucity, the relationship between deep-sea snapper presence and their environments was sufficiently strong to predict their distribution across a large area of the Pacific Ocean. Our results therefore provide a strong baseline for designing monitoring programs that balance resource exploitation and conservation planning, and for predicting future distributions of deep-sea snappers.	[Gomez, Celine; Williams, Ashley J.; Nicol, Simon J.; Loeun, Kim L.] Secretariat Pacific Commun, Ocean Fisheries Programme, Noumea 98848, New Caledonia; [Mellin, Camille; Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Mellin, Camille; Bradshaw, Corey J. A.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Mellin, Camille] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	University of Adelaide; University of Adelaide; Australian Institute of Marine Science	Gomez, C (corresponding author), Secretariat Pacific Commun, Ocean Fisheries Programme, BP D5, Noumea 98848, New Caledonia.	celine.c.gomez@gmail.com	Mellin, Camille/X-9161-2019; Williams, Ashley J/G-2017-2014; Mellin, Camille/AAB-1768-2019; Bradshaw, Corey J.A./A-1311-2008; Williams, Ashley/ABA-5921-2020	Mellin, Camille/0000-0002-7369-2349; Williams, Ashley J/0000-0002-5530-0073; Bradshaw, Corey J.A./0000-0002-5328-7741; Williams, Ashley/0000-0002-5530-0073; Nicol, Simon/0000-0001-8193-8719	Australian Agency for International Development (AusAID) through the Pacific Fisheries for Food Security Program (PFFSP); French Pacific Fund; Zone Economique de Nouvelle-Caledonie (ZoNeCo); Marine Biodiversity Hub	Australian Agency for International Development (AusAID) through the Pacific Fisheries for Food Security Program (PFFSP); French Pacific Fund; Zone Economique de Nouvelle-Caledonie (ZoNeCo); Marine Biodiversity Hub	This research was funded by the Australian Agency for International Development (AusAID) through the Pacific Fisheries for Food Security Program (PFFSP), the French Pacific Fund, and the Zone Economique de Nouvelle-Caledonie (ZoNeCo) program. CM was funded by the Marine Biodiversity Hub (www.nerpmarine.edu.au).	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barnier B, 2006, OCEAN DYNAM, V56, P543, DOI 10.1007/s10236-006-0082-1; Beger M, 2008, MAR ECOL PROG SER, V361, P1, DOI 10.3354/meps07481; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Carpenter K.E., 2001, LIVING MARINE RESO 3, V5; Chapman L. B., 2008, FISH SPECIES IDENTIF; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Dalzell P, 1992, 2 S PAC COMM; Dunn DC, 2014, MAR POLICY, V49, P137, DOI 10.1016/j.marpol.2013.12.002; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fry GC, 2006, FISH RES, V81, P126, DOI 10.1016/j.fishres.2006.08.002; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Koslow JA, 1997, AM SCI, V85, P168; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Koslow JA, 1996, J FISH BIOL, V49, P54, DOI 10.1111/j.1095-8649.1996.tb06067.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Merritt D, 2011, FISH B-NOAA, V109, P56; Metcalfe K, 2013, DIVERS DISTRIB, V19, P1, DOI 10.1111/j.1472-4642.2012.00921.x; Misa WFXE, 2013, FISH B-NOAA, V111, P293, DOI 10.7755/FB.111.4.1; Moore CH, 2013, MAR ECOL PROG SER, V476, P167, DOI 10.3354/meps10132; Morato T, 2006, J FISH BIOL, V68, P209, DOI 10.1111/j.0022-1112.2006.00894.x; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Reignier T, 2013, MEMOIRE STAGE MASTER, V1; Rodriguez JP, 2003, ORYX, V37, P411, DOI 10.1017/S0030605303000759; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Ross RE, 2013, DIVERS DISTRIB, V19, P433, DOI 10.1111/ddi.12010; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Vierod ADT, 2014, DEEP-SEA RES PT II, V99, P6, DOI 10.1016/j.dsr2.2013.06.010; Virly S, 1997, PROGRAMME ZONECO EVA; Watson RA, 2013, FISH RES, V140, P63, DOI 10.1016/j.fishres.2012.12.004; Weng JS, 2013, J APPL ICHTHYOL, V29, P990, DOI 10.1111/jai.12265; Williams AJ, 2013, J APPL ICHTHYOL, V29, P395, DOI 10.1111/jai.12123; Williams AJ, 2012, REV FISH BIOL FISHER, V22, P527, DOI [10.1007/s11160-011-9234-6, DOI 10.1007/S11160-011-9234-6]; Wright DJ, 2000, MAR GEOPHYS RES, V21, P489, DOI 10.1023/A:1026514914220; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	50	14	14	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127395	10.1371/journal.pone.0127395	http://dx.doi.org/10.1371/journal.pone.0127395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030067	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900049
J	Phiwpan, K; Guo, J; Zhang, W; Hu, TY; Boruah, BM; Zhang, JH; Zhou, XY				Phiwpan, Krung; Guo, Jie; Zhang, Wei; Hu, Tanyu; Boruah, Bhargavi M.; Zhang, Jianhua; Zhou, Xuyu			A Novel Transgenic Mouse Line for Tracing MicroRNA-155-5p Activity In Vivo	PLOS ONE			English	Article							CELL-DIFFERENTIATION; T-CELLS; EXPRESSION; MIR-155; GENE; INFLAMMATION; GENERATION; RESPONSES; SYSTEM; RNA	MicroRNA-155 (miR-155) plays significant role in various physiological processes involving both innate and adaptive immunity. miR-155 expression level changes dynamically during various immune responses. However, current approaches for miR-155 detection at the RNA level do not precisely reflect the real-time activity. Herein, we generated a transgenic mouse line (R26-DTR-155T) for determination of miR-155-5p activity in vivo by inserting miR-155-5p target sequence downstream of a reporter transgene comprising Diphtheria Toxin Receptor and TagBlue fluorescence protein. Using this approach, R26-DTR-155T mice were able to measure variation in levels of miR-155-5p activity in specific cell types of interest. The DTR expression levels were inversely correlated with the endogenous miR-155 expression pattern as detected by quantitative RT-PCR. Our data demonstrate a novel transgenic mouse line which could be useful for tracing miR-155-5p activity in specific cell types through measurement of miR-155-5p activity at single cell level.	[Phiwpan, Krung; Guo, Jie; Zhang, Wei; Hu, Tanyu; Zhang, Jianhua; Zhou, Xuyu] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol CASPMI, Beijing, Peoples R China; [Phiwpan, Krung; Hu, Tanyu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Boruah, Bhargavi M.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhou, XY (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol CASPMI, Beijing, Peoples R China.	zhouxy@im.ac.cn	Zhou, Xuyu/L-7422-2019	Zhou, Xuyu/0000-0002-6626-0898; PHIWPAN, KRUNG/0000-0003-3332-5912; Boruah, Bhargavi/0000-0002-3645-785X	National Natural Science Foundation of China [31270959]; National Key Basic Research and Development 973 Program of China [2012CB917102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development 973 Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31270959), http://www.nsfc.gov.cn, and the National Key Basic Research and Development 973 Program of China under Grant No. 2012CB917102, http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Amendola M, 2013, MOL THER, V21, P934, DOI 10.1038/mt.2013.12; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Das LM, 2013, MUCOSAL IMMUNOL, V6, P167, DOI 10.1038/mi.2012.60; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Elton TS, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/281692; Ezzine S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt797; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Giel-Moloney M, 2007, GENESIS, V45, P83, DOI 10.1002/dvg.20269; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Jeker LT, 2013, IMMUNOL REV, V253, P65, DOI 10.1111/imr.12061; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Kong W, 2009, J CELL PHYSIOL, V218, P22, DOI 10.1002/jcp.21577; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee JY, 2008, J NUCL MED, V49, P285, DOI 10.2967/jnumed.107.042507; Lind EF, 2014, EUR J IMMUNOL, V44, P11, DOI 10.1002/eji.201343962; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Moffett HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-221; Murai K, 1998, P NATL ACAD SCI USA, V95, P3461, DOI 10.1073/pnas.95.7.3461; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nehlsen K, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-100; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schug J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-264; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seddiki N, 2012, BLOOD, V119, P6396, DOI 10.1182/blood-2012-02-412874; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang G, 2011, SCI CHINA LIFE SCI, V54, P418, DOI 10.1007/s11427-011-4171-0; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	43	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128198	10.1371/journal.pone.0128198	http://dx.doi.org/10.1371/journal.pone.0128198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030404	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900123
J	Swain, NR; Reynolds, JD				Swain, Noel R.; Reynolds, John D.			Effects of Salmon-Derived Nutrients and Habitat Characteristics on Population Densities of Stream-Resident Sculpins	PLOS ONE			English	Article							TROUT SALVELINUS-FONTINALIS; ANADROMOUS SOCKEYE-SALMON; FRESH-WATER ECOSYSTEMS; PACIFIC SALMON; MARINE SUBSIDIES; COTTUS-ASPER; ONCORHYNCHUS-KISUTCH; CARCASSES INCREASE; COASTRANGE SCULPIN; PHYSICAL HABITAT	Movement of nutrients across ecosystem boundaries can have important effects on food webs and population dynamics. An example from the North Pacific Rim is the connection between productive marine ecosystems and freshwaters driven by annual spawning migrations of Pacific salmon (Oncorhynchus spp). While a growing body of research has highlighted the importance of both pulsed nutrient subsidies and disturbance by spawning salmon, their effects on population densities of vertebrate consumers have rarely been tested, especially across streams spanning a wide range of natural variation in salmon densities and habitat characteristics. We studied resident freshwater prickly (Cottus asper), and coastrange sculpins (C. aleuticus) in coastal salmon spawning streams to test whether their population densities are affected by spawning densities of pink and chum salmon (O. gorbuscha and O. keta), as well as habitat characteristics. Coastrange sculpins occurred in the highest densities in streams with high densities of spawning pink and chum salmon. They also were more dense in streams with high pH, large watersheds, less area covered by pools, and lower gradients. In contrast, prickly sculpin densities were higher in streams with more large wood and pools, and less canopy cover, but their densities were not correlated with salmon. These results for coastrange sculpins provide evidence of a numerical population response by freshwater fish to increased availability of salmon subsidies in streams. These results demonstrate complex and context-dependent relationships between spawning Pacific salmon and coastal ecosystems and can inform an ecosystem-based approach to their management and conservation.	[Swain, Noel R.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Swain, NR (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	swain.noel@gmail.com	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	NSERC Alexander Graham Bell Canada Graduate Scholarship; Pacific Century Graduate Scholarship; NSERC Discovery and Accelerator Grants; Pacific Salmon Foundation; BC Leading Edge Fund; Simon Fraser University	NSERC Alexander Graham Bell Canada Graduate Scholarship; Pacific Century Graduate Scholarship; NSERC Discovery and Accelerator Grants; Pacific Salmon Foundation; BC Leading Edge Fund; Simon Fraser University	This work was supported by the NSERC Alexander Graham Bell Canada Graduate Scholarship (www.nserc-crsng.gc.ca) and Pacific Century Graduate Scholarship to NRS; and NSERC Discovery and Accelerator Grants to JDR, and the Tom Buell Research Chair partnership between the Pacific Salmon Foundation (www.psf.ca), the BC Leading Edge Fund (www.leefbc.ca), and Simon Fraser University (www.sfu.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SB, 2007, T AM FISH SOC, V136, P1736, DOI 10.1577/T07-023.1; ANDERSON CS, 1985, ENVIRON BIOL FISH, V13, P93, DOI 10.1007/BF00002577; Anderson D.R, 2007, MODEL BASED INFERENC, DOI [10.2307/23014412, DOI 10.2307/23014412]; Anderson WB, 1998, OIKOS, V81, P75, DOI 10.2307/3546469; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Armstrong JB, 2013, ECOSYSTEMS, V16, P1429, DOI 10.1007/s10021-013-9693-9; BAIN M B, 1985, North American Journal of Fisheries Management, V5, P499, DOI 10.1577/1548-8659(1985)5<499:QSSFHA>2.0.CO;2; Baldigo BP, 2005, CAN J FISH AQUAT SCI, V62, P1168, DOI 10.1139/F05-022; Baldigo BP, 2001, AQUAT SCI, V63, P196, DOI 10.1007/PL00001352; Barton K., 2012, R PACKAGE MUMIN MULT; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Bentley KT, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00231.1; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; BROWN LR, 1995, ENVIRON BIOL FISH, V42, P329, DOI 10.1007/BF00001462; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARLE FL, 1978, BIOMETRICS, V34, P621, DOI 10.2307/2530381; Denton KP, 2009, T AM FISH SOC, V138, P1207, DOI 10.1577/T09-006.1; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Field RD, 2011, P ROY SOC B-BIOL SCI, V278, P3081, DOI 10.1098/rspb.2010.2731; Foote CJ, 1998, CAN J FISH AQUAT SCI, V55, P1524, DOI 10.1139/cjfas-55-6-1524; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harding JN, 2014, FRESHWATER BIOL, V59, P1361, DOI 10.1111/fwb.12351; Harvey BC, 2005, CAN J FISH AQUAT SCI, V62, P650, DOI 10.1139/F04-225; Harvey BC, 2010, N AM J FISH MANAGE, V30, P1445, DOI 10.1577/M10-022.1; HAWKINS CP, 1983, CAN J FISH AQUAT SCI, V40, P1173, DOI 10.1139/f83-134; Heintz RA, 2004, T AM FISH SOC, V133, P559, DOI 10.1577/T03-035.1; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hocking MD, 2009, OIKOS, V118, P1307, DOI 10.1111/j.1600-0706.2009.17302.x; Holtgrieve GW, 2011, ECOLOGY, V92, P373, DOI 10.1890/09-1694.1; HUNTER JG, 1959, J FISH RES BOARD CAN, V16, P835, DOI 10.1139/f59-061; Inoue M, 2001, ECOL RES, V16, P233, DOI 10.1046/j.1440-1703.2001.00389.x; Isaak DJ, 2000, CAN J FISH AQUAT SCI, V57, P468, DOI 10.1139/cjfas-57-2-468; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Kaeser AJ, 2001, T AM FISH SOC, V130, P1106, DOI 10.1577/1548-8659(2001)130<1106:TIOARE>2.0.CO;2; Kawaguchi Y, 2003, ECOLOGY, V84, P701, DOI 10.1890/0012-9658(2003)084[0701:TIIDTL]2.0.CO;2; Kiffney PM, 2007, T AM FISH SOC, V136, P1088, DOI 10.1577/T06-234.1; KLINE TC, 1990, CAN J FISH AQUAT SCI, V47, P136, DOI 10.1139/f90-014; KOZEL SJ, 1989, J FRESHWATER ECOL, V5, P113, DOI 10.1080/02705060.1989.9665219; Lamberti GA, 1997, J N AM BENTHOL SOC, V16, P95, DOI 10.2307/1468241; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MASON JC, 1976, FISH B-NOAA, V74, P131; McPhail J.D., 2007, FRESHWATER FISHES BR; Milner AM, 2011, ECOLOGY, V92, P1924, DOI 10.1890/10-2007.1; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Moore JW, 2006, BIOSCIENCE, V56, P237, DOI 10.1641/0006-3568(2006)056[0237:AEEIS]2.0.CO;2; Moore JW, 2004, CAN J FISH AQUAT SCI, V61, P1582, DOI [10.1139/f04-103, 10.1139/F04-103]; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; PHILLIPS RW, 1966, T AM FISH SOC, V95, P210, DOI 10.1577/1548-8659(1966)95[210:IMOTRS]2.0.CO;2; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Power ME, 2001, P NATL ACAD SCI USA, V98, P14, DOI 10.1073/pnas.98.1.14; Quinn TP, 1996, CAN J FISH AQUAT SCI, V53, P1555, DOI 10.1139/cjfas-53-7-1555; R Development Core Team, 2012, R LANG ENV STAT COMP; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Scheuerell MD, 2007, FRESHWATER BIOL, V52, P1944, DOI 10.1111/j.1365-2427.2007.01823.x; Scheuerell MD, 2005, CAN J FISH AQUAT SCI, V62, P961, DOI 10.1139/F05-113; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Swain NR, 2014, CAN J FISH AQUAT SCI, V71, P521, DOI 10.1139/cjfas-2013-0159; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tiegs SD, 2008, ECOL APPL, V18, P4, DOI 10.1890/07-0655.1; Verspoor JJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00011.1; Verspoor JJ, 2010, ECOSYSTEMS, V13, P1020, DOI 10.1007/s10021-010-9371-0; Wallace JB, 1999, ECOL MONOGR, V69, P409, DOI 10.1890/0012-9615(1999)069[0409:EORLOA]2.0.CO;2; Warren DR, 2010, ENVIRON BIOL FISH, V88, P51, DOI 10.1007/s10641-010-9617-x; White JL, 1999, COPEIA, P371; Wilzbach MA, 2005, CAN J FISH AQUAT SCI, V62, P58, DOI 10.1139/F04-177; Wipfli MS, 2010, T AM FISH SOC, V139, P824, DOI 10.1577/T09-114.1; Wipfli MS, 1998, CAN J FISH AQUAT SCI, V55, P1503, DOI 10.1139/cjfas-55-6-1503; Wipfli MS, 2003, T AM FISH SOC, V132, P371, DOI 10.1577/1548-8659(2003)132<0371:MSIFES>2.0.CO;2; Wolman M. G., 1954, T AM GEOPHYS UNION, V35, P951, DOI DOI 10.1029/TR035I006P00951; Wyatt RJ, 2002, CAN J FISH AQUAT SCI, V59, P695, DOI 10.1139/F02-041; Zimmerman JKH, 2007, T AM FISH SOC, V136, P1791, DOI 10.1577/T06-020.1; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	76	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0116090	10.1371/journal.pone.0116090	http://dx.doi.org/10.1371/journal.pone.0116090			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030145	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900001
J	Tokugawa, J; Cho, N; Suzuki, H; Sugiyama, N; Akiyama, O; Nakao, Y; Yamamoto, T				Tokugawa, Joji; Cho, Narisumi; Suzuki, Hiroharu; Sugiyama, Natsuki; Akiyama, Osamu; Nakao, Yasuaki; Yamamoto, Takuji			Novel Classification of the Posterior Auricular Artery Based on Angiographical Appearance	PLOS ONE			English	Article							ANATOMY; BYPASS; FLAP	Purpose To investigate the length variation of the posterior auricular artery and propose a novel classification of the posterior auricular artery based on angiographical appearance. Patients and Methods A series of 234 consecutive patients who had undergone conventional cerebral angiography was analyzed. The posterior auricular artery was examined on the lateral projection of the external carotid or common carotid arteriography. The posterior auricular artery was classified into four groups by length, using the external auditory canal and the top of the helix as radiographical landmarks. Our proposed classification is as follows: Type A, posterior auricular artery terminates between its origin and the center of the external auditory canal; Type B, posterior auricular artery terminates between the center of the external auditory canal and the top of the helix; Type C, posterior auricular artery terminates between the top of the helix and the vertex; and Type D, posterior auricular artery reaches up to the vertex. Results A total of 424 (right, 214; left, 210) posterior auricular arteries were analyzed in 111 men and 123 women aged 11 to 91 years (mean, 61.0 years) examined for aneurysms in 78 cases, occlusive vascular diseases in 56, intracranial hemorrhages in 41, tumors in 35, and others in 24. Types A, B, C, and D were found in 15.1%, 34.9%, 48.8%, and 1.2% of the patients, respectively. Conclusion A novel classification of the posterior auricular artery identifies four types based on its length on cerebral angiography.	[Tokugawa, Joji; Suzuki, Hiroharu; Sugiyama, Natsuki; Akiyama, Osamu; Nakao, Yasuaki; Yamamoto, Takuji] Juntendo Univ, Shizuoka Hosp, Dept Neurosurg, Izunokuni, Shizuoka, Japan; [Cho, Narisumi] Juntendo Univ, Shizuoka Hosp, Dept Radiol, Izunokuni, Shizuoka, Japan	Juntendo University; Juntendo University	Tokugawa, J (corresponding author), Juntendo Univ, Shizuoka Hosp, Dept Neurosurg, Izunokuni, Shizuoka, Japan.	dr_george1972@hotmail.com	tokugawa, joji/ABF-1365-2021	tokugawa, joji/0000-0003-0458-7673; Sugiyama, Natsuki/0000-0001-5299-0761	Juntendo Casualty Center	Juntendo Casualty Center	JT received funding from Juntendo Casualty Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Germans MR, 2014, ACTA NEUROCHIR, V156, P2095, DOI 10.1007/s00701-014-2206-6; Houseman ND, 2000, PLAST RECONSTR SURG, V105, P2287, DOI 10.1097/00006534-200006000-00001; KOLHE PS, 1987, BRIT J PLAST SURG, V40, P562, DOI 10.1016/0007-1226(87)90149-4; Krayenbuhl H, 1982, CEREBRAL ANGIOGRAPHY, P40; KRESPI YP, 1983, OTOLARYNG HEAD NECK, V91, P193, DOI 10.1177/019459988309100215; Lasjaunias P, 1987, SURG NEUROANGIOGRAPH, P325; McKinnon B J, 1999, Arch Facial Plast Surg, V1, P101, DOI 10.1001/archfaci.1.2.101; Moschella F, 2003, SURG RADIOL ANAT, V24, P343, DOI 10.1007/s00276-002-0077-7; Pinar YA, 2003, SURG RADIOL ANAT, V25, P175, DOI 10.1007/s00276-003-0128-8; Sharma RK, 2010, J PLAST RECONSTR AES, V63, pE775, DOI 10.1016/j.bjps.2010.06.022; Sharma RK, 1996, PLAST RECONSTR SURG, V97, P25, DOI 10.1097/00006534-199601000-00003; Tokugawa J, 2014, NEUROL MED-CHIR, V54, P841, DOI 10.2176/nmc.cr2012-0233; Toure G, 2010, SURG RADIOL ANAT, V32, P739, DOI 10.1007/s00276-010-0673-x	13	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128723	10.1371/journal.pone.0128723	http://dx.doi.org/10.1371/journal.pone.0128723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030595	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900188
J	Varricchio, DJ; Balanoff, AM; Norell, MA				Varricchio, David J.; Balanoff, Amy M.; Norell, Mark A.			Reidentification of Avian Embryonic Remains from the Cretaceous of Mongolia	PLOS ONE			English	Article							DINOSAUR EGGS; ENANTIORNITHINE BIRD; GOBI	Embryonic remains within a small (4.75 by 2.23 cm) egg from the Late Cretaceous, Mongolia are here re-described. High-resolution X-ray computed tomography (HRCT) was used to digitally prepare and describe the enclosed embryonic bones. The egg, IGM (Mongolian Institute for Geology, Ulaanbaatar) 100/2010, with a three-part shell microstructure, was originally assigned to Neoceratopsia implying extensive homoplasy among eggshell characters across Dinosauria. Re-examination finds the forelimb significantly longer than the hindlimbs, proportions suggesting an avian identification. Additional, postcranial apomorphies (strut-like coracoid, cranially located humeral condyles, olecranon fossa, slender radius relative to the ulna, trochanteric crest on the femur, and ulna longer than the humerus) identify the embryo as avian. Presence of a dorsal coracoid fossa and a craniocaudally compressed distal humerus with a strongly angled distal margin support a diagnosis of IGM 100/2010 as an enantiornithine. Re-identification eliminates the implied homoplasy of this tri-laminate eggshell structure, and instead associates enantiornithine birds with eggshell microstructure composed of a mammillary, squamatic, and external zones. Posture of the embryo follows that of other theropods with fore- and hindlimbs folded parallel to the vertebral column and the elbow pointing caudally just dorsal to the knees. The size of the egg and embryo of IGM 100/2010 is similar to the two other Mongolian enantiornithine eggs. Well-ossified skeletons, as in this specimen, characterize all known enantiornithine embryos suggesting precocial hatchlings, comparing closely to late stage embryos of modern precocial birds that are both flight-and run-capable upon hatching. Extensive ossification in enantiornithine embryos may contribute to their relatively abundant representation in the fossil record. Neoceratopsian eggs remain unrecognized in the fossil record.	[Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Balanoff, Amy M.] SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Montana State University System; Montana State University Bozeman; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; American Museum of Natural History (AMNH)	Varricchio, DJ (corresponding author), Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA.	djv@montana.edu			NSF grant [0847777]; Directorate For Geosciences [1258878] Funding Source: National Science Foundation; Division Of Earth Sciences [0847777] Funding Source: National Science Foundation	NSF grant(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by NSF grant #0847777 (EAR) to DJV.	Agnolin FL, 2012, CRETACEOUS RES, V35, P33, DOI 10.1016/j.cretres.2011.11.014; Balanoff AM, 2008, NATURWISSENSCHAFTEN, V95, P493, DOI 10.1007/s00114-008-0347-2; Bever GS, 2009, AM MUS NOVIT; Chiappe LM, 2007, J SYST PALAEONTOL, V5, P193, DOI 10.1017/S1477201906001969; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; COOMBS WP, 1980, NATURE, V283, P380, DOI 10.1038/283380a0; Eberth DA, 2009, J VERTEBR PALEONTOL, V29, P295, DOI 10.1080/02724634.2009.10010384; ELZANOWSKI A, 1981, Palaeontologia Polonica, P147; Elzanowski A., 1985, ACT 18 C INT ORN, V1, P178; Fastovsky DE, 2011, J PALEONTOL, V85, P1035; Forster Catherine A., 2002, P268; Gao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045203; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grellet-Tinner G, 2004, LIFE O PAST, P185; Grellet-Tinner G, 2002, J VERTEBR PALEONTOL, V22, P719, DOI 10.1671/0272-4634(2002)022[0719:AAEFTC]2.0.CO;2; Jackson FD, 2010, CRETACEOUS RES, V31, P255, DOI 10.1016/j.cretres.2009.11.006; Kurochkin EN, 2013, PALEONTOL J+, V47, P1252, DOI 10.1134/S0031030113110087; Kurochkin EN, 1996, PALAEONTOLOGICAL I M; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; MIKHAILOV K E, 1991, Acta Palaeontologica Polonica, V36, P193; Mikhailov Konstantin, 1994, P88; Mikhailov KE, 2014, HIST BIOL, V26, P144, DOI 10.1080/08912963.2013.829824; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; RIEPPEL O, 1993, ZOOL J LINN SOC-LOND, V109, P301, DOI 10.1111/j.1096-3642.1993.tb02537.x; Schweitzer MH, 2002, J VERTEBR PALEONTOL, V22, P191, DOI 10.1671/0272-4634(2002)022[0191:LCAEWE]2.0.CO;2; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Starck J.M., 1989, Courier Forschungsinstitut Senckenberg, V114, P1; Varricchio DJ, 2015, ACTA PALAEONTOL POL, V60, P11, DOI 10.4202/app.00085.2014; Varricchio DJ, 2004, J VERTEBR PALEONTOL, V24, P931, DOI 10.1671/0272-4634(2004)024[0931:APAOPD]2.0.CO;2; WALKER CA, 1981, NATURE, V292, P51, DOI 10.1038/292051a0; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Zelenitsky D. K., 2008, PALAEONTOLOGY, V2008, P1; Zhou ZH, 2004, SCIENCE, V306, P653, DOI 10.1126/science.1100000	37	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128458	10.1371/journal.pone.0128458	http://dx.doi.org/10.1371/journal.pone.0128458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030147	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900153
J	Zeppelin, TK; Johnson, DS; Kuhn, CE; Iverson, SJ; Ream, RR				Zeppelin, T. K.; Johnson, D. S.; Kuhn, C. E.; Iverson, S. J.; Ream, R. R.			Stable Isotope Models Predict Foraging Habitat of Northern Fur Seals (Callorhinus ursinus) in Alaska	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; MARINE ECOSYSTEM; PRIBILOF ISLANDS; PINNIPED DIETS; TELEMETRY; NITROGEN; BEHAVIOR; ECOLOGY; RATIOS; CARBON	We developed models to predict foraging habitat of adult female northern fur seals (Callorhinus ursinus) using stable carbon (gamma C-13) and nitrogen (gamma N-15) isotope values from plasma and red blood cells. Binomial generalized linear mixed models were developed using blood isotope samples collected from 35 adult female fur seals on three breeding colonies in Alaska during July-October 2006. Satellite location and dive data were used to define habitat use in terms of the proportion of time spent or dives made in different oceanographic/bathymetric domains. For both plasma and red blood cells, the models accurately predicted habitat use for animals that foraged exclusively off or on the continental shelf. The models did not perform as well in predicting habitat use for animals that foraged in both on-and off-shelf habitat; however, sample sizes for these animals were small. Concurrently collected scat, fatty acid, and dive data confirmed that the foraging differences predicted by isotopes were associated with diet differences. Stable isotope samples, dive data, and GPS location data collected from an additional 15 females during August-October 2008 validated the effective use of the models across years. Little within year variation in habitat use was indicated from the comparison between stable isotope values from plasma (representing 1-2 weeks) and red blood cells (representing the prior few months). Constructing predictive models using stable isotopes provides an effective means to assess habitat use at the population level, is inexpensive, and can be applied to other marine predators.	[Zeppelin, T. K.; Johnson, D. S.; Kuhn, C. E.; Ream, R. R.] Natl Ocean & Atmospher Adm, NMML, AFSC, Seattle, WA 98115 USA; [Iverson, S. J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	National Oceanic Atmospheric Admin (NOAA) - USA; Dalhousie University	Zeppelin, TK (corresponding author), Natl Ocean & Atmospher Adm, NMML, AFSC, Seattle, WA 98115 USA.	Tonya.Zeppelin@noaa.gov		Iverson, Sara/0000-0003-2842-4094; Kuhn, Carey/0000-0002-6835-9744	National Marine Fisheries Service; North Pacific Research Board (NPRB) [0514]	National Marine Fisheries Service; North Pacific Research Board (NPRB)	Funding for this project was provided by the National Marine Fisheries Service (http://www.nmfs.noaa.gov) and the North Pacific Research Board (NPRB project 0514, http://www.nprb.org).	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; AITCHISON J, 1983, BIOMETRIKA, V70, P57; Antonelis GA, 1997, J ZOOL, V242, P435, DOI 10.1111/j.1469-7998.1997.tb03847.x; Arim M, 2003, CAN J ZOOL, V81, P67, DOI 10.1139/Z02-221; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baylis AMM, 2008, CAN J ZOOL, V86, P774, DOI 10.1139/Z08-055; Benoit-Bird KJ, 2013, MAR ECOL PROG SER, V479, P283, DOI 10.3354/meps10209; Bigg M.A., 1985, P284; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; Bowen WD, 2000, CAN J FISH AQUAT SCI, V57, P898, DOI 10.1139/cjfas-57-5-898; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; Call KA, 2008, DEEP-SEA RES PT II, V55, P1883, DOI 10.1016/j.dsr2.2008.04.022; COACHMAN LK, 1986, CONT SHELF RES, V5, P23, DOI 10.1016/0278-4343(86)90011-7; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Cunjak RA, 2005, OECOLOGIA, V144, P636, DOI 10.1007/s00442-005-0101-9; Davenport SR, 2002, CAN J FISH AQUAT SCI, V59, P514, DOI 10.1139/F02-031; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Gentry RL, 1982, CONTRACT NO NMFS SSR; Gilmour Morgan E., 2012, Marine Ornithology, V40, P17; Goebel ME, 1991, THESIS; Gorbatenko KM, 2008, RUSS J MAR BIOL+, V34, P497, DOI 10.1134/S1063074008070092; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Gudmundson CJ, 2006, FISH B-NOAA, V104, P445; Hazen EL, 2012, MAR ECOL PROG SER, V457, P221, DOI 10.3354/meps09857; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hobson KA, 1997, CAN J ZOOL, V75, P1720, DOI 10.1139/z97-799; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Hobson KA, 1997, MAR MAMMAL SCI, V13, P114, DOI 10.1111/j.1748-7692.1997.tb00615.x; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2007, ECOL METHOD CONCEPT, P155, DOI 10.1002/9780470691854.ch6; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Hunsicker ME, 2010, MAR ECOL PROG SER, V415, P91, DOI 10.3354/meps08750; Iversen M, 2013, POLAR BIOL, V36, P561, DOI 10.1007/s00300-012-1284-2; Iverson SJ, 2007, MAR ECOL PROG SER, V352, P235, DOI 10.3354/meps07073; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Iverson SJ, 2002, MAR ECOL PROG SER, V241, P161, DOI 10.3354/meps241161; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kajimura H, 1984, NMFS SSRF 779; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kirsch PE, 2000, PHYSIOL BIOCHEM ZOOL, V73, P45, DOI 10.1086/316723; KOOYMAN GL, 1976, SCIENCE, V193, P411, DOI 10.1126/science.935876; KUBODERA T, 1984, Bulletin of the National Science Museum Series A (Zoology), V10, P165; Kuhn CE, 2014, CAN J ZOOL, V92, P861, DOI 10.1139/cjz-2014-0087; Kuhn CE, 2014, J ANIM ECOL, V83, P1169, DOI 10.1111/1365-2656.12202; Kuhn Carey E., 2010, Endangered Species Research, V12, P125, DOI 10.3354/esr00297; Kuhn CE, 2011, MAR BIOL, V158, P649, DOI 10.1007/s00227-010-1589-z; Kurle CM, 2011, MAR BIOL, V158, P2389, DOI 10.1007/s00227-011-1741-4; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; Kurle CM, 2002, CAN J ZOOL, V80, P902, DOI 10.1139/Z02-069; LOUGHLIN TR, 1987, CAN J ZOOL, V65, P2079, DOI 10.1139/z87-318; Lovell P, 2002, INTEGR COMP BIOL, P1; Lowther AD, 2011, MAR MAMMAL SCI, V27, P567, DOI 10.1111/j.1748-7692.2010.00425.x; Ludwig JA., 1988, STAT ECOLOGY; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Robards MD, 1999, PNW RP 521; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; SCHUMACHER JD, 1998, SEA GLOBAL COASTAL O, V11, P869; SINCLAIR EH, 1994, FISHERY B, V92, P132; Sobolevskii EI, 1994, J ICHTHYOL, V34, P20; Springer AM, 2008, FINAL REPORT; Stabeno PJ, 1999, UASGCP REP, V99, P193; Sullivan JC, 2006, ECOSCIENCE, V13, P11, DOI 10.2980/1195-6860(2006)13[11:MDFCAN]2.0.CO;2; Team RDC, 2006, R A LANGUAGE AND ENV; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Tollit D., 2010, MARINE MAMMAL ECOLOG, P165; Tollit DJ, 2003, MAR MAMMAL SCI, V19, P724, DOI 10.1111/j.1748-7692.2003.tb01127.x; Tollit DJ, 2009, ECOL APPL, V19, P889, DOI 10.1890/07-1701.1; Towell Rodney G., 2012, NOAA Technical Memorandum NMFS-AFSC, V241, P8; Waite JN, 2012, J EXP MAR BIOL ECOL, V416, P41, DOI 10.1016/j.jembe.2012.02.009; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WILKE FORD, 1957, JOUR WILDLIFE MANAGEMENT, V21, P237, DOI 10.2307/3797593; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; Zeppelin TK, 2006, J ZOOL, V270, P565, DOI 10.1111/j.1469-7998.2006.00122.x; Zeppelin TK, 2010, MAR ECOL PROG SER, V409, P241, DOI 10.3354/meps08624; Zhao L, 2002, THESIS; Zhao LY, 2006, COMP BIOCHEM PHYS A, V143, P469, DOI 10.1016/j.cbpa.2005.12.032	91	10	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127615	10.1371/journal.pone.0127615	http://dx.doi.org/10.1371/journal.pone.0127615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030280	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900066
J	Badaeva, ED; Keilwagen, J; Knupffer, H; Wassermann, L; Dedkova, OS; Mitrofanova, OP; Kovaleva, ON; Liapunova, OA; Pukhalskiy, VA; Ozkan, H; Graner, A; Willcox, G; Kilian, B				Badaeva, Ekaterina D.; Keilwagen, Jens; Knuepffer, Helmut; Wassermann, Louise; Dedkova, Olga S.; Mitrofanova, Olga P.; Kovaleva, Olga N.; Liapunova, Olga A.; Pukhalskiy, Vitaly A.; Ozkan, Hakan; Graner, Andreas; Willcox, George; Kilian, Benjamin			Chromosomal Passports Provide New Insights into Diffusion of Emmer Wheat	PLOS ONE			English	Article							TRITICUM-TURGIDUM L.; AGRICULTURAL ORIGINS; GENETIC DIVERSITY; DOMESTICATION; WILD; EVOLUTION; DICOCCUM; POLYMORPHISM; POPULATIONS; DIVERGENCE	Emmer wheat, Triticum dicoccon SCHRANK (syn. T. dicoccum (SCHRANK) SCHUBL.), is one of the earliest domesticated crops, harboring a wide range of genetic diversity and agronomically valuable traits. The crop, however, is currently largely neglected. We provide a wealth of karyotypic information from a comprehensive collection of emmer wheat and related taxa. In addition to C-banding polymorphisms, we identified 43 variants of chromosomal rearrangements in T. dicoccon; among them 26 (60.4%) were novel. The T7A:5B translocation was most abundant in Western Europe and the Mediterranean. The plant genetic resources investigated here might become important in the future for wheat improvement. Based on cluster analysis four major karyotypic groups were discriminated within the T. dicoccon genepool, each harboring characteristic C-banding patterns and translocation spectra: the BALKAN, ASIAN, EUROPEAN and ETHIOPIAN groups. We postulate four major diffusion routes of the crop and discuss their migration out of the Fertile Crescent considering latest archaeobotanical findings.	[Badaeva, Ekaterina D.; Dedkova, Olga S.; Pukhalskiy, Vitaly A.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow 119991, Russia; [Badaeva, Ekaterina D.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Keilwagen, Jens; Wassermann, Louise] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, D-06484 Quedlinburg, Germany; [Knuepffer, Helmut; Graner, Andreas; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, D-06466 Stadt Seeland Ot Gatersl, Germany; [Mitrofanova, Olga P.; Kovaleva, Olga N.; Liapunova, Olga A.] Russian Acad Agr Sci, NI Vavilov Inst Plant Ind VIR, St Petersburg 190000, Russia; [Ozkan, Hakan] Cukurova Univ, Fac Agr, Dept Field Crops, TR-01330 Adana, Turkey; [Willcox, George] Univ Lyon 2, Archeorient CNRS UMR 5133, F-07460 Berrias, St Paul Le Jeun, France	Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Julius Kuhn-Institut; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Vavilov All-Russian Institute of Plant Genetic Resources; Cukurova University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Badaeva, ED (corresponding author), Russian Acad Sci, NI Vavilov Inst Gen Genet, Gubkina St 3, Moscow 119991, Russia.	katerinabadaeva@gmail.com	Badaeva, Ekaterina D./N-4368-2017; ÖZKAN, Hakan/C-8510-2011	Badaeva, Ekaterina D./0000-0001-7101-9639; ÖZKAN, Hakan/0000-0003-3530-2626; Kilian, Benjamin/0000-0002-9145-6980; Keilwagen, Jens/0000-0002-6792-7076; Mitrofanova, Olga/0000-0002-9171-2964; Graner, Andreas/0000-0003-3246-6393; Knupffer, Helmut/0000-0002-0525-9244	German Federal Ministry of Food and Agriculture (BLE) [01/12-13-KAD]; Russian Foundation for Basic Research [14-04-00142a, 14-04-00247a]	German Federal Ministry of Food and Agriculture (BLE); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This study was supported by grants from German Federal Ministry of Food and Agriculture (BLE), Grant No 01/12-13-KAD and Russian Foundation for Basic Research, Grants Nos. 14-04-00142a, 14-04-00247a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby RG, 2010, VEG HIST ARCHAEOBOT, V19, P151, DOI 10.1007/s00334-009-0232-8; [Anonymous], 1970, EXCAVATIONS HACILAR; Badaeva ED, 2007, GENOME, V50, P907, DOI 10.1139/G07-072; Badaeva ED, 2005, BIOL MEMBRANY, V22, P232; BADAEVA ED, 1994, PLANT SYST EVOL, V192, P117, DOI 10.1007/BF00985912; BADAEVA ED, 1990, CEREAL RES COMMUN, V18, P273; Badaeva ED, 2013, CHROMOSOMAL CHANGES, P110; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Ballouche A, 2003, REV ARCHEOMETRIE, V27, P49, DOI DOI 10.3406/ARSCI.2003.1041; Bar-Yosef O, 2004, CURR ANTHROPOL, V45, pS1, DOI 10.1086/423970; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Blumler MA., 1998, ORIGINS AGR CROP DOM, P252; Boric D, 2013, P NATL ACAD SCI USA, V110, P3298, DOI 10.1073/pnas.1211474110; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Charles M., 2010, ORIGINS AGR W CENTRA, p[150, 256]; Civan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081955; Costantini L., 1984, S ASIAN ARCHAEOLOGY, P29; DAMANIA AB, 1992, HEREDITAS, V116, P163, DOI 10.1111/j.1601-5223.1992.tb00222.x; Dedkova OS, 2007, RUSS J GENET+, V43, P1271, DOI 10.1134/S1022795407110105; Dedkova OS, 2009, RUSS J GENET+, V45, P1082, DOI 10.1134/S1022795409090099; Dedkova OS, 2004, RUSS J GENET+, V40, P1111, DOI 10.1023/B:RUGE.0000044755.18085.7e; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dorofeev VF, 1979, CULTIVATED FLORA USS, V1; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; Figliuolo G, 2004, GENET RESOUR CROP EV, V51, P519, DOI 10.1023/B:GRES.0000024153.75636.6f; Friebe Bernd, 1996, P39; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Gupta PK, 2013, PLANT BREEDING, V132, P431, DOI 10.1111/pbr.12110; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hammer K, 2014, GENET RESOUR CROP EV, P1; Hamon C., 2008, PALEORIENT, V34, P85, DOI DOI 10.3406/PALE0.2008.5258; Heslot H, 1959, WHEAT INFORM SERV, V9-10, P15; Hovsepyan R, 2008, VEG HIST ARCHAEOBOT, V17, pS63, DOI 10.1007/s00334-008-0158-6; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jakubziner MM, 1956, MAT HIST AGR USSR, P17; Jones Huw, 2008, Plant Genetic Resources Characterization and Utilization, V6, P98, DOI 10.1017/S1479262108993138; Khoshbakht K, 2009, J AGR RURAL DEV TROP, P189; Kihara H, 1965, MORPHOLOGICAL PHYSL, P1; Kilian B, 2009, PLANT GENET GENOMICS, V7, P81, DOI 10.1007/978-0-387-77489-3_3; Knupffer H, 2009, PLANT GENET GENOMICS, V7, P31, DOI 10.1007/978-0-387-77489-3_2; Knupffer H, 2014, BIODIVERSITY DATA J; Kuckuck, 1956, DISTRIBUTION VARIATI; Lehmensiek A, 2005, AUST J AGR RES, V56, P1347, DOI 10.1071/AR05126; Lisitsyna GN, 1977, PALEO BOT FINDS CAUC; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Maechler M., 2015, CLUSTER CLUSTER ANAL; Mani BR, 2006, KASHMIR NEOLITHIC EA, P230; Masson VM, 1982, ENEOLYTH OF THE USSR; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Mondini L, 2014, GENET RESOUR CROP EV, V61, P69, DOI 10.1007/s10722-013-0016-y; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Mori N, 1997, GENES GENET SYST, V72, P153, DOI 10.1266/ggs.72.153; Mori N., 2003, P 10 INT WHEAT GEN S, P25; Nabholz B, 2014, MOL ECOL, V23, P2210, DOI 10.1111/mec.12738; Nesbitt M, 1996, HULLED WHEATS, V4, P41; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Ozkan H, 2005, THEOR APPL GENET, V110, P1052, DOI 10.1007/s00122-005-1925-8; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Peng JH, 2011, AUST J CROP SCI, V5, P1127; Pistrick E, 2004, GENET RESOUR CROP EV, V51, P1, DOI 10.1023/B:GRES.0000026038.92932.8b; Pomortsev AA, 2008, RUSS J GENET+, V44, P709, DOI 10.1134/S1022795408060112; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Roussel V, 2005, THEOR APPL GENET, V111, P162, DOI 10.1007/s00122-005-2014-8; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Schiemann E, 1939, NATURWISSENSCHAFTEN, V27, P394, DOI 10.1007/BF01489506; Schlegel R., 1996, WHEAT INF SERV, V83, P35; Stoletova EA, 1924, B APPL BOT PLANT BRE, V14, P1; SYBENGA J, 1970, GENETICA, V41, P101, DOI 10.1007/BF00958897; Szabo A. T., 1996, Hulled wheats. Proceedings of the First International Workshop on Hulled Wheats, held at Castelvecchio Pascoli, Tuscany, Italy, 21-22 July 1995., P2; Takenaka S, 2012, THEOR APPL GENET, V125, P999, DOI 10.1007/s00122-012-1890-y; Takenaka S, 2010, BREEDING SCI, V60, P212, DOI 10.1270/jsbbs.60.212; Tanno K, 2012, VEG HIST ARCHAEOBOT, V21, P107, DOI 10.1007/s00334-011-0316-0; Teklu Y, 2007, GENET RESOUR CROP EV, V54, P543, DOI 10.1007/s10722-006-0011-7; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Vavilov NI, 1926, NEWS IN AGRONOMY, P76; Watanabe N, 1999, EUPHYTICA, V106, P39, DOI 10.1023/A:1003589117853; Zaharieva MZ, 2010, GENET RESOUR CROP EV, V57, P937, DOI 10.1007/s10722-010-9572-6; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	81	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128556	10.1371/journal.pone.0128556	http://dx.doi.org/10.1371/journal.pone.0128556			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024381	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400097
J	Ejeskar, K; Vickes, O; Kuchipudi, A; Wettergren, Y; Uv, A; Sopasakis, VR				Ejeskar, Katarina; Vickes, Oscar; Kuchipudi, Arunakar; Wettergren, Yvonne; Uv, Anne; Sopasakis, Victoria Rotter			The Unique Non-Catalytic C-Terminus of P37delta-PI3K Adds Proliferative Properties In Vitro and In Vivo	PLOS ONE			English	Article							DROSOPHILA PHOSPHOINOSITIDE 3-KINASE; LIFE-SPAN; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROBLASTOMA TUMORS; P110 DELTA; FAT-BODY; GROWTH; EXPRESSION; SUBUNIT; PTEN	The PI3K/Akt pathway is central for numerous cellular functions and is frequently deregulated in human cancers. The catalytic subunits of PI3K, p110, are thought to have a potential oncogenic function, and the regulatory subunit p85 exerts tumor suppressor properties. The fruit fly, Drosophila melanogaster, is a highly suitable system to investigate PI3K signaling, expressing one catalytic, Dp110, and one regulatory subunit, Dp60, and both show strong homology with the human PI3K proteins p110 and p85. We recently showed that p37 delta, an alternatively spliced product of human PI3K p110 delta, displayed strong proliferation-promoting properties despite lacking the catalytic domain completely. Here we functionally evaluate the different domains of human p37 delta in Drosophila. The N-terminal region of Dp110 alone promotes cell proliferation, and we show that the unique C-terminal region of human p37 delta further enhances these proliferative properties, both when expressed in Drosophila, and in human HEK-293 cells. Surprisingly, although the N-terminal region of Dp110 and the C-terminal region of p37 delta both display proliferative effects, over-expression of full length Dp110 or the N-terminal part of Dp110 decreases survival in Drosophila, whereas the unique C-terminal region of p37 delta prevents this effect. Furthermore, we found that the N-terminal region of the catalytic subunit of PI3K p110, including only the Dp60 (p85)-binding domain and a minor part of the Ras binding domain, rescues phenotypes with severely impaired development caused by Dp60 over-expression in Drosophila, possibly by regulating the levels of Dp60, and also by increasing the levels of phosphorylated Akt. Our results indicate a novel kinase-independent function of the PI3K catalytic subunit.	[Ejeskar, Katarina; Vickes, Oscar; Kuchipudi, Arunakar] Univ Skovde, Syst Biol Res Ctr, Sch Biosci, Skovde, Sweden; [Ejeskar, Katarina; Uv, Anne] Gothenburg Univ, Dept Med & Clin Genet, Gothenburg, Sweden; [Wettergren, Yvonne] Gothenburg Univ, Dept Gen Surg, Gothenburg, Sweden; [Sopasakis, Victoria Rotter] Gothenburg Univ, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden	University of Skovde; University of Gothenburg; University of Gothenburg; University of Gothenburg	Ejeskar, K (corresponding author), Univ Skovde, Syst Biol Res Ctr, Sch Biosci, Skovde, Sweden.	katarina.ejeskar@his.se		Ejeskar, Katarina/0000-0001-8962-0860	Swedish Children's Cancer Fund; Assar Gabrielsson Foundation; Swedish research council; KK-Stiftelsen	Swedish Children's Cancer Fund; Assar Gabrielsson Foundation; Swedish research council(Swedish Research CouncilEuropean Commission); KK-Stiftelsen	This work was supported by grants from the Swedish Children's Cancer Fund (KE), the Assar Gabrielsson Foundation (KE), The Swedish research council (VRS) and KK-Stiftelsen (KE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber Domingo F, 2006, Sci STKE, V2006, ppe49, DOI 10.1126/stke.3622006pe49; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Cizkova M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-545; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Fransson S, 2012, ONCOGENE, V31, P3277, DOI 10.1038/onc.2011.492; Fransson S, 2007, GENE CHROMOSOME CANC, V46, P45, DOI 10.1002/gcc.20387; Fransson S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0724-3; Fransson S, 2013, INT J ONCOL, V42, P609, DOI 10.3892/ijo.2012.1732; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Moskalev AA, 2010, REJUV RES, V13, P246, DOI 10.1089/rej.2009.0903; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Oldham S, 2002, DEVELOPMENT, V129, P4103; Philp AJ, 2001, CANCER RES, V61, P7426; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tzenaki N, 2012, FASEB J, V26, P2498, DOI 10.1096/fj.11-198192; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weinkove D, 1997, J BIOL CHEM, V272, P14606, DOI 10.1074/jbc.272.23.14606	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127497	10.1371/journal.pone.0127497	http://dx.doi.org/10.1371/journal.pone.0127497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024481	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400038
J	Vigil, JM; Alcock, J; Coulombe, P; McPherson, L; Parshall, M; Murata, A; Brislen, H				Vigil, Jacob M.; Alcock, Joe; Coulombe, Patrick; McPherson, Laurie; Parshall, Mark; Murata, Allison; Brislen, Heather			Ethnic Disparities in Emergency Severity Index Scores among US Veteran's Affairs Emergency Department Patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; AMBULATORY-CARE USE; CARDIAC-CATHETERIZATION; SEX-DIFFERENCES; WAITING-TIMES; UNITED-STATES; PAIN; ANALGESIA	Background The goal of these analyses was to determine whether there were systematic differences in Emergency Severity Index (ESI) scores, which are intended to determine priority of treatment and anticipate resource needs, across categories of race and ethnicity, after accounting for patient-presenting vital signs and examiner characteristics, and whether these differences varied among male and female Veterans Affairs (VA) ED patients. Methods and Findings We used a large national database of electronic medical records of ED patients from twenty-two U.S. Department of Veterans Affairs ED stations to determine whether ESI assignments differ systematically by race or ethnicity. Multi-level, random effects linear modeling was used to control for demographic characteristics and patient's vital signs (heart rate, respiratory rate, and pain level), as well as age, gender, and experience of triage nurses. The dataset included 129,991 VA patients presenting for emergency care between 2008 and 2012 (91% males; 61% non-Hispanic White, 28% Black, 7% Hispanic, 2% Asian, <1% American Indian/Alaska Native, 1% mixed ethnicity) and 774 nurses for a total of 359,642 patient/examiner encounters. Approximately 13% of the variance in ESI scores was due to patient characteristics and 21% was due to the nurse characteristics. After controlling for characteristics of nurses and patients, Black patients were assigned less urgent ESI scores than White patients, and this effect was more prominent for Black males compared with Black females. A similar interaction was found for Hispanic males. It remains unclear how these results may generalize to EDs and patient populations outside of the U.S. VA Health Care system. Conclusions The findings suggest the possibility that subgroups of VA patients receive different ESI ratings in triage, which may have cascading, downstream consequences for patient treatment quality, satisfaction with care, and trust in the health equity of emergency care.	[Vigil, Jacob M.; Alcock, Joe; Coulombe, Patrick; McPherson, Laurie; Parshall, Mark] Univ New Mexico, Albuquerque, NM 87131 USA; [Murata, Allison; Brislen, Heather] New Mexico Vet Affairs Hlth Ctr, Albuquerque, NM USA	University of New Mexico	Vigil, JM (corresponding author), Univ New Mexico, Albuquerque, NM 87131 USA.	vigilj@unm.edu	Parshall, Mark/I-3696-2019	Parshall, Mark/0000-0003-0577-2387; Alcock, Joe/0000-0003-0807-164X	National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR000041]; New Mexico VA Health Care System, Albuquerque, New Mexico; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041, UL1TR001449] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); New Mexico VA Health Care System, Albuquerque, New Mexico; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported in part by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1 TR000041. This study was supported by the New Mexico VA Health Care System, Albuquerque, New Mexico. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the U. S. Department of Veterans Affairs. None of the authors declare any financial or other conflicts of interest related to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality Rockville MD, 2013, NAT HEALTHC QUAL REP; Arslanian-Engoren Cynthia, 2004, J Cardiovasc Nurs, V19, P280; Association of American College of Physicians, 2010, RAC ETHN DISP HLTH C; Bates D., 2014, LINEAR MIXED EFFECTS; Buschhorn HM, 2013, J EMERG NURS, V39, pE55, DOI 10.1016/j.jen.2011.11.003; Cahan A, 2003, QJM-INT J MED, V96, P763, DOI 10.1093/qjmed/hcg122; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Epps CD, 2008, PAIN MANAG NURS, V9, P26, DOI 10.1016/j.pmn.2007.07.005; Esmailian M, 2014, EMERGENCY, V2, P158; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Goransson Katarina E, 2006, Accid Emerg Nurs, V14, P83, DOI 10.1016/j.aaen.2005.12.001; Heins JK, 2006, J EMERG NURS, V32, P219, DOI 10.1016/j.jen.2006.01.010; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lopez JPF, 2005, J NATL MED ASSOC, V97, P667; Lopez L, 2010, ACAD EMERG MED, V17, P801, DOI 10.1111/j.1553-2712.2010.00823.x; Martin A, 2014, J EMERG NURS, V40, P461, DOI 10.1016/j.jen.2013.09.009; National Research Council, 2012, FAR HAVE WE COM RED; Okunseri C, 2013, J AM DENT ASSOC, V144, P828, DOI 10.14219/jada.archive.2013.0195; Paradies Y, 2014, J GEN INTERN MED, V29, P364, DOI 10.1007/s11606-013-2583-1; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; R Core Team, 2014, LANG ENV STAT COMP V; Saha S, 2008, J GEN INTERN MED, V23, P654, DOI 10.1007/s11606-008-0521-4; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Sonnenfeld N, 2012, MED CARE, V50, P335, DOI 10.1097/MLR.0b013e318245a53c; Tamayo-Sarver JH, 2003, AM J PUBLIC HEALTH, V93, P2067, DOI 10.2105/AJPH.93.12.2067; Tanabe P, 2004, ACAD EMERG MED, V11, P59, DOI 10.1197/S1069-6563(03)00585-2; Tanabe Paula, 2004, J Emerg Nurs, V30, P22, DOI 10.1016/j.jen.2003.11.004; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; Ulmer C, 2010, FUTURE DIRECTIONS NA; Vigil JM, 2011, PAIN, V152, P2125, DOI 10.1016/j.pain.2011.05.019; Vigil JM, 2009, BEHAV BRAIN SCI, V32, P375, DOI 10.1017/S0140525X09991075; Vigil JM, 2012, BEHAV BRAIN SCI, V35, P38, DOI [10.1017/S0140525X11001324, DOI 10.1017/S0140525X11001324]; Washington DL, 2005, AM J PUBLIC HEALTH, V95, P2231, DOI 10.2105/AJPH.2004.043570; Washington DL, 2002, MIL MED, V167, P235, DOI 10.1093/milmed/167.3.235	38	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126792	10.1371/journal.pone.0126792	http://dx.doi.org/10.1371/journal.pone.0126792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024515	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400021
J	Chen, J; Kim, H; Yoo, G				Chen, Jingjing; Kim, Hyunjin; Yoo, Gayoung			Effects of Biochar Addition on CO2 and N2O Emissions following Fertilizer Application to a Cultivated Grassland Soil	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NITROUS-OXIDE EMISSION; MICROBIAL BIOMASS-C; HETEROTROPHIC NITRIFICATION; RICE PADDY; LOAM SOIL; DENITRIFICATION; IMPACT; CROP; RESPIRATION	Carbon (C) sequestration potential of biochar should be considered together with emission of greenhouse gases when applied to soils. In this study, we investigated CO2 and N2O emissions following the application of rice husk biochars to cultivated grassland soils and related gas emissions tos oil C and nitrogen (N) dynamics. Treatments included biochar addition (CHAR, NO CHAR) and amendment (COMPOST, UREA, NO FERT). The biochar application rate was 0.3% by weight. The temporal pattern of CO2 emissions differed according to biochar addition and amendments. CO2 emissions from the COMPOST soils were significantly higher than those from the UREA and NO FERT soils and less CO2 emission was observed when biochar and compost were applied together during the summer. Overall N2O emission was significantly influenced by the interaction between biochar and amendments. In UREA soil, biochar addition increased N2O emission by 49% compared to the control, while in the COMPOST and NO FERT soils, biochar did not have an effect on N2O emission. Two possible mechanisms were proposed to explain the higher N2O emissions upon biochar addition to UREA soil than other soils. Labile C in the biochar may have stimulated microbial N mineralization in the C-limited soil used in our study, resulting in an increase in N2O emission. Biochar may also have provided the soil with the ability to retain mineral N, leading to increased N2O emission. The overall results imply that biochar addition can increase C sequestration when applied together with compost, and might stimulate N2O emission when applied to soil amended with urea.	[Chen, Jingjing; Kim, Hyunjin; Yoo, Gayoung] Kyung Hee Univ, Coll Engn, Ctr Environm Studies, Dept Appl Environm Sci, Gyeonggido, South Korea	Kyung Hee University	Yoo, G (corresponding author), Kyung Hee Univ, Coll Engn, Ctr Environm Studies, Dept Appl Environm Sci, 1 Seochon Dong, Gyeonggido, South Korea.	gayoo@khu.ac.kr	Yoo, Gayoung/AAK-7174-2020		"Cooperative Research Program for Agriculture Science & Technology Development," Rural Development Administration [PJ009253022015]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea [NRF-2013R1A1A2060747]	"Cooperative Research Program for Agriculture Science & Technology Development," Rural Development Administration; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea	This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009253022015)," Rural Development Administration, and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2060747), Republic of Korea.	Adam G, 2001, SOIL BIOL BIOCHEM, V33, P943, DOI 10.1016/S0038-0717(00)00244-3; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; Ameloot N, 2013, SOIL BIOL BIOCHEM, V57, P401, DOI 10.1016/j.soilbio.2012.10.025; [Anonymous], 1996, METHODS SOIL ANAL 3; Alburquerque JA, 2013, AGRON SUSTAIN DEV, V33, P475, DOI 10.1007/s13593-012-0128-3; Awad YM, 2012, EUR J SOIL BIOL, V48, P1, DOI 10.1016/j.ejsobi.2011.09.005; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Burton DL, 2008, CAN J SOIL SCI, V88, P219, DOI 10.4141/CJSS06020; Case SDC, 2012, SOIL BIOL BIOCHEM, V51, P125, DOI 10.1016/j.soilbio.2012.03.017; CASTIGNETTI D, 1984, APPL ENVIRON MICROB, V47, P620, DOI 10.1128/AEM.47.4.620-623.1984; Chan K. Y., 2010, BIOCHAR ENV MANAGEME, P67, DOI Gateshead; Chintala R, 2015, ENVIRON SCI POLLUT R, V22, P5152, DOI 10.1007/s11356-014-3762-2; Chintala R, 2014, J HAZARD MATER, V279, P244, DOI 10.1016/j.jhazmat.2014.06.074; Chintala R, 2014, CLEAN-SOIL AIR WATER, V42, P626, DOI 10.1002/clen.201300089; Chintala R, 2013, MICROPOR MESOPOR MAT, V179, P250, DOI 10.1016/j.micromeso.2013.05.023; Clough TJ, 2010, SOIL SCI SOC AM J, V74, P852, DOI 10.2136/sssaj2009.0185; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; DeLuca TH, 2006, ECOLOGY, V87, P2511, DOI 10.1890/0012-9658(2006)87[2511:FFANTI]2.0.CO;2; ELLINGTON A, 1986, FERT RES, V8, P283, DOI 10.1007/BF01048631; Gao XP, 2013, CAN J SOIL SCI, V93, P1, DOI 10.4141/CJSS2012-057; Gava GJD, 2005, PESQUI AGROPECU BRAS, V40, P689, DOI 10.1590/S0100-204X2005000700010; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; HAYNES RJ, 1993, J SOIL SCI, V44, P665, DOI 10.1111/j.1365-2389.1993.tb02331.x; Institute SAS, 2008, SAS US GUID; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Kammann C, 2012, J ENVIRON QUAL, V41, P1052, DOI 10.2134/jeq2011.0132; Karhu K, 2011, AGR ECOSYST ENVIRON, V140, P309, DOI 10.1016/j.agee.2010.12.005; Keith H, 1997, PLANT SOIL, V190, P127, DOI 10.1023/A:1004279300622; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Ogawa M, 1994, FARMING JAPAN, V28, P10; Pramer D., 1965, EXPT SOIL MICROBIOLO; Rochette P, 1998, CAN J SOIL SCI, V78, P283, DOI 10.4141/S97-066; Rogovska N, 2011, SOIL SCI SOC AM J, V75, P871, DOI 10.2136/sssaj2010.0270; Rondon MA, 2006, 18 WORLD C SOIL SCI; Sanchez-Monedero MA, 2008, BIOL FERT SOILS, V44, P885, DOI 10.1007/s00374-007-0263-1; Schindlbacher A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004590; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Spokas A, 2009, ANN ENV SCI, V3; Steiner C, 2008, PEDOBIOLOGIA, V51, P359, DOI 10.1016/j.pedobi.2007.08.002; Troy SM, 2013, SOIL BIOL BIOCHEM, V60, P173, DOI 10.1016/j.soilbio.2013.01.019; van Zwieten L, 2010, AUST J SOIL RES, V48, P569, DOI 10.1071/SR10003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Wang JY, 2011, BIOL FERT SOILS, V47, P887, DOI 10.1007/s00374-011-0595-8; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Wu L, 2002, J ENVIRON QUAL, V31, P1323, DOI 10.2134/jeq2002.1323; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Yoo G, 2014, SOIL SCI SOC AM J, V78, P852, DOI 10.2136/sssaj2013.05.0160; Yoo G, 2012, J ENVIRON QUAL, V41, P1193, DOI 10.2134/jeq2011.0157; Zhang AF, 2012, FIELD CROP RES, V127, P153, DOI 10.1016/j.fcr.2011.11.020; Zhang AF, 2012, PLANT SOIL, V351, P263, DOI 10.1007/s11104-011-0957-x; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	63	20	23	13	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126841	10.1371/journal.pone.0126841	http://dx.doi.org/10.1371/journal.pone.0126841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020941	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300026
J	Mao, FY; Wang, YQ; Meng, J				Mao, Fangyuan; Wang, Yuanqing; Meng, Jin			A Systematic Study on Tooth Enamel Microstructures of Lambdopsalis bulla (Multituberculate, Mammalia) - Implications for Multituberculate Biology and Phylogeny	PLOS ONE			English	Article							NUMERICAL DENSITY; EVOLUTION; TEETH; PIGMENTATION; THICKNESS; FIBRILS; TUBULES; ORIGIN; PRISMS; SIZE	Tooth enamel microstructure is a reliable and widely used indicator of dietary interpretations and data for phylogenetic reconstruction, if all levels of variability are investigated. It is usually difficult to have a thorough examination at all levels of enamel structures for any mammals, especially for the early mammals, which are commonly represented by sparse specimens. Because of the random preservation of specimens, enamel microstructures from different teeth in various species are often compared. There are few examples that convincingly show intraspecific variation of tooth enamel microstructure in full dentition of a species, including multituberculates. Here we present a systematic survey of tooth enamel microstructures of Lambdopsalis bulla, a taeniolabidoid multituberculate from the Late Paleocene Nomogen Formation, Inner Mongolia. We examined enamel structures at all hierarchical levels. The samples are treated differently in section orientations and acid preparation and examined using different imaging methods. The results show that, except for preparation artifacts, the crystallites, enamel types, Schmelzmuster and dentition types of Lambdopsalis are relatively consistent in all permanent teeth, but the prism type, including the prism shape, size and density, may vary in different portions of a single tooth or among different teeth of an individual animal. The most common Schmelzmuster of the permanent teeth in Lambdopsalis is a combination of radial enamel in the inner and middle layers, aprismatic enamel in the outer layer, and irregular decussations in tooth crown area with great curvature. The prism seam is another comparably stable characteristic that may be a useful feature for multituberculate taxonomy. The systematic documentation of enamel structures in Lambdopsalis may be generalized for the enamel microstructure study, and thus for taxonomy and phylogenetic reconstruction, of multituberculates and even informative for the enamel study of other early mammals.	[Mao, Fangyuan; Wang, Yuanqing; Meng, Jin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Mao, FY (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China.	maofangyuan@ivpp.ac.cn			Major Basic Research Projects of MST of China [2012CB821900]; National Natural Science Foundation of China [41404022]; Chinese Academy of Sciences [KZCX2-EW-106]; Special Fund for Fossil Excavation and Preparation of Chinese Academy of Sciences; China Geological Survey [1212011120142]	Major Basic Research Projects of MST of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for Fossil Excavation and Preparation of Chinese Academy of Sciences; China Geological Survey(China Geological Survey)	The work was supported by the Major Basic Research Projects of MST of China (Nos. 2012CB821900), the National Natural Science Foundation of China (No. 41404022), the Chinese Academy of Sciences (No. KZCX2-EW-106), the Special Fund for Fossil Excavation and Preparation of Chinese Academy of Sciences, and the China Geological Survey (Nos. 1212011120142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald J. D., 1982, STUDY MAMMALIA GEOLO; Avery J., 2006, ESSENTIALS ORAL HIST; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; Bonaparte J.F., 1986, 4 C ARG PAL BIOESTR, V4, P63; BOYDE A, 1982, ANAT EMBRYOL, V165, P193, DOI 10.1007/BF00305477; Boyde A., 1984, P341; BOYDE A, 1967, Z ZELLFORSCH MIK ANA, V82, P558, DOI 10.1007/BF00337122; Boyde A, 1964, THESIS LONDON HOSP M; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; CARLSON S J, 1985, Contributions from the Museum of Paleontology University of Michigan, V27, P1; Carlson S.J., 1990, SKELETAL BIOMINERALI, P235; Chiego JDJ, 2014, ESSENTIALS ORAL HIST; Clemens W.A., 1979, P99; Clemens WA, 1997, TOOTH ENAMEL MICROSTRUCTURE, P85; Clemens WA, 1991, J VERTEBR PALEONTOL, V11, p43A; COOPER JS, 1973, J ZOOL, V169, P85; CROMPTON AW, 1968, BIOL REV, V43, P427, DOI 10.1111/j.1469-185X.1968.tb00966.x; DOTSCH C, 1978, Z SAUGETIERKD, V43, P65; Dumont M, 2014, J STRUCT BIOL, V186, P38, DOI 10.1016/j.jsb.2014.02.006; FOSSE G, 1968, ACTA ODONTOL SCAND, V26, P315, DOI 10.3109/00016356809026139; Fosse G, 2003, ACTA PALAEONTOL POL, V48, P657; FOSSE G, 1978, ZOOL SCR, V7, P57, DOI 10.1111/j.1463-6409.1978.tb00588.x; FOSSE G, 1985, PALAEONTOLOGY, V28, P435; FOSSE G, 1969, ACTA ODONTOL SCAND, V27, P237, DOI 10.3109/00016356909008953; FOSSE G, 1971, Z ZELLFORSCH MIK ANA, V115, P341, DOI 10.1007/BF00324937; FREEMAN E F, 1976, Proceedings of the Geologists' Association, V87, P231; FREEMAN E F, 1979, Palaeontology (Oxford), V22, P135; Gantt D.G., 1983, P249; Gilkeson CF, 1997, TOOTH ENAMEL MICROSTRUCTURE, P113; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; Hahn G, 2003, ACTA PALAEONTOL POL, V48, P349; Hahn G., 1999, PALAEONTOGRAPHICA A, V253, P77; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; HOPSON JA, 1973, AM NAT, V107, P446, DOI 10.1086/282846; Kemp T.S, 1982, MAMMAL LIKE REPTILES; Kielan-Jaworowska Z, 2001, PALAEONTOLOGY, V44, P389, DOI 10.1111/1475-4983.00185; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Z, 2007, ACTA PALAEONTOL POL, V52, P257; KIELANJAWOROWSKA Z, 1979, NATURE, V277, P402, DOI 10.1038/277402a0; Koenigswald W.v., 1993, P303; Korvenkontio V. A., 1934, Annales Zoologici Societatis Zoologico-Botanicae Fennicae Vanamo, V2, P1; KOZAWA Y, 1988, HISTOCHEMISTRY, V90, P61, DOI 10.1007/BF00495708; Krause David W., 1997, P3; Krause DW, 2013, CAN J EARTH SCI, V50, P324, DOI 10.1139/e2012-074; Krause DW, 1992, J VERTEBR PALEONTOL, V12, P351, DOI 10.1080/02724634.1992.10011465; KRAUSE DW, 1987, J MAMMAL, V68, P755, DOI 10.2307/1381552; KRAUSE DW, 1986, SCAN ELECTRON MICROS, V1986, P1591; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1993, P NATL ACAD SCI USA, V90, P9379, DOI 10.1073/pnas.90.20.9379; Krause DW, 1996, J VERTEBR PALEONTOL, V16, p46A; KRISHTALKA L, 1982, J PALEONTOL, V56, P791; Lester K S, 1987, Adv Dent Res, V1, P181; LESTER KS, 1989, SCANNING MICROSCOPY, V3, P639; LESTER KS, 1988, SCANNING MICROSCOPY, V2, P371; LESTER KS, 1989, SCANNING MICROSCOPY, V3, P645; LESTER KS, 1987, SCANNING MICROSCOPY, V1, P421; LESTER KS, 1987, SCANNING MICROSCOPY, V1, P401; LESTER KS, 1970, J ULTRA MOL STRUCT R, V30, P64, DOI 10.1016/S0022-5320(70)90064-X; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Mao FY, 2016, ACTA PALAEONTOL POL, V61, P429, DOI 10.4202/app.00117.2014; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin T, 1992, SCHMELZMIKROSTRUKTUR; McKenna MC, 1997, CLASSIFICATION MAMMA; Meng Jin, 1994, Journal of Mammalian Evolution, V2, P185, DOI 10.1007/BF01473528; Miao D-S, 1986, ROCKY MOUNTAIN GEOLO, V24, P65; Miao D-S., 1988, CONTRIB GEOL U WYOMI, V4, P1; Parmar V, 2013, NATURWISSENSCHAFTEN, V100, P515, DOI 10.1007/s00114-013-1047-0; Pascual R, 1999, J VERTEBR PALEONTOL, V19, P373, DOI 10.1080/02724634.1999.10011148; POND CM, 1977, EVOLUTION, V31, P177, DOI [10.2307/2407556, 10.1111/j.1558-5646.1977.tb00995.x]; POOLE DFG, 1961, ARCH ORAL BIOL, V5, P14, DOI 10.1016/0003-9969(61)90110-8; Prothero D.R., 1992, EOCENE OLIGOCENE CLI, P46, DOI DOI 10.1515/9781400862924.46; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; Rich TH, 2009, ACTA PALAEONTOL POL, V54, P1, DOI 10.4202/app.2009.0101; RISNES S, 1974, ACTA ANAT, V87, P275; ROBINSON P, 1964, SCIENCE, V145, P809, DOI 10.1126/science.145.3634.809; SAHNI A, 1979, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V166, P37; Sander PM, 1997, TOOTH ENAMEL MICROSTRUCTURE, P41; SELVIG KA, 1975, SCAND J DENT RES, V83, P88; Sigogneau-Russell D, 1991, NEUES JB GEOLOGIE PA, V2, P119; Simmons Greenwald N., 1988, Journal of Vertebrate Paleontology, V8, P265; SIMMONS NB, 1993, MAMMAL PHYLOGENY, P146; Stefen C, 1995, THESIS U BONN BONN; STEIN G, 1959, ARCH ORAL BIOL, V1, P97, DOI 10.1016/0003-9969(59)90002-0; Stern DN, 1995, ASP DENT BIOL PAL AN, P3; v. Koenigswald Wighart, 1997, P267; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; von Koenigswald W., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P147; von Koenigswald W., 1980, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, P1; von Koenigswald Wighart, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V10, P605; VONKOENIGSWALD W, 1992, SCANNING MICROSCOPY, V6, P195; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P193; VONKOENIGSWALD W, 1994, ZOOL J LINN SOC-LOND, V110, P141, DOI 10.1006/zjls.1994.1008; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P203; Weil A, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P19; Wible John R., 2000, Bulletin of the American Museum of Natural History, V247, P1, DOI 10.1206/0003-0090(2000)247<0001:CAOKDM>2.0.CO;2; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324; Wood CB, 1997, TOOTH ENAMEL MICROSTRUCTURE, P63; Wood CB, 1992, COMP STUDIES ENAMEL; Wood CS, 2005, PHOTON SPECTRA, V39, P12; Zhao L-X, 2000, ACTA ANTHR SINICA S, V19, P77	100	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128243	10.1371/journal.pone.0128243	http://dx.doi.org/10.1371/journal.pone.0128243			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020958	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300093
J	Stavrakas, V; Melas, IN; Sakellaropoulos, T; Alexopoulos, LG				Stavrakas, Vassilis; Melas, Ioannis N.; Sakellaropoulos, Theodore; Alexopoulos, Leonidas G.			Network Reconstruction Based on Proteomic Data and Prior Knowledge of Protein Connectivity Using Graph Theory	PLOS ONE			English	Article							SIGNALING NETWORKS; MODELS; PATHWAYS	Modeling of signal transduction pathways is instrumental for understanding cells' function. People have been tackling modeling of signaling pathways in order to accurately represent the signaling events inside cells' biochemical microenvironment in a way meaningful for scientists in a biological field. In this article, we propose a method to interrogate such pathways in order to produce cell-specific signaling models. We integrate available prior knowledge of protein connectivity, in a form of a Prior Knowledge Network (PKN) with phosphoproteomic data to construct predictive models of the protein connectivity of the interrogated cell type. Several computational methodologies focusing on pathways' logic modeling using optimization formulations or machine learning algorithms have been published on this front over the past few years. Here, we introduce a light and fast approach that uses a breadth-first traversal of the graph to identify the shortest pathways and score proteins in the PKN, fitting the dependencies extracted from the experimental design. The pathways are then combined through a heuristic formulation to produce a final topology handling inconsistencies between the PKN and the experimental scenarios. Our results show that the algorithm we developed is efficient and accurate for the construction of medium and large scale signaling networks. We demonstrate the applicability of the proposed approach by interrogating a manually curated interaction graph model of EGF/TNFA stimulation against made up experimental data. To avoid the possibility of erroneous predictions, we performed a cross-validation analysis. Finally, we validate that the introduced approach generates predictive topologies, comparable to the ILP formulation. Overall, an efficient approach based on graph theory is presented herein to interrogate protein-protein interaction networks and to provide meaningful biological insights.	[Stavrakas, Vassilis; Sakellaropoulos, Theodore; Alexopoulos, Leonidas G.] Natl Tech Univ Athens, Dept Mech Engn, Zografos 15780, Greece; [Melas, Ioannis N.] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England	National Technical University of Athens; European Molecular Biology Laboratory (EMBL)	Alexopoulos, LG (corresponding author), Natl Tech Univ Athens, Dept Mech Engn, Heroon Polytech 9, Zografos 15780, Greece.	leo@mail.ntua.gr	Alexopoulos, Leonidas/AAN-1148-2021; Sakellaropoulos, Theodore/AAJ-7256-2021	Sakellaropoulos, Theodore/0000-0001-9946-9498; Alexopoulos, Leonidas G/0000-0003-0425-166X; Stavrakas, Vassilis/0000-0003-1073-4561	European Union (European Social Fund -ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Thalis	European Union (European Social Fund -ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Thalis	This work was supported by European Union (European Social Fund -ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Thalis. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; Bosl WJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-13; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Chu Y, 2007, IET SYST BIOL, V1, P342, DOI 10.1049/iet-syb:20060053; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Eungdamrong NJ, 2004, TRENDS CELL BIOL, V14, P661, DOI 10.1016/j.tcb.2004.10.007; Feiglin A, 2012, BIOINFORMATICS, V28, P2811, DOI 10.1093/bioinformatics/bts517; Floyd RW, 1962, COMMUN ACM, V5, P345; Gebser M, 2011, THEOR PRACT LOG PROG, V11, P323, DOI 10.1017/S1471068410000554; Gonzalez A, 2010, BIOSYSTEMS, V102, P16, DOI 10.1016/j.biosystems.2010.07.013; Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003; Guziolowski C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-244; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lipshtat A, 2009, ANN NY ACAD SCI, V1158, P44, DOI 10.1111/j.1749-6632.2008.03748.x; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451, DOI 10.1074/jbc.R800056200; MacNamara A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045003; Melas IN, 2014, OSTEOARTHR CARTILAGE, V22, P509, DOI 10.1016/j.joca.2014.01.001; Melas IN, 2013, BIOPHARM DRUG DISPOS, V34, P477, DOI 10.1002/bdd.1859; Melas IN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003204; Melas IN, 2012, MOL BIOSYST, V8, P1571, DOI 10.1039/c2mb05482e; Melas IN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-107; Mitsos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050085; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Poussin C, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.9; Qiu P, 2011, IEEE T BIO-MED ENG, V58, P3518, DOI 10.1109/TBME.2011.2163188; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saez-Rodriguez J, 2011, CANCER RES, V71, P5400, DOI 10.1158/0008-5472.CAN-10-4453; Saez-Rodriguez J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001844; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samaga R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000438; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sedgewick R., 1990, GRAPH ALGORITHMS ALG, V1, P485; Siegel A, 2006, BIOSYSTEMS, V84, P153, DOI 10.1016/j.biosystems.2005.10.006; Vasilyev Dmitry M, 2014, BMC Res Notes, V7, P516, DOI 10.1186/1756-0500-7-516; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Zheng Y, 2006, IEE P SYST BIOL, V153, P201, DOI 10.1049/ip-syb:20050088	47	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128411	10.1371/journal.pone.0128411	http://dx.doi.org/10.1371/journal.pone.0128411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020784	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300109
J	Zhang, W; Niu, YQ; Zou, H; Luo, LQ; Liu, QC; Wu, WJ				Zhang, Wen; Niu, Yanqing; Zou, Hua; Luo, Longqiang; Liu, Qianchao; Wu, Weijian			Accurate Prediction of Immunogenic T-Cell Epitopes from Epitope Sequences Using the Genetic Algorithm-Based Ensemble Learning	PLOS ONE			English	Article							MHC CLASS-I; PROTEIN SUBCELLULAR LOCATIONS; TAP TRANSPORT EFFICIENCY; BINDING PEPTIDES; PROTEASOMAL CLEAVAGE; AFFINITY; DATABASE; SERVER; SVMHC	Background T-cell epitopes play the important role in T-cell immune response, and they are critical components in the epitope-based vaccine design. Immunogenicity is the ability to trigger an immune response. The accurate prediction of immunogenic T-cell epitopes is significant for designing useful vaccines and understanding the immune system. Methods In this paper, we attempt to differentiate immunogenic epitopes from non-immunogenic epitopes based on their primary structures. First of all, we explore a variety of sequence-derived features, and analyze their relationship with epitope immunogenicity. To effectively utilize various features, a genetic algorithm (GA)-based ensemble method is proposed to determine the optimal feature subset and develop the high-accuracy ensemble model. In the GA optimization, a chromosome is to represent a feature subset in the search space. For each feature subset, the selected features are utilized to construct the base predictors, and an ensemble model is developed by taking the average of outputs from base predictors. The objective of GA is to search for the optimal feature subset, which leads to the ensemble model with the best cross validation AUC (area under ROC curve) on the training set. Results Two datasets named 'IMMA2' and 'PAAQD' are adopted as the benchmark datasets. Compared with the state-of-the-art methods POPI, POPISK, PAAQD and our previous method, the GA-based ensemble method produces much better performances, achieving the AUC score of 0.846 on IMMA2 dataset and the AUC score of 0.829 on PAAQD dataset. The statistical analysis demonstrates the performance improvements of GA-based ensemble method are statistically significant. Conclusions The proposed method is a promising tool for predicting the immunogenic epitopes. The source codes and datasets are available in S1 File.	[Zhang, Wen; Zou, Hua; Liu, Qianchao; Wu, Weijian] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Zhang, Wen] Wuhan Univ, Res Inst Shenzhen, Shenzhen 518057, Peoples R China; [Niu, Yanqing] South Cent Univ Nationalities, Sch Math & Stat, Wuhan 430074, Peoples R China; [Luo, Longqiang] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; South Central Minzu University; Wuhan University	Zhang, W (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	zhangwen@whu.edu.cn	Zhang, Wen/W-7471-2019	Zhang, Wen/0000-0001-5221-2628	National Science Foundation of China [61103126]; Shenzhen development Foundation [JCYJ20130401160028781]; China Scholarship Council [201406275015]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen development Foundation; China Scholarship Council(China Scholarship Council)	The financial disclosure is updated as follows. WZ's work is supported by the National Science Foundation of China (61103126), Shenzhen development Foundation (JCYJ20130401160028781) and China Scholarship Council (201406275015).	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Antes I, 2006, BIOINFORMATICS, V22, pE16, DOI 10.1093/bioinformatics/btl216; Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104; Bhasin M, 2005, NUCLEIC ACIDS RES, V33, pW202, DOI 10.1093/nar/gki587; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Donnes P, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-25; Donnes P, 2005, PROTEIN SCI, V14, P2132, DOI 10.1110/ps.051352405; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Hakenberg Jorg, 2003, Appl Bioinformatics, V2, P155; HORNE DS, 1988, BIOPOLYMERS, V27, P451, DOI 10.1002/bip.360270308; Jacob L, 2008, BIOINFORMATICS, V24, P358, DOI 10.1093/bioinformatics/btm611; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Liu W, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-182; Liu Wen, 2007, V409, P283, DOI 10.1007/978-1-60327-118-9_20; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; PARKER KC, 1994, J IMMUNOL, V152, P163; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Saethang T, 2013, J IMMUNOL METHODS, V387, P293, DOI 10.1016/j.jim.2012.09.016; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-463; Wen Zhang, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P4, DOI 10.1109/BIBM.2013.6732451; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043575; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341	44	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128194	10.1371/journal.pone.0128194	http://dx.doi.org/10.1371/journal.pone.0128194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020952	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300087
J	Xiong, JC; Wang, YQ; Zhang, Y; Nie, L; Wang, DH; Huang, YJ; Feng, B; Zhang, JB; Zhao, JH				Xiong, Jiachuan; Wang, Yiqin; Zhang, Ying; Nie, Ling; Wang, Daihong; Huang, Yunjian; Feng, Bing; Zhang, Jingbo; Zhao, Jinghong			Lack of Association between Interleukin-10 Gene Polymorphisms and Graft Rejection Risk in Kidney Transplantation Recipients: A Meta-Analysis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SINGLE NUCLEOTIDE POLYMORPHISMS; RENAL-ALLOGRAFT REJECTION; CYTOKINE GENOTYPE; INTERFERON-GAMMA; IMMUNE-RESPONSE; OUTCOMES; EXPRESSION; SURVIVAL; DONORS	Background Interleukin-10 (IL-10) is an important immunomodulatory cytokine. Several studies focused the association between IL-10 promoter gene polymorphisms and graft rejection risk in kidney transplantation recipients. However, the results of these studies remain inconclusive. The aim of this study was to conduct a meta-analysis to further assess the associations. Methods The PubMed, Embase, and Ovid Medline databases were searched. Two independent authors extracted data, and the effects were estimated from an odds ratio (OR) with 95% confidence intervals (CIs). Subgroup and sensitivity analyses identified sources of heterogeneity. Results A total of 16 studies including 595 rejection patients and 1239 stable graft patients were included in order to study the IL-10 -1082 (rs1800896 G/A), -819 (rs1800871 C/T), -592 (rs1800872 C/A) and IL-10 (-1082,-819,-592) polymorphisms. The -1082 G/A polymorphism was not associated with an increased graft rejection risk (OR = 1.03; 95% CI, 0.85-1.25, P = 0.74 for GA+AA vs. GG model). Moreover, all of the -819 C/T (OR = 1.06, 95% CI, 0.79-1.42, P = 0.70 for TA+TT vs. CC model), -592 C/A (OR = 1.10, 95% CI, 0.85-1.42, P = 0.47 for AC+AA vs. CC model) and IL-10 (-1082,-819,-592) polymorphisms (OR = 1.00, 95% CI, 0.79-1.27, P = 0.98 for I+L vs. H model) did not increase the graft rejection risk. In addition, we also performed subgroup analysis by ethnic group (mainly in Europeans or Asians) and rejection type (acute or chronic). There was also lack of evidence of a significant association between the IL-10 gene polymorphism and graft rejection risk. The present meta-analysis indicated that the IL-10 gene polymorphism was not associated with graft rejection risk in kidney transplantation recipients. Conclusion This meta-analysis found evidence that the IL-10 polymorphism does not increase the risk of graft rejection in kidney transplantation recipients. Further chronic rejection and other ethnic population studies are needed to confirm our results.	[Zhao, Jinghong] Third Mil Med Univ, Xinqiao Hosp, Inst Nephrol Chongqing, Dept Nephrol, Chongqing 400037, Peoples R China; Third Mil Med Univ, Xinqiao Hosp, Kidney Ctr PLA, Chongqing 400037, Peoples R China	Army Medical University; Army Medical University	Zhao, JH (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Inst Nephrol Chongqing, Dept Nephrol, Chongqing 400037, Peoples R China.	zhaojh@tmmu.edu.cn	Zhang, Jing/GWZ-7332-2022					Akalin E, 2001, CURR OPIN IMMUNOL, V13, P572, DOI 10.1016/S0952-7915(00)00261-2; Amirzargar M, TRANSPLANT P, V39, P954; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Asderakis A, 2001, TRANSPLANTATION, V71, P674, DOI 10.1097/00007890-200103150-00018; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Awad MR, 2001, J HEART LUNG TRANSPL, V20, P625, DOI 10.1016/S1053-2498(01)00246-7; Azarpira N, 2009, MOL BIOL REP, V36, P1621, DOI 10.1007/s11033-008-9361-x; Bathgate AJ, 2000, TRANSPLANTATION, V69, P1514, DOI 10.1097/00007890-200004150-00054; Breulmann B, 2007, CLIN TRANSPLANT, V21, P615, DOI 10.1111/j.1399-0012.2007.00697.x; Canossi A, 2007, TRANSPL P, V39, P1805, DOI 10.1016/j.transproceed.2007.05.035; Cavet J, 1999, BLOOD, V94, P3941, DOI 10.1182/blood.V94.11.3941.423k10_3941_3946; Chang HR, 2013, WORLD J SURG, V37, P466, DOI 10.1007/s00268-012-1815-6; Chapman JR, 2010, TRANSPLANTATION, V89, P644, DOI 10.1097/TP.0b013e3181d62f1b; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; Dhaouadi T, 2013, TRANSPL P, V45, P2152, DOI 10.1016/j.transproceed.2012.12.006; Djamali A, 2003, SEMIN NEPHROL, V23, P306, DOI 10.1016/S0270-9295(03)00066-4; Dmitrienko S, 2005, TRANSPLANTATION, V80, P1773, DOI 10.1097/01.tp.0000184624.54005.9f; Gaafar A, 2014, TRANSPL IMMUNOL, V30, P34, DOI 10.1016/j.trim.2013.11.006; Garcia GG, 2012, KIDNEY BLOOD PRESS R, V35, P299, DOI 10.1159/000337044; Gendzekhadze K, 2006, TRANSPL IMMUNOL, V16, P194, DOI 10.1016/j.trim.2006.09.001; George S, 2001, TRANSPL P, V33, P483, DOI 10.1016/S0041-1345(00)02103-5; Goldfarb-Rumyantzev AS, 2008, CURR OPIN NEPHROL HY, V17, P573, DOI 10.1097/MNH.0b013e32830f4579; Gondos A, 2013, TRANSPLANTATION, V95, P267, DOI 10.1097/TP.0b013e3182708ea8; HUTCHINSON IV, 1998, GRAFT, V1, P186; Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9; Manchanda PK, 2008, MOL CELL BIOCHEM, V311, P57, DOI 10.1007/s11010-007-9694-0; Marshall SE, 2000, TRANSPLANTATION, V70, P1485, DOI 10.1097/00007890-200011270-00016; MASON DW, 1986, ANNU REV IMMUNOL, V4, P119, DOI 10.1146/annurev.immunol.4.1.119; McDaniel DO, 2003, TRANSPL IMMUNOL, V11, P107, DOI 10.1016/S0966-3274(02)00171-5; Melk A, 2003, KIDNEY INT, V64, P314, DOI 10.1046/j.1523-1755.2003.00050.x; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; OdeHakim S, 1997, TRANSPL P, V29, P93, DOI 10.1016/S0041-1345(96)00019-X; Omrani MD, 2010, IRAN J KIDNEY DIS, V4, P141; Ponticelli C, 2011, TRANSPL P, V43, P2439, DOI 10.1016/j.transproceed.2011.06.025; Roberts DM, 2012, TRANSPLANTATION, V94, P775, DOI 10.1097/TP.0b013e31825d1587; Sankaran D, 1999, KIDNEY INT, V56, P281, DOI 10.1046/j.1523-1755.1999.00536.x; Seyhun Y, 2012, TRANSPL P, V44, P1670, DOI 10.1016/j.transproceed.2012.05.046; Tajik Nader, 2006, Iran J Immunol, V3, P150, DOI IJIv3i4A1; Thakkinstian A, 2008, NEPHROL DIAL TRANSPL, V23, P3017, DOI 10.1093/ndt/gfn185; XU GP, 1995, KIDNEY INT, V48, P1504, DOI 10.1038/ki.1995.440; Yilmaz V, 2005, CYTOKINE, V30, P188, DOI 10.1016/j.cyto.2005.01.006; Zhang YC, 2005, TRANSPLANTATION, V80, P530, DOI 10.1097/01.tp.0000168212.53172.06	44	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127540	10.1371/journal.pone.0127540	http://dx.doi.org/10.1371/journal.pone.0127540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035439	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100014
J	Bansal, R; Frelin, L; Brenndorfer, ED; Storm, G; Prakash, J; Sallberg, M				Bansal, Ruchi; Frelin, Lars; Brenndorfer, Erwin Daniel; Storm, Gert; Prakash, Jai; Sallberg, Matti			Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo	PLOS ONE			English	Article							TRANSGENIC MICE; STELLATE CELLS; OVAL CELL; LIVER; REPLICATION; MANAGEMENT; STEATOSIS; INFECTION; DISEASE; CORE	HCV infection typically induces liver injury and inflammation, which appears to be responsible for the associated fibrogenesis. To date, the mechanism underlying the different rates of disease progression remains unclear. The aim of the study is to understand the possible role of the HCV non-structural (NS) 3/4A protein in the fibrosis progression. We used NS3/4A-expressing transgenic mice (NS3/4A-Tg) to accomplish the goals of the study. Different stages of liver fibrosis were induced in wild-type and NS3/4A-Tg mice by single carbon tetrachloride (acute) or multiple injections for 4 (intermediate) or 8 (chronic) weeks. Fibrotic parameters, inflammatory responses and hepatocyte turnover were extensively examined. Hepatic expression of HCV NS3/4A did not induce spontaneous liver damage. However, NS3/4A expression exerted contrasting effects during acute and chronic liver damage. During early fibrogenesis and intermediate fibrosis (4 weeks), NS3/4A-Tg mice exhibited enhanced liver damage whereas reduced fibrosis was observed in NS3/4A-Tg during chronic liver fibrosis (8 weeks). Furthermore, attenuated inflammation was observed in NS3/4A-Tg during chronic fibrosis with increase in M2 macrophages, hepatocyte proliferation, decreased hepatocyte apoptosis and decreased ductular reaction. In conclusion, during early fibrogenesis, HCV NS3/4A contributes to liver damage. While, during chronic liver fibrosis, NS3/4A dampens inflammation and induces hepatocyte regeneration thereby contributing to slow fibrosis progression to promote its survival or persistence.	[Bansal, Ruchi; Frelin, Lars; Brenndorfer, Erwin Daniel; Sallberg, Matti] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Bansal, Ruchi; Storm, Gert; Prakash, Jai] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Biomat Sci & Technol,Targeted Therapeut, NL-7500 AE Enschede, Netherlands; [Storm, Gert] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, Utrecht, Netherlands	Karolinska Institutet; University of Twente; Utrecht University	Bansal, R (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	R.Bansal@utwente.nl	Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016; Storm, Gerrit/O-8696-2016; Bansal, Ruchi/F-4649-2014	Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876; Frelin, Lars/0000-0001-7452-1667; Brenndorfer, Erwin Daniel/0000-0002-9189-7479	EASL (Shiela Sherlock research fellowship); Ruth and Richard Julin's Foundation; University of Twente; Swedish Society for Medical Research; Ruth and Richard Julin Foundation; Professor Nanna Svartz Fund; Ake Wiberg Foundation; Clas Groschinsky Memorial Foundation; Goljes Memorial Fund; Lars Hierta Memorial Foundation; Erik and Edith Fernstrom Foundation; Karolinska Institutet; Swedish Research Council [K2012-99X-22017-01-3]; Swedish Research Council, Sweden; MIRA Institute at University of Twente; Swedish Research Council; Swedish Cancer Society; Stockholm County Council; Vinnova and Karolinska Institutet	EASL (Shiela Sherlock research fellowship); Ruth and Richard Julin's Foundation; University of Twente; Swedish Society for Medical Research; Ruth and Richard Julin Foundation; Professor Nanna Svartz Fund; Ake Wiberg Foundation; Clas Groschinsky Memorial Foundation; Goljes Memorial Fund; Lars Hierta Memorial Foundation; Erik and Edith Fernstrom Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council, Sweden(Swedish Research Council); MIRA Institute at University of Twente; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Vinnova and Karolinska Institutet(Vinnova)	Ruchi Bansal was supported by funding from EASL (Shiela Sherlock research fellowship), the Ruth and Richard Julin's Foundation and University of Twente. Daniel Brenndorfer was supported by grants from the Swedish Society for Medical Research, the Ruth and Richard Julin Foundation, the Professor Nanna Svartz Fund, the Ake Wiberg Foundation, the Clas Groschinsky Memorial Foundation, the Goljes Memorial Fund, the Lars Hierta Memorial Foundation, the Erik and Edith Fernstrom Foundation and Karolinska Institutet. Lars Frelin was supported by funding from the Swedish Research Council (K2012-99X-22017-01-3) and Karolinska Institutet. Jai Prakash was supported by funding from Swedish Research Council, Sweden and MIRA Institute at University of Twente. Matti Sallberg was supported by grants from the Swedish Research Council, the Swedish Cancer Society, Stockholm County Council, Vinnova and Karolinska Institutet. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Boyer N, 2000, J HEPATOL, V32, P98, DOI 10.1016/S0168-8278(00)80419-5; Brenndorfer ED, 2014, J IMMUNOL, V192, P1671, DOI 10.4049/jimmunol.1301077; Brenndorfer ED, 2010, HEPATOLOGY, V52, P1553, DOI 10.1002/hep.23870; Brody Herb, 2011, Nature, V474, pS1, DOI 10.1038/474S1a; Chouteau P, 2012, J HEPATOL, V57, P499, DOI 10.1016/j.jhep.2012.04.019; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farci P, 2012, P NATL ACAD SCI USA, V109, P14562, DOI 10.1073/pnas.1210592109; Frelin L, 2006, GUT, V55, DOI 10.1136/gut.2005.085050; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Knight B, 2007, J HEPATOL, V46, P134, DOI 10.1016/j.jhep.2006.08.015; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Seeff LB, 2002, HEPATOLOGY, V36, pS1, DOI 10.1053/jhep.2002.36992; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shin JY, 2005, EXP MOL MED, V37, P138, DOI 10.1038/emm.2005.19; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128466	10.1371/journal.pone.0128466	http://dx.doi.org/10.1371/journal.pone.0128466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030283	Green Published, gold			2022-12-27	WOS:000356630900154
J	Chaturvedi, V; Dye, DE; Kinnear, BF; van Kuppevelt, TH; Grounds, MD; Coombe, DR				Chaturvedi, Vishal; Dye, Danielle E.; Kinnear, Beverley F.; van Kuppevelt, Toin H.; Grounds, Miranda D.; Coombe, Deirdre R.			Interactions between Skeletal Muscle Myoblasts and their Extracellular Matrix Revealed by a Serum Free Culture System	PLOS ONE			English	Article							SATELLITE CELL EXPANSION; PHAGE DISPLAY TECHNOLOGY; SULFATE ANTIBODIES; ENDOTHELIAL-CELLS; STEM-CELLS; EXPRESSION; MODEL; DIFFERENTIATION; ISOFORMS; INJURY	Decellularisation of skeletal muscle provides a system to study the interactions of myoblasts with muscle extracellular matrix (ECM). This study describes the efficient decellularisation of quadriceps muscle with the retention of matrix components and the use of this matrix for myoblast proliferation and differentiation under serum free culture conditions. Three decellularisation approaches were examined; the most effective was phospholipase A2 treatment, which removed cellular material while maximizing the retention of ECM components. Decellularised muscle matrices were then solubilized and used as substrates for C2C12 mouse myoblast serum free cultures. The muscle matrix supported myoblast proliferation and differentiation equally as well as collagen and fibronectin. Immunofluorescence analyses revealed that myoblasts seeded on muscle matrix and fibronectin differentiated to form long, well-aligned myotubes, while myoblasts seeded on collagen were less organized. qPCR analyses showed a time dependent increase in genes involved in skeletal muscle differentiation and suggested that muscle-derived matrix may stimulate an increased rate of differentiation compared to collagen and fibronectin. Decellularized whole muscle three-dimensional scaffolds also supported cell adhesion and spreading, with myoblasts aligning along specific tracts of matrix proteins within the scaffolds. Thus, under serum free conditions, intact acellular muscle matrices provided cues to direct myoblast adhesion and migration. In addition, myoblasts were shown to rapidly secrete and organise their own matrix glycoproteins to create a localized ECM microenvironment. This serum free culture system has revealed that the correct muscle ECM facilitates more rapid cell organisation and differentiation than single matrix glycoprotein substrates.	[Chaturvedi, Vishal; Dye, Danielle E.; Kinnear, Beverley F.; Coombe, Deirdre R.] Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Sch Biomed Sci, Perth, WA 6845, Australia; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Grounds, Miranda D.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia	Curtin University; Radboud University Nijmegen; University of Western Australia	Coombe, DR (corresponding author), Curtin Univ, Fac Hlth Sci, CHIRI Biosci Res Precinct, Sch Biomed Sci, Perth, WA 6845, Australia.	D.Coombe@curtin.edu.au	Dye, Danielle/B-8143-2013; van Kuppevelt, A.H.M.S.M./L-4463-2015	Dye, Danielle/0000-0002-3564-6579; Coombe, Deirdre/0000-0001-9729-7549; Chaturvedi, Vishal/0000-0002-0421-7544; Grounds, Miranda/0000-0002-4530-9402	Defense Health Foundation; Curtin University Strategic International Research Scholarship; Curtin University Early Career Fellowship, Curtin University	Defense Health Foundation; Curtin University Strategic International Research Scholarship; Curtin University Early Career Fellowship, Curtin University	This work is financially supported by the Defense Health Foundation (http://www.defencehealthfoundation.org.au/ http://www.defencehealthfoundation.org.au/ResearchGrants/Grantsawardedin2011and2012/tabid/76/language/enUS/Default.aspx), VC was supported by a Curtin University Strategic International Research Scholarship and DD by a Curtin University Early Career Fellowship, Curtin University (http://www.curtin.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem AW, 2012, CLIN SPORT MED, V31, P665, DOI 10.1016/j.csm.2012.07.004; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com; Brandan E, 2013, MATRIX BIOL, V32, P289, DOI 10.1016/j.matbio.2013.03.007; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; Bryan N, 2011, BIOSCIENCE REP, V31, P199, DOI 10.1042/BSR20100064; Das M, 2009, BIOMATERIALS, V30, P5392, DOI 10.1016/j.biomaterials.2009.05.081; Das M, 2009, IN VITRO CELL DEV-AN, V45, P378, DOI 10.1007/s11626-009-9192-7; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Gawlitta D, 2008, TISSUE ENG PT A, V14, P161, DOI 10.1089/ten.a.2007.0095; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; Grounds Miranda D., 2008, V3, P269; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Li MTA, 2014, J BIOMECH, V47, P2013, DOI 10.1016/j.jbiomech.2013.10.057; Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Merritt EK, 2010, TISSUE ENG PT A, V16, P2871, DOI [10.1089/ten.tea.2009.0826, 10.1089/ten.TEA.2009.0826]; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; Ochala J, 2013, HUM MOL GENET, V22, P4398, DOI 10.1093/hmg/ddt289; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Perniconi B, 2011, BIOMATERIALS, V32, P7870, DOI 10.1016/j.biomaterials.2011.07.016; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; RAWLS A, 1995, DEV BIOL, V172, P37, DOI 10.1006/dbio.1995.0004; Ricotti L, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035010; Rogers CJ, 2012, METHODS MOL BIOL, V808, P321, DOI 10.1007/978-1-61779-373-8_22; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi L, 2013, INT J BURNS TRAUMA, V3, P173; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Sorokin LM, 2000, EXP CELL RES, V256, P500, DOI 10.1006/excr.2000.4842; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069; Stern-Straeter J, 2011, INT J MOL MED, V28, P907, DOI 10.3892/ijmm.2011.777; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029; Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039; van Kuppevelt T H, 2001, Methods Mol Biol, V171, P519; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P1317, DOI 10.1002/jbm.820211104; Vaz R, 2012, CELL TISSUE RES, V348, P569, DOI 10.1007/s00441-012-1364-1; Wang M, 2012, BIOCHEM BIOPH RES CO, V426, P83, DOI 10.1016/j.bbrc.2012.08.040; Wang YF, 2011, HEPATOLOGY, V53, P293, DOI 10.1002/hep.24012; Wilschut KJ, 2010, EXP CELL RES, V316, P341, DOI 10.1016/j.yexcr.2009.10.014; Xu Z, 2010, MATRIX BIOL, V29, P461, DOI 10.1016/j.matbio.2010.06.001	49	45	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127675	10.1371/journal.pone.0127675	http://dx.doi.org/10.1371/journal.pone.0127675			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030912	gold, Green Published			2022-12-27	WOS:000356630900071
J	Hauton, D; Al-Shammari, A; Gaffney, EA; Egginton, S				Hauton, David; Al-Shammari, Abdullah; Gaffney, Eamonn A.; Egginton, Stuart			Maternal Hypoxia Decreases Capillary Supply and Increases Metabolic Inefficiency Leading to Divergence in Myocardial Oxygen Supply and Demand	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; FATTY-ACID; PYRUVATE-DEHYDROGENASE; CARDIAC METABOLISM; IN-VIVO; HEART; SUSCEPTIBILITY; HYPERTROPHY; PERFORMANCE; SYNTHASE	Maternal hypoxia is associated with a decrease in left ventricular capillary density while cardiac performance is preserved, implying a mismatch between metabolism and diffusive exchange. We hypothesised this requires a switch in substrate metabolism to maximise efficiency of ATP production from limited oxygen availability. Rat pups from pregnant females exposed to hypoxia (FIO2=0.12) at days 10-20 of pregnancy were grown to adulthood and working hearts perfused ex vivo. C-14-labelled glucose and H-3-palmitate were provided as substrates and metabolism quantified from recovery of (CO2)-C-14 and (H2O)-H-3, respectively. Hearts of male offspring subjected to Maternal Hypoxia showed a 20% decrease in cardiac output (P<0.05), despite recording a 2-fold increase in glucose oxidation (P<0.01) and 2.5-fold increase (P<0.01) in palmitate oxidation. Addition of insulin to Maternal Hypoxic hearts, further increased glucose oxidation (P<0.01) and suppressed palmitate oxidation (P<0.05), suggesting preservation in insulin signalling in the heart. In vitro enzyme activity measurements showed that Maternal Hypoxia increased both total and the active component of cardiac pyruvate dehydrogenase (both P<0.01), although pyruvate dehydrogenase sensitivity to insulin was lost (NS), while citrate synthase activity declined by 30% (P<0.001) and acetyl-CoA carboxylase activity was unchanged by Maternal Hypoxia, indicating realignment of the metabolic machinery to optimise oxygen utilisation. Capillary density was quantified and oxygen diffusion characteristics examined, with calculated capillary domain area increased by 30% (P<0.001). Calculated metabolic efficiency decreased 4-fold (P<0.01) for Maternal Hypoxia hearts. Paradoxically, the decline in citrate synthase activity and increased metabolism suggest that the scope of individual mitochondria had declined, rendering the myocardium potentially more sensitive to metabolic stress. However, decreasing citrate synthase may be essential to preserve local PO2, minimising regions of hypoxia and hence maximising the area of myocardium able to preserve cardiac output following maternal hypoxia.	[Hauton, David] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Al-Shammari, Abdullah] Kuwait Univ, Fac Sci, Dept Math, Kuwait, Kuwait; [Gaffney, Eamonn A.] Univ Oxford, Math Inst, Wolfson Ctr Math Biol, Oxford, England; [Egginton, Stuart] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England	University of Leeds; Kuwait University; University of Oxford; University of Leeds	Hauton, D (corresponding author), Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England.	d.hauton@leeds.ac.uk	Gaffney, Eamonn/N-6403-2015; Alshammari, Abdullah A/F-6466-2012	Alshammari, Abdullah A/0000-0002-4512-1151; Gaffney, Eamonn/0000-0002-6888-4362; Egginton, Stuart/0000-0002-3084-9692	Advantage West Midlands (AWM); British Heart Foundation [PG/08/018/24599] Funding Source: researchfish	Advantage West Midlands (AWM); British Heart Foundation(British Heart Foundation)	The authors wish to thank Prof. J. M. Marshall and Dr. W. Rook (School of Clinical and Experimental Medicine, University of Birmingham) for providing the tissue used. All proteomics analysis was undertaken by the School of Biosciences, University of Birmingham and the Ulti-Mate 3000 series HPLC and LTQ Orbitrap Velos ETD mass spectrometer used in this research was made available through the Birmingham Science City Translational Medicine: Experimental Medicine Network of Excellence project, with support from Advantage West Midlands (AWM)	Al-Shammari AA, 2012, B MATH BIOL, V74, P2204, DOI 10.1007/s11538-012-9753-x; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Egginton S, 1989, Adv Exp Med Biol, V248, P281; Friedman BJ, 1997, J MOL CELL CARDIOL, V29, P2855, DOI 10.1006/jmcc.1997.0547; Hauton D, 2001, BBA-MOL CELL BIOL L, V1533, P99, DOI 10.1016/S1388-1981(01)00146-9; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; Hauton D, 2015, BBA-GEN SUBJECTS, V1850, P681, DOI 10.1016/j.bbagen.2014.12.014; Hauton D, 2012, BBA-MOL CELL BIOL L, V1821, P627, DOI 10.1016/j.bbalip.2011.12.004; Heather LC, 2009, J PHYSIOL PHARMACOL, V60, P31; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Honig C R, 1989, Adv Exp Med Biol, V248, P591; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; JEFFAY H, 1961, ANAL CHEM, V33, P612, DOI 10.1021/ac60172a041; Karch R, 2005, CARDIOVASC PATHOL, V14, P135, DOI 10.1016/j.carpath.2005.03.003; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; Lavery GG, 2007, ENDOCRINOLOGY, V148, P6100, DOI 10.1210/en.2007-0963; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; MANDARINO LJ, 1987, J CLIN INVEST, V80, P655, DOI 10.1172/JCI113118; Morgunov I, 1998, J BIOL CHEM, V273, P29540, DOI 10.1074/jbc.273.45.29540; NEVILLE JF, 1971, AM J CLIN PATHOL, V55, P152; Pathi B, 2012, J EXP BIOL, V215, P1871, DOI 10.1242/jeb.067207; POPEL AS, 1989, AM J PHYSIOL, V256, pH921, DOI 10.1152/ajpheart.1989.256.3.H921; Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004; Rueda-Clausen CF, 2011, CARDIOVASC RES, V90, P285, DOI 10.1093/cvr/cvq363; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Sabri A, 1998, HYPERTENSION, V32, P371, DOI 10.1161/01.HYP.32.2.371; SADDIK M, 1993, J BIOL CHEM, V268, P25836; Schenkman KA, 2001, AM J PHYSIOL-HEART C, V281, pH2463, DOI 10.1152/ajpheart.2001.281.6.H2463; Seymour AML, 1997, J MOL CELL CARDIOL, V29, P2771, DOI 10.1006/jmcc.1997.0512; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Williams JL, 2006, J PHYSIOL-LONDON, V570, P445, DOI 10.1113/jphysiol.2005.095596; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje	34	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127424	10.1371/journal.pone.0127424	http://dx.doi.org/10.1371/journal.pone.0127424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030353	Green Published, gold			2022-12-27	WOS:000356630900051
J	Janssen, G; Christis, C; Kooy-Winkelaar, Y; Edens, L; Smith, D; van Veelen, P; Koning, F				Janssen, George; Christis, Chantal; Kooy-Winkelaar, Yvonne; Edens, Luppo; Smith, Drew; van Veelen, Peter; Koning, Frits			Ineffective Degradation of Immunogenic Gluten Epitopes by Currently Available Digestive Enzyme Supplements	PLOS ONE			English	Article							CELIAC-DISEASE; PROLYL ENDOPROTEASE; AMINOPEPTIDASE; MODEL	Background Due to the high proline content of gluten molecules, gastrointestinal proteases are unable to fully degrade them leaving large proline-rich gluten fragments intact, including an immunogenic 33-mer from a-gliadin and a 26-mer from.-gliadin. These latter peptides can trigger pro-inflammatory T cell responses resulting in tissue remodeling, malnutrition and a variety of other complications. A strict lifelong gluten-free diet is currently the only available treatment to cope with gluten intolerance. Post-proline cutting enzymes have been shown to effectively degrade the immunogenic gluten peptides and have been proposed as oral supplements. Several existing digestive enzyme supplements also claim to aid in gluten degradation. Here we investigate the effectiveness of such existing enzyme supplements in comparison with a well characterized post-proline cutting enzyme, Prolyl EndoPeptidase from Aspergillus niger (AN-PEP). Methods Five commercially available digestive enzyme supplements along with purified digestive enzymes were subjected to 1) enzyme assays and 2) mass spectrometric identification. Gluten epitope degradation was monitored by 1) R5 ELISA, 2) mass spectrometric analysis of the degradation products and 3) T cell proliferation assays. Findings The digestive enzyme supplements showed comparable proteolytic activities with near neutral pH optima and modest gluten detoxification properties as determined by ELISA. Mass spectrometric analysis revealed the presence of many different enzymes including amylases and a variety of different proteases with aminopeptidase and carboxypeptidase activity. The enzyme supplements leave the nine immunogenic epitopes of the 26-mer and 33-mer gliadin fragments largely intact. In contrast, the pure enzyme AN-PEP effectively degraded all nine epitopes in the pH range of the stomach at much lower dose. T cell proliferation assays confirmed the mass spectrometric data. Conclusion Currently available digestive enzyme supplements are ineffective in degrading immunogenic gluten epitopes.	[Janssen, George; Kooy-Winkelaar, Yvonne; van Veelen, Peter; Koning, Frits] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Christis, Chantal; Edens, Luppo] DSM Food Specialties, Delft, Netherlands; [Smith, Drew] DSM Food Specialties, South Bend, IN USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; DSM NV; DSM NV	Koning, F (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	F.Koning@lumc.nl		Koning, Frits/0000-0002-4007-5715; van Veelen, Peter/0000-0002-7898-9408	Dutch government [BSIK03009]; DSM Food Specialties;  [7868083]	Dutch government; DSM Food Specialties; 	This work was carried out in the framework of the Celiac Disease Consortium, an Innovative Cluster approved by The Netherlands Genomics Initiative, and the Dutch government (grant BSIK03009). FK received the funding (http://www.academia.edu/7868083). This research was partly funded by DSM Food Specialties. FK received the funding (http://www.dsm.com/countrysites/dsmnl/nl_NL/over-dsm/onze-activiteiten/dsm-food-specialties.html). CC, LE, and DS are employed by DSM Food Specialties. DSM Food Specialties paid part of the salary of GJ. Neither GJ, YK-W, PvV, FK nor the LUMC has commercial interest in the marketing of the AN-PEP enzyme or digestive enzyme supplements for gluten degradation. DSM did not have a role in study design, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Edens L, 2005, J AGR FOOD CHEM, V53, P7950, DOI 10.1021/jf050652c; Ehren J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006313; Food and Drug Administration HHS, 2013, Fed Regist, V78, P47154; Joint FAO/WHO Expert Committee on Food Additives (JECFA), 2006, FAO JECFA MON, P148; Mena MC, 2012, TALANTA, V91, P33, DOI 10.1016/j.talanta.2011.12.073; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Ottesen M., 1970, METHOD ENZYMOL, P199, DOI [10.1016/0076-6879(70)19014-8, DOI 10.1016/0076-6879(70)19014-8]; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; READ NW, 1986, GUT, V27, P300, DOI 10.1136/gut.27.3.300; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2012, DIGEST DIS SCI, V57, P440, DOI 10.1007/s10620-011-1906-5; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; TACHI H, 1992, PHYTOCHEMISTRY, V31, P3707, DOI 10.1016/S0031-9422(00)97513-7; Tack GJ, 2013, WORLD J GASTROENTERO, V19, P5837, DOI 10.3748/wjg.v19.i35.5837; THOMPSON GA, 1976, J BIOL CHEM, V251, P53; Tjon JML, 2010, IMMUNOGENETICS, V62, P641, DOI 10.1007/s00251-010-0465-9; Tye-Din JA, 2010, CLIN IMMUNOL, V134, P289, DOI 10.1016/j.clim.2009.11.001; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Volta U, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-85; WIESER H, 1980, Z LEBENSM UNTERS FOR, V171, P430, DOI 10.1007/BF01907234; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	25	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128065	10.1371/journal.pone.0128065	http://dx.doi.org/10.1371/journal.pone.0128065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030273	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900106
J	Carreras, FJ; Aranda, CJ; Porcel, D; Rodriguez-Hurtado, F; Martinez-Agustin, O; Zarzuelo, A				Javier Carreras, F.; Aranda, Carlos J.; Porcel, David; Rodriguez-Hurtado, Francisco; Martinez-Agustin, Olga; Zarzuelo, Antonio			Expression of Glucose Transporters in the Prelaminar Region of the Optic-Nerve Head of the Pig as Determined by Immunolabeling and Tissue Culture	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ASTROCYTES; GLUT1; PATHOPHYSIOLOGY; LOCALIZATION; MECHANISM; GLYCOGEN; LACTATE; PROTEIN; SYSTEM	Background To develop the use of cultured tissue of the prelaminar optic nerve of the pig to explore possible alterations of the astrocyte-axon metabolic pathways in glaucoma, we map the distribution of the glucose transporters GLUT1 and GLUT3 in fresh and cultured tissue. Methods We monitor cell survival in cultures of the prelaminar optic-nerve tissue, measuring necrosis and apoptosis markers biochemically as well as morphologically, and establish the presence of the glucose transporters GLUT1 and GLUT3. We map the distribution of these transporters with immunolabeling in histological sections of the optic nerve using confocal and electronic transmission microscopy. Results We find that the main death type in prelaminar culture is apoptosis. Caspase 7 staining reveals an increment in apoptosis from day 1 to day 4 and a reduction from day 4 to day 8. Western blotting for GLUT1 shows stability with increased culture time. CLSM micrographs locate GLUT1 in the columnar astrocytes and in the area of axonal bundles. Anti-GLUT3 predominantly labels axonal bundles. TEM immunolabeling with colloidal gold displays a very specific distribution of GLUT-1 in the membranes of vascular endothelial cells and in periaxonal astrocyte expansions. The GLUT-3 isoform is observed with TEM only in axons in the axonal bundles. Conclusions Tissue culture is suitable for apoptosis-induction experiments. The results suggest that glucose is transported to the axonal cleft intracytoplasmically and delivered to the cleft by GLUT1 transporters. As monocarboxylate transporters have been reported in the prelaminar region of the optic-nerve head, this area is likely to use both lactate and glucose as energy sources.	[Javier Carreras, F.] Univ Granada, Fac Med, Dept Surg Ophthalmol, Granada, Spain; [Aranda, Carlos J.] Univ Granada, Fac Pharm, Dept Biochem & Mol Biol 2, E-18071 Granada, Spain; [Porcel, David] Univ Granada, Ctr Sci Instrumentat, Granada, Spain; [Rodriguez-Hurtado, Francisco] Licinio Fuente Univ Hosp, Div Ophthalmol, Granada, Spain; [Martinez-Agustin, Olga] Univ Granada, Fac Pharm, Dept Biochem & Mol Biol 2, E-18071 Granada, Spain; [Martinez-Agustin, Olga; Zarzuelo, Antonio] Networked Biomed Res Ctr Hepat & Digest Dis CIBER, Granada, Spain; [Zarzuelo, Antonio] Univ Granada, Fac Pharm, Dept Pharmacol, E-18071 Granada, Spain	University of Granada; University of Granada; University of Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBERES; University of Granada	Carreras, FJ (corresponding author), Univ Granada, Fac Med, Dept Surg Ophthalmol, Granada, Spain.	fcarrera@ugr.es	Aranda, Carlos J/K-3842-2014; Augustin, Olga Martínez/K-6720-2014	Aranda, Carlos J/0000-0001-6224-9352; Augustin, Olga Martínez/0000-0001-8291-3468; Carreras, Francisco Javier/0000-0002-8961-1291	Consejeria de Salud, Junta de Andalucia, Spain [PI-0655-2013]	Consejeria de Salud, Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by a grant from the Consejeria de Salud, Junta de Andalucia, Spain, Project PI-0655-2013. http://www.juntadeandalucia.es/fundacionprogresoysalud/gestionconvocatorias/.	Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Agarwal R, 2009, INDIAN J OPHTHALMOL, V57, P257, DOI 10.4103/0301-4738.53049; Allen A, 2013, BEHAV BRAIN RES, V240, P95, DOI 10.1016/j.bbr.2012.11.025; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Carreras FJ, 2011, MISTERY GLAUCOMA, P61; Carreras FJ, 2010, CLIN EXP OPHTHALMOL, V38, P300, DOI 10.1111/j.1442-9071.2010.02206.x; Casson RJ, 2014, OPHTHALMOLOGY, V121, P1203, DOI 10.1016/j.ophtha.2013.12.011; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; EYRE JA, 1994, BRAIN RES, V635, P349, DOI 10.1016/0006-8993(94)91461-3; FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779; GERHART DZ, 1995, NEUROSCIENCE, V66, P237, DOI 10.1016/0306-4522(94)00544-F; Ghosh A, 2005, J BIOL CHEM, V280, P11114, DOI 10.1074/jbc.M410894200; Gordon MO, 2007, OPHTHALMOLOGY, V114, P10, DOI 10.1016/j.ophtha.2006.08.031; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HABER RS, 1993, ENDOCRINOLOGY, V132, P2538, DOI 10.1210/en.132.6.2538; Ho WL, 2012, MOL VIS, V18, P2700; Carreras FJ, 2010, CLIN EXP OPHTHALMOL, V38, P705, DOI 10.1111/j.1442-9071.2010.02334.x; Carreras FJ, 2009, OPHTHALMIC RES, V42, P106, DOI 10.1159/000225964; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Kasischke K.A., 2009, ENCY NEUROSCIENCE, P53; Leino RL, 1997, J NEUROSCI RES, V49, P617; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; MASSA PT, 1982, NEUROSCIENCE, V7, P523; Matsunami T, 2006, CELL COMMUN ADHES, V13, P93, DOI 10.1080/15419060600631805; McEwen BS, 2004, EUR J PHARMACOL, V490, P13, DOI 10.1016/j.ejphar.2004.02.041; Merriman-Smith BR, 2003, INVEST OPHTH VIS SCI, V44, P3458, DOI 10.1167/iovs.02-1235; MORGELLO S, 1995, GLIA, V14, P43, DOI 10.1002/glia.440140107; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pesce A, 1984, LACTATE DEHYDROGENAS, P1124; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Regina A, 2001, BBA-MOL CELL RES, V1540, P233, DOI 10.1016/S0167-4889(01)00133-1; RODIECK RW, 1973, VERTEBRATE RETINA PR; Simpson PB, 1998, BRAIN RES REV, V26, P72, DOI 10.1016/S0165-0173(97)00056-8; Singh LD, 1996, METAB BRAIN DIS, V11, P343, DOI 10.1007/BF02029495; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Wiesinger H, 1997, GLIA, V21, P22, DOI 10.1002/(SICI)1098-1136(199709)21:1<22::AID-GLIA3>3.0.CO;2-3; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yu S, 1998, BRAIN RES, V797, P65, DOI 10.1016/S0006-8993(98)00372-2; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	50	5	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128516	10.1371/journal.pone.0128516	http://dx.doi.org/10.1371/journal.pone.0128516			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030125	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900161
J	Nagata, T; Yasuda, Y; Ando, M; Abe, T; Katsuno, T; Kato, S; Tsuboi, N; Matsuo, S; Maruyama, S				Nagata, Takanobu; Yasuda, Yoshinari; Ando, Masahiko; Abe, Tomoko; Katsuno, Takayuki; Kato, Sawako; Tsuboi, Naotake; Matsuo, Seiichi; Maruyama, Shoichi			Clinical Impact of Kidney Function on Presepsin Levels	PLOS ONE			English	Article							SOLUBLE CD14 SUBTYPE; SEVERE SEPSIS; EMERGENCY-DEPARTMENT; PROCALCITONIN LEVELS; SEPTIC SHOCK; MULTICENTER; INTERLEUKIN-6; INHIBITION; DIAGNOSIS; MARKER	Objective Presepsin is highlighted as a diagnostic and prognostic marker of sepsis. Little information is available regarding the accurate association between presepsin levels and the degree of kidney function. We analyzed presepsin levels in patients with a glomerular filtration rate (GFR) in the categories G1 to G5, evaluated via inulin renal clearance test, and receiving hemodialysis (HD). Methods Patients who were not receiving HD were included if they had undergone inulin renal clearance measurements for the accurate measurement of GFR (measured GFR), and patients who were receiving hemodialysis (HD) were included if they had anuria. Exclusion criteria were infection, cancer, liver disease, autoimmune disorders, or steroid or immunosuppressant use. GFR category was defined as follows; G1: GFR >= 90 ml/min/1.73m(2), G2: GFR = 60 to 90 ml/min/1.73m(2), G3: GFR = 30 to 60 ml/min/1.73m(2), G4: GFR = 15 to 30 ml/min/1.73m(2), G5: GFR <= 15 ml/min/1.73m(2). Results Seventy-one patients were included. The median (IQR) presepsin values of patients in each GFR category were as follows: G1 + G2: 69.8 (60.8-85.9) pg/ml; G3: 107.0 (68.7-150.0) pg/ml; G4: 171.0 (117.0-200.0) pg/ml; G5: 251.0 (213.0-297.5) pg/ml; and HD: 1160.0 (1070.0-1400.0) pg/ml. The log-transformed presepsin values, excluding patients receiving HD, inversely correlated with the measured GFR (Pearson's correlation coefficient = -0.687, P < 0.001). The multivariate analysis revealed that measured GFR and hemoglobin levels significantly correlated with elevated presepsin levels. Conclusion Presepsin levels were markedly high in patients receiving HD, similar to values seen in patients with severe sepsis or septic shock. In patients who were not receiving HD, presepsin levels increased as GFR decreased. Thus, the evaluation of presepsin levels in patients with chronic kidney disease requires further consideration, and a different cutoff value is needed for diagnosing sepsis in such patients.	[Nagata, Takanobu; Yasuda, Yoshinari; Abe, Tomoko; Katsuno, Takayuki; Kato, Sawako; Tsuboi, Naotake; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Maruyama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan.	marus@med.nagoya-u.ac.jp	Kato, Sawako/T-2422-2019; Tsuboi, Naotake/L-5960-2019; ANDO, Masahiko/F-7035-2015	Kato, Sawako/0000-0001-7210-1888; Tsuboi, Naotake/0000-0003-0760-845X; 	Kyowa Hakko Kirin Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.; Mochida Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [15H05291] Funding Source: KAKEN	Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); Mochida Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kyowa Hakko Kirin Co., Ltd. Otsuka Pharmaceutical Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., and Mochida Pharmaceutical Co., Ltd. provided support in the form of research grants for authors [TN, YY, MA, TA, TK, SK, NT, SM, SM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Behnes M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0507-z; Chenevier-Gobeaux C, 2014, CLIN CHIM ACTA, V427, P34, DOI 10.1016/j.cca.2013.09.019; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Endo Shigeatsu, 2008, Journal of Infection and Chemotherapy, V14, P244, DOI 10.1007/s10156-008-0608-1; Endo S, 2014, J INFECT CHEMOTHER, V20, P30, DOI 10.1016/j.jiac.2013.07.005; Endo S, 2012, J INFECT CHEMOTHER, V18, P891, DOI 10.1007/s10156-012-0435-2; Gilbert DN, 2010, J CLIN MICROBIOL, V48, P2325, DOI 10.1128/JCM.00655-10; Henriquez-Camacho C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/547818; HERBELIN A, 1991, KIDNEY INT, V39, P954, DOI 10.1038/ki.1991.120; HERBELIN A, 1990, KIDNEY INT, V37, P116, DOI 10.1038/ki.1990.16; Horio M, 2010, CLIN EXP NEPHROL, V14, P427, DOI 10.1007/s10157-010-0325-9; Horio M, 2009, CLIN EXP NEPHROL, V13, P50, DOI 10.1007/s10157-008-0084-z; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kurihara T, 2008, ANAL BIOCHEM, V375, P144, DOI 10.1016/j.ab.2007.12.030; Ledebo I, 1999, ARTIF ORGANS, V23, P37, DOI 10.1046/j.1525-1594.1999.06275.x; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Liu B, 2013, CRIT CARE, V17, DOI 10.1186/cc13070; Masson S, 2015, INTENS CARE MED, V41, P12, DOI 10.1007/s00134-014-3514-2; Masson S, 2014, CRIT CARE, V18, DOI 10.1186/cc13183; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; MEANS RT, 1993, J CLIN INVEST, V91, P416, DOI 10.1172/JCI116216; MEANS RT, 1990, J CLIN INVEST, V86, P538, DOI 10.1172/JCI114741; Meisner M, 2002, CLIN CHIM ACTA, V323, P17, DOI 10.1016/S0009-8981(02)00101-8; Nakamura Y, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-88; Okamura Y, 2011, CLIN CHIM ACTA, V412, P2157, DOI 10.1016/j.cca.2011.07.024; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Raja KB, 2005, BRIT J HAEMATOL, V131, P656, DOI 10.1111/j.1365-2141.2005.05814.x; Shozushima T, 2011, J INFECT CHEMOTHER, V17, P764, DOI 10.1007/s10156-011-0254-x; Ulla M, 2013, CRIT CARE, V17, DOI 10.1186/cc12847; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Yaegashi Yasunori, 2005, Journal of Infection and Chemotherapy, V11, P234, DOI 10.1007/s10156-005-0400-4	36	59	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129159	10.1371/journal.pone.0129159	http://dx.doi.org/10.1371/journal.pone.0129159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030716	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900212
J	Ranjbar, MRN; Luo, Y; Di Poto, C; Varghese, RS; Ferrarini, A; Zhang, C; Sarhan, NI; Soliman, H; Tadesse, MG; Ziada, DH; Roy, R; Ressom, HW				Ranjbar, Mohammad R. Nezami; Luo, Yue; Di Poto, Cristina; Varghese, Rency S.; Ferrarini, Alessia; Zhang, Chi; Sarhan, Naglaa I.; Soliman, Hanan; Tadesse, Mahlet G.; Ziada, Dina H.; Roy, Rabindra; Ressom, Habtom W.			GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort	PLOS ONE			English	Article							IDENTIFY SERUM BIOMARKERS; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; ALPHA-FETOPROTEIN; METABOLITE; METABONOMICS; TRANSPORTER; ACTIVATION; SURVIVAL; LEUCINE	This study evaluates changes in metabolite levels in hepatocellular carcinoma (HCC) cases vs. patients with liver cirrhosis by analysis of human blood plasma using gas chromatography coupled with mass spectrometry (GC-MS). Untargeted metabolomic analysis of plasma samples from participants recruited in Egypt was performed using two GC-MS platforms: a GC coupled to single quadruple mass spectrometer (GC-qMS) and a GC coupled to a time-of-flight mass spectrometer (GC-TOFMS). Analytes that showed statistically significant changes in ion intensities were selected using ANOVA models. These analytes and other candidates selected from related studies were further evaluated by targeted analysis in plasma samples from the same participants as in the untargeted metabolomic analysis. The targeted analysis was performed using the GC-qMS in selected ion monitoring (SIM) mode. The method confirmed significant changes in the levels of glutamic acid, citric acid, lactic acid, valine, isoleucine, leucine, alpha tocopherol, cholesterol, and sorbose in HCC cases vs. patients with liver cirrhosis. Specifically, our findings indicate up-regulation of metabolites involved in branched-chain amino acid (BCAA) metabolism. Although BCAAs are increasingly used as a treatment for cancer cachexia, others have shown that BCAA supplementation caused significant enhancement of tumor growth via activation of mTOR/AKT pathway, which is consistent with our results that BCAAs are up-regulated in HCC.	[Ranjbar, Mohammad R. Nezami; Luo, Yue; Di Poto, Cristina; Varghese, Rency S.; Ferrarini, Alessia; Zhang, Chi; Roy, Rabindra; Ressom, Habtom W.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Sarhan, Naglaa I.] Tanta Univ, Tanta Fac Med, Dept Histol & Genet, Tanta, Egypt; [Soliman, Hanan; Ziada, Dina H.] Tanta Univ, Tanta Fac Med, Dept Trop Med & Infect Dis, Tanta, Egypt; [Tadesse, Mahlet G.] Georgetown Univ, Dept Math & Stat, Washington, DC 20007 USA	Georgetown University; Egyptian Knowledge Bank (EKB); Tanta University; Egyptian Knowledge Bank (EKB); Tanta University; Georgetown University	Ressom, HW (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA.	hwr@georgetown.edu	Ferrarini, Alessia/ABD-6403-2021	Ferrarini, Alessia/0000-0002-4587-6095; soliman, hanan/0000-0001-5099-6158	NIH [R01CA143420]; NATIONAL CANCER INSTITUTE [R01CA143420] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH Grant R01CA143420 awarded to HWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Alda M, 2013, BIPOLAR DISORD, V15, P824, DOI 10.1111/bdi.12131; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beyoglu D, 2013, HEPATOLOGY, DOI [10.1002/hep.26350;10.1002/hep.26350, DOI 10.1002/HEP.26350;10.1002/HEP.26350]; Budhu A, 2013, GASTROENTEROLOGY, V144, P1066, DOI 10.1053/j.gastro.2013.01.054; Cao HC, 2011, ANAL CHIM ACTA, V691, P68, DOI 10.1016/j.aca.2011.02.038; Chen J, 2009, ANAL CHIM ACTA, V650, P3, DOI 10.1016/j.aca.2009.03.039; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Fitian AI, 2014, LIVER INT; Fong MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019963; Girniene J, 2003, CARBOHYD RES, V338, P711, DOI 10.1016/S0008-6215(03)00007-7; Greten TF, 2005, BRIT J CANCER, V92, P1862, DOI 10.1038/sj.bjc.6602590; Gupta S, 2003, ANN INTERN MED, V139, P46, DOI 10.7326/0003-4819-139-1-200307010-00012; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Huang Q, 2013, CANCER RES, V73, P4992, DOI 10.1158/0008-5472.CAN-13-0308; HUEPER WC, 1965, CANCER RES, V25, P440; Kinoshita H, 2013, ONCOL REP, V29, P685, DOI 10.3892/or.2012.2162; Kovach SJ, 2006, J CELL PHYSIOL, V206, P411, DOI 10.1002/jcp.20474; Liu KA, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-6; Liu Y, 2014, INT J CANCER, V135, P658, DOI 10.1002/ijc.28706; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; O'Connell TM, 2013, METABOLITES, V3, P931, DOI 10.3390/metabo3040931; Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885; Qin T, 2010, CANCER EPIDEM BIOMAR, V19, P2247, DOI 10.1158/1055-9965.EPI-10-0302; Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; STEIN SE, 1994, J AM SOC MASS SPECTR, V5, P316, DOI 10.1016/1044-0305(94)85022-4; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tan YX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010694; Terashima Y, 2014, ARCH BIOCHEM BIOPHYS, V555, P55, DOI 10.1016/j.abb.2014.05.013; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Wang BH, 2012, J PROTEOME RES, V11, P1217, DOI 10.1021/pr2009252; Xiao JF, 2012, J PROTEOME RES, V11, P5914, DOI 10.1021/pr300673x; Xiao JF, 2014, CANCER EPIDEM BIOMAR, V23, P64, DOI 10.1158/1055-9965.EPI-13-0327; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P3061, DOI 10.1002/rcm.3708; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466; Yang J, 2006, J PROTEOME RES, V5, P554, DOI 10.1021/pr050364w; Ye GZ, 2012, J PROTEOME RES, V11, P4361, DOI 10.1021/pr300502v; Yu LX, 2014, ONCOTARGETS THER, V7, P873, DOI 10.2147/OTT.S63594; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	44	51	53	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127299	10.1371/journal.pone.0127299	http://dx.doi.org/10.1371/journal.pone.0127299			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030804	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900045
J	Shi, CY; Liu, Y; Hu, XM; Xiong, JF; Zhang, B; Yuan, ZM				Shi, Chenyan; Liu, Yi; Hu, Xiaomin; Xiong, Jinfeng; Zhang, Bo; Yuan, Zhiming			A Metagenomic Survey of Viral Abundance and Diversity in Mosquitoes from Hubei Province	PLOS ONE			English	Article							TENO SUS VIRUS; GENOMIC ORGANIZATION; NUCLEOTIDE-SEQUENCE; CHANDIPURA VIRUS; RAPID DETECTION; TRANSMISSION; DENSOVIRUS; DIPTERA; RHABDOVIRUS; PARVOVIRUS	Mosquitoes as one of the most common but important vectors have the potential to transmit or acquire a lot of viruses through biting, however viral flora in mosquitoes and its impact on mosquito-borne disease transmission has not been well investigated and evaluated. In this study, the metagenomic techniquehas been successfully employed in analyzing the abundance and diversity of viral community in three mosquito samples from Hubei, China. Among 92,304 reads produced through a run with 454 GS FLX system, 39% have high similarities with viral sequences belonging to identified bacterial, fungal, animal, plant and insect viruses, and 0.02% were classed into unidentified viral sequences, demonstrating high abundance and diversity of viruses in mosquitoes. Furthermore, two novel viruses in subfamily Densovirinae and family Dicistroviridae were identified, and six torque tenosus virus1 in family Anelloviridae, three porcine parvoviruses in subfamily Parvovirinae and a Culex tritaeniorhynchus rhabdovirus in Family Rhabdoviridae were preliminarily characterized. The viral metagenomic analysis offered us a deep insight into the viral population of mosquito which played an important role in viral initiative or passive transmission and evolution during the process.	[Shi, Chenyan; Liu, Yi; Hu, Xiaomin; Zhang, Bo; Yuan, Zhiming] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China; [Shi, Chenyan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xiong, Jinfeng] Hubei Dis Control & Prevent Ctr, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yuan, ZM (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China.	yzm@wh.iov.cn	Hu, Xiaomin/GRY-1539-2022; Shi, Chenyan/H-7436-2018	Shi, Chenyan/0000-0002-1898-4170	Major State Basic Research Development Program [2013FY113500]; Important National Science & Technology Specific Projects [2012ZX10004219]; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety	Major State Basic Research Development Program(National Basic Research Program of China); Important National Science & Technology Specific Projects; Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety	This work was supported by Major State Basic Research Development Program (2013FY113500), Important National Science & Technology Specific Projects (2012ZX10004219) and Wuhan Key Laboratory on Emerging Infectious Diseases and Biosafety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFANASIEV BN, 1991, VIROLOGY, V185, P323, DOI 10.1016/0042-6822(91)90780-F; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; BOUBLIK Y, 1994, VIROLOGY, V200, P752, DOI 10.1006/viro.1994.1239; Cadar D, 2013, VET MICROBIOL, V166, P200, DOI 10.1016/j.vetmic.2013.06.010; CARTWRIGHT SF, 1969, J COMP PATHOL, V79, P371, DOI 10.1016/0021-9975(69)90053-X; Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cortey M, 2012, VET MICROBIOL, V156, P81, DOI 10.1016/j.vetmic.2011.10.026; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991; Ho Phui San, 2010, Virol J, V7, P13, DOI 10.1186/1743-422X-7-13; Hogenhout SA, 2003, TRENDS MICROBIOL, V11, P264, DOI 10.1016/S0966-842X(03)00120-3; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Jousset FX, 2000, VIRUS RES, V67, P11, DOI 10.1016/S0168-1702(00)00128-3; Jousset FX, 1993, VIRUS RES, P29; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kuwata R, 2011, J VIROL, V85, P6185, DOI 10.1128/JVI.00040-11; Liu JB, 2013, VIROLOGY J; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Mavale MS, 2007, AM J TROP MED HYG, V76, P307, DOI 10.4269/ajtmh.2007.76.307; Mavale MS, 2005, J MED ENTOMOL, V42, P909, DOI 10.1603/0022-2585(2005)042[0909:VAVTOC]2.0.CO;2; MAYR A, 1968, ARCH GES VIRUSFORSCH, V25, P38, DOI 10.1007/BF01243088; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Nederbragt AJ, 2014, GENOME BIOL, V15, DOI 10.1186/gb4173; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067; Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Shike H, 2000, VIROLOGY, V277, P167, DOI 10.1006/viro.2000.0589; Streck AF, 2011, J GEN VIROL, V92, P2628, DOI 10.1099/vir.0.033662-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zhai SL, 2013, ARCH VIROL, V158, P1567, DOI 10.1007/s00705-013-1644-4; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0	41	45	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129845	10.1371/journal.pone.0129845	http://dx.doi.org/10.1371/journal.pone.0129845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030271	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900234
J	Yu, FH; Chou, TA; Liao, WH; Huang, KJ; Wang, CT				Yu, Fu-Hsien; Chou, Ting-An; Liao, Wei-Hao; Huang, Kuo-Jung; Wang, Chin-Tien			Gag-Pol Transframe Domain p6*Is Essential for HIV-1 Protease-Mediated Virus Maturation	PLOS ONE			English	Article							TYPE-1 REVERSE-TRANSCRIPTASE; VIRAL INFECTIVITY; NUCLEOCAPSID PROTEIN; PARTICLE MATURATION; SEQUENCES UPSTREAM; IMMUNODEFICIENCY; POLYPROTEIN; PRECURSOR; MUTANTS; RNA	HIV-1 protease (PR) is encoded by pol, which is initially translated as a Pr160(gag-pol) polyprotein by a ribosomal frameshift event. Within Gag-Pol, truncated p6gag is replaced by a transframe domain (referred to as p6* or p6pol) located directly upstream of PR. p6* has been proposed as playing a role in modulating PR activation. Overlapping reading frames between p6* and p6gag present a challenge to researchers using genetic approaches to studying p6* biological functions. To determine the role of p6* in PR activation without affecting the gag reading frame, we constructed a series of Gag/Gag-Pol expression vectors by duplicating PR with or without p6* between PR pairs, and observed that PR duplication eliminated virus production due to significant Gag cleavage enhancement. This effect was mitigated when p6* was placed between the two PRs. Further, Gag cleavage enhancement was markedly reduced when either one of the two PRs was mutationally inactivated. Additional reduction in Gag cleavage efficiency was noted following the removal of p6* from between the two PRs. The insertion of a NC domain (wild-type or mutant) directly upstream of PR or p6* PR did not significantly improve Gag processing efficiency. With the exception of those containing p6* directly upstream of an active PR, all constructs were either noninfectious or weakly infectious. Our results suggest that (a) p6* is essential for triggering PR activation, (b) p6* has a role in preventing premature virus processing, and (c) the NC domain within Gag-Pol is not a major determinant of PR activation.	[Yu, Fu-Hsien; Huang, Kuo-Jung; Wang, Chin-Tien] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Yu, Fu-Hsien; Wang, Chin-Tien] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chou, Ting-An] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, CT (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.	chintien@ym.edu.tw			Taipei Veterans General Hospital [V101C-059, V102C-039]; Ministry of Science and Technology, Taiwan [NSC 97-2320-B-010-002-MY3, 100-2320-B-010-015-MY3]; Ministry of Education, Aiming for the Top University Plan	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Aiming for the Top University Plan	This work was supported by grants V101C-059 and V102C-039 from Taipei Veterans General Hospital, by grants NSC 97-2320-B-010-002-MY3 and 100-2320-B-010-015-MY3 from the Ministry of Science and Technology, Taiwan, and by a grant from the Ministry of Education, Aiming for the Top University Plan.	ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; ARRIGO SJ, 1995, J VIROL, V69, P5988, DOI 10.1128/JVI.69.10.5988-5994.1995; BERKOWITZ RD, 1993, J VIROL, V67, P7190, DOI 10.1128/JVI.67.12.7190-7200.1993; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Chatterjee A, 2005, J BIOL CHEM, V280, P11369, DOI 10.1074/jbc.M412603200; Chen AI, 2006, VIROLOGY, V348, P84, DOI 10.1016/j.virol.2005.12.009; Chen YL, 1997, J GEN VIROL, V78, P2497, DOI 10.1099/0022-1317-78-10-2497; Chiang CC, 2012, VIROLOGY, V422, P278, DOI 10.1016/j.virol.2011.11.001; Chiang CC, 2010, J VIROL, V84, P976, DOI 10.1128/JVI.01532-09; Chiu HC, 2002, J VIROL, V76, P3221, DOI 10.1128/JVI.76.7.3221-3231.2002; Chiu HC, 2006, J GEN VIROL, V87, P2041, DOI 10.1099/vir.0.81601-0; Dautin N, 2003, J VIROL, V77, P8216, DOI 10.1128/JVI.77.15.8216-8226.2003; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; FERRIS AL, 1990, VIROLOGY, V175, P456, DOI 10.1016/0042-6822(90)90430-Y; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003; Hill MK, 2001, J VIROL, V75, P6835, DOI 10.1128/JVI.75.15.6835-6840.2001; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; Huang MJ, 1997, J VIROL, V71, P4472, DOI 10.1128/JVI.71.6.4472-4478.1997; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; KRAUSSLICH HG, 1991, P NATL ACAD SCI USA, V88, P3213, DOI 10.1073/pnas.88.8.3213; Leiherer A, 2009, J VIROL, V83, P7210, DOI 10.1128/JVI.02603-08; Liao WH, 2004, VIROLOGY, V329, P180, DOI 10.1016/j.virol.2004.08.010; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Pan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032845; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Paulus C, 2004, VIROLOGY, V330, P271, DOI 10.1016/j.virol.2004.09.013; Paulus C, 1999, J BIOL CHEM, V274, P21539, DOI 10.1074/jbc.274.31.21539; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2003, J VIROL, V77, P366, DOI 10.1128/JVI.77.1.366-374.2003; Quillent C, 1996, VIROLOGY, V219, P29, DOI 10.1006/viro.1996.0219; ROSE JR, 1995, J VIROL, V69, P2751; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; SRINIVASAKUMAR N, 1995, J VIROL, V69, P6106, DOI 10.1128/JVI.69.10.6106-6114.1995; Swanstrom R., 1997, P263; Tachedjian G, 2005, FEBS LETT, V579, P379, DOI 10.1016/j.febslet.2004.11.099; Tachedjian G, 2001, P NATL ACAD SCI USA, V98, P7188, DOI 10.1073/pnas.121055998; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Wang CT, 2000, J VIROL, V74, P3418, DOI 10.1128/JVI.74.7.3418-3422.2000; ZYBARTH G, 1995, J VIROL, V69, P3878, DOI 10.1128/JVI.69.6.3878-3884.1995	53	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127974	10.1371/journal.pone.0127974	http://dx.doi.org/10.1371/journal.pone.0127974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030443	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900099
J	Zylstra, ER; Steidl, RJ; Swann, DE; Ratzlaff, K				Zylstra, Erin R.; Steidl, Robert J.; Swann, Don E.; Ratzlaff, Kristina			Hydrologic Variability Governs Population Dynamics of a Vulnerable Amphibian in an Arid Environment	PLOS ONE			English	Article							LOWLAND LEOPARD FROGS; SOUTHEASTERN ARIZONA; RANA-YAVAPAIENSIS; CLIMATE-CHANGE; DECLINE; ABUNDANCE; METAPOPULATION; SURVIVAL; DROUGHT; ECOLOGY	Dynamics of many amphibian populations are governed by the distribution and availability of water. Therefore, understanding the hydrological mechanisms that explain spatial and temporal variation in occupancy and abundance will improve our ability to conserve and recover populations of vulnerable amphibians. We used 16 years of survey data from intermittent mountain streams in the Sonoran Desert to evaluate how availability of surface water affected survival and adult recruitment of a threatened amphibian, the lowland leopard frog (Lithobates yavapaiensis). Across the entire study period, monthly survival of adults ranged from 0.72 to 0.99 during summer and 0.59 to 0.94 during winter and increased with availability of surface water (Z = 7.66; P < 0.01). Recruitment of frogs into the adult age class occurred primarily during winter and ranged from 1.9 to 3.8 individuals/season/pool; like survival, recruitment increased with availability of surface water (Z = 3.67; P < 0.01). Although abundance of frogs varied across seasons and years, we found no evidence of a systematic trend during the 16-year study period. Given the strong influence of surface water on population dynamics of leopard frogs, conservation of many riparian obligates in this and similar arid regions likely depends critically on minimizing threats to structures and ecosystem processes that maintain surface waters. Understanding the influence of surface-water availability on riparian organisms is particularly important because climate change is likely to decrease precipitation and increase ambient temperatures in desert riparian systems, both of which have the potential to alter fundamentally the hydrology of these systems.	[Zylstra, Erin R.; Steidl, Robert J.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Swann, Don E.; Ratzlaff, Kristina] Saguaro Natl Pk, Tucson, AZ USA	University of Arizona	Zylstra, ER (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	ezylstra@email.arizona.edu		Zylstra, Erin/0000-0002-2536-0403	National Park Service; Friends of Saguaro National Park; Nina M. Pulliam Charitable Trust; Western National Parks Association; Desert Southwest Cooperative Ecosystems Study Unit	National Park Service; Friends of Saguaro National Park; Nina M. Pulliam Charitable Trust; Western National Parks Association; Desert Southwest Cooperative Ecosystems Study Unit	This project was funded by the National Park Service, Friends of Saguaro National Park, Nina M. Pulliam Charitable Trust, Western National Parks Association, and the Desert Southwest Cooperative Ecosystems Study Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2005, AMPHIBIAN DECLINES C; Arizona Game and Fish Department, 2012, AR STAT WILDL ACT PL; Balling RC, 2010, PHYS GEOGR, V31, P293, DOI 10.2747/0272-3646.31.4.293; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; BOWERS JE, 1987, DESERT PLANTS, V8, P50; Bradford D. F, 2005, AMPHIBIAN DECLINES C, P567; Bradford DF, 2004, SOUTHWEST NAT, V49, P218, DOI 10.1894/0038-4909(2004)049<0218:PSADOA>2.0.CO;2; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Brand LA, 2011, ECOHYDROLOGY, V4, P130, DOI 10.1002/eco.143; CLARKSON RW, 1989, SOUTHWEST NAT, V34, P531, DOI 10.2307/3671513; Crooks KR, 2008, SOUTHWEST NAT, V53, P510, DOI 10.1894/CJ-146.1; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Dodd C. K, 2013, FROGS US CANADA; Dominguez F, 2010, CLIMATIC CHANGE, V99, P499, DOI 10.1007/s10584-009-9672-5; Ferner John W., 2010, P123; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Grafe TU, 2004, OECOLOGIA, V141, P40, DOI 10.1007/s00442-004-1639-7; Green AW, 2013, J APPL ECOL, V50, P1116, DOI 10.1111/1365-2664.12121; GRIMM NB, 1992, GLOBAL CLIMATE CHANGE AND FRESHWATER ECOSYSTEMS, P211; Hagen EM, 2012, J ARID ENVIRON, V84, P1, DOI 10.1016/j.jaridenv.2012.03.007; Heard GW, 2012, BIOL CONSERV, V148, P156, DOI 10.1016/j.biocon.2012.01.018; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; Hossack BR, 2013, CONSERV BIOL, V27, P1410, DOI 10.1111/cobi.12119; Jensen JB, 2003, AM MIDL NAT, V150, P185, DOI 10.1674/0003-0031(2003)150[0185:TRBBBT]2.0.CO;2; Joseph LN, 2009, ECOL APPL, V19, P631, DOI 10.1890/07-2107.1; Karraker NE, 2009, BIOL CONSERV, V142, P2293, DOI 10.1016/j.biocon.2009.05.002; Krebs C., 1978, ECOLOGY EXPT ANAL DI; McCaffery R, 2013, J HERPETOL, V47, P162, DOI 10.1670/11-327; McCaffery RM, 2010, P NATL ACAD SCI USA, V107, P8644, DOI 10.1073/pnas.0912945107; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Miller SN, 2007, ENVIRON MODELL SOFTW, V22, P365, DOI 10.1016/j.envsoft.2005.12.004; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Parker J.T.C., 2006, US GEOLOGICAL SURVEY; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Price SJ, 2012, HERPETOLOGICA, V68, P312, DOI 10.1655/HERPETOLOGICA-D-11-00084.1; Ratzlaff K, 2012, THESIS U ARIZONA ARI; Rorabaugh J.C., 2005, AMPHIBIAN DECLINES C, P593; Royle J. A., 2008, HIERARCHICAL MODELIN; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Sartorius SS, 2000, SOUTHWEST NAT, V45, P267, DOI 10.2307/3672829; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Schlaepfer MA, 2007, ECOHEALTH, V4, P421, DOI 10.1007/s10393-007-0136-y; Schmidt BR, 2005, CONSERV BIOL, V19, P1149, DOI 10.1111/j.1523-1739.2005.00164.x; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Semlitsch Raymond D., 1996, P217, DOI 10.1016/B978-012178075-3/50010-6; Semlitsch Raymond D., 2003, P8; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; SINERVO B, 1989, OECOLOGIA, V78, P411, DOI 10.1007/BF00379118; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Sredl M.J., 2005, AMPHIBIAN DECLINES C, P596; Sredl MJ, 2005, AMPHIBIAN DECLINES C, P588; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Vonesh JR, 2002, OECOLOGIA, V133, P325, DOI 10.1007/s00442-002-1039-9; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wallace JE, 2010, J WILDLIFE MANAGE, V74, P808, DOI 10.2193/2009-207; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Werner EE, 2009, ECOL MONOGR, V79, P503, DOI 10.1890/08-1047.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Witte CL, 2008, CONSERV BIOL, V22, P375, DOI 10.1111/j.1523-1739.2007.00878.x	71	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0125670	10.1371/journal.pone.0125670	http://dx.doi.org/10.1371/journal.pone.0125670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030825	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900014
J	Liu, HB; Hua, Y; Zheng, XY; Shen, ZJ; Luo, H; Tao, XJ; Wang, ZY				Liu, Haibin; Hua, Ying; Zheng, Xiangyun; Shen, Zhaojun; Luo, Hui; Tao, Xuejiao; Wang, Zhiyi			Effect of Coffee Consumption on the Risk of Gastric Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Review							CPG ISLAND METHYLATION; POLYPHENOLS; CARCINOMA; MORTALITY; WOMEN; MEN; TEA	Background and Objectives Results from observational epidemiologic studies on the relationship between coffee consumption and gastric cancer are inconsistent and inconclusive. To assess the association between coffee consumption and the risk of gastric cancer, we summarized evidence from prospective cohort studies. Methods Relevant studies were retrieved through computer searches (PubMed, EmBase and the Cochrane Library) and a review of references up to December 2014. The quality of the included studies was evaluated by Newcastle-Ottawa quality assessment scale. We used a meta-analytic approach to estimate overall hazard ratios (HRs) and 95% confidence intervals (CIs) for regular coffee drinkers versus individuals who seldom drank coffee. Sensitivity analysis and subgroup analysis were performed to assess the reliability of our results. A dose-response analysis was performed to assess the risk of gastric cancer based on the level of coffee consumption. Results Nine prospective cohort studies involving 1,250,825 participants and 3027 gastric cancer cases were included in this meta-analysis. The pooled HR of gastric cancer for the study-specific regularly versus seldom coffee drinking categories was 1.05 (95% CI, 0.88 to 1.25) with significant heterogeneity across studies (I-2 = 74.0%, P = 0.000). After the sensitivity analysis, three studies were deleted; however the association remained insignificant (HR, 0.99; 95% CI, 0.91 to 1.08). Subgroup analysis by anatomic location showed a risk for coffee consumption associated with cardia cancer (HR, 1.23; 95% CI, 1.04 to 1.45; heterogeneity, I-2 = 36.4, P = 0.207). In the dose-response analysis, there was no significant association between coffee intake (in cups) and the risk of gastric cancer (P for linearity trend and non-linearity > 0.05). Conclusion Our meta-analysis demonstrated that coffee consumption was not associated with overall gastric cancer risk; however, coffee consumption may be a risk factor for gastric cardia cancer.	[Liu, Haibin; Zheng, Xiangyun] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gen Surg, Wenzhou 325027, Peoples R China; [Hua, Ying; Shen, Zhaojun; Luo, Hui; Tao, Xuejiao] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou 325027, Peoples R China; [Wang, Zhiyi] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency Med, Wenzhou 325027, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, ZY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency Med, Wenzhou 325027, Peoples R China.	wzykdx203109@163.com			project of medical science and technology of Zhejiang province of China [Y201477434]	project of medical science and technology of Zhejiang province of China	This work was supported by grants from project of medical science and technology of Zhejiang province of China (No. Y201477434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie-Waldman CE, 2014, CANCER EPIDEM BIOMAR, V23, P638, DOI 10.1158/1055-9965.EPI-13-0886; Aly A, 2004, BBA-REV CANCER, V1704, P1, DOI 10.1016/j.bbcan.2004.01.004; Bidel S, 2013, INT J CANCER, V132, P1651, DOI 10.1002/ijc.27773; Boekema PJ, 1999, SCAND J GASTROENTERO, V34, P35, DOI 10.1080/003655299750025525; Cardenas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023407; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; Dawsey SM, 2002, GUT, V51, P457, DOI 10.1136/gut.51.3.457; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Evers BM, 2005, AM J SURG, V190, P279, DOI 10.1016/j.amjsurg.2005.05.027; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Galanis DJ, 1998, INT J EPIDEMIOL, V27, P173, DOI 10.1093/ije/27.2.173; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hecimovic I, 2011, FOOD CHEM, V129, P991, DOI 10.1016/j.foodchem.2011.05.059; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Jia-Qing, 2003, Can J Gastroenterol, V17 Suppl B, p18B; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; JACOBSEN BK, 1986, J NATL CANCER I, V76, P823; Kang GH, 2001, CANCER RES, V61, P2847; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Larsson SC, 2006, INT J CANCER, V119, P2186, DOI 10.1002/ijc.22105; Lee JH, 2004, ONCOGENE, V23, P4646, DOI 10.1038/sj.onc.1207588; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x; NOMURA A, 1986, JNCI-J NATL CANCER I, V76, P587, DOI 10.1093/jnci/76.4.587; Ren JS, 2010, EUR J CANCER, V46, P1873, DOI 10.1016/j.ejca.2010.03.025; Rota M, 2010, STAT MED, V29, P2679, DOI 10.1002/sim.4041; Sanikini H, 2014, INT J CANC; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; STENSVOLD I, 1994, CANCER CAUSE CONTROL, V5, P401, DOI 10.1007/BF01694753; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJ, 2000, METHODS METAANALYSIS, P64; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; van Loon AJM, 1998, J EPIDEMIOL COMMUN H, V52, P166, DOI 10.1136/jech.52.3.166; Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c; Xie FY, 2014, NUTRIENTS, V6, P3734, DOI 10.3390/nu6093734; Yen WJ, 2005, J AGR FOOD CHEM, V53, P2658, DOI 10.1021/jf0402429	38	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128501	10.1371/journal.pone.0128501	http://dx.doi.org/10.1371/journal.pone.0128501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023935	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400095
J	Sawada, T; Arai, D; Jing, XF; Furushima, K; Chen, QF; Kawakami, K; Yokote, H; Miyajima, M; Sakaguchi, K				Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Furushima, Kenryo; Chen, Qingfa; Kawakami, Kazuki; Yokote, Hideyuki; Miyajima, Masayasu; Sakaguchi, Kazushige			Trans-Activation between EphA and FGFR Regulates Self-Renewal and Differentiation of Mouse Embryonic Neural Stem/Progenitor Cells via Differential Activation of FRS2 alpha	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NUCLEOTIDE EXCHANGE FACTOR; STEM-CELLS; MAPK CASCADE; PC12 CELLS; IN-VIVO; RECEPTORS; PROLIFERATION; INHIBITION; MECHANISMS	Ephs and FGFRs belong to a superfamily of receptor tyrosine kinases, playing important roles in stem cell biology. We previously reported that EphA4 and FGFR form a heterodimer following stimulation with ligands, trans-activating each other and signaling through a docking protein, FRS2 alpha, that binds to both receptors. Here, we investigated whether the interaction between EphA4 and FGFRs can be generalized to other Ephs and FGFRs, and, in addition, examined the downstream signal mediating their function in embryonic neural stem/progenitor cells. We revealed that various Ephs and FGFRs interact with each other through similar molecular domains. When neural stem/progenitor cells were stimulated with FGF2 and ephrin-A1, the signal transduced from the EphA4/FGFR/FRS2 alpha complex enhanced self-renewal, while stimulation with ephrin-A1 alone induced neuronal differentiation. The downstream signal required for neuronal differentiation appears to be MAP kinase mainly linked to the Ras family of G proteins. MAP kinase activation was delayed and sustained, distinct from the transient activation induced by FGF2. Interestingly, this effect on neuronal differentiation required the presence of FGFRs. Specific FGFR inhibitor almost completely abolished the function of ephrin-A1 stimulation. These findings suggest that the ternary complex of EphA, FGFR and FRS2 alpha formed by ligand stimulation regulates self-renewal and differentiation of mouse embryonic neural stem/progenitor cells by ligand-specific fine tuning of the downstream signal via FRS2 alpha.	[Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Furushima, Kenryo; Chen, Qingfa; Kawakami, Kazuki; Yokote, Hideyuki; Sakaguchi, Kazushige] Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan	Wakayama Medical University	Sawada, T (corresponding author), Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Wakayama, Japan.	t-sawada@hokuto7.or.jp; ksaka@wakayama-med.ac.jp	Chen, Qingfa/AAG-1036-2020		Wakayama Medical Award for Young Reseachers; Japanese Government [19300132, 19700346]; Wakayama Medical University; Wakayama Foundation for the Promotion of Medicine	Wakayama Medical Award for Young Reseachers; Japanese Government; Wakayama Medical University; Wakayama Foundation for the Promotion of Medicine	This work was supported in part by the 2011 Wakayama Medical Award for Young Reseachers (to T.S.); the Japanese Government Grant-in-Aid for Scientific Research #19300132 (to K.S.); a Research Grant on Priority Areas from Wakayama Medical University (to K.S.); a Medical Research Grant from the Wakayama Foundation for the Promotion of Medicine (to K.S.); and the Japanese Government Grant-in-Aid for Scientific Research #19700346 (to T.S.).	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Hu JG, 2012, J MOL NEUROSCI, V46, P644, DOI 10.1007/s12031-011-9652-x; Jing XF, 2012, CELL REP, V2, P652, DOI 10.1016/j.celrep.2012.08.021; Jing XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032019; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shinya M, 2001, DEVELOPMENT, V128, P4153; Sun P, 2006, GENES CELLS, V11, P1097, DOI 10.1111/j.1365-2443.2006.01002.x; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yamamoto S, 2005, P NATL ACAD SCI USA, V102, P15983, DOI 10.1073/pnas.0507961102; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	29	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128826	10.1371/journal.pone.0128826	http://dx.doi.org/10.1371/journal.pone.0128826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024354	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400103
J	Yi, HS; Eun, HS; Lee, YS; Jung, JY; Park, SH; Park, KG; Choi, HS; Suh, JM; Jeong, WI				Yi, Hyon-Seung; Eun, Hyuk Soo; Lee, Young-Sun; Jung, Ju Yeon; Park, Seol-Hee; Park, Keun-Gyu; Choi, Hueng-Sik; Suh, Jae Myoung; Jeong, Won-Il			Treatment with 4-Methylpyrazole Modulated Stellate Cells and Natural Killer Cells and Ameliorated Liver Fibrosis in Mice	PLOS ONE			English	Article							INDUCED HEPATIC-FIBROSIS; RETINOIC ACID; VITAMIN-A; ETHYLENE-GLYCOL; TGF-BETA; RATS; ACTIVATION; ALCOHOL; CYTOTOXICITY; COLLAGEN	Background & Aims Accumulating evidence suggests that retinol and its metabolites are closely associated with liver fibrogenesis. Recently, we demonstrated that genetic ablation of alcohol dehydrogenase 3 (ADH3), a retinol metabolizing gene that is expressed in hepatic stellate cells (HSCs) and natural killer (NK) cells, attenuated liver fibrosis in mice. In the current study, we investigated whether pharmacological ablation of ADH3 has therapeutic effects on experimentally induced liver fibrosis in mice. Methods Liver fibrosis was induced by intraperitoneal injections of carbon tetrachloride (CCl4) or bile duct ligation (BDL) for two weeks. To inhibit ADH3-mediated retinol metabolism, 10 mu g 4-methylpyrazole (4-MP)/g of body weight was administered to mice treated with CCl4 or subjected to BDL. The mice were sacrificed at week 2 to evaluate the regression of liver fibrosis. Liver sections were stained for collagen and alpha-smooth muscle actin (alpha-SMA). In addition, HSCs and NK cells were isolated from control and treated mice livers for molecular and immunological studies. Results Treatment with 4-MP attenuated CCl4- and BDL-induced liver fibrosis in mice, without any adverse effects. HSCs from 4-MP treated mice depicted decreased levels of retinoic acids and increased retinol content than HSCs from control mice. In addition, the expression of alpha-SMA, transforming growth factor-beta 1 (TGF-beta 1), and type I collagen alpha 1 was significantly reduced in the HSCs of 4-MP treated mice compared to the HSCs from control mice. Furthermore, inhibition of retinol metabolism by 4-MP increased interferon-gamma production in NK cells, resulting in increased apoptosis of activated HSCs. Conclusions Based on our data, we conclude that inhibition of retinol metabolism by 4-MP ameliorates liver fibrosis in mice through activation of NK cells and suppression of HSCs. Therefore, retinol and its metabolizing enzyme, ADH3, might be potential targets for therapeutic intervention of liver fibrosis.	[Yi, Hyon-Seung; Eun, Hyuk Soo; Lee, Young-Sun; Jung, Ju Yeon; Suh, Jae Myoung; Jeong, Won-Il] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Liver Res, Taejon 305701, South Korea; [Lee, Young-Sun] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea; [Park, Seol-Hee] Seoul Natl Univ, Coll Vet Med, Dept Internal Med, Seoul, South Korea; [Park, Keun-Gyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Gwangju, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Kyungpook National University; Chonnam National University; Chonnam National University	Jeong, WI (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Liver Res, Taejon 305701, South Korea.	wijeong@kaist.ac.kr	Suh, Jae Myoung/B-3268-2015; Yi, Hyon-Seung/ABA-2729-2022; JEONG, WON IL/B-6615-2011	Suh, Jae Myoung/0000-0001-8097-4662; EUN, HYUK SOO/0000-0003-0485-0072; Yi, Hyon-Seung/0000-0002-3767-1954; Lee, Young-Sun/0000-0001-6396-0859	National Research Foundation of Korea (NRF) - Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111345, A111498]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ009957]	National Research Foundation of Korea (NRF) - Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by grants of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea, (A111345 and A111498) and a grant from the Next-Generation BioGreen 21 Program, (No. PJ009957), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BAUD FJ, 1988, NEW ENGL J MED, V319, P97, DOI 10.1056/NEJM198807143190206; Brent J, 1999, NEW ENGL J MED, V340, P832, DOI 10.1056/NEJM199903183401102; Brent J, 2001, NEW ENGL J MED, V344, P424, DOI 10.1056/NEJM200102083440605; CARMAN JA, 1991, J IMMUNOL, V147, P1247; Eipel C, 2013, INT J CLIN EXP PATHO, V6, P80; Faisel H, 2000, PUBLIC HEALTH NUTR, V3, P321, DOI 10.1017/S1368980000000367; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929; George J, 2004, INT J BIOCHEM CELL B, V36, P307, DOI 10.1016/S1357-2725(03)00253-X; George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8; Hisamori S, 2008, LIVER INT, V28, P1217, DOI 10.1111/j.1478-3231.2008.01745.x; Ichikawa S, 2011, J IMMUNOL, V186, P5549, DOI 10.4049/jimmunol.1003917; Jacobsen D, 1997, J TOXICOL-CLIN TOXIC, V35, P127, DOI 10.3109/15563659709001182; Jeong WI, 2008, GASTROENTEROLOGY, V134, P248, DOI 10.1053/j.gastro.2007.09.034; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Koda H, 1996, BIOCHEM BIOPH RES CO, V221, P565, DOI 10.1006/bbrc.1996.0636; Komarova TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090239; Lee YS, 2012, J GASTROEN HEPATOL, V27, P75, DOI 10.1111/j.1440-1746.2011.07007.x; Lopez-Valencia V, 2007, BIOCHEM PHARMACOL, V73, P586, DOI 10.1016/j.bcp.2006.10.021; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Murakami K, 2011, PEDIATR SURG INT, V27, P863, DOI 10.1007/s00383-011-2853-0; Natarajan SK, 2005, ARCH BIOCHEM BIOPHYS, V443, P93, DOI 10.1016/j.abb.2005.09.008; Okuno M, 1997, HEPATOLOGY, V26, P913, DOI 10.1002/hep.510260417; PALAKODETY RB, 1988, J BIOL CHEM, V263, P878; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Radaeva S, 2007, AM J PHYSIOL-GASTR L, V293, pG809, DOI 10.1152/ajpgi.00212.2007; Sarkola T, 2001, ALCOHOL CLIN EXP RES, V25, P513, DOI 10.1111/j.1530-0277.2001.tb02244.x; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; SENOO H, 1985, LAB INVEST, V52, P182; Sommerfeld K, 2012, PHARMACOL REP, V64, P1547, DOI 10.1016/S1734-1140(12)70952-0; Suh YG, 2012, HEPATOLOGY, V56, P1902, DOI 10.1002/hep.25817; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Wang L, 2002, ARCH BIOCHEM BIOPHYS, V401, P262, DOI 10.1016/S0003-9861(02)00058-9; Yi HS, 2014, HEPATOLOGY, V60, P1044, DOI 10.1002/hep.27137; Yi HS, 2013, J GASTROEN HEPATOL, V28, P99, DOI 10.1111/jgh.12017; ZHAO ZR, 1995, J NUTR, V125, P2064, DOI 10.1093/jn/125.8.2064; ZHAO ZR, 1994, NAT IMMUN, V13, P29	43	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127946	10.1371/journal.pone.0127946	http://dx.doi.org/10.1371/journal.pone.0127946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024318	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400061
J	Huang, LY; Lee, YL; Chou, P; Chiu, WY; Chu, DC				Huang, Li-Ying; Lee, Ya-Ling; Chou, Pesus; Chiu, Wei-Yih; Chu, Dachen			Thyroid Fine-Needle Aspiration Biopsy and Thyroid Cancer Diagnosis: A Nationwide Population-Based Study	PLOS ONE			English	Article							LIQUID-BASED CYTOLOGY; MANAGEMENT; NODULES; CARCINOMA; THERAPY; TRENDS; IMPACT; SMEARS	Background Thyroid cancer is the most common endocrine gland malignancy and fine-needle aspiration biopsy is widely used for thyroid nodule evaluation. Repeated aspiration biopsies are needed due to plausible false-negative results. This study aimed to investigate the overall relationship between aspiration biopsy and thyroid cancer diagnosis, and to explore factors related to shorter diagnostic time. Methods This nationwide retrospective cohort study retrieved data from the Longitudinal Health Insurance Database in Taiwan. Subjects without known thyroid malignancies and who received the first thyroid aspiration biopsy after 2004 were followed-up from 2004 to 2009 (n = 7700). Chi-square test, Kaplan-Meier survival analysis, and Cox proportional hazards model were used for data analysis. Results Of 7700 newly-aspirated patients, 276 eventually developed thyroid cancer (malignancy rate 3.6%). Among the 276 patients with thyroid cancer, 61.6% underwent only one aspiration biopsy and 81.2% were found within the first year after the initial aspiration. Cox proportional hazards model revealed that aspiration frequency (HR 1.07, 95% CI 1.06-1.08), ultrasound frequency (HR 1.02, 95% CI 1.01-1.03), older age, male sex, and aspiration biopsies arranged by surgery, endocrinology or otolaryngology subspecialties were all associated with shorter time to thyroid cancer diagnosis. Conclusions About 17.4% of thyroid cancer cases received more than two aspiration biopsies and 18.8% were diagnosed one year after the first biopsy. Regular follow-up with repeated aspiration or ultrasound may be required for patients with clinically significant thyroid nodules.	[Huang, Li-Ying] Taipei City Hosp, Dept Community Med, Taipei, Taiwan; [Huang, Li-Ying; Lee, Ya-Ling; Chou, Pesus; Chu, Dachen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Huang, Li-Ying; Lee, Ya-Ling; Chou, Pesus; Chu, Dachen] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chu, Dachen] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Chu, Dachen] Taipei City Hosp, Dept Neurosurg, Taipei, Taiwan; [Lee, Ya-Ling] Taipei City Hosp, Dept Dent, Taipei, Taiwan; [Lee, Ya-Ling] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Chiu, Wei-Yih] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan; [Chiu, Wei-Yih] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chu, DC (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	DAD57@tpech.gov.tw		CHIU, WEI-YIH/0000-0003-3124-7121				Alexander EK, 2002, J CLIN ENDOCR METAB, V87, P4924, DOI 10.1210/jc.2002-020865; [Anonymous], TAIW CANC REG ANN RE; Baloch Z, 2003, DIAGN CYTOPATHOL, V29, P203, DOI 10.1002/dc.10361; BRENNAN MD, 1991, MAYO CLIN PROC, V66, P11, DOI 10.1016/S0025-6196(12)61170-7; Castro M Regina, 2003, Endocr Pract, V9, P128; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chow LS, 2001, THYROID, V11, P1147, DOI 10.1089/10507250152740993; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cossu A, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/584768; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Danese D, 1998, THYROID, V8, P15, DOI 10.1089/thy.1998.8.15; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Fadda G, 2011, ACTA CYTOL, V55, P389, DOI 10.1159/000329029; Frates MC, 2006, J CLIN ENDOCR METAB, V91, P3411, DOI 10.1210/jc.2006-0690; Furlan JC, 2005, CAN J SURG, V48, P12; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Gharib H, 1995, Endocr Pract, V1, P410; GHARIB H, 1994, MAYO CLIN PROC, V69, P44, DOI 10.1016/S0025-6196(12)61611-5; Gharib Hossein, 2006, Endocr Pract, V12, P63; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; International Agency for Research on Cancer Brussels, 2012, EUCAN 2012 EST; Jeffrey P B, 1996, Pathology (Phila), V4, P319; Jung CK, 2008, ACTA CYTOL, V52, P313, DOI 10.1159/000325513; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kronenberg H., 2008, WILLIAMS TXB ENDOCRI, V11th edn; Lin JD, 2005, THYROID, V15, P708, DOI 10.1089/thy.2005.15.708; Ljung BM, 2008, CANCER CYTOPATHOL, V114, P144, DOI 10.1002/cncr.23541; Machens A, 2006, CLIN ENDOCRINOL, V65, P500, DOI 10.1111/j.1365-2265.2006.02623.x; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Torre EM, 2007, ACTA CYTOL, V51, P850, DOI 10.1159/000325859; Mitchell I, 2007, SURGERY, V142, P823, DOI 10.1016/j.surg.2007.09.011; National Cancer Institute, 2012, SEER STAT FACT SHEET; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Perros P., 2007, GUIDELINES MANAGEMEN, V3; Redman R, 2006, THYROID, V16, P55, DOI 10.1089/thy.2006.16.55; Rossi ED, 2009, ACTA CYTOL, V53, P659, DOI 10.1159/000325407; SHAHA AR, 1995, SURGERY, V118, P1131, DOI 10.1016/S0039-6060(05)80124-2; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Unal B, 2014, ASIAN PAC J CANCER P, V15, P8613, DOI 10.7314/APJCP.2014.15.20.8613; Yao R, 2011, EXPERT REV ENDOCRINO, V6, P215, DOI [10.1586/eem.11.9, 10.1586/EEM.11.9]; Yeh MW, 2004, THYROID, V14, P207, DOI 10.1089/105072504773297885	42	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127354	10.1371/journal.pone.0127354	http://dx.doi.org/10.1371/journal.pone.0127354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020790	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300037
J	Le Moing, V; Alla, F; Doco-Lecompte, T; Delahaye, F; Piroth, L; Chirouze, C; Tattevin, P; Lavigne, JP; Erpelding, ML; Hoen, B; Vandenesch, F; Duval, X				Le Moing, Vincent; Alla, Francois; Doco-Lecompte, Thanh; Delahaye, Francois; Piroth, Lionel; Chirouze, Catherine; Tattevin, Pierre; Lavigne, Jean-Philippe; Erpelding, Marie-Line; Hoen, Bruno; Vandenesch, Francois; Duval, Xavier		VIRSTA Study Grp	Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; BACTEREMIA; ECHOCARDIOGRAPHY; MORTALITY; COMPLICATIONS; DIAGNOSIS	Objectives To update the epidemiology of Staphylococcus aureusbloodstream infection (SAB) in a high-income country and its link with infective endocarditis (IE). Methods All consecutive adult patients with incident SAB (n = 2008) were prospectively enrolled between 2009 and 2011 in 8 university hospitals in France. Results SAB was nosocomial in 54%, non-nosocomial healthcare related in 18% and communityacquired in 26%. Methicillin resistance was present in 19% of isolates. SAB Incidence of nosocomial SAB was 0.159/1000 patients-days of hospitalization (95% confidence interval [CI] 0.111-0.219). A deep focus of infection was detected in 37%, the two most frequent were IE (11%) and pneumonia (8%). The higher rates of IE were observed in injecting drug users (IE: 38%) and patients with prosthetic (IE: 33%) or native valve disease (IE: 20%) but 40% of IE occurred in patients without heart disease nor injecting drug use. IE was more frequent in case of community-acquired (IE: 21%, adjusted odds-ratio (aOR) = 2.9, CI = 2.04.3) or non-nosocomial healthcare-related SAB (IE: 12%, aOR = 2.3, CI = 1.4-3.5). Staphylococcus aureus meningitis (IE: 59%), persistent bacteremia at 48 hours (IE: 25%) and C-reactive protein > 190 mg/L (IE: 15%) were also independently associated with IE. Criteria for severe sepsis or septic shock were met in 30% of SAB without IE (overall in hospital mortality rate 24%) and in 51% of IE (overall in hospital mortality rate 35%). Conclusion SAB is still a severe disease, mostly related to healthcare in a high-income country. IE is the most frequent complication and occurs frequently in patients without known predisposing conditions.	[Le Moing, Vincent] Univ Montpellier I, CHU Montpellier, Inst Rech Dev, Malad Infectieuses,UMI 233, Montpellier, France; [Alla, Francois; Erpelding, Marie-Line] Univ Paris 05, Univ Lorraine, CHU Nancy, Apemac,EA 4360,INSERM,CIC EC,CIE6, Nancy, France; [Doco-Lecompte, Thanh] CHU Nancy, Nancy, France; [Delahaye, Francois] Univ Lyon 1, Hosp Civils Lyon, F-69365 Lyon, France; [Piroth, Lionel] Univ Bourgogne, CHU Dijon, MERS, UMR 1347, Dijon, France; [Chirouze, Catherine] Univ Franche Comte, CHU Besancon, CNRS, UMR Chronoenvironm 6249, F-25030 Besancon, France; [Tattevin, Pierre] Univ Rennes 1, Hop Pontchaillou, Fac Med, INSERM U835,IFR140, Rennes, France; [Lavigne, Jean-Philippe] Univ Montpellier I, CHU Caremeau, INSERM U1047, Nimes, France; [Hoen, Bruno] Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, Pointe A Pitre, Guadeloupe, France; [Hoen, Bruno] CHU, Serv Malad Infectieuses, Pointe A Pitre, Guadeloupe, France; [Vandenesch, Francois] Univ Lyon 1, Hosp Civils Lyon, Ctr Int Rech Infectiol, CNRS, F-69365 Lyon, France; [Duval, Xavier] Univ Paris Diderot, Hop Bichat Claude Bernard, AP HP, INSERM,UMR 1137,CIC 1425, Paris, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Montpellier; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; CHU de Nancy; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; CHU Besancon; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Nimes; CHU Guadeloupe; Universite des Antilles; CHU Guadeloupe; Centre National de la Recherche Scientifique (CNRS); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Le Moing, V (corresponding author), Univ Montpellier I, CHU Montpellier, Inst Rech Dev, Malad Infectieuses,UMI 233, Montpellier, France.	v-le_moing@chu-montpellier.fr	Tristan, Anne/L-9464-2014; ETIENNE, Jerome/C-5471-2014; alla, francois/D-2295-2014; Ruimy, Raymond/P-6068-2016; Vandenesch, Francois/C-7209-2014; Revest, Matthieu/L-9533-2015; TRISTAN, Anne/GSN-8306-2022; Lavigne, Jean-Philippe/E-1756-2014; Minary, Laetitia/O-2264-2018	ETIENNE, Jerome/0000-0002-3348-3315; Vandenesch, Francois/0000-0001-9412-7106; TRISTAN, Anne/0000-0001-9471-2655; Lavigne, Jean-Philippe/0000-0002-9484-0304; Selton-Suty, Christine/0000-0003-4129-5784; Sotto, Albert/0000-0002-6463-9386; Le Moing, Vincent/0000-0002-9529-2792; alla, francois/0000-0002-5793-7190; Galtier, Florence/0000-0002-0720-6277; Minary, Laetitia/0000-0001-7328-6327; Sportouch, Catherine/0000-0001-5079-5874; Ruimy, Raymond/0000-0002-7179-662X	French Ministry of Health	French Ministry of Health	This study was funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerlaan HSM, 2013, CLIN INFECT DIS, V56, P798, DOI 10.1093/cid/cis1006; Asgeirsson H, 2011, CLIN MICROBIOL INFEC, V17, P513, DOI 10.1111/j.1469-0691.2010.03265.x; BAYER AS, 1987, ARCH INTERN MED, V147, P457, DOI 10.1001/archinte.147.3.457; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; del Rio A, 2009, CLIN INFECT DIS, V48, pS246, DOI 10.1086/598187; Duval X, 2007, EUR HEART J, V28, P59, DOI 10.1093/eurheartj/ehl318; El Atrouni WI, 2009, CLIN INFECT DIS, V49, pE130, DOI 10.1086/648442; El-Ahdab F, 2005, AM J MED, V118, P225, DOI 10.1016/j.amjmed.2004.12.017; Finkelstein R, 2012, SCAND J INFECT DIS, V44, P934, DOI 10.3109/00365548.2012.707331; Forsblom E, 2011, J HOSP INFECT, V78, P102, DOI 10.1016/j.jhin.2011.03.010; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hill EE, 2007, MAYO CLIN PROC, V82, P1165, DOI 10.4065/82.10.1165; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Joseph JP, 2013, J ANTIMICROB CHEMOTH, V68, P444, DOI 10.1093/jac/dks408; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Khatib R, 2013, AM J INFECT CONTROL, V41, P210, DOI 10.1016/j.ajic.2012.03.038; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P492, DOI 10.1111/1469-0691.12144; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mitchell BG, 2014, CLIN INFECT DIS, V59, P969, DOI 10.1093/cid/ciu508; Nethercott C, 2013, J CLIN MICROBIOL, V51, P2131, DOI 10.1128/JCM.00651-13; Rasmussen RV, 2011, EUR J ECHOCARDIOGR, V12, P414, DOI 10.1093/ejechocard/jer023; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Tristan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051172; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Van Hal SJ, 2005, J INFECTION, V51, P218, DOI 10.1016/j.jinf.2005.01.011; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vos FJ, 2011, NETH J MED, V69, P335	37	62	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127385	10.1371/journal.pone.0127385	http://dx.doi.org/10.1371/journal.pone.0127385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020939	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300038
J	Prasad, R; Dyrkheeva, N; Williams, J; Wilson, SH				Prasad, Rajendra; Dyrkheeva, Nadezhda; Williams, Jason; Wilson, Samuel H.			Mammalian Base Excision Repair: Functional Partnership between PARP-1 and APE1 in AP-Site Repair	PLOS ONE			English	Article							DNA-POLYMERASE-BETA; STRAND BREAK REPAIR; APURINIC APYRIMIDINIC SITES; CELL NUCLEAR ANTIGEN; POLY(ADP-RIBOSE) POLYMERASE-1; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; MOUSE FIBROBLASTS; PROTEIN XRCC1; LIGASE-III; IN-VITRO	The apurinic/apyrimidinic-(AP-) site in genomic DNA arises through spontaneous base loss and base removal by DNA glycosylases and is considered an abundant DNA lesion in mammalian cells. The base excision repair (BER) pathway repairs the AP-site lesion by excising and replacing the site with a normal nucleotide via template directed gap-filling DNA synthesis. The BER pathway is mediated by a specialized group of proteins, some of which can be found in multiprotein complexes in cultured mouse fibroblasts. Using a DNA polymerase (pol) beta immunoaffinity-capture technique to isolate such a complex, we identified five tightly associated and abundant BER factors in the complex: PARP-1, XRCC1, DNA ligase III, PNKP, and Tdp1. AP endonuclease 1 (APE1), however, was not present. Nevertheless, the complex was capable of BER activity, since repair was initiated by PARP-1's AP lyase strand incision activity. Addition of purified APE1 increased the BER activity of the pol beta complex. Surprisingly, the pol beta complex stimulated the strand incision activity of APE1. Our results suggested that PARP-1 was responsible for this effect, whereas other proteins in the complex had no effect on APE1 strand incision activity. Studies of purified PARP-1 and APE1 revealed that PARP-1 was able to stimulate APE1 strand incision activity. These results illustrate roles of PARP-1 in BER including a functional partnership with APE1.	[Prasad, Rajendra; Dyrkheeva, Nadezhda; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jason] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Dyrkheeva, Nadezhda/0000-0002-8360-1041	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences [Z01ES050158, Z01ES050159]; Eli Lilly and Co.; United States Department of State, United States-Russia; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050159, ZIAES050158, ZIAES050159, ZICES102488] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences; Eli Lilly and Co.(Eli Lilly); United States Department of State, United States-Russia; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences, project numbers Z01ES050158 and Z01ES050159. ND is supported in part by Eli Lilly and Co. and the United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program.	BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565; BAILLY V, 1989, BIOCHEM J, V262, P581, DOI 10.1042/bj2620581; Barnes DE, 1993, CURR OPIN CELL BIOL, V5, P424, DOI 10.1016/0955-0674(93)90007-D; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Caldecott KW, 2003, BIOCHEM SOC T, V31, P247, DOI 10.1042/bst0310247; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Cistulli C, 2004, DNA REPAIR, V3, P581, DOI 10.1016/j.dnarep.2003.09.012; Della-Maria J, 2012, J BIOL CHEM, V287, P39233, DOI 10.1074/jbc.M112.369975; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Hanssen-Bauer A, 2011, ENVIRON MOL MUTAGEN, V52, P623, DOI 10.1002/em.20663; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Horton JK, 2014, MOL CANCER RES, V12, P1128, DOI 10.1158/1541-7786.MCR-13-0502; Hou EW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm639; Jobert L, 2014, CELL MOL LIFE SCI, V71, P2451, DOI 10.1007/s00018-014-1562-y; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KUMAR A, 1990, J BIOL CHEM, V265, P2124; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lavrik OI, 2001, J BIOL CHEM, V276, P25541, DOI 10.1074/jbc.M102125200; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mendez F, 2000, RADIAT RES, V153, P186, DOI 10.1667/0033-7587(2000)153[0186:HSPAWB]2.0.CO;2; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Nakamura J, 1999, CANCER RES, V59, P2522; Oda N, 1996, J BIOL CHEM, V271, P13816, DOI 10.1074/jbc.271.23.13816; Parlanti E, 2004, DNA REPAIR, V3, P703, DOI 10.1016/j.dnarep.2003.12.009; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Poletto M, 2014, MOL BIOL CELL, V25, P1641, DOI 10.1091/mbc.E13-12-0717; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rusyn I, 2005, DNA REPAIR, V4, P1099, DOI 10.1016/j.dnarep.2005.05.009; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Schermerhorn KM, 2013, BIOCHEMISTRY-US, V52, P7669, DOI 10.1021/bi401218r; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tell G, 2009, CURR PHARM DESIGN, V15, P2908, DOI 10.2174/138161209789058174; Tsutakawa SE, 2013, J BIOL CHEM, V288, P8445, DOI 10.1074/jbc.M112.422774; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	79	34	37	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124269	10.1371/journal.pone.0124269	http://dx.doi.org/10.1371/journal.pone.0124269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020771	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300007
J	Suojalehto, H; Kinaret, P; Kilpelainen, M; Toskala, E; Ahonen, N; Wolff, H; Alenius, H; Puustinen, A				Suojalehto, Hille; Kinaret, Pia; Kilpelainen, Maritta; Toskala, Elina; Ahonen, Niina; Wolff, Henrik; Alenius, Harri; Puustinen, Anne			Level of Fatty Acid Binding Protein 5 (FABP5) Is Increased in Sputum of Allergic Asthmatics and Links to Airway Remodeling and Inflammation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DENDRITIC CELL-FUNCTION; CYSTEINYL-LEUKOTRIENES; RHINITIS; EXPRESSION; ELECTROPHORESIS; IDENTIFICATION; MACROPHAGE; PROTEOMICS; FLUID	Background The inflammatory processes in the upper and lower airways in allergic rhinitis and asthma are similar. Induced sputum and nasal lavage fluid provide a non-invasive way to examine proteins involved in airway inflammation in these conditions. Objectives We conducted proteomic analyses of sputum and nasal lavage fluid samples to reveal differences in protein abundances and compositions between the asthma and rhinitis patients and to investigate potential underlying mechanisms. Methods Induced sputum and nasal lavage fluid samples were collected from 172 subjects with 1) allergic rhinitis, 2) asthma combined with allergic rhinitis, 3) nonallergic rhinitis and 4) healthy controls. Proteome changes in 21 sputum samples were analysed with two-dimensional difference gel electrophoresis (2D-DIGE), and the found differentially regulated proteins identified with mass spectrometry. Immunological validation of identified proteins in the sputum and nasal lavage fluid samples was performed with Western blot and ELISA. Results Altogether 31 different proteins were identified in the sputum proteome analysis, most of these were found also in the nasal lavage fluid. Fatty acid binding protein 5 (FABP5) was up-regulated in the sputum of asthmatics. Immunological validation in the whole study population confirmed the higher abundance levels of FABP5 in asthmatic subjects in both the sputum and nasal lavage fluid samples. In addition, the vascular endothelial growth factor (VEGF) level was increased in the nasal lavage fluid of asthmatics and there were positive correlations between FABP5 and VEGF levels (r=0.660, p<0.001) and concentrations of FABP5 and cysteinyl leukotriene (CysLT) (r=0.535, p<0.001) in the nasal lavage fluid. Conclusions FABP5 may contribute to the airway remodeling and inflammation in asthma by fine-tuning the levels of CysLTs, which induce VEGF production.	[Suojalehto, Hille] Finnish Inst Occupat Hlth, Occupat Med Team, Helsinki, Finland; [Kinaret, Pia; Ahonen, Niina; Wolff, Henrik; Alenius, Harri; Puustinen, Anne] Finnish Inst Occupat Hlth, Unit Syst Toxicol, Helsinki, Finland; [Kilpelainen, Maritta] Univ Turku, Dept Pulm Dis & Allergol, Turku, Finland; [Toskala, Elina] Temple Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19122 USA	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Turku; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Suojalehto, H (corresponding author), Finnish Inst Occupat Hlth, Occupat Med Team, Helsinki, Finland.	hille.suojalehto@ttl.fi		Puustinen, Anne/0000-0002-0262-9975; Alenius, Harri/0000-0003-0106-8923; Kinaret, Pia/0000-0002-3312-5331				American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Amorim MM, 2010, CLIN EXP ALLERGY, V40, P867, DOI 10.1111/j.1365-2222.2009.03439.x; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Chetta A, 2005, CLIN EXP ALLERGY, V35, P1437, DOI 10.1111/j.1365-2222.2005.02360.x; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; Djukanovic R, 2002, EUR RESPIR J, V20, p1S, DOI 10.1183/09031936.02.00000102; Dragonieri S, 2009, Monaldi Arch Chest Dis, V71, P119; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; FERNLEY RT, 1979, FEBS LETT, V105, P299, DOI 10.1016/0014-5793(79)80634-1; Foresi A, 1997, J ALLERGY CLIN IMMUN, V100, P58, DOI 10.1016/S0091-6749(97)70195-7; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Gally F, 2013, AM J PHYSIOL-LUNG C, V305, pL64, DOI 10.1152/ajplung.00276.2012; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Gharib SA, 2011, J ALLERGY CLIN IMMUN, V128, P1176, DOI 10.1016/j.jaci.2011.07.053; Ghelfi E, 2013, AM J PATHOL, V182, P1425, DOI 10.1016/j.ajpath.2012.12.009; GORG A, 1987, ELECTROPHORESIS, V8, P122, DOI 10.1002/elps.1150080207; Gray RD, 2008, AM J RESP CRIT CARE, V178, P444, DOI 10.1164/rccm.200703-409OC; Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Jing C, 2001, CANCER RES, V61, P4357; Kim TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022711; Kiss M, 2013, J ALLERGY CLIN IMMUN, V132, P264, DOI 10.1016/j.jaci.2013.05.044; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Li B, 2009, J IMMUNOL, V182, P7625, DOI 10.4049/jimmunol.0804192; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Matoso A, 2013, MODERN PATHOL, V26, P665, DOI 10.1038/modpathol.2013.41; Matsuoka H, 2008, J ALLERGY CLIN IMMUN, V121, P774, DOI 10.1016/j.jaci.2007.11.032; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; MURAKAMI H, 1987, J BIOL CHEM, V262, P1382; PALOMAKI J, 2014, NANOTOXICOLOGY, V17, pE1; Papadaki G, 2013, RESP MED, V107, P1339, DOI 10.1016/j.rmed.2013.06.014; Pavord ID, 1999, AM J RESP CRIT CARE, V160, P1905, DOI 10.1164/ajrccm.160.6.9903114; Pignatti P, 2002, J ALLERGY CLIN IMMUN, V110, P667, DOI 10.1067/mai.2002.128279; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Poulin S, 2011, CLIN EXP ALLERGY, V41, P204, DOI 10.1111/j.1365-2222.2010.03653.x; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; Rostila A, 2012, LUNG CANCER, V77, P450, DOI 10.1016/j.lungcan.2012.03.024; Schachtrup C, 2008, BBA-MOL CELL BIOL L, V1781, P314, DOI 10.1016/j.bbalip.2008.04.010; Shuhui L, 2009, INT ARCH ALLERGY IMM, V149, P369, DOI 10.1159/000205583; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Suojalehto H, 2014, LARYNGOSCOPE, V124, pE213, DOI 10.1002/lary.24590; Suojalehto H, 2013, INT FORUM ALLERGY RH, V3, P612, DOI 10.1002/alr.21179; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Tomazic PV, 2014, J ALLERGY CLIN IMMUN, V133, P741, DOI 10.1016/j.jaci.2013.09.040; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023563; Yamamoto N, 2008, PROSTAG LEUKOTR ESS, V79, P21, DOI 10.1016/j.plefa.2008.06.003	56	26	27	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127003	10.1371/journal.pone.0127003	http://dx.doi.org/10.1371/journal.pone.0127003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020772	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300031
J	Tirado-Lee, L; Yamashita, M; Prakriya, M				Tirado-Lee, Leidamarie; Yamashita, Megumi; Prakriya, Murali			Conformational Changes in the Orai1 C-Terminus Evoked by STIM1 Binding	PLOS ONE			English	Article							ACTIVATES CRAC CHANNELS; OPERATED CA2+ ENTRY; COILED-COIL; ION PERMEATION; STORE; DOMAIN; DETERMINANTS; STIM1-ORAI1; INTERFACE; REGION	Store-operated CRAC channels regulate a wide range of cellular functions including gene expression, chemotaxis, and proliferation. CRAC channels consist of two components: the Orai proteins (Orai1-3), which form the ion-selective pore, and STIM proteins (STIM1-2), which form the endoplasmic reticulum (ER) Ca2+ sensors. Activation of CRAC channels is initiated by the migration of STIM1 to the ER-plasma membrane (PM) junctions, where it directly interacts with Orai1 to open the Ca2+-selective pores of the CRAC channels. The recent elucidation of the Drosophila Orai structure revealed a hexameric channel wherein the C-terminal helices of adjacent Orai subunits associate in an anti-parallel orientation. This association is maintained by hydrophobic interactions between the Drosophila equivalents of human Orai1 residues L273 and L276. Here, we used mutagenesis and chemical cross-linking to assess the nature and extent of conformational changes in the self-associated Orai1 C-termini during STIM1 binding. We find that linking the anti-parallel coiled-coils of the adjacent Orai1 C-termini through disulfide cross-links diminishes STIM1-Orai1 interaction, as assessed by FRET. Conversely, prior binding of STIM1 to the Orai1 C-terminus impairs cross-linking of the Orai1 C-termini. Mutational analysis indicated that a bend of the Orai1 helix located upstream of the self-associated coils (formed by the amino acid sequence SHK) establishes an appropriate orientation of the Orai1 C-termini that is required for STIM1 binding. Together, our results support a model wherein the self-associated Orai1 C-termini rearrange modestly to accommodate STIM1 binding.	[Tirado-Lee, Leidamarie; Yamashita, Megumi; Prakriya, Murali] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Prakriya, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA.	m-prakriya@northwestern.edu		Prakriya, Murali/0000-0003-0781-4480; Yamashita, Megumi/0000-0003-0196-0428	NIH [NS057499]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057499, R56NS057499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH NS057499. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Calloway N, 2010, BIOCHEMISTRY-US, V49, P1067, DOI 10.1021/bi901936q; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Guzman R, 2014, J HISTOCHEM CYTOCHEM, V62, P864, DOI 10.1369/0022155414554926; Hoover PJ, 2011, P NATL ACAD SCI USA, V108, P13299, DOI 10.1073/pnas.1101664108; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Lewis RS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003970; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Pan Z, 2015, SCI CHINA LIFE SCI, V58, P48, DOI 10.1007/s11427-014-4774-3; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Steinbeck JA, 2011, EXP NEUROL, V232, P185, DOI 10.1016/j.expneurol.2011.08.022; Wu MM, 2014, MOL BIOL CELL, V25, P3672, DOI 10.1091/mbc.E14-06-1107; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang W, 2011, SCI CHINA LIFE SCI, V54, P780, DOI 10.1007/s11427-011-4206-6; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	40	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128622	10.1371/journal.pone.0128622	http://dx.doi.org/10.1371/journal.pone.0128622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035642	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100039
J	Chang, S; Berman, J; Sheng, YM; Wang, YD; Capell, T; Shi, LX; Ni, XZ; Sandmann, G; Christou, P; Zhu, CF				Chang, Shu; Berman, Judit; Sheng, Yanmin; Wang, Yingdian; Capell, Teresa; Shi, Lianxuan; Ni, Xiuzhen; Sandmann, Gerhard; Christou, Paul; Zhu, Changfu			Cloning and Functional Characterization of the Maize (Zea mays L.) Carotenoid Epsilon Hydroxylase Gene	PLOS ONE			English	Article							COMPLEX METABOLIC PATHWAYS; PHYTOENE SYNTHASE; BETA-CAROTENE; RING; ARABIDOPSIS; TOMATO; TRANSFORMATION; STRESS; OVEREXPRESSION; AGROBACTERIUM	The assignment of functions to genes in the carotenoid biosynthesis pathway is necessary to understand how the pathway is regulated and to obtain the basic information required for metabolic engineering. Few carotenoid epsilon-hydroxylases have been functionally characterized in plants although this would provide insight into the hydroxylation steps in the pathway. We therefore isolated mRNA from the endosperm of maize (Zea mays L., inbred line B73) and cloned a full-length cDNA encoding CYP97C19, a putative heme-containing carotenoid epsilon hydroxylase and member of the cytochrome P450 family. The corresponding CYP97C19 genomic locus on chromosome 1 was found to comprise a single-copy gene with nine introns. We expressed CYP97C19 cDNA under the control of the constitutive CaMV 35S promoter in the Arabidopsis thaliana lut1 knockout mutant, which lacks a functional CYP97C1 (LUT1) gene. The analysis of carotenoid levels and composition showed that lutein accumulated to high levels in the rosette leaves of the transgenic lines but not in the untransformed lut1 mutants. These results allowed the unambiguous functional annotation of maize CYP97C19 as an enzyme with strong zeinoxanthin epsilon-ring hydroxylation activity.	[Chang, Shu; Sheng, Yanmin; Ni, Xiuzhen; Zhu, Changfu] Changchun Normal Univ, Sch Life Sci, Changchun 130032, Peoples R China; [Berman, Judit; Capell, Teresa; Christou, Paul; Zhu, Changfu] Univ Lleida, Agrotecnio Ctr, Dept Prod Vegetal & Ciencia Forestal, Lleida 25198, Spain; [Chang, Shu; Wang, Yingdian] Beijing Normal Univ, Sch Life Sci, Beijing 100875, Peoples R China; [Shi, Lianxuan] NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China; [Sandmann, Gerhard] Goethe Univ Frankfurt, Biosynth Grp, Mol Biosci, D-60438 Frankfurt, Germany; [Christou, Paul] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Changchun Normal University; Universitat de Lleida; Beijing Normal University; Northeast Normal University - China; Goethe University Frankfurt; ICREA	Zhu, CF (corresponding author), Changchun Normal Univ, Sch Life Sci, Changchun 130032, Peoples R China.	zhu@pvcf.udl.cat	Capell, Teresa/AAD-8609-2022; Christou, Paul/C-8645-2011; Capell, Teresa/B-2757-2011	Christou, Paul/0000-0001-6358-7396; Capell, Teresa/0000-0002-6436-4538	National Natural Science Foundation of China [31470394, 31070269]; MICINN, Spain [BIO2011-23324, BIO2011-22525, PIM2010PKB-00746]; European Union Framework 7 European Research Council IDEAS Advanced Grant Program-BIOFORCE; ERC Proof of Concept Grant; ICREA Funding Source: Custom	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union Framework 7 European Research Council IDEAS Advanced Grant Program-BIOFORCE; ERC Proof of Concept Grant; ICREA(ICREA)	This work was supported by the National Natural Science Foundation of China (31470394; 31070269); MICINN, Spain (BIO2011-23324; BIO2011-22525; PIM2010PKB-00746); European Union Framework 7 European Research Council IDEAS Advanced Grant (to PC) Program-BIOFORCE; and ERC Proof of Concept Grant (to PC).	Babu R, 2013, THEOR APPL GENET, V126, P389, DOI 10.1007/s00122-012-1987-3; Bai C, 2011, IN VITRO CELL DEV-PL, V47, P205, DOI 10.1007/s11627-011-9363-6; Berman J, 2015, PHYTOCHEM REV, V14, P727, DOI 10.1007/s11101-014-9373-1; Blasco F, 2004, APPL MICROBIOL BIOT, V64, P671, DOI 10.1007/s00253-003-1529-7; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Farre G, 2015, CURR OPIN BIOTECH, V32, P54, DOI 10.1016/j.copbio.2014.11.004; Farre G, 2014, ANNU REV PLANT BIOL, V65, P187, DOI 10.1146/annurev-arplant-050213-035825; Farre G, 2013, PLANT J, V75, P441, DOI 10.1111/tpj.12214; Farre G, 2011, TRENDS PLANT SCI, V16, P532, DOI 10.1016/j.tplants.2011.08.001; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; Giorio G, 2013, METAB ENG, V20, P167, DOI 10.1016/j.ymben.2013.10.007; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Kim J, 2006, P NATL ACAD SCI USA, V103, P3474, DOI 10.1073/pnas.0511207103; Kim J, 2009, PLANT CELL PHYSIOL, V50, P463, DOI 10.1093/pcp/pcp005; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li QR, 2010, TRANSGENIC RES, V19, P1053, DOI 10.1007/s11248-010-9381-x; Lv MZ, 2012, PLANT CELL PHYSIOL, V53, P987, DOI 10.1093/pcp/pcs041; MATTANOVICH D, 1989, NUCLEIC ACIDS RES, V17, P6747, DOI 10.1093/nar/17.16.6747; Messias RD, 2014, NUTRIENTS, V6, P546, DOI 10.3390/nu6020546; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naqvi S, 2011, PLANT BIOTECHNOL J, V9, P384, DOI 10.1111/j.1467-7652.2010.00554.x; Ojima K, 2006, MOL GENET GENOMICS, V275, P148, DOI 10.1007/s00438-005-0072-x; Quinlan RF, 2007, ARCH BIOCHEM BIOPHYS, V458, P146, DOI 10.1016/j.abb.2006.11.019; Quinlan RF, 2012, PLANT PHYSIOL, V160, P204, DOI 10.1104/pp.112.198556; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Stigliani AL, 2011, PLANT CELL PHYSIOL, V52, P851, DOI 10.1093/pcp/pcr037; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; Tian L, 2004, P NATL ACAD SCI USA, V101, P402, DOI 10.1073/pnas.2237237100; Tian L, 2003, PLANT CELL, V15, P1320, DOI 10.1105/tpc.011403; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Wurtzel ET, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00029; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang LE, 2014, J INTEGR PLANT BIOL, V56, P902, DOI 10.1111/jipb.12229; Zhou B, 2013, PLANT PHYSIOL BIOCH, V70, P235, DOI 10.1016/j.plaphy.2013.05.035; Zhou Y, 2012, J INTEGR PLANT BIOL, V54, P260, DOI 10.1111/j.1744-7909.2012.01106.x; Zhu CF, 2009, ARCH BIOCHEM BIOPHYS, V483, P182, DOI 10.1016/j.abb.2008.10.029; Zhu CF, 2008, P NATL ACAD SCI USA, V105, P18232, DOI 10.1073/pnas.0809737105	43	6	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128758	10.1371/journal.pone.0128758	http://dx.doi.org/10.1371/journal.pone.0128758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030746	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900189
J	Dehnhard, N; Eens, M; Demongin, L; Quillfeldt, P; Poisbleau, M				Dehnhard, Nina; Eens, Marcel; Demongin, Laurent; Quillfeldt, Petra; Poisbleau, Maud			Individual Consistency and Phenotypic Plasticity in Rockhopper Penguins: Female but Not Male Body Mass Links Environmental Conditions to Reproductive Investment	PLOS ONE			English	Article							LONG-TERM REPEATABILITY; EUDYPTES-C.-CHRYSOCOME; SOUTHERN ANNULAR MODE; FOOD AVAILABILITY; ANTARCTIC PENINSULA; BREEDING PHENOLOGY; METABOLIC-RATE; CLIMATE-CHANGE; MARION ISLAND; EGG MASS	In marine habitats, increasing ocean temperatures due to global climate change may distinctly reduce nutrient and consequently food availability for seabirds. Food availability is a known driver of body mass and reproductive investment in birds, but these traits may also depend on individual effects. Penguins show extreme intra-annual body mass variation and rely on accumulated body reserves for successful breeding. However, no study so far has tested individual consistency and phenotypic responses in body mass and reproductive investment in this taxon. Using a unique dataset on individually marked female and male southern rockhopper penguins (Eudyptes chrysocome chrysocome) across six years, we investigated 1) the individual consistency in body mass (measured at egg laying), body condition and reproductive investment across years, subsequently 2) identified the best-explanatory temperature-related environmental variables for female and male body mass, and 3) tested the effect of female and male body mass on reproductive investment. Body mass, body condition and reproductive investment were all highly repeatable. As body condition should control for the structural size of the birds, the similarly high repeatability estimates for body mass and body condition suggested that the consistent between-individual body mass differences were independent of structural size. This supported the use of body mass for the subsequent analyses. Body mass was higher under colder environmental conditions (positive Southern Annular Mode), but the overall phenotypic response appeared limited. Reproductive investment increased with female but not male body mass. While environmental effects on body mass in our study period were rather small, one can expect that ongoing global climate change will lead to a deterioration of food availability and we might therefore in the long-term expect a phenotypical decline in body mass and reproductive investment.	[Dehnhard, Nina; Eens, Marcel; Demongin, Laurent; Poisbleau, Maud] Univ Antwerp, Dept Biol Ethol, Antwerp, Belgium; [Dehnhard, Nina; Demongin, Laurent; Quillfeldt, Petra; Poisbleau, Maud] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Dehnhard, Nina; Demongin, Laurent; Quillfeldt, Petra; Poisbleau, Maud] Univ Konstanz, Dept Biol, Constance, Germany; [Quillfeldt, Petra] Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Germany	University of Antwerp; Max Planck Society; University of Konstanz; Justus Liebig University Giessen	Dehnhard, N (corresponding author), Univ Antwerp, Dept Biol Ethol, Campus Drie Eiken,Univ Pl 1, Antwerp, Belgium.	nina.dehnhard@uantwerpen.be	Eens, Marcel/AAC-8466-2020; Dehnhard, Nina/H-6160-2016; Quillfeldt, Petra/A-9549-2009	Dehnhard, Nina/0000-0002-4182-2698; Quillfeldt, Petra/0000-0002-4450-8688	FWO Flanders [1.2.619.10.N.00, 1.5.020.11.N.00, 1265414N]; Deutsche Forschungsgemeinschaft DFG [Qu 148/1-ff]; Environmental Studies Budget grant from Falkland Islands Government; University of Antwerp	FWO Flanders(FWO); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Environmental Studies Budget grant from Falkland Islands Government; University of Antwerp	The authors obtained funding from the University of Antwerp, FWO Flanders (grant numbers: 1.2.619.10.N.00, 1.5.020.11.N.00 and 1265414N), the Deutsche Forschungsgemeinschaft DFG (Qu 148/1-ff) and an Environmental Studies Budget grant from the Falkland Islands Government. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; Ardia DR, 2006, J AVIAN BIOL, V37, P252, DOI 10.1111/j.2006.0908-8857.03624.x; Arkhipkin A, 2010, FISH RES, V105, P156, DOI 10.1016/j.fishres.2010.03.022; Banbura Jerzy, 1998, Ardeola, V45, P183; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Baylis AMM, 2012, IBIS, V154, P30, DOI 10.1111/j.1474-919X.2011.01179.x; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; BirdLife International, 2012, IUCN RED LIST THREAT; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Broggi J, 2009, FUNCT ECOL, V23, P768, DOI 10.1111/j.1365-2435.2009.01561.x; Catry P, 1997, COLON WATERBIRD, V20, P399, DOI 10.2307/1521589; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Clausen AP, 2002, AQUAT CONSERV, V12, P51, DOI 10.1002/aqc.476; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Crawford RJM, 2008, AFR J MAR SCI, V30, P185, DOI 10.2989/AJMS.2008.30.1.19.469; Crawford RJM, 2006, CCAMLR SCI, V13, P175; Dehnhard N, 2015, MAR ECOL PROG SER, V524, P269, DOI 10.3354/meps11154; Dehnhard N, 2014, IBIS, V156, P548, DOI 10.1111/ibi.12167; Dehnhard N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079487; Dehnhard N, 2013, AQUAT CONSERV, V23, P777, DOI 10.1002/aqc.2331; Dehnhard N, 2011, POLAR BIOL, V34, P1763, DOI 10.1007/s00300-011-1026-x; Demongin L, 2010, POLAR BIOL, V33, P469, DOI 10.1007/s00300-009-0722-2; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Durant JM, 2010, MAR ECOL PROG SER, V420, P263, DOI 10.3354/meps08857; Ellis SL, 2000, J MAMMAL, V81, P1143, DOI 10.1644/1545-1542(2000)081<1143:MEOOMA>2.0.CO;2; Emmerson L, 2011, MAR ECOL PROG SER, V440, P203, DOI 10.3354/meps09265; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Frederiksen M, 2007, MAR ECOL PROG SER, V350, P137, DOI 10.3354/meps07126; Gauthier-Clerc M, 2001, ANIM BEHAV, V62, P661, DOI 10.1006/anbe.2001.1803; Gienapp P, 2014, J EVOLUTION BIOL, V27, P1849, DOI 10.1111/jeb.12438; Gladbach A, 2010, J ORNITHOL, V151, P817, DOI 10.1007/s10336-010-0518-8; Hatch MI, 2010, J FIELD ORNITHOL; Hauck J, 2013, GLOBAL BIOGEOCHEM CY, V27, P1236, DOI 10.1002/2013GB004600; HEPP GR, 1987, AUK, V104, P435, DOI 10.2307/4087542; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hindell MA, 2012, ECOL EVOL, V2, P1563, DOI 10.1002/ece3.281; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Horvathova T, 2012, P ROY SOC B-BIOL SCI, V279, P163, DOI 10.1098/rspb.2011.0663; HOUSTON AI, 1992, EVOL ECOL, V6, P243, DOI 10.1007/BF02214164; Husby A, 2011, AM NAT, V178, P202, DOI 10.1086/660834; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Kwok R, 2002, J CLIMATE, V15, P487, DOI 10.1175/1520-0442(2002)015<0487:SOCASI>2.0.CO;2; Lehikoinen A, 2011, OECOLOGIA, V165, P349, DOI 10.1007/s00442-010-1730-1; Lovenduski NS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022727; Ludynia K, 2013, ANIM BEHAV, V85, P255, DOI 10.1016/j.anbehav.2012.11.001; Ludynia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050429; Lynch HJ, 2012, MAR ECOL PROG SER, V454, P135, DOI 10.3354/meps09252; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Meredith MP, 2008, DEEP-SEA RES PT II, V55, P2007, DOI 10.1016/j.dsr2.2008.05.020; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Michel P, 2003, J ZOOL, V261, P427, DOI 10.1017/S0952836903004291; Milenkaya O, 2014, PHYSIOL BIOCHEM ZOOL, V87, P550, DOI 10.1086/676651; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Monticelli D, 2014, ESTUAR COAST SHELF S, V139, P110, DOI 10.1016/j.ecss.2013.12.026; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Patrick SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087269; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PETERSON RG, 1989, J GEOPHYS RES-OCEANS, V94, P10817, DOI 10.1029/JC094iC08p10817; Phillips RA, 1998, J AVIAN BIOL, V29, P190, DOI 10.2307/3677198; PIANKA ER, 1976, AM ZOOL, V16, P775; Poisbleau M, 2008, POLAR BIOL, V31, P925, DOI 10.1007/s00300-008-0431-2; Poisbleau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072136; Poisbleau M, 2011, J ORNITHOL, V152, P137, DOI 10.1007/s10336-010-0558-0; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Putz K, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P113; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Ratcliffe N, 2014, J BIOGEOGR, V41, P1183, DOI 10.1111/jbi.12279; Reale D, 1999, HEREDITY, V83, P526, DOI 10.1038/sj.hdy.6885430; Rey AR, 2005, POLAR BIOL, V28, P132, DOI 10.1007/s00300-004-0668-3; Robinson S, 2005, IBIS, V147, P483, DOI 10.1111/j.1474-919x.2005.00431.x; Schielzeth H, 2013, RPTR REPEATABILITY G; St. Clair Colleen Cassady, 1999, Marine Ornithology, V27, P37; STRANGE I J, 1982, Gerfaut, V72, P137; Szafranska PA, 2007, FUNCT ECOL, V21, P731, DOI 10.1111/j.1365-2435.2007.01273.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tveraa T, 1998, J ANIM ECOL, V67, P699, DOI 10.1046/j.1365-2656.1998.00234.x; Uller T, 2005, BEHAV ECOL SOCIOBIOL, V57, P584, DOI 10.1007/s00265-004-0886-2; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; Vleck CM, 2002, INTEGR COMP BIOL, V42, P76, DOI 10.1093/icb/42.1.76; Weiss F, 2009, POLAR BIOL, V32, P1753, DOI 10.1007/s00300-009-0674-6; Wendeln H, 1997, COLON WATERBIRD, V20, P235, DOI 10.2307/1521689; Wendeln H, 1999, J ANIM ECOL, V68, P205, DOI 10.1046/j.1365-2656.1999.00276.x; Williams T.D., 1995, PENGUINS; WILLIAMS TD, 1992, CONDOR, V94, P636, DOI 10.2307/1369249; Winkler DW, 1996, ECOLOGY, V77, P922, DOI 10.2307/2265512; WITTER MS, 1995, FUNCT ECOL, V9, P568, DOI 10.2307/2390146; YORIO P, 1994, CONDOR, V96, P1076, DOI 10.2307/1369116	96	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128776	10.1371/journal.pone.0128776	http://dx.doi.org/10.1371/journal.pone.0128776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030824	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900190
J	Elshazly, MO; Abd El-Rahman, SS; Morgan, AM; Ali, ME				Elshazly, M. O.; Abd El-Rahman, Sahar S.; Morgan, Ashraf M.; Ali, Merhan E.			The Remedial Efficacy of Spirulina platensis versus Chromium-Induced Nephrotoxicity in Male Sprague-Dawley Rats	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; RENAL INJURY; B6C3F1 MICE; F344 RATS; PROTECTS; DAMAGE; LEAD; PHYCOCYANIN; TISSUES; BRAIN	This study was conducted to investigate the possible protective effect of Spirulina platensis against chromium-induced nephrotoxicity. A total of 36 adult male Sprague-Dawley rats were divided into 4 equal groups (Gps). Gp1 served as control, rats of Gps 2, 3, and 4 were exposed to Spirulina platensis (300 mg/kg b.wt per os) and sodium dichromate dihydrate (SDD) via drinking water at concentration of 520 mg/l respectively. Chromium administration caused alterations in the renal function markers as evidenced by significant increase of blood urea and creatinine levels accompanied with significant increase in kidney's chromium residues and MDA level as well as decreased catalase activity and glutathion content in kidney tissue. Histologically, Cr provoked deleterious changes including: vascular congestion, wide spread tubular epithelium necrobiotic changes, atrophy of glomerular tuft and proliferative hyperplasia. The latter was accompanied with positive PCNA expression in kidney tissues as well as DNA ploidy interpretation of major cellular population of degenerated cells, appearance of tetraploid cells, high proliferation index and high DNA index. Morphometrical measurements revealed marked glomerular and tubular lumen alterations. On contrary, spirulina co-treatment with Cr significantly restored the histopathological changes, antioxidants and renal function markers and all the previously mentioned changes as well.	[Elshazly, M. O.; Abd El-Rahman, Sahar S.; Ali, Merhan E.] Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt; [Morgan, Ashraf M.] Cairo Univ, Fac Vet Med, Dept Toxicol & Forens Med, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Abd El-Rahman, SS (corresponding author), Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt.	saharsamirmah@cu.edu.eg	El-Rahman, Sahar S. Abd/A-1443-2016	Abd El-Rahman, Sahar S/0000-0001-8638-1737				Abdel-Rahman G. H., 2012, Global Veterinaria, V9, P225; Aebi H, 1984, Methods Enzymol, V105, P121; Agency for Toxic Substances and Disease Registry (ATSDR), 1998, TOX PROF CHROM; Arreola-Mendoza L, 2006, TOXICOLOGY, V218, P237, DOI 10.1016/j.tox.2005.11.010; Avdagic N, 2008, BOSNIAN J BASIC MED, V8, P331, DOI 10.17305/bjbms.2008.2892; BAGCHI D, 1995, COMP BIOCHEM PHYS C, V110, P177, DOI 10.1016/0742-8413(94)00093-P; Bagchi D, 2002, TOXICOLOGY, V175, P73, DOI 10.1016/S0300-483X(02)00062-8; Bancroft J.D., 2008, THEORY PRACTICE HIST; Banji D, 2013, FOOD CHEM, V140, P321, DOI 10.1016/j.foodchem.2013.02.076; Barrera D, 2003, LIFE SCI, V73, P3027, DOI 10.1016/j.lfs.2003.06.002; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; COULOMBE JJ, 1963, CLIN CHEM, V9, P102; Department for Environment Food and Rural Affairs (DEFRA) and Environment Agency (EA), 2002, CHROM R D PUBL TOX 4, V4; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; El-Desoky GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059177; Eldridge SR, 1996, FUND APPL TOXICOL, V32, P159, DOI 10.1006/faat.1996.0119; Estrada JEP, 2001, FARMACO, V56, P497; European Chemicals Bureau (ECB) European Union Risk Assessment Report, 2005, 201508 EUR EN ECB; EVM (Expert Group on Vitamins and Minerals), 2003, SAF UPP LEV VIT MIN; Farooq SM, 2004, CLIN CHIM ACTA, V348, P199, DOI 10.1016/j.cccn.2004.05.016; Farooq SM, 2004, CHEM-BIOL INTERACT, V149, P1, DOI 10.1016/j.cbi.2004.05.006; Fatima S, 2007, CLIN CHIM ACTA, V386, P94, DOI 10.1016/j.cca.2007.08.006; Gargouri M, 2012, FOOD CHEM TOXICOL, V50, P2303, DOI 10.1016/j.fct.2012.04.003; International Programme on Chemical Safety (IPCS), 2006, IN CHROM 6 IN PRESS; Karadeniz A, 2008, PHYTOTHER RES, V22, P1506, DOI 10.1002/ptr.2522; Khan M, 2006, J APPL TOXICOL, V26, P444, DOI 10.1002/jat.1159; Khan MR, 2010, CHEM-BIOL INTERACT, V186, P228, DOI 10.1016/j.cbi.2010.04.025; Khan Z, 2005, CURR PHARM BIOTECHNO, V6, P373, DOI 10.2174/138920105774370607; Kumar Dey S., 2009, IRAN J TOXICOL, V2, P260, DOI DOI 10.1093/JICRU/NDP032; LARSEN K, 1972, CLIN CHIM ACTA, V38, P475, DOI 10.1016/0009-8981(72)90146-5; Lee Stephen, 1994, P261; Lu J, 2010, BRIT J NUTR, V103, P1573, DOI 10.1017/S0007114509993758; Mohamed MA, 2013, PLOS ONE; Molina-Jijon E, 2012, TOXICOLOGY, V291, P93, DOI 10.1016/j.tox.2011.11.003; Ozaki K, 2001, TOXICOL PATHOL, V29, P440, DOI 10.1080/01926230152499791; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P619, DOI 10.1016/j.fct.2007.09.088; Sabina E., 2009, International Journal of Integrative Biology, V6, P1; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; Simsek N, 2009, J HAZARD MATER, V164, P1304, DOI 10.1016/j.jhazmat.2008.09.041; Soudani N, 2011, HUM EXP TOXICOL, V30, P1233, DOI 10.1177/0960327110387454; Soudani N, 2010, ECOTOX ENVIRON SAFE, V73, P671, DOI 10.1016/j.ecoenv.2009.10.002; Stivala LA, 1996, CARCINOGENESIS, V17, P2395, DOI 10.1093/carcin/17.11.2395; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Thompson CM, 2012, TOXICOL SCI, V125, P79, DOI 10.1093/toxsci/kfr280; Upasani CD, 2003, PHYTOTHER RES, V17, P330, DOI 10.1002/ptr.1135; Wang Y, 2011, BD BIOSIENCES    JUL; Yam-Canul P, 2008, FOOD CHEM TOXICOL, V46, P1089, DOI 10.1016/j.fct.2007.11.003	47	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126780	10.1371/journal.pone.0126780	http://dx.doi.org/10.1371/journal.pone.0126780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029926	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900032
J	Kleckner, AS; Wong, S; Corkey, BE				Kleckner, Amber S.; Wong, Siu; Corkey, Barbara E.			The Intra- or Extracellular Redox State Was Not Affected by a High vs. Low Glycemic Response Diet in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; ENERGY-EXPENDITURE; REDUCES ADIPOSITY; OXIDATIVE STRESS; STARCH PROMOTES; FAT OXIDATION; GLUCOSE; INDEX; FOOD; METABOLISM	A low glycemic response (LGR) vs. high glycemic response (HGR) diet helps curtail the development of obesity and diabetes, though the mechanisms are unknown. We hypothesized that consumption of a HGR vs. a LGR diet would lead to a more oxidized circulating redox state and predicted that a HGR diet would increase fat accumulation, reduce insulin sensitivity, and impair metabolic acclimation to a high fat diet in a mouse model. Hence, male C57BL/6 mice consumed a HGR or LGR diet for 16 weeks and a subset of the mice subsequently consumed a high fat diet for 4 weeks. We found that body mass increased at a faster rate for those consuming the HGR diet. Percent body fat was greater and percent lean mass was lesser in the HGR group starting at 12 weeks. However, the groups did not differ in terms of glucose tolerance at week 14 and metabolic parameters (respiratory exchange ratio, heat production, activity) at weeks 4 or 15. Moreover, mice on either diet did not show differences in metabolic acclimation to the high fat leg of the study. At the termination of the study, the groups did not differ in terms of redox pairs (lactate/pyruvate and beta-hydroxybutyrate/acetoacetate) or thioredoxin reductase activity in blood. Also, total and oxidized glutathione levels and lipid peroxidation were similar in blood and liver. Correlations between baseline measures, longitudinal parameters, environmental conditions, and terminal metrics revealed that individual mice have innate propensities to metabolic regulation that may be difficult to perturb with diet alone; for example, starting mass correlated negatively with energy expenditure 4 weeks into the study and total hepatic glutathione at the end of the study. In conclusion, these data suggest that the mechanism by which HGR carbohydrates contributes to obesity is not via prolonged oxidation of the circulating redox state.	[Kleckner, Amber S.; Wong, Siu; Corkey, Barbara E.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Corkey, BE (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	bcorkey@bu.edumailto			United States Department of Agriculture (USDA) Agriculture Food and Research Initiative (AFRI) - National Institute of Food and Agriculture (NIFA) postdoctoral fellowship [2012-67012-20658]; NIH [R01-DK56690]	United States Department of Agriculture (USDA) Agriculture Food and Research Initiative (AFRI) - National Institute of Food and Agriculture (NIFA) postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States Department of Agriculture (USDA) Agriculture Food and Research Initiative (AFRI) - National Institute of Food and Agriculture (NIFA) postdoctoral fellowship to ASK (2012-67012-20658, http://www.nifa.usda.gov/funding/rfas/afri.html) and NIH R01-DK56690 to BEC (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller EEJG, 2011, NUTRIENTS, V3, P341, DOI 10.3390/nu3030341; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Aziz AA, 2009, J NUTR, V139, P1881, DOI 10.3945/jn.109.110650; Belobrajdic DP, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-93; BRAND JC, 1985, AM J CLIN NUTR, V42, P1192, DOI 10.1093/ajcn/42.6.1192; Brand-Miller J, 2012, CURR OPIN LIPIDOL, V23, P62, DOI 10.1097/MOL.0b013e32834ec705; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BYRNES SE, 1995, J NUTR, V125, P1430; Chaabo F, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-29; Coate KC, 2010, NUTR RES, V30, P141, DOI 10.1016/j.nutres.2010.01.003; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Corkey BE, 2012, TRENDS ENDOCRIN MET, V23, P594, DOI 10.1016/j.tem.2012.07.006; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; DOLHOFER R, 1980, DIABETES, V29, P417, DOI 10.2337/diabetes.29.6.417; Dowse Harold B, 2013, J Circadian Rhythms, V11, P6, DOI 10.1186/1740-3391-11-6; Du D, 2010, EUR FOOD RES TECHNOL, V230, P935, DOI 10.1007/s00217-010-1240-8; ENGELGAU MM, 1995, DIABETES CARE, V18, P463, DOI 10.2337/diacare.18.4.463; Even PC, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00096; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Gromer S, 2002, METHOD ENZYMOL, V347, P382; Heinrichs SC, 2001, BEHAV BRAIN RES, V125, P81, DOI 10.1016/S0166-4328(01)00287-X; Higgins Janine A, 2004, Nutr Metab (Lond), V1, P8, DOI 10.1186/1743-7075-1-8; Isken F, 2010, AM J PHYSIOL-ENDOC M, V298, pE287, DOI 10.1152/ajpendo.00515.2009; Isken F, 2009, DIABETOLOGIA, V52, P2159, DOI 10.1007/s00125-009-1466-9; Islam A, 2012, OBESITY, V20, P349, DOI 10.1038/oby.2011.341; Johnston CA, 2013, AM J LIFESTYLE MED, V7, P115, DOI 10.1177/1559827612469762; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Keenan MJ, 2011, IFT PRESS SER, P79; Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402; LererMetzger M, 1996, BRIT J NUTR, V75, P723, DOI 10.1079/BJN19960176; Ludwig DS, 2000, J NUTR, V130, p280S, DOI 10.1093/jn/130.2.280S; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.005; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Pawlak DB, 2001, J NUTR, V131, P99, DOI 10.1093/jn/131.1.99; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Scribner KB, 2008, AM J PHYSIOL-ENDOC M, V295, pE1126, DOI 10.1152/ajpendo.90487.2008; Scribner KB, 2007, OBESITY, V15, P2190, DOI 10.1038/oby.2007.260; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; van Schothorst EM, 2009, FASEB J, V23, P1092, DOI 10.1096/fj.08-117119; Walker CG, 2002, HORM METAB RES, V34, P176, DOI 10.1055/s-2002-26707; Williamson J.R., 1969, METHOD ENZYMOL, V13, P434, DOI 10.1016/0076-687913072-4; Zhang L, 2011, PROTOC EXCH, P1; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10	51	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128380	10.1371/journal.pone.0128380	http://dx.doi.org/10.1371/journal.pone.0128380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030878	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900142
J	Lima, CT; Silva, JCD; Viegas, KAD; Oliveira, TCD; de Lima, RS; de Souza, LE; Aragao, D; Casarini, DE; Irigoyen, MC; Lacchini, S				Lima, Cintia Taniguti; de Souza Silva, Juliane Cristina; da Silva Viegas, Katia Aparecida; de Souza Oliveira, Thais Cristina; de Lima, Rariane Silva; de Souza, Leandro Ezequiel; Aragao, Danielle; Casarini, Dulce Elena; Irigoyen, Maria Claudia; Lacchini, Silvia			Increase in Vascular Injury of Sodium Overloaded Mice May be Related to Vascular Angiotensin Modulation	PLOS ONE			English	Article							HIGH-SALT DIET; CAROTID-ARTERY; CONVERTING-ENZYME; MECHANICAL-PROPERTIES; ATHEROSCLEROSIS; HYPERTENSION; RENIN; INFLAMMATION; INDUCTION; NEOINTIMA	This study aimed to analyzing the effect of chronic sodium overload upon carotid and femoral injury, and its relation to vascular angiotensin modulation. Male C57Bl6 mice were divided in: control (cont), receiving 1% NaCl solution for 2 weeks (salt-2) or 12 weeks (salt-12). Two-weeks before the end of the study, a 2mm catheter was implanted around the left femoral and carotid arteries to induce injury. Blood pressure (BP) and heart rate (HR) were measured at the end of the study by tail plethysmography. Arteries were collected and prepared for histological analysis to determine arterial thickening and perivascular collagen deposition. Angiotensin II and Ang(1-7) were quantified in fresh arteries using the HPLC method. There were no differences in body weight, BP and HR. Intima/media ratio had a similar increase in both injured arteries of cont and salt-2 mice, but a more pronounced increase was observed in salt-12 mice (31.1 +/- 6%). On the other hand, sodium overload modified perivascular collagen deposition, increasing thick fibers (cont: 0.5%; salt-2: 3.4%; salt-12: 0.6%) and decreasing thin fibers (cont: 7.4%; salt-2: 0.5%; salt-12: 6.8%) in non-injured arteries. Injured arteries presented similar collagen fiber distribution. Angiotensin quantification showed increased Ang(1-7) in salt treated mice (salt-2: +72%; salt-12: +45%) with a concomitant decrease in Ang II (salt-2: -54%; salt-12: -60%). Vascular injury increased significantly Ang(1-7) in salt-12 mice (+80%), maintaining Ang II reduction similar to that of a non-injured artery. The lack of changes in BP and HR suggests that the structural changes observed may be due to non-hemodynamic mechanisms such as local renin-angiotensin system. Collagen evaluation suggests that sodium overload induces time-related changes in vascular remodeling. The increase of artery injury with concomitant increase in Ang(1-7) in 12-week treated mice shows a direct association between the duration of salt treatment and the magnitude of vascular injury.	[Lima, Cintia Taniguti; de Souza Silva, Juliane Cristina; da Silva Viegas, Katia Aparecida; de Souza Oliveira, Thais Cristina; de Lima, Rariane Silva; Lacchini, Silvia] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, SP, Brazil; [de Souza, Leandro Ezequiel; Irigoyen, Maria Claudia] Univ Sao Paulo, Sch Med, Inst Heart, Hypertens Unit, Sao Paulo, SP, Brazil; [Aragao, Danielle; Casarini, Dulce Elena] Univ Fed Sao Paulo, Dept Med, Div Nephrol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Lacchini, S (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, SP, Brazil.	lacchini@icb.usp.br	Lacchini, Silvia/H-8592-2014; de Souza Oliveira, Thais/GXN-3513-2022; Viegas, Katia Aparecida da Silva/H-3290-2018; IRIGOYEN, MARIA CLAUDIA C/N-6880-2014; Casarini, Dulce E/D-4091-2012	Lacchini, Silvia/0000-0002-7937-8473; Viegas, Katia Aparecida da Silva/0000-0003-3077-478X; IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662; Casarini, Dulce/0000-0003-1912-4292	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo's state research funding agency Foundationof Support to Research of Sao Paulo State (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP) [2009/19653-6, 2008/56192-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo's state research funding agency Foundationof Support to Research of Sao Paulo State (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo's state research funding agency Foundation of Support to Research of Sao Paulo State (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, process no 2009/19653-6 and 2008/56192-7).	Ahn J, 2004, AM J PHYSIOL-HEART C, V287, pH767, DOI 10.1152/ajpheart.00047.2004; Almeida WS, 2006, KIDNEY INT, V69, P974, DOI 10.1038/sj.ki.5000134; BOOTH RFG, 1989, ATHEROSCLEROSIS, V76, P257, DOI 10.1016/0021-9150(89)90109-3; Chandramohan G, 2008, AM J NEPHROL, V28, P158, DOI 10.1159/000110021; de Resende MM, 2007, CLIN EXP PHARMACOL P, V34, P274, DOI 10.1111/j.1440-1681.2007.04556.x; FernandezAlfonso MS, 1997, HYPERTENSION, V30, P272, DOI 10.1161/01.HYP.30.2.272; Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Frisoli TM, 2012, AM J MED, V125, P433, DOI 10.1016/j.amjmed.2011.10.023; Fukuhara M, 2000, HYPERTENSION, V35, P353, DOI 10.1161/01.HYP.35.1.353; Johansson ME, 2009, J HYPERTENS, V27, P41, DOI 10.1097/HJH.0b013e328318697b; KOCKX MM, 1993, ARTERIOSCLER THROMB, V13, P1874, DOI 10.1161/01.ATV.13.12.1874; Kyotani Y, 2010, J PHARMACOL SCI, V113, P161, DOI 10.1254/jphs.09332FP; Labat C, 2001, HYPERTENSION, V38, P439, DOI 10.1161/01.HYP.38.3.439; Lacchini S, 2001, HYPERTENSION, V38, P326, DOI 10.1161/hy0901.091179; Lacchini S, 2009, PHYSIOL GENOMICS, V37, P225, DOI 10.1152/physiolgenomics.90288.2008; Larrousse M, 2006, AM J HYPERTENS, V19, P87, DOI 10.1016/j.amjhyper.2005.06.019; Levy BI, 1997, J HYPERTENS, V15, P251, DOI 10.1097/00004872-199715030-00006; LIMAS C, 1980, HYPERTENSION, V2, P477, DOI 10.1161/01.HYP.2.4.477; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mercier N, 2007, AM J HYPERTENS, V20, P319, DOI 10.1016/j.amjhyper.2006.09.002; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; Partovian C, 1998, AM J PHYSIOL-HEART C, V274, pH1423, DOI 10.1152/ajpheart.1998.274.5.H1423; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF749, DOI 10.1152/ajprenal.00383.2009; Raff U, 2012, ATHEROSCLEROSIS, V222, P235, DOI 10.1016/j.atherosclerosis.2012.02.006; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Ribichini F, 2000, CIRCULATION, V101, pE33; Roks AJM, 2004, J HYPERTENS, V22, P2355, DOI 10.1097/00004872-200412000-00018; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruiz-Ortega M, 2001, HYPERTENSION, V38, P1382, DOI 10.1161/hy1201.100589; Safar ME, 2003, AM J HYPERTENS, V16, P249, DOI 10.1016/S0895-7061(02)03259-4; Susic D, 2012, CURR OPIN LIPIDOL, V23, P11, DOI 10.1097/MOL.0b013e32834d9c52; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Takeda R, 2008, AM J PHYSIOL-HEART C, V294, pH2871, DOI 10.1152/ajpheart.00031.2008; Takeda Y, 2000, ENDOCRINOLOGY, V141, P1901, DOI 10.1210/en.141.5.1901; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; Varagic J, 2008, AM J PHYSIOL-HEART C, V294, pH853, DOI 10.1152/ajpheart.00737.2007; Varagic Jasmina, 2010, Ther Adv Cardiovasc Dis, V4, P17, DOI 10.1177/1753944709353337; Yilmaz R, 2012, EUR J CLIN NUTR, V66, P1214, DOI 10.1038/ejcn.2012.110; YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657	40	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128141	10.1371/journal.pone.0128141	http://dx.doi.org/10.1371/journal.pone.0128141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030299	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900114
J	Peters, CD; Kjaergaard, KD; Jensen, JD; Christensen, KL; Strandhave, C; Tietze, IN; Novosel, MK; Bibby, BM; Jespersen, B				Peters, Christian Daugaard; Kjaergaard, Krista Dybtved; Jensen, Jens Dam; Christensen, Kent Lodberg; Strandhave, Charlotte; Tietze, Ida Noerager; Novosel, Marija Kristina; Bibby, Bo Martin; Jespersen, Bente			Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study)	PLOS ONE			English	Article							HEMODIALYSIS-ASSOCIATED HYPOTENSION; ULTRASOUND DILUTION METHOD; CALCIUM-ION CONCENTRATION; MEASURE CARDIAC-OUTPUT; LOW-FLUX HEMODIALYSIS; BLOOD-VOLUME; MAINTENANCE HEMODIALYSIS; CARDIOVASCULAR EVENTS; PREDILUTION HEMODIAFILTRATION; ARTERIOVENOUS-FISTULA	Background and Aim Little is known about the tolerability of antihypertensive drugs during hemodialysis treatment. The present study evaluated the use of the angiotensin II receptor blocker (ARB) irbesartan. Design Randomized, double-blind, placebo-controlled, one-year intervention trial. Setting and Participants Eighty-two hemodialysis patients with urine output >300 mL/day and dialysis vintage <1 year. Intervention Irbesartan/placebo 300 mg/day for 12 months administered as add-on to antihypertensive treatment using a predialytic systolic blood pressure target of 140 mmHg in all patients. Outcomes and Measurements Cardiac output, stroke volume, central blood volume, total peripheral resistance, mean arterial blood pressure, and frequency of intradialytic hypotension. Results At baseline, the groups were similar regarding age, comorbidity, blood pressure, antihypertensive medication, ultrafiltration volume, and dialysis parameters. Over the one-year period, predialytic systolic blood pressure decreased significantly, but similarly in both groups. Mean start and mean end cardiac output, stroke volume, total peripheral resistance, heart rate, and mean arterial pressure were stable and similar in the two groups, whereas central blood volume increased slightly but similarly over time. The mean hemodynamic response observed during a dialysis session was a drop in cardiac output, in stroke volume, in mean arterial pressure, and in central blood volume, whereas heart rate increased. Total peripheral resistance did not change significantly. Overall, this pattern remained stable over time in both groups and was uninfluenced by ARB treatment. The total number of intradialytic hypotensive episodes was (placebo/ARB) 50/63 (P = 0.4). Ultrafiltration volume, left ventricular mass index, plasma albumin, and change in intradialytic total peripheral resistance were significantly associated with intradialytic hypotension in a multivariate logistic regression analysis based on baseline parameters. Conclusion Use of the ARB irbesartan as an add-on to other antihypertensive therapy did not significantly affect intradialytic hemodynamics, neither in short nor long-term, and no significant increase in hypotensive episodes was seen.	[Peters, Christian Daugaard; Kjaergaard, Krista Dybtved; Jensen, Jens Dam; Jespersen, Bente] Aarhus Univ Hosp, Dept Renal Med, DK-8000 Aarhus, Denmark; [Peters, Christian Daugaard; Kjaergaard, Krista Dybtved; Jensen, Jens Dam; Jespersen, Bente] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Christensen, Kent Lodberg] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Strandhave, Charlotte] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Tietze, Ida Noerager] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Novosel, Marija Kristina] Fredericia Cty Hosp, Dept Med, Fredericia, Denmark; [Bibby, Bo Martin] Aarhus Univ, Dept Biostat, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Peters, CD (corresponding author), Aarhus Univ Hosp, Dept Renal Med, DK-8000 Aarhus, Denmark.	cdp@ana.au.dk		Jespersen, Bente/0000-0001-7196-2870; Peters, Christian Daugaard/0000-0002-4917-1535	Danish Council for Independent Research Medical Sciences; Aase og Ejnar Danielsens Fond; Beckett-Fonden; Civilingenior Frode Nygaard og Hustrus Fond; Danish Society of Hypertension; Danish Society of Nephrology; Direktor Kurt Bonnelycke & Hustru Grethe Bonnelyckes Fond; Fabrikant Karl G Andersens Fond; Fausbolls Helsefond; Fonden til udvikling og uddannelse ved Nyremedicinsk Afdeling ved Aarhus Universitetshospital; Fresenius Medical Care Denmark; Frimodt-Heineke Fonden; Helen & Ejnar Bjornows Fond; Institute of Clinical Medicine at Aarhus University; Kirsten Anthonius' Fond; Leo Pharmas Hypertensionslegat; Nyreforeningens Forskningsfond; Overlaege Poul M Christiansen Hustrus Fond; Region Midtjyllands Sundhedsvidenskabelige Forskningsfond; Snedkermester Sophus Jacobsen and Hustru Astrid Jacobsens Fond; Sanofi Denmark	Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Aase og Ejnar Danielsens Fond; Beckett-Fonden; Civilingenior Frode Nygaard og Hustrus Fond; Danish Society of Hypertension; Danish Society of Nephrology; Direktor Kurt Bonnelycke & Hustru Grethe Bonnelyckes Fond; Fabrikant Karl G Andersens Fond; Fausbolls Helsefond; Fonden til udvikling og uddannelse ved Nyremedicinsk Afdeling ved Aarhus Universitetshospital; Fresenius Medical Care Denmark; Frimodt-Heineke Fonden; Helen & Ejnar Bjornows Fond; Institute of Clinical Medicine at Aarhus University; Kirsten Anthonius' Fond; Leo Pharmas Hypertensionslegat(LEO Pharma); Nyreforeningens Forskningsfond; Overlaege Poul M Christiansen Hustrus Fond; Region Midtjyllands Sundhedsvidenskabelige Forskningsfond; Snedkermester Sophus Jacobsen and Hustru Astrid Jacobsens Fond; Sanofi Denmark(Sanofi-Aventis)	The SAFIR study was primarily supported by The Danish Council for Independent Research Medical Sciences, but also by (in alphabetical order): Aase og Ejnar Danielsens Fond, Beckett-Fonden, Civilingenior Frode Nygaard og Hustrus Fond, The Danish Society of Hypertension, The Danish Society of Nephrology, Direktor Kurt Bonnelycke & Hustru Grethe Bonnelyckes Fond, Fabrikant Karl G Andersens Fond, Fausbolls Helsefond, Fonden til udvikling og uddannelse ved Nyremedicinsk Afdeling ved Aarhus Universitetshospital, Fresenius Medical Care Denmark, Frimodt-Heineke Fonden, Helen & Ejnar Bjornows Fond, The Institute of Clinical Medicine at Aarhus University, Kirsten Anthonius' Fond, Leo Pharmas Hypertensionslegat, Nyreforeningens Forskningsfond, Overlaege Poul M Christiansen & Hustrus Fond, Region Midtjyllands Sundhedsvidenskabelige Forskningsfond, Snedkermester Sophus Jacobsen and Hustru Astrid Jacobsens Fond. Sanofi Denmark provided original study medication (placebo and active tablets) free of charge and financially supported some meeting activity. NorDiaTech Denmark provided one Transonic Flow-QC Hemodialysis Monitor for three years including yearly calibration. The funders including Sanofi Denmark and NorDiaTech Denmark had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Agarwal R, 2014, NEPHROL DIAL TRANSPL, V29, P672, DOI 10.1093/ndt/gft515; Al-Muhanna FA, 1999, E AFR MED J, V76, P664; BARAKAT MM, 1993, J AM SOC NEPHROL, V3, P1813; Barth C, 2003, NEPHROL DIAL TRANSPL, V18, P1353, DOI 10.1093/ndt/gfg171; Basile C, 2008, NEPHROL DIAL TRANSPL, V23, P282, DOI 10.1093/ndt/gfm549; Beerenhout C, 2004, NEPHROL DIAL TRANSPL, V19, P2354, DOI 10.1093/ndt/gfh315; Brewster UC, 2004, AM J MED, V116, P263, DOI 10.1016/j.amjmed.2003.09.034; Cice G, 2010, J AM COLL CARDIOL, V56, P1701, DOI 10.1016/j.jacc.2010.03.105; CIVATI G, 1991, NEPHROL DIAL TRANSPL, V6, P75; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dasselaar JJ, 2009, NEPHROL DIAL TRANSPL, V24, P604, DOI 10.1093/ndt/gfn501; Daugirdas JT, 2013, AM J KIDNEY DIS, V61, P861, DOI 10.1053/j.ajkd.2013.03.004; DAUGIRDAS JT, 1991, KIDNEY INT, V39, P233, DOI 10.1038/ki.1991.28; Daugirdas JT, 2001, AM J KIDNEY DIS, V38, pS11, DOI 10.1053/ajkd.2001.28090; Davenport A, 2008, KIDNEY INT, V73, P759, DOI 10.1038/sj.ki.5002745; Davenport A, 2008, NEPHRON CLIN PRACT, V109, pC65, DOI 10.1159/000139991; Gabrielli D, 2009, J NEPHROL, V22, P232; Henderson LW, 2012, SEMIN DIALYSIS, V25, P320, DOI 10.1111/j.1525-139X.2012.01068.x; Hung SY, 2004, BLOOD PURIFICAT, V22, P338, DOI 10.1159/000079188; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Iseki K, 2013, NEPHROL DIAL TRANSPL, V28, P1579, DOI 10.1093/ndt/gfs590; Karamperis N, 2007, CLIN NEPHROL, V67, P230; Karamperis N, 2005, KIDNEY INT, V67, P1601, DOI 10.1111/j.1523-1755.2005.00242.x; Karamperis N, 2005, AM J KIDNEY DIS, V46, P470, DOI 10.1053/j.ajkd.2005.05.022; Kisloukhine VV, 1996, ASAIO J, V42, pM906, DOI 10.1097/00002480-199609000-00125; Kjaergaard KD, 2014, AM J KIDNEY DIS, V64, P892, DOI 10.1053/j.ajkd.2014.05.011; Knoll GA, 2002, AM J MED, V112, P110, DOI 10.1016/S0002-9343(01)01068-3; Kooman J, 2007, NEPHROL DIAL TRANSPL, V22, P22, DOI 10.1093/ndt/gfm019; Korsheed S, 2011, NEPHROL DIAL TRANSPL, V26, P3296, DOI 10.1093/ndt/gfq851; Krivitski NM, 1999, ADV RENAL REPLACE TH, V6, P225, DOI 10.1016/S1073-4449(99)70018-X; KRIVITSKI NM, 1995, ASAIO J, V41, pM741, DOI 10.1097/00002480-199507000-00111; Leidig M, 2008, CLIN NEPHROL, V69, P425; Man in 't Veld AJ, 1980, BRIT MED J, V280, P288; Marino MR, 1998, J CLIN PHARMACOL, V38, P246, DOI 10.1002/j.1552-4604.1998.tb04422.x; McIntyre CW, 2008, CLIN J AM SOC NEPHRO, V3, P19, DOI 10.2215/CJN.03170707; Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; MOSER M, 1988, BASIC RES CARDIOL, V83, P577, DOI 10.1007/BF01906951; Nikiforov YV, 1996, ASAIO J, V42, pM903, DOI 10.1097/00002480-199609000-00124; Peters CD, 2014, KIDNEY INT, V86, P625, DOI 10.1038/ki.2014.69; Peters Christian Daugaard, 2013, Dan Med J, V60, pA4602; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Sands JJ, 2014, HEMODIAL INT, V18, P415, DOI 10.1111/hdi.12138; Santoro Antonio, 2006, Hemodial Int, V10 Suppl 1, pS51, DOI 10.1111/j.1542-4758.2006.01192.x; Sherman R A, 1990, ASAIO Trans, V36, P67, DOI 10.1097/00002480-199004000-00005; Shoji T, 2004, KIDNEY INT, V66, P1212, DOI 10.1111/j.1523-1755.2004.00812.x; Sica DA, 1997, CLIN PHARMACOL THER, V62, P610, DOI 10.1016/S0009-9236(97)90080-1; Suzuki H, 2008, AM J KIDNEY DIS, V52, P501, DOI 10.1053/j.ajkd.2008.04.031; Tai DJ, 2010, CLIN J AM SOC NEPHRO, V5, P623, DOI 10.2215/CJN.07831109; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Tisler A, 2002, KIDNEY BLOOD PRESS R, V25, P97, DOI 10.1159/000063515; Toyoda K, 2005, AM J KIDNEY DIS, V45, P1058, DOI 10.1053/j.ajkd.2005.02.028; Tsutsui M, 2009, J CARDIOTHOR VASC AN, V23, P835, DOI 10.1053/j.jvca.2009.03.007; van der Sande FM, 2000, AM J KIDNEY DIS, V35, DOI 10.1016/S0272-6386(00)70284-8; van der Sande FM, 1998, AM J KIDNEY DIS, V32, P125, DOI 10.1053/ajkd.1998.v32.pm9669433; vanKuijk WHM, 1996, NEPHROL DIAL TRANSPL, V11, P323, DOI 10.1093/oxfordjournals.ndt.a027261; Yang LY, 2013, AM J MED SCI, V345, P1, DOI 10.1097/MAJ.0b013e318249d387; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657	58	5	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126882	10.1371/journal.pone.0126882	http://dx.doi.org/10.1371/journal.pone.0126882			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030651	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900036
J	Scoditti, E; Massaro, M; Carluccio, MA; Pellegrino, M; Wabitsch, M; Calabriso, N; Storelli, C; De Caterina, R				Scoditti, Egeria; Massaro, Marika; Carluccio, Maria Annunziata; Pellegrino, Mariangela; Wabitsch, Martin; Calabriso, Nadia; Storelli, Carlo; De Caterina, Raffaele			Additive Regulation of Adiponectin Expression by the Mediterranean Diet Olive Oil Components Oleic Acid and Hydroxytyrosol in Human Adipocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; N-TERMINAL KINASE; FREE FATTY-ACIDS; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPOSE-TISSUE; OBESITY; LEPTIN; DIFFERENTIATION; CELLS	Adiponectin, an adipocyte-derived insulin-sensitizing and anti-inflammatory hormone, is suppressed in obesity through mechanisms involving chronic inflammation and oxidative stress. Olive oil consumption is associated with beneficial cardiometabolic actions, with possible contributions from the antioxidant phenol hydroxytyrosol (HT) and the monounsaturated fatty acid oleic acid (OA, 18:1n-9 cis), both possessing anti-inflammatory and vasculo-protective properties. We determined the effects of HT and OA, alone and in combination, on adiponectin expression in human and murine adipocytes under pro-inflammatory conditions induced by the cytokine tumor necrosis factor(TNF)-alpha. We used human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes and murine 3T3-L1 adipocytes as cell model systems, and pretreated them with 1-100 mu mol/L OA, 0.1-20 mu mol/L HT or OA plus HT combination before stimulation with 10 ng/mL TNF-alpha. OA or HT significantly (P<0.05) prevented TNF-alpha-induced suppression of total adiponectin secretion (by 42% compared with TNF-alpha alone) as well as mRNA levels (by 30% compared with TNF-alpha alone). HT and OA also prevented-by 35%-TNF-alpha-induced downregulation of peroxisome proliferator-activated receptor PPAR gamma. Co-treatment with HT and OA restored adiponectin and PPAR gamma expression in an additive manner compared with single treatments. Exploring the activation of JNK, which is crucial for both adiponectin and PPAR gamma suppression by TNF-alpha, we found that HT and OA additively attenuated TNF-alpha-stimulated JNK phosphorylation (up to 55% inhibition). In conclusion, the virgin olive oil components OA and HT, at nutritionally relevant concentrations, have additive effects in preventing adiponectin downregulation in inflamed adipocytes through an attenuation of JNK-mediated PPAR gamma suppression.	[Scoditti, Egeria; Massaro, Marika; Carluccio, Maria Annunziata; Calabriso, Nadia] Natl Res Council CNR, Inst Clin Physiol, Lecce, Italy; [Pellegrino, Mariangela; Storelli, Carlo] Univ Salento, Dept Biol & Environm Sci & Technol DISTEBA, Lecce, Italy; [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol Diabet & Obes, D-89069 Ulm, Germany; [De Caterina, Raffaele] Univ G DAnnunzio, Chieti, Italy; [De Caterina, Raffaele] Ctr Excellence Aging, Chieti, Italy; [De Caterina, Raffaele] G Monasterio Fdn Clin Res, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Salento; Ulm University; G d'Annunzio University of Chieti-Pescara	De Caterina, R (corresponding author), Univ G DAnnunzio, Chieti, Italy.	rdecater@unich.it	De Caterina, Raffaele/K-3857-2016; massaro, marika/AAQ-1204-2020; Carluccio, Maria Annunziata/AAO-1683-2020; SCODITTI, EGERIA/J-8609-2016	De Caterina, Raffaele/0000-0003-1637-574X; massaro, marika/0000-0001-6124-5077; CARLUCCIO, MARIA ANNUNZIATA/0000-0002-8307-1829; Calabriso, Nadia/0000-0003-0726-2081; SCODITTI, EGERIA/0000-0003-2753-8487	CNR Institute of Clinical Physiology, Pisa, Italy; Apulian Region POR Strategic Projects [CIP PS_101, CIP PS_008]; National Operational Program for Research and Competitiveness [PON01_01958]	CNR Institute of Clinical Physiology, Pisa, Italy; Apulian Region POR Strategic Projects; National Operational Program for Research and Competitiveness	This work was supported by grants from the CNR Institute of Clinical Physiology, Pisa, Italy (Junior Grant 2009 to E. Scoditti), the Apulian Region POR Strategic Projects (CIP PS_101, CIP PS_008), and the National Operational Program for Research and Competitiveness 2007-2013 (PON01_01958, PIVOLIO project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Cammisotto PG, 2003, AM J PHYSIOL-ENDOC M, V285, pE521, DOI 10.1152/ajpendo.00052.2003; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Cao K, 2014, FREE RADICAL BIO MED, V67, P396, DOI 10.1016/j.freeradbiomed.2013.11.029; Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003; Carluccioll MA, 2007, MOL NUTR FOOD RES, V51, P1225, DOI 10.1002/mnfr.200600305; Chuang CC, 2010, AM J CLIN NUTR, V92, P1511, DOI 10.3945/ajcn.2010.29807; Covas MI, 2006, FREE RADICAL BIO MED, V40, P608, DOI 10.1016/j.freeradbiomed.2005.09.027; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Bock M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057622; Drira R, 2011, LIFE SCI, V89, P708, DOI 10.1016/j.lfs.2011.08.012; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fawcett RL, 2000, J CLIN ENDOCR METAB, V85, P530, DOI 10.1210/jc.85.2.530; Fragopoulou E, 2010, J NUTR BIOCHEM, V21, P285, DOI 10.1016/j.jnutbio.2008.12.013; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Giordano E, 2014, NUTR METAB CARDIOVAS, V24, P1144, DOI 10.1016/j.numecd.2014.05.003; Granados N, 2011, BRIT J NUTR, V105, P1226, DOI 10.1017/S0007114510004885; Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Incani A, 2010, MOL NUTR FOOD RES, V54, P788, DOI 10.1002/mnfr.200900098; Ito M, 2011, J LIPID RES, V52, P1450, DOI 10.1194/jlr.M012427; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kappelle PJWH, 2012, EUR J INTERN MED, V23, P755, DOI 10.1016/j.ejim.2012.06.013; Kawano Jordan, 2009, J Cardiometab Syndr, V4, P44, DOI 10.1111/j.1559-4572.2008.00030.x; Kim K, 2005, BIOCHEM BIOPH RES CO, V327, P460, DOI 10.1016/j.bbrc.2004.12.026; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Lasa A, 2014, EUR J CLIN NUTR, V68, P767, DOI 10.1038/ejcn.2014.1; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Madonna R, 2011, VASC PHARMACOL, V54, P75, DOI 10.1016/j.vph.2011.03.007; Mantzoros CS, 2006, AM J CLIN NUTR, V84, P328; Massaro M, 2002, THROMB HAEMOSTASIS, V88, P335; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Paniagua JA, 2007, DIABETES CARE, V30, P1717, DOI 10.2337/dc06-2220; Perez-Martinez P, 2011, CURR PHARM DESIGN, V17, P769, DOI 10.2174/138161211795428948; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Richard N, 2011, PLANTA MED, V77, P1890, DOI 10.1055/s-0031-1280022; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ruano J, 2007, AM J CLIN NUTR, V86, P341, DOI 10.1093/ajcn/86.2.341; Ryan M, 2000, QJM-MON J ASSOC PHYS, V93, P85, DOI 10.1093/qjmed/93.2.85; Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834; Scoditti E, 2014, VASC PHARMACOL, V63, P127, DOI 10.1016/j.vph.2014.07.001; Scoditti E, 2014, ATHEROSCLEROSIS, V232, P17, DOI 10.1016/j.atherosclerosis.2013.10.017; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Shin DW, 2009, BIOCHEM PHARMACOL, V77, P125, DOI 10.1016/j.bcp.2008.09.033; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Tabernero M, 2014, FOOD FUNCT, V5, P1556, DOI 10.1039/c3fo60677e; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; van Dijk SJ, 2009, AM J CLIN NUTR, V90, P1656, DOI 10.3945/ajcn.2009.27792; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Warodomwichit D, 2009, OBESITY, V17, P510, DOI 10.1038/oby.2008.583; Yeung EH, 2010, OBESITY, V18, P1632, DOI 10.1038/oby.2009.402; Zaletel J, 2010, J ENDOCRINOL INVEST, V33, P514, DOI [10.1007/BF03346639, 10.3275/6811]; Zhang HH, 2000, MOL CELL ENDOCRINOL, V159, P79, DOI 10.1016/S0303-7207(99)00194-X	58	43	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128218	10.1371/journal.pone.0128218	http://dx.doi.org/10.1371/journal.pone.0128218			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030149	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900129
J	Takekawa, JY; Ackerman, JT; Brand, LA; Graham, TR; Eagles-Smith, CA; Herzog, MP; Topping, BR; Shellenbarger, GG; Kuwabara, JS; Mruz, E; Piotter, SL; Athearn, ND				Takekawa, John Y.; Ackerman, Joshua T.; Brand, L. Arriana; Graham, Tanya R.; Eagles-Smith, Collin A.; Herzog, Mark P.; Topping, Brent R.; Shellenbarger, Gregory G.; Kuwabara, James S.; Mruz, Eric; Piotter, Sara L.; Athearn, Nicole D.			Unintended Consequences of Management Actions in Salt Pond Restoration: Cascading Effects in Trophic Interactions	PLOS ONE			English	Article							SAN-FRANCISCO BAY; DISSOLVED-OXYGEN; EVAPORATION PONDS; FORSTERS TERNS; MERCURY CONCENTRATIONS; FISH ASSEMBLAGES; FOOD-WEB; SALINITY; CALIFORNIA; WATERBIRDS	Salt evaporation ponds have played an important role as habitat for migratory waterbirds across the world, however, efforts to restore and manage these habitats to maximize their conservation value has proven to be challenging. For example, salinity reduction has been a goal for restoring and managing former salt evaporation ponds to support waterbirds in the South Bay Salt Pond Restoration Project in San Francisco Bay, California, USA. Here, we describe a case study of unexpected consequences of a low-dissolved oxygen (DO) event on trophic interactions in a salt pond system following management actions to reduce salinity concentrations. We document the ramifications of an anoxic event in water quality including salinity, DO, and temperature, and in the response of the biota including prey fish biomass, numerical response by California Gulls (Larus californicus), and chick survival of Forster's Tern (Sterna forsteri). Management actions intended to protect receiving waters resulted in decreased DO concentrations that collapsed to zero for >= 4 consecutive days, resulting in an extensive fish kill. DO depletion likely resulted from an algal bloom that arose following transition of the pond system from high to low salinity as respiration and decomposition outpaced photosynthetic production. We measured a >= 6-fold increase in biomass of fish dropped on the levee by foraging avian predators compared with weeks prior to and following the low-DO event. California Gulls rapidly responded to the availability of aerobically-stressed and vulnerable fish and increased in abundance by two orders of magnitude. Mark-recapture analysis of 254 Forster's Tern chicks indicated that their survival declined substantially following the increase in gull abundance. Thus, management actions to reduce salinity concentrations resulted in cascading effects in trophic interactions that serves as a cautionary tale illustrating the importance of understanding the interaction of water quality and trophic structure when managing restoration of salt ponds.	[Takekawa, John Y.; Brand, L. Arriana; Graham, Tanya R.; Piotter, Sara L.; Athearn, Nicole D.] US Geol Survey, Western Ecol Res Ctr, San Francisco Bay Estuary Field Stn, Vallejo, CA 94592 USA; [Ackerman, Joshua T.; Herzog, Mark P.] US Geol Survey, Western Ecol Res Ctr, Dixon Field Stn, Dixon, CA 95620 USA; [Eagles-Smith, Collin A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97331 USA; [Topping, Brent R.; Kuwabara, James S.] US Geol Survey, Natl Res Program, Menlo Pk, CA 94025 USA; [Shellenbarger, Gregory G.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA 95819 USA; [Mruz, Eric] US Fish & Wildlife Serv, Don Edwards San Francisco Bay Natl Wildlife Refug, Newark, CA 94560 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Takekawa, JY (corresponding author), US Geol Survey, Western Ecol Res Ctr, San Francisco Bay Estuary Field Stn, 505 Azuar Dr, Vallejo, CA 94592 USA.	john_takekawa@usgs.gov	Eagles-Smith, Collin/T-8580-2019; Ackerman, Joshua T./AAF-9503-2019; Eagles-Smith, Collin/AAH-3811-2019	Eagles-Smith, Collin/0000-0003-1329-5285; Ackerman, Josh/0000-0002-3074-8322; Kuwabara, James/0000-0003-2502-1601; Herzog, Mark/0000-0002-5203-2835	South Bay Salt Pond Restoration Project, U.S. Fish and Wildlife [81420-3-H067]; U.S. Geological Survey Priority Ecosystem Science Program; CALFED Ecosystem Restoration Program [114204N203]	South Bay Salt Pond Restoration Project, U.S. Fish and Wildlife; U.S. Geological Survey Priority Ecosystem Science Program; CALFED Ecosystem Restoration Program	Funding was provided by the South Bay Salt Pond Restoration Project, U.S. Fish and Wildlife (Agreement #: 81420-3-H067), U.S. Geological Survey Priority Ecosystem Science Program, and the CALFED Ecosystem Restoration Program (Agreement # 114204N203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman J.T., 2009, CALIFORNIA GULL MOVE; Ackerman JT, 2008, ECOTOXICOLOGY, V17, P789, DOI 10.1007/s10646-008-0237-6; Ackerman JT, 2008, ENVIRON TOXICOL CHEM, V27, P897, DOI 10.1897/07-230.1; Ackerman JT, 2014, J AVIAN BIOL, V45, P609, DOI 10.1111/jav.00385; Ackerman JT, 2014, J WILDLIFE MANAGE, V78, P818, DOI 10.1002/jwmg.728; Ackerman JT, 2011, ENVIRON SCI TECHNOL, V45, P5418, DOI 10.1021/es200647g; Ackerman JT, 2009, CONDOR, V111, P100, DOI 10.1525/cond.2009.080054; [Anonymous], 2008, PROGRAM MARK GENTLE; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Brand LA, 2014, WATERBIRDS, V37, P52, DOI 10.1675/063.037.0108; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARPELAN LH, 1957, ECOLOGY, V38, P375, DOI 10.2307/1929880; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Dzubin A. E., 1992, MEASUREMENTS GEESE G; Fraser G, 1997, COLON WATERBIRD, V20, P87, DOI 10.2307/1521767; HAFNER H, 1993, IBIS, V135, P25, DOI 10.1111/j.1474-919X.1993.tb02806.x; Herbst DB, 2006, WETLANDS, V26, P475, DOI 10.1672/0277-5212(2006)26[475:SCOTIA]2.0.CO;2; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; KUWABARA JS, 1993, ESTUARIES, V16, P567, DOI 10.2307/1352604; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lonzarich DG, 1997, CALIF FISH GAME, V83, P89; Lorenz JJ, 2006, HYDROBIOLOGIA, V569, P401, DOI 10.1007/s10750-006-0145-9; Ma ZJ, 2010, WETLANDS, V30, P15, DOI 10.1007/s13157-009-0001-6; Mejia F, 2008, SOUTHWEST NAT, V53, P335, DOI 10.1894/GG-26.1; MOSS SA, 1970, MAR BIOL, V5, P100, DOI 10.1007/BF00352592; Moyle P.B., 2002, INLAND FISHES CALIFO; Power ME, 2001, OIKOS, V94, P118, DOI 10.1034/j.1600-0706.2001.11317.x; R Development Core Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUR0IMAGE.2011.01.013]; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; Saiki MK, 2009, CALIF FISH GAME, V95, P38; Smith KJ, 2003, MAR ECOL PROG SER, V258, P223, DOI 10.3354/meps258223; Takekawa JY, 2006, HYDROBIOLOGIA, V567, P307, DOI 10.1007/s10750-006-0061-z; Takekawa JY, 2009, HYDROBIOLOGIA, V626, P155, DOI 10.1007/s10750-009-9743-7; Thronson A, 2008, ESTUAR COAST, V31, P802, DOI 10.1007/s12237-008-9056-5; US Fish and Wildlife Service, 2006, R220040018 RWQCB US; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Wagner R.J., 2006, US GEOLOGICAL SURVEY, V1-D3; Warnock N, 2002, WATERBIRDS, V25, P79; White Gary C., 1999, Bird Study, V46, pS120; Workman ML, 2005, SAN FRANCISCO ESTUAR, V5, P1; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	43	10	10	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0119345	10.1371/journal.pone.0119345	http://dx.doi.org/10.1371/journal.pone.0119345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030415	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900003
J	Taroni, P; Quarto, G; Pifferi, A; Abbate, F; Balestreri, N; Menna, S; Cassano, E; Cubeddu, R				Taroni, Paola; Quarto, Giovanna; Pifferi, Antonio; Abbate, Francesca; Balestreri, Nicola; Menna, Simona; Cassano, Enrico; Cubeddu, Rinaldo			Breast Tissue Composition and Its Dependence on Demographic Risk Factors for Breast Cancer: Non-Invasive Assessment by Time Domain Diffuse Optical Spectroscopy	PLOS ONE			English	Article							BACKGROUND PARENCHYMAL ENHANCEMENT; MAMMOGRAPHIC DENSITY; NEOADJUVANT CHEMOTHERAPY; FIBROGLANDULAR-TISSUE; SCATTERING PARAMETERS; RESOLVED REFLECTANCE; YOUNG-WOMEN; MRI; QUANTIFICATION; PROLIFERATION	Background Breast tissue composition is recognized as a strong and independent risk factor for breast cancer. It is a heritable feature, but is also significantly affected by several other elements (e.g., age, menopause). Nowadays it is quantified by mammographic density, thus requiring the use of ionizing radiation. Optical techniques are absolutely non-invasive and have already proved effective in the investigation of biological tissues, as they are sensitive to tissue composition and structure. Methods Time domain diffuse optical spectroscopy was performed at 7 wavelengths (635-1060 nm) on 200 subjects to derive their breast tissue composition (in terms of water, lipid and collagen content), blood parameters (total hemoglobin content and oxygen saturation level), and information on the microscopic structure (scattering amplitude and power). The dependence of all optically-derived parameters on age, menopausal status, body mass index, and use of oral contraceptives, and the correlation with mammographic density were investigated. Results Younger age, premenopausal status, lower body mass index values, and use of oral contraceptives all correspond to significantly higher water, collagen and total hemoglobin content, and lower lipid content (always p < 0.05 and often p < 10(-4)), while oxygen saturation level and scattering parameters show significant dependence only on some conditions. Even when age-adjusted groups of subjects are compared, several optically derived parameters (and in particular always collagen and total hemoglobin content) remain significantly different. Conclusions Time domain diffuse optical spectroscopy can probe non-invasively breast tissue composition and physiologic blood parameters, and provide information on tissue structure. The measurement is suitable for in vivo studies and monitoring of changes in breast tissue (e.g., with age, lifestyle, chemotherapy, etc.) and to gain insight into related processes, like the origin of cancer risk associated with breast density.	[Taroni, Paola; Quarto, Giovanna; Pifferi, Antonio; Cubeddu, Rinaldo] Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy; [Pifferi, Antonio; Cubeddu, Rinaldo] CNR, Ist Foton & Nanotecnol, I-20133 Milan, Italy; [Abbate, Francesca; Menna, Simona; Cassano, Enrico] European Inst Oncol, Breast Imaging Unit, Milan, Italy; [Balestreri, Nicola] European Inst Oncol, Dept Radiol, Milan, Italy	Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO)	Taroni, P (corresponding author), Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy.	paola.taroni@polimi.it	Menna, Simona/AAQ-7127-2020; Pifferi, Antonio/C-4688-2012; Taroni, Paola/C-4709-2012	Pifferi, Antonio/0000-0002-2261-2089; Taroni, Paola/0000-0001-7486-0001				Anderson GL, 2007, IWG E CR H COMBINED; [Anonymous], BI RADS MAMM 2013; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bassi A, 2007, OPT EXPRESS, V15, P14482, DOI 10.1364/OE.15.014482; Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd N, 2009, LANCET ONCOL, V10, P569, DOI 10.1016/S1470-2045(09)70078-6; Boyd NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100937; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Boyd NF, 2010, JNCI-J NATL CANCER I, V102, P1224, DOI 10.1093/jnci/djq239; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Choe R, 2012, IEEE J SEL TOP QUANT, V18, P1367, DOI 10.1109/JSTQE.2011.2177963; CUBEDDU R, 1994, IEEE J QUANTUM ELECT, V30, P2421, DOI 10.1109/3.328616; D'Andrea C, 2006, OPT EXPRESS, V14, P1888, DOI 10.1364/OE.14.001888; Dorgan JF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3228; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Evans A, 2013, BRIT J CANCER, V109, P2798, DOI 10.1038/bjc.2013.660; Farina A, 2009, APPL SPECTROSC, V63, P48, DOI 10.1366/000370209787169795; Ghosh K, 2012, BREAST CANCER RES TR, V131, P267, DOI 10.1007/s10549-011-1727-4; Gibson A, 2009, PHILOS T R SOC A, V367, P3055, DOI 10.1098/rsta.2009.0080; Gibson AP, 2005, PHYS MED BIOL, V50, pR1, DOI 10.1088/0031-9155/50/4/R01; HASKELL RC, 1994, J OPT SOC AM A, V11, P2727, DOI 10.1364/JOSAA.11.002727; Hattangadi J, 2008, AM J ROENTGENOL, V190, P1630, DOI 10.2214/AJR.07.2533; Isaksson E, 2001, BREAST CANCER RES TR, V65, P163, DOI 10.1023/A:1006482418082; Kim J, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3221; King V, 2012, EUR RADIOL, V22, P2641, DOI 10.1007/s00330-012-2553-8; Lee NA, 1997, AM J ROENTGENOL, V168, P501, DOI 10.2214/ajr.168.2.9016235; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Luparello C, 2013, J CARCINOG MUTAGEN, V13, DOI [10.4172/2157-2518.S13-007, DOI 10.4172/2157-2518.S13-007]; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Nilsson AMK, 1998, APPL OPTICS, V37, P1256, DOI 10.1364/AO.37.001256; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Pifferi A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2735567; Pike MC, 2013, ANN ONCOL, V24, P37, DOI 10.1093/annonc/mdt310; Pogue BW, 2004, J BIOMED OPT, V9, P541, DOI 10.1117/1.1691028; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Shah N, 2003, DIS MARKERS, V19, P95, DOI 10.1155/2004/460797; Shah N, 2004, J BIOMED OPT, V9, P534, DOI 10.1117/1.1695560; Stomper PC, 1996, AM J ROENTGENOL, V167, P1261, DOI 10.2214/ajr.167.5.8911192; Stone J, 2006, CANCER EPIDEM BIOMAR, V15, P612, DOI 10.1158/1055-9965.EPI-05-0127; Taroni P, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.060507; Taroni P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3506043; Taroni P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251051; Taroni P, 2009, OPT EXPRESS, V17, P15932, DOI 10.1364/OE.17.015932; Tromberg B, 2012, CANCER RES, V71, DOI [10.1158/0008-5472.SABCS11-OT2-05-02, DOI 10.1158/0008-5472.SABCS11-0T2-05-02]; Ueda S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-514; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; Wang X, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2098607	50	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128941	10.1371/journal.pone.0128941	http://dx.doi.org/10.1371/journal.pone.0128941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029912	gold, Green Published			2022-12-27	WOS:000356630900200
J	Vagner, M; Lacoue-Labarthe, T; Infante, JLZ; Mazurais, D; Dubillot, E; Le Delliou, H; Quazuguel, P; Lefrancois, C				Vagner, Marie; Lacoue-Labarthe, Thomas; Infante, Jose-Luis Zambonino; Mazurais, David; Dubillot, Emmanuel; Le Delliou, Herve; Quazuguel, Patrick; Lefrancois, Christel			Depletion of Essential Fatty Acids in the Food Source Affects Aerobic Capacities of the Golden Grey Mullet Liza aurata in a Warming Seawater Context	PLOS ONE			English	Article							SALMON SALMO-SALAR; SWIMMING PERFORMANCE; ATLANTIC SALMON; UNCOUPLING PROTEIN-2; OXYGEN-CONSUMPTION; HOMEOVISCOUS ADAPTATION; VENTILATION FREQUENCY; LIPID-COMPOSITION; TEMPERATURE; MITOCHONDRIAL	The objective of this study was to evaluate the combined effects of thermal acclimation and n-3 highly unsaturated fatty acids (n-3 HUFA) content of the food source on the aerobic capacities of fish in a thermal changing environment. The model used was the golden grey mullet Liza aurata, a species of high ecological importance in temperate coastal areas. For four months, fish were exposed to two food sources with contrasting n-3 HUFA contents (4.8% ecosapentaenoic acid EPA + docosahexaenoic acid DHA on the dry matter DM basis vs. 0.2% EPA+DHA on DM) combined with two acclimation temperatures (12 degrees C vs. 20 degrees C). The four experimental conditions were LH12, LH20, HH12 and HH20. Each group was then submitted to a thermal challenge consisting of successive exposures to five temperatures (9 degrees C, 12 degrees C, 16 degrees C, 20 degrees C, 24 degrees C). At each temperature, the maximal and minimal metabolic rates, metabolic scope, and the maximum swimming speed were measured. Results showed that the cost of maintenance of basal metabolic activities was particularly higher when n-3 HUFA food content was low. Moreover, fish exposed to high acclimation temperature combined with a low n-3 HUFA dietary level (LH20) exhibited a higher aerobic scope, as well as a greater expenditure of energy to reach the same maximum swimming speed as other groups. This suggested a reduction of the amount of energy available to perform other physiological functions. This study is the first to show that the impact of lowering n-3 HUFA food content is exacerbated for fish previously acclimated to a warmer environment. It raises the question of the consequences of longer and warmer summers that have already been recorded and are still expected in temperate areas, as well as the pertinence of the lowering n-3 HUFA availability in the food web expected with global change, as a factor affecting marine organisms and communities.	[Vagner, Marie; Lacoue-Labarthe, Thomas; Dubillot, Emmanuel; Lefrancois, Christel] Littoral Environm Societes, UMR 7266, La Rochelle, France; [Infante, Jose-Luis Zambonino; Mazurais, David; Le Delliou, Herve; Quazuguel, Patrick] IFREMER, Lab Sci Environm Marin, UMR 6539, Plouzane, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Vagner, M (corresponding author), Littoral Environm Societes, UMR 7266, La Rochelle, France.	marie.vagner@hotmail.fr	ZAMBONINO-INFANTE, Jose L/F-9828-2010; , Mazurais/AAI-1961-2019; , Mazurais/AAF-9981-2019; Lacoue-Labarthe, Thomas/H-4963-2019; Vagner, Marie/H-5717-2019	ZAMBONINO-INFANTE, Jose L/0000-0001-8436-4773; , Mazurais/0000-0002-5686-2510; Lacoue-Labarthe, Thomas/0000-0002-4682-8730; Vagner, Marie/0000-0002-2777-006X; Quazuguel, Patrick/0000-0003-3503-2347	Contrat-Plan Etat-Region; FEDER (European Research Funding)	Contrat-Plan Etat-Region; FEDER (European Research Funding)	This study was funded by the Contrat-Plan Etat-Region (regional and national financial support), as well as by the FEDER (European Research Funding) for the first author.	BEAMISH F. W. H., 1964, TRANS AMER FISH SOC, V93, P103, DOI 10.1577/1548-8659(1964)93[103:IOSOSA]2.0.CO;2; Bethoux JP, 1998, GEOPHYS RES LETT, V25, P1023, DOI 10.1029/98GL00724; BRAND MD, 1990, J THEOR BIOL, V145, P267, DOI 10.1016/S0022-5193(05)80131-6; Carpentier A, 2014, J SEA RES, V92, P86, DOI 10.1016/j.seares.2013.10.007; Cerezo J, 2004, J APPL ICHTHYOL, V20, P488, DOI 10.1111/j.1439-0426.2004.00601.x; Chatelier A, 2006, J EXP BIOL, V209, P4033, DOI 10.1242/jeb.02470; Chatelier A, 2006, J EXP BIOL, V209, P3429, DOI 10.1242/jeb.02347; Clark TD, 2011, J EXP BIOL, V214, P3074, DOI 10.1242/jeb.060517; COSSINS AR, 1994, PORTL PR P, P63; Crawford Michael A., 2012, Nutrition and Health (Bicester), V21, P17, DOI 10.1177/0260106012437550; Dalla Valle AZ, 2003, J FISH BIOL, V63, P1578, DOI 10.1111/j.1095-8649.2003.00268.x; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; Dosanjh BS, 1998, FISH PHYSIOL BIOCHEM, V19, P123, DOI 10.1023/A:1007727618179; Egginton S, 1996, J FISH BIOL, V49, P753, DOI 10.1111/j.1095-8649.1996.tb00074.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontaine EM, 1996, BBA-BIOENERGETICS, V1276, P181, DOI 10.1016/0005-2728(96)00075-8; Frisk M, 2012, AQUACULTURE, V324, P151, DOI 10.1016/j.aquaculture.2011.10.024; Fry F.E.J., 1971, P1; Fulton T. W., 1904, Report of the Fishery Board for Scotland, Vxxii, P141; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Goffart A, 2002, MAR ECOL PROG SER, V236, P45, DOI 10.3354/meps236045; Gomez F, 2008, CR BIOL, V331, P678, DOI 10.1016/j.crvi.2008.06.005; Gypens N, 2007, J SEA RES, V57, P19, DOI 10.1016/j.seares.2006.07.004; Halver J.E., 2002, LIPIDS, V3rd Edn, P182; Hammill E, 2004, J THERM BIOL, V29, P251, DOI 10.1016/j.jtherbio.2004.04.002; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; He W, 2013, COMP BIOCHEM PHYS A, V166, P308, DOI 10.1016/j.cbpa.2013.07.003; HENDERSON RJ, 1985, COMP BIOCHEM PHYS B, V82, P79, DOI 10.1016/0305-0491(85)90131-2; Ifremer, 2012, B DONN SURV ENV RESS; Jastroch M, 2004, PHYSIOL GENOMICS, V17, P130, DOI 10.1152/physiolgenomics.00165.2003; Jobling M, 2000, FOOD INTAKE IN FISH, P354; JOHNSTON I, 1978, J COMP PHYSIOL, V124, P111, DOI 10.1007/BF00689170; JONES PL, 1982, J EXP ZOOL, V219, P163, DOI 10.1002/jez.1402190205; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kainz MJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P93, DOI 10.1007/978-0-387-89366-2_5; Lebreton B, 2011, ESTUAR COAST SHELF S, V92, P140, DOI 10.1016/j.ecss.2010.12.027; Lee CG, 2003, J EXP BIOL, V206, P3253, DOI 10.1242/jeb.00548; Leu E, 2006, J EXP MAR BIOL ECOL, V337, P65, DOI 10.1016/j.jembe.2006.06.005; Liang XF, 2003, COMP BIOCHEM PHYS A, V136, P655, DOI 10.1016/S1095-6433(03)00218-6; LINARES F, 1991, J FISH BIOL, V38, P335, DOI 10.1111/j.1095-8649.1991.tb03124.x; Luna-Acosta A, 2011, AQUACULTURE, V317, P162, DOI 10.1016/j.aquaculture.2011.03.004; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; McKenzie DJ, 1998, FISH PHYSIOL BIOCHEM, V19, P111, DOI 10.1023/A:1007779619087; McKenzie DJ, 2001, COMP BIOCHEM PHYS A, V128, P607, DOI 10.1016/S1095-6433(00)00338-X; Millidine KJ, 2008, CAN J FISH AQUAT SCI, V65, P2081, DOI 10.1139/F08-118; Pahl SL, 2010, J BIOSCI BIOENG, V109, P235, DOI 10.1016/j.jbiosc.2009.08.480; Person-Le Ruyet J, 2004, AQUACULTURE, V242, P571, DOI 10.1016/j.aquaculture.2004.09.011; Ramsey JJ, 2005, COMP BIOCHEM PHYS B, V140, P99, DOI 10.1016/j.cbpc.2004.09.016; RAYNARD RS, 1991, AM J PHYSIOL, V260, pR916, DOI 10.1152/ajpregu.1991.260.5.R916; Riggs A, 1970, PROPERTIES FISH HEMO, P209; SCHURMANN H, 1994, J EXP BIOL, V197, P129; Selmi Salah, 2008, Nutrition and Health (Bicester), V19, P189; Sidell BD, 1985, CIRCULATION RESPIRAT, P386; Sollid J, 2006, RESP PHYSIOL NEUROBI, V154, P241, DOI 10.1016/j.resp.2006.02.006; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Stuart JA, 1999, BBA-BIOENERGETICS, V1413, P50, DOI 10.1016/S0005-2728(99)00081-X; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Vagner M, 2008, MAR BIOL, V155, P183, DOI 10.1007/s00227-008-1016-x; Vagner M, 2014, MAR BIOL, V161, P2547, DOI 10.1007/s00227-014-2526-3; Wagner GN, 2004, COMP BIOCHEM PHYS A, V137, P567, DOI 10.1016/j.cbpb.2003.11.005; WEBB PW, 1975, J EXP BIOL, V63, P451; Wodtke E, 1991, BIOCHIM BIOPHYS ACTA, V640, P710	62	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126489	10.1371/journal.pone.0126489	http://dx.doi.org/10.1371/journal.pone.0126489			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030666	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900028
J	Wu, RH; Tang, XQ; Sheng, XZ; Zhan, WB				Wu, Ronghua; Tang, Xiaoqian; Sheng, Xiuzhen; Zhan, Wenbin			Relationship between Expression of Cellular Receptor-27.8kDa and Lymphocystis Disease Virus (LCDV) Infection	PLOS ONE			English	Article							FLOUNDER PARALICHTHYS-OLIVACEUS; CANINE-DISTEMPER VIRUS; MONOCLONAL-ANTIBODIES; GILL; PROTEIN; IDENTIFICATION; INTEGRIN; CELLS; ENTRY; LINE	The 27.8kDa membrane protein from flounder (Paralichthys olivaceus) gill (FG) cells was previously identified as a putative cellular receptor involved in lymphocystis disease virus (LCDV) infection. In this paper, the expression of receptor-27.8kDa (27.8R) and LCDV loads in FG cells and hirame natural embryo (HINAE) cells were investigated upon LCDV infection and anti-27.8R monoclonal antibody (MAb) treatment. The results showed the 27.8R was expressed and co-localized with LCDV in both FG and HINAE cell surface. After LCDV infection, the expression of 27.8R exhibited a dose-dependent up-regulation with the increasing of LCDV titers, and demonstrated a tendency to increase firstly and then decrease during a time course up to 9 days; LCDV copies showed a similar variation trend to the 27.8R expression, however, it reached the highest level later than did the 27.8R expression. Additionally, the 27.8R expression and LCDV copies in FG cells were higher than those in HINAE cells. In the presence of increasing concentration of the anti-27.8R MAbs, the up-regulation of 27.8R expression and the copy numbers of LCDV significantly declined post LCDV infection, and the cytopathic effect induced by LCDV in the two cell lines was accordingly reduced, indicating anti-27.8R MAbs pre-incubation could inhibit the up-regulation of 27.8R expression and LCDV infection. These results suggested that LCDV infection could induce up-regulation of 27.8R expression, which in turn increased susceptibility and availability of FG and HINAE cells for LCDV entry, providing important new insights into the LCDV replication cycle and the interaction between this virus and the host cells.	[Wu, Ronghua; Tang, Xiaoqian; Sheng, Xiuzhen; Zhan, Wenbin] Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Qingdao 266003, Peoples R China	Ocean University of China	Sheng, XZ (corresponding author), Ocean Univ China, Lab Pathol & Immunol Aquat Anim, 5 Yushan Rd, Qingdao 266003, Peoples R China.	xzsheng@ouc.edu.cn			National Science Fund of China [31472295, 31172429, 31072232]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Science Fund of China (grant 31472295, 31172429 and 31072232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN F, 1986, INTERVIROLOGY, V25, P141, DOI 10.1159/000149667; Charlermroj R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062344; Cheng SF, 2006, J VIROL METHODS, V135, P173, DOI 10.1016/j.jviromet.2006.03.016; Harikrishnan R, 2010, FISH SHELLFISH IMMUN, V29, P868, DOI 10.1016/j.fsi.2010.07.031; HEPPELL J, 1992, ARCH VIROL, V125, P215, DOI 10.1007/BF01309639; Hu GB, 2004, J FISH DIS, V27, P657, DOI 10.1111/j.1365-2761.2004.00588.x; Iwakiri S, 2014, FISH SHELLFISH IMMUN, V38, P406, DOI 10.1016/j.fsi.2014.03.028; Iwamoto R, 2002, J AQUAT ANIM HEALTH, V14, P114, DOI 10.1577/1548-8667(2002)014&lt;0114:IACOTJ&gt;2.0.CO;2; Jang HB, 2011, J FISH DIS, V34, P555, DOI 10.1111/j.1365-2761.2011.01268.x; Kasai Hisae, 2001, Bulletin of Fisheries Sciences Hokkaido University, V52, P67; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Noutsias M, 2001, CIRCULATION, V104, P275; Noyce RS, 2013, VIROLOGY, V436, P210, DOI 10.1016/j.virol.2012.11.011; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Pontejo SM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-188; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Sheng XZ, 2012, DIS AQUAT ORGAN, V100, P19, DOI 10.3354/dao02485; Sun C, 2013, DEV COMP IMMUNOL, V40, P28, DOI 10.1016/j.dci.2012.12.009; Tang QH, 2010, VET IMMUNOL IMMUNOP, V133, P237, DOI 10.1016/j.vetimm.2009.07.005; Tang XQ, 2012, AQUACULTURE, V358, P132, DOI 10.1016/j.aquaculture.2012.06.031; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031965; Tian JY, 2011, FISH SHELLFISH IMMUN, V30, P109, DOI 10.1016/j.fsi.2010.09.016; Tong SL, 1997, AQUACULTURE, V156, P327, DOI 10.1016/S0044-8486(97)00070-7; Wang M, 2011, DIS AQUAT ORGAN, V94, P9, DOI 10.3354/dao02311; Wenzlow N, 2007, VET PATHOL, V44, P943, DOI 10.1354/vp.44-6-943; Zhan WB, 1999, J AQUAT ANIM HEALTH, V11, P17, DOI 10.1577/1548-8667(1999)011&lt;0017:POMAMA&gt;2.0.CO;2; Zhan WB, 2010, CHIN J OCEANOL LIMN, V28, P1213, DOI 10.1007/s00343-010-9934-0; Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051; Zhong RJ, 2013, FISH SHELLFISH IMMUN, V35, P539, DOI 10.1016/j.fsi.2013.05.004; Zhu ZW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056662, 10.1371/journal.pone.0080028]	32	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127940	10.1371/journal.pone.0127940	http://dx.doi.org/10.1371/journal.pone.0127940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024218	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400060
J	Zarmi, Y				Zarmi, Yair			Sine-Gordon Equation in (1+2) and (1+3) dimensions: Existence and Classification of Traveling-Wave Solutions	PLOS ONE			English	Article							DIFFERENTIAL-EQUATIONS; MODEL; SOLITONS; INTEGRABILITY	The (1+1)-dimensional Sine-Gordon equation passes integrability tests commonly applied to nonlinear evolution equations. Its kink solutions (one-dimensional fronts) are obtained by a Hirota algorithm. In higher space-dimensions, the equation does not pass these tests. Although it has been derived over the years for quite a few physical systems that have nothing to do with Special Relativity, the Sine-Gordon equation emerges as a non-linear relativistic wave equation. This opens the way for exploiting the tools of the Theory of Special Relativity. Using no more than the relativistic kinematics of tachyonic momentum vectors, from which the solutions are constructed through the Hirota algorithm, the existence and classification of N-moving-front solutions of the (1+2)- and (1+3)-dimensional equations for all N >= 1 are presented. In (1+2) dimensions, each multi-front solution propagates rigidly at one velocity. The solutions are divided into two subsets: Solutions whose velocities are lower than a limiting speed, c = 1, or are greater than or equal to c. To connect with concepts of the Theory of Special Relativity, c will be called "the speed of light." In (1+3)-dimensions, multifront solutions are characterized by spatial structure and by velocity composition. The spatial structure is either planar (rotated (1+2)-dimensional solutions), or genuinely three-dimensional - branes. Planar solutions, propagate rigidly at one velocity, which is lower than, equal to, or higher than c. Branes must contain clusters of fronts whose speed exceeds c = 1. Some branes are "hybrids": different clusters of fronts propagate at different velocities. Some velocities may be lower than c but some must be equal to, or exceed, c. Finally, the speed of light cannot be approached from within the subset of slower-than-light solutions in both (1+2) and (1+3) dimensions.	Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-8499000 Midreshet Ben Gurion, Israel	Ben Gurion University	Zarmi, Y (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-8499000 Midreshet Ben Gurion, Israel.	zarmi@bgu.ac.il						ABLOWITZ MJ, 1973, PHYS REV LETT, V30, P1262, DOI 10.1103/PhysRevLett.30.1262; Ablowitz MJ, 1991, NONLINEAR EVOLUTION; Babelon O, 1996, COMMUN MATH PHYS, V182, P319, DOI 10.1007/BF02517893; Barone A, 1971, RIV NUOVO CIMENTO, V1, P227, DOI DOI 10.1007/BF02820622; CLARKSON PA, 1985, LETT MATH PHYS, V10, P297, DOI 10.1007/BF00420570; COLEMAN S, 1975, PHYS REV D, V11, P2088, DOI 10.1103/PhysRevD.11.2088; DASHEN RF, 1975, PHYS REV D, V11, P3424, DOI 10.1103/PhysRevD.11.3424; Fadeev LD, 1978, PHYS REP, V420, P1; Frenkel Y, 1939, J PHYS USSR, V1, P137; GIBBON JD, 1978, PHYS LETT A, V65, P380, DOI 10.1016/0375-9601(78)90443-7; GRELLA G, 1978, LETT NUOVO CIMENTO, V23, P459, DOI 10.1007/BF02770537; HIROTA R, 1972, J PHYS SOC JPN, V33, P1459, DOI 10.1143/JPSJ.33.1459; HIROTA R, 1973, J PHYS SOC JPN, V35, P1566, DOI 10.1143/JPSJ.35.1566; JOSEPHSO.BD, 1965, ADV PHYS, V14, P419, DOI 10.1080/00018736500101091; KOBAYASHI KK, 1976, J PHYS SOC JPN, V41, P1091, DOI 10.1143/JPSJ.41.1091; LAMB GL, 1971, REV MOD PHYS, V43, P99, DOI 10.1103/RevModPhys.43.99; MANDELSTAM S, 1975, PHYS REV D, V11, P3026, DOI 10.1103/PhysRevD.11.3026; MARTINOV NK, 1994, J PHYS A-MATH GEN, V27, P4611, DOI 10.1088/0305-4470/27/13/034; Mikhailov A, 2006, J GEOM PHYS, V56, P2429, DOI 10.1016/j.geomphys.2006.01.001; OSBORNE AD, 1978, PHYS LETT A, V67, P328, DOI 10.1016/0375-9601(78)90320-1; PERK JHH, 1981, PHYS REV D, V23, P2482, DOI 10.1103/PhysRevD.23.2482; PERRING JK, 1962, NUCL PHYS, V31, P550, DOI 10.1016/0029-5582(62)90774-5; RUBINSTE.J, 1970, J MATH PHYS, V11, P258, DOI 10.1063/1.1665057; RUIJSENAARS SNM, 1987, COMMUN MATH PHYS, V110, P191, DOI 10.1007/BF01207363; Ruijsenaars SNM, 2001, NATO SCI SER II-MATH, V35, P273; SCOTT AC, 1969, AM J PHYS, V37, P52, DOI 10.1119/1.1975404; SCOTT AC, 1973, P IEEE, V61, P1443, DOI 10.1109/PROC.1973.9296; SEEGER A, 1953, Z PHYS, V134, P173, DOI 10.1007/BF01329410; WEISS J, 1984, J MATH PHYS, V25, P2226, DOI 10.1063/1.526415; WEISS J, 1983, J MATH PHYS, V24, P522, DOI 10.1063/1.525721; Woodhouse NMJ, 2003, SPRINGER UNDERGRADUA; ZAGRODZINSKI J, 1976, PHYS LETT A, V57, P213, DOI 10.1016/0375-9601(76)90039-6; Zarmi Y, 2013, J MATH PHYS, V54, DOI 10.1063/1.4776194	34	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124306	10.1371/journal.pone.0124306	http://dx.doi.org/10.1371/journal.pone.0124306			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020922	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300008
J	Liu, XL; Wang, JQ; Liu, TT; Kong, WW; He, XQ; Jin, Y; Zhang, BL				Liu, Xiaolu; Wang, Jingqi; Liu, Tingting; Kong, Weiwen; He, Xiaoqing; Jin, Yi; Zhang, Bolin			Effects of Assimilable Organic Carbon and Free Chlorine on Bacterial Growth in Drinking Water	PLOS ONE			English	Article							BIOLOGICAL STABILITY; DISTRIBUTION-SYSTEMS; RECLAIMED WATER; FULL-SCALE; ENUMERATION; REGROWTH; QUALITY	Assimilable organic carbon (AOC) is one of the most important factors affecting the re-growth of microorganisms in drinking water. High AOC concentrations result in biological instability, but disinfection kills microbes to ensure the safety of drinking water. Free chlorine is an important oxidizing agent used during the disinfection process. Therefore, we explored the combined effects of AOC and free chlorine on bacterial growth in drinking water using flow cytometry (FCM). The initial AOC concentration was 168 mu g.L-1 in all water samples. Without free chlorine, the concentrations of intact bacteria increased but the level of AOC decreased. The addition of sodium hypochlorite caused an increase and fluctuation in AOC due to the oxidation of organic carbon. The concentrations of intact bacteria decreased from 1.1x10(5) cells. mL(-1) to 2.6x10(4) cells. mL(-1) at an initial free chlorine dose of 0.6 mg. L-1 to 4.8x10(4) cells. mL(-1) at an initial free chlorine dose of 0.3 mg.L-1 due to free chlorine originating from sodium hypochlorite. Additionally, free chlorine might be more obviously affected AOC concentrations than microbial growth did. These results suggested that AOC and free chlorine might have combined effects on microbial growth. In this study, our results showed concentrations determined by FCM were higher than those by HPC, which indicated that some E. coli detected by FCM might not be detected using HPC in drinking water. The level of free chlorine might restrain the consumption of AOC by inhibiting the growth of E. coli; on the other hand, chlorination might increase the level of AOC, thereby increase the potential for microbial growth in the drinking water network.	[Liu, Xiaolu; Wang, Jingqi; Liu, Tingting; Kong, Weiwen; He, Xiaoqing; Jin, Yi; Zhang, Bolin] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing 100083, Peoples R China; [Liu, Xiaolu; Wang, Jingqi; Liu, Tingting; Kong, Weiwen] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Aquat Chem, Beijing 100085, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	He, XQ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, POB 162, Beijing 100083, Peoples R China.	lenahe@bjfu.edu.cn; wizard.jin@163.com; zhangbolin888@163.com	Zhang, bolin/GZN-2017-2022; liu, xiaolu/AAC-6908-2020; He, Xiaoqing/AGM-1178-2022	He, Xiaoqing/0000-0001-9098-9980	Fundamental Research Funds for the Central University [TD2012-03]; non-profit Industry Financial Program of MWR [201201032]; Natural Science Foundation of China [51108029]	Fundamental Research Funds for the Central University; non-profit Industry Financial Program of MWR; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central University (TD2012-03), non-profit Industry Financial Program of MWR (201201032), and Natural Science Foundation of China (51108029).	Allen MJ, 2004, INT J FOOD MICROBIOL, V92, P265, DOI 10.1016/j.ijfoodmicro.2003.08.017; Arnoldini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080117; Berney M, 2008, WATER RES, V42, P4010, DOI 10.1016/j.watres.2008.07.017; Brown JM, 2008, WATER SCI TECHNOL, V58, P757, DOI 10.2166/wst.2008.439; Cheng L., 2010, POLLUTION CHARACTERI; Constantin A, 2010, CONSTANTA MARITIME U, V13, P18; Dark PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7886; Du M, 2007, APPL ENVIRON MICROB, V73, P1349, DOI 10.1128/AEM.02243-06; Fang H., 2006, STUDY BIOL STABILITY; Gillespie S, 2014, WATER RES, V65, P224, DOI 10.1016/j.watres.2014.07.029; Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c; Hammes F, 2010, J WATER SUPPLY RES T, V59, P31, DOI 10.2166/aqua.2010.052; Islam MS, 2007, J APPL MICROBIOL, V103, P80, DOI 10.1111/j.1365-2672.2006.03234.x; KAPLAN LA, 1993, APPL ENVIRON MICROB, V59, P1532, DOI 10.1128/AEM.59.5.1532-1539.1993; Khan MMT, 2010, APPL ENVIRON MICROB, V76, P5088, DOI 10.1128/AEM.02932-09; Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032; LeChevallier MW, 1996, APPL ENVIRON MICROB, V62, P2201, DOI 10.1128/AEM.62.7.2201-2211.1996; Liang T, 2009, VARIATION ASSIMILABL; Manti A, 2008, WATER ENVIRON RES, V80, P346, DOI 10.2175/106143007X221418; Mesquita S, 2013, RECENT DEV MONITORIN, DOI [10.5772/52312, DOI 10.5772/52312]; Mezule L., 2013, Drinking Water and Engineering Science, V6, P25; Nescerecka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096354; Ohkouchi Y, 2013, ENVIRON MONIT ASSESS, V185, P1427, DOI 10.1007/s10661-012-2642-9; Prest EI, 2014, WATER RES, V63, P179, DOI 10.1016/j.watres.2014.06.020; Prest EI, 2013, WATER RES, V47, P7131, DOI 10.1016/j.watres.2013.07.051; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Siebel E., 2008, Drinking Water and Engineering Science, V1, P1; SLMB, 2012, 3331 SLMB; Sun LY, 2013, SCI TOTAL ENVIRON, V443, P864, DOI 10.1016/j.scitotenv.2012.11.021; Teng F, 2008, CORROS SCI, V50, P2816, DOI 10.1016/j.corsci.2008.07.008; Thayanukul P, 2013, WATER RES, V47, P225, DOI 10.1016/j.watres.2012.09.051; VANDERKOOIJ D, 1982, J AM WATER WORKS ASS, V74, P540; VANDERKOOIJ D, 1992, J AM WATER WORKS ASS, V84, P57, DOI 10.1002/j.1551-8833.1992.tb07305.x; Vital M, 2007, MICROBIOL-SGM, V153, P1993, DOI 10.1099/mic.0.2006/005173-0; Wang YY, 2010, TRENDS BIOTECHNOL, V28, P416, DOI 10.1016/j.tibtech.2010.04.006; Weinrich LA, 2010, WATER RES, V44, P5367, DOI 10.1016/j.watres.2010.06.035; [余辉 Yu Hui], 2012, [微生物学通报, Microbiology], V39, P1171; Zhang JF, 2010, LANCET, V375, P1110, DOI 10.1016/S0140-6736(10)60062-1	38	20	22	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128825	10.1371/journal.pone.0128825	http://dx.doi.org/10.1371/journal.pone.0128825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034988	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100051
J	Agnoli, C; Grioni, S; Sieri, S; Sacerdote, C; Ricceri, F; Tumino, R; Frasca, G; Pala, V; Mattiello, A; Chiodini, P; Iacoviello, L; De Curtis, A; Panico, S; Krogh, V				Agnoli, Claudia; Grioni, Sara; Sieri, Sabina; Sacerdote, Carlotta; Ricceri, Fulvio; Tumino, Rosario; Frasca, Graziella; Pala, Valeria; Mattiello, Amalia; Chiodini, Paolo; Iacoviello, Licia; De Curtis, Amalia; Panico, Salvatore; Krogh, Vittorio			Metabolic Syndrome and Breast Cancer Risk: A Case-Cohort Study Nested in a Multicentre Italian Cohort	PLOS ONE			English	Article							GROWTH-FACTOR-I; BINDING PROTEIN-3; AFRICAN-AMERICAN; SYSTEM; DIET; ADIPOSITY; AROMATASE; ESTROGENS; DESIGN	Background Metabolic syndrome (defined as at least three among abdominal obesity, high blood triglycerides, low high-density lipoprotein cholesterol, high blood glucose, and high blood pressure) is emerging as a risk factor for breast cancer; however few studies - most confined to postmenopausal women - have investigated associations between breast cancer risk and metabolic syndrome. The purpose of this study was to examine the association between metabolic syndrome and its components, and risk of breast cancer in postmenopausal and premenopausal women. Methods We performed a case-cohort study on 22,494 women recruited in 1993-1998 to four Italian centres (Turin, Varese, Naples, Ragusa) of the European Prospective Investigation into Cancer and Nutrition (EPIC) and followed-up for up to 15 years. A random subcohort of 565 women was obtained and 593 breast cancer cases were diagnosed. Hazard ratios (HR) with 95% confidence intervals (CI), adjusted for potential confounders, were estimated by Prentice-weighted Cox proportional hazards models. Results Presence of metabolic syndrome was associated with significantly increased breast cancer risk in all women (HR 1.52, 95% CI 1.14-2.02). When the analyses were repeated separately for menopausal status, the association was limited to postmenopausal women (HR 1.80, 95% CI 1.22-2.65) and absent in premenopausal women (HR 0.71, 95%CI 0.43-1.16); P for interaction between metabolic syndrome and menopausal status was 0.001. Of metabolic syndrome components, only high blood glucose was significantly associated with increased breast cancer risk in all women (HR 1.47, 95%CI 1.13-1.91) and postmenopausal women (HR 1.89, 95%CI 1.29-2.77), but not premenopausal women (HR 0.80, 95%CI 0.52-1.22; P interaction=0.004). Conclusions These findings support previous data indicating that metabolic syndrome is an important risk factor for breast cancer in postmenopausal women, but not in premenopausal women, and suggest that prevention of metabolic syndrome through lifestyle changes could confer protection against breast cancer.	[Agnoli, Claudia; Grioni, Sara; Sieri, Sabina; Pala, Valeria; Krogh, Vittorio] Fdn IRCCS, Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Sacerdote, Carlotta; Ricceri, Fulvio] Human Genet Fdn, Turin, Italy; [Sacerdote, Carlotta; Ricceri, Fulvio] Piemonte Ctr Canc Prevent, Turin, Italy; [Tumino, Rosario; Frasca, Graziella] Canc Registry, ASP Ragusa 7, Turin, Italy; [Mattiello, Amalia; Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Chiodini, Paolo] Univ Naples 2, Dept Mental & Phys Hlth & Prevent Med, Naples, Italy; [Iacoviello, Licia; De Curtis, Amalia] IRCCS, Ist Neurol Mediterraneo Neuromed, Dept Epidemiol & prevent, Lab Mol & Nutr Epidemiol, Pozzilli, IS, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Universita della Campania Vanvitelli; IRCCS Neuromed	Sieri, S (corresponding author), Fdn IRCCS, Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy.	sabina.sieri@istitutotumori.mi.it	Ricceri, Fulvio/I-9910-2018; Krogh, Vittorio/AAA-9171-2019; Mattiello, Amalia AM/K-5112-2016; Krogh, Vittorio/K-2628-2016; Siani, Alfonso/B-7925-2015; Chiodini, Paolo/E-7290-2014; de curtis, amalia/AAC-2829-2020; Grioni, Sara/K-5320-2016; Panico, Salvatore/K-6506-2016; Iacoviello, Licia/AGX-7071-2022; Agnoli, Claudia/K-5916-2016; Iacoviello, Licia/K-4676-2016; Pala, Valeria/K-4738-2016; Sieri, Sabina/K-4667-2016	Ricceri, Fulvio/0000-0001-8749-9737; Krogh, Vittorio/0000-0003-0122-8624; Mattiello, Amalia AM/0000-0003-3676-7353; Krogh, Vittorio/0000-0003-0122-8624; Chiodini, Paolo/0000-0003-0139-2264; de curtis, amalia/0000-0001-5104-0318; Grioni, Sara/0000-0002-5891-8426; Panico, Salvatore/0000-0002-5498-8312; Iacoviello, Licia/0000-0003-0514-5885; Agnoli, Claudia/0000-0003-4472-1179; Iacoviello, Licia/0000-0003-0514-5885; Pala, Valeria/0000-0001-5438-970X; Sieri, Sabina/0000-0001-5201-172X; Persichillo, Mariarosaria/0000-0002-9731-0173; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X	Italian Association for Cancer Research (AIRC); Compagnia di San Paolo	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by the Italian Association for Cancer Research (AIRC) and the Compagnia di San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli C, 2010, NUTR METAB CARDIOVAS, V20, P41, DOI 10.1016/j.numecd.2009.02.006; Al-Delaimy WK, 2006, BIOMARKERS, V11, P370, DOI 10.1080/13547500600799748; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Beaulieu LM, 2007, BIOESSAYS, V29, P1029, DOI 10.1002/bies.20640; Bhandari R, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/189384; Bjorge T, 2010, CANCER EPIDEM BIOMAR, V19, P1737, DOI 10.1158/1055-9965.EPI-10-0230; Bosco JLF, 2012, BREAST CANCER RES TR, V134, P1247, DOI 10.1007/s10549-012-2131-4; Boso JLF, 2011, THESIS; Bradley LM, 2008, J STEROID BIOCHEM, V109, P185, DOI 10.1016/j.jsbmb.2007.10.006; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; Brismar Kerstin, 1995, Progress in Growth Factor Research, V6, P449, DOI 10.1016/0955-2235(96)00006-3; Capasso I, 2010, CANCER BIOL THER, V10, P1240, DOI 10.4161/cbt.10.12.13473; Esposito K, 2013, MENOPAUSE, V20, P1301, DOI [10.1097/GME.0b013e31828ce95d, 10.1097/gme.0b013e31828ce95d]; Ferlay J, 2012, INT J CANC; Iacoviello L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003725; Inoue M, 2009, EUR J CANCER PREV, V18, P240, DOI 10.1097/CEJ.0b013e3283240460; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Kabat GC, 2009, CANCER EPIDEM BIOMAR, V18, P2046, DOI 10.1158/1055-9965.EPI-09-0235; Lawlor DA, 2004, CANCER CAUSE CONTROL, V15, P267, DOI 10.1023/B:CACO.0000024225.14618.a8; McTernan PG, 2000, INT J OBESITY, V24, P875, DOI 10.1038/sj.ijo.0801254; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Nestler John E., 1997, Human Reproduction (Oxford), V12, P53; Norat T, 2007, EUR J CLIN NUTR, V61, P91, DOI 10.1038/sj.ejcn.1602494; Osaki Y, 2012, CANCER EPIDEMIOL, V36, P141, DOI 10.1016/j.canep.2011.03.007; Pala V, 2003, TUMORI J, V89, P594, DOI 10.1177/030089160308900603; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535; Potischman N, 1996, JNCI-J NATL CANCER I, V88, P756, DOI 10.1093/jnci/88.11.756; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Probst-Hensch NM, 1999, ENDOCR-RELAT CANCER, V6, P165, DOI 10.1677/erc.0.0060165; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Reeves KW, 2012, CANCER CAUSE CONTROL, V23, P1241, DOI 10.1007/s10552-012-0002-2; Riccardi G, 2000, BRIT J NUTR, V83, pS143; Ronco AL, 2012, ASIAN PAC J CANCER P, V13, P2879, DOI 10.7314/APJCP.2012.13.6.2879; Ronco AL, 2012, ASIAN PAC J CANCER P, V13, P139, DOI 10.7314/APJCP.2012.13.1.139; Rosato V, 2011, ANN ONCOL, V22, P2687, DOI 10.1093/annonc/mdr025; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; ROSE G, 1965, LANCET, V1, P673; Russo A, 2008, EUR J CANCER, V44, P293, DOI 10.1016/j.ejca.2007.11.005; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Sherif K, 1998, METABOLISM, V47, P70, DOI 10.1016/S0026-0495(98)90195-0; Sieminska Lucyna, 2006, Endokrynol Pol, V57, P15; Sieri S, 2012, INT J CANCER, V130, P921, DOI 10.1002/ijc.26071; Strange KS, 2004, BREAST CANCER RES TR, V84, P77, DOI 10.1023/B:BREA.0000018384.64326.dd; TONIOLO PG, 1995, JNCI-J NATL CANCER I, V87, P190, DOI 10.1093/jnci/87.3.190; Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; World Cancer Research Fund/American Institute for Cancer Research, 2010, CONT UPD PROJ REP FO; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S	51	47	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128891	10.1371/journal.pone.0128891	http://dx.doi.org/10.1371/journal.pone.0128891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030767	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900197
J	Chiang, KV; Shu, J; Zempleni, J; Cui, J				Chiang, Kevin; Shu, Jiang; Zempleni, Janos; Cui, Juan			Dietary MicroRNA Database (DMD): An Archive Database and Analytic Tool for Food-Borne microRNAs	PLOS ONE			English	Article							DETECTABLE ORAL BIOAVAILABILITY; BLOOD MONONUCLEAR-CELLS; PLANT MICRORNAS; GENE-EXPRESSION; MESSENGER-RNA; IDENTIFICATION; PROGNOSIS; TARGETS; MILK; CLASSIFICATION	With the advent of high throughput technology, a huge amount of microRNA information has been added to the growing body of knowledge for non-coding RNAs. Here we present the Dietary MicroRNA Databases (DMD), the first repository for archiving and analyzing the published and novel microRNAs discovered in dietary resources. Currently there are fifteen types of dietary species, such as apple, grape, cow milk, and cow fat, included in the database originating from 9 plant and 5 animal species. Annotation for each entry, a mature microRNA indexed as DM0000*, covers information of the mature sequences, genome locations, hairpin structures of parental pre-microRNAs, cross-species sequence comparison, disease relevance, and the experimentally validated gene targets. Furthermore, a few functional analyses including target prediction, pathway enrichment and gene network construction have been integrated into the system, which enable users to generate functional insights through viewing the functional pathways and building protein-protein interaction networks associated with each microRNA. Another unique feature of DMD is that it provides a feature generator where a total of 411 descriptive attributes can be calculated for any given microRNAs based on their sequences and structures. DMD would be particularly useful for research groups studying microRNA regulation from a nutrition point of view.	[Chiang, Kevin; Shu, Jiang; Cui, Juan] Univ Nebraska, Dept Comp Sci & Engn, Lincoln, NE 68588 USA; [Zempleni, Janos] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Cui, J (corresponding author), Univ Nebraska, Dept Comp Sci & Engn, Lincoln, NE 68588 USA.	jcui@unl.edu		Shu, Jiang/0000-0001-7677-721X	NIH-supported Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules [P20GM104320]; National Institute of Food and Agriculture [2015-67017-23181]; Gerber Foundation; Egg Nutrition Center; University of Nebraska Agricultural Research Division (Hatch Act); United States Department of Agriculture Multi-State Group [W3002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER	NIH-supported Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Gerber Foundation; Egg Nutrition Center; University of Nebraska Agricultural Research Division (Hatch Act)(United States Department of Agriculture (USDA)); United States Department of Agriculture Multi-State Group; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DMD received funding through the NIH-supported Nebraska Center for the Prevention of Obesity Diseases through Dietary Molecules (P20GM104320). Funding was also received from the National Institute of Food and Agriculture (2015-67017-23181), the Gerber Foundation, the Egg Nutrition Center, the University of Nebraska Agricultural Research Division (Hatch Act), and the United States Department of Agriculture Multi-State Group W3002. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Arnold CN, 2012, P NATL ACAD SCI USA, V109, P12286, DOI 10.1073/pnas.1209134109; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Blevins R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005020; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen X, 2013, NAT BIOTECHNOL, V31, P967, DOI 10.1038/nbt.2741; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cui J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021730; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Gomes Clarissa P. C., 2013, Frontiers in Genetics, V4, P81, DOI 10.3389/fgene.2013.00081; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Knudsen V, 2008, NUCLEIC ACIDS RES, V36, pW85, DOI 10.1093/nar/gkn220; Leclercq M, 2013, NUCLEIC ACIDS RES, V41, P7200, DOI 10.1093/nar/gkt466; Lertampaiporn S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku325; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Liu RJ, 2012, J CLIN ENDOCR METAB, V97, pE968, DOI 10.1210/jc.2011-2982; Lopes IDN, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-124; Mathelier A, 2013, NUCLEIC ACIDS RES, V41, P4392, DOI 10.1093/nar/gkt112; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Ruepp Andreas, 2012, Methods Mol Biol, V822, P249, DOI 10.1007/978-1-61779-427-8_17; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schulz MH, 2013, P NATL ACAD SCI USA, V110, P15686, DOI 10.1073/pnas.1303236110; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Wang HY, 2015, GENE, V559, P119, DOI 10.1016/j.gene.2015.01.021; Wang HY, 2013, MOL BIOSYST, V9, P2154, DOI 10.1039/c3mb70084d; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xuan P, 2015, BIOINFORMATICS, V31, P1805, DOI 10.1093/bioinformatics/btv039; Xuan P, 2011, BIOINFORMATICS, V27, P1368, DOI 10.1093/bioinformatics/btr153; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158	54	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128089	10.1371/journal.pone.0128089	http://dx.doi.org/10.1371/journal.pone.0128089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030752	gold, Green Published			2022-12-27	WOS:000356630900109
J	Heublein, S; Mayr, D; Meindl, A; Angele, M; Gallwas, J; Jeschke, U; Ditsch, N				Heublein, Sabine; Mayr, Doris; Meindl, Alfons; Angele, Martin; Gallwas, Julia; Jeschke, Udo; Ditsch, Nina			Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; BETA-CATENIN GENE; OVARIAN-CANCER; HEREDITARY BREAST; CELL-PROLIFERATION; PATIENT SURVIVAL; RETINOID-X; VITAMIN-D; TUMOR; PROTEIN	Since BRCA1 associated breast cancers are frequently classified as hormone receptor negative or even triple negative, the application of endocrine therapies is rather limited in these patients. Like hormone receptors that bind to estrogen or progesterone, thyroid hormone receptors (TRs) are members of the nuclear hormone receptor superfamily. TRs might be interesting biomarkers-especially in the absence of classical hormone receptors. The current study aimed to investigate whether TRs may be specifically expressed in BRCA1 associated cancer cases and whether they are of prognostic significance in these patients as compared to sporadic breast cancer cases. This study analyzed TR alpha and TR beta immunopositivity in BRCA1 associated (n = 38) and sporadic breast cancer (n = 86). Further, TRs were studied in MCF7 (BRCA1 wildtype) and HCC3153 (BRCA1 mutated) cells. TR beta positivity rate was significantly higher in BRCA1 associated as compared to sporadic breast cancers (p = 0.001). The latter observation remained to be significant when cases that had been matched for clinicopathological criteria were compared (p = 0.037). Regarding BRCA1 associated breast cancer cases TR beta positivity turned out to be a positive prognostic factor for five-year (p = 0.007) and overall survival (p = 0.026) while TR alpha positivity predicted reduced five-year survival (p = 0.030). Activation of TR beta resulted in down-modulation of CTNNB1 while TR alpha inhibition reduced cell viability in HCC3153. However, only BRCA1 wildtype MCF7 cells were capable of rapidly degrading TR alpha 1 in response to T3 stimulation. Significantly, this study identified TR beta to be up-regulated in BRCA1 associated breast cancer and revealed TRs to be associated with patients' prognosis. TRs were also found to be expressed in triple negative BRCA1 associated breast cancer. Further studies need to be done in order to evaluate whether TRs may become interesting targets of endocrine therapeutic approaches, especially when tumors are triple-negative.	[Heublein, Sabine; Gallwas, Julia; Jeschke, Udo; Ditsch, Nina] Univ Munich, Dept Obstet & Gynecol, Munich, Germany; [Mayr, Doris] Univ Munich, Dept Pathol, Munich, Germany; [Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynecol, D-80290 Munich, Germany; [Angele, Martin] Univ Munich, Dept Surg, Munich, Germany	University of Munich; University of Munich; Technical University of Munich; University of Munich	Heublein, S (corresponding author), Univ Munich, Dept Obstet & Gynecol, Munich, Germany.	sabine.heublein@med.uni-muenchen.de	Jeschke, Udo/A-6643-2009	Jeschke, Udo/0000-0003-2623-3235; Angele, Martin/0000-0003-0565-7688	Deutschlandstipendium scholarship of the Ludwig-Maximilians-University of Munich Medical Faculty	Deutschlandstipendium scholarship of the Ludwig-Maximilians-University of Munich Medical Faculty	This work was supported by a Deutschlandstipendium scholarship of the Ludwig-Maximilians-University of Munich Medical Faculty to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Bayraktar S, 2012, BREAST CANCER RES TR, V135, P355, DOI 10.1007/s10549-012-2158-6; Brunelle M, 2011, THYROID, V21, P311, DOI 10.1089/thy.2009.0363; Calvo V, 2011, CANCER RES, V71, P3422, DOI 10.1158/0008-5472.CAN-10-3670; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chi HC, 2013, BIOCHEM BIOPH RES CO, V439, P60, DOI 10.1016/j.bbrc.2013.08.028; Da Silva L, 2010, MODERN PATHOL, V23, pS46, DOI 10.1038/modpathol.2010.37; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; Denver RJ, 2009, DEV BIOL, V326, P155, DOI 10.1016/j.ydbio.2008.11.005; Ditsch N, 2012, IN VIVO, V26, P87; Ditsch N, 2013, HISTOL HISTOPATHOL, V28, P227, DOI 10.14670/HH-28.227; Ditsch N, 2012, ONCOL LETT, V4, P665, DOI 10.3892/ol.2012.799; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; Ditsch N, 2010, ANTICANCER RES, V30, P1713; Ferreira E, 2007, PATHOL RES PRACT, V203, P39, DOI 10.1016/j.prp.2006.09.005; Fischer C, 2013, J MED GENET, V50, P360, DOI 10.1136/jmedgenet-2012-101415; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Giani C, 1996, J CLIN ENDOCR METAB, V81, P990, DOI 10.1210/jc.81.3.990; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guigon CJ, 2010, ENDOCRINOLOGY, V151, P5528, DOI 10.1210/en.2010-0475; Heublein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071791; Heublein S, 2012, REPROD SCI, V19, P1197, DOI 10.1177/1933719112446085; Honma N, 2011, CANCER SCI, V102, P1848, DOI 10.1111/j.1349-7006.2011.02018.x; Honrado E, 2006, ONCOGENE, V25, P5837, DOI 10.1038/sj.onc.1209875; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim DW, 2012, AM J CANCER RES, V2, P606; Kim WG, 2014, THYROID, V24, P260, DOI 10.1089/thy.2013.0054; Kim WG, 2013, ENDOCRINOLOGY, V154, P25, DOI 10.1210/en.2012-1728; Lenhard M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-553; Lenhard M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-2; Lenhard M, 2011, HISTOPATHOLOGY, V58, P990, DOI 10.1111/j.1365-2559.2011.03848.x; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; Lin YH, 2013, ONCOGENE, V32, P4509, DOI 10.1038/onc.2013.309; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Olivares-Hernandez R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-33; Perri A, 2014, MOL CELL ENDOCRINOL, V382, P205, DOI 10.1016/j.mce.2013.10.001; PERRY M, 1978, ANN ROY COLL SURG, V60, P290; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Raparti Girish, 2013, Indian J Endocrinol Metab, V17, P211, DOI 10.4103/2230-8210.109663; RASMUSSON B, 1987, EUR J CANCER CLIN ON, V23, P553, DOI 10.1016/0277-5379(87)90319-1; Santos CT, 2009, ORBIT, V28, P162, DOI 10.1080/01676830802418781; Sirakov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034162; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; TSUCHIYA A, 1981, JPN J SURG, V11, P108, DOI 10.1007/BF02468879; van Beeren HC, 2003, ENDOCRINOLOGY, V144, P552, DOI 10.1210/en.2002-220604; Wang XQ, 2010, J CELL MOL MED, V14, P368, DOI 10.1111/j.1582-4934.2008.00489.x; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	49	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127072	10.1371/journal.pone.0127072	http://dx.doi.org/10.1371/journal.pone.0127072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029931	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900040
J	Lins, J; Lima, HP; Baccaro, FB; Kinupp, VF; Shepard, GH; Clement, CR				Lins, Juliana; Lima, Helena P.; Baccaro, Fabricio B.; Kinupp, Valdely F.; Shepard, Glenn H., Jr.; Clement, Charles R.			Pre-Columbian Floristic Legacies in Modern Homegardens of Central Amazonia	PLOS ONE			English	Article							DOMESTICATION; DIVERSITY; PATTERNS; GARDENS	Historical ecologists have demonstrated legacy effects in apparently wild landscapes in Europe, North America, Mesoamerica, Amazonia, Africa and Oceania. People live and farm in archaeological sites today in many parts of the world, but nobody has looked for the legacies of past human occupations in the most dynamic areas in these sites: homegardens. Here we show that the useful flora of modern homegardens is partially a legacy of pre-Columbian occupations in Central Amazonia: the more complex the archaeological context, the more variable the floristic composition of useful native plants in homegardens cultivated there today. Species diversity was 10% higher in homegardens situated in multi-occupational archaeological contexts compared with homegardens situated in single-occupational ones. Species heterogeneity (beta-diversity) among archaeological contexts was similar for the whole set of species, but markedly different when only native Amazonian species were included, suggesting the influence of pre-conquest indigenous occupations on current homegarden species composition. Our findings show that the legacy of pre-Columbian occupations is visible in the most dynamic of all agroecosystems, adding another dimension to the human footprint in the Amazonian landscape.	[Lins, Juliana] INPA, Programa Posgrad Bot, Manaus, Amazonas, Brazil; [Lima, Helena P.] Museu Paraense Emilio Goeldi, Coordenacao Ciencias Humanas, Belem, Para, Brazil; [Baccaro, Fabricio B.] Univ Fed Amazonas UFAM, Dept Biol, Manaus, Amazonas, Brazil; [Kinupp, Valdely F.] Inst Fed Educ Ciencia & Tecnol Amazonas IFAM, Herbario EAFM, Manaus, Amazonas, Brazil; [Shepard, Glenn H., Jr.] Museu Paraense Emilio Goeldi, Dept Anthropol, Belem, Para, Brazil; [Clement, Charles R.] INPA, Coordenacao Tecnol & Inovacao, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi; Universidade Federal de Amazonas; Instituto Federal do Amazonas (IFAM); Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia	Lins, J (corresponding author), INPA, Programa Posgrad Bot, Manaus, Amazonas, Brazil.	judearacaju@gmail.com	Baccaro, Fabricio/HIR-4297-2022; Shepard, Glenn H./C-3667-2014; Shepard, Glenn/AAS-4059-2021; Clement, Charles Roland/G-6081-2010; Lima, Helena Pinto/AAC-9252-2021; Lima, Helena/AAC-1814-2019; Baccaro, Fabricio/H-3885-2012	Baccaro, Fabricio/0000-0003-4747-1857; Shepard, Glenn H./0000-0003-3195-8230; Shepard, Glenn/0000-0003-3195-8230; Clement, Charles Roland/0000-0002-8421-1029; Lima, Helena Pinto/0000-0001-5787-7231; Baccaro, Fabricio/0000-0003-4747-1857	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [134197/2011-9]; Fundacao de Amparo a Pesquisa do Estado do Amazonas [624/2007]; Conselho Nacional de Desenvolvimento Cientifico e Tecnoloogico [306382/2011-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas; Conselho Nacional de Desenvolvimento Cientifico e Tecnoloogico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JL received a Master's scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), grant number: 134197/2011-9; HPL received financial support to field logistics from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) and Fundacao de Amparo a Pesquisa do Estado do Amazonas (http://www.fapeam.am.gov.br/), grant number: 624/2007; and CRC received a research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnoloogico (http://www.cnpq.br/), grant number: 306382/2011-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2010, LISTA ESPECIES FLORA; Baayen RH, 2011, LANGUAGER DATA SETS; Bailey K., 2008, METHODS SOCIAL RES, V4th ed; Balee W., 2010, Diversity, V2, P163; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayliss-Smith T, 2003, AMBIO, V32, P346, DOI 10.1639/0044-7447(2003)032[0346:RCAHOH]2.0.CO;2; Clement C. R., 2010, Diversity, V2, P72; Clement C. R., 2014, ENCY GLOBAL ARCHAEOL, P4388, DOI [DOI 10.1007/978-1-4419-0465-2_817, 10.1007/978-1-4419-0465-2_817]; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Dambrine E, 2007, ECOLOGY, V88, P1430, DOI 10.1890/05-1314; Denevan WM, 1996, ANN ASSOC AM GEOGR, V86, P654, DOI 10.1111/j.1467-8306.1996.tb01771.x; Ducke A, 1946, B TECNICO I AGRONOMI, V8, P1; Embrapa, 1999, MANUAL ANALISES QUIM; Eriksen L, 2011, NATURE CULTURE PREHI, V12; Fraser JA, 2011, ECON BOT, V65, P1, DOI 10.1007/s12231-010-9143-y; Fraser JA, 2014, ANN ASSOC AM GEOGR, V104, P1222, DOI 10.1080/00045608.2014.941735; Fraser JA, 2011, HUM ECOL, V39, P395, DOI 10.1007/s10745-011-9405-z; Junqueira AB, 2010, BIODIVERS CONSERV, V19, P1933, DOI 10.1007/s10531-010-9813-1; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kumar BM, 2004, AGROFOREST SYST, V61-2, P135, DOI 10.1023/B:AGFO.0000028995.13227.ca; Leon J., 2000, BOT CULTIVOS TROPICA, Vthird; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Lima HP, 2014, FRONTEIRAS PASSADO A, P35; McMichael CH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2475; McMichael CH, 2012, SCIENCE, V336, P1429, DOI 10.1126/science.1219982; Meggers Betty, 1983, ANCIENT S AM, P287; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pearsall DM, 2010, HDB PROCEDURES; Perrault-Archambault M, 2008, ECON BOT, V62, P109, DOI 10.1007/s12231-008-9010-2; PETERS CM, 2000, IMPERFECT BALANCE LA, P203; Piperno D.R., 2006, PHYTOLITHS COMPREHEN; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; R Core Team, 2021, R LANGUAGE ENV STAT; Renfrew C, 2005, ARCHEOLOGY KEY CONCE; Ross NJ, 2011, ECOL APPL, V21, P75, DOI 10.1890/09-0662.1; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Simoes MF, 1981, PESQUISAS ARQUEOLOGI; Simoes MF, 1983, PESQUISA CADASTRO SI; Simoes MF, 1987, REV ARQUEOL, V4, P49; Simoes MF, 1978, AREAS AMAZONIA LEGAL; Souza M, 2009, HIST AMAZONIA; Tollefson J, 2013, NATURE, V502, P160, DOI 10.1038/502160a; TURNER BL, 1984, ECON BOT, V38, P179, DOI 10.1007/BF02858831; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zuur A, 2009, MIXED EFFECTS MODELS	47	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127067	10.1371/journal.pone.0127067	http://dx.doi.org/10.1371/journal.pone.0127067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030879	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900038
J	Nicolai, S; Filippi, S; Caputo, M; Cipak, L; Gregan, J; Ammerer, G; Frontini, M; Willems, D; Prantera, G; Balajee, AS; Proietti-De-Santis, L				Nicolai, Serena; Filippi, Silvia; Caputo, Manuela; Cipak, Lubos; Gregan, Juraj; Ammerer, Gustav; Frontini, Mattia; Willems, Daniela; Prantera, Giorgio; Balajee, Adayabalam S.; Proietti-De-Santis, Luca			Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics	PLOS ONE			English	Article							TRANSCRIPTION-COUPLED REPAIR; DNA TOPOISOMERASE-I; TANDEM AFFINITY PURIFICATION; POLYMERASE-II; P53; ELONGATION; MUTATIONS; COMPLEX; CANCER; CELLS	The CSB protein, a member of the SWI/SNF ATP dependent chromatin remodeling family of proteins, plays a role in a sub-pathway of nucleotide excision repair (NER) known as transcription coupled repair (TCR). CSB is frequently mutated in Cockayne syndrome group B, a segmental progeroid human autosomal recessive disease characterized by growth failure and degeneration of multiple organs. Though initially classified as a DNA repair protein, recent studies have demonstrated that the loss of CSB results in pleiotropic effects. Identification of novel proteins belonging to the CSB interactome may be useful not only for predicting the molecular basis for diverse pathological symptoms of CS-B patients but also for unraveling the functions of CSB in addition to its authentic role in DNA repair. In this study, we performed tandem affinity purification (TAP) technology coupled with mass spectrometry and co-immunoprecipitation studies to identify and characterize the proteins that potentially interact with CSB-TAP. Our approach revealed 33 proteins that were not previously known to interact with CSB. These newly identified proteins indicate potential roles for CSB in RNA metabolism involving repression and activation of transcription process and in the maintenance of chromatin dynamics and integrity.	[Nicolai, Serena; Filippi, Silvia; Caputo, Manuela; Willems, Daniela; Prantera, Giorgio; Proietti-De-Santis, Luca] Univ Tuscia, Dept Ecol & Biol, Unit Mol Genet Aging, I-01100 Viterbo, Italy; [Cipak, Lubos] Slovak Acad Sci, Canc Res Inst, Bratislava, Slovakia; [Gregan, Juraj] Comenius Univ, Dept Genet, Bratislava, Slovakia; [Ammerer, Gustav] Univ Vienna, Dept Biochem, Max F Perutz Labs, Mass Spectrometry Facil, Vienna, Austria; [Frontini, Mattia] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Balajee, Adayabalam S.] Columbia Univ, Med Ctr, Ctr Radiol Res, Dept Radiat Oncol, New York, NY 10032 USA	Tuscia University; Slovak Academy of Sciences; Comenius University Bratislava; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Cambridge; Columbia University	Proietti-De-Santis, L (corresponding author), Univ Tuscia, Dept Ecol & Biol, Unit Mol Genet Aging, I-01100 Viterbo, Italy.	proietti@unitus.it	Gregan, Juraj/I-4161-2014; De Santis, Luca Proietti/A-4119-2015; Cipak, Lubos/G-5553-2015; Filippi, Silvia/ABC-5528-2021; /C-4479-2018	Gregan, Juraj/0000-0002-2989-8374; De Santis, Luca Proietti/0000-0002-2715-9113; Cipak, Lubos/0000-0001-7897-6001; /0000-0003-0495-7953; Prantera, Giorgio/0000-0003-0970-9561; FILIPPI, Silvia/0000-0001-6213-7350	AIRC [IG13074]; Telethon [GGP11176]; Slovak Research and Development Agency [2/0014/14]; FWF [P21437, P23609]; EC [PCIG11-GA-2012-322300]; APVV [APVV-0334-12]; Austrian Science Foundation [1/0196/14]; Slovak Research and Development Agency; European Commission; Austrian Science Fund (FWF) [P 21437] Funding Source: researchfish	AIRC(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); Slovak Research and Development Agency; FWF(Austrian Science Fund (FWF)); EC; APVV(Slovak Research and Development Agency); Austrian Science Foundation; Slovak Research and Development Agency; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from AIRC (IG13074) and Telethon (GGP11176) to LPDS. LC was supported by the VEGA grant (2/0014/14) from the Slovak Research and Development Agency; and JG by FWF grants (P21437, P23609), EC (PCIG11-GA-2012-322300), APVV (APVV-0334-12) and VEGA (1/0196/14) from the Austrian Science Foundation, the European Commission, and the Slovak Research and Development Agency, respectively.	Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Ballif BC, 2012, HUM GENET, V131, P145, DOI 10.1007/s00439-011-1073-y; Bedford L, 2008, BBA-MOL BASIS DIS, V1782, P683, DOI 10.1016/j.bbadis.2008.10.009; Bladen CL, 2005, J BIOL CHEM, V280, P5205, DOI 10.1074/jbc.M412758200; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; Brooks PJ, 2008, DNA REPAIR, V7, P834, DOI 10.1016/j.dnarep.2008.01.017; Caputo M, 2013, DNA REPAIR, V12, P293, DOI 10.1016/j.dnarep.2013.01.008; Ciaffardini F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.228; Cipak L, 2009, PROTEOMICS, V9, P4825, DOI 10.1002/pmic.200800948; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Frontini M, 2012, AGING-US, V4, P89, DOI 10.18632/aging.100439; Frontini M, 2009, CELL CYCLE, V8, P693, DOI 10.4161/cc.8.5.7754; Gregan J, 2007, NAT PROTOC, V2, P1145, DOI 10.1038/nprot.2007.172; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; Huber C, 2005, NAT GENET, V37, P1119, DOI 10.1038/ng1628; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Laposa RR, 2007, P NATL ACAD SCI USA, V104, P1389, DOI 10.1073/pnas.0610619104; Latini P, 2011, CELL CYCLE, V10, P3719, DOI 10.4161/cc.10.21.17905; Li L, 2008, MOL CELL BIOL, V28, P6413, DOI 10.1128/MCB.01053-08; Licht CL, 2003, AM J HUM GENET, V73, P1217, DOI 10.1086/380399; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; Monti M, 2005, CLIN CHIM ACTA, V357, P140, DOI 10.1016/j.cccn.2005.03.019; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Nogues G, 2003, IUBMB LIFE, V55, P235, DOI 10.1080/1521654031000119830; Pegoraro G, 2009, AGING-US, V1, P1017, DOI 10.18632/aging.100106; Phee BK, 2006, PROTEOMICS, V6, P3671, DOI 10.1002/pmic.200500222; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Ren L, 2003, J BIOCHEM BIOPH METH, V57, P143, DOI 10.1016/S0165-022X(03)00105-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rumpf C, 2010, CELL CYCLE, V9, P3997, DOI 10.4161/cc.9.19.13233; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sarasin A, 2007, DNA REPAIR, V6, P265, DOI 10.1016/j.dnarep.2006.12.001; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shih SJ, 2005, CANCER RES, V65, P9194, DOI 10.1158/0008-5472.CAN-05-2387; Straub T, 2000, BIOCHEMISTRY-US, V39, P7552, DOI 10.1021/bi992898e; Tanackovic G, 2011, HUM MOL GENET, V20, P2116, DOI 10.1093/hmg/ddr094; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tuduri S, 2010, CELL CYCLE, V9, P1886, DOI 10.4161/cc.9.10.11539; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	58	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128558	10.1371/journal.pone.0128558	http://dx.doi.org/10.1371/journal.pone.0128558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030138	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900169
J	Yao, W; Li, YX; Li, BJ; Luo, H; Xu, HT; Pan, ZX; Xie, Z; Li, QF				Yao, Wang; Li, Yinxia; Li, Bojiang; Luo, Hua; Xu, Hongtao; Pan, Zengxiang; Xie, Zhuang; Li, Qifa			Epigenetic Regulation of Bovine Spermatogenic Cell-Specific Gene Boule	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; UNIQUE DNA-BINDING; TRANSCRIPTION FACTOR; METHYLATION STATUS; Y-CHROMOSOME; DAZL GENE; SACCHAROMYCES-CEREVISIAE; MALE-INFERTILITY; SPLICE VARIANTS; CONSERVED ROLE	Non-primate mammals have two deleted azoospermia (DAZ) family genes, DAZL and Boule; genes in this family encode RNA-binding proteins essential for male fertility in diverse animals. Testicular DAZL transcription is regulated by epigenetic factors such as DNA methylation. However, nothing is known about the epigenetic regulation of Boule. Here, we explored the role of DNA methylation in the regulation of the bovine Boule (bBoule) gene. We found that a long CpG island (CGI) in the bBoule promoter was hypermethylated in the testes of cattle-yak hybrids with low bBoule expression, whereas cattle had relatively low methylation levels (P < 0.01), and there was no difference in the methylation level in the short CGI of the gene body between cattle and cattle-yak hybrids (P > 0.05). We identified a 107 bp proximal core promoter region of bBoule. Intriguingly, the differences in the methylation level between cattle and cattle-yak hybrids were larger in the core promoter than outside the core promoter. An in vitro methylation assay showed that the core promoter activity of bBoule decreased significantly after M.SssI methylase treatment (P < 0.01). We also observed dramatically increased bBoule transcription in bovine mammary epithelial cells (BMECs) after treatment with the methyltransferase inhibitor 5-Aza-dC. Taken together, our results establish that methylation status of the core promoter might be involved in testicular bBoule transcription, and may provide new insight into the epigenetic regulation of DAZ family genes and clinical insights regarding male infertility.	[Yao, Wang; Li, Bojiang; Luo, Hua; Xu, Hongtao; Pan, Zengxiang; Xie, Zhuang; Li, Qifa] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Li, Yinxia] Jiangsu Acad Agr Sci, Inst Anim Sci, Nanjing 210014, Jiangsu, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences	Li, QF (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.	liqifa@njau.edu.cn	Li, Qifa/GPX-2381-2022		National Natural Science Foundation of China [30500360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (Grant No. 30500360), http://www.nsfc.gov.cn/.	Asada K, 2003, ONCOLOGY-BASEL, V64, P380, DOI 10.1159/000070297; Bennett KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006931; Berkowitz KM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002996; Bhat N, 2014, GENE, V540, P140, DOI 10.1016/j.gene.2014.02.057; Blattler A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0469-0; Braun KA, 2013, MOL CELL BIOL, V33, P712, DOI 10.1128/MCB.01226-12; Camprubi C, 2012, EPIGENETICS-US, V7, P1115, DOI 10.4161/epi.21743; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Comazzetto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004597; Correa S, 2014, EPIGENETICS-US, V9, P1172, DOI 10.4161/epi.29675; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Friemel C, 2014, FERTIL STERIL, V101, P1097, DOI 10.1016/j.fertnstert.2013.12.054; Gasmi N, 2014, GENETICS, V198, P547, DOI 10.1534/genetics.114.168609; Gu Y, 2013, ANIM REPROD SCI, V140, P131, DOI 10.1016/j.anireprosci.2013.05.010; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Gutjahr A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku192; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; He J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073996; Heyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047892; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Huang YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04570; Hughes JF, 2012, BIOESSAYS, V34, P1035, DOI 10.1002/bies.201200066; Jenkins HT, 2011, P NATL ACAD SCI USA, V108, P18266, DOI 10.1073/pnas.1105211108; Jones B, 2014, NAT REV GENET, V15, DOI 10.1038/nrg3797; Julaton VTA, 2011, HUM MOL GENET, V20, P2238, DOI 10.1093/hmg/ddr114; Kasimanickam V, 2014, REPROD DOMEST ANIM, V49, P315, DOI 10.1111/rda.12276; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim B, 2014, REPROD FERT DEVELOP, V26, P307, DOI 10.1071/RD12290; Klaver R, 2012, J ASSIST REPROD GEN, V29, P943, DOI 10.1007/s10815-012-9813-z; Knower KC, 2010, MOL CELL ENDOCRINOL, V321, P123, DOI 10.1016/j.mce.2010.02.035; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071215; Li BJ, 2014, GENE, V550, P193, DOI 10.1016/j.gene.2014.08.028; Li MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015910; Li MZ, 2013, MOL BIOL REP, V40, P4383, DOI 10.1007/s11033-013-2527-1; Li MZ, 2013, J CELL BIOCHEM, V114, P294, DOI 10.1002/jcb.24368; Lin YM, 2005, HUM REPROD, V20, P782, DOI 10.1093/humrep/deh647; Linher K, 2009, DIFFERENTIATION, V77, P335, DOI 10.1016/j.diff.2008.08.001; Liu ZS, 2011, ANIM REPROD SCI, V126, P258, DOI 10.1016/j.anireprosci.2011.05.013; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Lu CG, 2013, DEVELOPMENT, V140, P3522, DOI 10.1242/dev.098947; Lu YH, 2014, CELL REP, V8, P500, DOI 10.1016/j.celrep.2014.06.035; Luetjens CM, 2004, J CLIN ENDOCR METAB, V89, P1926, DOI 10.1210/jc.2003-031178; Luo H, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-58; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Miyata K, 2015, HUM MOL GENET, V24, P410, DOI 10.1093/hmg/ddu457; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Peng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102265; Pinheiro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038076; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Rotondo JC, 2013, EPIGENETICS-US, V8, P990, DOI 10.4161/epi.25798; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Shen W, 2012, ENDOCRINOLOGY, V153, P3482, DOI 10.1210/en.2011-1456; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Sun LY, 2014, MOL MED REP, V10, P423, DOI 10.3892/mmr.2014.2196; Teng YN, 2012, HUM REPROD, V27, P2857, DOI 10.1093/humrep/des227; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Wu W, 2010, CLIN CHEM LAB MED, V48, P355, DOI 10.1515/CCLM.2010.007; Xie WS, 2002, J BIOL CHEM, V277, P17765, DOI 10.1074/jbc.M200954200; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013; Zhang QB, 2009, MOL GENET GENOMICS, V281, P67, DOI 10.1007/s00438-008-0394-6; Zhang SM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04642; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200; Zhu L, 2014, HUM MOL GENET, V23, P1563, DOI 10.1093/hmg/ddt547	74	13	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128250	10.1371/journal.pone.0128250	http://dx.doi.org/10.1371/journal.pone.0128250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030766	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900133
J	Lev, N; Barhum, Y; Ben-Zur, T; Aharony, I; Trifonov, L; Regev, N; Melamed, E; Gruzman, A; Offen, D				Lev, Nirit; Barhum, Yael; Ben-Zur, Tali; Aharony, Israel; Trifonov, Lena; Regev, Noa; Melamed, Eldad; Gruzman, Arie; Offen, Daniel			A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; PROTECTS; NEUROPROTECTION; ACTIVATION; MUTATIONS; REGULATOR; TOXICITY; NEURONS; BINDING	Drugs currently used for treating Parkinson's disease patients provide symptomatic relief without altering the neurodegenerative process. Our aim was to examine the possibility of using DJ-1 (PARK7), as a novel therapeutic target for Parkinson's disease. We designed a short peptide, named ND-13. This peptide consists of a 13 amino acids segment of the DJ-1-protein attached to 7 amino acids derived from TAT, a cell penetrating protein. We examined the effects of ND-13 using in vitro and in vivo experimental models of Parkinson's disease. We demonstrated that ND-13 protects cultured cells against oxidative and neurotoxic insults, reduced reactive oxygen species accumulation, activated the protective erythroid-2 related factor 2 system and increased cell survival. ND-13 robustly attenuated dopaminergic system dysfunction and in improved the behavioral outcome in the 6-hydroxydopamine mouse model of Parkinson's disease, both in wild type and in DJ-1 knockout mice. Moreover, ND-13 restored dopamine content in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model. These findings validate DJ-1 as a promising therapeutic target in Parkinson's disease and identify a novel peptide with clinical potential, which may be significant for a broader range of neurological diseases, possibly with an important impact for the neurosciences.	[Lev, Nirit; Barhum, Yael; Ben-Zur, Tali; Aharony, Israel; Regev, Noa; Melamed, Eldad; Offen, Daniel] Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Lev, Nirit; Melamed, Eldad] Rabin Med Ctr, Dept Neurol, Petah Tiqwa, Israel; [Trifonov, Lena; Gruzman, Arie] Bar Ilan Univ, Fac Exact Sci, Dept Chem, Div Med Chem, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Bar Ilan University	Offen, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	danioffen@gmail.com	Lev, Nirit/AAA-1253-2020	Trifonov, Lena/0000-0002-8559-6944; Regev, Noa/0000-0002-5865-4774	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation [1690/09]; UGH Pharma, Inc.	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation; UGH Pharma, Inc.	This research was supported by The Legacy Heritage Clinical Research Initiative of the Israel Science Foundation (grant No. 1690/09) and funding from UGH Pharma, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Doeppner TR, 2010, NEUROBIOL DIS, V40, P265, DOI 10.1016/j.nbd.2010.05.033; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105; Gan L, 2010, EUR J NEUROSCI, V31, P967, DOI 10.1111/j.1460-9568.2010.07138.x; Gou XC, 2011, J DRUG TARGET, V19, P86, DOI 10.3109/10611861003733961; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117190; Lev N, 2013, J GERONTOL A-BIOL, V68, P215, DOI 10.1093/gerona/gls147; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Siebert A, 2009, J NEUROSCI RES, V87, P1659, DOI 10.1002/jnr.21975; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192; Tarantino P, 2009, PARKINSONISM RELAT D, V15, P324, DOI 10.1016/j.parkreldis.2008.07.001; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Waragai M, 2007, NEUROSCI LETT, V425, P18, DOI 10.1016/j.neulet.2007.08.010; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhong ZY, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-30	43	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127549	10.1371/journal.pone.0127549	http://dx.doi.org/10.1371/journal.pone.0127549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024237	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400042
J	Musicki, B; Zhang, YX; Chen, HL; Brown, TR; Zirkin, BR; Burnett, AL				Musicki, Biljana; Zhang, Yuxi; Chen, Haolin; Brown, Terry R.; Zirkin, Barry R.; Burnett, Arthur L.			Mechanism of Testosterone Deficiency in the Transgenic Sickle Cell Mouse	PLOS ONE			English	Article							TESTICULAR INFARCTION; TRANSLOCATOR PROTEIN; LIPID-PEROXIDATION; GONADAL-FUNCTION; DISEASE; MICE; ANEMIA; MEN; SECONDARY; HORMONE	Testosterone deficiency is associated with sickle cell disease (SCD), but its underlying mechanism is not known. We investigated the possible occurrence and mechanism of testosterone deficiency in a mouse model of human SCD. Transgenic sickle male mice (Sickle) exhibited decreased serum and intratesticular testosterone and increased luteinizing hormone (LH) levels compared with wild type (WT) mice, indicating primary hypogonadism in Sickle mice. LH-, dbcAMP-, and pregnenolone- (but not 22-hydroxycholesterol)-stimulated testosterone production by Leydig cells isolated from the Sickle mouse testis was decreased compared to that of WT mice, implying defective Leydig cell steroidogenesis. There also was reduced protein expression of steroidogenic acute regulatory protein (STAR), but not cholesterol side-chain cleavage enzyme (P450scc), in the Sickle mouse testis. These data suggest that the capacity of P450scc to support testosterone production may be limited by the supply of cholesterol to the mitochondria in Sickle mice. The sickle mouse testis exhibited upregulated NADPH oxidase subunit gp91phox and increased oxidative stress, measured as 4-hydroxy-2-nonenal, and unchanged protein expression of an antioxidant glutathione peroxidase-1. Mice heterozygous for the human sickle globin (Hemi) exhibited intermediate hypogonadal changes between those of WT and Sickle mice. These results demonstrate that testosterone deficiency occurs in Sickle mice, mimicking the human condition. The defects in the Leydig cell steroidogenic pathway in Sickle mice, mainly due to reduced availability of cholesterol for testosterone production, may be related to NADPH oxidase-derived oxidative stress. Our findings suggest that targeting testicular oxidative stress or steroidogenesis mechanisms in SCD offers a potential treatment for improving phenotypic changes associated with testosterone deficiency in this disease.	[Musicki, Biljana; Zhang, Yuxi; Burnett, Arthur L.] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Musicki, Biljana; Zhang, Yuxi; Burnett, Arthur L.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA; [Chen, Haolin; Brown, Terry R.; Zirkin, Barry R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Musicki, B (corresponding author), Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA.	bmusicki@jhmi.edu			NIH/NIDDK [RO1DK093917]; NIH/NIA [R37AG021092]; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021092] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIDDK grant RO1DK093917 (to ALB) and NIH/NIA grant R37AG021092 (to BRZ). The University of Virginia, Center for Research in Reproduction, Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASI AA, 1976, ANN INTERN MED, V85, P601, DOI 10.7326/0003-4819-85-5-601; Abudu Emmanuel K, 2011, BMC Res Notes, V4, P298, DOI 10.1186/1756-0500-4-298; Akinsheye I, 2010, J CELL PHYSIOL, V224, P620, DOI 10.1002/jcp.22195; Bomhard EM, 2013, ARCH TOXICOL, V87, P1201, DOI 10.1007/s00204-013-1024-6; Brachet C, 2007, J PEDIAT HEMATOL ONC, V29, P445, DOI 10.1097/MPH.0b013e31806451ac; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; CHANDRASHEKAR V, 1991, BIOL REPROD, V44, P135, DOI 10.1095/biolreprod44.1.135; Chung JY, 2013, ENDOCRINOLOGY, V154, P2156, DOI 10.1210/en.2012-2226; Cohen G, 2013, FREE RADICAL BIO MED, V65, P978, DOI 10.1016/j.freeradbiomed.2013.08.163; COLLIN O, 1993, J REPROD FERTIL, V97, P115; DADA OA, 1980, CLIN CHIM ACTA, V105, P269, DOI 10.1016/0009-8981(80)90469-6; ELHAZMI MAF, 1992, J TROP PEDIATRICS, V38, P307, DOI 10.1093/tropej/38.6.307; FALLEST PC, 1995, BIOL REPROD, V53, P103, DOI 10.1095/biolreprod53.1.103; Gofrit ON, 1998, J UROLOGY, V160, P835, DOI 10.1016/S0022-5347(01)62803-9; Hebbel Robert P., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P271; Holmes NM, 1998, J UROLOGY, V160, P130, DOI 10.1016/S0022-5347(01)63058-1; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Kassim AA, 2013, ANNU REV MED, V64, P451, DOI 10.1146/annurev-med-120611-143127; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; Kaul DK, 2008, AM J PHYSIOL-HEART C, V295, pH39, DOI 10.1152/ajpheart.00162.2008; Le B, 2014, ANDROLOGY-US, V2, P484, DOI 10.1111/j.2047-2927.2014.00225.x; Li M, 2003, UROLOGY, V62, P551; Loscalzo Joseph, 2010, Expert Rev Endocrinol Metab, V5, P15; Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075; Manci EA, 2006, BLOOD, V107, P1651, DOI 10.1182/blood-2005-07-2839; Midzak A, 2014, TRAFFIC, V15, P895, DOI 10.1111/tra.12177; MODEBE O, 1995, FERTIL STERIL, V63, P907, DOI 10.1016/S0015-0282(16)57500-1; Montezano AC, 2011, CLIN SCI, V120, P131, DOI 10.1042/CS20100384; Morrison BF, 2013, ANDROLOGY-US, V1, P576, DOI 10.1111/j.2047-2927.2013.00084.x; Musicki B, 2014, J SEX MED, V11, P424, DOI 10.1111/jsm.12391; Naik RP, 2014, JAMA-J AM MED ASSOC, V312, P2115, DOI 10.1001/jama.2014.15063; Odievre Marie-Helene, 2011, Indian J Med Res, V134, P532; OSEGBE DN, 1987, POSTGRAD MED J, V63, P95, DOI 10.1136/pgmj.63.736.95; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; PARSHAD O, 1994, W INDIAN MED J, V43, P12; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Reyes JG, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/929285; Ridha A, 2014, LANCET, V384, P2172, DOI 10.1016/S0140-6736(14)61944-9; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Salva A, 2001, J ANDROL, V22, P665; SINGHAL A, 1995, W INDIAN MED J, V44, P20; Sun KQ, 2013, CURR OPIN HEMATOL, V20, P215, DOI 10.1097/MOH.0b013e32835f55f9; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Williams R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00015; Wood KC, 2007, CLIN EXP PHARMACOL P, V34, P926, DOI 10.1111/j.1440-1681.2007.04639.x; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Zhang GL, 2013, REPROD TOXICOL, V36, P60, DOI 10.1016/j.reprotox.2012.12.002	50	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128694	10.1371/journal.pone.0128694	http://dx.doi.org/10.1371/journal.pone.0128694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023917	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400101
J	Novella-Maestre, E; Herraiz, S; Rodriguez-Iglesias, B; Diaz-Garca, C; Pellicer, A				Novella-Maestre, Edurne; Herraiz, Sonia; Rodriguez-Iglesias, Beatriz; Diaz-Garca, Cesar; Pellicer, Antonio			Short-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer Patients	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; FERTILITY PRESERVATION; VITRIFICATION; AUTOTRANSPLANTATION; TRANSPLANTATION; SUPPRESSION; CHILDHOOD; CULTURE; OOCYTES; TARGET	Introduction In vitro activation and growth of primordial dormant follicles to produce fertilizable oocytes would provide a useful instrument for fertility preservation. The employment of Phosphatase and TENsin homolog (PTEN) inhibitors, in combination with Protein kinase B (Akt) stimulating molecules, has been previously employed to increase follicular activation through the stimulation of the PTEN-Akt pathway. Methods We aim to establish improved in vitro activation also for cancer patients whose ovarian tissue has already been cryopreserved. Fresh and previously cryopreserved human ovarian cortex were exposed to short-term, low-concentration and ovary-specific treatment with only a PTEN inhibitor. Results Our in vitro activation protocol enhances the activation mechanisms of primordial follicles in both fresh and cryopreserved samples, and enlarges growing populations without inducing apoptosis in either follicles or the surrounding stroma. Treatment augments estradiol secretion wand restores the expression levels of the previously diminished Anti-Mullerian hormone by means of cryopreservation procedures. Genomic modulation of the relative expression of PTEN pathway genes was found in treated samples. Conclusion The in vitro activation protocol offers new alternatives for patients with cryopreserved tissue as it increases the pool of viable activated follicles available for in vitro growth procedures. The combination of ovarian tissue cryopreservation and in vitro activation of primordial follicles, the main ovarian reserve component, will be a major advancement in fertility preservation.	[Novella-Maestre, Edurne] Hosp Univ & Politecn La Fe, Unidad Genet, Valencia, Spain; [Novella-Maestre, Edurne; Herraiz, Sonia; Rodriguez-Iglesias, Beatriz; Diaz-Garca, Cesar; Pellicer, Antonio] Inst Invest Sanitario La Fe, Grp Invest Med Reprod, Valencia, Spain; [Novella-Maestre, Edurne; Herraiz, Sonia; Rodriguez-Iglesias, Beatriz; Diaz-Garca, Cesar; Pellicer, Antonio] Hosp Univ & Politecn La Fe, Area Salud Mujer, Unidad Preservac Fertilidad, Valencia, Spain; [Rodriguez-Iglesias, Beatriz] IGENOMIX, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Herraiz, S (corresponding author), Inst Invest Sanitario La Fe, Grp Invest Med Reprod, Valencia, Spain.	Sonia.Herraiz@ivi.es	Pellicer, Antonio/AAA-6005-2020; Herraiz, Sonia/M-6119-2015	Pellicer, Antonio/0000-0002-8254-863X; Herraiz, Sonia/0000-0003-0703-6922; Diaz-Garcia, Cesar/0000-0002-2773-1343	Spanish Ministry of Economy and Competitiveness [SAF 2011-30031-CO2-01, FIS PI13/02353, CD11/00292]; Dexeus Women's Health Foundation; Regional Valencian Ministry of Education [PROMETEOII/2014/045, GV/2014/115]; Spanish Ministry of Education, Culture and Sport [AP-2010-0675]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Dexeus Women's Health Foundation; Regional Valencian Ministry of Education; Spanish Ministry of Education, Culture and Sport(Spanish Government)	This work has been supported by Grants SAF 2011-30031-CO2-01 and FIS PI13/02353 from the Spanish Ministry of Economy and Competitiveness, by the Dexeus Women's Health Foundation Grant 2011 and by PROMETEOII/2014/045 and GV/2014/115 by the Regional Valencian Ministry of Education. SH participation has been supported by a grant CD11/00292 from the Spanish Ministry of Economy and Competitiveness and BRI by AP-2010-0675 grant from the Spanish Ministry of Education, Culture and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Amorim CA, 2013, HUM REPROD, V28, P2146, DOI 10.1093/humrep/det103; Amorim CA, 2012, FERTIL STERIL, V98, P1291, DOI 10.1016/j.fertnstert.2012.07.1109; Anderson RA, 2008, REPRODUCTION, V136, P681, DOI 10.1530/REP-08-0097; Bastings L, 2013, HUM REPROD UPDATE, V19, P483, DOI 10.1093/humupd/dmt020; Bedoschi G, 2013, FERTIL STERIL, V99, P1496, DOI 10.1016/j.fertnstert.2013.03.020; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chambers EL, 2010, HUM REPROD, V25, P2559, DOI 10.1093/humrep/deq192; Cobo A, 2008, CLIN TRANSL ONCOL, V10, P268, DOI 10.1007/s12094-008-0196-7; Depalo R, 2009, REPROD BIOMED ONLINE, V19, P808, DOI 10.1016/j.rbmo.2009.09.024; Depalo R, 2009, SYST BIOL REPROD MED, V55, P236, DOI 10.3109/19396360903046761; Dolmans MM, 2010, BLOOD, V116, P2908, DOI 10.1182/blood-2010-01-265751; Domingo J, 2012, FERTIL STERIL, V97, P930, DOI 10.1016/j.fertnstert.2012.01.093; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; GOUGEON A, 1986, HUM REPROD, V1, P81, DOI 10.1093/oxfordjournals.humrep.a136365; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Guo W, 2011, P NATL ACAD SCI USA, V108, P1409, DOI 10.1073/pnas.1006937108; Herraiz S, 2014, FERTIL STERIL, V101, P775, DOI 10.1016/j.fertnstert.2013.11.016; Hovatta O, 2005, REPROD BIOMED ONLINE, V10, P729, DOI 10.1016/S1472-6483(10)61116-9; Howlader N, 2014, SEER CANC STAT REV 1; Jadoul P, 2010, HUM REPROD UPDATE, V16, P617, DOI 10.1093/humupd/dmq010; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kim SS, 2012, J ASSIST REPROD GEN, V29, P465, DOI 10.1007/s10815-012-9786-y; Lerer-Serfaty G, 2013, J ASSIST REPROD GEN, V30, P1279, DOI 10.1007/s10815-013-0052-8; Levy DS, 2009, BLOOD, V113, P1723, DOI 10.1182/blood-2008-02-137737; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; McLaughlin M, 2011, FERTIL STERIL, V96, P1154, DOI 10.1016/j.fertnstert.2011.08.040; Oktay K, 2004, EUR J OBSTET GYN R B, V113, pS45, DOI 10.1016/j.ejogrb.2003.11.010; Oktem O, 2011, FERTIL STERIL, V95, P2661, DOI 10.1016/j.fertnstert.2010.12.057; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Sanchez M, 2008, CLIN TRANSL ONCOL, V10, P433, DOI 10.1007/s12094-008-0227-4; Sanchez-Serrano M, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.09.046; Schenker JG, 2004, J ASSIST REPROD GEN, V21, P375, DOI 10.1007/s10815-004-7523-x; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Titus S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004925; vanBalen F, 1997, HUM REPROD, V12, P623; von Wolff M, 2009, EUR J CANCER, V45, P1547, DOI 10.1016/j.ejca.2009.01.029; Vu C, 2010, CLIN CANCER RES, V16, P5374, DOI 10.1158/1078-0432.CCR-10-0480; Young G, 2000, AM FAM PHYSICIAN, V61, P2144; Zhou MX, 2003, CANCER RES, V63, P6357; Zuurbier L, 2012, HAEMATOL-HEMATOL J, V97, P1405, DOI 10.3324/haematol.2011.059030	52	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127786	10.1371/journal.pone.0127786	http://dx.doi.org/10.1371/journal.pone.0127786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024525	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400051
J	Petty, SK; Zuckerberg, B; Pauli, JN				Petty, Sonia K.; Zuckerberg, Benjamin; Pauli, Jonathan N.			Winter Conditions and Land Cover Structure the Subnivium, A Seasonal Refuge beneath the Snow	PLOS ONE			English	Article							CLIMATE; FOREST; RANGE; DISTRIBUTIONS; ACCUMULATION; TEMPERATURE; MELT	In seasonally snow-covered environments, many organisms endure winter by using the subnivium, a below-snow thermally stable seasonal refugium. Because the insulation of snow is dependent on snow depth and density, the stability of temperatures within the subnivium varies across land cover types. Additionally, across much of the Northern Hemisphere snow extent, depth and duration are generally decreasing while snow density is increasing due to climate change. These changes are likely to destabilize the thermal profile of the subnivium, although they have not yet been quantified. To explore the effects of land cover and climate change on the subnivium, we measured snow pack characteristics (depth and density), and ambient and subnivium temperatures from three different land cover types (prairie, deciduous forest, and coniferous forest) and within a micro-greenhouse (2.5 x 2.5 x 2 m) that maintained a temperature of 5 degrees C warmer than outdoor ambient temperatures, and automatically opened during snow events throughout the winter of 2013/14. We found that the mean daily subnivium temperature was significantly colder in the deciduous cover type than the prairie cover type, and that prairie had higher maximum subnivium temperatures than both of the other cover types. Our climate change simulation revealed that, although ambient temperatures within the micro-greenhouse were 5 degrees C warmer than outside the greenhouse, the daily minimum subnivium temperature was significantly lower inside the greenhouse. Our findings suggest that climate change could have considerable effects on the refuge quality of the subnivium, and that some cover types appear to be more susceptible to these effects than others.	[Petty, Sonia K.; Zuckerberg, Benjamin; Pauli, Jonathan N.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pauli, JN (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	jnpauli@wisc.edu			National Science Foundation [EF-1340632]; Wisconsin Department of Natural Resources; Division Of Environmental Biology [1340632] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Wisconsin Department of Natural Resources; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation (EF-1340632) and the Wisconsin Department of Natural Resources to JNP and BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breshears DD, 2010, AUSTRAL ECOL, V35, P31, DOI 10.1111/j.1442-9993.2009.02009.x; Brown PJ, 2011, AGR FOREST METEOROL, V151, P947, DOI 10.1016/j.agrformet.2011.02.014; Brown RD, 2011, CRYOSPHERE, V5, P219, DOI 10.5194/tc-5-219-2011; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dery SJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031474; Ford KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065008; Ge Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012798; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jost G, 2007, J HYDROL, V347, P101, DOI 10.1016/j.jhydrol.2007.09.006; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lundquist JD, 2013, WATER RESOUR RES, V49, P6356, DOI 10.1002/wrcr.20504; Lundquist JD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006979; Lutz JA, 2012, NORTHWEST SCI, V86, P108, DOI 10.3955/046.086.0203; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli JN, 2013, FRONT ECOL ENVIRON, V11, P260, DOI 10.1890/120222; Pinzer BR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039618; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rowlands DJ, 2012, NAT GEOSCI, V5, P256, DOI [10.1038/NGEO1430, 10.1038/ngeo1430]; Scull P, 2007, PHYS GEOGR, V28, P360, DOI 10.2747/0272-3646.28.4.360; Sinha T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012188; Storck P, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001281; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Varhola A, 2010, J HYDROL, V392, P219, DOI 10.1016/j.jhydrol.2010.08.009; Williams CM, 2015, BIOL REV, V90, P214, DOI 10.1111/brv.12105; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	30	27	27	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127613	10.1371/journal.pone.0127613	http://dx.doi.org/10.1371/journal.pone.0127613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024489	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400044
J	Wirth, K; Peter, RS; Saely, CH; Concin, H; Nagel, G				Wirth, Katharina; Peter, Raphael S.; Saely, Christoph H.; Concin, Hans; Nagel, Gabriele			Long-Term Weight Change: Association with Impaired Glucose Metabolism in Young Austrian Adults	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; FASTING GLUCOSE; OBESITY; PREVALENCE; OVERWEIGHT; COHORT; RISK; MEN; MORTALITY	Little is known about the associations between long-term weight change and the natural history of impaired fasting glucose (IFG) in young adults. We investigated the association between long-term body mass index (BMI) change and the risk of IFG using data of 24,930 20- to 40-year-old participants from the Vorarlberg Health Monitoring and Promotion Program (VHM&PP) cohort. Poisson models were applied to estimate the 10-year risk for new development of IFG (>= 5.6 mmol/L), and persistence of IFG. Over 10 years, most men (68.2%) and women (70.0%) stayed within their initial BMI category. The risk for incident IFG was highest for men and women with persisting obesity (37.4% and 24.1%) and lowest with persisting normal weight (15.7% and 9.3%). Men transitioning from normal to overweight increased their risk of incident IFG by factor 1.45 (95%- CI: 1.31, 1.62), women by 1.70 (95%- CI: 1.50, 1.93), whereas transitioning from overweight to normal weight decreased the risk in men by 0.69 (95%- CI: 0.53, 0.90) and 0.94 (95%- CI: 0.66, 1.33) in women. Relative risks for men and women transitioning from obesity to overweight were 0.58 and 0.44, respectively. In conclusion, 10 year weight increase was associated with an increased IFG risk, weight decrease with a decreased risk of IFG in young adults.	[Wirth, Katharina; Peter, Raphael S.; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Saely, Christoph H.] Vorarlberg Inst Vasc Investigat & Treatment, Feldkirch, Austria; [Saely, Christoph H.] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Saely, Christoph H.] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Austria	Ulm University	Nagel, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	gabriele.nagel@uni-ulm.de	Peter, Raphael/J-3101-2019; Nagel, Gabriele/C-3635-2012; vhmpp, aks/F-9756-2012	Peter, Raphael/0000-0003-4310-9500; Nagel, Gabriele/0000-0001-6185-8535; 	federal state of Vorarlberg	federal state of Vorarlberg	The VHM& PP was supported by the federal state of Vorarlberg.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; [Anonymous], 2014, AM J HUM BIOL; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Chen CM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1123; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gallus S., 2014, EUR J NUTR, P1, DOI [DOI 10.1007/S00394-014-0776-Y, 10.1007/s00394-014-0776-y]; Grossschadl F, 2013, EUR J PUBLIC HEALTH, V23, P306, DOI 10.1093/eurpub/cks033; Hastie T., 1986, STAT SCI, V1, P297; Jacobs-van der Bruggen MAM, 2010, AM J EPIDEMIOL, V172, P263, DOI 10.1093/aje/kwq134; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; Kodama S, 2013, EPIDEMIOLOGY, V24, P778, DOI 10.1097/EDE.0b013e31829f6c31; Koebnick C, 2012, ANN EPIDEMIOL, V22, P609, DOI 10.1016/j.annepidem.2012.05.006; Lahti-Koski M, 2001, INT J OBESITY, V25, P727, DOI 10.1038/sj.ijo.0801588; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Nagel G, 2008, CLIN CHEM, V54, P317, DOI 10.1373/clinchem.2007.094821; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Schmidt M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002698; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Song SH, 2013, ADV EXP MED BIOL, V771, P51; Stabouli S, 2012, HELL J CARDIOL, V53, P41; The NS, 2013, DIABETES CARE, V36, P865, DOI 10.2337/dc12-0536; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127186	10.1371/journal.pone.0127186	http://dx.doi.org/10.1371/journal.pone.0127186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024372	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400031
J	Saanchez, MA; Trinidad, JE; Garciia, J; Fernaandez, M				Angel Sanchez, Miguel; Trinidad, Juan E.; Garcia, Jose; Fernandez, Manuel			The Effect of the Underlying Distribution in Hurst Exponent Estimation	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; MOVING AVERAGE; LONG-MEMORY; MARKET-EFFICIENCY; SELF-SIMILARITY; DEPENDENCE; CALCULATE; BEHAVIOR; MULTIFRACTALITY; ALGORITHM	In this paper, a heavy-tailed distribution approach is considered in order to explore the behavior of actual financial time series. We show that this kind of distribution allows to properly fit the empirical distribution of the stocks from S&P500 index. In addition to that, we explain in detail why the underlying distribution of the random process under study should be taken into account before using its self-similarity exponent as a reliable tool to state whether that financial series displays long-range dependence or not. Finally, we show that, under this model, no stocks from S&P500 index show persistent memory, whereas some of them do present anti-persistent memory and most of them present no memory at all.	[Angel Sanchez, Miguel] Univ Almeria, Dept Math, Almeria, Spain; [Trinidad, Juan E.; Garcia, Jose] Univ Almeria, Dept Econ, Almeria, Spain; [Fernandez, Manuel] Spanish Air Force Acad, Univ Ctr Def, MDE UPCT, Murcia, Spain	Universidad de Almeria; Universidad de Almeria	Fernaandez, M (corresponding author), Spanish Air Force Acad, Univ Ctr Def, MDE UPCT, Murcia, Spain.	fmm124@gmail.com	Fernández-Martínez, Manuel/J-5440-2014; TRINIDAD, JUAN E. E/K-7842-2012; GRANERO, MIGUEL ANGEL SANCHEZ/J-9350-2014; Trinidad-Segovia, Juan E./K-5129-2019; Fernández-Martínez, Manuel/ABG-8830-2020	Fernández-Martínez, Manuel/0000-0001-6291-9205; GRANERO, MIGUEL ANGEL SANCHEZ/0000-0001-9153-8321; Trinidad-Segovia, Juan E./0000-0002-5017-2615; Fernández-Martínez, Manuel/0000-0001-6291-9205	Spanish Ministry of Economy & Competitiveness (Ministerio Espanol de Economia y Competitividad) [MTM2012-37894-C02-01]; Junta de Andalucia (Ministerio Espanol de Economia y Competitividad) [MTM2012-37894-C02-01]	Spanish Ministry of Economy & Competitiveness (Ministerio Espanol de Economia y Competitividad); Junta de Andalucia (Ministerio Espanol de Economia y Competitividad)	Miguel Angel Sanchez-Granero, from University of Almeria (Spain), appreciates the support of Spanish Ministry of Economy & Competitiveness (Ministerio Espanol de Economia y Competitividad), grant MTM2012-37894-C02-01 (http://www.idi.mineco.gob.es/stfls/eSede/Ficheros/2012/Anexo153_Matematicas_Preseleccionados.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Juan Evangelista Trinidad Segovia, from University of Almeria (Spain), acknowledges the support of Junta de Andalucia (Ministerio Espanol de Economia y Competitividad), grant MTM2012-37894-C02-01 (http://investigacion.ugr.es/pages/docu/proy_excelencia/concesion2009/2009_anexo_iv_no_seleccionados/!). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio E, 2002, EUR PHYS J B, V27, P197, DOI 10.1140/epjb/e20020150; [Anonymous], 2009, PROBABILITY MATH STA; Arianos S, 2007, PHYSICA A, V382, P9, DOI 10.1016/j.physa.2007.02.074; BARABASI AL, 1991, PHYS REV A, V44, P2730, DOI 10.1103/PhysRevA.44.2730; Barunik J, 2012, PHYSICA A, V391, P4234, DOI 10.1016/j.physa.2012.03.037; Barunik J, 2010, PHYSICA A, V389, P3844, DOI 10.1016/j.physa.2010.05.025; BenSaida A, 2014, APPL MATH COMPUT, V226, P258, DOI 10.1016/j.amc.2013.10.064; Boyarchenko S., 2000, INT J THEOR APPL FIN, V3, P549, DOI DOI 10.1142/S0219024900000541; Carbone A, 2004, PHYSICA A, V344, P267, DOI 10.1016/j.physa.2004.06.130; Carr P, 2002, J BUS, V75, P305, DOI 10.1086/338705; CLARK PK, 1973, ECONOMETRICA, V41, P135, DOI 10.2307/1913889; Das A, 2006, APPL MATH COMPUT, V174, P483, DOI 10.1016/j.amc.2005.04.096; Di Matteo T, 2007, QUANT FINANC, V7, P21, DOI 10.1080/14697680600969727; Di Matteo T, 2005, J BANK FINANC, V29, P827, DOI 10.1016/j.jbankfin.2004.08.004; Di Matteo T, 2003, PHYSICA A, V324, P183, DOI 10.1016/S0378-4371(02)01996-9; Evertsz CJG, 1995, FRACTALS, V3, P609, DOI 10.1142/S0218348X95000539; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Feder J, 1988, FRACTALS; Fernandez-Martinez M, 2014, PHYS LETT A, V378, P2355, DOI 10.1016/j.physleta.2014.06.018; Fernandez-Martinez M, 2013, PHYSICA A, V392, P5330, DOI 10.1016/j.physa.2013.06.026; Garcia CB, 2011, STAT METHOD APPL-GER, V20, P463, DOI 10.1007/s10260-011-0173-0; Gencay R., 2001, INTRO HIGH FREQUENCY; Geweke J., 1983, J TIME SER ANAL, V4, P221, DOI [10.1111/j.1467-9892.1983.tb00371.x, DOI 10.1111/J.1467-9892.1983.TB00371.X]; Ghashghaie S, 1996, NATURE, V381, P767, DOI 10.1038/381767a0; Granero MAS, 2008, PHYSICA A, V387, P5543, DOI 10.1016/j.physa.2008.05.053; Gray J.B., 1990, J BUS FINANC ACC, V17, P451, DOI [10.1111/j.1468-5957.1990.tb01197.x, DOI 10.1111/J.1468-5957.1990.TB01197.X]; GREENE MT, 1977, J FINANC ECON, V4, P339, DOI 10.1016/0304-405X(77)90006-X; Groenendijk PA, 1998, HYBRID JOINT MOMENT, V1, P1; Gu GF, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011136; Hampton J., 1996, NEUROVEST J, V4, P27; HASLETT J, 1989, J R STAT SOC C-APPL, V38, P1; Hirschberg J, 1992, APPL FINANC EC, V2, P221, DOI [10.1080/758527104, DOI 10.1080/758527104]; HOLS MCAB, 1991, J APPL ECONOM, V6, P287, DOI 10.1002/jae.3950060306; Horvatic D, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18007; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Jiang ZQ, 2014, PHYSICA A, V405, P235, DOI 10.1016/j.physa.2014.02.042; Jiang ZQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016106; Jun WC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066128; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kim YS, 2008, J BANK FINANC, V32, P1363, DOI 10.1016/j.jbankfin.2007.11.004; KOPONEN I, 1995, PHYS REV E, V52, P1197, DOI 10.1103/PhysRevE.52.1197; Kotz S, 2005, STAT PROBABIL LETT, V71, P383, DOI 10.1016/j.spl.2004.11.019; Kozubowski TJ, 1999, MATH COMPUT MODEL, V29, P241, DOI 10.1016/S0895-7177(99)00107-7; Kozubowski TJ, 1999, MATH COMPUT MODEL, V29, P83, DOI 10.1016/S0895-7177(99)00094-1; Kozubowski TJ, 2001, MATH COMPUT MODEL, V34, P1003, DOI 10.1016/S0895-7177(01)00114-5; Kristoufek L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02857; Kristoufek L, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50113-6; Kristoufek L, 2013, PHYSICA A, V392, P184, DOI 10.1016/j.physa.2012.08.003; Kristoufek L, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500658; Lamperti J., 1962, T AM MATH SOC, V104, P62, DOI [10.1090/s0002-9947-1962-0138128-7, DOI 10.1090/S0002-9947-1962-0138128-7]; LAU HS, 1989, MANAGE SCI, V35, P1139, DOI 10.1287/mnsc.35.9.1139; Levy H, 2004, J PORTFOLIO MANAGE, V30, P47, DOI 10.3905/jpm.2004.412319; Lillo F, 2004, STUD NONLINEAR DYN E, V8; Lim KP, 2007, PHYSICA A, V376, P445, DOI 10.1016/j.physa.2006.10.013; Linden M, 2001, INT J FINANC ECON, V6, P159, DOI 10.1002/ijfe.149; Lo Andrew W., 1999, NONRANDOM WALK WALL; LO AW, 1991, ECONOMETRICA, V59, P1279, DOI 10.2307/2938368; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P967, DOI 10.1029/WR005i005p00967; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mandelbrot B, 1997, FRACTALS SCALING FIN; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; McDonald J.B., 1996, HDB STAT, VVolume 14, P427; Mercik S, 2003, ACTA PHYS POL B, V34, P3773; Moore AB., 1964, RANDOM CHARACTER STO, P262; Morales R, 2013, PHYSICA A, V392, P6470, DOI 10.1016/j.physa.2013.08.037; Panas E., 2001, APPL FINANCIAL EC, V11, P395, DOI DOI 10.1080/096031001300313956; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Peters E., 1992, FINANC ANAL J, V48, P32, DOI DOI 10.2469/FAJ.V48.N6.81; Peters E.E., 1994, FRACTAL MARKET ANAL; Peters EE, 1991, CHAOS ORDER CAPITAL; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; PRAETZ PD, 1972, J BUS, V45, P49, DOI 10.1086/295425; Rachev S.T., 2003, HDB HEAVY TAILED DIS; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Sanchez-Granero MJ, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20803-2; Shao YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00835; Stanley H. E, 2000, INTRO ECONOPHYSICS; Segovia JET, 2012, PHYSICA A, V391, P2209, DOI 10.1016/j.physa.2011.11.044; van Dorp JR, 2002, AM STAT, V56, P90, DOI 10.1198/000313002317572745; Weron A, 2000, CHAOS SOLITON FRACT, V11, P289, DOI 10.1016/S0960-0779(98)00295-1; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; West B.J., 1995, LURE MODERN SCI FRAC; Willinger W., 1999, FINANC STOCH, V3, P1, DOI DOI 10.1007/S007800050049; Xu LM, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051101; Zhou WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066211; Zunino L, 2010, PHYSICA A, V389, P1891, DOI 10.1016/j.physa.2010.01.007	87	14	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127824	10.1371/journal.pone.0127824	http://dx.doi.org/10.1371/journal.pone.0127824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020942	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300056
J	Babur, BK; Kabiri, M; Klein, TJ; Lott, WB; Doran, MR				Babur, Betul Kul; Kabiri, Mahboubeh; Klein, Travis Jacob; Lott, William B.; Doran, Michael Robert			The Rapid Manufacture of Uniform Composite Multicellular-Biomaterial Micropellets, Their Assembly into Macroscopic Organized Tissues, and Potential Applications in Cartilage Tissue Engineering	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; MATRIX; KNEE	We and others have published on the rapid manufacture of micropellet tissues, typically formed from 100-500 cells each. The micropellet geometry enhances cellular biological properties, and in many cases the micropellets can subsequently be utilized as building blocks to assemble complex macrotissues. Generally, micropellets are formed from cells alone, however when replicating matrix-rich tissues such as cartilage it would be ideal if matrix or biomaterials supplements could be incorporated directly into the micropellet during the manufacturing process. Herein we describe a method to efficiently incorporate donor cartilage matrix into tissue engineered cartilage micropellets. We lyophilized bovine cartilage matrix, and then shattered it into microscopic pieces having average dimensions < 10 mu m diameter; we termed this microscopic donor matrix "cartilage dust (CD)". Using a microwell platform, we show that similar to 0.83 mu g CD can be rapidly and efficiently incorporated into single multicellular aggregates formed from 180 bone marrow mesenchymal stem/stromal cells (MSC) each. The microwell platform enabled the rapid manufacture of thousands of replica composite micropellets, with each micropellet having a material/CD core and a cellular surface. This micropellet organization enabled the rapid bulking up of the micropellet core matrix content, and left an adhesive cellular outer surface. This morphological organization enabled the ready assembly of the composite micropellets into macroscopic tissues. Generically, this is a versatile method that enables the rapid and uniform integration of biomaterials into multicellular micropellets that can then be used as tissue building blocks. In this study, the addition of CD resulted in an approximate 8-fold volume increase in the micropellets, with the donor matrix functioning to contribute to an increase in total cartilage matrix content. Composite micropellets were readily assembled into macroscopic cartilage tissues; the incorporation of CD enhanced tissue size and matrix content, but did not enhance chondrogenic gene expression.	[Babur, Betul Kul; Kabiri, Mahboubeh; Lott, William B.; Doran, Michael Robert] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia; [Kabiri, Mahboubeh] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Klein, Travis Jacob] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Cartilage Regenerat Lab, Brisbane, Qld 4001, Australia; [Doran, Michael Robert] Univ Queensland, Mater Med Res, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Tehran; Queensland University of Technology (QUT); Mater Research; University of Queensland	Doran, MR (corresponding author), Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.	michael.doran@qut.edu.au	Doran, Michael R/F-6059-2014; Lott, William B/J-1062-2012; Kabiri, Mahboubeh/ABE-1182-2021; Klein, Travis/J-1117-2012	Lott, William B/0000-0001-7118-7560; Klein, Travis/0000-0002-6669-7766; Doran, Michael/0000-0001-5876-4757	Australian National Health and Medical Research Council (NHMRC) [631629]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian National Health and Medical Research Council (NHMRC), grant number 631629 (https://www.nhmrc.gov.au/), MRD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869; Behrens P, 1999, MMW Fortschr Med, V141, P49; Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111; Brand CA, 2013, ARTHRITIS CARE RES H; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de; Chen A, 2012, ARTHRITIS, DOI 10.1155/2012/698709; Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541; Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002; Ebert JR, 2008, OSTEOARTHR CARTILAGE, V16, P1131, DOI 10.1016/j.joca.2008.03.010; Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9; Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009; Peretti GM, 1998, J ORTHOP RES, V16, P89, DOI 10.1002/jor.1100160115; Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206; Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367; POTTENGER LA, 1982, J BIOL CHEM, V257, P1479; Robertson WB, 2004, STANDARD PRACTICE EX; Schuurman W, 2013, J TISSUE ENG REGENER; Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	27	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0122250	10.1371/journal.pone.0122250	http://dx.doi.org/10.1371/journal.pone.0122250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020956	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300003
J	Romero, IC; Schwing, PT; Brooks, GR; Larson, RA; Hastings, DW; Ellis, G; Goddard, EA; Hollander, DJ				Romero, Isabel C.; Schwing, Patrick T.; Brooks, Gregg R.; Larson, Rebekka A.; Hastings, David W.; Ellis, Greg; Goddard, Ethan A.; Hollander, David J.			Hydrocarbons in Deep-Sea Sediments following the 2010 Deepwater Horizon Blowout in the Northeast Gulf of Mexico	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TERRIGENOUS ORGANIC-MATTER; SURFACE SEDIMENTS; MISSISSIPPI RIVER; OIL-SPILL; POLYAROMATIC HYDROCARBONS; PETROLEUM BIOMARKERS; SOURCE APPORTIONMENT; ATCHAFALAYA RIVER; COASTAL SEDIMENTS	The Deepwater Horizon (DWH) spill released 4.9 million barrels of oil into the Gulf of Mexico (GoM) over 87 days. Sediment and water sampling efforts were concentrated SW of the DWH and in coastal areas. Here we present geochemistry data from sediment cores collected in the aftermath of the DWH event from 1000 - 1500 m water depth in the DeSoto Canyon, NE of the DWH wellhead. Cores were analyzed at high-resolution (at 2 mm and 5 mm intervals) in order to evaluate the concentration, composition and input of hydrocarbons to the seafloor. Specifically, we analyzed total organic carbon (TOC), aliphatic, polycyclic aromatic hydrocarbon (PAHs), and biomarker (hopanes, steranes, diasteranes) compounds to elucidate possible sources and transport pathways for deposition of hydrocarbons. Results showed higher hydrocarbon concentrations during 2010-2011 compared to years prior to 2010. Hydrocarbon inputs in 2010-2011 were composed of a mixture of sources including terrestrial, planktonic, and weathered oil. Our results suggest that after the DWH event, both soluble and highly insoluble hydrocarbons were deposited at enhanced rates in the deep-sea. We proposed two distinct transport pathways of hydrocarbon deposition: 1) sinking of oil-particle aggregates (hydrocarbon-contaminated marine snow and/or suspended particulate material), and 2) advective transport and direct contact of the deep plume with the continental slope surface sediments between 1000-1200 m. Our findings underline the complexity of the depositional event observed in the aftermath of the DWH event in terms of multiple sources, variable concentrations, and spatial (depth-related) variability in the DeSoto Canyon, NE of the DWH wellhead.	[Romero, Isabel C.; Schwing, Patrick T.; Larson, Rebekka A.; Ellis, Greg; Goddard, Ethan A.; Hollander, David J.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Brooks, Gregg R.; Larson, Rebekka A.; Hastings, David W.] Eckerd Coll, St Petersburg, FL 33711 USA	State University System of Florida; University of South Florida	Romero, IC (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	isabelromero@mail.usf.edu	Schwing, Patrick/AAK-8593-2020	Schwing, Patrick/0000-0001-8466-4952; Goddard, Ethan/0000-0001-6749-7937; Romero, Isabel C./0000-0002-8590-5989	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; BP/The Gulf of Mexico Research Initiative (GOMRI); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; BP/The Gulf of Mexico Research Initiative (GOMRI); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	The authors acknowledge the British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program for funding several of the initial research cruises and laboratory analysis during 2010 and 2011. This research was made possible by funding from BP/The Gulf of Mexico Research Initiative (GOMRI), specifically the Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE) and the Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia.	Aeppli C, 2014, ENVIRON SCI TECHNOL, V48, P6726, DOI 10.1021/es500825q; Ahad JME, 2011, MAR CHEM, V126, P239, DOI 10.1016/j.marchem.2011.06.002; [Anonymous], 2007, 8015C EM, P1; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Barakat AO, 2002, SPILL SCI TECHNOL B, V7, P229, DOI 10.1016/S1353-2561(02)00039-7; Barakat AO, 2011, MAR POLLUT BULL, V62, P1969, DOI 10.1016/j.marpolbul.2011.06.024; Baumard P, 1998, MAR POLLUT BULL, V36, P951, DOI 10.1016/S0025-326X(98)00088-5; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Brodie CR, 2011, QUATERNARY SCI REV, V30, P3076, DOI 10.1016/j.quascirev.2011.07.003; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Chang YL, 2011, OCEAN DYNAM, V61, P829, DOI 10.1007/s10236-011-0397-4; Chanton JP, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045303; Commendatore MG, 2012, MAR ENVIRON RES, V74, P20, DOI 10.1016/j.marenvres.2011.11.010; Corbett DR, 2006, CONT SHELF RES, V26, P2125, DOI 10.1016/j.csr.2006.07.012; Dickhut RM, 2000, ENVIRON SCI TECHNOL, V34, P4635, DOI 10.1021/es000971e; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; El Nemr A, 2013, ENVIRON MONIT ASSESS, V185, P4571, DOI 10.1007/s10661-012-2889-1; Goni MA, 1997, NATURE, V389, P275, DOI 10.1038/38477; Goni MA, 1998, GEOCHIM COSMOCHIM AC, V62, P3055, DOI 10.1016/S0016-7037(98)00217-8; Gordon ES, 2004, MAR CHEM, V92, P331, DOI 10.1016/j.marchem.2004.06.035; Gordon ES, 2003, GEOCHIM COSMOCHIM AC, V67, P2359, DOI 10.1016/S0016-7037(02)01412-6; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Harrison RM, 1996, ENVIRON SCI TECHNOL, V30, P825, DOI 10.1021/es950252d; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hu LM, 2009, MAR CHEM, V113, P197, DOI 10.1016/j.marchem.2009.02.001; Iqbal J, 2007, MAR POLLUT BULL, V54, P792, DOI 10.1016/j.marpolbul.2007.02.004; Joye SB, 2011, NAT GEOSCI, V4, P160, DOI [10.1038/ngeo1067, 10.1038/NGEO1067]; KENNICUTT MC, 1988, AQUAT TOXICOL, V11, P191, DOI 10.1016/0166-445X(88)90013-6; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Khelifa A, 2005, DEV EARTH ENV SCI, V3, P131; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kujau A, 2010, PALAEOGEOGR PALAEOCL, V298, P311, DOI 10.1016/j.palaeo.2010.10.005; Lang YH, 2014, B ENVIRON CONTAM TOX, V92, P30, DOI 10.1007/s00128-013-1164-7; Li GC, 2006, ENVIRON POLLUT, V144, P985, DOI 10.1016/j.envpol.2006.01.047; Lin Q, 2012, IMPACTS RECOVERY DEE; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; MacDonald IR, 2002, GEOFLUIDS, V2, P95, DOI 10.1046/j.1468-8123.2002.00023.x; MCGRODDY SE, 1995, ENVIRON SCI TECHNOL, V29, P1542, DOI 10.1021/es00006a016; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20222, DOI 10.1073/pnas.1214389109; Mitra S, 2003, MAR CHEM, V82, P273, DOI 10.1016/S0304-4203(03)00074-4; Mitra S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049505; Montagna PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070540; Mulabagal V, 2013, MAR POLLUT BULL, V70, P147, DOI 10.1016/j.marpolbul.2013.02.026; Murawski SA, 2014, T AM FISH SOC, V143, P1084, DOI 10.1080/00028487.2014.911205; Ocean Studies Board and Marine Board, 2003, OIL SEA; OSAT-1, 2010, SUMM REP SUBS SUBS O; Paris CB, 2012, ENVIRON SCI TECHNOL, V46, P13293, DOI 10.1021/es303197h; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Payne JR, 2003, SPILL SCI TECHNOL B, V8, P201, DOI 10.1016/S1353-2561(03)00048-3; Peterson CH, 1996, CAN J FISH AQUAT SCI, V53, P2637, DOI 10.1139/cjfas-53-11-2637; Presley BJ, 1998, HIST CONTAMINATION M; Qiao M, 2006, ENVIRON INT, V32, P28, DOI 10.1016/j.envint.2005.04.005; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Rosenheim BE, 2016, DEEP-SEA RES PT II, V129, P249, DOI 10.1016/j.dsr2.2014.03.020; Rowe G., 2009, NO GULF MEXICO CONTI; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; Santschi PH, 2001, MAR ENVIRON RES, V52, P51, DOI 10.1016/S0141-1136(00)00260-9; Scarlett A, 2007, J SOIL SEDIMENT, V7, P200, DOI 10.1065/jss2007.06.232; Schaum J, 2010, ENVIRON SCI TECHNOL, V44, P9383, DOI 10.1021/es103559w; Schneider AR, 2001, ENVIRON SCI TECHNOL, V35, P3809, DOI 10.1021/es002044d; Schwing P, 2015, PLOS ONE; Song Z, 2008, GEOFLUIDS, V8, P293, DOI 10.1111/j.1468-8123.2008.00225.x; Tansel B, 2011, MAR POLLUT BULL, V62, P2659, DOI 10.1016/j.marpolbul.2011.09.026; Turpin R., 1999, INT OIL SPILL C P, V1999, P1287, DOI [10.7901/2169-3358-1999-1-1287, DOI 10.7901/2169-3358-1999-1-1287]; USEPA (United States Environmental Protection Agency), 2007, TECHNICAL RESOURCE D, P1; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; Valentine DL, 2012, P NATL ACAD SCI USA, V109, P20286, DOI 10.1073/pnas.1108820109; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Valentine MM, 2013, MAR POLLUT BULL, V77, P196, DOI 10.1016/j.marpolbul.2013.10.004; Valsangkar AB, 2007, CURRENT SCI, V92, P5; VERSCHUREN D, 1993, LIMNOL OCEANOGR, V38, P1796, DOI 10.4319/lo.1993.38.8.1796; Wang CY, 2013, MAR POLLUT BULL, V71, P64, DOI 10.1016/j.marpolbul.2013.03.034; Wang CP, 2011, MAR POLLUT BULL, V62, P2714, DOI 10.1016/j.marpolbul.2011.09.016; Wang ZD, 2003, MAR POLLUT BULL, V47, P423, DOI 10.1016/S0025-326X(03)00215-7; Waterson EJ, 2008, ORG GEOCHEM, V39, P422, DOI 10.1016/j.orggeochem.2008.01.011; Weisberg RH, 2011, GEOPHYS MONOGR SER, V195, P205, DOI 10.1029/2011GM001131; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Yu CC, 1992, PETROGENIC BIOGENIC, P53; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0; Zhang ZL, 2004, ENVIRON POLLUT, V130, P249, DOI 10.1016/j.envpol.2003.12.002; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	83	80	80	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128371	10.1371/journal.pone.0128371	http://dx.doi.org/10.1371/journal.pone.0128371			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020923	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300104
J	Ali, A; Kazi, AM; Cortese, MM; Fleming, JA; Moon, S; Parashar, UD; Jiang, BM; McNeal, MM; Steele, D; Bhutta, Z; Zaidi, AKM				Ali, Asad; Kazi, Abdul Momin; Cortese, Margaret M.; Fleming, Jessica A.; Moon, SungSil; Parashar, Umesh D.; Jiang, Baoming; McNeal, Monica M.; Steele, Duncan; Bhutta, Zulfiqar; Zaidi, Anita K. M.			Impact of Withholding Breastfeeding at the Time of Vaccination on the Immunogenicity of Oral Rotavirus Vaccine-A Randomized Trial	PLOS ONE			English	Article							MILK; LIVE; COUNTRIES; INFANTS	Background Breast milk contains anti-rotavirus IgA antibodies and other innate immune factors that inhibit rotavirus replication in vitro. These factors could diminish the immunogenicity of oral rotavirus vaccines, particularly if breastfeeding occurs close to the time of vaccine administration. Methods Between April 2011 and November 2012, we conducted an open label, randomized trial to compare the immunogenicity of Rotarix (RV1) in infants whose breastfeeding was withheld one hour before through one hour after vaccination with that in infants breastfed at the time of vaccination. The trial was conducted in the peri-urban area of Ibrahim Hyderi in Karachi, Pakistan. Both groups received three doses of RV1 at 6, 10 and 14 weeks of age. Seroconversion (anti-rotavirus IgA antibodies >= 20 U/mL in subjects seronegative at 6 weeks of age) following three vaccine doses (6, 10 and 14 weeks) was determined at 18 weeks of age (primary objective) and seroconversion following two doses (6 and 10 weeks) was determined at 14 weeks of age (secondary objective). Results Four hundred eligible infants were randomly assigned in a 1: 1 ratio between the withholding breastfeeding and immediate breastfeeding arms. Overall, 353 (88.3%) infants completed the study according to protocol; 181 in the withholding breastfeeding group and 172 in the immediate breastfeeding group. After three RV1 doses, anti-rotavirus IgA antibody seroconversion was 28.2%(95% CI: 22.1; 35.1) in the withholding arm and 37.8%(95% CI: 30.9; 45.2) in the immediate breastfeeding arm (difference: -9.6% [95% CI: -19.2; 0.2] p = 0.07). After two doses of RV1, seroconversion was 16.6%(95% CI: 11.9; 22.7) in the withholding arm and 29.1%(95% CI: 22.8, 36.3) in the immediate breastfeeding arm (difference: -12.5% [95% CI: -21.2,-3.8] p = 0.005). Conclusions Withholding breastfeeding around the time of RV1 vaccine administration did not lead to increased anti-rotavirus IgA seroconversion compared with that seen with a breastfeed at the time of vaccination. On the contrary, IgA seroconversion in infants immediately breastfed tended to be higher than in those withheld from a feeding. Our findings suggest that breastfeeding should be continued adlib around the time of rotavirus vaccination and withholding breastfeeding at that time is unlikely to improve the vaccine immunogenicity.	[Ali, Asad; Kazi, Abdul Momin; Bhutta, Zulfiqar; Zaidi, Anita K. M.] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; [Cortese, Margaret M.; Moon, SungSil; Parashar, Umesh D.; Jiang, Baoming] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA; [Fleming, Jessica A.; Steele, Duncan] PATH, Vaccine Access & Delivery, Seattle, WA USA; [McNeal, Monica M.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Infect Dis, Cincinnati, OH 45229 USA	Aga Khan University; Centers for Disease Control & Prevention - USA; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Ali, A (corresponding author), Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan.	asad.ali@aku.edu		McNeal, Monica/0000-0002-3784-9062; Steele, Andrew Duncan/0000-0002-4946-037X; Ali, Syed Asad/0000-0001-5274-7665	PATH from Gavi; Vaccine Alliance	PATH from Gavi; Vaccine Alliance	Support for this project was provided by PATH through funding from Gavi, the Vaccine Alliance. The views expressed by the authors do not necessarily reflect the views of Gavi and/or PATH. Investigators from PATH participated in study design, monitoring, data analysis and manuscript preparation.	Ali SA, 2014, J INFECT DIS, V210, P1772, DOI 10.1093/infdis/jiu335; Bernstein DI, 1998, VACCINE, V16, P381, DOI 10.1016/S0264-410X(97)00210-7; Department of Child and Adolescent Health and Development World Health Organization, 2005, TREATM DIARRH MAN PH; GLASS RI, 1989, ACTA PAEDIATR SCAND, P131; Groome MJ, 2014, B WORLD HEALTH ORGAN, V92, P238, DOI 10.2471/BLT.13.128066; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; KNOWLTON DR, 1991, J VIROL METHODS, V33, P127, DOI 10.1016/0166-0934(91)90013-P; Kvistgaard AS, 2004, J DAIRY SCI, V87, P4088, DOI 10.3168/jds.S0022-0302(04)73551-1; Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Rennels MB, 1996, J INFECT DIS, V174, pS107, DOI 10.1093/infdis/174.Supplement_1.S107; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5	13	46	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127622	10.1371/journal.pone.0127622	http://dx.doi.org/10.1371/journal.pone.0127622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035743	Green Published, gold			2022-12-27	WOS:000355699100016
J	Gross, JJ; Kessler, EC; Albrecht, C; Bruckmaier, RM				Gross, Josef J.; Kessler, Evelyne C.; Albrecht, Christiane; Bruckmaier, Rupert M.			Response of the Cholesterol Metabolism to a Negative Energy Balance in Dairy Cows Depends on the Lactational Stage	PLOS ONE			English	Article							CELLULAR CHOLESTEROL; TRANSFER PROTEIN; TRANSITION PERIOD; INSULIN-RESISTANCE; HEPATIC REGULATION; MAMMARY-GLAND; FATTY LIVER; DRY PERIOD; ACYLTRANSFERASE; DENSITY	The response of cholesterol metabolism to a negative energy balance (NEB) induced by feed restriction for 3 weeks starting at 100 days in milk (DIM) compared to the physiologically occurring NEB in week 1 postpartum (p.p.) was investigated in 50 dairy cows (25 control (CON) and 25 feed-restricted (RES)). Blood samples, liver biopsies and milk samples were taken in week 1 p.p., and in weeks 0 and 3 of feed restriction. Plasma concentrations of total cholesterol (C), phospholipids (PL), triglycerides (TAG), very low density lipoprotein-cholesterol (VLDL-C) and low density lipoprotein-cholesterol (LDL-C) increased in RES cows from week 0 to 3 during feed restriction and were higher in week 3 compared to CON cows. In contrast, during the physiologically occurring NEB in week 1 p.p., C, PL, TAG and lipoprotein concentrations were at a minimum. Plasma phospholipid transfer protein (PLTP) and lecithin: cholesterol acyltransferase (LCAT) activities did not differ between week 0 and 3 for both groups, whereas during NEB in week 1 p.p. PLTP activity was increased and LCAT activity was decreased. Milk C concentration was not affected by feed restriction in both groups, whereas milk C mass was decreased in week 3 for RES cows. In comparison, C concentration and mass in milk were elevated in week 1 p.p. Hepatic mRNA abundance of sterol regulatory element-binding factor-2 (SREBF-2), 3-hydroxy-3-methylglutaryl-coenzyme A synthase 1 (HMGCS1), 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), and ATP-binding cassette transporter (ABCA1) were similar in CON and RES cows during feed restriction, but were upregulated during NEB in week 1 p.p. compared to the non-lactating stage without a NEB. In conclusion, cholesterol metabolism in dairy cows is affected by nutrient and energy deficiency depending on the stage of lactation.	[Gross, Josef J.; Kessler, Evelyne C.; Bruckmaier, Rupert M.] Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland; [Albrecht, Christiane] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Albrecht, Christiane] Univ Bern, Swiss Natl Ctr Competence Res, NCCR TransCure, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Bruckmaier, RM (corresponding author), Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland.	rupert.bruckmaier@vetsuisse.unibe.ch	Kessler, Evelyne C./M-5699-2018; Gross, Josef J./C-3833-2016	Kessler, Evelyne C./0000-0003-0359-1136; Gross, Josef J./0000-0002-2578-6076; Albrecht, Christiane/0000-0002-7846-6930	H. Wilhelm Schaumann-Stiftung (Hamburg, Germany); Swiss National Center of Competence in Research, NCCR TransCure, University of Bern, Switzerland	H. Wilhelm Schaumann-Stiftung (Hamburg, Germany); Swiss National Center of Competence in Research, NCCR TransCure, University of Bern, Switzerland	E. C. Kessler was supported by a scholarship of the H. Wilhelm Schaumann-Stiftung (Hamburg, Germany). C. Albrecht was supported by the Swiss National Center of Competence in Research, NCCR TransCure, University of Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITMAN J, 1990, J DAIRY SCI, V73, P1208, DOI 10.3168/jds.S0022-0302(90)78784-X; Bjerre-Harpoth V, 2012, J DAIRY SCI, V95, P2362, DOI 10.3168/jds.2011-4419; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Bremmer DR, 2000, J DAIRY SCI, V83, P2239, DOI 10.3168/jds.S0022-0302(00)75108-3; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Gross J, 2011, J DAIRY SCI, V94, P3484, DOI 10.3168/jds.2011-4251; Gross J, 2011, J DAIRY SCI, V94, P1820, DOI 10.3168/jds.2010-3707; Gross JJ, 2013, J DAIRY SCI, V96, P5008, DOI 10.3168/jds.2012-6245; GRUMMER RR, 1993, J DAIRY SCI, V76, P3882, DOI 10.3168/jds.S0022-0302(93)77729-2; Hayirli A, 2006, VET RES COMMUN, V30, P749, DOI 10.1007/s11259-006-3320-6; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; JONAS A, 1984, J BIOL CHEM, V259, P6369; Kamelska AM, 2012, ACTA BIOCHIM POL, V59, P243; Kang SW, 2010, NUTR RES PRACT, V4, P477, DOI 10.4162/nrp.2010.4.6.477; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kessler EC, 2014, J DAIRY SCI, V97, P5481, DOI 10.3168/jds.2014-7926; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Mani O, 2009, J DAIRY SCI, V92, P3744, DOI 10.3168/jds.2009-2063; Mani O, 2010, AM J PHYSIOL-REG I, V299, pR642, DOI 10.1152/ajpregu.00723.2009; Nakagawa H, 1997, VET RES COMMUN, V21, P1, DOI 10.1023/B:VERC.0000009695.02015.20; Ontsouka EC, 2014, J MAMMARY GLAND BIOL, V19, P43, DOI 10.1007/s10911-014-9316-x; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Paradkar MM, 2002, INT J DAIRY TECHNOL, V55, P127, DOI 10.1046/j.1471-0307.2002.00044.x; Poso AR, 2000, RES VET SCI, V68, P169, DOI 10.1053/rvsc.1999.0355; Precht D, 2001, NAHRUNG, V45, P2, DOI 10.1002/1521-3803(20010101)45:1&lt;2::AID-FOOD2&gt;3.0.CO;2-5; Schlegel G, 2012, J DAIRY SCI, V95, P3826, DOI 10.3168/jds.2011-5221; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; TALL AR, 1985, J LIPID RES, V26, P842; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; VandenTop AM, 1996, J NUTR, V126, P76, DOI 10.1093/jn/126.1.76; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wolfbauer G, 1999, BBA-MOL CELL BIOL L, V1439, P65, DOI 10.1016/S1388-1981(99)00077-3	40	29	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0121956	10.1371/journal.pone.0121956	http://dx.doi.org/10.1371/journal.pone.0121956			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034989	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100003
J	Qiu, MK; Wang, SC; Dai, YX; Wang, SQ; Ou, JM; Quan, ZW				Qiu, Ming-Ke; Wang, Song-Cun; Dai, Yu-Xin; Wang, Shu-Qing; Ou, Jing-Min; Quan, Zhi-Wei			PD-1 and Tim-3 Pathways Regulate CD8(+) T Cells Function in Atherosclerosis	PLOS ONE			English	Article							LYMPHOCYTES; EXPRESSION; CD4(+); DIFFERENTIATION; IMMUNOGLOBULIN; EXHAUSTION; RECEPTOR; SUBSETS	T cell-mediated immunity plays a significant role in the development of atherosclerosis (AS). There is increasing evidence that CD8(+) T cells are also involved in AS but their exact roles remain unclear. The inhibitory receptors programmed cell death-1 (PD-1) and T cell immunoglobulin and mucin domain 3 (Tim-3) are well known inhibitory molecules that play a crucial role in regulating CD8(+) T cell activation or tolerance. Here, we demonstrate that the co-expression of PD-1 and Tim-3 on CD8(+) T cells is up-regulated in AS patients. PD-1(+) Tim-3(+) CD8(+) T cells are enriched for within the central T (T-CM) cell subset, with high proliferative activity and CD127 expression. Co-expression of PD-1 and Tim-3 on CD8(+) T cells is associated with increased anti-atherogenic cytokine production as well as decreased proatherogenic cytokine production. Blockade of PD-1 and Tim-3 results in a decrease of anti-atherogenic cytokine production by PD-1(+) Tim-3(+) CD8(+) T cells and in an augmentation of TNF-alpha and IFN-gamma production. These findings highlight the important role of the PD-1 and Tim-3 pathways in regulating CD8(+) T cells function in human AS.	[Qiu, Ming-Ke; Dai, Yu-Xin; Wang, Shu-Qing; Ou, Jing-Min; Quan, Zhi-Wei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China; [Wang, Song-Cun] Fudan Univ, Shanghai Med Coll, Hosp & Inst Obstet & Gynecol, Lab Reprod Immunol, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Ou, JM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China.	jingminoy@163.com; zhiwqu@163.com			National Natural Science Foundation of China [81272747]; Science and Technology Commission foundation of Shanghai, China [13140903802]; Medicine and Engineering Cross foundation of Shanghai Jiaotong University [YG2012MS33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission foundation of Shanghai, China; Medicine and Engineering Cross foundation of Shanghai Jiaotong University	This work was supported by National Natural Science Foundation of China (grant no. 81272747), the Science and Technology Commission foundation of Shanghai, China (no. 13140903802), and the Medicine and Engineering Cross foundation of Shanghai Jiaotong University (no. YG2012MS33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bu DX, 2011, ARTERIOSCL THROM VAS, V31, P1100, DOI 10.1161/ATVBAHA.111.224709; Dimayuga PC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000155; Dimayuga PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020214; Elhage R, 2004, AM J PATHOL, V165, P2013, DOI 10.1016/S0002-9440(10)63252-X; Foks AC, 2013, ARTERIOSCL THROM VAS, V33, P2558, DOI 10.1161/ATVBAHA.113.301879; Fourcade J, 2014, CANCER RES, V74, P1045, DOI 10.1158/0008-5472.CAN-13-2908; FYFE AI, 1994, J CLIN INVEST, V94, P2516, DOI 10.1172/JCI117622; GERDES J, 1984, J IMMUNOL, V133, P1710; Gewaltig J, 2008, HUM PATHOL, V39, P1756, DOI 10.1016/j.humpath.2008.04.018; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Gotsman I, 2007, J CLIN INVEST, V117, P2974, DOI 10.1172/JCI31344; Grivel JC, 2011, ARTERIOSCL THROM VAS, V31, P2929, DOI 10.1161/ATVBAHA.111.237081; Hou N, 2012, ATHEROSCLEROSIS, V222, P67, DOI 10.1016/j.atherosclerosis.2012.02.009; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KLEINDIENST R, 1993, AM J PATHOL, V142, P1927; Kolbus D, 2013, J INTERN MED, V274, P41, DOI 10.1111/joim.12038; Kolbus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033932; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Oh SJ, 2011, J IMMUNOL, V186, P6815, DOI 10.4049/jimmunol.1003916; Packard RRS, 2009, SEMIN IMMUNOPATHOL, V31, P5, DOI 10.1007/s00281-009-0153-8; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tse K, 2013, INT IMMUNOL, V25, P615, DOI 10.1093/intimm/dxt043; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang ZZ, 2014, LEUKEMIA, V28, P1872, DOI 10.1038/leu.2014.84; Zarling S, 2013, J IMMUNOL, V190, P5128, DOI 10.4049/jimmunol.1203396; Zhou JC, 2014, BIOCHEM BIOPH RES CO, V443, P864, DOI 10.1016/j.bbrc.2013.12.057; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhou XH, 1996, AM J PATHOL, V149, P359; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	38	35	40	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128523	10.1371/journal.pone.0128523	http://dx.doi.org/10.1371/journal.pone.0128523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035207	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100036
J	Wu, JC; Fang, ZH; Xu, J; Zhu, WK; Li, Y; Yu, YC				Wu, Jianchun; Fang, Zhihong; Xu, Jing; Zhu, Weikang; Li, Yan; Yu, Yongchun			Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis	PLOS ONE			English	Article							MIR-200 FAMILY; MESENCHYMAL TRANSITION; CELL CARCINOMA; BREAST-CANCER; BIOMARKER; OVARIAN; ZEB1; MARKERS; PLASMA; MIRNAS	MiR-200c has been shown to be related to cancer formation and progression. However, the prognostic and clinicopathologic significance of miR-200c expression in cancer remain inconclusive. We carried out this systematic review and meta-analysis to investigate the prognostic value of miR-200c expression in cancer. Pooled hazard ratios (HRs) of miR-200c for overall survival (OS) and progression-free survival (PFS) were calculated to measure the effective value of miR-200c expression on prognosis. The association between miR-200c expression and clinical significance was measured by odds ratios (ORs). Twenty-three studies were included in our meta-analysis. We found that miR-200c was not significantly correlated with OS (HR = 1.41, 95%CI: 0.95-2.10; P = 0.09) and PFS (HR = 1.12, 95%CI: 0.68-1.84; P = 0.67) in cancer. In our subgroup analysis, higher expression of miR-200c was significantly associated with poor OS in blood (HR = 2.10, 95%CI: 1.52-2.90, P<0.00001). Moreover, in clinicopathology analysis, miR-200c expression in blood was significantly associated with TNM stage, lymph node metastasis and distant metastasis. MiR-200c may have the potential to become a new blood biomarker to monitor cancer prognosis and progression.	[Wu, Jianchun; Fang, Zhihong; Xu, Jing; Zhu, Weikang; Li, Yan] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China; [Yu, Yongchun] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Li, Y (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Dept Oncol, Shanghai, Peoples R China.	18916767226@163.com; yueyongchun88@163.com			Natural Science Foundation of China [31171086]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Natural Science Foundation of China (Grant Nos: 31171086). The funders Yongchun Yu designed this research.	Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Cao Q, 2014, INT J CLIN EXP PATHO, V7, P2392; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chen J, 2013, TUMOUR BIOL; Dai J, 2014, ASIAN PAC J CANCER P, V15, P3369, DOI 10.7314/APJCP.2014.15.8.3369; Diaz T, 2014, J SURG ONCOL; Elgaaen BV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-80; Gasparrini A, 2011, STAT MED, V30; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; He J, 2013, DIS MARKERS, V34, P379, DOI [10.1155/2013/856750, 10.3233/DMA-130984]; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Kim MK, 2014, VIRCHOWS ARCH, V465, P463, DOI 10.1007/s00428-014-1640-4; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Leskela S, 2011, ENDOCR-RELAT CANCER, V18, P85, DOI 10.1677/ERC-10-0148; Li JY, 2014, ONCOTARGET, V5, P7902, DOI 10.18632/oncotarget.2302; Li J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1033; Li MM, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/106197; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Liu YQ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-181; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma XL, 2013, BREAST, V22, P462, DOI 10.1016/j.breast.2013.03.005; Madhavan D, 2012, CLIN CANCER RES, V18, P5972, DOI 10.1158/1078-0432.CCR-12-1407; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Song FJ, 2014, CLIN CANCER RES, V20, P878, DOI 10.1158/1078-0432.CCR-13-1844; Tanaka K, 2013, ANN SURG ONCOL, V20, pS607, DOI 10.1245/s10434-013-3093-4; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Toiyama Y, 2014, ANN SURG, V259, P735, DOI 10.1097/SLA.0b013e3182a6909d; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Tuomarila M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109508; Valladares-Ayerbes M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-186; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wotschofsky Z, 2013, CLIN CHIM ACTA, V416, P5, DOI 10.1016/j.cca.2012.11.010; Yang H, 2013, INT J GYNECOL CANCER, V23, P2, DOI 10.1097/IGC.0b013e3182749139; Yang Y, 2014, TUMOUR BIOL; Yu H, 2014, AM J TRANSL RES, V6, P71; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Zeng R, 2013, CHINESE J CANCER RES, V25, P637, DOI 10.3978/j.issn.1000-9604.2013.11.03; Zhang GJ, 2013, MOL CLIN ONCOL, V1, P379, DOI 10.3892/mco.2013.61; Zhang X, 2014, SCI REP-UK, V4, DOI 10.1038/srep07241	48	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128642	10.1371/journal.pone.0128642	http://dx.doi.org/10.1371/journal.pone.0128642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035744	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100040
J	Khayyeri, H; Gustafsson, A; Heuijerjans, A; Matikainen, MK; Julkunen, P; Eliasson, P; Aspenberg, P; Isaksson, H				Khayyeri, Hanifeh; Gustafsson, Anna; Heuijerjans, Ashley; Matikainen, Marko K.; Julkunen, Petro; Eliasson, Pernilla; Aspenberg, Per; Isaksson, Hanna			A Fibre-Reinforced Poroviscoelastic Model Accurately Describes the Biomechanical Behaviour of the Rat Achilles Tendon	PLOS ONE			English	Article							STRUCTURAL CONSTITUTIVE MODEL; STRESS-RELAXATION; MECHANICAL-PROPERTIES; SOFT-TISSUES; VISCOELASTIC PROPERTIES; ARTICULAR-CARTILAGE; DAMAGE MODEL; STRAIN-RATE; TENSILE; LIGAMENT	Background Computational models of Achilles tendons can help understanding how healthy tendons are affected by repetitive loading and how the different tissue constituents contribute to the tendon's biomechanical response. However, available models of Achilles tendon are limited in their description of the hierarchical multi-structural composition of the tissue. This study hypothesised that a poroviscoelastic fibre-reinforced model, previously successful in capturing cartilage biomechanical behaviour, can depict the biomechanical behaviour of the rat Achilles tendon found experimentally. Materials and Methods We developed a new material model of the Achilles tendon, which considers the tendon's main constituents namely: water, proteoglycan matrix and collagen fibres. A hyperelastic formulation of the proteoglycan matrix enabled computations of large deformations of the tendon, and collagen fibres were modelled as viscoelastic. Specimen-specific finite element models were created of 9 rat Achilles tendons from an animal experiment and simulations were carried out following a repetitive tensile loading protocol. The material model parameters were calibrated against data from the rats by minimising the root mean squared error (RMS) between experimental force data and model output. Results and Conclusions All specimen models were successfully fitted to experimental data with high accuracy (RMS 0.42-1.02). Additional simulations predicted more compliant and soft tendon behaviour at reduced strain-rates compared to higher strain-rates that produce a stiff and brittle tendon response. Stress-relaxation simulations exhibited strain-dependent stress-relaxation behaviour where larger strains produced slower relaxation rates compared to smaller strain levels. Our simulations showed that the collagen fibres in the Achilles tendon are the main load-bearing component during tensile loading, where the orientation of the collagen fibres plays an important role for the tendon's viscoelastic response. In conclusion, this model can capture the repetitive loading and unloading behaviour of intact and healthy Achilles tendons, which is a critical first step towards understanding tendon homeostasis and function as this biomechanical response changes in diseased tendons.	[Khayyeri, Hanifeh; Gustafsson, Anna; Isaksson, Hanna] Lund Univ, Dept Biomed Engn, Lund, Sweden; [Heuijerjans, Ashley] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Matikainen, Marko K.] Lappeenranta Univ Technol, Dept Mech Engn, Lappeenranta, Finland; [Julkunen, Petro] Kuopio Univ Hosp, Dept Clin Neurophysiol, SF-70210 Kuopio, Finland; [Julkunen, Petro] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Eliasson, Pernilla; Aspenberg, Per] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Lund University; Eindhoven University of Technology; Lappeenranta University of Technology; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Linkoping University	Isaksson, H (corresponding author), Lund Univ, Dept Biomed Engn, Lund, Sweden.	hanna.isaksson@bme.lth.se	Gustafsson, Anna/AAX-5694-2020; Julkunen, Petro/AAS-5293-2020; Eliasson, Pernilla/AAY-2126-2020; Isaksson, Hanna/L-1340-2015	Gustafsson, Anna/0000-0002-5735-9503; Eliasson, Pernilla/0000-0001-6718-034X; Isaksson, Hanna/0000-0002-9690-8907; Julkunen, Petro/0000-0002-0461-1058; Khayyeri, Hanifeh/0000-0001-5751-3737	Marie Curie Intra-European Fellowship for Career Development [PIEF-GA-2012-626941]; Academy of Finland [259543]	Marie Curie Intra-European Fellowship for Career Development; Academy of Finland(Academy of Finland)	This research project is supported by a Marie Curie Intra-European Fellowship for Career Development (PIEF-GA-2012-626941) and the Academy of Finland (no. 259543).	Adeeb S, 2004, COMPUT METHOD BIOMEC, V7, P33, DOI 10.1080/10255840310001637266; Birch Helen L, 2013, Muscles Ligaments Tendons J, V3, P12, DOI 10.11138/mltj/2013.3.1.012; Calvo B, 2007, INT J NUMER METH ENG, V69, P2036, DOI 10.1002/nme.1825; Ciarletta P, 2006, J BIOMECH, V39, P2034, DOI 10.1016/j.jbiomech.2005.06.025; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; Davis FM, 2014, BIOMECH MODEL MECHAN, V13, P653, DOI 10.1007/s10237-013-0525-9; De Vita R, 2006, INT J SOLIDS STRUCT, V43, P1561, DOI 10.1016/j.ijsolstr.2005.04.022; Duenwald SE, 2010, BIORHEOLOGY, V47, P1, DOI 10.3233/BIR-2010-0559; Duenwald SE, 2009, ANN BIOMED ENG, V37, P1131, DOI 10.1007/s10439-009-9687-0; Eliasson P, 2007, J APPL PHYSIOL, V103, P459, DOI 10.1152/japplphysiol.01333.2006; Fan R, 2014, J BIOMECH, V47, P2043, DOI 10.1016/j.jbiomech.2014.03.014; Franchi M, 2007, THESCIENTIFICWORLDJO, V7, P404, DOI 10.1100/TSW.2007.92; Freedman Benjamin R, 2014, Muscles Ligaments Tendons J, V4, P245; Freutel M, 2014, CLIN BIOMECH, V29, P363, DOI 10.1016/j.clinbiomech.2014.01.006; Gautieri A, 2013, INT J NONLIN MECH, V56, P25, DOI 10.1016/j.ijnonlinmec.2013.03.012; Grytz R, 2009, J MECH BEHAV BIOMED, V2, P522, DOI 10.1016/j.jmbbm.2008.12.009; Gupta HS, 2010, J STRUCT BIOL, V169, P183, DOI 10.1016/j.jsb.2009.10.002; HANNAFIN JA, 1994, J ORTHOPAED RES, V12, P350, DOI 10.1002/jor.1100120307; Helmer KG, 2004, J BIOMECH ENG-T ASME, V126, P651, DOI 10.1115/1.1800573; Hess Gregory William, 2010, Foot Ankle Spec, V3, P29, DOI 10.1177/1938640009355191; Holzapfel GA, 2001, COMPUT METHOD APPL M, V190, P4379, DOI 10.1016/S0045-7825(00)00323-6; Johnstone AJ, 2005, TENDON INJURIES: BASIC SCIENCE AND CLINICAL MEDICINE, P128, DOI 10.1007/1-84628-050-8_14; JULKUNEN P, 2013, COMPUT MATH METHOD M, V2013, DOI DOI 10.1155/2013/326150; Julkunen P, 2007, J BIOMECH, V40, P1862, DOI 10.1016/j.jbiomech.2006.07.026; Kahn CJF, 2013, J MECH BEHAV BIOMED, V26, P81, DOI 10.1016/j.jmbbm.2013.05.028; Kahn CJF, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002552; Kosters A, 2014, CLIN BIOMECH, V29, P323, DOI 10.1016/j.clinbiomech.2013.12.010; Kongsgaard M, 2005, J APPL PHYSIOL, V99, P1965, DOI 10.1152/japplphysiol.00384.2005; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; LANIR Y, 1979, J BIOMECH, V12, P423, DOI 10.1016/0021-9290(79)90027-7; Lavagnino M, 2008, BIOMECH MODEL MECHAN, V7, P405, DOI 10.1007/s10237-007-0104-z; Liu J, 2009, IFMBE PROC, V23, P1631; Lynch HA, 2003, J BIOMECH ENG-T ASME, V125, P726, DOI 10.1115/1.1614819; Nagel T, 2010, BIOMECH MODEL MECHAN, V9, P359, DOI 10.1007/s10237-009-0182-1; Narici, 2007, EXERC SPORT SCI REV, V35, P196; Natali AN, 2005, MED ENG PHYS, V27, P209, DOI 10.1016/j.medengphy.2004.10.011; Parkinson J, 2011, J MUSCULOSKEL NEURON, V11, P86; Pioletti DP, 2000, J BIOMECH, V33, P1729, DOI 10.1016/S0021-9290(00)00128-7; Prendergast PJ, 1997, P I MECH ENG H, V211, P209; Provenzano P, 2001, ANN BIOMED ENG, V29, P908, DOI 10.1114/1.1408926; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Quinn KP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004205; Reese SP, 2010, J BIOMECH, V43, P1394, DOI 10.1016/j.jbiomech.2010.01.004; Riggin CN, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026285; Rigozzi S, 2011, STRUCTURE FUNCTION T; Rodriguez JF, 2006, J MECH PHYS SOLIDS, V54, P864, DOI 10.1016/j.jmps.2005.10.005; Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671; Screen HRC, 2005, ANN BIOMED ENG, V33, P1090, DOI 10.1007/s10439-005-5777-9; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052; Shepherd JH, 2014, P I MECH ENG H, V228, P49, DOI 10.1177/0954411913509977; SIMO JC, 1985, COMPUT METHOD APPL M, V49, P221, DOI 10.1016/0045-7825(85)90061-1; Smith DW, 2013, WIRES SYST BIOL MED, V5, P523, DOI 10.1002/wsbm.1229; Sverdlik A, 2002, J BIOMECH ENG-T ASME, V124, P78, DOI 10.1115/1.1427699; Szczesny SE, 2014, ACTA BIOMATER, V10, P2582, DOI 10.1016/j.actbio.2014.01.032; Tang CY, 2011, BIO-MED MATER ENG, V21, P9, DOI 10.3233/BME-2011-0653; Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192; Wilson W, 2005, J BIOMECH, V38, P1195, DOI 10.1016/j.jbiomech.2004.07.003; Wilson W, 2004, J BIOMECH, V37, P357, DOI 10.1016/S0021-9290(03)00267-7; Wren TAL, 2001, CLIN BIOMECH, V16, P245, DOI 10.1016/S0268-0033(00)00089-9; Yin LH, 2004, J BIOMECH, V37, P907, DOI 10.1016/j.jbiomech.2003.10.007; Zhang Lihai, 2008, Molecular & Cellular Biomechanics, V5, P133; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066301; Zhu YL, 2014, J BIOMECH, V47, P996, DOI 10.1016/j.jbiomech.2014.01.004	64	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126869	10.1371/journal.pone.0126869	http://dx.doi.org/10.1371/journal.pone.0126869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030436	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900035
J	Lucci, V; Di Palma, T; Zannini, M				Lucci, Valeria; Di Palma, Tina; Zannini, Mariastella			Neuropilin-2 Is a Newly Identified Target of PAX8 in Thyroid Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; PAIRED BOX GENE; CONGENITAL HYPOTHYROIDISM; TRANSCRIPTION FACTORS; TUMOR ANGIOGENESIS; VESSEL DEVELOPMENT; TRANSGENIC MICE; EXPRESSION; CANCER; CARCINOMA	PAX8 is a transcription factor essential for thyroid gland development, as well as for the maintenance of the thyroid differentiated state in the adult. In particular, PAX8 has been comprehensively shown to regulate genes that are considered markers of thyroid differentiation. However, a better knowledge of genes transcriptionally regulated by PAX8 is desirable to clarify its role in endocrine syndromes and cancer susceptibility. In order to further investigate PAX8 downstream targets, we recently performed a genome-wide expression analysis following PAX8 knockdown in FRTL-5 thyroid cells and Neuropilin-2 was identified as a potential transcriptional target of PAX8. In this study, we determined the role of the transcription factor PAX8 in the regulation of Neuropilin-2 expression. Indeed, in thyroid cells PAX8 directly binds the Neuropilin-2 promoter leading to its transcriptional repression. Interestingly, we observed an inverse correlation between the expression of PAX8 and Neuropilin-2 in thyroid carcinoma tissues and cell lines compared to non-tumor counterparts, suggesting a critical role of PAX8 in regulating Neuropilin-2 expression in vivo. Notably, ectopic overexpression of PAX8 in FB-2 thyroid cancer cells promotes Neuropilin-2 downregulation producing a significant reduction in cell proliferation, migration ability, and invasion activity and reverting the cell phenotype from mesenchymal to a more epithelial one. These findings uncover the novel interplay between PAX8 and Neuropilin-2, which is likely to be important in the pathogenesis of thyroid diseases.	[Lucci, Valeria; Di Palma, Tina; Zannini, Mariastella] CNR, IEOS Inst Expt Endocrinol & Oncol G Salvatore, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Zannini, M (corresponding author), CNR, IEOS Inst Expt Endocrinol & Oncol G Salvatore, I-80125 Naples, Italy.	s.zannini@ieos.cnr.it	Zannini, Mariastella/I-1735-2012; Di+Palma, Tina/AAN-6853-2021	LUCCI, Valeria/0000-0002-0702-3630	Italian Ministry of Economy and Finance; grant Medical Research in Italy (MERIT) [RBNE08YFN3_001]	Italian Ministry of Economy and Finance; grant Medical Research in Italy (MERIT)	This work was supported by grants from the Italian Ministry of Economy and Finance to the CNR for the Project FaReBio di Qualita and by the grant Medical Research in Italy (MERIT) RBNE08YFN3_001.	Al Taji E, 2007, EUR J ENDOCRINOL, V156, P521, DOI 10.1530/EJE-06-0709; Ambesi-Impiombato F S, 1979, Int Rev Cytol Suppl, P163; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Dallas NA, 2008, CLIN CANCER RES, V14, P8052, DOI 10.1158/1078-0432.CCR-08-1520; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Di Palma T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.262; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Di Palma T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025162; Di Palma T, 2010, CLIN ENDOCRINOL, V73, P808, DOI 10.1111/j.1365-2265.2010.03851.x; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; FABBRO D, 1994, CANCER RES, V54, P4744; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Fujisawa H, 1997, CELL TISSUE RES, V290, P465, DOI 10.1007/s004410050954; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Grandclement Camille, 2011, Cancers (Basel), V3, P1899, DOI 10.3390/cancers3021899; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Handa A, 2000, INT J ONCOL, V17, P291; Hansel DE, 2004, AM J SURG PATHOL, V28, P347, DOI 10.1097/00000478-200403000-00007; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Jubb AM, 2012, HISTOPATHOLOGY, V61, P340, DOI 10.1111/j.1365-2559.2012.04224.x; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Koch S, 2012, BIOCHEM SOC T, V40, P20, DOI 10.1042/BST20110689; Kreuter M, 2006, LEUKEMIA, V20, P1950, DOI 10.1038/sj.leu.2404384; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; LEDENT C, 1991, ENDOCRINOLOGY, V129, P1391, DOI 10.1210/endo-129-3-1391; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Mittag J, 2007, ENDOCRINOLOGY, V148, P719, DOI 10.1210/en.2006-1054; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Nakamura Y, 2006, J CLIN ENDOCR METAB, V91, P1582, DOI 10.1210/jc.2005-1790; Narumi S, 2010, J CLIN ENDOCR METAB, V95, P1981, DOI 10.1210/jc.2009-2373; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Parlato R, 2004, DEV BIOL, V276, P464, DOI 10.1016/j.ydbio.2004.08.048; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; PLACHOV D, 1990, DEVELOPMENT, V110, P643; POLEEV A, 1992, DEVELOPMENT, V116, P611; Powell DJ, 1998, CANCER RES, V58, P5523; Rizzolio S, 2011, CURR MED CHEM, V18, P3563, DOI 10.2174/092986711796642544; Ros P, 1999, BIOCHIMIE, V81, P389, DOI 10.1016/S0300-9084(99)80086-8; Russell JP, 2000, ONCOGENE, V19, P5729, DOI 10.1038/sj.onc.1203922; Sangoi AR, 2011, MODERN PATHOL, V24, P412, DOI 10.1038/modpathol.2010.176; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tong GX, 2008, AM J SURG PATHOL, V32, P1380, DOI 10.1097/PAS.0b013e31816b1020; Tong GX, 2009, MODERN PATHOL, V22, P1218, DOI 10.1038/modpathol.2009.88; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Vitagliano D, 2006, ONCOGENE, V25, P5467, DOI 10.1038/sj.onc.1209527; Wild JRL, 2012, INT J EXP PATHOL, V93, P81, DOI 10.1111/j.1365-2613.2012.00810.x; Wistuba J, 2007, J ENDOCRINOL, V192, P99, DOI 10.1677/JOE-06-0054; Yasuoka H, 2005, MODERN PATHOL, V18, P1127, DOI 10.1038/modpathol.3800402; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	65	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128315	10.1371/journal.pone.0128315	http://dx.doi.org/10.1371/journal.pone.0128315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030152	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900137
J	Cole, GG; Wright, D; Doneva, SP; Skarratt, PA				Cole, Geoff G.; Wright, Damien; Doneva, Silviya P.; Skarratt, Paul A.			When Your Decisions Are Not (Quite) Your Own: Action Observation Influences Free Choices	PLOS ONE			English	Article							BIAS; COMPATIBILITY; PERCEPTION	A growing number of studies have begun to assess how the actions of one individual are represented in an observer. Using a variant of an action observation paradigm, four experiments examined whether one person's behaviour can influence the subjective decisions and judgements of another. In Experiment 1, two observers sat adjacent to each other and took turns to freely select and reach to one of two locations. Results showed that participants were less likely to make a response to the same location as their partner. In three further experiments observers were asked to decide which of two familiar products they preferred or which of two faces were most attractive. Results showed that participants were less likely to choose the product or face occupying the location of their partner's previous reaching response. These findings suggest that action observation can influence a range of free choice preferences and decisions. Possible mechanisms through which this influence occurs are discussed.	[Cole, Geoff G.; Wright, Damien; Doneva, Silviya P.] Univ Essex, Ctr Brain Sci, Colchester CO4 3SQ, Essex, England; [Skarratt, Paul A.] Univ Hull, Dept Psychol, Kingston Upon Hull, Yorks, England	University of Essex; University of Hull	Cole, GG (corresponding author), Univ Essex, Ctr Brain Sci, Colchester CO4 3SQ, Essex, England.	ggcole@essex.ac.uk		Wright, Damien/0000-0002-9105-3559				BAVELAS JB, 1986, J NONVERBAL BEHAV, V10, P102, DOI 10.1007/BF01000007; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cole GG, 2012, PSYCHOL RES-PSYCH FO, V76, P736, DOI 10.1007/s00426-011-0395-7; Cole GG, 2010, ATTEN PERCEPT PSYCHO, V72, P1367, DOI 10.3758/APP.72.5.1367; Croson R, 2005, J RISK UNCERTAINTY, V30, P195, DOI 10.1007/s11166-005-1153-2; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Goodfellow LD, 1940, J GEN PSYCHOL, V23, P201, DOI 10.1080/00221309.1940.10544078; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jeannerod M, 1999, HUM MOVEMENT SCI, V18, P201, DOI 10.1016/S0167-9457(99)00008-1; Ondobaka S, 2012, PSYCHOL SCI, V23, P30, DOI 10.1177/0956797611424163; Paccalin C, 2000, BRAIN RES, V862, P194, DOI 10.1016/S0006-8993(00)02145-4; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; RABINOWITZ FM, 1970, PSYCHOL BULL, V74, P141, DOI 10.1037/h0029551; SCHEFLEN AE, 1964, PSYCHIATR, V27, P316; Schlaghecken F, 2004, PSYCHON B REV, V11, P463, DOI 10.3758/BF03196596; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Skarratt PA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00196; Skarratt PA, 2010, ACTA PSYCHOL, V134, P48, DOI 10.1016/j.actpsy.2009.12.003; Wang ZG, 2012, VIS COGN, V20, P825, DOI 10.1080/13506285.2012.705358; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Welsh TN, 2007, PSYCHON B REV, V14, P950, DOI 10.3758/BF03194127; Welsh TN, 2009, BRAIN COGNITION, V71, P64, DOI 10.1016/j.bandc.2009.04.001; Welsh TN, 2005, NEUROSCI LETT, V385, P99, DOI 10.1016/j.neulet.2005.05.013; Wilke A, 2014, EVOL HUM BEHAV, V35, P291, DOI 10.1016/j.evolhumbehav.2014.02.010; Wilson DE, 2007, ACTA PSYCHOL, V126, P216, DOI 10.1016/j.actpsy.2006.12.003; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127766	10.1371/journal.pone.0127766	http://dx.doi.org/10.1371/journal.pone.0127766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024480	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000355319400050
J	Demain, S; Goncalves, AC; Areia, C; Oliveira, R; Marcos, AJ; Marques, A; Parmar, R; Hunt, K				Demain, Sara; Goncalves, Ana-Carolina; Areia, Carlos; Oliveira, Ruben; Marcos, Ana Jorge; Marques, Alda; Parmar, Ranj; Hunt, Katherine			Living With, Managing and Minimising Treatment Burden in Long Term Conditions: A Systematic Review of Qualitative Research	PLOS ONE			English	Review							OF-LIFE; PATIENTS EXPERIENCES; CHRONIC ILLNESS; FRAMEWORK; MANAGEMENT	Background 'Treatment burden', defined as both the workload and impact of treatment regimens on function and well-being, has been associated with poor adherence and unfavourable outcomes. Previous research focused on treatment workload but our understanding of treatment impact is limited. This research aimed to systematically review qualitative research to identify: 1) what are the treatment generated disruptions experienced by patients across all chronic conditions and treatments? 2) what strategies do patients employ to minimise these treatment generated disruptions? Methods and Findings The search strategy centred on: treatment burden and qualitative methods. Medline, CINAHL, Embase, and PsychINFO were searched electronically from inception to Dec 2013. No language limitations were set. Teams of two reviewers independently conducted paper screening, data extraction, and data analysis. Data were analysed using framework synthesis informed by Cumulative Complexity Model. Eleven papers reporting data from 294 patients, across a range of conditions, age groups and nationalities were included. Treatment burdens were experienced as a series of disruptions: biographical disruptions involved loss of freedom and independence, restriction of meaningful activities, negative emotions and stigma; relational disruptions included strained family and social relationships and feeling isolated; and, biological disruptions involved physical side-effects. Patients employed "adaptive treatment work" and "rationalised non-adherence" to minimise treatment disruptions. Rationalised non-adherence was sanctioned by health professionals at end of life; at other times it was a "secret-act" which generated feelings of guilt and impacted on family and clinical relationships. Conclusions Treatments generate negative emotions and physical side effects, strain relationships and affect identity. Patients minimise these disruptions through additional adaptive work and/ or by non-adherence. This affects physical outcomes and care relationships. There is a need for clinicians to engage with patients in honest conversations about treatment disruptions and the 'adhere-ability' of recommended regimens. Patient-centred practice requires management plans which optimise outcomes and minimise disruptions.	[Demain, Sara; Goncalves, Ana-Carolina; Parmar, Ranj; Hunt, Katherine] Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England; [Demain, Sara; Hunt, Katherine] NIHR Wessex Collaborat Leadership & Res Hlth Care, Southampton, Hants, England; [Goncalves, Ana-Carolina; Areia, Carlos; Oliveira, Ruben; Marcos, Ana Jorge; Marques, Alda] Univ Aveiro ESSUA, Sch Hlth Sci, P-3810193 Aveiro, Portugal; [Marques, Alda] Unidade Invest & Form Adultos & Idosos UNIFAI, Oporto, Portugal	University of Southampton; Universidade de Aveiro; Universidade do Porto	Demain, S (corresponding author), Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England.	S.H.Demain@soton.ac.uk	Areia, Carlos/J-1389-2019; Marques, Alda Sofia Pires/K-3150-2013	Areia, Carlos/0000-0002-4668-7069; Goncalves, Ana-Carolina/0000-0003-4055-0894; Marques, Alda Sofia Pires/0000-0003-4980-6200	National Institute for Health Research; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Wessex; National Institute for Health Research Cover Letter Collaboration for Leadership in Applied Health Research and Care Wessex; National Institute for Health Research [PDF-2011-04-016] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Wessex; National Institute for Health Research Cover Letter Collaboration for Leadership in Applied Health Research and Care Wessex; National Institute for Health Research(National Institute for Health Research (NIHR))	Contributions to this paper by SD were supported by a post-doctoral fellowship awarded by the National Institute for Health Research and by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Wessex. Contributions to this paper by KH were supported by the National Institute for Health Research and by the National Institute for Health Research Cover Letter Collaboration for Leadership in Applied Health Research and Care Wessex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, END LIFE CARE STRATE; Baylor CR, 2007, J VOICE, V21, P231, DOI 10.1016/j.jvoice.2006.01.007; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BURY M, 1991, SOCIOL HEALTH ILL, V13, P451, DOI 10.1111/j.1467-9566.1991.tb00522.x; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Corbin J., 1985, QUALITATIVE SOCIOLOG, V8, P224, DOI [10.1007/BF00989485, DOI 10.1007/BF00989485]; Critical Appraisal Skills Programme, 2020, CASP CHECKL; Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486; Dixon-Woods M, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-39; Eton DT, 2012, PATIENT-RELAT OUTCOM, V3, P39, DOI 10.2147/PROM.S34681; Fried Terri R, 2003, J Palliat Med, V6, P237, DOI 10.1089/109662103764978489; Gallacher K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001473; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; George M, 2010, J CYST FIBROS, V9, P425, DOI 10.1016/j.jcf.2010.08.016; GMC, CONS GUID PAT DOCT M; Grootscholten C, 2003, QUAL LIFE RES, V12, P635, DOI 10.1023/A:1025176407776; HOLM S, 1993, J MED ETHICS, V19, P108, DOI 10.1136/jme.19.2.108; Janssens GO, 2013, INT J RADIAT ONCOL, V85, P315, DOI 10.1016/j.ijrobp.2012.04.006; Johnston S, 2012, J CLIN NURS, V21, P1215, DOI 10.1111/j.1365-2702.2011.04001.x; Jordan S, 2006, J ADV NURS, V56, P270, DOI 10.1111/j.1365-2648.2006.04006.x; Karamanidou C, 2014, J HEALTH PSYCHOL, V19, P556, DOI 10.1177/1359105313475898; Kerr NM, 2013, CLIN EXP OPHTHALMOL, V41, P27, DOI 10.1111/j.1442-9071.2012.02823.x; Lewis CP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-190; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Noyes J, 2011, COCHRANE HDB SYSTEMA; Oliver SR, 2008, HEALTH EXPECT, V11, P72, DOI 10.1111/j.1369-7625.2007.00476.x; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; Russell S, 2003, J ADV NURS, V43, P281, DOI 10.1046/j.1365-2648.2003.02711.x; Sav A, 2013, HLTH EXPECTATIONS IN; Sav A, 2013, HEALTH SOC CARE COMM, V21, P665, DOI 10.1111/hsc.12052; Schofield LM, 2014, PHYSIOTHER THEOR PR, V30, P157, DOI 10.3109/09593985.2013.845863; Sen A., 2010, IDEA JUSTICE, DOI DOI 10.2307/J.CTVJNRV7N; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Ziaian T, 2006, J PAEDIATR CHILD H, V42, P596, DOI 10.1111/j.1440-1754.2006.00943.x	39	74	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125457	10.1371/journal.pone.0125457	http://dx.doi.org/10.1371/journal.pone.0125457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024379	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000355319400007
J	Okada, H; Hasegawa, G; Tanaka, M; Osaka, T; Shiotsu, Y; Narumiya, H; Inoue, M; Nakano, K; Nakamura, N; Fukui, M				Okada, Hiroshi; Hasegawa, Goji; Tanaka, Muhei; Osaka, Takafumi; Shiotsu, Yayoi; Narumiya, Hiromichi; Inoue, Mamoru; Nakano, Koji; Nakamura, Naoto; Fukui, Michiaki			Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease	PLOS ONE			English	Article							AUTONOMIC NEUROPATHY; CHRONIC HYPOXIA; RISK-FACTORS; ANEMIA; NEPHROPATHY; PREDICTORS; MORTALITY; DEATH; MELLITUS; FAILURE	Aims Anemia, which might contribute to pathogenesis of kidney dysfunction, is a common finding in patients with type 2 diabetes. The aim of this study was to investigate if hemoglobin concentration is associated with the degree of change in urinary albumin-creatinine ratio or the development of albuminuria in patients with type 2 diabetes. Methods We measured hemoglobin concentration in 470 (296 men and 174 women) consecutive type 2 diabetic patients without albuminuria. We performed a follow-up study to assess the progression or development of albuminuria, the interval of which was 3.0 years. Then we evaluated relationships between hemoglobin concentration and albuminuria, using multivariate linear regression analyses and logistic regression analyses. Results Eighty four patients developed albuminuria during follow-up duration. In multivariate analyses, hemoglobin concentration was negatively associated with a change in urinary albumin creatinine ratio in men (beta = -0.259, P= 0.0002) and women (beta = -0.194, P= 0.030). Moreover, multivariate adjusted odds ratio associated with 1 g/L in hemoglobin for the development of albuminuria was 0.93 (95% confidence interval; 0.89-0.96) in men and 0.94 (95% confidence interval; 0.88-0.99) in women, respectively. And, multivariate analyses revealed that adjusted odds ratios for the development of albuminuria were 4.78 (95% confidence interval; 1.65-13.91) in men and 4.62 (95% confidence interval; 1.34-16.68) in women with anemia (hemoglobin < 130 g/L for men and < 120 g/L for women), which were higher than those without anemia. Conclusions Low hemoglobin concentration could be a predictor for the progression and development of albuminuria in patients with type 2 diabetes.	[Okada, Hiroshi; Hasegawa, Goji; Osaka, Takafumi; Shiotsu, Yayoi; Narumiya, Hiromichi; Inoue, Mamoru] Japanese Red Cross, Kyoto Daini Hosp, Dept Metab Nephrol & Immunol, Kamigyo Ku, Kyoto 6028026, Japan; [Tanaka, Muhei; Nakamura, Naoto; Fukui, Michiaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan; [Nakano, Koji] Kyoto Yamashiro Gen Med Ctr, Dept Endocrinol & Metab, Kyoto, Japan	Japanese Red Cross Medical Center; Kyoto Prefectural University of Medicine	Fukui, M (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan.	sayarinapm@hotmail.com	Okada, Hiroshi/AAG-1588-2020	Okada, Hiroshi/0000-0002-1707-970X; Fukui, Michiaki/0000-0003-0903-1797				Al-Ahmad A, 2001, J AM COLL CARDIOL, V38, P955, DOI 10.1016/S0735-1097(01)01470-X; American Diabetes Association, 2014, DIABETES CARE, V37, pS1; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Babazono T, 2006, DIABETOLOGIA, V49, P1387, DOI 10.1007/s00125-006-0247-y; Basturk T, 2006, RENAL FAILURE, V28, P125, DOI 10.1080/08860220500530510; Bosman DR, 2002, DIABETIC MED, V19, P65, DOI 10.1046/j.1464-5491.2002.00634.x; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Craig KJ, 2005, DIABETES CARE, V28, P1118, DOI 10.2337/diacare.28.5.1118; Dikow R, 2002, NEPHROL DIAL TRANSPL, V17, P67, DOI 10.1093/ndt/17.suppl_1.67; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Drury PL, 2011, DIABETOLOGIA, V54, P32, DOI 10.1007/s00125-010-1854-1; Gavin JR, 1999, DIABETES CARE, V22, pS5; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Harusato I, 2010, METABOLISM, V59, P808, DOI 10.1016/j.metabol.2009.09.028; Holland DC, 2000, NEPHROL DIAL TRANSPL, V15, P650, DOI 10.1093/ndt/15.5.650; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; Molitch ME, 2003, DIABETES CARE, V26, P2702, DOI 10.2337/diacare.26.9.2702; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; NICE Guidelines, 2011, NICE GUID AN MAN CHR; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Sahai A, 1999, KIDNEY INT, V56, P1277, DOI 10.1046/j.1523-1755.1999.00703.x; Spallone V, 2004, DIABETIC MED, V21, P1174, DOI 10.1111/j.1464-5491.2004.01306.x; Stevens PE, 2012, J RENAL CARE, V38, P67, DOI 10.1111/j.1755-6686.2012.00281.x; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Thomas MC, 2004, NEPHROL DIAL TRANSPL, V19, P1792, DOI 10.1093/ndt/gfh248; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Thomas MC, 2006, AM J KIDNEY DIS, V48, P537, DOI 10.1053/j.ajkd.2006.06.011; Ueda H, 2003, DIABETES CARE, V26, P1530, DOI 10.2337/diacare.26.5.1530; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Weiner DE, 2005, J AM SOC NEPHROL, V16, P1803, DOI 10.1681/ASN.2004070597; World Health Organization Nutritional Anemia, 1968, NUTR AM REP WHO SCI; Yokoyama H, 1997, DIABETOLOGIA, V40, P405, DOI 10.1007/s001250050694	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0129192	10.1371/journal.pone.0129192	http://dx.doi.org/10.1371/journal.pone.0129192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023923	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400107
J	Prendiville, TW; Guo, HD; Lin, ZQ; Zhou, PZ; Stevens, SM; He, AB; VanDusen, N; Chen, JH; Zhong, L; Wang, DZ; Gao, GP; Pu, WT				Prendiville, Terence W.; Guo, Haidong; Lin, Zhiqiang; Zhou, Pingzhu; Stevens, Sean M.; He, Aibin; VanDusen, Nathan; Chen, Jinghai; Zhong, Li; Wang, Da-Zhi; Gao, Guangping; Pu, William T.			Novel Roles of GATA4/6 in the Postnatal Heart Identified through Temporally Controlled, Cardiomyocyte-Specific Gene Inactivation by Adeno-Associated Virus Delivery of Cre Recombinase	PLOS ONE			English	Article							MYOCARDIAL EXPRESSION; CARDIAC-HYPERTROPHY; TAMOXIFEN; MICE; INDUCTION; DELETION; FAILURE; GATA-4	GATA4 and GATA6 are central cardiac transcriptional regulators. The postnatal, stage-specific function of the cardiac transcription factors GATA4 and GATA6 have not been evaluated. In part, this is because current Cre-loxP approaches to cardiac gene inactivation require time consuming and costly breeding of Cre-expressing and "floxed" mouse lines, often with limited control of the extent or timing of gene inactivation. We investigated the stage-specific functions of GATA4 and GATA6 in the postnatal heart by using adeno-associated virus serotype 9 to control the timing and extent of gene inactivation by Cre. Systemic delivery of recombinant, adeno-associated virus 9 (AAV9) expressing Cre from the cardiac specific Tnnt2 promoter was well tolerated and selectively and efficiently recombined floxed target genes in cardiomyocytes. AAV9: Tnnt2-Cre efficiently inactivated Gata4 and Gata6. Neonatal Gata4/6 inactivation caused severe, rapidly lethal systolic heart failure. In contrast, Gata4/6 inactivation in adult heart caused only mild systolic dysfunction but severe diastolic dysfunction. Reducing the dose of AAV9: Tnnt2-Cre generated mosaics in which scattered cardiomyocytes lacked Gata4/6. This mosaic knockout revealed that Gata4/6 are required cell autonomously for physiological cardiomyocyte growth. Our results define novel roles of GATA4 and GATA6 in the neonatal and adult heart. Furthermore, our data demonstrate that evaluation of gene function hinges on controlling the timing and extent of gene inactivation. AAV9: Tnnt2-Cre is a powerful tool for controlling these parameters.	[Prendiville, Terence W.; Guo, Haidong; Lin, Zhiqiang; Zhou, Pingzhu; Stevens, Sean M.; He, Aibin; VanDusen, Nathan; Chen, Jinghai; Wang, Da-Zhi; Pu, William T.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Guo, Haidong] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, Shanghai, Peoples R China; [He, Aibin] Peking Univ, Peking Tsinghua Ctr Life Sci, Inst Mol Med, Beijing, Peoples R China; [Zhong, Li; Gao, Guangping; Pu, William T.] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Wang, Da-Zhi] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Shanghai University of Traditional Chinese Medicine; Peking University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University	Pu, WT (corresponding author), Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	wpu@pulab.org	VanDusen, Nathan/ABF-9945-2021; Pu, William/AAJ-8301-2020; He, Aibin/AAI-1639-2019; Zhong, Li/GZM-4358-2022	VanDusen, Nathan/0000-0002-2636-7228; Pu, William/0000-0002-4551-8079; He, Aibin/0000-0002-3489-2305; Zhong, Li/0000-0003-1611-5171; Lin, zhiqiang/0000-0002-2034-2492	Irish Cardiac Society Brian McGovern Travelling Fellowship; NIH [R01 HL095712, U01 HL098166]; AHA Established Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098166, R01HL095712, T32HL007572] Funding Source: NIH RePORTER	Irish Cardiac Society Brian McGovern Travelling Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	TWP was funded by the Irish Cardiac Society Brian McGovern Travelling Fellowship. WTP was supported by NIH (R01 HL095712, U01 HL098166), an AHA Established Investigator Award, and by a charitable donation from Dr. and Mrs. Edwin A. Boger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2010, METHOD ENZYMOL, V477, P109, DOI 10.1016/S0076-6879(10)77007-5; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Charron F, 1999, MOL CELL BIOL, V19, P4355; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; He AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5907; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Lin ZQ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006681; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Molkentin JD, 2009, J MOL CELL CARDIOL, V46, P130, DOI 10.1016/j.yjmcc.2008.09.002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; van Berlo JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084591; van Berlo JH, 2010, CIRC RES, V107, P1032, DOI 10.1161/CIRCRESAHA.110.220764; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Werfel S, 2014, CARDIOVASC RES, V104, P15, DOI 10.1093/cvr/cvu174; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zacchigna S, 2014, CIRC RES, V114, P1827, DOI 10.1161/CIRCRESAHA.114.302331; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zheng RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083723; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	31	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128105	10.1371/journal.pone.0128105	http://dx.doi.org/10.1371/journal.pone.0128105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023924	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400071
J	Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gachter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Woll, E				Hilbe, Wolfgang; Pall, Georg; Kocher, Florian; Pircher, Andreas; Zabernigg, August; Schmid, Thomas; Schumacher, Michael; Jamnig, Herbert; Fiegl, Michael; Gaechter, Anne; Freund, Martin; Kendler, Dorota; Manzl, Claudia; Zelger, Bettina; Popper, Helmut; Woell, Ewald			Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)	PLOS ONE			English	Article							CELL LUNG-CANCER; NEOADJUVANT CHEMOTHERAPY; SURVIVAL; TRIAL; TUMORS; FLEX	Background Different strategies for neoadjuvant chemotherapy in patients with early stage NSCLC have already been evaluated. The aim of this study was to evaluate the tolerability and efficacy of a chemoimmunotherapy when limited to two cycles. Methods Between 01/2007 and 03/2010 41 patients with primarily resectable NSCLC stage IB to IIIA were included. Treatment consisted of two cycles cisplatin (40 mg/m(2) d1+2) and docetaxel (75 mg/m(2) d1) q3 weeks, accompanied by the administration of cetuximab (400 mg/m(2) d1, then 250 mg weekly). The primary endpoint was radiological response according to RECIST. Results 40 patients were evaluable for toxicity, 39 for response. The main grade 3/4 toxicities were: neutropenia 25%, leucopenia 11%, febrile neutropenia 6%, nausea 8% and rash 8%. 20 patients achieved a partial response, 17 a stable disease, 2 were not evaluable. 37 patients (95%) underwent surgery and in three of them a complete pathological response was achieved. At a median follow-up of 44.2 months, 41% of the patients had died, median progression- free survival was 22.5 months. Conclusions Two cycles of cisplatin/docetaxel/cetuximab showed promising efficacy in the neoadjuvant treatment of early-stage NSCLC and rapid operation was possible in 95% of patients. Toxicities were manageable and as expected.	[Hilbe, Wolfgang; Pall, Georg; Kocher, Florian; Pircher, Andreas; Fiegl, Michael; Gaechter, Anne] Med Univ Innsbruck, Dept Internal Med Haematol & Oncol 5, Innsbruck, Austria; [Zabernigg, August] Cty Hosp Kufstein, Dept Internal Med, Kufstein, Austria; [Schmid, Thomas] Med Univ Innsbruck, Dept Surg, A-6020 Innsbruck, Austria; [Schumacher, Michael] Gen Hosp Linz, Elisabethinen Linz, Dept Pneumol, Linz, Austria; [Jamnig, Herbert] Cty Hosp Natters, Dept Pneumol, Natters, Austria; [Freund, Martin] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Kendler, Dorota] Med Univ Innsbruck, Nucl Med, A-6020 Innsbruck, Austria; [Manzl, Claudia; Zelger, Bettina; Popper, Helmut] Med Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria; [Popper, Helmut] Med Univ Graz, Dept Pathol, Graz, Austria; [Woell, Ewald] St Vincent Hosp Zams, Dept Internal Med, Zams, Austria; [Kocher, Florian] Tyrolean Canc Res Inst, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Kepler University Hospital; Ordensklinikum Linz Elisabethinen; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Graz	Hilbe, W (corresponding author), Med Univ Innsbruck, Dept Internal Med Haematol & Oncol 5, Innsbruck, Austria.	wolfgang.hilbe@i-med.ac.at	Pircher, Andreas/L-2150-2019	Pircher, Andreas/0000-0002-7747-3012	Sanofi-Aventis; Merck; Association of Cancer Research ("Verein fur Tumorforschung")	Sanofi-Aventis(Sanofi-Aventis); Merck(Merck & Company); Association of Cancer Research ("Verein fur Tumorforschung")	This academic study was in part financed by two unrestricted grants offered by the companies Sanofi-Aventis and Merck. Drug supply concerning Cetuximab was donated by Merck. Additional fundings were granted by the Association of Cancer Research ("Verein fur Tumorforschung"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fundings do not alter our adherence to PLOS ONE policies on sharing data and materials.	Baik C, 2013, ROLE CHEMOTHERAPY MA; Betticher DC, 2003, J CLIN ONCOL, V21, P1752, DOI 10.1200/JCO.2003.11.040; Burdett S, 2006, J THORAC ONCOL, V1, P611; Depierre A, 2002, J CLIN ONCOL, V20, P247, DOI 10.1200/JCO.20.1.247; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Gilligan D, 2007, LANCET, V369, P1929, DOI 10.1016/S0140-6736(07)60714-4; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Greene DL, 2002, AJCC CANC STAGING MA; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Pisters KMW, 2010, J CLIN ONCOL, V28, P1843, DOI 10.1200/JCO.2009.26.1685; Scagliotti GV, 2012, J CLIN ONCOL, V30, P172, DOI 10.1200/JCO.2010.33.7089; Song WA, 2010, J THORAC ONCOL, V5, P510, DOI 10.1097/JTO.0b013e3181cd3345; Steger V, 2013, THORAC CARDIOV SURG, V61, P109, DOI 10.1055/s-0032-1311529; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Westeel V, 2010, J CLIN ONCOL S15, V28	17	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125364	10.1371/journal.pone.0125364	http://dx.doi.org/10.1371/journal.pone.0125364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020783	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300013
J	Li, XP; Li, YP; Zhang, Z; Li, XG				Li, Xiaopeng; Li, Yupeng; Zhang, Zhong; Li, Xingang			Influences of Environmental Factors on Leaf Morphology of Chinese Jujubes	PLOS ONE			English	Article							REGULATED DEFICIT IRRIGATION; PLANT FUNCTIONAL TRAITS; DIFFERENT GROWTH-STAGES; WATER-USE EFFICIENCY; VENATION ARCHITECTURE; SOUTHERN BEECH; EVOLUTION; DROUGHT; CLIMATE; LEAVES	Rainfall and temperature are the primary limiting factors for optimum quality and yield of cultivated jujube (Ziziphus jujuba Mill.). Adaptation to arid and cool environments has been and remains an important goal of many jujube improvement programs. This study summarized the survey results of 116 Chinese jujube varieties grown at 33 sites in China. The objective was to identify the environmental factors that influence leaf morphology, and the implications for breeding and introduction of new jujube varieties. Jujube leaf morphological traits were evaluated for their potential relationships with mean annual temperature (MAT) and mean annual precipitation (MAP). The results showed that many leaf morphological traits had a strong linear relationship with local precipitation and temperature. Longer veins per unit area (VLA) and reduced leaf area and leaf perimeter were typical of arid areas. VLA was inversely related to MAT and MAP at the centers of origin of jujube. There was a positive relationship between leaf shape (perimeter(2)/area) and both MAT and MAP. These results indicated that leaf vein traits of Chinese jujubes might have resulted from their adaptation to environmental factors in the course of long-term evolution. Principal component analysis allocated the 116 jujube varieties to three different groups, differentiated on the basis of morphological and physiological leaf characteristics. Jujube varieties from the Hebei, Shandong, Henan, southern Shanxi and central Shaanxi provinces were closely related, as were varieties from northwest Shanxi and northeast Shaanxi provinces, and varieties from the Gansu and Ningxia provinces. These close relationships were partially attributed to the frequent exchanges of varieties within each group. Leaf venation characteristics might be used as reference indices for jujube variety introduction between different locations.	[Li, Xiaopeng; Zhang, Zhong; Li, Xingang] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Li, Xiaopeng; Zhang, Zhong; Li, Xingang] Northwest A&F Univ, State Forestry Adm, Res Ctr Jujube Engn & Technol, Yangling, Shaanxi, Peoples R China; [Li, Yupeng] Northwest A&F Univ, Coll Water Resources & Architectural Engineeing, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Li, XG (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	xingangle@nwsuaf.edu.cn			State Forestry Administration of P. R. China [201304110]; Ministry of Science and Technology of P. R. China [2013BAD14B03]	State Forestry Administration of P. R. China; Ministry of Science and Technology of P. R. China(Ministry of Science and Technology, China)	The Public Welfare Project from the State Forestry Administration of P. R. China (Grant no. 201304110); The Ministry of Science and Technology of P. R. China (Grant no. 2013BAD14B03).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Breckle S.W, 2002, WALTERS VEGETATION E; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Choat B, 2007, NEW PHYTOL, V175, P686, DOI 10.1111/j.1469-8137.2007.02137.x; Cruz ZN, 2012, PLANT SCI, V197, P77, DOI 10.1016/j.plantsci.2012.09.006; Cui NB, 2008, AGR WATER MANAGE, V95, P489, DOI 10.1016/j.agwat.2007.11.007; Cui NB, 2009, AGR WATER MANAGE, V96, P1615, DOI 10.1016/j.agwat.2009.06.009; Cui NB, 2009, AGR WATER MANAGE, V96, P1237, DOI 10.1016/j.agwat.2009.03.015; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Donovan LA, 2011, TRENDS ECOL EVOL, V26, P88, DOI 10.1016/j.tree.2010.11.011; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Flann C, 2002, AUST SYST BOT, V15, P205, DOI 10.1071/SB01018; Gao QH, 2011, SCI HORTIC-AMSTERDAM, V130, P67, DOI 10.1016/j.scienta.2011.06.005; Garnier J, 2002, SCOPE COLL MAR RES, P51; Gupta AK, 2004, CURR SCI INDIA, V87, P54; Hao GY, 2010, FUNCT ECOL, V24, P731, DOI 10.1111/j.1365-2435.2010.01724.x; Hovenden MJ, 2004, NEW PHYTOL, V161, P585, DOI 10.1046/j.1469-8137.2003.00931.x; Hovenden MJ, 2001, AUST J BOT, V49, P427, DOI 10.1071/BT01001; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; JONES CS, 1995, AM J BOT, V82, P346, DOI 10.2307/2445580; Li F., 2005, CHIN B BOT, VS1, P118; Li L, 2010, AGR SCI CHINA, V9, P1278, DOI 10.1016/S1671-2927(09)60217-0; Li Li, 2009, Acta Horticulturae Sinica, V36, P475; Liu MengJun, 2006, Horticultural Reviews, V32, P229; Liu MengJun, 1999, Acta Horticulturae Sinica, V26, P302; Ma FS, 2007, AGR WATER MANAGE, V90, P190, DOI 10.1016/j.agwat.2006.12.009; McLellan T, 1998, SYST BIOL, V47, P264, DOI 10.1080/106351598260914; Mengjun Liu MW., 2008, GERMPLASM RESOURCES; Niinemets U, 2006, PROG BOT, V67, P385, DOI 10.1007/3-540-27998-9_17; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Peng JianYing, 2000, Acta Horticulturae Sinica, V27, P171; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Qu Z, 1993, FRUIT TREE RECORD CH; Quero JL, 2006, NEW PHYTOL, V170, P819, DOI 10.1111/j.1469-8137.2006.01713.x; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2003, AM J BOT, V90, P32, DOI 10.3732/ajb.90.1.32; Sack L, 2013, REV LIFE LEAF S VOGE, V63, P981; Sack L, 2008, P NATL ACAD SCI USA, V105, P1567, DOI 10.1073/pnas.0709333105; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Scoffoni C, 2011, PLANT PHYSIOL, V156, P832, DOI 10.1104/pp.111.173856; Su PX, 2005, SCI HORTIC-AMSTERDAM, V104, P339, DOI 10.1016/j.scienta.2004.08.012; Traiser C, 2005, NEW PHYTOL, V166, P465, DOI 10.1111/j.1469-8137.2005.01316.x; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Volaire F, 2008, EUR J AGRON, V29, P116, DOI 10.1016/j.eja.2008.04.008; Walter A, 2005, ANN BOT-LONDON, V95, P891, DOI 10.1093/aob/mci103; Wolfe A, 1998, PLANT MOL SYSTEMATIC, DOI [10.1007/978-1-4615-5419-6, DOI 10.1007/978-1-4615-5419-6]; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080; Zhu YH, 2012, TREES-STRUCT FUNCT, V26, P597, DOI 10.1007/s00468-011-0624-0	63	16	18	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127825	10.1371/journal.pone.0127825	http://dx.doi.org/10.1371/journal.pone.0127825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020971	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300057
J	Azar, OH				Azar, Ofer H.			A Linear City Model with Asymmetric Consumer Distribution	PLOS ONE			English	Article							EQUILIBRIUM PRICE DISPERSION; COMPETITION; SEARCH; PREFERENCE; LOCATION; STRATEGY; MARKETS	The article analyzes a linear-city model where the consumer distribution can be asymmetric, which is important because in real markets this distribution is often asymmetric. The model yields equilibrium price differences, even though the firms' costs are equal and their locations are symmetric (at the two endpoints of the city). The equilibrium price difference is proportional to the transportation cost parameter and does not depend on the good's cost. The firms' markups are also proportional to the transportation cost. The two firms' prices will be equal in equilibrium if and only if half of the consumers are located to the left of the city's midpoint, even if other characteristics of the consumer distribution are highly asymmetric. An extension analyzes what happens when the firms have different costs and how the two sources of asymmetry - the consumer distribution and the cost per unit - interact together. The model can be useful as a tool for further development by other researchers interested in applying this simple yet flexible framework for the analysis of various topics.	Ben Gurion Univ Negev, Dept Business Adm, IL-84105 Beer Sheva, Israel	Ben Gurion University	Azar, OH (corresponding author), Ben Gurion Univ Negev, Dept Business Adm, IL-84105 Beer Sheva, Israel.	azar@som.bgu.ac.il	AZAR, OFER H/F-1666-2012	AZAR, OFER H/0000-0003-0154-327X				Anderson SP, 2005, J ECON MANAGE STRAT, V14, P61, DOI 10.1111/j.1430-9134.2005.00034.x; Anderson SP, 1997, J ECON THEORY, V77, P102, DOI 10.1006/jeth.1997.2323; Azar OH, 2014, INT J IND ORGAN, V37, P130, DOI 10.1016/j.ijindorg.2014.08.008; Azar OH, 2013, APPL ECON, V45, P901, DOI 10.1080/00036846.2011.613778; Backus MR, 2014, EUR ECON REV, V71, P173, DOI 10.1016/j.euroecorev.2014.06.005; Benassi C, 2008, J ECON, V94, P125, DOI 10.1007/s00712-008-0006-2; CAPLIN A, 1991, ECONOMETRICA, V59, P25, DOI 10.2307/2938239; Cason TN, 2003, J ECON THEORY, V112, P232, DOI 10.1016/S0022-0531(03)00135-0; Chudik A, 2012, ECON LETT, V117, P344, DOI 10.1016/j.econlet.2012.06.003; Ellison G, 2005, Q J ECON, V120, P585, DOI 10.1093/qje/120.2.585; FERSHTMAN C, 1982, J ECON BEHAV ORGAN, V3, P389, DOI 10.1016/0167-2681(82)90012-9; Hopkins E., PRICE DISPERSION; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Janssen MCW, 2004, REV ECON STUD, V71, P1089, DOI 10.1111/j.1467-937X.2004.00315.x; Kim H, 2006, J IND ECON, V54, P569, DOI 10.1111/j.1467-6451.2006.00300.x; PNG IPL, 1994, RAND J ECON, V25, P619, DOI 10.2307/2555978; POLO M, 1991, J IND ECON, V39, P701, DOI 10.2307/2098672; REINGANUM JF, 1979, J POLIT ECON, V87, P851, DOI 10.1086/260796; ROB R, 1985, REV ECON STUD, V52, P487, DOI 10.2307/2297666; SHILONY Y, 1981, ECON LETT, V8, P39, DOI 10.1016/0165-1765(81)90090-2; Sinitsyn M, 2009, INT J IND ORGAN, V27, P197, DOI 10.1016/j.ijindorg.2008.07.001; Sorensen AT, 2000, J POLIT ECON, V108, P833, DOI 10.1086/316103; TABUCHI T, 1995, INT J IND ORGAN, V13, P213, DOI 10.1016/0167-7187(94)00449-C	23	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129068	10.1371/journal.pone.0129068	http://dx.doi.org/10.1371/journal.pone.0129068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26034984	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100067
J	Couvigny, B; Therial, C; Gautier, C; Renault, P; Briandet, R; Guedon, E				Couvigny, Benoit; Therial, Claire; Gautier, Celine; Renault, Pierre; Briandet, Romain; Guedon, Eric			Streptococcus thermophilus Biofilm Formation: A Remnant Trait of Ancestral Commensal Life?	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HORIZONTAL GENE-TRANSFER; BACTERIAL BIOFILMS; LACTOCOCCUS-LACTIS; EPITHELIAL-CELLS; WOODEN VAT; ADAPTATION; STRAIN; RESISTANCE; EVOLUTION	Microorganisms have a long history of use in food production and preservation. Their adaptation to food environments has profoundly modified their features, mainly through genomic flux. Streptococcus thermophilus, one of the most frequent starter culture organisms consumed daily by humans emerged recently from a commensal ancestor. As such, it is a useful model for genomic studies of bacterial domestication processes. Many streptococcal species form biofilms, a key feature of the major lifestyle of these bacteria in nature. However, few descriptions of S. thermophilus biofilms have been reported. An analysis of the ability of a representative collection of natural isolates to form biofilms revealed that S. thermophilus was a poor biofilm producer and that this characteristic was associated with an inability to attach firmly to surfaces. The identification of three biofilm-associated genes in the strain producing the most biofilms shed light on the reasons for the rarity of this trait in this species. These genes encode proteins involved in crucial stages of biofilm formation and are heterogeneously distributed between strains. One of the biofilm genes appears to have been acquired by horizontal transfer. The other two are located in loci presenting features of reductive evolution, and are absent from most of the strains analyzed. Their orthologs in commensal bacteria are involved in adhesion to host cells, suggesting that they are remnants of ancestral functions. The biofilm phenotype appears to be a commensal trait that has been lost during the genetic domestication of S. thermophilus, consistent with its adaptation to the milk environment and the selection of starter strains for dairy fermentations.	[Couvigny, Benoit; Therial, Claire; Gautier, Celine; Renault, Pierre; Briandet, Romain; Guedon, Eric] INRA, UMR Micalis 1319, Domaine Vilvert, F-78352 Jouy En Josas, France; [Couvigny, Benoit; Therial, Claire; Gautier, Celine; Renault, Pierre; Briandet, Romain; Guedon, Eric] AgroParisTech, UMR MICALIS, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Guedon, E (corresponding author), INRA, UMR Micalis 1319, Domaine Vilvert, F-78352 Jouy En Josas, France.	eric.guedon@jouy.inra.fr	Guédon, Eric/AAP-4143-2021; GUEDON, Eric/N-8624-2019; Guedon, Eric/S-5635-2016; Briandet, Romain/AAD-2102-2020	GUEDON, Eric/0000-0002-0901-4447; Guedon, Eric/0000-0002-0901-4447; Briandet, Romain/0000-0002-8123-3492				Anisimova M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-154; Aponte M, 2008, INT DAIRY J, V18, P403, DOI 10.1016/j.idairyj.2007.10.011; Barbosa TM, 1999, ENVIRON MICROBIOL, V1, P53, DOI 10.1046/j.1462-2920.1999.00004.x; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Cefalo AD, 2011, CAN J MICROBIOL, V57, P1002, DOI [10.1139/W11-090, 10.1139/w11-090]; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Cruciata M, 2014, APPL ENVIRON MICROB, V80, P2050, DOI 10.1128/AEM.03837-13; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Delorme C, 2008, INT J FOOD MICROBIOL, V126, P274, DOI 10.1016/j.ijfoodmicro.2007.08.014; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Delorme C, 2015, INFECT GENET EVOL, V33, P381, DOI 10.1016/j.meegid.2014.10.001; Delorme C, 2011, J BACTERIOL, V193, P5581, DOI 10.1128/JB.05404-11; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Du Y, 2011, J STRUCT BIOL, V174, P252, DOI 10.1016/j.jsb.2010.10.016; Etzold S, 2014, ENVIRON MICROBIOL, V16, P888, DOI 10.1111/1462-2920.12377; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Francino M Pilar, 2012, Int J Evol Biol, V2012, P394026, DOI 10.1155/2012/394026; Frese SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004057; Ghafoor A, 2013, APPL ENVIRON MICROB, V79, P2968, DOI 10.1128/AEM.03666-12; Goh YJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S22; Guedon E, 2001, MOL MICROBIOL, V40, P1227, DOI 10.1046/j.1365-2958.2001.02470.x; Guedon E, 2011, J BACTERIOL, V193, P5024, DOI 10.1128/JB.05390-11; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Jans C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-200; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Jensen H, 2014, MICROBIOL-SGM, V160, P671, DOI 10.1099/mic.0.073551-0; Kang XH, 2012, J BACTERIOL, V194, P4428, DOI 10.1128/JB.00740-12; Kazimierczak KA, 2006, ANTIMICROB AGENTS CH, V50, P2632, DOI 10.1128/AAC.01587-05; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Licitra G, 2007, APPL ENVIRON MICROB, V73, P6980, DOI 10.1128/AEM.00835-07; Liu MJ, 2009, APPL ENVIRON MICROB, V75, P4120, DOI 10.1128/AEM.02898-08; Lortal S, 2009, INT J FOOD MICROBIOL, V132, P1, DOI 10.1016/j.ijfoodmicro.2009.02.026; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Maniatis T., 1982, MOL CLONING; Marks LR, 2014, INFECT IMMUN, V82, P1141, DOI 10.1128/IAI.01310-13; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Marri PR, 2006, MOL BIOL EVOL, V23, P2379, DOI 10.1093/molbev/msl115; McLoon AL, 2011, J BACTERIOL, V193, P2027, DOI 10.1128/JB.01542-10; Minic Z, 2007, J BACTERIOL, V189, P1351, DOI 10.1128/JB.01122-06; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Papadimitriou K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-272; Prajapati JB, 2013, J MICROBIOL BIOTECHN, V23, P459, DOI 10.4014/jmb.1210.10030; Rao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064129; Rasmussen TB, 2008, APPL ENVIRON MICROB, V74, P4703, DOI 10.1128/AEM.00132-08; Richards VP, 2014, GENOME BIOL EVOL, V6, P741, DOI 10.1093/gbe/evu048; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Settanni L, 2012, INT J FOOD MICROBIOL, V155, P73, DOI 10.1016/j.ijfoodmicro.2012.01.022; Sperandio B, 2010, J BACTERIOL, V192, P3464, DOI 10.1128/JB.00119-10; Sun ZH, 2011, J BACTERIOL, V193, P793, DOI 10.1128/JB.01374-10; Treu L, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00126-14; Treu L, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00067-14; Treu L, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01129-13; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vasseur P, 2007, BIOCHIMIE, V89, P903, DOI 10.1016/j.biochi.2007.04.002; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Ward PN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-54; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027	71	21	21	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128099	10.1371/journal.pone.0128099	http://dx.doi.org/10.1371/journal.pone.0128099			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035177	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100028
J	Hsiao, FJ; Yu, HY; Chen, WT; Kwan, SY; Chen, C; Yen, DJ; Yiu, CH; Shih, YH; Lin, YY				Hsiao, Fu-Jung; Yu, Hsiang-Yu; Chen, Wei-Ta; Kwan, Shang-Yeong; Chen, Chien; Yen, Der-Jen; Yiu, Chun-Hing; Shih, Yang-Hsin; Lin, Yung-Yang			Increased Intrinsic Connectivity of the Default Mode Network in Temporal Lobe Epilepsy: Evidence from Resting-State MEG Recordings	PLOS ONE			English	Article							ALTERED FUNCTIONAL CONNECTIVITY; GRAPH-THEORETICAL ANALYSIS; ALZHEIMERS-DISEASE; GENERALIZED SPIKE; CINGULATE CORTEX; DELTA-ACTIVITY; BOLD SIGNAL; SMALL-WORLD; BRAIN; FMRI	The electrophysiological signature of resting state oscillatory functional connectivity within the default mode network (DMN) during spike-free periods in temporal lobe epilepsy (TLE) remains unclear. Using magnetoencephalographic (MEG) recordings, this study investigated how the connectivity within the DMN was altered in TLE, and we examined the effect of lateralized TLE on functional connectivity. Sixteen medically intractable TLE patients and 22 controls participated in this study. Whole-scalp 306-channel MEG epochs without interictal spikes generated from both MEG and EEG data were analyzed using a minimum norm estimate (MNE) and source-based imaginary coherence analysis. With this processing, we obtained the cortical activation and functional connectivity within the DMN. The functional connectivity was increased between DMN and the right medial temporal (MT) region at the delta band and between DMN and the bilateral anterior cingulate cortex (ACC) regions at the theta band. The functional change was associated with the lateralization of TLE. The right TLE showed enhanced DMN connectivity with the right MT while the left TLE demonstrated increased DMN connectivity with the bilateral MT. There was no lateralization effect of TLE upon the DMN connectivity with ACC. These findings suggest that the resting-state functional connectivity within the DMN is reinforced in temporal lobe epilepsy during spike-free periods. Future studies are needed to examine if the altered functional connectivity can be used as a biomarker for treatment responses, cognitive dysfunction and prognosis in patients with TLE.	[Hsiao, Fu-Jung; Chen, Wei-Ta; Shih, Yang-Hsin; Lin, Yung-Yang] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Yu, Hsiang-Yu; Chen, Wei-Ta; Kwan, Shang-Yeong; Chen, Chien; Yen, Der-Jen; Yiu, Chun-Hing; Shih, Yang-Hsin; Lin, Yung-Yang] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 112, Taiwan; [Hsiao, Fu-Jung; Lin, Yung-Yang] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Hsiao, Fu-Jung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Hsiao, Fu-Jung; Chen, Wei-Ta; Lin, Yung-Yang] Taipei Vet Gen Hosp, Div Med Res, Lab Neurophysiol Med, Taipei, Taiwan; [Yu, Hsiang-Yu; Chen, Wei-Ta; Kwan, Shang-Yeong; Chen, Chien; Yen, Der-Jen; Yiu, Chun-Hing; Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Shih, Yang-Hsin] Taipei Vet Gen Hosp, Dept Neurosurg, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Hsiao, FJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan.	fujunghsiao@gmail.com; yylin@vghtpe.gov.tw		Yu, Hsiang-Yu/0000-0002-8183-1863	Taipei City Hospital [100TPECH04, 102TPECH02]; Taipei Veterans General Hospital [V101C-023, V102C-103, VGHUST 102-G7-6-2]; Brain Research Center [102AC-B22, 102AC-B7, 103U-001, 103AC-B16, 103AC-B7]; National Science Council in Taipei, Taiwan [NSC 98-2321-B-010-007, NSC 99-2321-B-010-004, NSC 99-2628-B-010-011-MY3, NSC 100-2218-E-010-002, NSC 100-2321-B-010-004, NSC 101-2314-B-010-068-MY3, NSC 101-2314-B-075-068-MY2, NSC 102-2221-E-010-003]	Taipei City Hospital; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Brain Research Center; National Science Council in Taipei, Taiwan	This study was supported in part by research grants from Taipei City Hospital (100TPECH04, 102TPECH02), Taipei Veterans General Hospital (V101C-023, V102C-103, VGHUST 102-G7-6-2), Brain Research Center (102AC-B22, 102AC-B7, 103U-001,103AC-B16 and 103AC-B7), and from the National Science Council (NSC 98-2321-B-010-007, NSC 99-2321-B-010-004, NSC 99-2628-B-010-011-MY3, NSC 100-2218-E-010-002, NSC 100-2321-B-010-004, NSC 101-2314-B-010-068-MY3, NSC 101-2314-B-075-068-MY2, NSC 102-2221-E-010-003) in Taipei, Taiwan.	Archer JS, 2003, NEUROIMAGE, V20, P1915, DOI 10.1016/S1053-8119(03)00294-5; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bai F, 2011, J ALZHEIMERS DIS, V23, P87, DOI 10.3233/JAD-2010-101533; Bai X, 2011, NEUROLOGY, V76, P1960, DOI 10.1212/WNL.0b013e31821e54de; Basar E., 1999, BRAIN FUNCTION OSCIL, VII, P978; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; BLUME WT, 1993, ANN NEUROL, V34, P703, DOI 10.1002/ana.410340513; Bonilha L, 2007, J NEUROL NEUROSUR PS, V78, P286, DOI 10.1136/jnnp.2006.103994; Bonilha L, 2013, NEUROLOGY, V81, P1704, DOI 10.1212/01.wnl.0000435306.95271.5f; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Chaudhary UJ, 2012, BRAIN, V135, P3645, DOI 10.1093/brain/aws302; Clemens B, 2013, EPILEPSY RES, V106, P357, DOI 10.1016/j.eplepsyres.2013.06.017; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dupont S, 2000, BRAIN, V123, P1722, DOI 10.1093/brain/123.8.1722; Fahoum F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068038; Fahoum F, 2012, EPILEPSIA, V53, P1618, DOI 10.1111/j.1528-1167.2012.03533.x; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Frei MG, 2010, EPILEPSY BEHAV, V19, P4, DOI 10.1016/j.yebeh.2010.06.009; GHATAN PH, 1995, NEUROIMAGE, V2, P112, DOI 10.1006/nimg.1995.1014; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Guerra Andrea, 2011, Int J Alzheimers Dis, V2011, P263817, DOI 10.4061/2011/263817; Guggisberg AG, 2008, ANN NEUROL, V63, P193, DOI 10.1002/ana.21224; Guo ZL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044847, 10.1371/journal.pone.0028196]; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Haneef Z, 2012, EPILEPSY BEHAV, V25, P350, DOI 10.1016/j.yebeh.2012.07.019; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Helmstaedter C, 2002, PROG BRAIN RES, V135, P439; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; HERMANN BP, 1995, EPILEPSIA, V36, P480, DOI 10.1111/j.1528-1157.1995.tb00490.x; HERMANN BP, 1987, EPILEPSIA, V28, P547, DOI 10.1111/j.1528-1157.1987.tb03687.x; Hsiao FJ, 2014, NEUROSCI LETT, V558, P47, DOI 10.1016/j.neulet.2013.10.056; Hsiao FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068792; Hsiao FJ, 2013, NEUROIMAGE, V72, P133, DOI 10.1016/j.neuroimage.2013.01.041; International Federation of Societies for Electroencephalography and Clinical Neurophysiology, 1974, ELECTROENCEPHALOGR C, V37, P521; Jerbi K, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00027; Jin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068192; Kay BP, 2013, EPILEPSIA, V54, P461, DOI 10.1111/epi.12057; Kemmotsu N, 2011, EPILEPSIA, V52, P2257, DOI 10.1111/j.1528-1167.2011.03278.x; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kobayashi E, 2009, EPILEPSIA, V50, P2549, DOI 10.1111/j.1528-1167.2009.02180.x; Koutroumanidis M, 2004, EPILEPSIA, V45, P1351, DOI 10.1111/j.0013-9580.2004.61203.x; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; LADAVAS E, 1979, EPILEPSIA, V20, P493, DOI 10.1111/j.1528-1157.1979.tb04831.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lin YY, 2003, NEUROIMAGE, V19, P1115, DOI 10.1016/S1053-8119(03)00181-2; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Madhavan D, 2013, NEUROSCI LETT, V542, P26, DOI 10.1016/j.neulet.2013.02.052; Martino J, 2011, ANN NEUROL, V69, P521, DOI 10.1002/ana.22167; MAYEUX R, 1980, NEUROLOGY, V30, P120, DOI 10.1212/WNL.30.2.120; Morgan VL, 2012, EPILEPSIA, V53, P1628, DOI 10.1111/j.1528-1167.2012.03590.x; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; MURPHY JT, 1967, NEW ENGL J MED, V276, P309, DOI 10.1056/NEJM196702092760602; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; O'Muircheartaigh J, 2012, BRAIN, V135, P3635, DOI 10.1093/brain/aws296; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Oyegbile TO, 2004, NEUROLOGY, V62, P1736, DOI 10.1212/01.WNL.0000125186.04867.34; PANETRAYMOND D, 1990, ELECTROEN CLIN NEURO, V75, P474, DOI 10.1016/0013-4694(90)90134-6; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rutter L, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00093; Sakurai K, 2010, EPILEPSY RES, V89, P176, DOI 10.1016/j.eplepsyres.2009.12.004; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sekihara K, 2011, IEEE T BIO-MED ENG, V58, P3121, DOI 10.1109/TBME.2011.2162514; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tao JX, 2011, EPILEPSIA, V52, P467, DOI 10.1111/j.1528-1167.2010.02918.x; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varotto G, 2012, EPILEPSIA, V53, P359, DOI 10.1111/j.1528-1167.2011.03352.x; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Voets NL, 2011, NEUROLOGY, V76, P138, DOI 10.1212/WNL.0b013e318205d521; Voets NL, 2012, BRAIN, V135, P2350, DOI 10.1093/brain/aws137; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Yang TH, 2013, HUM BRAIN MAPP, V34, P1761, DOI 10.1002/hbm.22025; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042	96	44	45	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128787	10.1371/journal.pone.0128787	http://dx.doi.org/10.1371/journal.pone.0128787			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035750	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100048
J	Liu, MJ; Chen, YQ; Zhou, JJ; Liu, Y; Wang, FM; Shi, SF; Zhao, YF; Wang, SX; Liu, LJ; Lv, JC; Zhang, H; Zhao, MH				Liu, Maojing; Chen, Yuqing; Zhou, Jingjing; Liu, Ying; Wang, Fengmei; Shi, Sufang; Zhao, Yanfeng; Wang, Suxia; Liu, Lijun; Lv, Jicheng; Zhang, Hong; Zhao, Minghui			Implication of Urinary Complement Factor H in the Progression of Immunoglobulin A Nephropathy	PLOS ONE			English	Article							IGA NEPHROPATHY; GLOMERULAR DEPOSITION; NATURAL-HISTORY; ACTIVATION; PATHWAY; C5B-9	Background After activation, the complement system is involved in the pathogenesis of Immunoglobulin A nephropathy (IgAN). Complement factor H (CFH) is a crucial inhibitory factor of the alternative pathway of the complement system. The study investigated the effects of urinary CFH levels on IgAN progression. Methods A total of 351patients with IgAN participated in this study. They were followed up for an average of 51.8 +/- 26.6 months. Renal outcome was defined as a composite endpoint, that included instances of end-stage renal disease (ESRD), >= 50% decline in estimated glomerular filtration rate (eGFR) or doubling of plasma creatinine levels. Urinary CFH levels were measured by enzyme-linked immunosorbent assay and calculated as the ratio of urinary CFH over creatinine (uCFH/uCr). Results In the whole cohort, uCFH/uCr values were associated with disease progression either as continuous [log(uCFH/uCr)] or categorical traits (dichotomous and quartile variables) after adjusting for eGFR, proteinuria, mean arterial blood pressure, histological grading and immunosuppressive therapy in the Cox proportional hazard model. Kaplan-Meier analysis showed that higher uCFH/uCr values at baseline predicted worse renal outcome during follow-up (log-rank, P<0.001). Receiver operating characteristic curve (ROC) analysis showed that log(uCFH/uCr) had predictive value for renal outcome (area under curve [AUC]=0.745), and the AUC increased to 0.805 after being incorporated into baseline eGFR and proteinuria. In subgroup analysis with eGFR >= 60 mL/min/1.73m(2), log(uCFH/uCr) had better predictive value (AUC=0.724, P=0.002) for renal outcome compared to eGFR (AUC = 0.582, P=0.259) and proteinuria (AUC = 0.615, P=0.114). Conclusions Urinary CFH levels are associated with renal function decline and increased urinary CFH levels are a risk factor for progression of IgA nephropathy.	[Liu, Maojing; Chen, Yuqing; Zhou, Jingjing; Liu, Ying; Wang, Fengmei; Shi, Sufang; Zhao, Yanfeng; Liu, Lijun; Lv, Jicheng; Zhang, Hong; Zhao, Minghui] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China; [Liu, Maojing; Chen, Yuqing; Zhou, Jingjing; Liu, Ying; Wang, Fengmei; Shi, Sufang; Zhao, Yanfeng; Liu, Lijun; Lv, Jicheng; Zhang, Hong; Zhao, Minghui] Peking Univ, Inst Nephrol, Beijing 100034, Peoples R China; [Liu, Maojing; Chen, Yuqing; Zhou, Jingjing; Liu, Ying; Wang, Fengmei; Shi, Sufang; Zhao, Yanfeng; Liu, Lijun; Lv, Jicheng; Zhang, Hong; Zhao, Minghui] Minist Hlth China, Key Lab Renal Dis, Beijing 100034, Peoples R China; [Liu, Maojing; Chen, Yuqing; Zhou, Jingjing; Liu, Ying; Wang, Fengmei; Shi, Sufang; Zhao, Yanfeng; Liu, Lijun; Lv, Jicheng; Zhang, Hong; Zhao, Minghui] Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100034, Peoples R China; [Wang, Suxia] Peking Univ, Hosp 1, Lab Electron Microscopy, Beijing 100034, Peoples R China	Peking University; Peking University; Peking University	Chen, YQ (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China.	cyq@bjmu.edu.cn			National Natural Science Foundation of China [81270820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81270820).	BOGENSCHUTZ O, 1990, AM J NEPHROL, V10, P137, DOI 10.1159/000168068; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Endo M, 1998, NEPHROL DIAL TRANSPL, V13, P1984, DOI 10.1093/ndt/13.8.1984; Frimat L, 1997, NEPHROL DIAL TRANSPL, V12, P2569; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; HIEMSTRA PS, 1987, EUR J IMMUNOL, V17, P321, DOI 10.1002/eji.1830170304; Kim S, 2012, IEEE INT SYMP INTELL, P7, DOI 10.1109/ISIC.2012.6398252; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Nakagawa H, 2000, AM J NEPHROL, V20, P122, DOI 10.1159/000013568; Onda K, 2007, J CLIN LAB ANAL, V21, P77, DOI 10.1002/jcla.20154; Onda K, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-64; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; RAUTERBERG EW, 1987, KIDNEY INT, V31, P820, DOI 10.1038/ki.1987.72; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861; Stangou M, 2008, SCAND J UROL NEPHROL, V42, P373, DOI 10.1080/00365590801943241; Tamano M, 2002, NEPHRON, V92, P705, DOI 10.1159/000064090; TOMINO Y, 1981, Tokai Journal of Experimental and Clinical Medicine, V6, P217; WYATT RJ, 1987, KIDNEY INT, V31, P1019, DOI 10.1038/ki.1987.101; Zhang JJ, 2009, SCAND J IMMUNOL, V69, P457, DOI 10.1111/j.1365-3083.2009.02234.x; ZHANG W, 1994, IMMUNOLOGY, V81, P137; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197; Zwirner J, 1997, KIDNEY INT, V51, P1257, DOI 10.1038/ki.1997.171	26	15	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0126812	10.1371/journal.pone.0126812	http://dx.doi.org/10.1371/journal.pone.0126812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035554	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100007
J	Bergamo, LW; Fresia, P; Azeredo-Espin, AML				Bergamo, Luana Walravens; Fresia, Pablo; Azeredo-Espin, Ana Maria L.			Incongruent Nuclear and Mitochondrial Genetic Structure of New World Screwworm Fly Populations Due to Positive Selection of Mutations Associated with Dimethyl- and Diethyl-Organophosphates Resistance	PLOS ONE			English	Article							COCHLIOMYIA-HOMINIVORAX DIPTERA; MULTIPLE SEQUENCE ALIGNMENT; AMINO-ACID SUBSTITUTION; MUSCA-DOMESTICA L.; INSECTICIDE RESISTANCE; LUCILIA-CUPRINA; DIAZINON RESISTANCE; STATISTICAL TESTS; AEDES-AEGYPTI; HOUSE-FLY	Livestock production is an important economic activity in Brazil, which has been suffering significant losses due to the impact of parasites. The New World screwworm (NWS) fly, Cochliomyia hominivorax, is an ectoparasite and one of the most important myiasis-causing flies endemic to the Americas. The geographic distribution of NWS has been reduced after the implementation of the Sterile Insect Technique (SIT), being eradicated in North America and part of Central America. In South America, C. hominivorax is controlled by chemical insecticides, although indiscriminate use can cause selection of resistant individuals. Previous studies have associated the Gly137Asp and Trp251Leu mutations in the active site of carboxylesterase E3 to resistance of diethyl and dimethyl-organophosphates insecticides, respectively. Here, we have sequenced a fragment of the carboxylesterase E3 gene (ChaE7), comprising part of intron iII, exon eIII, intron iIII and part of exon eIV, and three mitochondrial gene sequences (CR, COI and COII), of NWS flies from 21 locations in South America. These markers were used for population structure analyses and the ChaE7 gene was also investigated to gain insight into the selective pressures that have shaped its evolution. Analysis of molecular variance (AMOVA) and pairwise FST analysis indicated an increased genetic structure between locations in the ChaE7 compared to the concatenated mitochondrial genes. Discriminant analysis of principal components (DAPC) and spatial analysis of molecular variance (SAMOVA) indicated different degrees of genetic structure for all markers, in agreement with the AMOVA results, but with low correlation to geographic data. The NWS fly is considered a panmitic species based on mitochondrial data, while it is structured into three groups considering the ChaE7 gene. A negative association between the two mutations related to organophosphate resistance and Fay & Wu's H significant negative values for the exons, suggest that these mutations evolved under positive selection.	[Bergamo, Luana Walravens; Fresia, Pablo; Azeredo-Espin, Ana Maria L.] Univ Estadual Campinas, CBMEG, Campinas, SP, Brazil; [Bergamo, Luana Walravens; Azeredo-Espin, Ana Maria L.] Univ Estadual Campinas, IB, DGEB, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Bergamo, LW (corresponding author), Univ Estadual Campinas, CBMEG, Campinas, SP, Brazil.	bergamo.luana@gmail.com	Espin, Ana Maria Azeredo/N-2213-2015; FRESIA, pablo/AGF-5679-2022	Walravens Bergamo, Luana/0000-0003-1497-8811; Azeredo-Espin, Ana Maria/0000-0002-9664-6791	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/11654-9, 2011/15739-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://www.fapesp.br/) grant 2012/11654-9. LWB received a fellowship from FAPESP (2011/15739-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, BASIC PRINCIPLES INS; Araya-Anchetta A, 2015, INFECT GENET EVOL, V29, P164, DOI 10.1016/j.meegid.2014.11.008; de Carvalho RA, 2006, VET PARASITOL, V140, P344, DOI 10.1016/j.vetpar.2006.04.010; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Azeredo-Espin AM, 2006, GENETICA, V126, P111, DOI 10.1007/s10709-005-1439-y; Batterham P, 1996, BIOESSAYS, V18, P841, DOI 10.1002/bies.950181011; BERTORELLE G, 1995, MOL BIOL EVOL, V12, P887; Campbell PM, 1998, J ECON ENTOMOL, V91, P367, DOI 10.1093/jee/91.2.367; Campbell PM, 1997, BIOCHEM GENET, V35, P17, DOI 10.1023/A:1022256412623; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P139, DOI 10.1016/S0965-1748(97)00109-4; Carvalho RA, 2009, MED VET ENTOMOL, V23, P86, DOI 10.1111/j.1365-2915.2008.00788.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Claudianos C, 1999, INSECT BIOCHEM MOLEC, V29, P675, DOI 10.1016/S0965-1748(99)00035-1; Coquerel C, 1859, REV MAG ZOOL, V2, P356; de Carvalho RA, 2010, VET PARASITOL, V170, P297, DOI 10.1016/j.vetpar.2010.02.029; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endersby NM, 2008, B ENTOMOL RES, V98, P145, DOI 10.1017/S0007485307005494; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fay JC, 2000, GENETICS, V155, P1405; Feldmann U, 2014, ACTA TROP, V138, pS1, DOI 10.1016/j.actatropica.2014.03.025; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Fournier D, 2005, CHEM-BIOL INTERACT, V157, P257, DOI 10.1016/j.cbi.2005.10.040; Fresia P, 2014, ACTA TROP, V138, pS34, DOI 10.1016/j.actatropica.2014.04.003; Fresia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076168; Fresia P, 2011, J MED ENTOMOL, V48, P280, DOI 10.1603/ME10153; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; GEORGHIOU GP, 1990, ACS SYM SER, V421, P18; Guimaraes J. H., 1999, BIBLIOGRAPHIC DATABA; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Infante-Malachias ME, 1999, GENOME, V42, P772, DOI 10.1139/gen-42-4-772; Jackson CJ, 2013, P NATL ACAD SCI USA, V110, P10177, DOI 10.1073/pnas.1304097110; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Lyra ML, 2009, MED VET ENTOMOL, V23, P32, DOI 10.1111/j.1365-2915.2008.00776.x; Lyra ML, 2005, J MED ENTOMOL, V42, P589, DOI 10.1603/0022-2585(2005)042[0589:AOMDVA]2.0.CO;2; Macher JN, 2015, ECOL EVOL, V5, P648, DOI 10.1002/ece3.1366; MANTEL N, 1967, CANCER RES, V27, P209; MARJORAM P, 1994, GENETICS, V136, P673; Mastrangelo T, 2014, ACTA TROP, V138, pS26, DOI 10.1016/j.actatropica.2014.04.002; MCKENZIE JA, 1993, GENETICA, V89, P67, DOI 10.1007/BF02424506; MCKENZIE JA, 1982, HEREDITY, V49, P1, DOI 10.1038/hdy.1982.60; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Newcomb RD, 2005, J MOL EVOL, V60, P207, DOI 10.1007/s00239-004-0104-x; Newcomb RD, 1997, INSECT BIOCHEM MOLEC, V27, P15, DOI 10.1016/S0965-1748(96)00065-3; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oyarzun MP, 2011, J ECON ENTOMOL, V104, P258, DOI 10.1603/EC10188; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Piiroinen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-13; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reyes PFM, 2007, MOL ECOL, V16, P3554, DOI 10.1111/j.1365-294X.2007.03410.x; Robin C, 1996, J MOL EVOL, V43, P241, DOI 10.1007/PL00006083; Acevedo GR, 2009, PARASITOL RES, V105, P489, DOI 10.1007/s00436-009-1425-x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakamoto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101389; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1995, GENETICS, V139, P457; Smissaert H. R., 1964, Science New York, V143, P129; Smyth KA, 1996, PESTIC BIOCHEM PHYS, V54, P48, DOI 10.1006/pest.1996.0008; Smyth KA, 2000, HEREDITY, V84, P63, DOI 10.1046/j.1365-2540.2000.00641.x; TABACHNICK WJ, 1995, PARASITOL TODAY, V11, P27, DOI 10.1016/0169-4758(95)80105-7; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taskin V, 2004, RUSS J GENET+, V40, P377, DOI 10.1023/B:RUGE.0000024974.58424.f9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres TT, 2009, MED VET ENTOMOL, V23, P23, DOI 10.1111/j.1365-2915.2008.00786.x; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; VARGAS MEI, 1995, BIOCHEM GENET, V33, P237, DOI 10.1007/BF02401854; Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x; Zhao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095260	92	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128441	10.1371/journal.pone.0128441	http://dx.doi.org/10.1371/journal.pone.0128441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030866	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900150
J	Chintapalli, SV; Bhardwaj, G; Patel, R; Shah, N; Patterson, RL; van Rossum, DB; Anishkin, A; Adams, SH				Chintapalli, Sree V.; Bhardwaj, Gaurav; Patel, Reema; Shah, Natasha; Patterson, Randen L.; van Rossum, Damian B.; Anishkin, Andriy; Adams, Sean H.			Molecular Dynamic Simulations Reveal the Structural Determinants of Fatty Acid Binding to Oxy-Myoglobin	PLOS ONE			English	Article							RESONANCE ASSIGNMENT; AUTOMATED DOCKING; CRYSTAL-STRUCTURE; PROTEIN; RESIDUES; SITE; MYOCARDIUM; PREDICTION; RESOLUTION; SCAVENGER	The mechanism(s) by which fatty acids are sequestered and transported in muscle have not been fully elucidated. A potential key player in this process is the protein myoglobin (Mb). Indeed, there is a catalogue of empirical evidence supporting direct interaction of globins with fatty acid metabolites; however, the binding pocket and regulation of the interaction remains to be established. In this study, we employed a computational strategy to elucidate the structural determinants of fatty acids (palmitic & oleic acid) binding to Mb. Sequence analysis and docking simulations with a horse (Equus caballus) structural Mb reference reveals a fatty acid- binding site in the hydrophobic cleft near the heme region in Mb. Both palmitic acid and oleic acid attain a "U" shaped structure similar to their conformation in pockets of other fatty acid- binding proteins. Specifically, we found that the carboxyl head group of palmitic acid coordinates with the amino group of Lys45, whereas the carboxyl group of oleic acid coordinates with both the amino groups of Lys45 and Lys63. The alkyl tails of both fatty acids are supported by surrounding hydrophobic residues Leu29, Leu32, Phe33, Phe43, Phe46, Val67, Val68 and Ile107. In the saturated palmitic acid, the hydrophobic tail moves freely and occasionally penetrates deeper inside the hydrophobic cleft, making additional contacts with Val28, Leu69, Leu72 and Ile111. Our simulations reveal a dynamic and stable binding pocket in which the oxygen molecule and heme group in Mb are required for additional hydrophobic interactions. Taken together, these findings support a mechanism in which Mb acts as a muscle transporter for fatty acid when it is in the oxygenated state and releases fatty acid when Mb converts to deoxygenated state.	[Chintapalli, Sree V.; Adams, Sean H.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Chintapalli, Sree V.; Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Bhardwaj, Gaurav; Patel, Reema; Shah, Natasha; Patterson, Randen L.] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Patel, Reema; Shah, Natasha; Patterson, Randen L.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [van Rossum, Damian B.] Penn State Univ, Ctr Computat Prote, State Coll, PA USA; [van Rossum, Damian B.] Penn State Univ, Dept Biol, State Coll, PA USA; [Anishkin, Andriy] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University System of Maryland; University of Maryland College Park	Chintapalli, SV (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA.	dr.sreechintapalli@gmail.com; shadams@uams.edu	; ADAMS, SEAN/N-9262-2018	Bhardwaj, Gaurav/0000-0001-6554-2335; van Rossum, Damian/0000-0003-1011-2586; ADAMS, SEAN/0000-0002-9515-2319	Searle Young Investigators Award; UC Davis; NIH [R01 GM087410-01]; intramural USDA-ARS Project [5306-51530-019-00]; NIH-NIDDK [R01DK078328-01]; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087410] Funding Source: NIH RePORTER; ARS [ARS-0426826] Funding Source: Federal RePORTER	Searle Young Investigators Award; UC Davis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural USDA-ARS Project; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Searle Young Investigators Award (RLP), start-up money from UC Davis (RLP), NIH R01 GM087410-01 (RLP, DBR), intramural USDA-ARS Project 5306-51530-019-00 (SHA) and NIH-NIDDK R01DK078328-01 (SHA). This project was also supported by a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds (DBR).	BERNIER I, 1987, BIOCHIMIE, V69, P1127, DOI 10.1016/0300-9084(87)90140-4; Bhardwaj G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034261; Boechi L, 2013, J BIOL CHEM, V288, P6754, DOI 10.1074/jbc.M112.426056; Brown JRaS, 1982, LIPID PROTEIN INTERA, V1, P25; Capaldi S, 2006, PROTEINS, V64, P79, DOI 10.1002/prot.20961; Chintapalli SV, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-240; D'Angelo P, 2004, BIOPHYS J, V86, P3882, DOI 10.1529/biophysj.103.034876; Daigle R, 2009, PROTEINS, V75, P735, DOI 10.1002/prot.22283; EMERSON SD, 1990, BIOCHEMISTRY-US, V29, P1545, DOI 10.1021/bi00458a028; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Flogel U, 2005, CIRC RES, V96, pE68, DOI 10.1161/01.RES.0000165481.36288.d2; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; GLATZ JFC, 1990, MOL CELL BIOCHEM, V98, P237, DOI 10.1007/BF00231390; GLOSTER J, 1977, BIOCHEM BIOPH RES CO, V74, P506, DOI 10.1016/0006-291X(77)90333-3; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; GOTZ FM, 1994, BIOL CHEM H-S, V375, P387, DOI 10.1515/bchm3.1994.375.6.387; Hedgepeth SC, 2015, J BIOL CHEM, V290, P7304, DOI 10.1074/jbc.M114.611186; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Hersleth HP, 2007, J BIOL CHEM, V282, P23372, DOI 10.1074/jbc.M701948200; Hong Y, 2011, J INTEGRATED OMICS, V1, P14; Hong Yoojin, 2009, J Proteomics Bioinform, V2, P139; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kreutzer U, 2004, AM J PHYSIOL-HEART C, V286, pH985, DOI 10.1152/ajpheart.00115.2003; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; LECOMTE JTJ, 1987, J AM CHEM SOC, V109, P7219, DOI 10.1021/ja00257a068; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nelson DL, 2000, LEHNINGER PRINCIPLES; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PHILLIPS SEV, 1980, J MOL BIOL, V142, P531, DOI 10.1016/0022-2836(80)90262-4; QIN J, 1992, J BIOMOL NMR, V2, P597, DOI 10.1007/BF02192849; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Roche DB, 2013, NUCLEIC ACIDS RES, V41, pW303, DOI 10.1093/nar/gkt498; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Shih L, 2014, BBA-GEN SUBJECTS, V1840, P656, DOI 10.1016/j.bbagen.2013.10.028; Sriram R, 2008, FEBS LETT, V582, P3643, DOI 10.1016/j.febslet.2008.09.047; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; TAKANO T, 1977, J MOL BIOL, V110, P569, DOI 10.1016/S0022-2836(77)80112-5; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; VINOGRADOV SN, 1993, COMP BIOCHEM PHYS B, V106, P1, DOI 10.1016/0305-0491(93)90002-M; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541	51	21	21	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128496	10.1371/journal.pone.0128496	http://dx.doi.org/10.1371/journal.pone.0128496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030763	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900157
J	Deniger, DC; Yu, JQ; Huls, MH; Figliola, MJ; Mi, TJ; Maiti, SN; Widhopf, GF; Hurton, LV; Thokala, R; Singh, H; Olivares, S; Champlin, RE; Wierda, WG; Kipps, TJ; Cooper, LJN				Deniger, Drew C.; Yu, Jianqiang; Huls, M. Helen; Figliola, Matthew J.; Mi, Tiejuan; Maiti, Sourindra N.; Widhopf, George F.; Hurton, Lenka V.; Thokala, Radhika; Singh, Harjeet; Olivares, Simon; Champlin, Richard E.; Wierda, William G.; Kipps, Thomas J.; Cooper, Laurence J. N.			Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; B-LINEAGE MALIGNANCIES; CLINICAL-TRIAL; GENE-THERAPY; SPECIFICITY; SYSTEM; IMMUNOTHERAPY; EXPRESS; CANCER	T cells modified with chimeric antigen receptors (CARs) targeting CD19 demonstrated clinical activity against some B-cell malignancies. However, this is often accompanied by a loss of normal CD19(+) B cells and humoral immunity. Receptor tyrosine kinase-like orphan receptor-1 (ROR1) is expressed on sub-populations of B-cell malignancies and solid tumors, but not by healthy B cells or normal post-partum tissues. Thus, adoptive transfer of T cells specific for ROR1 has potential to eliminate tumor cells and spare healthy tissues. To test this hypothesis, we developed CARs targeting ROR1 in order to generate T cells specific for malignant cells. Two Sleeping Beauty transposons were constructed with 2nd generation ROR1-specific CARs signaling through CD3 zeta and either CD28 (designated ROR1RCD28) or CD137 (designated ROR1RCD137) and were introduced into T cells. We selected for T cells expressing CAR through co-culture with gamma-irradiated activating and propagating cells (AaPC), which co-expressed ROR1 and co-stimulatory molecules. Numeric expansion over one month of co-culture on AaPC in presence of soluble interleukin (IL)-2 and IL-21 occurred and resulted in a diverse memory phenotype of CAR(+) T cells as measured by non-enzymatic digital array (NanoString) and multi-panel flow cytometry. Such T cells produced interferon-gamma and had specific cytotoxic activity against ROR1(+) tumors. Moreover, such cells could eliminate ROR1(+) tumor xenografts, especially T cells expressing ROR1RCD137. Clinical trials will investigate the ability of ROR1-specific CAR(+) T cells to specifically eliminate tumor cells while maintaining normal B-cell repertoire.	[Deniger, Drew C.; Huls, M. Helen; Figliola, Matthew J.; Mi, Tiejuan; Maiti, Sourindra N.; Hurton, Lenka V.; Thokala, Radhika; Singh, Harjeet; Olivares, Simon; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp, Pediat, Houston, TX 77030 USA; [Deniger, Drew C.; Hurton, Lenka V.; Thokala, Radhika; Cooper, Laurence J. N.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX USA; [Yu, Jianqiang; Widhopf, George F.] Univ Calif San Diego, Moores Canc Ctr, Med, San Diego, CA 92103 USA; [Champlin, Richard E.] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Wierda, William G.] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Cooper, LJN (corresponding author), Univ Texas MD Anderson Canc Ctr, Childrens Canc Hosp, Pediat, Houston, TX 77030 USA.	ljncooper@mdanderson.org	Radhika Thokala Perelman school of Medicine, University of Pennsylvania/AAP-1753-2020	Hurton, Lenka/0000-0001-5670-5155; THOKALA, RADHIKA/0000-0002-4279-4115	Cancer Center Core Grant [CA16672, RO1 (CA124782), RO1 (CA120956), RO1 (CA141303), R33 (CA116127), P01 (CA148600), S10RR026916]; SPORE [CA83639]; Albert J. Ward Foundation; Burroughs Wellcome Fund; Cancer Prevention and Research Institute of Texas; CLL Global Research Foundation; Department of Defense; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Fund for Leukemia Immunotherapy; Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society SCOR; Lymphoma Research Foundation; Miller Foundation; Mr. Herb Simons; Mr. and Mrs. Joe H. Scales; Mr. Thomas Scott; MDACC Moon Shot; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Production Assistance for Cellular Therapies (PACT); TeamConnor; Thomas Scott; William Lawrence and Blanche Hughes Children's Foundation; NATIONAL CANCER INSTITUTE [P01CA148600, R01CA124782, P50CA083639, R01CA141303, R33CA116127, P01CA081534, R01CA120956, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026916] Funding Source: NIH RePORTER	Cancer Center Core Grant; SPORE; Albert J. Ward Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Prevention and Research Institute of Texas; CLL Global Research Foundation; Department of Defense(United States Department of Defense); Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Fund for Leukemia Immunotherapy; Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); Lymphoma Research Foundation; Miller Foundation; Mr. Herb Simons; Mr. and Mrs. Joe H. Scales; Mr. Thomas Scott; MDACC Moon Shot; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Production Assistance for Cellular Therapies (PACT); TeamConnor; Thomas Scott; William Lawrence and Blanche Hughes Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funding from: Cancer Center Core Grant (CA16672); RO1 (CA124782, CA120956, CA141303; CA141303); R33 (CA116127); P01 (CA148600); S10RR026916; SPORE (CA83639); Albert J. Ward Foundation; Burroughs Wellcome Fund; Cancer Prevention and Research Institute of Texas; CLL Global Research Foundation; Department of Defense; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Fund for Leukemia Immunotherapy; Institute of Personalized Cancer Therapy; Leukemia and Lymphoma Society SCOR; Lymphoma Research Foundation; Miller Foundation; Mr. Herb Simons; Mr. and Mrs. Joe H. Scales; Mr. Thomas Scott; MDACC Moon Shot; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Production Assistance for Cellular Therapies (PACT); TeamConnor; Thomas Scott; William Lawrence and Blanche Hughes Children's Foundation.	Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Berger C, 2015, CANCER IMMUNOL RES, V3, P206, DOI 10.1158/2326-6066.CIR-14-0163; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Broome HE, 2011, LEUKEMIA RES, V35, P1390, DOI 10.1016/j.leukres.2011.06.021; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Dave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052655; Deniger DC, 2014, CLIN CANCER RES, V20, P5708, DOI 10.1158/1078-0432.CCR-13-3451; Deniger DC, 2013, MOL THER, V21, P638, DOI 10.1038/mt.2012.267; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hackett PB, 2013, TRANSL RES, V161, P265, DOI 10.1016/j.trsl.2012.12.005; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Huls MH, 2013, JOVE-J VIS EXP, DOI 10.3791/50070; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kebriaei P, 2012, HUM GENE THER, V23, P444, DOI 10.1089/hum.2011.167; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Maiti SN, 2013, J IMMUNOTHER, V36, P112, DOI 10.1097/CJI.0b013e3182811ce9; Manuri PVR, 2010, HUM GENE THER, V21, P427, DOI 10.1089/hum.2009.114; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; O'Connor CM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00249; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rebagay G, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00034; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2014, IMMUNOL REV, V257, P181, DOI 10.1111/imr.12137; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Stonier SW, 2008, BLOOD, V112, P4546, DOI 10.1182/blood-2008-05-156307; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Zhang SP, 2014, P NATL ACAD SCI USA, V111, P17266, DOI 10.1073/pnas.1419599111; Zhang SP, 2012, AM J PATHOL, V181, P1903, DOI 10.1016/j.ajpath.2012.08.024; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]	52	40	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128151	10.1371/journal.pone.0128151	http://dx.doi.org/10.1371/journal.pone.0128151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030772	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900117
J	Gallas, G; Waters, ER				Gallas, Genna; Waters, Elizabeth R.			Boechera Species Exhibit Species-Specific Responses to Combined Heat and High Light Stress	PLOS ONE			English	Article							GENE-EXPRESSION; SHOCK PROTEINS; CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; ARABIDOPSIS; REVEALS; PHOTOSYNTHESIS; ACCLIMATION; DROUGHT; PHOTOINHIBITION	As sessile organisms, plants must be able to complete their life cycle in place and therefore tolerance to abiotic stress has had a major role in shaping biogeographical patterns. However, much of what we know about plant tolerance to abiotic stresses is based on studies of just a few plant species, most notably the model species Arabidopsis thaliana. In this study we examine natural variation in the stress responses of five diverse Boechera (Brassicaceae) species. Boechera plants were exposed to basal and acquired combined heat and high light stress. Plant response to these stresses was evaluated based on chlorophyll fluorescence measurements, induction of leaf chlorosis, and gene expression. Many of the Boechera species were more tolerant to heat and high light stress than A. thaliana. Gene expression data indicates that two important marker genes for stress responses: APX2 (Ascorbate peroxidase 2) and HsfA2 (Heat shock transcription factor A2) have distinct species-specific expression patterns. The findings of species-specific responses and tolerance to stress indicate that stress pathways are evolutionarily labile even among closely related species.	[Gallas, Genna; Waters, Elizabeth R.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Waters, ER (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	ewaters@mail.sdsu.edu			National Science Foundation [IOS 0920611]; Joshua Tree National Park; Community Foundation; SDSU Graduate Equity Grant; Mabel Myers Memorial Scholarship; Frank Alverson Memorial Scholarship; Harold & June Grant Memorial Scholarship; Hardman Foundation Scholarship; Ted Cohn Evolutionary Biology Graduate Scholarship	National Science Foundation(National Science Foundation (NSF)); Joshua Tree National Park; Community Foundation; SDSU Graduate Equity Grant; Mabel Myers Memorial Scholarship; Frank Alverson Memorial Scholarship; Harold & June Grant Memorial Scholarship; Hardman Foundation Scholarship; Ted Cohn Evolutionary Biology Graduate Scholarship	This work was supported by National Science Foundation grant IOS 0920611 to E. R. Waters. G. Gallas was partially supported by grants from Joshua Tree National Park and the Community Foundation, and from the following scholarships: SDSU Graduate Equity Grant, Mabel Myers Memorial Scholarship, Frank Alverson Memorial Scholarship, Harold & June Grant Memorial Scholarship, Hardman Foundation Scholarship, and the Ted Cohn Evolutionary Biology Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska I, 1997, PHYSIOL PLANTARUM, V100, P794, DOI 10.1034/j.1399-3054.1997.1000406.x; Alexander PJ, 2013, SYST BOT, V38, P192, DOI 10.1600/036364413X661917; Amano M, 2012, ANN BOT-LONDON, V109, P443, DOI 10.1093/aob/mcr300; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Caverzan A, 2014, PLANT SCI, V214, P74, DOI 10.1016/j.plantsci.2013.10.001; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Franklin KA, 2014, J EXP BOT, V65, P2859, DOI 10.1093/jxb/eru059; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Jaspers P, 2010, PHYSIOL PLANTARUM, V138, P405, DOI 10.1111/j.1399-3054.2009.01321.x; Johnson SM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-456; Jung HS, 2013, P NATL ACAD SCI USA, V110, P14474, DOI 10.1073/pnas.1311632110; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Kiefer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036491; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nath K, 2013, FEBS LETT, V587, P3372, DOI 10.1016/j.febslet.2013.09.015; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; RABELER RK, 1993, SCIENCE, V262, P261, DOI 10.1126/science.262.5131.261; Rivero RM, 2014, PLANT CELL ENVIRON, V37, P1059, DOI 10.1111/pce.12199; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Robinson SA, 2001, PLANT LIGHT STRESS; Rohacek K., 2008, Plant cell compartments: selected topics, P41; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Rossel JB, 2002, PLANT PHYSIOL, V130, P1109, DOI 10.1104/pp.005595; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero George N., 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-1; Song BH, 2006, MOL ECOL, V15, P357, DOI 10.1111/j.1365-294X.2005.02817.x; Stitt M, 2014, PLANT CELL ENVIRON, V37, P2453, DOI 10.1111/pce.12379; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Systat Software, 2017, PEAKFIT; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Tzvetkova-Chevolleau T, 2007, PLANT J, V50, P795, DOI 10.1111/j.1365-313X.2007.03090.x; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vollenweider Pierre, 2006, Environ Pollut, V140, P562, DOI 10.1016/j.envpol.2006.01.002; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Walz HWG, 2007, JUNIOR PAM TEACHING; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang X, 2011, J PLANT PHYSIOL, V168, P585, DOI 10.1016/j.jplph.2010.09.016; Windham Michael D., 2006, Harvard Papers in Botany, V11, P61, DOI 10.3100/1043-4534(2006)11[61:NANSOB]2.0.CO;2; Windham Michael D., 2007, Harvard Papers in Botany, V12, P235, DOI 10.3100/1043-4534(2007)12[235:NANSOB]2.0.CO;2; Windham Michael D., 2007, Harvard Papers in Botany, V11, P257, DOI 10.3100/1043-4534(2007)11[257:NANSOB]2.0.CO;2; Yeh CH, 2012, PLANT SCI, V195, P10, DOI 10.1016/j.plantsci.2012.06.004; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169	62	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129041	10.1371/journal.pone.0129041	http://dx.doi.org/10.1371/journal.pone.0129041			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030823	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900206
J	Liu, FJ; Kaur, P; Karolina, DS; Sepramaniam, S; Armugam, A; Wong, PTH; Jeyaseelan, K				Liu, Fu Jia; Kaur, Prameet; Karolina, Dwi S.; Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Wong, Peter T. H.; Jeyaseelan, Kandiah			MiR-335 Regulates Hif-1 alpha to Reduce Cell Death in Both Mouse Cell Line and Rat Ischemic Models	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; BLOOD-BRAIN-BARRIER; FOCAL ISCHEMIA; FACTOR-I; SUBVENTRICULAR ZONE; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; GLOBAL-ISCHEMIA; APOPTOTIC GENES	Hypoxia inducible factor-1 alpha facilitates cellular adaptation to hypoxic conditions. Hence its tight regulation is crucial in hypoxia related diseases such as cerebral ischemia. Changes in hypoxia inducible factor-1 alpha expression upon cerebral ischemia influence the expression of its downstream genes which eventually determines the extent of cellular damage. Micro-RNAs are endogenous regulators of gene expression that have rapidly emerged as promising therapeutic targets in several diseases. In this study, we have identified miR-335 as a direct regulator of hypoxia inducible factor-1 alpha and as a potential therapeutic target in cerebral ischemia. MiR-335 and hypoxia inducible factor-1 alpha mRNA showed an inverse expression profile, both in vivo and in vitro ischemic conditions. Given the biphasic nature of hypoxia inducible factor-1 alpha expression during cerebral ischemia, miR-335 mimic was found to reduce infarct volume in the early time (immediately after middle cerebral artery occlusion) of embolic stroke animal models while the miR-335 inhibitor appears to be beneficial at the late time of stroke (24 hrs after middle cerebral artery occlusion). Modulation of hypoxia inducible factor-1 alpha expression by miR-335 also influenced the expression of crucial genes implicated in neurovascular permeability, cell death and maintenance of the blood brain barrier. These concerted effects, resulting in a reduction in infarct volume bring about a beneficial outcome in ischemic stroke.	[Liu, Fu Jia; Kaur, Prameet; Karolina, Dwi S.; Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Wong, Peter T. H.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Jeyaseelan, Kandiah] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	National University of Singapore; National University of Singapore; Monash University	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	National Medical Research Council Singapore [NMRC-IRG/1279/2010, R-183-000-290-213]; National Research Foundation-Competitive Research Program on Stroke, Singapore [NRF-CRP3-2008-01, R-184-002-165-281]	National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation-Competitive Research Program on Stroke, Singapore(National Research Foundation, Singapore)	This work was supported by National Medical Research Council Singapore (NMRC-IRG/1279/2010: R-183-000-290-213), KJ; and National Research Foundation-Competitive Research Program on Stroke (NRF-CRP3-2008-01: R-184-002-165-281), Singapore, KJ, PTHW.	Ahn YT, 2010, INT J ONCOL, V37, P1627, DOI 10.3892/ijo_00000817; Aminova LR, 2005, J BIOL CHEM, V280, P3996, DOI 10.1074/jbc.M409223200; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bartoszewska S, 2015, FASEB J, V29, P1467, DOI 10.1096/fj.14-267054; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Bunn HF, 1998, J EXP BIOL, V201, P1197; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Chen CH, 2010, J NEUROSCI RES, V88, P2046, DOI 10.1002/jnr.22361; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; Cunningham LA, 2012, BEHAV BRAIN RES, V227, P410, DOI 10.1016/j.bbr.2011.08.002; Doeppner TR, 2012, BRAIN, V135, P3282, DOI 10.1093/brain/aws269; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karra D, 2010, J NEUROSCI, V30, P6171, DOI 10.1523/JNEUROSCI.0183-10.2010; Kaur P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103525; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Lee SR, 2006, J NEUROSCI, V26, P3491, DOI 10.1523/JNEUROSCI.4085-05.2006; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Liu FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066393; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Nagai N, 2005, J THROMB HAEMOST, V3, P1379, DOI 10.1111/j.1538-7836.2005.01466.x; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rosell A, 2008, CURR OPIN PHARMACOL, V8, P82, DOI 10.1016/j.coph.2007.12.001; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sepramaniam S, 2012, J BIOL CHEM, V287, P12006, DOI 10.1074/jbc.M111.280701; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Song T, 2011, ASIAN PAC J CANCER P, V12, P1307; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Wang Y, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/276540; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yeh SH, 2011, BRAIN PATHOL, V21, P249, DOI 10.1111/j.1750-3639.2010.00443.x; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002	65	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128432	10.1371/journal.pone.0128432	http://dx.doi.org/10.1371/journal.pone.0128432			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030758	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900149
J	van Gurp, J; Soyannwo, O; Odebunmi, K; Dania, S; van Selm, M; van Leeuwen, E; Vissers, K; Hasselaar, J				van Gurp, Jelle; Soyannwo, Olaitan; Odebunmi, Kehinde; Dania, Simpa; van Selm, Martine; van Leeuwen, Evert; Vissers, Kris; Hasselaar, Jeroen			Telemedicine's Potential to Support Good Dying in Nigeria: A Qualitative Study	PLOS ONE			English	Article							AFRICAN PALLIATIVE CARE; LIFE CARE; GOOD DEATH; OF-LIFE; CANCER; NEEDS; END; INTERVENTIONS; OPPORTUNITIES; TECHNOLOGIES	Objectives This qualitative study explores Nigerian health care professionals' concepts of good dying/a good death and how telemedicine technologies and services would fit the current Nigerian palliative care practice. Materials and Methods Supported by the Centre for Palliative Care Nigeria (CPCN) and the University College Hospital (UCH) in Ibadan, Nigeria, the authors organized three focus groups with Nigerian health care professionals interested in palliative care, unstructured interviews with key role players for palliative care and representatives of telecom companies, and field visits to primary, secondary and tertiary healthcare clinics that provided palliative care. Data analysis consisted of open coding, constant comparison, diagramming of categorizations and relations, and extensive member checks. Results The focus group participants classified good dying into 2 domains: a feeling of completion of the individual life and dying within the community. Reported barriers to palliative care provision were socio-economic consequences of being seriously ill, taboos on dying and being ill, restricted access to adequate medical-technical care, equation of religion with medicine, and the faulty implementation of palliative care policy by government. The addition of telemedicine to Nigeria's palliative care practice appears problematic, due to irregular bandwidth, poor network coverage, and unstable power supply obstructing interactivity and access to information. However, a tele-education 'lite' scenario seemed viable in Nigeria, wherein low-tech educational networks are central that build on non-synchronous online communication. Discussion Nigerian health care professionals' concepts on good dying/a good death and barriers and opportunities for palliative care provision were, for the greater part, similar to prior findings from other studies in Africa. Information for and education of patient, family, and community are essential to further improve palliative care in Africa. Telemedicine can only help if low-tech solutions are applied that work around network coverage problems by focusing on non-synchronous online communication.	[van Gurp, Jelle; Vissers, Kris; Hasselaar, Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [Soyannwo, Olaitan] Univ Coll Ibadan Hosp, Ctr Palliat Care Nigeria, Ibadan, Nigeria; [Odebunmi, Kehinde] Univ Coll Ibadan Hosp, Hosp & Palliat Care Unit, Ibadan, Nigeria; [Dania, Simpa] Univ Coll Ibadan Hosp, Dept Telemed, Ibadan, Nigeria; [van Selm, Martine] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands; [van Leeuwen, Evert] Radboud Univ Nijmegen, Med Ctr, Eth Sect, Dept IQ Healthcare, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; University of Amsterdam; Radboud University Nijmegen	van Gurp, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands.	Jelle.vanGurp@radboudumc.nl	van Gurp, Jelle/AAW-9371-2021; Vissers, Kris/H-8110-2014; van Gurp, Jelle/P-6169-2015; van Selm, Martine/AAY-3721-2021; Vissers, Kris C.P./D-3569-2009; Hasselaar, Jeroen/C-9446-2011; Leeuwen, E./H-8068-2014	van Gurp, Jelle/0000-0002-9904-2571; Vissers, Kris/0000-0002-2919-6356; van Gurp, Jelle/0000-0002-9904-2571; van Selm, Martine/0000-0001-9188-4021; Vissers, Kris C.P./0000-0002-2919-6356; Leeuwen, E./0000-0001-6356-3917	Netherlands Organisation for Scientific Research (NWO) [313-99-120]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organisation for Scientific Research (NWO) funded this research (File number 313-99-120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WHO GLOBAL HLTH OBSE; Blaya JA, 2010, HEALTH AFFAIR, V29, P244, DOI 10.1377/hlthaff.2009.0894; Cabieses B, 2013, TELEMED E-HEALTH, V19, P879, DOI 10.1089/tmj.2012.0232; Charmaz K., 2014, INTRO QUALITATIVE ME, V2nd ed.; Corbin JM, 2008, BASICS QUALITITIVE R; Donner J, 2008, INFORM SOC, V24, P140, DOI 10.1080/01972240802019970; Downing J, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-4; Grant E, 2003, J PALLIATIVE CARE, V19, P159, DOI 10.1177/082585970301900303; Gurman TA, 2012, J HEALTH COMMUN, V17, P82, DOI 10.1080/10810730.2011.649160; Gysels M, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-6; Harding R, 2008, J PAIN SYMPTOM MANAG, V36, P304, DOI 10.1016/j.jpainsymman.2008.04.008; Harding R, 2013, LANCET ONCOL, V14, pE183, DOI 10.1016/S1470-2045(12)70396-0; Harding R, 2011, EUR J CANCER, V47, P51, DOI 10.1016/j.ejca.2010.08.003; Hazin R, 2010, LANCET ONCOL, V11, P204, DOI 10.1016/S1470-2045(09)70288-8; Herce ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110457; Higginson IJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-111; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Kahn JG, 2010, HEALTH AFFAIR, V29, P254, DOI 10.1377/hlthaff.2009.0965; Kikule E, 2003, BRIT MED J, V327, P192, DOI 10.1136/bmj.327.7408.192; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Latifi R, 2012, TELEMED E-HEALTH, V18, P388, DOI [10.1089/tmj.2011.0263, 10.1089/tmj.2011.1263]; Lehoux P, 2002, SOC SCI MED, V54, P889, DOI 10.1016/S0277-9536(01)00063-6; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lucas H, 2008, SOC SCI MED, V66, P2122, DOI 10.1016/j.socscimed.2008.01.033; Lynch T, 2013, J PAIN SYMPTOM MANAG, V45, P1094, DOI 10.1016/j.jpainsymman.2012.05.011; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Odigie VI, 2012, PSYCHO-ONCOLOGY, V21, P332, DOI 10.1002/pon.1894; Olakunde BO, 2012, ANN NIGERIAN MED, V6, P4, DOI DOI 10.4103/0331-3131.100199; Onyeka TC, 2011, INDIAN J PALLIAT CAR, V17, P131, DOI 10.4103/0973-1075.84534; Patterson V, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21465; Pols J., 2012, CARE DISTANCE CLOSEN; Powell RA, 2014, J PAIN SYMPTOM MANAG, V47, P620, DOI 10.1016/j.jpainsymman.2013.04.004; Scott RE, 2013, J MED INTERNET RES, V15, P11, DOI 10.2196/jmir.2250; Seale C, 2000, SOC SCI MED, V51, P917, DOI 10.1016/S0277-9536(00)00071-X; Selman L, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-35; Selman L, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-94; van der Geest S, 2004, SOC SCI MED, V58, P899, DOI 10.1016/j.socscimed.2003.10.041; van Gurp J, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-12; Van Rensburg JJMJ, 2013, PALLIAT SUPPORT CARE, V11, P21, DOI 10.1017/S1478951512000430; *WHO, 2009, WHO COUNTR COOP STRA; Wootton Richard, 2010, JRSM Short Rep, V1, P37, DOI 10.1258/shorts.2010.010045; World Health Organization, 2014, WHO DEF PALL CAR; World Health Organization, 2011, GLOB HLTH OBS DAT RE; World Health Organization, 2014, AFR PROJ PALL CAR; Worldwide Palliative Care Alliance and World Health Organization, 2014, GLOB ATL PALL CAR EN	47	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126820	10.1371/journal.pone.0126820	http://dx.doi.org/10.1371/journal.pone.0126820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030154	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900033
J	Watson, SJ; Zizzo, DJ; Fleming, P				Watson, Steven James; Zizzo, Daniel John; Fleming, Piers			Determinants of Unlawful File Sharing: A Scoping Review	PLOS ONE			English	Review							INTELLECTUAL PROPERTY-RIGHTS; COLLEGE-STUDENTS; DIGITAL PIRACY; MUSIC PIRACY; SOFTWARE PIRACY; SELF-CONTROL; P2P; MOTIVATIONS; INTENTION; IMPACT	We employ a scoping review methodology to consider and assess the existing evidence on the determinants of unlawful file sharing (UFS) transparently and systematically. Based on the evidence, we build a simple conceptual framework to model the psychological decision to engage in UFS, purchase legally or do nothing. We identify social, moral, experiential, technical, legal and financial utility sources of the decision to purchase or to file share. They interact in complex ways. We consider the strength of evidence within these areas and note patterns of results. There is good evidence for influences on UFS within each of the identified determinants, particularly for self-reported measures, with more behavioral research needed. There are also indications that the reasons for UFS differ across media; more studies exploring media other than music are required.	[Watson, Steven James] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, Lancs, England; [Zizzo, Daniel John] Newcastle Univ, BENC, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Zizzo, Daniel John] Newcastle Univ, Sch Business, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fleming, Piers] Univ E Anglia, Sch Psychol, Norwich NR4 7TJ, Norfolk, England	Lancaster University; Newcastle University - UK; Newcastle University - UK; University of East Anglia	Zizzo, DJ (corresponding author), Newcastle Univ, BENC, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	daniel.zizzo@ncl.ac.uk	Zizzo, Daniel J./H-7841-2016; Fleming, Piers/C-1116-2009; Watson, Steven James/ABA-9233-2020; Watson, Steven/H-8129-2012	Zizzo, Daniel J./0000-0003-4830-4364; Fleming, Piers/0000-0003-3066-5313; Watson, Steven James/0000-0002-9042-2391; 	University of East Anglia; RCUK via the Centre for Copyright and New Business Models in the Creative Economy (CREATe), Arts and Humanities Research Council [AH/K000179/1]	University of East Anglia; RCUK via the Centre for Copyright and New Business Models in the Creative Economy (CREATe), Arts and Humanities Research Council	Funding for this project was from the RCUK via the Centre for Copyright and New Business Models in the Creative Economy (CREATe), Arts and Humanities Research Council Grant Number AH/K000179/1 (www.ahrc.ac.uk), and from the University of East Anglia (www.uea.ac.uk).	Adermon A, 2011, PIRACY MUSIC AND MOV; Aguiar L, 2013, WORKING PAPER 2013 0; Al-Rafee S, 2012, J GLOB INF TECH MAN, V15, P5, DOI 10.1080/1097198X.2012.10845610; Aleassa H, 2011, J BUS ETHICS, V98, P663, DOI 10.1007/s10551-010-0645-4; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Bahanovich D, 2009, MUSIC EXPERIENCE AND; Bakker P, 2005, TELEMAT INFORM, V22, P41, DOI [10.1016/j.tele.2004.06.004, DOI 10.1016/J.TELE.2004.06.004]; Balducci F, 2009, RIVISTA ITALIANA DEG, V14, P361, DOI [10.1427/30395, DOI 10.1427/30395]; Beekhuyzen J, 2011, ONLINE INFORM REV, V35, P699, DOI 10.1108/14684521111176453; Bhattacharjee S, 2006, J LAW ECON, V49, P91, DOI 10.1086/501085; Blackburn D, 2005, ESSAYS ON THE ECONOM; BMRB Social Research, 2009, FUTURE COPYRIGHT DEV; Bonner S, 2010, MANAGE DECIS, V48, P1341, DOI 10.1108/00251741011082099; Boorstin ES, 2004, MUSIC SALES IN THE A; Brunton G., 2012, INTRO SYSTEMATIC REV, P107; Cenite M, 2009, J COMMUN INQ, V33, P206, DOI 10.1177/0196859909333697; Chan RYK, 2011, EUR J INFORM SYST, V20, P659, DOI 10.1057/ejis.2011.31; Chen YC, 2008, ELECTRON COMMER R A, V7, P411, DOI 10.1016/j.elerap.2008.02.001; Cockrill A, 2012, J CONSUM BEHAV, V11, P1, DOI 10.1002/cb.357; Coyle JR, 2009, J BUS RES, V62, P1031, DOI 10.1016/j.jbusres.2008.05.002; Crooks VA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-266; Danaher B, 2013, GONE IN 60 SECONDS T; Danaher B, 2012, THE EFFECT OF GRADUA; Danaher B, 2012, REEL PIRACY THE EFFE; Danaher B, 2010, MARKET SCI, V29, P1138, DOI 10.1287/mksc.1100.0600; DCMS, 2011, CREATIVE INDUSTRIES; Denegri-Knott J., 2004, J COMPUT-MEDIAT COMM, V9, DOI [10. 1111/j. 1083-6101. 2004. tb00293. x, DOI 10.1111/J.1083-6101.2004.TB00293.X, 10.1111/j.1083-6101.2004.tb00293.x]; Easley RW, 2000, J BUS RES, V48, P83, DOI 10.1016/S0148-2963(98)00079-4; Fetscherin M, 2007, AXMEDIS 2007: THIRD INTERNATIONAL CONFERENCE ON AUTOMATED PRODUCTION OF CROSS MEDIA CONTENT FOR MULTI-CHANNEL DISTRIBUTION, PROCEEDINGS, P189, DOI 10.1109/AXMEDIS.2007.41; Filiciak M, 2012, THE CIRCULATIONS OF; Frank N. Magid Associates, 2009, INTRODUCING HOLLYWOO; Fukugawa N, 2011, EMPIRICAL EC LETT, V10, P225; Garbharran A, 2012, INT J PSYCHOL, V47, P404; GOUGH D, 2012, AN INTRODUCTION TO S, V1, P1; Grolleau G., 2008, J SOCIO-ECON, V37, P2417, DOI [10.2139/ssrn.930388Gross, DOI 10.2139/SSRN.930388GROSS, 10.1016/j.socec.2008.02.001, DOI 10.1016/J.SOCEC.2008.02.001]; Hemingway P, WHAT IS A SYSTEMATIC; Hennig-Thurau T, 2007, J MARKETING, V71, P1, DOI 10.1509/jmkg.71.4.1; Hetrick SE, 2010, J EVAL CLIN PRACT, V16, P1025, DOI 10.1111/j.1365-2753.2008.01112.x; Higgins GE, 2004, PSYCHOL REP, V95, P921, DOI 10.2466/PR0.95.7.921-931; Higgins GE, 2007, SOC SCI COMPUT REV, V25, P339, DOI 10.1177/0894439307299934; Holt TJ, 2010, DEVIANT BEHAV, V31, P625, DOI 10.1080/01639620903231548; Hsu JL, 2008, J BUS ETHICS, V81, P715, DOI 10.1007/s10551-007-9543-9; Hunt R, 2009, DIGITAL CONSUMERS IN; Huygen A., 2009, TNO INFORM COMMUNICA, DOI [10.2139/SSRN.1350451, DOI 10.2139/SSRN.1350451]; Ingram JR, 2008, DEVIANT BEHAV, V29, P334, DOI 10.1080/01639620701588131; Jambon MM, 2012, J APPL DEV PSYCHOL, V33, P31, DOI 10.1016/j.appdev.2011.09.001; Karaganis J, 2013, COPY CULTURE IN THE; Karakaya M, 2011, ANALYSIS OF THE KEY; Kinnally W, 2008, NEW MEDIA SOC, V10, P893, DOI 10.1177/1461444808096250; Konstantakis NI, 2010, BEHAV INFORM TECHNOL, V29, P277, DOI 10.1080/01449290902765076; Kwan SSK, 2008, ENDUSER DIGITAL PIRA; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Liao CC, 2010, J BUS ETHICS, V91, P237, DOI 10.1007/s10551-009-0081-5; Long XL, 2011, FRONT ECON CHINA, V6, P211, DOI 10.1007/s11459-011-0129-1; Mandel P, 2012, JAHRB NATL STAT, V232, P394; Mateus AM, 2008, PROCEEDINGS OF 2008; Mishra A, 2007, BEHAV INFORM TECHNOL, V26, P437, DOI 10.1080/01449290500483577; Molteni L, 2003, LONG RANGE PLANN, V36, P389, DOI 10.1016/S0024-6301(03)00073-6; Pons JDM, 2008, EUR J LAW ECON, V26, P153, DOI 10.1007/s10657-008-9056-8; Montoro-Pons JD, 2006, 14TH INTERNATIONAL C; Nathan M, 2013, MEASURING THE UKS DI; Ofcom, 2013, OCI TRACKER BENCHMAR; Ofcom, 2011, QUALITATIVE RESEARCH; Ofcom, 2012, OCI TRACKER BENCHMAR; Peha JM, 2014, TELECOMMUN POLICY, V38, P66, DOI 10.1016/j.telpol.2013.04.007; Peukert C, 2012, PIRACY AND MOVIE REV; Plouffe CR, 2008, EUR J MARKETING, V42, P1179, DOI 10.1108/03090560810903637; Poort J., 2010, COMMUNICATIONS STRAT, V1, P35; Poort J, 2012, FILE SHARING 2C12 DO; Poort J, 2014, TELECOMMUN POLICY, V38, P383, DOI 10.1016/j.telpol.2013.12.008; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Rochelandet F, 2005, REV EC RES COPYRIGHT, V2, P69; Sandulli FD, 2007, TECHNOVATION, V27, P325, DOI 10.1016/j.technovation.2006.12.007; Sheehan B, 2012, J ADVERTISING RES, V52, P309, DOI 10.2501/JAR-52-3-309-321; Sheehan B, 2010, ATL J COMMUN, V18, P241, DOI 10.1080/15456870.2010.521471; Siponen MT, 2005, BEHAV INFORM TECHNOL, V24, P249, DOI 10.1080/01449290512331321857; Smith MD, 2010, INF ECON POLICY, V22, P289, DOI 10.1016/j.infoecopol.2010.02.001; Steinmetz KF, 2013, DEVIANT BEHAV, V34, P53, DOI 10.1080/01639625.2012.707536; Sung T-W, 2007, AN ECONOMIC ANALYSIS; Svensson M, RESEARCH REPORT IN S, V12009; Taylor SA, 2009, J SERV RES-US, V11, P246, DOI 10.1177/1094670508328924; Thomas J., 2012, INTRO SYSTEMATIC REV, P179; Tzantzara K, 2010, PEER PEER NETW APPL, V3, P161, DOI 10.1007/s12083-009-0056-4; Waldfogel J, 2010, INF ECON POLICY, V22, P306, DOI 10.1016/j.infoecopol.2010.02.002; Walls WD, 2008, APPL ECON, V40, P625, DOI 10.1080/13504850600707337; Wolfe SE, 2008, SOC SCI COMPUT REV, V26, P317, DOI 10.1177/0894439307309465; Won Seoung Joun, 2012, [The Korean Journal of Economics, 한국경제학보(구 연세경제연구)], V19, P213; Xia M, 2006, UNRAVEL THE DRIVERS; Xia M, 2012, INFORM SYST RES, V23, P247, DOI 10.1287/isre.1100.0344; Zamoon S, 2008, J BUS ETHICS, V83, P515, DOI 10.1007/s10551-007-9636-5; Zentner A, 2010, MEASURING THE IMPACT	92	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127921	10.1371/journal.pone.0127921	http://dx.doi.org/10.1371/journal.pone.0127921			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030384	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000356630900091
J	Wu, YY; Xiao, N; Yu, L; Pan, CH; Li, YH; Zhang, XX; Liu, GQ; Dai, ZY; Pan, XB; Li, AH				Wu, Yunyu; Xiao, Ning; Yu, Ling; Pan, Cunhong; Li, Yuhong; Zhang, Xiaoxiang; Liu, Guangqing; Dai, Zhengyuan; Pan, Xuebiao; Li, Aihong			Combination Patterns of Major R Genes Determine the Level of Resistance to the M-oryzae in Rice (Oryza sativa L.)	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; QUANTITATIVE TRAIT LOCI; NBS-LRR PROTEIN; BLAST-RESISTANCE; CONFERRING RESISTANCE; JAPONICA RICE; MARKER; IDENTIFICATION; ENCODES; LINES	Rice blast caused by Magnaporthe oryzae is the most devastating disease of rice and poses a serious threat to world food security. In this study, the distribution and effectiveness of 18 R genes in 277 accessions were investigated based on pathogenicity assays and molecular markers. The results showed that most of the accessions exhibited some degree of resistance (resistance frequency, RF >50%). Accordingly, most of the accessions were observed to harbor two or more R genes, and the number of R genes harbored in accessions was significantly positively correlated with RF. Some R genes were demonstrated to be specifically distributed in the genomes of rice sub-species, such as Pigm, Pi9, Pi5 and Pi1, which were only detected in indica-type accessions, and Pik and Piz, which were just harbored in japonica-type accessions. By analyzing the relationship between R genes and RF using a multiple stepwise regression model, the R genes Pid3, Pi5, Pi9, Pi54, Pigmand Pit were found to show the main effects against M. oryzae in indica-type accessions, while Pita, Pb1, Pik, Pizt and Pia were indicated to exhibit the main effects against M. oryzae in japonica-type accessions. Principal component analysis (PCA) and cluster analysis revealed that combination patterns of major R genes were the main factors determining the resistance of rice varieties to M. oryzae, such as 'Pi9+Pi54', 'Pid3+Pigm', 'Pi5+Pid3+Pigm', 'Pi5+Pi54+Pid3+Pigm', 'Pi5+Pid3' and 'Pi5+Pit+Pid3' in indica-type accessions and 'Pik+Pib', 'Pik+Pita', 'Pik+Pb1', 'Pizt+Pia' and 'Pizt+Pita' in japonica-type accessions, which were able to confer effective resistance against M. oryzae. The above results provide good theoretical support for the rational utilization of combinations of major R genes in developing rice cultivars with broad-spectrum resistance.	[Wu, Yunyu; Xiao, Ning; Yu, Ling; Pan, Cunhong; Li, Yuhong; Zhang, Xiaoxiang; Liu, Guangqing; Dai, Zhengyuan; Li, Aihong] Lixiahe Agr Res Inst Jiangsu Prov, Yangzhou 225007, Jiangsu, Peoples R China; [Wu, Yunyu; Pan, Xuebiao] Yangzhou Univ, Minist Educ, Key Lab Plant Funct Genom, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Pan, XB (corresponding author), Yangzhou Univ, Minist Educ, Key Lab Plant Funct Genom, Yangzhou 225009, Jiangsu, Peoples R China.	xbpan@yzu.edu.cn; yzlah@126.com			Innovation Fund of Jiangsu Province Agricultural Science and Technology [CX (12)1003-4]; Supporting Project of Jiangsu Province Science and Technology [BE2013301]; Special Construction Project of a Modern Agricultural Industry Technology System [CARS-01-45]; National Transgenic Major Project [2011ZX08001-001-006]	Innovation Fund of Jiangsu Province Agricultural Science and Technology; Supporting Project of Jiangsu Province Science and Technology; Special Construction Project of a Modern Agricultural Industry Technology System; National Transgenic Major Project	This study was supported by the Innovation Fund of Jiangsu Province Agricultural Science and Technology, (CX (12)1003-4), the Supporting Project of Jiangsu Province Science and Technology, (BE2013301), the Special Construction Project of a Modern Agricultural Industry Technology System, (CARS-01-45), and the National Transgenic Major Project, (2011ZX08001-001-006).	[Anonymous], 2001, ZUO WU XUE BAO; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chen XW, 2004, J PHYTOPATHOL, V152, P77, DOI 10.1046/j.1439-0434.2003.00803.x; Deng YW, 2006, THEOR APPL GENET, V113, P705, DOI 10.1007/s00122-006-0338-7; Deng YW, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P161, DOI 10.1007/978-1-4020-9500-9_16; Feng Hui, 2013, Southwest China Journal of Agricultural Sciences, V26, P987; Fjellstrom R, 2004, CROP SCI, V44, P1790, DOI 10.2135/cropsci2004.1790; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gouda PK, 2013, PLANT BREEDING, V132, P61, DOI 10.1111/pbr.12017; Hayashi K, 2010, THEOR APPL GENET, V121, P1357, DOI 10.1007/s00122-010-1393-7; Hayashi N, 2010, PLANT J, V64, P498, DOI 10.1111/j.1365-313X.2010.04348.x; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Hua LX, 2012, THEOR APPL GENET, V125, P1047, DOI 10.1007/s00122-012-1894-7; Huang HM, 2011, PHYTOPATHOLOGY, V101, P620, DOI 10.1094/PHYTO-08-10-0209; Ingvardsen Christina Roenn, 2008, V69, P61, DOI 10.1007/978-3-540-72954-9_3; INUKAI T, 1994, PHYTOPATHOLOGY, V84, P1278, DOI 10.1094/Phyto-84-1278; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Jeung JU, 2007, THEOR APPL GENET, V115, P1163, DOI 10.1007/s00122-007-0642-x; Jia Y, 2011, PHYTOPATHOLOGY, V101, P176, DOI 10.1094/PHYTO-06-10-0151; Jia YL, 2004, EUPHYTICA, V138, P97, DOI 10.1023/B:EUPH.0000047079.42768.4d; Jiang HC, 2012, MOL BREEDING, V30, P1679, DOI 10.1007/s11032-012-9751-6; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Kiyosawa S., 1984, RICE GENET NEWSL, V1, P95; Koide Y, 2010, PLANT BREEDING, V129, P670, DOI 10.1111/j.1439-0523.2010.01781.x; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Mertler C.A., 2002, ADV MULTIVARIATE STA; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Tacconi G, 2010, MOL BREEDING, V26, P595, DOI 10.1007/s11032-010-9394-4; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Wang H, 2013, ACTA AGRON SIN, V38, P1960; Wang Jun, 2014, Zhongguo Shuidao Kexue, V28, P141, DOI 10.3969/j.issn.1001-7216.2014.02.005; Wu YY, 2013, PHYTOPATHOLOGY, V103, P1162, DOI 10.1094/PHYTO-02-13-0044-R; Xu CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041694; YAMADA M, 1976, Annals of the Phytopathological Society of Japan, V42, P216, DOI 10.3186/jjphytopath.42.216; Yu MiaoMiao, 2013, Acta Agronomica Sinica, V39, P1927, DOI 10.3724/SP.J.1006.2013.01927; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; 조영찬, 2007, Journal of Crop Science and Biotechnology, V10, P265	47	27	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126130	10.1371/journal.pone.0126130	http://dx.doi.org/10.1371/journal.pone.0126130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030358	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900019
J	Mora, I; Cabrefiga, J; Montesinos, E				Mora, Isabel; Cabrefiga, Jordi; Montesinos, Emilio			Cyclic Lipopeptide Biosynthetic Genes and Products, and Inhibitory Activity of Plant-Associated Bacillus against Phytopathogenic Bacteria	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; COMPLETE GENOME SEQUENCE; BIOLOGICAL-CONTROL; ANTIFUNGAL ACTIVITY; BIOFILM FORMATION; BACILLOMYCIN-D; SUBTILIS; IDENTIFICATION; BIOCONTROL; STRAINS	The antibacterial activity against bacterial plant pathogens and its relationships with the presence of the cyclic lipopeptide (cLP) biosynthetic genes ituC (iturin), bmyB (bacillomycin), fenD (fengycin) and srfAA (surfactin), and their corresponding antimicrobial peptide products have been studied in a collection of 64 strains of Bacillus spp. isolated from plant environments. The most frequent antimicrobial peptide (AMP) genes were bmyB, srfAAand fenD (34-50% of isolates). Most isolates (98.4%) produced surfactin isoforms, 90.6% iturins and 79.7% fengycins. The antibacterial activity was very frequent and generally intense among the collection of strains because 75% of the isolates were active against at least 6 of the 8 bacterial plant pathogens tested. Hierarchical and correspondence analysis confirmed the presence of two clearly differentiated groups. One group consisted of Bacillus strains that showed a strong antibacterial activity, presented several cLPs genes and produced several isoforms of cLPs simultaneously, mainly composed of B. subtilis and B. amyloliquefaciens, although the last one was exclusive to this group. Another group was characterized by strains with very low or none antibacterial activity, that showed one or none of the cLP genes and produced a few or none of the corresponding cLPs, and was the most heterogenous group including B. subtilis, B. licheniformis, B. megaterium, B. pumilus, B. cereusand B. thuringiensis, although the last two were exclusive to this group. This work demonstrated that the antagonistic capacity of plant-associated Bacillusagainst plant pathogenic bacteria is related to the presence of cLP genes and to the production of the corresponding cLPs, and it is mainly associated to the species B. subtilisand B. amyloliquefaciens. Our findings would help to increase the yield and efficiency of screening methods to obtain candidate strains to biocontrol agents with a mechanism of action relaying on the production of antimicrobial cLPs.	[Mora, Isabel; Cabrefiga, Jordi; Montesinos, Emilio] Univ Girona, Plant Pathol Lab, Inst Food & Agr Technol XaRTA CIDSAV, Girona 17071, Spain	Universitat de Girona	Montesinos, E (corresponding author), Univ Girona, Plant Pathol Lab, Inst Food & Agr Technol XaRTA CIDSAV, Campus Montilivi, Girona 17071, Spain.	emilio.montesinos@udg.edu	Mora, Isabel/H-7734-2015; Cabrefiga, Jordi/H-3340-2015; Cabrefiga, Jordi/AAV-7844-2021; Montesinos, Emili/H-5246-2015	Mora, Isabel/0000-0001-7447-7520; Cabrefiga, Jordi/0000-0002-8913-2573; Cabrefiga, Jordi/0000-0002-8913-2573; Montesinos, Emili/0000-0003-4455-8332	Programa Nacional de Agricultura y Alimentacion (CICYT) of the MINECO of Spain [AGL-2009-13255-C02-01]; DROPSA project of the European Union [613678]; TECNIO net from Catalonia;  [SGR 2009-0812];  [2014 SGR 697]	Programa Nacional de Agricultura y Alimentacion (CICYT) of the MINECO of Spain(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); DROPSA project of the European Union; TECNIO net from Catalonia; ; 	Funding was provided by Programa Nacional de Agricultura y Alimentacion (CICYT) (Ref. AGL-2009-13255-C02-01) of the MINECO of Spain, and FP7 KBBE.2013.1.2-04. Ref. 613678. DROPSA project of the European Union. The research group is accredited and supported in part by SGR 2009-0812, 2014 SGR 697 and TECNIO net from Catalonia.	Abderrahmani A, 2011, APPL MICROBIOL BIOT, V92, P571, DOI 10.1007/s00253-011-3453-6; Arguelles-Arias A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-63; Athukorala SNP, 2009, CAN J MICROBIOL, V55, P1021, DOI [10.1139/W09-067, 10.1139/w09-067]; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Beric T, 2012, FOOD TECHNOL BIOTECH, V50, P25; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Cazorla FM, 2007, J APPL MICROBIOL, V103, P1950, DOI 10.1111/j.1365-2672.2007.03433.x; Chandna P, 2013, APPL MICROBIOL BIOT, V97, P6991, DOI 10.1007/s00253-012-4434-0; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chitarra GS, 2003, J APPL MICROBIOL, V94, P159, DOI 10.1046/j.1365-2672.2003.01819.x; Cho MJ, 2004, J MICROBIOL BIOTECHN, V14, P599; Chung S, 2008, APPL MICROBIOL BIOT, V80, P115, DOI 10.1007/s00253-008-1520-4; Chung S, 2007, APPL MICROBIOL BIOT, V76, P217, DOI 10.1007/s00253-007-0992-y; De Meyer SE, 2015, SOIL BIOL BIOCHEM, V83, P1, DOI 10.1016/j.soilbio.2015.01.002; Eppinger M, 2011, J BACTERIOL, V193, P4199, DOI 10.1128/JB.00449-11; Fahim S, 2012, BIORESOURCE TECHNOL, V126, P1, DOI 10.1016/j.biortech.2012.09.019; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Fritze D, 2004, PHYTOPATHOLOGY, V94, P1245, DOI 10.1094/PHYTO.2004.94.11.1245; Giacomodonato MN, 2001, WORLD J MICROB BIOT, V17, P51, DOI 10.1023/A:1016610610294; Henry G, 2011, CELL MICROBIOL, V13, P1824, DOI 10.1111/j.1462-5822.2011.01664.x; Hofemeister J, 2004, MOL GENET GENOMICS, V272, P363, DOI 10.1007/s00438-004-1056-y; Hu QP, 2008, WORLD J MICROB BIOT, V24, P2451, DOI 10.1007/s11274-008-9767-6; Jacobsen BJ, 2004, PHYTOPATHOLOGY, V94, P1272, DOI 10.1094/PHYTO.2004.94.11.1272; Joshi R, 2006, PHYTOPATHOLOGY, V96, P145, DOI 10.1094/PHYTO-96-0145; Ki JS, 2009, J MICROBIOL METH, V77, P48, DOI 10.1016/j.mimet.2009.01.003; Kim PI, 2010, J MICROBIOL BIOTECHN, V20, P138, DOI 10.4014/jmb.0905.05007; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Ko KS, 2003, J CLIN MICROBIOL, V41, P2908, DOI 10.1128/JCM.41.7.2908-2914.2003; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Landa BB, 1997, PHYTOPARASITICA, V25, P305, DOI 10.1007/BF02981094; Landa BB, 2004, PLANT PATHOL, V53, P341, DOI 10.1111/j.0032-0862.2004.01008.x; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Lee KJ, 2008, WORLD J MICROB BIOT, V24, P1139, DOI 10.1007/s11274-007-9585-2; Liu JJ, 2014, FUNGAL BIOL-UK, V118, P855, DOI 10.1016/j.funbio.2014.07.004; LOEFFLER W, 1986, J PHYTOPATHOL, V115, P204, DOI 10.1111/j.1439-0434.1986.tb00878.x; Malfanova N, 2012, ARCH MICROBIOL, V194, P893, DOI 10.1007/s00203-012-0823-0; McSpadden GBB, 2004, PHYTOPATHOLOGY, V94, P1252, DOI DOI 10.1094/PHYT0.2004.94.11.1252; Miranda CAC, 2008, ANTON LEEUW INT J G, V93, P297, DOI 10.1007/s10482-007-9204-0; Montesinos E, 2009, ENCY MICROBIOLOGY, P110, DOI DOI 10.1016/J.BIOTECHADV.2013.01.004; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Mora I, 2011, INT MICROBIOL, V14, P213, DOI 10.2436/20.1501.01.151; Moyne AL, 2001, J APPL MICROBIOL, V90, P622, DOI 10.1046/j.1365-2672.2001.01290.x; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Pathak KV, 2014, 3 BIOTECH, V4, P41, DOI 10.1007/s13205-013-0119-3; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Phister TG, 2004, APPL ENVIRON MICROB, V70, P631, DOI 10.1128/AEM.70.1.631-634.2004; Price NPJ, 2007, FEMS MICROBIOL LETT, V271, P83, DOI 10.1111/j.1574-6968.2007.00702.x; Pueyo M, 2009, MICROB ECOL, V57, P367, DOI 10.1007/s00248-008-9464-x; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Ramarathnam R, 2007, CAN J MICROBIOL, V53, P901, DOI 10.1139/W07-049; Romero D, 2004, APPL MICROBIOL BIOT, V64, P263, DOI 10.1007/s00253-003-1439-8; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Ruckert C, 2011, J BIOTECHNOL, V155, P78, DOI 10.1016/j.jbiotec.2011.01.006; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stein T, 2008, RAPID COMMUN MASS SP, V22, P1146, DOI 10.1002/rcm.3481; Suihko ML, 2003, J APPL MICROBIOL, V94, P25, DOI 10.1046/j.1365-2672.2003.01803.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yu XM, 2011, EUR J SOIL BIOL, V47, P138, DOI 10.1016/j.ejsobi.2010.11.001; Zeriouh H, 2011, MOL PLANT MICROBE IN, V24, P1540, DOI 10.1094/MPMI-06-11-0162	68	64	71	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127738	10.1371/journal.pone.0127738	http://dx.doi.org/10.1371/journal.pone.0127738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024374	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400049
J	Zhang, YC; Ma, YN; Bu, DF; Liu, H; Xia, CY; Zhang, Y; Zhu, SN; Pan, H; Pei, P; Zheng, XF; Wang, ST; Xu, YF; Qi, Y				Zhang, Yanchun; Ma, Yinan; Bu, Dingfang; Liu, Hui; Xia, Changyu; Zhang, Ying; Zhu, Sainan; Pan, Hong; Pei, Pei; Zheng, Xuefei; Wang, Songtao; Xu, Yufeng; Qi, Yu			Deletion of a 4977-bp Fragment in the Mitochondrial Genome Is Associated with Mitochondrial Disease Severity	PLOS ONE			English	Article							SKELETAL-MUSCLE; COMMON-DELETION; COPY NUMBER; QUANTITATIVE-ANALYSIS; DNA DELETION; BP DELETION; DISORDERS; DIAGNOSIS; MUTATION; BREAST	Large deletions in mitochondrial DNA (mtDNA) may be involved in the pathogenesis of mitochondrial disease. In this study, we investigated the relationship between a 4,977-bp deletion in the mitochondrial genome (Delta mtDNA(4977)) and the severity of clinical symptoms in patients with mitochondrial disease lacking known point mutations. A total of 160 patients with mitochondrial disease and 101 healthy controls were recruited for this study. The copy numbers of Delta mtDNA(4977) and wild-type mtDNA were determined by real-time quantitative PCR and analyzed using Spearman's bivariate correlation analysis, t-tests, or one-way ANOVA. The overall Delta mtDNA(4977) copy number per cell and the proportion of mtDNA(4977) relative to the total wild-type mtDNA, increased with patient age and symptom severity. Surprisingly, the total mtDNA copy number decreased with increasing symptom severity. Our analyses revealed that increases in the proportion and total copy number of Delta mtDNA(4977) in the blood may be associated with disease severity in patients with mitochondrial dysfunction.	[Zhang, Yanchun; Ma, Yinan; Bu, Dingfang; Zhang, Ying; Pan, Hong; Pei, Pei; Zheng, Xuefei; Wang, Songtao; Xu, Yufeng; Qi, Yu] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100034, Peoples R China; [Liu, Hui] Beijing Childrens Hosp, Dept Resp, Beijing 100045, Peoples R China; [Xia, Changyu] Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100034, Peoples R China; [Zhu, Sainan] Peking Univ, Hosp 1, Dept Biostat, Beijing 100034, Peoples R China	Peking University; Capital Medical University; Peking University; Peking University	Ma, YN (corresponding author), Peking Univ, Hosp 1, Dept Cent Lab, 8 West Dist, Beijing 100034, Peoples R China.	mayinan1014@163.com; qiyu0724@163.com			National Natural Science Foundation of China [81271256, 81471153]; Beijing Municipal Science & Technology Commission [Z131107002213062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This study was financially supported by grants from the National Natural Science Foundation of China (No. 81271256) and (No. 81471153) and Beijing Municipal Science & Technology Commission (No. Z131107002213062). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akouchekian M, 2011, J RES MED SCI, V16, P50; Aral C, 2010, GENET MOL BIOL, V33, P1, DOI 10.1590/S1415-47572009005000102; Berneburg M, 1997, PHOTOCHEM PHOTOBIOL, V66, P271, DOI 10.1111/j.1751-1097.1997.tb08654.x; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8; Cho YM, 2007, DIABETES RES CLIN PR, V77, pS172, DOI 10.1016/j.diabres.2007.01.052; Czarny P, 2014, MUTAT RES-FUND MOL M, V760, P42, DOI 10.1016/j.mrfmmm.2013.12.001; Kamalidehghan B, 2013, ARCH MED RES, V44, P79, DOI 10.1016/j.arcmed.2012.11.004; Kato T, 1997, BIOL PSYCHIAT, V42, P311, DOI 10.1016/S0006-3223(96)00377-0; Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067146; Manea EM, 2009, J PEDIAT HEMATOL ONC, V31, P947, DOI 10.1097/MPH.0b013e3181bbc4ef; Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITOMAP, HUM MIT GEN DAT; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112; Nie HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067953; Obara-Moszynska M, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-27; Ohnuki Y, 2014, INTERNAL MED, V53, P1365, DOI 10.2169/internalmedicine.53.1320; Pavicic WH, 2009, MUTAT RES-FUND MOL M, V670, P99, DOI 10.1016/j.mrfmmm.2009.07.009; Pesce V, 2002, GENE, V286, P143, DOI 10.1016/S0378-1119(01)00815-0; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504; Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y; Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; Shao JY, 2004, WORLD J GASTROENTERO, V10, P1560, DOI 10.3748/wjg.v10.i11.1560; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Sun MJ, 2009, INT UROGYNECOL J, V20, P867, DOI 10.1007/s00192-009-0871-4; Thayer RE, 2003, EXP GERONTOL, V38, P567, DOI 10.1016/S0531-5565(03)00033-0; Upadhyay R, 2009, CANCER GENET CYTOGEN, V195, P175, DOI 10.1016/j.cancergencyto.2009.06.017; von Wurmb N, 1998, MUTAT RES-FUND MOL M, V422, P247, DOI 10.1016/S0027-5107(98)00205-X; von Wurmb-Schwark N, 2010, MECH AGEING DEV, V131, P179, DOI 10.1016/j.mad.2010.01.005; Wang J, 2009, CHINESE MED J-PEKING, V122, P431, DOI 10.3760/cma.j.issn.0366-6999.2009.04.0014; Welle S, 2003, J APPL PHYSIOL, V94, P1479, DOI 10.1152/japplphysiol.01061.2002; Ye CZ, 2008, BREAST CANCER RES TR, V108, P427, DOI 10.1007/s10549-007-9613-9; Yu-Wai-Man P, 2010, HUM MOL GENET, V19, P3043, DOI 10.1093/hmg/ddq209; Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008	39	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128624	10.1371/journal.pone.0128624	http://dx.doi.org/10.1371/journal.pone.0128624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024530	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400099
J	Moriyama, T; Ito, A; Omote, S; Miura, Y; Tsumoto, H				Moriyama, Takanori; Ito, Aimi; Omote, Sumire; Miura, Yuri; Tsumoto, Hiroki			Heat Resistant Characteristics of Major Royal Jelly Protein 1 (MRJP1) Oligomer	PLOS ONE			English	Article							RAT HEPATOCYTES; 57-KDA PROTEIN; IN-VITRO; HONEY; PROTEOMICS; PROLIFERATION; PURIFICATION; STIMULATION; RECOMBINANT; COMPONENT	Soluble royal jelly protein is a candidate factor responsible for mammiferous cell proliferation. Major royal jelly protein 1 (MRJP1), which consists of oligomeric and monomeric forms, is an abundant proliferative protein in royal jelly. We previously reported that MRJP1 oligomer has biochemical heat resistance. Therefore, in the present study, we investigated the effects of several heat treatments (56, 65 and 96 degrees C) on the proliferative activity of MRJP1 oligomer. Heat resistance studies showed that the oligomer molecular forms were slightly maintained until 56 degrees C, but the molecular forms were converted to macromolecular heat-aggregated MRJP1 oligomer at 65 degrees C and 96 degrees C. But, the growth activity of MRJP1 oligomer treated with 96 degrees C was slightly attenuated when compared to unheated MRJP1 oligomer. On the other hand, the cell proliferation activity was preserved until 96 degrees C by the cell culture analysis of Jurkat cells. In contrast, those of IEC-6 cells were not preserved even at 56 degrees C. The present observations suggest that the bioactive heat-resistance properties were different by the origin of the cells. The cell proliferation analysis showed that MRJP1 oligomer, but not MRJP2 and MRJP3, significantly increased cell numbers, suggesting that MRJP1 oligomer is the predominant proliferation factor for mammiferous cells.	[Moriyama, Takanori] Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Ito, Aimi] Toranomon Gen Hosp, Div Clin Labs, Kawasaki, Kanagawa, Japan; [Omote, Sumire] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Miura, Yuri; Tsumoto, Hiroki] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, Tokyo, Japan	Hokkaido University; Toranomon Hospital; Hokkaido University; Tokyo Metropolitan Institute of Gerontology	Moriyama, T (corresponding author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan.	moriyama@hs.hokudai.ac.jp			Sapporo Regional Innovation Strategy Promotion Program Grant from the Knowledge Cluster Initiative of the Ministry of Education, Sports, Science and Technology (MEXT); Japan Royal Jelly Co., Ltd.; Hokkaido University, Sapporo, Japan	Sapporo Regional Innovation Strategy Promotion Program Grant from the Knowledge Cluster Initiative of the Ministry of Education, Sports, Science and Technology (MEXT); Japan Royal Jelly Co., Ltd.; Hokkaido University, Sapporo, Japan	This study was supported by a Sapporo Regional Innovation Strategy Promotion Program Grant from the Knowledge Cluster Initiative of the Ministry of Education, Sports, Science and Technology (MEXT) and by Japan Royal Jelly Co., Ltd. Other research funds were provided from the internal funds of Hokkaido University, Sapporo, Japan. Japan Royal Jelly Co., Ltd., did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albert T, 2004, J INSECT PHYSIOL, V50, P51, DOI 10.1016/j.jinsphys.2003.09.008; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Bilikova K, 2010, J AGR FOOD CHEM, V58, P8776, DOI 10.1021/jf101583s; Bilikova K, 2009, PROTEOMICS, V9, P2131, DOI 10.1002/pmic.200800705; CHEN CS, 1995, FOOD CHEM, V54, P195, DOI 10.1016/0308-8146(95)00031-D; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Furusawa T, 2008, J PROTEOME RES, V7, P3194, DOI 10.1021/pr800061j; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; HOWE SR, 1985, J APICULT RES, V24, P52, DOI 10.1080/00218839.1985.11100649; Iwamura Makoto, 2014, Fukuoka University Review of Technological Sciences, P1; JONES DB, 1982, J IMMUNOL METHODS, V53, P201, DOI 10.1016/0022-1759(82)90142-9; Judova J, 1998, BIOLOGIA, V53, P777; Kamakura M, 2002, J BIOCHEM, V132, P911, DOI 10.1093/oxfordjournals.jbchem.a003304; Kamakura M, 2001, BIOSCI BIOTECH BIOCH, V65, P277, DOI 10.1271/bbb.65.277; Kamakura M, 2001, BIOCHEM BIOPH RES CO, V282, P865, DOI 10.1006/bbrc.2001.4656; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Kohno K, 2004, BIOSCI BIOTECH BIOCH, V68, P138, DOI 10.1271/bbb.68.138; LENSKY Y, 1983, COMP BIOCHEM PHYS B, V75, P607, DOI 10.1016/0305-0491(83)90104-9; Li JK, 2008, J PROTEOME RES, V7, P3339, DOI 10.1021/pr8002276; Li JK, 2007, J AGR FOOD CHEM, V55, P8411, DOI 10.1021/jf0717440; Majtan J, 2006, INT IMMUNOPHARMACOL, V6, P269, DOI 10.1016/j.intimp.2005.08.014; MAKINO M, 1986, J CLIN LAB IMMUNOL, V21, P151; Mishima S, 2005, J ETHNOPHARMACOL, V101, P215, DOI 10.1016/j.jep.2005.04.012; Narita Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2508, DOI 10.1271/bbb.60240; Nozaki R, 2012, FOOD CHEM, V134, P2332, DOI 10.1016/j.foodchem.2012.03.106; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; OSTREIKO KK, 1987, IMMUNOL LETT, V15, P311, DOI 10.1016/0165-2478(87)90134-9; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Schonleben S, 2007, ANAL BIOANAL CHEM, V389, P1087, DOI 10.1007/s00216-007-1498-2; Shen LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047194; Shen LR, 2010, J AGR FOOD CHEM, V58, P9190, DOI 10.1021/jf1007133; Simuth J, 2004, J AGR FOOD CHEM, V52, P2154, DOI 10.1021/jf034777y; Simuth J, 2001, APIDOLOGIE, V32, P69, DOI 10.1051/apido:2001112; Tamura S, 2009, PROTEOMICS, V9, P5534, DOI 10.1002/pmic.200900541; Tamura S, 2009, FOOD CHEM, V114, P1491, DOI 10.1016/j.foodchem.2008.11.058; Watanabe K, 1996, BIOTECHNOL TECH, V10, P959, DOI 10.1007/BF00180402; Watanabe K, 1998, CYTOTECHNOLOGY, V26, P23, DOI 10.1023/A:1007928408128; Yohannes G, 2010, ANAL CHIM ACTA, V675, P191, DOI 10.1016/j.aca.2010.07.016	40	19	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0119169	10.1371/journal.pone.0119169	http://dx.doi.org/10.1371/journal.pone.0119169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020775	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300001
J	Oprenyeszk, F; Sanchez, C; Dubuc, JE; Maquet, V; Henrist, C; Compere, P; Henrotin, Y				Oprenyeszk, Frederic; Sanchez, Christelle; Dubuc, Jean-Emile; Maquet, Veronique; Henrist, Catherine; Compere, Philippe; Henrotin, Yves			Chitosan Enriched Three-Dimensional Matrix Reduces Inflammatory and Catabolic Mediators Production by Human Chondrocytes	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; KNEE OSTEOARTHRITIS; OARSI RECOMMENDATIONS; ARTHROSCOPIC DEBRIDEMENT; CARTILAGE DEFECTS; TISSUE INHIBITOR; IN-VIVO; ALGINATE; MANAGEMENT	This in vitro study investigated the metabolism of human osteoarthritic (OA) chondrocytes encapsulated in a spherical matrix enriched of chitosan. Human OA chondrocytes were encapsulated and cultured for 28 days either in chitosan-alginate beads or in alginate beads. The beads were formed by slowly passing dropwise either the chitosan 0.6%-alginate 1.2% or the alginate 1.2% solution through a syringe into a 102 mM CaCl2 solution. Beads were analyzed histologically after 28 days. Interleukin (IL)-6 and -8, prostaglandin (PG) E-2, matrix metalloproteinases (MMPs), hyaluronan and aggrecan were quantified directly in the culture supernatant by specific ELISA and nitric oxide (NO) by using a colorimetric method based on the Griess reaction. Hematoxylin and eosin staining showed that chitosan was homogeneously distributed through the matrix and was in direct contact with chondrocytes. The production of IL-6, IL-8 and MMP-3 by chondrocytes significantly decreased in chitosan-alginate beads compared to alginate beads. PGE(2) and NO decreased also significantly but only during the first three days of culture. Hyaluronan and aggrecan production tended to increase in chitosan-alginate beads after 28 days of culture. Chitosan-alginate beads reduced the production of inflammatory and catabolic mediators by OA chondrocytes and tended to stimulate the synthesis of cartilage matrix components. These particular effects indicate that chitosan-alginate beads are an interesting scaffold for chondrocytes encapsulation before transplantation to repair cartilage defects.	[Oprenyeszk, Frederic; Sanchez, Christelle; Henrotin, Yves] Univ Liege, Arthropole Liege, Bone & Cartilage Res Unit, Liege, Belgium; [Dubuc, Jean-Emile] Clin Univ St Luc, Dept Orthopaed, B-1200 Brussels, Belgium; [Maquet, Veronique] KitoZyme SA, Herstal, Belgium; [Henrist, Catherine] Univ Liege, Grp Res Energy & Environm Mat, Liege, Belgium; [Henrist, Catherine] Univ Liege, Ctr Appl Technol Microscopy, Liege, Belgium; [Compere, Philippe] Univ Liege, Dept Environm Sci & Management, Lab Funct & Evolut Morphol, Liege, Belgium	University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Liege; University of Liege; University of Liege	Henrotin, Y (corresponding author), Univ Liege, Arthropole Liege, Bone & Cartilage Res Unit, Liege, Belgium.	yhenrotin@ulg.ac.be		sanchez, christelle/0000-0002-1005-8172; Henrotin, Yves/0000-0003-1073-449X	KitoZyme S.A.; "Region Wallonne": FIRST Post-Doc program for the CARTIMAT project [716609]; CWaLity-Appel, ARTHROVISC [1217650]; University of Liege	KitoZyme S.A.; "Region Wallonne": FIRST Post-Doc program for the CARTIMAT project; CWaLity-Appel, ARTHROVISC; University of Liege(University of Liege)	This work was supported in part by KitoZyme S.A. and was granted by "Region Wallonne": FIRST Post-Doc program for the CARTIMAT project (funding grant No. 716609) and CWaLity-Appel 2012:ARTHROVISC (funding grant No. 1217650). University of Liege received the funding. The funder provided support in the form of salaries for authors FO, CS, CH, PC, and YH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American College of Rheumatology Subcommittee on Osteoarthritis Guidelines, 2000, ARTHRITIS AND RHEUMA, V43, P1905, DOI DOI 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P; Babister JC, 2008, BIOMATERIALS, V29, P58, DOI 10.1016/j.biomaterials.2007.09.006; Berenbaum F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2462; Bertone AL, 2001, VET SURG, V30, P528, DOI 10.1053/jvet.2001.28430; Day B, 2005, ORTHOP CLIN N AM, V36, P413, DOI 10.1016/j.ocl.2005.06.003; de Vries-van Melle ML, 2014, EUR CELLS MATER, V27, P112, DOI 10.22203/eCM.v027a09; Dewan AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/272481; Forsey RW, 2012, BIOTECHNOL APPL BIOC, V59, P142, DOI 10.1002/bab.1009; Galois L, 2005, PATHOL BIOL, V53, P590, DOI 10.1016/j.patbio.2004.12.019; Garcia FJB, 1999, OSTEOARTHR CARTILAGE, V7, P308, DOI 10.1053/joca.1998.0174; Guo CA, 2007, J BIOSCI BIOENG, V103, P547, DOI 10.1263/jbb.103.547; Hao T, 2010, OSTEOARTHR CARTILAGE, V18, P257, DOI 10.1016/j.joca.2009.08.007; Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742, DOI 10.1152/ajpcell.1996.271.3.C742; HEMBRY RM, 1995, ANN RHEUM DIS, V54, P25, DOI 10.1136/ard.54.1.25; Henrotin Y. KF, INVENTORCELL CULTIVA; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Henrotin Yves, 2009, F1000 Med Rep, V1, DOI 10.3410/M1-88; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kerker JT, 2008, SPORTS MED ARTHROSC, V16, P208, DOI 10.1097/JSA.0b013e31818cdbaa; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; KNAUPER V, 1993, BIOCHEM J, V295, P581; Lahiji A, 2000, J BIOMED MATER RES, V51, P586; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Li ZS, 2008, J BIOMED MATER RES A, V86A, P552, DOI 10.1002/jbm.a.31596; Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449; Liu SQ, 2005, RHEUMATOL INT, V26, P52, DOI 10.1007/s00296-004-0569-3; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lu JX, 1999, BIOMATERIALS, V20, P1937; Marcacci M, 2007, AM J SPORT MED, V35, P2014, DOI 10.1177/0363546507305455; Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307; Martel-Pelletier Johanne, 1999, Frontiers in Bioscience, V4, pd694, DOI 10.2741/Martel; MARTELPELLETIER J, 1994, LAB INVEST, V70, P807; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MOSKOWITZ RW, 1973, ARTHRITIS RHEUM-US, V16, P397, DOI 10.1002/art.1780160317; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; Nam KS, 2007, J MICROBIOL BIOTECHN, V17, P2042; Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94; Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Pleumeekers MM, 2014, EUR CELLS MATER, V27, P264, DOI 10.22203/eCM.v027a19; Qin Yimin, 2004, Med Device Technol, V15, P34; Rannou F, 2010, BEST PRACT RES CL RH, V24, P93, DOI 10.1016/j.berh.2009.08.013; Sakharov AV, 2008, B EXP BIOL MED+, V146, P124, DOI 10.1007/s10517-008-0220-5; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; Sanchez C, 2004, OSTEOARTHR CARTILAGE, V12, P801, DOI 10.1016/j.joca.2004.06.011; Sanchez C, 2003, BIOCHEM PHARMACOL, V65, P377, DOI 10.1016/S0006-2952(02)01485-5; Sanchez C, 2002, J RHEUMATOL, V29, P772; Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#; Siparsky P, 2007, CLIN ORTHOP RELAT R, P107, DOI 10.1097/BLO.0b013e31802fc18c; Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345; Stark Y, 2006, EXP TOXICOL PATHOL, V57, P305, DOI 10.1016/j.etp.2005.10.005; Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002; Stuart MJ, 2006, ARTHROSCOPY, V22, P238, DOI 10.1016/j.arthro.2006.01.008; TASKIRAN D, 1994, BIOCHEM BIOPH RES CO, V200, P142, DOI 10.1006/bbrc.1994.1426; Tigli RS, 2009, J MATER SCI-MATER M, V20, P699, DOI 10.1007/s10856-008-3624-x; Xu FY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/539789; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	59	20	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128362	10.1371/journal.pone.0128362	http://dx.doi.org/10.1371/journal.pone.0128362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020773	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300103
J	Quan, H; Kim, JM; Lee, HJ; Lee, SH; Choi, JI; Bae, HB				Quan, Hui; Kim, Joung-Min; Lee, Hyun-Jung; Lee, Seong-Heon; Choi, Jeong-Il; Bae, Hong-Beom			AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase	PLOS ONE			English	Article							ACUTE LUNG INJURY; SIGNALING PATHWAY; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; INHIBITS EFFEROCYTOSIS; BACTERIAL PHAGOCYTOSIS; SAURURUS-CHINENSIS; MUSCLE-CELLS; MAP KINASE; TGF-BETA; EXPRESSION	Recent studies have suggested that 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) increases macrophage phagocytosis through adenosine monophosphate-activated protein kinase (AMPK). However, little information is available on the effects of AICAR on the clearance of apoptotic cells by macrophages, known as efferocytosis, which is essential in maintaining tissue homeostasis and resolving inflammation. AICAR increased p38 MAPK activation and the phagocytosis of apoptotic cells by macrophages, which were inhibited by the p38 MAPK inhibitor, SB203580, the TGF-beta-activated kinase 1 (TAK1) inhibitor, (5Z)-7-oxozeaenol, and siRNA-mediated knock-down of p38 alpha. AICAR increased phosphorylation of Akt, but the inhibition of PI3K/Akt activity using LY294002 did not affect the AICAR-induced changes in efferocytosis in macrophages. CGS15943, a nonselective adenosine receptor antagonist, did not affect AICAR-induced changes in efferocytosis, but dipyridamole, an adenosine transporter inhibitor, diminished the AICAR-mediated increases in efferocytosis. AICAR-induced p38 MAPK phosphorylation was not inhibited by the AMPK inhibitor, compound C, or siRNA-mediated knock-down of AMPK alpha 1. Inhibition of AMPK using compound C or 5'-iodotubercidin did not completely block AICAR-mediated increases in efferocytosis. Furthermore, AICAR also increased the removal of apoptotic neutrophils or thymocytes in mouse lungs. These results reveal a novel mechanism by which AICAR increases macrophage-mediated phagocytosis of apoptotic cells and suggest that AICAR may be used to treat efferocytosis-related inflammatory conditions.	[Quan, Hui; Kim, Joung-Min; Lee, Hyun-Jung; Lee, Seong-Heon; Choi, Jeong-Il; Bae, Hong-Beom] Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwangju, South Korea; [Quan, Hui; Bae, Hong-Beom] Chonnam Natl Univ, Res Inst Med Sci, Gwangju, South Korea	Chonnam National University; Chonnam National University	Bae, HB (corresponding author), Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwangju, South Korea.	nextphil2@jnu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1003707]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI051202] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A1003707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HB, 2013, J IMMUNOL, V190, P2273, DOI 10.4049/jimmunol.1200625; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Bumpus NN, 2011, J PHARMACOL EXP THER, V339, P886, DOI 10.1124/jpet.111.184242; Chang MY, 2010, BIOCHEM PHARMACOL, V80, P1210, DOI 10.1016/j.bcp.2010.06.049; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cui J, 2009, CELL IMMUNOL, V256, P6, DOI 10.1016/j.cellimm.2008.12.003; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Friggeri A, 2012, MOL MED, V18, P825, DOI 10.2119/molmed.2012.00005; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Han HJ, 2013, INT IMMUNOPHARMACOL, V17, P471, DOI 10.1016/j.intimp.2013.07.011; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hoogendijk AJ, 2013, J BIOL CHEM, V288, P7047, DOI 10.1074/jbc.M112.413138; Ishii N, 2009, J BIOL CHEM, V284, P34561, DOI 10.1074/jbc.M109.028043; Jeong KM, 2014, EUR J PHARMACOL, V728, P176, DOI 10.1016/j.ejphar.2014.01.039; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Jiang SN, 2013, J BIOL CHEM, V288, P26013, DOI 10.1074/jbc.M113.489468; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040813; Kim MS, 2008, DIABETES, V57, P64, DOI 10.2337/db07-0832; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Ninkovic J, 2012, AM J PATHOL, V180, P1068, DOI 10.1016/j.ajpath.2011.11.034; Osada Y, 2009, J BIOCHEM, V145, P387, DOI 10.1093/jb/mvn176; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xing JJ, 2013, AM J PATHOL, V182, P1021, DOI 10.1016/j.ajpath.2012.11.022; Yang YP, 2010, AM J RESP CRIT CARE, V182, P1516, DOI 10.1164/rccm.201003-0452OC; Zhang WY, 2010, ARTERIOSCL THROM VAS, V30, P1000, DOI 10.1161/ATVBAHA.110.203141; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	42	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127885	10.1371/journal.pone.0127885	http://dx.doi.org/10.1371/journal.pone.0127885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020972	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300063
J	Rosauer, DF; Catullo, RA; VanDerWal, J; Moussalli, A; Moritz, C				Rosauer, Dan F.; Catullo, Renee A.; VanDerWal, Jeremy; Moussalli, Adnan; Moritz, Craig			Lineage Range Estimation Method Reveals Fine-Scale Endemism Linked to Pleistocene Stability in Australian Rainforest Herpetofauna	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BRAZILIAN ATLANTIC FOREST; QUATERNARY CLIMATE-CHANGE; NARROW CONTACT ZONE; HISTORICAL BIOGEOGRAPHY; WET TROPICS; COMPARATIVE PHYLOGEOGRAPHY; PHYLOGENETIC ENDEMISM; PHYLLURUS LACERTILIA; NORTHEAST AUSTRALIA	Areas of suitable habitat for species and communities have arisen, shifted, and disappeared with Pleistocene climate cycles, and through this shifting landscape, current biodiversity has found paths to the present. Evolutionary refugia, areas of relative habitat stability in this shifting landscape, support persistence of lineages through time, and are thus crucial to the accumulation and maintenance of biodiversity. Areas of endemism are indicative of refugial areas where diversity has persisted, and endemism of intraspecific lineages in particular is strongly associated with late-Pleistocene habitat stability. However, it remains a challenge to consistently estimate the geographic ranges of intraspecific lineages and thus infer phylogeographic endemism, because spatial sampling for genetic analyses is typically sparse relative to species records. We present a novel technique to model the geographic distribution of intraspecific lineages, which is informed by the ecological niche of a species and known locations of its constituent lineages. Our approach allows for the effects of isolation by unsuitable habitat, and captures uncertainty in the extent of lineage ranges. Applying this method to the arc of rainforest areas spanning 3500 km in eastern Australia, we estimated lineage endemism for 53 species of rainforest dependent herpetofauna with available phylogeographic data. We related endemism to the stability of rainforest habitat over the past 120,000 years and identified distinct concentrations of lineage endemism that can be considered putative refugia. These areas of lineage endemism are strongly related to historical stability of rainforest habitat, after controlling for the effects of current environment. In fact, a dynamic stability model that allows movement to track suitable habitat over time was the most important factor in explaining current patterns of endemism. The techniques presented here provide an objective, practical method for estimating geographic ranges below the species level, and including them in spatial analyses of biodiversity.	[Rosauer, Dan F.; Catullo, Renee A.; Moritz, Craig] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Rosauer, Dan F.; Catullo, Renee A.; Moritz, Craig] Australian Natl Univ, Ctr Biodivers Anal, Canberra, ACT, Australia; [Catullo, Renee A.; Moritz, Craig] CSIRO Land & Water Flagship, Canberra, ACT, Australia; [VanDerWal, Jeremy] James Cook Univ, Coll Marine & Environm Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [VanDerWal, Jeremy] James Cook Univ, ERes Ctr, Div Res & Innovat, Townsville, Qld 4811, Australia; [Moussalli, Adnan] Museum Victoria, Dept Sci, Melbourne, Vic, Australia	Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University; Museum Victoria	Rosauer, DF (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	dan.rosauer@anu.edu.au	Rosauer, Dan F/C-3735-2008	Rosauer, Dan F/0000-0002-2371-1767; Catullo, Renee/0000-0002-1790-7085	Australian Research Council Laureate Fellowship [FL110100104]; Science and Industry Endowment Fund	Australian Research Council Laureate Fellowship(Australian Research Council); Science and Industry Endowment Fund	DR and CM were funded by an Australian Research Council Laureate Fellowship FL110100104 to CM, www.arc.gov.au/. RC was partially funded by a grant from the Science and Industry Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Amante C., 2009, ETOPO1 1 ARC MINUTE; [Anonymous], 2012, ARCG2S 10 1; Australian Government Department of Sustainability E Water Population and Communities, 2012, AUSTR EST PRE 1750 M; Bell RC, 2012, P ROY SOC B-BIOL SCI, V279, P991, DOI 10.1098/rspb.2011.1229; Bell RC, 2010, MOL ECOL, V19, P2531, DOI 10.1111/j.1365-294X.2010.04676.x; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bivand R, 2014, SPDEP R PACKAGE SPAT; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; Bush A, 2014, DIVERS DISTRIB, V20, P1016, DOI 10.1111/ddi.12196; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Carnaval AC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Costion CM, 2015, DIVERS DISTRIB, V21, P279, DOI 10.1111/ddi.12266; Couper PJ, 2008, REC AUST MUS, V60, P87, DOI 10.3853/j.0067-1975.60.2008.1492; Couper Patrick J., 2008, Memoirs of the Queensland Museum, V52, P139; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Crisp MD, 1995, SYST BIOL, V44, P457, DOI 10.2307/2413654; Davies TJ, 2009, AM NAT, V174, P297, DOI 10.1086/603614; de Lima NE, 2014, J BIOGEOGR, V41, P673, DOI 10.1111/jbi.12269; DiNezio PN, 2013, NAT GEOSCI, V6, P485, DOI [10.1038/ngeo1823, 10.1038/NGEO1823]; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Dolman G, 2006, EVOLUTION, V60, P573, DOI 10.1554/05-487.1; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Forester BR, 2013, DIVERS DISTRIB, V19, P1480, DOI 10.1111/ddi.12098; Fuchs J, 2013, BIOL J LINN SOC, V108, P658, DOI 10.1111/j.1095-8312.2012.02022.x; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans R. J., 2013, R PACKAGE DISMO SPEC; Hilbert DW, 2007, PALAEOGEOGR PALAEOCL, V251, P104, DOI 10.1016/j.palaeo.2007.02.020; Hoskin CJ, 2003, AUST J ZOOL, V51, P153, DOI 10.1071/ZO02072; Hoskin CJ, 2013, ZOOTAXA, V3722, P385; Hoskin CJ, 2013, ZOOTAXA, V3717, P543, DOI 10.11646/zootaxa.3717.4.6; Hoskin CJ, 2011, AM NAT, V178, P561, DOI 10.1086/662164; Houlder D. J., 2000, ANUCLIM USERS GUIDE; Hugall A, 2003, SM S COMP E, P270; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; KERSHAW AP, 1988, J BIOGEOGR, V15, P589, DOI 10.2307/2845438; Knowles R, 2004, REC AUST MUS, V56, P57, DOI 10.3853/j.0067-1975.56.2004.1391; Kooyman RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080685; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Macqueen P, 2010, MOL PHYLOGENET EVOL, V57, P1134, DOI 10.1016/j.ympev.2010.08.010; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; Moritz C, 2005, CONSERV BIOL SER, V8, P243; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Moritz C, 2012, PHILOS T R SOC B, V367, P1680, DOI 10.1098/rstb.2012.0018; Moussalli A, 2005, MOL PHYLOGENET EVOL, V34, P190, DOI 10.1016/j.ympev.2004.08.022; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nix HA, 1991, RAINFOREST ANIMALS A, P11; Oza AU, 2012, MOL PHYLOGENET EVOL, V62, P407, DOI 10.1016/j.ympev.2011.10.010; Phillips BL, 2004, EVOLUTION, V58, P1536; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Powney GD, 2010, GLOBAL ECOL BIOGEOGR, V19, P386, DOI 10.1111/j.1466-8238.2009.00521.x; Reside A. E., 2013, CLIMATE CHANGE REFUG; Reside AE, 2014, AUSTRAL ECOL, V39, P887, DOI 10.1111/aec.12146; Rissler LJ, 2006, AM NAT, V167, P655, DOI 10.1086/503332; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; Rosauer DF, 2015, GLOBAL ECOL BIOGEOGR, V24, P168, DOI 10.1111/geb.12237; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Shea G, 2011, ZOOTAXA, P1; Shoo LP, 2010, INT J BIOMETEOROL, V54, P475, DOI 10.1007/s00484-009-0286-4; Shull HC, 2005, MOL PHYLOGENET EVOL, V37, P249, DOI 10.1016/j.ympev.2005.04.034; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Singhal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2246; Singhal S, 2012, EVOLUTION, V66, P1474, DOI 10.1111/j.1558-5646.2011.01539.x; Slatyer C, 2007, J BIOGEOGR, V34, P583, DOI 10.1111/j.1365-2699.2006.01647.x; Slavich E, 2014, DIVERS DISTRIB, V20, P952, DOI 10.1111/ddi.12216; Stuart-Fox DM, 2001, AUST J ZOOL, V49, P119, DOI 10.1071/ZO00092; Tarroso P, 2015, MOL ECOL RESOUR, V15, P349, DOI 10.1111/1755-0998.12312; Thomassen HA, 2010, EVOL APPL, V3, P1, DOI 10.1111/j.1752-4571.2009.00093.x; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; VanDerWal J., 2011, CLIMATES METHODS WOR; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219	85	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126274	10.1371/journal.pone.0126274	http://dx.doi.org/10.1371/journal.pone.0126274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020936	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355187300020
J	Skeie, JM; Roybal, CN; Mahajan, VB				Skeie, Jessica M.; Roybal, C. Nathaniel; Mahajan, Vinit B.			Proteomic Insight into the Molecular Function of the Vitreous	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; VITRECTOMY; EXPRESSION; UVEITIS; KINASE; INFLAMMATION; MEMBRANE; PROTEINS; MUTATION; PEPTIDE	The human vitreous contains primarily water, but also contains proteins which have yet to be fully characterized. To gain insight into the four vitreous substructures and their potential functions, we isolated and analyzed the vitreous protein profiles of three non-diseased human eyes. The four analyzed substructures were the anterior hyaloid, the vitreous cortex, the vitreous core, and the vitreous base. Proteins were separated by multidimensional liquid chromatography and identified by tandem mass spectrometry. Bioinformatics tools then extracted the expression profiles, signaling pathways, and interactomes unique to each tissue. From each substructure, a mean of 2,062 unique proteins were identified, with many being differentially expressed in a specific substructure: 278 proteins were unique to the anterior hyaloid, 322 to the vitreous cortex, 128 to the vitreous base, and 136 to the vitreous core. When the identified proteins were organized according to relevant functional pathways and networks, key patterns appeared. The blood coagulation pathway and extracellular matrix turnover networks were highly represented. Oxidative stress regulation and energy metabolism proteins were distributed throughout the vitreous. Immune functions were represented by high levels of immunoglobulin, the complement pathway, damage-associated molecular patterns (DAMPs), and evolutionarily conserved antimicrobial proteins. The majority of vitreous proteins detected were intracellular proteins, some of which originate from the retina, including rhodopsin (RHO), phosphodiesterase 6 (PDE6), and glial fibrillary acidic protein (GFAP). This comprehensive analysis uncovers a picture of the vitreous as a biologically active tissue, where proteins localize to distinct substructures to protect the intraocular tissues from infection, oxidative stress, and energy disequilibrium. It also reveals the retina as a potential source of inflammatory mediators. The vitreous proteome catalogues the dynamic interactions between the vitreous and surrounding tissues. It therefore could be an indirect and effective method for surveying vitreoretinal disease for specific biomarkers.	[Skeie, Jessica M.; Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Omics Lab, Iowa City, IA 52242 USA; [Roybal, C. Nathaniel; Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA	University of Iowa; University of Iowa	Mahajan, VB (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Omics Lab, Iowa City, IA 52242 USA.	vinit-mahajan@uiowa.edu		Mahajan, Vinit/0000-0003-1886-1741	National Institutes of Health [K08EY020530]; Doris Duke Charitable Foundation [2013103]; NATIONAL EYE INSTITUTE [R01EY024665, K08EY020530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding sources are National Institutes of Health (K08EY020530), The Doris Duke Charitable Foundation (2013103) and Research to Prevent Blindness. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Aliyar HA, 2004, POLYM PREP, V45, P469; Angi M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/148039; Beavis Ronald C., 2006, V328, P217; Becker M, 2005, AM J OPHTHALMOL, V140, P1096, DOI 10.1016/j.ajo.2005.07.017; Benoit YD, 2014, CLIN CANCER RES, V20, P5372, DOI 10.1158/1078-0432.CCR-13-2491; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bjornson RD, 2008, J PROTEOME RES, V7, P293, DOI 10.1021/pr0701198; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Colombo E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00063; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Ekins S, 2007, METH MOL B, V356, P319; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Funaki H, 2001, INVEST OPHTH VIS SCI, V42, P1193; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Hauck SM, 2012, J PROTEOMICS, V75, P4545, DOI 10.1016/j.jprot.2012.04.052; Holekamp NM, 2010, AM J OPHTHALMOL, V149, P32, DOI 10.1016/j.ajo.2009.07.036; Hong SK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/526341; Huang J, 2015, AGEING RES REV, V24, P3, DOI 10.1016/j.arr.2014.10.004; Kang GY, 2014, J PROTEOME RES, V13, P581, DOI 10.1021/pr400751k; Kim T, 2007, PROTEOMICS, V7, P4203, DOI 10.1002/pmic.200700745; Koss MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096895; Li Y, 2010, RAPID COMMUN MASS SP, V24, P807, DOI 10.1002/rcm.4448; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Mahajan VB, 2014, PROTEOM CLIN APPL, V8, P204, DOI 10.1002/prca.201300062; Mahajan VB, 2010, AM J MED GENET A, V152A, P2875, DOI 10.1002/ajmg.a.33621; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Moller B, 2001, MOL HUM REPROD, V7, P65, DOI 10.1093/molehr/7.1.65; Montenarh M, 2010, CELL TISSUE RES, V342, P139, DOI 10.1007/s00441-010-1068-3; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Nace G, 2012, J INNATE IMMUN, V4, P6, DOI 10.1159/000334245; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Simo-Servat O, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/872978; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Skeie JM, 2014, JAMA OPHTHALMOL, V132, P1271, DOI 10.1001/jamaophthalmol.2014.2065; Skeie JM, 2014, PROTEOM CLIN APPL, V8, P209, DOI 10.1002/prca.201300043; Skeie JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082140; Skeie JM, 2011, MOL VIS, V17, P576; Skeie JM, 2011, JOVE-J VIS EXP, DOI 10.3791/2455; Smith SK, 1995, HUM REPROD UPDATE, V1, P162, DOI 10.1093/humupd/1.2.162; Soheilian M, 2013, OCUL IMMUNOL INFLAMM, V21, P93, DOI 10.3109/09273948.2012.734536; Verbraeken H, 1996, GRAEF ARCH CLIN EXP, V234, P288, DOI 10.1007/BF00220702; Kamei RRW, 2012, ARQ BRAS OFTALMOL, V75, P107, DOI 10.1590/S0004-27492012000200007; Walia S, 2010, SEMIN OPHTHALMOL, V25, P289, DOI 10.3109/08820538.2010.518912; Wang H, 2013, EXP EYE RES, V108, P110, DOI 10.1016/j.exer.2012.11.023; Wilkins HM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00311; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yin J, 2014, AMYLOID, V21, P140, DOI 10.3109/13506129.2014.892871; Yokoi T, 2009, GRAEF ARCH CLIN EXP, V247, P715, DOI 10.1007/s00417-008-1016-z	57	56	56	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127567	10.1371/journal.pone.0127567	http://dx.doi.org/10.1371/journal.pone.0127567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020955	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300045
J	Asraf, H; Avunie-Masala, R; Hershfinkel, M; Gheber, L				Asraf, Hila; Avunie-Masala, Rachel; Hershfinkel, Michal; Gheber, Larisa			Mitotic Slippage and Expression of Survivin Are Linked to Differential Sensitivity of Human Cancer Cell-Lines to the Kinesin-5 Inhibitor Monastrol	PLOS ONE			English	Article							ANAPHASE SPINDLE ELONGATION; SACCHAROMYCES-CEREVISIAE; PHASE-II; IN-VIVO; GENOMIC INSTABILITY; CRYSTAL-STRUCTURE; BIPOLAR KINESIN; MOTOR DOMAIN; CROSS-LINKS; PROTEIN	The mitotic Kinesin-5 motor proteins crosslink and slide apart antiparallel spindle microtubules, thus performing essential functions in mitotic spindle dynamics. Specific inhibition of their function by monastrol-like small molecules has been examined in clinical trials as anticancer treatment, with only partial success. Thus, strategies that improve the efficiency of monastrol-like anticancer drugs are required. In the current study, we examined the link between sensitivity to monastrol and occurrence of mitotic slippage in several human celllines. We found that the rank of sensitivity to monastrol, from most sensitive to least sensitive, is: AGS>HepG2>Lovo>Du145 >= HT29. We show correlation between the sensitivity of a particular cell-line to monastrol and the tendency of the same cell-line to undergo mitotic slippage. We also found that in the monastrol resistant HT29 cells, prolonged monastrol treatments increase mRNA and protein levels of the chromosomal passenger protein survivin. In contrast, survivin levels are not increased by this treatment in the monastrol-sensitive AGS cells. We further show that over-expression of survivin in the monastrol-sensitive AGS cells reduces mitotic slippage and increases resistance to monastrol. Finally, we show that during short exposure to monastrol, Si RNA silencing of survivin expression reduces cell viability in both AGS and HT29 cells. Our data suggest that the efficiency of anti-cancer treatment with specific kinesin-5 inhibitors may be improved by modulation of expression levels of survivin.	[Asraf, Hila; Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Avunie-Masala, Rachel; Gheber, Larisa] Ben Gurion Univ Negev, Dept Chem, Fac Nat Sci, IL-84105 Beer Sheva, Israel; [Gheber, Larisa] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Gheber, L (corresponding author), Ben Gurion Univ Negev, Dept Chem, Fac Nat Sci, IL-84105 Beer Sheva, Israel.	lgheber@bgu.ac.il		Hershfinkel, Michal/0000-0003-1652-1989	Startup Fund, Faculty of Health Sciences, Ben-Gurion University of the Negev; Israeli Science Foundation [165/2013, 891/2014]	Startup Fund, Faculty of Health Sciences, Ben-Gurion University of the Negev; Israeli Science Foundation(Israel Science Foundation)	This work was supported in part by the Startup Fund, Faculty of Health Sciences, Ben-Gurion University of the Negev, awarded to MH and LG; by the Israeli Science Foundation grant 165/2013 awarder to LG (http://www.isf.org.il/english/) and the Israeli Science Foundation grant no. 891/2014 awarded to MH (http://www.isf.org.il/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Andreassen PR, 2003, MUTAT RES-FUND MOL M, V532, P245, DOI 10.1016/j.mrfmmm.2003.08.020; Avunie-Masala R, 2011, J CELL SCI, V124, P873, DOI 10.1242/jcs.077396; Beer TM, 2008, CLIN GENITOURIN CANC, V6, P103, DOI 10.3816/CGC.2008.n.016; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374; DUHL DM, 1982, CANCER RES, V42, P594; El-Nassan HB, 2013, EUR J MED CHEM, V62, P614, DOI 10.1016/j.ejmech.2013.01.031; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; Fridman V, 2013, J CELL SCI, V126, P4147, DOI 10.1242/jcs.125153; Fridman V, 2009, EMBO REP, V10, P387, DOI 10.1038/embor.2009.7; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gerson-Gurwitz A, 2009, CELL MOL LIFE SCI, V66, P301, DOI 10.1007/s00018-008-8479-2; Gerson-Gurwitz A, 2011, EMBO J, V30, P4942, DOI 10.1038/emboj.2011.403; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Gordon DM, 1999, J BIOL CHEM, V274, P28779, DOI 10.1074/jbc.274.40.28779; Goulet A, 2013, INT REV CEL MOL BIO, V304, P419, DOI 10.1016/B978-0-12-407696-9.00008-7; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; Grossman D, 2001, P NATL ACAD SCI USA, V98, P635, DOI 10.1073/pnas.230450097; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hansen GM, 1999, ONCOGENE, V18, P6531, DOI 10.1038/sj.onc.1203023; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; ISAACS WB, 1991, CANCER RES, V51, P4716; JENKINS VK, 1986, INT J RADIAT BIOL, V50, P269, DOI 10.1080/09553008614550651; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Lee CW, 2008, INVEST NEW DRUG, V26, P249, DOI 10.1007/s10637-007-9097-9; Leizerman I, 2004, CELL MOL LIFE SCI, V61, P2060, DOI 10.1007/s00018-004-4074-3; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Lin-Lee YC, 2001, BIOCHEM PHARMACOL, V61, P555, DOI 10.1016/S0006-2952(00)00592-X; MATOZAKI T, 1992, BIOCHEM BIOPH RES CO, V182, P215, DOI 10.1016/S0006-291X(05)80133-0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Meek DW, 2000, PATHOL BIOL, V48, P246; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; Movshovich N, 2008, J CELL SCI, V121, P2529, DOI 10.1242/jcs.022996; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Ostlund RE, 1996, J BIOL CHEM, V271, P10073, DOI 10.1074/jbc.271.17.10073; Pocard M, 1996, ONCOGENE, V12, P875; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Saunders AM, 2007, CURR BIOL, V17, pR453, DOI 10.1016/j.cub.2007.05.001; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Silkworth WT, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-19; Tang PA, 2008, INVEST NEW DRUG, V26, P257, DOI 10.1007/s10637-007-9098-8; Thiede Christina, 2012, Bioarchitecture, V2, P70; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Touitou I, 2001, J CELL SCI, V114, P481; Wojcik EJ, 2013, GENE, V531, P133, DOI 10.1016/j.gene.2013.08.004	58	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129255	10.1371/journal.pone.0129255	http://dx.doi.org/10.1371/journal.pone.0129255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035434	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100070
J	Illing, B; Moyano, M; Niemax, J; Peck, MA				Illing, Bjoern; Moyano, Marta; Niemax, Jan; Peck, Myron A.			Direct Effects of Microalgae and Protists on Herring (Clupea harengus) Yolk Sac Larvae	PLOS ONE			English	Article							FISH LARVAE; CLASS STRENGTH; MARINE FISHES; LIFE-HISTORY; ATLANTIC COD; MISMATCH; SURVIVAL; GROWTH; POPULATIONS; PREDATION	This study investigated effects of microalgae (Rhodomonas baltica) and heterotrophic protists (Oxyrrhis marina) on the daily growth, activity, condition and feeding success of Atlantic herring (Clupea harengus) larvae from hatch, through the end of the endogenous (yolk sac) period. Yolk sac larvae were reared in the presence and absence of microplankton and, each day, groups of larvae were provided access to copepods. Larvae reared with microalgae and protists exhibited precocious (2 days earlier) and >= 60% increased feeding incidence on copepods compared to larvae reared in only seawater (SW). In the absence and presence of microalgae and protists, life span and growth trajectories of yolk sac larvae were similar and digestive enzyme activity (trypsin) and nutritional condition (RNA-DNA ratio) markedly declined in all larvae directly after yolk sac depletion. Thus, microplankton promoted early feeding but was not sufficient to alter life span and growth during the yolk sac phase. Given the importance of early feeding, field programs should place greater emphasis on the protozooplankton-ichthyoplankton link to better understand match-mismatch dynamics and bottom-up drivers of year class success in marine fish.	[Illing, Bjoern; Moyano, Marta; Niemax, Jan; Peck, Myron A.] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany	University of Hamburg	Illing, B (corresponding author), Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Olbersweg 24, Hamburg, Germany.	Bjoern.Illing@uni-hamburg.de	Peck, Myron A/H-6164-2011; Illing, Björn/S-9351-2019	Peck, Myron A/0000-0001-7423-1854; Illing, Björn/0000-0002-5217-805X; Moyano, Marta/0000-0002-3026-9225	University of Hamburg PhD fellowship; EU FP7 Program FACTS (Forage Fish Interactions); Alexander von Humboldt Foundation; EU FP7 program VECTORS (Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors)	University of Hamburg PhD fellowship; EU FP7 Program FACTS (Forage Fish Interactions); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EU FP7 program VECTORS (Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors)	BI was funded by a University of Hamburg PhD fellowship (http://www.uni-hamburg.de/forschung/nachwuchs/promotion/stipendienwegweiser/promotionsstipendien.html) and by the EU FP7 Program FACTS (Forage Fish Interactions), MM was funded by a fellowship received from the Alexander von Humboldt Foundation (http://www.humboldt-foundation.de/web/humboldt-fellowship-postdoc.html). The work was also funded by the EU FP7 program VECTORS (Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY KM, 1989, ADV MAR BIOL, V25, P1; BLAXTER J. H. S., 1963, JOUR CONS CONS PERM INTERNATL EXPLOR MER, V28, P211; BUCKLEY LJ, 1979, FISH B-NOAA, V77, P703; Busch A, 1996, MAR ECOL PROG SER, V130, P39, DOI 10.3354/meps130039; Cahu CL, 1998, AQUACULTURE, V161, P479, DOI 10.1016/S0044-8486(97)00295-0; Caldarone E.M., 2001, 0111 NE FISH SCI CTR; Caldarone EM, 2006, LIMNOL OCEANOGR-METH, V4, P153, DOI 10.4319/lom.2006.4.153; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; De Figueiredo GM, 2007, J MAR BIOL ASSOC UK, V87, P843, DOI 10.1017/S002531540705713X; Dutz J, 1998, MAR ECOL PROG SER, V175, P97, DOI 10.3354/meps175097; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fukami K, 1999, MAR ECOL PROG SER, V185, P285, DOI 10.3354/meps185285; Hesse J, 2010, THESIS U ROSTOCK BAL; HJELMELAND K, 1988, MAR BIOL, V98, P331, DOI 10.1007/BF00391108; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Houde E.D., 1987, American Fisheries Society Symposium, P17; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Hufnagl M, 2011, ICES J MAR SCI, V68, P1170, DOI 10.1093/icesjms/fsr078; KIORBOE T, 1985, DANA-J FISH MAR RES, V5, P95; LASKER R, 1970, MAR BIOL, V5, P345; Lazo JP, 2000, AQUACULTURE, V188, P339, DOI 10.1016/S0044-8486(00)00339-2; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Llopiz JK, 2013, J MARINE SYST, V109, P69, DOI 10.1016/j.jmarsys.2012.05.002; Meyer S, 2012, J MARINE SYST, V93, P11, DOI 10.1016/j.jmarsys.2011.09.010; MOFFATT N M, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P475; Moller EF, 2001, J PLANKTON RES, V23, P527, DOI 10.1093/plankt/23.5.527; Montagnes DJS, 2011, J PLANKTON RES, V33, P549, DOI 10.1093/plankt/fbq121; Montagnes DJS, 2010, J EUKARYOT MICROBIOL, V57, P223, DOI 10.1111/j.1550-7408.2010.00476.x; NAAS KE, 1992, AQUACULTURE, V105, P143, DOI 10.1016/0044-8486(92)90126-6; Oeberst R, 2009, ICES J MAR SCI, V66, P1667, DOI 10.1093/icesjms/fsp143; Overton JL, 2010, MAR ECOL PROG SER, V410, P197, DOI 10.3354/meps08658; Peck MA, 2013, PROG OCEANOGR, V116, P220, DOI 10.1016/j.pocean.2013.05.012; Peck MA, 2012, ADV ECOL RES, V47, P177, DOI 10.1016/B978-0-12-398315-2.00003-X; Peck MA, 2012, ICES J MAR SCI, V69, P529, DOI 10.1093/icesjms/fss038; PEDERSEN BH, 1987, MAR BIOL, V94, P171, DOI 10.1007/BF00392929; Pelegri SP, 1999, AQUAT MICROB ECOL, V16, P273, DOI 10.3354/ame016273; Pepin P, 2007, J PLANKTON RES, V29, P727, DOI 10.1093/plankt/fbm052; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; Salvesen I, 1999, AQUACULTURE, V175, P337, DOI 10.1016/S0044-8486(99)00110-6; Skjermo J., 1993, P 1 INT C FISH FARM, P61; UEBERSCHAR B, 1992, ICES J MAR SCI, V49, P245, DOI 10.1093/icesjms/49.2.245; Ueberschar B, 1999, THESIS U HAMBURG GER; Ueberschar Bernd, 1993, P233; VANDERMEEREN T, 1991, J FISH BIOL, V39, P225; von Herbing IH, 2000, MAR BIOL, V136, P591, DOI 10.1007/s002270050719; von Herbing IH, 2001, MAR ECOL PROG SER, V216, P201, DOI 10.3354/meps216201; Wasmund N, 2012, ICES PHYTOPLANKTON M, P60; Watts PC, 2011, J PLANKTON RES, V33, P579, DOI 10.1093/plankt/fbq148; Yufera M, 2007, AQUACULTURE, V268, P53, DOI 10.1016/j.aquaculture.2007.04.050	51	14	14	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129344	10.1371/journal.pone.0129344	http://dx.doi.org/10.1371/journal.pone.0129344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035592	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100071
J	Kilian, S; Asmal, L; Goosen, A; Chiliza, B; Phahladira, L; Emsley, R				Kilian, Sanja; Asmal, Laila; Goosen, Anneke; Chiliza, Bonginkosi; Phahladira, Lebogang; Emsley, Robin			Instruments Measuring Blunted Affect in Schizophrenia: A Systematic Review	PLOS ONE			English	Review							CLINICAL-ASSESSMENT INTERVIEW; NEGATIVE SYMPTOM ASSESSMENT; SYNDROME SCALE PANSS; FACIAL EXPRESSION; BRAIN ACTIVITY; RATING-SCALE; VALIDATION; EXPERIENCE; VALIDITY; EMOTION	Blunted affect, also referred to as emotional blunting, is a prominent symptom of schizophrenia. Patients with blunted affect have difficulty in expressing their emotions. The work of Abrams and Taylor and their development of the Rating Scale for Emotional Blunting in the late 1970's was an early indicator that blunted affect could indeed be assessed reliably. Since then, several new instruments assessing negative symptoms with subscales measuring blunted affect have been developed. In light of this, we aim to provide researchers and clinicians with a systematic review of the different instruments used to assess blunted affect by providing a comparison of the type, characteristics, administration and psychometric properties of these instruments. Studies reporting on the psychometric properties of instruments assessing blunted affect in patients with schizophrenia were included. Reviews and case studies were excluded. We reviewed 30 full-text articles and included 15 articles and 10 instruments in this systematic review. On average the instruments take 15-30 minutes to administer. We found that blunted affect items common across all instruments assess: gestures, facial expressions and vocal expressions. The CAINS Self-report Expression Subscale, had a low internal consistency score. This suggests that this sub-scale does not reliably assess patients' self-reported blunted affect symptoms and is likely due to the nature of blunted affect. Instruments correlated minimally with instruments measuring positive symptoms and more importantly with depression suggesting that the instruments distinguish between seemingly similar symptoms.	[Kilian, Sanja; Asmal, Laila; Goosen, Anneke; Chiliza, Bonginkosi; Phahladira, Lebogang; Emsley, Robin] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Psychiat, ZA-7505 Tygerberg, South Africa	Stellenbosch University	Kilian, S (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Psychiat, ZA-7505 Tygerberg, South Africa.	sanjakilian83@gmail.com	Chiliza, Bonga/AAD-6259-2019	Chiliza, Bonginkosi/0000-0001-5417-5920	Janssen; Lundbeck; AstraZeneca	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lundbeck(Lundbeck Corporation); AstraZeneca(AstraZeneca)	Robin Emsley has received honoraria from AstraZeneca, Bristol-Myers Squibb, Janssen, Lilly, Lundbeck, Organon, Pfizer, Servier, Otsuka and Wyeth for participating in advisory boards and speaking at educational meetings, and has received research funding from Janssen, Lundbeck and AstraZeneca. Bonginkosi Chiliza has received honoraria from Sandoz and Janssen for speaking at educational meetings. Sanja Kilian, Laila Asmal, Anneke Goosen, and Lebogang Phahladira report no conflicts of interest. The authors would like to note that even though two of the authors (RE and BC) have conflict of interests this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ABRAMS R, 1978, AM J PSYCHIAT, V135, P226; Aghevli MA, 2003, PSYCHIAT RES, V119, P261, DOI 10.1016/S0165-1781(03)00133-1; Alphs L, 2011, INT J METH PSYCH RES, V20, pE31, DOI 10.1002/mpr.339; Alvino C, 2007, J NEUROSCI METH, V163, P350, DOI 10.1016/j.jneumeth.2007.03.002; AXELROD BN, 1993, J PSYCHIAT RES, V27, P253, DOI 10.1016/0022-3956(93)90036-2; BERENBAUM SA, 1987, PSYCHIAT RES, V20, P57, DOI 10.1016/0165-1781(87)90123-5; BOERINGA JA, 1982, AM J PSYCHIAT, V139, P1131; Carlson KD, 2012, ORGAN RES METHODS, V15, P17, DOI 10.1177/1094428110392383; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DELEON J, 1993, J CLIN PSYCHIAT, V54, P103; Fahim C, 2005, PSYCHIAT RES-NEUROIM, V140, P1, DOI 10.1016/j.pscychresns.2005.06.003; GUR RE, 1991, AM J PSYCHIAT, V148, P472; Hamm J, 2014, SCHIZOPHR RES TREAT, V2014, DOI 10.1155/2014/243907; Henry JD, 2007, SCHIZOPHR RES, V95, P197, DOI 10.1016/j.schres.2007.06.002; Iancu I, 2005, COMPR PSYCHIAT, V46, P61, DOI 10.1016/j.comppsych.2004.07.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kirkpatrick B, 2014, SCHIZOPHRENIA BULL, V40, pS101, DOI 10.1093/schbul/sbt158; Kirkpatrick B, 2014, J CLIN PSYCHIAT, V75, P3, DOI [10.4088/JCP.13049su1c.01, 10.4088/JCP.13049tx3c]; Kirkpatrick B, 2011, SCHIZOPHRENIA BULL, V37, P300, DOI 10.1093/schbul/sbq059; Kring AM, 2013, AM J PSYCHIAT, V170, P165, DOI 10.1176/appi.ajp.2012.12010109; Lako IM, 2012, J AFFECT DISORDERS, V140, P38, DOI 10.1016/j.jad.2011.10.014; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Moller HJ, 2007, EUR PSYCHIAT, V22, P380, DOI 10.1016/j.eurpsy.2007.03.010; MUESER KT, 1994, AM J PSYCHIAT, V151, P1453; Muller M J, 2002, Eur J Health Econ, V3 Suppl 2, pS99, DOI 10.1007/s10198-002-0114-9; Myin-Germeys I, 2000, SCHIZOPHRENIA BULL, V26, P847, DOI 10.1093/oxfordjournals.schbul.a033499; Park SG, 2012, SCHIZOPHR RES, V135, P139, DOI 10.1016/j.schres.2011.12.007; PERALTA V, 1994, PSYCHIAT RES, V53, P31, DOI 10.1016/0165-1781(94)90093-0; POGUEGEILE MF, 1985, SCHIZOPHRENIA BULL, V11, P427, DOI 10.1093/schbul/11.3.427; Rabany L, 2011, SCHIZOPHR RES, V126, P226, DOI 10.1016/j.schres.2010.09.023; SELTEN JPCJ, 1993, COMPR PSYCHIAT, V34, P192, DOI 10.1016/0010-440X(93)90047-8; Stip E, 2005, PROG NEURO-PSYCHOPH, V29, P21, DOI 10.1016/j.pnpbp.2004.08.015; Strauss GP, 2012, SCHIZOPHR RES, V142, P88, DOI 10.1016/j.schres.2012.10.012; Sweet LH, 1998, PSYCHIAT RES, V81, P301, DOI 10.1016/S0165-1781(98)00121-8; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tremeau F, 2008, PSYCHIAT RES, V160, P346, DOI 10.1016/j.psychres.2007.06.021; Wang P, 2008, J NEUROSCI METH, V168, P224, DOI 10.1016/j.jneumeth.2007.09.030; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wolfaardt JB, 2003, INTRO PSYCHOL ASSESS, P34	39	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127740	10.1371/journal.pone.0127740	http://dx.doi.org/10.1371/journal.pone.0127740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26035179	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100020
J	Atkinson, L; Beitchman, J; Gonzalez, A; Young, A; Wilson, B; Escobar, M; Chisholm, V; Brownlie, E; Khoury, JE; Ludmer, J; Villani, V				Atkinson, Leslie; Beitchman, Joseph; Gonzalez, Andrea; Young, Arlene; Wilson, Beth; Escobar, Michael; Chisholm, Vivienne; Brownlie, Elizabeth; Khoury, Jennifer E.; Ludmer, Jaclyn; Villani, Vanessa			Cumulative Risk, Cumulative Outcome: A 20-Year Longitudinal Study	PLOS ONE			English	Article							14-YEAR FOLLOW-UP; SPEECH-LANGUAGE STABILITY; ALLOSTATIC LOAD; BEHAVIOR PROBLEMS; CONTROL CHILDREN; SERUM COTININE; MISSING DATA; RELIABILITY; ADJUSTMENT; DISORDERS	Cumulative risk (CR) models provide some of the most robust findings in the developmental literature, predicting numerous and varied outcomes. Typically, however, these outcomes are predicted one at a time, across different samples, using concurrent designs, longitudinal designs of short duration, or retrospective designs. We predicted that a single CR index, applied within a single sample, would prospectively predict diverse outcomes, i.e., depression, intelligence, school dropout, arrest, smoking, and physical disease from childhood to adulthood. Further, we predicted that number of risk factors would predict number of adverse outcomes (cumulative outcome; CO). We also predicted that early CR (assessed at age 5/6) explains variance in CO above and beyond that explained by subsequent risk (assessed at ages 12/13 and 19/20). The sample consisted of 284 individuals, 48% of whom were diagnosed with a speech/language disorder. Cumulative risk, assessed at 5/6-, 12/13-, and 19/20-years-old, predicted aforementioned outcomes at age 25/26 in every instance. Furthermore, number of risk factors was positively associated with number of negative outcomes. Finally, early risk accounted for variance beyond that explained by later risk in the prediction of CO. We discuss these findings in terms of five criteria posed by these data, positing a "mediated net of adversity" model, suggesting that CR may increase some central integrative factor, simultaneously augmenting risk across cognitive, quality of life, psychiatric and physical health outcomes.	[Atkinson, Leslie; Khoury, Jennifer E.; Ludmer, Jaclyn; Villani, Vanessa] Ryerson Univ, Toronto, ON, Canada; [Beitchman, Joseph; Brownlie, Elizabeth] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Beitchman, Joseph; Escobar, Michael; Brownlie, Elizabeth] Univ Toronto, Toronto, ON, Canada; [Gonzalez, Andrea] McMaster Univ, Hamilton, ON, Canada; [Young, Arlene] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Wilson, Beth] Social Planning Toronto, Toronto, ON, Canada; [Chisholm, Vivienne] Queen Margaret Univ, Edinburgh, Midlothian, Scotland	Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; McMaster University; University of Guelph; Queen Margaret University	Atkinson, L (corresponding author), Ryerson Univ, Toronto, ON, Canada.	atkinson@psych.ryerson.ca	Gonzalez, Andrea/G-4302-2017; Gonzalez, Andrea/HDM-9987-2022; González Ríos, Andrea/HGU-7618-2022	Atkinson, Leslie/0000-0003-1265-3298; Gonzalez, Andrea/0000-0003-0087-830X; Escobar, Michael/0000-0001-9055-4709	Canadian Institutes of Health Research [MOP 84421]; Social Sciences Research Council of Canada [430-20120432]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences Research Council of Canada	This work was funded by Canadian Institutes of Health Research, MOP 84421 (www.cihrirsc.gc.ca/e/193/html) to JB LA ME AY. Social Sciences Research Council of Canada, 430-20120432 (www.sshrc-crsh.gc.ca/home-accueil-eng.aspx) to LA JB AG.	ABELSON RP, 1985, PSYCHOL BULL, V97, P129, DOI 10.1037/0033-2909.97.1.129; Ackerman BP, 2004, DEV PSYCHOL, V40, P204, DOI 10.1037/0012-1649.40.2.204; Appleyard K, 2005, J CHILD PSYCHOL PSYC, V46, P235, DOI 10.1111/j.1469-7610.2004.00351.x; ATKINSON L, 1989, EDUC PSYCHOL MEAS, V49, P141, DOI 10.1177/0013164489491013; Atkinson L, 2012, PARENT-SCI PRACT, V12, P185, DOI 10.1080/15295192.2012.683356; Babinski LM, 2001, AGGRESSIVE BEHAV, V27, P44, DOI 10.1002/1098-2337(20010101/31)27:1<44::AID-AB4>3.0.CO;2-O; Bankson N. W, 1977, BANKSON LANGUAGE SCR; BAROCAS R, 1991, DEV PSYCHOL, V27, P479, DOI 10.1037/0012-1649.27.3.479; BEITCHMAN JH, 1986, J SPEECH HEAR DISORD, V51, P98, DOI 10.1044/jshd.5102.98; BEITCHMAN JH, 1986, J AM ACAD CHILD PSY, V25, P528, DOI 10.1016/S0002-7138(10)60013-1; Beitchman JH, 1996, J AM ACAD CHILD PSY, V35, P804, DOI 10.1097/00004583-199606000-00021; Beitchman JH, 1999, J CLIN CHILD PSYCHOL, V28, P312, DOI 10.1207/S15374424jccp280303; Beitchman JH, 2001, J AM ACAD CHILD PSY, V40, P75, DOI 10.1097/00004583-200101000-00019; BEITCHMAN JH, 1994, J AM ACAD CHILD PSY, V33, P1322, DOI 10.1097/00004583-199411000-00015; Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; BLANZ B, 1991, J CHILD PSYCHOL PSYC, V32, P939, DOI 10.1111/j.1469-7610.1991.tb01921.x; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; BRENER ND, 1995, AM J EPIDEMIOL, V141, P575, DOI 10.1093/oxfordjournals.aje.a117473; BUMPASS LL, 1978, DEMOGRAPHY, V15, P75, DOI 10.2307/2060491; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Canada S Division CO, 1981, 1981 CENSUS POPULATI; Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Carrow E, 1973, SCREENING TEST AUDIT; Cicchetti D, 2009, J CHILD PSYCHOL PSYC, V50, P16, DOI 10.1111/j.1469-7610.2008.01979.x; COIE JD, 1993, AM PSYCHOL, V48, P1013, DOI 10.1037/0003-066X.48.10.1013; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Deater-Deckard K, 1998, DEV PSYCHOPATHOL, V10, P469, DOI 10.1017/S0954579498001709; Dunn L.M., 2007, PEABODY PICTURE VOCA; Evans GW, 2007, DEV PSYCHOL, V43, P341, DOI 10.1037/0012-1649.43.2.341; Evans GW, 2013, PSYCHOL BULL, V139, P1342, DOI 10.1037/a0031808; Evans GW, 2003, DEV PSYCHOL, V39, P924, DOI 10.1037/0012-1649.39.5.924; Fergusson DM, 1996, J CHILD PSYCHOL PSYC, V37, P281, DOI 10.1111/j.1469-7610.1996.tb01405.x; FERGUSSON DM, 1995, J AM ACAD CHILD PSY, V34, P1308, DOI 10.1097/00004583-199510000-00016; Freier M, 1991, DO TEENS TELL TRUTH; Garbarino J, 1996, CHILD DEV, V67, P33, DOI 10.1111/j.1467-8624.1996.tb01717.x; Gest SD, 1999, DEV PSYCHOPATHOL, V11, P171, DOI 10.1017/S095457949900200X; Goldman R., 1974, GOLDMAN FRISTOE WOOD; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hammill DD, 1988, TEST LANGUAGE DEV IN; Hammill DD, 1994, TEST ADOLESCENT ADUL; Jack D.C., 1991, SILENCING SELF WOMEN; Johnson CJ, 1999, J SPEECH LANG HEAR R, V42, P744, DOI 10.1044/jslhr.4203.744; Johnson CJ, 1999, J SPEECH LANG HEAR R, V42, P761, DOI 10.1044/jslhr.4203.761; Kagan J., 1962, BIRTH MATURITY STUDY, DOI 10.1037/13129-000; Kroner D., 2007, PSYCHOL SERV, V4, P85, DOI DOI 10.1037/1541-1559.4.2.85; Larson K, 2008, PEDIATRICS, V121, P337, DOI 10.1542/peds.2007-0447; Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; LOCKE HJ, 1959, MARRIAGE FAM LIVING, V21, P251, DOI 10.2307/348022; Lundberg U., 1993, TIME PRESSURE STRESS, P41; LUSTER T, 1994, CHILD DEV, V65, P1080, DOI 10.2307/1131306; Martinez Gladys, 2012, Natl Health Stat Report, P1; Masten AS, 1998, AM PSYCHOL, V53, P205, DOI 10.1037/0003-066X.53.2.205; Masten AS., 1994, CHILD ADOLESCENT PSY, P191; McCartney K, 2000, CHILD DEV, V71, P173, DOI 10.1111/1467-8624.00131; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; NEWCOMB MD, 1986, AM J PUBLIC HEALTH, V76, P525, DOI 10.2105/AJPH.76.5.525; Newcomer PL, 1977, TEST OF LANGUAGE DEV; OLEARY KD, 1978, J CONSULT CLIN PSYCH, V46, P747, DOI 10.1037/0022-006X.46.4.747; Pendergast K, 1969, PHOTO ARTICULATION T; PEREZSTABLE EJ, 1995, PREV MED, V24, P171, DOI 10.1006/pmed.1995.1031; Pinquart M, 2013, ATTACH HUM DEV, V15, P189, DOI 10.1080/14616734.2013.746257; PRENTICE DA, 1992, PSYCHOL BULL, V112, P160, DOI 10.1037/0033-2909.112.1.160; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROSENTHAL R, 1982, J EDUC PSYCHOL, V74, P166, DOI 10.1037/0022-0663.74.2.166; RUTTER M, 1989, J AM ACAD CHILD PSY, V28, P633, DOI 10.1097/00004583-198909000-00001; Rutter M, 1977, ECOLOGICAL FACTORS H, P173; Rutter M., 1978, AGGRESSION ANTISOCIA, P95; SAMEROFF AJ, 1987, PEDIATRICS, V79, P343; SAMEROFF AJ, 1993, CHILD DEV, V64, P80, DOI 10.2307/1131438; Sameroff A, 2006, JACOBS FOUND SER ADO, P53, DOI 10.1017/CBO9780511616259.004; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schoon I, 2002, CHILD DEV, V73, P1486, DOI 10.1111/1467-8624.00485; SIMMONS RG, 1987, CHILD DEV, V58, P1220, DOI 10.2307/1130616; Snow P. C., 2004, ADV SPEECH LANGUAGE, V6, P221, DOI [10.1080/14417040400010132, DOI 10.1080/14417040400010132]; Snyder H, 2002, JUVENILE JUSTICE B; Tabachnick B. G., 2001, USING MULTIVARIATE S; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; TELLEGEN A, 1967, J CONSULT PSYCHOL, V31, P499, DOI 10.1037/h0024963; Thompson R.A., 2008, HDB ATTACHMENT THEOR, P348; Vida R, 2009, ADDICT BEHAV, V34, P800, DOI 10.1016/j.addbeh.2009.03.035; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; WILLIAMS S, 1990, J AM ACAD CHILD PSY, V29, P413, DOI 10.1097/00004583-199005000-00013; [No title captured]; [No title captured]; [No title captured]	88	55	55	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127650	10.1371/journal.pone.0127650	http://dx.doi.org/10.1371/journal.pone.0127650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030616	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900068
J	Dubay, S; Jacques, C; Golden, N; Kern, B; Mahoney, K; Norton, A; Patnayak, D; Van Deelen, T				Dubay, Shelli; Jacques, Christopher; Golden, Nigel; Kern, Bryant; Mahoney, Kathleen; Norton, Andrew; Patnayak, Devi; Van Deelen, Timothy			Environmental Factors Influencing White-Tailed Deer (Odocoileus virginianus) Exposure to Livestock Pathogens in Wisconsin	PLOS ONE			English	Article							BOVINE-VIRAL-DIARRHEA; SEROLOGIC SURVEY; ANTICOSTI ISLAND; VIRUS-INFECTION; SOUTH-DAKOTA; MULE DEER; NET-GUN; ANTIBODIES; MINNESOTA; PREVALENCE	White-tailed deer (Odocoileus virginianus) are commonly exposed to disease agents that affect livestock but environmental factors that predispose deer to exposure are unknown for many pathogens. We trapped deer during winter months on two study areas (Northern Forest and Eastern Farmland) in Wisconsin from 2010 to 2013. Deer were tested for exposure to six serovars of Leptospira interrogans (grippotyphosa, icterohaemorrhagiae, canicola, bratislava, pomona, and hardjo), bovine viral diarrhea virus (BVDV-1 and BVDV-2), infectious bovine rhinotracheitis virus (IBR), and parainfluenza 3 virus (PI3). We used logistic regression to model potential intrinsic (e.g., age, sex) and extrinsic (e.g., land type, study site, year, exposure to multiple pathogens) variables we considered biologically meaningful to exposure of deer to livestock pathogens. Deer sampled in 2010-2011 did not demonstrate exposure to BVDV, so we did not test for BVDV in subsequent years. Deer had evidence of exposure to PI3 (24.7%), IBR (7.9%), Leptospira interrogans serovar pomona (11.7%), L. i. bratislava (1.0%), L. i. grippotyphosa (2.5%) and L. i. hardjo (0.3%). Deer did not demonstrate exposure to Leptospira interrogans serovars canicola and icterohaemorrhagiae. For PI3, we found that capture site and year influenced exposure. Fawns (n = 119) were not exposed to L. i. pomona, but land type was an important predictor of exposure to L. i. pomona for older deer. Our results serve as baseline exposure levels of Wisconsin white-tailed deer to livestock pathogens, and helped to identify important factors that explain deer exposure to livestock pathogens.	[Dubay, Shelli; Golden, Nigel; Kern, Bryant] Univ Wisconsin, Coll Nat Resources, Stevens Point, WI 54481 USA; [Jacques, Christopher] Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA; [Mahoney, Kathleen] Florida Fish & Wildlife Conservat Commiss, Holt, FL USA; [Norton, Andrew; Van Deelen, Timothy] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Patnayak, Devi] Univ Minnesota, Vet Diagnost Lab, St Paul, MN 55108 USA	University of Wisconsin System; University of Wisconsin Stevens Point; Western Illinois University; Florida Fish & Wildlife Conservation Commission; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Dubay, S (corresponding author), Univ Wisconsin, Coll Nat Resources, Stevens Point, WI 54481 USA.	sdubay@uwsp.edu		Golden, Nigel/0000-0001-8154-3880	Consortium for Extension and Research in Agriculture and Natural Resources at University of Wisconsin-Madison	Consortium for Extension and Research in Agriculture and Natural Resources at University of Wisconsin-Madison	The work was supported by Consortium for Extension and Research in Agriculture and Natural Resources at University of Wisconsin-Madison: http://research.cals.wisc.edu/funding-opportunities/cals/uw-consortium-for-extension-and-research-in-agricultureand-natural-resources-ceranr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE AA, 1995, PREV VET MED, V21, P313, DOI 10.1016/0167-5877(94)00386-W; BARRETT M W, 1975, Journal of Wildlife Diseases, V11, P157; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cantu A, 2008, J WILDLIFE DIS, V44, P1002, DOI 10.7589/0090-3558-44.4.1002; Castro Anthony E., 2001, P175; Chase CCL, 2008, J WILDLIFE DIS, V44, P753, DOI 10.7589/0090-3558-44.3.753; CIRONE SM, 1978, J WILDLIFE DIS, V14, P193, DOI 10.7589/0090-3558-14.2.193; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Demarais S., 2000, ECOLOGY MANAGEMENT L, P601; Dubay SA, 2006, J WILDLIFE DIS, V42, P844, DOI 10.7589/0090-3558-42.4.844; FOURNIER JS, 1986, J WILDLIFE DIS, V22, P335, DOI 10.7589/0090-3558-22.3.335; Freund R, 2003, STAT METHODS; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; GOYAL SM, 1992, J WILDLIFE DIS, V28, P445, DOI 10.7589/0090-3558-28.3.445; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Grzybowski M, 1997, ACAD EMERG MED, V4, P818, DOI 10.1111/j.1553-2712.1997.tb03793.x; HOSKINSON RL, 1976, J WILDLIFE MANAGE, V40, P429, DOI 10.2307/3799944; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; INGEBRIGTSEN DK, 1986, J WILDLIFE DIS, V22, P83, DOI 10.7589/0090-3558-22.1.83; Jacques CN, 2011, J WILDLIFE MANAGE, V75, P221, DOI 10.1002/jwmg.23; Jacques CN, 2009, J WILDLIFE MANAGE, V73, P1282, DOI 10.2193/2009-039; Jacques CN, JWILDL DIS IN PRESS; Kreeger TJ, 2002, HDB WILDLIFE CHEM IM; LAMONTAGNE L, 1989, J WILDLIFE DIS, V25, P202, DOI 10.7589/0090-3558-25.2.202; Leighton Frederick A., 2001, P498; Myers WL, 2015, J WILDLIFE DIS, V51, P125, DOI 10.7589/2014-05-119; National Agricultural Statistics Service, QUICK STATS; Passler T, 2008, J VET DIAGN INVEST, V20, P79, DOI 10.1177/104063870802000116; Passler T, 2009, VET MICROBIOL, V134, P362, DOI 10.1016/j.vetmic.2008.08.012; PELLERIN C, 1994, VIROLOGY, V203, P260, DOI 10.1006/viro.1994.1483; RAMSEY CW, 1968, J WILDLIFE MANAGE, V32, P187, DOI 10.2307/3798257; Richards SH, 1981, DIS PARASITES WHITE, V7, P108; Rolley R. E., 2013, WHITE TAILED DEER PO; Rongstad O.J., 1984, P655; Roug A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050600; SADI L, 1991, J WILDLIFE DIS, V27, P569, DOI 10.7589/0090-3558-27.4.569; Shah KV, 1965, J WILDLIFE DIS, V1, P31; Smith RH, 1976, W78R AR GAM FISH; STAUBER EH, 1977, J WILDLIFE MANAGE, V41, P515, DOI 10.2307/3800525; Tate CM, 2005, J WILDLIFE DIS, V41, P241, DOI 10.7589/0090-3558-41.1.241; TRAINER DANIEL O., 1960, JOUR WILDLIFE MANAGEMENT, V24, P44, DOI 10.2307/3797355; TRAINER DO, 1961, J INFECT DIS, V108, P278, DOI 10.1093/infdis/108.3.278; Van Campen Hana, 2001, P271, DOI 10.1002/9780470344880.ch15; Van Campen Hana, 2001, P232, DOI 10.1002/9780470344880.ch12; Webb SL, 2008, J WILDLIFE MANAGE, V72, P310, DOI 10.2193/2007-101; Willging R. C., 2008, HUNT HIST DEER HUNTI; WILLIAMS ES, 2001, INFECT DIS WILD ANIM; Wisconsin Department of Natural Resources, 2001, MAN WORKB WHIT TAIL; Wisconsin Department of Natural Resources [WDNR], WISC DEER MAN PROGR; Wobeser G.A, 2006, ESSENTIALS DIS WILD; Wolf KN, 2008, J WILDLIFE DIS, V44, P181, DOI 10.7589/0090-3558-44.1.181	51	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128827	10.1371/journal.pone.0128827	http://dx.doi.org/10.1371/journal.pone.0128827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030150	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900193
J	Li, QL; Fu, ZT; Yuan, NM				Li, Qinglei; Fu, Zuntao; Yuan, Naiming			Beyond Benford's Law: Distinguishing Noise from Chaos	PLOS ONE			English	Article							EXPONENTIAL DECAY; POWER SPECTRA; FORGETS; SYSTEMS; NUMBERS	Determinism and randomness are two inherent aspects of all physical processes. Time series from chaotic systems share several features identical with those generated from stochastic processes, which makes them almost undistinguishable. In this paper, a new method based on Benford's law is designed in order to distinguish noise from chaos by only information from the first digit of considered series. By applying this method to discrete data, we confirm that chaotic data indeed can be distinguished from noise data, quantitatively and clearly.	[Li, Qinglei; Fu, Zuntao; Yuan, Naiming] Peking Univ, Sch Phys, Dept Atmospher & Ocean Sci, Lab Climate & Ocean Atmosphere Studies, Beijing 100871, Peoples R China; [Yuan, Naiming] Univ Giessen, Dept Geog Climatol Climate Dynam & Climate Change, D-35390 Giessen, Germany	Peking University; Justus Liebig University Giessen	Fu, ZT (corresponding author), Peking Univ, Sch Phys, Dept Atmospher & Ocean Sci, Lab Climate & Ocean Atmosphere Studies, Beijing 100871, Peoples R China.	fuzt@pku.edu.cn; naimingyuan@hotmail.com			National Science Foundation of China [41175141, 41475048]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China under grant no. 41175141, and 41475048. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alili A, 2005, STOCH MODELS, V21, P967, DOI 10.1080/15326340500294702; Alves AD, 2014, SCIENTOMETRICS, V98, P173, DOI 10.1007/s11192-013-1030-8; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Berger A, 2011, PROBAB SURV, V8, P1, DOI 10.1214/11-PS175; Berger A, 2011, MATH INTELL, V33, P85, DOI 10.1007/s00283-010-9182-3; Binder PM, 2014, NATURE, V510, P343, DOI 10.1038/510343a; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; Gao JB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066204; Gillespie DT, 1996, PHYS REV E, V54, P2084, DOI 10.1103/PhysRevE.54.2084; Ravetti MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108004; Goudsmit SA, 1944, NATURE, V154, P800, DOI 10.1038/154800a0; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; HILL TP, 1995, P AM MATH SOC, V123, P887, DOI 10.2307/2160815; Hill TP, 1998, AM SCI, V86, P358, DOI 10.1511/1998.4.358; HILL TP, 1995, AM MATH MON, V102, P322, DOI 10.2307/2974952; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; James RG, 2014, PHYS LETT A, V378, P2124, DOI 10.1016/j.physleta.2014.05.014; Kowalski AM, 2011, ENTROPY-SWITZ, V13, P1055, DOI 10.3390/e13061055; Lacasa L, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036120; Makse HA, 1996, PHYS REV E, V53, P5445, DOI 10.1103/PhysRevE.53.5445; Mebane Walter R., 2004, PERSPECTIVES POLITIC, V2, P525; NAMAJUNAS A, 1995, PHYS LETT A, V204, P255, DOI 10.1016/0375-9601(95)00480-Q; Newcomb S., 1881, AM J MATH, V4, P39, DOI [10.2307/2369148, DOI 10.2307/2369148]; Nigrini MJ, 2007, MATH GEOL, V39, P469, DOI 10.1007/s11004-007-9109-5; Nigrini MJ, 2009, AUDITING-J PRACT TH, V28, P305, DOI 10.2308/aud.2009.28.2.305; Osprey SM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048181; Pace DC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.085001; Pietronero L, 2001, PHYSICA A, V293, P297, DOI 10.1016/S0378-4371(00)00633-6; Ramdani S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036204; RICCIARDI LM, 1988, J APPL PROBAB, V25, P43, DOI 10.2307/3214232; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; Rosso OA, 2013, EUR PHYS J B, V86, DOI [10.1140/epjb/e2013-30764-5, 10.1140/epjb/e2012-30307-8]; Sambridge M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044830; Sen A, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/50008; Shahverdiev EM, 2006, CHAOS SOLITON FRACT, V29, P854, DOI 10.1016/j.chaos.2005.08.128; SIGETI DE, 1995, PHYSICA D, V82, P136, DOI 10.1016/0167-2789(94)00225-F; SIGETI DE, 1995, PHYS REV E, V52, P2443, DOI 10.1103/PhysRevE.52.2443; Sprott JC, 2012, COMPLEX SYSTEMS, V21, P193; Tolle CR, 2000, CHAOS, V10, P331, DOI 10.1063/1.166498; TSONIS AA, 1992, NATURE, V358, P217, DOI 10.1038/358217a0; Vannitsem S, 2011, NONLINEAR PROC GEOPH, V18, P911, DOI 10.5194/npg-18-911-2011; Wood ATA, 1994, J COMPUT GRAPHICAL S, V3, P409, DOI [DOI 10.2307/1390903, DOI 10.1080/10618600.1994.10474655]; WOOTTERS WK, 1981, PHYS REV D, V23, P357, DOI 10.1103/PhysRevD.23.357; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701; Zunino L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021115; Zunino L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046210	50	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129161	10.1371/journal.pone.0129161	http://dx.doi.org/10.1371/journal.pone.0129161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030809	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900213
J	Mathew, S; Fatima, K; Fatmi, MQ; Archunan, G; Ilyas, M; Begum, N; Azhar, E; Damanhouri, G; Qadri, I				Mathew, Shilu; Fatima, Kaneez; Fatmi, M. Qaiser; Archunan, Govindaraju; Ilyas, Muhammad; Begum, Nargis; Azhar, Esam; Damanhouri, Ghazi; Qadri, Ishtiaq			Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; IMINOSUGAR DERIVATIVES; PROTEIN; INFECTION; SEQUENCE; INHIBITION; ACTIVATION; QUERCETIN; MECHANISM; DOMAIN	Background The current standard care therapy for hepatitis C virus (HCV) infection consists of two regimes, namely interferon-based and interferon-free treatments. The treatment through the combination of ribavirin and pegylated interferon is expensive, only mildly effective, and is associated with severe side effects. In 2011, two direct-acting antiviral (DAA) drugs, boceprevir and telaprevir, were licensed that have shown enhanced sustained virologic response (SVR) in phase III clinical trial, however, these interferon-free treatments are more sensitive to HCV genotype 1 infection. The variable nature of HCV, and the limited number of inhibitors developed thus aim in expanding the repertoire of available drug targets, resulting in targeting the virus assembly therapeutically. Aim We conducted this study to predict the 3D structure of the p7 protein from the HCV genotypes 3 and 4. Approximately 63 amino acid residues encoded in HCV render this channel sensitive to inhibitors, making p7 a promising target for novel therapies. HCV p7 protein forms a small membrane known as viroporin, and is essential for effective self-assembly of large channels that conduct cation assembly and discharge infectious virion particles. Method In this study, we screened drugs and flavonoids known to disrupt translation and production of HCV proteins, targeted against the active site of p7 residues of HCV genotype 3 (GT3) (isolatek3a) and HCV genotype 4a (GT4) (isolateED43). Furthermore, we conducted a quantitative structure-activity relationship and docking interaction study. Results The drug NB-DNJ formed the highest number of hydrogen bond interactions with both modeled p7 proteins with high interaction energy, followed by BIT225. A flavonoid screen demonstrated that Epigallocatechin gallate (EGCG), nobiletin, and quercetin, have more binding modes in GT3 than in GT4. Thus, the predicted p7 protein molecule of HCV from GT3 and GT4 provides a general avenue to target structure-based antiviral compounds. Conclusions We hypothesize that the inhibitors of viral p7 identified in this screen may be a new class of potent agents, but further confirmation in vitro and in vivo is essential. This structure-guided drug design for both GT3 and GT4 can lead to the identification of drug-like natural compounds, confirming p7 as a new target in the rapidly increasing era of HCV.	[Mathew, Shilu; Begum, Nargis] Jamal Mohamed Coll, Dept Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Mathew, Shilu] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia; [Mathew, Shilu; Archunan, Govindaraju] Bharathidasan Univ, Dept Anim Sci, Tiruchirappalli, Tamil Nadu, India; [Fatima, Kaneez] IQ Inst Infect & Immun, Lahore, Punjab, Pakistan; [Fatmi, M. Qaiser] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Ilyas, Muhammad] Jamal Mohamed Coll, Dept Bot, Tiruchirappalli, Tamil Nadu, India; [Azhar, Esam; Damanhouri, Ghazi; Qadri, Ishtiaq] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia	Jamal Mohamed College; King Abdulaziz University; Bharathidasan University; COMSATS University Islamabad (CUI); Jamal Mohamed College; King Abdulaziz University	Qadri, I (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	ishtiaq80262@yahoo.com	Qadri, Ishtiaq/I-6889-2013; Azhar, Esam/ABI-1044-2020; Damanhouri, Ghazi/Q-7901-2019; GOVINDARAJU, ARCHUNAN/A-9072-2019	GOVINDARAJU, ARCHUNAN/0000-0002-7094-0351; Azhar, Esam/0000-0002-1736-181X; Qadri, Ishtiaq/0000-0003-4334-0585	King Abdulaziz City for Science and Technology, (KACST) [162-34]	King Abdulaziz City for Science and Technology, (KACST)	Financial support of this work was provided by the King Abdulaziz City for Science and Technology, (KACST)-Large grant 162-34, to Ishtiaq Qadri.	[Anonymous], 1999, COMPUT CHEM, P23341; [Anonymous], 2000, CURR PROTEIN PEPT SC, V1, P816; [Anonymous], 2002, COMPUT CHEM, V26, P459; [Anonymous], 1988, BIOCH BIOPHYS ACTA; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Apweiler R B Aa, 1999, NUCLEIC ACIDS RES, P2749; Aslam S, 2021, PREVENTION TRANSMISS; Atoom AM, 2014, VIROLOGY, V462, P377, DOI 10.1016/j.virol.2014.04.018; Bachmetov L, 2012, J VIRAL HEPATITIS, V19, pE81, DOI 10.1111/j.1365-2893.2011.01507.x; Bichmann L, 2014, COMPUT BIOL CHEM, V53, P308, DOI 10.1016/j.compbiolchem.2014.11.001; Calland N, 2012, HEPATOLOGY, P55720; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Chamberlain RW, 1997, J GEN VIROL, V78, P1341, DOI 10.1099/0022-1317-78-6-1341; Cheng ZGR, 2006, NAT STRUCT BIOL, P13930; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Communie G, 2013, J VIROL, V87, P7166, DOI 10.1128/JVI.00487-13; Conteduca V, 2014, J INFECTION, V68, P1, DOI 10.1016/j.jinf.2013.08.019; Cooper C, 2013, QJM-INT J MED, V106, P153, DOI 10.1093/qjmed/hcs214; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Durantel D, 2001, J VIROL, V75, P8987, DOI 10.1128/JVI.75.19.8987-8998.2001; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177; Fields BN, 1996, M H HEPATITIS C VIRU; Fink A, 2012, BIOCHIM BIOPHYS ACTA; Gabriel A, 2013, BIOCHEMISTRY-US, V52, DOI [10.1021/bi4005655, DOI 10.1021/BI4005655]; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Goldwasser J C P, 2011, J HEPATOL, P55963; Gonzalez O, 2009, HEPATOLOGY, V50, P1756, DOI 10.1002/hep.23232; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Griffin S S C, 2008, HEPATOLOGY; Griffin SD, 2004, J GEN VIROL, P85451; Griffin SD, 2003, FEBS LETT, P53534; Haid S N A, 2012, GASTROENTEROLOGY; Hegde VR, 2003, BIOORG MED CHEM LETT; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hessa TKH, 2005, NAT STRUCT BIOL; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21; Hsu H-J, 2011, J MOL MODEL, P18501; Johnson AE, 1999, ANNU REV CELL DEV BI, P15799; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Kruger JFW, 2009, J CHEM THEORY COMPUT, P52503; Lan KH, 2012, LIVER INT, V32, P989, DOI 10.1111/j.1478-3231.2011.02621.x; Laskowski R A, 1993, J APP CRYST, P26283; Lemaitre V A R, 2004, FEBS LETT, P56375; Liu MM, 2012, EUR J MED CHEM, P5233; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Luscombe CA, 2010, ANTIVIR RES, P86144; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Manns MP, 2006, GUT; Mondelli MU, 1999, J HEPATOL, V31, P65, DOI 10.1016/S0168-8278(99)80377-8; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; Mould JA, 2000, J BIOL CHEM, V275, P31038, DOI 10.1074/jbc.M003663200; Nahmias Y G J, 2008, HEPATOLOGY; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Patargias G, 2006, J MED CHEM, V49, P648, DOI 10.1021/jm050721e; Pavlovic D, 2003, P NATL ACAD SCI USA; Pawlotsky JM, 2007, GASTROENTEROLOGY; Pawlotsky SCaJM, 2006, HCV GENOME LIFE CYCL; Pielak RM, 2009, P NATL ACAD SCI USA; PINTO LH, 1995, TRENDS MICROBIOL, V3, P271, DOI 10.1016/S0966-842X(00)88942-8; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; Polyak SJ, 2007, GASTROENTEROLOGY, V132, P1925, DOI 10.1053/j.gastro.2007.02.038; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Prabal K, 2004, NUCLEIC ACIDS RES, V32, P6047; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Rapoport TA, 2004, TRENDS CELL BIOL, P14568; Rosenberg MR, 2010, P NATL ACAD SCI USA, V107, P13866, DOI 10.1073/pnas.1002051107; Sakai A C M, 2003, P NATL ACAD SCI USA; Saldanha JW, 2002, PROTEIN PEPTIDE LETT, V9, P495, DOI 10.2174/0929866023408418; Schnell JR C J, 2008, NATURE; Seeff LB, 2002, HEPATOLOGY, V36, pS35; Shimbo K, 1996, BIOPHYS J, V70, P1335, DOI 10.1016/S0006-3495(96)79690-X; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Smith JP, 1997, DIGEST DIS SCI, V42, P1681, DOI 10.1023/A:1018857314351; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; Suzuki M, 2005, AM J CHINESE MED, V33, P87, DOI 10.1142/S0192415X05002680; Tedbury P, 2011, J GEN VIROL, V92, P819, DOI 10.1099/vir.0.027441-0; Toshana L, 2013, VIRAL HEPATITIS, V59; TOSTESON MT, 1994, J MEMBRANE BIOL, V142, P117; van Soest H, 2010, DIGEST LIVER DIS, V42, P496, DOI 10.1016/j.dld.2009.10.006; Vieyres G, 2013, J VIROL, V87, P1664, DOI 10.1128/JVI.02782-12; Von Wagner M H W, 2008, HEPATOLOGY; Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587; WANG Y, 2013, PLOS ONE, V2013; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; YAMADA N, 1994, J GEN VIROL, V75, P3279, DOI 10.1099/0022-1317-75-11-3279; Zhang H, 2012, INT J MOL SCI, V13, P11210, DOI 10.3390/ijms130911210	91	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126510	10.1371/journal.pone.0126510	http://dx.doi.org/10.1371/journal.pone.0126510			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030803	Green Published, Green Submitted			2022-12-27	WOS:000356630900029
J	Tatematsu, T; Kimura, M; Nakashima, M; Machida, J; Yamaguchi, S; Shibata, A; Goto, H; Nakayama, A; Higashi, Y; Miyachi, H; Shimozato, K; Matsumoto, N; Tokita, Y				Tatematsu, Tadashi; Kimura, Masashi; Nakashima, Mitsuko; Machida, Junichiro; Yamaguchi, Seishi; Shibata, Akio; Goto, Hiroki; Nakayama, Atsuo; Higashi, Yujiro; Miyachi, Hitoshi; Shimozato, Kazuo; Matsumoto, Naomichi; Tokita, Yoshihito			An Aberrant Splice Acceptor Site Due to a Novel Intronic Nucleotide Substitution in MSX1 Gene Is the Cause of Congenital Tooth Agenesis in a Japanese Family	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT OLIGODONTIA; MISSENSE MUTATION; NONSENSE MUTATION; ISOLATED HYPODONTIA; CHINESE FAMILY; PAX9; SEQUENCE; AXIN2; POLYMORPHISMS; HUMANS	Congenital tooth agenesis is caused by mutations in the MSX1, PAX9, WNT10A, or AXIN2 genes. Here, we report a Japanese family with nonsyndromic tooth agenesis caused by a novel nucleotide substitution in the intronic region between exons 1 and 2 of the MSX1 gene. Because the mutation is located 9 bp before exon 2 (c.452-9G>A), we speculated that the nucleotide substitution would generate an abnormal splice site. Using cDNA analysis of an immortalized patient blood cell, we confirmed that an additional 7-nucleotide sequence was inserted at the splice junction between exons 1 and 2 (c.451_452insCCCTCAG). The consequent frameshift generated a homeodomain-truncated MSX1 (p.R151fsX20). We then studied the subcellular localization of truncated MSX1 protein in COS cells, and observed that it had a whole cell distribution more than a nuclear localization, compared to that of wild-type protein. This result suggests a deletion of the nuclear localization signal, which is mapped to the MSX1 homeodomain. These results indicate that this novel intronic nucleotide substitution is the cause of tooth agenesis in this family. To date, most MSX1 variants isolated from patients with tooth agenesis involve single amino acid substitutions in the highly conserved homeodomain or deletion mutants caused by frameshift or nonsense mutations. We here report a rare case of an intronic mutation of the MSX1 gene responsible for human tooth agenesis. In addition, the missing tooth patterns were slightly but significantly different between an affected monozygotic twin pair of this family, showing that epigenetic or environmental factors also affect the phenotypic variations of missing teeth among patients with nonsyndromic tooth agenesis caused by an MSX1 haploinsufficiency.	[Tatematsu, Tadashi; Kimura, Masashi; Machida, Junichiro; Yamaguchi, Seishi; Shibata, Akio; Goto, Hiroki; Miyachi, Hitoshi; Shimozato, Kazuo] Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, Nagoya, Aichi 464, Japan; [Kimura, Masashi] Ogaki Municipal Hosp, Dept Dent Oral & Maxillofacial Surg, Ogaki, Gifu, Japan; [Nakashima, Mitsuko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Machida, Junichiro] Toyota Mem Hosp, Dept Oral & Maxillofacial Surg, Toyota, Aichi, Japan; [Yamaguchi, Seishi] Aichi Childrens Hlth & Med Ctr, Dept Dent & Oral Surg, Obu, Aichi, Japan; [Nakayama, Atsuo] Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi, Japan; [Tatematsu, Tadashi; Kimura, Masashi; Shibata, Akio; Goto, Hiroki; Higashi, Yujiro; Tokita, Yoshihito] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi, Japan	Aichi Gakuin University; Ogaki Municipal Hospital; Yokohama City University	Tokita, Y (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi, Japan.	tokita@inst-hsc.jp			Yokohama City University; Aichi-Gakuin 253 University; Institute for Developmental Research	Yokohama City University; Aichi-Gakuin 253 University; Institute for Developmental Research	This work was supported by grants from Yokohama City University, Aichi-Gakuin 253 University, and the Institute for Developmental Research.	Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Chishti MS, 2006, J HUM GENET, V51, P872, DOI 10.1007/s10038-006-0037-x; De Muynck S, 2004, AM J MED GENET A, V128A, P401, DOI 10.1002/ajmg.a.30181; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Kamamoto M, 2011, EUR J HUM GENET, V19, P844, DOI 10.1038/ejhg.2011.47; Kantaputra P, 2011, AM J MED GENET A, V155A, P1119, DOI 10.1002/ajmg.a.33840; Kim JW, 2006, J DENT RES, V85, P267, DOI 10.1177/154405910608500312; Kimura Masashi, 2014, Hum Genome Var, V1, P14005, DOI 10.1038/hgv.2014.5; Kimura M, 2014, EUR J ORAL SCI, V122, P15, DOI 10.1111/eos.12105; Kobielak A, 2001, FOLIA HISTOCHEM CYTO, V39, P113; Li Wu-li, 2008, Zhonghua Kou Qiang Yi Xue Za Zhi, V43, P157; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Machida J, 2015, CLIN GENET, V88, P167, DOI 10.1111/cge.12456; Modesto A, 2006, J DENT RES, V85, P542, DOI 10.1177/154405910608500612; Mostowska A, 2006, J APPL GENETICS, V47, P159, DOI 10.1007/BF03194616; Mostowska A, 2006, J HUM GENET, V51, P262, DOI 10.1007/s10038-005-0353-6; Mostowska A, 2012, ARCH ORAL BIOL, V57, P790, DOI 10.1016/j.archoralbio.2012.01.003; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Pawlowska E, 2009, TOHOKU J EXP MED, V217, P307, DOI 10.1620/tjem.217.307; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Tokita Y, 2001, J NEUROSCI, V21, P1257; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vieira AR, 2004, J DENT RES, V83, P723, DOI 10.1177/154405910408300913; Wang J, 2011, ARCH ORAL BIOL, V56, P1027, DOI 10.1016/j.archoralbio.2011.03.023; Wong SW, 2014, MUTAGENESIS, V29, P319, DOI 10.1093/mutage/geu019; Xuan K, 2008, ARCH ORAL BIOL, V53, P773, DOI 10.1016/j.archoralbio.2008.02.012; Yamaguchi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102944	30	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128227	10.1371/journal.pone.0128227	http://dx.doi.org/10.1371/journal.pone.0128227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030286	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900130
J	Deng, RZ; Hua, X; Li, J; Chi, W; Zhang, ZD; Lu, F; Zhang, LL; Pflugfelder, SC; Li, DQ				Deng, Ruzhi; Hua, Xia; Li, Jin; Chi, Wei; Zhang, Zongduan; Lu, Fan; Zhang, Lili; Pflugfelder, Stephen C.; Li, De-Quan			Oxidative Stress Markers Induced by Hyperosmolarity in Primary Human Corneal Epithelial Cells	PLOS ONE			English	Article							REACTIVE OXYGEN; OCULAR SURFACE; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; REDOX REGULATION; DNA; EXPRESSION; ACTIVATION; INDUCTION; ACONITASE	Oxidative stress has been known to be involved in pathogenesis of dry eye disease. However, few studies have comprehensively investigated the relationship between hyperosmolarity and oxidative damage in human ocular surface. This study was to explore whether and how hyperosmolarity induces oxidative stress markers in primary human corneal epithelial cells (HCECs). Primary HCECs were established from donor limbal explants. The hyperosmolarity model was made in HCECs cultured in isosmolar (312 mOsM) or hyperosmotic (350, 400, 450 mOsM) media. Production of reactive oxygen species (ROS), oxidative damage markers, oxygenases and anti-oxidative enzymes were analyzed by DCFDA kit, RT-qPCR, immunofluorescent and immunohistochemical staining and Western blotting. Compared to isosmolar medium, ROS production significantly increased at time-and osmolarity-dependent manner in HCECs exposed to media with increasing osmolarities (350450 mOsM). Hyperosmolarity significantly induced oxidative damage markers in cell membrane with increased toxic products of lipid peroxidation, 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA), and in nuclear and mitochondria DNA with increased aconitase-2 and 8-OHdG. Hyperosmotic stress also increased the mRNA expression and protein production of heme oxygenase-1 (HMOX1) and cyclooxygenase-2 (COX2), but reduced the levels of antioxidant enzymes, superoxide dismutase-1 (SOD1), and glutathione peroxidase-1 (GPX1). In conclusion, our comprehensive findings demonstrate that hyperosmolarity induces oxidative stress in HCECs by stimulating ROS production and disrupting the balance of oxygenases and antioxidant enzymes, which in turn cause cell damage with increased oxidative markers in membrane lipid peroxidation and mitochondrial DNA damage.	[Deng, Ruzhi; Hua, Xia; Li, Jin; Zhang, Zongduan; Lu, Fan] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China; [Deng, Ruzhi; Li, Jin; Chi, Wei; Zhang, Zongduan; Zhang, Lili; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Ocular Surface Ctr, Cullen Eye Inst, Dept Ophthalmol, Houston, TX 77030 USA; [Hua, Xia] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Clin Coll Ophthalmol, Tianjin, Peoples R China	Wenzhou Medical University; Baylor College of Medicine; Tianjin Medical University	Lu, F (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China.	lufan@mail.eye.ac.cn; dequanl@bcm.edu			NIH [R01EY023598, EY011915, EY002520]; Allergan Inc.; Eye Bank Association of America; Lions Foundation for Sight, Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE [R01EY023598, R01EY011915, P30EY002520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan Inc.(AbbVieAllergan); Eye Bank Association of America; Lions Foundation for Sight, Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH NEI Grants R01EY023598 (DQL), EY011915 (SCP) and Core Grant for Vision Research EY002520, Allergan Inc., Eye Bank Association of America (DQL), Lions Foundation for Sight, Research to Prevent Blindness, Oshman Foundation, and William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AS, 2014, EXP EYE RES, V120, P1, DOI 10.1016/j.exer.2013.12.014; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Bao F, 2004, J NEUROCHEM, V90, P1194, DOI 10.1111/j.1471-4159.2004.02580.x; Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003; Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Boyle JJ, 2012, CURR OPIN LIPIDOL, V23, P453, DOI 10.1097/MOL.0b013e328356b145; BRAMBILLA G, 1986, MUTAT RES, V171, P169, DOI 10.1016/0165-1218(86)90051-0; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Cejkova J, 2009, HISTOL HISTOPATHOL, V24, P1357, DOI 10.14670/HH-24.1357; Chang YC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00191; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen YH, 2014, J CLIN NEUROL, V10, P84, DOI 10.3988/jcn.2014.10.2.84; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Delanty N, 1998, ACTA NEUROL SCAND, V98, P145, DOI 10.1111/j.1600-0404.1998.tb07285.x; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Dong QY, 2008, EUR J OPHTHALMOL, V18, P94, DOI 10.1177/112067210801800116; ECKL PM, 1993, MUTAT RES, V290, P183, DOI 10.1016/0027-5107(93)90158-C; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Gronert K, 2010, EXP EYE RES, V91, P478, DOI 10.1016/j.exer.2010.07.004; Higuchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045612; Julio G, 2012, OPHTHAL PHYSL OPT, V32, P317, DOI 10.1111/j.1475-1313.2012.00915.x; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kim SJ, 2014, J BIOL CHEM, V289, P6165, DOI 10.1074/jbc.M113.515130; Kleiveland CR, 2008, EXP CELL RES, V314, P1831, DOI 10.1016/j.yexcr.2008.02.004; Lee SH, 2005, J BIOL CHEM, V280, P28337, DOI 10.1074/jbc.M504178200; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Li DQ, 2004, INVEST OPHTH VIS SCI, V45, P4302, DOI 10.1167/iovs.04-0299; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Ma P, 2009, INVEST OPHTH VIS SCI, V50, P2702, DOI 10.1167/iovs.08-3074; Madrigal Jose L. M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P561; Marczynski B, 2000, MUTAT RES-GEN TOX EN, V468, P195, DOI 10.1016/S1383-5718(00)00053-X; Maynard S, 2013, AGING-US, V5, P850, DOI 10.18632/aging.100618; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Pan Z, 2011, INVEST OPHTH VIS SCI, V52, P485, DOI 10.1167/iovs.10-5801; Patel PR, 2007, FREE RADICAL BIO MED, V42, P552, DOI 10.1016/j.freeradbiomed.2006.11.025; Pescosolido N, 2008, DRUGS R&D, V9, P3, DOI 10.2165/0126839-200809001-00002; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; Polidori MC, 2001, FREE RADICAL BIO MED, V30, P456, DOI 10.1016/S0891-5849(00)00345-2; Raukas M, 2012, FREE RADICAL RES, V46, P1490, DOI 10.3109/10715762.2012.728286; Shah AA, 2013, EUR J DERMATOL, V23, P5, DOI 10.1684/ejd.2012.1884; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Tyrrell R, 1999, FREE RADICAL RES, V31, P335, DOI 10.1080/10715769900300901; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uchino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045805; Uchino Yuichi, 2012, Cornea, V31 Suppl 1, pS63, DOI 10.1097/ICO.0b013e31826a5de1; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wakamatsu TH, 2013, INVEST OPHTH VIS SCI, V54, P201, DOI 10.1167/iovs.12-10325; Wakamatsu TH, 2010, MOL VIS, V16, P2465; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Waldeck AR, 1996, CHEM RES TOXICOL, V9, P954, DOI 10.1021/tx960057s; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Woo JM, 2012, MOL VIS, V18, P901; Yang TX, 2005, J BIOL CHEM, V280, P34966, DOI 10.1074/jbc.M502430200; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Zhang Y, 2011, MOL VIS, V17, P2325; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zheng QX, 2014, EXP EYE RES, V125, P1, DOI 10.1016/j.exer.2014.05.001	66	84	85	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126561	10.1371/journal.pone.0126561	http://dx.doi.org/10.1371/journal.pone.0126561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024535	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400015
J	Fresard, L; Leroux, S; Roux, PF; Klopp, C; Fabre, S; Esquerre, D; Dehais, P; Djari, A; Gourichon, D; Lagarrigue, S; Pitel, F				Fresard, Laure; Leroux, Sophie; Roux, Pierre-Francois; Klopp, Christophe; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Gourichon, David; Lagarrigue, Sandrine; Pitel, Frederique			Genome-Wide Characterization of RNA Editing in Chicken Embryos Reveals Common Features among Vertebrates	PLOS ONE			English	Article							B MESSENGER-RNA; ACCURATE IDENTIFICATION; TRANSCRIPTOME; ADENOSINE; SEQ; MECHANISMS; EVOLUTION; FRAGMENT; TARGETS; OCCURS	RNA editing results in a post-transcriptional nucleotide change in the RNA sequence that creates an alternative nucleotide not present in the DNA sequence. This leads to a diversification of transcription products with potential functional consequences. Two nucleotide substitutions are mainly described in animals, from adenosine to inosine(A-to-I) and from cytidine to uridine(C-to-U). This phenomenon is described in more details in mammals, notably since the availability of next generation sequencing technologies allowing whole genome screening of RNA-DNA differences. The number of studies recording RNA editing in other vertebrates like chicken is still limited. We chose to use high throughput sequencing technologies to search for RNA editing in chicken, and to extend the knowledge of its conservation among vertebrates. We performed sequencing of RNA and DNA from 8 embryos. Being aware of common pitfalls inherent to sequence analyses that lead to false positive discovery, we stringently filtered our datasets and found fewer than 40 reliable candidates. Conservation of particular sites of RNA editing was attested by the presence of 3 edited sites previously detected in mammals. We then characterized editing levels for selected candidates in several tissues and at different time points, from 4.5 days of embryonic development to adults, and observed a clear tissue-specificity and a gradual increase of editing level with time. By characterizing the RNA editing landscape in chicken, our results highlight the extent of evolutionary conservation of this phenomenon within vertebrates, attest to its tissue and stage specificity and provide support of the absence of non A-to-I events from the chicken transcriptome.	[Fresard, Laure; Leroux, Sophie; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Pitel, Frederique] INRA, Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France; [Fresard, Laure; Leroux, Sophie; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Pitel, Frederique] Univ Toulouse, INP, ENSAT, Genet Physiol & Syst Elevage, Castanet Tolosan, France; [Fresard, Laure; Leroux, Sophie; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Pitel, Frederique] Univ Toulouse, INP, ENVT, Genet Physiol & Syst Elevage, Toulouse, France; [Roux, Pierre-Francois; Lagarrigue, Sandrine] Agrocampus Ouest Physiol Environm & Genet Anim, Rennes, France; [Roux, Pierre-Francois; Lagarrigue, Sandrine] INRA, Physiol Environm & Genet Anim & Syst Elevage, F-35042 Rennes, France; [Klopp, Christophe; Dehais, Patrice; Djari, Anis] INRA, Sigenae Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Esquerre, Diane] INRA, GeT PlaGe Genotoul, F-31326 Castanet Tolosan, France; [Gourichon, David] INRA, Pole Expt Avicole Tours, F-37380 Nouzilly, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut Agro; Agrocampus Ouest; INRAE; INRAE; INRAE; INRAE	Lagarrigue, S (corresponding author), Agrocampus Ouest Physiol Environm & Genet Anim, Rennes, France.	sandrine.lagarrigue@agrocampus-ouest.fr; frederique.pitel@toulouse.inra.fr	Pitel, Frédérique/C-2847-2009; FABRE, Stéphane/AAQ-8400-2020; Klopp, Christophe/J-3164-2019; Fabre, Stéphane/ABC-1483-2020; Roux, Pierre-François/J-8875-2019	Pitel, Frédérique/0000-0002-1477-7633; FABRE, Stéphane/0000-0001-7350-9500; Klopp, Christophe/0000-0001-7126-5477; Roux, Pierre-François/0000-0002-0695-4206; Lagarrigue, Sandrine/0000-0002-4887-7245; Fresard, Laure/0000-0001-8154-6328	Region Midi-Pyrenees and Animal Genetics Division (INRA); Region Bretagne and Animal Genetics Division (INRA); French Agence Nationale de la Recherche "EpiBird" grant [ANR-009-GENM-004]; INRA Animal Genetics Division ELASETIC program	Region Midi-Pyrenees and Animal Genetics Division (INRA)(Region Occitanie); Region Bretagne and Animal Genetics Division (INRA); French Agence Nationale de la Recherche "EpiBird" grant(French National Research Agency (ANR)); INRA Animal Genetics Division ELASETIC program	LF is supported by Region Midi-Pyrenees and Animal Genetics Division (INRA). PFR is co-supported by Region Bretagne and Animal Genetics Division (INRA). This work is supported by the French Agence Nationale de la Recherche "EpiBird" grant (ANR-009-GENM-004) and the INRA Animal Genetics Division ELASETIC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; BORDAS A, 1992, BRIT POULTRY SCI, V33, P741, DOI 10.1080/00071669208417515; BUMSTEAD N, 1988, BRIT POULTRY SCI, V29, P521, DOI 10.1080/00071668808417078; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Daniel C, 2011, J BIOL CHEM, V286, P2031, DOI 10.1074/jbc.M110.130096; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enstero M, 2009, NUCLEIC ACIDS RES, V37, P6916, DOI 10.1093/nar/gkp731; Fresard L, 2014, NUCLEIC ACIDS RES, V42, P3768, DOI 10.1093/nar/gkt1390; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gray MW, 2012, BIOCHEMISTRY-US, V51, P5235, DOI 10.1021/bi300419r; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holmes AP, 2013, BIOGERONTOLOGY, V14, P395, DOI 10.1007/s10522-013-9433-8; Irimia M, 2012, RNA BIOL, V9, P12, DOI 10.4161/rna.9.1.18387; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Kubota-Sakashita M, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-5; Lagarrigue S, 2013, GENETICS, V193, P1107, DOI 10.1534/genetics.112.149054; LAU PP, 1991, J BIOL CHEM, V266, P20550; Lee JH, 2013, RNA, V19, P725, DOI 10.1261/rna.037903.112; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Ring H, 2010, VISUAL NEUROSCI, V27, P149, DOI 10.1017/S0952523810000180; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Savva YA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4157; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Severi F, 2011, MOL BIOL EVOL, V28, P1125, DOI 10.1093/molbev/msq338; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shtrichman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041576; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Speijer D, 2011, BIOESSAYS, V33, P344, DOI 10.1002/bies.201100010; TENG BB, 1992, J BIOL CHEM, V267, P21265; Tian N, 2011, NUCLEIC ACIDS RES, V39, P5669, DOI 10.1093/nar/gkr144; Veno MT, 2012, RNA BIOL, V9, P1054, DOI 10.4161/rna.21082; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Yang JH, 1997, P NATL ACAD SCI USA, V94, P4354, DOI 10.1073/pnas.94.9.4354	61	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126776	10.1371/journal.pone.0126776	http://dx.doi.org/10.1371/journal.pone.0126776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024316	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400019
J	Tedjo, DI; Jonkers, DMAE; Savelkoul, PH; Masclee, AA; van Best, N; Pierik, MJ; Penders, J				Tedjo, Danyta I.; Jonkers, Daisy M. A. E.; Savelkoul, Paul H.; Masclee, Ad A.; van Best, Niels; Pierik, Marieke J.; Penders, John			The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects	PLOS ONE			English	Article							EFFICACY	Large-scale cohort studies are currently being designed to investigate the human microbiome in health and disease. Adequate sampling strategies are required to limit bias due to shifts in microbial communities during sampling and storage. Therefore, we examined the impact of different sampling and storage conditions on the stability of fecal microbial communities in healthy and diseased subjects. Fecal samples from 10 healthy controls, 10 irritable bowel syndrome and 8 inflammatory bowel disease patients were collected on site, aliquoted immediately after defecation and stored at -80 degrees C, -20 degrees C for 1 week, at +4 degrees C or room temperature for 24 hours. Fecal transport swabs (FecalSwab, Copan) were collected and stored for 48-72 hours at room temperature. We used pyrosequencing of the 16S gene to investigate the stability of microbial communities. Alpha diversity did not differ between all storage methods and -80 degrees C, except for the fecal swabs. UPGMA clustering and principal coordinate analysis showed significant clustering by test subject (p<0.001) but not by storage method. Bray-Curtis dissimilarity and (un) weighted UniFrac showed a significant higher distance between fecal swabs and -80 degrees C versus the other methods and -80 degrees C samples (p<0.009). The relative abundance of Ruminococcus and Enterobacteriaceae did not differ between the storage methods versus -80 degrees C, but was higher in fecal swabs (p<0.05). Storage up to 24 hours (at +4 degrees C or room temperature) or freezing at -20 degrees C did not significantly alter the fecal microbial community structure compared to direct freezing of samples from healthy subjects and patients with gastrointestinal disorders.	[Tedjo, Danyta I.; Jonkers, Daisy M. A. E.; Masclee, Ad A.; Pierik, Marieke J.] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Div Gastroenterol Hepatol, NL-6200 MD Maastricht, Netherlands; [Tedjo, Danyta I.; Savelkoul, Paul H.; van Best, Niels; Penders, John] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands; [Penders, John] Maastricht Univ, Sch Publ Hlth & Primary Care Caphri, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Penders, J (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands.	j.penders@maastrichtuniversity.nl	van Best, Niels/AAA-9232-2020; Penders, John/A-1280-2011	van Best, Niels/0000-0003-3577-7285; Penders, John/0000-0001-9146-5919	DSM; Grunenthal; Abott; Danone	DSM; Grunenthal(HAL Allergy Group); Abott; Danone(Danone Nutricia)	A. Masclee receives grants from DSM, Grunenthal, Abott and Danone. M. Pierik acted as a consultant for Takeda in the past and was a former lecturer for Abbvie, Falk, MSD and Ferning.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Favalli C., 2013, ADV MICROBIOL, V2013, P504, DOI [10.4236/aim.2013.36067, DOI 10.4236/AIM.2013.36067]; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mehal WZ, 2013, NAT REV GASTRO HEPAT, V10, P637, DOI 10.1038/nrgastro.2013.146; Musser JMB, 2011, J VET DIAGN INVEST, V23, P95, DOI 10.1177/104063871102300115; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409, DOI 10.1016/S0025-6196(12)61634-6; Santiago A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-112; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; WASFY M, 1995, J CLIN MICROBIOL, V33, P2176, DOI 10.1128/JCM.33.8.2176-2178.1995; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	20	113	117	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126685	10.1371/journal.pone.0126685	http://dx.doi.org/10.1371/journal.pone.0126685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024217	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400018
J	Yin, HC; Shakeel, M; Kuang, J; Li, JH				Yin, Haichen; Shakeel, Muhammad; Kuang, Jing; Li, Jianhong			An Opposite Pattern to the Conventional Thermal Hypothesis: Temperature-Dependent Variation in Coloration of Adults of Saccharosydne procerus (Homoptera: Delphacidae)	PLOS ONE			English	Article							IMMUNE FUNCTION; TRADE-OFFS; CUTICULAR MELANISM; PEPPERED MOTHS; RESISTANCE; MELANIZATION; PROPHYLAXIS; EXPRESSION; THERMOREGULATION; LEPIDOPTERA	Melanism is a common polymorphism in many insect species that also influences immune function. According to the thermal melanin hypothesis, ectothermic individuals from cooler environments have darker cuticles and higher polyphenol oxidase (PO) levels, which represent a better immunocompetence. In this study, the links among environmental temperature, melanism, and PO activity of Saccharosydne procerus (Matsumura) were examined. Most S. procerus have a black spot on their forewings at high temperatures in the field and in the laboratory. In PO activity assay, a positive association between PO level and temperature was found. Our results showed that a diversification of melanism occurred under different temperatures and that melanism in S. procerus presented an opposite pattern to the one proposed by the thermal hypothesis.	[Yin, Haichen; Shakeel, Muhammad; Li, Jianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Kuang, Jing] Wuhan Vegetable Res Inst, Wuhan, Peoples R China	Huazhong Agricultural University	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	jianhl@mail.hzau.edu.cn	Shakeel, Muhammad/B-5096-2019	Shakeel, Muhammad/0000-0002-8515-0053	National Key Technology RD Program [2012BAD27B00]; Hubei Research and Development Program [2011BBB043]; Fundamental Research Funds for the Central Universities [2014PY036]	National Key Technology RD Program(National Key Technology R&D Program); Hubei Research and Development Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by (1) National Key Technology R&D Program (grant no. 2012BAD27B00); (2) Hubei Research and Development Program (grant no. 2011BBB043); (3) Fundamental Research Funds for the Central Universities (grant no. 2014PY036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsaei SM, 2013, EUR J ENTOMOL, V110, P241, DOI 10.14411/eje.2013.035; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Bailey NW, 2011, PHYSIOL ENTOMOL, V36, P155, DOI 10.1111/j.1365-3032.2011.00782.x; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; BENJAMIN ND, 1973, J FOOD SCI, V38, P799, DOI 10.1111/j.1365-2621.1973.tb02079.x; Catalan TP, 2012, J INSECT PHYSIOL, V58, P1450, DOI 10.1016/j.jinsphys.2012.08.011; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Clusella-Trullas S, 2008, FUNCT ECOL, V22, P232, DOI 10.1111/j.1365-2435.2007.01377.x; Clusella-Trullas S, 2009, ECOLOGY, V90, P2297, DOI 10.1890/08-1502.1; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; CREED ER, 1980, BIOL J LINN SOC, V13, P251, DOI 10.1111/j.1095-8312.1980.tb00086.x; DeJong PW, 1996, J EXP BIOL, V199, P2655; Dubovskiy IM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0584; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Fedorka KM, 2013, EVOL ECOL, V27, P521, DOI 10.1007/s10682-012-9620-0; Futahashi R, 2011, INSECT BIOCHEM MOLEC, V41, P191, DOI 10.1016/j.ibmb.2010.12.003; Grant BS, 1996, J HERED, V87, P351, DOI 10.1093/oxfordjournals.jhered.a023013; HARRIS AC, 1988, J ROY SOC NEW ZEAL, V18, P333, DOI 10.1080/03036758.1988.10426474; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Ito K, 2013, EXP APPL ACAROL, V60, P471, DOI 10.1007/s10493-013-9660-3; Karlsson M, 2010, EVOL ECOL, V24, P975, DOI 10.1007/s10682-010-9399-9; Kuang J, 2012, PRELIMINARY STUDY GR; Kutch IC, 2014, J EXP BIOL, V217, P3664, DOI 10.1242/jeb.106294; Lee KP, 2006, ECOL ENTOMOL, V31, P196, DOI 10.1111/j.0307-6946.2006.00780.x; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Masuoka Y, 2013, ARTHROPOD STRUCT DEV, V42, P469, DOI 10.1016/j.asd.2013.08.003; Mills S, 2012, CORAL REEFS, V31, P603, DOI 10.1007/s00338-012-0883-2; Rajpurohit Subhash, 2008, Entomological Research, V38, P49, DOI 10.1111/j.1748-5967.2008.00129.x; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Roulin A, 2016, BIOL REV, V91, P328, DOI 10.1111/brv.12171; Roulin A, 2014, GLOBAL CHANGE BIOL, V20, P3344, DOI 10.1111/gcb.12594; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Verhoog MD, 1996, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 7, 1996, P127; Wang S, 2013, J INSECT BEHAV, V26, P679; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zufelato MS, 2004, INSECT BIOCHEM MOLEC, V34, P1257, DOI 10.1016/j.ibmb.2004.08.005	44	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128859	10.1371/journal.pone.0128859	http://dx.doi.org/10.1371/journal.pone.0128859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024474	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400104
J	Li, SF; Wang, ML; Shen, S; Hu, ZH; Wang, HL; Deng, F				Li, Shufen; Wang, Manli; Shen, Shu; Hu, Zhihong; Wang, Hualin; Deng, Fei			The FP25K Acts as a Negative Factor for the Infectivity of AcMNPV Budded Virus	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; OCCLUSION-DERIVED VIRUS; SINGLE NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; BACULOVIRUS EXPRESSION VECTORS; GP64 ENVELOPE GLYCOPROTEIN; PROTEIN-COMPOSITION; TRICHOPLUSIA-NI; SERIAL PASSAGE; FUSION PROTEIN	Baculoviruses generally produce two progeny phenotypes-the budded virus (BV) and the occlusion-derived virus (ODV)-and the intricate mechanisms that regulate the temporal synthesis of the two phenotypes are critical for the virus replication cycle, which are far from being clearly understood. FP25K was reported to be responsible for the regulation of BV/ODV, and the mutations within result in a decrease of normal ODVs formation and an increase of BVs production. In this study, we demonstrated that the increase of BV titer in an fp25k knockout recombinant (fp25k-negative) was a result of higher infectivity of BVs rather than an increased production of BVs. The constitution of the major structural proteins and genome of parental and fp25k-negative BVs were analyzed. The results showed that the integrity of the majority of DNA packaged into the fp25k-negative BVs was intact; i.e., the genomic DNA of fp25k-negative BV had better transformation and transfection efficiency than that of the parental virus, indicating more intact genomes in the virions. Although the analysis of proteins associated with BVs revealed that more envelope protein GP64 were incorporated into the fp25k-negative BVs, subsequent experiments suggested that overexpression of GP64 did not improve the titer of BVs. Thus, we conclude that the main reason for higher infectivity of BVs is due to better genome integrity, which benefits from the deletion of fp25k resulting in increased stability of the genome and produce a higher proportion of infectious BVs. FP25K acts as a negative factor for the infectivity of BV.	[Li, Shufen; Wang, Manli; Shen, Shu; Hu, Zhihong; Wang, Hualin; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, HL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	h.wang@wh.iov.cn; df@wh.iov.cn	Hu, Zhihong/AAS-2215-2020	Hu, Zhihong/0000-0002-1560-0928; shen, shu/0000-0002-0013-5365	National Science Foundation of China [31125003, 31130058, 31321001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Science Foundation of China (Grant Nos. 31125003, 31130058, and 31321001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMES B, 1989, VIROLOGY, V168, P344, DOI 10.1016/0042-6822(89)90275-4; BEAMES B, 1988, VIROLOGY, V162, P206, DOI 10.1016/0042-6822(88)90410-2; BLISSARD GW, 1989, VIROLOGY, V170, P537, DOI 10.1016/0042-6822(89)90445-5; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1999, J VIROL, V73, P8559, DOI 10.1128/JVI.73.10.8559-8570.1999; Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07; Fang M, 2007, J VIROL, V81, P9859, DOI 10.1128/JVI.00588-07; Giri L, 2012, J GEN VIROL, V93, P389, DOI 10.1099/vir.0.036566-0; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; Harrison RL, 1996, VIROLOGY, V226, P34, DOI 10.1006/viro.1996.0625; HARRISON RL, 1995, J GEN VIROL, V76, P1451, DOI 10.1099/0022-1317-76-6-1451; HINK WF, 1973, J INVERTEBR PATHOL, V22, P168, DOI 10.1016/0022-2011(73)90129-8; Hitchman RB, 2010, BIOTECHNOL APPL BIOC, V56, P85, DOI 10.1042/BA20090130; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Hou S, 2002, BIOTECHNIQUES, V32, P783, DOI 10.2144/02324st04; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; KOOL M, 1991, VIROLOGY, V183, P739, DOI 10.1016/0042-6822(91)91003-Y; Li Shu-fen, 2012, Virologica Sinica, V27, P71, DOI 10.1007/s12250-012-3236-y; Liu XY, 2008, INTERVIROLOGY, V51, P369, DOI 10.1159/000193462; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Oomens AGP, 1999, VIROLOGY, V254, P297, DOI 10.1006/viro.1998.9523; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Perera O, 2007, J VIROL, V81, P4585, DOI 10.1128/JVI.02391-06; Pijlman GP, 2003, J GEN VIROL, V84, P2669, DOI 10.1099/vir.0.19438-0; POTTER KN, 1976, J VIROL, V18, P1040; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Rosas-Acosta G, 2001, J VIROL, V75, P10829, DOI 10.1128/JVI.75.22.10829-10842.2001; Sambrook J, 2006, CONDENSED PROTOCOLS, V800; Shen S, 2012, J GEN VIROL, V93, P2705, DOI 10.1099/vir.0.046458-0; SUMMERS MD, 1971, J ULTRA MOL STRUCT R, V35, P606, DOI 10.1016/S0022-5320(71)80014-X; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLKMAN LE, 1977, J INVERTEBR PATHOL, V30, P102, DOI 10.1016/0022-2011(77)90045-3; Wang ML, 2008, J VIROL, V82, P9800, DOI 10.1128/JVI.00759-08; Wang ML, 2010, J VIROL, V84, P8821, DOI 10.1128/JVI.00072-10; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wu D, 2005, J GEN VIROL, V86, P2439, DOI 10.1099/vir.0.81110-0; Wu WB, 2008, J VIROL, V82, P12356, DOI 10.1128/JVI.00948-08	40	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128471	10.1371/journal.pone.0128471	http://dx.doi.org/10.1371/journal.pone.0128471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020780	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300115
J	Wickramasinghe, INA; de Vries, RP; Eggert, AM; Wandee, N; de Haan, CAM; Grone, A; Verheije, MH				Wickramasinghe, Iresha N. Ambepitiya; de Vries, Robert P.; Eggert, Amber M.; Wandee, Nantaporn; de Haan, Cornelis A. M.; Grone, Andrea; Verheije, Monique H.			Host Tissue and Glycan Binding Specificities of Avian Viral Attachment Proteins Using Novel Avian Tissue Microarrays	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS VIRUS; INFLUENZA-A VIRUS; SIALIC-ACID; INTESTINAL TRACTS; FERAL PIGEONS; CORONAVIRUS; RECEPTORS; DETERMINANT; CHICKEN; CELLS	The initial interaction between viral attachment proteins and the host cell is a critical determinant for the susceptibility of a host for a particular virus. To increase our understanding of avian pathogens and the susceptibility of poultry species, we developed novel avian tissue microarrays (TMAs). Tissue binding profiles of avian viral attachment proteins were studied by performing histochemistry on multi-species TMA, comprising of selected tissues from ten avian species, and single-species TMAs, grouping organ systems of each species together. The attachment pattern of the hemagglutinin protein was in line with the reported tropism of influenza virus H5N1, confirming the validity of TMAs in profiling the initial virus-host interaction. The previously believed chicken-specific coronavirus (CoV) M41 spike (S1) protein displayed a broad attachment pattern to respiratory tissues of various avian species, albeit with lower affinity than hemagglutinin, suggesting that other avian species might be susceptible for chicken CoV. When comparing tissue-specific binding patterns of various avian coronaviral S1 proteins on the single-species TMAs, chicken and partridge CoV S1 had predominant affinity for the trachea, while pigeon CoV S1 showed marked preference for lung of their respective hosts. Binding of all coronaviral S1 proteins was dependent on sialic acids; however, while chicken CoV S1 preferred sialic acids type I lactosamine (Gal(1-3)GlcNAc) over type II (Gal(1-4)GlcNAc), the fine glycan specificities of pigeon and partridge CoVs were different, as chicken CoV S1-specific sialylglycopolymers could not block their binding to tissues. Taken together, TMAs provide a novel platform in the field of infectious diseases to allow identification of binding specificities of viral attachment proteins and are helpful to gain insight into the susceptibility of host and organ for avian pathogens.	[Wickramasinghe, Iresha N. Ambepitiya; Eggert, Amber M.; Wandee, Nantaporn; Grone, Andrea; Verheije, Monique H.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [de Vries, Robert P.; de Haan, Cornelis A. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University	Verheije, MH (corresponding author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands.	m.h.verheije@uu.nl	de Vries, Robert/K-7212-2013	de Haan, Cornelis/0000-0002-4459-9874; de Vries, Robert/0000-0002-1586-4464	NWO MEERVOUD [836.12.012]; NWO RUBICON [825.11.035]	NWO MEERVOUD(Netherlands Organization for Scientific Research (NWO)); NWO RUBICON(Netherlands Organization for Scientific Research (NWO))	Funding for this work came from http://www.nwo.nl/, with NWO MEERVOUD 836.12.012 to MHV and NWO RUBICON 825.11.035 to RPdV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesto M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007384; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Casais R, 2003, J VIROL, V77, P9084, DOI 10.1128/JVI.77.16.9084-9089.2003; Cavanagh D, 2005, AVIAN PATHOL, V34, P439, DOI 10.1080/03079450500367682; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chen GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072918; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; Circella E, 2007, AVIAN PATHOL, V36, P251, DOI 10.1080/03079450701344738; Costa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-28; de Graaf M, 2014, EMBO J, V33, P823, DOI 10.1002/embj.201387442; Dortmans JCFM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03058; Felippe PAN, 2010, AVIAN DIS, V54, P1191, DOI 10.1637/9371-041510-Reg.1; Franca MS, 2014, CURR TOP MICROBIOL, V385, P221, DOI 10.1007/82_2014_385; Gambaryan AS, 2003, AVIAN DIS, V47, P1154, DOI 10.1637/0005-2086-47.s3.1154; Hewitt SM, 2012, METHODS MOL BIOL, V823, P201, DOI 10.1007/978-1-60327-216-2_13; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Kimble B, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-365; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kuchipudi Suresh V, 2009, J Mol Genet Med, V3, P143; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Mork AK, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-67; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Qian DH, 2006, AM J VET RES, V67, P1575, DOI 10.2460/ajvr.67.9.1575; Shahwan K, 2013, VIRUSES-BASEL, V5, P1924, DOI 10.3390/v5081924; Sun L, 2007, VIRUS RES, V130, P121, DOI 10.1016/j.virusres.2007.06.003; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wei YQ, 2014, APPL MICROBIOL BIOT, V98, P1727, DOI 10.1007/s00253-013-5352-5; Wickramasinghe INA, 2011, J VIROL, V85, P8903, DOI 10.1128/JVI.05112-11; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Winter C, 2008, MICROBES INFECT, V10, P367, DOI 10.1016/j.micinf.2007.12.009; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164; Yu JE, 2011, J VET SCI, V12, P7, DOI 10.4142/jvs.2011.12.1.7	33	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128893	10.1371/journal.pone.0128893	http://dx.doi.org/10.1371/journal.pone.0128893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035584	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100055
J	Alferink, M; de Zeeuw, J; Sopoh, G; Agossadou, C; Abass, KM; Phillips, RO; Loth, S; Jutten, E; Barogui, YT; Stewart, RE; van der Werf, TS; Stienstra, Y; Ranchor, AV				Alferink, Marike; de Zeeuw, Janine; Sopoh, Ghislain; Agossadou, Chantal; Abass, Karibu M.; Phillips, Richard O.; Loth, Susanne; Jutten, Emma; Barogui, Yves T.; Stewart, Roy E.; van der Werf, Tjip S.; Stienstra, Ymkje; Ranchor, Adelita V.			Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin	PLOS ONE			English	Article							SELF-REPORT; FUNCTIONAL LIMITATIONS; PROCEDURAL PAIN; CHILDREN; INFECTION; DISEASE; SCALES; YOUNG; PAINLESSNESS; MYCOLACTONE	Buruli ulcer (BU) is a necrotizing skin disease caused by Mycobacterium ulcerans. People living in remote areas in tropical Sub Saharan Africa are mostly affected. Wound care is an important component of BU management; this often needs to be extended for months after the initial antibiotic treatment. BU is reported in the literature as being painless, however clinical observations revealed that some patients experienced pain during wound care. This was the first study on pain intensity during and after wound care in BU patients and factors associated with pain. In Ghana and Benin, 52 BU patients above 5 years of age and their relatives were included between December 2012 and May 2014. Information on pain intensity during and after wound care was obtained during two consecutive weeks using theWong-Baker Pain Scale. Median pain intensity during wound care was in the lower range (Mdn = 2, CV = 1), but severe pain (score > 6) was reported in nearly 30% of the patients. Nevertheless, only one patient received pain medication. Pain declined over time to low scores 2 hours after treatment. Factors associated with higher self-reported pain scores were; male gender, fear prior to treatment, pain during the night prior to treatment, and pain caused by cleaning the wound. The general idea that BU is painless is incorrect for the wound care procedure. This procedural pain deserves attention and appropriate intervention.	[Alferink, Marike; Ranchor, Adelita V.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, NL-9700 AD Groningen, Netherlands; [de Zeeuw, Janine; Jutten, Emma; van der Werf, Tjip S.; Stienstra, Ymkje] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Infect Dis Serv, NL-9700 AD Groningen, Netherlands; [Sopoh, Ghislain; Agossadou, Chantal; Barogui, Yves T.] Minist Hlth, Programme Lutte Lepre & Ulcere Buruli, Cotonou, Benin; [Abass, Karibu M.] Agogo Presbyterian Hosp, Agogo, Ghana; [Phillips, Richard O.] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Stewart, Roy E.] Univ Groningen, Univ Med Ctr Groningen, Dept Publ Hlth, NL-9700 AD Groningen, Netherlands	University of Groningen; University of Groningen; Kwame Nkrumah University Science & Technology; University of Groningen	Ranchor, AV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, POB 196, NL-9700 AD Groningen, Netherlands.	a.v.ranchor@umcg.nl	Stienstra, Ymkje/F-2222-2010; Sopoh, Ghislain Emmanuel/AAP-2220-2021; Phillips, Richard Odame/ABD-5394-2021; Ranchor, Adelita/X-5725-2019	Stienstra, Ymkje/0000-0002-8844-8859; Phillips, Richard Odame/0000-0001-8992-0222; Ranchor, Adelita/0000-0001-7048-3771; de Zeeuw, Janine/0000-0002-7979-9366; BAROGUI, Yves Thierry/0000-0002-9266-1476; Stewart, Roy/0000-0001-9227-433X; SOPOH, Ghislain Emmanuel/0000-0003-1237-1047; van der Werf, Tjip/0000-0002-4824-1642	research institute SHARE, Graduate School of Medical Sciences of the UMC Groningen; VENI grant from the Dutch Organization for Scientific Research; Medical Research Council [MR/J01477X/1] Funding Source: researchfish; MRC [MR/J01477X/1] Funding Source: UKRI	research institute SHARE, Graduate School of Medical Sciences of the UMC Groningen; VENI grant from the Dutch Organization for Scientific Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the research institute SHARE, which is part of the Graduate School of Medical Sciences of the UMC Groningen. YS receives a VENI grant from the Dutch Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi Salahadin, 2002, Curr Opin Anaesthesiol, V15, P563, DOI 10.1097/00001503-200210000-00015; Alaki SM, 2010, J CLIN PEDIATR DENT, V34, P313, DOI 10.17796/jcpd.34.4.p40419378417352m; BACHANAS PJ, 1995, J PEDIATR PSYCHOL, V20, P261, DOI 10.1093/jpepsy/20.3.261; Barogui Y, 2009, AM J TROP MED HYG, V81, P82, DOI 10.4269/ajtmh.2009.81.82; de Jong A, 2010, PAIN, V150, P561, DOI 10.1016/j.pain.2010.06.016; de Vet HCW, 2011, J BIOPHARM STAT, V23, P277; Debacker M, 2006, EMERG INFECT DIS, V12, P1325, DOI 10.3201/eid1209.050598; En J, 2008, INFECT IMMUN, V76, P2002, DOI 10.1128/IAI.01588-07; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Goto M, 2006, AM J PATHOL, V168, P805, DOI 10.2353/ajpath.2006.050375; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Johnson PDR, 2005, PLOS MED, V2, P282, DOI 10.1371/journal.pmed.0020108; KVALSETH TO, 1995, PERCEPT MOTOR SKILL, V80, P843, DOI 10.2466/pms.1995.80.3.843; Lehman L., 2005, BURULI ULCER PREVENT; Marion E, 2014, CELL, V157, P1565, DOI 10.1016/j.cell.2014.04.040; McMurtry CM, 2011, HEALTH PSYCHOL, V30, P780, DOI 10.1037/a0024817; Nienhuis WA, 2012, CLIN INFECT DIS, V54, P519, DOI 10.1093/cid/cir856; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; Rhudy JL, 2003, PAIN, V104, P617, DOI 10.1016/S0304-3959(03)00119-2; Sarfo FS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-202; Sopoh GE, 2007, EMERG INFECT DIS, V13, P1374, DOI 10.3201/eid1309.061338; Stanford EA, 2006, PAIN, V120, P16, DOI 10.1016/j.pain.2005.10.004; Stienstra Y, 2005, TROP MED INT HEALTH, V10, P1251, DOI 10.1111/j.1365-3156.2005.01519.x; Stinson JN, 2009, PAIN RES MANAG, V14, P59, DOI 10.1155/2009/915302; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tomlinson D, 2010, PEDIATRICS, V126, pE1168, DOI 10.1542/peds.2010-1609; Turk DC., 2011, HDB PAIN ASSESSMENT, V3rd edn; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Velding K, 2014, AM J TROP MED HYG, V91, P313, DOI 10.4269/ajtmh.13-0255; von Baeyer CL, 2009, EUR J PAIN, V13, P209, DOI 10.1016/j.ejpain.2008.03.017; WHO, 2010, WOUND LYMPH MAN; World Health Organization, 2012, TREATM MYC ULC DIS B; World Health Organization, 2014, BUR ULC DIAGN MYC UL; World Health Organization, 2014, WORLD HLTH ASS AD RE; Young KD, 2005, ANN EMERG MED, V45, P160, DOI 10.1016/j.annemergmed.2004.09.019; Zavattaro E, 2012, HISTOPATHOLOGY, V61, P224, DOI 10.1111/j.1365-2559.2012.04206.x	37	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0119926	10.1371/journal.pone.0119926	http://dx.doi.org/10.1371/journal.pone.0119926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030764	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900005
J	Collado, S; Coll, E; Nicolau, C; Pons, M; Cruzado, JM; Pascual, J; Cases, A				Collado, Slvia; Coll, Elisabeth; Nicolau, Carlos; Pons, Mercedes; Cruzado, Josep M.; Pascual, Julio; Cases, Aleix			Carotid Atherosclerotic Disease Predicts Cardiovascular Events in Hemodialysis Patients: A Prospective Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ALL-CAUSE MORTALITY; RISK-FACTORS; DIALYSIS PATIENTS; PROGNOSTIC VALUE; WALL THICKNESS; FOLLOW-UP; PLAQUE	Background To evaluate the predictive value of carotid atherosclerotic disease (CAD) and intima-media thickness (IMT) on incident cardiovascular disease and mortality in hemodialysis patients. Methods Multicenter, observational, prospective study including 110 patients, followed-up to 6 years. Carotid doppler ultrasonographic findings were classified in 4 degrees of severity: 1) IMT < 0.9 mm, 2) IMT > 0.9 mm, 3) carotid plaque with stenosis < 50% and 4) plaque with stenosis > 50%. The associations between IMT and CAD and cardiovascular events, total and cardiovascular mortality were assessed. Results 83% of the patients had atherosclerotic plaques (CAD degrees 3-4). During follow-up, 29.1% of patients experienced cardiovascular events, and 28.2% died, 38.7% of cardiovascular origin. The presence of plaques was associated with cardiovascular events (p = 0.03) while calcified plaques were associated with both cardiovascular events (p = 0.01), cardiovascular mortality (p = 0.03) and non-significantly with overall mortality (p = 0.08) in the survival analysis. Carotid IMT was not associated with outcomes. Cardiovascular events correlated with CAD severity (HR 2.27, 95% CI 1.13-4.54), age (HR 1.04, 1.01-1.06), previous cardiovascular disease (HR 1.75, 1.05-4.42), dyslipidemia (HR 2.25, 1.11-4.53), lipoprotein (a) (HR 1.01, 1.00-1.02), troponin I (HR 3.89, 1.07-14.18), fibrinogen levels (HR 1.38, 0.98-1.94) and antiplatelet therapy (HR 2.14, 1.04-4.4). In an age-adjusted multivariate model, cardiovascular events were independently associated with previous coronary artery disease (HR 3.29, 1.52-7.15) and lipoprotein (a) (HR 1.01, 1.00-1.02). Conclusions The presence of carotid plaques and, especially, calcified plaques, are predictors of new cardiovascular events and cardiovascular mortality in hemodialysis patients, while IMT was not. The prognostic value of calcified plaques should be confirmed in future studies.	[Collado, Slvia; Pascual, Julio] Hosp del Mar, Dept Nephrol, Barcelona, Spain; [Coll, Elisabeth] Fdn Puigvert, Dept Nephrol, Barcelona, Spain; [Nicolau, Carlos] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain; [Pons, Mercedes] CETIRSA Barcelona, Fresenius Med Care,Barcelona, Barcelona, Spain; [Cruzado, Josep M.] Inst Hemodialisi Barcelona, Barcelona, Spain; [Cases, Aleix] Hosp Clin Barcelona, Dept Nephrol, Barcelona, Spain; [Cases, Aleix] Univ Barcelona, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Fundacio Puigvert; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Collado, S (corresponding author), Hosp del Mar, Dept Nephrol, Barcelona, Spain.	scolladonieto@yahoo.es	Cases, Aleix/N-4736-2018	Cases, Aleix/0000-0002-6962-8184; COLLADO NIETO, SILVIA/0000-0002-1812-1367	Spanish Ministry of Health [03/0791]; Fondo de Investigacion Sanitaria Instituto Carlos III, Ministerio de Sanidad y Consumo [03/0791]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fondo de Investigacion Sanitaria Instituto Carlos III, Ministerio de Sanidad y Consumo	This study was supported in part by the FISS project 03/0791 (a public grant from the Spanish Ministry of Health) ["Fondo de Investigacion Sanitaria Instituto Carlos III, Ministerio de Sanidad y Consumo. FIS project 03/0791, http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/ convocatorias-ayudas-accion-estrategica-salud.shtml].	Aggarwal HK, 2010, RENAL FAILURE, V32, P647, DOI 10.3109/0886022X.2010.486097; Benedetto FA, 2001, J AM SOC NEPHROL, V12, P2458, DOI 10.1681/ASN.V12112458; Benedetto FA, 2008, J AM SOC NEPHROL, V19, P757, DOI 10.1681/ASN.2007070813; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Cao JJ, 2007, CIRCULATION, V116, P32, DOI 10.1161/CIRCULATIONAHA.106.645606; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Drozdz Maciej, 2011, Przegl Lek, V68, P1162; Falaknazil K, 2012, SAUDI J KIDNEY DIS T, V23, P31; Junyent M, 2010, NEFROLOGIA, V30, P119, DOI 10.3265/Nefrologia.pre2010.Jan.10216; Kato A, 2003, KIDNEY INT, V64, P1472, DOI 10.1046/j.1523-1755.2003.00205.x; Kato K, 2013, CIRC-CARDIOVASC IMAG, V6, P448, DOI 10.1161/CIRCIMAGING.112.000165; Leskinen Y, 2003, ATHEROSCLEROSIS, V171, P295, DOI 10.1016/j.atherosclerosis.2003.08.010; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Nakano T, 2013, KIDNEY INT, V84, P373, DOI 10.1038/ki.2013.111; Nakashima A, 2003, INTERNAL MED, V42, P1095, DOI 10.2169/internalmedicine.42.1095; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; NICHOLS P, 1990, Q J MED, V77, P1175, DOI 10.1093/qjmed/77.2.1175; Ortiz A, 2012, NAT REV NEPHROL, V8, P141, DOI 10.1038/nrneph.2011.170; Ossareh S, 2011, IRAN J KIDNEY DIS, V5, P169; Park SH, 2012, J RENAL NUTR, V22, P120, DOI 10.1053/j.jrn.2011.10.021; Peters SAE, 2011, AM J CARDIOVASC DRUG, V11, P253, DOI 10.2165/11591960-000000000-00000; Rakhit DJ, 2006, HEART, V92, P1402, DOI 10.1136/hrt.2005.074393; Sanchez-Alvarez JE, 2010, NEFROLOGIA, V30, P427, DOI 10.3265/Nefrologia.pre2010.Mar.10277; Savage T, 1998, NEPHROL DIAL TRANSPL, V13, P2004, DOI 10.1093/ndt/13.8.2004; Schwaiger JP, 2006, AM J KIDNEY DIS, V47, P888, DOI 10.1053/j.ajkd.2006.01.011; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Shah DS, 2008, NEPHROLOGY, V13, P667, DOI 10.1111/j.1440-1797.2008.00982.x; Sharma K, 2009, AM J CARDIOL, V103, P1316, DOI 10.1016/j.amjcard.2009.01.020; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2012, NAT REV NEPHROL, V8, P72, DOI 10.1038/nrneph.2011.212; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; van den Oord SCH, 2013, ATHEROSCLEROSIS, V228, P1, DOI 10.1016/j.atherosclerosis.2013.01.025; Wang JG, 2006, STROKE, V37, P1933, DOI 10.1161/01.STR.0000227223.90239.13; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P454, DOI 10.1093/ndt/15.4.454	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127344	10.1371/journal.pone.0127344	http://dx.doi.org/10.1371/journal.pone.0127344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029907	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900048
J	Huang, CC; Lee, CC; Lin, HH; Chen, MC; Lin, CC; Chang, JY				Huang, Chien-Chang; Lee, Cheng-Che; Lin, Hsiao-Han; Chen, Mei-Chi; Lin, Chun-Cheng; Chang, Jang-Yang			Autophagy-Regulated ROS from Xanthine Oxidase Acts as an Early Effector for Triggering Late Mitochondria-Dependent Apoptosis in Cathepsin S-Targeted Tumor Cells	PLOS ONE			English	Article							DNA-DAMAGE; DEATH; INHIBITION; EXPRESSION; PROGRESSION; SURVIVAL; INVASION; DESIGN; BAX	Cathepsin S (CTSS), which is highly expressed in various malignant tumor cells, has been proposed to promote tumor progression, migration, and invasion. CTSS inhibition not only blocks tumor cell invasion and endothelial tube formation but also induces cellular cytotoxicity. In our previous studies, we have observed that CTSS inhibition induces autophagy, which is responsible for up-regulating xanthine oxidase for early ROS generation and consequent cell death. However, whether the autophagy-regulated early ROS triggers apoptosis remains unclear. We conducted a long-term follow-up study to investigate the relationship between early autophagy and late mitochondria-dependent apoptosis. We demonstrated that early ROS generation is critical for mitochondria damage and the activation of intrinsic apoptotic pathway. Attenuating the early ROS level diminished later mitochondrial damage and downstream apoptotic signaling. Collectively, mitochondria-dependent apoptosis is regulated by autophagy-regulated early ROS, which serves as an early effector that triggers mitochondrial signaling for late apoptosis. The data emphasize the essential role of autophagy-regulated early ROS in triggering late apoptotic signaling.	[Huang, Chien-Chang; Lee, Cheng-Che; Lin, Hsiao-Han; Chen, Mei-Chi; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Lin, Hsiao-Han] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Lin, Chun-Cheng] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Hematol & Oncol, Tainan 70101, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Tsing Hua University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Chang, JY (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jychang@nhri.org.tw			National Science Council [MOST 103-2320-B-006-036-MY3]; Headquarters of University Advancement at the National Cheng Kung University of Taiwan, ROC [D103-35A09]; National Health Research Institutes of Taiwan, ROC [CA-103-PP-22]	National Science Council(Ministry of Science and Technology, Taiwan); Headquarters of University Advancement at the National Cheng Kung University of Taiwan, ROC; National Health Research Institutes of Taiwan, ROC(National Health Research Institutes - Taiwan)	This research was supported by grants MOST 103-2320-B-006-036-MY3 from the National Science Council and D103-35A09 from the Headquarters of University Advancement at the National Cheng Kung University of Taiwan, ROC. This study also received funding (CA-103-PP-22) from the National Health Research Institutes of Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Chen JC, 2010, J MED CHEM, V53, P4545, DOI [10.1021/jm100089c, 10.1021/jm100089e]; Chen KL, 2012, CANCER LETT, V317, P89, DOI 10.1016/j.canlet.2011.11.015; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Elie BT, 2010, BIOCHIMIE, V92, P1618, DOI 10.1016/j.biochi.2010.04.023; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fernandez PL, 2001, INT J CANCER, V95, P51, DOI 10.1002/1097-0215(20010120)95:1<51::AID-IJC1009>3.0.CO;2-J; Flannery T, 2003, AM J PATHOL, V163, P175, DOI 10.1016/S0002-9440(10)63641-3; Flannery T, 2006, INT J CANCER, V119, P854, DOI 10.1002/ijc.21911; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gormley JA, 2011, BRIT J CANCER, V105, P1487, DOI 10.1038/bjc.2011.408; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Huang CC, 2013, FREE RADICAL BIO MED, V65, P1473, DOI 10.1016/j.freeradbiomed.2013.07.020; Kanzawa T, 2003, CANCER RES, V63, P2103; Kim BS, 2013, FREE RADICAL BIO MED, V60, P336, DOI 10.1016/j.freeradbiomed.2013.01.023; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Kwok HF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-147; Lee-Dutra A, 2011, EXPERT OPIN THER PAT, V21, P311, DOI 10.1517/13543776.2011.553800; Levin S, 1999, TOXICOL PATHOL, V27, P484, DOI 10.1177/019262339902700419; Lindahl Charlotta, 2009, Cancer Genomics & Proteomics, V6, P149; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Meng CL, 1998, ARCH ORAL BIOL, V43, P979, DOI 10.1016/S0003-9969(98)00078-8; Munafo DB, 2001, J CELL SCI, V114, P3619; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Paraoan L, 2009, FRONT BIOSCI-LANDMRK, V14, P2504, DOI 10.2741/3393; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Ward C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012543; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu J, 2009, MOL MED REP, V2, P713, DOI 10.3892/mmr_00000161; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; YANG CY, 1994, J DENT RES, V73, P1407, DOI 10.1177/00220345940730080301; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	47	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128045	10.1371/journal.pone.0128045	http://dx.doi.org/10.1371/journal.pone.0128045			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029922	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900104
J	Kim, HJ; Park, E; Storr, CL; Tran, K; Juon, HS				Kim, Hee Jun; Park, EunMi; Storr, Carla L.; Tran, Katherine; Juon, Hee-Soon			Depression among Asian-American Adults in the Community: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEALTH-SERVICE UTILIZATION; PRIMARY-CARE PATIENTS; NON-HISPANIC WHITES; MENTAL-HEALTH; CHINESE-AMERICANS; MAJOR DEPRESSION; KOREAN IMMIGRANTS; OLDER-ADULTS; RACIAL-DISCRIMINATION; GENDER-DIFFERENCES	Objectives In this systematic review, we provide an overview of the literature on depression among Asian-Americans and explore the possible variations in depression prevalence estimates by methodological and demographic factors. Methods Six databases were used to identify studies reporting a prevalence estimate for depression in Asian-American adults in non-clinical settings. Meta-analysis was used to calculate pooled estimates of rates of depression by assessment type. Statistical heterogeneity was assessed for subgroup analyses by gender, age, ethnicity, and other participant characteristics. Results A total of 58 studies met the review criteria (n = 21.731 Asian-American adults). Heterogeneity across the studies was considerably high. The prevalence of major depression assessed via standardized clinical interviews ranged between 4.5% and 11.3%. Meta-analyses revealed comparable estimated prevalence rates of depression as measured by the Center for Epidemiologic Studies Depression Scale (35.6%, 95% CI 27.6%-43.7%) and the Geriatric Depression Scale (33.1%, 95% CI 14.9%-51.3%). Estimates varied by Asian racial/ethnic group and other participant characteristics. Estimates of depression among special populations, which included maternity, caregivers, and homosexuals, were significantly higher than estimates obtained from other samples (58.8% vs 29.3%, p = .003). Estimates of depression among Korean and Filipino-Americans were similar (33.3%-34.4%); however, the estimates were twice as high as those for Chinese-Americans (15.7%; p = .012 for Korean, p = .049 for Filipino). Conclusion There appears to be wide variability in the prevalence rates of depression among Asian-Americans in the US. Practitioners and researchers who serve Asian-American adults need to be sensitive to the potential diversity of the expression of depression and treatment-seeking across Asian-American subgroups. Public health policies to increase Asian-American access to mental health care, including increased screening, are necessary. Further work is needed to determine whether strategies to reduce depression among specific Asian racial/ethnic groups is warranted.	[Kim, Hee Jun] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Park, EunMi] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Storr, Carla L.] Univ Maryland, Sch Nursing, Dept Family & Community Hlth, Baltimore, MD 21201 USA; [Tran, Katherine] Johns Hopkins Univ, Baltimore, MD USA; [Juon, Hee-Soon] Thomas Jefferson Univ, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Jefferson University	Juon, HS (corresponding author), Thomas Jefferson Univ, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA.	hee-soon.juon@jefferson.edu			National Cancer Institute [R01CA163805]; NATIONAL CANCER INSTITUTE [R01CA163805] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (R01CA163805).	Agency for Healthcare Research and Quality, 2009, METHODS GUIDE FOR EF; Alderete E, 2006, PSYCHO-ONCOLOGY, V15, P66, DOI 10.1002/pon.923; Alegria M, 2014, DEPRESS ANXIETY, V31, P27, DOI 10.1002/da.22197; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Berg CJ, 2012, ETHNIC HEALTH, V17, P55, DOI 10.1080/13557858.2012.654766; Bernstein KS, 2011, COMMUNITY MENT HLT J, V47, P24, DOI 10.1007/s10597-009-9261-0; Birman D, 2008, AM J ORTHOPSYCHIAT, V78, P109, DOI 10.1037/0002-9432.78.1.109; Bostwick WB, 2014, AM J ORTHOPSYCHIAT, V84, P35, DOI 10.1037/h0098851; Bromberger JT, 2004, AM J PUBLIC HEALTH, V94, P1378, DOI 10.2105/AJPH.94.8.1378; Camacho A, 2014, J AFFECT DISORDERS, V164, P165, DOI 10.1016/j.jad.2014.04.018; Chae DH, 2008, HEALTH PSYCHOL, V27, P140, DOI 10.1037/0278-6133.27.2.140; Chae DH, 2012, J IMMIGR MINOR HEALT, V14, P361, DOI 10.1007/s10903-011-9548-4; Chen ACC, 2014, J AM COLL HEALTH, V62, P390, DOI 10.1080/07448481.2014.917648; Cheung M, 2013, SOC WORK, V58, P201, DOI 10.1093/sw/swt016; Cheung M, 2011, INT J SOC WELF, V20, P421, DOI 10.1111/j.1468-2397.2010.00764.x; Chou T, 2012, CULT DIVERS ETHN MIN, V18, P74, DOI 10.1037/a0025432; Chung H, 2003, COMMUNITY MENT HLT J, V39, P33, DOI 10.1023/A:1021221806912; David EJR, 2008, CULT DIVERS ETHN MIN, V14, P118, DOI 10.1037/1099-9809.14.2.118; Dong XQ, 2014, J AGGRESS MALTREAT T, V23, P81, DOI 10.1080/10926771.2014.864740; Dong XQ, 2014, J AGING HEALTH, V26, P1155, DOI 10.1177/0898264314527611; Donnelly PL, 2007, J TRANSCULT NURS, V18, P324, DOI 10.1177/1043659607305191; Donnelly PaJa Lee, 2008, J Cult Divers, V15, P24; Fried EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090311; Gavin AR, 2010, PSYCHOL MED, V40, P51, DOI 10.1017/S0033291709006023; Goebert D, 2007, MATERN CHILD HLTH J, V11, P249, DOI 10.1007/s10995-006-0165-0; Goyal D, 2006, JOGNN-J OBST GYN NEO, V35, P98, DOI 10.1111/J.1552-6909.2006.00007.x; Hahm HC, 2012, WOMEN HEALTH ISS, V22, pE35, DOI 10.1016/j.whi.2011.07.003; Harada N, 2012, AM J GERIAT PSYCHIAT, V20, P337, DOI 10.1097/JGP.0b013e3182107e3b; Herman S, 2011, J AM COLL HEALTH, V59, P715, DOI 10.1080/07448481.2010.529625; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang ZJ, 2012, MATERN CHILD HLTH J, V16, P40, DOI 10.1007/s10995-010-0716-2; Hwang WC, 2007, SOC PSYCH PSYCH EPID, V42, P189, DOI 10.1007/s00127-006-0152-1; Hwang WC, 2010, J CONSULT CLIN PSYCH, V78, P655, DOI 10.1037/a0020542; Hwang WC, 2008, CULT DIVERS ETHN MIN, V14, P326, DOI 10.1037/1099-9809.14.4.326; Inaba A, 2005, SOC SCI MED, V61, P2280, DOI 10.1016/j.socscimed.2005.07.014; Iwamasa GY, 1999, CLIN PSYCHOL REV, V19, P343, DOI 10.1016/S0272-7358(98)00043-9; Jang Y, 2005, AGING MENT HEALTH, V9, P500, DOI 10.1080/13607860500193021; Jang YR, 2011, J AGING HEALTH, V23, P767, DOI 10.1177/0898264310396214; Jang Y, 2011, SOC WORK PUBLIC HLTH, V26, P96, DOI 10.1080/10911350902987003; Jang Y, 2009, J IMMIGR MINOR HEALT, V11, P7, DOI 10.1007/s10903-007-9112-4; Jimenez DE, 2010, J AM GERIATR SOC, V58, P256, DOI 10.1111/j.1532-5415.2009.02685.x; John DA, 2012, SOC SCI MED, V75, P2085, DOI 10.1016/j.socscimed.2012.01.035; Joling KJ, 2015, AM J GERIAT PSYCHIAT, V23, P293, DOI 10.1016/j.jagp.2014.05.005; Jonas BS, 2003, SOC PSYCH PSYCH EPID, V38, P618, DOI 10.1007/s00127-003-0682-8; Kalibatseva Z, 2014, PSYCHOL MED, V44, P2567, DOI 10.1017/S0033291714000130; Kalibatseva Zornitsa, 2011, Depress Res Treat, V2011, P320902, DOI 10.1155/2011/320902; Kang SY, 2009, J GERONTOL SOC WORK, V52, P489, DOI 10.1080/01634370902983153; Kim Eunjung, 2012, Issues Ment Health Nurs, V33, P370, DOI 10.3109/01612840.2012.656822; Kim Eunjung, 2011, Issues Ment Health Nurs, V32, P114, DOI 10.3109/01612840.2010.529239; Kim Eunjung, 2010, Issues Ment Health Nurs, V31, P576, DOI 10.3109/01612840.2010.483566; Kim Eunjung, 2009, Issues Ment Health Nurs, V30, P98, DOI 10.1080/01612840802597663; Kim JM, 2014, J ABNORM PSYCHOL, V123, P754, DOI 10.1037/a0038114; Lam CY, 2004, PSYCHIAT QUART, V75, P361, DOI 10.1023/B:PSAQ.0000043511.13623.1b; Lee Eunice E, 2004, J Transcult Nurs, V15, P18, DOI 10.1177/1043659603260010; Lee HB, 2014, AGING MENT HEALTH, V18, P102, DOI 10.1080/13607863.2013.814099; Lee SY, 2014, J AFFECT DISORDERS, V155, P130, DOI 10.1016/j.jad.2013.10.037; Lee SY, 2011, PSYCHIAT SERV, V62, P1180, DOI 10.1176/ps.62.10.pss6210_1180; Lee S, 2013, PSYCHIAT RES, V210, P315, DOI 10.1016/j.psychres.2013.03.030; Lemieux AF, 2013, PUBLIC HEALTH, V127, P1041, DOI 10.1016/j.puhe.2013.04.017; Leng JCF, 2010, J IMMIGR MINOR HEALT, V12, P234, DOI 10.1007/s10903-009-9254-7; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Leung P, 2012, SOC WORK, V57, P61, DOI 10.1093/sw/swr009; Li ZH, 2010, PSYCHIAT RES, V175, P227, DOI 10.1016/j.psychres.2009.03.007; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Matcham F, 2013, RHEUMATOLOGY, V52, P2136, DOI 10.1093/rheumatology/ket169; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mui AC, 2006, SOC WORK, V51, P243, DOI 10.1093/sw/51.3.243; Oquendo MA, 2001, AM J PSYCHIAT, V158, P1652, DOI 10.1176/appi.ajp.158.10.1652; Pang KYC, 1998, CULT MED PSYCHIAT, V22, P93, DOI 10.1023/A:1005389321714; Park HS, 2012, INT J INTERCULT REL, V36, P611, DOI 10.1016/j.ijintrel.2012.04.008; Park M, 2014, J IMMIGR MINOR HEALT, V16, P1103, DOI 10.1007/s10903-013-9926-1; Park SY, 2013, COMMUNITY MENT HLT J, V49, P765, DOI 10.1007/s10597-013-9604-8; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Ryan R, 2014, HETEROGENEITY AND SU; Sangalang CC, 2012, SOC WORK, V57, P49, DOI 10.1093/sw/swr005; Santor DA, 2006, MEAS-INTERDISCIP RES, V4, P135, DOI 10.1207/s15366359mea0403_1; Segre LS, 2014, ISSUES MENT HEALTH N, V35, P444, DOI 10.3109/01612840.2013.879358; Sterne J, 2009, META ANALYSIS IN STA; Suen LJW, 2006, J GERONTOL NURS, V32, P28, DOI 10.3928/00989134-20060401-06; Suen LJW, 2004, GERIATR NURS, V25, P157, DOI 10.1016/j.gerinurse.2004.04.005; Sulaiman AH, 2014, PSYCHIAT CLIN NEUROS, V68, P245, DOI 10.1111/pcn.12118; Tan TX, 2014, J AFFECT DISORDERS, V167, P30, DOI 10.1016/j.jad.2014.05.046; Tran TV, 2007, INT J SOC PSYCHIATR, V53, P85, DOI 10.1177/0020764007075025; US Census Bureau, 2012, THE ASIAN POPULATION; Wang JW, 2013, J TRADIT CHIN MED, V33, P156, DOI 10.1016/S0254-6272(13)60118-1; Williams DR, 2007, ARCH GEN PSYCHIAT, V64, P305, DOI 10.1001/archpsyc.64.3.305; Yang L, 2007, IEEE-RAS INT C HUMAN, P379, DOI 10.1109/ICHR.2007.4813897; Yeung A, 2004, GEN HOSP PSYCHIAT, V26, P24, DOI 10.1016/j.genhosppsych.2003.08.006; Yoon JM, 2008, CULT DIVERS ETHN MIN, V14, P92, DOI 10.1037/1099-9809.14.2.92; Zhang J, 2013, J NERV MENT DIS, V201, P17, DOI 10.1097/NMD.0b013e31827ab2e2	90	37	37	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127760	10.1371/journal.pone.0127760	http://dx.doi.org/10.1371/journal.pone.0127760			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26029911	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900080
J	Lahtela, HM; Kiviniemi, TO; Puurunen, MK; Schlitt, A; Rubboli, A; Ylitalo, A; Valencia, J; Lip, GYH; Airaksinen, KEJ				Lahtela, Heli M.; Kiviniemi, Tuomas O.; Puurunen, Marja K.; Schlitt, Axel; Rubboli, Andrea; Ylitalo, Antti; Valencia, Jose; Lip, Gregory Y. H.; Airaksinen, K. E. Juhani			Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; DRUG-ELUTING STENTS; MYOCARDIAL-INFARCTION; ORAL ANTICOAGULATION; CONSENSUS DOCUMENT; RISK; MORTALITY; INSUFFICIENCY; ASSOCIATION	Background Renal impairment is a well-known risk factor for cardiovascular complications, but the effect of different stages of renal impairment on thrombotic/thromboembolic and bleeding complications in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) remains largely unknown. We sought to evaluate the incidence and clinical impact of four stages of renal impairment in patients with AF undergoing PCI. Methods We assessed renal function by estimated glomerular filtration rate (eGFR) and outcomes in 781 AF patients undergoing PCI by using the data from a prospective European multicenter registry. End-points included all-cause mortality, major adverse cardiac and cerebrovascular events (MACCE) and bleeding events at 12 months. Results A total of 195 (25%) patients had normal renal function (eGFR >= 90 mL/min), 290 (37%) mild renal impairment (eGFR 60-89), 263 (34%) moderate renal impairment (eGFR 30-59) and 33 (4%) severe renal impairment (eGFR <30). Degree of renal impairment remained an independent predictor of mortality and MACCE in an adjusted a Cox regression model. Even patients with mild renal impairment had a higher risk of all-cause mortality (HR 2.25, 95% CI 1.02-4.98, p=0.04) and borderline risk for MACCE (HR 1.56, 95% CI 0.98-2.50, p=0.06) compared to those with normal renal function. Conclusions Renal impairment is common in patients with AF undergoing PCI and even mild renal impairment has an adverse prognostic effect in these patients requiring multiple antithrombotic medications.	[Lahtela, Heli M.; Kiviniemi, Tuomas O.; Airaksinen, K. E. Juhani] Turku Univ Hosp, Ctr Heart, FIN-20520 Turku, Finland; [Lahtela, Heli M.; Kiviniemi, Tuomas O.; Airaksinen, K. E. Juhani] Univ Turku, Turku, Finland; [Puurunen, Marja K.] Finnish Red Cross Blood Serv, Hemostasis Lab, Helsinki, Finland; [Schlitt, Axel] Univ Halle Wittenberg, Fac Med, D-06108 Halle, Germany; [Schlitt, Axel] Paracelsus Harz Clin Bad Suderode, Halle, Germany; [Rubboli, Andrea] Osped Maggiore Bologna, Div Cardiol, Lab Intervent Cardiol, Bologna, Italy; [Ylitalo, Antti] Lapland Cent Hosp, Dept Internal Med, Rovaniemi, Finland; [Ylitalo, Antti] Univ Oulu, Med Res Ctr, Oulu, Finland; [Valencia, Jose] Univ Alicante, Dept Cardiol, Gen Hosp, E-03080 Alicante, Spain; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	University of Turku; University of Turku; Martin Luther University Halle Wittenberg; AUSL di Bologna; University of Oulu; General University Hospital of Alicante; Universitat d'Alacant; University of Birmingham	Airaksinen, KEJ (corresponding author), Turku Univ Hosp, Ctr Heart, FIN-20520 Turku, Finland.	juhani.airaksinen@tyks.fi	Kiviniemi, Tuomas/A-1107-2016; Airaksinen, Juhani/AAC-7857-2021	Kiviniemi, Tuomas/0000-0002-0908-3741; Airaksinen, Juhani/0000-0002-0193-568X	Finnish Foundation for Cardiovascular Research, Helsinki, Finland	Finnish Foundation for Cardiovascular Research, Helsinki, Finland	This study was supported by grants from the Finnish Foundation for Cardiovascular Research, Helsinki, Finland. There are no conflicts of interest.	Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Apostolakis S., 2013, EUR HEART J; Baber U, 2011, CIRC-ARRHYTHMIA ELEC, V4, P26, DOI 10.1161/CIRCEP.110.957100; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Campbell NG, 2012, HEART, V98, P42, DOI 10.1136/heartjnl-2011-300024; FOUNDATION NK, 2002, AM J KIDNEY DIS S, V39, pS1; Gibson CM, 2004, EUR HEART J, V25, P1998, DOI 10.1016/j.ehj.2004.08.016; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Iguchi Y, 2008, AM J CARDIOL, V102, P1056, DOI 10.1016/j.amjcard.2008.06.018; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kaya E, 2011, CLIN RES CARDIOL, V100, P1103, DOI 10.1007/s00392-011-0347-7; Kiviniemi T, 2013, AM J CARDIOL, V112, P493, DOI 10.1016/j.amjcard.2013.04.007; Lahtela H, 2012, CIRC J, V76, P1363, DOI 10.1253/circj.CJ-11-1206; Lambert ND, 2009, AM HEART J, V157, P688, DOI 10.1016/j.ahj.2009.01.009; Latif F, 2009, JACC-CARDIOVASC INTE, V2, P37, DOI 10.1016/j.jcin.2008.06.012; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lip GYH, 2010, EUR HEART J, V31, P1311, DOI 10.1093/eurheartj/ehq117; Manzano-Fernandez S, 2012, THROMB HAEMOSTASIS, V107, P51, DOI 10.1160/TH11-08-0524; Marenzi G, 2013, AM J CARDIOL, V111, P816, DOI 10.1016/j.amjcard.2012.11.046; Marinigh R, 2011, J AM COLL CARDIOL, V57, P1339, DOI 10.1016/j.jacc.2010.12.013; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Nelson SE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002097; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Parikh PB, 2012, CATHETER CARDIO INTE, V80, P352, DOI 10.1002/ccd.23394; Puurunen M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004700; Reinecke H, 2003, KIDNEY INT, V63, P696, DOI 10.1046/j.1523-1755.2003.00784.x; Rubboli A, 2008, ANN MED, V40, P428, DOI 10.1080/07853890802089786; Schlitt A., 2013, CATHETER CARDIOVASC; Schoebel FC, 1997, HEART, V78, P337, DOI 10.1136/hrt.78.4.337; Simsek C, 2012, CATHETER CARDIO INTE, V80, P18, DOI 10.1002/ccd.23199; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	32	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128492	10.1371/journal.pone.0128492	http://dx.doi.org/10.1371/journal.pone.0128492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030623	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900156
J	Lamy, PJ; Plassot, C; Pujol, JL				Lamy, Pierre-Jean; Plassot, Carine; Pujol, Jean-Louis			Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; WHEY ACIDIC PROTEIN; HUMAN EPIDIDYMIS 4; PREDICTIVE-VALUE; TUMOR-MARKER; PELVIC MASS; EXPRESSION; CARCINOMA; SURVIVAL; CHEMOTHERAPY	Human epididymis secretory protein 4 (HE4) is a secreted glycosylated protein encoded by the WAP four-disulfide core domain 2 (WFDC2) gene, located on a chromosome 20 segment that is frequently amplified in many cancers. This study aimed at determining serum HE4 prognostic value in non-small cell lung cancer (NSCLC), following the REMARK guidelines. Serum samples from 346 consecutive patients with histologically proven and previously untreated NSCLC and 41 patients with benign pulmonary disease were collected at the Montpellier-Nimes Academic Hospital. Work-up investigations performed to determine the disease characteristics and treatment algorithms were congruent with international guidelines. HE4 levels in serum were measured with an ELISA test (Fujirebio Diagnostics) that uses two monoclonal antibodies, 2H5 and 3D8, against the C-WFDC domain of HE4. The area under the ROC curve (i.e., overall ability of HE4 to discriminate between controls and patients) was 0.78 (95% confidence interval [CI], 0.738-0.821; z test P < 0.0001). Serum HE4 levels were significantly higher in patients with worse performance status, advanced TNM stage and positive nodal status. In the Cox model, overall survival was shorter in patients with high pretreatment serum HE4 (above 140 pmol/L) than in patients with serum H4 level <= 140 pmol/L [median survival: 17.7 weeks (95% CI, 11.9 to 24.9) and 46.4 weeks (95% CI, 38.6 to 56.3), respectively; hazard ratio: 1.48 (95% CI, 1.12 to 1.95) for high HE4; adjusted P = 0.0057]. High serum HE4 level at diagnosis is an independent determinant of poor prognosis in NSCLC.	[Lamy, Pierre-Jean] Montpellier Canc Inst, Dept Biol & Oncogenet, Montpellier, France; [Lamy, Pierre-Jean] Reg Canc Ctr, ICM Biobank, Montpellier, France; [Plassot, Carine] Univ Montpellier I, Inst Clin Res, Dept Stat & Epidemiol, Montpellier, France; [Pujol, Jean-Louis] Hosp Univ Ctr Montpellier, Thorac Oncol Unit, Montpellier, France	Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Lamy, PJ (corresponding author), Montpellier Canc Inst, Dept Biol & Oncogenet, Montpellier, France.	pierre-jean.lamy@labosud-ocbiologie.fr	Lamy, Pierre-Jean/AAZ-1696-2020	Lamy, Pierre-Jean/0000-0002-5750-159X	Fujirebio Diagnostics	Fujirebio Diagnostics	The study was supported by grant from Fujirebio Diagnostics. HE4 assays kits were provided by Fujirebio Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasi E, 2010, TUMOR BIOL, V31, P113, DOI 10.1007/s13277-009-0015-y; [Anonymous], 1982, Am J Clin Pathol, V77, P123; Bingle L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-61; Bolstad N, 2012, TUMOR BIOL, V33, P141, DOI 10.1007/s13277-011-0256-4; Bouchard D, 2006, LANCET ONCOL, V7, P167, DOI 10.1016/S1470-2045(06)70579-4; Charloux A, 1997, LUNG CANCER, V17, P123, DOI 10.1016/S0169-5002(97)00655-7; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Depierre A, 2002, J CLIN ONCOL, V20, P247, DOI 10.1200/JCO.20.1.247; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Elsammak MY, 2012, TUMOR BIOL, V33, P1701, DOI 10.1007/s13277-012-0427-y; Escudero JM, 2011, CLIN CHEM, V57, P1534, DOI 10.1373/clinchem.2010.157073; Furuse K, 1999, J CLIN ONCOL, V17, P2692, DOI 10.1200/JCO.1999.17.9.2692; Galgano MT, 2006, MODERN PATHOL, V19, P847, DOI 10.1038/modpathol.3800612; Hellstrom I, 2003, CANCER RES, V63, P3695; Hertlein L, 2012, CLIN CHEM LAB MED, V50, P2181, DOI 10.1515/cclm-2012-0097; Huhtinen K, 2009, BRIT J CANCER, V100, P1315, DOI 10.1038/sj.bjc.6605011; Iwahori K, 2012, TUMOR BIOL, V33, P1141, DOI 10.1007/s13277-012-0356-9; Jiang YZ, 2014, INT J CLIN EXP MED, V7, P5568; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; KOMAKI R, 1993, LUNG CANCER-J IASLC, V10, P189, DOI 10.1016/0169-5002(93)90179-2; Kristjansdottir B, 2013, GYNECOL ONCOL, V131, P52, DOI 10.1016/j.ygyno.2013.07.094; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; McShane LM, 2012, J CLIN ONCOL, V30, P4223, DOI 10.1200/JCO.2012.42.6858; Merrill RM, 1999, CHEST, V116, P697, DOI 10.1378/chest.116.3.697; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Paesmans M, 1997, EUR J CANCER, V33, P2326, DOI 10.1016/S0959-8049(97)00325-0; Pujol JL, 2003, LUNG CANCER, V39, P131, DOI 10.1016/S0169-5002(02)00513-5; Pujol JL, 2001, LUNG CANCER, V31, P221, DOI 10.1016/S0169-5002(00)00186-0; Ranganathan S, 1999, J MOL GRAPH MODEL, V17, P106, DOI 10.1016/S1093-3263(99)00023-6; Schummer M, 1999, GENE, V238, P375, DOI 10.1016/S0378-1119(99)00342-X; SOBIN LH, 1988, CANCER, V61, P2310, DOI 10.1002/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0.CO;2-X; Steffensen KD, 2012, INT J GYNECOL CANCER, V22, P1474, DOI 10.1097/IGC.0b013e3182681cfd; TISI GM, 1983, AM REV RESPIR DIS, V127, P659, DOI 10.1164/arrd.1983.127.5.659; WILLIAMS DE, 1981, J THORAC CARDIOV SUR, V82, P70; Yamashita S, 2012, TUMOR BIOL, V33, P2365, DOI 10.1007/s13277-012-0499-8; Yamashita S, 2011, TUMOR BIOL, V32, P265, DOI 10.1007/s13277-010-0118-5	39	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128836	10.1371/journal.pone.0128836	http://dx.doi.org/10.1371/journal.pone.0128836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030627	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900196
J	Li, J; Hernanda, PY; Bramer, WM; Peppelenbosch, MP; van Luijk, J; Pan, QW				Li, Juan; Hernanda, Pratika Y.; Bramer, Wichor M.; Peppelenbosch, Maikel P.; van Luijk, Judith; Pan, Qiuwei			Anti-Tumor Effects of Metformin in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PREVENTS LIVER TUMORIGENESIS; IN-VITRO; DIABETIC-PATIENTS; RISK; VIVO; APOPTOSIS; KINASE; GROWTH; CANCER; MICE	Background Several studies have reported that metformin can reduce the risk of hepatocellular carcinoma (HCC) in diabetes patients. However, the direct anti-HCC effects of metformin have hardly been studied in patients, but have been extensively investigated in animal models of HCC. We therefore performed a systematic review and meta-analysis of animal studies evaluating the effects of metformin on HCC. Methods We collected the relevant studies by searching EMBASE, Medline (OvidSP), Web of Science, Scopus, PubMed Publisher, and Google Scholar. Studies were included according to the following inclusion criteria: HCC, animal study, and metformin intervention. Study quality was assessed using SYRCLE's risk of bias tool. A meta-analysis was performed for the outcome measures: tumor growth (tumor volume, weight and size), tumor number and incidence. Results The search resulted in 573 references, of which 13 could be included in the review and 12 included in the meta-analysis. The study characteristics of the included studies varied considerably. Two studies used rats, while the others used mice. Only one study used female animals, nine used male, and three studies didn't mention the gender of animals in their experiments. The quality of the included studies was low to moderate based on the assessment of their risk of bias. The meta-analysis showed that metformin significantly inhibited the growth of HCC tumour (SMD -2.20[-2.96,-1.43]; n=16), but no significant effect on the number of tumors (SMD-1.05[-2.13,0.03]; n=5) or the incidence of HCC was observed (RR 0.62[0.33,1.16]; n=6). To investigate the potential sources of significant heterogeneitiesfound in outcome of tumor growth (I-2 = 81%), subgroup analyses of scales of growth measures and of types of animal models used were performed. Conclusion Metformin appears to have a direct anti-HCC effect in animal models. Although the intrinsic limitations of animal studies, this systematic review could provide an important reference for future preclinical animal trials of good quality and clinical development.	[Li, Juan; Peppelenbosch, Maikel P.; Pan, Qiuwei] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Hernanda, Pratika Y.] Wijaya Kusuma Univ, Biomol Res Ctr, Med Genet Lab, Surabaya, Indonesia; [Bramer, Wichor M.] Erasmus Univ, Med Ctr, Med Lib, Rotterdam, Netherlands; [van Luijk, Judith] Radboud Univ Nijmegen, Med Ctr, SYRCLE Cent Anim Lab, NL-6525 ED Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Li, J (corresponding author), Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	j.li@erasmusmc.nl; q.pan@erasmusmc.nl	Bramer, Wichor/P-5044-2014; Peppelenbosch, Maikel P./U-5304-2019	Bramer, Wichor/0000-0003-2681-9180; Pan, Qiuwei/0000-0001-9982-6184; Peppelenbosch, Maikel/0000-0001-9112-6028; hernanda, pratika yuhyi/0000-0003-2025-2136	Daniel den Hoed Foundation; Netherlands Organization for Scientific Research (NWO/ZonMw) for a VENI grant [916-13-032]; China Scholarship Council [201307720054]	Daniel den Hoed Foundation; Netherlands Organization for Scientific Research (NWO/ZonMw) for a VENI grant; China Scholarship Council(China Scholarship Council)	This study was supported by the Daniel den Hoed Foundation for a Centennial Award fellowship and the Netherlands Organization for Scientific Research (NWO/ZonMw) for a VENI grant (No. 916-13-032) (to Q. Pan), and the China Scholarship Council for funding PhD fellowship to J. Li (No. 201307720054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal M, 2012, SAUDI PHARM J, V20, P365, DOI 10.1016/j.jsps.2012.05.012; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859; Cai XB, 2013, ONCOL REP, V30, P2449, DOI 10.3892/or.2013.2718; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Chen K, 2014, LIVER TRANSPLANT, V20, P261, DOI 10.1002/lt.23806; Chen TM, 2011, J GASTROEN HEPATOL, V26, P858, DOI 10.1111/j.1440-1746.2011.06664.x; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093256; de Vries RBM., 2015, EVID BASED PRECLIN M, V2, DOI [10.1002/ebm2.7, DOI 10.1002/EBM2.7]; DePeralta DK., 2014, J SURG RES, V186, P633, DOI [10.1016/j.jss.2013.11.645, DOI 10.1016/J.JSS.2013.11.645]; Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Kim JH, 2013, KOREAN J PHYSIOL PHA, V17, P455, DOI 10.4196/kjpp.2013.17.5.455; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Miyoshi H, 2014, INT J ONCOL, V45, P322, DOI 10.3892/ijo.2014.2419; Oliveria SA, 2008, DIABETES METAB SYND, V2, P47, DOI 10.1016/j.dsx.2007.11.002; Qu Z, 2012, HEPATOL RES, V42, P922, DOI 10.1111/j.1872-034X.2012.01007.x; Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070010; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Singh S, 2013, AM J GASTROENTEROL, V108, P881, DOI 10.1038/ajg.2013.5; Tajima K, 2013, AM J PHYSIOL-ENDOC M, V305, pE987, DOI 10.1152/ajpendo.00133.2013; Xiong Y, 2012, ASIAN PAC J CANCER P, V13, P3275, DOI 10.7314/APJCP.2012.13.7.3275; Zhang H, 2013, SCAND J GASTROENTERO, V48, P78, DOI 10.3109/00365521.2012.719926; Zheng LY, 2013, CLIN CANCER RES, V19, P5372, DOI 10.1158/1078-0432.CCR-13-0203; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	26	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127967	10.1371/journal.pone.0127967	http://dx.doi.org/10.1371/journal.pone.0127967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030161	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900097
J	Seo, HG; Paik, NJ; Lee, SU; Oh, BM; Chun, MH; Kwon, BS; Bang, MS				Seo, Han Gil; Paik, Nam-Jong; Lee, Shi-Uk; Oh, Byung-Mo; Chun, Min Ho; Kwon, Bum Sun; Bang, Moon Suk			Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial	PLOS ONE			English	Article							TOXIN TYPE-A; PLACEBO-CONTROLLED TRIAL; BOTULINUM-TOXIN; DOUBLE-BLIND; STROKE; NEUROTOXIN; EFFICACY; DISABILITY; SAFETY	Background Botulinum toxin type A is widely used for treating spasticity. Neuronox (Neu-BoNT/A), a newly manufactured botulinum toxin a, has not yet been investigated for its efficacy and safety in the treatment of post-stroke upper limb spasticity. Objective We evaluated the efficacy and safety of Neuronox (Neu-BoNT/A) compared with BOTOX (onabotulinum toxin A) for treating post-stroke upper limb spasticity. Methods In total, 196 stroke patients with moderate to severe upper limb spasticity were randomly assigned to either Neuronox or BOTOX intervention. The wrist flexors were mandatory and elbow, finger, and thumb flexors were optional muscles to be injected. Assessments were performed at baseline and 4, 8, and 12 weeks after the intervention. The primary outcome measure was the change from baseline of the Modified Ashworth Scale (MAS) at the wrist flexors at week 4. Secondary outcome measures included the change of MAS at each visit, response rate, Disability Assessment Scale (DAS), Carer Burden Scale, and Global Assessment of treatment benefit. Results Primary outcome measures were -1.39 +/- 0.79 and -1.56 +/- 0.81 in the Neuronox and BOTOX groups, respectively. The difference was within the noninferiority margin of 0.45 (95% upper limit=0.40). There were no significant differences between the groups in the secondary outcome and safety measures, except the change of the MAS at the elbow flexors at week 12 (-0.88 +/- 0.75 in the Neuronox group, -0.65 +/- 0.74 in the BOTOX group; P=0.0429). Both groups showed significant improvements in the MAS, DAS, and Carer Burden Scale at weeks 4, 8, and 12. Conclusion Neuronox showed equivalent efficacy and safety compared with BOTOX for treating poststroke upper limb spasticity.	[Seo, Han Gil; Oh, Byung-Mo; Bang, Moon Suk] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea; [Paik, Nam-Jong] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Rehabil Med, Songnam, South Korea; [Lee, Shi-Uk] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Rehabil Med, Seoul, South Korea; [Chun, Min Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Seoul, South Korea; [Kwon, Bum Sun] Dongguk Univ, Ilsan Hosp, Dept Rehabil Med, Goyang, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center; Dongguk University; NHIS Ilsan Hospital	Bang, MS (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea.	msbang@snu.ac.kr	Paik, Nam-Jong/D-5798-2012	Paik, Nam-Jong/0000-0002-5193-8678; Seo, Han Gil/0000-0001-6904-7542	Medytox Inc, Republic of Korea	Medytox Inc, Republic of Korea	The study was sponsored by Medytox Inc, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheit AMO, 2001, EUR J NEUROL, V8, P559, DOI 10.1046/j.1468-1331.2001.00277.x; Bensmail D, 2010, NEUROREHAB NEURAL RE, V24, P273, DOI 10.1177/1545968309347682; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bohannon R. W., 1987, PHYS THER, V67, P206; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Kanovsky P, 2009, CLIN NEUROPHARMACOL, V32, P259, DOI 10.1097/WNF.0b013e3181b13308; Kim K, 2011, DEV MED CHILD NEUROL, V53, P239, DOI 10.1111/j.1469-8749.2010.03830.x; Ney John P, 2007, Neuropsychiatr Dis Treat, V3, P785; Ravenni R, 2013, NEUROL SCI, V34, P1043, DOI 10.1007/s10072-013-1357-1; Rousseaux M, 2002, J NEUROL, V249, P76, DOI 10.1007/PL00007851; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy Association of Chartered Physiotherapists Interested in Neurology, 2009, SPAST AD MAN US BOT; Shaw LC, 2011, STROKE, V42, P1371, DOI 10.1161/STROKEAHA.110.582197; Simpson DM, 2009, J NEUROL NEUROSUR PS, V80, P380, DOI 10.1136/jnnp.2008.159657; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Stone AV, 2007, J ORTHOP RES, V25, P1658, DOI 10.1002/jor.20450; van Kuijk AA, 2007, J REHABIL MED, V39, P33, DOI 10.2340/16501977-0009; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Yang GH, 2013, DERMATOL SURG, V39, P165, DOI 10.1111/dsu.12073	22	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128633	10.1371/journal.pone.0128633	http://dx.doi.org/10.1371/journal.pone.0128633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030192	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900178
J	van Hoek, AHAM; Schouls, L; van Santen, MG; Florijn, A; de Greeff, SC; van Duijkeren, E				van Hoek, Angela H. A. M.; Schouls, Leo; van Santen, Marga G.; Florijn, Alice; de Greeff, Sabine C.; van Duijkeren, Engeline			Molecular Characteristics of Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae from Humans in the Community	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; COMPANION ANIMALS; PUBLIC-HEALTH; CHICKEN MEAT; RISK-FACTORS; PLASMIDS; SALMONELLA	Objective To investigate the molecular characteristics of extended-spectrum cephalosporin (ESC)-resistant Enterobacteriaceae collected during a cross-sectional study examining the prevalence and risk factors for faecal carriage of extended-spectrum beta-lactamase (ESBL)producing Enterobacteriaceae in humans living in areas with high or low broiler density. Methods ESC-resistant Enterobacteriaceae were identified by combination disc-diffusion test. ESBL/AmpC/carbapenemase genes were analysed using PCR and sequencing. For E. coli, phylogenetic groups and MLST were determined. Plasmids were characterized by transformation and PCR-based replicon typing. Subtyping of plasmids was done by plasmid multilocus sequence typing. Results 175 ESC-resistant Enterobacteriaceae were cultured from 165/1,033 individuals. The isolates were Escherichia coli(n=65), Citrobacter freundii (n=52), Enterobacter cloacae (n=38), Morganella morganii (n=5), Enterobacter aerogenes (n=4), Klebsiella pneumoniae (n=3), Hafnia alvei (n=2), Shigella spp. (n=2), Citrobacter amalonaticus (n=1), Escherichia hermannii (n=1), Kluyvera cryocrescens (n=1), and Pantoea agglomerans (n=1). The following ESBL genes were recovered in 55 isolates originating from 49 of 1,033 (4.7 %) persons: blaCTX-M-1 (n=17), blaCTX-M-15 (n=16), blaCTX-M-14 (n=9), blaCTX-M-2 (n=3), blaCTX-M-3 (n=2), blaCTX-M-24 (n=2), blaCTX-M-27 (n=1), blaCTX-M-32 (n=1), blaSHV-12 (n=2), blaSHV-65 (n=1) and blaTEM-52 (n=1). Plasmidic AmpC (pAmpC) genes were discovered in 6 out of 1,033 (0.6 %) persons. One person carried two different E. coli isolates, one with blaCTX-M-1 and the other with blaCMY-2 and therefore the prevalence of persons carrying Enterobacteriaceae harboring ESBL and/or pAmpC genes was 5.2 %. In eight E. coli isolates the AmpC phenotype was caused by mutations in the AmpC promoter region. No carbapenemase genes were identified. A large variety of E. coli genotypes was found, ST131 and ST10 being most common. Conclusions ESBL/pAmpC genes resembled those from patients in Dutch hospitals, indicating that healthy humans form a reservoir for transmission of these determinants to vulnerable people. The role of poultry in the transmission to humans in the community remains to be elucidated.	[van Hoek, Angela H. A. M.; Schouls, Leo; van Santen, Marga G.; Florijn, Alice; de Greeff, Sabine C.; van Duijkeren, Engeline] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	van Duijkeren, E (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands.	engeline.van.duijkeren@rivm.nl						Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Caroff N, 1999, FEMS MICROBIOL LETT, V173, P459, DOI 10.1016/S0378-1097(99)00111-1; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI S; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Freeman JT, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-27; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2011, J ANTIMICROB CHEMOTH, V66, P1987, DOI 10.1093/jac/dkr225; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hordijk J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065681; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Paltansing S, 2013, EMERG INFECT DIS, V19, P1206, DOI [10.3201/eid1908.130257, 10.3201/eid.1908.130257]; Peirano G, 2014, ANTIMICROB AGENTS CH, V58, P3762, DOI 10.1128/AAC.02428-14; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Reuland EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113033; Smet A, 2009, J ANTIMICROB CHEMOTH, V63, P1286, DOI 10.1093/jac/dkp101; Steward CD, 2001, J CLIN MICROBIOL, V39, P2864, DOI 10.1128/JCM.39.8.2864-2872.2001; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	37	46	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129085	10.1371/journal.pone.0129085	http://dx.doi.org/10.1371/journal.pone.0129085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029910	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900208
J	Wang, L; Liang, J; Leung, PS				Wang, Lin; Liang, Juan; Leung, Po Sing			The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos	PLOS ONE			English	Article							CONVERTING ENZYME 2; ANGIOTENSIN-II RECEPTORS; IN-VIVO; ACE2; EXPRESSION; TYPE-2; SYSTEM; ANGIOGENESIS; FETAL; MICE	Angiotensin-converting enzyme 2 (ACE2), its product Angiotensin-(1-7) [Ang-(1-7)], and Ang-(1-7) receptor Mas, have been shown to regulate organogenesis during embryonic development in various species. However, it is not known whether a local ACE2/Ang-(1-7)/Mas axis is present in the fetal pancreas. It is hypothesized that there is a local ACE2/Ang(1-7)/Mas axis in the embryonic pancreas in mice that is involved in regulating islet cell development. To address this issue, the endogenous expression profile of axis constituents in embryonic mouse pancreata was examined. Involvement of the ACE2 axis in the regulation of pancreatic development was also examined. The present experiments showed in an in vivo animal model that endogenous expression levels of ACE2 and the Mas receptor were upregulated in mouse pancreata in late embryogenesis, peaking on embryonic day E16.5, when it reached 3 folds compared to that seen at E12.5. Consistently, endogenous expression of Ang-(1-7) also peaked at E16.5. Treatment with the ACE2 inhibitor DX600 did not alter islet development. However, prenatal treatment with A779, a Mas receptor antagonist, reduced the beta-cell to alpha-cell ratio in neonatal islets, impaired islet insulin secretory function, and impaired the pups' glucose tolerance. In ex vivo pancreas explant cultures, A779 again decreased the beta-cell to alpha-cell ratio, apparently through its effects on alpha-cell proliferation (reduced proliferation shown with Ki67 staining), and also decreased Insulin and Ngn3 mRNA expression. Furthermore, treatment of explant cultures with Ang-(1-7) increased mRNA levels of Insulin and pancreatic progenitor marker Ngn3, as well as Nox4, the ROS generation enzyme; these stimulatory effects were attenuated by co-treatment with A779, suggesting that Ang-(1-7), via Mas receptor signaling, may promote differentiation of pancreatic progenitors into insulin-producing cells via modulation of reactive oxygen species. These data together suggest that a Mas receptor-mediated mechanism may stimulate pancreatic cell development.	[Wang, Lin; Liang, Juan; Leung, Po Sing] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Leung, PS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	psleung@cuhk.edu.hk	Leung, Po Sing/P-5758-2014	Leung, Po Sing/0000-0001-8074-3178	General Research Fund from The Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK468912, CUHK470413]	General Research Fund from The Research Grants Council of the Hong Kong Special Administrative Region, China	This work was supported by the General Research Fund from The Research Grants Council of the Hong Kong Special Administrative Region, China (Reference CUHK468912 and CUHK470413), awarded to PS Leung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Bharadwaj MS, 2011, HYPERTENSION, V58, P852, DOI 10.1161/HYPERTENSIONAHA.111.179358; Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Chappell MC, 2007, HYPERTENSION, V50, P596, DOI 10.1161/HYPERTENSIONAHA.106.076216; Chen YP, 2014, J HYPERTENS, V32, P1833, DOI 10.1097/HJH.0000000000000251; Cheng QN, 2008, J PHARMACOL EXP THER, V327, P683, DOI 10.1124/jpet.108.142703; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Feng Y, 2011, ONCOL REP, V26, P1157, DOI 10.3892/or.2011.1394; Hoarau E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.441; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; KALINYAK JE, 1991, J ENDOCRINOL INVEST, V14, P647, DOI 10.1007/BF03347886; Kim SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039739; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Leung KK, 2014, DEV DYNAM, V243, P415, DOI 10.1002/dvdy.24084; Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193; Liu C, 2012, ACTA DIABETOL, V49, P291, DOI 10.1007/s00592-011-0348-z; Lysy PA, 2012, STEM CELL TRANSL MED, V1, P150, DOI 10.5966/sctm.2011-0025; Mauda-Havakuk M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026298; Meng Y, 2015, ANTIOXID REDOX SIGN, V22, P241, DOI 10.1089/ars.2013.5818; Moritz KM, 2001, AM J PHYSIOL-REG I, V280, pR404, DOI 10.1152/ajpregu.2001.280.2.R404; Munoz MC, 2014, J ENDOCRINOL, V221, P215, DOI 10.1530/JOE-13-0497; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; Norwood VF, 1997, AM J PHYSIOL-REG I, V272, pR662, DOI 10.1152/ajpregu.1997.272.2.R662; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Perlegas D, 2005, AM J PHYSIOL-HEART C, V288, pH96, DOI 10.1152/ajpheart.00620.2004; Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020; Reis FM, 2011, FERTIL STERIL, V95, P176, DOI 10.1016/j.fertnstert.2010.06.060; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Schutz S, 1996, AM J PATHOL, V149, P2067; Singh T, 2010, METHOD FIND EXP CLIN, V32, P19, DOI 10.1358/mf.2010.32.1.1434160; Song RF, 2012, PEDIATR RES, V71, P13, DOI 10.1038/pr.2011.7; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Takeda M, 2013, DIABETES, V62, P223, DOI 10.2337/db12-0177; Tikellis C, 2012, CLIN SCI, V123, P519, DOI 10.1042/CS20110668; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Valdes G, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-5; Wong TP, 2012, AM J PHYSIOL-ENDOC M, V303, pE669, DOI 10.1152/ajpendo.00562.2011; Yousif MHM, 2012, PHARMACOL RES, V66, P269, DOI 10.1016/j.phrs.2012.05.001; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200; Zheng J, 2014, NEUROSCIENCE, V273, P39, DOI 10.1016/j.neuroscience.2014.04.060; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369; Zimmerman MC, 2011, CURR OPIN PHARMACOL, V11, P138, DOI 10.1016/j.coph.2011.01.001	43	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128216	10.1371/journal.pone.0128216	http://dx.doi.org/10.1371/journal.pone.0128216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029927	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900128
J	Yan, DD; Tu, YF; Jiang, F; Wang, J; Zhang, R; Sun, X; Wang, T; Wang, SY; Bao, YQ; Hu, C; Jia, WP				Yan, Dandan; Tu, Yinfang; Jiang, Feng; Wang, Jie; Zhang, Rong; Sun, Xue; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping			Uric Acid Is Independently Associated with Diabetic Kidney Disease: A Cross-Sectional Study in a Chinese Population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; NITRIC-OXIDE; NEPHROPATHY; RISK; ALLOPURINOL; PROGRESSION; GLUCOSE	Background Association between hyperuricaemia and chronic kidney disease has been studied widely, but the influence of uric acid on the kidneys remains controversial. We aimed to summarize the association between uric acid and diabetic kidney disease (DKD), and to evaluate the role of uric acid in DKD. Methods We enrolled 3,212 type 2 diabetic patients in a cross-sectional study. The patients' basic characteristics (sex, age, BMI, duration of disease, and blood pressure) and chemical parameters (triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), microalbuminuria, creatinine, and uric acid) were recorded, and the association between uric acid and DKD was evaluated. Results In the 3,212 diabetic patients, the prevalence of diabetic kidney disease was higher in hyperuricaemic patients than in patients with normouricaemia (68.3% vs 41.5%). The prevalence of DKD increased with increasing uric acid (p<0.0001). Logistic analysis identified uric acid as an independent predictor of DKD (p<0.0001; adjusted OR (95%CI) = 1.005 (1.004-1.007), p<0.0001). Uric acid was positively correlated with albuminuria and creatinine levels (p<0.0001) but negatively correlated with eGFR (p<0.0001) after adjusting for confounding factors. Conclusions Hyperuricaemia is a risk factor for DKD. Serum uric acid levels within the high-normal range are independently associated with DKD.	[Yan, Dandan; Tu, Yinfang; Jiang, Feng; Wang, Jie; Zhang, Rong; Sun, Xue; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China; [Hu, Cheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, South Branch, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China.	alfredhc@sjtu.edu.cn; wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008	Hu, Cheng/0000-0003-4314-2386	National Science Foundation of China [81200582, 81322010, 81300691]; Key Discipline of Public Health of Shanghai [12GWZX0104]; Excellent Young Medical Expert of Shanghai [XYQ2011041]; Shanghai Talent Development Grant [2012041]; National Program for Support of Top-notch Young Professionals	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Discipline of Public Health of Shanghai; Excellent Young Medical Expert of Shanghai; Shanghai Talent Development Grant; National Program for Support of Top-notch Young Professionals	This work was funded by grants from the National Science Foundation of China (81200582, 81322010 and 81300691), Key Discipline of Public Health of Shanghai (12GWZX0104), Excellent Young Medical Expert of Shanghai (XYQ2011041), Shanghai Talent Development Grant (2012041) and the National Program for Support of Top-notch Young Professionals. The authors appreciate all of the participants of this research study. The authors gratefully acknowledge the skillful technical support of all nursing and medical staff at the Shanghai Clinical Center for Diabetes.	Altemtam N, 2012, NEPHROL DIAL TRANSPL, V27, P1847, DOI 10.1093/ndt/gfr561; Arora MK, 2014, CURR DRUG TARGETS, V15, P531, DOI 10.2174/1389450115666140321120635; Bardin T, 2014, CURR OPIN RHEUMATOL, V26, P186, DOI 10.1097/BOR.0000000000000028; BECK LH, 1986, KIDNEY INT, V30, P280, DOI 10.1038/ki.1986.179; Cai XL, 2011, CHINESE MED J-PEKING, V124, P3629, DOI 10.3760/cma.j.issn.0366-6999.2011.22.006; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Chino Y, 2014, BIOPHARM DRUG DISPOS, V35, P391, DOI 10.1002/bdd.1909; Choi HK, 2008, RHEUMATOLOGY, V47, P713, DOI 10.1093/rheumatology/ken066; Feig DI, 2006, J AM SOC NEPHROL, V17, pS69, DOI 10.1681/ASN.2005121331; Filiopoulos V, 2012, RENAL FAILURE, V34, P510, DOI 10.3109/0886022X.2011.653753; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Ito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027817; Jalal DI, 2011, SEMIN NEPHROL, V31, P459, DOI 10.1016/j.semnephrol.2011.08.011; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kao MP, 2011, J AM SOC NEPHROL, V22, P1382, DOI 10.1681/ASN.2010111185; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Miyaoka T, 2014, HEART VESSELS, V29, P504, DOI 10.1007/s00380-013-0396-0; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Sakurai H, 2013, CURR OPIN NEPHROL HY, V22, P545, DOI 10.1097/MNH.0b013e328363ffc8; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Sheikhbahaei S, 2014, METAB SYNDR RELAT D, V12, P102, DOI 10.1089/met.2013.0119; SHICHIRI M, 1990, AM J NEPHROL, V10, P115, DOI 10.1159/000168065; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	35	32	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129797	10.1371/journal.pone.0129797	http://dx.doi.org/10.1371/journal.pone.0129797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029914	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900232
J	Bucchioni, G; Lelard, T; Ahmaidi, S; Godefroy, O; Krystkowiak, P; Mouras, H				Bucchioni, Giulia; Lelard, Thierry; Ahmaidi, Said; Godefroy, Olivier; Krystkowiak, Pierre; Mouras, Harold			Do We Feel the Same Empathy for Loved and Hated Peers?	PLOS ONE			English	Article							PERSPECTIVE-TAKING; NEURAL PROCESSES; PAIN; OTHERS; VALIDATION; RESONANCE; GENDER; BRAIN; SCALE; THINK	Empathy allows us to understand and react to other people's feelings and sensations; we can more accurately judge another person's situation when we are aware of his/her emotions. Empathy for pain is a good working model of the behavioral and neural processes involved in empathy in general. Although the influence of perspective-taking processes (notably "Self" vs. "Other") on pain rating has been studied, the impact of the degree of familiarity with the person representing the "Other" perspective has not been previously addressed. In the present study, we asked participants to adopt four different perspectives: "Self", "Other-Most-Loved-Familiar", "Other-Most-Hated-Familiar" and "Other-Stranger". The results showed that higher pain ratings were attributed to the Other-Most-Loved-Familiar perspective than to the Self, Other-Stranger and Other-Most-Hated-Familiar perspectives. Moreover, participants were quicker to rate pain for the Other-Most-Loved-Familiar perspective and the Self-perspective than for the other two perspectives. These results for a perspective-taking task therefore more clearly define the role of familiarity in empathy for pain.	[Bucchioni, Giulia; Godefroy, Olivier; Krystkowiak, Pierre] CURS, CHU Sud, Lab Neurosci Fonct & Pathol, Univ Picardie Jules Verne,EA 4559, F-80054 Amiens, France; [Godefroy, Olivier; Krystkowiak, Pierre] CHU Amiens, Serv Neurol, F-80054 Amiens, France; [Lelard, Thierry; Ahmaidi, Said] Univ Picardie Jules Verne, UFR Sci Sport, Adaptat Physiol Exercice & Readaptat Effort, EA 3300, F-80025 Amiens, France; [Bucchioni, Giulia; Lelard, Thierry; Ahmaidi, Said; Godefroy, Olivier; Krystkowiak, Pierre; Mouras, Harold] Univ Federale Europeenne Champagne Ardenne Picard, Pole Rech & Enseignement Super, Struct Federat Rech CAP Sante FED 4231, F-51097 Reims, France; [Mouras, Harold] Univ Picardie Jules Verne, Dept Psychol, Ctr Rech Psychol, Cognit Psychisme & Organisat,UFR Sci Humaines Sci, F-80000 Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Mouras, H (corresponding author), Univ Federale Europeenne Champagne Ardenne Picard, Pole Rech & Enseignement Super, Struct Federat Rech CAP Sante FED 4231, F-51097 Reims, France.	harold.mouras@u-picardie.fr	Mouras, Harold/L-8117-2019	Godefroy, Olivier/0000-0001-6789-6620	Regional Council of Picardy; AXA Research Fund	Regional Council of Picardy(Region Hauts-de-France); AXA Research Fund(AXA Research Fund)	This study was supported by a grant from the Regional Council of Picardy (postdoctoral grant to TL) and the AXA Research Fund (PhD grant to GB). The authors thank Jean Decety for the use of his stimuli database. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; ARON A, 1991, J PERS SOC PSYCHOL, V60, P241, DOI 10.1037/0022-3514.60.2.241; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Avenanti A, 2009, CORTEX, V45, P1072, DOI 10.1016/j.cortex.2008.10.004; Azevedo RT, 2013, HUM BRAIN MAPP, V34, P3168, DOI 10.1002/hbm.22133; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; BATSON CD, 1991, J PERS SOC PSYCHOL, V61, P413, DOI 10.1037/0022-3514.61.3.413; Beamesderfer, 1974, ASSESSMENT DEPRESSIO; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Cheng YW, 2010, NEUROIMAGE, V51, P923, DOI 10.1016/j.neuroimage.2010.02.047; Coll MP, 2012, J PAIN, V13, P695, DOI 10.1016/j.jpain.2012.04.009; D'Ambrosio F, 2009, PERS INDIV DIFFER, V46, P160, DOI 10.1016/j.paid.2008.09.020; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, PROG NEUROBIOL, V98, P38, DOI 10.1016/j.pneurobio.2012.05.001; Eisenberg N., 2009, SOCIAL NEUROSCIENCE; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Goubert L, 2008, J PAIN, V9, P272, DOI 10.1016/j.jpain.2007.11.006; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Han SH, 2008, BRAIN RES, V1196, P85, DOI 10.1016/j.brainres.2007.12.062; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Lelard T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00004; Leonard MT, 2006, J PAIN, V7, P377, DOI 10.1016/j.jpain.2006.01.442; Li W, 2010, NEUROSCI LETT, V469, P328, DOI 10.1016/j.neulet.2009.12.021; Montalan B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00389; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Perry A, 2010, COGN AFFECT BEHAV NE, V10, P493, DOI 10.3758/CABN.10.4.493; Preis MA, 2012, EUR J PAIN, V16, P1311, DOI 10.1002/j.1532-2149.2012.00119.x; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Riddell RRP, 2007, J PEDIATR PSYCHOL, V32, P501, DOI 10.1093/jpepsy/jsl049; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Spielberger C. D., 1983, MIND GARDEN, V4061, P261, DOI DOI 10.1002/9780470479216.corpsy0943; Thoma P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00135; Vachon DD, 2015, ASSESSMENT; Van Boven L, 2003, PERS SOC PSYCHOL B, V29, P1159, DOI 10.1177/0146167203254597; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; Yang CY, 2009, BRAIN RES, V1251, P176, DOI 10.1016/j.brainres.2008.11.062; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003556	52	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125871	10.1371/journal.pone.0125871	http://dx.doi.org/10.1371/journal.pone.0125871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024234	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400012
J	Finlay, K; Stoecker, C; Cunningham, S				Finlay, Keith; Stoecker, Charles; Cunningham, Scott			Willingness-To-Accept Pharmaceutical Retail Inconvenience: Evidence from a Contingent Choice Experiment	PLOS ONE			English	Article							METHAMPHETAMINE USE; PRESCRIPTION; PSEUDOEPHEDRINE; PHENYLEPHRINE; BENEFITS; DRUGS	Objectives Restrictions on retail purchases of pseudoephedrine are one regulatory approach to reduce the social costs of methamphetamine production and use, but may impose costs on legitimate users of nasal decongestants. This is the first study to evaluate the costs of restricting access to medications on consumer welfare. Our objective was to measure the inconvenience cost consumers place on restrictions for cold medication purchases including identification requirements, purchase limits, over-the-counter availability, prescription requirements, and the active ingredient. Methods We conducted a contingent choice experiment with Amazon Mechanical Turk workers that presented participants with randomized, hypothetical product prices and combinations of restrictions that reflect the range of public policies. We used a conditional logit model to calculate willingness-to-accept each restriction. Results Respondents' willingness-to-accept prescription requirements was $14.17 ($9.76-$18.58) and behind-the-counter restrictions was $9.68 ($7.03-$12.33) per box of pseudoephedrine product. Participants were willing to pay $4.09 ($1.66-$6.52) per box to purchase pseudoephedrine- based products over phenylephrine-based products. Conclusions Restricting access to medicines as a means of reducing the social costs of non-medical use can imply large inconvenience costs for legitimate consumers. These results are relevant to discussions of retail access restrictions on other medications.	[Finlay, Keith] Tulane Univ, Dept Econ, New Orleans, LA 70118 USA; [Stoecker, Charles] Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Cunningham, Scott] Baylor Univ, Dept Econ, Waco, TX 76798 USA	Tulane University; Tulane University; Baylor University	Stoecker, C (corresponding author), Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	cfstoecker@tulane.edu			National Science Foundation award [SMA-1004569]; Robert Wood Johnson Foundation [70509]	National Science Foundation award(National Science Foundation (NSF)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was supported by the National Science Foundation award SMA-1004569 (www.nsf. gov, KF SC) and the Robert Wood Johnson Foundation (Public Health Law Research award 70509, http://publichealthlawresearch.org/, KF SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Brass EP, 2001, NEW ENGL J MED, V345, P810, DOI 10.1056/NEJMra011080; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cohen JP, 2005, BRIT MED J, V330, P39, DOI 10.1136/bmj.330.7481.39; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; DeShazo JR, 2002, J ENVIRON ECON MANAG, V44, P123, DOI 10.1006/jeem.2001.1199; Eccles R, 2007, BRIT J CLIN PHARMACO, V63, P10, DOI 10.1111/j.1365-2125.2006.02833.x; Hanley N, 1998, J AGR ECON, V49, P1, DOI 10.1111/j.1477-9552.1998.tb01248.x; Hatton RC, 2007, ANN PHARMACOTHER, V41, P381, DOI 10.1345/aph.1H679; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hershey MR, 2009, PS-POLIT SCI POLIT, V42, P87, DOI 10.1017/S1049096509090234; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Iritani BJ, 2007, ADDICTION, V102, P1102, DOI 10.1111/j.1360-0443.2007.01847.x; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Krieger A. M., 1991, MARKET LETT, V2, P337, DOI DOI 10.1007/BF00664220; Krupnikov Yanna., 2014, J EXP POLIT SCI, V1, P59, DOI DOI 10.1017/XPS.2014.7; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Louviere JJ, 2008, J CONSUM RES, V35, P360, DOI 10.1086/586913; Luchini S, 2014, ECON LETT, V124, P9, DOI 10.1016/j.econlet.2014.04.005; McKetin R, 2014, ADDICTION, V109, P798, DOI 10.1111/add.12474; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Prasad M, 2002, VALUE HEALTH, V5, P193, DOI [10.1016/S1098-3015(10)60991-6, DOI 10.1016/S1098-3015(10)60991-6]; Reynolds T, 2002, ANN INTERN MED, V136, P177, DOI 10.7326/0003-4819-136-2-200201150-00026; RYAN M, 1990, HEALTH POLICY, V16, P233, DOI 10.1016/0168-8510(90)90424-C; Shoptaw S, 2007, ADDICTION, V102, P130, DOI 10.1111/j.1360-0443.2006.01775.x; Simons DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051876; Talbert J, 2012, JAMA-J AM MED ASSOC, V308, P1524, DOI 10.1001/jama.2012.12992; [US DEA] United States Drug Enforcement Administration, 2010, FED REGISTER, V75, P79407; [US DEA] United States Drug Enforcement Administration, 2007, 2005 EPH PSEUD LEG M; Wiley JB., 1978, ADV CONSUM RES, V5, P171	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126790	10.1371/journal.pone.0126790	http://dx.doi.org/10.1371/journal.pone.0126790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024444	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400020
J	Sato, S; Ohara, S; Tsutsui, KI; Iijima, T				Sato, Sho; Ohara, Shinya; Tsutsui, Ken-Ichiro; Iijima, Toshio			Effects of G-gene Deletion and Replacement on Rabies Virus Vector Gene Expression	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; MATRIX PROTEIN; TRANSNEURONAL TRACER; IN-VIVO; GLYCOPROTEIN; TRANSCRIPTION; RECOMBINANT; REPLICATION; APOPTOSIS	The glycoprotein-gene (G gene) -deleted rabies virus (RV) vector is a powerful tool to examine the function and structure of neural circuits. We previously reported that the deletion of the G gene enhances the transgene expression level of the RV vector. However, the mechanism of this enhancement remains to be clarified. We presume that there are two possible factors for this enhancement. The first factor is the glycoprotein of RV, which shows cytotoxicity; thus, may cause a dysfunction in the translation process of infected cells. The second possible factor is the enhanced expression of the L gene, which encodes viral RNA polymerase. In the RV, it is known that the gene expression level is altered depending on the position of the gene. Since G-gene deletion displaces the L gene in the genome, the expression of the L gene and viral transcription may be enhanced. In this study, we compared the transgene expression level and viral transcription of three recombinant RV vectors. The effect of glycoprotein was examined by comparing the viral gene expression of G-gene-intact RV and G-gene-replaced RV. Despite the fact that the L-gene transcription level of these two RV vectors was similar, the G-gene-replaced RV vector showed higher viral transcription and transgene expression level than the G-gene-intact RV vector. To examine the effect of the position of the L gene, we compared the viral gene expression of the G-gene-deleted RV and G-gene-replaced RV. The G-gene-deleted RV vector showed higher L-gene transcription, viral transcription, and transgene expression level than the G-gene-replaced RV vector. These results indicate that G-gene deletion enhances the transgene expression level through at least two factors, the absence of glycoprotein and enhancement of L-gene expression. These findings enable investigators to design a useful viral vector that shows a controlled desirable transgene expression level in applications.	[Sato, Sho; Ohara, Shinya; Tsutsui, Ken-Ichiro; Iijima, Toshio] Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan	Tohoku University	Iijima, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan.	t-iijima@m.tohoku.ac.jp	Tsutsui, Ken-Ichiro/B-4378-2008; Ohara, Shinya/AAW-9705-2021	Tsutsui, Ken-Ichiro/0000-0001-5781-2948; Ohara, Shinya/0000-0003-0681-5086	Institute for International Advanced Research and Education of Tohoku University; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24333004];  [25119001]	Institute for International Advanced Research and Education of Tohoku University; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported by Research fund for IIARE doctoral course students from the Institute for International Advanced Research and Education of Tohoku University, and by Grant-in-Aid for Scientific Research (KAKENHI) #24333004 from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The study was partly supported by Grants-in-Aid for Scientific Research on Innovative Areas (#25119001). The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; BALL LA, 1976, P NATL ACAD SCI USA, V73, P442, DOI 10.1073/pnas.73.2.442; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Faber M, 2002, J VIROL, V76, P3374, DOI 10.1128/JVI.76.7.3374-3381.2002; Faber M, 2007, J VIROL, V81, P7041, DOI 10.1128/JVI.00357-07; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Finke S, 2003, J VIROL, V77, P12074, DOI 10.1128/JVI.77.22.12074-12082.2003; Finke S, 2003, J GEN VIROL, V84, P1613, DOI 10.1099/vir.0.19128-0; Ginger M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00002; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; Inoue K, 2004, SOC NEUR ABSTR, V124, P12; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morimoto K, 2000, J NEUROVIROL, V6, P373, DOI 10.3109/13550280009018301; Morimoto K, 2011, MICROBIOL IMMUNOL, V55, P558, DOI 10.1111/j.1348-0421.2011.00354.x; Nakahara K, 1999, MICROBIOL IMMUNOL, V43, P259, DOI 10.1111/j.1348-0421.1999.tb02402.x; Ohara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080245; Ohara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078928; Ohara S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.001.2009; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Pulmanausahakul R, 2008, J VIROL, V82, P2330, DOI 10.1128/JVI.02327-07; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3332; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; WIKTOR TJ, 1984, DEV BIOLOGICALS, V57, P199	41	0	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128020	10.1371/journal.pone.0128020	http://dx.doi.org/10.1371/journal.pone.0128020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023771	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400064
J	Chen, JJ; Wu, SD; Wen, S; Shen, LJ; Peng, JP; Yan, C; Cao, XN; Zhou, Y; Long, CL; Lin, T; He, DW; Hua, Y; Wei, GH				Chen, Jinjun; Wu, Shengde; Wen, Sheng; Shen, Lianju; Peng, Jinpu; Yan, Chao; Cao, Xining; Zhou, Yue; Long, Chunlan; Lin, Tao; He, Dawei; Hua, Yi; Wei, Guanghui			The Mechanism of Environmental Endocrine Disruptors (DEHP) Induces Epigenetic Transgenerational Inheritance of Cryptorchidism	PLOS ONE			English	Article							DI-2-(ETHYLHEXYL) PHTHALATE; EXPRESSION; CANCER; CELLS; MICE	Discussion on the role of DEHP in the critical period of gonadal development in pregnant rats (F0), studied the evolution of F1-F4 generation of inter-generational inheritance of cryptorchidism and the alteration of DNA methylation levels in testis. Pregnant SD rats were randomly divided into two groups: normal control group and DEHP experimental group. From pregnancy 7d to 19d, experimental group was sustained to gavage DEHP 750mg/kg bw/day, observed the incidence of cryptorchidism in offspring and examined the pregnancy rate of female rats through mating experiments. Continuous recording the rat's weight and AGD value, after maturation (PND80) recording testis and epididymis' size and weight, detected the sperm number and quality. Subsequently, we examined the evolution morphological changes of testicular tissue for 4 generation rats by HE staining and Western Blot. Completed the MeDIP-sequencing analysis of 6 samples (F1 generation, F4 generation and Control). DEHP successfully induced cryptorchidism occurrence in offspring during pregnancy. The incidence of cryptorchidism in F1 was 30%, in F2 was 12.5%, and there was no cryptorchidism coming up in F3 and F4. Mating experiment shows conception rate 50% in F1, F2 generation was 75%, the F3 and F4 generation were 100%. HE staining showed that the seminiferous epithelium of F1 generation was atrophy and with a few spermatogenic cell, F2 generation had improved, F3 and F4 generation were tend to be normal. The DNA methyltransferase expression was up-regulated with the increase of generations by Real Time-PCR, immunohistochemistry and Western Blot. MeDIP-seq Data Analysis Results show many differentially methylated DNA sequences between F1 and F4. DEHP damage male reproductive function in rats, affect expression of DNA methyltransferase enzyme, which in turn leads to genomic imprinting methylation pattern changes and passed on to the next generation, so that the offspring of male reproductive system critical role in the development of imprinted genes imbalances, and eventually lead to producing offspring cryptorchidism. This may be an important mechanism of reproductive system damage.	[Chen, Jinjun; Wu, Shengde; Wen, Sheng; Shen, Lianju; Peng, Jinpu; Yan, Chao; Cao, Xining; Zhou, Yue; Long, Chunlan; Lin, Tao; He, Dawei; Hua, Yi; Wei, Guanghui] Chongqing Med Univ, Minist Educ, Key Lab Child Dev & Disorders, Dept Pediat Res Inst,Childrens Hosp, Chongqing, Peoples R China	Chongqing Medical University	Hua, Y (corresponding author), Chongqing Med Univ, Minist Educ, Key Lab Child Dev & Disorders, Dept Pediat Res Inst,Childrens Hosp, Chongqing, Peoples R China.	525107529@qq.com; ghwei@cqmu.edu.cn	he, dawei/GZK-8280-2022		national natural science funds [81070475]	national natural science funds(National Natural Science Foundation of China (NSFC))	The project by the national natural science funds, grant numbers: 81070475, and http://isisn.nsfc.gov.cn/egrantweb/.	Bai-lin C, 2011, REPROD CONTRACEPTION; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Bhullar JS, 2013, INT J CASE REPORTS I, V3, P21; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Gannon JR, 2014, ADV EXP MED BIOL, V791, P53, DOI 10.1007/978-1-4614-7783-9_4; Guerrero-Bosagna C, 2014, CURR OPIN GENET DEV, V26, P79, DOI 10.1016/j.gde.2014.06.005; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Jeng HA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00055; Kim Kyeoung-Hwa, 2014, Clin Exp Reprod Med, V41, P47, DOI 10.5653/cerm.2014.41.2.47; Li S, ASS PHTHALATE EXPOSU; Lip SZL, 2013, ARCH DIS CHILD, V98, P20, DOI 10.1136/archdischild-2012-302051; Marques-Pinto A, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0036; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Raudsepp T., 2013, Equine genomics, P199; Rissman EF, 2014, ENDOCRINOLOGY; [吴盛德 Sheng-de WU], 2009, [生殖与避孕, Reproduction and Contraception], V29, P502; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Song XF, 2008, J INT MED RES, V36, P512, DOI 10.1177/147323000803600316; Song XF, 2006, REPROD CONTRACEPTION, P712; Vilahur N, 2014, ENVIRON INT, V71, P81, DOI 10.1016/j.envint.2014.06.006; Wan S, 2014, PEDIATRICS, V133, pE624, DOI 10.1542/peds.2013-2285; Wu SD, 2010, INT J TOXICOL, V29, P193, DOI 10.1177/1091581809355488; Wu SD, 2010, BASIC CLIN PHARMACOL, V106, P118, DOI 10.1111/j.1742-7843.2009.00483.x	27	49	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0126403	10.1371/journal.pone.0126403	http://dx.doi.org/10.1371/journal.pone.0126403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035430	gold, Green Submitted, Green Published			2022-12-27	WOS:000355699100006
J	Lyons, R; Rusu, A; Stiller, J; Powell, J; Manners, JM; Kazan, K				Lyons, Rebecca; Rusu, Anca; Stiller, Jiri; Powell, Jonathan; Manners, John M.; Kazan, Kemal			Investigating the Association between Flowering Time and Defense in the Arabidopsis thaliana-Fusarium oxysporum Interaction	PLOS ONE			English	Article							CIS-REGULATORY VARIATION; DISEASE-RESISTANCE; TRANSCRIPTION FACTOR; AUTONOMOUS PATHWAY; CIRCADIAN CLOCK; PLANT DEFENSE; LOCUS-D; FLORAL TRANSITION; SYMPTOM RESPONSE; INNATE IMMUNITY	Plants respond to pathogens either by investing more resources into immunity which is costly to development, or by accelerating reproductive processes such as flowering time to ensure reproduction occurs before the plant succumbs to disease. In this study we explored the link between flowering time and pathogen defense using the interaction between Arabidopsis thaliana and the root infecting fungal pathogen Fusarium oxysporum. We report that F. oxysporum infection accelerates flowering time and regulates transcription of a number of floral integrator genes, including FLOWERING LOCUS C (FLC), FLOWERING LOCUS T (FT) and GIGANTEA (GI). Furthermore, we observed a positive correlation between late flowering and resistance to F. oxysporum in A. thaliana natural ecotypes. Late-flowering gi and autonomous pathway mutants also exhibited enhanced resistance to F. oxysporum, supporting the association between flowering time and defense. However, epistasis analysis showed that accelerating flowering time by deletion of FLC in fve-3 or fpa-7 mutants did not alter disease resistance, suggesting that the effect of autonomous pathway on disease resistance occurs independently from flowering time. Indeed, RNA-seq analyses suggest that fve-3 mediated resistance to F. oxysporum is most likely a result of altered defense-associated gene transcription. Together, our results indicate that the association between flowering time and pathogen defense is complex and can involve both pleiotropic and direct effects.	[Lyons, Rebecca; Rusu, Anca; Stiller, Jiri; Powell, Jonathan; Kazan, Kemal] CSIRO Agr Flagship, Queensland Biosci Precinct, Brisbane, Qld 4067, Australia; [Manners, John M.] CSIRO Agr Flagship, Black Mt Labs, Canberra, ACT 2601, Australia; [Kazan, Kemal] Univ Queensland, QAAFI, Brisbane, Qld 4067, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Lyons, R (corresponding author), CSIRO Agr Flagship, Queensland Biosci Precinct, Brisbane, Qld 4067, Australia.	rebeccalyons23@hotmail.com	Manners, John M/A-4922-2008; Kazan, Kemal/B-8032-2008; Stiller, Jiri/E-1564-2012	Kazan, Kemal/0000-0002-5169-8934; Powell, Jonathan/0000-0002-6222-8030	CSIRO OCE Postdoctoral Fellowship	CSIRO OCE Postdoctoral Fellowship	This work was supported by CSIRO OCE Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; Cecchini E, 2002, MOL PLANT PATHOL, V3, P81, DOI 10.1046/j.1464-6722.2001.00097.x; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Chin K, 2013, PLANT PHYSIOL, V163, P611, DOI 10.1104/pp.113.225680; Cole SJ, 2014, MOL PLANT PATHOL, V15, P589, DOI 10.1111/mpp.12117; Cole SJ, 2013, NEW PHYTOL, V200, P172, DOI 10.1111/nph.12368; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Coppinger P, 2004, PLANT J, V40, P225, DOI 10.1111/j.1365-313X.2004.02203.x; Czymmek KJ, 2007, FUNGAL GENET BIOL, V44, P1011, DOI 10.1016/j.fgb.2007.01.012; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; De Bruyne L, 2014, MOL PLANT, V7, P943, DOI 10.1093/mp/ssu050; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Diener AC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-171; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duc C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003867; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fornara F, 2015, PLANT J, V81, P695, DOI 10.1111/tpj.12759; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Gangappa SN, 2010, PLANT SIGNAL BEHAV, V5, P1650, DOI 10.4161/psb.5.12.13981; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Gu XF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002366; Haffner E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-235; Hua J, 2013, CURR OPIN PLANT BIOL, V16, P406, DOI 10.1016/j.pbi.2013.06.017; Jeon J, 2011, MOL CELLS, V32, P227, DOI 10.1007/s10059-011-1022-6; Keatley MR, 2012, AUSTRAL ECOL, V37, P825, DOI 10.1111/j.1442-9993.2011.02344.x; Kenzior A, 2015, PLANT MOL BIOL, V87, P329, DOI 10.1007/s11103-014-0280-z; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kim HG, 2014, FEBS LETT, V588, P1652, DOI 10.1016/j.febslet.2014.02.062; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kim WY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2357; Korves TM, 2003, PLANT PHYSIOL, V133, P339, DOI 10.1104/pp.103.027094; Kurepa J, 1998, PLANT GROWTH REGUL, V26, P91, DOI 10.1023/A:1006043914056; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li L, 2012, GENE, V506, P50, DOI 10.1016/j.gene.2012.06.070; Li PJ, 2014, GENE DEV, V28, P1635, DOI 10.1101/gad.245993.114; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Li Y, 2014, GENETICS, V196, P569, DOI 10.1534/genetics.113.157628; Liu LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089799; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121902; Lyons R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02866; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; Martinez C, 2004, PLANT J, V37, P209, DOI 10.1046/j.1365-313X.2003.01954.x; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Ogawara T, 2003, J PLANT PHYSIOL, V160, P1335, DOI 10.1078/0176-1617-01129; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pazhouhandeh M, 2011, P NATL ACAD SCI USA, V108, P3430, DOI 10.1073/pnas.1018242108; Putarjunan A, 2014, PLANT PHYSIOL, V166, P2115, DOI 10.1104/pp.114.250647; Riboni M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29036; Riboni M, 2013, PLANT PHYSIOL, V162, P1706, DOI 10.1104/pp.113.217729; Rosas U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4651; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Schiestl FP, 2014, NEW PHYTOL, V203, P257, DOI 10.1111/nph.12783; Schwartz C, 2009, GENETICS, V183, P723, DOI 10.1534/genetics.109.104984; Shen YP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003525; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Singh V, 2014, J BIOSCIENCES, V39, P119, DOI 10.1007/s12038-013-9407-7; Singh V, 2013, MOL PLANT MICROBE IN, V26, P1079, DOI 10.1094/MPMI-04-13-0096-R; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Sonmez C, 2011, P NATL ACAD SCI USA, V108, P8508, DOI 10.1073/pnas.1105334108; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Stinchcombe JR, 2005, AM J BOT, V92, P1701, DOI 10.3732/ajb.92.10.1701; Strange A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019949; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Takahashi H, 2012, MOL PLANT MICROBE IN, V25, P1171, DOI 10.1094/MPMI-04-12-0076-R; Thatcher LF, 2012, PLANT PHYSIOL, V160, P407, DOI 10.1104/pp.112.199067; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsuchiya T, 2010, PLANT J, V62, P518, DOI 10.1111/j.1365-313X.2010.04169.x; Veronese P, 2003, PLANT J, V35, P574, DOI 10.1046/j.1365-313X.2003.01830.x; Wagner MR, 2014, ECOL LETT, V17, P717, DOI 10.1111/ele.12276; Wang GF, 2011, PLANT PHYSIOL, V156, P1508, DOI 10.1104/pp.111.176776; Wang WF, 2014, CELL HOST MICROBE, V15, P401, DOI 10.1016/j.chom.2014.03.014; Wilson DC, 2013, PLANT MOL BIOL, V83, P235, DOI 10.1007/s11103-013-0083-7; Wilson IW, 2005, PLANT CELL PHYSIOL, V46, P1190, DOI 10.1093/pcp/pci128; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Yang CH, 1999, PLANT CELL PHYSIOL, V40, P647, DOI 10.1093/oxfordjournals.pcp.a029588; Yang X, 2010, FRONT BIOL, V7, P155; Yang YJ, 2014, PLANT CELL, V26, P2038, DOI 10.1105/tpc.114.124867; Yu CW, 2011, PLANT PHYSIOL, V156, P173, DOI 10.1104/pp.111.174417; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zhang X, 2014, ANN APPL BIOL, V164, P384, DOI 10.1111/aab.12107; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	100	46	46	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127699	10.1371/journal.pone.0127699	http://dx.doi.org/10.1371/journal.pone.0127699			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034991	gold, Green Submitted, Green Published			2022-12-27	WOS:000355699100019
J	Stetina, T; Kostal, V; Korbelova, J				Stetina, Tomas; Kostal, Vladimir; Korbelova, Jaroslava			The Role of Inducible Hsp70, and Other Heat Shock Proteins, in Adaptive Complex of Cold Tolerance of the Fruit Fly (Drosophila melanogaster)	PLOS ONE			English	Article							UP-REGULATION; GENE-EXPRESSION; CHILLING INJURY; FLESH FLY; TRANSCRIPTION FACTORS; TEMPORAL EXPRESSION; ION HOMEOSTASIS; STRESS-RESPONSE; PUPAL DIAPAUSE; MESSENGER-RNA	Background The ubiquitous occurrence of inducible Heat Shock Proteins (Hsps) up-regulation in response to cold-acclimation and/or to cold shock, including massive increase of Hsp70 mRNA levels, often led to hasty interpretations of its role in the repair of cold injury expressed as protein denaturation or misfolding. So far, direct functional analyses in Drosophila melanogaster and other insects brought either limited or no support for such interpretations. In this paper, we analyze the cold tolerance and the expression levels of 24 different mRNA transcripts of the Hsps complex and related genes in response to cold in two strains of D. melanogaster: the wild-type and the Hsp70(-) null mutant lacking all six copies of Hsp70 gene. Principal Findings We found that larvae of both strains show similar patterns of Hsps complex gene expression in response to long-term cold-acclimation and during recovery from chronic cold exposures or acute cold shocks. No transcriptional compensation for missing Hsp70 gene was seen in Hsp70(-) strain. The cold-induced Hsps gene expression is most probably regulated by alternative splice variants C and D of the Heat Shock Factor. The cold tolerance in Hsp70(-) null mutants was clearly impaired only when the larvae were exposed to severe acute cold shock. No differences in mortality were found between two strains when the larvae were exposed to relatively mild doses of cold, either chronic exposures to 0 degrees C or acute cold shocks at temperatures down to -4 degrees C. Conclusions The up-regulated expression of a complex of inducible Hsps genes, and Hsp70 mRNA in particular, is tightly associated with cold-acclimation and cold exposure in D. melanogaster. Genetic elimination of Hsp70 up-regulation response has no effect on survival of chronic exposures to 0 degrees C or mild acute cold shocks, while it negatively affects survival after severe acute cold shocks at temperaures below -8 degrees C.	[Stetina, Tomas; Kostal, Vladimir; Korbelova, Jaroslava] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Stetina, Tomas] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Kostal, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	kostal@entu.cas.cz	Stetina, Tomas/AAB-5364-2021; Kostal, Vladimir/G-6688-2014	Stetina, Tomas/0000-0001-7289-5534; Kostal, Vladimir/0000-0002-4994-5123	Czech Science Foundation [13-01057S]; Ministry of Education, Youth and Sports of the Czech Republic [KONTAKT II LH 12103]; University of South Bohemia [GAJU 038/2014/P]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); University of South Bohemia	This work was supported by the Czech Science Foundation (http://www.gacr.cz/en/) grant 13-01057S to V.K. and by Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/research-and-development-1) grant KONTAKT II LH 12103 to V.K. The work of T.S. was supported by University of South Bohemia (https://www.jcu.cz/?set_language=en) grant GAJU 038/2014/P.	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Bettencourt BR, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-5; Bing X, 2012, INSECT MOL BIOL, V21, P31, DOI 10.1111/j.1365-2583.2011.01108.x; BURTON V, 1988, MOL CELL BIOL, V8, P3550, DOI 10.1128/MCB.8.8.3550; Colinet H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032606; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Colinet H, 2010, INSECT BIOCHEM MOLEC, V40, P425, DOI 10.1016/j.ibmb.2010.03.002; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Coulson M, 2005, GENETICS, V171, P1799, DOI 10.1534/genetics.105.043265; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Denlinger D.L., 1991, P174; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Emerson KJ, 2009, J COMP PHYSIOL A, V195, P825, DOI 10.1007/s00359-009-0460-5; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; Feder ME, 1998, AM ZOOL, V38, P503; Feder ME, 2005, J EVOLUTION BIOL, V18, P901, DOI 10.1111/j.1420-9101.2005.00921.x; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Goto SG, 1998, J INSECT PHYSIOL, V44, P1009, DOI 10.1016/S0022-1910(97)00143-1; Goto SG, 1998, J INSECT PHYSIOL, V44, P1233, DOI 10.1016/S0022-1910(98)00101-2; Goto SG, 2001, GENE, V270, P259, DOI 10.1016/S0378-1119(01)00465-6; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hayward SAL, 2007, ADV EXP MED BIOL, V594, P132; Hayward SAL, 2014, CURR OPIN INSECT SCI, V4, P35, DOI 10.1016/j.cois.2014.08.005; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; ISHHOROWICZ D, 1979, CELL, V17, P565, DOI 10.1016/0092-8674(79)90264-2; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kelty JD, 2001, J EXP BIOL, V204, P1659; KNIGHT JD, 1986, CRYO-LETT, V7, P194; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Kostal Vladimir, 2010, P116, DOI 10.1017/CBO9780511675997.006; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Krebs RA, 1997, J EXP BIOL, V200, P2007; Lalouette L, 2011, COMP BIOCHEM PHYS A, V158, P229, DOI 10.1016/j.cbpa.2010.11.007; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee Richard E. Jr, 2010, P3, DOI 10.1017/CBO9780511675997.002; Lee Richard E. Jr, 2010, P35, DOI 10.1017/CBO9780511675997.003; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lindsley D.L., 1968, GENETIC VARIATIONS D, V627; MacMillan HA, 2012, P NATL ACAD SCI USA, V109, P20750, DOI 10.1073/pnas.1212788109; MacMillan HA, 2011, J EXP BIOL, V214, P726, DOI 10.1242/jeb.051540; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Muldrew K, 2004, LIFE IN THE FROZEN STATE, P67, DOI 10.1201/9780203647073.ch2; Nielsen MM, 2005, J INSECT PHYSIOL, V51, P1320, DOI 10.1016/j.jinsphys.2005.08.002; PALTER KB, 1986, MOL CELL BIOL, V6, P1187, DOI 10.1128/MCB.6.4.1187; Papaconstantinou M, 2005, MOL CELL BIOL, V25, P9960, DOI 10.1128/MCB.25.22.9960-9972.2005; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rojas RR, 1996, CRYOBIOLOGY, V33, P447, DOI 10.1006/cryo.1996.0045; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; SOMME L, 1982, COMP BIOCHEM PHYS A, V73, P519, DOI 10.1016/0300-9629(82)90260-2; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Storey K.B., 1991, P64; Teets NM, 2013, PHYSIOL ENTOMOL, V38, P105, DOI 10.1111/phen.12019; Tsai CJ, 2002, CRIT REV BIOCHEM MOL, V37, P55, DOI 10.1080/10409230290771456; Udaka H, 2013, INSECT MOL BIOL, V22, P541, DOI 10.1111/imb.12044; Vesala L, 2012, INSECT MOL BIOL, V21, P107, DOI 10.1111/j.1365-2583.2011.01119.x; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Weber MHW, 2002, NUCLEIC ACIDS RES, V30, P375, DOI 10.1093/nar/30.1.375; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wisniewski J, 1996, NUCLEIC ACIDS RES, V24, P367, DOI 10.1093/nar/24.2.367; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yi SX, 2007, APOPTOSIS, V12, P1183, DOI 10.1007/s10495-006-0048-2; Yocum GD, 2006, J INSECT PHYSIOL, V52, P1113, DOI 10.1016/j.jinsphys.2006.07.010; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; Yocum GD, 1998, INSECT BIOCHEM MOLEC, V28, P677, DOI 10.1016/S0965-1748(98)00046-0; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	93	46	50	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128976	10.1371/journal.pone.0128976	http://dx.doi.org/10.1371/journal.pone.0128976			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034990	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100059
J	Zimmer, S; Kirchner, G; Bizhang, M; Benedix, M				Zimmer, Stefan; Kirchner, Georg; Bizhang, Mozhgan; Benedix, Mathias			Influence of Various Acidic Beverages on Tooth Erosion. Evaluation by a New Method	PLOS ONE			English	Article							DENTAL EROSION; WEAR; PREVALENCE; ADOLESCENTS; CHILDREN	Material & Methods We have analyzed the loss of enamel and dentine after exposure to different non-alcoholic drinks with a simple new method using bovine teeth. 100 enamel and 100 dentine specimens from freshly extracted bovine incisors were randomly attributed to 10 groups (n=10 for enamel and dentine each). Prior to the start of the experiment all specimens were weighed using a precision balance. The mean initial masses (SD) were 35.8 mg (7.2) for enamel and 24.7 mg (7.0) for dentine. No statistically significant differences were found between groups for initial masses (p>0.05, ANOVA with Bonferroni post hoc test). Thereafter, all specimens of one group were simultaneously placed in 200 ml of the following fluids: Coca-Cola, Coca-Cola light, Sprite, apple juice, Red Bull, orange juice, Bonaqua Fruits (Mango-Acai), tap water, chlorinated swimming pool water, and lemon juice. Fluids were continuously ventilated at 37 degrees C for 7 days. Thereafter the specimens were weighed again and the mean mass loss was calculated. Results The values were (enamel/dentine): Coca-Cola 7.5 mg/6.6 mg; Coca-Cola light 5.2 mg/3.5 mg, Sprite 26.1 mg/17.7 mg, apple juice 27.1 mg/15.2 mg, Red Bull 16.6 mg/17.0 mg, orange juice 24.3 mg/20.2 mg, Bonaqua Fruits (Mango-Acai) 17.8 mg/16.2 mg, tap water -0.2 mg/-0.3 mg, swimming pool water -0.3 mg/-0.2 mg, and lemon juice 32.0 mg/28.3 mg. From all drinks, Cola and Cola light showed the least erosivity (p<0.001, ANOVA with Bonferroni post hoc test) whereas lemon juice showed statistically significant higher erosivity than all other drinks except Sprite and apple juice (p<0.01, ANOVA with Bonferroni post hoc test). Conclusions In conclusion, erosivity of common non-alcoholic drinks varies widely. For example, Sprite, apple juice, and orange juice are about five times more erosive than Coca-Cola light. The findings from the present study should be taken into account in choosing a diet that provides satisfactory nutrition while minimizing tooth erosion.	[Zimmer, Stefan; Kirchner, Georg; Bizhang, Mozhgan; Benedix, Mathias] Univ Witten Herdecke, Sch Dent, Dept Operat & Prevent Dent, Witten, Germany	Witten Herdecke University	Zimmer, S (corresponding author), Univ Witten Herdecke, Sch Dent, Dept Operat & Prevent Dent, Alfred Herrhausen Str 50, Witten, Germany.	stefan.zimmer@uni-wh.de						Barbour ME, 2014, MONOGR ORAL SCI, V25, P143, DOI 10.1159/000359941; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS27, DOI 10.1007/s00784-007-0177-1; Bowes JH, 1935, BIOCHEM J, V29, P102, DOI 10.1042/bj0290102; Chorzempa Michael W., 2006, VIERTE DTSCH MUNDGES, P1; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; Gambon DL, 2012, BRIT DENT J, V213, P55, DOI 10.1038/sj.bdj.2012.613; Geurtsen W, 2000, AM J DENT, V13, P291; Habib M, 2013, J CLIN PEDIATR DENT, V38, P143, DOI 10.17796/jcpd.38.2.4300111x4321l313; HOPPENBROUWERS PMM, 1986, J DENT RES, V65, P955, DOI 10.1177/00220345860650071101; Jaeggi T, 2014, MONOGR ORAL SCI, V25, P55, DOI 10.1159/000360973; Jager DHJ, 2012, J DENT, V40, P1103, DOI 10.1016/j.jdent.2012.09.004; Jensdottir I, 2006, J DENT RES, V85, P226, DOI 10.1177/154405910608500304; Li HF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042626, 10.1371/journal.pone.0048872]; Lussi A, 2014, MONOGR ORAL SCI, V25, P1, DOI 10.1159/000360380; Mulic A, 2012, EUR J ORAL SCI, V120, P531, DOI 10.1111/j.1600-0722.2012.00997.x; Salas MMS, 2015, J DENT, V43, P42, DOI 10.1016/j.jdent.2014.10.012; Schlueter N, 2011, CARIES RES, V45, P13, DOI 10.1159/000326819; Schmidt-Nielsen B, 1946, ACTA ODONTOL SCAND, V7; Shellis RP, 2011, CARIES RES, V45, P69, DOI 10.1159/000325971; Smith BGN, 1997, J PROSTHET DENT, V78, P367, DOI 10.1016/S0022-3913(97)70043-X; Vered Y, 2014, CLIN ORAL INVEST, V18, P1985, DOI 10.1007/s00784-013-1175-0; von Fraunhofer J Anthony, 2005, Gen Dent, V53, P28; von Fraunhofer J Anthony, 2004, Gen Dent, V52, P308; Wegehaupt F, 2008, J ORAL REHABIL, V35, P390, DOI 10.1111/j.1365-2842.2007.01843.x; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th	25	25	27	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129462	10.1371/journal.pone.0129462	http://dx.doi.org/10.1371/journal.pone.0129462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035729	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100072
J	Kawano, A; Kadomatsu, R; Ono, M; Kojima, S; Tsukimoto, M; Sakamoto, H				Kawano, Ayumi; Kadomatsu, Remi; Ono, Miyu; Kojima, Shuji; Tsukimoto, Mitsutoshi; Sakamoto, Hikaru			Autocrine Regulation of UVA-Induced IL-6 Production via Release of ATP and Activation of P2Y Receptors	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; PURINERGIC RECEPTORS; PROTEIN-KINASE; LYSOPHOSPHATIDIC ACID; SIGNALING PATHWAYS; DERMAL FIBROBLASTS; ULTRAVIOLET-LIGHT; SOLAR-RADIATION; SKIN; INTERLEUKIN-6	Extracellular nucleotides, such as ATP, are released from cells in response to various stimuli and act as intercellular signaling molecules through activation of P2 receptors. Exposure to the ultraviolet radiation A (UVA) component of sunlight causes molecular and cellular damage, and in this study, we investigated the involvement of extracellular nucleotides and P2 receptors in the UVA-induced cellular response. Human keratinocyte-derived HaCaT cells were irradiated with a single dose of UVA (2.5 J/cm(2)), and ATP release and interleukin (IL)-6 production were measured. ATP was released from cells in response to UVA irradiation, and the release was blocked by pretreatment with inhibitors of gap junction hemichannels or P2X7 receptor antagonist. IL-6 production was increased after UVA irradiation, and this increase was inhibited by ecto-nucleotidase or by antagonists of P2Y11 or P2Y13 receptor. These results suggest that UVA-induced IL-6 production is mediated by release of ATP through hemichannels and P2X7 receptor, followed by activation of P2Y11 and P2Y13 receptors. Interestingly, P2Y11 and P2Y13 were associated with the same pattern of IL-6 production, though they trigger different intracellular signaling cascades: Ca2+-dependent and PI3K-dependent, respectively. Thus, IL-6 production in response to UVA-induced ATP release involves at least two distinct pathways, mediated by activation of P2Y11 and P2Y13 receptors.	[Kawano, Ayumi; Kadomatsu, Remi; Ono, Miyu; Sakamoto, Hikaru] Kitasato Univ, Sch Pharm, Radioisotope Res Lab, Minato Ku, Tokyo, Japan; [Kojima, Shuji] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Radiat Biosci, Noda, Chiba 278, Japan	Kitasato University; Tokyo University of Science	Sakamoto, H (corresponding author), Kitasato Univ, Sch Pharm, Radioisotope Res Lab, Minato Ku, Tokyo, Japan.	sakamotohi@pharm.kitasato-u.ac.jp			Japan Society for the Promotion of Science [26860147]; Kitasato University; Grants-in-Aid for Scientific Research [26860147] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kitasato University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Parts of this work were supported by a Grant-in-Aid for Young Scientists (B) (No. 26860147) from Japan Society for the Promotion of Science and Kitasato University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; An L, 2010, PHOTODERMATOL PHOTO, V26, P28, DOI 10.1111/j.1600-0781.2009.00481.x; Bachelor MA, 2004, SEMIN CANCER BIOL, V14, P131, DOI 10.1016/j.semcancer.2003.09.017; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Barr TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056744; Bellei B, 2008, EXP DERMATOL, V17, P115, DOI 10.1111/j.1600-0625.2007.00662.x; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; Cho Jun-Lae, 2012, Photochem Photobiol Sci, V11, P309, DOI 10.1039/c1pp05265a; Chou CH, 2005, CARCINOGENESIS, V26, P45, DOI 10.1093/carcin/bgh301; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; Fagot D, 2004, PHOTOCHEM PHOTOBIOL, V79, P499, DOI 10.1562/YG-03-11-R1.1; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; GILCHREST BA, 1992, BRIT J DERMATOL, V127, P25, DOI 10.1111/j.1365-2133.1992.tb16984.x; GOLIGER JA, 1994, DEV DYNAM, V200, P1, DOI 10.1002/aja.1002000102; Greig AVH, 2003, J INVEST DERMATOL, V120, P1007, DOI 10.1046/j.1523-1747.2003.12261.x; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; He YY, 2004, J BIOL CHEM, V279, P53867, DOI 10.1074/jbc.M405781200; Hwang YP, 2011, J DERMATOL SCI, V61, P23, DOI 10.1016/j.jdermsci.2010.10.016; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee Y, 2009, J INVEST DERMATOL, V129, P460, DOI 10.1038/jid.2008.261; Lyubchenko T, 2011, AM J PHYSIOL-CELL PH, V300, pC266, DOI 10.1152/ajpcell.00237.2010; Ohshima Y, 2012, J RADIAT RES, V53, P551, DOI 10.1093/jrr/rrs014; Onami K, 2014, J INVEST DERMATOL, V134, P1951, DOI 10.1038/jid.2014.93; Ortega F, 2011, NEUROPHARMACOLOGY, V61, P1210, DOI 10.1016/j.neuropharm.2011.07.010; Parisi AV, 2000, J PHOTOCH PHOTOBIO B, V54, P126, DOI 10.1016/S1011-1344(00)00006-3; Ralevic V, 1998, PHARMACOL REV, V50, P413; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SCHARFFETTER K, 1991, ARCH DERMATOL RES, V283, P506, DOI 10.1007/BF00371923; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Takai E, 2011, RADIAT RES, V175, P358, DOI 10.1667/RR2375.1; Takashima A, 1996, PHOTOCHEM PHOTOBIOL, V63, P397, DOI 10.1111/j.1751-1097.1996.tb03054.x; Takeda H, 1999, EMBO J, V18, P386, DOI 10.1093/emboj/18.2.386; Tsukimoto M, 2010, RADIAT RES, V173, P298, DOI 10.1667/RR1732.1; URBANSKI A, 1990, J INVEST DERMATOL, V94, P808, DOI 10.1111/1523-1747.ep12874666; WLASCHEK M, 1993, J INVEST DERMATOL, V101, P164, DOI 10.1111/1523-1747.ep12363644; Wolfle U, 2012, REJUV RES, V15, P466, DOI 10.1089/rej.2011.1309; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008	46	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127919	10.1371/journal.pone.0127919	http://dx.doi.org/10.1371/journal.pone.0127919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030257	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900090
J	Smith, AMC; Yang, CG; Ma, HB; Culverhouse, P; Cangelosi, A; Burdet, E				Smith, Alex M. C.; Yang, Chenguang; Ma, Hongbin; Culverhouse, Phil; Cangelosi, Angelo; Burdet, Etienne			Novel Hybrid Adaptive Controller for Manipulation in Complex Perturbation Environments	PLOS ONE			English	Article							UNSTABLE DYNAMICS; IMPEDANCE CONTROL; FUZZY; SYSTEMS	In this paper we present a hybrid control scheme, combining the advantages of task-space and joint-space control. The controller is based on a human-like adaptive design, which minimises both control effort and tracking error. Our novel hybrid adaptive controller has been tested in extensive simulations, in a scenario where a Baxter robot manipulator is affected by external disturbances in the form of interaction with the environment and tool-like end-effector perturbations. The results demonstrated improved performance in the hybrid controller over both of its component parts. In addition, we introduce a novel method for online adaptation of learning parameters, using the fuzzy control formalism to utilise expert knowledge from the experimenter. This mechanism of meta-learning induces further improvement in performance and avoids the need for tuning through trial testing.	[Smith, Alex M. C.; Yang, Chenguang; Culverhouse, Phil; Cangelosi, Angelo] Univ Plymouth, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [Yang, Chenguang] S China Univ Technol, Coll Automat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China; [Ma, Hongbin] Beijing Inst Technol, State Key Lab Intelligent Control & Decis Complex, Beijing 100081, Peoples R China; [Ma, Hongbin] Beijing Inst Technol, Sch Automat, Beijing 100081, Peoples R China; [Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	University of Plymouth; South China University of Technology; Beijing Institute of Technology; Beijing Institute of Technology; Imperial College London	Yang, CG (corresponding author), Univ Plymouth, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England.	cyang@ieee.org	Cangelosi, Angelo/D-6784-2011; Yang, Chenguang/AAJ-2509-2020	Cangelosi, Angelo/0000-0002-4709-2243; Burdet, Etienne/0000-0002-2123-0185; Culverhouse, Phil/0000-0002-7586-6496; Smith, Alexander/0000-0001-5797-6360	Engineering and Physical Sciences Research Council (EPSRC) [EP/L026856/1, EP/J004561/1]; National Natural Science Foundation of China (NSFC) [61473120, 61473038]; Guangdong Provincial Natural Science Foundation of China [2014A030313266]; European Commission [FP7-ICT-601003]; EPSRC [EP/L026856/1, EP/J004561/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L026856/1, EP/J004561/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); European Commission(European CommissionEuropean Commission Joint Research Centre); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to acknowledge support from Engineering and Physical Sciences Research Council (EPSRC) grants EP/L026856/1 and EP/J004561/1 BABEL, National Natural Science Foundation of China (NSFC) grants 61473120 and 61473038, Guangdong Provincial Natural Science Foundation of China grant 2014A030313266, and European Commission grant FP7-ICT-601003 BALANCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchon-Meunier B., 1996, P 1 ONL WORKSH SOFT; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Cheng L, 2012, IEEE T SYST MAN CY B, V42, P1470, DOI 10.1109/TSMCB.2012.2192270; Cheng L, 2011, IEEE-ASME T MECH, V16, P1155, DOI 10.1109/TMECH.2010.2083680; Cheng L, 2009, AUTOMATICA, V45, P2312, DOI 10.1016/j.automatica.2009.06.007; COLBAUGH R, 1993, J ROBOTIC SYST, V10, P217, DOI 10.1002/rob.4620100205; Corke PI, 1996, IEEE ROBOT AUTOM MAG, V3, P24, DOI 10.1109/100.486658; Franklin DW, 2008, J NEUROSCI, V28, P11165, DOI 10.1523/JNEUROSCI.3099-08.2008; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Ganesh Gowrishankar, 2010, 2010 IEEE International Conference on Robotics and Automation (ICRA 2010), P2705, DOI 10.1109/ROBOT.2010.5509994; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Ganesh G, 2012, IEEE INT CONF ROBOT, P3329, DOI 10.1109/ICRA.2012.6225057; Hogan N., 1984, 1984 AM CONTROL C, P304, DOI DOI 10.23919/ACC.1984.4788393; Ju ZF, 2014, CHIN CONTR CONF, P8518, DOI 10.1109/ChiCC.2014.6896430; KELLY R, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P572, DOI 10.1109/ROBOT.1989.100046; Khan SG, 2014, INT J HUM ROBOT, V11, DOI 10.1142/S0219843614300025; Lambercy O, 2007, IEEE T NEUR SYS REH, V15, P356, DOI 10.1109/TNSRE.2007.903913; Li HY, 2013, IEEE T IND ELECTRON, V60, P3328, DOI 10.1109/TIE.2012.2202354; Li ZJ, 2013, IET CONTROL THEORY A, V7, P397, DOI 10.1049/iet-cta.2011.0334; Li ZJ, 2012, INT J CONTROL AUTOM, V10, P421, DOI 10.1007/s12555-012-0222-y; Mahyuddin MN, 2014, ROBOT AUTON SYST, V62, P294, DOI 10.1016/j.robot.2013.09.013; MAMDANI EH, 1975, INT J MAN MACH STUD, V7, P1, DOI 10.1016/S0020-7373(75)80002-2; MAMDANI EH, 1974, P I ELECTR ENG, V121, P1585, DOI 10.1049/piee.1974.0328; MIZUMOTO M, 1988, INFORM SCIENCES, V45, P129, DOI 10.1016/0020-0255(88)90037-0; Peshkin MA, 2001, IEEE T ROBOTIC AUTOM, V17, P377, DOI 10.1109/70.954751; Ross T.J., 2009, FUZZY LOGIC ENG APPL; Smith A, 2014, IEEE INT SYMP INTELL, P560, DOI 10.1109/ISIC.2014.6967605; Smith A, 2014, IEEE INT CONF CON AU, P1013, DOI 10.1109/ICCA.2014.6871059; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Tan JC, 2011, INT J FUZZY SYST, V13, P292; Tanaka K, 1997, AN INTRODUCTION TO F; Tee KP, 2010, BIOL CYBERN, V102, P31, DOI 10.1007/s00422-009-0348-z; WANG W, 1998, AN INT J, V25, P48, DOI DOI 10.1108/01439919810196964; Woodson W.E., 1992, HUMAN FACTORS DESIGN; Yang CG, 2011, IEEE T ROBOT, V27, P918, DOI 10.1109/TRO.2011.2158251; ZADEH LA, 1988, COMPUTER, V21, P83, DOI 10.1109/2.53; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	37	41	42	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129281	10.1371/journal.pone.0129281	http://dx.doi.org/10.1371/journal.pone.0129281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029916	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900216
J	Symonova, O; Topp, CN; Edelsbrunner, H				Symonova, Olga; Topp, Christopher N.; Edelsbrunner, Herbert			DynamicRoots: A Software Platform for the Reconstruction and Analysis of Growing Plant Roots	PLOS ONE			English	Article							ARCHITECTURE; QUANTIFICATION; ELONGATION; RICE	We present a software platform for reconstructing and analyzing the growth of a plant root system from a time-series of 3D voxelized shapes. It aligns the shapes with each other, constructs a geometric graph representation together with the function that records the time of growth, and organizes the branches into a hierarchy that reflects the order of creation. The software includes the automatic computation of structural and dynamic traits for each root in the system enabling the quantification of growth on fine-scale. These are important advances in plant phenotyping with applications to the study of genetic and environmental influences on growth.	[Symonova, Olga; Edelsbrunner, Herbert] IST Austria, Klosterneuburg, Austria; [Topp, Christopher N.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Institute of Science & Technology - Austria; Donald Danforth Plant Science Center	Symonova, O (corresponding author), IST Austria, Klosterneuburg, Austria.	olga.symonova@gmail.com	Topp, Christopher N/M-2852-2013	Symonova, Olga/0000-0003-2012-9947; Topp, Christopher/0000-0001-9228-6752	United States Department of Agriculture-National Institute of Food and Agriculture [2011-67012-30773]; Donald Danforth Plant Science Center	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Donald Danforth Plant Science Center	This work was supported by United States Department of Agriculture-National Institute of Food and Agriculture (grant number 2011-67012-30773 to CNT, http://www.csrees.usda.gov/fo/fellowshipsgrantprogramafri.cfm) and Donald Danforth Plant Science Center (startup funds to CNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiger D, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360684; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Fang SQ, 2009, PLANT J, V60, P1096, DOI 10.1111/j.1365-313X.2009.04009.x; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; Galkovskyi T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-116; Gregory PJ, 2003, PLANT SOIL, V255, P351, DOI 10.1023/A:1026179919689; Hargreaves CE, 2009, PLANT SOIL, V316, P285, DOI 10.1007/s11104-008-9780-4; Heeraman DA, 1997, PLANT SOIL, V189, P167, DOI 10.1023/A:1004258818538; Iijima M, 1998, ANN BOT-LONDON, V81, P603, DOI 10.1006/anbo.1998.0611; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; Jahnke S, 2009, PLANT J, V59, P634, DOI 10.1111/j.1365-313X.2009.03888.x; Le Bot J, 2010, PLANT SOIL, V326, P261, DOI 10.1007/s11104-009-0005-2; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Miller ND, 2010, GENETICS, V186, P585, DOI 10.1534/genetics.110.118711; Perret JS, 2007, SOIL BIOL BIOCHEM, V39, P391, DOI 10.1016/j.soilbio.2006.07.018; Pound MP, 2013, PLANT PHYSIOL, V162, P1802, DOI 10.1104/pp.113.221531; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; TARJAN RE, 1983, DATA STRUCTURES NETW; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Topp CN, 2013, P NATL ACAD SCI USA, V110, pE1695, DOI 10.1073/pnas.1304354110; Tracy SR, 2010, J EXP BOT, V61, P311, DOI 10.1093/jxb/erp386; Van As H, 2009, PHOTOSYNTH RES, V102, P213, DOI 10.1007/s11120-009-9486-3; Yazdanbakhsh N, 2011, PLANT ROOT, V5, P17, DOI 10.3117/plantroot.5.17; Yazdanbakhsh N, 2009, FUNCT PLANT BIOL, V36, P938, DOI 10.1071/FP09167; Zheng Y, 2011, IEEE I CONF COMP VIS, P2026, DOI 10.1109/ICCV.2011.6126475	29	24	25	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127657	10.1371/journal.pone.0127657	http://dx.doi.org/10.1371/journal.pone.0127657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030757	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900069
J	Twinomujuni, C; Nuwaha, F; Babirye, JN				Twinomujuni, Cyprian; Nuwaha, Fred; Babirye, Juliet Ndimwibo			Understanding the Low Level of Cervical Cancer Screening in Masaka Uganda Using the ASE Model: A Community-Based Survey	PLOS ONE			English	Article							KNOWLEDGE; WOMEN; DETERMINANTS; TRANSMISSION; INFECTIONS; AWARENESS; BARRIERS; HEALTH	Cervical cancer is one of the leading causes of cancer deaths among women globally and its impact is mostly felt in developing countries like Uganda where its prevalence is higher and utilization of cancer screening services is low. This study aimed to identify factors associated with intention to screen for cervical cancer among women of reproductive age in Masaka Uganda using the attitude, social influence and self efficacy (ASE) model. A descriptive community based survey was conducted among 416 women. A semi-structured interviewer administered questionnaire was used to collect data. Unadjusted and adjusted prevalence ratios (PR) were computed using a generalized linear model with Poisson family and a log link using STATA 12. Only 7% (29/416) of our study respondents had ever screened for cervical cancer although a higher proportion (63%, 262/416) reported intention to screen for cervical cancer. The intention to screen for cervical cancer was higher among those who said they were at risk of developing cervical cancer (Adjusted prevalence ratio [PR] 2.0, 95% CI 1.60-2.58), those who said they would refer other women for screening (Adjusted PR 1.4, 95% CI 1.06-1.88) and higher among those who were unafraid of being diagnosed with cervical cancer (Adjusted PR 1.6, 95% CI 1.36-1.93). Those who reported discussions on cervical cancer with health care providers (Adjusted PR 1.2, 95% CI 1.05-1.44), those living with a sexual partner (Adjusted PR 1.4, 95% CI 1.11-1.68), and those who were formally employed (Adjusted PR 1.2, 95% CI 1.03-1.35) more frequently reported intention to screen for cervical cancer. In conclusion, health education to increase risk perception, improve women's attitudes towards screening for cervical cancer and address the fears held by the women would increase intention to screen for cervical cancer. Interventions should also target increased discussions with health workers.	[Twinomujuni, Cyprian; Nuwaha, Fred; Babirye, Juliet Ndimwibo] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda	Makerere University	Babirye, JN (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda.	jnbabirye@yahoo.co.uk						Alam N, 2010, SOC SCI MED, V71, P1921, DOI 10.1016/j.socscimed.2010.09.009; Amarin Z O, 2008, East Mediterr Health J, V14, P389; Aswathy S, 2012, INDIAN J MED RES, V136, P205; Ayinde O A, 2003, J Obstet Gynaecol, V23, P59, DOI 10.1080/0144361021000043272; Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432; Babirye JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-723; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bruni L, 2019, ICO IARC INFORM CTR; Busingye P, 2012, INT J GYNECOL OBSTET, V119, P262, DOI 10.1016/j.ijgo.2012.06.015; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; Koo K, 2013, AIDS EDUC PREV, V25, P14, DOI 10.1521/aeap.2013.25.1.14; Low JJH, 2012, ASIAN PAC J CANCER P, V13, P305, DOI 10.7314/APJCP.2012.13.1.305; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; MOH, 2010, UG MIN HLTH STRAT PL; Mutyaba Twaha, 2006, BMC Med Educ, V6, P13, DOI 10.1186/1472-6920-6-13; Mutyaba Twaha, 2007, Reprod Health, V4, P4, DOI 10.1186/1742-4755-4-4; Mwaka AD, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-193; Ngugi CW, 2012, HEALTH CARE WOMEN IN, V33, P595, DOI 10.1080/07399332.2011.646367; Nuwaha F, 2002, East Afr Med J, V79, P626; Paz-Soldan VA, 2012, REPROD HEALTH MATTER, V20, P49, DOI 10.1016/S0968-8080(12)40680-2; Safaeian M, 2008, CANCER EPIDEM BIOMAR, V17, P1300, DOI 10.1158/1055-9965.EPI-07-2678; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Simon AE, 2012, J FAM PLAN REPROD H, V38, P167, DOI 10.1136/jfprhc-2011-100118; Stubbings S, 2009, BRIT J CANCER, V101, pS13, DOI 10.1038/sj.bjc.6605385; Tacken MAJB, 2007, EUR J PUBLIC HEALTH, V17, P178, DOI 10.1093/eurpub/ckl082; Thippeveeranna C, 2013, ASIAN PAC J CANCER P, V14, P849, DOI 10.7314/APJCP.2013.14.2.849; [Uganda g Statistics UBo], 2008, UG BUR STAT SUBN PRO, P5; van Es SM, 2002, PATIENT EDUC COUNS, V47, P165, DOI 10.1016/S0738-3991(01)00195-1; WHO, 2014, COMPR CERV CANC CONT	31	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128498	10.1371/journal.pone.0128498	http://dx.doi.org/10.1371/journal.pone.0128498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030869	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900158
J	Wang, YL; Jin, JF; Bai, BJ; Wei, MZ				Wang, Yanling; Jin, Jiafeng; Bai, Baojun; Wei, Mingzhen			Study of Displacement Efficiency and Flow Behavior of Foamed Gel in Non-Homogeneous Porous Media	PLOS ONE			English	Article							NAPL REMOVAL; VISUALIZATION; MICROMODEL	Field trials have demonstrated that foamed gel is a very cost-effective technology for profile modification and water shut-off. However, the mechanisms of profile modification and flow behavior of foamed gel in non-homogeneous porous media are not yet well understood. In order to investigate these mechanisms and the interactions between foamed gel and oil in porous media, coreflooding and pore-scale visualization waterflooding experiments were performed in the laboratory. The results of the coreflooding experiment in non-homogeneous porous media showed that the displacement efficiency improved by approximately 30% after injecting a 0.3 pore volume of foamed gel, and was proportional to the pore volumes of the injected foamed gel. Additionally, the mid-high permeability zone can be selectively plugged by foamed gel, and then oil located in the low permeability zone will be displaced. The visualization images demonstrated that the amoeba effect and Jamin effect are the main mechanisms for enhancing oil recovery by foamed gel. Compared with conventional gel, a unique benefit of foamed gel is that it can pass through micropores by transforming into arbitrary shapes without rupturing, this phenomenon has been named the amoeba effect. Additionally, the stability of foam in the presence of crude oil also was investigated. Image and statistical analysis showed that these foams boast excellent oil resistance and elasticity, which allows them to work deep within formations.	[Wang, Yanling; Jin, Jiafeng] China Univ Petr East China, Petr Engn Coll, Qingdao, Shandong, Peoples R China; [Bai, Baojun; Wei, Mingzhen] Missouri Univ Sci & Technol, Dept Geol Sci & Engn, Rolla, MO USA	China University of Petroleum; University of Missouri System; Missouri University of Science & Technology	Wang, YL (corresponding author), China Univ Petr East China, Petr Engn Coll, Qingdao, Shandong, Peoples R China.	wangyl@upc.edu.cn	wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022; Bai, Baojun/AAZ-7316-2020; wang, yi/GVT-8516-2022	Jin, Jiafeng/0000-0002-4477-0440	Natural Foundation for Outstanding Youth of China [50925414]; Fundamental Research Funds for the Central Universities [15CX06034A]; Project of Science and Technology Development of the Shandong Province [2010GSF10601]	Natural Foundation for Outstanding Youth of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Project of Science and Technology Development of the Shandong Province	This work was sponsored by the Natural Foundation for Outstanding Youth of China (50925414), Fundamental Research Funds for the Central Universities (15CX06034A), and from the Project of Science and Technology Development of the Shandong Province (2010GSF10601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang FF, 2001, 68919MS SPE; Chang SH, 1994, 27784MS SPE; Head DA, 2003, PHYS REV, V68, P77; Jeong SW, 2005, J HAZARD MATER, V126, P8, DOI 10.1016/j.jhazmat.2005.06.015; Jeong SW, 2002, ENVIRON SCI TECHNOL, V36, P5238, DOI 10.1021/es0157705; Jeong SW, 2003, J CONTAM HYDROL, V60, P77, DOI 10.1016/S0169-7722(02)00054-2; [刘琳波 Liu Linbo], 2010, [油田化学, Oilfield Chemistry], V27, P153; Manev E, 1997, J DISPER SCI TECHNOL, V18, P769, DOI 10.1080/01932699708943771; Matthew JM, 1995, SPE PROD FACIL, V7, P45; MILLER MJ, 1995, SPE PROD FACIL, V10, P62, DOI 10.2118/24662-PA; Romero Z, 2006, J CANADIAN PETROLEUM, V45, P51; Romero-Zeron L, 2005, J CAN PETROL TECHNOL, V44, P44; Romero-Zeron L, 2007, SPE RESERV EVAL ENG, V10, P150, DOI 10.2118/89388-PA; Sandiford B., 1978, United States. Patent, Patent No. [4,069,869, 4069869, US 4069869]; SCHRAMM LL, 1993, SPE RESERVOIR ENG, V8, P201, DOI 10.2118/20197-PA; Wassmuth F. R., 2004, 89403MS SPE; ZELIN MG, 1994, ACTA METALL MATER, V42, P119, DOI 10.1016/0956-7151(94)90054-X	17	10	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128414	10.1371/journal.pone.0128414	http://dx.doi.org/10.1371/journal.pone.0128414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030282	Green Published, gold			2022-12-27	WOS:000356630900146
J	Chirita-Emandi, A; Socolov, D; Haivas, C; Calapis, A; Gheorghiu, C; Puiu, M				Chirita-Emandi, Adela; Socolov, Demetra; Haivas, Carmen; Calapis, Anca; Gheorghiu, Cristina; Puiu, Maria			Vitamin D Status: A Different Story in the Very Young versus the Very Old Romanian Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; D DEFICIENCY; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; CALCIUM; ADOLESCENTS; CHILDREN	Background In Romania (latitude 48 degrees 15'N to 43 degrees 40'N), vitamin D supplementation is common practice mostly in infants 0-1 year old. No published information is available regarding epidemiological data on vitamin D status in the Romanian population for a wide age range and geographical territory. In this context, we aimed to evaluate the seasonal and age variation of vitamin D status in a large Romanian population. Methods 6631 individuals from across Romania had performed 7544 vitamin D assessments (20122014) in a chain of private laboratories. Vitamin D (25-hydroxyvitamin D2 and 25-hydroxyvitamin D3) was measured using High Performance Liquid Chromatography. Vitamin D levels were classified as severe deficiency<10ng/mL, deficiency 10-20ng/mL, insufficiency 2129ng/mL, sufficiency >= 30ng/mL and potentially harmful>100ng/ml. Results Male to female ratio was 1: 2.9. Age ranged from 0 to 85 years. Mean vitamin D levels increased from April (26.3ng/ml) to September (35.6ng/ml) and decreased from October (33.5ng/ml) to March (24.4ng/ml). Overall 40% had sufficient vitamin D, while the rest were insufficient 33%, deficient 22%, severely deficient 4% and 1% potentially harmful (of them 81% under 1 year old). Males compared to females showed higher percentages of sufficiency (47% vs. 38%). Children 0-2 years presented the highest percentage of vitamin D sufficiency (77%). Lowest percentages (21%) of sufficiency were in people 80-84 years. Conclusion In Romania, suboptimal vitamin D levels are common (59%), especially in older age, wintertime and in women. Vitamin D supplementation would be most warranted from January to April in the Romanian population. 25-hydroxyvitamin D levels>100ng/ml were relatively prevalent in children 0-1 year old (17.3%). This was attributed to supplementation errors and the fact that high-risk individuals were more likely to visit for medical check-up. Nonetheless, it stresses the need to increase awareness of the importance of preventing Vitamin D supplementation administration errors in the young.	[Chirita-Emandi, Adela; Gheorghiu, Cristina; Puiu, Maria] Univ Med & Farm Timisoara, Dept Genet, Timisoara, Romania; [Socolov, Demetra] Univ Med & Pharm Gr T Popa, Ginecol Dept, Iasi, Romania; [Haivas, Carmen] Univ Med & Farm Timisoara, Dept Anat, Timisoara, Romania; [Calapis, Anca] Bioclin Lab SA, Timisoara, Romania; [Puiu, Maria] Clin Emergency Hosp Children Louis Turcanu, Dept Genet, Timisoara, Romania	Romanian Academy of Sciences; Institute of Chemistry, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Grigore T Popa University of Medicine & Pharmacy; Victor Babes University of Medicine & Pharmacy, Timisoara; Romanian Academy of Sciences; Institute of Chemistry, Timisoara	Chirita-Emandi, A (corresponding author), Univ Med & Farm Timisoara, Dept Genet, Timisoara, Romania.	adela.chirita@umft.ro	Puiu, Maria/F-3138-2016; Chirita-Emandi, Adela/G-5574-2016; Socolov, Demetra/AAT-2782-2021	Chirita-Emandi, Adela/0000-0001-7554-4625; Puiu, Maria/0000-0002-4078-2831	Human Resources Development Operational Programme [POSDRU/159/1.5/136893]; Center of Genomic Medicine from the University of Medicine and Pharmacy "Victor Babes" Timisoara [POSCCE-A2O2.2.1-2013-1]; Bioclinica Laboratoarele	Human Resources Development Operational Programme; Center of Genomic Medicine from the University of Medicine and Pharmacy "Victor Babes" Timisoara; Bioclinica Laboratoarele	Chirita-Emandi Adela is a Postdoctoral fellow under the frame of European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/136893. Maria Puiu was funded under Operational program: Development of existing infrastructure and creation of new infrastructure (laboratories, research centers). POSCCE-A2O2.2.1-2013-1, in the Center of Genomic Medicine from the University of Medicine and Pharmacy "Victor Babes" Timisoara. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors received no specific funding for this work. Coauthor Anca CalapiS is employed by Bioclinica Laboratoarele, SA. Bioclinica Laboratoarele provided support in the form of salary for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179; [Anonymous], 2014, REV MED CHIR SOC MED; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell A, 2007, AGE AGEING, V36, P574, DOI 10.1093/ageing/afm091; Azab SFA, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-73; Bener A, 2014, J FAM COMMUNITY MED, V21, P154, DOI 10.4103/2230-8229.142967; Braegger C, 2013, J PEDIATR GASTR NUTR, V56, P692, DOI 10.1097/MPG.0b013e31828f3c05; Bruyere O, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-32; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; de Wildt SN, 2014, ARCH DIS CHILD, V99, P1137, DOI 10.1136/archdischild-2013-305212; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dumitrescu G, 2013, MED-SURG J, V117, P23; El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436; Fodor D, 2014, ACTA PHYSIOL HUNG, V101, P216, DOI 10.1556/APhysiol.101.2014.2.10; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Gill RS, 2012, CAN J SURG, V55, P239, DOI 10.1503/cjs.035710; Gill TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1001; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Gonzalez-Gross M, 2012, BRIT J NUTR, V107, P755, DOI 10.1017/S0007114511003527; Gradinaru D, 2012, AGING CLIN EXP RES, V24, P595, DOI 10.3275/8591; Grundmann M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-146; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hunt K, 2011, J HEALTH SERV RES PO, V16, P108, DOI 10.1258/jhsrp.2010.009131; Huss L, 2014, CANCER CAUSE CONTROL, V25, P1131, DOI 10.1007/s10552-014-0413-3; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Looker AC, 2011, NCHS DATA BRIEF, V59, P1; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113; Mocanu V, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-137; Pludowski P, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/589587; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Porojnicu AC, 2012, PUBLIC HEALTH NUTR, V15, P2157, DOI 10.1017/S1368980012000158; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Smith GR, 2005, J RHEUMATOL, V32, P684; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336; Vierucci F, 2013, EUR J PEDIATR, V172, P1607, DOI 10.1007/s00431-013-2119-z; Villamor E, 2011, AM J CLIN NUTR, V94, P1020, DOI 10.3945/ajcn.111.018168	39	17	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128010	10.1371/journal.pone.0128010	http://dx.doi.org/10.1371/journal.pone.0128010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024516	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400063
J	Murakami, M; Kouyama, T				Murakami, Midori; Kouyama, Tsutomu			Crystallographic Study of the LUMI Intermediate of Squid Rhodopsin	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; LOW-TEMPERATURES; NMR SYSTEM; PHOTOREACTION; CONFORMATION; MOVEMENT; OPSIN; LIGHT	Upon absorption of light, the retinal chromophore in rhodopsin isomerizes from the 11-cis to the trans configuration, initiating a photoreaction cycle. The primary photoreaction state, bathorhodopsin (BATHO), relaxes thermally through lumirhodopsin (LUMI) into a photoactive state, metarhodopsin (META), which stimulates the conjugated G-protein. Previous crystallographic studies of squid and bovine rhodopsins have shown that the structural change in the primary photoreaction of squid rhodopsin is considerably different from that observed in bovine rhodopsin. It would be expected that there is a fundamental difference in the subsequent thermal relaxation process between vertebrate and invertebrate rhodopsins. In this work, we performed crystallographic analyses of the LUMI state of squid rhodopsin using the P62 crystal. When the crystal was illuminated at 100 K with blue light, a half fraction of the protein was converted into BATHO. This reaction state relaxed into LUMI when the illuminated crystal was warmed in the dark to 170 K. It was found that, whereas trans retinal is largely twisted in BATHO, it takes on a more planar configuration in LUMI. This relaxation of retinal is accompanied by reorientation of the Schiff base NH bond, the hydrogen-bonding partner of which is switched to Asn185 in LUMI. Unlike bovine rhodopsin, the BATHO-to-LUMI transition in squid rhodopsin was accompanied by no significant change in the position/orientation of the beta-ionone ring of retinal.	[Murakami, Midori; Kouyama, Tsutomu] Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 464, Japan; [Kouyama, Tsutomu] RIKEN, Harima Inst, Sayo, Hyogo, Japan	Nagoya University; RIKEN	Kouyama, T (corresponding author), Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 464, Japan.	kouyama@bio.hys.nagoya-u.ac.jp	murakami, midori/AAL-1023-2021		Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; [Anonymous], PYMOL MOL GRAPH SYST; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MAEDA A, 1978, FEBS LETT, V92, P77, DOI 10.1016/0014-5793(78)80725-X; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Murakami M, 2011, J MOL BIOL, V413, P615, DOI 10.1016/j.jmb.2011.08.044; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; Nishimura S, 1997, BIOCHEMISTRY-US, V36, P864, DOI 10.1021/bi961795i; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Sakai K, 2002, J APPL CRYSTALLOGR, V35, P270, DOI 10.1107/S0021889801021331; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SHICHIDA Y, 1978, BIOCHIM BIOPHYS ACTA, V504, P413, DOI 10.1016/0005-2728(78)90064-6; Yamamoto M, 2009, J MOL BIOL, V393, P559, DOI 10.1016/j.jmb.2009.08.047; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0; YOSHIZAWA T, 1964, NATURE, V201, P340, DOI 10.1038/201340a0	28	5	5	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126970	10.1371/journal.pone.0126970	http://dx.doi.org/10.1371/journal.pone.0126970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024518	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400027
J	Rotsch, D; Brossard, T; Bihmidine, S; Ying, WJ; Gaddam, V; Harmata, M; Robertson, JD; Swyers, M; Jurisson, SS; Braun, DM				Rotsch, David; Brossard, Tom; Bihmidine, Saadia; Ying, Weijiang; Gaddam, Vikram; Harmata, Michael; Robertson, J. David; Swyers, Michael; Jurisson, Silvia S.; Braun, David M.			Radiosynthesis of 6 '-Deoxy-6 '[F-18] Fluorosucrose via Automated Synthesis and Its Utility to Study In Vivo Sucrose Transport in Maize (Zea mays) Leaves	PLOS ONE			English	Article							PROMOTE CARBOHYDRATE EXPORT; SUBSTRATE-SPECIFICITY; PHLOEM; PLANT; GENE; CARBON; TRANSLOCATION; ACCUMULATION; METABOLISM; INHIBITION	Sugars produced from photosynthesis in leaves are transported through the phloem tissues within veins and delivered to non-photosynthetic organs, such as roots, stems, flowers, and seeds, to support their growth and/or storage of carbohydrates. However, because the phloem is located internally within the veins, it is difficult to access and to study the dynamics of sugar transport. Radioactive tracers have been extensively used to study vascular transport in plants and have provided great insights into transport dynamics. To better study sucrose partitioning in vivo, a novel radioactive analog of sucrose was synthesized through a completely chemical synthesis route by substituting fluorine-18 (half-life 110 min) at the 6' position to generate 6'-deoxy-6'[18F] fluorosucrose ((FS)-F-18). This radiotracer was then used to compare sucrose transport between wild-type maize plants and mutant plants lacking the Sucrose transporter1 (Sut1) gene, which has been shown to function in sucrose phloem loading. Our results demonstrate that (FS)-F-18 is transported in vivo, with the wild-type plants showing a greater rate of transport down the leaf blade than the sut1 mutant plants. A similar transport pattern was also observed for universally labeled [U-C-14] sucrose ([U-C-14] suc). Our findings support the proposed sucrose phloem loading function of the Sut1 gene in maize, and additionally demonstrate that the (FS)-F-18 analog is a valuable, new tool that offers imaging advantages over [U-C-14] suc for studying phloem transport in plants.	[Rotsch, David; Brossard, Tom; Ying, Weijiang; Gaddam, Vikram; Harmata, Michael; Robertson, J. David; Jurisson, Silvia S.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Bihmidine, Saadia; Swyers, Michael; Braun, David M.] Univ Missouri, Div Biol Sci, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Bihmidine, Saadia; Swyers, Michael; Braun, David M.] Univ Missouri, Missouri Maize Ctr, Columbia, MO 65211 USA; [Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Braun, DM (corresponding author), Univ Missouri, Div Biol Sci, Interdisciplinary Plant Grp, Columbia, MO 65211 USA.	braundm@missouri.edu		Robertson, John/0000-0002-6675-8469	U.S. Department of Energy [DE-SC0002040, DE-SC0006810]; U.S. National Science Foundation [IOS-1025976, IIA-1430428]; Direct For Biological Sciences [1025976] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the U.S. Department of Energy (DE-SC0002040 to SJ, and DE-SC0006810 to DMB) and the U.S. National Science Foundation (IOS-1025976 to DMB, and IIA-1430428 to SJ and DMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Alauddin MM, 2012, AM J NUCL MED MOLEC, V2, P55; Alauddin MM, 2002, J LABELLED COMPD RAD, V45, P583, DOI 10.1002/jlcr.549; Alauddin MM, 2002, SYNTHETIC COMMUN, V32, P1757, DOI 10.1081/SCC-120004272; Anderson H, 2010, NUCL MED BIOL, V37, P439, DOI 10.1016/j.nucmedbio.2010.01.003; Aoki N, 1999, PLANT CELL PHYSIOL, V40, P1072, DOI 10.1093/oxfordjournals.pcp.a029489; Aoki N, 2003, PLANT CELL PHYSIOL, V44, P223, DOI 10.1093/pcp/pcg030; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Babst BA, 2013, PLANT CELL PHYSIOL, V54, P1016, DOI 10.1093/pcp/pct045; Baker RF, 2007, PLANT PHYSIOL, V144, P867, DOI 10.1104/pp.107.098814; Baker RF, 2012, MOL PLANT, V5, P766, DOI 10.1093/mp/sss054; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; BINDER TP, 1986, CARBOHYD RES, V147, P149, DOI 10.1016/0008-6215(86)85014-5; Braun DM, 2014, J EXP BOT, V65, P1713, DOI 10.1093/jxb/ert416; Braun DM, 2012, SCIENCE, V335, P173, DOI 10.1126/science.1216828; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; Burkle L, 1998, PLANT PHYSIOL, V118, P59, DOI 10.1104/pp.118.1.59; CALVIN M, 1948, SCIENCE, V107, P476, DOI 10.1126/science.107.2784.476; CARD PJ, 1984, J AM CHEM SOC, V106, P5348, DOI 10.1021/ja00330a051; CARD PJ, 1986, J AM CHEM SOC, V108, P158, DOI 10.1021/ja00261a025; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; Chandran D, 2003, J BIOL CHEM, V278, P44320, DOI 10.1074/jbc.M308490200; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chin FT, 2008, MOL IMAGING BIOL, V10, P82, DOI 10.1007/s11307-007-0122-3; EKLUND SH, 1988, CARBOHYD RES, V177, P253, DOI 10.1016/0008-6215(88)85061-4; Fatangare A, 2014, NUCL MED BIOL, V41, P737, DOI 10.1016/j.nucmedbio.2014.05.143; Ferrieri AP, 2013, PLANT PHYSIOL, V161, P692, DOI 10.1104/pp.112.208868; Ferrieri AP, 2012, NUCL MED BIOL, V39, P1152, DOI 10.1016/j.nucmedbio.2012.06.005; Ferrieri RA, 2005, PLANT CELL ENVIRON, V28, P591, DOI 10.1111/j.1365-3040.2004.01303.x; FRITZ E, 1983, PLANTA, V159, P193, DOI 10.1007/BF00397525; Gaddam V, 2013, CARBOHYD RES, V369, P38, DOI 10.1016/j.carres.2012.12.001; Gao XF, 2014, CARBOHYD RES, V400, P14, DOI 10.1016/j.carres.2014.08.015; Gifford AN, 2012, J LABELLED COMPD RAD, V55, P441, DOI 10.1002/jlcr.2969; GOLDBERG RN, 1989, J BIOL CHEM, V264, P9901; Gomez S, 2012, ENTOMOL EXP APPL, V144, P101, DOI 10.1111/j.1570-7458.2012.01268.x; Goodman MM, 1997, J NUCL MED, V38, P119; Goodman MM, 2000, NUCL MED BIOL, V27, P1, DOI 10.1016/S0969-8051(99)00080-3; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Hanik N, 2010, J CHEM ECOL, V36, P1058, DOI 10.1007/s10886-010-9835-x; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hattori E, 2008, PLANTA, V227, P1181, DOI 10.1007/s00425-008-0701-9; Hirose T, 2010, J EXP BOT, V61, P3639, DOI 10.1093/jxb/erq175; HITZ WD, 1988, ACS SYM SER, V374, P138; HITZ WD, 1986, J BIOL CHEM, V261, P1986; HITZ WD, 1985, PLANT PHYSIOL, V77, P291, DOI 10.1104/pp.77.2.291; HOFSTRA G, 1969, CAN J BOTANY, V47, P1435, DOI 10.1139/b69-205; Horst RJ, 2008, J PLANT PHYSIOL, V165, P19, DOI 10.1016/j.jplph.2007.05.008; Kim D, 2014, APPL RADIAT ISOTOPES, V94, P338, DOI 10.1016/j.apradiso.2014.09.008; Kiser MR, 2008, HFSP J, V2, P189, DOI 10.2976/1.2921207; Kronzucker HJ, 1998, PLANT PHYSIOL, V116, P581, DOI 10.1104/pp.116.2.581; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Kuhn C, 1996, PLANT CELL ENVIRON, V19, P1115, DOI 10.1111/j.1365-3040.1996.tb00426.x; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lappchen T, 2012, APPL RADIAT ISOTOPES, V70, P205, DOI 10.1016/j.apradiso.2011.09.005; Lee S, 2013, NORTHEAST ASIAN PERSPECTIVES ON INTERNATIONAL LAW: CONTEMPORARY ISSUES AND CHALLENGES, P1; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Li ZB, 2010, ADV DRUG DELIVER REV, V62, P1031, DOI 10.1016/j.addr.2010.09.007; Ma Y, 2008, PLANTA, V227, P527, DOI 10.1007/s00425-007-0636-6; Mangner TJ, 2003, NUCL MED BIOL, V30, P215, DOI 10.1016/S0969-8051(02)00445-6; MARGOLIS HA, 1991, CAN J BOT, V69, P1225, DOI 10.1139/b91-157; Mason MG, 2014, P NATL ACAD SCI USA, V111, P6092, DOI 10.1073/pnas.1322045111; Matsuhashi S, 2006, APPL RADIAT ISOTOPES, V64, P435, DOI 10.1016/j.apradiso.2005.08.020; Nakanishi TM, 2001, J RADIOANAL NUCL CH, V249, P503; PADGETT HC, 1989, APPL RADIAT ISOTOPES, V40, P433, DOI 10.1016/0883-2889(89)90213-X; Paolillo V, 2009, J LABELLED COMPD RAD, V52, P553, DOI 10.1002/jlcr.1674; Peng D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00615; Rae AL, 2005, PLANTA, V220, P817, DOI 10.1007/s00425-004-1399-y; Reinders A, 2006, PLANT CELL ENVIRON, V29, P1871, DOI 10.1111/j.1365-3040.2006.01563.x; Reinders A, 2012, J BIOL CHEM, V287, P30296, DOI 10.1074/jbc.M112.372888; Reinders A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00022; RIESMEIER JW, 1994, EMBO J, V13, P1; ROBINSONBEERS K, 1990, BOT ACTA, V103, P424, DOI 10.1111/j.1438-8677.1990.tb00184.x; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; SIMIAND C, 1995, J CARBOHYD CHEM, V14, P977, DOI 10.1080/07328309508005389; Slewinski TL, 2012, PLANT PHYSIOL, V160, P1540, DOI 10.1104/pp.112.202473; Slewinski TL, 2010, PLANT SIGNAL BEHAV, V5, P687, DOI 10.4161/psb.5.6.11575; Slewinski TL, 2010, GENETICS, V185, P221, DOI 10.1534/genetics.109.113357; Slewinski TL, 2010, PLANT SCI, V178, P341, DOI 10.1016/j.plantsci.2010.01.010; Slewinski TL, 2009, J EXP BOT, V60, P881, DOI 10.1093/jxb/ern335; Sowinski P, 1999, ACTA PHYSIOL PLANT, V21, P75, DOI 10.1007/s11738-999-0030-z; Srivastava AC, 2008, PLANT PHYSIOL, V148, P200, DOI 10.1104/pp.108.124776; Srivastava AC, 2009, ANN BOT-LONDON, V104, P1121, DOI 10.1093/aob/mcp215; Tanoi K, 2005, J RADIOANAL NUCL CH, V263, P547; Thorpe MR, 2007, PLANTA, V226, P541, DOI 10.1007/s00425-007-0503-5; Torres A. P., 1994, Journal of Food Process Engineering, V17, P191, DOI 10.1111/j.1745-4530.1994.tb00335.x; TURGEON R, 1988, PLANT PHYSIOL, V87, P179, DOI 10.1104/pp.87.1.179; Turkman N, 2010, J LABELLED COMPD RAD, V53, P782, DOI 10.1002/jlcr.1797; VANBEL AJE, 1993, ANNU REV PLANT PHYS, V44, P253, DOI 10.1146/annurev.pp.44.060193.001345; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang Q, 2014, PHYS MED BIOL, V59, P5613, DOI 10.1088/0031-9155/59/19/5613; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Ying WJ, 2013, ORG LETT, V15, P2723, DOI 10.1021/ol401044h; ZIKOPOULOS JN, 1982, CARBOHYD RES, V104, P245, DOI 10.1016/S0008-6215(00)82586-0	93	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128989	10.1371/journal.pone.0128989	http://dx.doi.org/10.1371/journal.pone.0128989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024520	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400105
J	El-Tarabany, MS; El-Bayomi, K; Abdelhamid, T				El-Tarabany, Mahmoud Salah; El-Bayomi, Khairy; Abdelhamid, Tamer			Semen Characteristics of Purebred and Crossbred Male Rabbits	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; DAMASCUS GOATS; SPERM OUTPUT; SAUDI ARADI; GROWTH-RATE; TRAITS; HETEROSIS; VARIABILITY; FERTILITY; QUALITY	The aim of this investigation was to evaluate the semen quality traits of purebred male rabbits and their crosses under subtropical Egyptian conditions. A full 3 x 3 diallel crossing was performed for producing the first generation progeny of New Zealand White (N), Flander (F) and Rex (R) breeds. The highest ejaculate volume (p<0.05) and percentage of live sperms (p<0.01) with the lowest percentage of sperm cell morphological abnormalities (p<0.05) had been recorded in the NF bucks. Moreover, they possessed positive estimates of direct heterosis for ejaculate volume, mass motility (Mm), individual motility (Im) and sperm cell concentration (SCC). On the contrary, pH had negative estimates of direct heterosis in all crosses and their reciprocal. Semen pH was negatively correlated with SCC (r = -0.18), Mm (r = -0.13) and Im (r = -0.23). In conclusion, the superiority of crossbreeding was particularly obvious in the New Zealand White x Flander males, which cumulated heterosis and favorable maternal effects of the Flander dams.	[El-Tarabany, Mahmoud Salah; El-Bayomi, Khairy; Abdelhamid, Tamer] Zagazig Univ, Anim Wealth Dev Dept, Sharkia, Egypt	Egyptian Knowledge Bank (EKB); Zagazig University	El-Tarabany, MS (corresponding author), Zagazig Univ, Anim Wealth Dev Dept, Sharkia, Egypt.	mahmoudtarabany2887@yahoo.com		El-Tarabany, Mahmoud/0000-0002-9354-2209				Ain-Baziz H, 2012, P 10 WORLD RABB C 3, VA, P347; ALSOBAYIL K, 2002, P 3 SCI C RABB PROD, P151; Alvarino J., 2000, P 7 WORLD RABB C VAL, V8, P13; ARROITA Z, 2000, P 7 WORLD RABB C 4 7, P81; BAMBA K, 1988, THERIOGENOLOGY, V29, P1245, DOI 10.1016/0093-691X(88)90004-0; BENCHEIKH N, 1995, ANN ZOOTECH, V44, P263, DOI 10.1051/animres:19950306; Brun JM, 2002, ANIM REPROD SCI, V70, P139, DOI 10.1016/S0378-4320(01)00197-X; Brun JM, 2002, ANIM RES, V51, P433, DOI 10.1051/animres:2002030; Coffey D.S., 1988, P1081; Dickerson GE., 1969, ANIM BREED ABSTR, V37, P191; DUCROCQ V, 1995, LIVEST PROD SCI, V41, P1, DOI 10.1016/0301-6226(94)00029-7; El-Bayomi KM, 1992, ZAG VET J, V20, P420; ELEZZ ZRA, 1985, BEILTRGE TROPISCHEN, V23, P249; Garcia-Tomas M, 2006, ANIM REPROD SCI, V93, P88, DOI 10.1016/j.anireprosci.2005.06.011; Garcia-Tomas M, 2006, LIVEST SCI, V100, P111, DOI 10.1016/j.livprodsci.2005.08.004; Goericke-Pesch S, 2015, ANIM REPROD SCI, V152, P83, DOI 10.1016/j.anireprosci.2014.11.002; Hagen D. R., 2002, World Rabbit Science, V10, P135; Khalil MH, 2007, ANIMAL, V1, P923, DOI 10.1017/S1751731107000341; Khalil MH, 2010, SMALL RUMINANT RES, V94, P10, DOI 10.1016/j.smallrumres.2010.05.020; Klein M, 1963, PHYSIOLOGIE, P697; Lavara R, 2011, J ANIM BREED GENET, V128, P44, DOI 10.1111/j.1439-0388.2010.00889.x; MINELLI G, 1999, WORLD RABBIT SCI, V7, P31; Mohammed KM, 2013, SMALL RUMINANT RES, V112, P7, DOI 10.1016/j.smallrumres.2012.10.001; More O'Ferral GJ, 1968, P 6 INT C REPR AN AR, V2, P1279; MORRELL JM, 1995, BRIT VET J, V151, P477, DOI 10.1016/S0007-1935(05)80022-3; Oseni SO, 2014, WORLD RABBIT SCI, V22, P147, DOI 10.4995/wrs.2014.1348; Petitjean M, 1965, MEMOIREE ETUDES INGE, P85; Piles M, 2013, WORLD RABBIT SCI, V21, P61, DOI 10.4995/wrs.2013.1240; Pirchner F., 1983, POPULATION GENETICS, V2nd, P414; RAMAMURTHY N, 1989, INDIAN VET J, V66, P584; Rodriguez-De Lara R, 2015, ANIM REPROD SCI, V152, P90, DOI 10.1016/j.anireprosci.2014.11.005; Ruiz-Sanchez AL, 2006, THERIOGENOLOGY, V66, P736, DOI 10.1016/j.theriogenology.2005.12.012; SAS Institute Inc, 2003, SAS STAT US GUID; Schlolaut W., 1992, 5 C WORLD RABB SCI A, VA, P594; Sharaf MM, 1992, ZAG VET J, V20, P471; Shrestha JNB, 2007, SMALL RUMINANT RES, V67, P93, DOI 10.1016/j.smallrumres.2005.10.018; Smital J, 2004, ANIM REPROD SCI, V80, P121, DOI 10.1016/S0378-4320(03)00142-8; SMITH JT, 1955, FERTIL STERIL, V6, P271; Tusell L, 2012, J ANIM SCI, V90, P1385, DOI 10.2527/jas.2011-4165; VENGE O., 1951, Acta Agriculturae Scandinavica, V1, P291; Wierzbicki Heliodor, 2010, Medycyna Weterynaryjna, V66, P765; WILLIAMS J, 1990, FUND APPL TOXICOL, V15, P651, DOI 10.1016/0272-0590(90)90182-J; Wysokinska A, 2013, ARCH TIERZUCHT, V56, P65, DOI 10.7482/0003-9438-56-007	43	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128435	10.1371/journal.pone.0128435	http://dx.doi.org/10.1371/journal.pone.0128435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020961	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300111
J	Gaskill, BN; Pritchett-Corning, KR				Gaskill, Brianna N.; Pritchett-Corning, Kathleen R.			The Effect of Cage Space on Behavior and Reproduction in Crl:CD1(Icr) and C57BL/6NCrl Laboratory Mice	PLOS ONE			English	Article							HOUSING DENSITY; PLASMA-CORTICOSTERONE; POPULATION-DENSITY; ADRENAL GLANDS; MUS-MUSCULUS; FLOOR SPACE; SIZE; STEREOTYPIES; ORGANS; PERFORMANCE	Recommendations for the amount of cage space required for female mice with litters were first made in the 2011 Guide for the Care and Use of Laboratory Animals. We hypothesized that if a difference in mouse behavior and reproduction exists within the limits of commercially available caging, this difference would be detected between the smallest and largest cages. C57BL/6NCrl and Crl:CD1(Icr) breeding mice were randomly assigned to a cage treatment: LP 18790 (226cm(2)); A RC1 (305cm(2)); A N10 (432cm(2)); T 1291 (800cm(2)) and a breeding configuration: single (male removed after birth); pair (1 male + 1 female); or trio (1 male + 2 females) in a factorial design for 12 weeks. All cages received 8-10g of nesting material and nests were scored weekly. Pups were weaned between post-natal day 18 and 26 and were weighed at weaning. Adult behavior and location in the cage were recorded by scan samples every 30 min over 48 hr of video recorded on PND 0-8 and PND 14-21 when pups were in the cage. Press posture and play behavior were recorded by 1/0 sampling method. Cage space did not significantly alter typical reproductive measures. Pups in the smallest cage played less than in the other cages. Adults in the smallest cage displayed more press posture than in the two largest cages. Mice in the largest cage spent more time under the feeder than in other areas of the cage. Nest score was also the highest in the largest cage. Housing breeding groups of mice in a range of commercially available cage sizes does not affect reproduction but behavioral measures suggest that the smallest cage tested, LP 18790, may be stressful for outbred mice when pups are present.	[Gaskill, Brianna N.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Pritchett-Corning, Kathleen R.] Harvard Univ, Fac Arts & Sci, Off Anim Resources, Cambridge, MA 02138 USA; [Gaskill, Brianna N.; Pritchett-Corning, Kathleen R.] Charles River, Wilmington, MA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University	Gaskill, BN (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	bgaskill@purdue.edu	Pritchett-Corning, Kathleen R/E-7675-2011; Gaskill, Brianna/F-5950-2011	Pritchett-Corning, Kathleen R/0000-0002-1888-4751; Gaskill, Brianna/0000-0002-1884-803X	Charles River	Charles River	All work was funded by Charles River. The funder reviewed the manuscript before submission. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aziz NHKA, 2012, BEHAV BRAIN RES, V231, P29, DOI 10.1016/j.bbr.2012.02.040; BAUM A, 1978, J PERS SOC PSYCHOL, V36, P1000, DOI 10.1037/0022-3514.36.9.1000; Boivin GP, 2013, LAB ANIMAL, V42, P135, DOI 10.1038/laban.187; BRONSON F. H., 1963, PHYSIOL ZOOL, V36, P161; BRONSON FH, 1964, ANIM BEHAV, V12, P470, DOI 10.1016/0003-3472(64)90067-3; BROWN RZ, 1953, ECOL MONOGR, V23, P217, DOI 10.2307/1943592; Buob M, 2013, APPL ANIM BEHAV SCI, V147, P194, DOI 10.1016/j.applanim.2013.05.004; Cabib S, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P227, DOI 10.1079/9780851990040.0227; Chambers LK, 2000, J MAMMAL, V81, P59, DOI 10.1644/1545-1542(2000)081&lt;0059:MASOOW&gt;2.0.CO;2; CHRISTIAN JJ, 1955, AM J PHYSIOL, V182, P292, DOI 10.1152/ajplegacy.1955.182.2.292; CHRISTIAN JJ, 1955, AM J PHYSIOL, V181, P477, DOI 10.1152/ajplegacy.1955.181.3.477; Cloutier S, 2013, AALAS NAT M BALT MD, P673; Cooper JJ, 2004, ANIM WELFARE, V13, pS47; Council of Europe, 2006, APP A EUR CONV PROT, P21; CRAMER CP, 1990, DEV PSYCHOBIOL, V23, P479, DOI 10.1002/dev.420230604; CROWCROFT PETER, 1963, PROC ZOOL SOC LONDON, V140, P517; DAWKINS M, 1980, ANIM REGULAT STUD, V3, P57; Dawson L, 2013, APPL ANIM BEHAV SCI, V147, P224, DOI 10.1016/j.applanim.2013.04.001; DELONG KT, 1967, ECOLOGY, V48, P611, DOI 10.2307/1936505; DiVincenti L, 2012, LAB ANIMAL, V41, P68, DOI 10.1038/laban0312-68; Fraser D., 2008, UNDERSTANDING ANIMAL; Fullwood Steven, 1998, ILAR J, V39, P29; Garner JP, 2004, APPL ANIM BEHAV SCI, V89, P263, DOI 10.1016/j.applanim.2004.07.004; Garner JP, 2004, COMPARATIVE MED, V54, P216; Gaskill BN, 2014, APPL ANIMAL BEHAV SC; Gaskill BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074153; Gaskill BN, 2013, PHYSIOL BEHAV, V110, P87, DOI 10.1016/j.physbeh.2012.12.018; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Grafen A., 2002, MODERN STAT LIFE SCI; HARVEY PW, 1985, HORM BEHAV, V19, P86, DOI 10.1016/0018-506X(85)90009-1; Hess SE, 2008, J AM ASSOC LAB ANIM, V47, P25; Horn MJ, 2012, J AM ASSOC LAB ANIM, V51, P781; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Krackow S, 1997, J REPROD FERTIL, V110, P87, DOI 10.1530/jrf.0.1100087; Laber K, 2008, J AM ASSOC LAB ANIM, V47, P16; Lewis MH, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P190, DOI 10.1079/9780851990040.0190; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Morgan JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090012; National Research Council, 2011, GUIDE CARE USE LAB A; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nevison CM, 1999, ANIM WELFARE, V8, P361; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; O'Malley J, 2008, J AM ASSOC LAB ANIM, V47, P9; ORTIZ R, 1985, PHYSIOL BEHAV, V34, P857, DOI 10.1016/0031-9384(85)90003-4; ORTIZ R, 1984, EXPERIENTIA, V40, P1428, DOI 10.1007/BF01951927; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Pellis SM, 1999, DEV PSYCHOBIOL, V34, P175, DOI 10.1002/(SICI)1098-2302(199904)34:3<175::AID-DEV2>3.0.CO;2-#; PENG X, 1989, LAB ANIM, V23, P302, DOI 10.1258/002367789780746042; Pritchett-Corning KR, 2009, J AM ASSOC LAB ANIM, V48, P492; Rosenblatt J., 1963, MATERNAL BEHAVIOR MA, P8; ROWE FP, 1964, J ANIM ECOL, V33, P477, DOI 10.2307/2567; Ryabinin AE, 1999, PHARMACOL BIOCHEM BE, V63, P143, DOI 10.1016/S0091-3057(98)00239-1; Sherwin CM, 2007, ANIM BEHAV, V73, P29, DOI 10.1016/j.anbehav.2006.04.008; Sherwin CM, 2004, ANIM BEHAV, V67, P711, DOI 10.1016/j.anbehav.2003.08.018; Sherwin CM, 1997, ANIM BEHAV, V53, P67, DOI 10.1006/anbe.1996.0278; Smith AL, 2005, COMPARATIVE MED, V55, P368; Smith AL, 2004, COMPARATIVE MED, V54, P656; Smith T.M., 2012, ELEMENTS ECOLOGY, V3rd; Son GH, 2011, FRONT NEUROENDOCRIN, V32, P451, DOI 10.1016/j.yfrne.2011.07.003; SOUTHWICK CH, 1955, ECOLOGY, V36, P627, DOI 10.2307/1931300; SOUTHWICK CH, 1959, AM J PHYSIOL, V197, P111, DOI 10.1152/ajplegacy.1959.197.1.111; SOUTHWICK CH, 1955, ECOLOGY, V36, P212, DOI 10.2307/1933227; STOKOLS D, 1972, PSYCHOL REV, V79, P275, DOI 10.1037/h0032706; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Walsh PT, 2013, ANIM BEHAV, V86, P559, DOI 10.1016/j.anbehav.2013.06.011; Weber EM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-83; Whitaker J, 2007, LAB ANIMAL, V36, P32, DOI 10.1038/laban1107-32; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Whittaker AL, 2012, LAB ANIM-UK, V46, P3, DOI 10.1258/la.2011.011049; Wurbel H, 1996, ETHOLOGY, V102, P371; Wurbel H, 1997, ANIM BEHAV, V53, P891, DOI 10.1006/anbe.1996.0424; YOUNG H, 1950, J MAMMAL, V31, P403, DOI 10.2307/1375107	72	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127875	10.1371/journal.pone.0127875	http://dx.doi.org/10.1371/journal.pone.0127875			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020792	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300061
J	Chen, D; Wu, YX; Zhang, XL; Li, FG				Chen, Di; Wu, Yuxiang; Zhang, Xiling; Li, Fuguang			Analysis of [Gossypium capitis-viridis x (G.hirsutum x G.australe)(2)] Trispecific Hybrid and Selected Characteristics	PLOS ONE			English	Article							POLYPLOID FORMATION; GENETICS; ANCIENT; COTTON; EVOLUTION; L.	Speciation is always a contentious and challenging issue following with the presence of gene flow. In Gossypium, there are many valuable resources and wild diploid cotton especially C and B genome species possess some excellent traits which cultivated cotton always lacks. In order to explore character transferring rule from wild cotton to upland tetraploid cotton, the [G. capitis-viridis x (G. hirsutum x G. australe) 2] triple hybrid was synthesized by interspecies hybridization and chromosome doubling. Morphology comparisons were measured among this hybrid and its parents. It showed that trispecific hybrid F1 had some intermediate morphological characters like leaf style between its parents and some different characters from its parents, like crawl growth characteristics and two kind flower color. It is highly resistant to insects comparing with other cotton species by four year field investigation. By cytogenetic analysis, triple hybrid was further confirmed by meiosis behavior of pollen mother cells. Comparing with regular meiosis of its three parents, it was distinguished by the occurrence of polyads with various numbers of unbalanced microspores and finally generating various abnormal pollen grains. All this phenomenon results in the sterility of this hybrid. This hybrid was further identified by SSR marker from DNA molecular level. It showed that 98 selected polymorphism primers amplified effective bands in this hybrids and its parents. The genetic proportion of three parents in this hybrid is 47.8% from G. hirsutum, 14.3% from G. australe, 7.0% from G. capitis-viridis, and 30.9% recombination bands respectively. It was testified that wild genetic material has been transferred into cultivated cotton and this new germplasm can be incorporated into cotton breeding program.	[Chen, Di; Zhang, Xiling; Li, Fuguang] Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Henan, Peoples R China; [Wu, Yuxiang] Shanxi Agr Univ, Dept Agr, Taigu, Shanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shanxi Agricultural University	Zhang, XL (corresponding author), Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Henan, Peoples R China.	zhangxiling1962@126.com; lifuguang2014@hotmail.com			National Natural Science Foundation of China [31301364, 31171599]; Special fund for basic scientific research business of central public research institutes [1610162014018]; Scientific and technological project in Shanxi province [20130311004-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special fund for basic scientific research business of central public research institutes; Scientific and technological project in Shanxi province	This research was financially supported by National Natural Science Foundation of China (No. 31301364, No. 31171599), Special fund for basic scientific research business of central public research institutes (1610162014018) and Scientific and technological project in Shanxi province (No. 20130311004-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benbouza H, 2010, MOL BREEDING, V25, P273, DOI 10.1007/s11032-009-9331-6; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; Henn HJ, 1998, PLANT CELL REP, V18, P220, DOI 10.1007/s002990050560; Hieter P, 1999, SCIENCE, V285, P210, DOI 10.1126/science.285.5425.210; HILU KW, 1993, AM J BOT, V80, P1494, DOI 10.2307/2445679; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Krapovickas A., 2008, BONPLANDIA, V17, P55, DOI [10.30972/bon.1711361, DOI 10.30972/BON.1711361]; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MCMICHAEL SC, 1954, AGRON J, V46, P527, DOI 10.2134/agronj1954.00021962004600110016x; Mergeai G, 2006, CAH AGRIC, V15, P135; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Rambani A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-3; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Rieseberg LH, 2001, CURR BIOL, V11, pR925, DOI 10.1016/S0960-9822(01)00556-5; RIESEBERG LH, 1992, INT J PLANT SCI, V153, pR5, DOI 10.1086/ijps.153.1.2995698; Rieseberg LH, 2000, EVOLUTION, V54, P859, DOI 10.1111/j.0014-3820.2000.tb00086.x; Rieseberg LH, 2007, J HERED, V98, P101, DOI 10.1093/jhered/esl066; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; STEBBINS GL, 1958, ADV GENET, V9, P147, DOI 10.1016/S0065-2660(08)60162-5; Turelli M, 2000, GENETICS, V154, P1663; Wang K., 2012, NAT GENET, V44, P1; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; Yu XS, 2012, THEOR APPL GENET, V125, P1503, DOI 10.1007/s00122-012-1929-0	27	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127023	10.1371/journal.pone.0127023	http://dx.doi.org/10.1371/journal.pone.0127023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035817	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100009
J	Chen, YL; Yang, F; Sun, ZY; Wang, QT; Mi, KX; Deng, HT				Chen, Yuling; Yang, Fan; Sun, Zhongyuan; Wang, Qingtao; Mi, Kaixia; Deng, Haiteng			Proteomic Analysis of Drug-Resistant Mycobacteria: Co-Evolution of Copper and INH Resistance	PLOS ONE			English	Article							TUBERCULOSIS; MECHANISMS; HOST; MACROPHAGES; LYSOSOMES; VIRULENCE	Tuberculosis, caused by the pathogen Mycobacterium tuberculosis, is a worldwide public health threat. Mycobacterium tuberculosis is capable of resisting various stresses in host cells, including high levels of ROS and copper ions. To better understand the resistance mechanisms of mycobacteria to copper, we generated a copper-resistant strain of Mycobacterium smegmatis, mc(2)155-Cu from the selection of copper sulfate treated-bacteria. The mc(2)155-Cu strain has a 5-fold higher resistance to copper sulfate and a 2-fold higher resistance to isoniazid (INH) than its parental strain mc(2)155, respectively. Quantitative proteomics was carried out to find differentially expressed proteins between mc(2)155 and mc(2)155-Cu. Among 345 differentially expressed proteins, copper-translocating P-type ATPase was up-regulated, while all other ABC transporters were down-regulated in mc(2)155-Cu, suggesting copper-translocating P-type ATPase plays a crucial role in copper resistance. Results also indicated that the down-regulation of metabolic enzymes and decreases in cellular NAD, FAD, mycothiol, and glutamine levels in mc(2)155-Cu were responsible for its slowing growth rate as compared to mc(2)155. Down-regulation of KatG2 expression in both protein and mRNA levels indicates the co-evolution of copper and INH resistance in copper resistance bacteria, and provides new evidence to understanding of the molecular mechanisms of survival of mycobacteria under stress conditions.	[Chen, Yuling; Yang, Fan; Sun, Zhongyuan; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Wang, Qingtao] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Mi, Kaixia] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China	Tsinghua University; Capital Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Mi, KX (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	mik@im.ac.cn; dengh@biomed.tsinghua.edu.cn		Deng, Haiteng/0000-0001-9496-1280	National Natural Science Foundation of China (NSFC) [31270871, 31270178]; Ministry Of Education And Culture (MOEC) [2012Z02293]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry Of Education And Culture (MOEC)	The study design, data collection and analysis, decision to publish and preparation of the manuscript of this work were supported by National Natural Science Foundation of China (NSFC) 31270871 (H.T.D), Ministry Of Education And Culture (MOEC) 2012Z02293 (H.T.D), and National Natural Science Foundation of China (NSFC) 31270178 (K.M).	Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; BROWN CA, 1969, NATURE, V221, P658, DOI 10.1038/221658a0; CALVORI C, 1965, NATURE, V207, P417, DOI 10.1038/207417a0; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Mattle D, 2013, J MOL BIOL, V425, P2299, DOI 10.1016/j.jmb.2013.03.008; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neyrolles O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00089; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rowland JL, 2012, TUBERCULOSIS, V92, P202, DOI 10.1016/j.tube.2011.12.006; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Shi XS, 2014, MBIO, V5, DOI 10.1128/mBio.00876-13; Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; World Health Organization, 2010, WHOHTMTB20103	27	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127788	10.1371/journal.pone.0127788	http://dx.doi.org/10.1371/journal.pone.0127788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035302	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100021
J	Heringer, AS; Barroso, T; Macedo, AF; Santa-Catarina, C; Souza, GHMF; Floh, EIS; de Souza, GA; Silveira, V				Heringer, Angelo Schuabb; Barroso, Tatiana; Macedo, Amanda Ferreira; Santa-Catarina, Claudete; Martins Ferreira Souza, Gustavo Henrique; Segal Floh, Eny Iochevet; de Souza-Filho, Gonalo Apolinario; Silveira, Vanildo			Label-Free Quantitative Proteomics of Embryogenic and Non-Embryogenic Callus during Sugarcane Somatic Embryogenesis	PLOS ONE			English	Article							NITRIC-OXIDE; SHIKIMATE PATHWAY; CALLOSE SYNTHASE; CELL PLATE; ARABIDOPSIS; PROTEIN; IDENTIFICATION; GENE; BIOSYNTHESIS; PLANTS	The development of somatic cells in to embryogenic cells occurs in several stages and ends in somatic embryo formation, though most of these biochemical and molecular changes have yet to be elucidated. Somatic embryogenesis coupled with genetic transformation could be a biotechnological tool to improve potential crop yields potential in sugarcane cultivars. The objective of this study was to observe somatic embryo development and to identify differentially expressed proteins in embryogenic (E) and non-embryogenic (NE) callus during maturation treatment. E and NE callus were cultured on maturation culture medium supplemented with different concentrations (0.0, 0.75, 1.5 and 2.0 g L-1) of activated charcoal (AC). Somatic embryo formation and differential protein expression were evaluated at days 0 and 21 using shotgun proteomic analyses. Treatment with 1.5 g L-1 AC resulted in higher somatic embryo maturation rates (158 somatic embryos in 14 days) in E callus but has no effect in NE callus. A total of 752 co-expressed proteins were identified through the SUCEST (The Sugarcane EST Project), including many housekeeping proteins. E callus showed 65 exclusive proteins on day 0, including dehydrogenase, desiccation-related protein, callose synthase 1 and nitric oxide synthase. After 21 days on maturation treatment, 14 exclusive proteins were identified in E callus, including catalase and secreted protein. NE callus showed 23 exclusive proteins on day 0 and 10 exclusive proteins after 21 days on maturation treatment, including many proteins related to protein degradation. The induction of maturation leads to somatic embryo development, which likely depends on the expression of specific proteins throughout the process, as seen in E callus under maturation treatment. On the other hand, some exclusive proteins can also specifically prevent of somatic embryos development, as seen in the NE callus.	[Heringer, Angelo Schuabb; Barroso, Tatiana; de Souza-Filho, Gonalo Apolinario; Silveira, Vanildo] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Ctr Biociencias & Biotecnol, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Macedo, Amanda Ferreira; Segal Floh, Eny Iochevet] Univ Sao Paulo, Inst Biociencias, Lab Biol Celular Plantas, Sao Paulo, SP, Brazil; [Santa-Catarina, Claudete] CBB UENF, Lab Biol Celular & Tecidual, Campos Dos Goytacazes, RJ, Brazil; [Martins Ferreira Souza, Gustavo Henrique] Waters Corp, Mass Spectrometry Res & Dev Lab, Sao Paulo, SP, Brazil	Universidade Estadual do Norte Fluminense; Universidade de Sao Paulo	Silveira, V (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Ctr Biociencias & Biotecnol, Lab Biotecnol, Campos Dos Goytacazes, RJ, Brazil.	vanildo@uenf.br	Silveira, Vanildo/E-8887-2011; Heringer, Angelo/S-3033-2019; SOUZA, GUSTAVO HENRIQUE MARTINS FERREIRA/B-5101-2017; Santa-Catarina, Claudete/L-5531-2014; Macedo, Amanda Ferreira F/L-2166-2014; Heringer, Angelo S/M-8275-2014; de Souza Filho, Goncalo/S-7251-2017; Iochevet Segal Floh, Eny/D-9526-2012	Silveira, Vanildo/0000-0001-5697-6932; Heringer, Angelo/0000-0002-2723-7353; SOUZA, GUSTAVO HENRIQUE MARTINS FERREIRA/0000-0002-9410-8578; Santa-Catarina, Claudete/0000-0002-1669-660X; Heringer, Angelo S/0000-0002-2723-7353; de Souza Filho, Goncalo/0000-0003-1028-4425; Iochevet Segal Floh, Eny/0000-0001-6529-2065; Macedo, Amanda/0000-0002-2679-2021	Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro-FAPERJ [E26/110.058/2014, E26/111.828/2013, E26/110.610/2014]; National Council for Scientific and Technological Development-CNPq [454451/2014-8, 304997/2013-7]	Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by the Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro-FAPERJ (Proc. E26/110.058/2014, E26/111.828/2013 and E26/110.610/2014) and the National Council for Scientific and Technological Development-CNPq (Proc. 454451/2014-8 and 304997/2013-7). Center of Innovation and Research & Development Laboratory, Waters Corporation, provided support in the form of salaries for author GHMFS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Agrawal GK, 2012, J PROTEOMICS, V75, P4588, DOI 10.1016/j.jprot.2012.03.055; Ahsan N, 2007, CR BIOL, V330, P735, DOI 10.1016/j.crvi.2007.08.001; ALAMILLO JM, 1994, AGRONOMIE, V14, P161, DOI 10.1051/agro:19940302; Arruda P., 2011, Tropical Plant Biology, V4, P3, DOI 10.1007/s12042-011-9074-5; Arruda P, 2012, CURR OPIN BIOTECH, V23, P315, DOI 10.1016/j.copbio.2011.10.012; Baba AI, 2008, PLANT SCI, V175, P717, DOI 10.1016/j.plantsci.2008.07.014; Balbuena TS, 2009, J PROTEOMICS, V72, P337, DOI 10.1016/j.jprot.2009.01.011; BARTELS D, 1992, EMBO J, V11, P2771, DOI 10.1002/j.1460-2075.1992.tb05344.x; Basset GJC, 2005, CROP SCI, V45, P449, DOI 10.2135/cropsci2005.0449; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Butterfield M, 1996, P AFRICAN SUGARCANE; Butterfield M, 2001, P AFRICAN SUGARCANE; Chakraborty AB, 2007, RAPID COMMUN MASS SP, V21, P730, DOI 10.1002/rcm.2888; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Cohen JD, 2003, TRENDS PLANT SCI, V8, P197, DOI 10.1016/S1360-1385(03)00058-X; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; DUBOIS T, 1990, ANN BOT-LONDON, V65, P539, DOI 10.1093/oxfordjournals.aob.a087967; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; FAO, 2014, FAOSTAT CROP PROD FO; Feher A, 2014, BIOCHIMICA BIOPHYSIC; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Giles K, 2011, RAPID COMMUN MASS SP, V25, P1559, DOI 10.1002/rcm.5013; Gillaspy GE, 2010, PLANT CELL MONOGR, V16, P117, DOI [10.1007/978-3-642-03873-0_8, 10.1109/ASYNC.2010.15]; Guerra M, 1999, CULTURA TECIDOS TRAN; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Hattori J, 1998, MOL GEN GENET, V259, P424, DOI 10.1007/s004380050832; He WH, 2000, CURR OPIN CELL BIOL, V12, P346, DOI 10.1016/S0955-0674(00)00098-3; Heringer AS, 2014, SCI HORTIC-AMSTERDAM, V179, P284, DOI 10.1016/j.scienta.2014.09.041; HERRMANN KM, 1995, PLANT CELL, V7, P907; Heyneke E, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-104; Hong ZL, 2001, PLANT CELL, V13, P755, DOI 10.1105/tpc.13.4.755; Ikeda-Iwai M, 2003, PLANT J, V34, P107, DOI 10.1046/j.1365-313X.2003.01702.x; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jimenez VM, 2005, PLANT GROWTH REGUL, V47, P91, DOI 10.1007/s10725-005-3478-x; KESSELL RHJ, 1972, J EXP BOT, V23, P996, DOI 10.1093/jxb/23.4.996; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; Kobayashi K, 2007, PLANT CELL, V19, P1885, DOI 10.1105/tpc.106.045666; Kotake T, 2007, BIOSCI BIOTECH BIOCH, V71, P761, DOI 10.1271/bbb.60605; Kube M, 2014, IN VITRO CELL DEV-PL, V50, P45, DOI 10.1007/s11627-013-9589-6; Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643; Lalli PM, 2013, J MASS SPECTROM, V48, P989, DOI 10.1002/jms.3245; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Litterer LA, 2006, PHYSIOL PLANTARUM, V128, P200, DOI 10.1111/j.1399-3054.2006.00728.x; LU CC, 1989, PLANT CELL REP, V7, P696, DOI 10.1007/BF00272064; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Luge T, 2014, PROTEOMICS, V14, P1882, DOI 10.1002/pmic.201300551; Mahdisoltani F., 2014, PLANT CELL TISS ORG, P1; Malik MR, 2007, PLANT PHYSIOL, V144, P134, DOI 10.1104/pp.106.092932; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; MARTINELLI L, 1993, J PLANT PHYSIOL, V141, P476, DOI 10.1016/S0176-1617(11)80197-5; Martzivanou M, 2003, PHYSIOL PLANTARUM, V118, P221, DOI 10.1034/j.1399-3054.2003.00092.x; Matsumura T, 2002, PHYSIOL PLANTARUM, V116, P317, DOI 10.1034/j.1399-3054.2002.1160306.x; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Ming R, 1998, GENETICS, V150, P1663; Moon HK, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1710-x; Mordhorst AP, 1997, CRIT REV PLANT SCI, V16, P535, DOI 10.1080/713608156; Murad AM, 2011, J SEP SCI, V34, P2618, DOI 10.1002/jssc.201100238; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mussig C, 2005, PLANT BIOLOGY, V7, P110, DOI 10.1055/s-2005-837493; Otvos K, 2005, PLANT J, V43, P849, DOI 10.1111/j.1365-313X.2005.02494.x; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; Peterman TK, 2004, PLANT PHYSIOL, V136, P3080, DOI 10.1104/pp.104.045369; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Poon S, 2012, PLANT PHYSIOL, V160, P684, DOI 10.1104/pp.112.203075; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Qi YH, 2005, PLANT SCI, V168, P15, DOI 10.1016/j.plantsci.2004.07.004; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ravanel S, 2001, P NATL ACAD SCI USA, V98, P15360, DOI 10.1073/pnas.261585098; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; ROSE AB, 1992, PLANT PHYSIOL, V100, P582, DOI 10.1104/pp.100.2.582; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Silva RD, 2014, J PROTEOMICS, V104, P112, DOI 10.1016/j.jprot.2014.03.013; Silveira V, 2006, PLANT SCI, V171, P91, DOI 10.1016/j.plantsci.2006.02.015; Silveira V, 2013, PLANT CELL TISS ORG, V114, P351, DOI 10.1007/s11240-013-0330-2; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Smulders MJM, 2011, PLANT GROWTH REGUL, V63, P137, DOI 10.1007/s10725-010-9531-4; Snyman SJ, 2011, IN VITRO CELL DEV-PL, V47, P234, DOI 10.1007/s11627-011-9354-7; Steinmacher DA, 2007, PLANT CELL TISS ORG, V89, P15, DOI 10.1007/s11240-007-9207-6; Steinmacher DA, 2012, PHYSIOL PLANTARUM, V146, P336, DOI 10.1111/j.1399-3054.2012.01642.x; Sugiharto B, 2002, PLANT CELL PHYSIOL, V43, P350, DOI 10.1093/pcp/pcf039; TAUTORUS TE, 1991, CAN J BOT, V69, P1873, DOI 10.1139/b91-237; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsuwamoto R, 2007, PLANTA, V225, P641, DOI 10.1007/s00425-006-0388-8; Tzin V, 2012, NEW PHYTOL, V194, P430, DOI 10.1111/j.1469-8137.2012.04052.x; USDA, 2012, SUG WORLD PROD SUPPL; Vale ED, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-37; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; VIERSTRA RD, 1993, ANNU REV PLANT PHYS, V44, P385, DOI 10.1146/annurev.pp.44.060193.002125; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wu C, 2000, ANAL CHEM, V72, P391, DOI 10.1021/ac990601c; Yu YQ, 2003, ANAL CHEM, V75, P6023, DOI 10.1021/ac0346196; Zhang JW, 2009, PLANT SCI, V177, P103, DOI 10.1016/j.plantsci.2009.04.003; Zhang JY, 2011, J PLANT PHYSIOL, V168, P1844, DOI 10.1016/j.jplph.2011.04.005; Zhou S, 2007, AFR J ENV SCI TECHNO, V1, P14	103	41	43	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127803	10.1371/journal.pone.0127803	http://dx.doi.org/10.1371/journal.pone.0127803			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035435	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100022
J	Smith, CD; Freed, TZ; Leisnham, PT				Smith, Cassandra D.; Freed, T. Zachary; Leisnham, Paul T.			Prior Hydrologic Disturbance Affects Competition between Aedes Mosquitoes via Changes in Leaf Litter	PLOS ONE			English	Article							TRISERIATUS DIPTERA; COMMUNITY STRUCTURE; ALBOPICTUS; RESOURCE; HABITAT; POPULATIONS; CULICIDAE; PERFORMANCE; DYNAMICS; DROUGHT	Allochthonous leaf litter is often the main resource base for invertebrate communities in ephemeral water-filled containers, and detritus quality can be affected by hydrologic conditions. The invasive mosquito Aedes albopictus utilizes container habitats for its development where it competes as larvae for detritus and associated microorganisms with the native Aedes triseriatus. Different hydrologic conditions that containers are exposed to prior to mosquito utilization affect litter decay and associated water quality. We tested the hypothesis that larval competition between A. albopictus and A. triseriatus would be differentially affected by prior hydrologic conditions. Experimental microcosms provisioned with Quercus alba L. litter were subjected to one of three different hydrologic treatments prior to the addition of water and mosquito larvae: dry, flooded, and a wet/dry cycle. Interspecific competition between A. albopictus and A. triseriatus was mediated by hydrologic treatment, and was strongest in the dry treatment vs. the flooded or wet/dry treatments. Aedes triseriatus estimated rate of population change (lambda') was lowest in the dry treatment. Aedes albopictus lambda' was unaffected by hydrologic treatment, and was on average always increasing (i.e., > 1). Aedes triseriatus lambda' was affected by the interaction of hydrologic treatment with interspecific competition, and was on average declining (i.e., < 1.0), at the highest interspecific densities in the dry treatment. Dry treatment litter had the slowest decay rate and leached the highest concentration of tannin-lignin, but supported more total bacteria than the other treatments. These results suggest that dry conditions negatively impact A. triseriatus population performance and may result in the competitive exclusion of A. triseriatus by A. albopictus, possibly by reducing microbial taxa that Aedes species browse. Changing rainfall patterns with climate change are likely to affect competition between A. triseriatus and A. albopictus, probably enhancing negative competitive effects of A. albopictus on A. triseriatus in areas that experience drought.	[Smith, Cassandra D.; Freed, T. Zachary; Leisnham, Paul T.] Univ Maryland, Ecosyst Hlth & Nat Resource Management, Dept Environm Sci & Technol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Leisnham, PT (corresponding author), Univ Maryland, Ecosyst Hlth & Nat Resource Management, Dept Environm Sci & Technol, College Pk, MD 20742 USA.	leisnham@umd.edu		Freed, Zach/0000-0002-1274-6374; Leisnham, Paul T./0000-0003-3527-8435				Aliabadi Brianna W., 2002, Biological Invasions, V4, P283, DOI 10.1023/A:1020933705556; Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646; Aspbury AS, 1998, OECOLOGIA, V115, P137, DOI 10.1007/s004420050500; BOULTON AJ, 1992, ECOLOGY, V73, P2192, DOI 10.2307/1941467; BRADSHAW WE, 1988, OECOLOGIA, V74, P507, DOI 10.1007/BF00380047; CAMERON GN, 1978, OECOLOGIA, V32, P349, DOI 10.1007/BF00345113; CARPENTER SR, 1983, ECOLOGY, V64, P219, DOI 10.2307/1937068; Cassell DL, 2011, RANDOMIZATION TEST W; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; CUMMINS KW, 1979, ANNU REV ECOL SYST, V10, P147, DOI 10.1146/annurev.es.10.110179.001051; David JP, 2001, J CHEM ECOL, V27, P161, DOI 10.1023/A:1005632403561; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Duguma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072522; Frank J. H., 1983, PHYTOTELMATA TERREST; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Hense BA, 2005, AQUAT TOXICOL, V73, P190, DOI 10.1016/j.aquatox.2005.03.010; HUBERTY CJ, 1989, PSYCHOL BULL, V105, P302, DOI 10.1037/0033-2909.105.2.302; Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x; Joy JE, 2000, WILD ENVIRON MED, V11, P79, DOI 10.1580/1080-6032(2000)011[0079:LHCFAT]2.3.CO;2; JULIANO SA, 1994, OECOLOGIA, V97, P369, DOI 10.1007/BF00317327; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kaufman MG, 1999, APPL ENVIRON MICROB, V65, P2661; LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535; LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204; Lounibos L. P., 2001, Biological Invasions, V3, P151, DOI 10.1023/A:1014519919099; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nannini MA, 1998, ANN ENTOMOL SOC AM, V91, P33, DOI 10.1093/aesa/91.1.33; Parkos JJ, 2011, OIKOS, V120, P1519, DOI 10.1111/j.1600-0706.2011.19178.x; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Schneider DW, 1996, J N AM BENTHOL SOC, V15, P64, DOI 10.2307/1467433; Skiff JJ, 2014, J MED ENTOMOL, V51, P375, DOI 10.1603/ME13159; Smith C, 2013, J MED ENTOMOL, V50, P521, DOI 10.1603/ME12149; SOTA T, 1993, ANN ENTOMOL SOC AM, V86, P450, DOI 10.1093/aesa/86.4.450; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Tilman D., 1982, Monographs in Population Biology, pi; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953	45	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128956	10.1371/journal.pone.0128956	http://dx.doi.org/10.1371/journal.pone.0128956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035819	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100057
J	Bollegala, D; Kontonatsios, G; Ananiadou, S				Bollegala, Danushka; Kontonatsios, Georgios; Ananiadou, Sophia			A Cross-Lingual Similarity Measure for Detecting Biomedical Term Translations	PLOS ONE			English	Article							ALGORITHMS	Bilingual dictionaries for technical terms such as biomedical terms are an important resource for machine translation systems as well as for humans who would like to understand a concept described in a foreign language. Often a biomedical term is first proposed in English and later it is manually translated to other languages. Despite the fact that there are large monolingual lexicons of biomedical terms, only a fraction of those term lexicons are translated to other languages. Manually compiling large-scale bilingual dictionaries for technical domains is a challenging task because it is difficult to find a sufficiently large number of bilingual experts. We propose a cross-lingual similarity measure for detecting most similar translation candidates for a biomedical term specified in one language (source) from another language (target). Specifically, a biomedical term in a language is represented using two types of features: (a) intrinsic features that consist of character n-grams extracted from the term under consideration, and (b) extrinsic features that consist of unigrams and bigrams extracted from the contextual windows surrounding the term under consideration. We propose a cross-lingual similarity measure using each of those feature types. First, to reduce the dimensionality of the feature space in each language, we propose prototype vector projection (PVP)-a non-negative lower-dimensional vector projection method. Second, we propose a method to learn a mapping between the feature spaces in the source and target language using partial least squares regression (PLSR). The proposed method requires only a small number of training instances to learn a cross-lingual similarity measure. The proposed PVP method outperforms popular dimensionality reduction methods such as the singular value decomposition (SVD) and non-negative matrix factorization (NMF) in a nearest neighbor prediction task. Moreover, our experimental results covering several language pairs such as English-French, English-Spanish, English-Greek, and English-Japanese show that the proposed method outperforms several other feature projection methods in biomedical term translation prediction tasks.	[Bollegala, Danushka] Univ Liverpool, Dept Comp Sci, Liverpool L69 3BX, Merseyside, England; [Kontonatsios, Georgios; Ananiadou, Sophia] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Kontonatsios, Georgios; Ananiadou, Sophia] Univ Manchester, Natl Ctr Text Min, Manchester, Lancs, England	University of Liverpool; University of Manchester; University of Manchester	Bollegala, D (corresponding author), Univ Liverpool, Dept Comp Sci, Liverpool L69 3BX, Merseyside, England.	danushka.bollegala@liverpool.ac.uk		Kontonatsios, Georgios/0000-0001-5935-4709	UK Medical Research Council [MR/L01078X/1]; AHRC, Mining the History of Medicine [AH/L00982X/1]; AHRC [AH/L00982X/1] Funding Source: UKRI; MRC [MR/L01078X/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/L00982X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1428752] Funding Source: researchfish; Medical Research Council [MR/L01078X/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AHRC, Mining the History of Medicine(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SA and GK acknowledge support from the UK Medical Research Council MR/L01078X/1 Supporting Evidence-based Public Health Interventions using Text Mining and AHRC AH/L00982X/1, Mining the History of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollegala D, 2005, LECT NOTES ARTIF INT, V3651, P624, DOI 10.1007/11562214_55; Bollegala D., 2007, P 16 INT C WORLD WID, P757, DOI DOI 10.1145/1242572.1242675; Bollegala D, 2007, HLT NAACL, P340; Bollegala D, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P613; Bollegala D, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P385; Bouamor D, 2013, P 2013 C EMP METH NA, P479; Bouamor D, 2013, 6 WORKSH BUILD US CO, P16; Bouamor Dhouha, 2013, SHORT PAPERS ASS COM, P759; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Cichocki A, 2007, LECT NOTES COMPUT SC, V4493, P793; Dagan I., 1994, P 4 C APPL NAT LANG, P34, DOI DOI 10.3115/974358.974367; Delpech E, 2012, COLING 2012, P745; Duc N. T., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P196, DOI 10.1109/WI-IAT.2010.167; Duc N. T., 2011, AAAI 11, P1237; Duc NT, 2012, ACM T ASIAN LANGUAGE, V11, P1, DOI 10.1145/2334801.2334805; Fang H., 2008, P 46 ANN M ASS COMPU, P139; Firth J.R., 1957, STUDIES LINGUISTIC A, P1; Frantzi K., 2000, INT J DIGITAL LIB, V3, P117, DOI DOI 10.1007/S007999900023; Frege G, 1950, FDN ARITHMETIC LOGIC; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Golub G.H., 1996, MATRIX COMPUTATIONS; Haghighi A, 2008, ACL 2008, P771; He X., 2003, NEURIPS, P153; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Kontonatsios G., 2014, P 14 C EUR CHAPT ASS, P111; Kontonatsios G., 2014, EMNLP; Lee DD, 2001, ADV NEUR IN, V13, P556; Lin D, 1998, P 36 ANN M ASS COMP, P768, DOI DOI 10.3115/980432.980696; Littman ML, 1998, KLUW S INF, V2, P51; Manning CD, 2008, INTRO INFORM RETRIEV; McCallum, 2009, P 2009 C EMP METH NA, P880, DOI DOI 10.3115/1699571.1699627; MORIN E, 2012, COLING 2012, P1797; Morin E, 2010, LANG RESOUR EVAL, V44, P79, DOI 10.1007/s10579-009-9098-8; Och F. J., 2003, Computational Linguistics, V29, P19, DOI 10.1162/089120103321337421; Okazaki N, 2010, BIOINFORMATICS, V26, P1246, DOI 10.1093/bioinformatics/btq129; Ponzetto SP, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P1522; Ravichandran Deepak, 2005, P 43 ANN M ASS COMP, P622, DOI DOI 10.3115/1219840.1219917; Robitaille X, 2006, 11 C EUR CHAPT ASS C; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Tanaka T, 2002, P INT C COMP LING CO, V1, P1; Tipping ME, 1999, NEURAL COMPUT, V11, P443, DOI 10.1162/089976699300016728; Turney PD, 2006, COMPUT LINGUIST, V32, P379, DOI 10.1162/coli.2006.32.3.379; Turney PD, 2012, J ARTIF INTELL RES, V44, P533, DOI 10.1613/jair.3640; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vuli I, 2014, P 2014 C EMP METH NA, P349; Wold H., 1985, ENCY STAT SCI, P581, DOI DOI 10.1002/0471667196; Wold H., 1975, QUANTITATIVE SOCIOLO; Xu JX, 2000, PROCEEDINGS OF THE 2000 JOINT SIGDAT CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND VERY LARGE CORPORA, P95; Xu Y, 2013, PLOS ONE; Yogatama D., 2009, P 2009 C EMPIRICAL M, P871; Yokote K., 2012, P 26 AAAI C ART INT, P1720	54	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126196	10.1371/journal.pone.0126196	http://dx.doi.org/10.1371/journal.pone.0126196			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030738	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900021
J	Lu, J; Chu, P; Wang, HM; Jin, YQ; Han, SJ; Han, W; Tai, J; Guo, YL; Ni, X				Lu, Jie; Chu, Ping; Wang, Huanmin; Jin, Yaqiong; Han, Shujing; Han, Wei; Tai, Jun; Guo, Yongli; Ni, Xin			Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1	PLOS ONE			English	Article							BARD1; SUSCEPTIBILITY; IDENTIFICATION; REPLICATION; GENOMICS; TARGETS; LOCUS	Neuroblastoma (NB) is the most common extra-cranial solid tumor in children and the most frequently diagnosed cancer in the first year of life. Previous genome-wide association studies (GWAS) of Caucasian and African populations have shown that common single nucleotide polymorphisms (SNPs) in several genes are associated with the risk of developing NB, while few studies have been performed on Chinese children. Herein, we examined the association between the genetic polymorphisms in candidate genes and the risk of NB in Chinese children. In total, 127 SNPs in nine target genes, revealed by GWAS studies of other ethnic groups and four related lincRNAs, were genotyped in 549 samples (244 NB patients and 305 healthy controls). After adjustment for gender and age, there were 21 SNPs associated with NB risk at the two-sided P < 0.05 level, 11 of which were located in LMO1. After correction for multiple comparisons, only rs204926 in LMO1 remained significantly different between cases and controls (OR = 0.45, 95% CI: 0.31-0.65, adjusted P=0.003). In addition, 16 haplotypes in four separate genes were significantly different between case and control groups at an unadjusted P value < 0.05, 11 of which were located in LMO1. A major haplotype, ATC, containing rs204926, rs110420, and rs110419, conferred a significant increase in risk for NB (OR = 1.82, 95% CI: 1.41-2.36, adjusted P < 0.001). The major finding of our study was obtained for risk alleles within the LMO1 gene. Our data suggest that genetic variants in LMO1 are associated with increased NB risk in Chinese children.	[Lu, Jie; Chu, Ping; Jin, Yaqiong; Han, Shujing; Guo, Yongli; Ni, Xin] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Beijing Key Lab Pediat Dis Otolaryngol Head & Nec, Beijing, Peoples R China; [Wang, Huanmin; Han, Wei] Capital Med Univ, Beijing Childrens Hosp, Dept Surg Oncol, Beijing, Peoples R China; [Tai, Jun; Ni, Xin] Capital Med Univ, Beijing Childrens Hosp, Head & Neck Surg, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Guo, YL (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Beijing Key Lab Pediat Dis Otolaryngol Head & Nec, Beijing, Peoples R China.	guoyongli@bch.com.cn; nixin@bch.com.cn		Jin, Yaqiong/0000-0002-9318-6531	Research Funds of Profession Quota Budjet from Beijing Municipal Science and Technology Commission [2013-bjsekyjs-6]; National Natural Science Foundation of China [31401067]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201510025021]	Research Funds of Profession Quota Budjet from Beijing Municipal Science and Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This work was supported by Research Funds of Profession Quota Budjet from Beijing Municipal Science and Technology Commission (2013-bjsekyjs-6), National Natural Science Foundation of China (31401067), and Scientific Research Common Program of Beijing Municipal Commission of Education (KM201510025021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet-Walsh E, 2012, EUR UROL, V62, P88, DOI 10.1016/j.eururo.2011.12.021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Capasso M, 2013, CARCINOGENESIS, V34, P605, DOI 10.1093/carcin/bgs380; Capasso M, 2010, CANCER TREAT RES, V155, P65, DOI 10.1007/978-1-4419-6033-7_4; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Fan QH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090008; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; GREENBERG JM, 1990, NATURE, V344, P158, DOI 10.1038/344158a0; Haynes BP, 2010, CLIN CANCER RES, V16, P1790, DOI 10.1158/1078-0432.CCR-09-2481; Latorre V, 2012, CANCER EPIDEM BIOMAR, V21, P658, DOI 10.1158/1055-9965.EPI-11-0830; Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098251; Malek MM, 2010, J PEDIATR SURG, V45, P1622, DOI 10.1016/j.jpedsurg.2010.03.018; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matis C, 2007, DEV DYNAM, V236, P2675, DOI 10.1002/dvdy.21266; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sakurai N, 2006, J STEROID BIOCHEM, V99, P174, DOI 10.1016/j.jsbmb.2006.01.010; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Szajnik M, 2012, GYNECOL ONCOL, V127, P587, DOI 10.1016/j.ygyno.2012.08.010; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252	28	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127856	10.1371/journal.pone.0127856	http://dx.doi.org/10.1371/journal.pone.0127856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030754	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900085
J	Poncelet, PE; Giersch, A				Poncelet, Patrick Eric; Giersch, Anne			Tracking Visual Events in Time in the Absence of Time Perception: Implicit Processing at the ms Level	PLOS ONE			English	Article							ATTENTION; SCHIZOPHRENIA; SYNCHRONY; CONFLICT	Previous studies have suggested that even if subjects deem two visual stimuli less than 20 ms apart to be simultaneous, implicitly they are nonetheless distinguished in time. It is unclear, however, how information is encoded within this short timescale. We used a priming paradigm to demonstrate how successive visual stimuli are processed over time intervals of less than 20 ms. The primers were two empty square frames displayed either simultaneously or with a 17ms asynchrony. The primers were followed by the target information after a delay of 25 ms to 100 ms. The two square frames were filled in one after another with a delay of 100 ms between them, and subjects had to decide on the location of the first of the frames to be filled in. In a second version of the paradigm, only one square frame was filled in, and subjects had to decide where it was positioned. The influence of the primers is revealed through faster response times depending on the location of the first and second primers. Experiment 1 replicates earlier results, with a bias towards the side of the second primer, but only when there is a delay of 75 to 100 ms between primers and targets. The following experiments suggest this effect to be relatively independent of the task context, except for a slight effect on the time course of the biases. For the temporal order judgment task, identical results were observed when subjects have to answer to the side of the second rather than the first target, showing the effect to be independent of the hand response, and suggesting it might be related to a displacement of attention. All in all the results suggest the flow of events is followed more efficiently than suggested by explicit asynchrony judgment studies. We discuss the possible impact of these results on our understanding of the sense of time continuity.	[Poncelet, Patrick Eric; Giersch, Anne] Strasbourg Univ Hosp, Federat Med Translat Strasbourg, INSERM, Dept Psychiat,U1114, Strasbourg, France	CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giersch, A (corresponding author), Strasbourg Univ Hosp, Federat Med Translat Strasbourg, INSERM, Dept Psychiat,U1114, Strasbourg, France.	giersch@unistra.fr	Giersch, Anne/H-6444-2016	Giersch, Anne/0000-0002-8577-6021	French National Institute for Health and Medical Research (INSERM); Centre Hospitalier Regional Universitaire of Strasbourg [3494]; Medicine Faculty of Strasbourg; French National Research Agency (ANR) [ANR-10-BLAN-1903]	French National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre Hospitalier Regional Universitaire of Strasbourg; Medicine Faculty of Strasbourg; French National Research Agency (ANR)(French National Research Agency (ANR))	The research reviewed in this manuscript was supported by the French National Institute for Health and Medical Research (INSERM), the Centre Hospitalier Regional Universitaire of Strasbourg (API-HUSno 3494), the Medicine Faculty of Strasbourg and the French National Research Agency (ANR FeellnControl no ANR-10-BLAN-1903).	Battaglini L, 2015, ATTEN PERCEPT PSYCHO, V77, P603, DOI 10.3758/s13414-014-0795-z; Bodelon C, 2007, J NEUROSCI, V27, P725, DOI 10.1523/JNEUROSCI.3860-06.2007; BRECHER GERHARD A., 1932, ZEITSCHR VERGLEICH PHYSIOL, V18, P204; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; Elliott MA, 2007, PSYCHOL RES-PSYCH FO, V71, P687, DOI 10.1007/s00426-006-0057-3; Elliott MA, 2006, J COGNITIVE NEUROSCI, V18, P1663, DOI 10.1162/jocn.2006.18.10.1663; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; Fujisaki W, 2010, P ROY SOC B-BIOL SCI, V277, P2281, DOI 10.1098/rspb.2010.0243; Giersch A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00281; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hommel B, 2011, ACTA PSYCHOL, V136, P265, DOI 10.1016/j.actpsy.2010.10.002; Hommel B, 2011, ACTA PSYCHOL, V136, P189, DOI 10.1016/j.actpsy.2010.04.011; Husserl E, 1928, VORLEFUNGEN PHANOMEN; James W, 1890, Science, V15, P304, DOI 10.1126/science.ns-15.380.304; Karniel A, 2011, J INTEGR NEUROSCI, V10, P385, DOI 10.1142/S0219635211002749; Kentridge RW, 2008, NEUROPSYCHOLOGIA, V46, P864, DOI 10.1016/j.neuropsychologia.2007.11.036; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; LALANNE L, 1876, NOTE COMPTES RENDUS, V39, P1314; Lalanne L, 2012, NEUROPSYCHOLOGIA, V50, P2736, DOI 10.1016/j.neuropsychologia.2012.07.023; Lalanne L, 2012, SCHIZOPHRENIA BULL, V38, P506, DOI 10.1093/schbul/sbq107; Mattler U, 2007, PERCEPT PSYCHOPHYS, V69, P1389, DOI 10.3758/BF03192954; Murray SO, 2004, NEURAL NETWORKS, V17, P695, DOI 10.1016/j.neunet.2004.03.010; POPPEL E, 1994, INT REV NEUROBIOL, V37, P185; Poppel E, 1997, BEHAV BRAIN SCI, V20, P155, DOI 10.1017/S0140525X97300053; Ries AJ, 2011, VISION RES, V51, P1820, DOI 10.1016/j.visres.2011.06.012; Schiff S, 2011, J COGNITIVE NEUROSCI, V23, P3998, DOI 10.1162/jocn_a_00080; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Steinman BA, 1997, VISION RES, V37, P17, DOI 10.1016/S0042-6989(96)00151-4; Sturmer B, 2007, EXP BRAIN RES, V183, P329, DOI 10.1007/s00221-007-1053-6; Van der Lubbe RHJ, 2011, ACTA PSYCHOL, V136, P259, DOI 10.1016/j.actpsy.2010.09.007; van Wassenhove V, 2009, PHILOS T R SOC B, V364, P1815, DOI 10.1098/rstb.2009.0023; von Baer K. E., 1864, REDEN GEHALTEN WISSE, P237; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wittmann M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00066	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127106	10.1371/journal.pone.0127106	http://dx.doi.org/10.1371/journal.pone.0127106			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030155	Green Published, gold			2022-12-27	WOS:000356630900041
J	Batrakou, DG; Heras, JID; Czapiewski, R; Mouras, R; Schirmer, EC				Batrakou, Dzmitry G.; Heras, Jose I. de Las; Czapiewski, Rafal; Mouras, Rabah; Schirmer, Eric C.			TMEM120A and B: Nuclear Envelope Transmembrane Proteins Important for Adipocyte Differentiation	PLOS ONE			English	Article							LMNA MUTATIONS; LAMIN A/C; MEMBRANE PROTEIN; PPAR-GAMMA; CELL; TRANSCRIPTION; ACTIVATION; LIPODYSTROPHY; ADIPOGENESIS; ADIPONECTIN	Recent work indicates that the nuclear envelope is a major signaling node for the cell that can influence tissue differentiation processes. Here we present two nuclear envelope transmembrane proteins TMEM120A and TMEM120B that are paralogs encoded by the Tmem120A and Tmem120B genes. The TMEM120 proteins are expressed preferentially in fat and both are induced during 3T3-L1 adipocyte differentiation. Knockdown of one or the other protein altered expression of several genes required for adipocyte differentiation, Gata3, Fasn, Glut4, while knockdown of both together additionally affected Pparg and Adipoq. The double knockdown also increased the strength of effects, reducing for example Glut4 levels by 95% compared to control 3T3-L1 cells upon pharmacologically induced differentiation. Accordingly, TMEM120A and B knockdown individually and together impacted on adipocyte differentiation/metabolism as measured by lipid accumulation through binding of Oil Red O and coherent anti-Stokes Raman scattering microscopy (CARS). The nuclear envelope is linked to several lipodystrophies through mutations in lamin A; however, lamin A is widely expressed. Thus it is possible that the TMEM120A and B fat-specific nuclear envelope transmembrane proteins may play a contributory role in the tissue-specific pathology of this disorder or in the wider problem of obesity.	[Batrakou, Dzmitry G.; Heras, Jose I. de Las; Czapiewski, Rafal; Schirmer, Eric C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Mouras, Rabah] Univ Edinburgh, Inst Mat & Proc, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Schirmer, EC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	e.schirmer@ed.ac.uk	Mouras, Rabah/AAV-8487-2020	Mouras, Rabah/0000-0001-5100-4739; Schirmer, Eric/0000-0003-2635-1338; Czapiewski, Rafal/0000-0003-0211-8435	Wellcome Trust [076616, 095209]; Wellcome Trust Centre for Cell Biology [092076]; Darwin Trust studentship	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Centre for Cell Biology(Wellcome Trust); Darwin Trust studentship	This work was supported by Wellcome Trust Senior Research Fellowship (076616 and 095209) to ECS, core funding to the Wellcome Trust Centre for Cell Biology (092076), and a Darwin Trust studentship to DGB. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001; Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Byerly MS, 2010, PHYSIOL GENOMICS, V42, P157, DOI 10.1152/physiolgenomics.00029.2010; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; Dahm AEA, 2012, THROMB RES, V130, P45, DOI 10.1016/j.thromres.2011.12.009; de las Heras JI, 2013, NUCLEUS-PHILA, V4, P460, DOI 10.4161/nucl.26872; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Dittmer TA, 2014, MOL BIOL CELL, V25, P1493, DOI 10.1091/mbc.E14-02-0733; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Korfali N, 2012, NUCLEUS-PHILA, V3, P552, DOI 10.4161/nucl.22257; Korfali N, 2010, MOL CELL PROTEOMICS, V9, P2571, DOI 10.1074/mcp.M110.002915; Liu W, 2014, MOL GENET GENOMICS, V289, P847, DOI 10.1007/s00438-014-0859-8; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Mouras R, 2011, PROC SPIE, V8086, DOI 10.1117/12.889780; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto MT, 2014, AIDS RES HUM RETROV, V30, P610, DOI [10.1089/aid.2013.0109, 10.1089/AID.2013.0109]; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; R Core Team, 2018, R LANG ENV STAT COMP; Raju GP, 2003, J BIOL CHEM, V278, P428, DOI 10.1074/jbc.M210505200; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Taher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028358; Tilgner K, 2009, J CELL SCI, V122, P401, DOI 10.1242/jcs.026179; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wilkie GS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003129; Willyard C, 2014, NATURE, V508, pS58, DOI 10.1038/508S58a; World Health Organization, 2016, OB OV; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zuleger N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r14; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	55	33	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127712	10.1371/journal.pone.0127712	http://dx.doi.org/10.1371/journal.pone.0127712			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024229	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400048
J	de Vos-Kerkhof, E; Nijman, RG; Vergouwe, Y; Polinder, S; Steyerberg, EW; van der Lei, J; Moll, HA; Oostenbrink, R				de Vos-Kerkhof, Evelien; Nijman, Ruud G.; Vergouwe, Yvonne; Polinder, Suzanne; Steyerberg, Ewout W.; van der Lei, Johan; Moll, Henriette A.; Oostenbrink, Rianne			Impact of a Clinical Decision Model for Febrile Children at Risk for Serious Bacterial Infections at the Emergency Department: A Randomized Controlled Trial	PLOS ONE			English	Article							SUPPORT-SYSTEMS; PREDICTION RULES; APPARENT SOURCE; FEVER; CARE; MANAGEMENT; SIGNS; IMPLEMENTATION; DIAGNOSIS; MENINGITIS	Objectives To assess the impact of a clinical decision model for febrile children at risk for serious bacterial infections (SBI) attending the emergency department (ED). Methods Randomized controlled trial with 439 febrile children, aged 1 month-16 years, attending the pediatric ED of a Dutch university hospital during 2010-2012. Febrile children were randomly assigned to the intervention (clinical decision model; n=219) or the control group (usual care; n=220). The clinical decision model included clinical symptoms, vital signs, and C-reactive protein and provided high/low-risks for "pneumonia" and "other SBI". Nurses were guided by the intervention to initiate additional tests for high-risk children. The clinical decision model was evaluated by 1) area-under-the-receiver-operating-characteristic-curve (AUC) to indicate discriminative ability and 2) feasibility, to measure nurses' compliance to model recommendations. Primary patient outcome was defined as correct SBI diagnoses. Secondary process outcomes were defined as length of stay; diagnostic tests; antibiotic treatment; hospital admission; revisits and medical costs. Results The decision model had good discriminative ability for both pneumonia (n=33; AUC 0.83 (95% CI 0.75-0.90)) and other SBI (n=22; AUC 0.81 (95% CI 0.72-0.90)). Compliance to model recommendations was high (86%). No differences in correct SBI determination were observed. Application of the clinical decision model resulted in less full-blood-counts (14% vs. 22%, p-value<0.05) and more urine-dipstick testing (71% vs. 61%, p-value<0.05). Conclusions In contrast to our expectations no substantial impact on patient outcome was perceived. The clinical decision model preserved, however, good discriminatory ability to detect SBI, achieved good compliance among nurses and resulted in a more standardized diagnostic approach towards febrile children, with less full blood-counts and more rightfully urine-dipstick testing.	[de Vos-Kerkhof, Evelien; Nijman, Ruud G.; Moll, Henriette A.; Oostenbrink, Rianne] ErasmusMC Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands; [Vergouwe, Yvonne; Steyerberg, Ewout W.] Erasmus Univ, Med Ctr, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van der Lei, Johan] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Oostenbrink, R (corresponding author), ErasmusMC Sophia Childrens Hosp, Dept Gen Pediat, Rotterdam, Netherlands.	r.oostenbrink@erasmusmc.nl		Nijman, Ruud Gerard/0000-0001-9671-8161	ZonMW; Dutch organization for Health Research and Development; Erasmus University Medical Centre Rotterdam; European Society of Pediatric Infectious Diseases	ZonMW(Netherlands Organization for Health Research and Development); Dutch organization for Health Research and Development; Erasmus University Medical Centre Rotterdam; European Society of Pediatric Infectious Diseases	Authors EK and RN are supported by ZonMW, the Dutch organization for Health Research and Development, and Erasmus University Medical Centre Rotterdam. Author RO is supported by a fellowship of the European Society of Pediatric Infectious Diseases. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, R LANG ENV STAT COMP; Armon K, 2001, ARCH DIS CHILD, V84, P390, DOI 10.1136/adc.84.5.390; BARAFF LJ, 1992, PEDIATR INFECT DIS J, V11, P146, DOI 10.1097/00006454-199202000-00031; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Biesheuvel C, 2007, CLIN CHEM, V53, P1725, DOI 10.1373/clinchem.2007.087403; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; Bleeker SE, 2001, ACTA PAEDIATR, V90, P1226, DOI 10.1080/080352501317130236; Bourgeois FC, 2010, CLIN PEDIATR, V49, P976, DOI 10.1177/0009922810373649; Bouwhuis C B, 2001, Ned Tijdschr Geneeskd, V145, P1847; Brent AJ, 2011, ARCH DIS CHILD, V96, P368, DOI 10.1136/adc.2010.183129; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Edmonds ZV, 2002, ANN EMERG MED, V39, P233, DOI 10.1067/mem.2002.122017; Galetto-Lacour A, 2010, ARCH DIS CHILD, V95, P968, DOI 10.1136/adc.2009.176800; Geurts DHF, 2014, EUR J PEDIATR, V173, P463, DOI 10.1007/s00431-013-2182-5; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Group MT, 1997, EM TRIAG; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Mackway-Jones K, 2006, EMERGENCY TRIAGE; Maconochie I, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1507; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Martin NG, 2014, LANCET INFECT DIS, V14, P397, DOI 10.1016/S1473-3099(14)70027-1; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Mori R, 2007, BRIT MED J, V335, P395, DOI 10.1136/bmj.39286.700891.AD; National Institute for Health and Care Excellence, 2013, FEV ILLN CHILDR ASS; Nijman R, 2014, C REACTIVE IN PRESS; Nijman RG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1706; Oostenbrink R, 2001, PEDIATR EMERG CARE, V17, P161, DOI 10.1097/00006565-200106000-00003; Oostenbrink R, 2012, ARCH DIS CHILD, V97, P667, DOI 10.1136/archdischild-2011-300667; Pantell RH, 2004, JAMA-J AM MED ASSOC, V291, P1203, DOI 10.1001/jama.291.10.1203; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Roukema J, 2006, EMERG MED J, V23, P906, DOI 10.1136/emj.2006.038877; Roukema J, 2008, J AM MED INFORM ASSN, V15, P107, DOI 10.1197/jamia.M2164; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Sim I, 2001, J AM MED INFORM ASSN, V8, P527, DOI 10.1136/jamia.2001.0080527; Slater M, 1999, TLS-TIMES LIT SUPPL, P4; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Van Calster B, 2012, EUR J EPIDEMIOL, V27, P761, DOI 10.1007/s10654-012-9733-3; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; van Veen M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1501; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62	49	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127620	10.1371/journal.pone.0127620	http://dx.doi.org/10.1371/journal.pone.0127620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024532	Green Published, gold			2022-12-27	WOS:000355319400045
J	Joshi, SC; Diwan, V; Tamhankar, AJ; Joshi, R; Shah, H; Sharma, M; Pathak, A; Macaden, R; Lundborg, CS				Joshi, Sudhir Chandra; Diwan, Vishal; Tamhankar, Ashok J.; Joshi, Rita; Shah, Harshada; Sharma, Megha; Pathak, Ashish; Macaden, Ragini; Lundborg, Cecilia Stalsby			Staff Perception on Biomedical or Health Care Waste Management: A Qualitative Study in a Rural Tertiary Care Hospital in India	PLOS ONE			English	Article							HAND HYGIENE; SYSTEM; CITY	Background Health care or biomedical waste, if not managed properly, can be of high risk to the hospital staff, the patients, the community, public health and the environment, especially in low and middle income settings where proper disposal norms are often not followed. Our aim was to explore perceptions of staff of an Indian rural tertiary care teaching hospital on hospital waste management. Method A qualitative study was conducted using 10 focus group discussions (FGDs), with different professional groups, cleaning staff, nurses, medical students, doctors and administrators. The FGD guide included the following topics: (i) role of Health Care Waste Management (HCWM) in prevention of health care associated infections, (ii) awareness of and views about HCWM-related guidelines/legislation, (iii) current HCWM practices, (iv) perception and preparedness related to improvements of the current practices, and (v) proper implementation of the available guidelines/legislation. The FGDs were recorded, transcribed verbatim, translated to English (when conducted in Hindi) and analysed using content analysis. Results Two themes were identified: Theme (A), 'Challenges in integration of HCWM in organizational practice,' with the categories (I) Awareness and views about HCWM, (II) Organizational practices regarding HCWM, and (III) Challenges in Implementation of HCWM; and Theme (B), 'Interventions to improve HCWM,' with three categories, (I) Educational and motivational interventions, (II) Organizational culture change, and (III) Policy-related interventions. Conclusion A gap between knowledge and actual practice regarding HCWM was highlighted in the perception of the hospital staff. The participants suggested organizational changes, training and monitoring to address this. The information generated is relevant not merely to the microsystem studied but to other institutions in similar settings.	[Joshi, Sudhir Chandra] RD Gardi Med Coll, Dept Community Med, Ujjain, Madhya Pradesh, India; [Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Diwan, Vishal] RD Gardi Med Coll, Int Ctr Hlth Res, Ujjain, Madhya Pradesh, India; [Diwan, Vishal; Tamhankar, Ashok J.; Sharma, Megha; Pathak, Ashish; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Tamhankar, Ashok J.] RD Gardi Med Coll, Dept Environm Med, Indian Initiat Management Antibiot Resistance, Ujjain, Madhya Pradesh, India; [Joshi, Rita; Shah, Harshada] RD Gardi Med Coll, Dept Microbiol, Ujjain, Madhya Pradesh, India; [Sharma, Megha] RD Gardi Med Coll, Dept Pharmacol, Ujjain, Madhya Pradesh, India; [Pathak, Ashish] RD Gardi Med Coll, Dept Pediat, Ujjain, Madhya Pradesh, India; [Pathak, Ashish] Uppsala Univ, Dept Women & Childrens Hlth, Int Maternal & Child Hlth Unit, Uppsala, Sweden; [Macaden, Ragini] St Johns Res Inst, Bangalore, Karnataka, India	Karolinska Institutet; Uppsala University; St. John's National Academy of Health Sciences; St. John's Research Institute	Diwan, V (corresponding author), RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India.	vishaldiwan@hotmail.com	Pathak, Ashish/Y-1821-2019; Pathak, Ashish/N-2303-2019; Sharma, Megha/AAJ-1119-2021	Pathak, Ashish/0000-0002-7576-895X; Sharma, Megha/0000-0001-9165-9393; Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Diwan, Vishal/0000-0001-7948-8579	Swedish Research Council; Swedish Institute; Erasmus Mundus External Co-operation Window Lot 15 India; Swedish Research School for Global Health for doctoral studies at Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Erasmus Mundus External Co-operation Window Lot 15 India; Swedish Research School for Global Health for doctoral studies at Karolinska Institutet	This study is part of a project funded by the Swedish Research Council. VD and MS received an Erasmus Mundus External Co-operation Window Lot 15 India post-doctoral scholarship at Karolinska Institutet. VD also received a scholarship from the Swedish Institute. AP received scholarships from Erasmus Mundus External Co-operation Window Lot 15 India and the Swedish Research School for Global Health for doctoral studies at Karolinska Institutet. The funders had no involvement in any parts of the study.	Abdulla F, 2008, WASTE MANAGE, V28, P450, DOI 10.1016/j.wasman.2007.02.035; Al-Emad A. A., 2011, Eastern Mediterranean Health Journal, V17, P730; Ananth AP, 2010, WASTE MANAGE, V30, P154, DOI 10.1016/j.wasman.2009.07.018; [Anonymous], 2005, REV BIOMED; Arora NK, 2014, INDIAN J MED RES, V139, P141; Basu R N, 1995, J Acad Hosp Adm, V7-8, P79; Chartier Y, 2014, SAFE MANAGEMENT OF W; Chattopadhyay Dipankar, 2010, Indian J Public Health, V54, P104, DOI 10.4103/0019-557X.73279; Ciplak N, 2012, WASTE MANAGE RES, V30, P576, DOI 10.1177/0734242X12443405; Farzadkia M, 2009, WASTE MANAGE RES, V27, P384, DOI 10.1177/0734242X09335703; Fishbein M, 1984, DIALOGUES AND DEBATE; Gai RY, 2010, WASTE MANAGE, V30, P246, DOI 10.1016/j.wasman.2008.08.023; Goddu V.K., 2007, P INT C SUST SOL WAS, P134; Goldinger S.D, 2003, PSYCHOL SCI, V3, P53; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gupta S, 2006, WASTE MANAGE RES, V24, P584, DOI 10.1177/0734242X06068342; Gupta S, 2009, WASTE MANAGE, V29, P812, DOI 10.1016/j.wasman.2008.06.009; Jahnavi G, 2006, Indian J Public Health, V50, P53; Jenner EA, 2005, J HOSP INFECT, V59, P77, DOI 10.1016/j.jhin.2004.07.002; Joshi SC, 2012, J HOSP INFECT, V80, P340, DOI 10.1016/j.jhin.2011.12.017; Klangsin P, 1998, J AIR WASTE MANAGE, V48, P516, DOI 10.1080/10473289.1998.10463706; Lakshmi K, 2003, THE HINDU ONLINE EDI; Lundborg CS, 2014, UPSALA J MED SCI, V119, P125, DOI 10.3109/03009734.2014.905664; Mujeeb SA, 2003, INFECT CONT HOSP EP, V24, P145, DOI 10.1086/502175; Ndiaye M, 2012, Bull Soc Pathol Exot, V105, P296, DOI 10.1007/s13149-012-0244-y; Nema A, 2011, WASTE MANAGE RES, V29, P669, DOI 10.1177/0734242X10396753; Patil GV, 2005, WASTE MANAGE, V25, P592, DOI 10.1016/j.wasman.2004.07.011; Paudel R, 2010, J Nepal Health Res Counc, V8, P86; Rao PH, 2008, WASTE MANAGE RES, V26, P297, DOI 10.1177/0734242X08088693; Rao PH, 2009, WASTE MANAGE RES, V27, P313, DOI 10.1177/0734242X09104128; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Sharma S, 2008, J ENVIRON BIOL, V29, P159; Verma LK, 2008, WASTE MANAGE, V28, P2723, DOI 10.1016/j.wasman.2007.12.013; Yuan CT, 2009, J HOSP INFECT, V71, P157, DOI 10.1016/j.jhin.2008.09.017; Zhang HJ, 2013, WASTE MANAGE RES, V31, P655, DOI 10.1177/0734242X13482161; Zhang Y, 2009, WASTE MANAGE, V29, P1376, DOI 10.1016/j.wasman.2008.10.023	37	9	10	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128383	10.1371/journal.pone.0128383	http://dx.doi.org/10.1371/journal.pone.0128383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26023783	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400088
J	Wigg, JP; Zhang, H; Yang, D				Wigg, Jonathan P.; Zhang, Hong; Yang, Dong			A Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; IN-VIVO; MONOCLONAL-ANTIBODY; MURINE MODEL; LASER; MICE; AGE; INHIBITOR; RETINOPATHY	Introduction In-vivo imaging of choroidal neovascularization (CNV) has been increasingly recognized as a valuable tool in the investigation of age-related macular degeneration (AMD) in both clinical and basic research applications. Arguably the most widely utilised model replicating AMD is laser generated CNV by rupture of Bruch's membrane in rodents. Heretofore CNV evaluation via in-vivo imaging techniques has been hamstrung by a lack of appropriate rodent fundus camera and a non-standardised analysis method. The aim of this study was to establish a simple, quantifiable method of fluorescein fundus angiogram (FFA) image analysis for CNV lesions. Methods Laser was applied to 32 Brown Norway Rats; FFA images were taken using a rodent specific fundus camera (Micron III, Phoenix Laboratories) over 3 weeks and compared to conventional ex-vivo CNV assessment. FFA images acquired with fluorescein administered by intraperitoneal injection and intravenous injection were compared and shown to greatly influence lesion properties. Utilising commonly used software packages, FFA images were assessed for CNV and chorioretinal burns lesion area by manually outlining the maximum border of each lesion and normalising against the optic nerve head. Net fluorescence above background and derived value of area corrected lesion intensity were calculated. Results CNV lesions of rats treated with anti-VEGF antibody were significantly smaller in normalised lesion area (p<0.001) and fluorescent intensity (p<0.001) than the PBS treated control two weeks post laser. The calculated area corrected lesion intensity was significantly smaller (p<0.001) in anti-VEGF treated animals at 2 and 3 weeks post laser. The results obtained using FFA correlated with, and were confirmed by conventional lesion area measurements from isolectin stained choroidal flatmounts, where lesions of anti-VEGF treated rats were significantly smaller at 2 weeks (p = 0.049) and 3 weeks (p<0.001) post laser. Conclusion The presented method of in-vivo FFA quantification of CNV, including acquisition variable corrections, using the Micron III system and common use software establishes a reliable method for detecting and quantifying CNV enabling longitudinal studies and represents an important alternative to conventional CNV quantification methods.	[Wigg, Jonathan P.; Zhang, Hong; Yang, Dong] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia; [Zhang, Hong] Harbin Med Univ, Hosp Eye, Harbin, Heilongjiang Pr, Peoples R China	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Harbin Medical University	Zhang, H (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia.	hong.zhang@unimelb.edu.au	Zhang, Hong/AAX-9632-2020		National Health and Medical Research Council (NHMRC) [APP1047603]; National Natural Science Foundation of China (NNSFC) [81201184]; Heilongjiang Provincial Nature Science Grants [LC2012C24]; Foundation for the New Century Talents by the Educational Committee of Heilongjiang Province [1251-NCET-011]; Doctoral Program of Higher Education Research Fund [20132307110027];  [2014CJHB006]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Nature Science Grants; Foundation for the New Century Talents by the Educational Committee of Heilongjiang Province; Doctoral Program of Higher Education Research Fund; 	This work was supported by the following sources of funding: 1. National Health and Medical Research Council (NHMRC, http://www.nhmrc.gov.au/) Grant No APP1047603, HZ; 2. National Natural Science Foundation of China (NNSFC http://www.nsfc.gov.cn/) Grant No. 81201184, HZ; 3. Heilongjiang Provincial Nature Science Grants (http://www.nsf.hljkj.cn) Grant No. LC2012C24; 4. Foundation for the New Century Talents by the Educational Committee of Heilongjiang Province (http://www.hlje.net) Grant No. 1251-NCET-011).; 5. Support Program for Changjiang Scholars candidate (http://www.hlje.net) Grant No. 2014CJHB006, HZ; and 6. Doctoral Program of Higher Education Research Fund (http://www.nsf.hljkj.cn) Grant No. 20132307110027, HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Criswell MH, 2008, ARCH OPHTHALMOL-CHIC, V126, P946, DOI 10.1001/archopht.126.7.946; Cui J, 2014, PHOTOMED LASER SURG, V32, P30, DOI 10.1089/pho.2013.3588; DOBI ET, 1989, ARCH OPHTHALMOL-CHIC, V107, P264, DOI 10.1001/archopht.1989.01070010270035; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Espinosa-Heidmann DG, 2002, INVEST OPHTH VIS SCI, V43, P1567; FRANK RN, 1989, CURR EYE RES, V8, P239, DOI 10.3109/02713688908997565; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Funakoshi T, 2006, EXP EYE RES, V83, P1102, DOI 10.1016/j.exer.2006.05.016; Geng Y, 2009, INVEST OPHTH VIS SCI, V50, P5872, DOI 10.1167/iovs.09-3675; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Guaiquil VH, 2013, INVEST OPHTH VIS SCI, V54, P5294, DOI 10.1167/iovs.12-11492; Han ZC, 2013, INVEST OPHTH VIS SCI, V54, P574, DOI 10.1167/iovs.12-10959; Hardin W, 2010, VISION SYSTEM DESIGN, V15; Hu Y, 2013, INVEST OPHTH VIS SCI, V54, P141, DOI 10.1167/iovs.12-10281; Huang HL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001620; Kim Hyungjin Myra, 2007, J Diabetes Sci Technol, V1, P531; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Lu F, 2009, GRAEF ARCH CLIN EXP, V247, P171, DOI 10.1007/s00417-008-0936-y; Nishiwaki H, 2002, PHOTOCHEM PHOTOBIOL, V75, P149, DOI 10.1562/0031-8655(2002)075<0149:LTPOOR>2.0.CO;2; Qu Y, 2009, OPHTHALMIC RES, V42, P36, DOI 10.1159/000219683; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Schalenbourg A, 2013, EYE, V27, P224, DOI 10.1038/eye.2012.267; Seo MS, 1999, AM J PATHOL, V154, P1743, DOI 10.1016/S0002-9440(10)65430-2; Serlin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061599; Tanemura M, 2003, INVEST OPHTH VIS SCI, V44, pU109; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Toma HS, 2010, MICROVASC RES, V80, P295, DOI 10.1016/j.mvr.2010.05.011; Wang JL, 2012, INVEST OPHTH VIS SCI, V53, P7348, DOI 10.1167/iovs.12-9955; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Xie B, 2009, J CELL PHYSIOL, V218, P192, DOI 10.1002/jcp.21588; Zarbin MA, 1998, EUR J OPHTHALMOL, V8, P199, DOI 10.1177/112067219800800401; Zhao Shi-hong, 2003, Zhonghua Yan Ke Za Zhi, V39, P298; Zhou XL, 2012, BIOMED OPT EXPRESS, V3, P1811, DOI 10.1364/BOE.3.001811; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128418	10.1371/journal.pone.0128418	http://dx.doi.org/10.1371/journal.pone.0128418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024231	Green Published, gold			2022-12-27	WOS:000355319400090
J	Chintala, S; Cheng, M; Zhang, X				Chintala, Shravan; Cheng, Mei; Zhang, Xiao			Decreased Expression of DREAM Promotes the Degeneration of Retinal Neurons	PLOS ONE			English	Article							GANGLION-CELL DEATH; NMDA-RECEPTOR; RAT RETINA; IN-VIVO; PROTEIN; ACTIVATION; DAMAGE; MATRIX-METALLOPROTEINASE-9; PHOSPHORYLATION; EXCITOTOXICITY	The intrinsic mechanisms that promote the degeneration of retinal ganglion cells (RGCs) following the activation of N-Methyl-D-aspartic acid-type glutamate receptors (NMDARs) are unclear. In this study, we have investigated the role of downstream regulatory element antagonist modulator (DREAM) in NMDA-mediated degeneration of the retina. NMDA, phosphate-buffered saline (PBS), and MK801 were injected into the vitreous humor of C57BL/6 mice. At 12, 24, and 48 hours after injection, expression of DREAM in the retina was determined by immunohistochemistry, western blot analysis, and electrophoretic mobility-shift assay (EMSA). Apoptotic death of cells in the retina was determined by terminal deoxynucleotidyl transferace dUTP nick end labeling (TUNEL) assays. Degeneration of RGCs in cross sections and in whole mount retinas was determined by using antibodies against Tuj1 and Brn3a respectively. Degeneration of amacrine cells and bipolar cells was determined by using antibodies against calretinin and protein kinase C (PKC)-alpha respectively. DREAM was expressed constitutively in RGCs, amacrine cells, bipolar cells, as well as in the inner plexiform layer (IPL). NMDA promoted a progressive decrease in DREAM levels in all three cell types over time, and at 48 h after NMDA-treatment very low DREAM levels were evident in the IPL only. DREAM expression in retinal nuclear proteins was decreased progressively after NMDA-treatment, and correlated with its decreased binding to the c-fos-DRE oligonucleotides. A decrease in DREAM expression correlated significantly with apoptotic death of RGCs, amacrine cells and bipolar cells. Treatment of eyes with NMDA antagonist MK801, restored DREAM expression to almost normal levels in the retina, and significantly decreased NMDA-mediated apoptotic death of RGCs, amacrine cells, and bipolar cells. Results presented in this study show for the first time that down-regulation of DREAM promotes the degeneration of RGCs, amacrine cells, and bipolar cells.	[Chintala, Shravan] Oakland Univ, Lab Ophthalm Neurobiol, Rochester, MI 48063 USA; Oakland Univ, Eye Res Inst, Rochester, MI 48063 USA	Oakland University; Oakland University	Chintala, S (corresponding author), Oakland Univ, Lab Ophthalm Neurobiol, Rochester, MI 48063 USA.	Chintala@oakland.edu			National Eye Institute project [EY017853-01A2]; NATIONAL EYE INSTITUTE [R01EY017853] Funding Source: NIH RePORTER	National Eye Institute project; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Eye Institute project grant EY017853-01A2 (to SKC).	Asami Y, 2014, CURR EYE RES, V30, P1; Bai N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-34; Chavira-Suarez E, 2008, NEUROSCI LETT, V432, P121, DOI 10.1016/j.neulet.2007.12.021; Chavira-Suarez E, 2011, BIOCHEM BIOPH RES CO, V404, P678, DOI 10.1016/j.bbrc.2010.12.041; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Chintala SK, 2015, INVEST OPHTH VIS SCI, V56, P505, DOI 10.1167/iovs.14-15539; Furuya T, 2012, CURR EYE RES, V37, P170, DOI 10.3109/02713683.2011.645105; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Hama Y, 2006, NEUROSCI RES, V56, P279, DOI 10.1016/j.neures.2006.07.008; Kaur C, 2012, J NEUROPATH EXP NEUR, V71, P330, DOI 10.1097/NEN.0b013e31824deb21; Kumada M, 2005, INVEST OPHTH VIS SCI, V46, P1504, DOI 10.1167/iovs.04-0595; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Kwong JMK, 2000, EXP EYE RES, V71, P437, DOI 10.1006/exer.2000.0894; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Mali RS, 2011, EXP EYE RES, V92, P528, DOI 10.1016/j.exer.2011.03.017; Mali RS, 2005, FASEB J, V19, P1280, DOI 10.1096/fj.04-3403com; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Manabe S, 2003, INVEST OPHTH VIS SCI, V44, P385, DOI 10.1167/iovs.02-0187; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; Munemasa Y, 2006, J NEUROSCI RES, V83, P907, DOI 10.1002/jnr.20786; Naruoka T, 2013, EUR J PHARMACOL, V718, P138, DOI 10.1016/j.ejphar.2013.08.041; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Oku H, 2004, CURR EYE RES, V29, P403, DOI 10.1080/02713680490517917; Omodaka K, 2014, BRAIN RES, V1586, P203, DOI 10.1016/j.brainres.2014.08.053; Onder HI, 2013, J OCUL PHARMACOL TH, V29, P427, DOI 10.1089/jop.2012.0075; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Takeda H, 2007, BRAIN RES, V1184, P306, DOI 10.1016/j.brainres.2007.09.055; Wang KW, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00039; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Zaidi NF, 2004, J NEUROCHEM, V89, P593, DOI 10.1046/j.1471-4159.2004.02362.x; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010	32	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127776	10.1371/journal.pone.0127776	http://dx.doi.org/10.1371/journal.pone.0127776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020793	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300055
J	Chen, AL; Liao, PF; Li, QY; Zhao, QL; Yang, WK; Zhu, SF; Wu, F; He, RF; Dong, ZP; Huang, P				Chen, Anli; Liao, Pengfei; Li, Qiongyan; Zhao, Qiaoling; Yang, Weike; Zhu, Shuifen; Wu, Fang; He, Rongfan; Dong, Zhanpeng; Huang, Ping			The Structural Variation Is Associated with the Embryonic Lethality of a Novel Red Egg Mutant Fuyin-lre of Silkworm, Bombyx mori	PLOS ONE			English	Article							RNA-SEQ; GENE; SEQUENCE; INSECT; GENOME	Bombyx mori presents several types of egg color mutations, all of which have been extensively discussed in sericulture. While the red egg mutation has been previously observed, lethal red-egg mutants have not been reported. In the present work, the red egg mutant Fuyin-lre (Fuyin-lethal red egg) was discovered from the Fuyin germplasm resource of B. mori. This mutant features red-colored eggs and embryonic lethality. Genetic analysis showed that Fuyin-lre follows recessive inheritance, with the red egg gene re governing the egg color, and the embryonic lethality of Fuyin-lre may be caused by mutations of other genes closely linked to re. Digital gene expression (DGE) was employed to compare the transcription profiles of Fuyin and Fuyin-lre eggs after 24 and 48 h of incubation. A total of 48 differentially expressed genes followed the same expression patterns in both groups at both time points (FDR < 0.01 and log 2 Ratio >= 1). Further analyses indicated that 8 out of the 48 genes (including re) were closely linked to re. These 8 genes were highly expressed in wild-type Fuyin and the red egg mutant re but showed nearly absent expression in Fuyin-lre. Sequencing of the re gene confirmed that the re gene itself does not induce embryonic lethality, and structure analysis showed that the structural variation of the region where the 8 genes were located may be associated with the embryonic lethality of Fuyin-lre. The present work provides a good foundation for future studies on the mechanism of embryonic lethality and embryonic development in Fuyin-lre.	[Chen, Anli; Liao, Pengfei; Li, Qiongyan; Yang, Weike; Zhu, Shuifen; Dong, Zhanpeng; Huang, Ping] Yunnan Acad Agr Sci, Sericultural & Apicultural Res Inst, Mengzi, Yunnan, Peoples R China; [Zhao, Qiaoling; Wu, Fang; He, Rongfan] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China	Yunnan Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences	Dong, ZP (corresponding author), Yunnan Acad Agr Sci, Sericultural & Apicultural Res Inst, Mengzi, Yunnan, Peoples R China.	scsdong@163.com; ynmzhp@163.com			National Natural Science Foundation of China [31460640, 31360586]; Industry Technology System of Silkworm in China [CARS-22-SYZ27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Industry Technology System of Silkworm in China	This work was supported by the National Natural Science Foundation of China (No. 31460640), the Industry Technology System of Silkworm in China (No. CARS-22-SYZ27) and the National Natural Science Foundation of China (No. 31360586).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Dai FY, 2001, CHINA SERICULTURE, V22, P8; Fan Xiao-Dong, 2006, Acta Entomologica Sinica, V49, P543; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 1999, SCI SERICULTURE, V25, P74; Lu C, 1988, NEWSLETTER SERICULTU, V7, P1; Lu Cheng, 2003, Scientia Agricultura Sinica, V36, P968; Lv H-S, 2011, PRINCIPLES SILKWORM, P178; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOUNIER N, 1986, BIOCHIMIE, V68, P1053, DOI 10.1016/S0300-9084(86)80179-1; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xiang ZH, 2005, BIOL SERICULTURE, P107; Zhao QL, 2000, SCI SERICULTURE, V26, P63	21	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128211	10.1371/journal.pone.0128211	http://dx.doi.org/10.1371/journal.pone.0128211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030868	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900126
J	Dangisso, MH; Datiko, DG; Lindtjorn, B				Dangisso, Mesay Hailu; Datiko, Daniel Gemechu; Lindtjorn, Bernt			Spatio-Temporal Analysis of Smear-Positive Tuberculosis in the Sidama Zone, Southern Ethiopia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SPATIAL-ANALYSIS; RISK-FACTORS; CLUSTERS; EPIDEMIOLOGY; TRANSMISSION; ANTANANARIVO; PORTUGAL; PATTERNS; ALTITUDE	Background Tuberculosis (TB) is a disease of public health concern, with a varying distribution across settings depending on socio-economic status, HIV burden, availability and performance of the health system. Ethiopia is a country with a high burden of TB, with regional variations in TB case notification rates (CNRs). However, TB program reports are often compiled and reported at higher administrative units that do not show the burden at lower units, so there is limited information about the spatial distribution of the disease. We therefore aim to assess the spatial distribution and presence of the spatio-temporal clustering of the disease in different geographic settings over 10 years in the Sidama Zone in southern Ethiopia. Methods A retrospective space-time and spatial analysis were carried out at the kebele level (the lowest administrative unit within a district) to identify spatial and space-time clusters of smear-positive pulmonary TB (PTB). Scan statistics, Global Moran's I, and Getis and Ordi (Gi*) statistics were all used to help analyze the spatial distribution and clusters of the disease across settings. Results A total of 22,545 smear-positive PTB cases notified over 10 years were used for spatial analysis. In a purely spatial analysis, we identified the most likely cluster of smear-positive PTB in 192 kebeles in eight districts (RR= 2, p<0.001), with 12,155 observed and 8,668 expected cases. The Gi* statistic also identified the clusters in the same areas, and the spatial clusters showed stability in most areas in each year during the study period. The space-time analysis also detected the most likely cluster in 193 kebeles in the same eight districts (RR= 1.92, p<0.001), with 7,584 observed and 4,738 expected cases in 2003-2012. Conclusion The study found variations in CNRs and significant spatio-temporal clusters of smear-positive PTB in the Sidama Zone. The findings can be used to guide TB control programs to devise effective TB control strategies for the geographic areas characterized by the highest CNRs. Further studies are required to understand the factors associated with clustering based on individual level locations and investigation of cases.	[Dangisso, Mesay Hailu; Lindtjorn, Bernt] Univ Bergen, Fac Med & Dent, Ctr Int Hlth, Bergen, Norway; [Dangisso, Mesay Hailu] Sidama Zone Hlth Dept, Hawassa, Ethiopia; [Datiko, Daniel Gemechu] Hawassa Univ, Hawassa, Ethiopia; [Datiko, Daniel Gemechu] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Bergen; Hawassa University; Liverpool School of Tropical Medicine	Dangisso, MH (corresponding author), Univ Bergen, Fac Med & Dent, Ctr Int Hlth, Bergen, Norway.	mesayhailudangiso@yahoo.com	Datiko, Daniel/AAE-7019-2020; Lindtjorn, Bernt/K-9465-2018; Datiko, Daniel G./AAE-6856-2020; Dangisso, Mesay Hailu/AAU-7743-2020	Datiko, Daniel/0000-0002-8556-3069; Lindtjorn, Bernt/0000-0002-6267-6984; 	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health	The University of Bergen, Centre for International Health funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Beyers N, 1996, S AFR MED J, V86, P40; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Couceiro L, 2011, INT J TUBERC LUNG D, V15, P1445, DOI 10.5588/ijtld.10.0302; Cromley EK, 2012, GIS PUBLIC HLTH; CSA, 2003, POPULATION; da Roza DL, 2012, REV SOC BRAS MED TRO, V45, P607, DOI 10.1590/S0037-86822012000500013; De Fede AL, 2008, INT J TUBERC LUNG D, V12, P1425; Edelson PJ, 2011, TRAVEL MED INFECT DI, V9, P27, DOI 10.1016/j.tmaid.2010.11.001; Federal Ministry of Health, 2011, TUB PREV CONTR PROGR; Feske ML, 2011, TUBERCULOSIS, V91, pS24, DOI 10.1016/j.tube.2011.10.006; Feske ML, 2011, TUBERCULOSIS, V91, pS16, DOI 10.1016/j.tube.2011.10.005; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Geraldes Santos Mde L, 2007, REV LATINO AM ENFERM, V15; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gomez-Barroso D, 2013, INT J TUBERC LUNG D, V17, P745, DOI 10.5588/ijtld.12.0702; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Jacobson LM, 2005, TROP MED INT HEALTH, V10, P305, DOI 10.1111/j.1365-3156.2005.01392.x; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2010, SATSCANTM USER GUIDE; Liu Y, 2012, INT J TUBERC LUNG D, V16, P486, DOI 10.5588/ijtld.11.0255; Maciel ELN, 2010, INT J TUBERC LUNG D, V14, P1395; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Ng IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050740; Nunes C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-30; Onozuka D, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-26; Oren E, 2012, INT J TUBERC LUNG D, V16, P880, DOI 10.5588/ijtld.11.0700; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Randremanana RV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-21; Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x; Tadesse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065022; Tanrikulu AC, 2008, PUBLIC HEALTH, V122, P613, DOI 10.1016/j.puhe.2007.09.005; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; Vargas MH, 2004, INT J TUBERC LUNG D, V8, P1321; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong MK, 2013, WEST PAC SURVEILL RE, V4, P25, DOI [10.5365/WPSAR.2013.4.1.002, 10.5365/wpsar.2013.4.1.002]; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	43	22	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126369	10.1371/journal.pone.0126369	http://dx.doi.org/10.1371/journal.pone.0126369			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030162	gold, Green Accepted, Green Published			2022-12-27	WOS:000356630900025
J	Roybon, L; Mastracci, TL; Li, J; Stott, SRW; Leiter, AB; Sussel, L; Brundin, P; Li, JY				Roybon, Laurent; Mastracci, Teresa L.; Li, Joyce; Stott, Simon R. W.; Leiter, Andrew B.; Sussel, Lori; Brundin, Patrik; Li, Jia-Yi			The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1	PLOS ONE			English	Article							PARVALBUMIN-IMMUNOREACTIVE NEURONS; ADULT SUBVENTRICULAR ZONE; HIPPOCAMPAL NEUROGENESIS; GLOMERULAR FORMATION; POSTNATAL CHANGES; GRANULE CELLS; MOUSE; DIFFERENTIATION; TBR2; RAT	Production of olfactory bulb neurons occurs continuously in the rodent brain. Little is known, however, about cellular diversity in the glutamatergic neuron subpopulation. In the central nervous system, the basic helix-loop-helix transcription factor NeuroD1 (ND1) is commonly associated with glutamatergic neuron development. In this study, we utilized ND1 to identify the different subpopulations of olfactory bulb glutamategic neurons and their progenitors, both in the embryo and postnatally. Using knock-in mice, transgenic mice and retroviral transgene delivery, we demonstrate the existence of several different populations of glutamatergic olfactory bulb neurons, the progenitors of which are ND1(+) and ND1(-) lineage-restricted, and are temporally and regionally separated. We show that the first olfactory bulb glutamatergic neurons produced - the mitral cells - can be divided into molecularly diverse subpopulations. Our findings illustrate the complexity of neuronal diversity in the olfactory bulb and that seemingly homogenous neuronal populations can consist of multiple subpopulations with unique molecular signatures of transcription factors and expressing neuronal subtype-specific markers.	[Roybon, Laurent] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Stem Cell Lab CNS Dis Modeling, S-22184 Lund, Sweden; [Roybon, Laurent] Lund Univ, Strateg Res Area MultiPk, S-22184 Lund, Sweden; [Roybon, Laurent] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden; [Mastracci, Teresa L.; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Li, Joyce; Leiter, Andrew B.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Stott, Simon R. W.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Brundin, Patrik] Ctr Neurodegenerat Sci, Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Li, Jia-Yi] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neural Plast & Repair Unit, S-22184 Lund, Sweden	Lund University; Lund University; Lund University; Columbia University; University of Massachusetts System; University of Massachusetts Worcester; University of Cambridge; Van Andel Institute; Lund University	Roybon, L (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Stem Cell Lab CNS Dis Modeling, BMC A10, S-22184 Lund, Sweden.	laurent.roybon@med.lu.se		Stott, Simon/0000-0002-5741-4664; Li, Jia-Yi/0000-0002-7770-7376	Swedish Brain Foundation (Hjarnfonden); Kungliga Fysiografiska in Lund [KF-23115]; Swedish research council [K2010-61X-15072-07-3]; NIH [U01 DK072504, DK90000]; JDRF Postdoctoral Fellowship [3-2010-791]; Stem Cell Center Program - Swedish Foundation for Strategic Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072504, R01DK090000] Funding Source: NIH RePORTER	Swedish Brain Foundation (Hjarnfonden); Kungliga Fysiografiska in Lund; Swedish research council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF Postdoctoral Fellowship(Juvenile Diabetes Research Foundation); Stem Cell Center Program - Swedish Foundation for Strategic Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Swedish Brain Foundation (Hjarnfonden; P.B.), the Kungliga Fysiografiska in Lund (KF-23115 to L.R.), Swedish research council grant K2010-61X-15072-07-3 (to J.Y.L.), and NIH grants U01 DK072504 (to L.S.) and DK90000 (to A.B.L.). T.L.M. was supported by a JDRF Postdoctoral Fellowship (#3-2010-791). S.R.W.S. was supported by the Stem Cell Center Program funded by the Swedish Foundation for Strategic Research. L.R. was supported by a postdoctoral fellowship from the Swedish Brain Foundation (Hjarnfonden) and is now group leader of the Stem Cell laboratory for CNS disease modeling at Lund University, Department of Experimental Medical Science, Sweden.	Allen ZJ, 2007, J MOL HISTOL, V38, P517, DOI 10.1007/s10735-007-9115-4; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Antal M, 2006, EUR J NEUROSCI, V24, P1124, DOI 10.1111/j.1460-9568.2006.04988.x; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Bailey MS, 1999, J COMP NEUROL, V415, P423; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Bayatti N, 2008, EUR J NEUROSCI, V28, P1449, DOI 10.1111/j.1460-9568.2008.06475.x; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Hodge RD, 2012, CELL MOL LIFE SCI, V69, P2125, DOI 10.1007/s00018-011-0916-y; Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754; Kimura N, 1999, DEV BRAIN RES, V115, P183, DOI 10.1016/S0165-3806(99)00064-4; KOSAKA K, 1994, EXP BRAIN RES, V99, P205, DOI 10.1007/BF00239587; Lagace DC, 2007, AM J PSYCHIAT, V164, P205, DOI 10.1176/appi.ajp.164.2.205; Lazarini F, 2014, J NEUROSCI, V34, P14430, DOI 10.1523/JNEUROSCI.5366-13.2014; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; MONTIGRAZIADEI GA, 1980, NEUROSCIENCE, V5, P1239; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Munoz EM, 2007, J NEUROCHEM, V102, P887, DOI 10.1111/j.1471-4159.2007.04605.x; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ohmomo H, 2009, NEUROSCIENCE, V160, P419, DOI 10.1016/j.neuroscience.2009.02.048; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Roybon L, 2008, J NEUROSCI, V28, P3644, DOI 10.1523/JNEUROSCI.0311-08.2008; Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Sequerra EB, 2010, CEREB CORTEX, V20, P2583, DOI 10.1093/cercor/bhq006; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Treloar HB, 1999, J COMP NEUROL, V413, P289; Wang Y, 2007, P NATL ACAD SCI USA, V104, P11328, DOI 10.1073/pnas.0702665104; Winpenny E, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-12; WOUTERLOOD FG, 1995, J NEUROCYTOL, V24, P135, DOI 10.1007/BF01181556	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128035	10.1371/journal.pone.0128035	http://dx.doi.org/10.1371/journal.pone.0128035			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030886	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900102
J	Torres, RT; Silva, N; Brotas, G; Fonseca, C				Torres, Rita Tinoco; Silva, Nicole; Brotas, Goncalo; Fonseca, Carlos			To Eat or Not To Eat? The Diet of the Endangered Iberian Wolf (Canis lupus signatus) in a Human- Dominated Landscape in Central Portugal	PLOS ONE			English	Article							LIVESTOCK DEPREDATION; WOLVES; PREDATION; PREY; WILD; SELECTION; WESTERN; DAMAGE	Livestock predation by large carnivores and their persecution by local communities are major conservation concerns. In order to prevent speculations and reduce conflicts, it is crucial to get detailed and accurate data on predators' dietary ecology, which is particularly important in human dominated landscapes where livestock densities are high. This is the case of the endangered Iberian wolf in Portugal, an endemic subspecies of the Iberian Peninsula, which has seen its population distribution and abundance decline throughout the 20th century. Accordingly, the diet of the Iberian wolf was analyzed, using scat analysis, in a humanized landscape in central Portugal. From 2011 to 2014, a total of 295 wolf scats were collected from transects distributed throughout the study area, prospected on a monthly basis. Scat analysis indicated a high dependence of Iberian wolf on livestock. Domestic goat predominated the diet (62% of the scats), followed by cow (20%) and sheep (13%); the only wild ungulate present in the scat analysis was the wild boar (4% of the scats). Our results show that even though livestock constitute most part of wolves diet, different livestock species may represent different predation opportunities. We conclude that the high levels of livestock consumption may be a result of low diversity and density of wild ungulates that settles livestock as the only abundant prey for wolves. Our findings help on the understanding of the Iberian wolf feeding ecology and have implications for conflict management strategies. Finally, management implications are discussed and solutions are recommended.	[Torres, Rita Tinoco; Silva, Nicole; Fonseca, Carlos] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Torres, Rita Tinoco; Silva, Nicole; Fonseca, Carlos] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Brotas, Goncalo] Assoc Conservacao Habitat Lobo Iberico, Esposende, Portugal	Universidade de Aveiro; Universidade de Aveiro	Torres, RT (corresponding author), Univ Aveiro, Dept Biol, Campus Santiago, P-3800 Aveiro, Portugal.	rita.torres@ua.pt	Fonseca, Carlos MMS/D-9744-2011; Torres, Rita Tinoco/G-1638-2011	Fonseca, Carlos MMS/0000-0001-6559-7133; Torres, Rita Tinoco/0000-0003-4570-459X	European Funds through COMPETE; National Funds through the Portuguese Science Foundation (FCT) [UID/AMB/50017/2013]	European Funds through COMPETE; National Funds through the Portuguese Science Foundation (FCT)	This work was co-supported by European Funds through COMPETE and by National Funds through the Portuguese Science Foundation (FCT) within project UID/AMB/50017/2013.	[Anonymous], 2011, THESIS I CONSERVACAO; [Anonymous], HAIR W EUROPEAN MAMM; Ansorge H, 2006, ACTA THERIOL, V51, P99, DOI 10.1007/BF03192661; Athreya V, 2016, ORYX, V50, P156, DOI 10.1017/S0030605314000106; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Barja I, 2009, WILDLIFE BIOL, V15, P147, DOI 10.2981/07-096; Berger KM, 2006, CONSERV BIOL, V20, P751, DOI 10.1111/j.1523-1739.2006.00336.x; Cabral M.J., 2005, LIVRO VERMELHO VERTE; Capitani C, 2004, MAMM BIOL, V69, P1, DOI 10.1078/1616-5047-112; Ciucci P, 1998, WILDLIFE SOC B, V26, P504; Cruz Tarnira, 2014, Galemys, V26, P31; Davis ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047894; Espuno N, 2004, WILDLIFE SOC B, V32, P1195, DOI 10.2193/0091-7648(2004)032[1195:HRTPSH]2.0.CO;2; Fonseca C, 2008, COLECCAO PATRIMONIO; Gazzola A, 2008, J ZOOL, V274, P261, DOI 10.1111/j.1469-7998.2007.00381.x; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Gula R, 2008, J WILDLIFE MANAGE, V72, P283, DOI 10.2193/2006-368; Hosseini-Zavarei F, 2013, J ZOOL, V290, P127, DOI 10.1111/jzo.12022; HUGGARD DJ, 1993, CAN J ZOOL, V71, P130, DOI 10.1139/z93-019; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; Iliopoulos Y, 2009, ACTA THERIOL, V54, P11, DOI 10.1007/BF03193133; INE, 2011, REC AGR 2009 AN PRIN, DOI [10.1002/ece3.1303, DOI 10.1002/ECE3.1303]; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Kaczensky P, 2013, STATUS MANAGEMENT DI; Karlsson J, 2010, J APPL ECOL, V47, P166, DOI 10.1111/j.1365-2664.2009.01747.x; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kojola I, 2004, J ZOOL, V263, P229, DOI 10.1017/S0952836904005084; LEVINS RICHARD, 1968; Meriggi A, 2011, ETHOL ECOL EVOL, V23, P195, DOI 10.1080/03949370.2011.577814; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Nowak S, 2005, ACTA THERIOL, V50, P263, DOI 10.1007/BF03194489; Nowak S, 2011, MAMM BIOL, V76, P709, DOI 10.1016/j.mambio.2011.06.007; Odden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079261; OKARMA H, 1993, BIOL CONSERV, V66, P153, DOI 10.1016/0006-3207(93)90001-H; OLI MK, 1993, J ZOOL, V231, P71, DOI 10.1111/j.1469-7998.1993.tb05354.x; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shehzad W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032104; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sidorovich VE, 2003, WILDLIFE BIOL, V9, P103, DOI 10.2981/wlb.2003.032; Smith ME, 2000, ACTA AGR SCAND A-AN, V50, P279, DOI 10.1080/090647000750069476; van Duyne C, 2009, J WILDLIFE MANAGE, V73, P836, DOI 10.2193/2008-027; Vos J, 2000, J ZOOL, V251, P457, DOI 10.1111/j.1469-7998.2000.tb00801.x; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278	48	32	34	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129379	10.1371/journal.pone.0129379	http://dx.doi.org/10.1371/journal.pone.0129379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030294	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900218
J	Xue, RF; Wu, J; Zhu, ZD; Wang, LF; Wang, XM; Wang, SM; Blair, MW				Xue, Renfeng; Wu, Jing; Zhu, Zhendong; Wang, Lanfen; Wang, Xiaoming; Wang, Shumin; Blair, Matthew W.			Differentially Expressed Genes in Resistant and Susceptible Common Bean (Phaseolus vulgaris L.) Genotypes in Response to Fusarium oxysporum f. sp phaseoli	PLOS ONE			English	Article							CHICKPEA CICER-ARIETINUM; BOX RNA HELICASE; DEFENSE RESPONSES; SALICYLIC-ACID; ANTHRACNOSE RESISTANCE; DISEASE RESISTANCE; CO-2 LOCUS; PROTEIN; CLONING; INFECTION	Fusarium wilt of common bean (Phaseolus vulgaris L.), caused by Fusarium oxysporum Schlechtend.:Fr. f.sp. phaseoli (Fop), is one of the most important diseases of common beans worldwide. Few natural sources of resistance to Fop exist and provide only moderate or partial levels of protection. Despite the economic importance of the disease across multiple crops, only a few of Fop induced genes have been analyzed in legumes. Therefore, our goal was to identify transcriptionally regulated genes during an incompatible interaction between common bean and the Fop pathogen using the cDNA amplified fragment length polymorphism (cDNA-AFLP) technique. We generated a total of 8,730 transcript-derived fragments (TDFs) with 768 primer pairs based on the comparison of a moderately resistant and a susceptible genotype. In total, 423 TDFs (4.9%) displayed altered expression patterns after inoculation with Fop inoculum. We obtained full amplicon sequences for 122 selected TDFs, of which 98 were identified as annotated known genes in different functional categories based on their putative functions, 10 were predicted but non-annotated genes and 14 were not homologous to any known genes. The 98 TDFs encoding genes of known putative function were classified as related to metabolism(22), signal transduction (21), protein synthesis and processing (20), development and cytoskeletal organization (12), transport of proteins (7), gene expression and RNA metabolism (4), redox reactions (4), defense and stress responses (3), energy metabolism (3), and hormone responses (2). Based on the analyses of homology, 19 TDFs from different functional categories were chosen for expression analysis using quantitative RT-PCR. The genes found to be important here were implicated at various steps of pathogen infection and will allow a better understanding of the mechanisms of defense and resistance to Fop and similar pathogens. The differential response genes discovered here could also be used asmolecular markers in association mapping or QTL analysis.	[Xue, Renfeng] Liaoning Acad Agr Sci, Crop Res Inst, Shenyang, Peoples R China; [Xue, Renfeng; Wu, Jing; Zhu, Zhendong; Wang, Lanfen; Wang, Xiaoming; Wang, Shumin] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Fac Crop Gene Resources & Genet Improvem, Beijing 100193, Peoples R China; [Blair, Matthew W.] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Tennessee State University	Wang, SM (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Fac Crop Gene Resources & Genet Improvem, Beijing 100193, Peoples R China.	wangshumin@caas.cn; mblair@tnstate.edu			Ministry of Agriculture of China [CARS-09-G12, CARS-09-Z8]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAD01B03-18a]; Scientific Innovation Program of CAAS	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Scientific Innovation Program of CAAS	This work was supported by grants from the Ministry of Agriculture of China [Earmarked fund for Modern Agro-industry Technology Research System (CARS-09-G12 and CARS-09-Z8)], National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAD01B03-18a) and the Scientific Innovation Program of CAAS.	[Anonymous], SCIENCE, V270, P1804; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Berrocal-Lobo M, 2008, TRENDS PLANT SCI, V13, P145, DOI 10.1016/j.tplants.2007.12.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buruchara RA, 2000, J PHYTOPATHOL, V148, P39, DOI 10.1111/j.1439-0434.2000.tb04622.x; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chen JB, 2009, J PLANT PHYSIOL, V166, P12, DOI 10.1016/j.jplph.2008.02.010; Cho YG, 1996, GENOME, V39, P373, DOI 10.1139/g96-048; Cordoba JM, 2010, PLANT GENOME-US, V3, P154, DOI 10.3835/plantgenome2010.06.0013; Cordoba JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-436; Creusot F, 1999, GENOME, V42, P254, DOI 10.1139/gen-42-2-254; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; De Ascensao ARDCF, 2000, PHYTOPATHOLOGY, V90, P1173, DOI 10.1094/PHYTO.2000.90.10.1173; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Frost MR, 1999, NUCLEIC ACIDS RES, V27; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Garzon LN, 2013, PHYTOPATHOLOGY, V103, P156, DOI 10.1094/PHYTO-07-12-0180-R; Garzon LN, 2014, CROP J, V2, P183, DOI 10.1016/j.cj.2014.04.002; Geffroy V, 1998, THEOR APPL GENET, V96, P494, DOI 10.1007/s001220050766; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Gupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009030; Gupta S, 2009, PHYTOPATHOLOGY, V99, P1245, DOI 10.1094/PHYTO-99-11-1245; HARTER L. L., 1929, Phytopathology, V19, pp; Jaiti F, 2009, PHYSIOL MOL PLANT P, V74, P84, DOI 10.1016/j.pmpp.2009.09.005; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Klessig DF, 1998, RECENT ADV PHYTOCHEM, V32, P119; Komjanc M, 1999, PLANT MOL BIOL, V40, P945, DOI 10.1023/A:1006275924882; Lagopodi AL, 2002, MOL PLANT MICROBE IN, V15, P172, DOI 10.1094/MPMI.2002.15.2.172; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Lin YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068749; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Mutlu N, 2006, MOL BREEDING, V17, P127, DOI 10.1007/s11032-005-4474-6; Qu ZL, 2006, PLANT CELL PHYSIOL, V47, P1058, DOI 10.1093/pcp/pcj076; Ramirez-Suero M, 2010, EUR J PLANT PATHOL, V126, P517, DOI 10.1007/s10658-009-9560-x; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schwartz HF, 2005, COMPENDIUM BEAN DIS; Summer Heike, 2009, J Vis Exp, DOI 10.3791/1485; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075430; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xue RF, 2014, MOL BREEDING, V34, P855, DOI 10.1007/s11032-014-0080-9; Xue RF, 2014, J PLANT GROWTH REGUL, V33, P470, DOI 10.1007/s00344-013-9376-y; Xue RenFeng, 2012, Acta Agronomica Sinica, V38, P791; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zvirin T, 2010, PLANT PATHOL, V59, P576, DOI 10.1111/j.1365-3059.2009.02225.x	61	32	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127698	10.1371/journal.pone.0127698	http://dx.doi.org/10.1371/journal.pone.0127698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030070	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900073
J	Yue, HM; Li, CJ; Du, H; Zhang, SH; Wei, QW				Yue, Huamei; Li, Chuangju; Du, Hao; Zhang, Shuhuan; Wei, Qiwei			Sequencing and De Novo Assembly of the Gonadal Transcriptome of the Endangered Chinese Sturgeon (Acipenser sinensis)	PLOS ONE			English	Article							SEX-DETERMINING GENE; RAINBOW-TROUT; UNDIFFERENTIATED SPERMATOGONIA; MOLECULAR CHARACTERIZATION; DIMORPHIC EXPRESSION; SIBERIAN STURGEON; FEMALE STERLET; STEM-CELLS; C-ELEGANS; IGF-I	Background The Chinese sturgeon (Acipenser sinensis) is endangered through anthropogenic activities including over-fishing, damming, shipping, and pollution. Controlled reproduction has been adopted and successfully conducted for conservation. However, little information is available on the reproductive regulation of the species. In this study, we conducted de novo transcriptome assembly of the gonad tissue to create a comprehensive dataset for A. sinensis. Results The Illumina sequencing platform was adopted to obtain 47,333,701 and 47,229,705 high quality reads from testis and ovary cDNA libraries generated from three-year-old A. sinensis. We identified 86,027 unigenes of which 30,268 were annotated in the NCBI non-redundant protein database and 28,281 were annotated in the Swiss-prot database. Among the annotated unigenes, 26,152 and 7,734 unigenes, respectively, were assigned to gene ontology categories and clusters of orthologous groups. In addition, 12,557 unigenes were mapped to 231 pathways in the Kyoto Encyclopedia of Genes and Genomes Pathway database. A total of 1,896 unigenes, potentially differentially expressed between the two gonad types, were found, with 1,894 predicted to be up-regulated in ovary and only two in testis. Fifty-five potential gametogenesis-related genes were screened in the transcriptome and 34 genes with significant matches were found. Besides, more paralogs of 11 genes in three gene families (sox, apolipoprotein and cyclin) were found in A. sinensis compared to their orthologs in the diploid Danio rerio. In addition, 12,151 putative simple sequence repeats (SSRs) were detected. Conclusions This study provides the first de novo transcriptome analysis currently available for A. sinensis. The transcriptomic data represents the fundamental resource for future research on the mechanism of early gametogenesis in sturgeons. The SSRs identified in this work will be valuable for assessment of genetic diversity of wild fish and genealogy management of cultured fish.	[Yue, Huamei; Li, Chuangju; Du, Hao; Zhang, Shuhuan; Wei, Qiwei] Chinese Acad Fisheries Sci, Yangtze River Fisheries Res Inst, Key Lab Freshwater Biodivers Conservat, Minist Agr China, Wuhan 430223, Peoples R China; [Yue, Huamei; Li, Chuangju; Du, Hao; Zhang, Shuhuan; Wei, Qiwei] Chinese Acad Fisheries Sci, Freshwater Fisheries Res Ctr, Wuxi 214081, Peoples R China	Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS	Wei, QW (corresponding author), Chinese Acad Fisheries Sci, Yangtze River Fisheries Res Inst, Key Lab Freshwater Biodivers Conservat, Minist Agr China, Wuhan 430223, Peoples R China.	weiqw@yfi.ac.cn			National Nonprofit Institute Research Grant of Chinese Academy of Fisheries [2013A0403]; National High Technology Research and Development Program of China [2011AA100401]; National Natural Science Foundation of China [31472286, 31172413]; National Basic Research Program of China (973 Program) [2015CB150702]; National Nonprofit Institute Research Grant of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences [2013JBFZ01]	National Nonprofit Institute Research Grant of Chinese Academy of Fisheries; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nonprofit Institute Research Grant of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences	This work was supported by grants from the National Nonprofit Institute Research Grant of Chinese Academy of Fisheries (2013A0403), the National High Technology Research and Development Program of China (2011AA100401), the National Natural Science Foundation of China (31472286 and 31172413), the National Basic Research Program of China (973 Program) (2015CB150702), and the National Nonprofit Institute Research Grant of Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences (2013JBFZ01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg JJ, 2010, FISH PHYSIOL BIOCHEM, V36, P923, DOI 10.1007/s10695-009-9369-8; Berbejillo J, 2013, FISH PHYSIOL BIOCHEM, V39, P91, DOI 10.1007/s10695-012-9666-5; Berbejillo J, 2012, MOL REPROD DEV, V79, P504, DOI 10.1002/mrd.22053; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P427, DOI 10.1023/A:1007382724251; Breton B, 1998, GEN COMP ENDOCR, V111, P38, DOI 10.1006/gcen.1998.7088; Cakici O, 2007, SU URUN DERG, V24, P137; Cao H, 2009, MOL CELL ENDOCRINOL, V303, P34, DOI 10.1016/j.mce.2009.01.015; Chang JP, 2009, GEN COMP ENDOCR, V161, P42, DOI 10.1016/j.ygcen.2008.09.005; Chen X, 2006, J APPL ICHTHYOL, V22, P358, DOI 10.1111/j.1439-0426.2007.00984.x; CHEN XH, 2004, ACTA ZOOL SINICA, V28, P633; Cheng CY, 2010, PHILOS T R SOC B, V365, P1459, DOI 10.1098/rstb.2010.0024; Chuang-Ju L, 2011, FISH PHYSIOL BIOCHEM, V37, P471, DOI 10.1007/s10695-010-9448-x; De Rooij DG, 2000, J ANDROL, V21, P776; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; Fontana F, 2008, GENOME, V51, P113, DOI [10.1139/G07-112, 10.1139/g07-112]; Forconi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056006; Gomez JM, 1999, GEN COMP ENDOCR, V113, P413, DOI 10.1006/gcen.1998.7222; Goto-Kazeto R, 2004, GEN COMP ENDOCR, V139, P72, DOI 10.1016/j.ygcen.2004.07.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YQ, 2004, BIOCHEM BIOPH RES CO, V324, P569, DOI 10.1016/j.bbrc.2004.09.085; Haag ES, 2005, PLOS BIOL, V3, P21, DOI 10.1371/journal.pbio.0030021; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Halm S, 2007, GENE, V388, P148, DOI 10.1016/j.gene.2006.10.018; HODGKIN J, 1986, GENETICS, V114, P15; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Jiang T, 2013, MOL BIOL REP, V40, P2187, DOI 10.1007/s11033-012-2279-3; Jin SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076840; Krakow D, 2001, GENE, V279, P213, DOI 10.1016/S0378-1119(01)00756-9; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; Lolicato F, 2008, DEV BIOL, V313, P725, DOI 10.1016/j.ydbio.2007.11.011; Ludwig A, 2008, J APPL ICHTHYOL, V24, P2, DOI 10.1111/j.1439-0426.2008.01085.x; Ludwig A, 2001, GENETICS, V158, P1203; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Miura C, 2007, BIOL REPROD, V77, P822, DOI 10.1095/biolreprod.107.061408; Modig C, 2006, BIOL REPROD, V75, P717, DOI 10.1095/biolreprod.106.050757; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Patino R, 2001, COMP BIOCHEM PHYS B, V129, P427, DOI 10.1016/S1096-4959(01)00344-X; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Raverot G, 2005, DEV BIOL, V283, P215, DOI 10.1016/j.ydbio.2005.04.013; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rossi P., 2013, FRONT ENDOCRINOL, V4, P181, DOI [10.3389/fendo.2013.00181, DOI 10.3389/FENDO.2013.00181]; Russell LD, 1993, INT J ANDROL, V1, P83, DOI DOI 10.1111/J.1365-2605.1993.TB01156.X; Sawatari E, 2007, DEV BIOL, V301, P266, DOI 10.1016/j.ydbio.2006.10.001; Schlatt S, 2014, SEMIN CELL DEV BIOL, V29, P2, DOI 10.1016/j.semcdb.2014.03.007; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Sun FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068452; Sun LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050676; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Ventura-Holman T, 1998, GENOMICS, V54, P221, DOI 10.1006/geno.1998.5569; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Villalpando I, 2008, EXP BIOL MED, V233, P419, DOI 10.3181/0708-RM-212; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy.21212; Volff JN, 2003, J MOL EVOL, V57, pS241, DOI 10.1007/s00239-003-0033-0; [危起伟 Wei Qiwei], 2013, [中国水产科学, Journal of Fishery Sciences of China], V20, P1; Wei QW, 1997, ENVIRON BIOL FISH, V48, P241, DOI 10.1023/A:1007395612241; Weil C, 1995, GEN COMP ENDOCR, V100, P327, DOI 10.1006/gcen.1995.1163; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Wuertz S, 2007, GEN COMP ENDOCR, V150, P140, DOI 10.1016/j.ygcen.2006.07.005; Wuertz S, 2007, COMP BIOCHEM PHYS A, V147, P223, DOI 10.1016/j.cbpa.2006.12.031; Yamaguchi A, 2006, COMP BIOCHEM PHYS D, V1, P59, DOI 10.1016/j.cbd.2005.08.003; Ye H, 2012, FISH PHYSIOL BIOCHEM, V38, P929, DOI 10.1007/s10695-011-9579-8; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshinaga N, 2004, BIOCHEM BIOPH RES CO, V322, P508, DOI 10.1016/j.bbrc.2004.07.162; Yue HM, 2013, COMP BIOCHEM PHYS A, V166, P529, DOI 10.1016/j.cbpa.2013.08.011; Zhang H, 2011, J APPL ICHTHYOL, V27, P251, DOI 10.1111/j.1439-0426.2011.01708.x; Zhang SH, 2013, CONSERV GENET RESOUR, V5, P409, DOI 10.1007/s12686-012-9815-2; Zhang Si-Ming, 1999, Acta Zoologica Sinica, V45, P200; Ziv T, 2008, COMP BIOCHEM PHYS D, V3, P12, DOI 10.1016/j.cbd.2007.06.004	82	67	70	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127332	10.1371/journal.pone.0127332	http://dx.doi.org/10.1371/journal.pone.0127332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030930	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900047
J	Vermathen, M; Paul, LEH; Diserens, G; Vermathen, P; Furrer, J				Vermathen, Martina; Paul, Lydia E. H.; Diserens, Gaelle; Vermathen, Peter; Furrer, Julien			H-1 HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug	PLOS ONE			English	Article							VISIBLE LIPIDS; PLATINUM DRUGS; MOBILE LIPIDS; TUMOR-CELLS; HEPG2 CELLS; NAMI-A; H-1-NMR; DEATH; SPECTROSCOPY; INHIBITION	H-1 high resolution magic angle spinning (HR-MAS) NMR spectroscopy was applied in combination with multivariate statistical analyses to study the metabolic response of whole cells to the treatment with a hexacationic ruthenium metallaprism [1](6+) as potential anticancer drug. Human ovarian cancer cells (A2780), the corresponding cisplatin resistant cells (A2780cisR), and human embryonic kidney cells (HEK-293) were each incubated for 24 h and 72 h with [1](6+) and compared to untreated cells. Different responses were obtained depending on the cell type and incubation time. Most pronounced changes were found for lipids, choline containing compounds, glutamate and glutathione, nucleotide sugars, lactate, and some amino acids. Possible contributions of these metabolites to physiologic processes are discussed. The time-dependent metabolic response patterns suggest that A2780 cells on one hand and HEK-293 cells and A2780cisR cells on the other hand may follow different cell death pathways and exist in different temporal stages thereof.	[Vermathen, Martina; Paul, Lydia E. H.; Furrer, Julien] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Diserens, Gaelle; Vermathen, Peter] Univ Bern, Dept Clin Res, Bern, Switzerland; [Diserens, Gaelle; Vermathen, Peter] Univ Bern, AMSM, Dept Radiol, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Vermathen, M (corresponding author), Univ Bern, Dept Chem & Biochem, Bern, Switzerland.	martina.vermathen@dcb.unibe.ch	Vermathen, Martina/ABA-1385-2020; Vermathen, P./J-5789-2012; Furrer, Julien/A-9482-2015	Vermathen, P./0000-0001-8649-1098; Furrer, Julien/0000-0003-2096-0618; Vermathen, Martina/0000-0002-0796-1643	Department of Chemistry & Biochemistry at the University of Bern; Swiss National Science Foundation SNF [206021-128736, 200021_149438, 320030-138150]	Department of Chemistry & Biochemistry at the University of Bern; Swiss National Science Foundation SNF(Swiss National Science Foundation (SNSF))	Financial supports from the Department of Chemistry & Biochemistry at the University of Bern (http://www.dcb.unibe.ch/content/index_ger.html) (JF) and from the Swiss National Science Foundation SNF (http://www.snf.ch/en/Pages/default.aspx) grants # 206021-128736 (MV, PV), # 200021_149438 (MV, JF), and # 320030-138150 (PV) are greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Allardyce CS, 2001, CHEM COMMUN, P1396, DOI 10.1039/b104021a; Ang WH, 2011, J ORGANOMET CHEM, V696, P989, DOI 10.1016/j.jorganchem.2010.11.009; Antonarakis ES, 2010, CANCER CHEMOTH PHARM, V66, P1, DOI 10.1007/s00280-010-1293-1; Baban DF, 1998, ADV DRUG DELIVER REV, V34, P109, DOI 10.1016/S0169-409X(98)00003-9; Barry NPE, 2009, EUR J INORG CHEM, P4695, DOI 10.1002/ejic.200900649; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bayet-Robert M, 2010, MAGN RESON MED, V63, P1172, DOI 10.1002/mrm.22303; Bergamo A, 2012, J INORG BIOCHEM, V106, P90, DOI 10.1016/j.jinorgbio.2011.09.030; Blankenberg FG, 1996, BLOOD, V87, P1951; Blunden BM, 2014, MACROMOLECULES, V47, P1646, DOI 10.1021/ma402078d; Brisdelli F, 2003, BIOCHEM PHARMACOL, V65, P1271, DOI 10.1016/S0006-2952(03)00080-7; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; del Val IJ, 2013, ANAL BIOCHEM, V443, P172, DOI 10.1016/j.ab.2013.09.005; Delikatny EJ, 2002, CANCER RES, V62, P1394; Di Vito M, 2001, BBA-MOL CELL BIOL L, V1530, P47, DOI 10.1016/S1388-1981(00)00165-7; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duarte IF, 2013, MOL PHARMACEUT, V10, P4242, DOI 10.1021/mp400335k; Duarte IF, 2010, J PROTEOME RES, V9, P5877, DOI 10.1021/pr100635n; Duarte IF, 2009, ANAL CHEM, V81, P5023, DOI 10.1021/ac900545q; European Collection of Cell Cultures (ECACC), 2014, PROD INF; Gao D, 2014, TALANTA, V118, P382, DOI 10.1016/j.talanta.2013.09.018; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Grande S, 2011, NMR BIOMED, V24, P68, DOI 10.1002/nbm.1557; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Griffin JL, 2003, BBA-GEN SUBJECTS, V1619, P151, DOI 10.1016/S0304-4165(02)00475-0; Griffin JL, 2002, NMR BIOMED, V15, P375, DOI 10.1002/nbm.792; Hagrman D, 2004, J PHARMACOL EXP THER, V308, P658, DOI 10.1124/jpet.103.059410; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hayeshi R, 2004, PHYTOTHER RES, V18, P877, DOI 10.1002/ptr.1481; Lamego I, 2014, J PROTEOME RES, V13, P6033, DOI 10.1021/pr500907d; Lindon JC, 2009, PROG NUCL MAG RES SP, V55, P79, DOI 10.1016/j.pnmrs.2008.11.004; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Massimi M, 2012, BBA-GEN SUBJECTS, V1820, P1, DOI 10.1016/j.bbagen.2011.10.005; Miccheli AT, 2006, BBA-GEN SUBJECTS, V1760, P1723, DOI 10.1016/j.bbagen.2006.09.009; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Muhammad N, 2014, CURR OPIN CHEM BIOL, V19, P144, DOI 10.1016/j.cbpa.2014.02.003; Murray BS, 2014, CHEM SCI, V5, P2536, DOI 10.1039/c4sc00116h; Pan XY, 2011, J PROTEOME RES, V10, P3493, DOI 10.1021/pr200114v; Paul LEH, 2015, J BIOL INORG CHEM, V20, P49, DOI 10.1007/s00775-014-1208-4; Paul LEH, 2013, J ORGANOMET CHEM, V734, P45, DOI 10.1016/j.jorganchem.2012.12.011; Paul LEH, 2012, J BIOL INORG CHEM, V17, P1053, DOI 10.1007/s00775-012-0918-8; Paul LEH, 2012, INORG CHEM, V51, P1057, DOI 10.1021/ic2021935; PLOEMEN JHTM, 1991, BIOCHEM PHARMACOL, V41, P1665, DOI 10.1016/0006-2952(91)90167-4; Rainaldi G, 2008, RADIAT RES, V169, P170, DOI 10.1667/RR0958.1; Rehberg M, 2014, APPL MICROBIOL BIOT, V98, P385, DOI 10.1007/s00253-013-5329-4; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Rosi A, 2004, NMR BIOMED, V17, P76, DOI 10.1002/nbm.867; Sava G, 1996, INT J CANCER, V68, P60, DOI 10.1002/(SICI)1097-0215(19960927)68:1<60::AID-IJC12>3.3.CO;2-7; Sava G, 2003, CLIN CANCER RES, V9, P1898; Sawers L, 2014, BRIT J CANCER, V111, P1150, DOI 10.1038/bjc.2014.386; Schreier C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/878374; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Sitter B, 2009, PROG NUCL MAG RES SP, V54, P239, DOI 10.1016/j.pnmrs.2008.10.001; Suss-Fink G, 2010, DALTON T, V39, P1673, DOI 10.1039/b916860p; Therrien B, 2008, ANGEW CHEM INT EDIT, V47, P3773, DOI 10.1002/anie.200800186; Therrien B, 2007, J CLUST SCI, V18, P741, DOI 10.1007/s10876-007-0140-y; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Valverde D, 2006, NMR BIOMED, V19, P223, DOI 10.1002/nbm.1024; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wolters DA, 2012, METALLOMICS, V4, P1185, DOI 10.1039/c2mt20070h; Wu B, 2011, CHEM-EUR J, V17, P3562, DOI 10.1002/chem.201100298; Yang T, 2010, BIOCHEM J, V429, P533, DOI 10.1042/BJ20100238; Zhang AH, 2013, MAGN RESON CHEM, V51, P549, DOI 10.1002/mrc.3985; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	68	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128478	10.1371/journal.pone.0128478	http://dx.doi.org/10.1371/journal.pone.0128478			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024484	Green Published, gold			2022-12-27	WOS:000355319400092
J	Gu, Y; Yang, J; Chen, HJ; Li, J; Xu, M; Hua, J; Yao, J; Wang, YJ; Liu, Y; Liu, M				Gu, Yun; Yang, Jian; Chen, Haijiao; Li, Jing; Xu, Man; Hua, Juan; Yao, Jian; Wang, Yongjun; Liu, Yan; Liu, Mei			Different Astrocytic Activation between Adult Gekko japonicus and Rats during Wound Healing In Vitro	PLOS ONE			English	Article							REGENERATION; INJURY; GENE; TOOL	Glial scar formation is a major obstacle to regeneration after spinal cord injury. Moreover, it has been shown that the astrocytic response to injury differs between species. Gekko japonicas is a type of reptile and it shows differential glial activation compared to that of rats. The purpose of the present study was to compare the proliferation and migration of astrocytes in the spinal cords of geckos and rats after injury in vitro. Spinal cord homogenate stimulation and scratch wound models were used to induce astrocytic activation in adult and embryonic rats, as well as in adult geckos. Our results indicated that astrocytes from the adult rat were likely activated by mechanical stimulation, even though they showed lower proliferation abilities than the astrocytes from the gecko under normal conditions. Furthermore, a transcriptome analysis revealed that the differentially expressed genes in astrocytes from adult rats and those from geckos were enriched in pathways involved in proliferation and the response to stimuli. This implies that intrinsic discrepancies in gene expression patterns might contribute to the differential activation of astrocytes between species.	[Gu, Yun; Yang, Jian; Chen, Haijiao; Li, Jing; Xu, Man; Hua, Juan; Wang, Yongjun; Liu, Yan; Liu, Mei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Yao, Jian] Nantong Univ, Coll Med, Dept Histol & Embryol, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Liu, Y (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.	liuyan@ntu.edu.cn; liumei@ntu.edu.cn	Liu, Mei/K-9005-2019; J, Y/GYE-2288-2022	Liu, Mei/0000-0003-1168-6119; J, Y/0000-0001-6318-8854	NSFC [31171007, 31071874]; NSF of Education department of Jiangsu province [11KJA180004]; Starting Foundation for Returned Overseas Chinese Scholars; PAPD of Jiangsu Higher Education Institutions	NSFC(National Natural Science Foundation of China (NSFC)); NSF of Education department of Jiangsu province; Starting Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); PAPD of Jiangsu Higher Education Institutions	This study was supported by the grants to ML from NSFC (31171007), NSF of Education department of Jiangsu province (11KJA180004), and the Starting Foundation for Returned Overseas Chinese Scholars, the funding from PAPD of Jiangsu Higher Education Institutions; and a grant from NSFC (31071874) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Chou RC, 2003, BRAIN RES PROTOC, V11, P162, DOI 10.1016/S1385-299X(03)00043-6; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Ferretti P, 2008, CELL MOL LIFE SCI, V65, P45, DOI 10.1007/s00018-007-7430-2; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gao DH, 2010, CELL MOL BIOL LETT, V15, P582, DOI 10.2478/s11658-010-0029-x; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Huang Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0966-8; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Li J, 2013, INT J MOL SCI, V14, P8787, DOI 10.3390/ijms14058787; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu M, 2010, CELL BIOL INT, V34, P153, DOI 10.1042/CBI20090015; M'Dahoma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102027; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Qing, 2011, Invest Ophthalmol Vis Sci, V52, P1723, DOI 10.1167/iovs.10-5866; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; ZHOU Y, 2012, GUANGZHOU DAXUE XUEB, V11, P44; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	27	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127663	10.1371/journal.pone.0127663	http://dx.doi.org/10.1371/journal.pone.0127663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020931	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300050
J	Rice, KB; Fleischer, SJ; De Moraes, CM; Mescher, MC; Tooker, JF; Gish, M				Rice, Kevin B.; Fleischer, Shelby J.; De Moraes, Consuelo M.; Mescher, Mark C.; Tooker, John F.; Gish, Moshe			Handheld Lasers Allow Efficient Detection of Fluorescent Marked Organisms in the Field	PLOS ONE			English	Article							MARKING INSECTS; FALL ARMYWORM; MIGRATION; DISPERSAL; PIGMENTS; DUST	Marking organisms with fluorescent dyes and powders is a common technique used in ecological field studies that monitor movement of organisms to examine life history traits, behaviors, and population dynamics. External fluorescent marking is relatively inexpensive and can be readily employed to quickly mark large numbers of individuals; however, the ability to detect marked organisms in the field at night has been hampered by the limited detection distances provided by portable fluorescent ultraviolet lamps. In recent years, significant advances in LED lamp and laser technology have led to development of powerful, low-cost ultraviolet light sources. In this study, we evaluate the potential of these new technologies to improve detection of fluorescent-marked organisms in the field and to create new possibilities for tracking marked organisms in visually challenging environments such as tree canopies and aquatic habitats. Using handheld lasers, we document a method that provides a fivefold increase in detection distance over previously available technologies. This method allows easy scouting of tree canopies (from the ground), as well as shallow aquatic systems. This novel detection method for fluorescent-marked organisms thus promises to significantly enhance the use of fluorescent marking as a non-destructive technique for tracking organisms in natural environments, facilitating field studies that aim to document otherwise inaccessible aspects of the movement, behavior, and population dynamics of study organisms, including species with significant economic impacts or relevance for ecology and human health.	[Rice, Kevin B.; Fleischer, Shelby J.; Tooker, John F.; Gish, Moshe] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [De Moraes, Consuelo M.; Mescher, Mark C.] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gish, M (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	mug32@psu.edu	Fleischer, Shelby/AAN-1392-2020; Fleischer, Shelby/AAD-6663-2020		U.S. Department of Agriculture-National Institute of Food and Agriculture-Specialty Crops Research Initiative grant [2011-51181-30937]; Stoy G. and Della A. Sunday Program Support for Fruit Production Research; Pennsylvania State University	U.S. Department of Agriculture-National Institute of Food and Agriculture-Specialty Crops Research Initiative grant; Stoy G. and Della A. Sunday Program Support for Fruit Production Research; Pennsylvania State University	This work was supported by a U.S. Department of Agriculture-National Institute of Food and Agriculture-Specialty Crops Research Initiative grant 2011-51181-30937 and the Stoy G. and Della A. Sunday Program Support for Fruit Production Research, The Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey DH, 1991, USE ELEMENTAL MARK S; Byrne DN, 1996, OECOLOGIA, V105, P320, DOI 10.1007/BF00328734; Corbett A, 1996, BIOL CONTROL, V6, P35, DOI 10.1006/bcon.1996.0005; Coviella CE, 2006, J ECON ENTOMOL, V99, P1051, DOI 10.1603/0022-0493-99.4.1051; Ellis CD., 2014, AQUAC RES, V46, P1; Fargo Roberto J., 1997, Transactions of the Western Section of the Wildlife Society, V33, P12; FLEISCHER SJ, 1988, ENVIRON ENTOMOL, V17, P533, DOI 10.1093/ee/17.3.533; Foltan P, 2008, J MOLLUS STUD, V74, P293, DOI 10.1093/mollus/eyn012; Furman BLS, 2011, HERPETOL CONSERV BIO, V6, P473; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hein S, 2005, ECOL ENTOMOL, V30, P225, DOI 10.1111/j.0307-6946.2005.00680.x; Kaiser P.K, 1996, HUMAN COLOR VISION; Kearns C. A., 1993, TECHNIQUES POLLINATI; KNITTLE CE, 1987, J FIELD ORNITHOL, V58, P490; Lemke A, 2009, J APPL ECOL, V46, P1122, DOI 10.1111/j.1365-2664.2009.01691.x; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; LONGLAND WS, 1995, J MAMMAL, V76, P1260, DOI 10.2307/1382621; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McFarlane G., 1990, AM FISHERIES SOC S, V7, P9; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2009, ENVIRON ENTOMOL, V38, P1546, DOI 10.1603/022.038.0605; Narisu, 1999, J APPL ECOL, V36, P604, DOI 10.1046/j.1365-2664.1999.00421.x; O'Neal M. E., 2004, American Entomologist, V50, P212; PAL R, 1947, NATURE, V160, P298, DOI 10.1038/160298b0; Pandey JK, 2011, J FLUORESC, V21, P785, DOI 10.1007/s10895-010-0771-5; POLIVKA JB, 1949, J ECON ENTOMOL, V42, P818, DOI 10.1093/jee/42.5.818; QUAY WB, 1948, J MAMMAL, V29, P225, DOI 10.2307/1375388; Reiter J, 2006, BIOTROPICA, V38, P64, DOI 10.1111/j.1744-7429.2005.00111.x; RICE KB, 2014, J INTEGR PEST MANAG, V5, P1, DOI DOI 10.1603/IPM14002; STERN VM, 1968, J ECON ENTOMOL, V61, P1232, DOI 10.1093/jee/61.5.1232; Warner KA, 2009, ENTOMOL EXP APPL, V131, P320, DOI 10.1111/j.1570-7458.2009.00851.x; Willis TJ, 1998, NEW ZEAL J MAR FRESH, V32, P247, DOI 10.1080/00288330.1998.9516823; Yang M, 2005, BIOTECHNIQUES, V39, P170, DOI 10.2144/05392BM02	33	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129175	10.1371/journal.pone.0129175	http://dx.doi.org/10.1371/journal.pone.0129175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035303	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100069
J	Cai, HP; Zhang, GW; Wang, Z; Luo, ZH; Zhou, XC				Cai, Heping; Zhang, Gongwu; Wang, Zhuo; Luo, Zhihong; Zhou, Xiaochun			Relationship Between the Use of Statins and Patient Survival in Colorectal Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							LOVASTATIN-INDUCED APOPTOSIS; CHOLESTEROL LEVELS; CELL-GROWTH; RISK; PRAVASTATIN; EVENTS; COHORT; ASSOCIATION; PREVENTION; PROGNOSIS	Background Studies have indicated that statins influence the risks and mortality rates of several types of solid tumors. However, the association between statin use and survival in patients with colorectal cancer (CRC) remains unclear. Methods We searched the PubMed and Embase databases for relevant studies published up to September 2014 that assessed statin use and CRC prognosis. The primary outcomes were overall survival (OS) and cancer-specific survival (CSS). The secondary outcomes were disease-free survival (DFS) and recurrence-free survival (RFS). Hazard ratios (HRs) and 95% confidence intervals (CIs) were extracted and pooled with Mantel-Haenszel random-effect modeling. All statistical tests were two-sided. Results Four studies on post-diagnosis statin therapy and five studies on pre-diagnosis statin use were included in our meta-analysis of 70,608 patients. Compared with the non-users, the patients with post-diagnosis statin use gained survival benefits for OS (HR 0.76; 95% CI: 0.68 to 0.85, P<0.001) and CSS (HR 0.70; 95% CI: 0.60 to 0.81, P<0.001). In addition, we observed that pre-diagnosis statin use prolonged the survival of patients with CRC for OS (HR 0.70; 95% CI: 0.54 to 0.91, P=0.007) and CSS (HR 0.80; 95% CI: 0.74 to 0.86, P<0.001). However, we did not observe a survival benefit for DFS (HR 1.13; 95% CI: 0.78 to 1.62, P=0.514) or RFS (HR 0.98; 95% CI: 0.36 to 2.70, P=0.975) in the CRC patients with Conclusions Statin use before or after cancer diagnosis is related to reductions in overall and cancer-specific mortality in colorectal cancer survivors.	[Cai, Heping; Zhang, Gongwu; Luo, Zhihong] Anhui Prov Childrens Hosp, Dept Pharm, Hefei, Anhui, Peoples R China; [Wang, Zhuo] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China; [Zhou, Xiaochun] Lianyungang Oriental Hosp, Dept Gen Surg, Lianyungang, Jiangsu, Peoples R China	Naval Medical University	Wang, Z (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China.	wangzhuo088@163.com; hfluozhihong@gmail.com; heixia000@126.com						Agarwal B, 2002, CARCINOGENESIS, V23, P521, DOI 10.1093/carcin/23.3.521; Bonovas S, 2007, J CLIN ONCOL, V25, P3462, DOI 10.1200/JCO.2007.10.8936; Cardwell CR, 2014, J CLIN ONCOL, V32, P3177, DOI 10.1200/JCO.2013.54.4569; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; Choi SK, 2013, MOL CLIN ONCOL, V1, P365, DOI 10.3892/mco.2012.55; Coogan PF, 2007, JNCI-J NATL CANCER I, V99, P32, DOI 10.1093/jnci/djk003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Habis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104521; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Jensen AB, 2006, AM J GASTROENTEROL, V101, P1283, DOI 10.1111/j.1572-0241.2006.00520.x; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; Lakha F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-487; Lee JE, 2011, CANCER PREV RES, V4, P1808, DOI 10.1158/1940-6207.CAPR-11-0113; Liu YQ, 2014, GYNECOL ONCOL, V133, P647, DOI 10.1016/j.ygyno.2014.04.007; Liu YQ, 2014, CANCER CAUSE CONTROL, V25, P237, DOI 10.1007/s10552-013-0326-6; Livingstone E, 2014, CANCER MED-US, V3, P1284, DOI 10.1002/cam4.285; Ma WL, 2013, J CLIN ONCOL, P31; Mace AG, 2013, DIS COLON RECTUM, V56, P1217, DOI 10.1097/DCR.0b013e3182a4b236; Narisawa T, 1996, JPN J CANCER RES, V87, P798, DOI 10.1111/j.1349-7006.1996.tb02103.x; Ng K, 2011, JNCI-J NATL CANCER I, V103, P1540, DOI 10.1093/jnci/djr307; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Popat S, 2005, EUR J CANCER, V41, P2060, DOI 10.1016/j.ejca.2005.04.039; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Pradelli D, 2013, EUR J CANCER PREV, V22, P229, DOI 10.1097/CEJ.0b013e328358761a; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Siddiqui AA, 2009, DIGEST DIS SCI, V54, P1307, DOI 10.1007/s10620-009-0790-8; Singh PP, 2013, ANN ONCOL, V24, P1721, DOI 10.1093/annonc/mdt150; Song C, 2015, PROSTATE, V75, P211, DOI 10.1002/pros.22907; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Ukomadu C, 2003, J BIOL CHEM, V278, P43586, DOI 10.1074/jbc.M307194200; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Wang JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077950; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Zhang XL, 2013, CANCER CAUSE CONTROL, V24, P769, DOI 10.1007/s10552-013-0159-3	37	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126944	10.1371/journal.pone.0126944	http://dx.doi.org/10.1371/journal.pone.0126944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030771	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900037
J	Lehner, P; Larndorfer, C; Garcia-Robledo, E; Larsen, M; Borisov, SM; Revsbech, NP; Glud, RN; Canfield, DE; Klimant, I				Lehner, Philipp; Larndorfer, Christoph; Garcia-Robledo, Emilio; Larsen, Morten; Borisov, Sergey M.; Revsbech, Niels-Peter; Glud, Ronnie N.; Canfield, Donald E.; Klimant, Ingo			LUMOS - A Sensitive and Reliable Optode System for Measuring Dissolved Oxygen in the Nanomolar Range	PLOS ONE			English	Article							SENSING MATERIALS; CONTAMINATION; RESPIRATION; SENSORS; GROWTH; FILM	Most commercially available optical oxygen sensors target the measuring range of 300 to 2 mu mol L-1. However these are not suitable for investigating the nanomolar range which is relevant for many important environmental situations. We therefore developed a miniaturized phase fluorimeter based measurement system called the LUMOS (Luminescence Measuring Oxygen Sensor). It consists of a readout device and specialized "sensing chemistry" that relies on commercially available components. The sensor material is based on palladium(II)-5,10,15,20-tetrakis-(2,3,4,5,6-pentafluorphenyl)-porphyrin embedded in a Hyflon AD 60 polymer matrix and has a K-SV of 6.25 x 10(-3) ppmv(-1). The applicable measurement range is from 1000 nM down to a detection limit of 0.5 nM. A second sensor material based on the platinum(II) analogue of the porphyrin is spectrally compatible with the readout device and has a measurement range of 20 mu M down to 10 nM. The LUMOS device is a dedicated system optimized for a high signal to noise ratio, but in principle any phase flourimeter can be adapted to act as a readout device for the highly sensitive and robust sensing chemistry. Vise versa, the LUMOS fluorimeter can be used for read out of less sensitive optical oxygen sensors based on the same or similar indicator dyes, for example for monitoring oxygen at physiological conditions. The presented sensor system exhibits lower noise, higher resolution and higher sensitivity than the electrochemical STOX sensor previously used to measure nanomolar oxygen concentrations. Oxygen contamination in common sample containers has been investigated and microbial or enzymatic oxygen consumption at nanomolar concentrations is presented.	[Lehner, Philipp; Larndorfer, Christoph; Borisov, Sergey M.; Klimant, Ingo] Graz Univ Technol, Inst Analyt Chem & Food Chem, NAWI Graz, A-8010 Graz, Austria; [Garcia-Robledo, Emilio; Revsbech, Niels-Peter] Aarhus Univ, Dept Biosci, DK-8000 Aarhus, Denmark; [Larsen, Morten; Glud, Ronnie N.; Canfield, Donald E.] Univ Southern Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark	Graz University of Technology; Aarhus University; University of Southern Denmark	Klimant, I (corresponding author), Graz Univ Technol, Inst Analyt Chem & Food Chem, NAWI Graz, Stremayrgasse 9, A-8010 Graz, Austria.	Klimant@Tugraz.At	Revsbech, Niels P/I-8040-2013; Garcia-Robledo, Emilio/B-3781-2017; Canfield, Don/C-1735-2012	Garcia-Robledo, Emilio/0000-0002-4337-6433; Canfield, Don/0000-0001-7602-8366; Glud, Ronnie N./0000-0002-7069-893X; Revsbech, Niels Peter/0000-0002-2193-262X; Borisov, Sergey/0000-0001-9318-8273	European Research Council (Project 'Oxygen') [267233]	European Research Council (Project 'Oxygen')	The work was financially supported by the European Research Council (Project 'Oxygen', N 267233).	Amao Y, 2001, REACT FUNCT POLYM, V47, P49, DOI 10.1016/S1381-5148(00)00070-5; Anderlei T, 2001, BIOCHEM ENG J, V7, P157, DOI 10.1016/S1369-703X(00)00116-9; Arcella V, 2003, ANN NY ACAD SCI, V984, P226, DOI 10.1111/j.1749-6632.2003.tb06002.x; BERGER H, 1991, MICROELECTRON ENG, V10, P259, DOI 10.1016/0167-9317(91)90026-A; BERGERSEN FJ, 1990, PROC R SOC SER B-BIO, V238, P295, DOI 10.1098/rspb.1990.0001; Borisov SM, 2008, ANAL CHEM, V80, P9435, DOI 10.1021/ac801521v; Borisov SM, 2011, ANAL CHIM ACTA, V690, P108, DOI 10.1016/j.aca.2011.01.057; CARRAWAY ER, 1991, LANGMUIR, V7, P2991, DOI 10.1021/la00060a015; Chen X, 2002, SENSOR ACTUAT B-CHEM, V87, P233, DOI 10.1016/S0925-4005(02)00241-1; Crank J, 1996, DIFFUSION POLYM; De Brabandere L, 2012, J MICROBIOL METH, V88, P147, DOI 10.1016/j.mimet.2011.11.001; DEMAS JN, 1995, ANAL CHEM, V67, P1377, DOI 10.1021/ac00104a012; Enko B, 2013, J PHYS CHEM A, V117, P8873, DOI 10.1021/jp4046462; Goudar CT, 1999, BBA-PROTEIN STRUCT M, V1429, P377, DOI 10.1016/S0167-4838(98)00247-7; Gupta A, 2003, BIOTECHNOL BIOENG, V84, P351, DOI 10.1002/bit.10740; JOHNSON MJ, 1967, J BACTERIOL, V94, P101, DOI 10.1128/JB.94.1.101-108.1967; Klimant I, 1999, MIKROCHIM ACTA, V131, P35, DOI 10.1007/s006040050007; Lee SK, 1997, ANAL COMMUN, V34, P185, DOI 10.1039/a701130j; LONGMUIR IS, 1954, BIOCHEM J, V57, P81, DOI 10.1042/bj0570081; McDonagh C, 2008, CHEM REV, V108, P400, DOI 10.1021/cr068102g; Nemser S. M., 1991, US Patent, Patent No. [5,051,114, 5051114, 5051114A]; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Quaranta Michela, 2012, Bioanal Rev, V4, P115; Revsbech NP, 2011, METHOD ENZYMOL, V486, P325, DOI [10.1016/S0076-6879(11)86014-3, 10.1016/B978-0-12-381294-0.00014-6]; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; TANNO K, 1964, B CHEM SOC JPN, V37, P804, DOI 10.1246/bcsj.37.804; Tiano L, 2014, DEEP-SEA RES PT I, V94, P173, DOI 10.1016/j.dsr.2014.10.001; Tiano L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105399; Trinkel M, 1998, THESIS U GRAZ; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Wang XD, 2014, CHEM SOC REV, V43, P3666, DOI 10.1039/c4cs00039k; Wolfbeis OS, 2005, J MATER CHEM, V15, P2657, DOI 10.1039/b501536g	33	40	40	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128125	10.1371/journal.pone.0128125	http://dx.doi.org/10.1371/journal.pone.0128125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029920	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900112
J	Nagasawa, K; Oouchi, H; Itoh, N; Takahashi, KG; Osada, M				Nagasawa, Kazue; Oouchi, Hitoshi; Itoh, Naoki; Takahashi, Keisuke G.; Osada, Makoto			In Vivo Administration of Scallop GnRH-Like Peptide Influences on Gonad Development in the Yesso Scallop, Patinopecten yessoensis	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; VERTEBRATE SEX STEROIDS; OCTOPUS-VULGARIS; PACIFIC OYSTER; SYSTEM; EXPRESSION; MOLLUSKS; PROLIFERATION; STIMULATION	Existing research on the role of gonadotropin-releasing hormone (GnRH) in bivalve reproduction is inadequate, even though a few bivalve GnRH orthologs have been cloned. The objective of this paper was to elucidate the in vivo effect of GnRH administration in Yesso scallop reproduction. We performed in vivo administration of scallop GnRH (py-GnRH) synthetic peptide into the developing gonad, and analyzed its effect on gonad development for 6 weeks during the reproductive season. The resulting sex ratio in the GnRH administered (GnRH(+)) group might be male biased, whereas the control (GnRH(-)) group had an equal sex ratio throughout the experiment. The gonad index (GI) of males in the GnRH(+) group increased from week 2 to 24.8% at week 6. By contrast the GI of the GnRH(-) group peaked in week 4 at 16.6%. No significant difference was seen in female GI between the GnRH(+) and GnRH(-) groups at any sampling point. Oocyte diameter in the GnRH(+) group remained constant (about 42-45 mu m) throughout the experiment, while in the GnRH(-) group it increased from 45 to 68 mu m i.e. normal oocyte growth. The number of spermatogonia in the germinal acini of males in the GnRH(+) group increased from week 4 to 6. Hermaphrodites appeared in the GnRH(+) group in weeks 2 and 4. Their gonads contained many apoptotic cells including oocytes. In conclusion, this study suggests that py-GnRH administration could have a potential to accelerate spermatogenesis and cause an inhibitory effect on oocyte growth in scallops.	[Nagasawa, Kazue; Oouchi, Hitoshi; Takahashi, Keisuke G.; Osada, Makoto] Tohoku Univ, Grad Sch Agr Sci, Lab Aquacultural Biol, Aoba Ku, Sendai, Miyagi, Japan; [Itoh, Naoki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Tohoku University; University of Tokyo	Osada, M (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Lab Aquacultural Biol, Aoba Ku, 1-1 Amamiya Machi, Sendai, Miyagi, Japan.	mosada@bios.tohoku.ac.jp	Takahashi, Keisuke/U-1779-2019; Nagasawa, Kazue/ABH-6117-2020; Osada, Makoto/AAI-9967-2020	Nagasawa, Kazue/0000-0003-2819-3302; Osada, Makoto/0000-0001-6247-5106	JSPS KAKENHI [23380109]; Tohoku Ecosystem-Associated Marine Sciences (TEAMS) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tohoku Ecosystem-Associated Marine Sciences (TEAMS) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology	JSPS KAKENHI (23380109) to MO and Tohoku Ecosystem-Associated Marine Sciences (TEAMS) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber Bruce J., 2006, Developments in Aquaculture and Fisheries Science, V35, P357; Beninger PG, 2003, BIOL BULL-US, V205, P83, DOI 10.2307/1543448; Bigot L, 2012, PEPTIDES, V34, P303, DOI 10.1016/j.peptides.2012.01.017; Di Cosmo A, 2001, J EXP ZOOL, V289, P33, DOI 10.1002/1097-010X(20010101/31)289:1<33::AID-JEZ4>3.0.CO;2-A; Di Cristo C, 2013, INVERTEBR NEUROSCI, V13, P27, DOI 10.1007/s10158-013-0149-x; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Fricker LD, 2005, AAPS J, V7, DOI 10.1208/aapsj070244; Giusti A, 2013, COMP BIOCHEM PHYS C, V158, P187, DOI 10.1016/j.cbpc.2013.08.003; Gorbman A, 2003, GEN COMP ENDOCR, V131, P62, DOI 10.1016/S0016-6480(02)00647-0; Ivin VV, 2006, SCALLOPS BIOL ECOLOG, V35, P1163; Iwakoshi E, 2000, PEPTIDES, V21, P623, DOI 10.1016/S0196-9781(00)00201-1; Iwakoshi-Ukena E, 2004, J COMP NEUROL, V477, P310, DOI 10.1002/cne.20260; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Kanda A, 2006, BIOCHEM J, V395, P125, DOI 10.1042/BJ20051615; Kogo H, 1999, CELL TISSUE RES, V297, P459, DOI 10.1007/s004410051372; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; MORI K, 1969, BULL JAP SOC SCI FISH, V35, P1072; Moss S. M., 1989, PAC SCI, V43, P200; Nakamura S, 2007, MOL REPROD DEV, V74, P108, DOI 10.1002/mrd.20544; Nyuji M, 2013, FISHERIES SCI, V79, P251, DOI 10.1007/s12562-013-0599-4; Osada M, 2007, FISHERIES SCI, V73, P1318, DOI 10.1111/j.1444-2906.2007.01470.x; Osada M, 2013, GEN COMP ENDOCR, V181, P254, DOI 10.1016/j.ygcen.2012.09.002; Pazos AJ, 1999, GEN COMP ENDOCR, V113, P112, DOI 10.1006/gcen.1998.7186; Roch GJ, 2014, GEN COMP ENDOCR, V209, P118, DOI 10.1016/j.ygcen.2014.07.025; Roch GJ, 2014, MOL BIOL EVOL, V31, P765, DOI 10.1093/molbev/mst269; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Rodet F, 2005, BBA-GENE STRUCT EXPR, V1730, P187, DOI 10.1016/j.bbaexp.2005.05.012; Scott AP, 2013, STEROIDS, V78, P268, DOI 10.1016/j.steroids.2012.11.006; Scott AP, 2012, STEROIDS, V77, P1450, DOI 10.1016/j.steroids.2012.08.009; Scotti L, 2011, MOL CELL ENDOCRINOL, V335, P116, DOI 10.1016/j.mce.2011.01.002; Sun Biao, 2011, Front Endocrinol (Lausanne), V2, P36, DOI 10.3389/fendo.2011.00036; Sun B, 2012, GEN COMP ENDOCR, V176, P321, DOI 10.1016/j.ygcen.2011.11.030; Treen N, 2012, GEN COMP ENDOCR, V176, P167, DOI 10.1016/j.ygcen.2012.01.008; Tsai PS, 2010, GEN COMP ENDOCR, V166, P280, DOI 10.1016/j.ygcen.2009.09.009; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; Wang C, 2004, AQUACULTURE, V238, P483, DOI 10.1016/j.aquaculture.2004.05.024; Wang CD, 2006, AQUACULTURE, V256, P423, DOI 10.1016/j.aquaculture.2006.01.017; Wang MQ, 2011, DEV COMP IMMUNOL, V35, P511, DOI 10.1016/j.dci.2010.12.005; WHITELAW PF, 1995, ENDOCRINOLOGY, V136, P172, DOI 10.1210/en.136.1.172; Zhang LH, 2000, GEN COMP ENDOCR, V118, P77, DOI 10.1006/gcen.2000.7457; Zhao SM, 2000, GYNECOL OBSTET INVES, V49, P52, DOI 10.1159/000010213; Zohar Y, 2001, AQUACULTURE, V197, P99, DOI 10.1016/S0044-8486(01)00584-1	42	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129571	10.1371/journal.pone.0129571	http://dx.doi.org/10.1371/journal.pone.0129571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030928	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900223
J	Qin, XS; Cao, MJ; Lai, FN; Yang, F; Ge, W; Zhang, XF; Cheng, SF; Sun, XF; Qin, GQ; Shen, W; Li, L				Qin, Xunsi; Cao, Mingjun; Lai, Fangnong; Yang, Fan; Ge, Wei; Zhang, Xifeng; Cheng, Shunfeng; Sun, Xiaofeng; Qin, Guoqing; Shen, Wei; Li, Lan			Oxidative Stress Induced by Zearalenone in Porcine Granulosa Cells and Its Rescue by Curcumin In Vitro	PLOS ONE			English	Article							ESTROGENIC MYCOTOXIN; IONIZING-RADIATION; FEMALE MICE; PC12 CELLS; ANTIOXIDANT; APOPTOSIS; TOXICITY; RATS; METABOLISM; DAMAGE	Oxidative stress (OS), as a signal of aberrant intracellular mechanisms, plays key roles in maintaining homeostasis for organisms. The occurrence of OS due to the disorder of normal cellular redox balance indicates the overproduction of reactive oxygen species (ROS) and/or deficiency of antioxidants. Once the balance is broken down, repression of oxidative stress is one of the most effective ways to alleviate it. Ongoing studies provide remarkable evidence that oxidative stress is involved in reproductive toxicity induced by various stimuli, such as environmental toxicants and food toxicity. Zearalenone (ZEA), as a toxic compound existing in contaminated food products, is found to induce mycotoxicosis that has a significant impact on the reproduction of domestic animals, especially pigs. However, there is no information about how ROS and oxidative stress is involved in the influence of ZEA on porcine granulosa cells, or whether the stress can be rescued by curcumin. In this study, ZEA-induced effect on porcine granulosa cells was investigated at low concentrations (15 mu M, 30 mu M and 60 mu M). In vitro ROS levels, the mRNA level and activity of superoxide dismutase, glutathione peroxidase and catalase were obtained. The results showed that in comparison with negative control, ZEA increased oxidative stress with higher ROS levels, reduced the expression and activity of antioxidative enzymes, increased the intensity of fluorogenic probes 2',7'-Dichlorodihydrofluorescin diacetate and dihydroethidium in flow cytometry assay and fluorescence microscopy. Meanwhile, the activity of glutathione (GSH) did not change obviously following 60 mu M ZEA treatment. Furthermore, the underlying protective mechanisms of curcumin on the ZEA-treated porcine granulosa cells were investigated. The data revealed that curcumin pre-treatment significantly suppressed ZEA-induced oxidative stress. Collectively, porcine granulosa cells were sensitive to ZEA, which may induce oxidative stress. The findings from this study clearly demonstrate that curcumin is effective to reduce the dysregulation of cellular redox balance on porcine granulosa cells in vitro and should be further investigated for its protective role against ZEA in animals.	[Qin, Xunsi; Cao, Mingjun; Lai, Fangnong; Yang, Fan; Ge, Wei; Zhang, Xifeng; Cheng, Shunfeng; Sun, Xiaofeng; Shen, Wei; Li, Lan] Qingdao Agr Univ, Shandong Univ, Key Lab Anim Reprod & Germplasm Enhancement, Qingdao 266109, Peoples R China; [Qin, Xunsi; Cao, Mingjun; Ge, Wei; Zhang, Xifeng; Cheng, Shunfeng; Shen, Wei; Li, Lan] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao 266109, Peoples R China; [Lai, Fangnong; Yang, Fan; Sun, Xiaofeng] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China; [Qin, Guoqing] EMF Nutr Ltd, Winnipeg, MB R2J 0K6, Canada	Qingdao Agricultural University; Shandong University; Qingdao Agricultural University; Qingdao Agricultural University	Li, L (corresponding author), Qingdao Agr Univ, Shandong Univ, Key Lab Anim Reprod & Germplasm Enhancement, Qingdao 266109, Peoples R China.	lilan9600@126.com	Cheng, Shunfeng/AAG-2058-2021	Ge, Wei/0000-0002-4610-7933	National Nature Science Foundation [31440081]; Program for New Century Excellent Talents in University [NCET-12-1026]; Nature Science Foundation of Shandong Province [ZR2013CQ029]; EMF Nutrition Ltd	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Nature Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); EMF Nutrition Ltd	This work was supported by National Nature Science Foundation (31440081), Program for New Century Excellent Talents in University (NCET-12-1026), and Nature Science Foundation of Shandong Province (ZR2013CQ029). EMF Nutrition Ltd provided support in the form of salaries for author Guoqing Qin. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Aggarwal BB, 2005, CRC SER MOD NUTR SCI, P349; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Aktas C, 2012, TOXICOL IND HEALTH, V28, P852, DOI 10.1177/0748233711425080; Al Dhaheri Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109630; Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1; [Anonymous], 2011, EFSA J, V8, P9; [Anonymous], 2012, ANIMAL FEED SCI TECH, V173, P134; Aquila S, 2014, EXP CELL RES, V328, P303, DOI 10.1016/j.yexcr.2014.07.015; Bengmark S, 2006, JPEN-PARENTER ENTER, V30, P45, DOI 10.1177/014860710603000145; BIEHL ML, 1993, TOXICOL APPL PHARM, V121, P152, DOI 10.1006/taap.1993.1140; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Cetica PD, 2001, IUBMB LIFE, V51, P57, DOI 10.1080/15216540152035073; Clegg DJ, 2012, MOL ENDOCRINOL, V26, P1957, DOI 10.1210/me.2012-1284; DACASTO M, 1995, VET HUM TOXICOL, V37, P359; DELCORSO A, 1994, INT J BIOCHEM, V26, P745, DOI 10.1016/0020-711X(94)90103-1; Duda M, 2011, REPROD BIOL, V11, P117, DOI 10.1016/S1642-431X(12)60049-7; Ehsani M NAC, 2014, MEASURING TOXIN ZEAR; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Filipiak E, 2009, FOLIA HISTOCHEM CYTO, V47, pS113, DOI 10.2478/v10042-009-0049-4; Fink-Gremmels J, 1999, VET QUART, V21, P115, DOI 10.1080/01652176.1999.9695005; Gresakova L, 2012, ACTA VET HUNG, V60, P103, DOI 10.1556/AVet.2012.009; Hassen W, 2007, TOXICOLOGY, V232, P294, DOI 10.1016/j.tox.2007.01.015; (JECFA) FWECoFA, 2000, WHO FOOD ADD SER, V44, P393; JOE B, 1994, BBA-MOL CELL RES, V1224, P255, DOI 10.1016/0167-4889(94)90198-8; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kanter M, 2013, MOL NUTR FOOD RES, V57, P1578, DOI 10.1002/mnfr.201200170; Kidder GM, 2010, CAN J PHYSIOL PHARM, V88, P399, DOI [10.1139/Y10-009, 10.1139/y10-009]; Kim IH, 2003, TOXICOL LETT, V138, P185, DOI 10.1016/S0378-4274(02)00405-8; Koraichi F, 2013, TOXICOLOGY, V310, P29, DOI 10.1016/j.tox.2013.05.002; Kouadio JH, 2005, TOXICOLOGY, V213, P56, DOI 10.1016/j.tox.2005.05.010; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106412; Luderer U, 2014, VITAM HORM, V94, P99, DOI 10.1016/B978-0-12-800095-3.00004-3; Marin DE, 2013, FOOD CHEM TOXICOL, V58, P408, DOI 10.1016/j.fct.2013.05.033; Massart F, 2010, INT J ANDROL, V33, P369, DOI 10.1111/j.1365-2605.2009.01009.x; Mayer C, 2010, P NATL ACAD SCI USA, V107, P22693, DOI 10.1073/pnas.1012406108; Muller H M, 1997, Nat Toxins, V5, P24, DOI 10.1002/(SICI)(1997)5:1<24::AID-NT4>3.0.CO;2-#; Oguzturk H, 2012, ANDROLOGIA, V44, P243, DOI 10.1111/j.1439-0272.2012.01273.x; Osweiler G D, 1990, J Vet Diagn Invest, V2, P73; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Pereyra MLG, 2008, LETT APPL MICROBIOL, V46, P555, DOI 10.1111/j.1472-765X.2008.02347.x; Picton HM, 1999, J REPROD FERTIL, V115, P67, DOI 10.1530/jrf.0.1150067; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; Reddy KRN, 2010, TOXIN REV, V29, P3, DOI 10.3109/15569541003598553; Sakata S, 2015, J ORTHOP RES, V33, P359, DOI 10.1002/jor.22767; Sambuu R, 2011, J REPROD DEVELOP, V57, P303, DOI 10.1262/jrd.10-106M; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Sharma P, 2010, B ENVIRON CONTAM TOX, V84, P378, DOI 10.1007/s00128-010-9942-y; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; Whitaker BD, 2008, REPROD FERT DEVELOP, V20, P694, DOI 10.1071/RD08037; Zhao F, 2014, REPROD TOXICOL, V47, P81, DOI 10.1016/j.reprotox.2014.06.005; Zhou C, 2015, HUM EXP TOXICOL, V34, P65, DOI 10.1177/0960327113504972; Zhu L, 2012, J CELL PHYSIOL, V227, P1814, DOI 10.1002/jcp.22906; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030; Zwierzchowski W., 2005, Polish Journal of Veterinary Sciences, V8, P209	58	53	58	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127551	10.1371/journal.pone.0127551	http://dx.doi.org/10.1371/journal.pone.0127551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030649	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900060
J	Scott, AE; Vasilescu, DM; Seal, KAD; Keyes, SD; Mavrogordato, MN; Hogg, JC; Sinclair, I; Warner, JA; Hackett, TL; Lackie, PM				Scott, Anna E.; Vasilescu, Dragos M.; Seal, Katherine A. D.; Keyes, Samuel D.; Mavrogordato, Mark N.; Hogg, James C.; Sinclair, Ian; Warner, Jane A.; Hackett, Tillie-Louise; Lackie, Peter M.			Three Dimensional Imaging of Paraffin Embedded Human Lung Tissue Samples by Micro-Computed Tomography	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SMALL-AIRWAY-OBSTRUCTION; TOOL; CT; MORPHOMETRY; EMPHYSEMA; DENSITY; MASS	Background Understanding the three-dimensional (3-D) micro-architecture of lung tissue can provide insights into the pathology of lung disease. Micro computed tomography (mu CT) has previously been used to elucidate lung 3D histology and morphometry in fixed samples that have been stained with contrast agents or air inflated and dried. However, non-destructive microstructural 3D imaging of formalin-fixed paraffin embedded (FFPE) tissues would facilitate retrospective analysis of extensive tissue archives of lung FFPE lung samples with linked clinical data. Methods FFPE human lung tissue samples (n = 4) were scanned using a Nikon metrology mu CT scanner. Semi-automatic techniques were used to segment the 3D structure of airways and blood vessels. Airspace size (mean linear intercept, Lm) was measured on mu CT images and on matched histological sections from the same FFPE samples imaged by light microscopy to validate mu CT imaging. Results The mu CT imaging protocol provided contrast between tissue and paraffin in FFPE samples (15mm x 7mm). Resolution (voxel size 6.7 mu m) in the reconstructed images was sufficient for semi-automatic image segmentation of airways and blood vessels as well as quantitative airspace analysis. The scans were also used to scout for regions of interest, enabling time-efficient preparation of conventional histological sections. The Lm measurements from mu CT images were not significantly different to those from matched histological sections. Conclusion We demonstrated how non-destructive imaging of routinely prepared FFPE samples by laboratory mu CT can be used to visualize and assess the 3D morphology of the lung including by morphometric analysis.	[Scott, Anna E.; Keyes, Samuel D.; Mavrogordato, Mark N.; Sinclair, Ian] Univ Southampton, Fac Engn & Environm, VIS Ctr, Southampton, Hants, England; [Vasilescu, Dragos M.; Seal, Katherine A. D.; Hogg, James C.; Hackett, Tillie-Louise] Univ British Columbia, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Warner, Jane A.; Lackie, Peter M.] Univ Southampton, Southampton Gen Hosp, Sir Henry Wellcome Labs, Fac Med, Southampton, Hants, England; [Hackett, Tillie-Louise] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	University of Southampton; University of British Columbia; University of Southampton; University of British Columbia	Lackie, PM (corresponding author), Univ Southampton, Southampton Gen Hosp, Sir Henry Wellcome Labs, Fac Med, Southampton, Hants, England.	p.m.lackie@soton.ac.uk	Keyes, Samuel/AAL-3079-2021; Sinclair, Ian/ABB-5502-2021	Keyes, Samuel/0000-0002-4129-2228	Institute for Life Sciences, University of Southampton; EPSRC grant [EP-H01506X]; Canadian Institutes for Health Research grant; IMPACT/CIHR; Canadian Thoracic Society (CTS); Parker B. Francis Fellowship; EPSRC [EP/H01506X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H01506X/1] Funding Source: researchfish	Institute for Life Sciences, University of Southampton; EPSRC grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Canadian Institutes for Health Research grant(Canadian Institutes of Health Research (CIHR)); IMPACT/CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Thoracic Society (CTS); Parker B. Francis Fellowship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding from a 'Bridging the Gap' grant from the Institute for Life Sciences, University of Southampton and support by EPSRC grant EP-H01506X and Canadian Institutes for Health Research grant are gratefully acknowledged. The IMPACT/CIHR and Canadian Thoracic Society (CTS) supported DMV through their postdoctoral fellowships, TLH is the recipient of a Parker B. Francis Fellowship.	Diallo MHH, 2000, CHEST, V118, P1566, DOI 10.1378/chest.118.6.1566; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Guenette JA, 2007, J APPL PHYSIOL, V103, P875, DOI 10.1152/japplphysiol.00247.2007; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hogg JC, 2013, CHEST, V143, P1436, DOI 10.1378/chest.12-1766; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hubbell J. H., 1996, TABLES XRAY MASS ATT; HUBBELL JH, 1982, INT J APPL RADIAT IS, V33, P1269, DOI 10.1016/0020-708X(82)90248-4; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; National Physical Laboratory, 1995, TABL PHYS CHEM CONST; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; RANGA V, 1978, ARCH PATHOL LAB MED, V102, P609; Ritman EL, 2004, ANNU REV BIOMED ENG, V6, P185, DOI 10.1146/annurev.bioeng.6.040803.140130; Roberts N, 2012, AM J PATHOL, V180, P1835, DOI 10.1016/j.ajpath.2012.01.033; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seal K, 2013, AM J RESP CRIT CARE, V187; Seal K, 2012, EUR RESP J S56, V40, p26s; Sorzano COS, 2005, IEEE T BIO-MED ENG, V52, P652, DOI 10.1109/TBME.2005.844030; Vasilescu DM, 2013, J APPL PHYSIOL, V114, P716, DOI 10.1152/japplphysiol.00855.2012; Vasilescu DM, 2012, P NATL ACAD SCI USA, V109, P17105, DOI 10.1073/pnas.1215112109; WEIBEL ER, 1961, AM REV RESPIR DIS, V84, P856; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006	25	83	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126230	10.1371/journal.pone.0126230	http://dx.doi.org/10.1371/journal.pone.0126230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030902	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000356630900023
J	Wagenaar, D; van der Graaf, ER; van der Schaaf, A; Greuter, MJW				Wagenaar, Dirk; van der Graaf, Emiel R.; van der Schaaf, Arjen; Greuter, Marcel J. W.			Quantitative Comparison of Commercial and Non-Commercial Metal Artifact Reduction Techniques in Computed Tomography	PLOS ONE			English	Article							ATTENUATION CORRECTION; CT; IMPLANTS; SCANNER; IMPACT	Objectives Typical streak artifacts known as metal artifacts occur in the presence of strongly attenuating materials in computed tomography (CT). Recently, vendors have started offering metal artifact reduction (MAR) techniques. In addition, a MAR technique called the metal deletion technique (MDT) is freely available and able to reduce metal artifacts using reconstructed images. Although a comparison of the MDT to other MAR techniques exists, a comparison of commercially available MAR techniques is lacking. The aim of this study was therefore to quantify the difference in effectiveness of the currently available MAR techniques of different scanners and the MDT technique. Materials and Methods Three vendors were asked to use their preferential CT scanner for applying their MAR techniques. The scans were performed on a Philips Brilliance ICT 256 (S1), a GE Discovery CT 750 HD (S2) and a Siemens Somatom Definition AS Open (S3). The scans were made using an anthropomorphic head and neck phantom (Kyoto Kagaku, Japan). Three amalgam dental implants were constructed and inserted between the phantom's teeth. The average absolute error (AAE) was calculated for all reconstructions in the proximity of the amalgam implants. Results The commercial techniques reduced the AAE by 22.0 +/- 1.6%, 16.2 +/- 2.6% and 3.3 +/- 0.7% for S1 to S3 respectively. After applying the MDT to uncorrected scans of each scanner the AAE was reduced by 26.1 +/- 2.3%, 27.9 +/- 1.0% and 28.8 +/- 0.5% respectively. The difference in efficiency between the commercial techniques and the MDT was statistically significant for S2 (p = 0.004) and S3 (p < 0.001), but not for S1 (p = 0.63). Conclusions The effectiveness of MAR differs between vendors. S1 performed slightly better than S2 and both performed better than S3. Furthermore, for our phantom and outcome measure the MDT was more effective than the commercial MAR technique on all scanners.	[Wagenaar, Dirk; van der Schaaf, Arjen] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [van der Graaf, Emiel R.] Univ Groningen, KVI Ctr Adv Radiat Technol, Groningen, Netherlands; [Greuter, Marcel J. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Wagenaar, D (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands.	d.wagenaar@umcg.nl	Greuter, Marcel J W/B-4363-2013; Van+Der+Schaaf, Arjen/AEX-0530-2022	Greuter, Marcel J W/0000-0001-5721-9159; Van+Der+Schaaf, Arjen/0000-0003-4067-7975; van der Graaf, Emiel/0000-0002-9254-3349				Abdoli M, 2010, NUCL MED COMMUN, V31, P22, DOI 10.1097/MNM.0b013e32832fa241; Bal M, 2006, MED PHYS, V33, P2852, DOI 10.1118/1.2218062; Bamberg F, 2011, EUR RADIOL, V21, P1424, DOI 10.1007/s00330-011-2062-1; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Boas FE, 2011, RADIOLOGY, V259, P894, DOI 10.1148/radiol.11101782; De Man B., 1998, 1998 IEEE Nuclear Science Symposium Conference Record. 1998 IEEE Nuclear Science Symposium and Medical Imaging Conference (Cat. No.98CH36255), P1860, DOI 10.1109/NSSMIC.1998.773898; De Marzi L, 2013, PHYS MED BIOL, V58, P4255, DOI 10.1088/0031-9155/58/12/4255; Golden C, 2011, PROC SPIE, V7961, DOI 10.1117/12.878896; Joemai RMS, 2012, MED PHYS, V39, P1125, DOI 10.1118/1.3679863; Kamel EM, 2003, EUR RADIOL, V13, P724, DOI 10.1007/s00330-002-1564-2; Kidoh M, 2014, CLIN RADIOL, V69, pE11, DOI 10.1016/j.crad.2013.08.008; Lemmens C, 2008, PHYS MED BIOL, V53, P4417, DOI 10.1088/0031-9155/53/16/013; Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Mouton A, 2013, J X-RAY SCI TECHNOL, V21, P193, DOI 10.3233/XST-130372; Rinkel J, 2008, J COMPUT ASSIST TOMO, V32, P621, DOI 10.1097/RCT.0b013e318149e215; Spadea MF, 2013, J APPL CLIN MED PHYS, V14, P299, DOI 10.1120/jacmp.v14i1.4027; Verburg JM, 2013, MED PHYS, V40, DOI 10.1118/1.4810942; Yu HY, 2007, ACAD RADIOL, V14, P495, DOI 10.1016/j.acra.2006.12.015; Zhao SY, 2000, IEEE T MED IMAGING, V19, P1238, DOI 10.1109/42.897816	20	18	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127932	10.1371/journal.pone.0127932	http://dx.doi.org/10.1371/journal.pone.0127932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030821	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900094
J	Werner, MU; Pereira, MP; Andersen, LPH; Dahl, JB				Werner, Mads U.; Pereira, Manuel P.; Andersen, Lars Peter H.; Dahl, Jorgen B.			Endogenous Opioid Antagonism in Physiological Experimental Pain Models: A Systematic Review	PLOS ONE			English	Review							STRESS-INDUCED ANALGESIA; PERIPHERAL CONDITIONING STIMULATION; BUPRENORPHINE-INDUCED ANALGESIA; NOXIOUS INHIBITORY CONTROLS; CENTRAL SENSITIZATION; BRAIN-STIMULATION; CONSORT STATEMENT; BLOOD-PRESSURE; ISCHEMIC PAIN; SAMPLE-SIZE	Opioid antagonists are pharmacological tools applied as an indirect measure to detect activation of the endogenous opioid system (EOS) in experimental pain models. The objective of this systematic review was to examine the effect of mu-opioid-receptor (MOR) antagonists in placebo-controlled, double-blind studies using 'inhibitory' or 'sensitizing', physiological test paradigms in healthy human subjects. The databases PubMed and Embase were searched according to predefined criteria. Out of a total of 2,142 records, 63 studies (1,477 subjects [male/female ratio = 1.5]) were considered relevant. Twenty-five studies utilized 'inhibitory' test paradigms (ITP) and 38 studies utilized 'sensitizing' test paradigms (STP). The ITP-studies were characterized as conditioning modulation models (22 studies) and repetitive transcranial magnetic stimulation models (rTMS; 3 studies), and, the STP-studies as secondary hyperalgesia models (6 studies), 'pain' models (25 studies), summation models (2 studies), nociceptive reflex models (3 studies) and miscellaneous models (2 studies). A consistent reversal of analgesia by a MOR-antagonist was demonstrated in 10 of the 25 ITP-studies, including stress-induced analgesia and rTMS. In the remaining 14 conditioning modulation studies either absence of effects or ambiguous effects by MOR-antagonists, were observed. In the STP-studies, no effect of the opioid-blockade could be demonstrated in 5 out of 6 secondary hyperalgesia studies. The direction of MOR-antagonist dependent effects upon pain ratings, threshold assessments and somatosensory evoked potentials (SSEP), did not appear consistent in 28 out of 32 'pain' model studies. In conclusion, only in 2 experimental human pain models, i.e., stress-induced analgesia and rTMS, administration of MOR-antagonist demonstrated a consistent effect, presumably mediated by an EOS-dependent mechanisms of analgesia and hyperalgesia.	[Werner, Mads U.; Pereira, Manuel P.] Rigshosp, Ctr Neurosci, Ctr Multidisciplinary Pain, DK-2100 Copenhagen, Denmark; [Pereira, Manuel P.; Dahl, Jorgen B.] Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, DK-2100 Copenhagen, Denmark; [Andersen, Lars Peter H.] Herlev Hosp, Dept Surg D, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Werner, MU (corresponding author), Rigshosp, Ctr Neurosci, Ctr Multidisciplinary Pain, DK-2100 Copenhagen, Denmark.	mads.u.werner@gmail.com	Pereira, Manuel Pedro/AAP-8484-2020	Werner, Mads/0000-0003-1540-8845				ADAMS JE, 1976, PAIN, V2, P161, DOI 10.1016/0304-3959(76)90111-1; Al'Absi M, 2004, PSYCHOSOM MED, V66, P198, DOI 10.1097/01.psy.0000116250.81254.5d; Altman DG, 1996, BRIT MED J, V313, P570; Anderson WS, 2002, PAIN, V99, P207, DOI 10.1016/S0304-3959(02)00103-3; Backonja MM, 2009, CLIN J PAIN, V25, P641, DOI 10.1097/AJP.0b013e3181a68c7e; Benedetti F, 1999, J NEUROSCI, V19, P3639; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Bingel U, 2008, PAIN, V140, P393, DOI 10.1016/j.pain.2008.09.030; Borras MC, 2004, J NEUROPHYSIOL, V91, P2723, DOI 10.1152/jn.00249.2003; BOUREAU F, 1978, NEUROPHARMACOLOGY, V17, P565, DOI 10.1016/0028-3908(78)90149-1; Brennum J, 2001, ACTA ANAESTH SCAND, V45, P954, DOI 10.1034/j.1399-6576.2001.450806.x; Brock C, 2012, CLIN NEUROPHYSIOL, V123, P829, DOI 10.1016/j.clinph.2011.07.047; BROMM B, 1983, EUR J PHARMACOL, V87, P431, DOI 10.1016/0014-2999(83)90082-1; Bruehl S, 2012, EUR J PAIN, V16, P370, DOI 10.1002/j.1532-2149.2011.00021.x; Bruehl S, 2013, PAIN, V154, P1856, DOI 10.1016/j.pain.2013.06.002; Bruehl S, 2011, PSYCHOSOM MED, V73, P612, DOI 10.1097/PSY.0b013e318227cb88; BUCHSBAUM MS, 1983, PSYCHOPHARMACOLOGY, V79, P99, DOI 10.1007/BF00427792; BUCHSBAUM MS, 1977, NATURE, V270, P620, DOI 10.1038/270620a0; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P579, DOI 10.1080/10408440802026281; CHAMBERLAIN JM, 1994, AM J EMERG MED, V12, P650, DOI 10.1016/0735-6757(94)90033-7; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chu LF, 2011, J PAIN, V12, P108, DOI 10.1016/j.jpain.2010.05.006; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook DB, 2000, AM J PHYSIOL-REG I, V279, pR1565, DOI 10.1152/ajpregu.2000.279.5.R1565; Corder G, 2013, SCIENCE, V341, P1394, DOI 10.1126/science.1239403; CRABTREE BL, 1984, CLIN PHARMACY, V3, P273; de Andrade DC, 2011, PAIN, V152, P320, DOI 10.1016/j.pain.2010.10.032; Drummond PD, 2000, ANESTH ANALG, V90, P923, DOI 10.1213/00000539-200004000-00027; Edwards RR, 2004, PERCEPT MOTOR SKILL, V99, P679, DOI 10.2466/pms.99.2.679-687; Eissenberg T, 2000, EXP CLIN PSYCHOPHARM, V8, P47, DOI 10.1037/1064-1297.8.1.47; ELSOBKY A, 1976, NATURE, V263, P783, DOI 10.1038/263783a0; ERNST M, 1986, PAIN, V26, P221, DOI 10.1016/0304-3959(86)90077-1; France CR, 2007, BIOL PSYCHOL, V75, P95, DOI 10.1016/j.biopsycho.2006.12.005; France CR, 2005, BIOL PSYCHOL, V70, P168, DOI 10.1016/j.biopsycho.2005.01.012; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; FROST JJ, 1989, J CEREBR BLOOD F MET, V9, P398, DOI 10.1038/jcbfm.1989.59; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; GLASER EM, 1953, J PHYSIOL-LONDON, V122, pP43; GLASS PSA, 1994, ANESTH ANALG, V78, P536; GONZALEZ JP, 1988, DRUGS, V35, P192, DOI 10.2165/00003495-198835030-00002; Gracely RH, 2013, WALL MELZACKS TXB PA, P283; Graven-Nielsen T, 2002, EXP BRAIN RES, V146, P213, DOI 10.1007/s00221-002-1169-7; GREVERT P, 1983, BIOL PSYCHIAT, V18, P1375; GREVERT P, 1977, P NATL ACAD SCI USA, V74, P1291, DOI 10.1073/pnas.74.3.1291; GREVERT P, 1978, SCIENCE, V199, P1093, DOI 10.1126/science.343250; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JANAL MN, 1984, PAIN, V19, P13, DOI 10.1016/0304-3959(84)90061-7; Julien N, 2006, NEUROSCI LETT, V401, P256, DOI 10.1016/j.neulet.2006.03.032; JUNGKUNZ G, 1983, PSYCHIAT RES, V8, P13, DOI 10.1016/0165-1781(83)90133-6; Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; King CD, 2013, J BEHAV MED, V36, P315, DOI 10.1007/s10865-012-9424-2; Koppert W, 2005, J PAIN, V6, P757, DOI 10.1016/j.jpain.2005.07.002; Koppert W, 2005, PAIN, V118, P15, DOI 10.1016/j.pain.2005.06.030; Koppert W, 2003, PAIN, V106, P91, DOI 10.1016/S0304-3959(03)00294-X; Kotlyar M, 2008, BIOL PSYCHOL, V77, P233, DOI 10.1016/j.biopsycho.2007.10.005; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; LAUTENBACHER S, 1994, PSYCHOSOM MED, V56, P345, DOI 10.1097/00006842-199407000-00010; LAUTENBACHER S, 1990, PSYCHOSOM MED, V52, P673, DOI 10.1097/00006842-199011000-00008; Le Bars D, 1992, Patol Fiziol Eksp Ter, P55; LEBARS D, 1992, PAIN, V48, P13, DOI 10.1016/0304-3959(92)90126-V; Leonard G, 2010, PAIN, V151, P215, DOI 10.1016/j.pain.2010.07.012; LEVINE JD, 1984, NATURE, V312, P755, DOI 10.1038/312755a0; LEVINE JD, 1979, NATURE, V278, P740, DOI 10.1038/278740a0; LEVINE JD, 1986, BRAIN RES, V365, P377, DOI 10.1016/0006-8993(86)91653-7; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; MCCUBBIN JA, 1994, PAIN, V57, P63, DOI 10.1016/0304-3959(94)90108-2; Mikkelsen S, 1999, ANESTHESIOLOGY, V90, P1539, DOI 10.1097/00000542-199906000-00007; Mobascher A, 2010, INT J PSYCHOPHYSIOL, V75, P16, DOI 10.1016/j.ijpsycho.2009.10.008; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nickel FT, 2014, EUR J PAIN, V18, P56, DOI 10.1002/j.1532-2149.2013.00339.x; Noordzij M, 2011, NEPHRON CLIN PRACT, V118, pC319, DOI 10.1159/000322830; OLAUSSON B, 1986, ACTA PHYSIOL SCAND, V126, P299, DOI 10.1111/j.1748-1716.1986.tb07818.x; Pereira MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064608; PERT A, 1974, BRAIN RES, V80, P135, DOI 10.1016/0006-8993(74)90731-8; PERTOVAARA A, 1982, BRAIN RES, V251, P83, DOI 10.1016/0006-8993(82)91276-8; PERTOVAARA A, 1982, PAIN, V13, P379, DOI 10.1016/0304-3959(82)90006-9; PERTOVAARA A, 1981, BRAIN RES, V215, P426, DOI 10.1016/0006-8993(81)90529-1; Petersen KL, 1999, NEUROREPORT, V10, P1511, DOI 10.1097/00001756-199905140-00022; Pickering G, 2013, FUND CLIN PHARMACOL, V27, P339, DOI 10.1111/j.1472-8206.2011.01010.x; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; POSNER J, 1985, PSYCHOPHARMACOLOGY, V87, P468, DOI 10.1007/BF00432515; Poulsen L, 1996, ANALGESIA, V2, P255; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Rang HP, 2007, RANG DALES PHARM, P588; Ravn P, 2013, J PAIN RES, V6, P23, DOI 10.2147/JPR.S36827; Rennefeld C, 2010, PAIN, V148, P503, DOI 10.1016/j.pain.2009.12.014; RICHARDSON DE, 1976, IEEE T BIO-MED ENG, V23, P304, DOI 10.1109/TBME.1976.324589; Robertson LJ, 2008, J PAIN, V9, P79, DOI 10.1016/j.jpain.2007.08.008; Robertson LJ, 2007, J PAIN, V8, P489, DOI 10.1016/j.jpain.2007.01.007; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schobel HP, 1998, J AUTONOM NERV SYST, V69, P49, DOI 10.1016/S0165-1838(98)00005-8; Schoell ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012344; Schulz KF, 2010, LANCET, V376, P1222, DOI 10.1016/S0140-6736(10)61879-X; Schweinhardt P, 2008, NEUROSCIENTIST, V14, P415, DOI 10.1177/1073858407312521; Smith K, 2012, INT J CLIN PHARM TH, V50, P360, DOI 10.5414/CP201646; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; STACHER G, 1988, PAIN, V34, P271, DOI 10.1016/0304-3959(88)90122-4; Staud R, 2012, J PAIN, V13, P725, DOI 10.1016/j.jpain.2012.04.006; Taylor JJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1189, DOI 10.1038/npp.2013.13; Taylor JJ, 2012, PAIN, V153, P1219, DOI 10.1016/j.pain.2012.02.030; Taylor R, 2013, EXPERT OPIN INV DRUG, V22, P517, DOI 10.1517/13543784.2013.778973; Troster A, 2012, CLIN J PAIN, V28, P705, DOI 10.1097/AJP.0b013e318241d948; van Wijk G, 2010, J PAIN, V11, P408, DOI 10.1016/j.jpain.2009.10.009; van Wilgen CP, 2012, PAIN MANAG NURS, V13, P60, DOI 10.1016/j.pmn.2010.03.001; Vignoletti F, 2012, J CLIN PERIODONTOL, V39, P6, DOI 10.1111/j.1600-051X.2011.01830.x; Watson M, 2005, OXFORD HDB PALLIATIV, P35; Werner MU, 2013, ACTA ANAESTH SCAND, V57, P957, DOI 10.1111/aas.12150; Werner MU, 2013, SCAND J PAIN, V4, P163, DOI 10.1016/j.sjpain.2013.04.003; WILLER JC, 1980, BRAIN RES, V198, P419, DOI 10.1016/0006-8993(80)90755-6; WILLER JC, 1981, SCIENCE, V212, P689, DOI 10.1126/science.6261330; WILLER JC, 1990, EUR J PHARMACOL, V182, P347, DOI 10.1016/0014-2999(90)90293-F; WILLER JC, 1986, BRAIN RES, V362, P398, DOI 10.1016/0006-8993(86)90472-5; WILLER JC, 1982, BRAIN RES, V239, P322, DOI 10.1016/0006-8993(82)90860-5; WILLER JC, 1986, ANN NY ACAD SCI, V467, P256, DOI 10.1111/j.1749-6632.1986.tb14634.x; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004; Younger JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005180	125	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0125887	10.1371/journal.pone.0125887	http://dx.doi.org/10.1371/journal.pone.0125887			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029906	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900016
J	Xing, B; Liang, XP; Liu, P; Zhao, Y; Chu, Z; Dang, YH				Xing, Bo; Liang, Xiao-ping; Liu, Peng; Zhao, Yan; Chu, Zheng; Dang, Yong-hui			Valproate Inhibits Methamphetamine Induced Hyperactivity via Glycogen Synthase Kinase 3 beta Signaling in the Nucleus Accumbens Core	PLOS ONE			English	Article							INDUCED BEHAVIORAL SENSITIZATION; VENTROLATERAL ORBITAL CORTEX; DEPENDENT BEHAVIORS; DOPAMINE RELEASE; RAT-BRAIN; SHELL; AMPHETAMINE; EXPRESSION; COCAINE; RECEPTORS	Valproate (VPA) has recently been shown to influence the behavioral effects of psycho-stimulants. Although glycogen synthase kinase 3 beta (GSK3 beta) signaling in the nucleus accumbens (NAc) plays a key role in mediating dopamine (DA)-dependent behaviors, there is less direct evidence that how VPA acts on the GSK3 beta signaling in the functionally distinct sub-regions of the NAc, the NAc core (NAcC) and the NAc shell (NAcSh), during psycho-stimulant-induced hyperactivity. In the present study, we applied locomotion test after acute methamphetamine (MA) (2 mg/kg) injection to identify the locomotor activity of rats received repeated VPA (300 mg/kg) pretreatment. We next measured phosphor-GSK3 beta at serine 9 and total GSK3 beta levels in NAcC and NAcSh respectively to determine the relationship between the effect of VPA on MA-induced hyperlocomotor and changes in GSK3 beta activity. We further investigated whether microinjection of VPA (300 mu g/0.5 mu l/side, once daily for 7 consecutive days) into NAcC or NAcSh could affect hyperactivity induced by MA. Our data indicated that repeated VPA treatment attenuated MA-induced hyperlocomotor, and the effect was associated with decreased levels of phosphorylated GSK3 beta at Ser 9 in the NAcC. Moreover, repeated bilateral intra-NAcC, but not intra-NAcSh VPA treatment, significantly attenuated MA-induced hyperactivity. Our results suggested that GSK3 beta activity in NAcC contributes to the inhibitory effects of VPA on MA-induced hyperactivity.	[Xing, Bo; Liu, Peng; Zhao, Yan; Chu, Zheng; Dang, Yong-hui] Xi An Jiao Tong Univ, Dept Forens Med, Key Lab Environm & Genes Related Dis, Minist Educ,Sch Med, Xian 710049, Shaanxi, Peoples R China; [Xing, Bo; Liang, Xiao-ping] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Yan] Xian Med Univ, Sch Basic Med Sci, Dept Pathophysiol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University	Dang, YH (corresponding author), Xi An Jiao Tong Univ, Dept Forens Med, Key Lab Environm & Genes Related Dis, Minist Educ,Sch Med, Xian 710049, Shaanxi, Peoples R China.	psydyh@mail.xjtu.edu.cn		Chu, Zheng/0000-0003-1805-3824				Agmo A, 1996, J NEURAL TRANSM, V103, P925, DOI 10.1007/BF01291783; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bossert JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2197, DOI 10.1038/sj.npp.1300977; Cacciapaglia F, 2012, NEUROPHARMACOLOGY, V62, P2050, DOI 10.1016/j.neuropharm.2011.12.027; COTT J, 1977, J NEURAL TRANSM, V40, P253, DOI 10.1007/BF01257019; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Enman NM, 2012, BEHAV BRAIN RES, V231, P217, DOI 10.1016/j.bbr.2012.03.027; FIBIGER HC, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P615; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Heimer L, 1997, J NEUROPSYCH CLIN N, V9, P354; Ito R, 2011, J NEUROSCI, V31, P6001, DOI 10.1523/JNEUROSCI.6588-10.2011; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kim WY, 2008, NEUROSCI LETT, V432, P54, DOI 10.1016/j.neulet.2007.12.005; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li JX, 2005, BEHAV BRAIN RES, V161, P125, DOI 10.1016/j.bbr.2005.01.015; Li YC, 2011, NEUROSCI BIOBEHAV R, V35, P645, DOI 10.1016/j.neubiorev.2010.08.001; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu FF, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-41; Machado-Vieira R, 2004, PROG NEURO-PSYCHOPH, V28, P209, DOI 10.1016/j.pnpbp.2003.10.015; Miller JA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115750, 10.1371/journal.pone.0088026]; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mylecharane EJ, 1996, BEHAV BRAIN RES, V73, P1; Nelson CD, 2013, J NEUROSCI, V33, P12122, DOI 10.1523/JNEUROSCI.0131-13.2013; Owens Michael J, 2003, Psychopharmacol Bull, V37 Suppl 2, P17; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; SANDOVAL MRL, 1995, BRAZ J MED BIOL RES, V28, P88; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Urs NM, 2012, P NATL ACAD SCI USA, V109, P20732, DOI 10.1073/pnas.1215489109; WATSON C, 1986, RAT BRAIN STEREOTAXI; WESTERINK BHC, 1995, BEHAV BRAIN RES, V70, P103, DOI 10.1016/0166-4328(95)80001-8; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xing B, 2014, NEUROSCI LETT, V574, P11, DOI 10.1016/j.neulet.2014.04.050; Xing B, 2011, BRAIN RES BULL, V85, P153, DOI 10.1016/j.brainresbull.2011.03.007; Xu CM, 2011, J NEUROCHEM, V118, P126, DOI 10.1111/j.1471-4159.2011.07281.x; Xu CM, 2009, J NEUROCHEM, V111, P1357, DOI 10.1111/j.1471-4159.2009.06414.x; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052698; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	44	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128068	10.1371/journal.pone.0128068	http://dx.doi.org/10.1371/journal.pone.0128068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030405	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900107
J	Yan, XR; Jiao, WZ; Li, ZW; Xu, WW; Li, FJ; Wang, LH				Yan, Xiao-Ran; Jiao, Wan-Zhen; Li, Zhi-Wei; Xu, Wen-Wen; Li, Feng-Jiao; Wang, Li-Hua			Performance of the Plusoptix A09 Photoscreener in Detecting Amblyopia Risk Factors in Chinese Children Attending an Eye Clinic	PLOS ONE			English	Article							VISION SCREENER; REFERRAL CRITERIA; REFRACTIVE ERRORS; ACCURACY; AUTOREFRACTOR; RETINOSCOPY; RETINOMAX; S08	Purpose To assess the accuracy of the Plusoptix A09 photoscreener in detecting amblyopia risk factors in children and determine referral criteria when using Plusoptix A09 for a large-scale vision screening. Methods Pediatric patients attending our eye clinic underwent a comprehensive ophthalmic examination that included photorefraction, orthoptic examination, anterior segment assessment, fundus examination and cycloplegic retinoscopy. The measurements were collected for statistical analyses. Results One hundred and seventy-eight children (mean age +/- SD: 6.2 +/- 2.4 years, range: 2.2 to 14.1 years) were included in the study. The mean spherical equivalent (SE) obtained using Plusoptix A09 (P-SE) was 0.57 D lower than that obtained from cycloplegic retinoscopy (CRSE) (P = 0.00). However, there was no statistically significant difference of Jackson cross cylinder J(0) and J(45) between Plusoptix A09 (P-J) and cycloplegic retinoscopy (CRJ) (P = 0.14, P = 0.26). The relationship of SE obtained from Plusoptix A09 and SE obtained from cycloplegic retinoscopy was presented as the equation: CRSE = 0.358 + 0.776 P-SE + 0.064 P-SE(2) + 0.011 P-SE(3). Based on the Receiver Operating Characteristic (ROC) curve, the Plusoptix A09 had an overall sensitivity of 94.9% and specificity of 67.5% for detecting refractive amblyopia risk factors. The sensitivity and specificity of the Plusoptix A09 for detection of strabismus were 40.7% and 98.3%, respectively; detection of amblyopia and/or strabismus was 84.7% and 63.2%, respectively. Conclusions The Plusoptix A09 photoscreener underestimated hyperopia and overestimated myopia according to SE when compared with cycloplegic retinoscopy. The accuracy of the Plusoptix A09 in detecting amblyopia risk factors in children could be improved by the regression equation and optimized criteria for refractive amblyopia risk factors developed in the present study. Moreover, the Plusoptix A09 photoscreener is not suitable for a large-scale strabismus screening when it is applied solely.	[Yan, Xiao-Ran; Jiao, Wan-Zhen; Li, Zhi-Wei; Xu, Wen-Wen; Li, Feng-Jiao; Wang, Li-Hua] Shandong Univ, Shandong Prov Hosp, Dept Ophthalmol, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, LH (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Ophthalmol, Jinan, Shandong, Peoples R China.	wang_glasses@aliyun.com						American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus Panel, 2012, PREF PRACT PATT GUID; [Anonymous], 2005, PLUSOPTIX S04 HAND H; [Anonymous], ALASKA BLIND CHILD D; Arthur BW, 2009, J AAPOS, V13, P51, DOI 10.1016/j.jaapos.2008.08.016; Ayse YK, 2011, CAN J OPHTHALMOL, V46, P153, DOI 10.3129/i10-110; Berg AO, 2004, ANN FAM MED, V2, P263, DOI 10.1370/afm.193; Bloomberg JD, 2013, J AAPOS, V17, P301, DOI 10.1016/j.jaapos.2013.03.014; Cordonnier M, 2001, Strabismus, V9, P59, DOI 10.1076/stra.9.2.59.701; Cordonnier M, 1999, BRIT J OPHTHALMOL, V83, P157, DOI 10.1136/bjo.83.2.157; Cotter S, 2003, AM J OPHTHALMOL, V136, P630, DOI 10.1016/S0002-9394(03)00458-6; Dahlmann-Noor AH, 2009, BRIT J OPHTHALMOL, V93, P342, DOI 10.1136/bjo.2008.138115; Dahlmann-Noor AH, 2009, BRIT J OPHTHALMOL, V93, P346, DOI 10.1136/bjo.2008.138123; Davies LN, 2003, OPTOMETRY VISION SCI, V80, P320, DOI 10.1097/00006324-200304000-00011; Donahue SP, 2003, J AAPOS, V7, P314, DOI 10.1016/S1091-8531(03)00182-4; Doshi NR, 2007, AM FAM PHYSICIAN, V75, P361; Eibschitz-Tsimhoni M, 2000, J AAPOS, V4, P194, DOI 10.1067/mpa.2000.105274; Erdurmus M, 2007, J AAPOS, V11, P606, DOI 10.1016/j.jaapos.2007.04.006; Jost RM, 2014, JAMA OPHTHALMOL, V132, P814, DOI 10.1001/jamaophthalmol.2014.424; Matta NS, 2008, J AAPOS, V12, P490, DOI 10.1016/j.jaapos.2008.04.004; Matta NS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1591, DOI 10.1001/archophthalmol.2009.294; Mirzajani A, 2013, CLIN EXP OPTOM, V96, P394, DOI 10.1111/cxo.12063; Moghaddam AAS, 2012, BRIT J OPHTHALMOL, V96, P83, DOI 10.1136/bjo.2010.190405; Nathan NR, 2011, J AAPOS, V15, P551, DOI 10.1016/j.jaapos.2011.08.008; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Paff T, 2010, J AAPOS, V14, P478, DOI 10.1016/j.jaapos.2010.09.015; Pediavision Website, 2013, PEDIAVISION ASS SOL; Rajavi Zhale, 2012, J Ophthalmic Vis Res, V7, P3; Sachdev N, 2005, OPTOMETRY VISION SCI, V82, P9; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Silbert DI, 2012, J AAPOS, V16, P361, DOI 10.1016/j.jaapos.2012.02.016; Simons K, 1996, SURV OPHTHALMOL, V41, P3, DOI 10.1016/S0039-6257(97)81990-X; Singman E, 2013, STRABISMUS, V21, P190, DOI 10.3109/09273972.2013.811606; Singman E, 2013, STRABISMUS, V21, P85, DOI 10.3109/09273972.2013.786735; Steele G, 2003, OPTOMETRY VISION SCI, V80, P573, DOI 10.1097/00006324-200308000-00010; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Wesemann W, 2000, J CATARACT REFR SURG, V26, P62, DOI 10.1016/S0886-3350(99)00325-9; Wu C, 2006, AM J OPHTHALMOL, V141, P175, DOI 10.1016/j.ajo.2005.07.060	38	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126052	10.1371/journal.pone.0126052	http://dx.doi.org/10.1371/journal.pone.0126052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030210	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900018
J	Ma, XJ; Zhao, HX; Wang, BH				Ma, Xiujuan; Zhao, Haixing; Wang, Binghong			Controllability of Deterministic Networks with the Identical Degree Sequence	PLOS ONE			English	Article								Controlling complex network is an essential problem in network science and engineering. Recent advances indicate that the controllability of complex network is dependent on the network's topology. Liu and Barabasi, et al speculated that the degree distribution was one of the most important factors affecting controllability for arbitrary complex directed network with random link weights. In this paper, we analysed the effect of degree distribution to the controllability for the deterministic networks with unweighted and undirected. We introduce a class of deterministic networks with identical degree sequence, called (x,y)-flower. We analysed controllability of the two deterministic networks ((1, 3)-flower and (2, 2)-flower) by exact controllability theory in detail and give accurate results of the minimum number of driver nodes for the two networks. In simulation, we compare the controllability of (x,y)-flower networks. Our results show that the family of (x,y)-flower networks have the same degree sequence, but their controllability is totally different. So the degree distribution itself is not sufficient to characterize the controllability of deterministic networks with unweighted and undirected.	[Ma, Xiujuan] Shaanxi Normal Univ, Sch Comp Sci, Xian 710062, Shaanxi, Peoples R China; [Ma, Xiujuan; Zhao, Haixing] Qinghai Normal Univ, Sch Comp Sci, Xining 810008, Qinghai, Peoples R China; [Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Anhui, Peoples R China	Shaanxi Normal University; Qinghai Normal University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhao, HX (corresponding author), Qinghai Normal Univ, Sch Comp Sci, Xining 810008, Qinghai, Peoples R China.	h.x.zhao@163.com			National Natural Science Foundation of China [61164005, 11275186, 91024026]; Key Laboratory of Tibetan intelligent information processing and machine translation of Qinghai [2013-Z-Y17]; Open Funding Programme of Joint Laboratory of Flight Vehicle Ocean-based Measurement and Control [FOM2014OF001]; Research Fund for the Chunhui Program of Ministry of Education of China [Z2012101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Tibetan intelligent information processing and machine translation of Qinghai; Open Funding Programme of Joint Laboratory of Flight Vehicle Ocean-based Measurement and Control; Research Fund for the Chunhui Program of Ministry of Education of China	This work was supported to National Natural Science Foundation of China (grant nos: 61164005, 11275186, 91024026, http://www.nsfc.gov.cn/Portal0/default152.htm) received by HX Zhao. The funders had a role in study design, decision to publish, and preparation of the manuscript. This work was also supported by Key Laboratory of Tibetan intelligent information processing and machine translation of Qinghai P.R.C (grant no. 2013-Z-Y17), received by HX Zhao. The funders had a role in data collection, analysis and preparation of the manuscript. This work was also supported by The Open Funding Programme of Joint Laboratory of Flight Vehicle Ocean-based Measurement and Control (grant no. FOM2014OF001), received by BH Wang. The funders had a role in study design and preparation of the manuscript. This work was also supported by Research Fund for the Chunhui Program of Ministry of Education of China (grant no. Z2012101), received by XJ Ma. The funders had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	[Anonymous], ARXIV140300412014; [Anonymous], INFORM SCI; Antsaklis P. J., 2006, LINEAR SYSTEMS; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen ZQ, 2014, ENTROPY-SWITZ, V16, P5416, DOI 10.3390/e16105416; Chen ZQ, 2014, APPL MATH COMPUT, V242, P462, DOI 10.1016/j.amc.2014.05.105; Chui C. K., 1989, LINEAR SYSTEMS OPTIM; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094985; Dehmer M, 2014, INFORM SCIENCES, V260, P200, DOI 10.1016/j.ins.2013.11.008; Egerstedt M, 2012, IEEE CONTR SYST MAG, V32, P66, DOI 10.1109/MCS.2012.2195411; HAUTUS MLJ, 1969, P K NED AKAD A MATH, V72, P443; Jia T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02354; Jia T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3002; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kelly FP, 1998, J OPER RES SOC, V49, P237, DOI 10.2307/3010473; Li JW, 2014, EPL-EUROPHYS LETT, V105, DOI 10.1209/0295-5075/105/58001; Li RH, 2014, INFORM SCIENCES, V278, P685, DOI 10.1016/j.ins.2014.03.085; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Lin Y, 2011, J MATH PHYS, V52, DOI 10.1063/1.3659687; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nie S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089066; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; Rahman A, 2009, SIAM J CONTROL OPTIM, V48, P162, DOI 10.1137/060674909; Rozenfeld HD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061102; Rugh W, 1996, LINEAR SYSTEM THEORY, V2; Slotine J. -J. E., 1991, APPL NONLINEAR CONTR, V60; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Sontag E. D., 1998, TEXTS APPL MATH, V6; Srikant R., 2004, MATH INTERNET CONGES; Wang WX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026115; Wang XF, 2002, PHYSICA A, V310, P521, DOI 10.1016/S0378-4371(02)00772-0; Yu WW, 2009, AUTOMATICA, V45, P429, DOI 10.1016/j.automatica.2008.07.016; Yuan ZZ, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103036; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; Zhang ZZ, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/10007; Zhang ZZ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031110	42	3	3	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127545	10.1371/journal.pone.0127545	http://dx.doi.org/10.1371/journal.pone.0127545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020920	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300044
J	Riviello, ED; Letchford, S; Cook, EF; Waxman, AB; Gaziano, T				Riviello, Elisabeth D.; Letchford, Stephen; Cook, Earl Francis; Waxman, Aaron B.; Gaziano, Thomas			Improving Decision Making for Massive Transfusions in a Resource Poor Setting: A Preliminary Study in Kenya	PLOS ONE			English	Article							BLOOD-TRANSFUSION; TRAUMA PATIENTS; MORTALITY; PREDICTORS; SOCIETY	Background The reality of finite resources has a real-world impact on a patient's ability to receive life-saving care in resource-poor settings. Blood for transfusion is an example of a scarce resource. Very few studies have looked at predictors of survival in patients requiring massive transfusion. We used data from a rural hospital in Kenya to develop a prediction model of survival among patients receiving massive transfusion. Methods Patients who received five or more units of whole blood within 48 hours between 2004 and 2010 were identified from a blood registry in a rural hospital in Kenya. Presenting characteristics and in-hospital survival were collected from charts. Using stepwise selection, a logistic model was developed to predict who would survive with massive transfusion versus those who would die despite transfusion. An ROC curve was created from this model to quantify its predictive power. Results Ninety-five patients with data available met inclusion criteria, and 74% survived to discharge. The number of units transfused was not a predictor of mortality, and no threshold for futility could be identified. Preliminary results suggest that initial blood pressure, lack of comorbidities, and indication for transfusion are the most important predictors of survival. The ROC curve derived from our model demonstrates an area under the curve (AUC) equal to 0.757, with optimism of 0.023 based on a bootstrap validation. Conclusions This study provides a framework for making prioritization decisions for the use of whole blood in the setting of massive bleeding. Our analysis demonstrated an overall survival rate for patients receiving massive transfusion that was higher than clinical perception. Our analysis also produced a preliminary model to predict survival in patients with massive bleeding. Prediction analyses can contribute to more efficient prioritization decisions; these decisions must also include other considerations such as equity, acceptability, affordability and sustainability.	[Riviello, Elisabeth D.; Waxman, Aaron B.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Letchford, Stephen] Africa Inland Church Kijabe Hosp, Kijabe, Kenya; [Cook, Earl Francis; Gaziano, Thomas] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gaziano, Thomas] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Riviello, ED (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	beth_riviello@post.harvard.edu	Waxman, Aaron/L-7450-2019; Waxman, Aaron/I-8659-2019	Waxman, Aaron/0000-0001-7797-0361; Riviello, Elisabeth/0000-0002-9443-3928				Bates I, 2007, TRANSFUSION MED, V17, P434, DOI 10.1111/j.1365-3148.2007.00798.x; Campos A, 2007, MED CLIN-BARCELONA, V129, P366, DOI 10.1157/13110210; CHOJKIER M, 1986, J CLIN GASTROENTEROL, V8, P16, DOI 10.1097/00004836-198602000-00005; Como JJ, 2004, TRANSFUSION, V44, P809, DOI 10.1111/j.1537-2995.2004.03409.x; Criddle LM, 2005, J EMERG NURS, V31, P236, DOI 10.1016/j.jen.2005.03.004; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Huber-Wagner S, 2007, VOX SANG, V92, P69, DOI 10.1111/j.1423-0410.2006.00858.x; Mahambrey TD, 2009, CAN J ANAESTH, V56, P740, DOI 10.1007/s12630-009-9151-5; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; Mitra B, 2007, INJURY, V38, P1023, DOI 10.1016/j.injury.2007.03.021; Ngugi P M, 2007, East Afr Med J, V84, pS12; Rylance J, 2009, T ROY SOC TROP MED H, V103, P790, DOI 10.1016/j.trstmh.2009.05.004; Schreiber MA, 2007, J AM COLL SURGEONS, V205, P541, DOI 10.1016/j.jamcollsurg.2007.05.007; Turan A, 2013, CAN J ANESTH, V60, P761, DOI 10.1007/s12630-013-9937-3; Vaslef SN, 2002, J TRAUMA, V53, P291, DOI 10.1097/00005373-200208000-00017; Vaslef SN, 2002, J TRAUMA, V53, P5; Velmahos GC, 1998, ARCH SURG-CHICAGO, V133, P947, DOI 10.1001/archsurg.133.9.947; WUDEL JH, 1991, J TRAUMA, V31, P1, DOI 10.1097/00005373-199101000-00001; Zarocostas J, 2004, LANCET, V363, P2060, DOI 10.1016/S0140-6736(04)16493-3	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127987	10.1371/journal.pone.0127987	http://dx.doi.org/10.1371/journal.pone.0127987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020935	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300068
J	Spezzaferri, S; Kucera, M; Pearson, PN; Wade, BS; Rappo, S; Poole, CR; Morard, R; Stalder, C				Spezzaferri, Silvia; Kucera, Michal; Pearson, Paul Nicholas; Wade, Bridget Susan; Rappo, Sacha; Poole, Christopher Robert; Morard, Raphael; Stalder, Claudio			Fossil and Genetic Evidence for the Polyphyletic Nature of the Planktonic Foraminifera "Globigerinoides", and Description of the New Genus Trilobatus	PLOS ONE			English	Article							SACCULIFER BRADY; MOLECULAR EVOLUTION; PERFORMANCE	Planktonic foraminifera are one of the most abundant and diverse protists in the oceans. Their utility as paleo proxies requires rigorous taxonomy and comparison with living and genetically related counterparts. We merge genetic and fossil evidence of "Globigerinoides", characterized by supplementary apertures on spiral side, in a new approach to trace their "total evidence phylogeny" since their first appearance in the latest Paleogene. Combined fossil and molecular genetic data indicate that this genus, as traditionally understood, is polyphyletic. Both datasets indicate the existence of two distinct lineages that evolved independently. One group includes "Globigerinoides" trilobus and its descendants, the extant "Globigerinoides" sacculifer, Orbulina universa and Sphaeroidinella dehiscens. The second group includes the Globigerinoides ruber clade with the extant G. conglobatus and G. elongatus and ancestors. In molecular phylogenies, the trilobus group is not the sister taxon of the ruber group. The ruber group clusters consistently together with the modern Globoturborotalita rubescens as a sister taxon. The re-analysis of the fossil record indicates that the first "Globigerinoides" in the late Oligocene are ancestral to the trilobus group, whereas the ruber group first appeared at the base of the Miocene with representatives distinct from the trilobus group. Therefore, polyphyly of the genus "Globigerinoides" as currently defined can only be avoided either by broadening the genus concept to include G. rubescens and a large number of fossil species without supplementary apertures, or if the trilobus group is assigned to a separate genus. Since the former is not feasible due to the lack of a clear diagnosis for such a broad genus, we erect a new genus Trilobatus for the trilobus group (type species Globigerina triloba Reuss) and amend Globoturborotalita and Globigerinoides to clarify morphology and wall textures of these genera. In the new concept, Trilobatus n. gen. is paraphyletic and gave rise to the Praeorbulina / Orbulina and Sphaeroidinellopsis / Sphaeroidinella lineages.	[Spezzaferri, Silvia; Rappo, Sacha; Stalder, Claudio] Univ Fribourg, Dept Geosci, CH-1700 Fribourg, Switzerland; [Kucera, Michal; Morard, Raphael] Univ Bremen, Ctr Marine Environm Sci MARUM, D-28359 Bremen, Germany; [Pearson, Paul Nicholas] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AX, S Glam, Wales; [Wade, Bridget Susan; Poole, Christopher Robert] UCL, Dept Earth Sci, London, England	University of Fribourg; University of Bremen; Cardiff University; University of London; University College London	Spezzaferri, S (corresponding author), Univ Fribourg, Dept Geosci, CH-1700 Fribourg, Switzerland.	silvia.spezzaferri@unifr.ch	Kucera, Michal/AAE-8115-2020; Pearson, Paul N/B-2276-2009; Kucera, Michal/ABH-6065-2020; Wade, Bridget S/F-4987-2014; Kucera, Michal/B-9277-2009	Kucera, Michal/0000-0002-7817-9018; Pearson, Paul N/0000-0003-4628-9818; Wade, Bridget S/0000-0002-7245-8614; Kucera, Michal/0000-0002-7817-9018; Poole, Christopher R./0000-0003-1401-3307	Swiss National Science Foundation [200020_153125]; Natural Environment Research Council [NE/G014817/2] Funding Source: researchfish; NERC [NE/G014817/2] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors were funded by Swiss National Science Foundation grant 200020_153125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre A, 2013, PALEOBIOLOGY, V39, P21, DOI 10.1666/0094-8373-39.1.21; Aurahs R, 2009, BIOINFORM BIOL INSIG, V3, P155; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; BE AWH, 1977, ECOLOGICAL ZOOGEOGRA, P1; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; BIJMA J, 1994, DEEP-SEA RES PT I, V41, P485, DOI 10.1016/0967-0637(94)90092-2; Blow W. H., 1969, P199; Blow W.H., 1962, FUNDAMENTALS MIDTERT, P61; BLOW WH, 1979, CAINOZOIC FORAMINIFE; Bolli H. M., 1957, Bulletin United States National Museum, VNo. 215, P97; Bolli H.M., 1985, P155; BOLLL HANS M., 1966, ECOLOGAE GEOL HELV, V59, P449; Boltovskoy E., 1976, RECENT FORAMINIFERA; Brady HB, 1887, GEOL MAG, V4, P534; BRUMMER GJA, 1987, MAR MICROPALEONTOL, V12, P357, DOI 10.1016/0377-8398(87)90028-4; Calbet A, 2008, ICES J MAR SCI, V65, P325, DOI 10.1093/icesjms/fsn013; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Coxall HK, 2007, PALEOBIOLOGY, V33, P495, DOI 10.1666/06034.1; CUSHMAN JOSEPH A., 1927, CONTR CUSHMAN LAB FORAMINIFERAL RES, V2, P77; d'Orbigny A, 1846, FORAMINIFERES FOSSIL; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 1997, MAR MICROPALEONTOL, V30, P251, DOI 10.1016/S0377-8398(96)00057-6; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; deVargas C, 1997, J MOL EVOL, V45, P285, DOI 10.1007/PL00006232; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemleben C., 1991, Geologisches Jahrbuch Reihe A, V128, P117; HEMLEBEN C, 1987, MAR MICROPALEONTOL, V12, P305, DOI 10.1016/0377-8398(87)90025-9; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Hemleben Christoph, 2006, Cushman Foundation for Foraminiferal Research Special Publication, V41, P47; Jenkins D.G., 1985, P263; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KELLER G, 1981, MAR MICROPALEONTOL, V6, P269; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kucera M, 2013, SO2263 MARUM U BREM; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Kurasawa A, GENETIC VARIAB UNPUB; Kuroyanagi A, 2008, MAR MICROPALEONTOL, V68, P236, DOI 10.1016/j.marmicro.2008.04.004; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Loeblich Jr A.R., 1994, CUSHMAN FDN FORAMINI, V31; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Neil H, 2005, WATER ATMOSPHERE, V13, P18; Olsson Richard K., 2006, Cushman Foundation for Foraminiferal Research Special Publication, V41, P111; Papp A, 1985, FOSSILIEN FORAMINIFE; Parize O, 2008, CR GEOSCI, V340, P390, DOI 10.1016/j.crte.2008.03.004; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Pearson P.N., 2006, CUSHMAN FDN SPECIAL, V41; Pearson PN, 2014, PALEOBIOLOGY, V40, P130, DOI 10.1666/13004; Roegl Fred, 2012, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V114A, P179; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Sen Gupta B.K., 1999, MODERN FORAMINIFERA, DOI [10.1007/0-306-48104-9, DOI 10.1007/0-306-48104-9]; SHAFIK S, 1978, BMR (Bureau of Mineral Resources) Journal of Australian Geology and Geophysics, V3, P135; SPEZZAFERRI S, 1991, PALAEOGEOGR PALAEOCL, V83, P217, DOI 10.1016/0031-0182(91)90080-B; SPEZZAFERRI S, 1995, PALAEOGEOGR PALAEOCL, V114, P43, DOI 10.1016/0031-0182(95)00076-X; Spezzaferri Silvia, 1994, Palaeontographia Italica, V81, P1; Spezzaferri Silvia, 1996, Giornale di Geologia (Bologna), V58, P119; STEINECK PL, 1978, J PALEONTOL, V52, P618; Steininger FF, 1997, EPISODES, V20, P23; Turco E, 2011, STRATIGRAPHY, V8, P163; Ujiie Y, 2009, J FORAMIN RES, V39, P145, DOI 10.2113/gsjfr.39.3.145; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Weiner AKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092148	63	87	93	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128108	10.1371/journal.pone.0128108	http://dx.doi.org/10.1371/journal.pone.0128108			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020968	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000355187300081
J	Koenig, J; Werdehausen, R; Linley, JE; Habib, AM; Vernon, J; Lolignier, S; Eijkelkamp, N; Zhao, J; Okorokov, AL; Woods, CG; Wood, JN; Cox, JJ				Koenig, Jennifer; Werdehausen, Robert; Linley, John E.; Habib, Abdella M.; Vernon, Jeffrey; Lolignier, Stephane; Eijkelkamp, Niels; Zhao, Jing; Okorokov, Andrei L.; Woods, C. Geoffrey; Wood, John N.; Cox, James J.			Regulation of Na(v)1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia	PLOS ONE			English	Article							PRIMARY ERYTHERMALGIA; INFLAMMATORY PAIN; NONCODING RNA; MUTATIONS; NEURONS; CHANNELOPATHY; MECHANISMS; CELLS; PCR	The Na(v)1.7 voltage-gated sodium channel, encoded by SCN9A, is critical for human pain perception yet the transcriptional and post-transcriptional mechanisms that regulate this gene are still incompletely understood. Here, we describe a novel natural antisense transcript (NAT) for SCN9A that is conserved in humans and mice. The NAT has a similar tissue expression pattern to the sense gene and is alternatively spliced within dorsal root ganglia. The human and mouse NATs exist in cis with the sense gene in a tail-to-tail orientation and both share sequences that are complementary to the terminal exon of SCN9A/Scn9a. Overexpression analyses of the human NAT in human embryonic kidney (HEK293A) and human neuroblastoma (SH-SY5Y) cell lines show that it can function to downregulate Na(v)1.7 mRNA, protein levels and currents. The NAT may play an important role in regulating human pain thresholds and is a potential candidate gene for individuals with chronic pain disorders that map to the SCN9A locus, such as Inherited Primary Erythromelalgia, Paroxysmal Extreme Pain Disorder and Painful Small Fibre Neuropathy, but who do not contain mutations in the sense gene. Our results strongly suggest the SCN9A NAT as a prime candidate for new therapies based upon augmentation of existing antisense RNAs in the treatment of chronic pain conditions in man.	[Koenig, Jennifer; Werdehausen, Robert; Linley, John E.; Habib, Abdella M.; Vernon, Jeffrey; Lolignier, Stephane; Eijkelkamp, Niels; Zhao, Jing; Wood, John N.; Cox, James J.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England; [Werdehausen, Robert] Univ Dusseldorf, Fac Med, Dept Anesthesiol, Dusseldorf, Germany; [Eijkelkamp, Niels] UMC Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Okorokov, Andrei L.] UCL, Wolfson Inst Biomed Res, London, England; [Woods, C. Geoffrey] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Wood, John N.] Seoul Natl Univ, Coll Med, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	University of London; University College London; Heinrich Heine University Dusseldorf; Utrecht University; Utrecht University Medical Center; University of London; University College London; University of Cambridge; Seoul National University (SNU)	Cox, JJ (corresponding author), UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, Gower St, London, England.	j.j.cox@ucl.ac.uk	Cox, James/R-1910-2016; Lolignier, Stéphane/K-1281-2015	Lolignier, Stéphane/0000-0001-5407-4986; Habib, Abdella Mohammed/0000-0001-7453-3932; Linley, John/0000-0001-6450-8805; Zhao, Jing/0000-0003-2587-1198; Okorokov, Andrei/0000-0003-2477-3254; Eijkelkamp, Niels/0000-0003-0039-7063	German Research Foundation (DFG) [We 4860/1-1]; Medical Research Council; Arthritis Research UK; Rubicon Fellowship of the Netherlands Organisation for Scientific Research; Cambridge NIHR BRC; Wellcome Trust; BK21 programme; MRC Research Career Development fellow [G1100340]; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G1100340, G0901905] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905, MR/J012742/1, G1100340] Funding Source: UKRI	German Research Foundation (DFG)(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Rubicon Fellowship of the Netherlands Organisation for Scientific Research; Cambridge NIHR BRC(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); BK21 programme(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); MRC Research Career Development fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JK is a UCL Grand Challenge PhD student; RW is supported by the German Research Foundation (DFG We 4860/1-1); JEL, AMH, JZ, JNW and JJC are supported by the Medical Research Council (http://www.mrc.ac.uk/); JV and SL are supported by Arthritis Research UK (http://www.arthritisresearchuk.org/); NE is supported by a Rubicon Fellowship of the Netherlands Organisation for Scientific Research; CGW receives funding from the Cambridge NIHR BRC; JNW is supported by the Wellcome Trust (http://www.wellcome.ac.uk/index.htm) and the BK21 programme; JJC is a MRC Research Career Development fellow (G1100340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Drenth JPH, 2008, ARCH DERMATOL, V144, P320, DOI 10.1001/archderm.144.3.320; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; Klein CJ, 2013, J NEUROL NEUROSUR PS, V84, P386, DOI 10.1136/jnnp-2012-303719; Komine Y, 2006, MOL CELL NEUROSCI, V31, P273, DOI 10.1016/j.mcn.2005.09.017; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Minett MS, 2011, BEHAV MEASURES PAIN; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vetter I, 2012, BIOCHEM PHARMACOL, V83, P1562, DOI 10.1016/j.bcp.2012.02.022; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Werner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-19; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Zhao XL, 2013, NAT NEUROSCI, V16, P1024, DOI 10.1038/nn.3438	27	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128830	10.1371/journal.pone.0128830	http://dx.doi.org/10.1371/journal.pone.0128830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035178	Green Published, gold			2022-12-27	WOS:000355699100052
J	Santos, CL; Nebenzahl-Guimaraes, H; Mendes, MV; van Soolingen, D; Correia-Neves, M				Santos, Catarina Lopes; Nebenzahl-Guimaraes, Hanna; Mendes, Marta Vaz; van Soolingen, Dick; Correia-Neves, Margarida			To Be or Not to Be a Pseudogene: A Molecular Epidemiological Approach to the mclx Genes and Its Impact in Tuberculosis	PLOS ONE			English	Article							CYCLIC-AMP; MYCOBACTERIUM; GENOME; CYCLASES; LINEAGE; FAMILY	Tuberculosis presents a myriad of symptoms, progression routes and propagation patterns not yet fully understood. Whereas for a long time research has focused solely on the patient immunity and overall susceptibility, it is nowadays widely accepted that the genetic diversity of its causative agent, Mycobacterium tuberculosis, plays a key role in this dynamic. This study focuses on a particular family of genes, the mclxs (Mycobacterium cyclase/LuxR-like genes), which codify for a particular and nearly mycobacterial-exclusive combination of protein domains. mclxs genes were found to be pseudogenized by frameshift-causing insertion (s)/deletion(s) in a considerable number of M. tuberculosis complex strains and clinical isolates. To discern the functional implications of the pseudogenization, we have analysed the pattern of frameshift-causing mutations in a group of M. tuberculosis isolates while taking into account their microbial-, patient- and disease-related traits. Our logistic regression-based analyses have revealed disparate effects associated with the transcriptional inactivation of two mclx genes. In fact, mclx2 (Rv1358) pseudogenization appears to be primarily driven by the microbial phylogenetic background, being mainly related to the Euro-American (EAm) lineage; on the other hand, mclx3 (Rv2488c) presents a higher tendency for pseudogenization among isolates from patients born on the Western Pacific area, and from isolates causing extra-pulmonary infections. These results contribute to the overall knowledge on the biology of M. tuberculosis infection, whereas at the same time launch the necessary basis for the functional assessment of these so far overlooked genes.	[Santos, Catarina Lopes; Nebenzahl-Guimaraes, Hanna; Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Santos, Catarina Lopes; Nebenzahl-Guimaraes, Hanna; Correia-Neves, Margarida] ICVS 3Bs, PT Govt Associate Lab, Braga Guimaraes, Portugal; [Nebenzahl-Guimaraes, Hanna; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Mendes, Marta Vaz] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Porto, Portugal; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Universidade do Minho; Netherlands National Institute for Public Health & the Environment; Universidade do Porto; Radboud University Nijmegen	Santos, CL (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	catarinasantos@ecsaude.uminho.pt	Correia-Neves, Margarida/AAH-4636-2020; Correia-Neves, Margarida/C-9122-2009; Mendes, Marta Vaz/A-8541-2008	Correia-Neves, Margarida/0000-0002-2202-5431; Correia-Neves, Margarida/0000-0002-2202-5431; Mendes, Marta Vaz/0000-0002-6105-522X	Fundacao para a Ciencia e Tecnologia (FCT), Portugal; Programa Operacional Regional do Norte (ON.2-O Novo Norte); Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); Projeto Estrategico [LA 26, PEst-C/SAU/LA0026/2013]; personal FCT Grant [SFRH/BD/33902/2209]; Fundação para a Ciência e a Tecnologia [PEst-C/SAU/LA0026/2013] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Programa Operacional Regional do Norte (ON.2-O Novo Norte); Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER); Projeto Estrategico; personal FCT Grant; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal, and cofunded by Programa Operacional Regional do Norte (ON.2-O Novo Norte), Quadro de Referencia Estrategico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER), and from Projeto Estrategico - LA 26 - 2013-2014 (PEst-C/SAU/LA0026/2013). H.N.-G. received a personal FCT Grant (SFRH/BD/33902/2209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; [Anonymous], GLOB TUB REP 2014; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Castro LI, 2005, FEBS J, V272, P3085, DOI 10.1111/j.1742-4658.2005.04722.x; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; Drummond A., 2011, GENEIOUS V5 5; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Kim SP, 2012, CURR MICROBIOL, V65, P701, DOI 10.1007/s00284-012-0218-0; Kong Y, 2005, J CLIN MICROBIOL, V43, P6048, DOI 10.1128/JCM.43.12.6048-6053.2005; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lyell NL, 2013, J BACTERIOL, V195, P5051, DOI 10.1128/JB.00751-13; Nakamura K, 2009, MICROB PATHOGENESIS, V47, P183, DOI 10.1016/j.micpath.2009.06.006; Nebenzahl-Guimaraes H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097816; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Santos CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046758; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Singh P, 2011, FUTURE MICROBIOL, V6, P57, DOI 10.2217/FMB.10.153; Suzuki K, 2006, FEMS MICROBIOL LETT, V259, P208, DOI 10.1111/j.1574-6968.2006.00276.x; Williams DL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-397; Yang ZH, 2005, AM J RESP CRIT CARE, V171, P1436, DOI 10.1164/rccm.200408-1147OC; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128983	10.1371/journal.pone.0128983	http://dx.doi.org/10.1371/journal.pone.0128983			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035295	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100061
J	Seven, E; Husemoen, LLN; Sehested, TSG; Ibsen, H; Wachtell, K; Linneberg, A; Jeppesen, JL				Seven, Ekim; Husemoen, Lise L. N.; Sehested, Thomas S. G.; Ibsen, Hans; Wachtell, Kristian; Linneberg, Allan; Jeppesen, Jorgen L.			Adipocytokines, C-Reactive Protein, and Cardiovascular Disease: A Population-Based Prospective Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ADIPOSE-TISSUE; PLASMA LEPTIN; ADIPONECTIN; RISK; KIDNEY; OBESITY; ASSOCIATION; MECHANISMS	Background Being overweight or obese is associated with a greater risk of coronary heart disease and stroke compared with normal weight. The role of the specific adipose tissue-derived substances, called adipocytokines, in overweight- and obesity-related cardiovascular disease (CVD) is still unclear. Objective To investigate the associations of three adipose tissue-derived substances: adiponectin, leptin, and interleukin-6 with incident CVD in a longitudinal population-based study, including extensive adjustments for traditional and metabolic risk factors closely associated with overweight and obesity. C-reactive protein (CRP) was used as a proxy for interleukin-6. Methods Prospective population-based study of 6.502 participants, 51.9% women, aged 30-60 years, free of CVD at baseline, with a mean follow-up time of 11.4 years, equivalent to 74,123 person-years of follow-up. As outcome, we defined a composite outcome comprising of the first event of fatal and nonfatal coronary heart disease and fatal and nonfatal stroke. Results During the follow-up period, 453 composite CV outcomes occurred among participants with complete datasets. In models, including gender, age, smoking status, systolic blood pressure, treatment for hypertension, diabetes, body mass index (BMI), total cholesterol, high-density-lipoprotein cholesterol, homeostasis model assessment of insulin resistance, estimated glomerular filtration rate, adiponectin, leptin, and CRP, neither adiponectin (hazard ratio [HR] with 95% confidence interval [CI]: 0.97 [0.87-1.08] per SD increase, P = 0.60) nor leptin (0.97 [0.85-1.12] per SD increase, P = 0.70) predicted the composite outcome, whereas CRP was significantly associated with the composite outcome (1.19 [1.07-1.35] per SD increase, P = 0.002). Furthermore, in mediation analysis, adjusted for age and sex, CRP decreased the BMI-associated CV risk by 43% (95% CI 29-72). Conclusions In this study, neither adiponectin nor leptin were independently associated with CVD, raising questions over their role in CVD. The finding that CRP was significantly associated with an increased risk of CVD and decreased the BMI-associated CVD risk substantially, could imply that interleukin-6-related pathways may play a role in mediating overweight- and obesity-related CVD.	[Seven, Ekim; Wachtell, Kristian; Jeppesen, Jorgen L.] Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark; [Seven, Ekim; Husemoen, Lise L. N.; Linneberg, Allan] Res Ctr Prevent & Hlth, Glostrup, Denmark; [Sehested, Thomas S. G.] Univ Copenhagen, Gentofte Hosp, Dept Cardiol P, Gentofte, Denmark; [Ibsen, Hans] Univ Copenhagen, Holbaek Hosp, Dept Internal Med, Holbaek, Denmark; [Ibsen, Hans; Wachtell, Kristian; Linneberg, Allan; Jeppesen, Jorgen L.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Linneberg, Allan] Glostrup Cty Hosp, Dept Clin Expt Res, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Holbaek Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen	Seven, E (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Internal Med, Glostrup, Denmark.	ekim.seven@regionh.dk		Sehested, Thomas/0000-0003-0564-0237; Linneberg, Allan/0000-0002-0994-0184	Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk Foundation; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Interreg IVa program, European Union Region Development fund	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Interreg IVa program, European Union Region Development fund	The Inter99 study was supported by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, The Novo Nordisk Foundation, The Danish Heart Foundation, The Danish Pharmaceutical Association, The Augustinus Foundation and The Ib Henriksen Foundation. ES and KW have been supported by Interreg IVa program, The European Union Region Development fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2013, EUR J PREV CARDIOL, V20, P1088, DOI 10.1177/2047487312462825; Andersen TF, 1999, DAN MED BULL, V46, P263; Arregui M, 2014, STROKE, V45, P10, DOI 10.1161/STROKEAHA.113.001851; Bidulescu A, 2013, FRONT PUBLIC HEALTH, V24, P1, DOI [10.3389/fpubh.2013.00016, DOI 10.3389/FPUBH.2013.00016]; Boekholdt SM, 2012, LANCET, V379, P1176, DOI 10.1016/S0140-6736(12)60361-4; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Chai SB, 2014, ATHEROSCLEROSIS, V233, P3, DOI 10.1016/j.atherosclerosis.2013.11.069; Chudek J, 2003, TRANSPL P, V35, P2186, DOI 10.1016/j.transproceed.2003.08.001; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Golia E, 2014, WORLD J CARDIOL, V6, P539, DOI 10.4330/wjc.v6.i7.539; Iwashima Y, 2006, AM J CARDIOL, V98, P1603, DOI 10.1016/j.amjcard.2006.07.039; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Kanhai DA, 2013, OBES REV, V14, P555, DOI 10.1111/obr.12027; Kennedy A, 1997, J CLIN ENDOCR METAB, V82, P1293, DOI 10.1210/jc.82.4.1293; Kizer JR, 2008, J CLIN ENDOCR METAB, V93, P3357, DOI 10.1210/jc.2008-0640; Kokot F, 1998, NEPHROL DIAL TRANSPL, V13, P2276, DOI 10.1093/ndt/13.9.2276; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Lee ES, 2013, INT J EPIDEMIOL, V42, P1029, DOI 10.1093/ije/dyt087; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Matsubara M, 2002, J CLIN ENDOCR METAB, V87, P2764, DOI 10.1210/jc.87.6.2764; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Sattar N, 2009, J AM COLL CARDIOL, V53, P167, DOI 10.1016/j.jacc.2008.09.035; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Seven E, 2014, J HYPERTENS, V32, P1488, DOI 10.1097/HJH.0000000000000207; Sharma K, 1997, KIDNEY INT, V51, P1980, DOI 10.1038/ki.1997.269; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Toft UN, 2007, EUR J PUBLIC HEALTH, V17, P455, DOI 10.1093/eurpub/ckl262; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Withers SB, 2014, ARTERIOSCL THROM VAS, V34, P1637, DOI 10.1161/ATVBAHA.114.303031; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	41	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128987	10.1371/journal.pone.0128987	http://dx.doi.org/10.1371/journal.pone.0128987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035431	gold, Green Submitted, Green Published			2022-12-27	WOS:000355699100062
J	Chen, M; Zhang, MS; Zhang, XP; Li, J; Wang, Y; Fan, YY; Shi, RZ				Chen, Min; Zhang, Mingsheng; Zhang, Xuanping; Li, Jie; Wang, Yan; Fan, Yanying; Shi, Ruizan			Limb Ischemic Preconditioning Protects Endothelium from Oxidative Stress by Enhancing Nrf2 Translocation and Upregulating Expression of Antioxidases	PLOS ONE			English	Article							REMOTE; CARDIOPROTECTION; MECHANISMS; CELLS; ACTIVATION; PATHWAY; DYSFUNCTION; DAMAGE; HEART; SERUM	Remote ischemic preconditioning is often performed by limb ischemic preconditioning (LIPC), which has been demonstrated to be beneficial to various cells, including endothelial cells. The mechanisms underlying the protection have not been well clarified. The present study was designed to observe the effects of sera derived from rats after LIPC on human umbilical vein endothelial cells (HUVECs) injured by hydrogen peroxide (H2O2) -induced oxidative stress and explore the involvement of redox state in the protection. Incubation with 1 mM H2O2 for 2 h induced a significant reduction in HUVECs' viability with increased production of malondialdehyde (MDA) and reactive oxygen species (ROS). Preincubation with early preconditioning serum (EPS) or delayed preconditioning serum (DPS) derived from rats subjected to LIPC alleviated these changes. Both EPS and DPS increased the nuclear translocation of transcription factor nuclear factor E2-related factor 2 (Nrf2) and the expression of antioxidases. The protective effects of EPS and DPS were blocked neither by MEK/ERK inhibitors U0126 nor by PI3K/Akt inhibitors LY294002. In conclusion, the present study provides the evidence that LIPC protects the HUVECs from H2O2-induced injury by, at least partially, enhancement of Nrf2 translocation and upregulation of antioxidases via signaling pathways independent of MEK/ERK and PI3K/Akt.	[Chen, Min; Zhang, Mingsheng; Zhang, Xuanping; Li, Jie; Wang, Yan; Fan, Yanying; Shi, Ruizan] Shanxi Med Univ, Dept Pharmacol, Taiyuan 030001, Shanxi, Peoples R China	Shanxi Medical University	Zhang, MS (corresponding author), Shanxi Med Univ, Dept Pharmacol, Xinjiannanlu 56, Taiyuan 030001, Shanxi, Peoples R China.	zmspharmacol@sina.com			Key Discipline Construction Funds of Shanxi Province; Shanxi Province Nature Science Fund [2011011034-3]; Shanxi Medial University Research Fund for the Doctoral Program [03201310]	Key Discipline Construction Funds of Shanxi Province; Shanxi Province Nature Science Fund; Shanxi Medial University Research Fund for the Doctoral Program	This work was funded by the Key Discipline Construction Funds of Shanxi Province, Shanxi Province Nature Science Fund, No. 2011011034-3, and the Shanxi Medial University Research Fund for the Doctoral Program, No. 03201310.	Bailey TG, 2012, AM J PHYSIOL-HEART C, V303, pH533, DOI 10.1152/ajpheart.00272.2012; Bell RM, 2012, J MOL CELL CARDIOL, V53, P24, DOI 10.1016/j.yjmcc.2012.04.001; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chrissobolis S, 2011, FRONT BIOSCI-LANDMRK, V16, P1733, DOI 10.2741/3816; Contractor H, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0343-3; da Cunha NV, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00520.2013; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; He M, 2011, NUTR METAB CARDIOVAS, V21, P277, DOI 10.1016/j.numecd.2009.12.008; Jones H, 2014, AM J HYPERTENS, V27, P918, DOI 10.1093/ajh/hpu004; Joshi M, 2014, MOL CELL BIOCHEM, V386, P233, DOI 10.1007/s11010-013-1861-x; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Konior A, 2014, ANTIOXID REDOX SIGN, V20, P2794, DOI 10.1089/ars.2013.5607; Li J, 2011, CLIN SCI, V120, P451, DOI 10.1042/CS20100466; Luca MC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000075; Manchurov V, 2014, AM J MED, V127, P670, DOI 10.1016/j.amjmed.2014.02.012; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pecorelli A, 2013, TOXICOL APPL PHARM, V267, P30, DOI 10.1016/j.taap.2012.12.001; Randhawa PK, 2015, EUR J PHARMACOL, V746, P317, DOI 10.1016/j.ejphar.2014.08.016; Rassaf T, 2014, CIRC RES, V114, P1601, DOI 10.1161/CIRCRESAHA.114.303822; Saponara S, 2012, BIOCHEM PHARMACOL, V84, P1055, DOI 10.1016/j.bcp.2012.07.025; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Tong HY, 2000, CIRC RES, V87, P309, DOI 10.1161/01.RES.87.4.309; Ungvari Z, 2011, AM J PHYSIOL-HEART C, V300, pH1133, DOI 10.1152/ajpheart.00402.2010; Wang YY, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-251; Wang YH, 2014, BRIT J PHARMACOL, V171, P3171, DOI 10.1111/bph.12660; Weber NC, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0474-9; Weseler AR, 2010, CURR HYPERTENS REP, V12, P154, DOI 10.1007/s11906-010-0103-9; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zhou CH, 2014, J CARDIOVASC PHARM T, V19, P558, DOI 10.1177/1074248414524479; Zhou CH, 2014, J SURG RES, V191, P51, DOI 10.1016/j.jss.2014.03.054; Zitta K, 2012, MOL MED, V18, P29, DOI 10.2119/molmed.2011.00278	34	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128455	10.1371/journal.pone.0128455	http://dx.doi.org/10.1371/journal.pone.0128455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029932	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900152
J	Fazan, R; Silva, CAA; Oliveira, JAC; Salgado, HC; Montano, N; Garcia-Cairasco, N				Fazan, Rubens, Jr.; Silva, Carlos Alberto A.; Cortes Oliveira, Jose Antonio; Salgado, Helio Cesar; Montano, Nicola; Garcia-Cairasco, Norberto			Evaluation of Cardiovascular Risk Factors in the Wistar Audiogenic Rat (WAR) Strain	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SUDDEN UNEXPECTED DEATH; AUTONOMIC NERVOUS-SYSTEM; EPILEPSY; SEIZURES; STRESS; CATECHOLAMINES; CONTRACTILITY; ARRHYTHMIAS; MECHANISMS	Introduction Risk factors for life-threatening cardiovascular events were evaluated in an experimental model of epilepsy, the Wistar Audiogenic Rat (WAR) strain. Methods We used long-term ECG recordings in conscious, one year old, WAR and Wistar control counterparts to evaluate spontaneous arrhythmias and heart rate variability, a tool to assess autonomic cardiac control. Ventricular function was also evaluated using the pressure-volume conductance system in anesthetized rats. Results Basal RR interval (RRi) was similar between WAR and Wistar rats (188+/-5 vs 199+/-6 ms). RRi variability strongly suggests that WAR present an autonomic imbalance with sympathetic overactivity, which is an isolated risk factor for cardiovascular events. Anesthetized WAR showed lower arterial pressure (92+/-3 vs 115+/-5 mmHg) and exhibited indices of systolic dysfunction, such as higher ventricle end-diastolic pressure (9.2+/-0.6 vs 5.6+/-1 mmHg) and volume (137+/-9 vs 68+/-9 mu L) as well as lower rate of increase in ventricular pressure (5266+/-602 vs 7320+/-538 mmHg.s(-1)). Indices of diastolic cardiac function, such as lower rate of decrease in ventricular pressure (-5014+/-780 vs -7766+/-998 mmHg.s(-1)) and a higher slope of the linear relationship between end-diastolic pressure and volume (0.078+/-0.011 vs 0.036+/-0.011 mmHg.mu L), were also found in WAR as compared to Wistar control rats. Moreover, Wistar rats had 3 to 6 ventricular ectopic beats, whereas WAR showed 15 to 30 ectopic beats out of the 20,000 beats analyzed in each rat. Conclusions The autonomic imbalance observed previously at younger age is also present in aged WAR and, additionally, a cardiac dysfunction was also observed in the rats. These findings make this experimental model of epilepsy a valuable tool to study risk factors for cardiovascular events in epilepsy.	[Fazan, Rubens, Jr.; Silva, Carlos Alberto A.; Cortes Oliveira, Jose Antonio; Salgado, Helio Cesar; Garcia-Cairasco, Norberto] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Montano, Nicola] Univ Milan, Dept Clin Sci Luigi Sacco, Milan, Italy	Universidade de Sao Paulo; University of Milan; Luigi Sacco Hospital	Garcia-Cairasco, N (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil.	ngcairas@fmrp.usp.br	Cairasco, Norberto Garcia/E-3250-2015; Junior, Rubens Fazan/V-3114-2019; Fazan, Rubens/G-2980-2016	Cairasco, Norberto Garcia/0000-0001-8857-3775; Junior, Rubens Fazan/0000-0002-6200-6008; Montano, Nicola/0000-0001-9206-0075	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/50261-4]; FAPESP-Cinapce [2005/56447-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Programas de Excelencia (PROEX); Conselho Nacional de Pesquisas (CNPq); Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas (FAEPA/HC) da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FMRP-USP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP-Cinapce(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Programas de Excelencia (PROEX)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisas (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas (FAEPA/HC) da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FMRP-USP)	The authors here declare that the Funding Sources listed below have no participation in the decisions associated to the collection, analysis, interpretation and discussion of the current results. Funding Sources are: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Grant number: 2007/50261-4), FAPESP-Cinapce (Grant number 2005/56447-7); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Programas de Excelencia (PROEX), Conselho Nacional de Pesquisas (CNPq) and Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas (FAEPA/HC) da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FMRP-USP). RFJ, HCS and NGC hold CNPq Research Fellowships.	Adameova A, 2009, CAN J PHYSIOL PHARM, V87, P493, DOI [10.1139/Y09-042, 10.1139/y09-042]; Ansakorpi H, 2002, J NEUROL NEUROSUR PS, V72, P26, DOI 10.1136/jnnp.72.1.26; APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Arshad A, 2008, PROG CARDIOVASC DIS, V50, P420, DOI 10.1016/j.pcad.2007.12.003; Camm AJ, 1996, CIRCULATION, V93, P1043; CERUTTI C, 1991, AM J PHYSIOL, V261, pH1292, DOI 10.1152/ajpheart.1991.261.4.H1292; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; da Silva VJD, 2006, AUTON NEUROSCI-BASIC, V124, P49, DOI 10.1016/j.autneu.2005.11.004; DEVINSKY O, 1994, EPILEPSIA, V35, P199, DOI 10.1111/j.1528-1157.1994.tb02933.x; Devinsky O, 2011, NEW ENGL J MED, V365, P1801, DOI 10.1056/NEJMra1010481; Doretto MC, 2003, BEHAV GENET, V33, P33, DOI 10.1023/A:1021099432759; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; El-Sayed HL, 2007, ACTA NEUROL SCAND, V115, P377, DOI 10.1111/j.1600-0404.2006.00792.x; Faustmann P M, 1994, Int J Neurosci, V78, P43; Fazan R, 2011, EPILEPSY BEHAV, V22, P666, DOI 10.1016/j.yebeh.2011.09.010; Finsterer J, 2014, J NEUROL SCI, V345, P8, DOI 10.1016/j.jns.2014.07.003; FRYSINGER RC, 1993, NEUROLOGY, V43, P2136, DOI 10.1212/WNL.43.10.2136; Garcia-Cairasco N, 1998, PHYSIOL BEHAV, V64, P671, DOI 10.1016/S0031-9384(98)00129-2; GarciaCairasco N, 1996, EPILEPSY RES, V26, P177, DOI 10.1016/S0920-1211(96)00050-2; Goodman JH, 1999, EPILEPSY RES, V34, P169, DOI 10.1016/S0920-1211(98)00120-X; Harnod T, 2008, SEIZURE-EUR J EPILEP, V17, P297, DOI 10.1016/j.seizure.2007.09.002; Hotta H, 2009, EPILEPSIA, V50, P923, DOI 10.1111/j.1528-1167.2008.01860.x; Huikuri HV, 2013, PROG CARDIOVASC DIS, V56, P153, DOI 10.1016/j.pcad.2013.07.003; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; Kass DA, 1995, VENTRICULAR FUNCTION, P131; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Langan Y, 2002, J NEUROL NEUROSUR PS, V73, P751, DOI 10.1136/jnnp.73.6.751; LITTLE WC, 1985, CIRC RES, V56, P808, DOI 10.1161/01.RES.56.6.808; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Moodithaya Shailaja, 2012, J Aging Res, V2012, P679345, DOI 10.1155/2012/679345; Mukherjee S, 2009, EPILEPSY RES, V85, P261, DOI 10.1016/j.eplepsyres.2009.03.021; NAKANO K, 1990, CIRCULATION, V82, P1352, DOI 10.1161/01.CIR.82.4.1352; Nei M, 2004, EPILEPSIA, V45, P338, DOI 10.1111/j.0013-9580.2004.05503.x; Neufeld G, 2009, CARDIOLOGY, V114, P255, DOI 10.1159/000233236; Pacher P, 2004, AM J PHYSIOL-HEART C, V287, pH2132, DOI 10.1152/ajpheart.00405.2004; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Persson H, 2005, NEUROLOGY, V65, P1021, DOI 10.1212/01.wnl.0000181368.50750.1c; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Ronkainen E, 2006, EPILEPSIA, V47, P556, DOI 10.1111/j.1528-1167.2006.00467.x; Scheuer J, 1999, AM J CARDIOL, V83, p70H; Sgoifo A, 1998, AM J PHYSIOL-HEART C, V275, pH460, DOI 10.1152/ajpheart.1998.275.2.H460; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Stengl M, 2010, PHYSIOL RES, V59, pS25, DOI 10.33549/physiolres.932001; Su DF, 2001, CLIN EXP PHARMACOL P, V28, P709, DOI 10.1046/j.1440-1681.2001.03508.x; Surges R, 2012, CURR OPIN NEUROL, V25, P201, DOI 10.1097/WCO.0b013e3283506714; Surges R, 2009, NAT REV NEUROL, V5, P492, DOI 10.1038/nrneurol.2009.118; Tomson T, 1998, EPILEPSY RES, V30, P77, DOI 10.1016/S0920-1211(97)00094-6; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; Umeoka EHL, 2011, BRAIN RES, V1381, P141, DOI 10.1016/j.brainres.2011.01.042; Vanoli E, 2008, HEART RHYTHM, V5, P300, DOI 10.1016/j.hrthm.2007.10.021; Volders PGA, 2010, HEART RHYTHM, V7, P1900, DOI 10.1016/j.hrthm.2010.06.003; WALTON NY, 1993, EPILEPSIA, V34, pS54, DOI 10.1111/j.1528-1157.1993.tb05906.x; Woodiwiss AJ, 2001, CIRCULATION, V103, P155; Yanni J, 2010, J MOL CELL CARDIOL, V48, P653, DOI 10.1016/j.yjmcc.2009.08.023	56	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129574	10.1371/journal.pone.0129574	http://dx.doi.org/10.1371/journal.pone.0129574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029918	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900224
J	Gormley, AM; Forsyth, DM; Wright, EF; Lyall, J; Elliott, M; Martini, M; Kappers, B; Perry, M; McKay, M				Gormley, Andrew M.; Forsyth, David M.; Wright, Elaine F.; Lyall, John; Elliott, Mike; Martini, Mark; Kappers, Benno; Perry, Mike; McKay, Meredith			Cost-Effective Large-Scale Occupancy-Abundance Monitoring of Invasive Brushtail Possums (Trichosurus Vulpecula) on New Zealand's Public Conservation Land	PLOS ONE			English	Article							PRESENCE-ABSENCE DATA; CHAIN MONTE-CARLO; GLOBAL BIODIVERSITY; OBSERVING SYSTEM; DISTRIBUTIONS; ISLANDS; ECOLOGY; SPACE	There is interest in large-scale and unbiased monitoring of biodiversity status and trend, but there are few published examples of such monitoring being implemented. The New Zealand Department of Conservation is implementing a monitoring program that involves sampling selected biota at the vertices of an 8-km grid superimposed over the 8.6 million hectares of public conservation land that it manages. The introduced brushtail possum (Trichosurus Vulpecula) is a major threat to some biota and is one taxon that they wish to monitor and report on. A pilot study revealed that the traditional method of monitoring possums using leg-hold traps set for two nights, termed the Trap Catch Index, was a constraint on the cost and logistical feasibility of the monitoring program. A phased implementation of the monitoring program was therefore conducted to collect data for evaluating the trade-off between possum occupancy- abundance estimates and the costs of sampling for one night rather than two nights. Reducing trapping effort from two nights to one night along four trap-lines reduced the estimated costs of monitoring by 5.8% due to savings in labour, food and allowances; it had a negligible effect on estimated national possum occupancy but resulted in slightly higher and less precise estimates of relative possum abundance. Monitoring possums for one night rather than two nights would provide an annual saving of NZ$72,400, with 271 fewer field days required for sampling. Possums occupied 60% (95% credible interval; 53-68) of sampling locations on New Zealand's public conservation land, with a mean relative abundance (Trap Catch Index) of 2.7% (2.0-3.5). Possum occupancy and abundance were higher in forest than in non-forest habitats. Our case study illustrates the need to evaluate relationships between sampling design, cost, and occupancy-abundance estimates when designing and implementing large-scale occupancy-abundance monitoring programs.	[Gormley, Andrew M.] Landcare Res, Lincoln, NE USA; [Forsyth, David M.; Wright, Elaine F.; McKay, Meredith] Sci & Capabil Grp, Dept Conservat, Christchurch, New Zealand; [Lyall, John; Elliott, Mike; Martini, Mark] Dept Conservat, Hokitika, New Zealand; [Kappers, Benno] Sci & Capabil Grp, Dept Conservat, Wellington, New Zealand; [Perry, Mike] Landcare Res, Palmerston North, New Zealand	Landcare Research - New Zealand	Forsyth, DM (corresponding author), Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia.	dave.forsyth@delwp.vic.gov.au		Forsyth, David/0000-0001-5356-9573; Gormley, Andrew/0000-0001-9833-7012	Department of Conservation	Department of Conservation	The work presented, including the salaries of the two authors employed by Landcare Research, was funded by the Department of Conservation (www.doc.govt.nz). The Department of Conservation and Landcare Research had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of the authors being employees within those organisations. The specific roles of authors are articulated in the 'author contributions' section.	Allen RB, 2006, ECOL STU AN, V186, P435; Allen R. B., 2009, LC0809153 DEP CONS L; [Anonymous], 2005, HDB NZ MAMMALS; [Anonymous], 2010, AUSTR BIOD CONS STRA; Bellingham PJ, 2013, LC1621 DEP CONS LAND; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Brashares JS, 2005, BIODIVERS CONSERV, V14, P2709, DOI 10.1007/s10531-005-8404-z; BURBIDGE AA, 1991, NATURE CONSERVATION, P3; Caughley G., 1977, ANAL VERTEBRATE POPU; Clout Mick N., 2000, P1; Cochran WG., 1963, SAMPLING TECHNIQUES; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Department of Conservation, 2012, DOCDM828397; Department of Conservation, 2012, ANN REP YEAR END 30; Efford Murray, 2000, P47; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Elton C. S., 1958, ECOLOGY INVASIONS AN; Forsyth DM, 2005, J WILDLIFE MANAGE, V69, P976, DOI 10.2193/0022-541X(2005)069[0976:NASBIA]2.0.CO;2; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gibbs JP, 2000, METH C CONS, P213; Glen AS, 2012, NEW ZEAL J ECOL, V36, P29; Gormley AM, 2012, J APPL ECOL, V49, P1296, DOI 10.1111/j.1365-2664.2012.02219.x; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Hone J, 2007, WILDLIFE DAMAGE CONTROL, P1; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; King CM., 2005, HDB NZ MAMMALS; Landcare Research, 2012, LAN COV DAT VERS 3; Lee W, 2005, LC0405122 DEP CONS L; Levrel H, 2010, ECOL ECON, V69, P1580, DOI 10.1016/j.ecolecon.2010.03.001; Likens GE, 2011, AUSTRAL ECOL, V36, P1, DOI 10.1111/j.1442-9993.2010.02179.x; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Link WA, 2002, J WILDLIFE MANAGE, V66, P277, DOI 10.2307/3803160; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacLeod CJ, 2012, NEW ZEAL J ECOL, V36, P300; MacLeod CJ, 2012, LC1102 DEP CONS LAND; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; McDonald-Madden E, 2009, SCIENCE, V323, P43, DOI 10.1126/science.1164342; Morgan David, 2000, P143; National Pest Control Agencies, 2011, A1 POSS POP MON US T; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Nugent G, 2011, VET MICROBIOL, V151, P34, DOI 10.1016/j.vetmic.2011.02.023; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Payton IA, 2014, NZ CARBON MONITORING; Pekelharing CJ, 1998, NEW ZEAL J ECOL, V22, P197; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pereira HM, 2010, FRONT ECOL ENVIRON, V8, P458, DOI 10.1890/10.WB.23; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ramsey D, 2005, WILDLIFE RES, V32, P229, DOI 10.1071/WR03119; Robinson AC, 1991, NATURE CONSERVATION, P142; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sadleir Richard, 2000, P126; Sargeant GA, 2005, J WILDLIFE MANAGE, V69, P483, DOI 10.2193/0022-541X(2005)069[0483:MCMCEO]2.0.CO;2; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Veltman CJ, 2001, J WILDLIFE MANAGE, V65, P476, DOI 10.2307/3803100; Warburton Bruce, 2000, P132; Webster RA, 1999, OPTIMISING TRAP CATC; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	71	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127693	10.1371/journal.pone.0127693	http://dx.doi.org/10.1371/journal.pone.0127693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029890	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900072
J	Ikeda, Y; Kumagai, H; Okazaki, H; Fujishiro, M; Motozawa, Y; Nomura, S; Takeda, N; Toko, H; Takimoto, E; Akazawa, H; Morita, H; Suzuki, J; Yamazaki, T; Komuro, I; Yanagisawa, M				Ikeda, Yuichi; Kumagai, Hidetoshi; Okazaki, Hiroaki; Fujishiro, Mitsuhiro; Motozawa, Yoshihiro; Nomura, Seitaro; Takeda, Norifumi; Toko, Haruhiro; Takimoto, Eiki; Akazawa, Hiroshi; Morita, Hiroyuki; Suzuki, Jun-ichi; Yamazaki, Tsutomu; Komuro, Issei; Yanagisawa, Masashi			Monitoring beta-arrestin recruitment via beta-lactamase enzyme fragment complementation: purification of peptide E as a low-affinity ligand for mammalian bombesin receptors	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; 7-TRANSMEMBRANE RECEPTORS; COUPLED RECEPTORS; CLONAL SELECTION; BIASED AGONISM; IN-VIVO; CELLS; QUANTITATION; PROENKEPHALIN; SPECIFICITY	Identification of cognate ligands for G protein-coupled receptors (GPCRs) provides a starting point for understanding novel regulatory mechanisms. Although GPCR ligands have typically been evaluated through the activation of heterotrimeric G proteins, recent studies have shown that GPCRs signal not only through G proteins but also through beta-arrestins. As such, monitoring beta-arrestin signaling instead of G protein signaling will increase the likelihood of identifying currently unknown ligands, including beta-arrestin-biased agonists. Here, we developed a cell-based assay for monitoring ligand-dependent GPCR-beta-arrestin interaction via beta-lactamase enzyme fragment complementation. Inter alia, beta-lactamase is a superior reporter enzyme because of its cell-permeable fluorescent substrate. This substrate makes the assay non-destructive and compatible with fluorescence-activated cell sorting (FACS). In a reporter cell, complementary fragments of beta-lactamase (alpha and omega) were fused to beta-arrestin 2 and GPCR, respectively. Ligand stimulation initiated the interaction of these chimeric proteins (beta-arrestin-alpha and GPCR-omega), and this inducible interaction was measured through reconstituted beta-lactamase activity. Utilizing this system, we screened various mammalian tissue extracts for agonistic activities on human bombesin receptor subtype 3 (hBRS3). We purified peptide E as a low-affinity ligand for hBRS3, which was also found to be an agonist for the other two mammalian bombesin receptors such as gastrin-releasing peptide receptor (GRPR) and neuromedin B receptor (NMBR). Successful purification of peptide E has validated the robustness of this assay. We conclude that our newly developed system will facilitate the discovery of GPCR ligands.	[Ikeda, Yuichi; Kumagai, Hidetoshi; Motozawa, Yoshihiro; Nomura, Seitaro; Takeda, Norifumi; Toko, Haruhiro; Takimoto, Eiki; Akazawa, Hiroshi; Morita, Hiroyuki; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Ikeda, Yuichi; Kumagai, Hidetoshi; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Okazaki, Hiroaki] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; [Kumagai, Hidetoshi; Suzuki, Jun-ichi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Yamazaki, Tsutomu] Univ Tokyo, Clin Res Support Ctr, Tokyo, Japan; [Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan	University of Tokyo; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tsukuba	Ikeda, Y (corresponding author), Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan.	yikeda-tky@umin.ac.jp	藤城, 光弘/AAN-3131-2020; Takimoto, Eiki/AAC-5100-2021	TAKEDA, NORIFUMI/0000-0003-4818-3347	Howard Hughes Medical Institute; Perot Family Foundation; Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO);  [14463492]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Perot Family Foundation; Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO); 	This research was supported by the Howard Hughes Medical Institute, the Perot Family Foundation, Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO, to MY), and Grant-in-Aid for Scientific Research C (#14463492, to HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; Ikeda Y, 2013, CELL, V155, P1323, DOI 10.1016/j.cell.2013.10.052; Johanning K, 1998, J BIOL CHEM, V273, P22672, DOI 10.1074/jbc.273.35.22672; KILPATRICK DL, 1981, P NATL ACAD SCI-BIOL, V78, P3265, DOI 10.1073/pnas.78.5.3265; Liu J, 2002, BIOCHEMISTRY-US, V41, P8954, DOI 10.1021/bi0202777; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Mantey SA, 1997, J BIOL CHEM, V272, P26062, DOI 10.1074/jbc.272.41.26062; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; PITTIUS CW, 1985, EMBO J, V4, P1257, DOI 10.1002/j.1460-2075.1985.tb03769.x; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rakesh K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000769; Remy I, 1999, P NATL ACAD SCI USA, V96, P5394, DOI 10.1073/pnas.96.10.5394; Rossi F, 1997, P NATL ACAD SCI USA, V94, P8405, DOI 10.1073/pnas.94.16.8405; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wehrman T, 2002, P NATL ACAD SCI USA, V99, P3469, DOI 10.1073/pnas.062043699; Wollemann M, 2004, LIFE SCI, V75, P257, DOI 10.1016/j.lfs.2003.12.005; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	25	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127445	10.1371/journal.pone.0127445	http://dx.doi.org/10.1371/journal.pone.0127445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030739	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900053
J	Manning, PL; Egerton, VM; Romano, M				Manning, Phillip L.; Egerton, Victoria M.; Romano, Mike			A New Sauropod Dinosaur from the Middle Jurassic of the United Kingdom	PLOS ONE			English	Article							SALTWICK FORMATION; CLEVELAND BASIN; YORKSHIRE; CETIOSAURUS; EVOLUTION; ANATOMY; HISTORY; ENGLAND	A new record of a sauropodomorph dinosaur is here described from the Middle Jurassic (Aalenian) Saltwick Formation of Whitby (Yorkshire), UK. A single caudal vertebra represents an early sauropodomorph and signifies the earliest recognised eusauropod dinosaur from the United Kingdom. The absence of pleurocoels and a narrow, dorsoventrally deep, but craniocaudally short centrum, suggests a primitive sauropodomorph. Distinct spinopostzygopophyseal laminae rise from the lateral margins of the postzygapophyses and pass caudally along what remains of the neural spine, a character unique to a subgroup of sauropods that includes Barapasaurus, Omeisaurus and other neosauropods and eusauropods. The lack of phylogenetically robust characters in sauropod caudal vertebrae usually makes it difficult to establish affinities, but the absence of mild procoely excludes this specimen from both Diplodocoidea and Lithostrotia. The vertebra cannot be further distinguished from those of a wide range of basal sauropods, cetiosaurids and basal macronarians. However, this plesiomorphic vertebra still signifies the earliest stratigraphic occurrence for a British sauropod dinosaur.	[Manning, Phillip L.; Egerton, Victoria M.] Univ Manchester, Interdisciplinary Ctr Ancient Life, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	University of Manchester	Manning, PL (corresponding author), Univ Manchester, Interdisciplinary Ctr Ancient Life, Sch Earth Atmospher & Environm Sci, Oxford Rd, Manchester, Lancs, England.	phil.manning@manchester.ac.uk	Manning, Phillip/F-9966-2011	Manning, Phillip/0000-0002-7161-6246; Egerton, Victoria/0000-0002-0739-6533	STFC [ST/M001814/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/M001814/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BENTON M. J., 1984, P YORKS GEOL SOC, V44, P399, DOI DOI 10.1144/PYGS.44.4.399; Bonaparte J.F., 1986, P247; Bonaparte JF, 1979, NATURE, V205, P1377; Brodrick H., 1907, REPORT WHITBY PHILOS, V85, P8; Cope JCW, 1980, MIDDLE UPPER JURAS 2; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Hemingway J.E., 1973, P YORKS GEOL SOC, V39, P527, DOI DOI 10.1144/pygs.39.4.527; Lull R. S., 1919, MEMOIRS CONNECTICUT, V6, P1; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; McINTOSH J.S., 1988, KIRTLANDIA, V43, P3; Nanjing Institute of Geology and Palaeontology and Institute of Vertebrate Paleontology and Paleoanthropology Academia, 1983, PALAEONTOLOGIA SIN C, P1; Owen AW, 1842, INSTITUT, V10, P11; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Palliani RB, 2000, P YORKS GEOL SOC, V53, P1, DOI 10.1144/pygs.53.1.1; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Riding J.B., 1984, Proceedings of the Yorkshire Geological Society, V45, P109; Romano M, 2003, PALAEONTOLOGY, V46, P257, DOI 10.1111/1475-4983.00297; Romano M, 1999, P YORKS GEOL SOC, V52, P361, DOI 10.1144/pygs.52.4.361; Sarjeant W. A. S., 1970, Mercian Geol., V3, P269; Seeley HG, 1888, Q J GEOLOGICAL SOC L, V44, P79, DOI [10.1144/GSL.JGS.1888.044.01-04.11, DOI 10.1144/GSL.JGS.1888.044.01-04.11]; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Upchurch P, 2003, J VERTEBR PALEONTOL, V23, P208, DOI 10.1671/0272-4634(2003)23[208:TAATOC]2.0.CO;2; Upchurch P, 2002, PALAEONTOLOGY, V45, P1049, DOI 10.1111/1475-4983.00275; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch P, 2002, DINOSAURIA, VSecond, P259; Whyte M.A., 2001, Ichnos, V8, P223; Whyte M.A., 1993, Proceedings of the Geologists' Association, V104, P195; Whyte MA, 2001, P GEOLOGIST ASSOC, V112, P45, DOI 10.1016/S0016-7878(01)80047-X; Whyte Martin A., 1994, Gaia, V10, P15; Whyte MA, 2010, GEOL SOC SPEC PUBL, V343, P189, DOI 10.1144/SP343.11; Williamson W.C., 1837, T GEOLOGICAL SOC 2, V5, P223, DOI [10.1144/transgslb.5.1.223, DOI 10.1144/TRANSGSLB.5.1.223]; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Young C. C., 1954, Acta Palaeontologica Sinica, V2, P355; Young C. C., 1939, Bulletin of the Geological Society of China, V19, P279	36	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128107	10.1371/journal.pone.0128107	http://dx.doi.org/10.1371/journal.pone.0128107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030865	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900110
J	Miwa, M; Oishi, K; Nakagawa, Y; Maeno, H; Anzai, H; Kumagai, H; Okano, K; Tobioka, H; Hirooka, H				Miwa, Masafumi; Oishi, Kazato; Nakagawa, Yasuhiro; Maeno, Hiromichi; Anzai, Hiroki; Kumagai, Hajime; Okano, Kanji; Tobioka, Hisaya; Hirooka, Hiroyuki			Application of Overall Dynamic Body Acceleration as a Proxy for Estimating the Energy Expenditure of Grazing Farm Animals: Relationship with Heart Rate	PLOS ONE			English	Article							DOUBLY-LABELED WATER; METABOLIC-RATE; RATE-VARIABILITY; ACCELEROMETRY; GOATS; FIELD; BEHAVIOR; VALIDATION; LOCOMOTION; WELFARE	Estimating the energy expenditure of farm animals at pasture is important for efficient animal management. In recent years, an alternative technique for estimating energy expenditure by measuring body acceleration has been widely performed in wildlife and human studies, but the availability of the technique in farm animals has not yet been examined. In the present study, we tested the potential use of an acceleration index, overall dynamic body acceleration (ODBA), as a new proxy for estimating the energy expenditure of grazing farm animals (cattle, goats and sheep) at pasture with the simultaneous evaluation of a conventional proxy, heart rate. Body accelerations in three axes and heart rate for cows (n = 8, two breeds), goats (n = 6) and sheep (n = 5) were recorded, and the effect of ODBA calculated from the body accelerations on heart rate was analyzed. In addition, the effects of the two other activity indices, the number of steps and vectorial dynamic body acceleration (VeDBA), on heart rate were also investigated. The results of the comparison among three activity indices indicated that ODBA was the best predictor for heart rate. Although the relationship between ODBA and heart rate was different between the groups of species and breeds and between individuals (P<0.01), the difference could be explained by different body weights; a common equation could be established by correcting the body weights (M:kg): heart rate (beats/min) = 147.263.M-0.141 + 889.640.M-0.179.ODBA (g). Combining this equation with the previously reported energy expenditure per heartbeat, we estimated the energy expenditure of the tested animals, and the results indicated that ODBA is a good proxy for estimating the energy expenditure of grazing farm animals across species and breeds. The utility and simplicity of the procedure with acceleration loggers could make the accelerometry technique a worthwhile option in field research and commercial farm use.	[Miwa, Masafumi; Oishi, Kazato; Nakagawa, Yasuhiro; Maeno, Hiromichi; Anzai, Hiroki; Kumagai, Hajime; Hirooka, Hiroyuki] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto 6068502, Japan; [Okano, Kanji] Univ Shiga Prefecture, Sch Environm Sci, Dept Biol Resources Management, Anim Sci Lab, Shiga 5228533, Japan; [Tobioka, Hisaya] Tokai Univ, Sch Agr, Dept Anim Sci, Lab Anim Nutr & Feeding, Kumamoto 8691404, Japan	Kyoto University; University Shiga Prefecture; Tokai University	Oishi, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto 6068502, Japan.	kazato@kais.kyoto-u.ac.jp		Oishi, Kazato/0000-0001-9311-7432	Japan's Society for the Promotion of Science [24780255]	Japan's Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Young Scientists (B) (Grant Number: 24780255) of Japan's Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) (to KOishi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural and Food Research Council, 1997, NUTR ABSTR REV B, V10, P793; Aharoni Y, 2009, J ANIM SCI, V87, P2719, DOI 10.2527/jas.2008-1505; Animut G, 2005, SMALL RUMINANT RES, V59, P191, DOI 10.1016/j.smallrumres.2005.05.014; BLIX AS, 1974, AEROSPACE MED, V45, P1219; Brosh A, 2007, J ANIM SCI, V85, P1213, DOI 10.2527/jas.2006-298; Brosh A, 2006, J ANIM SCI, V84, P1951, DOI 10.2527/jas.2005-315; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; CAVAGNA GA, 1963, J APPL PHYSIOL, V18, P1, DOI 10.1152/jappl.1963.18.1.1; Commonwealth Scientific and Industrial Research Organization, 1990, FEED STAND AUSTR LIV, V23; FRAPPELL PB, 1989, J THEOR BIOL, V138, P479, DOI 10.1016/S0022-5193(89)80046-3; FUKUHARA K, 1986, Japanese Journal of Zootechnical Science, V57, P978; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gottschall JS, 2005, J BIOMECH, V38, P445, DOI 10.1016/j.jbiomech.2004.04.023; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; Groscolas R, 2010, J EXP BIOL, V213, P153, DOI 10.1242/jeb.033720; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Herren R, 1999, MED SCI SPORT EXER, V31, P1053, DOI 10.1097/00005768-199907000-00020; Hindle AG, 2010, AQUAT BIOL, V10, P139, DOI 10.3354/ab00279; Japan Meteorological Agency, 2014, CLIMATE STATISTICS I; Junghans P, 1997, Z ERNAHRUNGSWISS, V36, P268, DOI 10.1007/BF01617796; Koteja P, 1996, FUNCT ECOL, V10, P675, DOI 10.2307/2390179; Kovacs L, 2014, ANIMAL, V8, P316, DOI 10.1017/S1751731113002140; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Lachica M, 2008, SMALL RUMINANT RES, V79, P179, DOI 10.1016/j.smallrumres.2008.07.016; Lachica M, 2003, SMALL RUMINANT RES, V49, P303, DOI 10.1016/S0921-4488(03)00146-9; LIFSON N, 1955, J APPL PHYSIOL, V7, P704, DOI 10.1152/jappl.1955.7.6.704; Margaria R, 1976, BIOMECHANICS ENERGET, P146; MATSUMOTO T, 1990, Japanese Journal of Zootechnical Science, V61, P230; MCLEAN JA, 1972, BRIT J NUTR, V27, P597, DOI 10.1079/BJN19720130; National Research Council, 1981, NUTRIENT REQUIREMENT; OSUJI PO, 1974, J RANGE MANAGE, V27, P437, DOI 10.2307/3896717; Payne NL, 2011, J ANIM ECOL, V80, P422, DOI 10.1111/j.1365-2656.2010.01758.x; Puchala R, 2007, SMALL RUMINANT RES, V70, P183, DOI 10.1016/j.smallrumres.2006.03.002; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; SAS, 1997, SAS STAT US GUID VER; Shaffer SA, 2011, COMP BIOCHEM PHYS A, V158, P315, DOI 10.1016/j.cbpa.2010.07.012; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Shibata M., 1981, Bulletin of the Kyushu National Agricultural Experiment Station, V21, P589; Shinde AK, 2002, J AGR SCI-CAMBRIDGE, V139, P87, DOI 10.1017/S0021859602002228; Spivey RJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0404; TAYLOR CR, 1982, ANNU REV PHYSIOL, V44, P97, DOI 10.1146/annurev.ph.44.030182.000525; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1104, DOI 10.1152/ajplegacy.1970.219.4.1104; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Toerien CA, 1999, J ANIM SCI, V77, P3096; Trenel P, 2009, J DAIRY SCI, V92, P3397, DOI 10.3168/jds.2009-2040; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; YAMAMOTO S, 1990, Japanese Journal of Zootechnical Science, V61, P237; YAMAMOTO S, 1989, JARQ-JPN AGR RES Q, V23, P134	56	30	30	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128042	10.1371/journal.pone.0128042	http://dx.doi.org/10.1371/journal.pone.0128042			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030931	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900103
J	Prill, RJ; Vogel, R; Cecchi, GA; Altan-Bonnet, G; Stolovitzky, G				Prill, Robert J.; Vogel, Robert; Cecchi, Guillermo A.; Altan-Bonnet, Gregoire; Stolovitzky, Gustavo			Noise-Driven Causal Inference in Biomolecular Networks	PLOS ONE			English	Article							SINGLE-CELL; PROTEIN EXPRESSION; GENE-EXPRESSION; RESPONSES; LANGEVIN; ERK	Single-cell RNA and protein concentrations dynamically fluctuate because of stochastic ("noisy") regulation. Consequently, biological signaling and genetic networks not only translate stimuli with functional response but also random fluctuations. Intuitively, this feature manifests as the accumulation of fluctuations from the network source to the target. Taking advantage of the fact that noise propagates directionally, we developed a method for causation prediction that does not require time-lagged observations and therefore can be applied to data generated by destructive assays such as immunohistochemistry. Our method for causation prediction, "Inference of Network Directionality Using Covariance Elements (INDUCE)," exploits the theoretical relationship between a change in the strength of a causal interaction and the associated changes in the single cell measured entries of the covariance matrix of protein concentrations. We validated our method for causation prediction in two experimental systems where causation is well established: in an E. coli synthetic gene network, and in MEK to ERK signaling in mammalian cells. We report the first analysis of covariance elements documenting noise propagation from a kinase to a phosphorylated substrate in an endogenous mammalian signaling network.	[Prill, Robert J.; Cecchi, Guillermo A.; Stolovitzky, Gustavo] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Vogel, Robert; Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Program Computat Biol & Immunol, ImmunoDynam Grp, New York, NY 10065 USA	International Business Machines (IBM); Memorial Sloan Kettering Cancer Center	Stolovitzky, G (corresponding author), IBM TJ Watson Res Ctr, 1101 Kitchawan Rd,Route 134, Yorktown Hts, NY 10598 USA.	gustavo@us.ibm.com		Altan-Bonnet, Gregoire/0000-0002-7283-3162; Vogel, Robert/0000-0001-5400-5024	IBM Research; NIH [AI083408, U54 CA148967]; NATIONAL CANCER INSTITUTE [U54CA148967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083408, R56AI083408] Funding Source: NIH RePORTER	IBM Research(International Business Machines (IBM)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors R.J.P, G.C. and G.S. received salary from IBM Research to fund part of this study, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. R.V. and G.A.B. acknowledge support from NIH AI083408 and U54 CA148967. The authors also wish to thank Alexander van Oudenaarden for sharing the E. coli data.	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Altan-Bonnet G, MATLAB DATA FILE MAP; Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GARDNER CW, 1985, HDB STOCHASTIC METHO; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Gillespie DT, 1996, AM J PHYS, V64, P1246, DOI 10.1119/1.18387; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KOLLER D., 2009, PROBABILISTIC GRAPHI; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Prasad A, 2009, P NATL ACAD SCI USA, V106, P528, DOI 10.1073/pnas.0805981105; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Salman H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238105; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Xu TR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000517	25	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0125777	10.1371/journal.pone.0125777	http://dx.doi.org/10.1371/journal.pone.0125777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030907	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900015
J	Sun, XY; Zhao, Y; Liu, LL; Jia, B; Zhao, F; Huang, WD; Zhan, JC				Sun, Xiang-yu; Zhao, Yu; Liu, Ling-ling; Jia, Bo; Zhao, Fang; Huang, Wei-dong; Zhan, Ji-cheng			Copper Tolerance and Biosorption of Saccharomyces cerevisiae during Alcoholic Fermentation	PLOS ONE			English	Article							WINE; MECHANISMS; VINEYARD; BIOACCUMULATION; REMOVAL; BIOMASS; GROWTH; IONS; CU	At high levels, copper in grape mash can inhibit yeast activity and cause stuck fermentations. Wine yeast has limited tolerance of copper and can reduce copper levels in wine during fermentation. This study aimed to understand copper tolerance of wine yeast and establish the mechanism by which yeast decreases copper in the must during fermentation. Three strains of Saccharomyces cerevisiae (lab selected strain BH8 and industrial strains AWRI R2 and Freddo) and a simple model fermentation system containing 0 to 1.50 mM Cu2+ were used. ICP-AES determined Cu ion concentration in the must decreasing differently by strains and initial copper levels during fermentation. Fermentation performance was heavily inhibited under copper stress, paralleled a decrease in viable cell numbers. Strain BH8 showed higher copper-tolerance than strain AWRI R2 and higher adsorption than Freddo. Yeast cell surface depression and intracellular structure deformation after copper treatment were observed by scanning electron microscopy and transmission electron microscopy; electronic differential system detected higher surface Cu and no intracellular Cu on 1.50 mM copper treated yeast cells. It is most probably that surface adsorption dominated the biosorption process of Cu2+ for strain BH8, with saturation being accomplished in 24 h. This study demonstrated that Saccharomyces cerevisiae strain BH8 has good tolerance and adsorption of Cu, and reduces Cu2+ concentrations during fermentation in simple model system mainly through surface adsorption. The results indicate that the strain selected from China's stress-tolerant wine grape is copper tolerant and can reduce copper in must when fermenting in a copper rich simple model system, and provided information for studies on mechanisms of heavy metal stress.	[Sun, Xiang-yu; Liu, Ling-ling; Jia, Bo; Zhao, Fang; Huang, Wei-dong; Zhan, Ji-cheng] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Zhao, Yu] Univ Copenhagen, Fac Sci, Copenhagen S, Denmark	China Agricultural University; University of Copenhagen	Zhan, JC (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.	zhanjicheng@cau.edu.cn	Zhan, Jicheng/ABF-8501-2021		National Natural Science Foundation of China [31471835]; National "Twelfth Five-Year" Plan for Science & Technology Support [2012BAD31B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support	This research was supported by grants from the National Natural Science Foundation of China (31471835) and the National "Twelfth Five-Year" Plan for Science & Technology Support (2012BAD31B07).	Ash C, 2012, SOIL WATER RES, V7, P151, DOI 10.17221/41/2012-SWR; Azenha M, 2000, J BIOSCI BIOENG, V90, P163, DOI [10.1016/S1389-1723(00)80104-8, 10.1263/jbb.90.163]; Benitez P, 2002, ANAL CHIM ACTA, V458, P197, DOI 10.1016/S0003-2670(01)01499-4; BRADY D, 1994, BIOTECHNOL BIOENG, V44, P297, DOI 10.1002/bit.260440307; BRADY D, 1994, APPL MICROBIOL BIOT, V41, P149, DOI 10.1007/BF00166098; Brandolini V, 2002, WORLD J MICROB BIOT, V18, P499, DOI 10.1023/A:1016306813502; Brun LA, 1998, ENVIRON POLLUT, V102, P151, DOI 10.1016/S0269-7491(98)00120-1; Chen C, 2007, BIOMED ENVIRON SCI, V20, P478; Ciani M, 2006, INT J FOOD MICROBIOL, V108, P239, DOI 10.1016/j.ijfoodmicro.2005.11.012; Claus H, 2010, SOIL BIOL, V19, P281, DOI 10.1007/978-3-642-02436-8_13; Donmez G, 1999, PROCESS BIOCHEM, V35, P135, DOI 10.1016/S0032-9592(99)00044-8; Du G, 2012, AM J ENOL VITICULT, V63, P132, DOI 10.5344/ajev.2011.11067; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; Ferreira J, 2006, AUST J GRAPE WINE R, V12, P50, DOI 10.1111/j.1755-0238.2006.tb00043.x; Garcia-Esparza MA, 2006, FOOD ADDIT CONTAM A, V23, P274, DOI 10.1080/02652030500429117; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Li H, 2008, FOOD CHEM, V108, P1, DOI 10.1016/j.foodchem.2007.10.065; Li H, 2010, AM J ENOL VITICULT, V61, P529, DOI 10.5344/ajev.2010.09136; Liu L, 2012, COPPER BIOSORPTION B; Marullo P, 2004, FEMS YEAST RES, V4, P711, DOI 10.1016/j.femsyr.2004.01.006; Mira H, 2007, VITIS, V46, P138; Moreno IM, 2008, MICROCHEM J, V88, P56, DOI 10.1016/j.microc.2007.09.005; Mrvcic J, 2007, J BIOSCI BIOENG, V103, P331, DOI 10.1263/jbb.103.331; Naja G.M., 2010, ENCY IND BIOTECHNOLO, P1, DOI [10.1002/9780470054581.eib166, DOI 10.1002/9780470054581.EIB166]; Naughton DP, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-22; Nogueirol RC, 2010, J HAZARD MATER, V181, P931, DOI 10.1016/j.jhazmat.2010.05.102; NORRIS PR, 1977, J GEN MICROBIOL, V99, P317, DOI 10.1099/00221287-99-2-317; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; Probst B, 2008, BIOL FERT SOILS, V44, P443, DOI 10.1007/s00374-007-0225-7; Provenzano MR, 2010, FOOD CHEM, V122, P1338, DOI 10.1016/j.foodchem.2010.03.103; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Schubert M, 2010, J AGR FOOD CHEM, V58, P8300, DOI 10.1021/jf101127t; Shanmuganathan A, 2004, FEBS LETT, V556, P253, DOI 10.1016/S0014-5793(03)01428-5; Tamasi G, 2010, J FOOD COMPOS ANAL, V23, P333, DOI 10.1016/j.jfca.2009.12.011; Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; Volpe MG, 2009, FOOD CHEM, V117, P553, DOI 10.1016/j.foodchem.2009.04.033; Zu YG, 2006, J ENVIRON SCI-CHINA, V18, P1254, DOI 10.1016/S1001-0742(06)60071-5	40	48	48	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128611	10.1371/journal.pone.0128611	http://dx.doi.org/10.1371/journal.pone.0128611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030864	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900174
J	Xu, MS; Li, ZA; Ding, C; Zhang, JH; Fan, LX; Diao, LT; Yang, D				Xu, Mengsi; Li, Zhiai; Ding, Cody; Zhang, Junhua; Fan, Lingxia; Diao, Liuting; Yang, Dong			The Divergent Effects of Fear and Disgust on Inhibitory Control: An ERP Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; RESPONSE-INHIBITION; ATTENTION; PERCEPTION; MECHANISMS; PICTURES; ANXIETY	Negative emotional stimuli have been shown to attract attention and impair executive control. However, two different types of unpleasant stimuli, fearful and disgusting, are often inappropriately treated as a single category in the literature on inhibitory control. Therefore, the present study aimed to investigate the divergent effects of fearful and disgusting distracters on inhibitory control (both conscious and unconscious inhibition). Specifically, participants were engaged in a masked Go/No-Go task superimposed on fearful, disgusting, or neutral emotional contexts, while event-related potentials were measured concurrently. The results showed that for both conscious and unconscious conditions, disgusting stimuli elicited a larger P2 than fearful ones, and the difference waves of P3 amplitude under disgusting contexts were smaller than that under fearful contexts. These results suggest that disgusting distracters consume more attentional resources and therefore impair subsequent inhibitory control to a greater extent. This study is the first to provide electrophysiological evidence that fear and disgust differently affect inhibitory control. These results expand our understanding of the relationship between emotions and inhibitory control.	[Xu, Mengsi; Ding, Cody; Fan, Lingxia; Diao, Liuting; Yang, Dong] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Xu, Mengsi; Ding, Cody; Fan, Lingxia; Diao, Liuting; Yang, Dong] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Li, Zhiai] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China; [Ding, Cody] Univ Missouri, St Louis, MO 63121 USA; [Zhang, Junhua] S China Normal Univ, Dept Psychol, Ctr Psychol Applicat, Guangzhou, Guangdong, Peoples R China	Southwest University - China; Southwest University - China; East China Normal University; University of Missouri System; University of Missouri Saint Louis; South China Normal University	Yang, D (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	yangd@swu.edu.cn	Xu, Mengsi/D-9814-2017	Xu, Mengsi/0000-0003-1025-9289	National Natural Science Foundation of China [71472156]; Humanities and Social Science Research Funds of Ministry of Education, China [11XJC190003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Science Research Funds of Ministry of Education, China	1. This work was supported by National Natural Science Foundation of China (grant numbers 71472156) and the Humanities and Social Science Research Funds of Ministry of Education (grant numbers 11XJC190003), China. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Carretie L, 2011, BIOL PSYCHOL, V86, P247, DOI 10.1016/j.biopsycho.2010.12.005; Chapman HA, 2013, J EXP PSYCHOL GEN, V142, P1100, DOI 10.1037/a0030503; Chiu YC, 2014, J EXP PSYCHOL GEN, V143, P56, DOI 10.1037/a0031497; Cisler JM, 2009, CLIN PSYCHOL REV, V29, P34, DOI 10.1016/j.cpr.2008.09.007; Cohen N, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00033; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Desender K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055976; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dickie EW, 2008, PSYCHIAT RES-NEUROIM, V162, P51, DOI 10.1016/j.pscychresns.2007.08.002; Doallo S, 2006, NEUROREPORT, V17, P1797, DOI 10.1097/01.wnr.0000246325.51191.39; Esslen M, 2004, NEUROIMAGE, V21, P1189, DOI 10.1016/j.neuroimage.2003.10.001; Feng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029668; Gole M, 2012, NEUROSCI LETT, V507, P112, DOI 10.1016/j.neulet.2011.11.054; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Hartikainen KM, 2012, NEUROREPORT, V23, P447, DOI 10.1097/WNR.0b013e3283531e74; IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561; Kiefer M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00061; Krusemark EA, 2011, J NEUROSCI, V31, P3429, DOI 10.1523/JNEUROSCI.4394-10.2011; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 2005, INTERNATIONAL AFFECT, DOI [10.1016/j.psychres.2015.04.002, DOI 10.1016/J.PSYCHRES.2015.04.002]; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Schienle A, 2006, NEUROSCI LETT, V393, P174, DOI 10.1016/j.neulet.2005.09.072; Suhler CL, 2009, TRENDS COGN SCI, V13, P341, DOI 10.1016/j.tics.2009.04.010; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; van Gaal S, 2008, J NEUROSCI, V28, P8053, DOI 10.1523/JNEUROSCI.1278-08.2008; van Gaal S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0212; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P91, DOI 10.1162/jocn.2010.21431; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; van Hooff JC, 2013, ACTA PSYCHOL, V143, P1, DOI 10.1016/j.actpsy.2013.02.001; Verbruggen F, 2007, COGNITION EMOTION, V21, P391, DOI 10.1080/02699930600625081; Wokke ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025729; Yu FQ, 2009, NEUROREPORT, V20, P25, DOI 10.1097/WNR.0b013e32831ac9b1; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051110	37	8	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128932	10.1371/journal.pone.0128932	http://dx.doi.org/10.1371/journal.pone.0128932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030871	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900198
J	Bosserman, L; Rogers, K; Willis, C; Davidson, D; Whitworth, P; Karimi, M; Upadhyaya, G; Rutledge, J; Hallquist, A; Perree, M; Presant, CA				Bosserman, Linda; Rogers, Karl; Willis, Carl; Davidson, Dirk; Whitworth, Pat; Karimi, Misagh; Upadhyaya, Gargi; Rutledge, James; Hallquist, Allan; Perree, Mathieu; Presant, Cary A.			Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer	PLOS ONE			English	Article							MICROCULTURE KINETIC ASSAY; MICK ASSAY; IN-VITRO	Background A drug-induced apoptosis assay has been developed to determine which chemotherapy drugs or regimens can produce higher cell killing in vitro. This study was done to determine if this assay could be performed in patients with recurrent or metastatic breast cancer patients, to characterize the patterns of drug-induced apoptosis, and to evaluate the clinical utility of the assay. A secondary goal was to correlate assay use with clinical outcomes. Methods In a prospective, non-blinded, multi institutional controlled trial, 30 evaluable patients with recurrent or metastatic breast cancer who were treated with chemotherapy had tumor samples submitted for the MiCK drug-induced apoptosis assay. After receiving results within 72 hours after biopsy, physicians could use the test to determine therapy (users), or elect to not use the test (non-users). Results The assay was able to characterize drug-induced apoptosis in tumor specimens from breast cancer patients and identified which drugs or combinations gave highest levels of apoptosis. Patterns of drug activity were also analyzed in triple negative breast cancer. Different drugs from a single class of agents often produced significantly different amounts of apoptosis. Physician frequently (73%) used the assay to help select chemotherapy treatments in patients, Patients whose physicians were users had a higher response (CR+PR) rate compared to non-users (38.1% vs 0%, p = 0.04) and a higher disease control (CR+PR+Stable) rate (81% vs 25%, p<0.01). Time to relapse was longer in users 7.4 mo compared to non-users 2.2 mo (p<0.01). Conclusions The MiCK assay can be performed in breast cancer specimens, and results are often used by physicians in breast cancer patients with recurrent or metastatic disease. These results from a good laboratory phase II study can be the basis for a future larger prospective multi-center study to more definitively establish the value of the assay.	[Bosserman, Linda; Karimi, Misagh; Upadhyaya, Gargi; Presant, Cary A.] US Oncol, Wilshire Oncol Med Grp, La Verne, CA USA; [Rogers, Karl; Willis, Carl] Nashville Oncol Associates, Nashville, TN USA; [Davidson, Dirk] Tennessee Plateau Oncol, Crossville, TN USA; [Whitworth, Pat] Nashville Breast Ctr, Nashville, TN USA; [Rutledge, James] Data Vis, Dayton, OH USA; [Hallquist, Allan; Perree, Mathieu; Presant, Cary A.] DiaTech Oncol, Montreal, PQ, Canada	US Oncology Network	Bosserman, L (corresponding author), City Hope Med Grp, Duarte, CA 91010 USA.	bestchemo@gmail.com						Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Ballard KS, 2010, J GYNECOL ONCOL, V21, P45, DOI 10.3802/jgo.2010.21.1.45; Bosserman L, 2012, CANCER RES, V72, P3901, DOI 10.1158/0008-5472.CAN-12-0681; Bosserman LD, 2012, CANCER-AM CANCER SOC, V118, P4877, DOI 10.1002/cncr.27444; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; COX DR, 1972, J R STAT SOC B, V34, P187; Greenwood P. E., 1996, GUIDE CHI SQUARED TE, V280; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kravtsov VD, 1998, BLOOD, V92, P968; Kravtsov VD, 1996, LAB INVEST, V74, P557; Kravtsov VD, 1999, AM J PATHOL, V155, P1327, DOI 10.1016/S0002-9440(10)65235-2; Kravtsov VD, 2001, BLOOD, V98, p214B; KRAVTSOV VD, 1994, EUR J CANCER, V30A, P1564, DOI 10.1016/0959-8049(94)00291-C; Salom E, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-162; Strickland SA, 2013, LEUKEMIA LYMPHOMA, V54, P528, DOI 10.3109/10428194.2012.722217; Thomssen C, 2012, ONCOLOGY-BASEL, V82, P218, DOI 10.1159/000336892; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	18	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0122609	10.1371/journal.pone.0122609	http://dx.doi.org/10.1371/journal.pone.0122609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024531	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400003
J	Brito, H; Martins, AC; Lavrado, J; Mendes, E; Francisco, AP; Santos, SA; Ohnmacht, SA; Kim, NS; Rodrigues, CMP; Moreira, R; Neidle, S; Borralho, PM; Paulo, A				Brito, Hugo; Martins, Ana Claudia; Lavrado, Joao; Mendes, Eduarda; Francisco, Ana Paula; Santos, Sofia A.; Ohnmacht, Stephan A.; Kim, Nam-Soon; Rodrigues, Cecilia M. P.; Moreira, Rui; Neidle, Stephen; Borralho, Pedro M.; Paulo, Alexandra			Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; RNA G-QUADRUPLEXES; BINDING; DNA; APOPTOSIS; PROMOTER; INHIBITION; ACTIVATION; TYROSINASE; SEQUENCES	Background A guanine-rich strand within the promoter of the KRAS gene can fold into an intra-molecular G-quadruplex structure (G4), which has an important role in the regulation of KRAS transcription. We have previously identified indolo[3,2-b]quinolines with a 7-carboxylate group and three alkylamine side chains (IQ3A) as effective G4 stabilizers and promising selective anticancer leads. Herein we investigated the anticancer mechanism of action of these compounds, which we hypothesized due to stabilization of the G4 sequence in the KRAS promoter and subsequent down-regulation of gene expression. Methodology/Principal Findings IQ3A compounds showed greater stabilization of G4 compared to duplex DNA structures and reduced KRAS promoter activity in a dual luciferase reporter assay. Moreover, IQ3A compounds showed high anti-proliferative activity in HCT116 and SW620 colon cancer cells (IC50 < 2.69 mu M), without eliciting cell death in non-malignant HEK293T human embryonic kidney, and human colon fibroblasts CCD18co. IQ3A compounds significantly reduced KRAS mRNA and protein steady-state levels at IC50 concentrations, and increased p53 protein steady-state levels and cell death by apoptosis in HCT116 cells (mut KRAS, wt p53). Furthermore, KRAS silencing in HCT116 p53 wild-type (p53(+/+)) and null (p53(-/-)) isogenic cell lines induced a higher level of cell death, and a higher IQ3A-induced cell death in HCT116 p53(+/+) compared to HCT116 p53(-/-). Conclusions Herein we provide evidence that G4 ligands such as IQ3A compounds can target G4 motifs present in KRAS promoter, down-regulate the expression of the mutant KRAS gene through inhibition of transcription and translation, and induce cell death by apoptosis in colon cancer cell lines. Thus, targeting KRAS at the genomic level with G4 ligands may be a new anticancer therapy strategy for colon cancer.	[Brito, Hugo; Rodrigues, Cecilia M. P.; Borralho, Pedro M.] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Cell Funct & Therapeut Targeting Grp, P-1649003 Lisbon, Portugal; [Martins, Ana Claudia; Lavrado, Joao; Santos, Sofia A.; Moreira, Rui; Paulo, Alexandra] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Med Chem Grp, P-1649003 Lisbon, Portugal; [Mendes, Eduarda; Francisco, Ana Paula] Univ Lisbon, Fac Pharm, P-1649003 Lisbon, Portugal; [Santos, Sofia A.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ohnmacht, Stephan A.; Neidle, Stephen] UCL, UCL Sch Pharm, London WC1N 1AX, England; [Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305333, South Korea	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; University of London; University College London; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Borralho, PM (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Cell Funct & Therapeut Targeting Grp, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.	mapaulo@ff.ulisboa.pt; borralho@ff.ulisboa.pt	Moreira, Rui/G-7485-2011; iMed.ULisboa, CellFun/A-4244-2014; Mendes, Eduarda/E-1398-2015; AP, Francisco/M-4178-2013; Paulo, Alexandra/M-6683-2013; Rodrigues, Cecilia MP/M-3572-2013; Borralho, Pedro/AAJ-2829-2021; Lavrado, João MF/D-6757-2011; Paulo, Alexandra/AAE-3405-2020; Borralho, Pedro/C-2727-2011	Moreira, Rui/0000-0003-0727-9852; Mendes, Eduarda/0000-0002-7926-8821; AP, Francisco/0000-0001-6602-2075; Paulo, Alexandra/0000-0003-1433-5402; Rodrigues, Cecilia MP/0000-0002-4829-754X; Lavrado, João MF/0000-0001-7746-5808; Paulo, Alexandra/0000-0003-1433-5402; Brito, Hugo/0000-0002-4520-7203; Borralho, Pedro/0000-0003-4488-7240	Fundacao para a Ciencia e Tecnologia (FCT) Portugal [EXPL/QEQ-MED/0502/2012, HMSP-ICT/0018/2011, PEst-OE/SAU/UI4013/2014]; FCT [SFRH/BPD/72903/2010]; SAS [SFRH/BD/80162/2011]; Pancreatic Cancer Research Fund; Medical Research Council	Fundacao para a Ciencia e Tecnologia (FCT) Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); SAS; Pancreatic Cancer Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Authors from iMed-ULisboa acknowledge Fundacao para a Ciencia e Tecnologia (FCT), Portugal, for financial support through project grants EXPL/QEQ-MED/0502/2012, HMSP-ICT/0018/2011, and PEst-OE/SAU/UI4013/2014. HB, CMPR and PMB also thank Sociedade Portuguesa de Gastroenterologia and the Korea Human Gene Bank (KHGB), Medical Genomics Research Center, KRIBB, Republic of Korea. JL acknowledges FCT for the Post-Doctoral grant SFRH/BPD/72903/2010 and SAS for PhD grant SFRH/BD/80162/2011. The Neidle laboratory acknowledges support from the Pancreatic Cancer Research Fund and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Borralho PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023787; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Caprio V, 2000, BIOORG MED CHEM LETT, V10, P2063, DOI 10.1016/S0960-894X(00)00378-4; Capucha V, 2012, BIOORG MED CHEM LETT, V22, P6903, DOI 10.1016/j.bmcl.2012.09.029; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Collie GW, 2012, J AM CHEM SOC, V134, P2723, DOI 10.1021/ja2102423; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Faudale M, 2012, CHEM COMMUN, V48, P874, DOI 10.1039/c1cc15850c; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Krens LL, 2010, DRUG DISCOV TODAY, V15, P502, DOI 10.1016/j.drudis.2010.05.012; Lavrado J, 2010, CURR MED CHEM, V17, P2348, DOI 10.2174/092986710791698521; Lavrado J, 2013, CHEMMEDCHEM, V8, P1648, DOI 10.1002/cmdc.201300288; Lavrado J, 2010, BIOORG MED CHEM LETT, V20, P7042, DOI 10.1016/j.bmcl.2010.09.110; Lebedeva IV, 2007, ONCOGENE, V26, P733, DOI 10.1038/sj.onc.1209813; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Mansoor TA, 2013, J ETHNOPHARMACOL, V149, P463, DOI 10.1016/j.jep.2013.06.051; Monteiro AS, 2013, EUR J MED CHEM, V70, P1, DOI 10.1016/j.ejmech.2013.09.040; Moore MJB, 2006, J MED CHEM, V49, P582, DOI 10.1021/jm050555a; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Ohnmacht SA, 2014, BIOORG MED CHEM LETT, V24, P2602, DOI 10.1016/j.bmcl.2014.04.029; Ohnmacht SA, 2012, BIOORG MED CHEM LETT, V22, P5930, DOI 10.1016/j.bmcl.2012.07.065; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Paramasivam M, 2011, CHEM COMMUN, V47, P4965, DOI 10.1039/c1cc10269a; Perry MJ, 2009, EUR J MED CHEM, V44, P3228, DOI 10.1016/j.ejmech.2009.03.025; Silva TFS, 2012, DALTON T, V41, P12888, DOI 10.1039/c2dt11577h; Tsujii M, 2012, DIGESTION, V85, P99, DOI 10.1159/000334678; Wang JS, 2014, NUCLEIC ACIDS RES, V42, P3792, DOI 10.1093/nar/gkt1354; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	36	38	39	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126891	10.1371/journal.pone.0126891	http://dx.doi.org/10.1371/journal.pone.0126891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024321	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400025
J	Gomersall, S; Maher, C; English, C; Rowlands, A; Olds, T				Gomersall, Sjaan; Maher, Carol; English, Coralie; Rowlands, Alex; Olds, Tim			Time Regained: When People Stop a Physical Activity Program, How Does Their Time Use Change? A Randomised Controlled Trial	PLOS ONE			English	Article							HABIT; ACCELEROMETERS; VALIDATION; CHILDREN; WALKING; RECALL; SLEEP	The aim of this study was to investigate how previously inactive adults who had participated in a structured, partly supervised 6-week exercise program restructured their time budgets when the program ended. Using a randomised controlled trial design, 129 previously inactive adults were recruited and randomly allocated to one of three groups: a Moderate or Extensive six-week physical activity intervention (150 and 300 additional minutes of exercise per week, respectively) or a Control group. Additional physical activity was accumulated through both group and individual exercise sessions with a wide range of activities. Use of time and time spent in energy expenditure zones was measured using a computerised 24-h self-report recall instrument, the Multimedia Activity Recall for Children and Adults, and accelerometry at baseline, mid-and end-program and at 3-and 6-months follow up. At final follow up, all significant changes in time use domains had returned to within 20 minutes of baseline levels (Physical Activity 1-2 min/d, Active Transport 3-9 min/d, Self-Care 0-2 min/d, Television/Videogames 13-18 min/d in the Moderate and Extensive group, relative to Controls, respectively, p>0.05). Similarly, all significant changes in time spent in the moderate energy expenditure zone had returned to within 1-3 min/d baseline levels (p>0.05), however time spent in vigorous physical activity according to accelerometry estimates remained elevated, although the changes were small in magnitude (1 min/d in the Moderate and Extensive groups, relative to Controls, p=0.01). The results of this study demonstrate strong recidivist patterns in physical activity, but also in other aspects of time use. In designing and determining the effectiveness of exercise interventions, future studies would benefit from considering the whole profile of time use, rather than focusing on individual activities.	[Gomersall, Sjaan; Maher, Carol; Rowlands, Alex; Olds, Tim] Univ S Australia, Alliance Res Exercise Nutr & Phys Activ ARENA, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Gomersall, Sjaan] Univ Queensland, Sch Human Movement & Nutr Sci, Ctr Res Exercise Phys Activ & Hlth, Brisbane, Qld, Australia; [English, Coralie] Univ S Australia, Int Ctr Allied Hlth Evidence, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	University of South Australia; University of Queensland; University of South Australia	Gomersall, S (corresponding author), Univ S Australia, Alliance Res Exercise Nutr & Phys Activ ARENA, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.	s.gomersall1@uq.edu.au	Olds, Tim/A-1223-2008; Rowlands, Alex V/J-8878-2019; Rowlands, Alex/B-4543-2013; Gomersall, Sjaan/J-9665-2013; Maher, Carol/C-8169-2009; English, Coralie/D-4591-2009	Olds, Tim/0000-0001-6894-5519; Rowlands, Alex V/0000-0002-1463-697X; Rowlands, Alex/0000-0002-1463-697X; Gomersall, Sjaan/0000-0001-6808-0180; Maher, Carol/0000-0002-8676-0224; English, Coralie/0000-0001-5910-7927	National Health and Medical Research Council Project Grant [631916]	National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a National Health and Medical Research Council Project Grant (# 631916). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Abel MG, 2008, APPL PHYSIOL NUTR ME, V33, P1155, DOI [10.1139/H08-103, 10.1139/h08-103]; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Conroy MB, 2015, J GEN INTERN MED, V30, P207, DOI 10.1007/s11606-014-3077-5; Fjeldsoe B, 2011, HEALTH PSYCHOL, V30, P99, DOI 10.1037/a0021974; Foley LS, 2013, METABOLISM, V62, P163, DOI 10.1016/j.metabol.2012.07.021; Gomersall S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-851; Gomersall SR, 2015, J SCI MED SPORT, V18, P43, DOI 10.1016/j.jsams.2014.01.004; Gomersall SR, 2013, SPORTS MED, V43, P135, DOI 10.1007/s40279-012-0008-7; Gomersall SR, 2011, J SCI MED SPORT, V14, P143, DOI 10.1016/j.jsams.2010.08.006; Goodin RE, 2002, TIME PRESSURE ILUSIO; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hekler EB, 2013, HEALTH EDUC BEHAV, V40, p51S, DOI 10.1177/1090198113496787; Hillsdon M, 2005, Cochrane Database Syst Rev, pCD003180; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Liira H, 2014, SCAND J PRIM HEALTH, V32, P156, DOI 10.3109/02813432.2014.984967; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Norton LH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-133; Ridley K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-10; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Santos-Lozano A, 2012, MED ENG PHYS, V34, P787, DOI 10.1016/j.medengphy.2012.02.005; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; Sports Medicine Australia, 2009, SPORTS MED AUSTR PRE; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Van Dongen H.P., 2003, SLEEP BIOL RHYTHM, V1, P5, DOI [10.1046/j.1446-9235.2003.00006.x, DOI 10.1046/J.1446-9235.2003.00006.X]; Vanhelst Jeremy, 2012, BMC Res Notes, V5, P187, DOI 10.1186/1756-0500-5-187; Veerman JL, 2012, BRIT J SPORT MED, V46, P927, DOI [10.1136/bjsports-2011-085662, 10.1136/bjsm.2011.085662]; Weaver JB, 2003, PERS INDIV DIFFER, V35, P1427, DOI 10.1016/S0191-8869(02)00360-4; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	35	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126665	10.1371/journal.pone.0126665	http://dx.doi.org/10.1371/journal.pone.0126665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26023914	gold, Green Accepted, Green Published			2022-12-27	WOS:000355319400017
J	Li, MX; Bi, XY; Huang, Z; Zhao, JJ; Han, Y; Li, ZY; Zhang, YF; Li, Y; Chen, X; Hu, XH; Zhao, H; Cai, JQ				Li, Mu-xing; Bi, Xin-yu; Huang, Zhen; Zhao, Jian-jun; Han, Yue; Li, Zhi-yu; Zhang, Ye-fan; Li, Yuan; Chen, Xiao; Hu, Xu-hui; Zhao, Hong; Cai, Jian-qiang			Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; SIGNAL TRANSDUCER; TRANSCRIPTION 3; PHOSPHORYLATED STAT3; POOR-PROGNOSIS; CELL-SURVIVAL; UP-REGULATION; EXPRESSION; ACTIVATION; PATHWAY	Objective The definite prognostic role of p-STAT3 has not been well defined. We performed a meta-analysis evaluating the prognostic role of p-STAT3 expression in patients with digestive system cancers. Methods We searched the available articles reporting the prognostic value of p-STAT3 in patients with cancers of the digestive system, mainly including colorectal cancer, gastric cancer, hepatocellular carcinoma, esophagus cancer and pancreatic cancer. The pooled hazard ratios (HRs) with 95% confidence intervals (95% CIs) of overall survival (OS) and disease-free survival (DFS) were used to assess the prognostic role of p-STAT3 expression level in cancer tissues. And the association between p-STAT3 expression and clinicopathological characteristics was evaluated. Results A total of 22 studies with 3585 patients were finally enrolled in the meta-analysis. The results showed that elevated p-STAT3 expression level predicted inferior OS (HR=1.809, 95% CI: 1.442-2.270, P<0.001) and DFS (HR=1.481, 95% CI: 1.028-2.133, P=0.035) in patients with malignant cancers of the digestive system. Increased expression of p-STAT3 is significantly related with tumor cell differentiation (Odds ratio (OR)=1.895, 95% CI: 1.364-2.632, P<0.001) and lymph node metastases (OR=2.108, 95% CI: 1.104-4.024, P=0.024). Sensitivity analysis suggested that the pooled HR was stable and omitting a single study did not change the significance of the pooled HR. Funnel plots and Egger's tests revealed there was no significant publication bias in the meta-analysis. Conclusion Phospho-STAT3 might be a prognostic factor of patients with digestive system cancers. More well designed studies with adequate follow-up are needed to gain a thorough understanding of the prognostic role of p-STAT3.	[Li, Mu-xing; Bi, Xin-yu; Huang, Zhen; Zhao, Jian-jun; Li, Zhi-yu; Zhang, Ye-fan; Li, Yuan; Chen, Xiao; Hu, Xu-hui; Zhao, Hong; Cai, Jian-qiang] Chinese Acad Med Sci, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China; [Li, Mu-xing; Bi, Xin-yu; Huang, Zhen; Zhao, Jian-jun; Han, Yue; Li, Zhi-yu; Zhang, Ye-fan; Li, Yuan; Chen, Xiao; Hu, Xu-hui; Zhao, Hong; Cai, Jian-qiang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Han, Yue] Chinese Acad Med Sci, Canc Hosp, Dept Radiofrequency Ablat, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Cai, JQ (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Abdominal Surg Oncol, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.	caijianqiang@cicams.ac.cn			State Key Project on Infection Diseases of China [2012ZX10002016]	State Key Project on Infection Diseases of China	This work was supported by The State Key Project on Infection Diseases of China (Grant No. 2012ZX10002016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Chen SH, 2008, CANCER BIOL THER, V7, P1994, DOI 10.4161/cbt.7.12.6967; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Deng JY, 2010, WORLD J GASTROENTERO, V16, P5380, DOI 10.3748/wjg.v16.i42.5380; Deng JY, 2013, TUMOR BIOL, V34, P2791, DOI 10.1007/s13277-013-0837-5; Denley SM, 2013, J GASTROINTEST SURG, V17, P887, DOI 10.1007/s11605-013-2168-7; Dobi E, 2013, CLIN COLORECTAL CANC, V12, P28, DOI 10.1016/j.clcc.2012.09.002; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Huang C, 2012, NEOPLASMA, V59, P52, DOI 10.4149/neo_2012_007; Idikio HA, 2010, INT J CLIN EXP PATHO, V3, P169; Inokuchi M, 2011, EXP THER MED, V2, P251, DOI 10.3892/etm.2011.187; Koperek O, 2014, APMIS, V122, P476, DOI 10.1111/apm.12194; Kothmaier H, 2011, ARCH PATHOL LAB MED, V135, P744, DOI 10.1043/2009-0676-OA.1; Kusaba T, 2006, ONCOL REP, V15, P1445; Lavecchia A, 2014, EXPERT OPIN THER PAT, V24, P383, DOI 10.1517/13543776.2014.877443; Lee J, 2009, APMIS, V117, P598, DOI 10.1111/j.1600-0463.2009.02512.x; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mano Y, 2013, PATHOBIOLOGY, V80, P146, DOI 10.1159/000346196; Monnien F, 2010, J CLIN PATHOL, V63, P873, DOI 10.1136/jcp.2010.076414; Morikawa T, 2011, CLIN CANCER RES, V17, P1452, DOI 10.1158/1078-0432.CCR-10-2694; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Schoppmann SF, 2012, CLIN EXP METASTAS, V29, P615, DOI 10.1007/s10585-012-9475-3; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song YY, 2014, ONCOL LETT, V8, P431, DOI 10.3892/ol.2014.2059; Sonnenblick A, 2012, CLIN TRANSL ONCOL, V14, P232, DOI 10.1007/s12094-012-0789-z; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Wang M, 2011, EXP THER MED, V2, P517, DOI 10.3892/etm.2011.235; Woo S, 2011, PATHOBIOLOGY, V78, P295, DOI 10.1159/000321696; Wu LJ, 2014, INT J CLIN EXP PATHO, V7, P1140; Wu WY, 2011, EXP THER MED, V2, P647, DOI 10.3892/etm.2011.254; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Xiong H, 2012, J MOL MED, V90, P1037, DOI 10.1007/s00109-012-0869-0; Yakata Y, 2007, INT J ONCOL, V30, P437; You ZB, 2012, CLIN TRANSL ONCOL, V14, P143, DOI 10.1007/s12094-012-0774-6; Zhang CH, 2012, J SURG RES, V174, P120, DOI 10.1016/j.jss.2010.10.030; Zhang HF, 2014, CANCERS, V6, P1408, DOI 10.3390/cancers6031408	46	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127356	10.1371/journal.pone.0127356	http://dx.doi.org/10.1371/journal.pone.0127356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024373	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400037
J	Sohn, DH; Sohn, HJ; Lee, HJ; Lee, SD; Kim, S; Hyun, SJ; Cho, HI; Cho, SG; Lee, SK; Kim, TG				Sohn, Dae-Hee; Sohn, Hyun-Jung; Lee, Hyun-Joo; Lee, Seon-Duk; Kim, Sueon; Hyun, Seung-Joo; Cho, Hyun-Il; Cho, Seok-Goo; Lee, Suk-Kyeong; Kim, Tai-Gyu			Measurement of CD8(+) and CD4(+) T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; MHC CLASS-II; IMMUNE-RESPONSE; ANTIGEN; LYMPHOCYTES; IMMUNODOMINANCE; CD40; RECOGNITION; ASSOCIATION; MONOCYTES	An EBV-specific cellular immune response is associated with the control of EBV-associated malignancies and lymphoproliferative diseases, some of which have been successfully treated by adoptive T cell therapy. Therefore, many methods have been used to measure EBV-specific cellular immune responses. Previous studies have mainly used autologous EBV-transformed B-lymphoblastoid cell lines (B-LCLs), recombinant viral vectors transfected or peptide pulsed dendritic cells (DCs) as stimulators of CD8(+) and CD4(+) T lymphocytes. In the present study, we used an interferon-gamma (IFN-gamma) enzyme-linked immunospot (ELISPOT) assay by using isolated CD8(+) and CD4(+) T cells stimulated with mRNA-transfected DCs. The frequency of latent membrane protein 1 (LMP1)-specific IFN-gamma producing CD4(+) T cells was significantly higher than that of LMP2a. The frequency of IFN-gamma producing CD4(+) T cells was significantly correlated with that of CD8(+) T cells in LMP1-specific immune responses (r = 0.7187, Pc < 0.0001). To determine whether there were changes in LMP1- or LMP2a-specific immune responses, subsequent peripheral blood mononuclear cells (PBMCs) samples were analyzed. Significant changes were observed in 5 of the 10 donors examined, and CD4(+) T cell responses showed more significant changes than CD8(+) T cell responses. CD8(+) and CD4(+) T cells from EBV-seropositive donors secreted only the Th1 cytokines IFN-gamma, TNF-alpha, and IL-2, while Th2 (IL-4) and Th17 (IL-17a) cytokines were not detected. CD4(+) T cells secreted significantly higher cytokine levels than did CD8(+) T cells. Analysis of EBV-specific T cell responses using autologous DCs transfected with mRNA might provide a comprehensive tool for monitoring EBV infection and new insights into the pathogenesis of EBV-associated diseases.	[Sohn, Dae-Hee; Hyun, Seung-Joo; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Sohn, Hyun-Jung; Lee, Hyun-Joo; Lee, Seon-Duk; Kim, Sueon; Cho, Hyun-Il; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Hematopoiet Stem Cell Bank, Seoul, South Korea; [Cho, Hyun-Il; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Canc Res Inst, Seoul, South Korea; [Cho, Seok-Goo] Catholic Univ Korea, Coll Med, Dept Internal Med, Dept Hematol, Seoul, South Korea; [Lee, Suk-Kyeong] Catholic Univ Korea, Coll Med, Dept Med Lifesci, Res Inst Immunobiol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kim, TG (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.	kimtg@catholic.ac.kr	Lee, Suk Kyeong/ABD-6402-2020	Cho, Seok-Goo/0000-0002-5429-4839; KIM, SUEON/0000-0003-2591-5357; Lee, Suk Kyeong/0000-0002-3751-7682	Ministry of Health & Welfare, Republic of Korea [HI12C0718]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2065937]; Korean Health Technology RD Project	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea); Korean Health Technology RD Project	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0718) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2065937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000583; Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Bickham K, 2001, J CLIN INVEST, V107, P121, DOI 10.1172/JCI10209; Calarota SA, 2013, IMMUNOLOGY, V139, P533, DOI 10.1111/imm.12106; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chen MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00005; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Depil S, 2007, J IMMUNOTHER, V30, P215, DOI 10.1097/01.cji.0000211338.99137.4f; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Gahn B, 2001, INT J CANCER, V93, P706, DOI 10.1002/ijc.1396; Gaudreault E, 2007, J VIROL, V81, P8016, DOI 10.1128/JVI.00403-07; Gordillo GM, 1999, TRANSPL IMMUNOL, V7, P83, DOI 10.1016/S0966-3274(99)80024-0; Gottschalk S, 2003, BLOOD, V101, P1905, DOI 10.1182/blood-2002-05-1514; Gurer C, 2008, BLOOD, V112, P1231, DOI 10.1182/blood-2008-03-148072; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; James JA, 2006, CURR OPIN RHEUMATOL, V18, P462, DOI 10.1097/01.bor.0000240355.37927.94; Kalady MF, 2002, J SURG RES, V105, P17, DOI 10.1006/jsre.2002.6435; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kieff E, EPSTEIN BARR VIRUS A; Kobayashi H, 2008, CANCER RES, V68, P901, DOI 10.1158/0008-5472.CAN-07-3212; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kuball J, 2002, GENE THER, V9, P833, DOI 10.1038/sj.gt.3301709; Kuzushima K, 1999, BLOOD, V94, P3094, DOI 10.1182/blood.V94.9.3094.421k14_3094_3100; Leen A, 2001, J VIROL, V75, P8649, DOI 10.1128/JVI.75.18.8649-8659.2001; Leung C, 2013, EUR J IMMUNOL, V43, P2246, DOI 10.1002/eji.201343815; Lin XR, 2008, CANCER IMMUNOL IMMUN, V57, P963, DOI 10.1007/s00262-007-0427-8; Lunemann JD, 2008, J IMMUNOL, V181, P991, DOI 10.4049/jimmunol.181.2.991; McAulay KA, 2009, J IMMUNOL, V182, P3892, DOI 10.4049/jimmunol.0803572; Meij P, 2002, INT J CANCER, V99, P93, DOI 10.1002/ijc.10309; MEIXLSPERGER S, 2013, BLOOD, V121, P5034, DOI DOI 10.1182/BL00D-2012-12-473413; Morales O, 2012, J IMMUNOTHER, V35, P254, DOI 10.1097/CJI.0b013e31824d72c5; Munz C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00308; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Ning RJ, 2011, IMMUNOLOGY, V134, P161, DOI 10.1111/j.1365-2567.2011.03476.x; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Salvetti M, 2009, CURR OPIN NEUROL, V22, P201, DOI 10.1097/WCO.0b013e32832b4c8d; Severa M, 2013, EUR J IMMUNOL, V43, P147, DOI 10.1002/eji.201242552; Steigerwald-Mullen P, 2000, J VIROL, V74, P6748, DOI 10.1128/JVI.74.15.6748-6759.2000; Strobel I, 2000, GENE THER, V7, P2028, DOI 10.1038/sj.gt.3301326; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Sun Q, 2002, BLOOD, V99, P3302, DOI 10.1182/blood.V99.9.3302; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Vogl BA, 2012, J MED VIROL, V84, P119, DOI 10.1002/jmv.22258; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Yang J, 2000, BLOOD, V95, P241, DOI 10.1182/blood.V95.1.241.001a19_241_248; Younesi V, 2014, CYTOTECHNOLOGY, V66, P95, DOI 10.1007/s10616-013-9542-x; Zhai YF, 1996, J IMMUNOL, V156, P700	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127899	10.1371/journal.pone.0127899	http://dx.doi.org/10.1371/journal.pone.0127899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023769	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400058
J	Guo, JB; Zhu, Y; Chen, BL; Xie, B; Zhang, WY; Yang, YJ; Yue, YS; Wang, XQ				Guo, Jia-Bao; Zhu, Yi; Chen, Bing-Lin; Xie, Bin; Zhang, Wen-Yi; Yang, Yu-Jie; Yue, Yu-Shan; Wang, Xue-Qiang			Surgical Versus Non-Surgical Treatment for Vertebral Compression Fracture with Osteopenia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; PERCUTANEOUS VERTEBROPLASTY; BALLOON KYPHOPLASTY; RANDOMIZED-TRIAL; PAIN; OUTCOMES; WOMEN; OSTEOPOROSIS; REDUCTION; EXERCISE	Background Surgical and non-surgical interventions are the two categories for treatment of vertebral compression fractures (VCFs). However, there is clinical uncertainty over optimal management. This study aimed to examine the safety and effectiveness of surgical management for treatment of VCFs with osteopenia compared with non-surgical treatment. Methods We conducted a systematic search through electronic databases from inception to June 2014, with no limits on study data or language. Randomized controlled trials (RCTs) evaluating surgical versus non-surgical interventions for treatment of patients with VCFs due to osteopenia were considered. Primary outcomes were pain and adverse effects. A random-effects model was used to calculate the pooled mean difference (MD) or risk ratios with 95% confidence interval (CI). Results Sixteen reports (11 studies) met the inclusion criteria, and provided data for the meta-analysis with a total of 1,401 participants. Compared with conservative treatment, surgical treatment was more effective in reducing pain (short-term: MD -2.05, 95% CI -3.55 to -0.56, P=0.007; mid-term: MD -1.70, 95% CI -2.78 to -0.62, P=0.002; long-term: MD -1.24, 95% CI -2.20 to -0.29, P=0.01) and disability on the Roland-Morris Disability score (short-term: MD -4.97, 95% CI -8.71 to -1.23, P=0.009), as well as improving quality of life on the Short-Form 36 Physical Component Summary score (short-term: MD 5.53, 95% CI 1.45 to 9.61, P=0.008) and the Quality of Life Questionnaire of the European Foundation for Osteoporosis score (short-term: MD -5.01, 95% CI -8.11 to -1.91, P=0.002). Indirect comparisons between vertebroplasty and kyphoplasty found no evidence that the treatment effect differed across the two interventions for any outcomes assessed. Compared with the sham procedure, surgical treatment showed no evidence of improvement in pain relief and physical function. Based on these two comparisons, no significant difference between groups was noted in the pooled results for adverse events. Conclusion Compared to conservative treatment, surgical treatment was more effective in decreasing pain in the short, mid and long terms. However, no significant mid- and long-term differences in physical function and quality of life was observed. Little good evidence is available for surgical treatment compared with that for sham procedure. PV and BK are currently used to treat VCFs with osteopenia, with little difference in treatment effects. Evidence of better quality and from a larger sample size is required before a recommendation can be made.	[Guo, Jia-Bao; Zhu, Yi; Xie, Bin; Zhang, Wen-Yi; Yang, Yu-Jie; Yue, Yu-Shan] Nanjing Univ Chinese Med, Sch Clin Med 2, Nanjing, Jiangsu, Peoples R China; [Chen, Bing-Lin; Wang, Xue-Qiang] Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China	Nanjing University of Chinese Medicine; Shanghai University of Sport	Wang, XQ (corresponding author), Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China.	qiang897@163.com	Wang, Xueqiang/GPW-9671-2022		Key Laboratory of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport; Innovation Program of Shanghai Municipal Education Commission [15ZZ084]; Shanghai Committee of Science and Technology [14490503800]; Shanghai Youth Science and Technology Sail Project [15YF1411400]	Key Laboratory of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Youth Science and Technology Sail Project	This work was supported by Key Laboratory of Exercise and Health Sciences of Ministry of Education, Shanghai University of Sport, Innovation Program of Shanghai Municipal Education Commission (15ZZ084), Shanghai Committee of Science and Technology (14490503800), and Shanghai Youth Science and Technology Sail Project (15YF1411400).	Aebi M, 2009, EUR SPINE J, V18, P1247, DOI 10.1007/s00586-009-1164-9; Berenson J, 2011, LANCET ONCOL, V12, P225, DOI 10.1016/S1470-2045(11)70008-0; Blasco J, 2012, J BONE MINER RES, V27, P1159, DOI 10.1002/jbmr.1564; Boonen S, 2011, J BONE MINER RES, V26, P1627, DOI 10.1002/jbmr.364; Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P637, DOI 10.1007/s00198-005-0015-8; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; [曹立颖 Cao Liying], 2012, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V18, P516; Chen G, 2010, J CERVICODYNIA LUMBO, V31, P323; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Comstock BA, 2013, RADIOLOGY, V269, P224, DOI 10.1148/radiol.13120821; Connolly LJ, 2014, J SPORT HEALTH SCI, V3, P284, DOI 10.1016/j.jshs.2014.07.003; Deramond H, 1999, BONE, V25, p17S, DOI 10.1016/S8756-3282(99)00127-1; Farrokhi MR, 2011, J NEUROSURG-SPINE, V14, P561, DOI 10.3171/2010.12.SPINE10286; Fritzell P, 2011, SPINE, V36, P2243, DOI 10.1097/BRS.0b013e3182322d0f; GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Garfin SR, 2006, SPINE, V31, P2213, DOI 10.1097/01.brs.0000232803.71640.ba; Grafe IA, 2005, OSTEOPOROSIS INT, V16, P2005, DOI 10.1007/s00198-005-1982-5; Green AD, 2004, JAMA-J AM MED ASSOC, V292, P2890, DOI 10.1001/jama.292.23.2890; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kallmes D, 2009, AM J NEURORADIOL, V30, P1809, DOI 10.3174/ajnr.A1887; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Kendall KL, 2014, J SPORT HEALTH SCI, V3, P170, DOI 10.1016/j.jshs.2014.02.001; Klazen CAH, 2010, AM J NEURORADIOL, V31, P1447, DOI 10.3174/ajnr.A2148; Klazen CAH, 2010, LANCET, V376, P1085, DOI 10.1016/S0140-6736(10)60954-3; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Li RN, 2014, J SPORT HEALTH SCI, V3, P153, DOI 10.1016/j.jshs.2014.06.001; Liu JT, 2013, PAIN PHYSICIAN, V16, P455; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; McGraw JK, 2002, J VASC INTERV RADIOL, V13, P883, DOI 10.1016/S1051-0443(07)61770-9; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Munk PL, 2009, CAN ASSOC RADIOL J, V60, P170, DOI 10.1016/j.carj.2009.08.001; Paquette MR, 2014, J SPORT HLT IN PRESS; Rousing R, 2010, SPINE, V35, P478, DOI 10.1097/BRS.0b013e3181b71bd1; Rousing Rikke, 2009, Spine (Phila Pa 1976), V34, P1349, DOI 10.1097/BRS.0b013e3181a4e628; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Silverman SL, 2001, ARTHRITIS RHEUM, V44, P2611, DOI 10.1002/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N; Staples MP, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3952; [田征 TIAN Zheng], 2008, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V14, P396; Voormolen MHJ, 2007, AM J NEURORADIOL, V28, P555; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; [谢恩 XIE En], 2011, [中华创伤骨科杂志, Chinese Journal of Orthopaedic Trauma], V13, P719; [徐建成 Xu Jiancheng], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P2366	45	26	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127145	10.1371/journal.pone.0127145	http://dx.doi.org/10.1371/journal.pone.0127145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020950	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300033
J	Hedrick, E; Lee, SO; Kim, G; Abdelrahim, M; Jin, UH; Safe, S; Abudayyeh, A				Hedrick, Erik; Lee, Syng-Ook; Kim, Gyungeun; Abdelrahim, Maen; Jin, Un-Ho; Safe, Stephen; Abudayyeh, Ala			Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma	PLOS ONE			English	Article							CANCER; CARCINOMA; THERAPY; BCL-2; PROTECTOR; SELECTION; STRESS; TR3	The orphan nuclear receptor NR4A1 exhibits pro-oncogenic activity in cancer cell lines. NR4A1 activates mTOR signaling, regulates genes such as thioredoxin domain containing 5 and isocitrate dehydrogenase 1 that maintain low oxidative stress, and coactivates specificity protein 1 (Sp1)-regulated pro-survival and growth promoting genes. Transfection of renal cell carcinoma (RCC) ACHN and 786-O cells with oligonucleotides that target NR4A1 results in a 40-60% decrease in cell proliferation and induction of apoptosis. Moreover, knockdown of NR4A1 in RCC cells decreased bcl-2, survivin and epidermal growth factor receptor expression, inhibited of mTOR signaling, induced oxidative and endoplasmic reticulum stress, and decreased TXNDC5 and IDH1. We have recently demonstrated that selected 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methane (C-DIM) compounds including the p-hydroxyphenyl (DIM-C-pPhOH) and p-carboxymethyl (DIM-C-pPhCO(2)Me) analogs bind NR4A1 and act as antagonists. Both DIM-C-pPhOH and DIM-C-pPhCO(2)Me inhibited growth and induced apoptosis in ACHN and 786-O cells, and the functional and genomic effects of the NR4A1 antagonists were comparable to those observed after NR4A1 knockdown. These results indicate that NR4A1 antagonists target multiple growth promoting and pro-survival pathways in RCC cells and in tumors (xenograft) and represent a novel chemotherapy for treating RCC.	[Hedrick, Erik; Jin, Un-Ho; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Lee, Syng-Ook] Keimyung Univ, Dept Food Sci & Technol, Daegu, South Korea; [Kim, Gyungeun; Jin, Un-Ho; Safe, Stephen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Abdelrahim, Maen] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA; [Abudayyeh, Ala] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Keimyung University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu; aabudayyeh@mdanderson.org		Lee, Syng-Ook/0000-0002-8958-8634	MD Anderson Cancer Center (Kidney Cancer Research Program); National Institutes of Health [P30ES023512]; Sid Kyle Endowment; Texas AgriLife; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	MD Anderson Cancer Center (Kidney Cancer Research Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sid Kyle Endowment; Texas AgriLife; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by the MD Anderson Cancer Center (Kidney Cancer Research Program) (AA), National Institutes of Health (P30ES023512) (SS), the Sid Kyle Endowment (SS), and Texas AgriLife (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2013, INT J UROL, V20, P944, DOI 10.1111/iju.12187; Balasubramanian S, 2012, J AM SOC NEPHROL, V23, P674, DOI 10.1681/ASN.2011070646; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Choi JW, 2004, CANCER RES, V64, P35, DOI 10.1158/0008-5472.CAN-03-0145; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Coppin C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001425.pub2; Dordevic G, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-40; Escudier B, 2012, NAT REV CLIN ONCOL, V9, P327, DOI 10.1038/nrclinonc.2012.59; Ferlini C, 2009, CANCER RES, V69, P6906, DOI 10.1158/0008-5472.CAN-09-0540; Fishman MN, 2013, CANCER CONTROL, V20, P222, DOI 10.1177/107327481302000310; Hayashi K, 1996, MOL CELL ENDOCRINOL, V123, P205, DOI 10.1016/S0303-7207(96)03909-3; Hirai Y, 2006, BIOL PHARM BULL, V29, P1064, DOI 10.1248/bpb.29.1064; Jantzer P, 1998, CANCER RES, V58, P3078; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; Lee SO, 2014, MOL ENDOCRINOL, V28, P1729, DOI 10.1210/me.2014-1102; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li X, 2007, HISTOPATHOLOGY, V50, P484, DOI 10.1111/j.1365-2559.2007.02637.x; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Mattei J, 2014, CANCER LETT, V343, P156, DOI 10.1016/j.canlet.2013.09.038; Matusan-Ilijas K, 2013, CLIN TRANSL ONCOL, V15, P65, DOI 10.1007/s12094-012-0889-9; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mittal K, 2013, NAT REV UROL, V10, P70, DOI 10.1038/nrurol.2012.256; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 1997, CURR PROB CANCER, V21, P191, DOI 10.1016/S0147-0272(97)80007-4; Negrier S, 1998, NEW ENGL J MED, V338, P1272, DOI 10.1056/NEJM199804303381805; Okamura K, 2009, CANCER EPIDEMIOL, V33, P137, DOI 10.1016/j.canep.2009.06.005; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Phuoc NB, 2007, UROLOGY, V69, P843, DOI 10.1016/j.urology.2007.01.069; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sourbier C, 2010, CELL CYCLE, V9, P4183, DOI 10.4161/cc.9.20.13458; Wang WJ, 2014, NAT CHEM BIOL, V10, P133, DOI [10.1038/nchembio.1406, 10.1038/NCHEMBIO.1406]; Yoshimura K, 2013, INT J UROL, V20, P744, DOI 10.1111/iju.12147; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69; Zhao BX, 2006, EMBO J, V25, P5703, DOI 10.1038/sj.emboj.7601435	43	44	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128308	10.1371/journal.pone.0128308	http://dx.doi.org/10.1371/journal.pone.0128308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035713	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100032
J	Hwang, JJ; Johnson, A; Cline, G; Belfort-DeAguiar, R; Snegovskikh, D; Khokhar, B; Han, CS; Sherwin, RS				Hwang, Janice J.; Johnson, Andrea; Cline, Gary; Belfort-DeAguiar, Renata; Snegovskikh, Denis; Khokhar, Babar; Han, Christina S.; Sherwin, Robert S.			Fructose Levels Are Markedly Elevated in Cerebrospinal Fluid Compared to Plasma in Pregnant Women	PLOS ONE			English	Article							ERYTHROCYTE ALDOSE REDUCTASE; DIABETIC-RETINOPATHY; OXIDATIVE STRESS; SORBITOL PATHWAY; BRAIN; GLUCOSE; METABOLISM; BLOOD; COMPLICATIONS; HYPERGLYCEMIA	Background Fructose, unlike glucose, promotes feeding behavior in rodents and its ingestion exerts differential effects in the human brain. However, plasma fructose is typically 1/1000th of glucose levels and it is unclear to what extent fructose crosses the blood-brain barrier. We investigated whether local endogenous central nervous system (CNS) fructose production from glucose via the polyol pathway (glucose-->sorbitol-->fructose) contributes to brain exposure to fructose. Methods In this observational study, fasting glucose, sorbitol and fructose concentrations were measured using gas-chromatography-liquid mass spectroscopy in cerebrospinal fluid (CSF), maternal plasma, and venous cord blood collected from 25 pregnant women (6 lean, 10 overweight/obese, and 9 T2DM/gestational DM) undergoing spinal anesthesia and elective cesarean section. Results As expected, CSF glucose was similar to 60% of plasma glucose levels. In contrast, fructose was nearly 20-fold higher in CSF than in plasma (p < 0.001), and CSF sorbitol was similar to 9-times higher than plasma levels (p < 0.001). Moreover, CSF fructose correlated positively with CSF glucose (rho 0.45, p = 0.02) and sorbitol levels (rho 0.75, p < 0.001). Cord blood sorbitol was also similar to 7-fold higher than maternal plasma sorbitol levels (p = 0.001). There were no differences in plasma, CSF, and cord blood glucose, fructose, or sorbitol levels between groups. Conclusions These data raise the possibility that fructose may be produced endogenously in the human brain and that the effects of fructose in the human brain and placenta may extend beyond its dietary consumption.	[Hwang, Janice J.; Cline, Gary; Belfort-DeAguiar, Renata; Sherwin, Robert S.] Yale Univ, Sch Med, Div Endocrinol, New Haven, CT 06520 USA; [Johnson, Andrea; Han, Christina S.] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA; [Snegovskikh, Denis] Yale Univ, Sch Med, Dept Anesthesia, New Haven, CT USA; [Khokhar, Babar] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Sherwin, RS (corresponding author), Yale Univ, Sch Med, Div Endocrinol, New Haven, CT 06520 USA.	Robert.sherwin@yale.edu	Han, Christina S/AAC-8967-2019; Hwang, Janice/AAG-5138-2021	Han, Christina S/0000-0003-1627-3057; 	National Institues of Health [DK20495, K12 HD047018, KL2 TR000140]; Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020495, R37DK020495, P30DK045735, T32DK007058] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Fellows Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding supporting this work includes the National Institues of Health DK20495 (RSS), K12 HD047018 (CSH), KL2 TR000140, Endocrine Fellows Foundation (JJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRITTON HG, 1967, BIOCHIM BIOPHYS ACTA, V136, P426, DOI 10.1016/0304-4165(67)90002-5; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; CLEMENTS RS, 1968, LANCET, V2, P384; DAS B, 1985, DIABETES, V34, P1145, DOI 10.2337/diabetes.34.11.1145; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; GREENE DA, 1987, NEW ENGL J MED, V316, P599; Gruetter R, 1996, J CEREBR BLOOD F MET, V16, P427, DOI 10.1097/00004647-199605000-00009; GRUETTER R, 1992, P NATL ACAD SCI USA, V89, P1109, DOI 10.1073/pnas.89.3.1109; Hashimoto F, 2013, EARLY HUM DEV, V89, P315, DOI 10.1016/j.earlhumdev.2012.10.010; Hers, 1957, METABOLISME FRUCTOSE; HERS HG, 1960, BIOCHIM BIOPHYS ACTA, V37, P127, DOI 10.1016/0006-3002(60)90086-X; Hubbard RS, 1937, J BIOL CHEM, V119, P647; Ito T, 1997, DIABETES RES CLIN PR, V36, P161, DOI 10.1016/S0168-8227(97)00046-6; Jauniaux E, 2005, J CLIN ENDOCR METAB, V90, P1171, DOI 10.1210/jc.2004-1513; JEFFERY J, 1983, P NATL ACAD SCI-BIOL, V80, P901, DOI 10.1073/pnas.80.4.901; KADOR PF, 1981, ANAL BIOCHEM, V114, P53, DOI 10.1016/0003-2697(81)90450-4; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Lakhan SE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-114; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; MARGOLIS RU, 1972, BRAIN RES, V38, P371, DOI 10.1016/0006-8993(72)90719-6; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; NAKADA T, 1986, J NEUROCHEM, V46, P198, DOI 10.1111/j.1471-4159.1986.tb12945.x; NISHIMURA C, 1994, DIABETOLOGIA, V37, P328, DOI 10.1007/s001250050113; Nishimura C, 1997, DIABETES RES CLIN PR, V37, P173, DOI 10.1016/S0168-8227(97)00079-X; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; PROCKOP LD, 1971, ARCH NEUROL-CHICAGO, V25, P126, DOI 10.1001/archneur.1971.00490020044005; SAMANTA BK, 1984, EXPERIENTIA, V40, P1420, DOI 10.1007/BF01951922; SPINOWITZ BS, 1973, DIABETES, V22, P820, DOI 10.2337/diab.22.11.820; Sullivan JS, 2014, PEDIAT OBES; Tang WH, 2014, CIRCULATION, V129, P1598, DOI 10.1161/CIRCULATIONAHA.113.005224; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; Tang WH, 2011, J CLIN INVEST, V121, P4462, DOI 10.1172/JCI59291; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Trindade CEP, 2011, EARLY HUM DEV, V87, P193, DOI 10.1016/j.earlhumdev.2010.12.005; Vedantham S, 2014, DIABETES, V63, P761, DOI 10.2337/db13-0032; WICK AN, 1951, AM J PHYSIOL, V166, P421, DOI 10.1152/ajplegacy.1951.166.2.421; Wray H L, 1966, Diabetologia, V2, P82, DOI 10.1007/BF00423014; Wuest M, 2011, NUCL MED BIOL, V38, P461, DOI 10.1016/j.nucmedbio.2010.11.004	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128582	10.1371/journal.pone.0128582	http://dx.doi.org/10.1371/journal.pone.0128582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035307	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100037
J	Zhang, N; Zou, LQ; Huang, Y; Liu, DX; Tang, YK; Fan, ZY; Chen, HW; Liu, X				Zhang, Na; Zou, Liqiu; Huang, Yi; Liu, Dexiang; Tang, Yukuan; Fan, Zhaoyang; Chen, Hanwei; Liu, Xin			Non-Contrast Enhanced MR Angiography (NCE-MRA) of the Calf: A Direct Comparison between Flow-Sensitive Dephasing (FSD) Prepared Steady-State Free Precession (SSFP) and Quiescent-Interval Single-Shot (QISS) in Patients with Diabetes	PLOS ONE			English	Article							DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; PERIPHERAL VASCULAR-DISEASE; DISTAL LOWER-EXTREMITIES; OCCLUSIVE DISEASE; ARTERIAL-DISEASE; GADODIAMIDE	Objectives To compare the image quality and diagnostic performance of two non-contrast enhanced MR angiography (NCE-MRA) techniques using flow-sensitive dephasing (FSD) prepared steady-state free precession (SSFP) and quiescent-interval single-shot (QISS) for the calf arteries in patients with diabetes. Materials and Methods Twenty six patients underwent the two NCE-MRA techniques followed by contrast-enhanced MRA (CE-MRA) of lower extremity on a 1.5T MR system. Image quality scores, arterial stenosis scores, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), vessel sharpness, and diagnostic accuracy for detecting more than 50% arterial stenosis were evaluated and statistically compared using CE-MRA as the reference standard. Results All examinations were performed successfully. Of the total 153 calf arterial segments obtained in the 26 patients, FSD and QISS showed no significant difference in the number of diagnostic arterial segments (151 [98%] vs. 147 [96%], respectively, P>0.05). The image quality of FSD was higher than that of QISS in the peroneal artery and posterior tibial artery (P<0.05), but no significant difference in the anterior tibial artery (P>0.05). SNR and CNR of FSD were higher than those of QISS (P<0.01), while FSD showed comparable vessel sharpness compared with QISS (P>0.05). The time efficiency of SNR and CNR between FSD and QISS showed no significant difference when taking into account the times for FSD-related scout scans. There was no difference in sensitivity (95% vs. 93%, P>0.05) and negative predictive value (98% vs. 97%, P>0.05) between FSD and QISS for detecting stenosis greater than 50%. However, FSD showed higher specificities (99% vs. 92%, P<0.05) and diagnostic accuracy (98% vs. 92%, P<0.05) compared to QISS. Conclusion Both FSD and QISS had similar high sensitivity and negative predictive value for detecting calf arteries with over 50% stenosis, but FSD showed slightly higher diagnostic specificity and better depiction of arterial lesions due to its isotropic submillimeter spatial resolution. QISS, being an easier to use and less time-consuming technique, could be a method of choice for rapid screening of arterial disease of the lower extremity.	[Zhang, Na; Liu, Xin] Chinese Acad Sci, Lauterbur Res Ctr Biomed Imaging, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Zhang, Na; Liu, Xin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab MRI, Shenzhen, Peoples R China; [Zou, Liqiu] Peking Univ, Shenzhen Hosp, Dept Radiol, Shenzhen, Peoples R China; [Huang, Yi; Liu, Dexiang; Tang, Yukuan; Chen, Hanwei] Guangzhou Panyu Cent Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Fan, Zhaoyang] Cedars Sinai Med Ctr, Biomed Imaging Res Inst, Los Angeles, CA 90048 USA	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Peking University; Cedars Sinai Medical Center	Chen, HW (corresponding author), Guangzhou Panyu Cent Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	hwchengd@hotmail.com; xin.liu@siat.ac.cn			National Natural Science Foundation of China [81120108012, 81327801, 81301216]; National Basic Research Program 973 [2011CB707903]; Key Project of Shenzhen Basic Research Program [JC201005270317A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program 973(National Basic Research Program of China); Key Project of Shenzhen Basic Research Program	This work was supported in part by the National Natural Science Foundation of China [Grant Number 81120108012, 81327801, and 81301216], National Basic Research Program 973 [Grant Number 2011CB707903], and Key Project of Shenzhen Basic Research Program [Grant Number JC201005270317A].	Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; BAUM RA, 1995, JAMA-J AM MED ASSOC, V274, P875, DOI 10.1001/jama.274.11.875; Burbelko M, 2013, J MAGN RESON IMAGING, V37, P1427, DOI 10.1002/jmri.23944; Dewey M, 2006, ANN INTERN MED, V145, P407, DOI 10.7326/0003-4819-145-6-200609190-00004; Diop AD, 2013, AM J ROENTGENOL, V200, P1145, DOI 10.2214/AJR.12.8730; Edelman RR, 2010, MAGN RESON MED, V63, P951, DOI 10.1002/mrm.22287; Fan ZY, 2012, MAGN RESON MED, V67, P490, DOI 10.1002/mrm.23295; Fan ZY, 2011, MAGN RESON MED, V65, P964, DOI 10.1002/mrm.22847; Fan ZY, 2009, MAGN RESON MED, V62, P1523, DOI 10.1002/mrm.22142; Haneder S, 2011, EUR RADIOL, V21, P1452, DOI 10.1007/s00330-011-2063-0; Hodnett PA, 2011, RADIOLOGY, V260, P282, DOI 10.1148/radiol.11101336; Hunold P, 2004, J MAGN RESON IMAGING, V20, P506, DOI 10.1002/jmri.20125; Klasen J, 2012, CLIN RADIOL, V67, P441, DOI 10.1016/j.crad.2011.10.014; Kreitner KF, 2000, AM J ROENTGENOL, V174, P171, DOI 10.2214/ajr.174.1.1740171; Lanzman RS, 2010, ROFO-FORTSCHR RONTG, V182, P861, DOI 10.1055/s-0029-1245328; Larson AC, 2002, MAGN RESON MED, V48, P594, DOI 10.1002/mrm.10262; Lim RP, 2008, J MAGN RESON IMAGING, V28, P181, DOI 10.1002/jmri.21416; Lim RP, 2013, RADIOLOGY, V267, P293, DOI 10.1148/radiol.12120859; Liu X, 2014, J MAGN RESON IMAGING, V40, P1422, DOI 10.1002/jmri.24477; Loewe C, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1791013; Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; PARKER DL, 1990, MED PHYS, V17, P250, DOI 10.1118/1.596503; Rydahl C, 2008, INVEST RADIOL, V43, P141, DOI 10.1097/RLI.0b013e31815a3407; Schaper NC, 2000, DIABETES-METAB RES, V16, pS11, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR112>3.0.CO;2-V; Sheehan JJ, 2011, RADIOLOGY, V259, P248, DOI 10.1148/radiol.10100851; Ward EV, 2013, J MAGN RESON IMAGING, V38, P1531, DOI 10.1002/jmri.24124; Wheaton AJ, 2012, J MAGN RESON IMAGING, V36, P286, DOI 10.1002/jmri.23641	27	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128786	10.1371/journal.pone.0128786	http://dx.doi.org/10.1371/journal.pone.0128786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035645	gold, Green Submitted, Green Published			2022-12-27	WOS:000355699100047
J	Lee, EJ; Luo, W; Chan, EWL; Yousaf, MN				Lee, Eun-ju; Luo, Wei; Chan, Eugene W. L.; Yousaf, Muhammad N.			A Molecular Smart Surface for Spatio-Temporal Studies of Cell Mobility	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; GRADIENT SURFACES; GEOMETRIC CONTROL; MIGRATION; ADHESION; INTEGRINS; LIGANDS; RGD; DENSITY; DIFFERENTIATION	Active migration in both healthy and malignant cells requires the integration of information derived from soluble signaling molecules with positional information gained from interactions with the extracellular matrix and with other cells. How a cell responds and moves involves complex signaling cascades that guide the directional functions of the cytoskeleton as well as the synthesis and release of proteases that facilitate movement through tissues. The biochemical events of the signaling cascades occur in a spatially and temporally coordinated manner then dynamically shape the cytoskeleton in specific subcellular regions. Therefore, cell migration and invasion involve a precise but constantly changing subcellular nano-architecture. A multidisciplinary effort that combines new surface chemistry and cell biological tools is required to understand the reorganization of cytoskeleton triggered by complex signaling during migration. Here we generate a class of model substrates that modulate the dynamic environment for a variety of cell adhesion and migration experiments. In particular, we use these dynamic substrates to probe in real-time how the interplay between the population of cells, the initial pattern geometry, ligand density, ligand affinity and integrin composition affects cell migration and growth. Whole genome microarray analysis indicates that several classes of genes ranging from signal transduction to cytoskeletal reorganization are differentially regulated depending on the nature of the surface conditions.	[Lee, Eun-ju; Luo, Wei; Chan, Eugene W. L.; Yousaf, Muhammad N.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Lee, Eun-ju; Luo, Wei; Chan, Eugene W. L.; Yousaf, Muhammad N.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Luo, Wei; Yousaf, Muhammad N.] York Univ, Ctr Res Biomol Interact, Dept Biol & Chem, Toronto, ON M3J 2R7, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; York University - Canada	Yousaf, MN (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	chrchem@yorku.ca	Chan, Eugene/GSI-5883-2022		National Cancer Institute (USA); National Science Foundation (USA); Burroughs Wellcome Foundation (USA); National Science and Engineering Research Council of Canada (NSERC) (Canada); Canadian Foundation for Innovation (Canada)	National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation (USA)(National Science Foundation (NSF)); Burroughs Wellcome Foundation (USA); National Science and Engineering Research Council of Canada (NSERC) (Canada); Canadian Foundation for Innovation (Canada)	This work was supported by the National Cancer Institute (USA) to MNY, National Science Foundation (USA) to MNY, Burroughs Wellcome Foundation (USA) to MNY, National Science and Engineering Research Council of Canada (NSERC) (Canada) to MNY and the Canadian Foundation for Innovation (Canada) to MNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2008, CANCER METAST REV, V27, P75, DOI 10.1007/s10555-007-9111-x; Barrett DG, 2007, ANGEW CHEM INT EDIT, V46, P7437, DOI 10.1002/anie.200701841; BAUER JS, 1993, J CELL BIOL, V122, P209, DOI 10.1083/jcb.122.1.209; Chan EWL, 2008, MOL BIOSYST, V4, P746, DOI 10.1039/b801394b; Chan EWL, 2008, ANGEW CHEM INT EDIT, V47, P6267, DOI 10.1002/anie.200800166; Chan EWL, 2007, CHEMPHYSCHEM, V8, P1469, DOI 10.1002/cphc.200700303; Chan EWL, 2007, ANGEW CHEM INT EDIT, V46, P3881, DOI 10.1002/anie.200604079; Chan EWL, 2006, J AM CHEM SOC, V128, P15542, DOI 10.1021/ja065828l; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Dutta D, 2011, BIOCONJUGATE CHEM, V22, P2423, DOI 10.1021/bc200236m; Dutta D, 2011, J AM CHEM SOC, V133, P8704, DOI 10.1021/ja2022569; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Gooding JJ, 2014, LANGMUIR, V30, P3290, DOI 10.1021/la4037919; GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697; Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721; Hoover DK, 2008, J AM CHEM SOC, V130, P3280, DOI 10.1021/ja711016m; Hoover DK, 2007, CHEMBIOCHEM, V8, P1920, DOI 10.1002/cbic.200700421; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kahsai AW, 2006, CHEM BIOL, V13, P973, DOI 10.1016/j.chembiol.2006.07.011; Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Krabbenborg SO, 2014, ANGEW CHEM INT EDIT, V53, P9152, DOI 10.1002/anie.201310349; Lamb BM, 2008, CHEMBIOCHEM, V9, P2628, DOI 10.1002/cbic.200800473; Lamb BM, 2008, CHEMBIOCHEM, V9, P2220, DOI 10.1002/cbic.200800400; Lamb BM, 2014, ACS APPL MATER INTER, V6, P11523, DOI 10.1021/am502209k; Lamb BM, 2011, J AM CHEM SOC, V133, P8870, DOI 10.1021/ja203198y; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee EJ, 2014, RSC ADV, V4, P31581, DOI 10.1039/c4ra03795b; Luo W, 2008, LANGMUIR, V24, P13096, DOI 10.1021/la802775v; Luo W, 2008, LANGMUIR, V24, P12129, DOI 10.1021/la802836g; Luo W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494019; Luo W, 2011, J AM CHEM SOC, V133, P10780, DOI 10.1021/ja204893w; Luo W, 2011, J COLLOID INTERF SCI, V360, P325, DOI 10.1016/j.jcis.2011.04.098; Luo W, 2010, J AM CHEM SOC, V132, P2614, DOI 10.1021/ja907187f; Luo W, 2009, CHEM COMMUN, P1237, DOI 10.1039/b817212a; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Maheshwari G, 2000, J CELL SCI, V113, P1677; Mendes PM, 2008, CHEM SOC REV, V37, P2512, DOI 10.1039/b714635n; Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e; Nakanishi J, 2014, CHEM-ASIAN J, V9, P406, DOI 10.1002/asia.201301325; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Park S, 2008, LANGMUIR, V24, P6201, DOI 10.1021/la8005663; Park S, 2014, BIOCONJUGATE CHEM, V25, P543, DOI 10.1021/bc400565y; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Pulsipher A, 2014, ANGEW CHEM INT EDIT, V53, P9487, DOI 10.1002/anie.201404099; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Shimizu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091875; Thumshirn G, 2003, CHEM-EUR J, V9, P2717, DOI 10.1002/chem.200204304; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Westcott NP, 2008, LANGMUIR, V24, P2261, DOI 10.1021/la703744v; Yousaf MN, 2002, NEW TECHNOLOGIES LIF, P28	63	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0118126	10.1371/journal.pone.0118126	http://dx.doi.org/10.1371/journal.pone.0118126			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030281	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900002
J	Merhi, A; De Mees, C; Abdo, R; Alberola, JV; Marini, AM				Merhi, Ahmad; De Mees, Christelle; Abdo, Rami; Alberola, Jennifer Victoria; Marini, Anna Maria			Wnt/beta-Catenin Signaling Regulates the Expression of the Ammonium Permease Gene RHBG in Human Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; CYCLIN D1; TRANSPORTER PROTEINS; GLUTAMINE-SYNTHETASE; B GLYCOPROTEIN; COLON-CANCER; MOUSE; RHCG; ACTIVATION; IDENTIFICATION	Ammonium is a metabolic waste product mainly detoxified by the liver. Hepatic dysfunction can lead to cytotoxic accumulation of circulating ammonium and to subsequent encephalopathy. Transmembrane ammonium transport is a widely spread process ensured by the highly conserved proteins of the Mep-Amt-Rh superfamily, including the mammalian Rhesus (Rh) factors. The regulatory mechanisms involved in the control of RH genes expression remain poorly studied. Here we addressed the expression regulation of one of these factors, RHBG. We identify HepG2 hepatocellular carcinoma cells and SW480 colon adenocarcinoma cells as expressing RHBG and show that its expression relies on beta-catenin signaling. siRNA-mediated beta-catenin knockdown resulted in significant reduction of RHBG mRNA in both cell lines. Pharmaceutical inhibition of the TCF4/beta-catenin interaction or knockdown of the transcription factor TCF4 also downregulated RHBG expression. We identify a minimal RHBG regulatory sequence displaying a promoter activity and show that beta-catenin and TCF4 bind to this fragment in vivo. We finally characterize the role of potential TCF4 binding sites in RHBG regulation. Taken together, our results indicate RHBG expression as a direct target of beta-catenin regulation, a pathway frequently deregulated in many cancers and associated with tumorigenesis.	[Merhi, Ahmad; De Mees, Christelle; Abdo, Rami; Alberola, Jennifer Victoria; Marini, Anna Maria] Univ Libre Bruxelles, IBMM, Biol Membrane Transport Lab, Gosselies, Belgium	Universite Libre de Bruxelles	Marini, AM (corresponding author), Univ Libre Bruxelles, IBMM, Biol Membrane Transport Lab, Gosselies, Belgium.	amarini@ulb.ac.be		Merhi, Ahmad/0000-0001-7046-2508	Belgian Fonds de la Recherche Scientifique F.R.S.-FNRS [F.R.S.M. 3.4633.09, M.I.S. F.4.521.10.F]; Federation Wallonie-Bruxelles (Action de Recherche Concertee); International Brachet Stiftung; Jean Brachet foundation; Alice et David Van Buuren foundation; Televie grant; da Vinci program	Belgian Fonds de la Recherche Scientifique F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Federation Wallonie-Bruxelles (Action de Recherche Concertee); International Brachet Stiftung; Jean Brachet foundation; Alice et David Van Buuren foundation; Televie grant; da Vinci program	This work was supported by grants from the Belgian Fonds de la Recherche Scientifique F.R.S.-FNRS (F.R.S.M. 3.4633.09, M.I.S. F.4.521.10.F), the Federation Wallonie-Bruxelles (Action de Recherche Concertee), the International Brachet Stiftung, the Jean Brachet and the Alice et David Van Buuren foundations. A.M. is a scientific research worker supported by a Televie grant, C.D. was a scientific research worker of the F.R.S.-FNRS, JVA was supported by a da Vinci program, and A.M.M. is a senior research associate of the F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bishop JM, 2010, AM J PHYSIOL-RENAL, V299, pF1065, DOI 10.1152/ajprenal.00277.2010; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Desbois-Mouthon C, 2002, HEPATOLOGY, V36, P1528, DOI 10.1053/jhep.2002.37192; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Harder LM, 2014, COMP PHOSPHOPROTEOMI, P1, DOI [10.4161/auto.26863, DOI 10.4161/AUT0.26863]; Iyer VV, 2010, BIOTECHNOL BIOENG, V107, P347, DOI 10.1002/bit.22799; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lee HW, 2013, REPRODUCTION, V146, P283, DOI 10.1530/REP-13-0154; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Ma L, 2014, GASTROINTESTINAL CAN, V4, P49, DOI DOI 10.2147/GICTT.S44256; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mavri-Damelin Demetra, 2007, Int J Biochem Cell Biol, V39, P555, DOI 10.1016/j.biocel.2006.10.007; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Najafov A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037013; Nakhoul NL, 2013, MOL ASPECTS MED, V34, P629, DOI 10.1016/j.mam.2012.05.013; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Rubinfeld B, 1997, CANCER RES, V57, P4624; Saegusa M, 2006, INT J CANCER, V119, P2294, DOI 10.1002/ijc.22112; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Stahl S, 2005, HEPATOLOGY, V42, P353, DOI 10.1002/hep.20768; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tardito S, 2011, CURR CANCER DRUG TAR, V11, P929, DOI 10.2174/156800911797264725; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; von Wiren N, 2004, TOP CURR GENET, V9, P95; Weiner ID, 2013, COMPR PHYSIOL, V3, P201, DOI 10.1002/cphy.c120010; Weiner ID, 2003, ACTA PHYSIOL SCAND, V179, P331, DOI 10.1046/j.0001-6772.2003.01210.x; Weiner ID, 2003, GASTROENTEROLOGY, V124, P1432, DOI 10.1016/S0016-5085(03)00277-4; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xu LF, 2000, GENE DEV, V14, P585; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	68	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128683	10.1371/journal.pone.0128683	http://dx.doi.org/10.1371/journal.pone.0128683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029888	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900184
J	Muyoyeta, M; Moyo, M; Kasese, N; Ndhlovu, M; Milimo, D; Mwanza, W; Kapata, N; Schaap, A; Godfrey, P; Ayles, H				Muyoyeta, Monde; Moyo, Maureen; Kasese, Nkatya; Ndhlovu, Mapopa; Milimo, Deborah; Mwanza, Winfridah; Kapata, Nathan; Schaap, Albertus; Godfrey, Peter Faussett; Ayles, Helen			Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; CHEST RADIOGRAPHS; SOUTH-AFRICA; DIAGNOSIS; INFECTION; ACCURACY; FILMLESS; BURDEN; MALAWI	Background The current cost of Xpert MTB RIF (Xpert) consumables is such that algorithms are needed to select which patients to prioritise for testing with Xpert. Objective To evaluate two algorithms for prioritisation of Xpert in primary health care settings in a high TB and HIV burden setting. Method Consecutive, presumptive TB patients with a cough of any duration were offered either Xpert or Fluorescence microscopy (FM) test depending on their CXR score or HIV status. In one facility, sputa from patients with an abnormal CXR were tested with Xpert and those with a normal CXR were tested with FM ("CXR algorithm"). CXR was scored automatically using a Computer Aided Diagnosis (CAD) program. In the other facility, patients who were HIV positive were tested using Xpert and those who were HIV negative were tested with FM ("HIV algorithm"). Results Of 9482 individuals pre-screened with CXR, Xpert detected TB in 2090/6568 (31.8%) with an abnormal CXR, and FM was AFB positive in 8/2455 (0.3%) with a normal CXR. Of 4444 pre-screened with HIV, Xpert detected TB in 508/2265 (22.4%) HIV positive and FM was AFB positive in 212/1920 (11.0%) in HIV negative individuals. The notification rate of new bacteriologically confirmed TB increased; from 366 to 620/100,000/yr and from 145 to 261/100,000/yr at the CXR and HIV algorithm sites respectively. The median time to starting TB treatment at the CXR site compared to the HIV algorithm site was; 1(IQR 1-3 days) and 3 (2-5 days) (p<0.0001) respectively. Conclusion Use of Xpert in a resource-limited setting at primary care level in conjunction with pre-screening tests reduced the number of Xpert tests performed. The routine use of Xpert resulted in additional cases of confirmed TB patients starting treatment. However, there was no increase in absolute numbers of patients starting TB treatment. Same day diagnosis and treatment commencement was achieved for both bacteriologically confirmed and empirically diagnosed patients where Xpert was used in conjunction with CXR.	[Muyoyeta, Monde; Moyo, Maureen; Kasese, Nkatya; Ndhlovu, Mapopa; Milimo, Deborah; Mwanza, Winfridah; Schaap, Albertus; Ayles, Helen] Univ Zambia, Sch Med, ZAMBART Project, Lusaka, Zambia; [Kapata, Nathan] Minist Hlth, Natl TB Program, Lusaka, Zambia; [Schaap, Albertus; Godfrey, Peter Faussett; Ayles, Helen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	University of Zambia; University of London; London School of Hygiene & Tropical Medicine	Muyoyeta, M (corresponding author), Univ Zambia, Sch Med, ZAMBART Project, Lusaka, Zambia.	MondeMuy@gmail.com	Kapata, Nathan/AAW-2469-2020	Ayles, Helen/0000-0003-4108-2842	World Health Organisation through the stop TB partnership-TB REACH wave 2 grant [T9-370-114]; Sub grant-Delft Imaging systems-CAD4TBII	World Health Organisation through the stop TB partnership-TB REACH wave 2 grant; Sub grant-Delft Imaging systems-CAD4TBII	Funding sources: T9-370-114 World Health Organisation through the stop TB partnership-TB REACH wave 2 grant, http://www.stoptb.org/global awards/tbreach/grantees2.asp. Sub grant-Delft Imaging systems-CAD4TBII, http://delft.care/solutions/tb-solutions.html. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Arzhaeva Y, 2009, PATTERN RECOGN, V42, P1768, DOI 10.1016/j.patcog.2009.01.016; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Boehme Catharina C, 2008, 1 EVALUATION XPERT M; Cepheid, 2009, XPERT MTB RIF 2 HOUR, P3; Churcgyard Gavin, 2014, TOP ANTIVIR MED, P48; Cohen GM, 2014, JAIDS-J ACQ IMM DEF, V67, pE88, DOI 10.1097/QAI.0000000000000309; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; ELLIOTT AM, 1995, T ROY SOC TROP MED H, V89, P78, DOI 10.1016/0035-9203(95)90668-1; Fielding Katherine L, 2014, TOP ANTIVIR MED, P48; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; Jaeger S, 2013, QUANT IMAG MED SURG, V3, P89, DOI 10.3978/j.issn.2223-4292.2013.04.03; Kurihara Y, 2001, ST HEAL T, V84, P1166; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Maduskar P, 2013, INT J TUBERC LUNG D, V17, P1613, DOI 10.5588/ijtld.13.0325; Muto H, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-246; Muyoyeta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093757; Mwandumba HC, 2008, TUBERCULOSIS, V88, P58, DOI 10.1016/j.tube.2007.06.003; Naidoo S, 2010, EVALUATION GENEXPERT; Naul LG, 2001, POSTGRAD MED, V109, P107, DOI 10.3810/pgm.2001.06.960; Onozaki I, 2014, BMC INFECT DIS, V14, P532, DOI [10.1186/1471-2334-14-532, DOI 10.1186/1471-2334-14-532]; PARRY CM, 1995, TUBERCLE LUNG DIS, V76, P72, DOI 10.1016/0962-8479(95)90583-9; Rieder HL, 2007, IUATALDT, V68; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; van Ginneken B, 2006, MED IMAGE ANAL, V10, P19, DOI 10.1016/j.media.2005.02.002; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; WHO, 2007, IMPR DIAGN TREATM SM; World Health Organisation, 2010, ROAD MAP ROLL XPERT; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2007, US LIQ TB CULT DRUG; World Health Organization Policy Statement, 2011, FLUOR LIGHT EM DIOD; Zachary D, 2012, PUBLIC HEALTH ACTION, V2, P56, DOI 10.5588/pha.12.0010	42	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126376	10.1371/journal.pone.0126376	http://dx.doi.org/10.1371/journal.pone.0126376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030301	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000356630900026
J	Pruzinova, K; Sadlova, J; Seblova, V; Homola, M; Votypka, J; Volf, P				Pruzinova, Katerina; Sadlova, Jovana; Seblova, Veronika; Homola, Miroslav; Votypka, Jan; Volf, Petr			Comparison of Bloodmeal Digestion and the Peritrophic Matrix in Four Sand Fly Species Differing in Susceptibility to Leishmania donovani	PLOS ONE			English	Article							PHLEBOTOMUS-PAPATASI DIPTERA; FLIES; PSYCHODIDAE; MIDGUT; VECTOR; ORIENTALIS; INFECTION; SANDFLIES; ENZYMES; BIOLOGY	The early stage of Leishmania development in sand flies is closely connected with bloodmeal digestion. Here we compared various parameters of bloodmeal digestion in sand flies that are either susceptible (Phlebotomus argentipes and P. orientalis) or refractory (P. papatasi and Sergentomyia schwetzi) to Leishmania donovani, to study the effects on vector competence. The volume of the bloodmeal ingested, time of defecation of bloodmeal remnants, timing of formation and degradation of the peritrophic matrix (PM) and dynamics of proteolytic activities were compared in four sand fly species. Both proven vectors of L. donovani showed lower trypsin activity and slower PM formation than refractory species. Interestingly, the two natural L. donovani vectors strikingly differed from each other in secretion of the PM and midgut proteases, with P. argentipes possessing fast bloodmeal digestion with a very high peak of chymotrypsin activity and rapid degradation of the PM. Experimental infections of P. argentipes did not reveal any differences in vector competence in comparison with previously studied P. orientalis; even the very low initial dose (2x103 promastigotes/ml) led to fully developed late-stage infections with colonization of the stomodeal valve in about 40% of females. We hypothesise that the period between the breakdown of the PM and defecation of the bloodmeal remnants, i.e. the time frame when Leishmania attach to the midgut in order to prevent defecation, could be one of crucial parameters responsible for the establishment of Leishmania in the sand fly midgut. In both natural L. donovani vectors this period was significantly longer than in S. schwetzi. Both vectors are equally susceptible to L. donovani; as average bloodmeal volumes taken by females of P. argentipes and P. orientalis were 0.63 mu l and 0.59 mu l, respectively, an infective dose corresponding to 1-2 parasites was enough to initiate mature infections.	[Pruzinova, Katerina; Sadlova, Jovana; Seblova, Veronika; Homola, Miroslav; Votypka, Jan; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic	Charles University Prague	Pruzinova, K (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	katerina.pruzinova@gmail.com	Pružinová, Kateřina/C-2035-2017; Volf, Petr/C-4300-2012; Votypka, Jan/C-5313-2012; Sadlova, Jovana/C-1327-2012	Pružinová, Kateřina/0000-0003-1350-4251; Volf, Petr/0000-0003-1790-1123; Votypka, Jan/0000-0002-0552-9363; Sadlova, Jovana/0000-0002-0432-2707	Czech Science Foundation [GACR 13-07 500S]; Bill and Melinda Gates Foundation Global Health Program [OPPGH5336]; EU [FP7-261504]; EurNegVec COST Action [TD1303, COST-CZ LD14076]	Czech Science Foundation(Grant Agency of the Czech Republic); Bill and Melinda Gates Foundation Global Health Program(Bill & Melinda Gates Foundation); EU(European Commission); EurNegVec COST Action(European Cooperation in Science and Technology (COST))	This study was partially funded by Czech Science Foundation (GACR 13-07 500S), the Bill and Melinda Gates Foundation Global Health Program (grant number OPPGH5336) and EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext271 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. JV is funded by EurNegVec COST Action TD1303, COST-CZ LD14076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1938, HAREFUAH, V14, P1; Bates PA, 2004, CURR MOL MED, V4, P601, DOI 10.2174/1566524043360285; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Benkova I, 2007, J MED ENTOMOL, V44, P150, DOI 10.1603/0022-2585(2007)44[150:EOTOMO]2.0.CO;2; BOROVSKY D, 1987, MED VET ENTOMOL, V1, P235, DOI 10.1111/j.1365-2915.1987.tb00349.x; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; DILLON RJ, 1993, MED VET ENTOMOL, V7, P225, DOI 10.1111/j.1365-2915.1993.tb00681.x; Dostalova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-276; Dostalova A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-223; Elnaiem DEA, 2011, J VECTOR ECOL, V36, pS23, DOI 10.1111/j.1948-7134.2011.00109.x; GEMETCHU T, 1974, ANN TROP MED PARASIT, V68, P111, DOI 10.1080/00034983.1974.11686930; HOOGSTRAAL H, 1969, AM J TROP MED HYG, V18, P1091, DOI 10.4269/ajtmh.1969.18.1091; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Myskova J, 2008, J MED ENTOMOL, V45, P133, DOI 10.1603/0022-2585(2008)45[133:LISFCO]2.0.CO;2; Myskova J, 2007, MICROBES INFECT, V9, P317, DOI 10.1016/j.micinf.2006.12.010; de Araujo APO, 2012, MEM I OSWALDO CRUZ, V107, P543, DOI 10.1590/S0074-02762012000400016; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Pimenta PFP, 1997, PARASITOLOGY, V115, P359, DOI 10.1017/S0031182097001510; Ramalho-Ortigao Marcelo, 2010, Open Parasitology Journal, V4, P195; Sadlova J, 1998, EUR J ENTOMOL, V95, P643; Sadlova J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-186; Sadlova J, 2009, CELL TISSUE RES, V337, P313, DOI 10.1007/s00441-009-0802-1; Sant'Anna MRV, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-62; Santos VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111241; Schlein Y, 1998, PARASITOLOGY, V117, P467, DOI 10.1017/S0031182098003321; SCHLEIN Y, 1986, EXP PARASITOL, V62, P376, DOI 10.1016/0014-4894(86)90045-7; Seblova V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002187; Telleria EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010697; Volf P, 2011, J VECTOR ECOL, V36, pS1, DOI 10.1111/j.1948-7134.2011.00106.x; Volf P, 2007, TRENDS PARASITOL, V23, P91, DOI 10.1016/j.pt.2006.12.010; Wilson R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000816	34	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128203	10.1371/journal.pone.0128203	http://dx.doi.org/10.1371/journal.pone.0128203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030610	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900124
J	Tagashira, H; Miyamoto, A; Kitamura, S; Tsubata, M; Yamaguchi, K; Takagaki, K; Imokawa, G				Tagashira, Hideki; Miyamoto, Aki; Kitamura, Sei-ichi; Tsubata, Masahito; Yamaguchi, Kazuya; Takagaki, Kinya; Imokawa, Genji			UVB Stimulates the Expression of Endothelin B Receptor in Human Melanocytes via a Sequential Activation of the p38/MSK1/CREB/MITF Pathway Which Can Be Interrupted by a French Maritime Pine Bark Extract through a Direct Inactivation of MSK1	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; HUMAN KERATINOCYTES; HUMAN SKIN; EPIDERMAL-KERATINOCYTES; SIGNALING MECHANISMS; WAARDENBURG-SYNDROME; GENE-EXPRESSION; TYROSINASE GENE; IN-SITU	Melanogenesis is the physiological process by which melanin is synthesized to protect the skin from UV damage. While paracrine interactions between keratinocytes and melanocytes are crucial for regulating epidermal pigmentation, the endothelin (EDN)-endothelin B-receptor (EDNRB) interaction is one of the key linkages. In this study, we found that a single exposure of normal human melanocytes (NHMs) with UVB stimulates the expression of EDNRB and its upstream transcription factor microphthalmia-associated transcription factor (MITF) at the transcriptional and translational levels. That stimulation can be abrogated by post-irradiation treatment with a French maritime pine bark extract (PBE). UVB stimulated the phosphorylation of p38 and c-jun N-terminal kinase (JNK), but not ERK, followed by the increased phosphorylation of MSK1 and CREB. The post-irradiation treatment with PBE did not affect the increased phosphorylation of p38 and JNK, but distinctly abrogated the phosphorylation of MSK1 and CREB. Post-irradiation treatment with the MSK1 inhibitor H89 significantly down-regulated the increased gene expression of MITF and EDNRB in UVB-exposed NHMs. Our findings indicate for the first time that the increased expression of MITF that leads to the up-regulation of melanocyte-specific proteins in UVB-exposed NHMs is mediated via activation of the p38/MSK1/CREB pathway but not the ERK/RSK/CREB pathway. The mode of action by PBE demonstrates that interrupting MSK1 activation is a new target for antioxidants including PBE which can serve as anti-pigmenting agents in a reactive oxygen species-depletion-independent manner.	[Tagashira, Hideki; Miyamoto, Aki; Kitamura, Sei-ichi; Tsubata, Masahito; Yamaguchi, Kazuya; Takagaki, Kinya] Toyo Shinyaku Co Ltd, Div Res & Dev, Tosu, Saga 8410005, Japan; [Imokawa, Genji] Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 4878501, Japan	Chubu University	Imokawa, G (corresponding author), Chubu Univ, Res Inst Biol Funct, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan.	imokawag@dream.ocn.ne.jp			Toyo Shinyaku Co., Ltd.	Toyo Shinyaku Co., Ltd.	Toyo Shinyaku Co., Ltd., provided support in the form of salaries for authors HT, AM, SK, MT, KY, KT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Malek ZA, 2010, PIGM CELL MELANOMA R, V23, P171, DOI 10.1111/j.1755-148X.2010.00679.x; Adhami VM, 2003, NEOPLASIA, V5, P74, DOI 10.1016/S1476-5586(03)80019-2; Afaq F, 2003, ONCOGENE, V22, P1035, DOI 10.1038/sj.onc.1206206; Brenner M, 2009, J INVEST DERMATOL, V129, P1002, DOI 10.1038/jid.2008.325; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Chida M, 1999, OPHTHALMIC RES, V31, P407, DOI 10.1159/000055565; Choi W, 2010, J INVEST DERMATOL, V130, P1685, DOI 10.1038/jid.2010.5; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Furumura M, 2012, CLIN INTERV AGING, V7, P275, DOI 10.2147/CIA.S33165; GANSS R, 1994, J BIOL CHEM, V269, P29808; Hachiya A, 2004, AM J PATHOL, V165, P2099, DOI 10.1016/S0002-9440(10)63260-9; Hachiya A, 2002, J BIOL CHEM, V277, P5395, DOI 10.1074/jbc.M105874200; Hornyak TJ, 2009, PIGM CELL MELANOMA R, V22, P307, DOI 10.1111/j.1755-148X.2009.00551.x; Hou L, 2000, DEVELOPMENT, V127, P5379; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Hur S, 2010, J DERMATOL SCI, V59, P163, DOI 10.1016/j.jdermsci.2010.07.001; Hyter S, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12063; Imokawa G, 1996, BIOCHEM J, V314, P305, DOI 10.1042/bj3140305; Imokawa G, 1997, PIGM CELL RES, V10, P218, DOI 10.1111/j.1600-0749.1997.tb00488.x; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; IMOKAWA G, 1992, J BIOL CHEM, V267, P24675; Kadono S, 2001, J INVEST DERMATOL, V116, P571, DOI 10.1046/j.1523-1747.2001.01296.x; Kim DS, 2003, ARCH PHARM RES, V26, P739, DOI 10.1007/BF02976685; Kim YJ, 2008, FOOD CHEM TOXICOL, V46, P2466, DOI 10.1016/j.fct.2008.04.002; Lee SJ, 2003, MOL CELLS, V16, P97; Li EPH, 2008, ADV CONSUM RES, V35, P444; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mizutani Y, 2010, ARCH DERMATOL RES, V302, P283, DOI 10.1007/s00403-009-1007-x; Muthusamy V, 2013, INT J MOL SCI, V14, P17029, DOI 10.3390/ijms140817029; Nelson AB, 1998, DRUG DEV IND PHARM, V24, P139, DOI 10.3109/03639049809085598; Ohkita M, 2011, J PHARMACOL SCI, V115, P461, DOI 10.1254/jphs.10R37FM; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Saliou C, 2001, FREE RADICAL BIO MED, V30, P154, DOI 10.1016/S0891-5849(00)00445-7; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Shimada T, 2012, EUR J PHARMACOL, V677, P147, DOI 10.1016/j.ejphar.2011.12.034; Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326; Suzuki Y, 2006, EXP EYE RES, V82, P275, DOI 10.1016/j.exer.2005.06.023; Tada A, 1998, CELL GROWTH DIFFER, V9, P575; Tada A, 2002, J INVEST DERMATOL, V118, P316, DOI 10.1046/j.0022-202x.2001.01694.x; Terazawa S, 2012, EXP DERMATOL, V21, P11, DOI 10.1111/j.1600-0625.2012.01496.x; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Wan P, 2011, MOL CELL BIOCHEM, V354, P241, DOI 10.1007/s11010-011-0823-4; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; YADA Y, 1991, J BIOL CHEM, V266, P18352; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yanase H, 2001, PIGM CELL RES, V14, P103, DOI 10.1034/j.1600-0749.2001.140205.x; Yang RF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6807; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; YOHN JJ, 1993, J INVEST DERMATOL, V100, P23, DOI 10.1111/1523-1747.ep12349932; Yoshida A, 2011, J CLIN BIOCHEM NUTR, V49, P79, DOI 10.3164/jcbn.10-103; Zhu WY, 2008, J INVEST DERM SYMP P, V13, P20, DOI 10.1038/jidsymp.2008.8	66	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128678	10.1371/journal.pone.0128678	http://dx.doi.org/10.1371/journal.pone.0128678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030901	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900183
J	Gupta, MK; Asosingh, K; Aronica, M; Comhair, S; Cao, GY; Erzurum, S; Panettieri, RA; Prasad, SVN				Gupta, Manveen K.; Asosingh, Kewal; Aronica, Mark; Comhair, Suzy; Cao, Gaoyuan; Erzurum, Serpil; Panettieri, Reynold A., Jr.; Prasad, Sathyamangla V. Naga			Defective Resensitization in Human Airway Smooth Muscle Cells Evokes beta-Adrenergic Receptor Dysfunction in Severe Asthma	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; IN-VIVO; DESENSITIZATION; AGONISTS; KINASE; BETA(2)-ADRENOCEPTOR; METAANALYSIS; INHIBITION; MECHANISMS	beta(2)-adrenergic receptor (beta(2)AR) agonists (beta(2)-agonist) are the most commonly used therapy for acute relief in asthma, but chronic use of these bronchodilators paradoxically exacerbates airway hyper-responsiveness. Activation of beta ARs by beta-agonist leads to desensitization (inactivation) by phosphorylation through G-protein coupled receptor kinases (GRKs) which mediate beta-arrestin binding and beta AR internalization. Resensitization occurs by dephosphorylation of the endosomal beta ARs which recycle back to the plasma membrane as agonist-ready receptors. To determine whether the loss in beta-agonist response in asthma is due to altered beta AR desensitization and/or resensitization, we used primary human airway smooth muscle cells (HASMCs) isolated from the lungs of non-asthmatic and fatal-asthmatic subjects. Asthmatic HASMCs have diminished adenylyl cyclase activity and cAMP response to beta-agonist as compared to non-asthmatic HASMCs. Confocal microscopy showed significant accumulation of phosphorylated beta(2)ARs in asthmatic HASMCs. Systematic analysis of desensitization components including GRKs and beta-arrestin showed no appreciable differences between asthmatic and non-asthmatic HASMCs. However, asthmatic HASMC showed significant increase in PI3K gamma activity and was associated with reduction in PP2A activity. Since reduction in PP2A activity could alter receptor resensitization, endosomal fractions were isolated to assess the agonist ready beta(2)ARs as a measure of resensitization. Despite significant accumulation of beta(2)ARs in the endosomes of asthmatic HASMCs, endosomal beta(2)ARs cannot robustly activate adenylyl cyclase. Furthermore, endosomes from asthmatic HASMCs are associated with significant increase in PI3K gamma and reduced PP2A activity that inhibits beta(2)AR resensitization. Our study shows that resensitization, a process considered to be a homeostasis maintaining passive process is inhibited in asthmatic HASMCs contributing to beta(2)AR dysfunction which may underlie asthma pathophysiology and loss in asthma control.	[Gupta, Manveen K.; Prasad, Sathyamangla V. Naga] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Asosingh, Kewal; Aronica, Mark; Comhair, Suzy; Erzurum, Serpil] Cleveland Clin, Lerner Res Inst, Dept Pathol, Cleveland, OH 44106 USA; [Cao, Gaoyuan; Panettieri, Reynold A., Jr.] Univ Penn, Airways Biol Initiat Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Pennsylvania	Prasad, SVN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	prasads2@ccf.org	panettieri, reynold/AAG-9485-2019		Molecular Cardiology start-up funds [HL089473, HL115008, HL081064, HL103453, P01-HL114471, P30-ES013508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, R24HL123767, U01HL110942, R01HL115008, P01HL081064, P01HL114471, R01HL089473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Molecular Cardiology start-up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Molecular Cardiology start-up funds & HL089473 (SVNP); HL115008 (SVNP & SE); HL081064, HL103453 (SE); P01-HL114471 & P30-ES013508 (RAP), http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2010, MED PRIN PRACT, V19, P330, DOI 10.1159/000316368; Bond RA, 2011, BRIT J PHARMACOL, V163, P1, DOI 10.1111/j.1476-5381.2011.01239.x; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Hata Jonathan A, 2003, Mol Interv, V3, P264, DOI 10.1124/mi.3.5.264; Hegde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116458; Heitzler D, 2009, CR BIOL, V332, P947, DOI 10.1016/j.crvi.2009.09.002; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Iaccarino G, 2005, EUR HEART J, V26, P1752, DOI 10.1093/eurheartj/ehi429; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Krueger KM, 1997, J BIOL CHEM, V272, P5; Li M, 1998, METH MOL B, V93, P59; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Lopez-Ilasaca M, 1998, J BIOL CHEM, V273, P2505, DOI 10.1074/jbc.273.5.2505; Loza Matthew J, 2010, Front Biosci (Schol Ed), V2, P969; Luttrell LM, 2002, J CELL SCI, V115, P455; Mak JCW, 2002, BRIT J PHARMACOL, V135, P987, DOI 10.1038/sj.bjp.0704545; Morgan SJ, 2014, J BIOL CHEM; Moulton BC, 2011, BRIT J PHARMACOL, V163, P44, DOI 10.1111/j.1476-5381.2010.01190.x; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Penn Raymond B, 2008, Proc Am Thorac Soc, V5, P47, DOI 10.1513/pats.200705-054VS; Penn Raymond B, 2014, Handb Exp Pharmacol, V219, P387, DOI 10.1007/978-3-642-41199-1_20; Penn RB, 2009, P NATL ACAD SCI USA, V106, P2095, DOI 10.1073/pnas.0812935106; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Salpeter SR, 2004, ANN INTERN MED, V140, P802, DOI 10.7326/0003-4819-140-10-200405180-00010; Shenoy SK, 2011, NATURE, V477, P546, DOI 10.1038/477546a; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; Shore SA, 2003, J CLIN INVEST, V112, P495, DOI 10.1172/JCI200319642; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; TURKI J, 1995, AM J RESP CELL MOL, V12, P531, DOI 10.1165/ajrcmb.12.5.7742016; Vasudevan NT, 2011, CELL CYCLE, V10, P3684, DOI 10.4161/cc.10.21.18042; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x	48	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125803	10.1371/journal.pone.0125803	http://dx.doi.org/10.1371/journal.pone.0125803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023787	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400010
J	Kuo, YL; Huang, KY; Chiang, PT; Lee, PY; Tsai, YJ				Kuo, Yi-Liang; Huang, Kuo-Yuan; Chiang, Pei-Tzu; Lee, Pei-Yun; Tsai, Yi-Ju			Steadiness of Spinal Regions during Single-Leg Standing in Older Adults with and without Chronic Low Back Pain	PLOS ONE			English	Article							PHYSICAL PERFORMANCE TESTS; RISK-FACTORS; FUNCTIONAL MOBILITY; POSTURAL CONTROL; ELDERLY PERSONS; HEALTHY-YOUNG; GO TEST; FALLS; PEOPLE; INDIVIDUALS	The aims of this study were to compare the steadiness index of spinal regions during single-leg standing in older adults with and without chronic low back pain (LBP) and to correlate measurements of steadiness index with the performance of clinical balance tests. Thirteen community-dwelling older adults (aged 55 years or above) with chronic LBP and 13 ageand gender-matched asymptomatic volunteers participated in this study. Data collection was conducted in a university research laboratory. Measurements were steadiness index of spinal regions (trunk, thoracic spine, lumbar spine, and pelvis) during single-leg standing including relative holding time (RHT) and relative standstill time (RST), and clinical balance tests (timed up and go test and 5-repetition sit to stand test). The LBP group had a statistically significantly smaller RHT than the control group, regardless of one leg stance on the painful or non-painful sides. The RSTs on the painful side leg in the LBP group were not statistically significantly different from the average RSTs of both legs in the control group; however, the RSTs on the non-painful side leg in the LBP group were statistically significantly smaller than those in the control group for the trunk, thoracic spine, and lumbar spine. No statistically significant intra-group differences were found in the RHTs and RSTs between the painful and non-painful side legs in the LBP group. Measurements of clinical balance tests also showed insignificant weak to moderate correlations with steadiness index. In conclusion, older adults with chronic LBP demonstrated decreased spinal steadiness not only in the symptomatic lumbar spine but also in the other spinal regions within the kinetic chain of the spine. When treating older adults with chronic LBP, clinicians may also need to examine their balance performance and spinal steadiness during balance challenging tests.	[Kuo, Yi-Liang] Tzu Chi Univ, Dept Phys Therapy, Hualien, Taiwan; [Huang, Kuo-Yuan] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan 70428, Taiwan; [Chiang, Pei-Tzu; Lee, Pei-Yun; Tsai, Yi-Ju] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan	Tzu Chi University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Tsai, YJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan.	yijutsai@mail.ncku.edu.tw	Tsai, Yi-Ju/C-3324-2009		National Science Council of Taiwan [NSC 101-2314-B-006 -008]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grants from the National Science Council of Taiwan (NSC 101-2314-B-006 -008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Boelens C, 2013, TECHNOL HEALTH CARE, V21, P521, DOI 10.3233/THC-130748; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; BYL NN, 1991, SPINE, V16, P325, DOI 10.1097/00007632-199103000-00012; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; Ng CT, 2013, AGE AGEING, V42, P561, DOI 10.1093/ageing/aft070; Clark M.S., 2007, NZ J PHYSIOTHERAPY, V35, P110; Crosbie J, 2010, J BIOMECH, V43, P1302, DOI 10.1016/j.jbiomech.2010.01.024; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; da Cunha-Filho Inacio Teixeira, 2010, Physiotherapy Theory and Practice, V26, P49, DOI 10.3109/09593980802602844; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Ham YW, 2010, J ELECTROMYOGR KINES, V20, P1134, DOI 10.1016/j.jelekin.2010.05.011; Hamaoui A, 2004, NEUROSCI LETT, V357, P135, DOI 10.1016/j.neulet.2003.12.047; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Jo HJ, 2011, EUR SPINE J, V20, P1297, DOI 10.1007/s00586-010-1686-1; Jonsson E, 2004, CLIN BIOMECH, V19, P688, DOI 10.1016/j.clinbiomech.2004.04.002; Jonsson E, 2003, J REHABIL MED, V35, P26, DOI 10.1080/16501970306099; Kim HJ, 2011, SPINE, V36, pE588, DOI 10.1097/BRS.0b013e3181f92d8e; Kuo YL, 2009, J MANIP PHYSIOL THER, V32, P210, DOI 10.1016/j.jmpt.2009.02.002; Lamoth CJC, 2002, SPINE, V27, pE92, DOI 10.1097/00007632-200202150-00016; Li R, 2014, CHINESE MED J-PEKING, V127, P1229, DOI 10.3760/cma.j.issn.0366-6999.20121430; Lue YJ, 2008, SPINE, V33, P2354, DOI 10.1097/BRS.0b013e31818018d8; Miura T, 2014, J PHYS THER SCI, V26, P323, DOI 10.1589/jpts.26.323; Muraki S, 2011, ARTHRIT CARE RES, V63, P1425, DOI 10.1002/acr.20562; Ogawa M, 2012, CLIN PHYSIOL FUNCT I, V32, P89, DOI 10.1111/j.1475-097X.2011.01057.x; Parthan Anju, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P359, DOI 10.1586/14737167.6.3.359; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Schache AG, 2001, CLIN BIOMECH, V16, P667, DOI 10.1016/S0268-0033(01)00061-4; Scheele J, 2012, EUR J PHYS REHAB MED, V48, P379; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Simmonds MJ, 1998, SPINE, V23, P2412, DOI 10.1097/00007632-199811150-00011; Smith R., 1994, PHYSIOTHERAPY, V80, P5, DOI [10.1016/S0031-9406(10)60612-8, DOI 10.1016/S0031-9406(10)60612-8]; Sung PS, 2010, SPINE, V35, pE753, DOI 10.1097/BRS.0b013e3181d53b9c; Tidstrand J, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-58; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; Vogt L, 2001, SPINE, V26, P1910, DOI 10.1097/00007632-200109010-00019; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005; Yokoyama K, 2014, J OCCUP HEALTH, V56, P197, DOI 10.1539/joh.13-0295-OA	46	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128318	10.1371/journal.pone.0128318	http://dx.doi.org/10.1371/journal.pone.0128318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024534	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400081
J	Lei, Y; Yang, L; Ye, CY; Qin, MY; Yang, HY; Jiang, HL; Tang, XC; Zhang, HY				Lei, Yun; Yang, Ling; Ye, Chun Yan; Qin, Ming Yan; Yang, Huai Yu; Jiang, Hua Liang; Tang, Xi Can; Zhang, Hai Yan			Involvement of Intracellular and Mitochondrial A beta in the Ameliorative Effects of Huperzine A against Oligomeric A beta(42)-Induced Injury in Primary Rat Neurons	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; CELL-DEATH; OXIDATIVE STRESS; ACCUMULATION; DYSFUNCTION; PEPTIDE; PROTEIN; AGGREGATION; HYPOTHESIS	Considerable studies indicate huperzine A is a promising natural product to suppress neuronal damages induced by beta-amyloid (A beta), a key pathogenic event in the Alzheimer's disease (AD). As an extension, the present study for the first time explored whether the beneficial profiles of huperzine A against oligomeric A beta(42) induced neurotoxicity are associated with the accumulation and detrimental function of intraneuronal/mitochondrial A beta, on the basis of the emerging evidence that intracellular A beta is more relevant to AD progression as compared with extracellular A beta. Huperzine A treatment was shown to significantly attenuate the neurotoxicity of oligomeric A beta(42), as demonstrated by increased neuronal viability. Interestingly, our results proved that exogenous A beta(42) could accumulate intraneuronally in a dose-and time-dependent manner, while huperzine A treatment markedly reduced the level of intracellular A beta(42). Moreover, huperzine A treatment rescued mitochondrial dysfunction induced by oligomeric A beta(42), including adenosine triphosphate (ATP) reduction, reactive oxygen species (ROS) overproduction and membrane potential depolarization. Further study demonstrated that huperzine A also significantly reduced the level of A beta(42) in the mitochondria-enriched subcellular fractions, as well as the A beta(42) fluorescent signals colocalized with mitochondrial marker. This study indicates that interfering intracellular A beta especially mitochondrial A beta accumulation, together with ameliorating A beta-associated mitochondrial dysfunction, may contribute to the protective effects of huperzine A against A beta neurotoxicity. Above results may shed more light on the pharmacological mechanisms of huperzine A and provide important clues for discovering novel therapeutic strategies for AD.	[Lei, Yun; Yang, Ling; Ye, Chun Yan] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China; [Qin, Ming Yan; Yang, Huai Yu; Jiang, Hua Liang; Tang, Xi Can; Zhang, Hai Yan] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhang, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	hzhang@simm.ac.cn		Lei, Yun/0000-0003-4572-6078	National Natural Science Foundation of China [81173034]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2012ZX09301001-004]; Ministry of Science and Technology of China [2011CB510004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (No 81173034), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China (No. 2012ZX09301001-004), and the Ministry of Science and Technology of China (No 2011CB510004).	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Belluti F, 2013, EXPERT OPIN THER PAT, V23, P581, DOI 10.1517/13543776.2013.772983; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Burton JD, 2005, METH MOLEC MED, V110, P69; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Choi H, 2012, NEUROTOXICOLOGY, V33, P85, DOI 10.1016/j.neuro.2011.12.005; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gao X, 2006, J NEUROSCI RES, V83, P1048, DOI 10.1002/jnr.20791; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Guo JH, 2014, EXP THER MED, V8, P1271, DOI 10.3892/etm.2014.1885; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He Y, 2011, ASN NEURO, V3, DOI [10.1042/AN20100025, DOI 10.1155/2012/843649]; He Y, 2011, ASN NEURO, V3, P13, DOI 10.1042/AN20100025; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Liang JH, 2009, NEUROCHEM INT, V55, P741, DOI 10.1016/j.neuint.2009.07.004; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Picone P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/780179; Pinho CM, 2014, BBA-BIOENERGETICS, V1837, P1069, DOI 10.1016/j.bbabio.2014.02.007; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takahashi RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051965; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Voigt W, 2005, METH MOLEC MED, V110, P39; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Wang Y, 2012, J NEUROSCI RES, V90, P508, DOI 10.1002/jnr.22775; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Xiao XQ, 2002, J NEUROSCI RES, V67, P30, DOI 10.1002/jnr.10075; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Zhang HY, 2008, CELL MOL NEUROBIOL, V28, P173, DOI 10.1007/s10571-007-9163-z; Zhang HY, 2006, TRENDS PHARMACOL SCI, V27, P619, DOI 10.1016/j.tips.2006.10.004; Zhang HY, 2002, NEUROSCI LETT, V317, P143, DOI 10.1016/S0304-3940(01)02437-5; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	61	21	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128366	10.1371/journal.pone.0128366	http://dx.doi.org/10.1371/journal.pone.0128366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024517	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400087
J	Miranda, A; Colomer, C; Fernandez, MI; Presentacion, MJ; Rosello, B				Miranda, Ana; Colomer, Carla; Inmaculada Fernandez, M.; Jesus Presentacion, M.; Rosello, Belen			Analysis of Personal and Family Factors in the Persistence of Attention Deficit Hyperactivity Disorder: Results of a Prospective Follow-Up Study in Childhood	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; CONDUCT PROBLEMS; PREDICT FUTURE; YOUNG-CHILDREN; ADHD SYMPTOMS; BOYS; ADOLESCENTS; IMPACT; RISK; ASSOCIATION	Objectives To study the course of ADHD during childhood and analyze possible personal and family predictor variables of the results. Method Sixty-one children with ADHD who were between 6 and 12 years old at the baseline assessment were evaluated 30 months later (mean age at baseline: 8.70 +/- 1.97; mean age at follow- up: 10.98 +/- 2.19). Status of ADHD in follow-up was identified as persistent (met DSMIV- TR criteria according to parents' and teachers' ratings), contextually persistent (met ADHD criteria according to one informant, and there was functional impairment) and remitted ADHD (with subthreshold clinical symptomatology). Associated psychological disorders of the three groups were analyzed in the follow-up with the Conners' Rating Scales. The groups were compared on ADHD characteristics (symptoms of ADHD and impairment), child psychopathology, executive functioning (EF; inhibition, working memory) and parenting characteristics (parental stress and discipline styles) at baseline. Results At the follow-up, 55.7% of the children continued to meet the DSM-IV-TR criteria for ADHD, 29.5% showed contextual persistence, and 14.8% presented remission of the disorder. The persistent and contextually persistent ADHD groups showed more associated psychological disorders. Inattention, oppositional problems, cognitive problems and impairment at baseline distinguished the remitted ADHD children from the persistent and contextually persistent ADHD children. Moreover, the persistent groups had significantly more emotional liability and higher parental stress than the group in remission, while no differences in EF where found among the groups. Conclusions ADHD children continue to present symptoms, as well as comorbid psychological problems, during adolescence and early adulthood. These findings confirm that persistence of ADHD is associated with child psychopathology, parental stress and impairment in childhood.	[Miranda, Ana; Inmaculada Fernandez, M.] Univ Valencia, Dept Psicol Evolut & Educ, Valencia, Spain; [Colomer, Carla] Univ Jaume 1, Dept Educ, Castellon de La Plana, Spain; [Jesus Presentacion, M.; Rosello, Belen] Univ Jaume 1, Dept Psicol Evolut Educ Social & Metodol, Castellon de La Plana, Spain	University of Valencia; Universitat Jaume I; Universitat Jaume I	Miranda, A (corresponding author), Univ Valencia, Dept Psicol Evolut & Educ, Valencia, Spain.	ana.miranda@uv.es	Fernandez, Inmaculada/M-5927-2019; Miranda, Ana/G-8619-2015; Colomer, Carla/H-3622-2015; Roselló-Miranda, Belén/H-2682-2015; Presentación, M. Jesús/H-4274-2015	Fernandez, Inmaculada/0000-0003-2808-0949; Miranda, Ana/0000-0001-6998-5686; Colomer, Carla/0000-0001-9272-7087; Roselló-Miranda, Belén/0000-0001-8223-4772; Presentación, M. Jesús/0000-0002-7598-1777	MICINN (Ministerio de Educacion y Ciencia, Spain) [EDU2009-07672]	MICINN (Ministerio de Educacion y Ciencia, Spain)	This work was supported by the MICINN (Ministerio de Educacion y Ciencia, Spain): Project grant EDU2009-07672.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Ambrosini PJ, 2013, J AFFECT DISORDERS, V145, P70, DOI 10.1016/j.jad.2012.07.014; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Arnold D.S., 1993, PSYCHOL ASSESSMENT, V9, P137, DOI [10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137]; Asherson P, 2004, EUR CHILD ADOLES PSY, V13, P50, DOI 10.1007/s00787-004-1006-6; Avila C, 2004, J ABNORM CHILD PSYCH, V32, P295, DOI 10.1023/B:JACP.0000026143.70832.4b; Bagwell CL, 2001, J AM ACAD CHILD PSY, V40, P1285, DOI 10.1097/00004583-200111000-00008; Barkley R. A., 2008, ADHD ADULTS WHAT SCI; BARKLEY RA, 1990, J AM ACAD CHILD PSY, V29, P546, DOI 10.1097/00004583-199007000-00007; Berlin L, 2003, CHILD NEUROPSYCHOL, V9, P255, DOI 10.1076/chin.9.4.255.23519; Biederman J, 1996, J AM ACAD CHILD PSY, V35, P343, DOI 10.1097/00004583-199603000-00016; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Biederman J, 2011, J PSYCHIATR RES, V45, P150, DOI 10.1016/j.jpsychires.2010.06.009; Biederman J, 2010, PSYCHIAT RES, V177, P299, DOI 10.1016/j.psychres.2009.12.010; Biederman J, 2009, PSYCHIAT RES, V170, P199, DOI 10.1016/j.psychres.2008.12.016; Chronis AM, 2007, DEV PSYCHOL, V43, P70, DOI 10.1037/0012-1649.43.1.70; Coghill DR, 2014, PSYCHOL MED, V44, P1087, DOI 10.1017/S0033291713001761; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colomer-Diago C, 2014, REV NEUROLOGIA, V58, pS31; Conners C. K., 2001, CONNERS PARENT RATIN; Cussen A, 2012, EUR J PEDIATR, V171, P271, DOI 10.1007/s00431-011-1524-4; Deault LC, 2010, CHILD PSYCHIAT HUM D, V41, P168, DOI 10.1007/s10578-009-0159-4; Demaray MK, 2003, PSYCHOL SCHOOLS, V40, P341, DOI 10.1002/pits.10112; Dubois B, 1995, ANN NY ACAD SCI, V769, P41, DOI 10.1111/j.1749-6632.1995.tb38130.x; Ebejer JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047404; El-Faddagh M, 2004, J NEURAL TRANSM, V111, P883, DOI 10.1007/s00702-003-0054-2; Franke B, 2010, NEUROPSYCHOPHARMACOL, V35, P656, DOI 10.1038/npp.2009.170; Gau SSF, 2013, RES DEV DISABIL, V34, P1581, DOI 10.1016/j.ridd.2013.02.002; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; Halperin JM, 2006, PSYCHOL BULL, V132, P560, DOI 10.1037/0033-2909.132.4.560; HART EL, 1995, J ABNORM CHILD PSYCH, V23, P729, DOI 10.1007/BF01447474; Holbrook JR, 2016, J ATTEN DISORD, V20, P11, DOI 10.1177/1087054714539997; Hurtig T, 2007, EUR CHILD ADOLES PSY, V16, P362, DOI 10.1007/s00787-007-0607-2; Jensen CM, 2014, ATTEN DEFIC IN PRESS, DOI [10.1007/s1202-014-0142-1, DOI 10.1007/S1202-014-0142-1]; Johnston C, 2007, J CAN ACAD CHILD ADO, V16, P74; Kent KM, 2011, J ABNORM CHILD PSYCH, V39, P451, DOI 10.1007/s10802-010-9472-4; Keown LJ, 2012, J ABNORM CHILD PSYCH, V40, P569, DOI 10.1007/s10802-011-9586-3; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Landaas ET, 2010, GENES BRAIN BEHAV, V9, P449, DOI 10.1111/j.1601-183X.2010.00567.x; Larson K, 2011, PEDIATRICS, V127, P462, DOI 10.1542/peds.2010-0165; Larsson H, 2006, J AM ACAD CHILD PSY, V45, P973, DOI 10.1097/01.chi.0000222787.57100.d8; Larsson H, 2011, J CHILD PSYCHOL PSYC, V52, P954, DOI 10.1111/j.1469-7610.2011.02379.x; Law EC, 2014, PEDIATRICS, V133, P659, DOI 10.1542/peds.2013-3433; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Loo S, 2011, ADHD REPORT, V19, P6, DOI DOI 10.1521/adhd.2011.19.3.6; Markel C, 2014, CAN J BEHAV SCI, V46, P40, DOI 10.1037/a0029854; Mattfeld AT, 2014, BRAIN IN PRESS, DOI 10.pii:awu 137; McAuley T, 2014, J CHILD PSYCHOL PSYC, V55, P292, DOI 10.1111/jcpp.12160; Miller M, 2012, J ABNORM CHILD PSYCH, V40, P657, DOI 10.1007/s10802-011-9599-y; Miranda A, 2007, ADV LEARN BEHAV DISA, V20, P139, DOI 10.1016/S0735-004X(07)20006-0; Miranda-Casas A, 2007, Rev Neurol, V44 Suppl 2, pS23; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-54; Richards JS, 2014, J AM ACAD CHILD PSY, V53, P311, DOI 10.1016/j.jaac.2013.11.011; Riddle MA, 2013, J AM ACAD CHILD PSY, V52, P264, DOI 10.1016/j.jaac.2012.12.007; Robinson T, 2013, JPN PSYCHOL RES, V55, P154, DOI 10.1111/jpr.12005; Sarver DE, 2014, J CHILD PSYCHOL PSYC, V55, P1345, DOI 10.1111/jcpp.12249; Sattler J.M., 1988, ASSESSMENT CHILDREN; Sciberras E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-18; Sibley MH, 2012, J CONSULT CLIN PSYCH, V80, P139, DOI 10.1037/a0026577; Sibley MH, 2011, J ABNORM CHILD PSYCH, V39, P21, DOI 10.1007/s10802-010-9443-9; Steinhausen HC, 2003, J AM ACAD CHILD PSY, V42, P1085, DOI 10.1097/01.CHI.0000070241.24125.A3; Taylor E, 1996, J AM ACAD CHILD PSY, V35, P1213, DOI 10.1097/00004583-199609000-00019; Theule J, 2013, J EMOT BEHAV DISORD, V21, P3, DOI 10.1177/1063426610387433; van Lieshout M, 2013, CLIN PSYCHOL REV, V33, P539, DOI 10.1016/j.cpr.2013.02.003; Wechsler D., 1993, ESCALA INTELIGENCIA; Weyandt LL, 2003, J LEARN DISABIL-US, V36, P382, DOI 10.1177/00222194030360040801; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	69	12	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128325	10.1371/journal.pone.0128325	http://dx.doi.org/10.1371/journal.pone.0128325			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024216	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400084
J	Pujari-Palmer, M; Pujari-Palmer, S; Engqvist, H; Ott, MK				Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Engqvist, Hakan; Ott, Marjam Karlsson			Rebamipide Delivered by Brushite Cement Enhances Osteoblast and Macrophage Proliferation	PLOS ONE			English	Article							WATER-SOLUBLE DRUGS; MC3T3-E1 CELLS; MECHANICAL-PROPERTIES; BONE-CEMENT; RAT MODEL; PHOSPHATE; DIFFERENTIATION; RELEASE; RECEPTOR; ACTIVATION	Many of the bioactive agents capable of stimulating osseous regeneration, such as bone morphogenetic protein-2 (BMP-2) or prostaglandin E2 (PGE2), are limited by rapid degradation, a short bioactive half-life at the target site in vivo, or are prohibitively expensive to obtain in large quantities. Rebamipide, an amino acid modified hydroxylquinoline, can alter the expression of key mediators of bone anabolism, cyclo-oxygenase 2 (COX-2), BMP-2 and vascular endothelial growth factor (VEGF), in diverse cell types such as mucosal and endothelial cells or chondrocytes. The present study investigates whether Rebamipide enhances proliferation and differentiation of osteoblasts when delivered from brushite cement. The reactive oxygen species (ROS) quenching ability of Rebampide was tested in macrophages as a measure of bioactivity following drug release incubation times, up to 14 days. Rebamipide release from brushite occurrs via non-fickian diffusion, with a rapid linear release of 9.70%+/- 0.37% of drug per day for the first 5 days, and an average of 0.5%-1% per day thereafter for 30 days. Rebamipide slows the initial and final cement setting time by up to 3 and 1 minute, respectively, but does not significantly reduce the mechanical strength below 4% (weight percentage). Pre-osteoblast proliferation increases by 24% upon exposure to 0.4uM Rebamipide, and by up to 73% when Rebamipide is delivered via brushite cement. Low doses of Rebamipide do not adversely affect peak alkaline phosphatase activity in differentiating pre-osteoblasts. Rebamipide weakly stimulates proliferation in macrophages at low concentrations (118 +/- 7.4% at 1uM), and quenches ROS by 40-60%. This is the first investigation of Rebamipide in osteoblasts.	[Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Engqvist, Hakan; Ott, Marjam Karlsson] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Uppsala, Sweden	Uppsala University	Ott, MK (corresponding author), Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Uppsala, Sweden.	marjam.ott@angstrom.uu.se	Pujari-Palmer, michael/W-4362-2018	Pujari-Palmer, michael/0000-0001-7004-2853	Swedish research council [GA 621-2011-3399]	Swedish research council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish research council GA 621-2011-3399 HE MP EU 7th framework project: Biodesign HE MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg J, 2013, J MATER SCI-MATER M, V24, P829, DOI 10.1007/s10856-013-4855-z; [Anonymous], 1999, AM PHYSL SOC; Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Bamba H, 2003, ALIMENT PHARM THER, V18, P113, DOI 10.1046/j.1365-2036.18.s1.13.x; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Bohner M LJ, 1996, J PHARM SCEINCES, V86, P565; Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028; Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013; BROXMEYER HE, 1977, CANCER RES, V37, P3578; Canal C, 2013, ACTA BIOMATER, V9, P8403, DOI 10.1016/j.actbio.2013.05.016; Chen WC, 2012, TISSUE ENG PT A, V18, P816, DOI [10.1089/ten.tea.2011.0267, 10.1089/ten.TEA.2011.0267]; Chou J, 2013, ADV HEALTHC MATER, V2, P678, DOI 10.1002/adhm.201200342; Choudhary S, 2004, BIOCHEM BIOPH RES CO, V322, P395, DOI 10.1016/j.bbrc.2004.07.129; Clarkin CE, 2008, J CELL PHYSIOL, V214, P537, DOI 10.1002/jcp.21234; Cortizo AM, 2006, EUR J PHARMACOL, V536, P38, DOI 10.1016/j.ejphar.2006.02.030; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Engstrand J, 2014, J MECH BEHAV BIOMED, V29, P81, DOI 10.1016/j.jmbbm.2013.08.024; Engstrand J, 2013, MAT SCI ENG C-MATER, V33, P527, DOI 10.1016/j.msec.2012.09.026; Ghanaati S, 2011, BIOMATERIALS, V32, P8150, DOI 10.1016/j.biomaterials.2011.07.041; Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X; Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R; Harland AG R.S., 1988, DRUG POLYM MATRIX SW, V5, P488; Hayashi K, 2005, J BONE JOINT SURG BR, V87B, P1150, DOI 10.1302/0301-620X.87B8.15886; Hofmann MP, 2009, ACTA BIOMATER, V5, P43, DOI 10.1016/j.actbio.2008.08.005; Hong WS, 2001, PHARMACOL RES, V44, P293, DOI 10.1006/phrs.2001.0839; Ishihara T, 2010, BIOCHEM PHARMACOL, V79, P1622, DOI 10.1016/j.bcp.2010.01.030; Itoh F, 2003, EUR J PHARMACOL, V477, P9, DOI 10.1016/j.ejphar.2003.08.011; Kamolratanakul P, 2011, ARTHRITIS RHEUM-US, V63, P1021, DOI 10.1002/art.30151; Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034; Kang DW, 2010, EXP MOL MED, V42, P555, DOI 10.3858/emm.2010.42.8.056; Kim JS, 2003, ALIMENTARY PHARM THE, V2003; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; KUU WY, 1989, INT J PHARM, V55, P77, DOI 10.1016/0378-5173(89)90279-2; KYEYUNENYOMBI E, 1995, CALCIFIED TISSUE INT, V56, P154, DOI 10.1007/BF00296348; Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029; Lubeck DP, 2003, BEST PRACT RES CL RH, V17, P529, DOI 10.1016/S1521-6942(03)00023-8; Monrad SU, 2011, CURR REV MUSCULOSKE, V4, P91, DOI 10.1007/s12178-011-9083-x; Montazerolghaem M, 2014, J BIOMED MATER RES A, V102, P340, DOI 10.1002/jbm.a.34702; Moon SJ, 2012, OSTEOARTHR CARTILAGE, V20, P1426, DOI 10.1016/j.joca.2012.08.002; Mulye N. TS, 1996, DRUG DEV IND PHARM, V22, P2621; Mulye NV, 1996, DRUG DEV IND PHARM, V22, P673, DOI 10.3109/03639049609063223; MULYE NV, 1995, DRUG DEV IND PHARM, V21, P943, DOI 10.3109/03639049509026658; Nishiya Y, 2002, CALCIFIED TISSUE INT, V70, P30, DOI 10.1007/s00223-001-1010-5; Pradhan R, 2014, ARCH PHARM RES; RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4; SCHOENFELD CM, 1974, MED BIOL ENG, V12, P313, DOI 10.1007/BF02477797; Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015; Shamir D KS, 1994, BONE, V34, P157; Shields LB RG, 2006, SPINE, V31; Suda M, 2000, CALCIFIED TISSUE INT, V66, P217, DOI 10.1007/s002230010043; Suetsugu H, 2000, J LAB CLIN MED, V136, P50, DOI 10.1067/mlc.2000.107303; Tarnawski AS, 2004, DIGEST DIS SCI, V49, P202, DOI 10.1023/B:DDAS.0000017439.60943.5c; Temizel N, 2011, MAT SCI ENG C-MATER, V31, P1136, DOI 10.1016/j.msec.2011.04.009; Tran RT, 2012, GASTROINTEST ENDOSC, V75, P1092, DOI 10.1016/j.gie.2011.12.009; von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059; Vorndran E, 2013, ACTA BIOMATER, V9, P9558, DOI 10.1016/j.actbio.2013.08.009; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Xiaobin ZH Q, 2011, BIOACTIVE MAT MED DE; Zhang J. Q., 2014, PLOS ONE, V9; Zhang WB, 2012, J ORTHOP SCI, V17, P289, DOI 10.1007/s00776-012-0206-z; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P591, DOI 10.1038/aps.2011.15	61	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128324	10.1371/journal.pone.0128324	http://dx.doi.org/10.1371/journal.pone.0128324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023912	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400083
J	Takeo, T; Nakagata, N				Takeo, Toru; Nakagata, Naomi			Superovulation Using the Combined Administration of Inhibin Antiserum and Equine Chorionic Gonadotropin Increases the Number of Ovulated Oocytes in C57BL/6 Female Mice	PLOS ONE			English	Article							METHYL-BETA-CYCLODEXTRIN; ASSISTED REPRODUCTIVE TECHNOLOGIES; IN-VITRO FERTILIZATION; INBRED MOUSE STRAINS; ENDOGENOUS INHIBIN; ESTROUS-CYCLE; SPERM; SECRETION; EMBRYOS; INDUCTION	Superovulation is a reproductive technique generally used to produce genetically engineered mice. Superovulation in mice involves the administration of equine chorionic gonadotropin (eCG) to promote follicle growth and then that of human chorionic gonadotropin (hCG) to induce ovulation. Previously, some published studies reported that inhibin antiserum (IAS) increased the number of ovulated oocytes in ddY and wild-derived strains of mice. However, the effect of IAS on the C57BL/6 strain, which is the most widely used inbred strain for the production of genetically engineered mice, has not been investigated. In addition, the combined effect of IAS and eCG (IASe) on the number of ovulated oocytes in superovulation treatment has not been examined. In this study, we examined the effect of IAS and eCG on the number of ovulated oocytes in immature female mice of the C57BL/6 strain in superovulation treatment. Furthermore, we evaluated the quality of obtained oocytes produced by superovulation using IASe by in vitro fertilization (IVF) with sperm from C57BL/6 or genetically engineered mice. The developmental ability of fresh or cryopreserved embryos was examined by embryo transfer. The administration of IAS or eCG had a similar effect on the number of ovulated oocytes in C57BL/6 female mice. The number of ovulated oocytes increased to about 3-fold by the administration of IASe than by the administration of IAS or eCG alone. Oocytes derived from superovulation using IASe normally developed into 2-cell embryos by IVF using sperm from C57BL/6 mice. Fresh or cryopreserved 2-cell embryos produced by IVF between oocytes of C57BL/6 mice and sperm from genetically engineered mice normally developed into live pups following embryo transfer. In summary, a novel technique of superovulation using IASe is extremely useful for producing a great number of oocytes and offspring from genetically engineered mice.	[Takeo, Toru; Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Chuo Ku, Kumamoto 8600811, Japan	Kumamoto University	Nakagata, N (corresponding author), Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	nakagata@kumamoto-u.ac.jp	Takeo, Toru/A-3119-2010	Takeo, Toru/0000-0002-8103-651X; Nakagata, Naomi/0000-0002-5737-9993	Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akagi S, 1997, J VET MED SCI, V59, P1129, DOI 10.1292/jvms.59.1129; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; DEJONG FH, 1988, PHYSIOL REV, V68, P555, DOI 10.1152/physrev.1988.68.2.555; Eppig JT, 1999, TRENDS GENET, V15, P81, DOI 10.1016/S0168-9525(98)01665-5; FOWLER RE, 1957, J ENDOCRINOL, V15, P374, DOI 10.1677/joe.0.0150374; Guan M, 2012, MAMM GENOME, V23, P572, DOI 10.1007/s00335-012-9423-1; Hasegawa A, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098491; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Kishi H, 1996, J ENDOCRINOL, V151, P65, DOI 10.1677/joe.0.1510065; KISHI H, 1995, J ENDOCRINOL, V146, P169, DOI 10.1677/joe.0.1460169; Kito S, 2008, ZYGOTE, V16, P259, DOI 10.1017/S0967199408004619; Medan MS, 2004, ENDOCRINE, V24, P115, DOI 10.1385/ENDO:24:2:115; Mochida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114305; NAKAGATA N, 1992, EXP ANIM TOKYO, V41, P387, DOI 10.1538/expanim1978.41.3_387; Nakagata N, 2013, CRYOBIOLOGY, V67, P188, DOI 10.1016/j.cryobiol.2013.06.011; Nakagata N, 2009, EXP ANIM TOKYO, V58, P343, DOI 10.1538/expanim.58.343; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; Nambo Y, 1998, THERIOGENOLOGY, V50, P545, DOI 10.1016/S0093-691X(98)00160-5; Ogasawara M, 2005, GENE, V349, P107, DOI 10.1016/j.gene.2004.11.050; QUINN P, 1985, FERTIL STERIL, V44, P493; RIVIER C, 1989, ENDOCRINOLOGY, V125, P152, DOI 10.1210/endo-125-1-152; Russell WMS, 2005, ANIM WELFARE, V14, P279; Shi F, 2000, J REPROD FERTIL, V118, P1, DOI 10.1530/reprod/118.1.1; Takeo T, 2010, LAB ANIM-UK, V44, P132, DOI 10.1258/la.2009.009074; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Takeo T, 2014, CRYOBIOLOGY, V68, P12, DOI 10.1016/j.cryobiol.2013.10.007; Takeo T, 2012, CRYOBIOLOGY, V65, P163, DOI 10.1016/j.cryobiol.2012.06.002; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Takeo T, 2010, J AM ASSOC LAB ANIM, V49, P415; Takeo T, 2009, CRYOBIOLOGY, V58, P196, DOI 10.1016/j.cryobiol.2008.12.011; Taya K, 1993, CURR TRENDS EXP ENDO, V1, P97; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang H, 2001, REPRODUCTION, V122, P809, DOI 10.1530/reprod/122.5.809	33	69	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128330	10.1371/journal.pone.0128330	http://dx.doi.org/10.1371/journal.pone.0128330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024317	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400085
J	Guo, ZY; Zhang, Q; Li, XG; Jing, ZY				Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu			Intravoxel Incoherent Motion Diffusion Weighted MR Imaging for Monitoring the Instantly Therapeutic Efficacy of Radiofrequency Ablation in Rabbit VX2 Tumors without Evident Links between Conventional Perfusion Weighted Images	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-TUMORS; CT; PARAMETERS; EXPERIENCE; THERAPIES; DIAGNOSIS; VALUES	Objective To investigate the intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) as a potential valuable marker to monitor the therapy responses of VX2 to radiofrequency ablation (RF Ablation). Methods The institutional animal care and use committee approved this study. In 10 VX2 tumor-bearing rabbits, IVIM-DWI examinations were performed with a 3.0T imaging unit by using 16 b values from 0 to 800 sec/mm(2). The true diffusion coefficient (D), pseudodiffusion coefficient (D*) and perfusion fraction (f) of tumors were compared between before and instantly after RF Ablation treatment. The differences of D, D* and f and conventional perfusion parameters (from perfusion CT and dynamic enhanced magnetic resonance imaging, DCE-MRI) in the coagulation necrosis area, residual unablated area, untreated area, and normal control had been calculated by compared t-test. The correlation between f or D* with perfusion weighted CT including blood flow, BF (milliliter per 100 mL/min), blood volume, BV (milliliter per 100 mL/min), and capillary permeability-surface area, PMB (as a fraction) or from DCE-MRI: transfer constant (K-trans), extra-vascular extra-cellular volume fraction (V-e) and reflux constant (K-ep) values had been analyzed by region-of-interest (ROI) methods to calculate Pearson's correlation coefficients. Results In the ablated necrosis areas, f and D* significantly decreased and D significantly increased, compared with residual unblazed areas or untreated control groups and normal control groups (P < 0.001). The IVIM-DWI derived f parameters showed significant increases in the residual unablated tumor area. There was no significant correlations between f or D* and conventional perfusion parameters. Conclusions The IVIM-DWderived f, D and D* parameters have the potential to indicate therapy response immediately after RF Ablation treatment, while no significant correlations with classical tumor perfusion metrics were derived from DCE-MRI and perfusion-CT measurements.	[Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China; [Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Peking Union Med Coll, Beijing 100730, Peoples R China; [Guo, Ziyi] Cent S Univ, Haikou Peoples Hosp, Xiangya Med Sch, Dept Radiol, Haikou 570208, Hainan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University	Li, XG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China.	xglee88@126.com; MRI_learn@163.com			Haikou Municipal Bureau of Industry and Information Bureau of the key projects [2012075]; Hainan Natural Science Foundation Project [813261]	Haikou Municipal Bureau of Industry and Information Bureau of the key projects; Hainan Natural Science Foundation Project	This work was supported by the Haikou Municipal Bureau of Industry and Information Bureau of the key projects (contract/grant numbers 2012075) and Hainan Natural Science Foundation Project (contract/grant numbers 813261).	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Bains LJ, 2012, CANCER IMAGING, V12, P395, DOI 10.1102/1470-7330.2012.9047; Bisdas S, 2014, NMR BIOMED, V27, P1184, DOI 10.1002/nbm.3172; Cheng HLM, 2008, J MAGN RESON IMAGING, V28, P136, DOI 10.1002/jmri.21415; Federau C, 2014, AM J NEURORADIOL, V35, P256, DOI 10.3174/ajnr.A3686; Fritzsche KH, 2012, METHOD INFORM MED, V51, P441, DOI 10.3414/ME11-02-0031; Hennedige T, 2013, CANCER IMAGING, V12, P530, DOI 10.1102/1470-7330.2012.0044; Hoang JK, 2014, AM J ROENTGENOL, V203, P1104, DOI 10.2214/AJR.14.12838; Ikink ME, 2014, EUR RADIOL, V24, P2118, DOI 10.1007/s00330-014-3274-y; Joo I, 2014, RADIOLOGY, V272, P417, DOI 10.1148/radiol.14131165; Kim HS, 2014, AM J NEURORADIOL, V35, P490, DOI 10.3174/ajnr.A3719; Kim YS, 2006, J COMPUT ASSIST TOMO, V30, P578, DOI 10.1097/00004728-200607000-00005; KING MD, 1992, MAGNET RESON MED, V24, P288, DOI 10.1002/mrm.1910240210; Kitchin D, 2014, INT J HYPERTHER, V30, P299, DOI 10.3109/02656736.2014.936050; Koh DM, 2007, AM J ROENTGENOL, V188, P1001, DOI 10.2214/AJR.06.0601; Koh DM, 2014, RADIOLOGY, V272, P307, DOI 10.1148/radiol.14140714; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Mazzetti S, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8443; Miki K, 2006, INT J UROL, V13, P880, DOI 10.1111/j.1442-2042.2006.01432.x; Nishikawa H, 2013, INT J HYPERTHER, V29, P558, DOI 10.3109/02656736.2013.821528; Okuma T, 2009, BRIT J RADIOL, V82, P989, DOI 10.1259/bjr/13217618; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Park MS, 2012, HEPATOLOGY, V56, P140, DOI 10.1002/hep.25681; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Sanelli PC, 2004, ACAD RADIOL, V11, P1085, DOI 10.1016/j.acra.2004.07.002; Schima Wolfgang, 2007, Cancer Imaging, V7 Spec No A, pS28, DOI 10.1102/1470-7330.2007.9047; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Viswanath S, 2013, PROC SPIE, V8671, DOI 10.1117/12.2008037; Vogl TJ, 2004, INT J HYPERTHER, V20, P713, DOI 10.1080/02656730400007212; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2	33	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127964	10.1371/journal.pone.0127964	http://dx.doi.org/10.1371/journal.pone.0127964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020785	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300067
J	Li, JX; Wu, LM; Tian, XL; Zhang, J; Shi, YJ				Li, Junxia; Wu, Longmei; Tian, Xinli; Zhang, Jian; Shi, Yujie			Intravascular Ultrasound Observation of the Mechanism of No-Reflow Phenomenon in Acute Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; STENT IMPLANTATION; ANGIOGRAPHY; OUTCOMES; SEGMENT; METAANALYSIS; TOMOGRAPHY; PREVENTION; INJURY; LESION	Objective To study the mechanism of the no-reflow phenomenon using coronary angiography (CAG) and intravascular ultrasound (IVUS). Methods A total of 120 patients with acute myocardial infarction (AMI) who successfully underwent indwelling intracoronary stent placement by percutaneous coronary intervention (PCI). All patients underwent pre- and post-PCI CAG and pre-IVUS. No-reflow was defined as post-PCI thrombolysis in myocardial infarction (TIMI) grade 0, 1, or 2 flow in the absence of mechanical obstruction. Normal reflow was defined as TIMI grade 3 flow. The pre-operation reference vascular area, minimal luminal cross-sectional area, plaque cross-sectional area, lesion length, plaque volume and plaque traits were measured by IVUS. Results The no-reflow group was observed in 14 cases (11.6%) and normal blood-flow group in 106 cases (89.4%) based on CAG results. There was no statistically significant difference in the patients' medical history, reference vascular area (no-flow vs. normal-flow; 15.5 +/- 3.2 vs. 16.2 +/- 3.3, p>0.05) and lesion length (21.9 +/- 5.1 vs. 19.5 +/- 4.8, p>0.05) between the two groups. No-reflow patients had a longer symptom onset to reperfusion time compared to normal blood-flow group [(6.6 +/- 3.1) h vs (4.3 +/- 2.7) h; p<0.05] and higher incidence of TIMI flow grade< 3 (71.4% vs 49.0%, p<0.05). By IVUS examination, the no-reflow group had a significantly increased coronary plaque area and plaque volume compared to normal blood-flow group [(13.7 +/- 3.0) mm(2) vs (10.2 +/- 2.9) mm(2); (285.4 +/- 99.8) mm(3) vs (189.7 +/- 86.4) mm3; p<0.01]. The presence of IVUS-detected soft plaque (57.1% vs. 24.0%, p<0.01), eccentric plaque (64.2% vs. 33.7%, p<0.05), plaque rupture (50.0% vs. 21.2%, p<0.01), and thrombosis (42.8% vs. 15.3%) were significantly more common in no-reflow group. Conclusion There was no obvious relationship between the coronary risk factors and no-reflow phenomenon. The symptom onset to reperfusion time, TIMI flow grade before stent deployment, plaque area, soft plaques, eccentric plaques, plaque rupture and thrombosis may be risk factors for the no-reflow phenomenon after PCI.	[Li, Junxia; Wu, Longmei; Tian, Xinli; Zhang, Jian; Shi, Yujie] Beijing Peoples Liberat Army Hosp, Mil Gen Hosp, Dept Cardiol, Beijing 100700, Peoples R China		Li, JX (corresponding author), Beijing Peoples Liberat Army Hosp, Mil Gen Hosp, Dept Cardiol, Beijing 100700, Peoples R China.	18600090805@163.com						Ahn JM, 2014, AM J CARDIOL, V113, P1338, DOI 10.1016/j.amjcard.2013.12.043; Akpek M, 2012, AM J CARDIOL, V110, P621, DOI 10.1016/j.amjcard.2012.04.041; Fishbein MC, 2010, CARDIOVASC PATHOL, V19, P6, DOI 10.1016/j.carpath.2008.08.004; Fleg JL, 2012, JACC-CARDIOVASC IMAG, V5, P941, DOI 10.1016/j.jcmg.2012.07.007; Groves EM, 2016, HEART FAIL CLIN, V12, P83, DOI [10.1016/j.ccl.2014.04.005, 10.1016/j.hfc.2015.08.007]; Harrison RW, 2013, AM J CARDIOL, V111, P178, DOI 10.1016/j.amjcard.2012.09.015; Hou Y, 2014, EUR RADIOL, V24, P3, DOI 10.1007/s00330-013-2969-9; Jaffe R, 2010, JACC-CARDIOVASC INTE, V3, P695, DOI 10.1016/j.jcin.2010.05.004; Kapoor N, 2014, CATHETER CARDIO INTE, V83, P1045, DOI 10.1002/ccd.25248; Katayama T, 2006, AM J CARDIOL, V97, P301, DOI 10.1016/j.amjcard.2005.08.043; Kloner RA, 2011, J CARDIOVASC PHARM T, V16, P244, DOI 10.1177/1074248411405990; Kotani J, 2002, CIRCULATION, V106, P1672, DOI 10.1161/01.CIR.0000030189.27175.4E; Maekawa Y, 2005, HEART VESSELS, V20, P13, DOI 10.1007/s00380-004-0798-0; Medical Advisory Secretariat, 2007, Ont Health Technol Assess Ser, V7, P1; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; Muthusamy P, 2013, CATHETER CARDIO INTE, V81, P6, DOI 10.1002/ccd.24537; Nakamura Tomohiro, 2007, J Interv Cardiol, V20, P335, DOI 10.1111/j.1540-8183.2007.00282.x; Ndrepepa G, 2010, CIRC-CARDIOVASC INTE, V3, P27, DOI 10.1161/CIRCINTERVENTIONS.109.896225; Niccoli G, 2011, EXPERT REV CARDIOVAS, V9, P615, DOI [10.1586/erc.11.49, 10.1586/ERC.11.49]; Park HC, 2015, INT J CARDIOVAS IMAG, V31, P229, DOI 10.1007/s10554-014-0543-4; Safi AM, 2000, ANGIOLOGY, V51, P247, DOI 10.1177/000331970005100309; Shinozaki N, 2007, INT HEART J, V48, P423, DOI 10.1536/ihj.48.423; Silber S, 2010, HERZ, V35, P558, DOI 10.1007/s00059-010-3401-8; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Tanaka A, 2002, CIRCULATION, V105, P2148, DOI 10.1161/01.CIR.0000015697.59592.07; Tanaka A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290810; Tu SX, 2014, JACC-CARDIOVASC INTE, V7, P768, DOI 10.1016/j.jcin.2014.03.004; von Elverfeldt D, 2014, CIRCULATION, V130, P676, DOI 10.1161/CIRCULATIONAHA.113.008157; Waltenberger J, 2014, JACC-CARDIOVASC IMAG, V7, P620, DOI 10.1016/j.jcmg.2014.01.017; Wang J, 2007, ANN THORAC SURG, V83, P1751, DOI 10.1016/j.athoracsur.2007.01.026; Wang L, 2015, ANN BIOMED ENG, V43, P107, DOI 10.1007/s10439-014-1118-1; Wentzel JJ, 2014, ATHEROSCLEROSIS, V236, P82, DOI 10.1016/j.atherosclerosis.2014.06.013; Wever-Pinzon O, 2014, J AM COLL CARDIOL, V63, P1992, DOI 10.1016/j.jacc.2014.01.071; Wu XF, 2013, CATHETER CARDIO INTE, V82, P203, DOI 10.1002/ccd.24644	34	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0119223	10.1371/journal.pone.0119223	http://dx.doi.org/10.1371/journal.pone.0119223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035818	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100002
J	Abou El Hassan, M; Huang, K; Eswara, MBK; Zhao, M; Song, L; Yu, T; Liu, Y; Liu, JC; McCurdy, S; Ma, AQ; Wither, J; Jin, J; Zacksenhaus, E; Wrana, JL; Bremner, R				Abou El Hassan, Mohamed; Huang, Katherine; Eswara, Manoja B. K.; Zhao, Michael; Song, Lan; Yu, Tao; Liu, Yu; Liu, Jeffrey C.; McCurdy, Sean; Ma, Anqi; Wither, Joan; Jin, Jian; Zacksenhaus, Eldad; Wrana, Jeffrey L.; Bremner, Rod			Cancer Cells Hijack PRC2 to Modify Multiple Cytokine Pathways	PLOS ONE			English	Article							IFN-GAMMA; ADAPTIVE IMMUNITY; GENE-EXPRESSION; TARGET GENES; NK CELLS; POLYCOMB; EZH2; RNA; BINDING; BRG1	Polycomb Repressive Complex 2 (PRC2) is an epigenetic regulator induced in many cancers. It is thought to drive tumorigenesis by repressing division, stemness, and/or developmental regulators. Cancers evade immune detection, and diverse immune regulators are perturbed in different tumors. It is unclear how such cell-specific effects are coordinated. Here, we show a profound and cancer-selective role for PRC2 in repressing multiple cytokine pathways. We find that PRC2 represses hundreds of IFN gamma stimulated genes (ISGs), cytokines and cytokine receptors. This target repertoire is significantly broadened in cancer vs non-cancer cells, and is distinct in different cancer types. PRC2 is therefore a higher order regulator of the immune program in cancer cells. Inhibiting PRC2 with either RNAi or EZH2 inhibitors activates cytokine/cytokine receptor promoters marked with bivalent H3K27me3/H3K4me3 chromatin, and augments responsiveness to diverse immune signals. PRC2 inhibition rescues immune gene induction even in the absence of SWI/SNF, a tumor suppressor defective in similar to 20% of human cancers. This novel PRC2 function in tumor cells could profoundly impact the mechanism of action and efficacy of EZH2 inhibitors in cancer treatment.	[Abou El Hassan, Mohamed; Huang, Katherine; Eswara, Manoja B. K.; Zhao, Michael; Song, Lan; Yu, Tao; Liu, Yu; McCurdy, Sean; Wrana, Jeffrey L.; Bremner, Rod] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Liu, Jeffrey C.; Zacksenhaus, Eldad] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [McCurdy, Sean; Zacksenhaus, Eldad; Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ma, Anqi; Jin, Jian] Mt Sinai Hosp, Icahn Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Wither, Joan] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Bremner, Rod] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Icahn School of Medicine at Mount Sinai; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Bremner, R (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	bremner@lunenfeld.ca	Zacksenhaus, Eldad/AAD-3584-2020; Bremner, Rod/I-6490-2012; Wrana, Jeffrey/F-8857-2013	Bremner, Rod/0000-0001-9184-7212; Zhao, Michael/0000-0002-0312-9526; Wither, Joan/0000-0001-5961-9228; LIU, YU/0000-0001-8359-6732	Canadian Cancer Society [703079]; Canadian Institutes of Health Research [MOP 74570]; Krembil Foundation [KF12-02]; National Institutes of Health (US) NIH [R01GM103893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103893] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; National Institutes of Health (US) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by RB: 703079 Canadian Cancer Society (http://www.cancer.ca/research), RB: MOP 74570 Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), RB: KF12-02 Krembil Foundation (http://www.krembilfoundation.ca/), JJ: R01GM103893 National Institutes of Health (US) NIH (http://www.nih.gov/).	Abou El Hassan M, 2009, Nucleic Acids Res, V37, pe35, DOI 10.1093/nar/gkp028; Abou El Hassan M, 2015, J IMMUNOL IN PRESS; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Cai L, 2013, MOL CELL, V49, P571, DOI 10.1016/j.molcel.2012.11.026; Chen S, 2013, J IMMUNOL, V191, P2614, DOI 10.4049/jimmunol.1203143; Chow MT, 2012, SEMIN CANCER BIOL, V22, P23, DOI 10.1016/j.semcancer.2011.12.004; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; De Gobbi M, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-9; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dorval KM, 2005, J BIOL CHEM, V280, P10100, DOI 10.1074/jbc.M412676200; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Haynes KA, 2011, J BIOL CHEM, V286, P27176, DOI 10.1074/jbc.C111.229567; Holling TM, 2007, J IMMUNOL, V179, P5317, DOI 10.4049/jimmunol.179.8.5317; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Klose RJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003717; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lion E, 2009, J IMMUNOL METHODS, V350, P89, DOI 10.1016/j.jim.2009.08.014; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Lund K, 2014, LEUKEMIA, V28, P44, DOI 10.1038/leu.2013.288; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mehta NT, 2011, EPIGENETICS-US, V6, P517, DOI 10.4161/epi.6.4.14516; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Mitra-Kaushik S, 2004, BLOOD, V104, P3305, DOI 10.1182/blood-2004-01-0266; Ni ZY, 2008, NAT IMMUNOL, V9, P785, DOI 10.1038/ni.1619; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Piunti A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4649; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truax AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036013; Turgeon N, 2013, J CELL BIOCHEM, V114, P1203, DOI 10.1002/jcb.24463; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang AB, 2013, J IMMUNOL, V191, P4908, DOI 10.4049/jimmunol.1300433; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805	65	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126466	10.1371/journal.pone.0126466	http://dx.doi.org/10.1371/journal.pone.0126466			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030458	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900027
J	Ao, D; Song, R; Tong, KY				Ao, Di; Song, Rong; Tong, Kai-yu			Sensorimotor Control of Tracking Movements at Various Speeds for Stroke Patients as Well as Age-Matched and Young Healthy Subjects	PLOS ONE			English	Article							KINEMATIC ANALYSIS; NEUROMOTOR NOISE; FEEDBACK-CONTROL; INTERNAL-MODELS; ONLINE CONTROL; MOTOR CONTROL; FEEDFORWARD; ARM; ADAPTATION; DEFICITS	There are aging- and stroke-induced changes on sensorimotor control in daily activities, but their mechanisms have not been well investigated. This study explored speed-, aging-, and stroke-induced changes on sensorimotor control. Eleven stroke patients (affected sides and unaffected sides) and 20 control subjects (10 young and 10 age-matched individuals) were enrolled to perform elbow tracking tasks using sinusoidal trajectories, which included 6 target speeds (15.7, 31.4, 47.1, 62.8, 78.5, and 94.2 deg/s). The actual elbow angle was recorded and displayed on a screen as visual feedback, and three indicators, the root mean square error (RMSE), normalized integrated jerk (NIJ) and integral of the power spectrum density of normalized speed (IPNS), were used to investigate the strategy of sensorimotor control. Both NIJ and IPNS had significant differences among the four groups (P<0.01), and the values were ranked in the following order: young controls < age-matched controls <un-affected sides of stroke patients <affected sides of stroke patients, which could be explained by the stroke-and aging-induced increase in reliance on feedback control. The RMSE increased with the increase in the target speed and the NIJ and IPNS initially declined and then remained steady for all four groups, which indicated a shift from feedback to feedforward control as the target speed increased. The feedback-feedforward trade-off induced by stroke, aging and speed might be explained by a change in the transmission delay and neuromotor noise. The findings in this study improve our understanding of the mechanism underlying the sensorimotor control and neurological changes caused by stroke and aging.	[Ao, Di; Song, Rong] Sun Yat Sen Univ, Sch Engn, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Kai-yu] Chinese Univ Hong Kong, Dept Elect Engn, Div Biomed Engn, Hong Kong, Peoples R China; [Ao, Di; Song, Rong] Key Lab Sensing Technol & Biomed Instrument Guang, Guangzhou, Guang Dong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong	Song, R (corresponding author), Sun Yat Sen Univ, Sch Engn, Guangzhou 510275, Guangdong, Peoples R China.	songrong@mail.sysu.edu.cn	Tong, Raymond Kai-yu/C-3546-2009	Tong, Raymond Kai-yu/0000-0003-4375-653X; Song, Rong/0000-0003-3662-116X	National Natural Science Foundation of China [61273359]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by the National Natural Science Foundation of China (Grant No. 61273359).	Adamovich SV, 2009, IEEE T NEUR SYS REH, V17, P512, DOI 10.1109/TNSRE.2009.2028830; Asano T, 2013, ADV COGNITIVE NEUROD, P559; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; Beer RF, 2000, EXP BRAIN RES, V131, P305, DOI 10.1007/s002219900275; Bennett SJ, 2012, EXP BRAIN RES, V216, P445, DOI 10.1007/s00221-011-2947-x; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Biermann-Ruben K, 2012, NEUROIMAGE, V22, P1775; Caimmi M, 2008, NEUROREHAB NEURAL RE, V22, P31, DOI 10.1177/1545968307302923; Carey JR, 1998, ARCH PHYS MED REHAB, V79, P435, DOI 10.1016/S0003-9993(98)90146-0; Cirstea CM, 2006, STROKE, V37, P1237, DOI 10.1161/01.STR.0000217417.89347.63; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Craik KJW, 1947, B J PSYCHOL-GEN SECT, V38, P56, DOI 10.1111/j.2044-8295.1947.tb01141.x; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Foulkes AJM, 2000, EXP BRAIN RES, V131, P101, DOI 10.1007/s002219900286; Gerisch H, 2013, HUM FACTORS, V55, P985, DOI 10.1177/0018720813480387; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; Guigon E, 2008, EUR J NEUROSCI, V27, P1003, DOI 10.1111/j.1460-9568.2008.06028.x; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hegele M, 2010, PSYCHOL RES-PSYCH FO, V74, P21, DOI 10.1007/s00426-008-0221-z; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Huang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051417; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kuo AD, 2002, MOTOR CONTROL, V6, P129, DOI 10.1123/mcj.6.2.129; Lee D, 1997, EXP BRAIN RES, V116, P421, DOI 10.1007/PL00005770; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; McCrea P, 2005, EXP BRAIN RES, V162, P70, DOI 10.1007/s00221-004-2106-8; McCrea PH, 2003, MUSCLE NERVE, V28, P46, DOI 10.1002/mus.10397; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; Milton JG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065005; Patel N, 2014, LANCET NEUROL, V13, P100, DOI 10.1016/S1474-4422(13)70213-8; Pohl PS, 1996, J GERONTOL B-PSYCHOL, V51, pP94, DOI 10.1093/geronb/51B.2.P94; Poston B, 2009, BRAIN COGNITION, V69, P30, DOI 10.1016/j.bandc.2008.05.002; Reed DW, 2003, NEUROSCI LETT, V338, P209, DOI 10.1016/S0304-3940(02)01389-7; Reinkensmeyer DJ, 2003, NEURAL COMPUT, V15, P2619, DOI 10.1162/089976603322385090; Rohrer B, 2002, J NEUROSCI, V22, P8297; Schlerf JE, 2011, J NEUROPHYSIOL, V106, P2622, DOI 10.1152/jn.00301.2010; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shin HK, 2011, J PHYS THER SCI, V23, P141, DOI 10.1589/jpts.23.141; SHIN KG, 1995, IEEE T CONTR SYST T, V3, P218, DOI 10.1109/87.388130; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Song R, 2008, ARCH PHYS MED REHAB, V89, P1140, DOI 10.1016/j.apmr.2007.10.035; Song R, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-18; Sosnoff JJ, 2006, NEUROSCI LETT, V392, P165, DOI 10.1016/j.neulet.2005.09.010; Sternad D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002159; Stroeve S, 1996, BIOL CYBERN, V75, P73, DOI 10.1007/BF00238741; Tanaka H, 2009, EXP BRAIN RES, V195, P371, DOI 10.1007/s00221-009-1798-1; Teulings HL, 1997, EXP NEUROL, V146, P159, DOI 10.1006/exnr.1997.6507; TROMBLY CA, 1992, AM J OCCUP THER, V46, P887, DOI 10.5014/ajot.46.10.887; Tyson SF, 2008, NEUROREHAB NEURAL RE, V22, P166, DOI 10.1177/1545968307305523; van Galen GP, 2000, BIOL PSYCHOL, V51, P151, DOI 10.1016/S0301-0511(99)00037-X; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	57	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128328	10.1371/journal.pone.0128328	http://dx.doi.org/10.1371/journal.pone.0128328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030289	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900138
J	Donegan, S; Williams, L; Dias, S; Tudur-Smith, C; Welton, N				Donegan, Sarah; Williams, Lisa; Dias, Sofia; Tudur-Smith, Catrin; Welton, Nicky			Exploring Treatment by Covariate Interactions Using Subgroup Analysis and Meta-Regression in Cochrane Reviews: A Review of Recent Practice	PLOS ONE			English	Article							INVESTIGATING CLINICAL HETEROGENEITY; SYSTEMATIC REVIEWS	Background Treatment by covariate interactions can be explored in reviews using interaction analyses (e.g., subgroup analysis). Such analyses can provide information on how the covariate modifies the treatment effect and is an important methodological approach for personalising medicine. Guidance exists regarding how to apply such analyses but little is known about whether authors follow the guidance. Methods Using published recommendations, we developed criteria to assess how well interaction analyses were designed, applied, interpreted, and reported. The Cochrane Database of Systematic Reviews was searched (8th August 2013). We applied the criteria to the most recently published review, with an accessible protocol, for each Cochrane Review Group. We excluded review updates, diagnostic test accuracy reviews, withdrawn reviews, and overviews of reviews. Data were summarised regarding reviews, covariates, and analyses. Results Each of the 52 included reviews planned or did interaction analyses; 51 reviews (98%) planned analyses and 33 reviews (63%) applied analyses. The type of analysis planned and the type subsequently applied (e.g., sensitivity or subgroup analysis) was discrepant in 24 reviews (46%). No review reported how or why each covariate had been chosen; 22 reviews (42%) did state each covariate a priori in the protocol but no review identified each post-hoc covariate as such. Eleven reviews (21%) mentioned five covariates or less. One review reported planning to use a method to detect interactions (i.e., interaction test) for each covariate; another review reported applying the method for each covariate. Regarding interpretation, only one review reported whether an interaction was detected for each covariate and no review discussed the importance, or plausibility, of the results, or the possibility of confounding for each covariate. Conclusions Interaction analyses in Cochrane Reviews can be substantially improved. The proposed criteria can be used to help guide the reporting and conduct of analyses.	[Donegan, Sarah; Williams, Lisa; Tudur-Smith, Catrin] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Dias, Sofia; Welton, Nicky] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Liverpool; University of Bristol	Donegan, S (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	sarah.donegan@liverpool.ac.uk	Dias, Sofia/F-1922-2010	Dias, Sofia/0000-0002-2172-0221; Donegan, Sarah/0000-0003-1709-2290; Welton, Nicky/0000-0003-2198-3205; Tudur Smith, Catrin/0000-0003-3051-1445	Medical Research Council, Career Development Award in Biostatistics [JXR11061]; MRC [G0802413, MR/K025643/1, MR/K021435/1] Funding Source: UKRI; Medical Research Council [MR/K021435/1, G0802413, MR/K025643/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10114] Funding Source: researchfish	Medical Research Council, Career Development Award in Biostatistics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by the Medical Research Council (http://www.mrc.ac.uk/, grant number JXR11061) as part of a Career Development Award in Biostatistics awarded to S. Donegan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centre for Reviews and Dissemination, 2013, WELC PROSPERO; Centre for Reviews and Dissemination, 2009, CRDS GUID UND REV HE; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008307.pub2; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Gagnier JJ, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-106; Gagnier JJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-111; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH9; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	12	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128804	10.1371/journal.pone.0128804	http://dx.doi.org/10.1371/journal.pone.0128804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029923	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900192
J	Hasler-Sheetal, H; Holmer, M				Hasler-Sheetal, Harald; Holmer, Marianne			Sulfide Intrusion and Detoxification in the Seagrass Zostera marina	PLOS ONE			English	Article							RADIAL OXYGEN LOSS; SULFUR METABOLISM; HYDROGEN-SULFIDE; ELEMENTAL SULFUR; BRASSICA-OLERACEA; ATMOSPHERIC H2S; SULFATE UPTAKE; DIE-OFF; ROOTS; ACCUMULATION	Gaseous sulfide intrusion into seagrasses growing in sulfidic sediments causes little or no harm to the plant, indicating the presence of an unknown sulfide tolerance or detoxification mechanism. We assessed such mechanism in the seagrass Zostera marina in the laboratory and in the field with scanning electron microscopy coupled to energy dispersive X-ray spectroscopy, chromatographic and spectrophotometric methods, and stable isotope tracing coupled with a mass balance of sulfur compounds. We found that Z. marina detoxified gaseous sediment-derived sulfide through incorporation and that most of the detoxification occurred in underground tissues, where sulfide intrusion was greatest. Elemental sulfur was a major detoxification compound, precipitating on the inner wall of the aerenchyma of underground tissues. Sulfide was metabolized into thiols and entered the plant sulfur metabolism as well as being stored as sulfate throughout the plant. We conclude that avoidance of sulfide exposure by reoxidation of sulfide in the rhizosphere or aerenchyma and tolerance of sulfide intrusion by incorporation of sulfur in the plant are likely major survival strategies of seagrasses in sulfidic sediments.	[Hasler-Sheetal, Harald; Holmer, Marianne] Univ Southern Denmark, Dept Biol, Odense, Denmark	University of Southern Denmark	Hasler-Sheetal, H (corresponding author), Univ Southern Denmark, Dept Biol, Odense, Denmark.	hasler@biology.sdu.dk	Holmer, Marianne/M-6989-2014; Hasler-Sheetal, Harald/J-2422-2012	Holmer, Marianne/0000-0002-6095-5488; Hasler-Sheetal, Harald/0000-0002-9171-1451	Danish Council of Independent Research [09-067485]; Danish National Research foundation [12127012]; Villum Fonden [00007292] Funding Source: researchfish	Danish Council of Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research foundation(Danmarks Grundforskningsfond); Villum Fonden(Villum Fonden)	Harald Hasler-Sheetal was funded by the Danish Council of Independent Research (grant no. 09-067485), Marianne Holmer was founded by the Danish National Research foundation (grant no. 12127012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong J, 2001, AM J BOT, V88, P1359, DOI 10.2307/3558443; ARMSTRONG W, 1994, ACTA BOT NEERL, V43, P307; BLUM LK, 1991, MAR ECOL PROG SER, V70, P73, DOI 10.3354/meps070073; Borum J, 2005, J ECOL, V93, P148, DOI 10.1111/j.1365-2745.2004.00943.x; Borum J, 2014, MAR BIOL, V161, P351, DOI 10.1007/s00227-013-2340-3; Buchner P, 2004, J EXP BOT, V55, P1765, DOI 10.1093/jxb/erh206; Buchner P, 2004, PLANT PHYSIOL, V136, P3396, DOI 10.1104/pp.104.046441; Canfield DE, 2001, GEOCHIM COSMOCHIM AC, V65, P1117, DOI 10.1016/S0016-7037(00)00584-6; CLINE JD, 1969, ENVIRON SCI TECHNOL, V3, P838, DOI 10.1021/es60032a004; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cooper RM, 2004, J EXP BOT, V55, P1947, DOI 10.1093/jxb/erh179; DeKok LJ, 1997, BOT ACTA, V110, P411, DOI 10.1111/j.1438-8677.1997.tb00657.x; DEKOK LJ, 1988, J PLANT PHYSIOL, V133, P502, DOI 10.1016/S0176-1617(88)80045-2; DEKOK LJ, 1989, NEW PHYTOL, V112, P533, DOI 10.1111/j.1469-8137.1989.tb00348.x; DEKOK LJ, 1985, PLANT CELL ENVIRON, V8, P189, DOI 10.1111/j.1365-3040.1985.tb01385.x; Dooley FD, 2013, AQUAT BOT, V105, P7, DOI 10.1016/j.aquabot.2012.10.007; Durenkamp M, 2004, J EXP BOT, V55, P1821, DOI 10.1093/jxb/erh187; Fenchel T., 1995, ECOLOGY EVOLUTION AN; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Frederiksen MS, 2008, J EXP MAR BIOL ECOL, V358, P98, DOI 10.1016/j.jembe.2008.01.021; Frederiksen MS, 2006, LIMNOL OCEANOGR, V51, P2308, DOI 10.4319/lo.2006.51.5.2308; Frederiksen MS, 2006, LIMNOL OCEANOGR, V51, P1072, DOI 10.4319/lo.2006.51.2.1072; FRY B, 1982, GEOCHIM COSMOCHIM AC, V46, P1121, DOI 10.1016/0016-7037(82)90063-1; Furtig K, 1996, FOLIA GEOBOT PHYTOTX, V31, P143, DOI 10.1007/BF02804003; Garcia R, 2013, GLOBAL CHANGE BIOL, V19, P3629, DOI 10.1111/gcb.12377; Garcia-Martinez M, 2009, ESTUAR COAST, V32, P276, DOI 10.1007/s12237-008-9115-y; Garcias-Bonet N, 2008, MAR ECOL PROG SER, V372, P1, DOI 10.3354/meps07714; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Heldt HW, 2011, PLANT BIOCH, P323; Himmel D, 2009, BIOL CELL, V101, P43, DOI 10.1042/BC20080051; Holmer M, 2005, AQUAT BOT, V81, P367, DOI 10.1016/j.aquabot.2004.12.006; Holmer M, 2007, J EXP MAR BIOL ECOL, V353, P245, DOI 10.1016/j.jembe.2007.09.010; Holmer M, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00064; Holmer M, 2013, ESTUAR COAST, V36, P116, DOI 10.1007/s12237-012-9550-7; Jensen SI, 2007, FEMS MICROBIOL ECOL, V62, P108, DOI 10.1111/j.1574-6941.2007.00373.x; Jensen SI, 2005, MAR ECOL PROG SER, V293, P49, DOI 10.3354/meps293049; Koch MS, 2007, J EXP MAR BIOL ECOL, V350, P73, DOI 10.1016/j.jembe.2007.05.031; Lamers LPM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00268; Lechaire JP, 2006, BIOL CELL, V98, P163, DOI 10.1042/BC20040502; Luther GW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00062; Mascaro O, 2009, J EXP MAR BIOL ECOL, V373, P26, DOI 10.1016/j.jembe.2009.03.001; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Nielsen SL, 1999, AQUAT BOT, V63, P261, DOI 10.1016/S0304-3770(98)00123-5; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pedersen O, 2004, PLANT CELL ENVIRON, V27, P595, DOI 10.1111/j.1365-3040.2004.01173.x; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Raven JA, 1997, ANN BOT-LONDON, V79, P79, DOI 10.1093/oxfordjournals.aob.a010309; REES CE, 1978, GEOCHIM COSMOCHIM AC, V42, P377, DOI 10.1016/0016-7037(78)90268-5; RENNENBERG H, 1984, ANNU REV PLANT PHYS, V35, P121, DOI 10.1146/annurev.pp.35.060184.001005; Sand-Jensen K, 2005, ANN BOT-LONDON, V96, P613, DOI 10.1093/aob/mci214; SAND-JENSEN K, 1975, Ophelia, V14, P185; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Tausz M, 2003, ENVIRON EXP BOT, V50, P211, DOI 10.1016/S0098-8472(03)00025-X; Terrados J, 1999, AQUAT BOT, V65, P175, DOI 10.1016/S0304-3770(99)00039-X; Valdemarsen T, 2009, BIOGEOCHEMISTRY, V95, P335, DOI 10.1007/s10533-009-9340-x; van der Heide T, 2012, SCIENCE, V336, P1432, DOI 10.1126/science.1219973; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041; Weber M, 1996, FOLIA GEOBOT PHYTOTX, V31, P37, DOI 10.1007/BF02803992; Westerman S, 2000, PHYSIOL PLANTARUM, V109, P443, DOI 10.1034/j.1399-3054.2000.100411.x; Williams JS, 2002, PLANT PHYSIOL, V128, P150, DOI 10.1104/pp.010687; Zopfi J, 2001, APPL ENVIRON MICROB, V67, P5530, DOI 10.1128/AEM.67.12.5530-5537.2001	64	50	52	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129136	10.1371/journal.pone.0129136	http://dx.doi.org/10.1371/journal.pone.0129136			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030258	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900210
J	Kamneva, OK; Poudel, S; Ward, NL				Kamneva, Olga K.; Poudel, Saroj; Ward, Naomi L.			Proteins Related to the Type I Secretion System Are Associated with Secondary SecA_DEAD Domain Proteins in Some Species of Planctomycetes, Verrucomicrobia, Proteobacteria, Nitrospirae and Chlorobi	PLOS ONE			English	Article							MEMBRANE TOPOLOGY; SIGNAL PEPTIDES; PVC SUPERPHYLUM; DNA-SEQUENCES; CELL-DIVISION; TRANSLOCATION; TRANSCRIPTION; NORMALIZATION; EVOLUTION; BACTERIA	A number of bacteria belonging to the PVC (Planctomycetes-Verrucomicrobia-Chlamydiae) super-phylum contain unusual ribosome-bearing intracellular membranes. The evolutionary origins and functions of these membranes are unknown. Some proteins putatively associated with the presence of intracellular membranes in PVC bacteria contain signal peptides. Signal peptides mark proteins for translocation across the cytoplasmic membrane in prokaryotes, and the membrane of the endoplasmic reticulum in eukaryotes, by highly conserved Sec machinery. This suggests that proteins might be targeted to intracellular membranes in PVC bacteria via the Sec pathway. Here, we show that canonical signal peptides are significantly over-represented in proteins preferentially present in PVC bacteria possessing intracellular membranes, indicating involvement of Sec translocase in their cellular targeting. We also characterized Sec proteins using comparative genomics approaches, focusing on the PVC super-phylum. While we were unable to detect unique changes in Sec proteins conserved among membrane-bearing PVC species, we identified (1) SecA ATPase domain re-arrangements in some Planctomycetes, and (2) secondary SecA_DEAD domain proteins in the genomes of some Planctomycetes, Verrucomicrobia, Proteobacteria, Nitrospirae and Chlorobi. This is the first report of potentially duplicated SecA in Gram-negative bacteria. The phylogenetic distribution of secondary SecA_DEAD domain proteins suggests that the presence of these proteins is not related to the occurrence of PVC endomembranes. Further genomic analysis showed that secondary SecA_DEAD domain proteins are located within genomic neighborhoods that also encode three proteins possessing domains specific for the Type I secretion system.	[Kamneva, Olga K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Poudel, Saroj] Montana State Univ, Dept Comp Sci, Bozeman, MT 59717 USA; [Ward, Naomi L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Ward, Naomi L.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Ward, Naomi L.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA	Stanford University; Montana State University System; Montana State University Bozeman; University of Wyoming; University of Wyoming; University of Wyoming	Kamneva, OK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	okamneva@stanford.edu		Poudel, Saroj/0000-0001-7147-1836	National Institutes of Health [P20 RR016474]; National Science Foundation [MCB-0920667, EPS-0447681]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health (P20 RR016474 to OKK) and National Science Foundation (MCB-0920667 to NLW). NLW and OKK were also partially supported by National Science Foundation EPS-0447681.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asplund-Samuelsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049888; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Bykova NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065012; Carroll SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003427; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dehal PS, 2009, NUCL ACIDS RES; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Devos DP, 2014, ANTON LEEUW INT J G, V105, P271, DOI 10.1007/s10482-013-0087-y; Domman DB, 2011, ARCH MICROBIOL, V193, P307, DOI 10.1007/s00203-010-0666-5; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D, 2003, BIOINFORMATICS, V19, P825, DOI 10.1093/bioinformatics/btg083; Fang J, 2011, PROTEIN PEPTIDE LETT, V18, P601, DOI 10.2174/092986611795222713; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Ferrer L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-493; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; Fuerst JA, 2013, ANTON LEEUW INT J G, V104, P451, DOI 10.1007/s10482-013-9986-1; Gaballo A, 2006, RES MICROBIOL, V157, P675, DOI 10.1016/j.resmic.2006.02.005; Gottshall EY, 2014, P NATL ACAD SCI USA, V111, P11067, DOI 10.1073/pnas.1409187111; Green DH, 2000, J BACTERIOL, V182, P278, DOI 10.1128/JB.182.2.278-285.2000; Hanada M, 1996, FEBS LETT, V381, P25, DOI 10.1016/0014-5793(96)00066-X; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Jogler C, 2012, J BACTERIOL, V194, P6419, DOI 10.1128/JB.01325-12; Jogler C, 2011, APPL ENVIRON MICROB, V77, P5826, DOI 10.1128/AEM.05132-11; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kamke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087353; Kamneva OK, 2012, GENOME BIOL EVOL, V4, P1375, DOI 10.1093/gbe/evs113; Kamneva OK, 2010, GENOME BIOL EVOL, V2, P870, DOI 10.1093/gbe/evq071; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karp PD, 2014, ECOSAL PLUS, V2014; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; KUMAMOTO CA, 1989, J BIOL CHEM, V264, P2242; Lee KC, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-5; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lindsay MR, 1997, MICROBIOL-UK, V143, P739, DOI 10.1099/00221287-143-3-739; Ludwig W, 2005, MICROBIAL PHYLOGENY, P70; McInerney JO, 2011, BIOESSAYS, V33, P810, DOI 10.1002/bies.201100045; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pilhofer M, 2008, J BACTERIOL, V190, P3192, DOI 10.1128/JB.01797-07; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; REEVES JH, 1992, J MOL EVOL, V35, P17, DOI 10.1007/BF00160257; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Sagulenko E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091344; Santarella-Mellwig R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001565; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Schultz Joachim E., 2009, V191, P93, DOI 10.1007/978-3-540-68964-5_6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Wooldridge KG, 2005, INFECT IMMUN, V73, P5554, DOI 10.1128/IAI.73.9.5554-5567.2005; Yang YH, 2003, INST MATH S, V40, P403; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	72	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129066	10.1371/journal.pone.0129066	http://dx.doi.org/10.1371/journal.pone.0129066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030905	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900207
J	Okada, KI; Kobayashi, Y				Okada, Ken-ichi; Kobayashi, Yasushi			Rhythmic Firing of Pedunculopontine Tegmental Nucleus Neurons in Monkeys during Eye Movement Task	PLOS ONE			English	Article							GUIDED SACCADE TASKS; CHOLINERGIC NEURONS; PARKINSONS-DISEASE; IN-VITRO; RAT; SLEEP; ACTIVATION; FREQUENCY; REWARD; SYNCHRONIZATION	The pedunculopontine tegmental nucleus (PPTN) has been thought to be involved in the control of behavioral state. Projections to the entire thalamus and reciprocal connections with the basal ganglia nuclei suggest a potential role for the PPTN in the control of various rhythmic behaviors, including waking/sleeping and locomotion. Recently, rhythmic activity in the local field potentials was recorded from the PPTN of patients with Parkinson's disease who were treated with levodopa, suggesting that rhythmic firing is a feature of the functioning PPTN and might change with the behaving conditions even within waking. However, it remains unclear whether and how single PPTN neurons exhibit rhythmic firing patterns during various behaving conditions, including executing conditioned eye movement behaviors, seeking reward, or during resting. We previously recorded from PPTN neurons in healthy monkeys during visually guided saccade tasks and reported task-related changes in firing rate, and in this paper, we reanalyzed these data and focused on their firing patterns. A population of PPTN neurons demonstrated a regular firing pattern in that the coefficient of variation of interspike intervals was lower than what would be expected of theoretical random and irregular spike trains. Furthermore, a group of PPTN neurons exhibited a clear periodic single spike firing that changed with the context of the behavioral task. Many of these neurons exhibited a periodic firing pattern during highly active conditions, either the fixation condition during the saccade task or the free-viewing condition during the intertrial interval. We speculate that these task context-related changes in rhythmic firing of PPTN neurons might regulate the monkey's attentional and vigilance state to perform the task.	[Okada, Ken-ichi; Kobayashi, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Okada, Ken-ichi; Kobayashi, Yasushi] Ctr Informat & Neural Networks CiNet, Natl Inst Informat & Commun Technol, Osaka, Japan; [Okada, Ken-ichi; Kobayashi, Yasushi] Osaka Univ, Suita, Osaka, Japan; [Kobayashi, Yasushi] Osaka Univ, Res Ctr Behav Econ, Suita, Osaka, Japan; [Kobayashi, Yasushi] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan	Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Kobayashi, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	yasushi@fbs.osaka-u.ac.jp		Okada, Ken-ichi/0000-0002-6377-1860; Kobayashi, Yasushi/0000-0002-2690-6527	"Construction of System for Spread of Primate Model Animals" by Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development (AMED); Precursory Research for Embryonic Science and Technology (PRESTO) from the Japan Science and Technology Agency; Japan Society for the Promotion of Science [26120715]; "Development of BMI Technologies for Clinical Application" by Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [15H02669] Funding Source: KAKEN	"Construction of System for Spread of Primate Model Animals" by Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Precursory Research for Embryonic Science and Technology (PRESTO) from the Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); "Development of BMI Technologies for Clinical Application" by Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by "Development of BMI Technologies for Clinical Application" and "Construction of System for Spread of Primate Model Animals" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Japan Agency for Medical Research and Development (AMED). This work was also supported by Precursory Research for Embryonic Science and Technology (PRESTO; to Y.K.) from the Japan Science and Technology Agency, and Grants-in-aid for scientific research (26120715; to Y.K.) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2011, BRAIN, V134, P11, DOI 10.1093/brain/awq322; Androulidakis AG, 2008, EXP NEUROL, V211, P59, DOI 10.1016/j.expneurol.2008.01.002; Aravamuthan BR, 2009, J CLIN NEUROSCI, V16, P413, DOI 10.1016/j.jocn.2008.03.018; Boucetta S, 2014, J NEUROSCI, V34, P4708, DOI 10.1523/JNEUROSCI.2617-13.2014; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Datta S, 2002, J NEUROSCI RES, V70, P611, DOI 10.1002/jnr.10405; Fraix V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083919; Garcia-Rill E, 2007, SLEEP, V30, P1405, DOI 10.1093/sleep/30.11.1405; Garcia-Rill E, 2013, SLEEP MED REV, V17, P227, DOI 10.1016/j.smrv.2012.06.002; GARCIARILL F, 1988, NEUROSCIENCE, V27, P639, DOI 10.1016/0306-4522(88)90295-3; Hutchison WD, 1997, EXP BRAIN RES, V113, P557, DOI 10.1007/PL00005606; Jacobs JV, 2009, NEUROSCIENCE, V164, P877, DOI 10.1016/j.neuroscience.2009.08.002; Kezunovic N, 2011, EUR J NEUROSCI, V34, P404, DOI 10.1111/j.1460-9568.2011.07766.x; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kobayashi Y, 2002, J NEUROPHYSIOL, V88, P715, DOI 10.1152/jn.2002.88.2.715; Koyama Y, 1998, NEUROSCIENCE, V83, P1105, DOI 10.1016/S0306-4522(97)00439-9; LEONARD CS, 1994, NEUROSCIENCE, V59, P309, DOI 10.1016/0306-4522(94)90599-1; Levy R, 2000, J NEUROSCI, V20, P7766; Maimon G, 2009, NEURON, V62, P426, DOI 10.1016/j.neuron.2009.03.021; Martinez-Gonzalez C, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00022; Matsumura M, 2000, NEUROSCIENCE, V98, P97, DOI 10.1016/S0306-4522(00)00099-3; Mazzone P, 2005, NEUROREPORT, V16, P1877, DOI 10.1097/01.wnr.0000187629.38010.12; Mena-Segovia J, 2009, J COMP NEUROL, V515, P397, DOI 10.1002/cne.22065; Mena-Segovia J, 2008, J PHYSIOL-LONDON, V586, P2947, DOI 10.1113/jphysiol.2008.153874; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Norton ABW, 2011, EUR J NEUROSCI, V33, P1885, DOI 10.1111/j.1460-9568.2011.07649.x; Okada K, 2014, EUR J NEUROSCI, V40, P2641, DOI 10.1111/ejn.12632; Okada K, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00036; Okada KI, 2009, EUR J NEUROSCI, V30, P2211, DOI 10.1111/j.1460-9568.2009.07009.x; Okada K, 2009, J NEUROSCI, V29, P4858, DOI 10.1523/JNEUROSCI.4415-08.2009; Pahapill PA, 2000, BRAIN, V123, P1767, DOI 10.1093/brain/123.9.1767; SAITO H, 1977, BRAIN RES, V134, P59, DOI 10.1016/0006-8993(77)90925-8; Saitoh K, 2003, EUR J NEUROSCI, V18, P879, DOI 10.1046/j.1460-9568.2003.02825.x; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; Simon C, 2010, J NEUROPHYSIOL, V104, P463, DOI 10.1152/jn.00242.2010; SPANN BM, 1992, ANAT EMBRYOL, V186, P215; STERIADE M, 1990, J NEUROSCI, V10, P2541; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Tachibana Y, 2012, NEURON, V76, P826, DOI 10.1016/j.neuron.2012.09.030; Takakusaki K, 1996, J COMP NEUROL, V371, P345, DOI 10.1002/(SICI)1096-9861(19960729)371:3<345::AID-CNE1>3.0.CO;2-2; Takakusaki K, 1997, NEUROSCIENCE, V79, P1089, DOI 10.1016/S0306-4522(97)00019-5; Takakusaki K, 2011, ARCH ITAL BIOL, V149, P383, DOI 10.4449/aib.v149i4.1383; Tattersall TL, 2014, NAT NEUROSCI, V17, P449, DOI 10.1038/nn.3642; Thevathasan W, 2012, BRAIN, V135, P148, DOI 10.1093/brain/awr315; WILLIAMS JA, 1993, J NEUROSCI, V13, P3878; Winn P, 2006, J NEUROL SCI, V248, P234, DOI 10.1016/j.jns.2006.05.036	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128147	10.1371/journal.pone.0128147	http://dx.doi.org/10.1371/journal.pone.0128147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030664	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900116
J	Stafford, M; Gale, CR; Mishra, G; Richards, M; Black, S; Kuh, DL				Stafford, Mai; Gale, Catharine R.; Mishra, Gita; Richards, Marcus; Black, Stephanie; Kuh, Diana L.			Childhood Environment and Mental Wellbeing at Age 60-64 Years: Prospective Evidence from the MRC National Survey of Health and Development	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIOECONOMIC POSITION; SATISFACTION; BEHAVIOR; ASSOCIATIONS; ADOLESCENTS; ADULTHOOD; PREDICTS; CHILDREN; WOMEN	Background Mental wellbeing, conceptualised as positive affect, life satisfaction and realisation of needs that contribute to psychological growth, captures more than the absence of mental ill health. Several nations now aim to monitor and improve mental wellbeing. Whilst many studies document associations between adverse childhood experiences and mental disorders in adulthood, possible links between childhood experiences and adult mental wellbeing have so far received less attention. Methods Using data from 1976 men and women in the MRC National Survey for Health and Development, we investigated prospective associations between childhood socioeconomic and psychosocial environments and the Warwick Edinburgh Mental Wellbeing Scale, designed to capture both hedonic and eudaimonic facets of wellbeing, at age 60-64. Results Whilst there was no evidence that childhood socioeconomic circumstances were related to later wellbeing independently of other childhood experiences, elements of childrearing and parenting, parental health and adjustment, and childhood illness were related. More advantaged socioeconomic position was associated with greater wellbeing but this did not explain the links between these childhood exposures and adult wellbeing, suggesting alternative explanatory pathways should be considered. Conclusions Childhood illness and family psychosocial environment are associated with mental wellbeing in early older age, with effects sizes that are larger or comparable to socioeconomic circumstances in adulthood. Initiatives to improve the nation's mental wellbeing that include programmes targeted to supporting families and children may additionally have benefits that continue into older age.	[Stafford, Mai; Richards, Marcus; Black, Stephanie; Kuh, Diana L.] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Gale, Catharine R.] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Gale, Catharine R.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Mishra, Gita] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of London; University College London; University of Southampton; University of Edinburgh; University of Queensland	Stafford, M (corresponding author), UCL, MRC, Unit Lifelong Hlth & Ageing, London, England.	m.stafford@ucl.ac.uk	Kuh, Diana/L-6019-2014	Kuh, Diana/0000-0001-7386-2857; Richards, Marcus/0000-0001-9191-2192; Gale, Catharine/0000-0002-3361-8638	United Kingdom Medical Research Council [MRC_MC_UU_12019, MRC_MC_UU_12011/2, MRC_MC_UP_A620_1015]; Australian Research Council Future Fellowship [FT12010081]; Medical Research Council [MC_U147585819, MR/K026992/1, MC_U147585827, U1475000001, MC_UU_12019/5, MC_U147585824, MC_UU_12011/1, U1475000002, MC_UU_12011/2, MC_UP_A620_1014, MC_UP_A620_1015, G0400491] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10085, NF-SI-0508-10082] Funding Source: researchfish; MRC [MC_UP_A620_1015, G0400491, MC_UU_12019/5, MC_UU_12011/2, MC_U147585827, MC_U147585819] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Research Council Future Fellowship(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MS, MR, SB and DK are funded by the United Kingdom Medical Research Council [MRC_MC_UU_12019]. CM is funded by the United Kingdom Medical Research Council [MRC_MC_UU_12011/2 and MRC_MC_UP_A620_1015]. GM is funded by the Australian Research Council Future Fellowship [FT120100812]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMATO PR, 1991, PSYCHOL BULL, V110, P26, DOI 10.1037/0033-2909.110.1.26; Blane D, 2004, SOC SCI MED, V58, P2171, DOI 10.1016/j.socscimed.2003.08.028; Boehm JK, 2011, HEALTH PSYCHOL, V30, P259, DOI 10.1037/a0023124; Chartier MJ, 2009, AM J PUBLIC HEALTH, V99, P847, DOI 10.2105/AJPH.2007.122408; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Deindl C, 2013, ADV LIFE COURSE RES, V18, P107, DOI 10.1016/j.alcr.2012.10.008; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; EYSENCK HJ, 1958, J APPL PSYCHOL, V42, P14, DOI 10.1037/h0041738; FERGUSSON DM, 1994, J CHILD PSYCHOL PSYC, V35, P1123, DOI 10.1111/j.1469-7610.1994.tb01813.x; Flouri E, 2004, EUR CHILD ADOLES PSY, V13, P35, DOI 10.1007/s00787-004-0355-5; Forgeard M.C., 2011, INT J WELLBEING, V1, P79; Gale CR, 2014, PSYCHOL MED, V44, P697, DOI 10.1017/S0033291713001384; Gale CR, 2013, J RES PERS, V47, P687, DOI 10.1016/j.jrp.2013.06.005; George LK, 2010, J GERONTOL B-PSYCHOL, V65, P331, DOI 10.1093/geronb/gbq006; Heller D, 2004, PSYCHOL BULL, V130, P574, DOI 10.1037/0033-2909.130.4.574; Huppert FA, 2010, PSYCHOL MED, V40, P1507, DOI 10.1017/S0033291709991978; Huurre T, 2003, SOC PSYCH PSYCH EPID, V38, P249, DOI 10.1007/s00127-003-0630-7; Kuh D, 2002, SOC SCI MED, V55, P1957, DOI 10.1016/S0277-9536(01)00324-0; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Layard R, 2014, ECON J, V124, pF720, DOI 10.1111/ecoj.12170; Luo Y, 2005, J GERONTOL B-PSYCHOL, V60, pS93, DOI 10.1093/geronb/60.2.S93; MACKINNON AJ, 1991, ACTA PSYCHIAT SCAND, V83, P153, DOI 10.1111/j.1600-0447.1991.tb07382.x; Malone SM, 2010, J CHILD PSYCHOL PSYC, V51, P1067, DOI 10.1111/j.1469-7610.2010.02219.x; Marmot MG, 1998, MILBANK Q, V76, P403, DOI 10.1111/1468-0009.00097; MCCRAE RR, 1988, J PERS, V56, P417, DOI 10.1111/j.1467-6494.1988.tb00894.x; McLaren L, 2007, J AFFECT DISORDERS, V100, P211, DOI 10.1016/j.jad.2006.10.021; McLaughlin KA, 2012, BRIT J PSYCHIAT, V200, P290, DOI 10.1192/bjp.bp.111.101253; Murray J, 2012, PSYCHOL BULL, V138, P175, DOI 10.1037/a0026407; Niedzwiedz CL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-628; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Richards M, 2011, J POSIT PSYCHOL, V6, P75, DOI 10.1080/17439760.2011.536655; Rodgers B, 1996, PSYCHOL MED, V26, P51, DOI 10.1017/S0033291700033717; RODGERS B, 1990, BRIT J PSYCHIAT, V157, P539, DOI 10.1192/bjp.157.4.539; Rothrauff TC, 2009, J GERONTOL B-PSYCHOL, V64, P137, DOI 10.1093/geronb/gbn008; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Sobolewski JM, 2005, J MARRIAGE FAM, V67, P141, DOI 10.1111/j.0022-2445.2005.00011.x; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Stansfeld SA, 2008, BRIT J PSYCHIAT, V192, P152, DOI 10.1192/bjp.bp.107.043208; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Steptoe A, 2014, CAN MED ASSOC J, V186, pE150, DOI 10.1503/cmaj.131155; Steverink N, 2011, EUR J AGEING, V8, P21, DOI 10.1007/s10433-011-0178-4; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Yeung WJ, 2002, CHILD DEV, V73, P1861, DOI 10.1111/1467-8624.t01-1-00511	45	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126683	10.1371/journal.pone.0126683	http://dx.doi.org/10.1371/journal.pone.0126683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030929	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000356630900031
J	Stoner, TD; Weston, TA; Trejo, J; Doran, KS				Stoner, Terri D.; Weston, Thomas A.; Trejo, JoAnn; Doran, Kelly S.			Group B Streptococcal Infection and Activation of Human Astrocytes	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; BINDING-PROTEIN; BACTERIAL-MENINGITIS; FIBRINOGEN-BINDING; INVASION; CELLS; PILI; CONTRIBUTES; CYTOKINES; POLYSACCHARIDE	Background Streptococcus agalactiae (Group B Streptococcus, GBS) is the leading cause of life-threatening meningitis in human newborns in industrialized countries. Meningitis results from neonatal infection that occurs when GBS leaves the bloodstream (bacteremia), crosses the blood-brain barrier (BBB), and enters the central nervous system (CNS), where the bacteria contact the meninges. Although GBS is known to invade the BBB, subsequent interaction with astrocytes that physically associate with brain endothelium has not been well studied. Methodology/Principal Findings We hypothesize that human astrocytes play a unique role in GBS infection and contribute to the development of meningitis. To address this, we used a well-characterized human fetal astrocyte cell line, SVG-A, and examined GBS infection in vitro. We observed that all GBS strains of representative clinically dominant serotypes (Ia, Ib, III, and V) were able to adhere to and invade astrocytes. Cellular invasion was dependent on host actin cytoskeleton rearrangements, and was specific to GBS as Streptococcus gordonii failed to enter astrocytes. Analysis of isogenic mutant GBS strains deficient in various cell surface organelles showed that anchored LTA, serine-rich repeat protein (Srr1) and fibronectin binding (SfbA) proteins all contribute to host cell internalization. Wild-type GBS also displayed an ability to persist and survive within an intracellular compartment for at least 12 h following invasion. Moreover, GBS infection resulted in increased astrocyte transcription of interleukin (IL)-1 beta, IL-6 and VEGF. Conclusions/Significance This study has further characterized the interaction of GBS with human astrocytes, and has identified the importance of specific virulence factors in these interactions. Understanding the role of astrocytes during GBS infection will provide important information regarding BBB disruption and the development of neonatal meningitis.	[Stoner, Terri D.; Weston, Thomas A.; Doran, Kelly S.] San Diego State Univ, Dept Biol, Ctr Microbial Sci, San Diego, CA 92182 USA; [Stoner, Terri D.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Doran, Kelly S.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego	Doran, KS (corresponding author), San Diego State Univ, Dept Biol, Ctr Microbial Sci, San Diego, CA 92182 USA.	kdoran@mail.sdsu.edu		TREJO, JOANN/0000-0003-4405-6228	San Diego IRACDA [K12 GM068524]; National Institutes of Health/NINDS [R01-NS051247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689, K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	San Diego IRACDA; National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the San Diego IRACDA program K12 GM068524 to TDS and the National Institutes of Health/NINDS R01-NS051247 to KSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alkuwaity K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042660; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Banerjee A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1474; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bian YQ, 2013, BEHAV BRAIN RES, V253, P253, DOI 10.1016/j.bbr.2013.07.028; Brega S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065832; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; CHIN KC, 1985, J PEDIATR-US, V106, P819, DOI 10.1016/S0022-3476(85)80365-6; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Claverys, 2013, PLOS PATHOG, V9, P1; CLERC PL, 1987, INFECT IMMUN, V55, P521, DOI 10.1128/IAI.55.3.521-527.1987; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Dudley DJ, 1996, J SOC GYNECOL INVEST, V3, P328, DOI 10.1016/S1071-5576(96)00042-1; EDWARDS MS, 1985, J PEDIATR-US, V106, P717, DOI 10.1016/S0022-3476(85)80342-5; Esen N, 2004, J NEUROCHEM, V88, P746, DOI 10.1046/j.1471-4159.2003.02202.x; Eskelinen EL, 2008, INT REV CEL MOL BIO, V266, P207, DOI 10.1016/S1937-6448(07)66005-5; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; FINLAY BB, 1992, INFECT IMMUN, V60, P2541, DOI 10.1128/IAI.60.6.2541-2543.1992; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Kabanov AV, 2007, PROG POLYM SCI, V32, P1054, DOI 10.1016/j.progpolymsci.2007.05.014; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; KIM YS, 1995, J NEUROPATH EXP NEUR, V54, P531, DOI 10.1097/00005072-199507000-00007; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Knodler LA, 2011, CELL MICROBIOL, V13, P1319, DOI 10.1111/j.1462-5822.2011.01632.x; Lamy MC, 2006, MICROBES INFECT, V8, P1714, DOI 10.1016/j.micinf.2006.02.008; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Libster R, 2012, PEDIATRICS, V130, pE8, DOI 10.1542/peds.2011-3453; Llull D, 2001, J BIOL CHEM, V276, P21053, DOI 10.1074/jbc.M010287200; MADOFF LC, 1991, INFECT IMMUN, V59, P204, DOI 10.1128/IAI.59.1.204-210.1991; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; MARTIN TR, 1988, J INFECT DIS, V157, P91, DOI 10.1093/infdis/157.1.91; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Mu R, 2014, INFECT IMMUN, V82, P2276, DOI 10.1128/IAI.01559-13; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; O'Seaghdha M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003394; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Pinto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070020; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Reinscheid DJ, 2001, J BACTERIOL, V183, P1175, DOI 10.1128/JB.183.4.1175-1183.2001; Reisenberger K, 1997, AM J OBSTET GYNECOL, V176, P981, DOI 10.1016/S0002-9378(97)70389-2; RUBENS CE, 1991, J INFECT DIS, V164, P320, DOI 10.1093/infdis/164.2.320; Santos GS, 2009, INT J MOL MED, V24, P393, DOI 10.3892/ijmm_00000245; Seo HS, 2013, J BIOL CHEM, V288, P35982, DOI 10.1074/jbc.M113.513358; Seo HW, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-194; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Shet A, 2004, INDIAN J MED RES, V120, P141; Shin S, 2006, MICROB PATHOGENESIS, V41, P168, DOI 10.1016/j.micpath.2006.07.003; Stella N, 1997, J NEUROSCI, V17, P2939; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; van Sorge NM, 2012, FUTURE MICROBIOL, V7, P383, DOI [10.2217/fmb.12.1, 10.2217/FMB.12.1]; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; vanFurth AM, 1996, INFECT IMMUN, V64, P4883, DOI 10.1128/IAI.64.12.4883-4890.1996; VonHunolstein C, 1997, INFECT IMMUN, V65, P4017, DOI 10.1128/IAI.65.10.4017-4021.1997; Weisner AM, 2004, CLIN INFECT DIS, V38, P1203, DOI 10.1086/382881; WESSELS MR, 1993, INFECT IMMUN, V61, P4760, DOI 10.1128/IAI.61.11.4760-4766.1993; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; Winram SB, 1998, INFECT IMMUN, V66, P4932, DOI 10.1128/IAI.66.10.4932-4941.1998; Xie LK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-53; Yamamoto M, 2013, BIOCHEM BIOPH RES CO, V439, P90, DOI 10.1016/j.bbrc.2013.08.022; Yim H, 1997, ANAL CAPSULE SYNTHES; Zaga V, 2004, BIOL REPROD, V71, P1296, DOI 10.1095/biolreprod.104.028621; Zeng J, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-157	83	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128431	10.1371/journal.pone.0128431	http://dx.doi.org/10.1371/journal.pone.0128431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030618	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900148
J	Raw, RK; Wilkie, RM; White, A; Williams, JHG; Mon-Williams, M				Raw, Rachael K.; Wilkie, Richard M.; White, Alan; Williams, Justin H. G.; Mon-Williams, Mark			The 'Goldilocks Zone': Getting the Measure of Manual Asymmetries	PLOS ONE			English	Article							AGE-RELATED-CHANGES; OLDER-ADULTS; HEMISPHERIC-ASYMMETRY; MOTOR; COORDINATION; MOVEMENT	Some studies have shown that manual asymmetries decrease in older age. These results have often been explained with reference to models of reduced hemispheric specialisation. An alternative explanation, however, is that hand differences are subtle, and capturing them requires tasks that yield optimal performance with both hands. Whereas the hemispheric specialisation account implies that reduced manual asymmetries should be reliably observed in older adults, the 'measurement difficulty' account suggests that manual asymmetries will be hard to detect unless a task has just the right level of difficulty-i.e. within the 'Goldilocks Zone', where it is not too easy or too hard, but just right. Experiment One tested this hypothesis and found that manual asymmetries were only detected when participants performed in this zone; specifically, performance on a tracing task was only superior in the preferred hand when task constraints were high (i.e. fast speed tracing). Experiment Two used three different tasks to examine age differences in manual asymmetries; one task produced no asymmetries, whilst two tasks revealed asymmetries in both younger and older groups (with poorer overall performance in the old group across all tasks). Experiment Three revealed task-dependent asymmetries in both age groups, but highlighted further detection difficulties linked with the metric of performance and compensatory strategies used by participants. Results are discussed with reference to structural learning theory, whereby we suggest that the processes of inter-manual transfer lead to relatively small performance differences between the hands (despite a strong phenomenological sense of performance disparities).	[Raw, Rachael K.; Wilkie, Richard M.; White, Alan; Mon-Williams, Mark] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Williams, Justin H. G.] Univ Aberdeen, Div Appl Hlth Sci, Clin Res Ctr, Royal Cornhill Hosp, Aberdeen, Scotland	University of Leeds; University of Aberdeen	Wilkie, RM (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.	r.m.wilkie@leeds.ac.uk	Williams, Justin/AAE-5903-2020; Raw, Rachael/AGT-7704-2022; Wilkie, Richard M./G-5977-2012; Raw, Rachael/K-4342-2019	Wilkie, Richard M./0000-0003-4299-7171; Mon-Williams, Mark/0000-0001-7595-8545; Raw, Rachael/0000-0001-7593-3436	Medical Research Council UK Industrial Collaborative Studentship Competition grant; Magstim Company Ltd; MRC Centenary Early Career Fellowship Award	Medical Research Council UK Industrial Collaborative Studentship Competition grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Magstim Company Ltd; MRC Centenary Early Career Fellowship Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Data were collected by RR through her funding from a Medical Research Council UK Industrial Collaborative Studentship Competition grant awarded to RMW and MMW in collaboration with the Magstim Company Ltd (http://www.mrc.ac.uk/). Analysis and publication was supported through an MRC Centenary Early Career Fellowship Award to RKR (supervisors MMW and RMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calautti C, 2001, STROKE, V32, P139, DOI 10.1161/01.STR.32.1.139; CHUA R, 1995, DEV NEUROPSYCHOL, V11, P129, DOI 10.1080/87565649509540608; Contreras-Vidal JL, 1998, ACTA PSYCHOL, V100, P25, DOI 10.1016/S0001-6918(98)00023-7; COOKE JD, 1989, NEUROBIOL AGING, V10, P159, DOI 10.1016/0197-4580(89)90025-0; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1013, DOI 10.1016/S0197-4580(03)00030-7; DESROSIERS J, 1995, AGE AGEING, V24, P108, DOI 10.1093/ageing/24.2.108; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Escalante-Mead PR, 2003, J AUTISM DEV DISORD, V33, P539, DOI 10.1023/A:1025887713788; FAGARD J, 1987, HUM MOVEMENT SCI, V6, P321, DOI 10.1016/0167-9457(87)90002-9; Fang M, 2005, BRAIN TOPOGR, V17, P127, DOI 10.1007/s10548-005-4446-5; Francis KL, 2000, EXP AGING RES, V26, P169, DOI 10.1080/036107300243632; Goble DJ, 2008, NEUROSCI BIOBEHAV R, V32, P598, DOI 10.1016/j.neubiorev.2007.10.006; GOLDSTEIN G, 1981, Journal of Clinical Neuropsychology, V3, P65, DOI 10.1080/01688638108403114; Johnson RL, 2010, EXP BRAIN RES, V207, P291, DOI 10.1007/s00221-010-2438-5; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; MITRUSHINA M, 1995, NEUROPSYCHOLOGIA, V33, P359, DOI 10.1016/0028-3932(94)00113-4; MORGAN M, 1994, J GERONTOL, V49, pM133, DOI 10.1093/geronj/49.3.M133; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orton ST., 1937, READING WRITING SPEE; Pohl PS, 1995, J GERONTOL B-PSYCHOL, V51B, P94, DOI DOI 10.1093/GERONB/51B.2.P94; PRATT J, 1994, PSYCHOL AGING, V9, P325, DOI 10.1037/0882-7974.9.2.325; Przybyla A, 2011, NEUROSCI LETT, V489, P99, DOI 10.1016/j.neulet.2010.11.074; Raw RK, 2012, J EXP PSYCHOL HUMAN, V38, P735, DOI 10.1037/a0026568; Raw RK, 2012, EXP BRAIN RES, V217, P35, DOI 10.1007/s00221-011-2971-x; Teixeira LA, 2008, CORTEX, V44, P707, DOI 10.1016/j.cortex.2006.10.002; TRUMAN G, 1990, J MOTOR BEHAV, V22, P521; VERKERK PH, 1990, CLIN NEUROL NEUROSUR, V92, P105, DOI 10.1016/0303-8467(90)90084-I; Wang JS, 2011, EXP BRAIN RES, V210, P283, DOI 10.1007/s00221-011-2631-1; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; WELLER MPI, 1985, PSYCHOL MED, V15, P867, DOI 10.1017/S0033291700005109; Welsh TN, 2007, HUM MOVEMENT SCI, V26, P892, DOI 10.1016/j.humov.2007.04.004; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Yousif N, 2012, J NEUROPHYSIOL, V108, P2373, DOI 10.1152/jn.00315.2012	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128322	10.1371/journal.pone.0128322	http://dx.doi.org/10.1371/journal.pone.0128322			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023774	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400082
J	Algarni, AA; Mussi, MCM; Moffa, EB; Lippert, F; Zero, DT; Siqueira, WL; Hara, AT				Algarni, A. A.; Mussi, M. C. M.; Moffa, E. B.; Lippert, F.; Zero, D. T.; Siqueira, W. L.; Hara, A. T.			The Impact of Stannous, Fluoride Ions and Its Combination on Enamel Pellicle Proteome and Dental Erosion Prevention	PLOS ONE			English	Article							IN-VITRO; ACQUIRED PELLICLE; SALIVARY PELLICLE; CHEMICAL-ANALYSIS; HYDROXYAPATITE; SITU; VIVO; DEMINERALIZATION; PROTEINS; SUSCEPTIBILITY	Objectives To compare the effects of stannous (Sn) and fluoride (F) ions and their combination on acquired enamel pellicle (AEP) protein composition (proteome experiment), and protection against dental erosion (functional experiment). Methods In the proteome experiment, bovine enamel specimens were incubated in whole saliva supernatant for 24h for AEP formation. They were randomly assigned to 4 groups (n=10), according to the rinse treatment: Sn (800ppm/6.7mM, SnCl2), F (225ppm/13mM, NaF), Sn and F combination (Sn+F) and deionized water (DIW, negative control). The specimens were immersed 3x in the test rinses for 2min, 2h apart. Pellicles were collected, digested, and analyzed for protein content using liquid chromatography electrospray ionization tandem mass spectrometry. In the functional experiment, bovine enamel specimens (n=10) were similarly treated for pellicle formation. Then, they were subjected to a five-day erosion cycling model, consisting of 5min erosive challenges (15.6 mM citric acid, pH 2.6, 6x/d) and 2min treatment with the rinses containing Sn, F or Sn+F (3x/d). Between the treatments, all specimens were incubated in whole saliva supernatant. Surface loss was determined by profilometry. Results Our proteome approach on bovine enamel identified 72 proteins that were common to all groups. AEP of enamel treated with Sn+F demonstrated higher abundance for most of the identified proteins than the other groups. The functional experiment showed reduction of enamel surface loss for Sn+F (89%), Sn (67%) and F (42%) compared to DIW (all significantly different, p<0.05). Conclusion This study highlighted that anti-erosion rinses (e.g. Sn+F) can modify quantitatively and qualitatively the AEP formed on bovine enamel. Moreover, our study demonstrated a combinatory effect that amplified the anti-erosive protection on tooth surface.	[Algarni, A. A.; Lippert, F.; Zero, D. T.; Hara, A. T.] Indiana Univ, Sch Dent, Oral Hlth Res Inst, Indianapolis, IN 46204 USA; [Mussi, M. C. M.; Moffa, E. B.; Siqueira, W. L.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada	Indiana University System; Indiana University-Purdue University Indianapolis; Western University (University of Western Ontario)	Hara, AT (corresponding author), Indiana Univ, Sch Dent, Oral Hlth Res Inst, Indianapolis, IN 46204 USA.	ahara@iu.edu	Algarni, Amnah/ABA-6912-2021; Siqueira, Walter/ABE-8924-2020; Hara, Anderson T/G-4045-2014; Lippert, Frank/AAJ-2326-2020; Siqueira, Walter/ABE-4069-2021; Mussi, Maria Carolina Martins/AAE-3128-2021; Moffa, Eduardo B/N-4260-2015	Algarni, Amnah/0000-0002-3405-3560; Siqueira, Walter/0000-0003-1921-3658; Hara, Anderson T/0000-0001-9822-6064; Lippert, Frank/0000-0003-1944-2960; Moffa, Eduardo B/0000-0002-0372-6830; Martins Mussi, Maria Carolina/0000-0002-7616-2845	Dental Erosion-Abrasion research program (Oral Health Research Institute, Indiana University School of Dentistry); Natural Sciences and Engineering Research Council of Canada (NSERC) [371813]; Canadian Institutes of Health Research, (CIHR) [106657, 97577]; CIHR New Investigator Award [113166]; Taibah University	Dental Erosion-Abrasion research program (Oral Health Research Institute, Indiana University School of Dentistry); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research, (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Taibah University	This project was supported by the Dental Erosion-Abrasion research program (Oral Health Research Institute, Indiana University School of Dentistry), and also by the Natural Sciences and Engineering Research Council of Canada (NSERC grant #371813) and the Canadian Institutes of Health Research, (CIHR grant #106657 and grant #97577). Dr. Walter L. Siqueira is recipient of a CIHR New Investigator Award (grant #113166). Dr. Amnah Algarni was sponsored by a scholarship from Taibah University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS J, 1986, CARIES RES, V20, P337, DOI 10.1159/000260954; Baron AC, 1999, ORAL DIS, V5, P234, DOI 10.1111/j.1601-0825.1999.tb00307.x; BENNICK A, 1982, MOL CELL BIOCHEM, V45, P83; EGGEN KH, 1983, SCAND J DENT RES, V91, P347; ELLINGSEN JE, 1986, SCAND J DENT RES, V94, P299; Ganss C, 2008, CARIES RES, V42, P2, DOI 10.1159/000111743; Ganss C, 2010, J DENT RES, V89, P1214, DOI 10.1177/0022034510375291; Ganss C, 2007, ARCH ORAL BIOL, V52, P9, DOI 10.1016/j.archoralbio.2006.07.004; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gracia LH, 2010, J DENT, V38, pS12, DOI 10.1016/S0300-5712(11)70004-5; Hannig C, 2009, ARCH ORAL BIOL, V54, P518, DOI 10.1016/j.archoralbio.2009.02.009; Hannig M, 2004, ARCH ORAL BIOL, V49, P903, DOI 10.1016/j.archoralbio.2004.05.008; Hannig M, 1999, CARIES RES, V33, P372, DOI 10.1159/000016536; Hara AT, 2013, CARIES RES, V47, P325, DOI 10.1159/000347051; Hellwig E, 2013, CARIES RES, V47, P553, DOI 10.1159/000351634; Hemingway CA, 2010, CARIES RES, V44, P525, DOI 10.1159/000320984; Hove LH, 2007, ACTA ODONTOL SCAND, V65, P259, DOI 10.1080/00016350701477581; Jager DHJ, 2011, CARIES RES, V45, P532, DOI 10.1159/000331938; Kielbassa AM, 2005, J ORAL REHABIL, V32, P90, DOI 10.1111/j.1365-2842.2004.01392.x; Kimoto M, 2006, ARCH ORAL BIOL, V51, P117, DOI 10.1016/j.archoralbio.2005.04.007; Leme AFP, 2008, CARIES RES, V42, P435, DOI 10.1159/000159607; LEVINE MJ, 1987, J DENT RES, V66, P436, DOI 10.1177/00220345870660020901; Magalhaes AC, 2011, MONOGR ORAL SCI, V22, P158, DOI 10.1159/000325167; Masson N, 2013, CARIES RES, V47, P251, DOI 10.1159/000346280; Nekrashevych Yuriy, 2004, Oral Health Prev Dent, V2, P5; RYKKE M, 1989, ACTA ODONTOL SCAND, V47, P245, DOI 10.3109/00016358909007709; RYKKE M, 1991, SCAND J DENT RES, V99, P205; Schlueter N, 2009, J DENT, V37, P944, DOI 10.1016/j.jdent.2009.07.010; Schlueter N, 2009, EUR J ORAL SCI, V117, P427, DOI 10.1111/j.1600-0722.2009.00647.x; Shah S, 2011, EUR J ORAL SCI, V119, P13, DOI 10.1111/j.1600-0722.2011.00899.x; Siqueira WL, 2012, J DENT RES, V91, P1110, DOI 10.1177/0022034512462578; Siqueira WL, 2007, J PROTEOME RES, V6, P2152, DOI 10.1021/pr060580k; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; SONJU T, 1973, CARIES RES, V7, P30; Veeregowda DH, 2011, EUR J ORAL SCI, V119, P21, DOI 10.1111/j.1600-0722.2010.00798.x; Vitorino R, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00328.x; Vukosavljevic D, 2014, ARCH ORAL BIOL, V59, P631, DOI 10.1016/j.archoralbio.2014.02.002; Wetton S, 2006, CARIES RES, V40, P213, DOI 10.1159/000092228; Yu H, 2010, ARCH ORAL BIOL, V55, P702, DOI 10.1016/j.archoralbio.2010.06.006; Zimmerman JN, 2013, INT J MOL SCI, V14, P920, DOI 10.3390/ijms14010920; Zwier N, 2013, CARIES RES, V47, P548, DOI 10.1159/000350361	41	31	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128196	10.1371/journal.pone.0128196	http://dx.doi.org/10.1371/journal.pone.0128196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030135	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900121
J	Alt, K; Simon, S; Helmeke, C; Kohlstock, C; Prager, R; Tietze, E; Rabsch, W; Karagiannis, I; Werber, D; Frank, C; Fruth, A				Alt, Katja; Simon, Sandra; Helmeke, Carina; Kohlstock, Claudia; Prager, Rita; Tietze, Erhard; Rabsch, Wolfgang; Karagiannis, Ioannis; Werber, Dirk; Frank, Christina; Fruth, Angelika			Outbreak of Uncommon O4 Non-Agglutinating Salmonella Typhimurium Linked to Minced Pork, Saxony-Anhalt, Germany, January to April 2013	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MULTIDRUG-RESISTANCE; MONOPHASIC VARIANT; STRAINS	Introduction In January 2013, the National Reference Centre for Salmonella (NRC) detected a salmonellosis cluster in Saxony-Anhalt, Germany, caused by uncommon O4 non-agglutinating, monophasic Salmonella (S.) Typhimurium DT193. Circulating predominant monophasic S. Typhimurium DT193 clones typically display resistance phenotype ASSuT. We investigated common exposures to control the outbreak, and conducted microbiological investigations to assess the strains' phenotype. Methods We conducted a case-control study defining cases as persons living or working in Saxony-Anhalt diagnosed with the O4 non-agglutinating strain between January and March 2013. We selected two controls contemporarily reported with norovirus infection, frequency matched on residence and age group, per case. We interviewed regarding food consumption, especially pork and its place of purchase. We calculated odds ratios (ORs) with 95% confidence intervals (95% CI) using logistic regression. The NRC investigated human and food isolates by PCR, SDS-PAGE, MLST, PFGE, MLVA and susceptibility testing. Results Altogether, 68 O4 non-agglutinating human isolates were confirmed between January and April 2013. Of those, 61 were assigned to the outbreak (median age 57 years, 44% female); 83% cases >= 60 years were hospitalized. Eating raw minced pork from butcheries within 3 days was associated with disease (31 cases, 28 controls; OR adjusted for sex: 3.6; 95% CI: 1.0-13). Phage type DT193 and MLST ST34 were assigned, and isolates' lipopolysaccharide (LPS) matched control strains. Isolates linked to Saxony-Anhalt exhibited PFGE type 5. ASSuT- and ACSSuT phenotype proportions were 34 and 39% respectively; 54% were resistant to chloramphenicol. Three pork isolates matched the outbreak strain. Discussion Raw minced pork was the most likely infection vehicle in this first reported outbreak caused by O4 non-agglutinating, mostly chloramphenicol-resistant S. Typhimurium DT193. High hospitalization proportions demand awareness on the risk of consumption of raw pork among elderly. LPS analysis indicated O4 expression; therefore, testing with antisera from different lots is recommendable in unexpected agglutination reactions.	[Alt, Katja; Karagiannis, Ioannis; Werber, Dirk; Frank, Christina] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Simon, Sandra; Prager, Rita; Tietze, Erhard; Rabsch, Wolfgang; Fruth, Angelika] Robert Koch Inst, Natl Reference Ctr Salmonella & Other Bacterial E, Wernigerode, Saxony Anhalt, Germany; [Helmeke, Carina; Kohlstock, Claudia] State Agcy Consumer Protect Saxony Anhalt, Magdeburg, Saxony Anhalt, Germany	Robert Koch Institute; Robert Koch Institute	Fruth, A (corresponding author), Robert Koch Inst, Natl Reference Ctr Salmonella & Other Bacterial E, Wernigerode, Saxony Anhalt, Germany.	FruthA@rki.de	Werber, Dirk/L-2264-2019	Werber, Dirk/0000-0002-8076-788X; Frank, Christina/0000-0001-6776-8450				Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Agasan A, 2002, J CLIN MICROBIOL, V40, P1924, DOI 10.1128/JCM.40.6.1924-1929.2002; Amavisit P, 2005, J CLIN MICROBIOL, V43, P2736, DOI 10.1128/JCM.43.6.2736-2740.2005; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Dionisi AM, 2011, INT J ANTIMICROB AG, V38, P384, DOI 10.1016/j.ijantimicag.2011.07.001; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Ewing W.H., 1986, EDWARDS EWINGS IDENT; [German Institute for Standardization (DIN) DIN], 2004, MED MICROBIOL IMMUN, P245; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Guerra B, 2001, ANTIMICROB AGENTS CH, V45, P1305, DOI 10.1128/AAC.45.4.1305-1308.2001; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hopkins KL, 2010, EUROSURVEILLANCE, V15, P2; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Larsson JT, 2009, EUROSURVEILLANCE, V14, P6; Lim YH, 2003, JPN J INFECT DIS, V56, P151; Lucarelli C, 2010, J CLIN MICROBIOL, V48, P2103, DOI 10.1128/JCM.01371-09; Mossong J, 2007, Euro Surveill, V12, pE11; Rabsch Wolfgang, 2007, V394, P177, DOI 10.1007/978-1-59745-512-1_10; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Robert Koch-Institute, 2014, ANN REP INF DIS EP 2; Rycroft AN, 2013, SALMONELLA IN DOMESTIC ANIMALS, 2ND EDITION, P20, DOI 10.1079/9781845939021.0020; SELTMANN G, 1994, EPIDEMIOL INFECT, V113, P411, DOI 10.1017/S0950268800068424; Seltmann G, 1988, BAKTERIELLE ZELLWAND; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Trupschuch S, 2010, INT J MED MICROBIOL, V300, P279, DOI 10.1016/j.ijmm.2010.02.001	27	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128349	10.1371/journal.pone.0128349	http://dx.doi.org/10.1371/journal.pone.0128349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030424	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900139
J	Baek, SH; Ahn, SY; Lee, SW; Park, YS; Kim, S; Na, KY; Chae, DW; Kim, S; Chin, HJ				Baek, Seon Ha; Ahn, Shin Young; Lee, Sung Woo; Park, Youn Su; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Kim, Suhnggwon; Chin, Ho Jun			Outcomes of Predialysis Nephrology Care in Elderly Patients Beginning to Undergo Dialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; EARLY MORTALITY; HEMODIALYSIS-PATIENTS; PRACTICE PATTERNS; 1ST YEAR; PREDICTORS; SURVIVAL; IMPACT; CONSEQUENCES	Background The proportion of elderly patients beginning to undergo dialysis is increasing globally. Whether early referral (ER) of elderly patients is associated with favorable outcomes remains under debate. We investigated the influence of referral timing on the mortality of elderly patients. Methods We retrospectively assessed mortality in 820 patients aged >= 70 years with end-stage renal disease (ESRD) who initiated hemodialysis at a tertiary university hospital between 2000 and 2010. Mortality data was obtained from the time of dialysis initiation until December 2010. We assigned patients to one of two groups according to the time of their first encounters with nephrologists: ER (>= 3 months) and late referral (LR; < 3 months). Results During a mean follow-up period of 25.1 months, the ER group showed a 24% reduced risk of long-term mortality relative to the LR group (HR = 0.760, P = 0.009). Rate of reduction in 90-day mortality for ER patients was 58% (HR = 0.422, P=0.012). However, the statistical significance of the difference in mortality rates between ER and LR group was not observed across age groups after 90 days. Old age, LR, central venous catheter, high white blood cell count and corrected Ca level, and lower levels of albumin, creatinine, hemoglobin, and sodium were significantly associated with increased risk of mortality. Conclusions Timely referral was also associated with reduced mortality in elderly ESRD patients who initiated hemodialysis. In particular, the initial 90-day mortality reduction in ER patients contributed to mortality differences during the follow-up period.	[Baek, Seon Ha; Ahn, Shin Young; Lee, Sung Woo; Park, Youn Su; Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea; [Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Kim, Suhnggwon; Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea.	mednep@hanmail.net	Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962				Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Astor BC, 2001, AM J KIDNEY DIS, V38, P494, DOI 10.1053/ajkd.2001.26833; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Cass A, 2002, MED J AUSTRALIA, V177, P135, DOI 10.5694/j.1326-5377.2002.tb04698.x; Chan KE, 2011, CLIN J AM SOC NEPHRO, V6, P2642, DOI 10.2215/CJN.03680411; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; de Jager DJ, 2011, NEPHROL DIAL TRANSPL, V26, P652, DOI 10.1093/ndt/gfq438; Dogan E, 2005, NEPHROLOGY, V10, P516, DOI 10.1111/j.1440-1797.2005.00433.x; Ellis PA, 1998, QJM-MON J ASSOC PHYS, V91, P727, DOI 10.1093/qjmed/91.11.727; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Foote C, 2014, AM J KIDNEY DIS, V64, P359, DOI 10.1053/j.ajkd.2014.02.023; Foote C, 2012, NEPHROL DIAL TRANSPL, V27, P3581, DOI 10.1093/ndt/gfs096; Gallego E, 2003, NEFROLOGIA, V23, P234; Hoffmann Maxime, 2006, Nephrol Ther, V2, P15, DOI 10.1016/j.nephro.2005.08.004; Jungers P, 2006, PRESSE MED, V35, P17, DOI 10.1016/S0755-4982(06)74514-6; JUNGERS P, 1993, KIDNEY INT, V43, pS170; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Kim do H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055323, DOI 10.1371/J0URNAL.P0NE.0055323]; Krishnan M, 2002, SEMIN DIALYSIS, V15, P79, DOI 10.1046/j.1525-139X.2002.00028.x; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lukowsky LR, 2012, AM J NEPHROL, V35, P548, DOI 10.1159/000338673; McQuillan R, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/435736; Perl J, 2011, J AM SOC NEPHROL, V22, P1113, DOI 10.1681/ASN.2010111155; Quaglia M, 2011, ARCH INTERN MED, V171, P2065, DOI 10.1001/archinternmed.2011.585; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Schmidt RJ, 1998, AM J KIDNEY DIS, V32, P278, DOI 10.1053/ajkd.1998.v32.pm9708613; Schwenger V, 2006, NEPHROL DIAL TRANSPL, V21, P962, DOI 10.1093/ndt/gfk030; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Stoves J, 2001, POSTGRAD MED J, V77, P586, DOI 10.1136/pmj.77.911.586; Winkelmayer WC, 2003, J AM SOC NEPHROL, V14, P486, DOI 10.1097/01.ASN.0000046047.66958.C3; Winkelmayer WC, 2001, AM J KIDNEY DIS, V38, P1178, DOI 10.1053/ajkd.2001.29207; Winkelmayer WC, 2011, ARCH INTERN MED, V171, P1371, DOI 10.1001/archinternmed.2011.360	35	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128715	10.1371/journal.pone.0128715	http://dx.doi.org/10.1371/journal.pone.0128715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030256	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900186
J	Borrelli, P; Palma, G; Tedeschi, E; Cocozza, S; Comerci, M; Alfano, B; Haacke, EM; Salvatore, M				Borrelli, Pasquale; Palma, Giuseppe; Tedeschi, Enrico; Cocozza, Sirio; Comerci, Marco; Alfano, Bruno; Haacke, E. Mark; Salvatore, Marco			Improving Signal-to-Noise Ratio in Susceptibility Weighted Imaging: A Novel Multicomponent Non-Local Approach	PLOS ONE			English	Article							MRI; IMAGES	In susceptibility-weighted imaging (SWI), the high resolution required to obtain a proper contrast generation leads to a reduced signal-to-noise ratio (SNR). The application of a denoising filter to produce images with higher SNR and still preserve small structures from excessive blurring is therefore extremely desirable. However, as the distributions of magnitude and phase noise may introduce biases during image restoration, the application of a denoising filter is non-trivial. Taking advantage of the potential multispectral nature of MR images, a multicomponent approach using a Non-Local Means (MNLM) denoising filter may perform better than a component-by-component image restoration method. Here we present a new MNLM-based method (Multicomponent-Imaginary-Real-SWI, hereafter MIR-SWI) to produce SWI images with high SNR and improved conspicuity. Both qualitative and quantitative comparisons of MIR-SWI with the original SWI scheme and previously proposed SWI restoring pipelines showed that MIR-SWI fared consistently better than the other approaches. Noise removal with MIR-SWI also provided improvement in contrast-to-noise ratio (CNR) and vessel conspicuity at higher factors of phase mask multiplications than the one suggested in the literature for SWI vessel imaging. We conclude that a proper handling of noise in the complex MR dataset may lead to improved image quality for SWI data.	[Borrelli, Pasquale; Tedeschi, Enrico; Cocozza, Sirio] Univ Naples Federico II, Adv Biomed Sci Dept, Naples, Italy; [Palma, Giuseppe; Comerci, Marco; Alfano, Bruno] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Haacke, E. Mark] MRI Inst Biomed Res, Detroit, MI USA; [Borrelli, Pasquale; Salvatore, Marco] IRCCS, SDN, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Borrelli, P (corresponding author), Univ Naples Federico II, Adv Biomed Sci Dept, Naples, Italy.	pasquale.borrelli@unina.it	Tedeschi, Enrico/AAN-7112-2020; Palma, Giuseppe/AAX-1413-2020; Borrelli, Pasquale/H-7493-2016; Borrelli, Pasquale/N-4880-2019; Cocozza, Sirio/ABD-1161-2020; Palma, Giuseppe/GXV-0228-2022; Salvatore, Marco/K-8083-2016	Tedeschi, Enrico/0000-0002-0511-0132; Borrelli, Pasquale/0000-0002-9299-9661; Borrelli, Pasquale/0000-0002-9299-9661; Cocozza, Sirio/0000-0002-0300-5160; Palma, Giuseppe/0000-0002-0210-268X; Salvatore, Marco/0000-0001-9734-7702; Alfano, Bruno/0000-0002-7315-3628	Italian Ministry of Education, University, and Research (MIUR) [2010XE5L2R]	Italian Ministry of Education, University, and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Italian Ministry of Education, University, and Research (MIUR) within the PRIN framework (2010XE5L2R).	Borrelli P, 2014, P IEEE INT C IMAGING, P346; Borrelli P, 2014, IEEE T ACOUST SPEECH, P1230; Buades A, 2010, SIAM REV, V52, P113, DOI 10.1137/090773908; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Cusack R, 2002, NEUROIMAGE, V16, P754, DOI 10.1006/nimg.2002.1092; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke EM, 2014, SUSCEPTIBILITY WEIGH; Jang U, 2013, NEUROIMAGE, V70, P308, DOI 10.1016/j.neuroimage.2012.12.067; Manjon JV, 2008, MED IMAGE ANAL, V12, P514, DOI 10.1016/j.media.2008.02.004; Manjon JV, 2009, J BIOMED IMAGING, V2009, P18; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Palma G, 2013, FED CONF COMPUT SCI, P495; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Wiest-Daessle N, 2008, LECT NOTES COMPUT SC, V5242, P171, DOI 10.1007/978-3-540-85990-1_21; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Xu YB, 2006, MAGN RESON IMAGING, V24, P155, DOI 10.1016/j.mri.2005.10.030; Yang Q, 2010, J CARDIOVASC MAGN R, V12, P1, DOI [10.1186/1532-429X-12-S1-O66, DOI 10.1186/1532-429X-12-S1-066]	27	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126835	10.1371/journal.pone.0126835	http://dx.doi.org/10.1371/journal.pone.0126835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030293	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900034
J	Fukutani, A; Kurihara, T; Isaka, T				Fukutani, Atsuki; Kurihara, Toshiyuki; Isaka, Tadao			Factors of Force Potentiation Induced by Stretch-Shortening Cycle in Plantarflexors	PLOS ONE			English	Article							MUSCLE-TENDON COMPLEX; GASTROCNEMIUS-MUSCLE; SKELETAL-MUSCLE; JUMP HEIGHT; ENHANCEMENT; PERFORMANCE; EXERCISE; LENGTH; PRESTRETCH; MOVEMENT	Muscle force is potentiated by countermovement; this phenomenon is called stretch-shortening cycle (SSC) effect. In this study, we examined the factors strongly related to SSC effect in vivo, focusing on tendon elongation, preactivation, and residual force enhancement. Twelve healthy men participated in this study. Ankle joint angle was passively moved by a dynamometer, with a range of motion from 15 degrees dorsiflexion (DF) to 15 degrees plantarflexion (PF). Muscle contraction was evoked by electrical stimulation, with stimulation timing adjusted to elicit three types of contraction: (1) concentric contraction without preliminary contraction (CON), (2) concentric contraction after preliminary eccentric contraction (ECC), and (3) concentric contraction after preliminary isometric contraction (ISO). Joint torque was recorded at DF5 degrees, PF0 degrees, and PF5 degrees, respectively. SSC effect was calculated as the ratio of joint torque obtained in ECC or ISO with respect to that obtained in CON at the aforementioned three joint angles. SSC effect was prominent in the first half of movement in both ECC (DF5 degrees, 329.3 +/- 101.2%; PF0 degrees, 159.2 +/- 29.4%; PF5 degrees, 125.5 +/- 20.8%) and ISO (DF5 degrees, 276.4 +/- 87.0%; PF0 degrees, 134.5 +/- 24.5%; PF5 degrees, 106.8 +/- 18.0%) conditions. SSC effect was significantly larger in ECC than in ISO at all joint angles (P < 0.001). Even without preliminary eccentric contraction (i.e., ISO condition), SSC effect was clearly large, indicating that a significant part of SSC effect is derived from preactivation. However, the active lengthening-induced force potentiation mechanism (residual force enhancement) also contributes to SSC effect.	[Fukutani, Atsuki] Ritsumeikan Univ, Res Org Sci & Technol, Shiga, Japan; [Fukutani, Atsuki] Japan Soc Promot Sci, Res Fellowship Young Scientists, Chiyoda Ku, Tokyo, Japan; [Kurihara, Toshiyuki; Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Shiga, Japan	Ritsumeikan University; Japan Society for the Promotion of Science; Ritsumeikan University	Fukutani, A (corresponding author), Ritsumeikan Univ, Res Org Sci & Technol, Shiga, Japan.	atsukifukutani@gmail.com		Fukutani, Atsuki/0000-0002-8572-7940	 [13J03159];  [26750313]; Grants-in-Aid for Scientific Research [26560361] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (13J03159) and a Grant-in-Aid for Young Scientists B (26750313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P77; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Bobbert MF, 2005, MED SCI SPORT EXER, V37, P440, DOI 10.1249/01.MSS.0000155389.34538.97; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; CAVAGNA GA, 1968, J APPL PHYSIOL, V24, P21, DOI 10.1152/jappl.1968.24.1.21; DIETZ V, 1979, J NEUROPHYSIOL, V42, P1212, DOI 10.1152/jn.1979.42.5.1212; Earp JE, 2014, EUR J APPL PHYSIOL, V114, P59, DOI 10.1007/s00421-013-2744-2; Edman KAP, 2012, J PHYSIOL-LONDON, V590, P1339, DOI 10.1113/jphysiol.2011.222729; EDMAN KAP, 1982, J GEN PHYSIOL, V80, P769, DOI 10.1085/jgp.80.5.769; EDMAN KAP, 1978, J PHYSIOL-LONDON, V281, P139, DOI 10.1113/jphysiol.1978.sp012413; ETTEMA GJC, 1990, J EXP BIOL, V152, P333; ETTEMA GJC, 1992, J EXP BIOL, V165, P121; Finni T, 2001, ACTA PHYSIOL SCAND, V173, P369, DOI 10.1046/j.1365-201X.2001.00915.x; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Herzog W, 2002, J EXP BIOL, V205, P1275; HERZOG W, 1991, CLIN BIOMECH, V6, P230, DOI 10.1016/0268-0033(91)90051-Q; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hirayama K, 2012, MED SCI SPORT EXER, V44, P1512, DOI 10.1249/MSS.0b013e3182535da5; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Ishikawa M, 2006, J ELECTROMYOGR KINES, V16, P423, DOI 10.1016/j.jelekin.2005.08.006; Iwanuma S, 2011, J APPL PHYSIOL, V110, P1615, DOI 10.1152/japplphysiol.00776.2010; JENSEN RC, 1991, MED SCI SPORT EXER, V23, P10; Joumaa V, 2008, P ROY SOC B-BIOL SCI, V275, P1411, DOI 10.1098/rspb.2008.0142; JULIAN FJ, 1979, J PHYSIOL-LONDON, V293, P379, DOI 10.1113/jphysiol.1979.sp012895; Kawakami Y, 2002, J PHYSIOL-LONDON, V540, P635, DOI 10.1113/jphysiol.2001.013459; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Kubo K, 2000, ACTA PHYSIOL SCAND, V170, P127, DOI 10.1046/j.1365-201x.2000.00768.x; Lee EJ, 2007, J BIOMECH, V40, P719, DOI 10.1016/j.jbiomech.2006.10.009; Lee HD, 2002, J PHYSIOL-LONDON, V545, P321, DOI 10.1113/jphysiol.2002.018010; Maganaris CN, 2003, CLIN ANAT, V16, P215, DOI 10.1002/ca.10064; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; NICHOLS TR, 1973, SCIENCE, V181, P182, DOI 10.1126/science.181.4095.182; Rassier DE, 2012, AM J PHYSIOL-CELL PH, V302, pC240, DOI 10.1152/ajpcell.00208.2011; SINKJAER T, 1988, J NEUROPHYSIOL, V60, P1110, DOI 10.1152/jn.1988.60.3.1110; SVANTESSON U, 1994, ACTA PHYSIOL SCAND, V152, P287, DOI 10.1111/j.1748-1716.1994.tb09808.x; Van Ingen Schenau GJ, 1997, J APPL BIOMECH, V13, P389, DOI [DOI 10.1123/jab.13.4.389, DOI 10.1123/JAB.13.4.389)]; Walshe AD, 1998, J APPL PHYSIOL, V84, P97, DOI 10.1152/jappl.1998.84.1.97; ZAJAC FE, 1993, J BIOMECH, V26, P109, DOI 10.1016/0021-9290(93)90083-Q	39	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0120579	10.1371/journal.pone.0120579	http://dx.doi.org/10.1371/journal.pone.0120579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030915	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900007
J	Kim, HN; Cho, J; Chang, Y; Ryu, S; Shin, H; Kim, HL				Kim, Han-Na; Cho, Juhee; Chang, Yoosoo; Ryu, Seungho; Shin, Hocheol; Kim, Hyung-Lae			Association between Personality Traits and Sleep Quality in Young Korean Women	PLOS ONE			English	Article							NEO-PI-R; 5-FACTOR MODEL; STRUCTURE COEFFICIENTS; MULTIPLE-REGRESSION; FOLLOW-UP; HEALTH; DURATION; INSOMNIA; DISEASE; AGE	Personality is a trait that affects behavior and lifestyle, and sleep quality is an important component of a healthy life. We analyzed the association between personality traits and sleep quality in a cross-section of 1,406 young women (from 18 to 40 years of age) who were not reporting clinically meaningful depression symptoms. Surveys were carried out from December 2011 to February 2012, using the Revised NEO Personality Inventory and the Pittsburgh Sleep Quality Index (PSQI). All analyses were adjusted for demographic and behavioral variables. We considered beta weights, structure coefficients, unique effects, and common effects when evaluating the importance of sleep quality predictors in multiple linear regression models. Neuroticism was the most important contributor to PSQI global scores in the multiple regression models. By contrast, despite being strongly correlated with sleep quality, conscientiousness had a near-zero beta weight in linear regression models, because most variance was shared with other personality traits. However, conscientiousness was the most noteworthy predictor of poor sleep quality status (PSQI >= 6) in logistic regression models and individuals high in conscientiousness were least likely to have poor sleep quality, which is consistent with an OR of 0.813, with conscientiousness being protective against poor sleep quality. Personality may be a factor in poor sleep quality and should be considered in sleep interventions targeting young women.	[Kim, Han-Na; Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Cho, Juhee; Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, SAHIST, Dept Hlth Sci & Technol, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr,Res Inst Future Med, Seoul, South Korea; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc & Epidemiol, Baltimore, MD USA; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Hlth Screening Ctr, Seoul, South Korea	Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Shin, H (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Family Med, Seoul, South Korea.	hcfm.shin@samsung.com; hyung@ewha.ac.kr	Cho, Juhee/ABD-2280-2021	Ryu, Seungho/0000-0002-3927-8646; Chang, Yoosoo/0000-0002-6945-9050	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A2A2A04006291]; Ministry of Education [NRF-2013R1A1A2062702]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Ministry of Education	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning(NRF-2014R1A2A2A04006291) and the Ministry of Education(NRF-2013R1A1A2062702).	Ahn C-K., 1997, KOREAN J COUNS PSYCH, V9, P443; Assari S, 2013, INT CARDIOVASC RES J, V7, P141; Bass J, 2005, ARCH INTERN MED, V165, P15, DOI 10.1001/archinte.165.1.15; Benny W. D., 1985, MULTIPLE REGRESSION; Berger AM, 2009, PSYCHO-ONCOLOGY, V18, P634, DOI 10.1002/pon.1438; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Castro-Costa E, 2011, J EPIDEMIOL COMMUN H, V65, pA229, DOI 10.1136/jech.2011.142976h.73; Chapman BP, 2007, PSYCHOSOM MED, V69, P277, DOI 10.1097/PSY.0b013e3180313975; Chapman BP, 2014, DEV PSYCHOL, V50, P1426, DOI 10.1037/a0034135; Cheng SH, 2012, PSYCHIAT RES, V197, P270, DOI 10.1016/j.psychres.2011.08.011; Cho MJ, 1998, J NERV MENT DIS, V186, P304, DOI 10.1097/00005053-199805000-00007; Cho YW, 2009, J CLIN NEUROL, V5, P20, DOI 10.3988/jcn.2009.5.1.20; Colten HR, 2006, SLEEP DISORDERS SLEE; Costa P.T., 1992, PSYCHOL ASSESSMENT R, V396; Courville T, 2001, EDUC PSYCHOL MEAS, V61, P229, DOI 10.1177/0013164401612006; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081; Doi Y, 2003, SLEEP, V26, P467, DOI 10.1093/sleep/26.4.467; Duggan KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090628; Friedman EM, 2007, PSYCHOSOM MED, V69, P682, DOI 10.1097/PSY.0b013e31814ceada; Gau SF, 2000, SLEEP, V23, P495; Glozier N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-33; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Gray EK, 2002, J PERS, V70, P177; Hemalatha A, 2013, GLOBAL J RES ANAL, V2, P188; Henson RK, 2010, EDUC RESEARCHER, V39, P229, DOI 10.3102/0013189X10365102; Hintsanen M, 2014, HEALTH PSYCHOL, V33, P1214, DOI 10.1037/hea0000105; Hooke GR, 2002, BEHAV MODIF, V26, P648, DOI 10.1177/014544502236655; Kajimura N, 1998, PSYCHIAT CLIN NEUROS, V52, P317, DOI 10.1046/j.1440-1819.1998.00401.x; Kamdar BB, 2013, CRIT CARE MED, V41, P800, DOI 10.1097/CCM.0b013e3182746442; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Klein DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI 10.1146/annurev-clinpsy-032210-104540; Knudsen HK, 2007, SOC SCI MED, V64, P1997, DOI 10.1016/j.socscimed.2007.02.020; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kraha A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00044; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Lichstein KL, 2004, EPIDEMIOLOGY OF SLEEP AGE, GENDER, AND ETHNICITY, P1; Lockenhoff CE, 2008, J RES PERS, V42, P1334, DOI 10.1016/j.jrp.2008.05.006; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; Nathans L. L., 2012, PRACTICAL ASSESSMENT, V17, P9, DOI DOI 10.7275/5FEX-B874; Pedhazur EJ, 1997, MULTIPLE REGRESSION, Vxiv; Piedmont RL, 1997, J CROSS CULT PSYCHOL, V28, P131, DOI 10.1177/0022022197282001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raynor DA, 2009, J AM COLL HEALTH, V58, P73, DOI 10.3200/JACH.58.1.73-82; Sanderson C, 2002, FURTHER USE NEO PI R, P351; Schwartz S, 1999, J PSYCHOSOM RES, V47, P313, DOI 10.1016/S0022-3999(99)00029-X; Sutin AR, 2010, BIOL PSYCHOL, V84, P186, DOI 10.1016/j.biopsycho.2010.01.012; Tan E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-189; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; Thompon B, 2006, FDN BEHAV STAT INSIG; THOMPSON B, 1985, EDUC PSYCHOL MEAS, V45, P203, DOI 10.1177/001316448504500202; Troxel WM, 2010, SLEEP, V33, P973, DOI 10.1093/sleep/33.7.973; van de Laar M, 2010, SLEEP MED REV, V14, P61, DOI 10.1016/j.smrv.2009.07.007; Vitiello MV, 2004, J PSYCHOSOM RES, V56, P503, DOI 10.1016/S0022-3999(04)00023-6; Williams PG, 2009, PERS INDIV DIFFER, V46, P598, DOI 10.1016/j.paid.2008.12.017; Yoshiike T, 2014, PSYCHOPHYSIOLOGY, V51, P396, DOI 10.1111/psyp.12180; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85	62	29	30	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129599	10.1371/journal.pone.0129599	http://dx.doi.org/10.1371/journal.pone.0129599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030141	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900225
J	Liu, QZ; Wang, YZ; Lin, F; Zhang, L; Li, Y; Ge, RW; Hong, YH				Liu, Qizhi; Wang, Yunzhi; Lin, Fan; Zhang, Lei; Li, Yan; Ge, Ruowen; Hong, Yunhan			Gene Transfer and Genome-Wide Insertional Mutagenesis by Retroviral Transduction in Fish Stem Cells	PLOS ONE			English	Article							ORYZIAS-LATIPES; VIRAL VECTORS; MEDAKA FISH; VIRUS ENTRY; HIGH-TITER; ZEBRAFISH; THERAPY; LINE; DIFFERENTIATION; INTEGRATION	Retrovirus (RV) is efficient for gene transfer and integration in dividing cells of diverse organisms. RV provides a powerful tool for insertional mutagenesis (IM) to identify and functionally analyze genes essential for normal and pathological processes. Here we report RV-mediated gene transfer and genome-wide IM in fish stem cells from medaka and zebrafish. Three RVs were produced for fish cell transduction: rvLegfp and rvLcherry produce green fluorescent protein (GFP) and mCherry fluorescent protein respectively under control of human cytomegalovirus immediate early promoter upon any chromosomal integration, whereas rvGTgfp contains a splicing acceptor and expresses GFP only upon gene trapping (GT) via intronic in-frame integration and spliced to endogenous active genes. We show that rvLegfp and rvLcherry produce a transduction efficiency of 11 similar to 23% in medaka and zebrafish stem cell lines, which is as 30 similar to 67% efficient as the positive control in NIH/3T3. Upon co-infection with rvGTgfp and rvLcherry, GFP-positive cells were much fewer than Cherry-positive cells, consistent with rareness of productive gene trapping events versus random integration. Importantly, rvGTgfp infection in the medaka haploid embryonic stem (ES) cell line HX1 generated GTgfp insertion on all 24 chromosomes of the haploid genome. Similar to the mammalian haploid cells, these insertion events were presented predominantly in intergenic regions and introns but rarely in exons. RV-transduced HX1 retained the ES cell properties such as stable growth, embryoid body formation and pluripotency gene expression. Therefore, RV is proficient for gene transfer and IM in fish stem cells. Our results open new avenue for genome-wide IM in medaka haploid ES cells in culture.	[Liu, Qizhi; Wang, Yunzhi; Lin, Fan; Zhang, Lei; Li, Yan; Ge, Ruowen; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Hong, YH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbshyh@nus.edu.sg	Ge, Ruowen/D-8352-2012	Ge, Ruowen/0000-0002-0750-7336	National Research Foundation Singapore [NRF-CRP7-2010-03]	National Research Foundation Singapore(National Research Foundation, Singapore)	This work was supported by the National Research Foundation Singapore (NRF-CRP7-2010-03) (http://www.nrf.gov.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2011, METHOD CELL BIOL, V104, P59, DOI 10.1016/B978-0-12-374814-0.00004-5; Anson Donald S, 2004, Genet Vaccines Ther, V2, P9, DOI 10.1186/1479-0556-2-9; Arai T, 1999, VIROLOGY, V260, P109, DOI 10.1006/viro.1999.9773; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Borysiewicz LK, 1996, LANCET, V347, P1523, DOI 10.1016/S0140-6736(96)90674-1; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; El Ashkar S, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.33; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Ghazizadeh S, 1999, GENE THER, V6, P1267, DOI 10.1038/sj.gt.3300956; Hirai H, 1997, BIOCHEM BIOPH RES CO, V241, P112, DOI 10.1006/bbrc.1997.7776; Ho SY, 2014, ZEBRAFISH, V11, P407, DOI 10.1089/zeb.2013.0879; Hong N, 2014, CELL TISSUE RES; Hong N, 2014, CELL TISSUE RES, V357, P623, DOI 10.1007/s00441-014-1882-0; Hong N, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0144; Hong N, 2012, STEM CELLS DEV, V21, P2333, DOI 10.1089/scd.2011.0630; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Hong YH, 2004, MECH DEVELOP, V121, P933, DOI 10.1016/j.mod.2004.03.028; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Hong YH, 2004, TRANSGENIC RES, V13, P41, DOI 10.1023/B:TRAG.0000017172.71391.fa; Hong YH, 1996, MECH DEVELOP, V60, P33, DOI 10.1016/S0925-4773(96)00596-5; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kawasaki T, 2009, ZEBRAFISH, V6, P253, DOI 10.1089/zeb.2009.0596; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kramm CM, 1997, HUM GENE THER, V8, P2057, DOI 10.1089/hum.1997.8.17-2057; Lee CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070339; Li Z, 2014, CELL TISSUE RES; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Lu JK, 1997, MOL MAR BIOL BIOTECH, V6, P289; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Rosmarin DM, 2012, P NATL ACAD SCI USA, V109, P10059, DOI 10.1073/pnas.1120244109; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Sarmasik A, 2001, MAR BIOTECHNOL, V3, P470, DOI 10.1007/s10126001-0019-0; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002; Wang TS, 2014, GENE, V543, P28, DOI 10.1016/j.gene.2014.04.013; Xiong F, 2013, MAR BIOTECHNOL, V15, P526, DOI 10.1007/s10126-013-9505-4; Yan Y, 2009, EXP CELL RES, V315, P2322, DOI 10.1016/j.yexcr.2009.04.015; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yi MS, 2010, NAT PROTOC, V5, P1418, DOI 10.1038/nprot.2010.104; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Yi Y, 2011, CURR GENE THER, V11, P218; Yuan YM, 2013, J GEN VIROL, V94, P2352, DOI 10.1099/vir.0.054460-0; Zhang X, 2014, MAR BIOTECHNOL, V16, P125, DOI 10.1007/s10126-013-9556-6; Zheng HX, 2009, J VIROL METHODS, V156, P129, DOI 10.1016/j.jviromet.2008.11.010; ZHOU SZ, 1994, J EXP MED, V179, P1867, DOI 10.1084/jem.179.6.1867; ZHU Z, 1985, Zeitschrift fuer Angewandte Ichthyologie, V1, P31	52	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127961	10.1371/journal.pone.0127961	http://dx.doi.org/10.1371/journal.pone.0127961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029933	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900096
J	Papaianni, E; El Maadidi, S; Schejtman, A; Neumann, S; Maurer, U; Marino-Merlo, F; Mastino, A; Borner, C				Papaianni, Emanuela; El Maadidi, Souhayla; Schejtman, Andrea; Neumann, Simon; Maurer, Ulrich; Marino-Merlo, Francesca; Mastino, Antonio; Borner, Christoph			Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; NF-KAPPA-B; BLOCKS APOPTOSIS; GLYCOPROTEIN-D; DEATH; REPLICATION; ACTIVATION; EXPRESSION; RECEPTOR; KINASE	Viruses can trigger apoptosis of infected host cells if not counteracted by cellular or viral anti-apoptotic proteins. These protective proteins either inhibit the activation of caspases or they act as Bcl-2 homologs to prevent Bax/Bak-mediated outer mitochondrial membrane permeabilization (MOMP). The exact mechanism by which viruses trigger MOMP has however remained enigmatic. Here we use two distinct types of viruses, a double stranded DNA virus, herpes simplex virus-1 (HSV-1) and a positive sense, single stranded RNA virus, Semliki Forest virus (SFV) to show that the BH3-only protein Puma is the major mediator of virus-induced Bax/Bak activation and MOMP induction. Indeed, when Puma was genetically deleted or downregulated by shRNA, mouse embryonic fibroblasts and IL-3-dependent monocytes as well as human colon carcinoma cells were as resistant to virus-induced apoptosis as their Bax/Bak double deficient counterparts (Bax/Bak-/-). Puma protein expression started to augment after 2 h postinfection with both viruses. Puma mRNA levels increased as well, but this occurred after apoptosis initiation (MOMP) because it was blocked in cells lacking Bax/Bak or overexpressing Bcl-xL. Moreover, none of the classical Puma transcription factors such as p53, p73 or p65 NF kappa B were involved in HSV-1-induced apoptosis. Our data suggest that viruses use a Puma protein-dependent mechanism to trigger MOMP and apoptosis in host cells.	[Papaianni, Emanuela; Marino-Merlo, Francesca; Mastino, Antonio] Univ Messina, Dept Biol & Environm Sci, I-98166 Messina, Italy; [Papaianni, Emanuela; Mastino, Antonio] CNR, Inst Translat Pharmacol, I-00133 Rome, Italy; [Papaianni, Emanuela; El Maadidi, Souhayla; Schejtman, Andrea; Neumann, Simon; Maurer, Ulrich; Borner, Christoph] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [El Maadidi, Souhayla] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Schejtman, Andrea] Univ Freiburg, IMBS Program, D-79104 Freiburg, Germany; [Schejtman, Andrea] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Maurer, Ulrich; Borner, Christoph] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Maurer, Ulrich; Borner, Christoph] Ctr Biol Signaling Studies, BIOSS, D-79104 Freiburg, Germany	University of Messina; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Freiburg; University of Freiburg; University of Freiburg; University of Buenos Aires; University of Freiburg	Mastino, A (corresponding author), Univ Messina, Dept Biol & Environm Sci, Via F Stagno dAlcontres 31, I-98166 Messina, Italy.	amastino@unime.it; christoph.borner@uniklinik-freiburg.de	Merlo, Francesca Marino/A-8390-2013; Mastino, Antonio/A-4686-2008	Merlo, Francesca Marino/0000-0001-7898-583X; Mastino, Antonio/0000-0002-0338-6450	Spemann Graduate School of Biology and Medicine (SGBM) - Excellence Initiative of the German Federal and State Governments, Germany [GSC-4]; Centre for Biological Signaling Studies (BIOSS) - Excellence Initiative of the German Federal and State Governments, Germany [EXC-294]; German Research Foundation (DFG) [FOR2036]; Italian Ministry of University and Research, Projects of National Interest	Spemann Graduate School of Biology and Medicine (SGBM) - Excellence Initiative of the German Federal and State Governments, Germany; Centre for Biological Signaling Studies (BIOSS) - Excellence Initiative of the German Federal and State Governments, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); Italian Ministry of University and Research, Projects of National Interest	This work was supported by the Spemann Graduate School of Biology and Medicine (SGBM, GSC-4) and the Centre for Biological Signaling Studies (BIOSS, EXC-294) (to CB and UM), both funded by the Excellence Initiative of the German Federal and State Governments, Germany as well as by the Research Group FOR2036 funded by the German Research Foundation (DFG) (to CB and SN). AM, FMM and EP were financed by the Italian Ministry of University and Research, Projects of National Interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert M, 1999, J VIROL, V73, P2803, DOI 10.1128/JVI.73.4.2803-2813.1999; Aubert M, 1999, J VIROL, V73, P10359, DOI 10.1128/JVI.73.12.10359-10370.1999; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Borner C, 1996, J BIOL CHEM, V271, P12695, DOI 10.1074/jbc.271.22.12695; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Branco FJ, 2005, J VIROL, V79, P9019, DOI 10.1128/JVI.79.14.9019-9025.2005; Carpenter RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078836; Castanier C, 2011, BBA-MOL CELL RES, V1813, P575, DOI 10.1016/j.bbamcr.2010.08.009; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Cruz CD, 2006, J VIROL, V80, P5644, DOI 10.1128/JVI.02400-05; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Du T, 2012, P NATL ACAD SCI USA, V109, P14616, DOI 10.1073/pnas.1212661109; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; El Maadidi S, 2014, J IMMUNOL, V192, P1171, DOI 10.4049/jimmunol.1300842; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Fleck M, 1999, VIRAL IMMUNOL, V12, P263, DOI 10.1089/vim.1999.12.263; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Galvan V, 1998, P NATL ACAD SCI USA, V95, P3931, DOI 10.1073/pnas.95.7.3931; Geissler A, 2013, CELL DEATH DIFFER, V20, P1317, DOI 10.1038/cdd.2013.78; Goodkin ML, 2003, J VIROL, V77, P7261, DOI 10.1128/JVI.77.13.7261-7280.2003; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hemmati PG, 2006, ONCOGENE, V25, P6582, DOI 10.1038/sj.onc.1209668; Hikisz P, 2012, CELL MOL BIOL LETT, V17, P646, DOI 10.2478/s11658-012-0032-5; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hutcheson J, 2005, J EXP MED, V201, P1949, DOI 10.1084/jem.20041484; Iannello A, 2011, VIRAL IMMUNOL, V24, P11, DOI 10.1089/vim.2010.0083; Ito M, 1997, J INFECT DIS, V175, P1220, DOI 10.1086/593672; Jerome KR, 2001, J IMMUNOL, V167, P3928, DOI 10.4049/jimmunol.167.7.3928; Kamiyama H, 2004, CANCER SCI, V95, P990, DOI 10.1111/j.1349-7006.2004.tb03188.x; Kather A, 2010, J VIROL, V84, P1034, DOI 10.1128/JVI.01409-09; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Koyama AH, 1997, J VIROL, V71, P2567, DOI 10.1128/JVI.71.3.2567-2571.1997; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Leopardi R, 1996, P NATL ACAD SCI USA, V93, P9583, DOI 10.1073/pnas.93.18.9583; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100109; Mastino A, 1997, CELL DEATH DIFFER, V4, P629, DOI 10.1038/sj.cdd.4400289; Medici MA, 2003, J BIOL CHEM, V278, P36059, DOI 10.1074/jbc.M306198200; Munger J, 2001, J VIROL, V75, P5491, DOI 10.1128/JVI.75.12.5491-5497.2001; Munger J, 2001, P NATL ACAD SCI USA, V98, P10410, DOI 10.1073/pnas.181344498; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Perkins D, 2003, J NEUROVIROL, V9, P101, DOI 10.1080/13550280390173427; Postigo A, 2009, MICROBES INFECT, V11, P1071, DOI 10.1016/j.micinf.2009.08.012; Roizman B, 2013, ANNU REV MICROBIOL, V67, P355, DOI 10.1146/annurev-micro-092412-155654; Sandow JJ, 2012, CELL DEATH DIFFER, V19, P633, DOI 10.1038/cdd.2011.131; Sciortino MT, 2008, CELL MICROBIOL, V10, P2297, DOI 10.1111/j.1462-5822.2008.01212.x; Sciortino MT, 2006, VIROLOGY, V356, P136, DOI 10.1016/j.virol.2006.08.001; Sciortino MT, 2008, BIOCHEM PHARMACOL, V76, P1522, DOI 10.1016/j.bcp.2008.07.030; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Thomson BJ, 2001, INT J EXP PATHOL, V82, P65, DOI 10.1111/j.1365-2613.2001.iep195.x; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Urban C, 2008, CELL DEATH DIFFER, V15, P1396, DOI 10.1038/cdd.2008.61; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang XJ, 2011, P NATL ACAD SCI USA, V108, P14632, DOI 10.1073/pnas.1111942108; Wang X, 2014, P NATL ACAD SCI USA, V111, P15438, DOI 10.1073/pnas.1412767111; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhou GY, 2000, J VIROL, V74, P11782, DOI 10.1128/JVI.74.24.11782-11791.2000	68	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126645	10.1371/journal.pone.0126645	http://dx.doi.org/10.1371/journal.pone.0126645			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030884	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900030
J	Yashiro, K; Tonson, A; Pecchi, E; Vilmen, C; Le Fur, Y; Bernard, M; Bendahan, D; Giannesini, B				Yashiro, Kazuya; Tonson, Anne; Pecchi, Emilie; Vilmen, Christophe; Le Fur, Yann; Bernard, Monique; Bendahan, David; Giannesini, Benoit			Capsiate Supplementation Reduces Oxidative Cost of Contraction in Exercising Mouse Skeletal Muscle In Vivo	PLOS ONE			English	Article							ENERGY-METABOLISM; MECHANICAL PERFORMANCE; CAPSAICIN ANALOG; DOWN-REGULATION; CAPACITY; PHOSPHOCREATINE; CREATINE; FAT; ATP; INCREASES	Chronic administration of capsiate is known to accelerate whole-body basal energy metabolism, but the consequences in exercising skeletal muscle remain very poorly documented. In order to clarify this issue, the effect of 2-week daily administration of either vehicle (control) or purified capsiate (at 10- or 100-mg/ kg body weight) on skeletalmuscle function and energetics were investigated throughout amultidisciplinary approach combining in vivo and in vitromeasurements in mice. Mechanical performance and energy metabolism were assessed strictly non-invasively in contracting gastrocnemius muscle using magnetic resonance (MR) imaging and 31-phosphorus MR spectroscopy (31P-MRS). Regardless of the dose, capsiate treatmentsmarkedly disturbed basal bioenergetics in vivo including intracellular pH alkalosis and decreased phosphocreatine content. Besides, capsiate administration did affect neither mitochondrial uncoupling protein-3 gene expression nor both basal and maximal oxygen consumption in isolated saponin-permeabilized fibers, but decreased by about twofold the Km of mitochondrial respiration for ADP. During a standardized in vivo fatiguing protocol (6-min of repeated maximal isometric contractions electrically induced at a frequency of 1.7 Hz), both capsiate treatments reduced oxidative cost of contraction by 30-40%, whereas force-generating capacity and fatigability were not changed. Moreover, the rate of phosphocreatine resynthesis during the post-electrostimulation recovery period remained unaffected by capsiate. Both capsiate treatments further promoted muscle mass gain, and the higher dose also reduced body weight gain and abdominal fat content. These findings demonstrate that, in addition to its anti-obesity effect, capsiate supplementation improves oxidative metabolism in exercisingmuscle, which strengthen this compound as a natural compound for improving health.	[Yashiro, Kazuya; Tonson, Anne; Pecchi, Emilie; Vilmen, Christophe; Le Fur, Yann; Bernard, Monique; Bendahan, David; Giannesini, Benoit] Aix Marseille Univ, CNRS, CRMBM, UMR 7339, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite	Giannesini, B (corresponding author), Aix Marseille Univ, CNRS, CRMBM, UMR 7339, F-13385 Marseille, France.	benoit.giannesini@univ-amu.fr	Bernard, Monique/Q-7254-2017; Bendahan, David/AAU-1420-2020	Bernard, Monique/0000-0002-3179-8698; 	French National Research Agency [ANR-07-BLAN-0354]	French National Research Agency(French National Research Agency (ANR))	This research was financially supported by a grant from the French National Research Agency (Grant ANR-07-BLAN-0354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GR, 1990, J APPL PHYSIOL, V69, P968, DOI 10.1152/jappl.1990.69.3.968; ALLY A, 1992, J CHROMATOGR-BIOMED, V575, P19, DOI 10.1016/0378-4347(92)80499-G; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; Azzu V, 2010, BIOCHEM J, V426, P13, DOI 10.1042/BJ20091321; Bahi L, 2004, J APPL PHYSIOL, V96, P59, DOI 10.1152/japplphysiol.00323.2003; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Faraut B, 2007, AM J PHYSIOL-ENDOC M, V292, pE1474, DOI 10.1152/ajpendo.00292.2006; Faraut B, 2009, INT J OBESITY, V33, P1348, DOI 10.1038/ijo.2009.182; Giannesini B, 2001, J PHYSIOL-LONDON, V536, P905, DOI 10.1111/j.1469-7793.2001.00905.x; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; GYULAI L, 1985, J BIOL CHEM, V260, P3947; Haramizu S, 2006, BIOSCI BIOTECH BIOCH, V70, P774, DOI 10.1271/bbb.70.774; Haramizu S, 2011, BIOSCI BIOTECH BIOCH, V75, P95, DOI 10.1271/bbb.100577; Hochachka PW, 1997, J EXP BIOL, V200, P381; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Inoue N, 2007, BIOSCI BIOTECH BIOCH, V71, P380, DOI 10.1271/bbb.60341; Ito N, 2013, NAT MED, V19, P101, DOI 10.1038/nm.3019; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Karagozian R, 2014, METABOLISM, V63, P607, DOI 10.1016/j.metabol.2014.01.011; Kazuya Y, 2014, AM J PHYSIOL-ENDOC M, V306, pE1110, DOI 10.1152/ajpendo.00520.2013; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kobata K, 2002, BIOSCI BIOTECH BIOCH, V66, P319, DOI 10.1271/bbb.66.319; Kodama T, 2010, INT J TOXICOL, V29, p27S, DOI 10.1177/1091581809358925; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Lida T, 2003, NEUROPHARMACOLOGY, V44, P958, DOI 10.1016/S0028-3908(03)00100-X; Lotteau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058673; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Masuda Y, 2003, J APPL PHYSIOL, V95, P2408, DOI 10.1152/japplphysiol.00828.2002; Mattei JP, 2006, MAGN RESON MATER PHY, V19, P275, DOI 10.1007/s10334-006-0051-1; Ohnuki K, 2001, BIOSCI BIOTECH BIOCH, V65, P2735, DOI 10.1271/bbb.65.2735; Ono K, 2011, J APPL PHYSIOL, V110, P789, DOI 10.1152/japplphysiol.00128.2010; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Saks V, 2008, J PHYSIOL-LONDON, V586, P2817, DOI 10.1113/jphysiol.2008.155358; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561; Stary CM, 2000, AM J PHYSIOL-REG I, V278, pR587, DOI 10.1152/ajpregu.2000.278.3.R587; THOMPSON CH, 1995, J APPL PHYSIOL, V78, P2131, DOI 10.1152/jappl.1995.78.6.2131; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Watanabe E, 2008, INT J TOXICOL, V27, P101, DOI 10.1080/10915810802513619; WOLFE CL, 1988, BIOCHIM BIOPHYS ACTA, V971, P9, DOI 10.1016/S0005-2728(88)80003-3; YAZAWA S, 1989, J JPN SOC HORTIC SCI, V58, P601, DOI 10.2503/jjshs.58.601; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	49	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128016	10.1371/journal.pone.0128016	http://dx.doi.org/10.1371/journal.pone.0128016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030806	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900101
J	Zhang, X; Li, QQ; Zou, Q; Fang, ZX; Zhou, BD				Zhang, Xing; Li, Qingquan; Zou, Qin; Fang, Zhixiang; Zhou, Baoding			Parametric Modeling of Visual Search Efficiency in Real Scenes	PLOS ONE			English	Article							COMPETITIVE INTERACTIONS; SPATIAL INTERACTION; TOP-DOWN; ATTENTION; WORLD; SIZE; RECOGNITION; PERCEPTION; GUIDANCE; FEATURES	How should the efficiency of searching for real objects in real scenes be measured? Traditionally, when searching for artificial targets, e.g., letters or rectangles, among distractors, efficiency is measured by a reaction time (RT) x Set Size function. However, it is not clear whether the set size of real scenes is as effective a parameter for measuring search efficiency as the set size of artificial scenes. The present study investigated search efficiency in real scenes based on a combination of low-level features, e.g., visible size and target-flanker separation factors, and high-level features, e.g., category effect and target template. Visible size refers to the pixel number of visible parts of an object in a scene, whereas separation is defined as the sum of the flank distances from a target to the nearest distractors. During the experiment, observers searched for targets in various urban scenes, using pictures as the target templates. The results indicated that the effect of the set size in real scenes decreased according to the variances of other factors, e.g., visible size and separation. Increasing visible size and separation factors increased search efficiency. Based on these results, an RT x Visible Size x Separation function was proposed. These results suggest that the proposed function is a practicable predictor of search efficiency in real scenes.	[Zhang, Xing] Shenzhen Univ, Coll Informat Engn, Shenzhen, Peoples R China; [Zhang, Xing; Li, Qingquan; Zhou, Baoding] Shenzhen Univ, Shenzhen Key Lab Spatial Smart Sensing & Serv, Shenzhen, Peoples R China; [Zhang, Xing; Li, Qingquan] Shenzhen Univ, Natl Adm Surveying Mapping & GeoInformat, Key Lab Geoenvironm Monitoring Coastal Zone, Shenzhen, Peoples R China; [Li, Qingquan; Fang, Zhixiang; Zhou, Baoding] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China; [Zou, Qin] Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China	Shenzhen University; Shenzhen University; Shenzhen University; Wuhan University; Wuhan University	Li, QQ (corresponding author), Shenzhen Univ, Shenzhen Key Lab Spatial Smart Sensing & Serv, Shenzhen, Peoples R China.	liqq@szu.edu.cn	方, 志祥/L-7411-2019; Zou, Qin/GVU-2237-2022	Zhang, Xing/0000-0003-2447-1408; Fang, Zhixiang/0000-0003-1651-878X; Zou, Qin/0000-0001-7955-0782	National Science Foundation of China [41301511, 41371377, 61301277, 41371420]; Postdoctoral Science Foundation of China [2013M542199]; Shenzhen Scientific Research and Development Funding Program [JCYJ20140418095735587, ZDSY20121019111146499, JSGG20121026111 056204]; Shenzhen Dedicated Funding of Strategic Emerging Industry Development Program [JCYJ201210 19111128765]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Shenzhen Scientific Research and Development Funding Program; Shenzhen Dedicated Funding of Strategic Emerging Industry Development Program	This research was supported by the National Science Foundation of China grant to XZ (41301511), QL (41371377), QZ (61301277) and ZF (41371420) (https://isisn.nsfc.gov.cn/egrantweb/); Postdoctoral Science Foundation of China grant to XZ (2013M542199) (http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx); Shenzhen Scientific Research and Development Funding Program grant to XZ (JCYJ20140418095735587) and QL (ZDSY20121019111146499, JSGG20121026111 056204) (http://apply.szsti.gov.cn/); and Shenzhen Dedicated Funding of Strategic Emerging Industry Development Program grant to QL (JCYJ201210 19111128765) (http://apply.szsti.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIESSEN JJ, 1976, VISION RES, V16, P71, DOI 10.1016/0042-6989(76)90078-X; Astle AT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01158; Bex PJ, 2003, VISION RES, V43, P2895, DOI 10.1016/S0042-6989(03)00460-7; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Bravo MJ, 2009, J VISION, V9, DOI 10.1167/9.1.34; Bravo MJ, 2004, PERCEPTION, V33, P643, DOI 10.1068/p5244; BUTLER TW, 1978, VISION RES, V18, P1387, DOI 10.1016/0042-6989(78)90231-6; Castelhano MS, 2010, ATTEN PERCEPT PSYCHO, V72, P1283, DOI 10.3758/APP.72.5.1283; Daoutis CA, 2006, VIS COGN, V14, P217, DOI 10.1080/13506280500158670; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Ehinger KA, 2009, VIS COGN, V17, P945, DOI 10.1080/13506280902834720; Farzin F, 2009, J VISION, V9, DOI 10.1167/9.6.18; Hayakawa S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00080; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JACOBS RJ, 1979, VISION RES, V19, P1187, DOI 10.1016/0042-6989(79)90183-4; Kaiser D, 2014, P NATL ACAD SCI USA, V111, P11217, DOI 10.1073/pnas.1400559111; KOCH C, 1985, HUM NEUROBIOL, V4, P219; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; LEVI DM, 1985, VISION RES, V25, P963, DOI 10.1016/0042-6989(85)90207-X; Louie EG, 2007, J VISION, V7, DOI 10.1167/7.2.24; Malcolm GL, 2010, J VISION, V10, DOI 10.1167/10.2.4; Malcolm GL, 2009, J VISION, V9, DOI 10.1167/9.11.8; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; McMains S, 2011, J NEUROSCI, V31, P587, DOI 10.1523/JNEUROSCI.3766-10.2011; McMains SA, 2010, J COGNITIVE NEUROSCI, V22, P2417, DOI 10.1162/jocn.2009.21391; Neider MB, 2008, VIS COGN, V16, P1, DOI 10.1080/13506280701381691; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; Peelen MV, 2014, TRENDS COGN SCI, V18, P242, DOI 10.1016/j.tics.2014.02.004; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pomplun M, 2006, VISION RES, V46, P1886, DOI 10.1016/j.visres.2005.12.003; Proulx MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015293; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; Torralba A, 2003, J OPT SOC AM A, V20, P1407, DOI 10.1364/JOSAA.20.001407; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Vlaskamp BNS, 2006, VISION RES, V46, P417, DOI 10.1016/j.visres.2005.04.006; Vo MLH, 2013, PSYCHOL SCI, V24, P1816, DOI 10.1177/0956797613476955; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Wolfe J., 2008, SCHOLARPEDIA, V3, P3325, DOI [DOI 10.4249/SCHOLARPEDIA.3325, 10.4249/scholarpedia.3325]; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Wolfe JM, 2011, ATTEN PERCEPT PSYCHO, V73, P1650, DOI 10.3758/s13414-011-0153-3; Wolfe JM, 2004, VISION RES, V44, P1411, DOI 10.1016/j.visres.2003.11.024; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006; Yang HJ, 2009, VISION RES, V49, P2095, DOI 10.1016/j.visres.2009.05.017	50	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128545	10.1371/journal.pone.0128545	http://dx.doi.org/10.1371/journal.pone.0128545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030908	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900167
J	Hamashima, C; Shabana, M; Okamoto, M; Osaki, Y; Kishimoto, T				Hamashima, Chisato; Shabana, Michiko; Okamoto, Mikizo; Osaki, Yoneatsu; Kishimoto, Takuji			Survival Analysis of Patients with Interval Cancer Undergoing Gastric Cancer Screening by Endoscopy	PLOS ONE			English	Article							BREAST-CANCER; REGISTRATION SYSTEM; PROGRAM; JAPAN; SWEDEN; COHORT; KOREA; WOMEN	Aims Interval cancer is a key factor that influences the effectiveness of a cancer screening program. To evaluate the impact of interval cancer on the effectiveness of endoscopic screening, the survival rates of patients with interval cancer were analyzed. Methods We performed gastric cancer-specific and all-causes survival analyses of patients with screen-detected cancer and patients with interval cancer in the endoscopic screening group and radiographic screening group using the Kaplan-Meier method. Since the screening interval was 1 year, interval cancer was defined as gastric cancer detected within 1 year after a negative result. A Cox proportional hazards model was used to investigate the risk factors associated with gastric cancer-specific and all-causes death. Results A total of 1,493 gastric cancer patients (endoscopic screening group: n = 347; radiographic screening group: n = 166; outpatient group: n = 980) were identified from the Tottori Cancer Registry from 2001 to 2008. The gastric cancer-specific survival rates were higher in the endoscopic screening group than in the radiographic screening group and the outpatients group. In the endoscopic screening group, the gastric cancer-specific survival rate of the patients with screen-detected cancer and the patients with interval cancer were nearly equal (P = 0.869). In the radiographic screening group, the gastric cancer-specific survival rate of the patients with screen-detected cancer was higher than that of the patients with interval cancer (P = 0.009). For gastric cancer-specific death, the hazard ratio of interval cancer in the endoscopic screening group was 0.216 for gastric cancer death (95% CI: 0.054-0.868) compared with the outpatient group. Conclusion The survival rate and the risk of gastric cancer death among the patients with screen-detected cancer and patients with interval cancer were not significantly different in the annual endoscopic screening. These results suggest the potential of endoscopic screening in reducing mortality from gastric cancer.	[Hamashima, Chisato] Natl Canc Ctr, Canc Screening Assessment & Management Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Shabana, Michiko] San In Rosai Hosp, Dept Internal Med, Yonago, Tottori, Japan; [Okamoto, Mikizo; Osaki, Yoneatsu; Kishimoto, Takuji] Tottori Univ, Fac Med, Dept Social Med, Div Environm & Prevent Med, Yonago, Tottori 683, Japan	National Cancer Center - Japan; Tottori University	Hamashima, C (corresponding author), Natl Canc Ctr, Canc Screening Assessment & Management Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan.	chamashi@ncc.go.jp	Hamashima, Chisato/AAI-3061-2021		Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid for H25-Third Term Comprehensive Control Research for Cancer 022 from the Japanese Ministry of Health, Labour and Welfare.	Bordas P, 2007, BREAST, V16, P47, DOI 10.1016/j.breast.2006.05.006; BREKELMANS CT, 1995, EUR J CANCER, V31A, P1830, DOI 10.1016/0959-8049(95)00324-C; Cho BY, 2014, EVALUATION VALIDITY; Choi KS, 2015, BRIT J CANCER, V112, P608, DOI 10.1038/bjc.2014.608; Choi KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050041; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Hamashima C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079088; Hamashima C, 2013, INT J CANCER, V133, P653, DOI 10.1002/ijc.28065; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; Japanese Gastric Cancer Association, 2010, JAP CLASS GASTR CARC; Kalager M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7536; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Matsuda T, 2015, INT J CLIN ONCOL, V20, P11, DOI 10.1007/s10147-014-0765-4; Matsumoto S, 2013, AUST J RURAL HEALTH, V21, P319, DOI 10.1111/ajr.12064; Ministry of Health Labour and Welfare, 2012, MED I SURV 2011; Ministry of Health Welfare and Labour., 2007, JAP ETH GUID EP STUD; Nishida M, 2009, J YOUNAGO MED ASS, V60, P184; Okamoto N, 2008, INT J CLIN ONCOL, V13, P90, DOI 10.1007/s10147-008-0759-1; Perry N, 2006, EUROPEAN GUIDELINES, V4th, P35; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Research Group for Survival statistics of Japanese association of Clinical Cancer Centers, 2012, SURV AN CANC PAT K M; Shabana M., 2010, JPN J CANC DIAGN, V17, P229; Sobue T, 2012, MONITORING CANC INCI, P140; Sobue T, 2008, INT J CLIN ONCOL, V13, P97, DOI 10.1007/s10147-008-0761-7; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; Zackrisson S, 2007, J MED SCREEN, V14, P138, DOI 10.1258/096914107782066239	27	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126796	10.1371/journal.pone.0126796	http://dx.doi.org/10.1371/journal.pone.0126796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023768	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400022
J	Hench, J; Henriksson, J; Abou-Zied, AM; Luppert, M; Dethlefsen, J; Mukherjee, K; Tong, YG; Tang, L; Gangishetti, U; Baillie, DL; Burglin, TR				Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Baillie, David L.; Burglin, Thomas R.			The Homeobox Genes of Caenorhabditis elegans and Insights into Their Spatio-Temporal Expression Dynamics during Embryogenesis	PLOS ONE			English	Article							EMBRYONIC-CELL LINEAGE; C-ELEGANS; HOMEODOMAIN PROTEIN; PROSPERO GENE; INTRAFLAGELLAR TRANSPORT; TRANSCRIPTION FACTORS; PHARYNGEAL MUSCLE; SENSORY NEURON; HOX; DROSOPHILA	Homeobox genes play crucial roles for the development of multicellular eukaryotes. We have generated a revised list of all homeobox genes for Caenorhabditis elegans and provide a nomenclature for the previously unnamed ones. We show that, out of 103 homeobox genes, 70 are co-orthologous to human homeobox genes. 14 are highly divergent, lacking an obvious ortholog even in other Caenorhabditis species. One of these homeobox genes encodes 12 homeodomains, while three other highly divergent homeobox genes encode a novel type of double homeodomain, termed HOCHOB. To understand how transcription factors regulate cell fate during development, precise spatio-temporal expression data need to be obtained. Using a new imaging framework that we developed, Endrov, we have generated spatio-temporal expression profiles during embryogenesis of over 60 homeobox genes, as well as a number of other developmental control genes using GFP reporters. We used dynamic feedback during recording to automatically adjust the camera exposure time in order to increase the dynamic range beyond the limitations of the camera. We have applied the new framework to examine homeobox gene expression patterns and provide an analysis of these patterns. The methods we developed to analyze and quantify expression data are not only suitable for C. elegans, but can be applied to other model systems or even to tissue culture systems.	[Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Burglin, Thomas R.] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Novum, Sweden; [Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Burglin, Thomas R.] Karolinska Inst, Ctr Biosci, SE-14183 Novum, Sweden; [Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Burglin, Thomas R.] Sodertoms Hogskola, Sch Life Sci, Huddinge, Sweden; [Baillie, David L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Karolinska Institutet; Karolinska Institutet; Sodertorn University; Simon Fraser University	Burglin, TR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	thomas.buerglin@unibas.ch	Henriksson, Johan/ABD-2430-2021	Henriksson, Johan/0000-0002-7745-2844	Swedish Research Council [621-2010-5634]; Swedish Foundation for Strategic Research; Natural Sciences and Engineering Research, Council of Canada; Wenner-Gren Stiftelserna	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Natural Sciences and Engineering Research, Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wenner-Gren Stiftelserna	Swedish Research Council, 621-2010-5634, www.vr.se, TRB; Swedish Foundation for Strategic Research, www.stratresearch.se, TRB; Natural Sciences and Engineering Research, Council of Canada, www.nserc-crsng.gc.ca, DLB; Wenner-Gren Stiftelserna, www.swgc.org, LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdus-Saboor I, 2011, DEVELOPMENT, V138, P3545, DOI 10.1242/dev.068148; Aspock G, 2003, DEVELOPMENT, V130, P3369, DOI 10.1242/dev.00551; Aspock G, 2001, DEV DYNAM, V222, P403, DOI 10.1002/dvdy.1201; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Boyl PP, 2001, INT J DEV NEUROSCI, V19, P353, DOI 10.1016/S0736-5748(01)00003-X; Boyle TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-275; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Brunschwig K, 1999, DEVELOPMENT, V126, P1537; Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5; Burglin TR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-127; Burglin Thomas R., 1994, P25; Burglin TR, 2000, J MICROSC-OXFORD, V200, P75, DOI 10.1046/j.1365-2818.2000.00741.x; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Burglin TR, 2001, DEVELOPMENT, V128, P779; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0; BURGLIN TR, 2005, ENCY MOL CELL BIOL M, P179; Cassata G, 1998, GENE, V212, P127, DOI 10.1016/S0378-1119(98)00137-1; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chin-Sang ID, 2002, DEVELOPMENT, V129, P5499, DOI 10.1242/dev.00122; Chow RL, 2001, MECH DEVELOP, V109, P315, DOI 10.1016/S0925-4773(01)00585-8; Chowdhuri SR, 2006, DEV BIOL, V295, P664, DOI 10.1016/j.ydbio.2006.04.001; CHULAGRAFF Q, 1991, DEVELOPMENT, P79; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; De Robertis EM, 2001, INT J DEV BIOL, V45, P189; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Dozier C, 2001, DEV BIOL, V236, P289, DOI 10.1006/dbio.2001.0325; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Goriely A, 1996, DEVELOPMENT, V122, P1641; Hamahashi S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-125; Hejnol A, 2006, INTEGR COMP BIOL, V46, P151, DOI 10.1093/icb/icj012; Hench J, 2009, DEV BIOL, V333, P1, DOI 10.1016/j.ydbio.2009.06.014; Henriksson J, 2013, NAT METHODS, V10, P454, DOI 10.1038/nmeth.2478; Hobert O, 1999, TRENDS GENET, V15, P214, DOI 10.1016/S0168-9525(99)01731-X; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Kagoshima H, 1999, DEV GENES EVOL, V209, P59, DOI 10.1007/s004270050227; Kagoshima H, 2013, DEV BIOL, V380, P314, DOI 10.1016/j.ydbio.2013.04.009; Kolotuev I, 2013, NAT CELL BIOL, V15, P157, DOI 10.1038/ncb2662; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Lemaire L, 1997, DEVELOPMENT, V124, P1443; Liu J, 2000, DEVELOPMENT, V127, P5179; LUNDELL MJ, 1992, DEV BIOL, V154, P84, DOI 10.1016/0012-1606(92)90050-Q; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Mello C, 1995, METHOD CELL BIOL, V48, P451; Minguillon C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r12; Mohler WA, 1998, BIOTECHNIQUES, V24, P1006; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Murray JI, 2006, NAT PROTOC, V1, P1468, DOI 10.1038/nprot.2006.222; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Nakano S, 2010, DEVELOPMENT, V137, P4017, DOI 10.1242/dev.058834; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Peden E, 2007, GENE DEV, V21, P3195, DOI 10.1101/gad.1607807; Perez-Bercoff A, 2006, BIOINFORMATICS, V22, P112, DOI 10.1093/bioinformatics/bti761; Perez-Bercoff A, 2010, SEQUENCE GENOME ANAL, VII; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Phirke P, 2011, DEV BIOL, V357, P235, DOI 10.1016/j.ydbio.2011.06.028; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Riddle D, 1997, C ELEGANS; Rohrig S, 2000, EMBO J, V19, P3694, DOI 10.1093/emboj/19.14.3694; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schulze J, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-18; Simeone A, 2001, INT J DEV BIOL, V45, P337; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Struckhoff EC, 2003, DEVELOPMENT, V130, P693, DOI 10.1242/dev.00300; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SVENDSEN PC, 1995, DEVELOPMENT, V121, P1253; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Thomas C, 1996, SCIENCE, V273, P603, DOI 10.1126/science.273.5275.603; Thomas CF, 1998, TRENDS BIOTECHNOL, V16, P175, DOI 10.1016/S0167-7799(97)01169-4; Underhill DA, 2012, CRIT REV EUKAR GENE, V22, P161, DOI 10.1615/CritRevEukarGeneExpr.v22.i2.70; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Wittmann C, 1997, DEVELOPMENT, V124, P4193; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109; Yanowitz JL, 2004, DEV BIOL, V272, P389, DOI 10.1016/j.ydbio.2004.05.010; Yu H, 2003, DEVELOPMENT, V130, P5217, DOI 10.1242/dev.00678; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhao ZY, 2008, DEV BIOL, V314, P93, DOI 10.1016/j.ydbio.2007.11.015	104	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126947	10.1371/journal.pone.0126947	http://dx.doi.org/10.1371/journal.pone.0126947			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024448	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400026
J	Li, SJ; Jiang, H; Yang, H; Chen, W; Peng, J; Sun, MW; Lu, CD; Peng, X; Zeng, J				Li, Shi-jun; Jiang, Hua; Yang, Hao; Chen, Wei; Peng, Jin; Sun, Ming-wei; Lu, Charles Damien; Peng, Xi; Zeng, Jun			The Dilemma of Heterogeneity Tests in Meta-Analysis: A Challenge from a Simulation Study	PLOS ONE			English	Article								Introduction After several decades' development, meta-analysis has become the pillar of evidence-based medicine. However, heterogeneity is still the threat to the validity and quality of such studies. Currently, Q and its descendant I-2 (I square) tests are widely used as the tools for heterogeneity evaluation. The core mission of this kind of test is to identify data sets from similar populations and exclude those are from different populations. Although Q and I2 are used as the default tool for heterogeneity testing, the work we present here demonstrates that the robustness of these two tools is questionable. Methods and Findings We simulated a strictly normalized population S. The simulation successfully represents randomized control trial data sets, which fits perfectly with the theoretical distribution (experimental group: p = 0.37, control group: p = 0.88). And we randomly generate research samples Si that fits the population with tiny distributions. In short, these data sets are perfect and can be seen as completely homogeneous data from the exactly same population. If Q and I-2 are truly robust tools, the Q and I-2 testing results on our simulated data sets should not be positive. We then synthesized these trials by using fixed model. Pooled results indicated that the mean difference (MD) corresponds highly with the true values, and the 95% confidence interval (CI) is narrow. But, when the number of trials and sample size of trials enrolled in the meta-analysis are substantially increased; the Q and I-2 values also increase steadily. This result indicates that I-2 and Q are only suitable for testing heterogeneity amongst small sample size trials, and are not adoptable when the sample sizes and the number of trials increase substantially. Conclusions Every day, meta-analysis studies which contain flawed data analysis are emerging and passed on to clinical practitioners as "updated evidence". Using this kind of evidence that contain heterogeneous data sets leads to wrong conclusion, makes chaos in clinical practice and weakens the foundation of evidence-based medicine. We suggest more strict applications of meta-analysis: it should only be applied to those synthesized trials with small sample sizes. We call upon that the tools of evidence-based medicine should keep up-to-dated with the cutting-edge technologies in data science. Clinical research data should be made available publicly when there is any relevant article published so the research community could conduct in-depth data mining, which is a better alternative for meta-analysis in many instances.	[Li, Shi-jun; Jiang, Hua; Yang, Hao; Chen, Wei; Peng, Jin; Sun, Ming-wei; Lu, Charles Damien; Peng, Xi; Zeng, Jun] Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Dept Computat Math & Biostat, Metabol & Multidisciplinary Lab Trauma Res, Chengdu, Sichuan, Peoples R China; [Jiang, Hua; Chen, Wei] Beijing Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing, Peoples R China; [Jiang, Hua; Peng, Xi] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, Chongqing, Peoples R China	Sichuan Provincial People's Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Army Medical University	Jiang, H (corresponding author), Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp, Dept Computat Math & Biostat, Metabol & Multidisciplinary Lab Trauma Res, Chengdu, Sichuan, Peoples R China.	cdjianghua@gmail.com	Jiang, Hua/ABE-5811-2021	Jiang, Hua/0000-0003-1465-0170	Sichuan Provincial Department of Science and Technology [2014FZ0125, 15ZC0656]; Chengdu Municipality Department of Science and Technology [11PPYB099SF]; Sichuan Academy of Medical Sciences	Sichuan Provincial Department of Science and Technology; Chengdu Municipality Department of Science and Technology; Sichuan Academy of Medical Sciences	This work was partially supported by Sichuan Provincial Department of Science and Technology (to Hua Jiang, No. 2014FZ0125 and Jun Zeng, No. 15ZC0656), and Chengdu Municipality Department of Science and Technology (to Hua Jiang, No. 11PPYB099SF) and Sichuan Academy of Medical Sciences (to Hao Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borenstein M, 2009, INTRO METAANALYSIS, P79; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kabacoff R, 2011, R ACTION DATA ANAL G, P158; Kulinskaya E, 2008, METAANALYSIS GUIDE C, P209; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Schwarzer G, 2014, META METAANALYSIS R	6	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127538	10.1371/journal.pone.0127538	http://dx.doi.org/10.1371/journal.pone.0127538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023932	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400041
J	Porter, AG; Scanes, PR				Porter, Augustine G.; Scanes, Peter R.			Scavenging Rate Ecoassay: A Potential Indicator of Estuary Condition	PLOS ONE			English	Article							CONSUMPTION	Monitoring of estuary condition is essential due to the highly productive and often intensely impacted nature of these ecosystems. Assessment of the physico-chemical condition of estuaries is expensive and difficult due to naturally fluctuating water quality and biota. Assessing the vigour of ecosystem processes is an alternative method with potential to overcome much of the variability associated with physico-chemical measures. Indicators of estuary condition should have small spatial and temporal variability, have a predictable response to perturbation and be ecologically relevant. Here, we present tests of the first criterion, the spatio-temporal variability of a potential ecoassay measuring the rate of scavenging in estuaries. We hypothesised that the proposed scavenging ecoassay would not vary significantly among A) sites in an estuary, B) trips separated by weeks, or C) days in a trip. Because not all habitats are present in all estuaries, this test was undertaken in two habitats. When conducted over bare substrate there were occasional significant differences, but no discernible patterns, within levels of the experiment. When conducted over vegetated substrate, days within a trip did not vary significantly, but later trips experienced greater scavenging. This scavenging ecoassay shows potential as a tool for assessing the condition of estuarine ecosystems, and further exploration of this protocol is warranted by implementation in estuaries across a gradient of anthropogenic stress.	[Porter, Augustine G.] Univ Sydney, Coastal & Marine Ecosyst Grp, Sydney, NSW 2006, Australia; [Porter, Augustine G.; Scanes, Peter R.] Off Environm & Heritage, Estuary & Catchment Sci, Sydney, NSW, Australia	University of Sydney; Office of Environment & Heritage - New South Wales	Porter, AG (corresponding author), Univ Sydney, Coastal & Marine Ecosyst Grp, Sydney, NSW 2006, Australia.	augustine.porter@sydney.edu.au		Scanes, Peter/0000-0002-6722-168X	NSW Office of Environment and Heritage	NSW Office of Environment and Heritage	This work was funded by NSW Office of Environment and Heritage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Basset A, 2013, ESTUAR COAST SHELF S, V132, P5, DOI 10.1016/j.ecss.2012.04.012; Biro PA, 2009, HYDROBIOLOGIA, V635, P395, DOI 10.1007/s10750-009-9902-x; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CROY MI, 1991, ANIM BEHAV, V41, P161, DOI 10.1016/S0003-3472(05)80511-1; Dafforn KA, 2012, ENVIRON POLLUT, V163, P207, DOI 10.1016/j.envpol.2011.12.029; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; Deeley D.M., 1999, ASSESSING ECOLOGICAL; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Fairweather PG, 1999, AUST J ECOL, V24, P441, DOI 10.1046/j.1442-9993.1999.00976.x; Fausch Kurt D., 1990, P123; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; Huijbers CM, 2015, DIVERS DISTRIB, V21, P55, DOI 10.1111/ddi.12282; Huijbers CM, 2013, LANDSCAPE URBAN PLAN, V119, P1, DOI 10.1016/j.landurbplan.2013.06.004; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Mayer-Pinto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047871; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; OEH N., 2013, ASS EST EC HLTH SAMP; Paxton JR, 1989, ZOOLOGICAL CATALOGUE, V7; Perez-Dominguez R, 2012, ECOL INDIC, V23, P34, DOI 10.1016/j.ecolind.2012.03.006; Putman R.J., 1983, CARRION DUNG DECOMPO; Ramsay K, 1997, J ANIM ECOL, V66, P884, DOI 10.2307/6004; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Scanes P., 2010, ECOLOGICAL CONDITION; Scanes P, 2007, ESTUAR COAST SHELF S, V74, P306, DOI 10.1016/j.ecss.2007.04.021; Sheaves M, 2007, ASSESSMENT TECHNIQUE; Sheaves M, 2013, ESTUAR COAST, V36, P893, DOI 10.1007/s12237-013-9610-7; Sokal R.R., 2012, BIOMETRY; Underwood, 1996, EXPT ECOLOGY THEIR L; Underwood A.J., 2002, GMAV 5 WINDOWS ANAL; VonTorne E, 1990, ASSESSING FEEDING AC, VI; Ward T., 1998, ESTUARIES SEA; Ward TJ, 2000, MAR FRESHWATER RES, V51, P435, DOI 10.1071/MF99052; Webley JA, 2008, ECOLOGY MUD CRAB SCY; Whitfield A, 2008, ECOLOGICAL INDICATOR, P1593, DOI DOI 10.1016/B978; Whitfield AK, 2002, J FISH BIOL, V61, P229, DOI 10.1006/jfbi.2002.2079; Williams R, 2007, NSW COMPREHENSIVE CO, V1005, P64; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	43	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127046	10.1371/journal.pone.0127046	http://dx.doi.org/10.1371/journal.pone.0127046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024225	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400030
J	Sovadinova, I; Babica, P; Boke, H; Kumar, E; Wilke, A; Park, JS; Trosko, JE; Upham, BL				Sovadinova, Iva; Babica, Pavel; Boeke, Hatice; Kumar, Esha; Wilke, Andrew; Park, Joon-Suk; Trosko, James E.; Upham, Brad L.			Phosphatidylcholine Specific PLC-Induced Dysregulation of Gap Junctions, a Robust Cellular Response to Environmental Toxicants, and Prevention by Resveratrol in a Rat Liver Cell Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; POLYCYCLIC AROMATIC-HYDROCARBONS; INTERCELLULAR COMMUNICATION; CONNEXIN43 PHOSPHORYLATION; PHOSPHOLIPASE-C; GROWTH-FACTOR; MAP-KINASE; STEM-CELLS; EPIGENETIC TOXICITY; ARACHIDONIC-ACID	Dysregulation of gap junctional intercellular communication (GJIC) has been associated with different pathologies, including cancer; however, molecular mechanisms regulating GJIC are not fully understood. Mitogen Activated Protein Kinase (MAPK)-dependent mechanisms of GJIC-dysregulation have been well-established, however recent discoveries have implicated phosphatidylcholine-specific phospholipase C (PC-PLC) in the regulation of GJIC. What is not known is how prevalent these two signaling mechanisms are in toxicant/toxin-induced dysregulation of GJIC, and do toxicants/toxins work through either signaling mechanisms or both, or through alternative signaling mechanisms. Different chemical toxicants were used to assess whether they dysregulate GJIC via MEK or PC-PLC, or both Mek and PC-PLC, or through other signaling pathways, using a pluripotent rat liver epithelial oval-cell line, WB-F344. Epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, thrombin receptor activating peptide-6 and lindane regulated GJIC through a MEK1/2-dependent mechanism that was independent of PC-PLC; whereas PAHs, DDT, PCB 153, dicumylperoxide and perfluorodecanoic acid inhibited GJIC through PC-PLC independent of Mek. Dysregulation of GJIC by perfluorooctanoic acid and R59022 required both MEK1/2 and PC-PLC; while benzoylperoxide, arachidonic acid, 18 beta-glycyrrhetinic acid, perfluorooctane sulfonic acid, 1-monolaurin, pentachlorophenol and alachlor required neither MEK1/2 nor PC-PLC. Resveratrol prevented dysregulation of GJIC by toxicants that acted either through MEK1/2 or PC-PLC. Except for alachlor, resveratrol did not prevent dysregulation of GJIC by toxicants that worked through PC-PLC-independent and MEK1/2-independent pathways, which indicated at least two other, yet unidentified, pathways that are involved in the regulation of GJIC. In conclusion: the dysregulation of GJIC is a contributing factor to the cancer process; however the underlying mechanisms by which gap junction channels are closed by toxicants vary. Thus, accurate assessments of risk posed by toxic agents, and the role of dietary phytochemicals play in preventing or reversing the effects of these agents must take into account the specific mechanisms involved in the cancer process.	[Sovadinova, Iva; Babica, Pavel; Boeke, Hatice; Kumar, Esha; Wilke, Andrew; Park, Joon-Suk; Trosko, James E.; Upham, Brad L.] Michigan State Univ, Ctr Integrat Toxicol, Dept Pediat & Human Devel, E Lansing, MI 48824 USA; [Sovadinova, Iva; Babica, Pavel; Boeke, Hatice; Kumar, Esha; Wilke, Andrew; Park, Joon-Suk; Trosko, James E.; Upham, Brad L.] Michigan State Univ, Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA; [Sovadinova, Iva] Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, CZ-62500 Brno, Czech Republic; [Babica, Pavel] ASCR, Inst Bot, Dept Expt Phycol & Ecotoxicol, CZ-60200 Brno, Czech Republic; [Park, Joon-Suk] Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Taegu, South Korea	Michigan State University; Michigan State University; Masaryk University Brno; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Upham, BL (corresponding author), Michigan State Univ, Ctr Integrat Toxicol, Dept Pediat & Human Devel, E Lansing, MI 48824 USA.	upham@msu.edu	Babica, Pavel/B-2587-2013; Babica, Pavel/GWC-6437-2022; Sovadinova, Iva/F-6251-2015; Trosko, James/J-5954-2019	Babica, Pavel/0000-0001-6399-3554; Sovadinova, Iva/0000-0003-0627-243X; Upham, Brad/0000-0003-4905-9145	National Institute of Environmental Health Sciences [R01 ES013268-01A2]; Czech Ministry of Youth, Education and Sports [LH12034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013268] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Czech Ministry of Youth, Education and Sports(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work received financial support from National Institute of Environmental Health Sciences (https://www.niehs.nih.gov/) grants #R01 ES013268-01A2 to BLU and this paper's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS. This work also received support from Czech Ministry of Youth, Education and Sports (http://www.msmt.cz/?lang=2) grant #LH12034 "CHEMOPREV" to PB.	Blaha L, 2002, TOXICOL SCI, V65, P43, DOI 10.1093/toxsci/65.1.43; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cheng J, 1997, J BIOL CHEM, V272, P17312, DOI 10.1074/jbc.272.28.17312; Chipman JK, 2003, TOXICOL SCI, V71, P146, DOI 10.1093/toxsci/71.2.146; COLEMAN WB, 1993, AM J PATHOL, V142, P1373; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Ghoshal S, 1999, ENVIRON SCI TECHNOL, V33, P1044, DOI 10.1021/es9809511; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Guan XJ, 1996, CARCINOGENESIS, V17, P1791, DOI 10.1093/carcin/17.9.1791; Guan XJ, 1996, MOL CARCINOGEN, V16, P157; Han EH, 2008, TOXICOL APPL PHARM, V233, P333, DOI 10.1016/j.taap.2008.09.003; Hossain MZ, 1999, J CELL PHYSIOL, V179, P87, DOI 10.1002/(SICI)1097-4652(199904)179:1<87::AID-JCP11>3.0.CO;2-K; Kim JH, 2009, MUTAT RES-FUND MOL M, V671, P40, DOI 10.1016/j.mrfmmm.2009.08.011; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Liu X, 2006, ENDOTHELIUM-J ENDOTH, V13, P205, DOI 10.1080/10623320600760423; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Machala M, 2003, TOXICOL SCI, V76, P102, DOI 10.1093/toxsci/kfg209; Malouf NN, 2001, AM J PATHOL, V158, P1929, DOI 10.1016/S0002-9440(10)64661-5; Martinez AD, 1999, BRAIN RES, V816, P411, DOI 10.1016/S0006-8993(98)01016-6; Matowe WC, 1996, PHARMACOLOGY, V53, P376, DOI 10.1159/000139453; Mehta PP, 2007, J MEMBRANE BIOL, V217, P5, DOI 10.1007/s00232-007-9068-2; Mograbi B, 2003, CARCINOGENESIS, V24, P1415, DOI 10.1093/carcin/bgg093; Nielsen M, 2000, BIOCHEM BIOPH RES CO, V275, P804, DOI 10.1006/bbrc.2000.3378; Ogawa T, 2004, J CELL SCI, V117, P2087, DOI 10.1242/jcs.01056; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; RAO GN, 1994, J BIOL CHEM, V269, P32586; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Rivedal E, 2005, EXP CELL RES, V302, P143, DOI 10.1016/j.yexcr.2004.09.004; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Rummel AM, 1999, TOXICOL SCI, V49, P232, DOI 10.1093/toxsci/49.2.232; Sai K, 1998, CANCER LETT, V130, P9, DOI 10.1016/S0304-3835(98)00082-2; Sirnes S, 2009, BIOCHEM BIOPH RES CO, V382, P41, DOI 10.1016/j.bbrc.2009.02.141; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Trosko JE, 2009, VET PATHOL, V46, P176, DOI 10.1354/vp.46-2-176; Trosko JE, 2005, MUTAGENESIS, V20, P81, DOI 10.1093/mutage/gei017; Trosko JE, 2002, CURR DRUG TARGETS, V3, P465, DOI 10.2174/1389450023347371; TROSKO JE, 2008, STEM CELLS CANC; Trosko JE, 2002, COMPREHENSIVE TOXICO, Vxiv, P409; TROSKO JE, 2002, BIOMARKERS ENV ASS D, P445; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Upham BL, 1997, OZONE-SCI ENG, V19, P351, DOI 10.1080/01919519708547298; Upham BL, 1998, INT J CANCER, V78, P491, DOI 10.1002/(SICI)1097-0215(19981109)78:4<491::AID-IJC16>3.0.CO;2-9; Upham BL, 1998, ENVIRON HEALTH PERSP, V106, P975, DOI 10.2307/3434140; Upham BL, 1996, FUND APPL TOXICOL, V34, P260, DOI 10.1006/faat.1996.0195; Upham BL, 2008, CANCER SCI, V99, P696, DOI 10.1111/j.1349-7006.2008.00752.x; Upham BL, 2007, NUTR CANCER, V57, P38, DOI 10.1080/01635580701268188; Upham BL, 2009, ENVIRON HEALTH PERSP, V117, P545, DOI 10.1289/ehp.11728; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Vinken M, 2009, CRIT REV BIOCHEM MOL, V44, P201, DOI 10.1080/10409230903061215; Wang N, 2008, INT J BIOCHEM CELL B, V40, P294, DOI 10.1016/j.biocel.2007.08.003; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; Weis LM, 1998, ENVIRON HEALTH PERSP, V106, P17, DOI 10.1289/ehp.9810617; Yamasaki H, 1999, CANCER DETECT PREV, V23, P273, DOI 10.1046/j.1525-1500.1999.99037.x	58	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0124454	10.1371/journal.pone.0124454	http://dx.doi.org/10.1371/journal.pone.0124454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023933	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400005
J	Tachtatzis, PM; Marshall, A; Aravinthan, A; Verma, S; Penrhyn-Lowe, S; Mela, M; Scarpini, C; Davies, SE; Coleman, N; Alexander, GJM				Tachtatzis, Phaedra M.; Marshall, Aileen; Aravinthan, Aloysius; Verma, Suman; Penrhyn-Lowe, Sue; Mela, Marianna; Scarpini, Cinzia; Davies, Susan E.; Coleman, Nicholas; Alexander, Graeme J. M.			Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis	PLOS ONE			English	Article							NATURAL-HISTORY; ARREST; CELLS; AGE	Background Chronic Hepatitis B virus (HBV) infection can lead to the development of chronic hepatitis, cirrhosis and hepatocellular carcinoma. We hypothesized that HBV might accelerate hepatocyte ageing and investigated the effect of HBV on hepatocyte cell cycle state and biological age. We also investigated the relation between inflammation, fibrosis and cell cycle phase. Methods Liver samples from patients with chronic HBV (n = 91), normal liver (n = 55) and regenerating liver (n = 15) were studied. Immunohistochemistry for cell cycle phase markers and HBV antigens was used to determine host cell cycle phase. Hepatocyte-specific telomere length was evaluated by quantitative fluorescent in-situ hybridization (Q-FISH) in conjunction with hepatocyte nuclear area and HBV antigen expression. The effects of induced cell cycle arrest and induced cellular senescence on HBV production were assessed in vitro. Results 13.7% hepatocytes in chronic HBV had entered cell cycle, but expression of markers for S, G2 and M phase was low compared with regenerating liver. Hepatocyte p21 expression was increased (10.9%) in chronic HBV and correlated with liver fibrosis. Mean telomere length was reduced in chronic HBV compared to normal. However, within HBV-affected livers, hepatocytes expressing HBV antigens had longer telomeres. Telomere length declined and hepatocyte nuclear size increased as HBV core antigen (HBcAg) expression shifted from the nucleus to cytoplasm. Nuclear co-expression of HBcAg and p21 was not observed. Cell cycle arrest induced in vitro was associated with increased HBV production, in contrast to in vitroinduction of cellular senescence, which had no effect. Conclusion Chronic HBV infection was associated with hepatocyte G1 cell cycle arrest and accelerated hepatocyte ageing, implying that HBV induced cellular senescence. However, HBV replication was confined to biologically younger hepatocytes. Changes in the cellular location of HBcAg may be related to the onset of cellular senescence.	[Tachtatzis, Phaedra M.] St James Univ Hosp, Dept Hepatol, Leeds, W Yorkshire, England; [Marshall, Aileen] Royal Free Hosp, Dept Hepatol, London NW3 2QG, England; [Aravinthan, Aloysius; Mela, Marianna; Alexander, Graeme J. M.] Univ Cambridge, Div Gastroenterol & Hepatol, Cambridge, England; [Verma, Suman] Kings Coll Hosp London, Inst Liver Studies, London, England; [Penrhyn-Lowe, Sue] Univ Cambridge, Hutchison MRC Res Ctr, Cambridge, England; [Scarpini, Cinzia; Coleman, Nicholas] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Davies, Susan E.] Univ Cambridge, Pancreat Canc Ctr, Cambridge, England	Saint James's University Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Cambridge; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Cambridge; University of Cambridge; University of Cambridge	Tachtatzis, PM (corresponding author), St James Univ Hosp, Dept Hepatol, Leeds, W Yorkshire, England.	p.tachtatzis@nhs.net	Aravinthan, Aloysious D/I-2557-2019	Aravinthan, Aloysious D/0000-0003-0527-5137; Scarpini, Cinzia G./0000-0003-4730-5197	Hepatology Endowment Fund, Addenbrooke's Hospital, Cambridge; Addenbrooke's Hospital NHS Trust; Cancer Research UK [13080] Funding Source: researchfish	Hepatology Endowment Fund, Addenbrooke's Hospital, Cambridge; Addenbrooke's Hospital NHS Trust; Cancer Research UK(Cancer Research UK)	This study received funding for all laboratory costs from the Hepatology Endowment Fund, Addenbrooke's Hospital, Cambridge. The salary of PMT was paid by Addenbrooke's Hospital NHS Trust.	Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904; Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031; Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641; BARNABA V, 1990, NATURE, V345, P258, DOI 10.1038/345258a0; Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269; Borel F, 2002, J CELL SCI, V115, P2829; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590; FERRARI C, 1986, CLIN EXP IMMUNOL, V66, P497; Huang Yan-Qing, 2004, Hepatobiliary Pancreat Dis Int, V3, P543; JUNG MC, 1991, J HEPATOL, V13, P310, DOI 10.1016/0168-8278(91)90074-L; Kao JiaHorng, 2006, Current Hepatitis Reports, V5, P5, DOI 10.1007/s11901-006-0017-9; Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; NAOUMOV N V, 1990, Gastroenterology, V99, P1248; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; WU PC, 1993, AM J CLIN PATHOL, V100, P648, DOI 10.1093/ajcp/100.6.648; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956	21	27	30	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127511	10.1371/journal.pone.0127511	http://dx.doi.org/10.1371/journal.pone.0127511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024529	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400039
J	Taujale, R; Yin, YB				Taujale, Rahil; Yin, Yanbin			Glycosyltransferase Family 43 Is Also Found in Early Eukaryotes and Has Three Subfamilies in Charophycean Green Algae	PLOS ONE			English	Article							GLUCURONOXYLAN BIOSYNTHESIS; LAND PLANTS; EVOLUTION; REVEALS; GENE; EXPRESSION; SEQUENCE; IRREGULAR-XYLEM9; MECHANISMS; DIVERSITY	The glycosyltransferase family 43 (GT43) has been suggested to be involved in the synthesis of xylans in plant cell walls and proteoglycans in animals. Very recently GT43 family was also found in Charophycean green algae (CGA), the closest relatives of extant land plants. Here we present evidence that non-plant and non-animal early eukaryotes such as fungi, Haptophyceae, Choanoflagellida, Ichthyosporea and Haptophyceae also have GT43-like genes, which are phylogenetically close to animal GT43 genes. By mining RNA sequencing data (RNA-Seq) of selected plants, we showed that CGA have evolved three major groups of GT43 genes, one orthologous to IRX14 (IRREGULAR XYLEM14), one orthologous to IRX9/IRX9L and the third one ancestral to all land plant GT43 genes. We confirmed that land plant GT43 has two major clades A and B, while in angiosperms, clade A further evolved into three subclades and the expression and motif pattern of A3 (containing IRX9) are fairly different from the other two clades likely due to rapid evolution. Our in-depth sequence analysis contributed to our overall understanding of the early evolution of GT43 family and could serve as an example for the study of other plant cell wall-related enzyme families.	[Taujale, Rahil; Yin, Yanbin] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Northern Illinois University	Yin, YB (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	yyin@niu.edu	Yin, Yanbin/AAH-2665-2020; Yin, Yanbin/C-9788-2010	Yin, Yanbin/0000-0001-7667-881X; Yin, Yanbin/0000-0001-7667-881X	Northern Illinois University	Northern Illinois University	This work was supported by the start-up funds and the research & artistry award to YY from Northern Illinois University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders N, 2010, ANN PLANT REV PLANT, V41, P251; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fangel JU, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00152; Fondeur-Gelinotte M, 2007, GLYCOBIOLOGY, V17, P857, DOI 10.1093/glycob/cwm055; Fondeur-Gelinotte M, 2006, PROTEIN SCI, V15, P1667, DOI 10.1110/ps.062089106; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harholt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035846; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Jia SG, 2013, ENVIRON MICROBIOL, V15, P3020, DOI 10.1111/1462-2920.12262; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kulkarni AR, 2012, GLYCOBIOLOGY, V22, P439, DOI 10.1093/glycob/cwr117; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Lee C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27809; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mikkelsen MD, 2014, ANN BOT-LONDON, V114, P1217, DOI 10.1093/aob/mcu171; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Ratke C, 2015, PLANT BIOTECHNOL J, V13, P26, DOI 10.1111/pbi.12232; Ren YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105014; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Yin YB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-260; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zeng W, 2010, PLANT PHYSIOL, V154, P78, DOI 10.1104/pp.110.159749; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104	47	9	10	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128409	10.1371/journal.pone.0128409	http://dx.doi.org/10.1371/journal.pone.0128409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023931	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400089
J	Lapadula, G; Chatenoud, L; Gori, A; Castelli, F; Di Giambenedetto, S; Fabbiani, M; Maggiolo, F; Foca, E; Ladisa, N; Sighinolfi, L; Di Pietro, M; Pan, A; Torti, C				Lapadula, Giuseppe; Chatenoud, Liliane; Gori, Andrea; Castelli, Francesco; Di Giambenedetto, Simona; Fabbiani, Massimiliano; Maggiolo, Franco; Foca, Emanuele; Ladisa, Nicoletta; Sighinolfi, Laura; Di Pietro, Massimo; Pan, Angelo; Torti, Carlo		Italian MASTER Cohort	Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+T-Cell Counts >200+/mu l Despite Effective HAART	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; T-CELL RECOVERY; VIROLOGICAL SUPPRESSION; HIV-1-INFECTED PATIENTS; IMMUNOLOGICAL RESPONSE; INCREASED MORTALITY; VIRAL SUPPRESSION; DEFINING EVENTS; NAIVE PATIENTS	Background Immunological non-response (INR) despite virological suppression is associated with AIDS-defining events/death (ADE). Little is known about its association with serious non-AIDS-defining events (nADE). Methods Patients highly-active antiretroviral therapy (HAART) with <200 CD4+/mu l and achieving HIV-RNA <50 copies/ml within 12 (+/- 3) months were categorized as INR if CD4+ T-cell count at year 1 was <200/mu l. Predictors of nADE (malignancies, severe infections, renal failure-ie, estimated glomerular filtration rate <30 ml/min, cardiovascular events and liver decompensation) were assessed using multivariable Cox models. Follow-up was right-censored in case of HAART discontinuation or confirmed HIV-RNA>50. Results 1221 patients were observed for a median of 3 (IQR: 1.3-6.1) years. Pre-HAART CD4+ were 77/mu l (IQR: 28-142) and 56% of patients had experienced an ADE. After 1 year, CD4+ increased to 286 (IQR: 197-387), but 26.1% of patients were INR. Thereafter, 86 nADE (30.2% malignancies, 27.9% infectious, 17.4% renal, 17.4% cardiovascular, 7% hepatic) were observed, accounting for an incidence of 1.83 events (95% CI: 1.73-2.61) per 100 PYFU. After adjusting for measurable confounders, INR had a significantly greater risk of nADE (HR 1.65; 95% CI: 1.06-2.56). Older age (per year, HR 1.03; 95% CI: 1.01-1.05), hepatitis C co-infection (HR 2.09; 95% CI: 1.19-3.7), a history of previous nADE (HR 2.16; 95% CI: 1.06-4.4) and the occurrence of ADE during the follow-up (HR 2.2; 95% CI: 1.15-4.21) were other independent predictors of newly diagnosed nADE. Conclusions Patients failing to restore CD4+ to >200 cells/mu l run a greater risk of serious nADE, which is intertwined or predicted by AIDS progression. Improved management of this fragile population and innovative therapy able to induce immune-reconstitution are urgently needed. Also, our results strengthen the importance of earlier diagnosis and HAART introduction.	[Lapadula, Giuseppe; Gori, Andrea] San Gerardo de Tintori Hosp, Clin Infect Dis, Monza, Italy; [Chatenoud, Liliane] IRCCS, Ist Ric Farmacol Mario Negri, Milan, Italy; [Castelli, Francesco; Foca, Emanuele; Torti, Carlo] Univ Brescia, Univ Div Infect & Trop Dis, Brescia, Italy; [Di Giambenedetto, Simona; Fabbiani, Massimiliano] Sacro Cuore Catholic Univ Rome, Clin Infect Dis, Rome, Italy; [Foca, Emanuele] Osped Riuniti Bergamo, Clin Infect Dis, I-24100 Bergamo, Italy; [Ladisa, Nicoletta] Osped Policlin, Clin Infect Dis, Bari, Italy; [Sighinolfi, Laura] Osped St Anna, Clin Infect Dis, Ferrara, Italy; [Di Pietro, Massimo] Osped SM Annunziata, Clin Infect Dis, Florence, Italy; [Pan, Angelo] Ist Ospitalieri, Clin Infect Dis, Cremona, Italy; [Torti, Carlo] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Infect Dis Unit, Catanzaro, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Brescia; Catholic University of the Sacred Heart; Ospedali Riuniti di Bergamo; University of Ferrara; Arcispedale Sant'Anna; Magna Graecia University of Catanzaro	Lapadula, G (corresponding author), San Gerardo de Tintori Hosp, Clin Infect Dis, Monza, Italy.	g.lapadula@hsgerardo.org	Chatenoud, Liliane/AAA-6377-2020; Gori, Andrea/AAC-6078-2022; Maggi, Paolo/K-6598-2016; Lapadula, Giuseppe/J-5163-2012; digiambenedetto, simona/AAL-4429-2020; Fabbiani, Massimiliano/K-8842-2016; Colafigli, Manuela/K-5167-2018; Sighinolfi, Laura/AAH-1426-2020; QUIROS ROLDAN, Maria Eugenia/K-7586-2015	Chatenoud, Liliane/0000-0001-9599-8229; Maggi, Paolo/0000-0002-0482-4969; Fabbiani, Massimiliano/0000-0002-1343-812X; Colafigli, Manuela/0000-0003-1610-6347; Puoti, Massimo/0000-0003-3278-7138; FOCA', Emanuele/0000-0003-4395-5379; MONNO, Laura/0000-0002-2713-4258; QUIROS ROLDAN, Maria Eugenia/0000-0003-1452-9100; ANGARANO, Gioacchino/0000-0003-3207-7523; Castelli, Francesco/0000-0001-9161-7804; CAUDA, Roberto/0000-0002-1498-4229; LAPADULA, Giuseppe/0000-0002-9976-8102	Infectious Diseases and International Health (MISI) Fundation, Brescia, Italy	Infectious Diseases and International Health (MISI) Fundation, Brescia, Italy	This work and the Italian MASTER cohort were sponsored by the Infectious Diseases and International Health (MISI) Fundation, Brescia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2014, JAMA PEDIATR, V168, P381, DOI 10.1001/jamapediatrics.2013.4531; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Butt AA, 2009, CLIN INFECT DIS, V49, P225, DOI 10.1086/599371; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Engsig FN, 2014, CLIN INFECT DIS; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lapadula G, 2013, AIDS, V27, P769, DOI 10.1097/QAD.0b013e32835cb747; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Loutfy MR, 2010, JAIDS-J ACQ IMM DEF, V55, P451, DOI 10.1097/QAI.0b013e3181ec28ff; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Marimoutou C, 2001, J ACQ IMMUN DEF SYND, V27, P161, DOI 10.1097/00126334-200106010-00011; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Moore DM, 2009, JAIDS-J ACQ IMM DEF, V52, P357, DOI 10.1097/QAI.0b013e3181b62933; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Ndiaye B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-11; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Peters L, 2009, JAIDS-J ACQ IMM DEF, V50, P457, DOI 10.1097/QAI.0b013e318198a0e1; Potter M, 2010, AIDS, V24, P1857, DOI 10.1097/QAD.0b013e32833adbb5; Sighinolfi L, 2008, INFECTION, V36, P244, DOI 10.1007/s15010-007-7227-0; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Torti C, 2007, HIV CLIN TRIALS, V8, P112, DOI 10.1310/hct0803-112; van Lelyveld SFL, 2012, AIDS, V26, P465, DOI 10.1097/QAD.0b013e32834f32f8; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Wilson KD, 2014, AIDS CARE, P1, DOI DOI 10.1080/09540121.2014.946384; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055; Zoufaly A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087160	39	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124741	10.1371/journal.pone.0124741	http://dx.doi.org/10.1371/journal.pone.0124741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020949	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300009
J	Ivaska, L; Niemela, J; Leino, P; Mertsola, J; Peltola, V				Ivaska, Lauri; Niemela, Jussi; Leino, Pia; Mertsola, Jussi; Peltola, Ville			Accuracy and Feasibility of Point-Of-Care White Blood Cell Count and C-Reactive Protein Measurements at the Pediatric Emergency Department	PLOS ONE			English	Article							FEBRILE CHILDREN; TESTS	Background Several point-of-care (POC) tests are available for evaluation of febrile patients, but the data about their performance in acute care setting is sparse. We investigated the analytical accuracy and feasibility of POC tests for white blood cell (WBC) count and C-reactive protein (CRP) at the pediatric emergency department (ED). Methods In the first part of the study, HemoCue WBC and Afinion AS100 CRP POC analyzers were compared with laboratory's routine WBC (Sysmex XE-2100) and CRP (Modular P) analyzers in the hospital central laboratory in 77 and 48 clinical blood samples, respectively. The POC tests were then adopted in use at the pediatric ED. In the second part of the study, we compared WBC and CRP levels measured by POC and routine methods during 171 ED patient visits by 168 febrile children and adolescents. Attending physicians performed POC tests in capillary fingerprick samples. Results In parallel measurements in the laboratory both WBC and CRP POC analyzers showed good agreement with the reference methods. In febrile children at the emergency department (median age 2.4 years), physician performed POC determinations in capillary blood gave comparable results with those in venous blood analyzed in the laboratory. The mean difference between POC and reference test result was 1.1 E9/L (95% limits of agreement from -6.5 to 8.8 E9/L) for WBC and -1.2 mg/L (95% limits of agreement from -29.6 to 27.2 mg/L) for CRP. Conclusions POC tests are feasible and relatively accurate methods to assess CRP level and WBC count among febrile children at the ED.	[Ivaska, Lauri; Niemela, Jussi; Mertsola, Jussi; Peltola, Ville] Turku Univ Hosp, Dept Paediat & Adolescent Med, FIN-20520 Turku, Finland; [Ivaska, Lauri; Peltola, Ville] Univ Turku, Dept Paediat & Adolescent Med, Turku, Finland; [Niemela, Jussi] Univ Turku, MediCity Res Lab, Turku, Finland; [Leino, Pia] Turku Univ Hosp, Tykslab, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Ivaska, L (corresponding author), Turku Univ Hosp, Dept Paediat & Adolescent Med, FIN-20520 Turku, Finland.	lauri.ivaska@utu.fi	Mertsola, Jussi/AAE-3460-2021	Ivaska, Lauri/0000-0001-8935-5032	Academy of Finland [277535]; Research Funds from Specified Government Transfers; Combined Research Grant of Turku University; Turku University Foundation; Finnish Medical Foundation; University of Turku Graduate School	Academy of Finland(Academy of Finland); Research Funds from Specified Government Transfers; Combined Research Grant of Turku University; Turku University Foundation; Finnish Medical Foundation; University of Turku Graduate School	This study was supported by the Academy of Finland (Grant no. 277535), Research Funds from Specified Government Transfers, Combined Research Grant of Turku University, Turku University Foundation, the Finnish Medical Foundation and University of Turku Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Casey JR, 2009, CLIN PEDIATR, V48, P291, DOI 10.1177/0009922808327106; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; de Kruif MD, 2010, J INFECTION, V60, P122, DOI 10.1016/j.jinf.2009.11.010; Di Serio F, 2003, CLIN CHIM ACTA, V333, P185, DOI 10.1016/S0009-8981(03)00184-0; Di Somma S, 2013, CLIN CHEM LAB MED, V51, P1167, DOI 10.1515/cclm-2012-0795; Doan Q, 2014, CAN J EMERG MED, V16, P405, DOI 10.2310/8000.2013.131280; Esposito S, 2005, CLIN CHEM LAB MED, V43, P438, DOI 10.1515/CCLM.2005.077; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hill CE, 2014, LABMEDICINE, V45, pE109, DOI 10.1309/LMTMW3VVN20HIFS; Hollis VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043702; Hsiao AL, 2007, PEDIATR EMERG CARE, V23, P457, DOI 10.1097/01.pec.0000280506.44924.de; Ivaska L, 2013, J CLIN VIROL, V57, P136, DOI 10.1016/j.jcv.2013.02.011; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kokko E, 2014, PEDIATR INT, V56, P698, DOI 10.1111/ped.12353; Korppi M, 1997, EUR RESPIR J, V10, P1125, DOI 10.1183/09031936.97.10051125; Kotani K, 2014, CLIN CHIM ACTA, V433, P145, DOI 10.1016/j.cca.2014.03.004; Monteny M, 2006, CLIN CHEM LAB MED, V44, P1428, DOI 10.1515/CCLM.2006.270; Mullins PM, 2014, AM J EMERG MED, V32, P634, DOI 10.1016/j.ajem.2014.02.008; Mumma BE, 2014, ACAD EMERG MED, V21, P504, DOI 10.1111/acem.12366; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Osei-Bimpong A, 2009, INT J LAB HEMATOL, V31, P657, DOI 10.1111/j.1751-553X.2008.01093.x; PADMANABHAN J, 1973, JOHNS HOPKINS MED J, V132, P146; Peltola V, 2006, J PEDIATR-US, V149, P721, DOI 10.1016/j.jpeds.2006.08.051; Pfafflin A, 2009, ANAL BIOANAL CHEM, V393, P1473, DOI 10.1007/s00216-008-2561-3; Rasooly IR, 2014, PEDIATR EMERG CARE, V30, P602, DOI 10.1097/PEC.0000000000000204; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Verbakel JY, 2014, J CLIN PATHOL, V67, P83, DOI 10.1136/jclinpath-2013-201654	28	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129920	10.1371/journal.pone.0129920	http://dx.doi.org/10.1371/journal.pone.0129920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034987	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100075
J	Petit, E; Coppi, MV; Hayes, JC; Tolonen, AC; Warnick, T; Latouf, WG; Amisano, D; Biddle, A; Mukherjee, S; Ivanova, N; Lykidis, A; Land, M; Hauser, L; Kyrpides, N; Henrissat, B; Lau, J; Schnell, DJ; Church, GM; Leschine, SB; Blanchard, JL				Petit, Elsa; Coppi, Maddalena V.; Hayes, James C.; Tolonen, Andrew C.; Warnick, Thomas; Latouf, William G.; Amisano, Danielle; Biddle, Amy; Mukherjee, Supratim; Ivanova, Natalia; Lykidis, Athanassios; Land, Miriam; Hauser, Loren; Kyrpides, Nikos; Henrissat, Bernard; Lau, Joanne; Schnell, Danny J.; Church, George M.; Leschine, Susan B.; Blanchard, Jeffrey L.			Genome and Transcriptome of Clostridium phytofermentans, Catalyst for the Direct Conversion of Plant Feedstocks to Fuels	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; GENE-EXPRESSION; FAMILY; IDENTIFICATION; CELLULOSE; ETHANOL; KEGG; ENDOGLUCANASE; FERREDOXIN; RESOURCE	Clostridium phytofermentans was isolated from forest soil and is distinguished by its capacity to directly ferment plant cell wall polysaccharides into ethanol as the primary product, suggesting that it possesses unusual catabolic pathways. The objective of the present study was to understand the molecular mechanisms of biomass conversion to ethanol in a single organism, Clostridium phytofermentans, by analyzing its complete genome and transcriptome during growth on plant carbohydrates. The saccharolytic versatility of C. phytofermentans is reflected in a diversity of genes encoding ATP-binding cassette sugar transporters and glycoside hydrolases, many of which may have been acquired through horizontal gene transfer. These genes are frequently organized as operons that may be controlled individually by the many transcriptional regulators identified in the genome. Preferential ethanol production may be due to high levels of expression of multiple ethanol dehydrogenases and additional pathways maximizing ethanol yield. The genome also encodes three different proteinaceous bacterial microcompartments with the capacity to compartmentalize pathways that divert fermentation intermediates to various products. These characteristics make C. phytofermentans an attractive resource for improving the efficiency and speed of biomass conversion to biofuels.	[Petit, Elsa; Coppi, Maddalena V.; Warnick, Thomas; Latouf, William G.; Amisano, Danielle; Biddle, Amy; Mukherjee, Supratim; Lau, Joanne; Leschine, Susan B.; Blanchard, Jeffrey L.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Hayes, James C.; Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Hayes, James C.; Latouf, William G.; Biddle, Amy; Mukherjee, Supratim; Leschine, Susan B.; Blanchard, Jeffrey L.] Univ Massachusetts, Inst Cellular Engn, Amherst, MA 01003 USA; [Tolonen, Andrew C.] CNRS, Commissariat Energie Atom & Energies Alternat CEA, Unite Mixte Rech UMR 8030, Evry, France; [Ivanova, Natalia; Lykidis, Athanassios; Kyrpides, Nikos] Joint Genome Inst, Dept Energy DOE, Genome Biol Program, Prod Genom Facil, Walnut Creek, CA USA; [Land, Miriam; Hauser, Loren] Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN USA; [Henrissat, Bernard] CNRS, Unite Mixte Rech UMR 6098, Architecture & Fonct Macromol Biol, Marseille, France; [Schnell, Danny J.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Leschine, Susan B.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Grad Program Organismal & Evolutionary Biol, Amherst, MA 01003 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Oak Ridge National Laboratory; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Blanchard, JL (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	jeffb@bio.umass.edu	Henrissat, Bernard/J-2475-2012; Blanchard, Jeffrey/AAA-5173-2020; Mukherjee, Supratim/K-1151-2019; Kyrpides, Nikos C./A-6305-2014; Land, Miriam L/A-6200-2011	Henrissat, Bernard/0000-0002-3434-8588; Blanchard, Jeffrey/0000-0002-7310-9678; Mukherjee, Supratim/0000-0002-6322-2271; Kyrpides, Nikos C./0000-0002-6131-0462; Land, Miriam L/0000-0001-7102-0031; Tolonen, Andrew/0000-0001-5907-4504; Ivanova, Natalia/0000-0002-5802-9485; Biddle, Amy/0000-0001-8261-1128; church, george/0000-0001-6232-9969; Lau, Joanne/0000-0002-3059-8846	U.S. Department of Energy [DE-FG02-02ER15330]; Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station [MAS00923, MAS009582]; Qteros; UMass College of Natural Sciences and Mathematics Excellence Initiatives; Howard Hughes Medical Institute Award; National Science Foundation equipment grant NSF-MRI [0722802]; National Science Foundation grant NSF [BBS 8714235]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	U.S. Department of Energy(United States Department of Energy (DOE)); Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Qteros; UMass College of Natural Sciences and Mathematics Excellence Initiatives; Howard Hughes Medical Institute Award(Howard Hughes Medical Institute); National Science Foundation equipment grant NSF-MRI; National Science Foundation grant NSF(National Science Foundation (NSF)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by U.S. Department of Energy grant DE-FG02-02ER15330 and Cooperative State Research, Extension, Education Service, U.S. Department of Agriculture, Massachusetts Agricultural Experiment Station Project No. MAS00923 to S.L. and Project No. MAS009582 to J.B., a Sponsored Research Agreement between Qteros and J.B. and S.L., UMass College of Natural Sciences and Mathematics Excellence Initiatives funding to E.P., a Howard Hughes Medical Institute Award to the University of Massachusetts Amherst, a National Science Foundation equipment grant NSF-MRI (0722802) and a National Science Foundation grant NSF BBS 8714235 to the University of Massachusetts Amherst Central Microscopy Facility. The work conducted by the U.S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1980, BIOCHIM BIOPHYS ACTA, V594, P105, DOI 10.1016/0304-4173(80)90007-5; Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x; Attwood TK, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas019; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Barak I, 2005, MOL MICROBIOL, V57, P611, DOI 10.1111/j.1365-2958.2005.04687.x; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Demeke MM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-89; Desvaux M, 2005, FEMS MICROBIOL REV, V29, P741, DOI 10.1016/j.femsre.2004.11.003; Desvaux M, 2006, BIOTECHNOL PROGR, V22, P1229, DOI 10.1021/bp060016e; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ezeji TC, 2004, CHEM REC, V4, P305, DOI 10.1002/tcr.20023; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferreira MJ, 2010, J BACTERIOL, V192, P5312, DOI 10.1128/JB.00832-10; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin MJ, 2012, BIOTECHNOL BIOENG, V109, P1929, DOI 10.1002/bit.24458; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Lee SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-5; Liu WJ, 2010, APPL ENVIRON MICROB, V76, P4914, DOI 10.1128/AEM.00958-10; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; McEntyre JO, 2002, CLUSTERS ORTHOLOGOUS; Mingardon F, 2005, APPL ENVIRON MICROB, V71, P1215, DOI 10.1128/AEM.71.3.1215-1222.2005; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Petit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054337; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Ren Z, 2007, J APPL MICROBIOL, V103, P2258, DOI 10.1111/j.1365-2672.2007.03477.x; Schwarz WH, 2001, APPL MICROBIOL BIOT, V56, P634, DOI 10.1007/s002530100710; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tolonen AC, 2011, MOL SYST BIOL, V7, DOI [10.1038/msb.2010.116, 10.1038/MSB.2010.116]; Tolonen AC, 2009, MOL MICROBIOL, V74, P1300, DOI 10.1111/j.1365-2958.2009.06890.x; VanFossen AL, 2009, APPL ENVIRON MICROB, V75, P7718, DOI 10.1128/AEM.01959-09; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Warnick TA, 2002, INT J SYST EVOL MICR, V52, P1155, DOI [10.1099/ijs.0.02125-0, 10.1099/00207713-52-4-1155]; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Zhang XZ, 2010, BIORESOURCE TECHNOL, V101, P5534, DOI 10.1016/j.biortech.2010.01.152; Zhang XZ, 2010, APPL MICROBIOL BIOT, V86, P525, DOI 10.1007/s00253-009-2231-1; Zhang YHP, 2008, NEW GENERATION BIOMA, P480; Zuroff TR, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-59	65	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0118285	10.1371/journal.pone.0118285	http://dx.doi.org/10.1371/journal.pone.0118285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035711	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100001
J	Vin-Raviv, N; Akinyemiju, TF; Galea, S; Bovbjerg, DH				Vin-Raviv, Neomi; Akinyemiju, Tomi F.; Galea, Sandro; Bovbjerg, Dana H.			Depression and Anxiety Disorders among Hospitalized Women with Breast Cancer	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; PSYCHOSOCIAL SUPPORT; MAJOR DEPRESSION; SURVIVAL; PREVALENCE; SYMPTOMS; INTERVENTION; COMORBIDITY; MORTALITY	Purpose To document the prevalence of depression and anxiety disorders, and their associations with mortality among hospitalized breast cancer patients. Methods We examined the associations between breast cancer diagnosis and the diagnoses of anxiety or depression among 4,164 hospitalized breast cancer cases matched with 4,164 non-breast cancer controls using 2006-2009 inpatient data obtained from the Nationwide Inpatient Sample database. Conditional logistic regression models were used to compute odds ratios (ORs) and 95% confidence intervals (CI) for the associations between breast cancer diagnosis and diagnoses of anxiety or depression. We also used binary logistic regression models to examine the association between diagnoses of depression or anxiety, and in-hospital mortality among breast cancer patients. Results We observed that breast cancer cases were less likely to have a diagnosis of depression (OR=0.63, 95% CI: 0.52-0.77), and less likely to have a diagnosis of anxiety (OR=0.68, 95% CI: 0.52-0.90) compared with controls. This association remained after controlling for race/ethnicity, residential income, insurance and residential region. Breast cancer patients with a depression diagnosis also had lower mortality (OR=0.69, 95% CI: 0.52-0.89) compared with those without a depression diagnosis, but there was no significant difference in mortality among those with and without anxiety diagnoses. Conclusion Diagnoses of depression and anxiety in breast cancer patients were less prevalent than expected based on our analysis of hospitalized breast cancer patients and matched non-breast cancer controls identified in the NIS dataset using ICD-9 diagnostic codes. Results suggest that under-diagnosis of mental health problems may be common among hospitalized women with a primary diagnosis of breast cancer. Future work may fruitfully explore reasons for, and consequences of, inappropriate identification of the mental health needs of breast cancer patients.	[Vin-Raviv, Neomi] Univ Colorado, Rocky Mt Canc Rehabil Inst, Sch Sport & Exercise Sci, Greeley, CO USA; [Akinyemiju, Tomi F.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Inst Canc, Biobehav Oncol Program, Dept Psychiat, Pittsburgh, PA USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Inst Canc, Biobehav Oncol Program, Dept Psychol, Pittsburgh, PA USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Inst Canc, Biobehav Oncol Program, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA	University of Colorado System; University of Alabama System; University of Alabama Birmingham; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Akinyemiju, TF (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	tomiakin@uab.edu	Galea, Sandro/GLR-6066-2022; Vin-Raviv, Neomi/AAL-6384-2021	Vin-Raviv, Neomi/0000-0003-1726-6596; Galea, Sandro/0000-0002-7534-0945	National Cancer Institute's R25 Cancer Training Grant [2-R25-CA-09529]; University of Pittsburgh Cancer Institute; Mailman School of Public Health; National Cancer Institute [P30 CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, T32CA009529] Funding Source: NIH RePORTER	National Cancer Institute's R25 Cancer Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Cancer Institute; Mailman School of Public Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was financially supported by the National Cancer Institute's R25 Cancer Training Grant 2-R25-CA-09529 (TA); Neomi Vin-Raviv was supported by postdoctoral fellowship funding from the University of Pittsburgh Cancer Institute and the Mailman School of Public Health. Support for Dr. Dana H. Bovbjerg was provided in part by institutional funds from the University of Pittsburgh Cancer Institute and a grant from the National Cancer Institute (P30 CA047904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BL, 2010, CLIN CANCER RES, V16, P3270, DOI 10.1158/1078-0432.CCR-10-0278; Andersen BL, 2008, CANCER-AM CANCER SOC, V113, P3450, DOI 10.1002/cncr.23969; Andrykowski Michael A, 2008, Semin Oncol Nurs, V24, P193, DOI 10.1016/j.soncn.2008.05.007; Barefoot JC, 2000, PSYCHOSOM MED, V62, P790, DOI 10.1097/00006842-200011000-00008; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Clark PG, 2011, PSYCHO-ONCOLOGY, V20, P664, DOI 10.1002/pon.1908; Dehal A, 2013, BREAST CANCER RES TR, V139, P469, DOI 10.1007/s10549-013-2543-9; Earle Craig C, 2007, J Cancer Surviv, V1, P156, DOI 10.1007/s11764-007-0013-2; Einsle F, 2012, J PSYCHOSOM RES, V72, P434, DOI 10.1016/j.jpsychores.2012.02.008; Ell K, 2005, J CLIN ONCOL, V23, P3052, DOI 10.1200/JCO.2005.08.041; ENDICOTT J, 1984, CANCER, V53, P2243; Fann JR, 2008, GEN HOSP PSYCHIAT, V30, P112, DOI 10.1016/j.genhosppsych.2007.10.008; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; FAWZY FI, 1993, ARCH GEN PSYCHIAT, V50, P681; Ganz PA, 2005, AM J MED, V118, P1410, DOI 10.1016/j.amjmed.2005.10.024; Goodwin JS, 2004, J AM GERIATR SOC, V52, P106, DOI 10.1111/j.1532-5415.2004.52018.x; Goodwin PJ, 2001, NEW ENGL J MED, V345, P1719, DOI 10.1056/NEJMoa011871; Goodwin PJ, 2004, J CLIN ONCOL, V22, P4184, DOI 10.1200/jco.2004.12.091; Guan NC, 2013, INT J PSYCHIAT MED, V45, P73, DOI 10.2190/PM.45.1.f; Himelhoch S, 2004, MED CARE, V42, P512, DOI 10.1097/01.mlr.0000127998.89246.ef; Hjerl K, 2003, PSYCHOSOMATICS, V44, P24, DOI 10.1176/appi.psy.44.1.24; Holland JC, 2002, PSYCHOSOM MED, V64, P206, DOI 10.1097/00006842-200203000-00004; Howden LM, 2011, AGE AND SEX COMPOSIT; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; IEZZONI LI, 1995, ANN INTERN MED, V123, P763, DOI 10.7326/0003-4819-123-10-199511150-00004; Iezzoni LI, 1997, ADMINISTRATIVE DATAB; Kangas Maria, 2013, Front Psychiatry, V4, P122, DOI 10.3389/fpsyt.2013.00122; Knobf M Tish, 2007, Semin Oncol Nurs, V23, P71, DOI 10.1016/j.soncn.2006.11.009; Low CA, 2014, PSYCHOSOM MED, V76, P248, DOI 10.1097/PSY.0000000000000067; Mandreker JN, 2012, AN INTRODUCTION TO M, P208; Massie Mary Jane, 2004, J Natl Cancer Inst Monogr, P57; Mehnert A, 2008, J PSYCHOSOM RES, V64, P383, DOI 10.1016/j.jpsychores.2007.12.005; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Mitchell A, 2008, PSYCHO-ONCOL, V17, P226, DOI 10.1002/pon.1228; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Osborne RH, 2003, EUR J CANCER, V39, P755, DOI 10.1016/S0959-8049(02)00814-6; Palesh O, 2007, J PSYCHOSOM RES, V63, P233, DOI 10.1016/j.jpsychores.2007.05.012; PHILLIPS KE, 2008, AUDUBON, V110, P26, DOI DOI 10.1016/j.jpsychores.2007.05.012; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; Ravi P, 2014, UROL ONCOL-SEMIN ORI, V32, P1333, DOI 10.1016/j.urolonc.2014.05.005; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Saquib N, 2011, PSYCHO-ONCOLOGY, V20, P252, DOI 10.1002/pon.1742; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sollner W, 2001, BRIT J CANCER, V84, P179, DOI 10.1054/bjoc.2000.1545; Spiegel D, 2007, CANCER-AM CANCER SOC, V110, P1130, DOI 10.1002/cncr.22890; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; Tross S, 1996, J NATL CANCER I, V88, P661, DOI 10.1093/jnci/88.10.661; Walker J, 2013, ANN ONCOL, V24, P895, DOI 10.1093/annonc/mds575; Walker J, 2014, LANCET PSYCHIAT, V1, P343, DOI 10.1016/S2215-0366(14)70313-X; Watson M, 2005, EUR J CANCER, V41, P1710, DOI 10.1016/j.ejca.2005.01.012; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y; Zhang AY, 2010, NURS RES PRACT, V2010, DOI 10.1155/2010/693961; Zhang SF, 2010, HEALTH CARE MANAG SC, V13, P137, DOI 10.1007/s10729-009-9119-6	55	35	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0129169	10.1371/journal.pone.0129169	http://dx.doi.org/10.1371/journal.pone.0129169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26035180	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000355699100068
J	Cheng, Y; Kiess, AP; Herman, JM; Pomper, MG; Meltzer, SJ; Abraham, JM				Cheng, Yulan; Kiess, Ana P.; Herman, Joseph M.; Pomper, Martin G.; Meltzer, Stephen J.; Abraham, John M.			Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage	PLOS ONE			English	Article							CHROMIC PHOSPHATE P-32; Y-90 RADIOEMBOLIZATION; P-32-CHROMIC PHOSPHATE; RADIOIODINE THERAPY; POLYCYTHEMIA-VERA; COLON-CANCER; METASTASES; DOSIMETRY; CARCINOMA; INJECTION	Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill target cells, including cancer cells. Aqueous P-32[PO4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. P-32[PO4] was directly compared to a more powerful pure beta-emitter, the clinically important Y-90 isotope. In vitro, P-32[PO4] was more effective at killing cells than was the more powerful isotope Y-90 (P <= 0.001) and also caused substantially more double-stranded DNA breaks than did Y-90. In vivo, a single low-dose intravenous dose of aqueous elemental P-32 significantly inhibited tumor growth in the syngeneic murine cancer model (P <= 0.001). This effect is exerted by direct incorporation into nascent DNA chains, resulting in double-stranded breakage, a unique mechanism not duplicatable by other, more powerful electron-emitting radioisotopes. P-32[PO4] should be considered for human clinical trials as a potential novel anti-cancer drug.	[Cheng, Yulan; Meltzer, Stephen J.; Abraham, John M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kiess, Ana P.; Herman, Joseph M.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat, Baltimore, MD USA; [Pomper, Martin G.] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Meltzer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	smeltzer@jhmi.edu			National Cancer Institute [CA133012-01, CA146799, CA190040]; National Institutes of Health Roadmap [DK087454-01]; Sidney Kimmel Cancer Center Pilot Project Grant; NATIONAL CANCER INSTITUTE [R01CA190040, R01CA133012, R01CA146799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Roadmap(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Cancer Center Pilot Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Cancer Institute CA133012-01, National Institutes of Health Roadmap DK087454-01, National Cancer Institute CA146799, National Cancer Institute CA190040, and a Sidney Kimmel Cancer Center Pilot Project Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbui T, 1998, HAEMATOLOGICA, V83, P143; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BRANDT L, 1995, EUR J HAEMATOL, V54, P21; Cheng YL, 2012, CELL CYCLE, V11, P1878, DOI 10.4161/cc.19955; Cheng YL, 2011, ONCOTARGET, V2, P461; Cotugno R, 2014, CANCER LETT, V354, P263, DOI 10.1016/j.canlet.2014.08.022; Fallahi P, 2015, INT J MOL SCI, V16, P6153, DOI 10.3390/ijms16036153; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Froehlich E, 2014, CANCER TREAT REV, V40, P665, DOI 10.1016/j.ctrv.2014.01.002; Gao W, 2010, CANCER BIOTHER RADIO, V25, P215, DOI 10.1089/cbr.2008.0596; Gao W, 2009, NUCL MED COMMUN, V30, P420, DOI 10.1097/MNM.0b013e328310af19; Goldsmith SJ, 2011, SEMIN NUCL MED, V41, P96, DOI 10.1053/j.semnuclmed.2010.11.002; GRADY ED, 1984, AM SURGEON, V50, P488; HEATH R, 1988, INT J RADIAT ONCOL, V15, P815, DOI 10.1016/0360-3016(88)90112-5; Horning SJ, 2005, J CLIN ONCOL, V23, P712, DOI 10.1200/JCO.2005.07.040; Kao YH, 2014, CARDIOVASC INTER RAD, V37, P1114, DOI 10.1007/s00270-013-0783-z; Kim DH, 2014, NUCL MED MOLEC IMAG, V48, P55, DOI 10.1007/s13139-013-0239-z; Knoop K, 2015, J NUCL MED, V56, P600, DOI 10.2967/jnumed.114.146662; Lam MGEH, 2013, INT J RADIAT ONCOL, V87, P323, DOI 10.1016/j.ijrobp.2013.05.041; Larsen RH, 2006, IN VIVO, V20, P325; Lechner A, 2008, PHYS MED BIOL, V53, P1961, DOI 10.1088/0031-9155/53/7/011; Lee I, 1997, CANCER, V80, P2611, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2611::AID-CNCR36>3.0.CO;2-D; Mayson SE, 2015, ONCOLOGY-BASEL, V88, P247, DOI 10.1159/000369496; Mellor HR, 2005, BIOCHEM PHARMACOL, V70, P1137, DOI 10.1016/j.bcp.2005.07.016; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Najean Y, 1997, BLOOD, V89, P2319, DOI 10.1182/blood.V89.7.2319; Nguyen H, 1997, INT J RADIAT ONCOL, V39, P481, DOI 10.1016/S0360-3016(97)00294-0; Nisa L, 2011, ANN NUCL MED, V25, P75, DOI 10.1007/s12149-010-0444-0; ORDER SE, 1994, INT J RADIAT ONCOL, V30, P715, DOI 10.1016/0360-3016(92)90960-P; Pandit-Taskar N, 2014, J NUCL MED, V55, P268, DOI 10.2967/jnumed.112.112482; Patrick MR, 1998, CANCER IMMUNOL IMMUN, V46, P229, DOI 10.1007/s002620050482; Perkins Ac, 2005, Biomed Imaging Interv J, V1, pe9, DOI 10.2349/biij.1.2.e9; POWELL JL, 1987, SOUTH MED J, V80, P1513, DOI 10.1097/00007611-198712000-00007; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; Sartor O, 2014, LANCET ONCOL, V15, P738, DOI 10.1016/S1470-2045(14)70183-4; Saxena A, 2014, INT J SURG, V12, P1403, DOI 10.1016/j.ijsu.2014.07.269; Silberstein EB, 2005, SEMIN NUCL MED, V35, P152, DOI 10.1053/j.semnuclmed.2004.11.006; SOPER JT, 1985, AM J OBSTET GYNECOL, V153, P191, DOI 10.1016/0002-9378(85)90112-7; Tennvall J, 2007, EUR J NUCL MED MOL I, V34, P1324, DOI 10.1007/s00259-007-0407-4; Varia MA, 2003, J CLIN ONCOL, V21, P2849, DOI 10.1200/JCO.2003.11.018; Wang TS, 2011, SEMIN RESP CRIT CARE, V32, P346, DOI 10.1055/s-0031-1279831; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wiseman GA, 2002, CANCER, V94, P1349, DOI 10.1002/cncr.10305; Yi JW, 2013, ONCOL REP, V29, P1617, DOI 10.3892/or.2013.2281; Zubillaga MB, 1996, NUCL MED BIOL, V23, P907, DOI 10.1016/S0969-8051(96)00123-0	45	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128152	10.1371/journal.pone.0128152	http://dx.doi.org/10.1371/journal.pone.0128152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030880	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900118
J	Di Mattei, VE; Carnelli, L; Bernardi, M; Bagliacca, EP; Zucchi, P; Lavezzari, L; Giorgione, V; Ambrosi, A; Mangili, G; Candiani, M; Sarno, L				Di Mattei, Valentina E.; Carnelli, Letizia; Bernardi, Martina; Bagliacca, Elena Pagani; Zucchi, Paola; Lavezzari, Luca; Giorgione, Veronica; Ambrosi, Alessandro; Mangili, Giorgia; Candiani, Massimo; Sarno, Lucio			An Investigative Study into Psychological and Fertility Sequelae of Gestational Trophoblastic Disease: The Impact on Patients' Perceived Fertility, Anxiety and Depression	PLOS ONE			English	Article							QUALITY-OF-LIFE; INVENTORY-SHORT-FORM; BREAST-CANCER; MOLAR PREGNANCY; PSYCHOMETRIC PROPERTIES; PSYCHOSOCIAL IMPACT; WOMEN; DIAGNOSIS; DISTRESS; OUTCOMES	Objectives Gestational Trophoblastic Disease (GTD) comprises a group of disorders that derive from the placenta. Even if full recovery is generally expected, women diagnosed with GTD have to confront: the loss of a pregnancy, a potentially life-threatening diagnosis and delays in future pregnancies. The aim of the study is to evaluate the psychological impact of GTD, focusing on perceived fertility, depression and anxiety. Methods 37 patients treated for GTD at San Raffaele Hospital, Milan, took part in the study. The STAI-Y (State-Trait Anxiety Inventory), the BDI-SF (Beck Depression Scale-Short Form) and the FPI (Fertility Problem Inventory) were used. Patients were grouped on the basis of presence of children (with or without), age (< or >= 35) and type of diagnosis (Hydatidiform Mole, HM, or Gestational Trophoblastic Neoplasia, GTN). Differences in the values between variables were assessed by a t-type test statistic. Three-way ANOVAs were also carried out considering the same block factors. Results The study highlights that women suffering from GTN had higher depression scores compared to women suffering from HM. A significant correlation was found between anxiety (state and trait) and depression. Younger women presented higher Global Stress scores on the FPI, especially tied to Need for Parenthood and Relationship Concern subscales. Need for Parenthood mean scores significantly varied between women with and without children too. Conclusions We can conclude that fertility perception seems to be negatively affected by GTD diagnosis, particularly in younger women and in those without children. Patients should be followed by a multidisciplinary team so as to be supported in the disease's psychological aspects too.	[Di Mattei, Valentina E.; Bernardi, Martina; Lavezzari, Luca; Ambrosi, Alessandro; Candiani, Massimo; Sarno, Lucio] Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy; [Di Mattei, Valentina E.; Carnelli, Letizia; Bagliacca, Elena Pagani; Zucchi, Paola; Sarno, Lucio] Hosp San Raffaele, IRCCS, Dept Clin Neurosci, Clin & Hlth Psychol Unit, I-20132 Milan, Italy; [Giorgione, Veronica; Mangili, Giorgia; Candiani, Massimo] Hosp San Raffaele, IRCCS, Dept Obstet & Gynecol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Carnelli, L (corresponding author), Hosp San Raffaele, IRCCS, Dept Clin Neurosci, Clin & Hlth Psychol Unit, I-20132 Milan, Italy.	carnelli.letizia@hsr.it	mangili, giorgia/Y-9673-2019; Di Mattei, Valentina/AAC-4634-2022; Candiani, Massimo/ABG-9811-2020; ambrosi, alessandro/H-4424-2011; Giorgione, Veronica/ABJ-9067-2022	ambrosi, alessandro/0000-0003-1976-5663; Giorgione, Veronica/0000-0003-3991-9308; DI MATTEI, VALENTINA/0000-0003-0546-3218; mangili, giorgia/0000-0002-8451-429X; CANDIANI, Massimo/0000-0002-2129-2626				Ambrosino A, THESIS U STUDI NAPOL; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Armuand GM, 2014, SUPPORT CARE CANCER, V22, P2805, DOI 10.1007/s00520-014-2279-z; Beck A., 1993, BECK DEPRESSION INVE; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Braga A, 2012, J REPROD MED, V57, P225; Carter J, 2010, J CANCER SURVIV, V4, P236, DOI 10.1007/s11764-010-0121-2; Den Oudsten BL, 2009, PSYCHO-ONCOLOGY, V18, P1230, DOI 10.1002/pon.1518; Di Mattei VE, 2014, J REPROD MED, V59, P488; EVANS DL, 1986, AM J PSYCHIAT, V143, P447; FLAM F, 1993, J PSYCHOSOM OBST GYN, V14, P241, DOI 10.3109/01674829309084447; Friedman L C, 1994, J Cancer Educ, V9, P37; Furlanetto LM, 2005, J AFFECT DISORDERS, V86, P87, DOI 10.1016/j.jad.2004.12.011; GANZ PA, 1985, J AM GERIATR SOC, V33, P429, DOI 10.1111/j.1532-5415.1985.tb07154.x; Garner E, 2003, BEST PRACT RES CL OB, V17, P959, DOI 10.1016/S1521-6934(03)00093-2; Garner EIO, 2007, CLIN OBSTET GYNECOL, V50, P112, DOI 10.1097/GRF.0b013e31802f17fc; GOLDEN RN, 1991, INT J PSYCHIAT MED, V21, P17, DOI 10.2190/HW7K-B3P8-3T8H-073M; Grassi L, 1997, J AFFECT DISORDERS, V44, P21, DOI 10.1016/S0165-0327(97)01445-6; Horowitz NS, 2009, GESTATIONAL TROPHOBL, Vthird, P460; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Lok CAR, 2011, J REPROD MED, V56, P47; Love AW, 2004, AUST NZ J PSYCHIAT, V38, P526, DOI 10.1111/j.1440-1614.2004.01385.x; Mangili G, 2014, INT J GYNECOL CANCER, V24, pS109, DOI 10.1097/IGC.0000000000000294; McQuellon RP, 1998, PSYCHO-ONCOL, V7, P207, DOI 10.1002/(SICI)1099-1611(199805/06)7:3<207::AID-PON304>3.0.CO;2-T; Newton CR, 1999, FERTIL STERIL, V72, P54, DOI 10.1016/S0015-0282(99)00164-8; Parazzini F, 2012, INT J GYNECOL CANCER, V22, P318, DOI 10.1097/IGC.0b013e31823b3504; Pedrabissi L, 1989, ITAL VERS; Pesarino F, 2012, PERMUTATION TESTS CO; Petersen RW, 2005, GYNECOL ONCOL, V97, P535, DOI 10.1016/j.ygyno.2005.01.015; Peterson BD, 2007, FERTIL STERIL, V88, P911, DOI 10.1016/j.fertnstert.2006.12.023; Quinlivan JA, 2012, PSYCHO-ONCOLOGY, V21, P970, DOI 10.1002/pon.1992; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Scilligo PF, 1988, SCALE PSICOLOGICHE, V1; Seckl MJ, 2013, ANN ONCOL, V24, P39, DOI 10.1093/annonc/mdt345; Seckl MJ, 2010, LANCET, V376, P717, DOI 10.1016/S0140-6736(10)60280-2; Spielberger C.D., 1983, MANUAL STATE TRAIT A; SPIELBERGER CD, 1984, J PERS ASSESS, V48, P95; Stafford L, 2011, INT J GYNECOL CANCER, V21, P161, DOI 10.1097/IGC.0b013e31820156d8; Thewes B, 2003, PSYCHO-ONCOLOGY, V12, P500, DOI 10.1002/pon.685; Ferreira EGV, 2009, J REPROD MED, V54, P239; Wang F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-326; WENZEL L, 1992, GYNECOL ONCOL, V46, P74, DOI 10.1016/0090-8258(92)90200-3; Wenzel L, 2002, J REPROD MED, V47, P387; WENZEL LB, 1994, J REPROD MED, V39, P163; Wong-Kim EC, 2005, PSYCHO-ONCOLOGY, V14, P564, DOI 10.1002/pon.873	46	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128354	10.1371/journal.pone.0128354	http://dx.doi.org/10.1371/journal.pone.0128354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030770	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900141
J	Juan-Baeza, I; Martinez-Garza, C; del-Val, E				Juan-Baeza, Iris; Martinez-Garza, Cristina; del-Val, Ek			Recovering More than Tree Cover: Herbivores and Herbivory in a Restored Tropical Dry Forest	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SEED RAIN; RESTORATION; LEPIDOPTERA; CATTLE; REGENERATION; BUTTERFLIES; DISTURBANCE; MANAGEMENT; HOST	Intense and chronic disturbance may arrest natural succession, reduce environmental quality and lead to ecological interaction losses. Where natural succession does not occur, ecological restoration aims to accelerate this process. While plant establishment and diversity is promoted by restoration, few studies have evaluated the effect of restoration activities on ecological processes and animal diversity. This study assessed herbivory and lepidopteran diversity associated with two pioneer tree species growing in 4-year-old experimental restoration plots in a tropical dry forest at Sierra de Huautla, in Morelos, Mexico. The study was carried out during the rainy season of 2010 (July-October) in eleven 50 x 50 m plots in three different habitats: cattle-excluded, cattle-excluded with restoration plantings, and cattle grazing plots. At the beginning of the rainy season, 10 juveniles of Heliocarpus pallidus (Malvaceae) and Ipomoea pauciflora (Convolvulaceae) were selected in each plot (N = 110 trees). Herbivory was measured in 10 leaves per plant at the end of the rainy season. To evaluate richness and abundance of lepidopteran larvae, all plants were surveyed monthly. Herbivory was similar among habitats and I. pauciflora showed a higher percentage of herbivory. A total of 868 lepidopteran larvae from 65 morphospecies were recorded. The family with the highest number of morphospecies (9 sp.) was Geometridae, while the most abundant family was Saturnidae, with 427 individuals. Lepidopteran richness and abundance were significantly higher in H. pallidus than in I. pauciflora. Lepidopteran richness was significantly higher in the cattle-excluded plots, while abundance was significantly higher in the non-excluded plots. After four years of cattle exclusion and the establishment of plantings, lepidopteran richness increased 20-fold in the excluded plots compared to the disturbed areas, whereas herbivory levels were equally high in both restored and disturbed sites. Restoration with plantings and exclusion of cattle and plantings was shown to be a successful strategy for attracting lepidopterans and cattle exclusion was the main factor explaining lepidopteran diversity.	[Juan-Baeza, Iris] Univ Autonoma Estado Morelos, Fac Ciencias Biol, Cuernavaca 62209, Morelos, Mexico; [Martinez-Garza, Cristina] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca 62209, Morelos, Mexico; [del-Val, Ek] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia 58190, Michoacan, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	del-Val, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Antigua Carretera Patzcuaro 8701, Morelia 58190, Michoacan, Mexico.	ekdelval@cieco.unam.mx	Martínez-Garza, Cristina/H-8956-2019; del val, Ek/AAB-8343-2019; Martínez-Garza, Cristina/K-4519-2019	Martínez-Garza, Cristina/0000-0002-9310-564X; del-val, ek/0000-0003-3862-1024	Universidad Nacional Autonoma de Mexico [PAPIIT-IN208610]; Mexican Program for the Improvement of Professors awarded to CM-G (PROMEP) [103.5/05/1901]; Cuerpo Academico de Ecologia Evolutiva (PROMEP); National Council of Science and Technology of Mexico [80027]	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Mexican Program for the Improvement of Professors awarded to CM-G (PROMEP); Cuerpo Academico de Ecologia Evolutiva (PROMEP); National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Universidad Nacional Autonoma de Mexico (PAPIIT-IN208610) fundes EDV, the Mexican Program for the Improvement of Professors awarded to CM-G (PROMEP, 103.5/05/1901), Cuerpo Academico de Ecologia Evolutiva (PROMEP) and the National Council of Science and Technology of Mexico (Grant # 80027), awarded to CM-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Medellin LA, 2014, BOT SCI, V92, P405, DOI 10.17129/botsci.92; Arnold AE, 2002, BIODIVERS CONSERV, V11, P1663, DOI 10.1023/A:1016888000369; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; Blanco-Garcia A, 2005, RESTOR ECOL, V13, P703, DOI 10.1111/j.1526-100X.2005.00089.x; Burgos A, 2004, AGR ECOSYST ENVIRON, V104, P475, DOI 10.1016/j.agee.2004.01.038; Challenger A, 2008, CAPITAL NATURAL MEXI, VI, DOI DOI 10.32800/ABC.2019.42.0187; Chapman CA, 1999, CONSERV BIOL, V13, P1301, DOI 10.1046/j.1523-1739.1999.98229.x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Conanp-Semarnat, 2005, PROGRAMA CONSERVACIO; Crawley M. J., 1983, HERBIVORY DYNAMICS A; Cuevas-Reyes P, 2011, J TROP ECOL, V27, P383, DOI 10.1017/S026646741100006X; de la O-Toris J, 2012, BOT SCI, V90, P469, DOI 10.17129/botsci.475; De Leon-Ibarra MA., 2005, THESIS U AUTONOMA ES; Diaz S, 2005, ECOSYSTEMS HUMAN WEL; Dorado O, 2005, PROGRAMA CONSERVACIO; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Elzinga JA, 2007, BASIC APPL ECOL, V8, P75, DOI 10.1016/j.baae.2006.04.003; Forup ML, 2005, RESTOR ECOL, V13, P265, DOI 10.1111/j.1526-100X.2005.00034.x; Gamboa Villa L, 2012, EFECTO PLANTACIONES; Griscom H. P., 2011, Forest Ecology and Management, V261, P1564, DOI 10.1016/j.foreco.2010.08.027; Griscom HP, 2009, RESTOR ECOL, V17, P117, DOI 10.1111/j.1526-100X.2007.00342.x; Gutierrez-Granados G, 2009, B SOC BOT MEX, V85, P51; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Hamer KC, 2003, J APPL ECOL, V40, P150, DOI 10.1046/j.1365-2664.2003.00783.x; Hernandez Y, 2014, SW NATURALIST; HOLL KD, 1995, RESTOR ECOL, V3, P76, DOI 10.1111/j.1526-100X.1995.tb00080.x; Howe HF, 2014, BOT SCI, V92, P459; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; King SL, 1999, RESTOR ECOL, V7, P348, DOI 10.1046/j.1526-100X.1999.72029.x; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Landero-Torres I., 2012, Cuadernos de Biodiversidad, V38, P4; Lewis OT, 2001, CONSERV BIOL, V15, P389, DOI 10.1046/j.1523-1739.2001.015002389.x; Lopez-Carretero A, 2010, COMPOSICION DIVERSID; MacGreggor CJ, 2014, ECOLOGICAL ENTOMOLOG; MARQUIS RJ, 1984, SCIENCE, V226, P537, DOI 10.1126/science.226.4674.537; Marquis RJ, 1996, VEGETATIO, V127, P85, DOI 10.1007/BF00054850; Martinez-Garza C, 2011, FOREST ECOL MANAG, V262, P2207, DOI 10.1016/j.foreco.2011.08.013; Miceli-Mendez Clara Luz, 2008, P165, DOI 10.1007/978-0-387-33642-8_7; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Piana RP, 2014, BIODIVERS CONSERV, V23, P559, DOI 10.1007/s10531-013-0616-z; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roth LC, 1999, J BIOGEOGR, V26, P739, DOI 10.1046/j.1365-2699.1999.00328.x; Ruiz-Guerra B, 2010, OIKOS, V119, P317, DOI 10.1111/j.1600-0706.2009.17614.x; Rzedowski J., 1978, VEGETACION MEXICO; Sanchez-Montoya G, 2002, VARIACION INTRASPECI; Sanchez-Velasquez L, 2002, POLIBOTANICA, V13, P25; SER, 2007, PRINC SER INT REST E; Simonetti JA, 2007, ACTA OECOL, V32, P312, DOI 10.1016/j.actao.2007.06.001; Stern M, 2002, REV BIOL TROP, V50, P1021; STEWARD JL, 1988, OIKOS, V53, P79, DOI 10.2307/3565666; Summerville KS, 2007, RESTOR ECOL, V15, P179, DOI 10.1111/j.1526-100X.2006.00182.x; Summerville KS, 2005, RESTOR ECOL, V13, P120, DOI 10.1111/j.1526-100X.2005.00014.x; Sweeney BW, 2007, SOUTH J APPL FOR, V31, P85, DOI 10.1093/sjaf/31.2.85; Trejo I, 2002, BIODIVERS CONSERV, V11, P2063, DOI 10.1023/A:1020876316013; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; VanderWerf EA, 2004, ECOLOGY, V85, P770, DOI 10.1890/02-0668; Vasquez PA, 2007, ACTA OECOL, V31, P48, DOI 10.1016/j.actao.2006.03.006; Vieira DLM, 2006, RESTOR ECOL, V14, P11, DOI 10.1111/j.1526-100X.2006.00100.x; Villa-Galaviz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053009; Waltz AEM, 2004, RESTOR ECOL, V12, P85, DOI 10.1111/j.1061-2971.2004.00262.x; Willott SJ, 2000, CONSERV BIOL, V14, P1055, DOI 10.1046/j.1523-1739.2000.98427.x; [No title captured]	63	19	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128583	10.1371/journal.pone.0128583	http://dx.doi.org/10.1371/journal.pone.0128583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030756	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900173
J	Jung, HS; Mithal, DS; Park, JE; Miller, RJ				Jung, Hosung; Mithal, Divakar S.; Park, Jeong Eun; Miller, Richard J.			Localized CCR2 Activation in the Bone Marrow Niche Mobilizes Monocytes by Desensitizing CXCR4	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; MESENCHYMAL STEM; FACTOR-I; CELLS; EMIGRATION; PROTEIN-1; DISEASE; ROLES; PAIN; MICE	Inflammatory (classical) monocytes residing in the bone marrow must enter the bloodstream in order to combat microbe infection. These monocytes express high levels of CCR2, a chemokine receptor whose activation is required for them to exit the bone marrow. How CCR2 is locally activated in the bone marrow and how their activation promotes monocyte egress is not understood. Here, we have used double transgenic lines that can visualize CCR2 activation in vivo and show that its chemokine ligand CCL2 is acutely released by stromal cells in the bone marrow, which make direct contact with CCR2-expressing monocytes. These monocytes also express CXCR4, whose activation immobilizes cells in the bone marrow, and are in contact with stromal cells expressing CXCL12, the CXCR4 ligand. During the inflammatory response, CCL2 is released and activates the CCR2 on neighboring monocytes. We demonstrate that acutely isolated bone marrow cells co-express CCR2 and CXCR4, and CCR2 activation desensitizes CXCR4. Inhibiting CXCR4 by a specific receptor antagonist in mice causes CCR2-expressing cells to exit the bone marrow in absence of inflammatory insults. Taken together, these results suggest a novel mechanism whereby the local activation of CCR2 on monocytes in the bone marrow attenuates an anchoring signalling provided by CXCR4 expressed by the same cell and mobilizes the bone marrow monocyte to the blood stream. Our results also provide a generalizable model that cross-desensitization of chemokine receptors fine-tunes cell mobility by integrating multiple chemokine signals.	[Jung, Hosung; Park, Jeong Eun] Yonsei Univ, Coll Med, Brain Res Inst, Dept Anat, Seoul 120752, South Korea; [Jung, Hosung; Park, Jeong Eun] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Mithal, Divakar S.; Miller, Richard J.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Northwestern University	Jung, HS (corresponding author), Yonsei Univ, Coll Med, Brain Res Inst, Dept Anat, Seoul 120752, South Korea.	hosungjung@yonsei.ac.kr	Jung, Hosung/A-4401-2012	Jung, Hosung/0000-0002-5059-8050	Basic Science Research Program [2013R1A1A1009625]; Bio and Medical Technology Development Program [2014M3A9B4043638]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MSTP) of the Korean government; Yonsei University College of Medicine [6-2013-0064-2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER	Basic Science Research Program; Bio and Medical Technology Development Program; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MSTP) of the Korean government; Yonsei University College of Medicine(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Basic Science Research Program (2013R1A1A1009625) and Bio and Medical Technology Development Program (2014M3A9B4043638), funded through the National Research Foundation of Korea (NRF). It was also supported by the Ministry of Education, Science and Technology (MSTP) of the Korean government, and a faculty research grant from the Yonsei University College of Medicine (6-2013-0064-2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Azar GA, 2010, P NATL ACAD SCI USA, V107, P3675, DOI 10.1073/pnas.0905901107; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; BISCHOFF SC, 1992, J EXP MED, V175, P1271, DOI 10.1084/jem.175.5.1271; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cohen MJ, 2004, ANN SURG, V240, P132, DOI 10.1097/01.sla.0000130724.84914.d6; Dzenko KA, 2001, J NEUROSCI, V21, P9214, DOI 10.1523/JNEUROSCI.21-23-09214.2001; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gouwy M, 2011, EUR J IMMUNOL, V41, P963, DOI 10.1002/eji.201041178; Jacquelin S, 2013, BLOOD, V122, P674, DOI 10.1182/blood-2013-01-480749; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Liu Q, 2012, BLOOD, V120, P181, DOI 10.1182/blood-2011-12-395608; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Maestroni GJM, 2006, ANN NY ACAD SCI, V1069, P195, DOI 10.1196/annals.1351.017; Martin C, 2003, AM POETRY REV, V32, P18; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; ROSL F, 1994, J VIROL, V68, P2142; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Szabo I, 2002, P NATL ACAD SCI USA, V99, P10276, DOI 10.1073/pnas.102327699; Tripathi A, 2015, P NATL ACAD SCI USA, V112, pE1659, DOI 10.1073/pnas.1417564112; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Wang YL, 2014, BRAIN RES, V1575, P78, DOI 10.1016/j.brainres.2014.05.035; Wilson NM, 2011, BRAIN BEHAV IMMUN, V25, P565, DOI 10.1016/j.bbi.2010.12.014	32	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128387	10.1371/journal.pone.0128387	http://dx.doi.org/10.1371/journal.pone.0128387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029924	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900144
J	Kucharski, AJ; Conlan, AJK; Eames, KTD				Kucharski, Adam J.; Conlan, Andrew J. K.; Eames, Ken T. D.			School's Out: Seasonal Variation in the Movement Patterns of School Children	PLOS ONE			English	Article							INFECTIOUS-DISEASE; SOCIAL NETWORKS; MIXING PATTERNS; SPREAD; INFLUENZA; TRANSMISSION; IMPACT; EPIDEMIC; BEHAVIOR; CONTACTS	School children are core groups in the transmission of many common infectious diseases, and are likely to play a key role in the spatial dispersal of disease across multiple scales. However, there is currently little detailed information about the spatial movements of this epidemiologically important age group. To address this knowledge gap, we collaborated with eight secondary schools to conduct a survey of movement patterns of school pupils in primary and secondary schools in the United Kingdom. We found evidence of a significant change in behaviour between term time and holidays, with term time weekdays characterised by predominately local movements, and holidays seeing much broader variation in travel patterns. Studies that use mathematical models to examine epidemic transmission and control often use adult commuting data as a proxy for population movements. We show that while these data share some features with the movement patterns reported by school children, there are some crucial differences between the movements of children and adult commuters during both term- time and holidays.	[Kucharski, Adam J.; Eames, Ken T. D.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Kucharski, Adam J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Conlan, Andrew J. K.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Cambridge	Kucharski, AJ (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.	adam.kucharski@lshtm.ac.uk	Conlan, Andrew/Q-3861-2019	Conlan, Andrew/0000-0002-2593-6353	Medical Research Council [MR/K021524/1]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Alborada Trust; NIHR [CDF-2011-04-019]; MRC [MR/K021524/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Alborada Trust; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AJK was supported by the Medical Research Council (fellowship MR/K021524/1, http://www.mrc.ac.uk/) and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (http://www.fic.nih.gov/about/staff/pages/epidemiology-population.aspx#rapidd). AJKC was supported by the Alborada Trust (http://www.alboradatrust.com/). KTDE was supported by the NIHR (CDF-2011-04-019, http://www.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolloni A, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-3; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Balmer M., 2008, AGENT BASED SIMULATI; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Charaudeau S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083002; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Conlan AJK, 2011, P ROY SOC B-BIOL SCI, V278, P1467, DOI 10.1098/rspb.2010.1807; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Danon L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1037; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Eames KTD, 2013, MATH SCH, V42, P7; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; House T, 2011, P ROY SOC B-BIOL SCI, V278, P2753, DOI 10.1098/rspb.2010.2688; Keeling M. J., 2007, MODELLING INFECT DIS; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Kucharski AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004206; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Office for National Statistics, 2001, 2001 CENS AGGR DAT E; Office for National Statistics, 2001, 2001 CENS DIG BOUND; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Smieszek T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-115; Swiss Federal Statistical Office, 2010, MIKR VERK; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	34	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128070	10.1371/journal.pone.0128070	http://dx.doi.org/10.1371/journal.pone.0128070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030611	gold, Green Published, Green Accepted			2022-12-27	WOS:000356630900108
J	Kumar, SR; Prabakaran, M; Raj, KVA; He, F; Kwang, J				Kumar, Subaschandrabose Rajesh; Prabakaran, Mookkan; Raj, Kattur Venkatachalam Ashok; He, Fang; Kwang, Jimmy			Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge	PLOS ONE			English	Article							BACULOVIRUS DISPLAYED HEMAGGLUTININ; INFLUENZA-VIRUS HEMAGGLUTININ; A VIRUS; VACCINE; CONJUNCTIVITIS; GLYCOSYLATION; PATHOGENICITY; INFECTION; HLA-A2.1; EFFICACY	Avian influenza A H7N7/NL/219/03 virus creates a serious pandemic threat to human health because it can transmit directly from domestic poultry to humans and from human to human. Our previous vaccine study reported that mice when immunized intranasally (i.n) with live Bac-HA were protected from lethal H7N7/NL/219/03 challenge, whereas incomplete protection was obtained when administered subcutaneously (s.c) due to the fact that H7N7 is a poor inducer of neutralizing antibodies. Interestingly, our recent vaccine studies reported that mice when vaccinated subcutaneously with Bac-HA (H7N9) was protected against both H7N9 (A/Sh2/2013) and H7N7 virus challenge. HA1 region of both H7N7 and H7N9 viruses are differ at 15 amino acid positions. Among those, we selected three amino acid positions (T143, T198 and I211) in HA1 region of H7N7. These amino acids are located within or near the receptor binding site. Following the selection, we substituted the amino acid at these three positions with amino acids found on H7N9HA wild-type. In this study, we evaluate the impact of amino acid substitutions in the H7N7 HA-protein on the immunogenicity. We generated six mutant constructs from wild-type influenza H7N7HA cDNA by site directed mutagenesis, and individually expressed mutant HA protein on the surface of baculovirus (Bac-HA(m)) and compared their protective efficacy of the vaccines with Bac-H7N7HA wild-type (Bac-HA) by lethal H7N7 viral challenge in a mouse model. We found that mice immunized subcutaneously with Bac-HA(m) constructs T143A or T198A-I211V or I211V-T143A serum showed significantly higher hemagglutination inhibition and neutralization titer against H7N7 and H7N9 viruses when compared to Bac-HA vaccinated mice groups. We also observed low level of lung viral titer, negligible weight loss and complete protection against lethal H7N7 viral challenge. Our results indicated that amino acid substitution at position 143 or 211 improve immunogenicity of H7N7HA vaccine against H7N7/NL/219/03 virus.	[Kumar, Subaschandrabose Rajesh; Prabakaran, Mookkan; Raj, Kattur Venkatachalam Ashok; He, Fang; Kwang, Jimmy] Natl Univ Singapore, Temasek Lifesci Lab, Anim Hlth Biotechnol, Singapore 117548, Singapore; [Kwang, Jimmy] Natl Univ Singapore, Fac Med, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Kwang, J (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, Anim Hlth Biotechnol, 1 Res Link, Singapore 117548, Singapore.	kwang@tll.org.sg		Kattur Venkatachalam, Ashok Raj/0000-0002-2628-3032; Prabakaran, Mookkan/0000-0002-9816-5908	Temasek Life Sciences Laboratory, Singapore	Temasek Life Sciences Laboratory, Singapore	We are grateful for the financial support received from Temasek Life Sciences Laboratory, Singapore. We thank Mr. Subramanian Kabilan and Mr. Govindarajan for animal work. We thank Ruben Donis, Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, for providing the plasmids for reverse genetics. We are thankful to Mr. Ng Qing Yong and Mr. Vishweshwaran Sridhar for manuscript editing.	CAMPBELL CH, 1970, J INFECT DIS, V122, P513, DOI 10.1093/infdis/122.6.513; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guo L, 2014, EMERG INFECT DIS, V20, P192, DOI 10.3201/eid2002.131094; He F, 2013, ANTIVIR RES, V100, P207, DOI 10.1016/j.antiviral.2013.08.003; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Klausberger M, 2014, VACCINE, V32, P355, DOI 10.1016/j.vaccine.2013.11.036; Kumar R, 2011, VACCINE, V29, P9064, DOI 10.1016/j.vaccine.2011.09.057; Kumar SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063856; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Lin SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092822; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Medina RA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005996; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Nicolson C, 2012, VACCINE, V30, P745, DOI 10.1016/j.vaccine.2011.11.081; NIH (National Institutes of Health U.S.); CDCP (Centers for Disease Control and Prevention U.S.), 1999, BIOSAFETY MICROBIOLO; Okazaki T, 2003, J IMMUNOL, V171, P2548, DOI 10.4049/jimmunol.171.5.2548; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Prabakaran M, 2008, VIROLOGY, V380, P412, DOI 10.1016/j.virol.2008.08.002; Prabakaran M, 2014, ANTIVIR RES, V109, P149, DOI 10.1016/j.antiviral.2014.06.017; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rudenko L, 2013, VACCINE, V31, P4702, DOI 10.1016/j.vaccine.2013.08.040; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Schreurs MWJ, 2005, VACCINE, V23, P4005, DOI 10.1016/j.vaccine.2005.03.014; Stansell Elizabeth, 2010, Yale Journal of Biology and Medicine, V83, P201; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Sun XJ, 2013, J VIROL, V87, P8756, DOI 10.1128/JVI.00593-13; Tanaka Y, 2001, INT J CANCER, V94, P540, DOI 10.1002/ijc.1508; Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294; Wanzeck K, 2011, AM J RESP CRIT CARE, V183, P767, DOI 10.1164/rccm.201007-1184OC; WEBSTER RG, 1981, NEW ENGL J MED, V304, P911; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061397	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128940	10.1371/journal.pone.0128940	http://dx.doi.org/10.1371/journal.pone.0128940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030920	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900199
J	Malesinski, S; Tsvetkov, PO; Kruczynski, A; Peyrot, V; Devred, F				Malesinski, Soazig; Tsvetkov, Philipp O.; Kruczynski, Anna; Peyrot, Vincent; Devred, Francois			Stathmin Potentiates Vinflunine and Inhibits Paclitaxel Activity	PLOS ONE			English	Article							ISOTHERMAL TITRATION CALORIMETRY; MICROTUBULE INHIBITOR; CARCINOMA-CELLS; IN-VITRO; TUBULIN; CANCER; TAXOL; OP18/STATHMIN; VINBLASTINE; MECHANISMS	Cell biology and crystallographic studies have suggested a functional link between stathmin and microtubule targeting agents (MTAs). In a previous study we showed that stathmin increases vinblastine (VLB) binding to tubulin, and that conversely VLB increases stathmin binding to tubulin. This constituted the first biochemical evidence of the direct relationship between stathmin and an antimitotic drug, and revealed a new mechanism of action for VLB. The question remained if the observed interaction was specific for this drug or represented a general phenomenon for all MTAs. In the present study we investigated the binding of recombinant stathmin to purified tubulin in the presence of paclitaxel or another Vinca alkaloid, vinflunine, using Isothermal Titration Calorimetry (ITC). These experiments revealed that stathmin binding to tubulin is increased in the presence of vinflunine, whereas no signal is observed in the presence of paclitaxel. Further investigation using turbidity and co-sedimentation showed that stathmin inhibited paclitaxel microtubule-stabilizing activity. Taken together with the previous study using vinblastine, our results suggest that stathmin can be seen as a modulator of MTA activity and binding to tubulin, providing molecular explanation for multiple previous cellular and in vivo studies showing that stathmin expression level affects MTAs efficiency.	[Malesinski, Soazig; Tsvetkov, Philipp O.; Peyrot, Vincent; Devred, Francois] Aix Marseille Univ, Fac Pharm, INSERM, CRO2 UMR S 911, Marseille, France; [Tsvetkov, Philipp O.] RAMS, Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Kruczynski, Anna] Ctr Rech & Dev Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS	Devred, F (corresponding author), Aix Marseille Univ, Fac Pharm, INSERM, CRO2 UMR S 911, Marseille, France.	francois.devred@univ-amu.fr	Devred, Francois/AAO-6337-2020	Devred, Francois/0000-0001-5990-8898	french Institut National du Cancer [INCa-DGOSInserm 6038]; Marie Curie Actions FP7-PEOPLE-IFF [627524]; Association pour la recherche contre le cancer [1035]	french Institut National du Cancer(Institut National du Cancer (INCA) France); Marie Curie Actions FP7-PEOPLE-IFF; Association pour la recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was partly supported by the french Institut National du Cancer (grant INCa-DGOSInserm 6038), Marie Curie Actions FP7-PEOPLE-2013-IIF#627524, Association pour la recherche contre le cancer (no 1035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli E, 2002, CANCER RES, V62, P6864; Alli E, 2007, MOL PHARMACOL, V71, P1233, DOI 10.1124/mol.106.029702; ARAKAWA T, 1984, J BIOL CHEM, V259, P4979; Barbier P, 2014, PHYTOCHEM REV, V13, P157, DOI 10.1007/s11101-013-9302-8; Broguer D, 2008, SEMIN ONCOL, V35, pS13, DOI 10.1053/j.seminoncol.2008.01.011; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Curmi PA, 2000, BRIT J CANCER, V82, P142, DOI 10.1054/bjoc.1999.0891; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; Devred F, 2008, FEBS LETT, V582, P2484, DOI 10.1016/j.febslet.2008.06.035; Feng W, 2015, CANC GENE THER; Ghosh R, 2007, PROSTATE, V67, P1038, DOI 10.1002/pros.20601; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gupta KK, 2013, P NATL ACAD SCI USA, V110, P20449, DOI 10.1073/pnas.1309958110; Hemdan T, 2014, BRIT J CANCER, V111, P1180, DOI 10.1038/bjc.2014.427; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Iancu C, 2000, CANCER RES, V60, P3537; Jordan MA, 2008, SEMIN ONCOL, V35, pS6, DOI 10.1053/j.seminoncol.2008.01.009; Lafitte D, 2002, BIOCHEMISTRY-US, V41, P7217, DOI 10.1021/bi0159837; Lin XC, 2014, CANCER BIOTHER RADIO, V29, P376, DOI 10.1089/cbr.2014.1649; Lobert S, 2000, METHOD ENZYMOL, V323, P77; Makarov AA, 2007, BIOCHEMISTRY-US, V46, P14899, DOI 10.1021/bi701803s; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Martello LA, 2003, CANCER RES, V63, P1207; Mistry SJ, 2007, MOL CANCER RES, V5, P773, DOI 10.1158/1541-7786.MCR-06-0290; Nishio K, 2001, CANCER, V91, P1494, DOI 10.1002/1097-0142(20010415)91:8<1494::AID-CNCR1157>3.0.CO;2-7; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Price DK, 2000, CANCER INVEST, V18, P722, DOI 10.3109/07357900009012204; Tsvetkov PO, 2013, METHOD CELL BIOL, V115, P283, DOI 10.1016/B978-0-12-407757-7.00018-9; Tsvetkov PO, 2011, MOL BIOL+, V45, P641, DOI 10.1134/S0026893311040108; Tsvetkov PO, 2012, BIOCHIMIE, V94, P916, DOI 10.1016/j.biochi.2011.09.011; Werner HMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090141	34	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128704	10.1371/journal.pone.0128704	http://dx.doi.org/10.1371/journal.pone.0128704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030092	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900185
J	van Gemert, WAM; van der Palen, J; Monninkhof, EM; Rozeboom, A; Peters, R; Wittink, H; Schuit, AJ; Peeters, PH				van Gemert, Willemijn A. M.; van der Palen, Job; Monninkhof, Evelyn M.; Rozeboom, Anouk; Peters, Roelof; Wittink, Harriet; Schuit, Albertine J.; Peeters, Petra H.			Quality of Life after Diet or Exercise-Induced Weight Loss in Overweight to Obese Postmenopausal Women: The SHAPE-2 Randomised Controlled Trial	PLOS ONE			English	Article							PHYSICAL-FITNESS; HEALTH-STATUS; OLDER-ADULTS; QUESTIONNAIRE; INTERVENTION; VALIDITY; SF-36	Introduction This study investigates the effect of a modest weight loss either by a calorie restricted diet or mainly by increased physical exercise on health related quality of life (HRQoL) in overweight-to-obese and inactive postmenopausal women. We hypothesize that HRQoL improves with weight loss, and that exercise-induced weight loss is more effective for this than diet-induced weight loss. Methods The SHAPE-2 trial was primarily designed to evaluate any additional effect of weight loss by exercise compared with a comparable amount of weight loss by diet on biomarkers relevant for breast cancer risk. In the present analysis we focus on HRQoL. We randomly assigned 243 eligible women to a diet (n = 97), exercise (n = 98), or control group (n = 48). Both interventions aimed for 5-6 kg weight loss. HRQoL was measured at baseline and after 16 weeks by the SF-36 questionnaire. Results Data of 214 women were available for analysis. Weight loss was 4.9 kg (6.1%) and 5.5 kg (6.9%) with diet and exercise, respectively. Scores of the SF-36 domain 'health change' increased significantly by 8.8 points (95% CI 1.6; 16.1) with diet, and by 20.5 points (95% CI 13.2; 27.7) with exercise when compared with control. Direct comparison of diet and exercise showed a statistically significantly stronger improvement with exercise. Both intervention groups showed a tendency towards improvements in most other domains, which were more pronounced in the exercise group, but not statistically different from control or each other. Conclusion In a randomized trial in overweight-to-obese and inactive postmenopausal women a comparable 6%-7% weight loss was achieved by diet-only or mainly by exercise and showed improvements in physical and mental HRQoL domains, but results were not statistically significant in either the diet or exercise group. However, a modest weight loss does lead to a positive change in self-perceived health status. This effect was significantly larger with exercise-induced weight loss than with comparable diet-induced weight loss.	[van Gemert, Willemijn A. M.; Monninkhof, Evelyn M.; Rozeboom, Anouk; Peeters, Petra H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, NL-3508 GA Utrecht, Netherlands; [van der Palen, Job] Med Spectrum Twente Hosp, Dept Epidemiol, NL-7500 KA Enschede, Netherlands; [van der Palen, Job] Univ Twente, Dept Res Methodol Measurement & Data Anal, NL-7500 AE Enschede, Netherlands; [Peters, Roelof; Wittink, Harriet] Utrecht Univ Appl Sci, Res Grp Lifestyle & Hlth, Fac Hlth Care, NL-3508 AD Utrecht, Netherlands; [Schuit, Albertine J.] Natl Inst Publ Hlth & Environm, Div Publ Hlth & Hlth Care, NL-3720 BA Bilthoven, Netherlands; [Schuit, Albertine J.] Vrije Univ Amsterdam, Dept Hlth Sci, NL-1081 BT Amsterdam, Netherlands; [Schuit, Albertine J.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Medical Spectrum Twente; University of Twente; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Gemert, WAM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, POB 85500, NL-3508 GA Utrecht, Netherlands.	w.vangemert@umcutrecht.nl	Schuit, Albertine J/I-3148-2018	Schuit, Jantine/0000-0002-7499-1391; van der Palen, Job/0000-0003-1071-6769	Dutch Cancer Society [UU 2010-4843]; Dutch Pink Ribbon Foundation [PR110032, PR110039]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Pink Ribbon Foundation	This work was supported by the Dutch Cancer Society (www.kwf.nl, grant number UU 2010-4843) and the Dutch Pink Ribbon Foundation (www.pinkribbon.nl, grant numbers PR110032 and PR110039). The support from the sponsors was unconditional, and the data collection, design, management, analysis, interpretation and reporting were performed without their interference. The role of the sponsors was limited to approving the scientific proposal of the study; covering salary costs of study personnel, costs for the data collection and costs for biochemical analyses.	Armstrong MJ, 2011, OBES REV, V12, P709, DOI 10.1111/j.1467-789X.2011.00892.x; Asbury EA, 2006, MENOPAUSE, V13, P561, DOI 10.1097/01.gme.0000196812.96128.e8; Blissmer B, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-43; Bowen DJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-34; Cohen J., 1988, STAT POWER ANAL BEHA, DOI [10.1002/bs.3830330104, DOI 10.1002/BS.3830330104]; Ferlay J, 2012, CANC INCIDENCE MORTA; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Gusi N, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-231; Health Council of the Netherlands, 2006, GUID HLTH DIET; Imayama I, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-118; Jenkinson CM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3170; Jones G L, 2008, Menopause Int, V14, P26, DOI 10.1258/mi.2007.007034; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; Maciejewski ML, 2005, J CLIN EPIDEMIOL, V58, P568, DOI 10.1016/j.jclinepi.2004.10.015; Martin CK, 2009, ARCH INTERN MED, V169, P269, DOI 10.1001/archinternmed.2008.545; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Ng M, 2013, LANCET; Perneger TV, 1997, J EPIDEMIOL COMMUN H, V51, P320, DOI 10.1136/jech.51.3.320; Rejeski WJ, 2002, HEALTH PSYCHOL, V21, P419, DOI 10.1037/0278-6133.21.5.419; Ross KM, 2009, EAT BEHAV, V10, P84, DOI 10.1016/j.eatbeh.2008.12.002; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Shaw K, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003818.pub2; Teoman N, 2004, MATURITAS, V47, P71, DOI 10.1016/S0378-5122(03)00241-X; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; van Gemert WAM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-395; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Warkentin LM, 2014, OBES REV, V15, P169, DOI 10.1111/obr.12113; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2013, FACT SHEET OB OV	33	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127520	10.1371/journal.pone.0127520	http://dx.doi.org/10.1371/journal.pone.0127520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26029921	Green Published, gold			2022-12-27	WOS:000356630900056
J	Zhao, L; Liu, ZB; Jia, HQ; Feng, ZH; Liu, JK; Li, XS				Zhao, Lin; Liu, Zhongbo; Jia, Haiqun; Feng, Zhihui; Liu, Jiankang; Li, Xuesen			Lipoamide Acts as an Indirect Antioxidant by Simultaneously Stimulating Mitochondrial Biogenesis and Phase II Antioxidant Enzyme Systems in ARPE-19 Cells	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; ALPHA-LIPOIC ACID; OXIDATIVE STRESS; COGNITIVE DYSFUNCTION; CALORIE RESTRICTION; GLUTATHIONE; METABOLISM; PATHWAY; DISEASE; DECAY	In our previous study, we found that pretreatment with lipoamide (LM) more effectively than alpha-lipoic acid (LA) protected retinal pigment epithelial (RPE) cells from the acrolein-induced damage. However, the reasons and mechanisms for the greater effect of LM than LA are unclear. We hypothesize that LM, rather than the more direct antioxidant LA, may act more as an indirect antioxidant. In the present study, we treated ARPE-19 cells with LA and LM and compared their effects on activation of mitochondrial biogenesis and induction of phase II enzyme systems. It is found that LM is more effective than LA on increasing mitochondrial biogenesis and inducing the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and its translocation to the nucleus, leading to an increase in expression or activity of phase II antioxidant enzymes (NQO-1, GST, GCL, catalase and Cu/Zn SOD). Further study demonstrated that mitochondrial biogenesis and phase II enzyme induction are closely coupled via energy requirements. These results suggest that LM, compared with the direct antioxidant LA, plays its protective effect on oxidative damage more as an indirect antioxidant to simultaneously stimulate mitochondrial biogenesis and induction of phase II antioxidant enzymes.	[Zhao, Lin; Liu, Zhongbo; Jia, Haiqun; Feng, Zhihui; Liu, Jiankang; Li, Xuesen] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Zhao, Lin; Liu, Zhongbo; Jia, Haiqun; Feng, Zhihui; Liu, Jiankang; Li, Xuesen] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Liu, Zhongbo] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA; [Jia, Haiqun] Calif Inst Biomed Res, La Jolla, CA USA; [Liu, Jiankang] Tianjin Univ Sport, Tianjin Key Lab Exercise Physiol & Sports Med, Tianjin, Peoples R China; [Li, Xuesen] Luzhou Med Coll, Inst Canc Med, Luzhou, Sichuan, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; New York University; Tianjin University of Sport; Southwest Medical University	Liu, JK (corresponding author), Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China.	j.liu@mail.xjtu.edu.cn; xuesen_li@163.com	Feng, Zhihui/E-7408-2011; Zhao, Lin/AHD-2506-2022; Liu, Zhongbo/U-3004-2017; Liu, Jiankang/A-1610-2011	Feng, Zhihui/0000-0002-2448-6565; Zhao, Lin/0000-0002-6056-8787; 	Tianjin Science and Technology Planning Major Project [12JCZDJC34400]; Tianjin Education Committee Sci-Tech Development Major Project [20112D05]; Tianjin Key Labs and Tech-Platform Project [10SYSYJC28400]; 973 Plan Project of the Ministry of Science and Technology of China [2015CB553602]	Tianjin Science and Technology Planning Major Project; Tianjin Education Committee Sci-Tech Development Major Project; Tianjin Key Labs and Tech-Platform Project; 973 Plan Project of the Ministry of Science and Technology of China	This study was supported by Tianjin Science and Technology Planning Major Project (#12JCZDJC34400), Tianjin Education Committee Sci-Tech Development Major Project (#20112D05), Tianjin Key Labs and Tech-Platform Project (#10SYSYJC28400), and The 973 Plan Project of the Ministry of Science and Technology of China (#2015CB553602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Fukuyama R, 2002, J BIOL CHEM, V277, P41455, DOI 10.1074/jbc.M204176200; GARDINER CS, 1995, ARCH BIOCHEM BIOPHYS, V318, P30, DOI 10.1006/abbi.1995.1200; GREEN WR, 1985, OPHTHALMOLOGY, V92, P615; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jia LH, 2007, INVEST OPHTH VIS SCI, V48, P339, DOI 10.1167/iovs.06-0248; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li X, 2008, FREE RADICAL BIO MED, V44, P1465, DOI 10.1016/j.freeradbiomed.2008.01.004; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Liu JK, 2008, NEUROCHEM RES, V33, P194, DOI 10.1007/s11064-007-9403-0; Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; Liu ZB, 2007, J NEUROCHEM, V103, P2690, DOI 10.1111/j.1471-4159.2007.04954.x; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; PABST MJ, 1974, J BIOL CHEM, V249, P7140; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Packer L, 2001, NUTRITION, V17, P888, DOI 10.1016/S0899-9007(01)00658-X; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Riganti C, 2002, FREE RADICAL BIO MED, V32, P938, DOI 10.1016/S0891-5849(02)00800-6; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Shen W, 2008, DIABETOLOGIA, V51, P165, DOI 10.1007/s00125-007-0852-4; Slyshenkov VS, 2004, FEBS LETT, V569, P169, DOI 10.1016/j.febslet.2004.05.044; SNOKE JE, 1953, J BIOL CHEM, V201, P573; Spraul CW, 1996, INVEST OPHTH VIS SCI, V37, P2724; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Vali S, 2007, NEUROSCIENCE, V149, P917, DOI 10.1016/j.neuroscience.2007.08.028; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YANARI S, 1953, J BIOL CHEM, V201, P561; Zhang HY, 2010, J CELL MOL MED, V14, P215, DOI 10.1111/j.1582-4934.2008.00390.x	45	16	16	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128502	10.1371/journal.pone.0128502	http://dx.doi.org/10.1371/journal.pone.0128502			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030919	gold, Green Submitted, Green Published			2022-12-27	WOS:000356630900159
J	Florencio, M; Lobo, JM; Cardoso, P; Almeida-Neto, M; Borges, PAV				Florencio, Margarita; Lobo, Jorge M.; Cardoso, Pedro; Almeida-Neto, Mario; Borges, Paulo A. V.			The Colonisation of Exotic Species Does Not Have to Trigger Faunal Homogenisation: Lessons from the Assembly Patterns of Arthropods on Oceanic Islands	PLOS ONE			English	Article							NESTED SUBSET PATTERNS; BIOTIC HOMOGENIZATION; BETA-DIVERSITY; TAXONOMIC HOMOGENIZATION; POLLINATION NETWORKS; FUNCTIONAL DIVERSITY; PLANT INVASIONS; ALIEN; MODEL; CONSERVATION	Human-caused disturbances can lead to the extinction of indigenous (endemic and native) species, while facilitating and increasing the colonisation of exotic species; this increase can, in turn, promote the similarity of species compositions between sites if human-disturbed sites are consistently invaded by a regionally species-poor pool of exotic species. In this study, we analysed the extent to which epigean arthropod assemblages of four islands of the Azorean archipelago are characterised by nestedness according to a habitat-altered gradient. The degree of nestedness represents the extent to which less ubiquitous species occur in subsets of sites occupied by the more widespread species, resulting in an ordered loss/gain of species across environmental or ecological gradients. A predictable loss of species across communities while maintaining others may lead to more similar communities (i.e. lower beta-diversity). In contrast, anti-nestedness occurs when different species tend to occupy distinct sites, thus characterising a replacement of species across such gradients. Our results showed that an increase in exotic species does not promote assemblage homogenisation at the habitat level. On the contrary, exotic species were revealed as habitat specialists that constitute new and well-differentiated assemblages, even increasing the species compositional heterogeneity within human-altered landscapes. Therefore, contrary to expectations, our results show that both indigenous and exotic species established idiosyncratic assemblages within habitats and islands. We suggest that both the historical extinction of indigenous species in disturbed habitats and the habitat-specialised character of some exotic invasions have contributed to the construction of current assemblages.	[Florencio, Margarita; Cardoso, Pedro; Borges, Paulo A. V.] Univ Acores, Ctr Ecol Evolut & Environm Changes CE3C, Azorean Biodivers Grp, Dept Ciencias Agr, Angra Do Heroismo, Acores, Portugal; [Florencio, Margarita; Cardoso, Pedro; Borges, Paulo A. V.] Univ Acores, CITA A, Dept Ciencias Agr, Angra Do Heroismo, Acores, Portugal; [Florencio, Margarita; Almeida-Neto, Mario] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Goiania, Go, Brazil; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Global Change, E-28006 Madrid, Spain; [Cardoso, Pedro] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	Universidade dos Acores; Universidade dos Acores; Universidade Federal de Goias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Helsinki	Florencio, M (corresponding author), Univ Acores, Ctr Ecol Evolut & Environm Changes CE3C, Azorean Biodivers Grp, Dept Ciencias Agr, Angra Do Heroismo, Acores, Portugal.	mflorenciodiaz@gmail.com	Borges, Paulo/B-2780-2008; Borges, Paulo/H-5153-2019; Cardoso, Pedro/A-8820-2008; Lobo, Jorge M/E-2309-2013; Florencio, Margarita/J-5566-2016; Almeida-Neto, M./A-6389-2009; Cardoso, Pedro/AAY-9650-2020	Borges, Paulo/0000-0002-8448-7623; Borges, Paulo/0000-0002-8448-7623; Cardoso, Pedro/0000-0001-8119-9960; Lobo, Jorge M/0000-0002-3152-4769; Florencio, Margarita/0000-0002-6688-7770; Almeida-Neto, M./0000-0002-2161-2968; Cardoso, Pedro/0000-0001-8119-9960	project "Consequences of land-use change on Azorean fauna and flora - the Target" [M.2.1.2/I/003/2008]; Mapping coastal and marine biodiversity of the Azores [M2.1.2/I/027/2011]; Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCT) [M3.1.7/F/002/2011]	project "Consequences of land-use change on Azorean fauna and flora - the Target"; Mapping coastal and marine biodiversity of the Azores; Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCT)	For data collection, financial support was provided by the project "Consequences of land-use change on Azorean fauna and flora - the 2010 Target" (Ref: Direccao Regional da Ciencia e Tecnologia M.2.1.2/I/003/2008) and "Mapping coastal and marine biodiversity of the Azores" (Ref: M2.1.2/I/027/2011). MF received a Postdoctoral Grant: Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCT) (M3.1.7/F/002/2011).	Alcaraz C, 2005, DIVERS DISTRIB, V11, P289, DOI 10.1111/j.1366-9516.2005.00170.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Almeida-Neto M, 2012, GLOBAL ECOL BIOGEOGR, V21, P772, DOI 10.1111/j.1466-8238.2011.00709.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Angeler DG, 2008, MAR FRESHWATER RES, V59, P418, DOI 10.1071/MF07206; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blair R, 2004, ECOL SOC, V9; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borges PAV., 2010, LISTAGEM ORGANISMOS, P179; Cam E, 2000, OIKOS, V91, P428, DOI 10.1034/j.1600-0706.2000.910303.x; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Cardoso P, 2014, J BIOGEOGR, V41, P749, DOI 10.1111/jbi.12239; Cardoso P, 2009, DIVERS DISTRIB, V15, P1081, DOI 10.1111/j.1472-4642.2009.00607.x; Cardoso P, 2009, ACTA OECOL, V35, P590, DOI 10.1016/j.actao.2009.05.005; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Cassey P, 2007, DIVERS DISTRIB, V13, P458, DOI 10.1111/j.1472-4642.2007.00366.x; Castro SA, 2007, J BIOGEOGR, V34, P213, DOI 10.1111/j.1365-2699.2006.01605.x; CUTLER AH, 1994, LANDSCAPE URBAN PLAN, V28, P73, DOI 10.1016/0169-2046(94)90045-0; Florencio M, 2013, DIVERS DISTRIB, V19, P1450, DOI 10.1111/ddi.12121; Florencio M, 2011, OECOLOGIA, V166, P469, DOI 10.1007/s00442-010-1847-2; Gasso N, 2009, DIVERS DISTRIB, V15, P50, DOI 10.1111/j.1472-4642.2008.00501.x; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Higgins CL, 2006, OIKOS, V114, P159; Lambdon PW, 2008, DIVERS DISTRIB, V14, P774, DOI 10.1111/j.1472-4642.2008.00490.x; McAbendroth L, 2005, J ANIM ECOL, V74, P41, DOI 10.1111/j.1365-2656.2004.00895.x; McCune JL, 2013, J ECOL, V101, P1542, DOI 10.1111/1365-2745.12156; McKinney M, 2008, J BIOGEOGR, V35, P1960, DOI 10.1111/j.1365-2699.2008.02011.x; McKinney ML, 2004, BIOL INVASIONS, V6, P495, DOI 10.1023/B:BINV.0000041562.31023.42; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Naaf T, 2010, BIOL CONSERV, V143, P848, DOI 10.1016/j.biocon.2009.12.027; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; PATTERSON BD, 1990, OIKOS, V59, P330, DOI 10.2307/3545143; Podani J, 2013, ECOL COMPLEX, V15, P52, DOI 10.1016/j.ecocom.2013.03.002; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Rogers DA, 2008, ECOLOGY, V89, P2482, DOI 10.1890/07-1129.1; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Ruhi A, 2013, OECOLOGIA, V171, P545, DOI 10.1007/s00442-012-2440-7; Sax DF, 2001, J BIOGEOGR, V28, P139, DOI 10.1046/j.1365-2699.2001.00536.x; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Shaw JD, 2010, J BIOGEOGR, V37, P217, DOI 10.1111/j.1365-2699.2009.02204.x; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; Traveset A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3040; Triantis KA, 2010, ECOGRAPHY, V33, P285, DOI 10.1111/j.1600-0587.2010.06203.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2012, ECOGRAPHY, V35, P865, DOI 10.1111/j.1600-0587.2012.07671.x; Ulrich W, 2012, ECOL MODEL, V244, P20, DOI 10.1016/j.ecolmodel.2012.06.030; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Van Calster H, 2007, FOREST ECOL MANAG, V241, P258, DOI 10.1016/j.foreco.2007.01.007; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Whittaker RJ, 2014, P NATL ACAD SCI USA, V111, P13709, DOI 10.1073/pnas.1218036111; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; Yelenik SG, 2013, NATURE, V503, P517, DOI 10.1038/nature12798	67	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128276	10.1371/journal.pone.0128276	http://dx.doi.org/10.1371/journal.pone.0128276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024235	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400078
J	Metushi, IG; Wriston, A; Banerjee, P; Gohlke, BO; English, M; Lucas, A; Moore, C; Sidney, J; Buus, S; Ostrov, DA; Mallal, S; Phillips, E; Shabanowitz, J; Hunt, DF; Preissner, R; Peters, B				Metushi, Imir G.; Wriston, Amanda; Banerjee, Priyanka; Gohlke, Bjoern Oliver; English, Michelle; Lucas, Andrew; Moore, Carrie; Sidney, John; Buus, Soren; Ostrov, David A.; Mallal, Simon; Phillips, Elizabeth; Shabanowitz, Jeffrey; Hunt, Donald F.; Preissner, Robert; Peters, Bjoern			Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity	PLOS ONE			English	Article							ELECTRON-TRANSFER DISSOCIATION; REACTION SUBSEQUENT; DRUG; HLA; PEPTIDES; DATABASE	Immune mediated adverse drug reactions (IM-ADRs) remain a significant source of patient morbidity that have more recently been shown to be associated with specific class I and/or II human leukocyte antigen (HLA) alleles. Abacavir-induced hypersensitivity syndrome is a CD8(+) T cell dependent IM-ADR that is exclusively mediated by HLA-B*57:01. We and others have previously shown that abacavir can occupy the floor of the peptide binding groove of HLA-B*57:01 molecules, increasing the affinity of certain self peptides resulting in an altered peptide-binding repertoire. Here, we have identified another drug, acyclovir, which appears to act in a similar fashion. As with abacavir, acyclovir showed a dose dependent increase in affinity for peptides with valine and isoleucine at their C-terminus. In agreement with the binding studies, HLA-B57:01 peptide-elution studies performed in the presence of acyclovir revealed an increased number of endogenously bound peptides with a C-terminal isoleucine. Accordingly, we have hypothesized that acyclovir acts by the same mechanism as abacavir, although our data also suggest the overall effect is much smaller: the largest changes of peptide affinity for acyclovir were 2-5 fold, whereas for abacavir this effect was as much as 1000-fold. Unlike abacavir, acyclovir is not known to cause IM-ADRs. We conclude that the modest effect of acyclovir on HLA binding affinity in contrast to the large effect of abacavir is insufficient to trigger a hypersensitivity syndrome. We further support this by functional in vitro studies where acyclovir, unlike abacavir, was unable to produce an increase in IFN-gamma upon expansion of HLA-B*57:01(+) PBMCs from healthy donors. Using abacavir and acyclovir as examples we therefore propose an in vitro pre-clinical screening strategy, whereby thresholds can be applied to MHC-peptide binding assays to determine the likelihood that a drug could cause a clinically relevant IM-ADR.	[Metushi, Imir G.; Moore, Carrie; Sidney, John; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Wriston, Amanda; English, Michelle; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA USA; [Banerjee, Priyanka; Gohlke, Bjoern Oliver; Preissner, Robert] Charite, Inst Physiol, D-13353 Berlin, Germany; [Banerjee, Priyanka; Gohlke, Bjoern Oliver; Preissner, Robert] Expt Clin Res Ctr, Berlin, Germany; [Banerjee, Priyanka; Preissner, Robert] Humboldt Univ, Grad Sch Computat Syst Biol, D-10099 Berlin, Germany; [Gohlke, Bjoern Oliver; Preissner, Robert] German Canc Consortium DKTK, Heidelberg, Germany; [Lucas, Andrew; Mallal, Simon; Phillips, Elizabeth] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Buus, Soren] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark; [Ostrov, David A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Mallal, Simon; Phillips, Elizabeth] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	La Jolla Institute for Immunology; University of Virginia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Murdoch University; University of Copenhagen; State University System of Florida; University of Florida; Vanderbilt University; University of Virginia	Peters, B (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	bpeters@liai.org	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309; Lucas, Andrew Douglas/0000-0003-2899-1806; preissner, robert/0000-0002-2407-1087; Lucas, Michaela/0000-0001-8881-9990; banerjee, priyanka/0000-0001-8072-5594; Gohlke, Bjoern/0000-0003-3094-1031	National Institutes of Health (NIH) [RO1-AI103348-02]; European Union Seventh Frame work Pro-gramme SYNSYS; Berlin-Brandenburg Research Platform BB3R (BMBF) [031A262C]; Innovative Toxicology for the Reduction of Animal Experimentation (e:ToP), Immunotox Project (BMBF) [031A268B]; NIH [AI 33993];  [HEALTH -2009-2.1.2-1 [242167]]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033993, R01AI033993] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Seventh Frame work Pro-gramme SYNSYS; Berlin-Brandenburg Research Platform BB3R (BMBF)(Federal Ministry of Education & Research (BMBF)); Innovative Toxicology for the Reduction of Animal Experimentation (e:ToP), Immunotox Project (BMBF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant number RO1-AI103348-02; European Union Seventh Frame work Pro-gramme SYNSYS; HEALTH -2009-2.1.2-1 [242167]; Berlin-Brandenburg Research Platform BB3R (BMBF) [031A262C]; Innovative Toxicology for the Reduction of Animal Experimentation (e:ToP), Immunotox Project (BMBF) [031A268B]. NIH grant number AI 33993 to (DFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LC, 2015, INT J MASS SPECTROM, V377, P617, DOI 10.1016/j.ijms.2014.06.023; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bauer RA, 2008, NUCLEIC ACIDS RES, V36, pW47, DOI 10.1093/nar/gkn285; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Earley L, 2013, ANAL CHEM, V85, P8385, DOI 10.1021/ac401783f; Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Lammintausta K, 2001, CONTACT DERMATITIS, V45, P181, DOI 10.1034/j.1600-0536.2001.045003181.x; Lucas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117160; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mir-Bonafe JM, 2013, TRANSPL INFECT DIS, V15, pE75, DOI 10.1111/tid.12058; Norcross MA, 2012, AIDS, V26, pF21, DOI 10.1097/QAD.0b013e328355fe8f; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Pompeu YA, 2012, IMMUNOL REV, V250, P158, DOI 10.1111/j.1600-065X.2012.01163.x; ROBINSON GE, 1985, GENITOURIN MED, V61, P62; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Sidney J, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1803s31; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Vernassiere C, 2003, CONTACT DERMATITIS, V49, P155, DOI 10.1111/j.0105-1873.2003.00199.x; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211	27	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0124878	10.1371/journal.pone.0124878	http://dx.doi.org/10.1371/journal.pone.0124878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024233	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000355319400006
J	Pignon, JC; Grisanzio, C; Carvo, I; Werner, L; Regan, M; Wilson, EL; Signoretti, S				Pignon, Jean-Christophe; Grisanzio, Chiara; Carvo, Ingrid; Werner, Lillian; Regan, Meredith; Wilson, E. Lynette; Signoretti, Sabina			Cell Kinetic Studies Fail to Identify Sequentially Proliferating Progenitors as the Major Source of Epithelial Renewal in the Adult Murine Prostate	PLOS ONE			English	Article							INVOLVE SPECIALIZED PROGENITORS; ANDROGEN-INDUCED REGENERATION; STEM-CELLS; MOUSE PROSTATE; LUMINAL CELLS; REGIONAL-VARIATION; DUCTAL SYSTEM; RAT PROSTATE; BASAL-CELLS; BETA-CELLS	There is evidence that stem cells and their progeny play a role in the development of the prostate. Although stem cells are also considered to give rise to differentiated progeny in the adult prostate epithelium ex vivo, the cohort of adult prostate stem cells in vivo as well as the mechanisms by which the adult prostate epithelium is maintained and regenerated remain highly controversial. We have attempted to resolve this conundrum by performing in vivo tracing of serially replicating cells after the sequential administration of two thymidine analogues to mice. Our results show that, during normal prostate homeostasis, sequentially proliferating cells are detected at a rate that is consistent with a stochastic process. These findings indicate that in vivo, under steady-state conditions, most adult prostate epithelial cells do not represent the progeny of a small number of specialized progenitors that generate sequentially replicating transit-amplifying (TA) cells but are formed by stochastic cell division. Similarly, no rapidly cycling TA cells were detected during regeneration following one cycle of androgen-mediated involution/regeneration of the prostate epithelium. These findings greatly enhance our understanding of the mechanisms regulating prostate epithelial cell renewal and may have significant implications in defining the cell of origin of proliferative prostatic diseases.	[Pignon, Jean-Christophe; Grisanzio, Chiara; Carvo, Ingrid; Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Pignon, Jean-Christophe; Grisanzio, Chiara; Werner, Lillian; Regan, Meredith; Signoretti, Sabina] Harvard Univ, Sch Med, Boston, MA USA; [Grisanzio, Chiara; Signoretti, Sabina] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Werner, Lillian; Regan, Meredith] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA; [Wilson, E. Lynette] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Wilson, E. Lynette] NYU, Sch Med, Dept Urol, New York, NY 10003 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; New York University; New York University	Signoretti, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	ssignoretti@partners.org			National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants [1R21DK72152, 1R01DK089975]; Harvard Stem Cell Institute [5R01CA132641]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA132641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072152, R01DK089975] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants 1R21DK72152 and 1R01DK089975 and the Harvard Stem Cell Institute (SS) and 5R01CA132641 (ELW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; EVANS GS, 1987, PROSTATE, V10, P163, DOI 10.1002/pros.2990100208; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Kwon OJ, 2014, P NATL ACAD SCI USA, V111, pE592, DOI 10.1073/pnas.1318157111; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; Liu J, 2011, MOL ENDOCRINOL, V25, P1849, DOI 10.1210/me.2011-1081; Mirosevich J, 1999, J ENDOCRINOL, V162, P341, DOI 10.1677/joe.0.1620341; Nemeth JA, 1996, PROSTATE, V28, P124; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; ROOP DR, 1984, J BIOL CHEM, V259, P8037; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tran CP, 2002, MOL CANCER RES, V1, P113; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; van Leenders G, 2000, LAB INVEST, V80, P1251, DOI 10.1038/labinvest.3780133; Waltregny D, 2001, MOL ENDOCRINOL, V15, P765, DOI 10.1210/me.15.5.765; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Xu C, 2007, PROSTATE, V67, P1621, DOI 10.1002/pros.20655	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128489	10.1371/journal.pone.0128489	http://dx.doi.org/10.1371/journal.pone.0128489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024527	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400093
J	Walenda, T; Diener, Y; Jost, E; Morin-Kensicki, E; Goecke, TW; Bosio, A; Rath, B; Brummendorf, TH; Bissels, U; Wagner, W				Walenda, Thomas; Diener, Yvonne; Jost, Edgar; Morin-Kensicki, Elizabeth; Goecke, Tamme W.; Bosio, Andreas; Rath, Bjoern; Bruemmendorf, Tim H.; Bissels, Ute; Wagner, Wolfgang			MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor Cells	PLOS ONE			English	Article							SELF-RENEWAL; CIRCULATING MICRORNAS; ARACHIDONIC-ACID; BILE-ACIDS; IN-VIVO; PLASMA; PROLIFERATION; MAINTENANCE; CHALLENGES; MECHANISM	Hematopoietic regeneration after high dose chemotherapy necessitates activation of the stem cell pool. There is evidence that serum taken after chemotherapy comprises factors stimulating proliferation and self-renewal of CD34(+) hematopoietic stem and progenitor cells (HSPCs) - however, the nature of these feedback signals is yet unclear. Here, we addressed the question if specific microRNAs (miRNAs) or metabolites are affected after high dose chemotherapy. Serum taken from the same patients before and after chemotherapy was supplemented for in vitro cultivation of HSPCs. Serum taken after chemotherapy significantly enhanced HSPC proliferation, better maintained a CD34(+) immunophenotype, and stimulated colony forming units. Microarray analysis revealed that 23 miRNAs changed in serum after chemotherapy - particularly, miRNA-320c and miRNA-1275 were down-regulated whereas miRNA-3663-3p was up-regulated. miRNA-320c was exemplarily inhibited by an antagomiR, which seemed to increase proliferation. Metabolomic profiling demonstrated that 44 metabolites were less abundant, whereas three (including 2-hydroxybutyrate and taurocholenate sulphate) increased in serum upon chemotherapy. Nine of these metabolites were subsequently tested for effects on HSPCs in vitro, but none of them exerted a clear concentration dependent effect on proliferation, immunophenotype and colony forming unit formation. Taken together, serum profiles of miRNAs and metabolites changed after chemotherapy. Rather than individually, these factors may act in concert to recruit HSPCs into action for hematopoietic regeneration.	[Walenda, Thomas; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany; [Diener, Yvonne; Bosio, Andreas; Bissels, Ute] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Jost, Edgar; Bruemmendorf, Tim H.] Rhein Westfal TH Aachen, Sch Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany; [Morin-Kensicki, Elizabeth] Metabolon Inc, Durham, NC 27519 USA; [Goecke, Tamme W.] Rhein Westfal TH Aachen, Sch Med, Dept Obstet & Gynecol, Aachen, Germany; [Rath, Bjoern] Rhein Westfal TH Aachen, Sch Med, Dept Orthoped, Aachen, Germany	Helmholtz Association; RWTH Aachen University; Miltenyi Biotec; RWTH Aachen University; Metabolon; RWTH Aachen University; RWTH Aachen University	Wagner, W (corresponding author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany.	wwagner@ukaachen.de	Rath, Björn/AFI-8239-2022; Rath, Björn/AAF-3938-2022	Bosio, Andreas/0000-0001-9776-2535; Wagner, Wolfgang/0000-0002-1971-3217	German Research Foundation [WA1706/2-1]; Stem Cell Network North Rhine Westphalia; Faculty of Medicine RWTH Aachen University within the START-Program [891208]; Interdisciplinary Center for Clinical Research [O1-1]; Miltenyi Biotec GmbH; Metabolon Inc.	German Research Foundation(German Research Foundation (DFG)); Stem Cell Network North Rhine Westphalia; Faculty of Medicine RWTH Aachen University within the START-Program; Interdisciplinary Center for Clinical Research; Miltenyi Biotec GmbH; Metabolon Inc.	This work was supported by German Research Foundation (WW; WA1706/2-1; www.dfg.de), Stem Cell Network North Rhine Westphalia (WW; www.stammzellen.nrw.de/), Faculty of Medicine RWTH Aachen University within the START-Program (TW; 891208; www.medizin.rwth-aachen.de/go/id/tfy), Interdisciplinary Center for Clinical Research (EJ, WW; O1-1; http://www.medizin.rwth-aachen.de). Miltenyi Biotec GmbH and Metabolon Inc. provided support in the form of salaries for authors YD, EMK, AB and UB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Brown JA, 2008, CLIN IMMUNOL, V127, P286, DOI 10.1016/j.clim.2008.02.008; Canpolat S, 2014, SCI WORLD J, DOI 10.1155/2014/624395; Chavali S, 2013, RNA, V19, P1552, DOI 10.1261/rna.038414.113; Chotinantakul K, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/909812; Desplat V, 2000, BLOOD CELL MOL DIS, V26, P427, DOI 10.1006/bcmd.2000.0321; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Farshidfar F, 2012, GENOME MED, V4, DOI 10.1186/gm341; Fimognari C, 2009, ANN NY ACAD SCI, V1171, P264, DOI 10.1111/j.1749-6632.2009.04710.x; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Giangreco AA, 2013, J STEROID BIOCHEM, V136, P86, DOI 10.1016/j.jsbmb.2013.01.001; Grasedieck S, 2013, BLOOD, V121, P4977, DOI 10.1182/blood-2013-01-480079; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gysin R, 2002, FASEB J, V16, P1952, DOI 10.1096/fj.02-0362fje; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurita M, 2008, PLAST RECONSTR SURG, V122, P438, DOI 10.1097/PRS.0b013e31817d618d; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Lento W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008011; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang HW, 2014, WIRES RNA, V5, P285, DOI 10.1002/wrna.1208; Marciniak-Czochra A, 2009, AGING-US, V1, P723, DOI 10.18632/aging.100072; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Phypers B, 2006, BJA EDUC, V6, P128, DOI 10.1093/bjaceaccp/mkl018; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qiu B, 2014, MOL MED REP, V10, P1157, DOI 10.3892/mmr.2014.2267; Rainer PP, 2013, HEART, V99, P1685, DOI 10.1136/heartjnl-2013-304163; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Walenda T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003599; Walenda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018012; Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011; Walenda T, 2010, J CELL MOL MED, V14, P337, DOI 10.1111/j.1582-4934.2009.00776.x; Wei SW, 2013, MOL ONCOL, V7, P297, DOI 10.1016/j.molonc.2012.10.003; Wells SR, 2010, J NUTR BIOCHEM, V21, P589, DOI 10.1016/j.jnutbio.2009.03.006; White AC, 2006, BONE MARROW TRANSPL, V38, P513, DOI 10.1038/sj.bmt.1705475; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128231	10.1371/journal.pone.0128231	http://dx.doi.org/10.1371/journal.pone.0128231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024523	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400075
J	Yamankurt, G; Wu, HC; McCarthy, M; Cunha, SR				Yamankurt, Gokay; Wu, Henry C.; McCarthy, Michael; Cunha, Shane R.			Exon Organization and Novel Alternative Splicing of Ank3 in Mouse Heart	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; ANKYRIN-G; LATERAL MEMBRANE; INTERCALATED DISC; SKELETAL-MUSCLE; BETA-SPECTRIN; REQUIRES; IDENTIFICATION; DOMAINS; BINDING	Ankyrin-G is an adaptor protein that links membrane proteins to the underlying cytoskeletal network. Alternative splicing of the Ank3 gene gives rise to multiple ankyrin-G isoforms in numerous tissues. To date, only one ankyrin-G isoform has been characterized in heart and transcriptional regulation of the Ank3 gene is completely unknown. In this study, we describe the first comprehensive analysis of Ank3 expression in heart. Using a PCR-based screen of cardiac mRNA transcripts, we identify two new exons and 28 alternative splice variants of the Ank3 gene. We measure the relative expression of each splice variant using quantitative real-time PCR and exon-exon boundary spanning primers that specifically amplify individual Ank3 variants. Six variants are rarely expressed (< 1%), while the remaining variants display similar expression patterns in three hearts. Of the five first exons in the Ank3 gene, exon 1d is only expressed in heart and skeletal muscle as it was not detected in brain, kidney, cerebellum, and lung. Immunoblot analysis reveals multiple ankyrin-G isoforms in heart, and two ankyrin-G subpopulations are detected in adult cardiomyocytes by immunofluorescence. One population co-localizes with the voltage-gated sodium channel NaV1.5 at the intercalated disc, while the other population expresses at the Z-line. Two of the rare splice variants excise a portion of the ZU5 motif, which encodes the minimal spectrin- binding domain, and these variants lack beta-spectrin binding. Together, these data demonstrate that Ank3 is subject to complex splicing regulation resulting in a diverse population of ankyrin-G isoforms in heart.	[Yamankurt, Gokay] Northwestern Univ, Dept Chem, Evanston, IL USA; [Wu, Henry C.; McCarthy, Michael; Cunha, Shane R.] UT Hlth, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Northwestern University	Cunha, SR (corresponding author), UT Hlth, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	shane.r.cunha@uth.tmc.edu		McCarthy, Michael/0000-0001-6534-2237	NIH NHLBI [092232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM105538] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH NHLBI 092232 to GY and SRC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalon G, 2011, J BIOL CHEM, V286, P7370, DOI 10.1074/jbc.M110.187831; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2008, J MOL CELL CARDIOL, V45, P724, DOI 10.1016/j.yjmcc.2008.08.005; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; Gagelin C, 2002, J BIOL CHEM, V277, P12978, DOI 10.1074/jbc.M111299200; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kordeli E, 1998, J CELL SCI, V111, P2197; La-Borde PJ, 2010, BIOCHEM BIOPH RES CO, V392, P490, DOI 10.1016/j.bbrc.2010.01.046; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Makara MA, 2014, CIRC RES, V115, P929, DOI 10.1161/CIRCRESAHA.115.305154; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Noujaim SF, 2012, FASEB J, V26, P63, DOI 10.1096/fj.10-179770; Peters B, 2001, J INVEST DERMATOL, V116, P216, DOI 10.1046/j.1523-1747.2001.01210.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Wang C, 2012, P NATL ACAD SCI USA, V109, P4822, DOI 10.1073/pnas.1200613109; Yasunaga M, 2012, J MOL BIOL, V417, P336, DOI 10.1016/j.jmb.2012.01.041; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571	33	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128177	10.1371/journal.pone.0128177	http://dx.doi.org/10.1371/journal.pone.0128177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024478	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400074
J	Ceschi, A; Heistermann, E; Gros, S; Reichert, C; Kupferschmidt, H; Banner, NR; Krahenbuhl, S; Taegtmeyer, AB				Ceschi, Alessandro; Heistermann, Elja; Gros, Sonja; Reichert, Cornelia; Kupferschmidt, Hugo; Banner, Nicholas R.; Kraehenbuehl, Stephan; Taegtmeyer, Anne B.			Acute Sirolimus Overdose: A Multicenter Case Series	PLOS ONE			English	Article							PRELIMINARY PHARMACOKINETICS; POISON CENTER; DOUBLE-BLIND; TRANSPLANT; RAPAMYCIN; TOLERANCE; SAFETY	Background There are few data relating to sirolimus overdose in the medical literature. Our objectives were to describe all cases of overdose with sirolimus reported to Swiss, German and Austrian Poisons Centres between 2002-2013. Methods An observational case-series analysis was performed to determine circumstances, magnitude, management and outcome of sirolimus overdose. Results Five cases of acute sirolimus overdose were reported - three in young children and two in adults. Four were accidental and one was with suicidal intent. Two patients developed symptoms probably related to sirolimus overdose: mild elevation of alkaline phosphatase, fever and gastroenteritis in a 2.5-year-old male who ingested 3 mg, and mild changes in total cholesterol in an 18-year-old female after ingestion of 103 mg. None of these events were life-threatening. Serial blood concentration measurements were performed starting 24 h after ingestion of 103 mg in a single case, and these followed a similar pharmacokinetic time-course to measurements taken after dosing in the therapeutic range. Conclusions Acute sirolimus overdose occurred accidentally in the majority of cases. Even large overdoses appeared to be well-tolerated, however children might be at greater risk of developing complications. Further study of sirolimus overdose is needed.	[Ceschi, Alessandro; Reichert, Cornelia; Kupferschmidt, Hugo] Univ Zurich, Swiss Toxicol Informat Ctr, Associated Inst, Zurich, Switzerland; [Ceschi, Alessandro] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Heistermann, Elja] Berlin Poison Informat Ctr, Berlin, Germany; [Gros, Sonja] Mainz Poison Control Ctr, Mainz, Germany; [Banner, Nicholas R.] Harefield Hosp, Royal Brompton & Harefield NHS Fdn Trust, Harefield UB9 6JH, Middx, England; [Banner, Nicholas R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Banner, Nicholas R.] Univ London Imperial Coll Sci Technol & Med, Inst Cardiovasc Med & Res, London, England; [Kraehenbuehl, Stephan; Taegtmeyer, Anne B.] Univ Basel, Dept Clin Pharmacol & Toxicol, Basel, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; Imperial College London; University of Basel	Taegtmeyer, AB (corresponding author), Univ Basel, Dept Clin Pharmacol & Toxicol, Basel, Switzerland.	anne.taegtmeyer@usb.ch	Krähenbühl, Stephan/Z-4744-2019	Ceschi, Alessandro/0000-0002-4308-0405	University and University Hospital Basel; Swiss Toxicological Information Centre; Society of Clinical Toxicology (GfKT); Swiss National Science Foundation [SNF31003A-132992]	University and University Hospital Basel; Swiss Toxicological Information Centre; Society of Clinical Toxicology (GfKT); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was through internal funds of the University and University Hospital Basel, the Swiss Toxicological Information Centre, and the Society of Clinical Toxicology (GfKT). SK is supported by grants from the Swiss National Science Foundation (SNF31003A-132992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brattstrom C, 1997, THER DRUG MONIT, V19, P397, DOI 10.1097/00007691-199708000-00007; Brattstrom C, 1996, TRANSPLANT P, V28, P985; Ceschi A, 2013, AM J TRANSPLANT, V13, P786, DOI 10.1111/j.1600-6143.2012.04347.x; Ceschi A, 2014, EXPERT OPIN DRUG SAF, V13, P525, DOI 10.1517/14740338.2014.903032; Ferron GM, 1997, CLIN PHARMACOL THER, V61, P416, DOI 10.1016/S0009-9236(97)90192-2; Gregoriano C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086390; Hoffinan RS, 2007, CLIN TOXICOL, V45, P943, DOI 10.1080/15563650701233370; Howland MA, 2010, GOLDFRANKS TOXICOLOG, P108; Johnson EM, 1996, TRANSPLANT P, V28, P987; Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x; Kelly PA, 1997, PHARMACOTHERAPY, V17, P1148; Klasco RK, 2014, POISINDEX TOMES SYST; Mahalati K, 2001, CLIN PHARMACOKINET, V40, P573, DOI 10.2165/00003088-200140080-00002; Persson HE, 1998, J TOXICOL-CLIN TOXIC, V36, P205, DOI 10.3109/15563659809028940; Pfizer AG, 2012, SWITZERLAND PRODUCT; Sturer A, 2013, CODEX ZUSAMMENARBEIT; WHO-UMC, 2014, US WHO UMC SYST STAN; Wu K, 2012, CPT-PHARMACOMET SYST, V1, DOI 10.1038/psp.2012.18; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zimmerman JJ, 1997, J CLIN PHARMACOL, V37, P405, DOI 10.1002/j.1552-4604.1997.tb04318.x	20	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128033	10.1371/journal.pone.0128033	http://dx.doi.org/10.1371/journal.pone.0128033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020944	gold, Green Accepted, Green Published			2022-12-27	WOS:000355187300074
J	Chen, J; Chen, S; Wang, JH; Zhang, MJ; Gong, ZH; Wei, YH; Li, L; Zhang, YY; Zhao, XM; Jiang, SM; Yu, L				Chen, Jian; Chen, Shuai; Wang, Jiahui; Zhang, Mingjun; Gong, Zhaohua; Wei, Youheng; Li, Li; Zhang, Yuanyuan; Zhao, Xuemei; Jiang, Songmin; Yu, Long			Cyclophilin J Is a Novel Peptidyl-Prolyl Isomerase and Target for Repressing the Growth of Hepatocellular Carcinoma	PLOS ONE			English	Article							CIS-TRANS ISOMERASES; B-VIRUS INFECTION; CYCLOSPORINE-A; CYCLIN D1; TRANSCRIPTIONAL ACTIVITY; TUMOR GROWTH; CELL-GROWTH; GENE; CALCINEURIN; EXPRESSION	Cyclophilin J (CYPJ) is a new member of the peptidyl-prolyl cis/trans-isomerase (PPIase) identified with upregulated expression in human glioma. However, the biological function of CYPJ remained unclear. We aimed to study the role of CYPJ in hepatocellular carcinoma (HCC) carcinogenesis and its therapeutic potential. We determined the expression of CYPJ in HCC/adjacent normal tissues using Western blot, Northern blot and semi-quantitative RT-PCR, analyzed the biochemical characteristics of CYPJ, and resolved the 3D-structure of CYPJ/Cyclosporin A (CsA) complex. We also studied the roles of CYPJ in cell cycle, cyclin D1 regulation, in vitro and in vivo tumor growth. We found that CYPJ expression was upregulated in over 60% HCC tissues. The PPIase activity of CYPJ could be inhibited by the widely used immunosuppressive drug CsA. CYPJ was found expressed in the whole cell of HCC with preferential location at the cell nucleus. CYPJ promoted the transition of cells from G1 phase to S phase in a PPIase-dependent manner by activating cyclin D1 promoter. CYPJ overexpression accelerated liver cell growth in vitro (cell growth assay, colony formation) and in vivo (xenograft tumor formation). Inhibition of CYPJ by its inhibitor CsA or CYPJ-specific RNAi diminished the growth of liver cancer cells in vitro and in vivo. In conclusion, CYPJ could facilitate HCC growth by promoting cell cycle transition from G1 to S phase through the upregulation of cyclin D1. Suppression of CYPJ could repress the growth of HCC, which makes CYPJ a potential target for the development of new strategies to treat this malignancy.	[Chen, Jian; Chen, Shuai; Zhang, Mingjun; Wei, Youheng; Li, Li; Zhang, Yuanyuan; Zhao, Xuemei; Jiang, Songmin; Yu, Long] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Chen, Jian; Wang, Jiahui] Qingdao Univ, Yantai Yuhuangding Hosp, Shandong Res Ctr Stem Cell Engn, Affiliated Hosp, Yantai, Shandong, Peoples R China; [Gong, Zhaohua] Qingdao Univ, Yantai Yuhuangding Hosp, Dept Oncol, Affiliated Hosp, Yantai, Shandong, Peoples R China	Fudan University; Qingdao University; Qingdao University	Chen, J (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	smjiang@fudan.edu.cn; jianchen2005@gmail.com	zhang, yuanyuan/GYA-4428-2022	Chen, Jian/0000-0002-1694-7763	National Key Basic Research and Development Plan of China (973 Program) [2013CB910504]; National Natural Science Foundation of China [30801338, 81071758]; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [2008BSA02012]; Yantai Science and Technology Program [2012085, 2009155-3]	National Key Basic Research and Development Plan of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shangdong Province Young and Middle-Aged Scientists Research Awards Fund; Yantai Science and Technology Program	Support for this work came from The National Key Basic Research and Development Plan of China (973 Program) (http://www.most.gov.cn/bszn/new/973/jbxx) grant number 2013CB910504 (SJ), National Natural Science Foundation of China (http://www.nsfc.gov.cn/) grant number 30801338 (JC) and 81071758 (JC), Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (http://jihlx.sdstc.gov.cn/STDPMS/BS/Default.aspx) grant number 2008BSA02012 (JC), and Yantai Science and Technology Program (http://www.ytstc.gov.cn/fund.aspx) grant number 2012085 (JC) and 2009155-3 (ZG). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azechi H, 2001, ONCOLOGY-BASEL, V60, P346, DOI 10.1159/000058531; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Chen S, 2006, CYTOGENET GENOME RES, V114, P131, DOI 10.1159/000093328; D'Costa S, 2003, LEUKEMIA LYMPHOMA, V44, P139, DOI 10.1080/1042819021000050043; Elmileik H, 2005, J SURG ONCOL, V91, P258, DOI 10.1002/jso.20304; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gudavicius G, 2014, RNA, V20, P1014, DOI 10.1261/rna.042648.113; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Hu H, 2005, ACTA CRYSTALLOGR F, V61, P216, DOI 10.1107/S1744309105000643; Huang LL, 2005, ACTA CRYSTALLOGR D, V61, P316, DOI 10.1107/S0907444904033189; Jiang JM, 2001, GENE, V281, P103, DOI 10.1016/S0378-1119(01)00787-9; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Kikuchi E, 2004, CLIN CANCER RES, V10, P1835, DOI 10.1158/1078-0432.CCR-03-0099; Kim H, 2005, CLIN IMMUNOL, V116, P217, DOI 10.1016/j.clim.2005.05.004; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lee J, 2010, J INT MED RES, V38, P1561, DOI 10.1177/147323001003800501; Lee J, 2010, ARCH PHARM RES, V33, P181, DOI 10.1007/s12272-010-0200-y; Lin HL, 2003, BRIT J CANCER, V88, P973, DOI 10.1038/sj.bjc.6600788; Lin Jun, 2012, Zhonghua Yi Xue Za Zhi, V92, P388; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lunn RM, 1997, CANCER RES, V57, P3471; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Ochocka AM, 2009, FEBS LETT, V583, P621, DOI 10.1016/j.febslet.2009.01.009; Qi ZY, 2005, CHINESE MED J-PEKING, V118, P799; Qian Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-442; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; ROUSSEL A, 1991, TURBOFRODO SILICON G; Satoh K, 2010, CIRC J, V74, P2249, DOI 10.1253/circj.CJ-10-0904; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Werneck MBF, 2012, CELL CYCLE, V11, P3997, DOI 10.4161/cc.22222; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Yao QZ, 2005, WORLD J SURG, V29, P276, DOI 10.1007/s00268-004-7812-7; Yeh KT, 2000, CANCER INVEST, V18, P123, DOI 10.3109/07357900009038243; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou Z, 2001, CYTOGENET CELL GENET, V92, P231, DOI 10.1159/000056909; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	49	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127668	10.1371/journal.pone.0127668	http://dx.doi.org/10.1371/journal.pone.0127668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020957	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300051
J	Huang, YS; Xia, LH; Wu, QF; Zeng, ZF; Huang, ZL; Zhou, SY; Jin, JC; Huang, HL				Huang, Yongshun; Xia, Lihua; Wu, Qifeng; Zeng, Zifang; Huang, Zhenlie; Zhou, Shanyu; Jin, Jiachun; Huang, Hanlin			Trichloroethylene Hypersensitivity Syndrome Is Potentially Mediated through Its Metabolite Chloral Hydrate	PLOS ONE			English	Article							GENERALIZED SKIN DISORDERS; OCCUPATIONAL EXPOSURE; DERMATITIS; REACTIVATION; WORKERS; DYSFUNCTION; EXPRESSION; ERYTHEMA; ERUPTION; PROTEIN	Background We documented previously the entity of trichloroethylene (TCE) hypersensitivity syndrome (THS) in occupational workers. Objectives To identify the culprit causative compound, determine the type of hypersensitivity of THS, and establish a screening test for subjects at risk of THS. Methods TCE and its main metabolites chloral hydrate (CH), trichloroethanol (TCOH) and trichloroacetic acid (TCA) were used as allergens at different concentrations in skin patch tests. The study included 19 case subjects diagnosed with occupational THS, 22 control healthy workers exposed to TCE (exposure >12 weeks), and 20 validation new workers exposed to TCE for <12 weeks free of THS. All subjects were followed-up for 12 weeks after the patch test. Results The highest patch test positive rate in subjects with THS was for CH, followed by TCOH, TCA and TCE. The CH patch test positive rate was 100% irrespective of CH concentrations (15%, 10% and 5%). The TCOH patch test positive rate was concentration-dependent (89.5%, 73.7% and 52.6% for 5%, 0.5% and 0.05%, respectively). Lower patch test positive rates were noted for TCA and TCE. All patch tests (including four allergens) were all negative in each of the 22 control subjects. None of the subjects of the validation group had a positive 15% CH patch test. Conclusions Chloral hydrate seems to be the culprit causative compound of THS and type IV seems to be the major type of hypersensitivity of THS. The CH patch test could be potentially useful for screening workers at risk of THS.	[Huang, Yongshun; Huang, Hanlin] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Occupat Hlth & Occupat Med, Guangzhou 510505, Guangdong, Peoples R China; [Huang, Yongshun; Xia, Lihua; Wu, Qifeng; Zeng, Zifang; Huang, Zhenlie; Zhou, Shanyu; Jin, Jiachun; Huang, Hanlin] Guangdong Prov Hosp Occupat Dis Prevent & Treatme, Dept Occupat Med, Guangzhou 510300, Guangdong, Peoples R China	Southern Medical University - China	Huang, HL (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Occupat Hlth & Occupat Med, Guangzhou 510505, Guangdong, Peoples R China.	huanghl@gdoh.org	Huang, Zhenlie/AAQ-9970-2020	Huang, Zhenlie/0000-0001-9818-8192	Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment [2012A061400007]; National Key Technology Research, Development Program of Ministry of Science and Technology of China during the 12th Five-Year Plan Period [2014BAI12B01]; Guangdong Medical Science Foundation [A2014071]	Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment; National Key Technology Research, Development Program of Ministry of Science and Technology of China during the 12th Five-Year Plan Period; Guangdong Medical Science Foundation	This study was supported by the Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment (2012A061400007) and the National Key Technology Research, Development Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan Period (2014BAI12B01) and Guangdong Medical Science Foundation (A2014071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caproni M, 2006, BRIT J DERMATOL, V155, P722, DOI 10.1111/j.1365-2133.2006.07398.x; Chae HJ, 2003, KOREAN J OCCUP ENV M, V15, P111; Chittasobhaktra Thirabhatra, 1997, Journal of the Medical Association of Thailand, V80, pS144; Chiu WHA, 2013, ENVIRON HEALTH PERSP, V121, P303, DOI 10.1289/ehp.1205879; CONDESALAZAR L, 1983, CONTACT DERMATITIS, V9, P235, DOI 10.1111/j.1600-0536.1983.tb04375.x; Friedmann PS, 2010, CURR OPIN ALLERGY CL, V10, P291, DOI 10.1097/ACI.0b013e32833aa54d; Gawkrodger DJ, 2001, OCCUP ENVIRON MED, V58, P823, DOI 10.1136/oem.58.12.823; Huang H., 2002, INT J IMMUNOPATH PH, V15, P30; Huang HL, 2006, J OCCUP HEALTH, V48, P417, DOI 10.1539/joh.48.417; Huang Y, 2010, CHINA OCCUP MED, V37, P157; Huang ZL, 2012, J OCCUP HEALTH, V54, P299, DOI 10.1539/joh.12-0012-OA; Jenkinson C, 2010, J INVEST DERMATOL, V130, P732, DOI 10.1038/jid.2009.271; Jia Q, 2012, TOXICOL LETT, V215, P31, DOI 10.1016/j.toxlet.2012.09.018; Kamijima M, 2007, INT ARCH OCC ENV HEA, V80, P357, DOI 10.1007/s00420-006-0147-y; Kamijima M, 2013, J DERMATOL SCI, V72, P218, DOI 10.1016/j.jdermsci.2013.07.003; Lash LH, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.1289/ehp.00108s2177; Li HS, 2007, ENVIRON HEALTH PERSP, V115, P1553, DOI 10.1289/ehp.10325; Liu H, 2004, CHINESE J IND MED, V17, P342; Liu J, 2009, IND HEALTH, V47, P685, DOI 10.2486/indhealth.47.685; NAKAYAMA H, 1988, CONTACT DERMATITIS, V19, P48, DOI 10.1111/j.1600-0536.1988.tb02867.x; Nomura Y, 2011, J DERMATOL, V38, P1076, DOI 10.1111/j.1346-8138.2010.01170.x; PHOON WH, 1984, CONTACT DERMATITIS, V10, P270, DOI 10.1111/j.1600-0536.1984.tb00145.x; Pichler WJ, 2011, J ALLERGY CLIN IMMUN, V127, pS74, DOI 10.1016/j.jaci.2010.11.048; Shear NH, 2008, AIDS, V22, P999, DOI 10.1097/QAD.0b013e3282f7cb60; Watanabe H, 2010, DERMATOLOGY, V221, P17, DOI 10.1159/000290775; Wu Q, 2013, OCCUP HLTH EMERG RES, V31, P1; Wu Q, 2013, OCCUP HLTH EMERG RES, V31, P11; Xia L, 2006, CHINA OCCUP MED, V33, P383; Zhao Na, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P284	29	17	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127101	10.1371/journal.pone.0127101	http://dx.doi.org/10.1371/journal.pone.0127101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020924	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300032
J	Chen, CM; Thiering, E; Zock, JP; Villani, S; Olivieri, M; Modig, L; Jarvis, D; Norback, D; Verlato, G; Heinrich, J				Chen, Chih-Mei; Thiering, Elisabeth; Zock, Jan-Paul; Villani, Simona; Olivieri, Mario; Modig, Lars; Jarvis, Deborah; Norbaeck, Dan; Verlato, Giuseppe; Heinrich, Joachim			Is There a Threshold Concentration of Cat Allergen Exposure on Respiratory Symptoms in Adults?	PLOS ONE			English	Article							HOUSE-DUST MITE; ASTHMA; HOMES; SENSITIZATION; DETERMINANTS; ENVIRONMENT; CHILDHOOD; INCREASES; SITE	Background and Objective Cat allergen concentrations higher than 8 mu g/g in settled house dust, have been suggested to provoke exacerbation of allergic respiratory symptoms. However, whether the 8 mu g/g of indoor cat allergen concentration is indeed the minimal exposure required for triggering the asthma related respiratory symptoms or the development of sensitization has not yet been confirmed. We studied the associations between domestic cat allergen concentrations and allergic symptoms in the European Community Respiratory Health Survey II, with the aim of confirming this suggested threshold. Methods Cat allergen concentrations were measured in the mattress dust of 3003 participants from 22 study centres. Levels of specific immunoglobulin E to cat allergens were measured in serum samples using an immunoassay. Information on allergic symptoms, medication use, home environment and smoking was obtained from a face-to-face interview. Results Domestic cat allergen concentrations were not associated with allergic/asthmatic symptoms in the entire study population, nor in the subset sensitized to cat allergen. We also found no association among individuals exposed to concentrations higher than 8 mu g/g. However, exposure to medium cat allergen concentrations (0.24-0.63 mu g/g) was positively associated with reported asthmatic respiratory symptoms in subjects who have experienced allergic symptoms when near animals. Conclusions The proposed 8 mu g/g threshold of cat allergen concentrations for the exacerbation of allergic/respiratory symptoms was not confirmed in a general European adult population. Potential biases attributable to avoidance behaviours and an imprecise exposure assessment cannot be excluded.	[Chen, Chih-Mei] Charite, Ctr Berlin, Inst Social Med Epidemiol & Hlth Econ, Paediat Epidemiol, D-13353 Berlin, Germany; [Chen, Chih-Mei; Thiering, Elisabeth; Heinrich, Joachim] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Zock, Jan-Paul] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Zock, Jan-Paul] Univ Pompeu Fabra, Barcelona, Spain; [Zock, Jan-Paul] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Zock, Jan-Paul] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Villani, Simona] Univ Pavia, Dept Hlth Sci, I-27100 Pavia, Italy; [Olivieri, Mario] Univ Hosp Verona, Unit Occupat Med, Verona, Italy; [Modig, Lars] Umea Univ, Occupat & Environm Med, Umea, Sweden; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Resp Epidemiol & Publ Hlth Grp, London, England; [Norbaeck, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden; [Verlato, Giuseppe] Univ Verona, Unit Epidemiol & Med Stat, I-37100 Verona, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Netherlands Institute for Health Services Research; University of Pavia; Umea University; Imperial College London; Uppsala University; University of Verona	Heinrich, J (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany.	joachim.heinrich@helmholtz-muenchen.de	Zock, Jan-Paul/P-5034-2018; Heinrich, Joachim/N-1720-2013	Zock, Jan-Paul/0000-0002-2941-6259; Heinrich, Joachim/0000-0002-9620-1629; Jarvis, Deborah/0000-0002-1753-3896; Thiering, Elisabeth/0000-0002-5429-9584; /0000-0003-2517-6515; Norback, Dan/0000-0002-5174-6668				Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, P1012, DOI 10.1016/S0091-6749(99)70172-7; Bollinger ME, 1996, J ALLERGY CLIN IMMUN, V97, P907, DOI 10.1016/S0091-6749(96)80064-9; Brunetto B, 2009, ANN I SUPER SANITA, V45, P415; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Celedon JC, 2002, LANCET, V360, P781, DOI 10.1016/S0140-6736(02)09906-3; Chen CM, 2010, INT J HYG ENVIR HEAL, V213, P1, DOI 10.1016/j.ijheh.2009.12.003; Chinn S, 2007, AM J RESP CRIT CARE, V176, P20, DOI 10.1164/rccm.200612-1840OC; Custovic A, 1998, CLIN EXP ALLERGY, V28, P53, DOI 10.1046/j.1365-2222.1998.00183.x; de Blay F, 1999, INT ARCH ALLERGY IMM, V120, P158, DOI 10.1159/000024234; Fahlbusch B, 2002, J INVEST ALLERG CLIN, V12, P12; Gehring U, 2001, EUR RESPIR J, V18, P555, DOI 10.1183/09031936.01.00096801; Gore RB, 2006, J ALLERGY CLIN IMMUN, V117, P649, DOI 10.1016/j.jaci.2005.12.1351; Gunnbjornsdottir MI, 2009, CLIN RESPIR J, V3, P85, DOI 10.1111/j.1752-699X.2008.00122.x; Heinrich J, 2006, J ALLERGY CLIN IMMUN, V118, P674, DOI 10.1016/j.jaci.2006.06.012; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Lodge CJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/176484; Olivieri M, 2012, J ALLERGY CLIN IMMUN, V129, P420, DOI 10.1016/j.jaci.2011.10.044; Perzanowski MS, 1999, J ALLERGY CLIN IMMUN, V103, P1018, DOI 10.1016/S0091-6749(99)70173-9; Simpson A, 1999, AM J RESP CRIT CARE, V160, P45, DOI 10.1164/ajrccm.160.1.9809091; Svanes C, 2003, J ALLERGY CLIN IMMUN, V112, P289, DOI 10.1067/mai.2003.1596; Svanes C, 2006, J ALLERGY CLIN IMMUN, V118, P691, DOI 10.1016/j.jaci.2006.06.017; Tarlo SM, 2000, OCCUP MED, V15, P471; WOODFOLK JA, 1992, ANN ALLERGY, V69, P273; Zock JP, 2006, J ALLERGY CLIN IMMUN, V118, P682, DOI 10.1016/j.jaci.2006.04.060	24	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127457	10.1371/journal.pone.0127457	http://dx.doi.org/10.1371/journal.pone.0127457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035304	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100013
J	Ogata, S; Hayashi, C; Sugiura, K; Hayakawa, K				Ogata, Soshiro; Hayashi, Chisato; Sugiura, Keiko; Hayakawa, Kazuo			Associations between Depressive State and Impaired Higher-Level Functional Capacity in the Elderly with Long-Term Care Requirements	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; DAILY LIVING DISABILITY; HIPPOCAMPAL VOLUME LOSS; LATE-LIFE DEPRESSION; INSTRUMENTAL ACTIVITIES; OLDER-ADULTS; LOGISTIC-REGRESSION; CONTROLLED-TRIAL; COMMUNITY; LIMITATIONS	Depressive state has been reported to be significantly associated with higher-level functional capacity among community-dwelling elderly. However, few studies have investigated the associations among people with long-term care requirements. We aimed to investigate the associations between depressive state and higher-level functional capacity and obtain marginal odds ratios using propensity score analyses in people with long-term care requirements. We conducted a cross-sectional study based on participants aged >= 65 years (n = 545) who were community dwelling and used outpatient care services for long-term preventive care. We measured higher-level functional capacity, depressive state, and possible confounders. Then, we estimated the marginal odds ratios (i.e., the change in odds of impaired higher-level functional capacity if all versus no participants were exposed to depressive state) by logistic models using generalized linear models with the inverse probability of treatment weighting (IPTW) for propensity score and design-based standard errors. Depressive state was used as the exposure variable and higher-level functional capacity as the outcome variable. The all absolute standardized differences after the IPTW using the propensity scores were <10% which indicated negligible differences in the mean or prevalence of the covariates between non-depressive state and depressive state. The marginal odds ratios were estimated by the logistic models with IPTW using the propensity scores. The marginal odds ratios were 2.17 (95% CI: 1.13-4.19) for men and 2.57 (95% CI: 1.26-5.26) for women. Prevention of depressive state may contribute to not only depressive state but also higher-level functional capacity.	[Ogata, Soshiro] Osaka City Univ, Support Off Female Researchers, Osaka 558, Japan; [Hayashi, Chisato] Osaka City Univ, Grad Sch Nursing, Dept Publ Hlth Nursing, Osaka 558, Japan; [Sugiura, Keiko] Senri Kinran Univ, Fac Nursing, Osaka, Japan; [Hayakawa, Kazuo] Mie Prefectural Coll Nursing, Tsu, Mie, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Ogata, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Hlth Promot Sci, Osaka, Japan.	sob0405@sahs.med.osaka-u.ac.jp			Osaka City University; Ministry of Education, Culture, Sports, Sciences and Technology	Osaka City University; Ministry of Education, Culture, Sports, Sciences and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Osaka City University subsidized by the Program to Support Female Researchers realized by the Ministry of Education, Culture, Sports, Sciences and Technology. http://www.jst.go.jp/shincho/en/program/woman_ken.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; Callahan CM, 2005, J AM GERIATR SOC, V53, P367, DOI 10.1111/j.1532-5415.2005.53151.x; Carriere I, 2011, J AFFECT DISORDERS, V133, P42, DOI 10.1016/j.jad.2011.03.020; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Covinsky KE, 2010, J AM GERIATR SOC, V58, P551, DOI 10.1111/j.1532-5415.2010.02723.x; Drageset J, 2011, J CLIN NURS, V20, P3111, DOI 10.1111/j.1365-2702.2010.03663.x; DRAKE C, 1993, BIOMETRICS, V49, P1231, DOI 10.2307/2532266; Fujiwara Y, 2003, ARCH GERONTOL GERIAT, V36, P141, DOI 10.1016/S0167-4943(02)00081-X; Fujiwara Y., 2002, GERIATR GERONTOL INT, V2, P57; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hybels CF, 2009, PSYCHOL MED, V39, P1677, DOI 10.1017/S0033291709005650; Iwasa H, 2009, INT J GERIATR PSYCH, V24, P1192, DOI 10.1002/gps.2245; Joffe MM, 2004, AM STAT, V58, P272, DOI 10.1198/000313004X5824; Kazama Mari, 2011, Environmental Health and Preventive Medicine, V16, P196, DOI 10.1007/s12199-010-0186-6; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Nickel MK, 2006, ARCH GERONTOL GERIAT, V42, P247, DOI 10.1016/j.archger.2005.07.004; Nickel MK, 2005, AGING CLIN EXP RES, V17, P293; Oakley F, 2002, ACTA PSYCHIAT SCAND, V105, P231, DOI 10.1034/j.1600-0447.2002.1sc021.x; Ogata S, 2015, ARCH GERONTOL GERIAT, V60, P201, DOI 10.1016/j.archger.2014.10.015; Okamoto N, 2006, ARCH GERONTOL GERIAT, V42, P175, DOI 10.1016/j.archger.2005.06.012; Patrick JH, 2004, QUAL LIFE RES, V13, P959, DOI 10.1023/B:QURE.0000025585.92340.7a; Pirracchio R, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-70; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1999, J NEUROSCI, V19, P5034; Stampf S, 2010, STAT MED, V29, P760, DOI 10.1002/sim.3811; van Buuren S, 2011, J STAT SOFTW, V45, P1; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Vu NQ, 2013, CURR OPIN NEUROL, V26, P656, DOI 10.1097/WCO.0000000000000028; Wada T, 2004, ARCH GERONTOL GERIAT, V39, P15, DOI 10.1016/j.archger.2003.12.003; Yamazaki S, 2012, GERIATR GERONTOL INT, V12, P680, DOI 10.1111/j.1447-0594.2012.00841.x; Yochim BP, 2008, J CLIN EXP NEUROPSYC, V30, P236, DOI 10.1080/13803390701370006	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127410	10.1371/journal.pone.0127410	http://dx.doi.org/10.1371/journal.pone.0127410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26035183	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100012
J	Chan, CL; Lin, W; Yang, NP; Lai, KR; Huang, HT				Chan, Chien-Lung; Lin, Wender; Yang, Nan-Ping; Lai, K. Robert; Huang, Hsin-Tsung			Pre-Emergency-Department Care-Seeking Patterns Are Associated with the Severity of Presenting Condition for Emergency Department Visit and Subsequent Adverse Events: A Timeframe Episode Analysis	PLOS ONE			English	Article							TIMELY PRIMARY-CARE; HEALTH-CARE; AMBULATORY-CARE; MEDICAID; BARRIERS; TAIWAN; INTERVENTIONS; BENEFICIARIES; VALIDATION; INSURANCE	Background Many patients treated in Emergency Department (ED) visits can be treated at primary or urgent care sectors, despite the fact that a number of ED visitors seek other forms of care prior to an ED visit. However, little is known regarding how the pre-ED activity episodes affect ED visits. Objectives We investigated whether care-seeking patterns involve the use of health care services of various types prior to ED visits and examined the associations of these patterns with the severity of the presenting condition for the ED visit (EDVS) and subsequent events. Methods This retrospective observational study used administrative data on beneficiaries of the universal health care insurance program in Taiwan. The service type, treatment capacity, and relative diagnosis were used to classify pre-ED visits into 8 care types. Frequent pattern analysis was used to identify sequential care-seeking patterns and to classify 667,183 eligible pre-ED episodes into patterns. Generalized linear models were developed using generalized estimating equations to examine the associations of these patterns with EDVS and subsequent events. Results The results revealed 17 care-seeking patterns. The EDVS and likelihood of subsequent events significantly differed among patterns. The ED severity index of patterns differ from patterns seeking directly ED care (coefficients ranged from -0.05 to 0.13), and the odds-ratios for the likelihood of subsequent ED visits and hospitalization ranged from 1.18 to 1.86 and 1.16 to 2.84, respectively. Conclusions The pre-ED care-seeking patterns differ in severity of presenting condition and subsequent events that may represent different causes of ED visit. Future health policy maker may adopt different intervention strategies for targeted population to reduce unnecessary ED visit effectively.	[Chan, Chien-Lung; Huang, Hsin-Tsung] Yuan Ze Univ, Dept Informat Management, Chungli, Taiwan; [Chan, Chien-Lung; Lai, K. Robert; Huang, Hsin-Tsung] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Chungli, Taiwan; [Lin, Wender] Chang Jung Christian Univ, Dept Hlth Care Adm, Tainan, Taiwan; [Yang, Nan-Ping] Natl Yang Ming Univ, Community Hlth Res Ctr, Taipei 112, Taiwan; [Yang, Nan-Ping] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lai, K. Robert] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan; [Huang, Hsin-Tsung] Natl Hlth Insurance Adm, Med Affairs Div, Minist Hlth & Welf, Taipei, Taiwan; [Yang, Nan-Ping] Keelung Hosp, Minist Hlth & Welf, Keelung, Taiwan	Yuan Ze University; Yuan Ze University; Chang Jung Christian University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Yuan Ze University	Huang, HT (corresponding author), Yuan Ze Univ, Dept Informat Management, Chungli, Taiwan.	huang.oct10@gmail.com	Chan, Chien-Lung/K-2086-2012	Chan, Chien-Lung/0000-0002-7486-7075; Lai, K. Robert/0000-0002-3365-3927				Adekoya N, 2005, PUBLIC HEALTH, V119, P914, DOI 10.1016/j.puhe.2005.03.006; Afilalo J, 2004, ACAD EMERG MED, V11, P1302, DOI 10.1197/j.aem.2004.08.032; Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Angoulvant F, 2013, EUR J PEDIATR, V172, P797, DOI 10.1007/s00431-013-1968-9; Ballard DW, 2010, MED CARE, V48, P58, DOI 10.1097/MLR.0b013e3181bd49ad; Bentler SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115088; Boushy D, 1999, J EMERG MED, V17, P405, DOI 10.1016/S0736-4679(99)00015-3; Braithwaite Sabina A, 2011, Acad Emerg Med, V18, pe39, DOI 10.1111/j.1553-2712.2011.01080.x; Brousseau DC, 2009, ACAD PEDIATR, V9, P33, DOI 10.1016/j.acap.2008.11.004; Byrne M, 2003, ANN EMERG MED, V41, P309, DOI 10.1067/mem.2003.68; Chan CL, 2013, HEALTH POLICY, V110, P271, DOI 10.1016/j.healthpol.2012.12.003; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Cheung PT, 2012, ANN EMERG MED, V60, P4, DOI 10.1016/j.annemergmed.2012.01.035; de la Fuente DO, 2007, EUR J PUBLIC HEALTH, V17, P186, DOI 10.1093/eurpub/ckl085; DeLia D, 2012, MED CARE RES REV, V69, P277, DOI 10.1177/1077558711430689; FitzGerald G, 2014, EMERG MED AUSTRALAS, V26, P291, DOI 10.1111/1742-6723.12241; Flores-Mateo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035903; Goransson KE, 2013, EUR J EMERG MED, V20, P45, DOI 10.1097/MEJ.0b013e3283509d3e; Han A, 2007, CAN J EMERG MED, V9, P428; Hao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112944; He J, 2011, WORLD J EMERG MED, V2, P253, DOI 10.5847/wjem.j.1920-8642.2011.04.002; Horney C, 2012, AM J EMERG MED, V30, P135, DOI 10.1016/j.ajem.2010.10.036; Huang JA, 2008, J FORMOS MED ASSOC, V107, P119, DOI 10.1016/S0929-6646(08)60125-4; Huibers L, 2013, J EVAL CLIN PRACT, V19, P243, DOI 10.1111/j.1365-2753.2011.01806.x; Jones K, 2013, MED CARE, V51, pe41, DOI 10.1097/MLR.0b013e318242315b; Kaskie B, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-173; Khaing HW, 2011, 2011 3 INT C BEIJ CH; Khan Y, 2011, ACAD EMERG MED, V18, P836, DOI 10.1111/j.1553-2712.2011.01127.x; Lowe RA, 2005, MED CARE, V43, P792, DOI 10.1097/01.mlr.0000170413.60054.54; Lowe RA, 2009, MED CARE, V47, P15, DOI 10.1097/MLR.0b013e3181844e1c; McCusker J, 2010, MED CARE, V48, P972, DOI 10.1097/MLR.0b013e3181eaf86d; Morgan SR, 2013, ACAD EMERG MED, V20, P969, DOI 10.1111/acem.12219; Nguyen CA, 2014, HARVARD HLTH POLICY, V14, P23; Rising KL, 2013, ANN EMERG MED, V62, P145, DOI 10.1016/j.annemergmed.2013.01.024; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rudge GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067943; Rust G, 2008, ARCH INTERN MED, V168, P1705, DOI 10.1001/archinte.168.15.1705; ShahCanning D, 1996, MED CARE, V34, P1171, DOI 10.1097/00005650-199612000-00002; Shu CC, 2012, INTERN MED J, V42, P677, DOI 10.1111/j.1445-5994.2011.02562.x; Shu CC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-96; Thompson MIW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003612; Tranquada KE, 2010, J EMERG MED, V38, P279, DOI 10.1016/j.jemermed.2008.11.031; Tsai JCH, 2011, HEALTH POLICY, V100, P189, DOI 10.1016/j.healthpol.2010.10.007; Wajnberg A, 2012, J EMERG MED, V43, P376, DOI 10.1016/j.jemermed.2011.06.056; Weinick RM, 2010, HEALTH AFFAIR, V29, P1630, DOI 10.1377/hlthaff.2009.0748; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wiler JL, 2012, ANN EMERG MED, V59, P351, DOI 10.1016/j.annemergmed.2011.08.020	47	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127793	10.1371/journal.pone.0127793	http://dx.doi.org/10.1371/journal.pone.0127793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030278	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900082
J	Cousminer, DL; Leinonen, JT; Sarin, AP; Chheda, H; Surakka, I; Wehkalampi, K; Ellonen, P; Ripatti, S; Dunkel, L; Palotie, A; Widen, E				Cousminer, Diana L.; Leinonen, Jaakko T.; Sarin, Antti-Pekka; Chheda, Himanshu; Surakka, Ida; Wehkalampi, Karoliina; Ellonen, Pekka; Ripatti, Samuli; Dunkel, Leo; Palotie, Aarno; Widen, Elisabeth			Targeted Resequencing of the Pericentromere of Chromosome 2 Linked to Constitutional Delay of Growth and Puberty	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FINAL HEIGHT; LOCI; GIRLS; POPULATION; VARIANTS; BOYS; DISORDERS; MUTATIONS; PATTERNS	Constitutional delay of growth and puberty (CDGP) is the most common cause of pubertal delay. CDGP is defined as the proportion of the normal population who experience pubertal onset at least 2 SD later than the population mean, representing 2.3% of all adolescents. While adolescents with CDGP spontaneously enter puberty, they are at risk for short stature, decreased bone mineral density, and psychosocial problems. Genetic factors contribute heavily to the timing of puberty, but the vast majority of CDGP cases remain biologically unexplained, and there is no definitive test to distinguish CDGP from pathological absence of puberty during adolescence. Recently, we published a study identifying significant linkage between a locus at the pericentromeric region of chromosome 2 (chr 2) and CDGP in Finnish families. To investigate this region for causal variation, we sequenced chr 2 between the genomic coordinates of 79-124 Mb (genome build GRCh37) in the proband and affected parent of the 13 families contributing most to this linkage signal. One gene, DNAH6, harbored 6 protein-altering low-frequency variants (< 6% in the Finnish population) in 10 of the CDGP probands. We sequenced an additional 135 unrelated Finnish CDGP subjects and utilized the unique Sequencing Initiative Suomi (SISu) population reference exome set to show that while 5 of these variants were present in the CDGP set, they were also present in the Finnish population at similar frequencies. Additional variants in the targeted region could not be prioritized for follow-up, possibly due to gaps in sequencing coverage or lack of functional knowledge of non-genic genomic regions. Thus, despite having a well-characterized sample collection from a genetically homogeneous population with a large population-based reference sequence dataset, we were unable to pinpoint variation in the linked region predisposing delayed puberty. This study highlights the difficulties of detecting genetic variants under linkage regions for complex traits and suggests that advancements in annotation of gene function and regulatory regions of the genome will be critical for solving the genetic background of complex phenotypes like CDGP.	[Cousminer, Diana L.; Leinonen, Jaakko T.; Sarin, Antti-Pekka; Chheda, Himanshu; Surakka, Ida; Ellonen, Pekka; Ripatti, Samuli; Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Sarin, Antti-Pekka] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Wehkalampi, Karoliina] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Wehkalampi, Karoliina] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; [Wehkalampi, Karoliina] Univ Helsinki, Helsinki, Finland; [Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Ripatti, Samuli; Palotie, Aarno] Hinxton, Wellcome Trust Sanger Inst, Cambridge, England; [Dunkel, Leo] William Harvey Res Inst, Barts & London Sch Med & Dent, Ctr Endocrinol, London, England; [Palotie, Aarno] Broad Inst MIT & Harvard, Med & Populat Genom Program, Cambridge, MA USA	University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Wellcome Trust Sanger Institute; University of London; Queen Mary University London; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Cousminer, DL (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	diana.cousminer@helsinki.fi	Ripatti, Samuli/H-9446-2014	Ripatti, Samuli/0000-0002-0504-1202; Surakka, Ida/0000-0002-6669-5541; Ellonen, Pekka/0000-0001-6072-0489; Palotie, Aarno/0000-0002-2527-5874	Finska lakaresallskapet; Academy of Finland [267561]; Helsinki Biomedical Graduate Program	Finska lakaresallskapet; Academy of Finland(Academy of Finland); Helsinki Biomedical Graduate Program	Funding was provided by Finska lakaresallskapet to EW (http://www.fls.fi/sallskapet/), Academy of Finland (grant number 267561) to EW (http://www.aka.fi/en-GB/A/), and Helsinki Biomedical Graduate Program (personal grant to DLC) (http://www.hbgp.helsinki.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ALBANESE A, 1993, EUR J PEDIATR, V152, P293, DOI 10.1007/BF01956736; BIERICH JR, 1992, ACTA ENDOCRINOL-COP, V127, P392, DOI 10.1530/acta.0.1270392; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Blogowska A, 2004, GYNECOL ENDOCRINOL, V19, P22, DOI 10.1080/09513590410001712866; Cousminer DL, 2014, HUM MOL GENET, V23, P4452, DOI 10.1093/hmg/ddu150; Cousminer DL, 2013, HUM MOL GENET, V22, P2735, DOI 10.1093/hmg/ddt104; CROWNE EC, 1990, TRENDS ENDOCRIN MET, V1, P239, DOI 10.1016/1043-2760(90)90003-L; CROWNE EC, 1991, EUR J PEDIATR, V150, P708, DOI 10.1007/BF01958760; CROWNE EC, 1990, ARCH DIS CHILD, V65, P1109, DOI 10.1136/adc.65.10.1109; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Gajdos ZKZ, 2010, MOL CELL ENDOCRINOL, V324, P21, DOI 10.1016/j.mce.2010.01.038; Harrington J, 2012, J CLIN ENDOCR METAB, V97, P3056, DOI 10.1210/jc.2012-1598; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lin L, 2006, J CLIN ENDOCR METAB, V91, P5117, DOI 10.1210/jc.2006-0807; Maiti AK, 2000, EUR J HUM GENET, V8, P923, DOI 10.1038/sj.ejhg.5200555; Majdoubi ME, 2000, P NATL ACAD SCI USA, V97, P6179; McCarthy DJ, 2014, GENOME MED, V6, DOI 10.1186/gm543; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Moreira-Andres MN, 1998, EUR J ENDOCRINOL, V139, P271, DOI 10.1530/eje.0.1390271; Morris DH, 2011, PAEDIATR PERINAT EP, V25, P306, DOI 10.1111/j.1365-3016.2010.01183.x; Palmert MR, 2012, NEW ENGL J MED, V366, P443, DOI 10.1056/NEJMcp1109290; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pugliese-Pires PN, 2011, EUR J ENDOCRINOL, V165, P233, DOI 10.1530/EJE-11-0168; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sewer M, 2008, LIPIDS, V43, P1109, DOI 10.1007/s11745-008-3221-2; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; TANNER JM, 1976, ANN HUM BIOL, V3, P109, DOI 10.1080/03014467600001231; Traggiai C, 2003, BEST PRACT RES CL OB, V17, P41, DOI 10.1053/ybeog.2003.0360; Tusset C, 2012, ARQ BRAS ENDOCRINOL, V56, P646, DOI 10.1590/S0004-27302012000900008; Vaaralahti K, 2011, FERTIL STERIL, V95, P2756, DOI 10.1016/j.fertnstert.2010.12.059; Vaughan KT, 1996, GENOMICS, V36, P29, DOI 10.1006/geno.1996.0422; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Wehkalampi K, 2008, J CLIN ENDOCR METAB, V93, P723, DOI 10.1210/jc.2007-1786; Wehkalampi K, 2008, J CLIN ENDOCR METAB, V93, P4833, DOI 10.1210/jc.2008-0882; WORKMAN PL, 1976, AM J PHYS ANTHROPOL, V44, P341, DOI 10.1002/ajpa.1330440216	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128524	10.1371/journal.pone.0128524	http://dx.doi.org/10.1371/journal.pone.0128524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030606	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900164
J	Guan, Y; Hohn, S; Merico, A				Guan, Yi; Hohn, Soenke; Merico, Agostino			Suitable Environmental Ranges for Potential Coral Reef Habitats in the Tropical Ocean	PLOS ONE			English	Article							CLIMATE-CHANGE; SEAWATER ACIDIFICATION; GLOBAL DISTRIBUTION; PHOTOSYNTHESIS; SALINITY; CALCIFICATION; RESPIRATION; TEMPERATURE; RATES; MORTALITY	Coral reefs are found within a limited range of environmental conditions or tolerance limits. Estimating these limits is a critical prerequisite for understanding the impacts of climate change on the biogeography of coral reefs. Here we used the diagnostic model ReefHab to determine the current environmental tolerance limits for coral reefs and the global distribution of potential coral reef habitats as a function of six factors: temperature, salinity, nitrate, phosphate, aragonite saturation state, and light. To determine these tolerance limits, we extracted maximum and minimum values of all environmental variables in corresponding locations where coral reefs are present. We found that the global, annually averaged tolerance limits for coral reefs are 21.7-29.6 degrees C for temperature, 28.7-40.4 psu for salinity, 4.51 mu mol L-1 for nitrate, 0.63 mu mol L-1 for phosphate, and 2.82 for aragonite saturation state. The averaged minimum light intensity in coral reefs is 450 mu mol photons m(-2) s(-1). The global area of potential reef habitats calculated by the model is 330.5 x 10(3) km(2). Compared with previous studies, the tolerance limits for temperature, salinity, and nutrients have not changed much, whereas the minimum value of aragonite saturation in coral reef waters has decreased from 3.28 to 2.82. The potential reef habitat area calculated with ReefHab is about 121x10(3) km(2) larger than the area estimated from the charted reefs, suggesting that the growth potential of coral reefs is higher than currently observed.	[Guan, Yi; Hohn, Soenke; Merico, Agostino] Leibniz Ctr Trop Marine Ecol, Syst Ecol, Bremen, Germany; [Merico, Agostino] Jacobs Univ Bremen, D-28759 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Jacobs University	Guan, Y (corresponding author), Leibniz Ctr Trop Marine Ecol, Syst Ecol, Fahrenheitstr 6, Bremen, Germany.	yi.guan@zmt-bremen.de	Merico, Agostino/C-1103-2013; /AAL-3738-2021; Hohn, Sönke/O-6446-2019	Merico, Agostino/0000-0001-8095-8056; Hohn, Sönke/0000-0002-9266-8344	China Scholarship Council	China Scholarship Council(China Scholarship Council)	China Scholarship Council (http://www.csc.edu.cn) provides funding for YG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Antonov J.I., 2010, NOAA ATLAS NESDIS 69, V69, P184; Arnone R, 1992, OCEAN OPTICAL DATABA; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Castro P, 2007, MAR BIOL, P303; Cesar H., 2004, EC VALUATION POLICY, P14; COPPER P, 1994, CORAL REEFS, V13, P3, DOI 10.1007/BF00426428; Couce E, 2012, J BIOGEOGR, V39, P1508, DOI 10.1111/j.1365-2699.2012.02706.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferrier-Pages C, 1999, MAR ECOL PROG SER, V181, P309, DOI 10.3354/meps181309; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Garcia H.E., 2010, WORLD OCEAN ATLAS 20, V4, P398; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; IMaRS-USF IRD (Institut de Recherche pour le Developpement), 2005, MILL COR REFF MAP PI; IMaRS-USF IRD (Institut de Recherche pour le Developpement), 2005, MILL COR REEF MAPP P; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; JOKIEL PL, 1986, MAR BIOL, V91, P15, DOI 10.1007/BF00397566; JONES PJ, 1994, BIODIVERS CONSERV, V3, P772, DOI 10.1007/BF00129657; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI DOI 10.1029/2004GB002247]; Kleypas JA, 1997, PALEOCEANOGRAPHY, V12, P533, DOI 10.1029/97PA01134; Kleypas JA, 1999, AM ZOOL, V39, P146; Kleypas JA, 1995, RECENT ADV MARINE TE, P211; Lalli CM, 1997, CORAL REEFS BIOL OCE, P213; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lesser MP, 2004, J EXP MAR BIOL ECOL, V300, P217, DOI 10.1016/j.jembe.2003.12.027; LEVITUS S, 1993, PROG OCEANOGR, V31, P245, DOI 10.1016/0079-6611(93)90003-V; Levitus S, 1994, WORLD OCEAN ATLAS 19; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Locarnini R. A., 2010, 68 NOAA NESDIS ATL, V1; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Meissner KJ, 2012, CORAL REEFS, V31, P309, DOI 10.1007/s00338-011-0866-8; Moberg F, 1997, MAR ECOL PROG SER, V157, P53, DOI 10.3354/meps157053; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moses CS, 2003, CORAL REEFS, V22, P506, DOI 10.1007/s00338-003-0346-x; MUTHIGA NA, 1987, BIOL BULL-US, V173, P539, DOI 10.2307/1541699; O'Farrell S, 2006, REPORT 2005 MASS C 1; PINKER RT, 1992, J CLIMATE, V5, P56, DOI 10.1175/1520-0442(1992)005<0056:GDOPAR>2.0.CO;2; Pohl T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04250; REYNOLDS RW, 1993, J CLIMATE, V6, P114, DOI 10.1175/1520-0442(1993)006<0114:AIRTGS>2.0.CO;2; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Sloss W. P, 1986, RELIEF SURFACE EARTH; SMITH SV, 1978, NATURE, V273, P225, DOI 10.1038/273225a0; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spalding M.D., 2001, WORLD ATLAS CORAL RE; Spalding MD, 1997, CORAL REEFS, V16, P225, DOI 10.1007/s003380050078; Thornhill D, 2012, DEFENDERS WILDL, V187; van Hooidonk R, 2014, GLOBAL CHANGE BIOL, V20, P103, DOI 10.1111/gcb.12394; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wethey D, 1976, NATURE, V262; Wood S, 2013, GLOB ECOL BIOGEOGR	66	28	28	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128831	10.1371/journal.pone.0128831	http://dx.doi.org/10.1371/journal.pone.0128831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030287	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900194
J	Harris, KM; Syu, JJ; Lello, OD; Chew, YLE; Willcox, CH; Ho, RHM				Harris, Keith M.; Syu, Jia-Jia; Lello, Owen D.; Chew, Y. L. Eileen; Willcox, Christopher H.; Ho, Roger H. M.			The ABC's of Suicide Risk Assessment: Applying a Tripartite Approach to Individual Evaluations	PLOS ONE			English	Article							SAMPLE-SIZE; SELF-HARM; RATING-SCALES; VALIDITY; IDEATION; VALIDATION; DEPRESSION; INTENT; ITEM; QUESTIONNAIRE	There is considerable need for accurate suicide risk assessment for clinical, screening, and research purposes. This study applied the tripartite affect-behavior-cognition theory, the suicidal barometer model, classical test theory, and item response theory (IRT), to develop a brief self-report measure of suicide risk that is theoretically-grounded, reliable and valid. An initial survey (n = 359) employed an iterative process to an item pool, resulting in the sixitem Suicidal Affect-Behavior-Cognition Scale (SABCS). Three additional studies tested the SABCS and a highly endorsed comparison measure. Studies included two online surveys (Ns = 1007, and 713), and one prospective clinical survey (n = 72; Time 2, n = 54). Factor analyses demonstrated SABCS construct validity through unidimensionality. Internal reliability was high (alpha = .86-.93, split-half = .90-.94)). The scale was predictive of future suicidal behaviors and suicidality (r = .68, .73, respectively), showed convergent validity, and the SABCS-4 demonstrated clinically relevant sensitivity to change. IRT analyses revealed the SABCS captured more information than the comparison measure, and better defined participants at low, moderate, and high risk. The SABCS is the first suicide risk measure to demonstrate no differential item functioning by sex, age, or ethnicity. In all comparisons, the SABCS showed incremental improvements over a highly endorsed scale through stronger predictive ability, reliability, and other properties. The SABCS is in the public domain, with this publication, and is suitable for clinical evaluations, public screening, and research.	[Harris, Keith M.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Syu, Jia-Jia] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Lello, Owen D.] Univ Newcastle, Sch Psychol, Newcastle, NSW 2300, Australia; [Chew, Y. L. Eileen] Illumina, Learning & Dev Dept, Singapore, Singapore; [Willcox, Christopher H.] Hunter New England Mental Hlth, Newcastle, NSW, Australia; [Willcox, Christopher H.; Ho, Roger H. M.] Natl Univ Singapore, Dept Psychol Med, Singapore 117548, Singapore	University of Queensland; University of Queensland; University of Newcastle; Illumina; National University of Singapore	Harris, KM (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	k.harris1@uq.edu.au	Harris, Keith M/K-9957-2013; Ho, Roger/ABD-8859-2021; Ho, Roger/H-8714-2014	Harris, Keith M/0000-0002-1199-2856; Ho, Roger/0000-0001-9629-4493				Academies TN, 2010, CNS CLIN TRIALS SUIC; [American Psychiatric Association Behaviors WGoS], 2010, PRACT GUID ASS TREAT; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Baca-Garcia E, 2011, J AFFECT DISORDERS, V134, P327, DOI 10.1016/j.jad.2011.06.026; BAUMEISTER RF, 1990, PSYCHOL REV, V97, P90, DOI 10.1037/0033-295X.97.1.90; Beck A.T., 1988, BECK HOPELESSNESS SC; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Beck AT, 1999, SUICIDE LIFE-THREAT, V29, P1; BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1975, JAMA-J AM MED ASSOC, V234, P1146, DOI 10.1001/jama.234.11.1146; Beck AT., 1996, MANUAL BECK DEPRESSI; BECK RW, 1974, PSYCHOL REP, V34, P445, DOI 10.2466/pr0.1974.34.2.445; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bilen K, 2011, EMERG MED J, V28, P1019, DOI 10.1136/emj.2010.102616; BMJ Publishing Group Limited, 2013, SUIC RISK MAN DIAG T; Borschmann R, 2012, EUR PSYCHIAT, V27, P176, DOI 10.1016/j.eurpsy.2011.04.005; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chehil S., 2012, SUICIDE RISK MANAGEM; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; Cooper J, 2006, ANN EMERG MED, V48, P459, DOI 10.1016/j.annemergmed.2006.07.944; Corona CD, 2013, ARCH SUICIDE RES, V17, P302, DOI 10.1080/13811118.2013.777002; Cox A, 2012, J PERS ASSESS, V94, P613, DOI 10.1080/00223891.2012.700464; De Ayala R.J., 2009, THEORY PRACTICE ITEM; DeVellis R., 2017, SCALE DEV THEORY APP, V4; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eagly A. H., 1993, PSYCHOL ATTITUDES, DOI DOI 10.1002/MAR; Embretson S. E., 2013, ITEM RESPONSE THEORY; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; Granello DH, 2010, J COUNS DEV, V88, P363, DOI 10.1002/j.1556-6678.2010.tb00034.x; Groth-Marnat G, 2009, HDB PSYCHOL ASSESSME; Gutierrez PM, 2004, ASSESSMENT, V11, P73, DOI 10.1177/1073191103261041; Harris K. M, 2015, MENTAL HLTH DIGITAL, P135; Harris KM, 2014, DEATH STUD, V38, P387, DOI 10.1080/07481187.2013.768313; Harris KM, 2010, SUICIDE LIFE-THREAT, V40, P181, DOI 10.1521/suli.2010.40.2.181; Harriss L, 2005, BRIT J PSYCHIAT, V186, P60, DOI 10.1192/bjp.186.1.60; Hatcher S, 2013, INT EMERG NURS, V21, P236, DOI 10.1016/j.ienj.2012.11.003; Hatcher Simon, 2007, Evid Based Med, V12, P89, DOI 10.1136/ebm.12.3.89; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Hofmans J, 2007, METHODOLOGY, V3, P160, DOI [10.1027/1614-2241.3.4.160, DOI 10.1027/1614-2241.3.4.160]; Horwitz AG, 2015, J CLIN CHILD ADOLESC, V44, P751, DOI 10.1080/15374416.2014.910789; Jobes D.A., 2016, MANAGING SUICIDAL RI, V2nd; Jobes DA, 1997, J COUNS PSYCHOL, V44, P368, DOI 10.1037/0022-0167.44.4.368; Jobes DA, 1999, SUICIDE LIFE-THREAT, V29, P97; Jobes DA, 2004, SUICIDE LIFE-THREAT, V34, P99, DOI 10.1521/suli.34.2.99.32788; Jobes DA, 2012, SUICIDE LIFE-THREAT, V42, P640, DOI 10.1111/j.1943-278X.2012.00119.x; Joinson AN, 2007, COMPUT HUM BEHAV, V23, P275, DOI 10.1016/j.chb.2004.10.012; Joinson AN, 2001, EUR J SOC PSYCHOL, V31, P177, DOI 10.1002/ejsp.36; Kalibatseva Z, 2014, PSYCHOL MED, V44, P2567, DOI 10.1017/S0033291714000130; Kim Y, 2002, PSYCHOL AGING, V17, P379, DOI 10.1037//0882-7974.17.3.379; KOVACS M, 1977, J CLIN PSYCHOL, V33, P361, DOI 10.1002/1097-4679(197704)33:2<361::AID-JCLP2270330207>3.0.CO;2-H; KOVACS M, 1976, ARCH GEN PSYCHIAT, V33, P198; KRAL MJ, 1994, DEATH STUD, V18, P311, DOI 10.1080/07481189408252680; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumagai Ryuichi, 2012, Shinrigaku Kenkyu, V83, P35; Lam TCM, 2008, APPL PSYCH MEAS, V32, P248, DOI 10.1177/0146621607301094; Linehan M.M., 1981, SUICIDAL BEHAV QUEST; LINEHAN MM, 1981, J CONSULT CLIN PSYCH, V49, P773, DOI 10.1037/0022-006X.49.5.773; Lozano LM, 2008, METHODOLOGY-EUR, V4, P73, DOI DOI 10.1027/1614-2241.4.2.73; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; Meyer RE, 2010, J CLIN PSYCHIAT, V71, P1040, DOI [10.4088/JCP.10cs06070ablu, 10.4088/JCP.10cs06070blu]; Michel K, 2002, AM J PSYCHOTHER, V56, P424, DOI 10.1176/appi.psychotherapy.2002.56.3.424; Misson H, 2010, J AFFECT DISORDERS, V121, P80, DOI 10.1016/j.jad.2009.05.012; Muehlenkamp JJ, 2005, J CLIN PSYCHOL, V61, P431, DOI 10.1002/jclp.20051; Mundt JC, 2013, J CLIN PSYCHIAT, V74, P887, DOI 10.4088/JCP.13m08398; Nader IW, 2013, SUICIDE LIFE-THREAT, V43, P174, DOI 10.1111/sltb.12006; New Zealand Guidelines Group Ministry of Health, 2003, ASS MAN PEOPL RISK S; Nock MK, 2007, PSYCHOL ASSESSMENT, V19, P309, DOI 10.1037/1040-3590.19.3.309; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Connor SS, 2012, COMPR PSYCHIAT, V53, P461, DOI 10.1016/j.comppsych.2011.09.007; Olfson M, 2014, JAMA-J AM MED ASSOC, V311, P1107, DOI 10.1001/jama.2014.501; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Osterlin SJ, 2009, DIFFERENTIAL ITEM FU; Ostini R, 2006, POLYTOMOUS ITEMS RES; Patry MW, 2015, ASSESSMENT, V22, P36, DOI 10.1177/1073191114539381; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Posner K, 2009, COLUMBIA SUICIDE SEV; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Range LM, 1997, DEATH STUD, V21, P25; REISE SP, 1990, J EDUC MEAS, V27, P133, DOI 10.1111/j.1745-3984.1990.tb00738.x; REYNOLDS WM, 1991, J PERS ASSESS, V56, P289, DOI 10.1207/s15327752jpa5602_9; Rizopoulos D, 2006, J STAT SOFTW, V17; Roussos LA, 1996, J EDUC MEAS, V33, P215, DOI 10.1111/j.1745-3984.1996.tb00490.x; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SAMHSA-HRSA Center for Integrated Health Solutions, 2015, SUIC PREV SCREEN TOO; Saunders K, 2014, EMERG MED J, V31, P796, DOI 10.1136/emermed-2013-202781; Shneidman E., 1996, SUICIDAL MIND; Shneidrnan ES, 2005, CLIN NEUROPSYCHIATR, V2, P7; Strauss ME, 2009, ANNU REV CLIN PSYCHO, V5, P1, DOI 10.1146/annurev.clinpsy.032408.153639; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Suokas J, 2001, ACTA PSYCHIAT SCAND, V104, P117, DOI 10.1034/j.1600-0447.2001.00243.x; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Thornton LK, DRUG ALOHOL IN PRESS; Topic MK, 2012, CROAT MED J, V53, P450, DOI 10.3325/cmj.2012.53.450; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Tran T, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-76; Velicer, 2006, DIFFERENTIATING NORM, V2, P209; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; Winters NC, 2002, J AM ACAD CHILD PSY, V41, P1150, DOI 10.1097/00004583-200210000-00006; World Health Organization, 2008, The global burden of disease: 2004 update; Yaseen ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044069; Yu MN, 2009, ITEM RESPONSE THEORY; Zheng LJ, 2008, PERS INDIV DIFFER, V45, P649, DOI 10.1016/j.paid.2008.07.009; Zhou XM, 2012, SOC PSYCH PSYCH EPID, V47, P1845, DOI 10.1007/s00127-012-0488-7; Zieky M, 2006, HANDBOOK OF TEST DEVELOPMENT, P359; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	114	38	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127442	10.1371/journal.pone.0127442	http://dx.doi.org/10.1371/journal.pone.0127442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030590	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900052
J	Jeong, YJ; Jung, MG; Son, Y; Jang, JH; Lee, YJ; Kim, SH; Ko, YG; Lee, YS; Lee, HJ				Jeong, Ye-Ji; Jung, Myung Gu; Son, Yeonghoon; Jang, Jun-Ho; Lee, Yoon-Jin; Kim, Sung-Ho; Ko, Young-Gyo; Lee, Yun-Sil; Lee, Hae-June			Coniferyl Aldehyde Attenuates Radiation Enteropathy by Inhibiting Cell Death and Promoting Endothelial Cell Function	PLOS ONE			English	Article							INDUCED INTESTINAL INJURY; HEAT-SHOCK PROTEINS; EUCOMMIA-ULMOIDES; GASTROINTESTINAL SYNDROME; DAMAGE; PROTECTS; FACTOR-1; EXTRACT; LEAVES	Radiation enteropathy is a common complication in cancer patients. The aim of this study was to investigate whether radiation-induced intestinal injury could be alleviated by coniferyl aldehyde (CA), an HSF1-inducing agent that increases cellular HSP70 expression. We systemically administered CA to mice with radiation enteropathy following abdominal irradiation (IR) to demonstrate the protective effects of CA against radiation-induced gastrointestinal injury. CA clearly alleviated acute radiation-induced intestinal damage, as reflected by the histopathological data and it also attenuated sub-acute enteritis. CA prevented intestinal crypt cell death and protected the microvasculature in the lamina propria during the acute and sub-acute phases of damage. CA induced HSF1 and HSP70 expression in both intestinal epithelial cells and endothelial cells in vitro. Additionally, CA protected against not only the apoptotic cell death of both endothelial and epithelial cells but also the loss of endothelial cell function following IR, indicating that CA has beneficial effects on the intestine. Our results provide novel insight into the effects of CA and suggest its role as a therapeutic candidate for radiation-induced enteropathy due to its ability to promote rapid re-proliferation of the intestinal epithelium by the synergic effects of the inhibition of cell death and the promotion of endothelial cell function.	[Jeong, Ye-Ji; Jung, Myung Gu; Son, Yeonghoon; Jang, Jun-Ho; Lee, Yoon-Jin; Lee, Hae-June] Korea Inst Radiol & Med Sci, Div Radiat Effects, Seoul, South Korea; [Kim, Sung-Ho] Chonnam Natl Univ, Coll Vet Med, Gwangju, South Korea; [Jeong, Ye-Ji; Ko, Young-Gyo] Korea Univ, Dept Life Sci, Seoul, South Korea; [Lee, Yun-Sil] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Lee, Yun-Sil] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Chonnam National University; Korea University; Ewha Womans University; Ewha Womans University	Lee, YS (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul, South Korea.	yslee@ewha.ac.kr; hjlee@kirams.re.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation of Korea (NRF) [NRF-2012M2A2A7012483, NRF-2013M2A2A7043580, NRF2013M2A2A704043384]; Korean government (Ministry of Science, ICT & Future Planning)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Science, ICT & Future Planning)(Korean Government)	This work was supported by the Nuclear Research and Development Program (NRF-2012M2A2A7012483, NRF-2013M2A2A7043580 and NRF2013M2A2A704043384) of the National Research Foundation of Korea (NRF), funded by the Korean government (Ministry of Science, ICT & Future Planning).	Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Calini V, 2003, TOXICOL IN VITRO, V17, P561, DOI 10.1016/S0887-2333(03)00116-4; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; FARAH MH, 1992, PLANTA MED, V58, P14, DOI 10.1055/s-2006-961380; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghosh SP, 2012, J RADIAT RES, V53, P526, DOI 10.1093/jrr/rrs001; Gregoire V, 1997, BRIT J CANCER, V76, P1315, DOI 10.1038/bjc.1997.554; Hauer-Jensen M, 2014, NAT REV GASTRO HEPAT, V11, P470, DOI 10.1038/nrgastro.2014.46; Kim JY, 2015, PHYTOTHER RES, V29, P148, DOI 10.1002/ptr.5195; Kim JS, 2012, FOOD CHEM TOXICOL, V50, P3174, DOI 10.1016/j.fct.2012.05.059; Kim SY, 2015, INT J RADIAT ONCOL, V91, P807, DOI 10.1016/j.ijrobp.2014.11.031; Kim SJ, 2010, MOLECULES, V15, P7208, DOI 10.3390/molecules15107208; Kim SY, 2010, J MED FOOD, V13, P1069, DOI 10.1089/jmf.2009.1365; Kim SH, 2009, J MED FOOD, V12, P1353, DOI 10.1089/jmf.2008.1322; Lee HJ, 2006, AM J PATHOL, V169, P1601, DOI 10.2353/ajpath.2006.060327; Lee MK, 2005, DIABETES RES CLIN PR, V67, P22, DOI 10.1016/j.diabres.2004.05.013; Li GH, 2010, INT J RADIAT ONCOL, V77, P1536, DOI 10.1016/j.ijrobp.2010.02.062; Maj JG, 2003, CANCER RES, V63, P4338; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; Meerungrueang W, 2014, PHARM BIOL, V52, P1104, DOI 10.3109/13880209.2013.877493; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Nam JW, 2013, CHEM BIODIVERS, V10, P1322, DOI 10.1002/cbdv.201200401; Niu PY, 2006, CELL STRESS CHAPERON, V11, P162, DOI 10.1379/CSC-175R.1; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Park SA, 2006, J ETHNOPHARMACOL, V107, P412, DOI 10.1016/j.jep.2006.03.034; Rotolo JA, 2009, INT J RADIAT ONCOL, V73, P6, DOI 10.1016/j.ijrobp.2008.09.009; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Son TG, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-103; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; Uchiyama T, 2007, ATHEROSCLEROSIS, V190, P321, DOI 10.1016/j.atherosclerosis.2006.03.037; Van Landeghem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051310; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1	35	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128552	10.1371/journal.pone.0128552	http://dx.doi.org/10.1371/journal.pone.0128552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029925	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900168
J	Kamimura, M; Mori, Y; Sugahara-Tobinai, A; Takai, T; Itoi, E				Kamimura, Masayuki; Mori, Yu; Sugahara-Tobinai, Akiko; Takai, Toshiyuki; Itoi, Eiji			Impaired Fracture Healing Caused by Deficiency of the Immunoreceptor Adaptor Protein DAP12	PLOS ONE			English	Article							TNF-ALPHA; BISPHOSPHONATE INCADRONATE; PRESENILE-DEMENTIA; RECEPTOR ACTIVATOR; BONE; REPAIR; EXPRESSION; OSTEOPROTEGERIN; MUTATIONS; APOPTOSIS	Osteoclasts play an important role in bone metabolism, but their exact role in fracture healing remains unclear. DAP12 is an immunoadaptor protein with associated immunoreceptors on myeloid lineage cells, including osteoclasts. Its deficiency causes osteopetrosis due to suppression of osteoclast development and activation. In this report, we assessed the impact of DAP12 on the fracture healing process using C57BL/6 (B6) and DAP12(-/-) mice. Healing was evaluated using radiography, micro-CT, histology, immunohistochemistry and real-time RT-PCR. Radiography showed lower callus volume and lower callus radiolucency in DAP12(-/-) mice during later stages. Micro-CT images and quantitative structural analysis indicated that DAP12(-/-) mice developed calluses of dense trabecular structures and experienced deteriorated cortical shell formation on the surface. Histologically, DAP12(-/-) mice showed less cartilaginous resorption and woven bone formation. In addition, prominent cortical shell formation was much less in DAP12(-/-) mice. Immunohistochemistry revealed lower invasion of F4/80 positive monocytes and macrophages into the fracture hematoma in DAP12(-/-) mice. The expression levels of Col1a1, Col2a1 and Col10a1 in DAP12(-/-) mice increased and subsequently became higher than those in B6 mice. There was a decrease in the gene expression of Tnf during the early stages in DAP12(-/-) mice. Our results indicate that DAP12 deficiency impairs fracture healing, suggesting a significant role of DAP12 in the initial inflammatory response, bone remodeling and regeneration.	[Kamimura, Masayuki; Mori, Yu; Itoi, Eiji] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Aoba Ku, Sendai, Miyagi 980, Japan; [Sugahara-Tobinai, Akiko; Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Mori, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 980, Japan.	yu-mori@med.tohoku.ac.jp	Mori, Yu/AAX-5874-2021	Mori, Yu/0000-0002-8225-4690				Amanat N, 2005, J ORTHOP RES, V23, P1029, DOI 10.1016/j.orthres.2005.03.004; Aoki N, 2000, J IMMUNOL, V165, P3790, DOI 10.4049/jimmunol.165.7.3790; ARO HT, 1990, J ORTHOPAED RES, V8, P238, DOI 10.1002/jor.1100080213; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Cao YP, 2002, J BONE MINER RES, V17, P2237, DOI 10.1359/jbmr.2002.17.12.2237; COLE AA, 1987, J HISTOCHEM CYTOCHEM, V35, P203, DOI 10.1177/35.2.3540104; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dempster DW, 2012, CLIN THER, V34, P521, DOI 10.1016/j.clinthera.2012.02.002; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Flick LM, 2003, J ORTHOP RES, V21, P676, DOI 10.1016/S0736-0266(03)00011-1; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kayal RA, 2010, J BONE MINER RES, V25, P1604, DOI 10.1002/jbmr.59; Koivukangas A, 2003, CLIN ORTHOP RELAT R, P268, DOI 10.1097/01.blo.0000053054.62337.e1; Komatsubara S, 2005, BONE, V36, P678, DOI 10.1016/j.bone.2005.02.002; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Kondo T, 2002, NEUROLOGY, V59, P1105, DOI 10.1212/WNL.59.7.1105; Lehmann W, 2005, BONE, V36, P300, DOI 10.1016/j.bone.2004.10.010; Li CY, 2001, J BONE MINER RES, V16, P429, DOI 10.1359/jbmr.2001.16.3.429; Li JL, 1999, J BONE MINER RES, V14, P969, DOI 10.1359/jbmr.1999.14.6.969; Li JL, 2000, J BONE MINER RES, V15, P2042, DOI 10.1359/jbmr.2000.15.10.2042; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Matos MA, 2010, J ORTHOP TRAUMATOL, V11, P7, DOI 10.1007/s10195-010-0083-1; McDonald MM, 2008, BONE, V43, P653, DOI 10.1016/j.bone.2008.05.019; McDonald MM, 2011, J ORTHOP RES, V29, P726, DOI 10.1002/jor.21293; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reszka Alfred A, 2003, Curr Rheumatol Rep, V5, P65, DOI 10.1007/s11926-003-0085-6; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Ulrich-Vinther M, 2005, CALCIFIED TISSUE INT, V76, P280, DOI 10.1007/s00223-004-0126-9; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1	38	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128210	10.1371/journal.pone.0128210	http://dx.doi.org/10.1371/journal.pone.0128210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030755	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900125
J	Mendham, AE; Duffield, R; Coutts, AJ; Marino, F; Boyko, A; Bishop, DJ				Mendham, Amy E.; Duffield, Rob; Coutts, Aaron J.; Marino, Frank; Boyko, Andriy; Bishop, David J.			Rugby-Specific Small-Sided Games Training Is an Effective Alternative to Stationary Cycling at Reducing Clinical Risk Factors Associated with the Development of Type 2 Diabetes: A Randomized, Controlled Trial	PLOS ONE			English	Article							HIGH-INTENSITY INTERVAL; HUMAN SKELETAL-MUSCLE; IMPROVES INSULIN SENSITIVITY; RECREATIONAL FOOTBALL; EXERCISE INTENSITY; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; SPRINT INTERVAL; ADAPTATIONS	Introduction The present study investigated whether rugby small-sided games (SSG) could be an effective alternative to continuous stationary cycling (CYC) training at reducing clinical risk factors associated with the development of type 2 diabetes mellitus (T2DM). Methods Thirty-three middle-aged (48.6 +/- 6.6y), inactive men were randomized into a CYC (n=11), SSG (n=11), or control (CON, n=11) group. Participants trained 3d.wk(-1) for 8 weeks, while control participants maintained normal activity and dietary patterns. Exercise duration was matched between groups, which involved CYC or SSG (four quarters, interspersed with 2-min passive recovery). Both training programs were designed to induce similar internal loads of maximal heart rate (similar to 80-85% HRmax) and rating of perceived exertion. Pre-and post-intervention testing included dual-energy x-ray absorptiometry scan, graded exercise test, fasting 2h oral glucose tolerance test and resting muscle biopsy. Western blotting was used to assess the content of skeletal muscle proteins associated with mitochondrial biogenesis and glucose regulation. Results Both CYC and SSG increased VO2 at 80% HRmax, and reduced glycated haemoglobin, glucose area under the curve (AUC; SSG, -2.3 +/- 2.4; CYC -2.2 +/- 1.6 mmol.L-1(120min)(1); p<0.05), and total body fat-mass (SSG-2.6 +/- 0.9%; CYC -2.9 +/- 1.1%), compared to no change in CON (p<0.05). SStotal body fat-free mass (1.1 +/- 1.2kg; p<0.05), with no change in CYC or CON (P>0.05). There were no differences within or between conditions for protein content of peroxisome proliferator-activated receptor gamma coactivator-1 alpha, sirtuin-1, p53, glucose transporter-4, protein kinase AKT/PKB, myocyte enhancer factor 2A, mitochondrial transcription factor, nuclear respiratory factor (NRF)-1, NRF-2 or mitochondrial complexes I-V (p>0.05). Conclusion Rugby small-sided games is an effective alternative to continuous cycling for improving metabolic risk-factors associated with the prevention of T2DM. Despite such positive adaptations in clinical risk factors, there were no changes in the content of skeletal muscle proteins associated with glucose regulation and mitochondrial biogenesis.	[Mendham, Amy E.; Marino, Frank] Charles Sturt Univ, Sch Human Movement Studies, Bathurst, NSW 2795, Australia; [Duffield, Rob; Coutts, Aaron J.] Univ Technol Sydney, Sport & Exercise Discipline Grp, UTS Hlth, Sydney, NSW 2007, Australia; [Boyko, Andriy] Greenmeadows Med Ctr, Port Macquarie, NSW, Australia; [Bishop, David J.] Victoria Univ, ISEAL, Melbourne, Vic 8001, Australia	Charles Sturt University; University of Technology Sydney; Victoria University	Mendham, AE (corresponding author), Charles Sturt Univ, Sch Human Movement Studies, Bathurst, NSW 2795, Australia.	amendham@csu.edu.au	Marino, Frank/AAD-2546-2020; Mendham, Amy E./AAF-4143-2022; Coutts, Aaron J/E-5261-2011; Bishop, David John/X-9826-2019; Duffield, Rob/G-2660-2017; Mendham, Amy E./AFI-8524-2022	Mendham, Amy E./0000-0002-1959-6698; Coutts, Aaron J/0000-0002-1782-7691; Bishop, David John/0000-0002-6956-9188; Duffield, Rob/0000-0002-5641-1314; Mendham, Amy E./0000-0002-1959-6698	Charles Sturt University, School of Human Movement Studies	Charles Sturt University, School of Human Movement Studies	Funding for the blood analyses was received from Charles Sturt University, School of Human Movement Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Andersen TR, 2014, SCAND J MED SCI SPOR, V24, P43, DOI 10.1111/sms.12259; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Cochran AJR, 2014, EXP PHYSIOL, V99, P782, DOI 10.1113/expphysiol.2013.077453; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; de Sousa MV, 2014, SCAND J MED SCI SPOR, V24, P57, DOI 10.1111/sms.12258; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Durstine JL, 2013, J SPORT HEALTH SCI, V2, P3, DOI 10.1016/j.jshs.2012.07.009; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Frosig C, 2007, DIABETES, V56, P2093, DOI 10.2337/db06-1698; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Gurd BJ, 2010, APPL PHYSIOL NUTR ME, V35, P350, DOI 10.1139/H10-030; Hansen PA, 1998, J BIOL CHEM, V273, P18173, DOI 10.1074/jbc.273.29.18173; Herman L., 2006, S AFR J SPORTS MED, V18, P14, DOI [DOI 10.17159/2078-516X/2006/V18I1A247, 10.17159/2078-516X/2006/v18i1a247]; Hill AM, 2007, OBESITY, V15, P504, DOI 10.1038/oby.2007.629; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Ishii T, 1998, DIABETES CARE, V21, P1353, DOI 10.2337/diacare.21.8.1353; Jurca R, 2005, MED SCI SPORT EXER, V37, P1849, DOI 10.1249/01.mss.0000175865.17614.74; Kennett DC, 2012, J STRENGTH COND RES, V26, P2037, DOI 10.1519/JSC.0b013e31823a3b26; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Knoepfli-Lenzin C, 2010, SCAND J MED SCI SPOR, V20, P72, DOI 10.1111/j.1600-0838.2009.01089.x; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P58, DOI 10.1111/j.1600-0838.2010.01111.x; Krustrup P, 2009, BRIT J SPORT MED, V43, P825, DOI 10.1136/bjsm.2008.053124; Krustrup P, 2013, MED SCI SPORT EXER, V45, P553, DOI 10.1249/MSS.0b013e3182777051; Krustrup P, 2010, EUR J APPL PHYSIOL, V108, P1247, DOI 10.1007/s00421-009-1319-8; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Marfell-Jones M. J., 2012, INT STANDARDS ANTHRO; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nassis GP, 2005, METABOLISM, V54, P1472, DOI 10.1016/j.metabol.2005.05.013; Randers MB, 2010, SCAND J MED SCI SPOR, V20, P80, DOI 10.1111/j.1600-0838.2010.01091.x; Serpiello FR, 2014, INT J SPORTS MED, V35, P863, DOI 10.1055/s-0034-1367045; Skleryk JR, 2013, DIABETES OBES METAB, V15, P1146, DOI 10.1111/dom.12150; Uchida MC, 2014, J SPORT SCI MED, V13, P59; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Wallman KE, 2007, J SCI MED SPORT, V10, P141, DOI 10.1016/j.jsams.2006.05.024; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8	48	14	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127548	10.1371/journal.pone.0127548	http://dx.doi.org/10.1371/journal.pone.0127548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030423	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000356630900059
J	Misra, SK; Ye, M; Kim, S; Pan, D				Misra, Santosh K.; Ye, Mao; Kim, Sumin; Pan, Dipanjan			Defined Nanoscale Chemistry Influences Delivery of Peptido-Toxins for Cancer Therapy	PLOS ONE			English	Article							SCORPION; VENOM; NANOPARTICLES; MEMBRANES; CHANNELS; LIGAND	We present an in-silico-to-in-vitro approach to develop well-defined, self-assembled, rigid-cored polymeric (Polybee) nano-architecture for controlled delivery of a key component of bee venom, melittin. A competitive formulation with lipid-encapsulated (Lipobee) rigid cored micelle is also synthesized. In a series of sequential experiments, we show how nanoscale chemistry influences the delivery of venom toxins for cancer regression and help evade systemic disintegrity and cellular noxiousness. A relatively weaker association of melittin in the case of lipid-based nanoparticles is compared to the polymeric particles revealed by energy minimization and docking studies, which are supported by biophysical studies. For the first time, the authors' experiment results indicate that melittin can play a significant role in DNA association-dissociation processes, which may be a plausible route for their anticancer activity.	[Pan, Dipanjan] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Carle Fdn Hosp, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Pan, D (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	dipanjan@illinois.edu	Mishra, Santosh/S-7516-2017	Mishra, Santosh/0000-0001-8616-2606; Misra, Santosh K./0000-0002-3313-4895; Pan, Dipanjan/0000-0003-0175-4704	University of Illinois	University of Illinois	This work was supported by the University of Illinois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SYBYL X 2 0; Bhat PA, 2009, J PHYS CHEM B, V113, P997, DOI 10.1021/jp807229c; Cao P, 2013, P NATL ACAD SCI USA, V110, P19279, DOI 10.1073/pnas.1305517110; Chen Q, 2011, MACROMOL RAPID COMM, V32, P1704, DOI 10.1002/marc.201100332; Chen Y, 2010, J PHYS CHEM B, V114, P7461, DOI 10.1021/jp100399d; Elgar D, 2006, AFR J BIOTECHNOL, V5, P2495; Elsabahy M, 2012, CHEM SOC REV, V41, P2545, DOI 10.1039/c2cs15327k; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2; Guo XX, 2013, BIOCHIMIE, V95, P1784, DOI 10.1016/j.biochi.2013.06.003; Han YY, 2013, BIOCHEM PHARMACOL, V86, P1254, DOI 10.1016/j.bcp.2013.08.008; Hmed B, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/958797; Isa L, 2011, SOFT MATTER, V7, P7663, DOI 10.1039/c1sm05407d; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kim B, 2012, J AM CHEM SOC, V134, P10377, DOI 10.1021/ja3040366; King GF, 2013, AUST BIOCH, V44, P13; Kondo E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1952; Misra SK, 2014, CHEM COMMUN, V50, P13220, DOI 10.1039/c4cc04748f; MURATA M, 1987, BIOCHEMISTRY-US, V26, P4056, DOI 10.1021/bi00387a047; Padovan-Merhar O, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3596745; Pan D, 2009, J AM CHEM SOC, V131, P15522, DOI 10.1021/ja906797z; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SUZUKI M, 1994, STRUCTURE, V2, P317, DOI 10.1016/S0969-2126(00)00033-2; Wheater P.R., 1987, FUNCTIONAL HISTOLOGY, P407; Wu J, 2006, J AM CHEM SOC, V128, P2880, DOI 10.1021/ja056064x; Yadav S, 2014, J MATER CHEM B, V2, P4848, DOI 10.1039/c4tb00657g; Yang YF, 2014, BIOMATERIALS, V35, P4368, DOI 10.1016/j.biomaterials.2014.01.076; Zuo XP, 2004, MOL NEUROBIOL, V30, P265, DOI 10.1385/MN:30:3:265	29	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0125908	10.1371/journal.pone.0125908	http://dx.doi.org/10.1371/journal.pone.0125908			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030072	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900017
J	Sun, Z; Cheng, TO; Li, L; Zhang, L; Wang, XF; Dong, NG; Lv, Q; Li, K; Yuan, L; Wang, J; Xie, MX				Sun, Zhenxing; Cheng, Tsung O.; Li, Ling; Zhang, Li; Wang, Xinfang; Dong, Nianguo; Lv, Qing; Li, Ke; Yuan, Li; Wang, Jing; Xie, Mingxing			Diagnostic Value of Transthoracic Echocardiography in Patients with Coarctation of Aorta: The Chinese Experience in 53 Patients Studied between 2008 and 2012 in One Major Medical Center	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; SURGICAL-TREATMENT; CORONARY-ARTERY; FOLLOW-UP; REPAIR; CHILDREN; ANEURYSM; ORIGIN; COHORT; SINUS	Although aortography is well known as the "gold standard" for the diagnosis of coarctation of aorta (CoA), the method is invasive, expensive and not readily accepted by some patients. Ultrasound diagnosis for CoA is non-invasive, inexpensive, readily accepted by every patient, and can be repeated as frequently as necessary. The purpose of this presentation is to evaluate the applicability of transthoracic echocardiography for the diagnosis of CoA. The echocardiographic appearances of 53 patients with CoA who had undergone surgery during a 5-year period from January 2008 to October 2012 were analyzed retrospectively, and the results were compared with findings at surgery. Fifty-three patients with CoA include six with isolated CoA and 47 of CoA associated with other cardiac anomalies. Of the 53 operated patients, 48 were correctly diagnosed preoperatively by echocardiography, while two were misdiagnosed as interrupted aortic arch and the diagnosis were missed in three other patients. Thus the diagnostic accuracy rate was 90.6%, and the misdiagnosis rate was 9.4%. Preoperative echocardiographic evaluation offers very satisfactory anatomic assessment in most patients with CoA. It makes preoperative angiography unnecessary. Thus transthoracic echocardiography should be the first-line method for the diagnosis of coarctation of the aorta.	[Sun, Zhenxing; Cheng, Tsung O.; Li, Ling; Zhang, Li; Wang, Xinfang; Lv, Qing; Li, Ke; Yuan, Li; Wang, Jing; Xie, Mingxing] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Ultrasound,Hubei Prov Key Lab Mol Imaging, Wuhan 430074, Peoples R China; [Cheng, Tsung O.] George Washington Univ, Med Ctr, Dept Med, Washington, DC 20037 USA; [Dong, Nianguo] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; George Washington University; Huazhong University of Science & Technology	Xie, MX (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Ultrasound,Hubei Prov Key Lab Mol Imaging, Wuhan 430074, Peoples R China.	xiemx64@126.com	Zhang, L/ABG-4378-2020; Zhang, L/A-8465-2019	Zhang, L/0000-0003-1620-1512; Zhang, L/0000-0003-1620-1512; Xie, Mingxing/0000-0003-4984-1567				Aboulhosn J, 2015, ECHOCARDIOGRAPHY S2, V32, P21; Banaszak P, 2009, CARDIOL J, V16, P20; BOWER C, 1994, J PAEDIATR CHILD H, V30, P414, DOI 10.1111/j.1440-1754.1994.tb00691.x; CAMPBELL M, 1961, LANCET, V1, P463; Cardoso G, 2014, J CARDIAC SURG, V29, P512, DOI 10.1111/jocs.12367; Cheng TO, 2014, INT J CARDIOL, V173, P33, DOI 10.1016/j.ijcard.2014.02.003; CLARKSON PM, 1983, AM J CARDIOL, V81, P1541; COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840; Courand PY, 2013, ECHOCARDIOGR-J CARD, V30, P829, DOI 10.1111/echo.12124; Cuspidi Cesare, 2005, Ital Heart J, V6, P424; Ghazal SS, 1998, ANN SAUDI MED, V18, P514, DOI 10.5144/0256-4947.1998.514; Godart F, 2002, EUR RADIOL, V12, P2034, DOI 10.1007/s00330-001-1260-7; Grech V, 1999, INT J CARDIOL, V68, P197, DOI 10.1016/S0167-5273(98)00352-0; Hoffman JL, 2014, PEDIATR CARDIOL, V35, P47, DOI 10.1007/s00246-013-0737-x; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P155; Iuliano L, 2007, INTERN EMERG MED, V2, P207, DOI 10.1007/s11739-007-0059-2; Jenkins NP, 1999, QJM-MON J ASSOC PHYS, V92, P365, DOI 10.1093/qjmed/92.7.365; Kenny D, 2011, CARDIOL J, V18, P487, DOI 10.5603/CJ.2011.0003; Lee MGY, 2014, HEART LUNG CIRC, V23, P297, DOI 10.1016/j.hlc.2014.03.001; [李渝芬 Li Yufen], 2005, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V20, P41; MERRILL WH, 1994, ANN THORAC SURG, V58, P399, DOI 10.1016/0003-4975(94)92214-4; Oliver JM, 2014, INT J CARDIOL, V174, P324, DOI 10.1016/j.ijcard.2014.04.060; Radha AS, 2004, ANN THORAC SURG, V78, P324, DOI 10.1016/S0003-4975(03)01469-3; Samanek M, 1999, PEDIATR CARDIOL, V20, P411, DOI 10.1007/s002469900502; Sherer DM, 2002, OBSTET GYNECOL, V100, P1094, DOI 10.1016/S0029-7844(02)02100-2; Simeone RM, 2014, BIRTH DEFECTS RES A, V100, P934, DOI 10.1002/bdra.23262; Tong F, 2014, HEART LUNG CIRC, V23, P339, DOI 10.1016/j.hlc.2013.10.060; VANHEURN LWE, 1994, J THORAC CARDIOV SUR, V107, P74; Vitarelli A, 2008, J AM SOC ECHOCARDIOG, V21, P729, DOI 10.1016/j.echo.2007.10.007; Wellen SL, 2014, AM J CARDIOL, V114, P117, DOI 10.1016/j.amjcard.2014.04.014; [夏红梅 XIA Hongmei], 2006, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V22, P363; Xie MX, 2013, INT J CARDIOL, V168, P1258, DOI 10.1016/j.ijcard.2012.11.113; Xie MX, 2014, INT J CARDIOL, V176, P470, DOI 10.1016/j.ijcard.2014.07.198	33	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127399	10.1371/journal.pone.0127399	http://dx.doi.org/10.1371/journal.pone.0127399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030197	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900050
J	Teng, ZW; Zhu, Y; Wu, FH; Zhu, YH; Zhang, XG; Zhang, CL; Wang, SN; Zhang, L				Teng, Zhaowei; Zhu, Yun; Wu, Feihu; Zhu, Yanhong; Zhang, Xiguang; Zhang, Chuanlin; Wang, Shuangneng; Zhang, Lei			Opioids Contribute to Fracture Risk: A Meta-Analysis of 8 Cohort Studies	PLOS ONE			English	Article							CHRONIC PAIN PATIENTS; OLDER-ADULTS; COMPARATIVE SAFETY; NONMALIGNANT PAIN; HIP FRACTURE; MEDICATIONS; ANALGESICS; BIAS; EPIDEMIOLOGY; ASSOCIATION	Objective To evaluate the association between chronic opioid use for non-cancer pain and fracture risk by conducting a meta-analysis of cohort studies. Methods Cohort studies were identified by searching PubMed and EMBASE from their inception to July 2014. A fracture was considered an endpoint. The information was extracted by two authors independently. When the heterogeneity was significant, a random-effects model was used to calculate the overall pooled risk estimates. Results Eight cohort studies were included in the final meta-analysis. On the basis of the Newcastle-Ottawa Scale (NOS), six studies were considered to be of high quality. The overall combined relative risk for the use of opioids and fractures was 1.88 (95% confidence interval [CI] 1.51-2.34). A subgroup analysis revealed the sources of heterogeneity. The sensitivity analysis indicated stable results, and no publication bias was observed. Conclusions This meta-analysis of cohort studies demonstrates that opioids significantly increase the risk of fractures.	[Teng, Zhaowei; Zhang, Xiguang; Zhang, Chuanlin; Wang, Shuangneng] Kunming Med Univ, Affiliated Hosp 6, Peoples Hosp Yuxi City, Dept Orthoped Surg, Yuxi, Yunan, Peoples R China; [Zhu, Yun] Kunming Med Univ, Affiliated Hosp 6, Peoples Hosp Yuxi City, Dept Nephrol, Yuxi, Yunan, Peoples R China; [Wu, Feihu; Zhu, Yanhong] Kunming Med Univ, Affiliated Hosp 6, Peoples Hosp Yuxi City, Dept Anesthesiol, Yuxi, Yunan, Peoples R China; [Zhang, Lei] Second Peoples Hosp Yunnan Prov, Trauma Ctr Yunnan Prov, Kunming, Yunan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University	Teng, ZW (corresponding author), Kunming Med Univ, Affiliated Hosp 6, Peoples Hosp Yuxi City, Dept Orthoped Surg, Yuxi, Yunan, Peoples R China.	tengzhaowei2003@163.com; gwkzxg@163.com						Ali II, 2004, EPILEPSY BEHAV, V5, P296, DOI 10.1016/j.yebeh.2004.02.005; Bazelier Marloes T, 2013, Front Endocrinol (Lausanne), V4, P11, DOI 10.3389/fendo.2013.00011; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Carbone LD, 2013, J SPINAL CORD MED, V36, P91, DOI 10.1179/2045772312Y.0000000060; Card T, 2004, GUT, V53, P251, DOI 10.1136/gut.2003.026799; Chen L, 2013, J PAIN, V14, P384, DOI 10.1016/j.jpain.2012.12.012; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; COURSOL A, 1986, PROF PSYCHOL-RES PR, V17, P136, DOI 10.1037/0735-7028.17.2.136; Daniell HW, 2002, J PAIN, V3, P377, DOI 10.1054/jpai.2002.126790; Daniell HW, 2004, ARCH INTERN MED, V164, P338, DOI 10.1001/archinte.164.3.338-a; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ensrud KE, 2003, ARCH INTERN MED, V163, P949, DOI 10.1001/archinte.163.8.949; Eom CS, 2012, J BONE MINER RES, V27, P1186, DOI 10.1002/jbmr.1554; Eriksen J, 2003, PAIN, V106, P221, DOI 10.1016/S0304-3959(03)00225-2; Guo ZC, 1998, AM J EPIDEMIOL, V148, P887; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kamal-Bahl Sachin J, 2006, Am J Geriatr Pharmacother, V4, P219, DOI 10.1016/j.amjopharm.2006.09.005; Kelly JP, 2008, PAIN, V138, P507, DOI 10.1016/j.pain.2008.01.027; Li L, 2013, AM J EPIDEMIOL, V178, P559, DOI 10.1093/aje/kwt013; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; SHORR RI, 1992, J GERONTOL, V47, pM111, DOI 10.1093/geronj/47.4.M111; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Spector W, 2007, J AM GERIATR SOC, V55, P327, DOI 10.1111/j.1532-5415.2007.01081.x; Stewart G, 2013, ANAEST INTENS CARE M, V14, P533, DOI 10.1016/j.mpaic.2013.09.002; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takkouche B, 2007, DRUG SAFETY, V30, P171, DOI 10.2165/00002018-200730020-00006; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Vestergaard P, 2012, OSTEOPOROSIS INT, V23, P1255, DOI 10.1007/s00198-011-1692-0; Wells G. A., 2009, NEWCASTLE OTTAWA SCA; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xu T, 2012, BRIT J DERMATOL, V167, P1345, DOI 10.1111/bjd.12002	35	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128232	10.1371/journal.pone.0128232	http://dx.doi.org/10.1371/journal.pone.0128232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030421	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900131
J	Zhang, JG; Reid, SA; Xu, J				Zhang, Jinguang; Reid, Scott A.; Xu, Jing			Predicting Attitudes toward Press- and Speech Freedom across the USA: A Test of Climato-Economic, Parasite Stress, and Life History Theories	PLOS ONE			English	Article							BEHAVIORAL IMMUNE-SYSTEM; POLITICAL CONSERVATISM; PATHOGEN PREVALENCE; DISEASE-AVOIDANCE; FAMILY TIES; CENSORSHIP; PATTERNS; SUPPORT; STATES	National surveys reveal notable individual differences in U.S. citizens' attitudes toward freedom of expression, including freedom of the press and speech. Recent theoretical developments and empirical findings suggest that ecological factors impact censorship attitudes in addition to individual difference variables (e.g., education, conservatism), but no research has compared the explanatory power of prominent ecological theories. This study tested climato-economic, parasite stress, and life history theories using four measures of attitudes toward censoring the press and offensive speech obtained from two national surveys in the U.S.A. Neither climate demands nor its interaction with state wealth-two key variables for climato-economic theory-predicted any of the four outcome measures. Interstate parasite stress significantly predicted two, with a marginally significant effect on the third, but the effects became non-significant when the analyses were stratified for race (as a control for extrinsic risks). Teenage birth rates (a proxy of human life history) significantly predicted attitudes toward press freedom during wartime, but the effect was the opposite of what life history theory predicted. While none of the three theories provided a fully successful explanation of individual differences in attitudes toward freedom of expression, parasite stress and life history theories do show potentials. Future research should continue examining the impact of these ecological factors on human psychology by further specifying the mechanisms and developing better measures for those theories.	[Zhang, Jinguang] Univ Hawaii, Dept Communicol, Honolulu, HI 96822 USA; [Reid, Scott A.] Univ Calif Santa Barbara, Dept Commun, Santa Barbara, CA 93106 USA; [Xu, Jing] Univ So Calif, Annenberg Sch Commun, Los Angeles, CA 90089 USA	University of Hawaii System; University of California System; University of California Santa Barbara; University of Southern California	Zhang, JG (corresponding author), Univ Hawaii, Dept Communicol, Honolulu, HI 96822 USA.	jzhang6@hawaii.edu			UCSB Open Access Fund Pilot	UCSB Open Access Fund Pilot	Publication of the manuscript will be supported by the UCSB Open Access Fund Pilot.	[Anonymous], 2014, GON GON INF CLAP DRI; Boydson MD, 1991, LOY LAL REV, V25, P1073; Brumbach BH, 2009, HUM NATURE-INT BIOS, V20, P25, DOI 10.1007/s12110-009-9059-3; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Downs DM, 2012, J APPL SOC PSYCHOL, V42, P1353, DOI 10.1111/j.1559-1816.2012.00902.x; Eppig C, 2011, INTELLIGENCE, V39, P155, DOI 10.1016/j.intell.2011.02.008; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Figueredo AJ, 2006, DEV REV, V26, P243, DOI 10.1016/j.dr.2006.02.002; Fincher CL, 2012, BEHAV BRAIN SCI, V35, P99, DOI 10.1017/S0140525X11001774; FISHER RD, 1994, J SEX RES, V31, P229, DOI 10.1080/00224499409551756; Gladden P. R., 2009, J EVOLUTIONARY PSYCH, V7, P167, DOI [10.1556/JEP.7.2009.2.5, DOI 10.1556/JEP.7.2009.2.5]; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P241, DOI 10.1037/a0021082; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P1015, DOI 10.1037/a0022403; Hackman J, 2013, EVOL HUM BEHAV, V34, P118, DOI 10.1016/j.evolhumbehav.2012.11.002; HENSE R, 1992, J APPL SOC PSYCHOL, V22, P1666, DOI 10.1111/j.1559-1816.1992.tb00968.x; Hummer RA, SOC SCI Q, V80, P136; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kaplan H. S., 2005, HDB EVOLUTIONARY PSY, P68, DOI DOI 10.1002/9780470939376.CH2; Lipset SeymourMartin., 1981, POLITICAL MAN SOCIAL; Malka A, 2012, POLIT PSYCHOL, V33, P275, DOI 10.1111/j.1467-9221.2012.00875.x; Murray DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062275; Murray DR, 2012, EUR J SOC PSYCHOL, V42, P180, DOI 10.1002/ejsp.863; Murray DR, 2011, PERS SOC PSYCHOL B, V37, P318, DOI 10.1177/0146167210394451; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Nisbet EC, 2013, COMMUN RES, V40, P720, DOI 10.1177/0093650211429117; Nisbett E. R., 1996, CULTURE HONOR PSYCHO; PERRY RL, 2002, COMP ANAL NATIONS QU; Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002; Pollet TV, 2014, HUM NATURE-INT BIOS, V25, P410, DOI 10.1007/s12110-014-9206-3; Raudenbush SW, 2004, HLM 6 WINDOWS; Schaller M, 2008, J PERS SOC PSYCHOL, V95, P212, DOI 10.1037/0022-3514.95.1.212; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Stearns S.C., 1992, pi; SUEDFELD P, 1994, J APPL SOC PSYCHOL, V24, P765, DOI 10.1111/j.1559-1816.1994.tb00611.x; Terrizzi JA, 2013, EVOL HUM BEHAV, V34, P99, DOI 10.1016/j.evolhumbehav.2012.10.003; Thornhill R., 2014, PARASITE STRESS THEO, DOI DOI 10.1007/978-3-319-08040-6; Thornhill R, 2007, EVOL HUM BEHAV, V28, P215, DOI 10.1016/j.evolhumbehav.2007.01.005; Thornhill R, 2013, EVOL HUM BEHAV, V34, P314, DOI 10.1016/j.evolhumbehav.2013.03.006; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; Van de Vliert E., 2008, CLIMATE AFFLUENCE CU; Van de Vliert E, 2013, BEHAV BRAIN SCI, V36, P465, DOI 10.1017/S0140525X12002828; Van de Vliert E, 2011, APPL PSYCHOL-INT REV, V60, P354, DOI 10.1111/j.1464-0597.2010.00439.x; van Leeuwen F, 2014, EVOL HUM BEHAV, V35, P464, DOI 10.1016/j.evolhumbehav.2014.06.005; Vandello JA, 1999, J PERS SOC PSYCHOL, V77, P279, DOI 10.1037/0022-3514.77.2.279; West B. T., 2007, LINEAR MIXED MODELS	45	2	2	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0125241	10.1371/journal.pone.0125241	http://dx.doi.org/10.1371/journal.pone.0125241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030736	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900013
J	Cheng, Y; Zhu, Y; Huang, XP; Zhang, W; Han, ZL; Liu, SD				Cheng, Yang; Zhu, Yun; Huang, Xiuping; Zhang, Wei; Han, Zelong; Liu, Side			Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; ULCERATIVE-COLITIS; ASP299GLY POLYMORPHISM; PUBLICATION BIAS; CD14 POLYMORPHISMS; IMMUNE-RESPONSE; GRAPHICAL TEST; MUTATIONS	Background The associations between toll-like receptor 2 (TLR2) and toll-like receptor 4(TLR4) polymorphisms and inflammatory bowel disease (IBD) susceptibility remain controversial. A meta-analysis was performed to assess these associations. Methods A systematic search was performed to identify all relevant studies relating TLR2 and TLR4 polymorphisms and IBD susceptibility. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Subgroup analyses were performed by ethnicity and publication quality. Results Thirty-eight eligible studies, assessing 10970 cases and 7061 controls were included. No TLR2 Arg677Trp polymorphism was found. No significant association was observed between TLR2 Arg753Gln polymorphism and Crohn's disease (CD) or ulcerative colitis (UC) in all genetic models. Interestingly, TLR4 Asp299Gly polymorphism was significantly associated with increased risk of CD and UC in all genetic models, except for the additive one in CD. In addition, a statistically significant association between TLR4 Asp299Gly polymorphism and IBD was observed among high quality studies evaluating Caucasians, but not Asians. Associations between TLR4 Thr399Ile polymorphisms and CD risk were found only in the allele and dominant models. The TLR4 Thr399Ile polymorphism was associated with UC risk in pooled results as well as subgroup analysis of high quality publications assessing Caucasians, in allele and dominant models. Conclusions The meta-analysis provides evidence that TLR2 Arg753Gln is not associated with CD and UC susceptibility in Asians; TLR4 Asp299Gly is associated with CD and UC susceptibility in Caucasians, but not Asians. TLR4 Thr399Ile may be associated with IBD susceptibility in Caucasians only. Additional well-powered studies of Asp299Gly and other TLR4 variants are warranted.	[Cheng, Yang; Huang, Xiuping; Zhang, Wei; Han, Zelong] Southern Med Univ, Clin Coll 1, Guangzhou, Guangdong, Peoples R China; [Zhu, Yun] Southern Med Univ, Nanfang Hosp, Liver Tumor Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Side] Southern Med Univ, Nanfang Hosp, Dept Digest, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Liu, SD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Digest, Guangzhou, Guangdong, Peoples R China.	huangzl0924@sina.com						Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akin H, 2008, GASTROENTEROLOGY, V134, pA465; Arnott IDR, 2004, GENES IMMUN, V5, P417, DOI 10.1038/sj.gene.6364111; Azzam N, 2012, INT J MOL SCI, V13, P4268, DOI 10.3390/ijms13044268; Baumgart DC, 2007, DIGESTION, V76, P196, DOI 10.1159/000112646; Braat H, 2005, J MOL MED, V83, P601, DOI 10.1007/s00109-005-0685-x; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Brittain EH, 2012, BIOSTATISTICS, V13, P637, DOI 10.1093/biostatistics/kxs006; Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen L., 2011, CORRELATION ATG16L1; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Chootrakool H, 2011, STAT MED, V30, P1183, DOI 10.1002/sim.4143; Coelho T, 2014, INFLAMM BOWEL DIS, V20, P1813, DOI 10.1097/MIB.0000000000000174; de Mesquita MB, 2009, EUR J PEDIATR, V168, P575, DOI 10.1007/s00431-008-0798-7; Ding-Liang Z, 2006, CHIN J INT, V45, P585; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Figueroa C, 2006, EUR CYTOKINE NETW, V17, P125; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fries W, 2005, AM J GASTROENTEROL, V100, P2730, DOI 10.1111/j.1572-0241.2005.00325.x; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Henckaerts L, 2007, GUT, V56, P1536, DOI 10.1136/gut.2007.125468; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong J, 2007, J GASTROEN HEPATOL, V22, P1760, DOI 10.1111/j.1440-1746.2006.04727.x; Hume GE, 2008, INFLAMM BOWEL DIS, V14, P585, DOI 10.1002/ibd.20362; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim EJ, 2012, J KOREAN MED SCI, V27, P72, DOI [10.3346/jkms.2011.27.1.72, 10.3346/jkms.2012.27.1.72]; Lakatos PL, 2005, WORLD J GASTROENTERO, V11, P1489; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Queiroz DMM, 2009, INFLAMM BOWEL DIS, V15, P353, DOI 10.1002/ibd.20757; Manolakis AC, 2013, DIGEST DIS SCI, V58, P371, DOI 10.1007/s10620-012-2348-4; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; Ng SC, 2012, INFLAMM BOWEL DIS, V18, P1164, DOI 10.1002/ibd.21845; Okayama N, 2002, J CLIN LAB ANAL, V16, P56, DOI 10.1002/jcla.2075; Oostenbrug LE, 2005, INFLAMM BOWEL DIS, V11, P567, DOI 10.1097/01.MIB.0000161305.81198.0f; Ouburg S, 2005, GUT, V54, P439; Pagnini C, 2012, DIGEST LIVER DIS, V44, P800, DOI 10.1016/j.dld.2012.03.024; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Rigoli L, 2008, WORLD J GASTROENTERO, V14, P4454, DOI 10.3748/wjg.14.4454; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rodriguez-Bores L, 2007, WORLD J GASTROENTERO, V13, P5560, DOI 10.3748/wjg.v13.i42.5560; Seitz M, 2003, ALLERGY, V58, P1247, DOI 10.1046/j.1398-9995.2003.00225.x; Shen Xiu-yun, 2010, Zhonghua Yi Xue Za Zhi, V90, P1416; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh JCI, 2005, AM J PHYSIOL-GASTR L, V288, pG514, DOI 10.1152/ajpgi.00377.2004; Sivaram G, 2012, HUM IMMUNOL, V73, P201, DOI 10.1016/j.humimm.2011.12.006; Song FJ, 1998, BRIT MED J, V316, P471; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thakkinstian A, 2004, J BONE MINER RES, V19, P419, DOI 10.1359/JBMR.0301265; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Wagner J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015376; WETERMAN IT, 1984, GASTROENTEROLOGY, V86, P449; Xiong L-F, 2006, WORLD J CHIN DIG, V14, P212; [薛惠平 XUE Huiping], 2007, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V27, P1226; Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193; Ye Byong Duk, 2009, Korean J Gastroenterol, V54, P377; Zouiten-Mekki L, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-62	65	30	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126803	10.1371/journal.pone.0126803	http://dx.doi.org/10.1371/journal.pone.0126803			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023918	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400023
J	Feichtinger, M; Stopp, T; Gobl, C; Feichtinger, E; Vaccari, E; Madel, U; Laccone, F; Stroh-Weigert, M; Hengstschlager, M; Feichtinger, W; Neesen, J				Feichtinger, Michael; Stopp, Tina; Goebl, Christian; Feichtinger, Elisabeth; Vaccari, Enrico; Maedel, Ulrike; Laccone, Franco; Stroh-Weigert, Monika; Hengstschlaeger, Markus; Feichtinger, Wilfried; Neesen, Juergen			Increasing Live Birth Rate by Preimplantation Genetic Screening of Pooled Polar Bodies Using Array Comparative Genomic Hybridization	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; CLEAVAGE STAGE EMBRYOS; BLASTOCYST TRANSFER; MEIOTIC ERRORS; BODY ANALYSIS; MATERNAL AGE; DIAGNOSIS; ANEUPLOIDY; IMPLANTATION; BIOPSY	Meiotic errors during oocyte maturation are considered the major contributors to embryonic aneuploidy and failures in human IVF treatment. Various technologies have been developed to screen polar bodies, blastomeres and trophectoderm cells for chromosomal aberrations. Array-CGH analysis using bacterial artificial chromosome (BAC) arrays is widely applied for preimplantation genetic diagnosis (PGD) using single cells. Recently, an increase in the pregnancy rate has been demonstrated using array-CGH to evaluate trophectoderm cells. However, in some countries, the analysis of embryonic cells is restricted by law. Therefore, we used BAC array-CGH to assess the impact of polar body analysis on the live birth rate. A disadvantage of polar body aneuploidy screening is the necessity of the analysis of both the first and second polar bodies, resulting in increases in costs for the patient and complex data interpretation. Aneuploidy screening results may sometimes be ambiguous if the first and second polar bodies show reciprocal chromosomal aberrations. To overcome this disadvantage, we tested a strategy involving the pooling of DNA from both polar bodies before DNA amplification. We retrospectively studied 351 patients, of whom 111 underwent polar body array-CGH before embryo transfer. In the group receiving pooled polar body array-CGH (aCGH) analysis, 110 embryos were transferred, and 29 babies were born, corresponding to live birth rates of 26.4% per embryo and 35.7% per patient. In contrast, in the control group, the IVF treatment was performed without preimplantation genetic screening (PGS). For this group, 403 embryos were transferred, and 60 babies were born, resulting in live birth rates of 14.9% per embryo and 22.7% per patient. In conclusion, our data show that in the aCGH group, the use of aneuploidy screening resulted in a significantly higher live birth rate compared with the control group, supporting the benefit of PGS for IVF couples in addition to the suitability and effectiveness of our polar body pooling strategy.	[Feichtinger, Michael; Stopp, Tina; Feichtinger, Elisabeth; Vaccari, Enrico; Maedel, Ulrike; Stroh-Weigert, Monika; Hengstschlaeger, Markus; Feichtinger, Wilfried] Wunschbaby Inst Feichtinger, Vienna, Austria; [Goebl, Christian] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Laccone, Franco; Hengstschlaeger, Markus; Neesen, Juergen] Med Univ Vienna, Inst Med Genet, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Neesen, J (corresponding author), Med Univ Vienna, Inst Med Genet, Vienna, Austria.	juergen.neesen@meduniwien.ac.at	Feichtinger, Michael/ABD-1214-2020; Laccone, Franco A/B-3655-2018	Feichtinger, Michael/0000-0001-6453-9281; Vaccari, Enrico/0000-0003-4128-1841; Neesen, Jurgen/0000-0002-3635-2097; Linder, Tina/0000-0001-5929-1285				Alfarawati S, 2011, HUM REPROD, V26, P1560, DOI 10.1093/humrep/der068; Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Capalbo A, 2014, EUR J HUM GENET; Capalbo A, 2013, HUM REPROD, V28, P509, DOI 10.1093/humrep/des394; Christopikou D, 2013, HUM REPROD, V28, P1732, DOI 10.1093/humrep/det076; Christopikou D, 2013, HUM REPROD, V28, P1426, DOI 10.1093/humrep/det053; Cohen J, 2007, FERTIL STERIL, V87, P496, DOI 10.1016/j.fertnstert.2006.07.1516; Edgar DH, 2000, HUM REPROD, V15, P175, DOI 10.1093/humrep/15.1.175; Ferraretti AP, 2004, HUM REPROD, V19, P694, DOI 10.1093/humrep/deh121; Fonseka KGL, 2011, CYTOGENET GENOME RES, V133, P280, DOI 10.1159/000322816; Forman EJ, 2013, HUM REPROD, V28, P502, DOI 10.1093/humrep/des393; Forman EJ, 2013, FERTIL STERIL, V100, P100, DOI 10.1016/j.fertnstert.2013.02.056; Fragouli E, 2006, HUM REPROD, V21, P2319, DOI 10.1093/humrep/del157; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Fragouli E, 2013, HUM REPROD, V28, P1731, DOI 10.1093/humrep/det069; Fragouli E, 2011, MOL HUM REPROD, V17, P286, DOI 10.1093/molehr/gar024; Gardner DK, 2004, FERTIL STERIL, V81, P551, DOI 10.1016/j.fertnstert.2003.07.023; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; GIORGETTI C, 1995, HUM REPROD, V10, P2427; Goossens V, 2012, HUM REPROD, V27, P1887, DOI 10.1093/humrep/des106; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Handyside AH, 2012, EUR J HUM GENET, V20, P742, DOI 10.1038/ejhg.2011.272; Harton GL, 2013, FERTIL STERIL, V100, P1695, DOI 10.1016/j.fertnstert.2013.07.2002; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hengstschlager M, 2005, WIEN KLIN WOCHENSCHR, V117, P725, DOI 10.1007/s00508-005-0461-5; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Lintsen AME, 2007, HUM REPROD, V22, P2455, DOI 10.1093/humrep/dem183; Mamas T, 2012, FERTIL STERIL, V97, P943, DOI 10.1016/j.fertnstert.2011.12.048; Mastenbroek S, 2011, HUM REPROD UPDATE, V17, P454, DOI 10.1093/humupd/dmr003; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Montag M, 2009, REPROD BIOMED ONLINE, V18, P6, DOI 10.1016/S1472-6483(10)60109-5; Montag M, 2013, FERTIL STERIL, V100, P603, DOI 10.1016/j.fertnstert.2013.05.053; Munne S, 2012, CURR GENOMICS, V13, P463, DOI 10.2174/138920212802510457; Munne Santiago, 2002, Reprod Biomed Online, V4, P183; Novik V, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-18; Pantos K, 1999, FERTIL STERIL, V71, P1144, DOI 10.1016/S0015-0282(99)00121-1; R Core Team, 2021, R LANGUAGE ENV STAT; Rabinowitz M, 2012, FERTIL STERIL, V97, P395, DOI 10.1016/j.fertnstert.2011.11.034; Rechitsky Svetlana, 2002, Reprod Biomed Online, V5, P148; Salvaggio CN, 2014, J ASSIST REPROD GEN, V31, P1221, DOI 10.1007/s10815-014-0293-1; Scott KL, 2013, FERTIL STERIL, V100, P608, DOI 10.1016/j.fertnstert.2013.07.004; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Scott RT, 2012, J ASSIST REPROD GEN, V29, P533, DOI 10.1007/s10815-012-9746-6; Shapiro BS, 2002, FERTIL STERIL, V77, P700, DOI 10.1016/S0015-0282(01)03251-4; Twisk M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005291.pub2; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Verlinsky Y, 2002, JAMA-J AM MED ASSOC, V287, P1018, DOI 10.1001/jama.287.8.1018; VERLINSKY Y, 1990, HUM REPROD, V5, P826, DOI 10.1093/oxfordjournals.humrep.a137192; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wells D, 2014, J MED GENET, V51, P553, DOI 10.1136/jmedgenet-2014-102497; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24	53	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128317	10.1371/journal.pone.0128317	http://dx.doi.org/10.1371/journal.pone.0128317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024488	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400080
J	Stern, J; Kahn, A; Vazana, Y; Shamshoum, M; Morais, S; Lamed, R; Bayer, EA				Stern, Johanna; Kahn, Amaranta; Vazana, Yael; Shamshoum, Melina; Morais, Sarah; Lamed, Raphael; Bayer, Edward A.			Significance of Relative Position of Cellulases in Designer Cellulosomes for Optimized Cellulolysis	PLOS ONE			English	Article							CLOSTRIDIUM-THERMOCELLUM; GENE-CLUSTER; MECHANISM; BINDING; DEGRADATION; COMPONENTS; SUBSTRATE; FAMILIES; INSIGHTS; SYSTEM	Degradation of cellulose is of major interest in the quest for alternative sources of renewable energy, for its positive effects on environment and ecology, and for use in advanced biotechnological applications. Due to its microcrystalline organization, celluose is extremely difficult to degrade, although numerous microbes have evolved that produce the appropriate enzymes. The most efficient known natural cellulolytic system is produced by anaerobic bacteria, such as C. thermocellum, that possess a multi-enzymatic complex termed the cellulosome. Our laboratory has devised and developed the designer cellulosome concept, which consists of chimaeric scaffoldins for controlled incorporation of recombinant polysaccharide-degrading enzymes. Recently, we reported the creation of a combinatorial library of four cellulosomal modules comprising a basic chimaeric scaffoldin, i.e., a CBM and 3 divergent cohesin modules. Here, we employed selected members of this library to determine whether the position of defined cellulolytic enzymes is important for optimized degradation of a microcrystalline cellulosic substrate. For this purpose, 10 chimaeric scaffoldins were used for incorporation of three recombinant Thermobifida fusca enzymes: the processive endoglucanase Cel9A, endoglucanase Cel5A and exoglucanase Cel48A. In addition, we examined whether the characteristic properties of the T. fusca enzymes as designer cellulosome components are unique to this bacterium by replacing them with parallel enzymes from Clostridium thermocellum. The results support the contention that for a given set of cellulosomal enzymes, their relative position within a scaffoldin can be critical for optimal degradation of microcrystaline cellulosic substrates.	[Stern, Johanna; Kahn, Amaranta; Vazana, Yael; Shamshoum, Melina; Morais, Sarah; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel	Weizmann Institute of Science; Tel Aviv University	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	ed.bayer@weizmann.ac.il		kahn, amaranta/0000-0001-8516-7296; Morais, Sarah/0000-0001-9026-2386	European Union [604530]; ERA-IB Consortium [EIB.12.022]; F. Warren Hellman Grant for Alternative Energy Research in Israel; Israel Science Foundation (ISF) [1349]; Sidney E. Frank Foundation through the ISF [24/11]; Israeli Center of Research Excellence (I-CORE Center) [152/11]; Weizmann Institute of Science Alternative Energy Research Initiative (AERI); Helmsley Foundation	European Union(European Commission); ERA-IB Consortium; F. Warren Hellman Grant for Alternative Energy Research in Israel; Israel Science Foundation (ISF)(Israel Science Foundation); Sidney E. Frank Foundation through the ISF; Israeli Center of Research Excellence (I-CORE Center); Weizmann Institute of Science Alternative Energy Research Initiative (AERI); Helmsley Foundation	The authors acknowledge the support of the European Union, Area NMP.2013.1.1-2: Self-assembly of naturally occurring nanosystems: CellulosomePlus Project number: 604530 and an ERA-IB Consortium (EIB.12.022), acronym FiberFuel. In addition, EAB is grateful for a grant from the F. Warren Hellman Grant for Alternative Energy Research in Israel in support of alternative energy research in Israel administered by the Israel Strategic Alternative Energy Foundation (I-SAEF). This research was also supported by a grant (No. 1349) to EAB also from the Israel Science Foundation (ISF) and a grant (No. 24/11) issued to RL by The Sidney E. Frank Foundation also through the ISF. Additional support was obtained from the establishment of an Israeli Center of Research Excellence (I-CORE Center No. 152/11) managed by the ISF, Jerusalem, Israel, by the Weizmann Institute of Science Alternative Energy Research Initiative (AERI) and the Helmsley Foundation. E.A.B. is the incumbent of The Maynard I. and Elaine Wishner Chair of Bio-organic Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; BAYER EA, 1985, J BACTERIOL, V163, P552, DOI 10.1128/JB.163.2.552-559.1985; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; Bayer EA, 1995, PROGR BIOTECHNOL, V10, P251, DOI 10.1016/S0921-0423(06)80108-5; Belaich JP, 1997, J BIOTECHNOL, V57, P3, DOI 10.1016/S0168-1656(97)00085-0; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Bomble YJ, 2011, J BIOL CHEM, V286, P5614, DOI 10.1074/jbc.M110.186031; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borne R, 2013, FEBS J, V280, P5764, DOI 10.1111/febs.12497; Caspi Jonathan, 2010, Systems and Synthetic Biology, V4, P193, DOI 10.1007/s11693-010-9056-1; Caspi J, 2007, EFFECT CELLULOSOMAL; Caspi J, 2008, J BIOTECHNOL, V135, P351, DOI 10.1016/j.jbiotec.2008.05.003; Caspi J, 2006, BIOCATAL BIOTRANSFOR, V24, P3, DOI 10.1080/10242420600598046; Caspi J, 2009, APPL ENVIRON MICROB, V75, P7335, DOI 10.1128/AEM.01241-09; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; JOHNSON EA, 1982, APPL ENVIRON MICROB, V43, P1125, DOI 10.1128/AEM.43.5.1125-1132.1982; LAMED R, 1983, BIOTECHNOL BIOENG, P163; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mingardon F, 2011, APPL ENVIRON MICROB, V77, P1436, DOI 10.1128/AEM.01802-10; MORAG E, 1995, APPL ENVIRON MICROB, V61, P1980, DOI 10.1128/AEM.61.5.1980-1986.1995; Morais S, 2012, MBIO, V3, DOI 10.1128/mBio.00508-12; Morais S, 2011, MBIO, V2, DOI 10.1128/mBio.00233-11; Morais S, 2010, MBIO, V1, DOI 10.1128/mBio.00285-10; Morais S, 2010, APPL ENVIRON MICROB, V76, P3787, DOI 10.1128/AEM.00266-10; Raman B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-134; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Sabathe F, 2002, FEMS MICROBIOL LETT, V217, P15, DOI 10.1016/S0378-1097(02)00991-6; Sakka M, 2010, BIOSCI BIOTECH BIOCH, V74, P2077, DOI 10.1271/bbb.100458; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Tamaru Y, 2000, J BACTERIOL, V182, P5906, DOI 10.1128/JB.182.20.5906-5910.2000; Vazana Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-182; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002	39	30	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127326	10.1371/journal.pone.0127326	http://dx.doi.org/10.1371/journal.pone.0127326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024227	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400036
J	Vieira, AE; Repeke, CE; Ferreira, SD; Colavite, PM; Biguetti, CC; Oliveira, RC; Assis, GF; Taga, R; Trombone, APF; Garlet, GP				Vieira, Andreia Espindola; Repeke, Carlos Eduardo; Ferreira Junior, Samuel de Barros; Colavite, Priscila Maria; Biguetti, Claudia Cristina; Oliveira, Rodrigo Cardoso; Assis, Gerson Francisco; Taga, Rumio; Favaro Trombone, Ana Paula; Garlet, Gustavo Pompermaier			Intramembranous Bone Healing Process Subsequent to Tooth Extraction in Mice: Micro-Computed Tomography, Histomorphometric and Molecular Characterization	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MATRIX METALLOPROTEINASES; POLARIZATION METHOD; NECROSIS-FACTOR; EXPRESSION; ANGIOGENESIS; REPAIR; PERIODONTITIS; REGENERATION; CYTOKINES	Bone tissue has a significant potential for healing, which involves a significant the interplay between bone and immune cells. While fracture healing represents a useful model to investigate endochondral bone healing, intramembranous bone healing models are yet to be developed and characterized. In this study, a micro-computed tomography, histomorphometric and molecular (RealTimePCRarray) characterization of post tooth-extraction alveolar bone healing was performed on C57Bl/6 WT mice. After the initial clot dominance (0h), the development of a provisional immature granulation tissue is evident (7d), characterized by marked cell proliferation, angiogenesis and inflammatory cells infiltration; associated with peaks of growth factors (BMP-2-4-7, TGF beta 1, VEGFa), cytokines (TNF alpha, IL-10), chemokines & receptors (CXCL12, CCL25, CCR5, CXCR4), matrix (Col1a1-2, ITGA4, VTN, MMP1a) and MSCs (CD105, CD106, OCT4, NANOG, CD34, CD146) markers expression. Granulation tissue is sequentially replaced by more mature connective tissue (14d), characterized by inflammatory infiltrate reduction along the increased bone formation, marked expression of matrix remodeling enzymes (MMP-2-9), bone formation/maturation (RUNX2, ALP, DMP1, PHEX, SOST) markers, and chemokines & receptors associated with healing (CCL2, CCL17, CCR2). No evidences of cartilage cells or tissue were observed, strengthening the intramembranous nature of bone healing. Bone microarchitecture analysis supports the evolving healing, with total tissue and bone volumes as trabecular number and thickness showing a progressive increase over time. The extraction socket healing process is considered complete (21d) when the dental socket is filled by trabeculae bone with well-defined medullary canals; it being the expression of mature bone markers prevalent at this period. Our data confirms the intramembranous bone healing nature of the model used, revealing parallels between the gene expression profile and the histomorphometric events and the potential participation of MCSs and immune cells in the healing process, supporting the forthcoming application of the model for the better understanding of the bone healing process.	[Vieira, Andreia Espindola; Repeke, Carlos Eduardo; Ferreira Junior, Samuel de Barros; Colavite, Priscila Maria; Biguetti, Claudia Cristina; Oliveira, Rodrigo Cardoso; Assis, Gerson Francisco; Taga, Rumio; Garlet, Gustavo Pompermaier] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Favaro Trombone, Ana Paula] Univ Sagrado Coracao, Dept Biol & Allied Hlth Sci, Bauru, Brazil	Universidade de Sao Paulo; Universidade do Sagrado Coracao	Garlet, GP (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil.	garletgp@usp.br	Taga, Rumio/E-5794-2012; Garlet, Gustavo Pompermaier/E-6762-2012; Garlet, Ana Paula Trombone/N-9346-2013; Repeke, Carlos Eduardo/AAQ-2968-2020; Vieira, Andreia Espindola/F-5892-2012; Biguetti, Claudia C/F-5118-2012; de Oliveira, Rodrigo Cardoso/E-2551-2012; Vieira, Andreia/HGC-4528-2022; Assis, Gerson Francisco/E-5871-2012	Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Garlet, Ana Paula Trombone/0000-0002-8102-6098; Vieira, Andreia Espindola/0000-0002-1344-1185; Biguetti, Claudia C/0000-0003-4503-3108; de Oliveira, Rodrigo Cardoso/0000-0003-3070-5960; Assis, Gerson Francisco/0000-0001-8225-3164; Repeke, Carlos Eduardo/0000-0001-7933-0114	Sao Paulo Research Foundation (FAPESP) [09/11496-1, 10/15755-9]; National Counsel of Technological and Scientific Development (CNPq) [470933/2011-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants and scholarships from the Sao Paulo Research Foundation (FAPESP) (#09/11496-1 and #10/15755-9) and the National Counsel of Technological and Scientific Development (CNPq) (#470933/2011-9). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi-Mendonca T, 2008, J MOL HISTOL, V39, P201, DOI 10.1007/s10735-007-9152-z; Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0; Araujo-Pires AC, 2015, J BONE MINER RES, V30, P400, DOI 10.1002/jbmr.2376; Araujo-Pires AC, 2014, J ENDODONT, V40, P1560, DOI 10.1016/j.joen.2014.02.012; Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berendsen AD, 2014, MATRIX BIOL, V35, P223, DOI 10.1016/j.matbio.2013.12.004; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bossini PS, 2012, EXP GERONTOL, V47, P136, DOI 10.1016/j.exger.2011.11.005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Campos K, 2015, J ENDODONT, V41, P212, DOI 10.1016/j.joen.2014.10.003; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x; Cardoso CL, 2011, ACTA CIR BRAS, V26, P365, DOI 10.1590/S0102-86502011000500007; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Claudino M, 2010, EUR J ORAL SCI, V118, P19, DOI 10.1111/j.1600-0722.2009.00706.x; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Coleman R, 2011, ACTA HISTOCHEM, V113, P231, DOI 10.1016/j.acthis.2010.02.002; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Taddei SRD, 2012, AM J ORTHOD DENTOFAC, V141, P153, DOI 10.1016/j.ajodo.2011.07.019; Devlin H, 1997, J BONE MINER RES, V12, P2061, DOI 10.1359/jbmr.1997.12.12.2061; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Discepoli N, 2013, J CLIN PERIODONTOL, V40, P638, DOI 10.1111/jcpe.12074; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009; Aranha AMF, 2013, J ENDODONT, V39, P83, DOI 10.1016/j.joen.2012.10.015; Ferreira SB, 2011, J DENT RES, V90, P632, DOI 10.1177/0022034510395021; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Garavello-Freltas I, 2003, J PHOTOCH PHOTOBIO B, V70, P81, DOI 10.1016/S1011-1344(03)00058-7; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Garlet GP, 2014, J DENT RES, V93, P834, DOI 10.1177/0022034514544300; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Garlet GP, 2013, J APPL ORAL SCI, V21, P98, DOI [10.1590/1678-77572013ed004, 10.1590/1678-77572013ed002]; Garlet GP, 2012, J ENDODONT, V38, P185, DOI 10.1016/j.joen.2011.09.011; Garlet TP, 2010, J ENDODONT, V36, P244, DOI 10.1016/j.joen.2009.09.004; Glowacki AJ, 2013, P NATL ACAD SCI USA, V110, P18525, DOI 10.1073/pnas.1302829110; Goodman SC, 2014, J ENDODONT, V40, P830, DOI 10.1016/j.joen.2013.10.021; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Javed A, 2010, ORAL MAXIL SURG CLIN, V22, P283, DOI 10.1016/j.coms.2010.05.001; JURGENS TM, 1990, PHARMACEUT RES, V7, P742, DOI 10.1023/A:1015871723330; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kanyama M, 2003, ARCH ORAL BIOL, V48, P723, DOI 10.1016/S0003-9969(03)00153-5; Kato T, 2011, EXP DERMATOL, V20, P669, DOI 10.1111/j.1600-0625.2011.01286.x; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052; Korpi JT, 2009, EUR J ORAL SCI, V117, P248, DOI 10.1111/j.1600-0722.2009.00620.x; Kuroshima S, 2013, J DENT RES, V92, P553, DOI 10.1177/0022034513487558; Lalani Z, 2003, J ORAL MAXIL SURG, V61, P1061, DOI 10.1016/S0278-2391(03)00319-7; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; Lin Z, 2011, J PERIODONTOL, V82, P1007, DOI 10.1902/jop.2010.100577; Lorenzo J, 2005, IMMUNOL REV, V208, P5, DOI 10.1111/j.0105-2896.2005.00340.x; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; McGrory K, 2004, BIOCHEM BIOPH RES CO, V324, P317, DOI 10.1016/j.bbrc.2004.09.056; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Morko J, 2009, BONE, V44, P717, DOI 10.1016/j.bone.2008.11.019; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Arantes RVN, 2015, J PERIODONTOL, V86, P162, DOI 10.1902/jop.2014.140259; Ohira T, 2004, J DENT RES, V83, P546, DOI 10.1177/154405910408300707; Okamoto T, 1990, Rev Odontol UNESP, V19, P63; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pagni G, 2012, INT J DENT, V2012, DOI 10.1155/2012/151030; Pereira NB, 2014, TOXICON, V84, P7, DOI 10.1016/j.toxicon.2014.03.003; PIERARD GE, 1989, MATRIX, V9, P68, DOI 10.1016/S0934-8832(89)80021-6; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Repeke CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022526; Repeke CE, 2009, J CLIN PERIODONTOL, V36, P726, DOI 10.1111/j.1600-051X.2009.01447.x; Sato H, 2007, CELLS TISSUES ORGANS, V186, P104, DOI 10.1159/000103513; Scala A, 2014, CLIN ORAL IMPLAN RES, V25, P288, DOI 10.1111/clr.12148; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Sedgwick JD, 2000, IMMUNOL TODAY, V21, P110, DOI 10.1016/S0167-5699(99)01573-X; Shah K, 2013, CURR OSTEOPOROS REP, V11, P130, DOI 10.1007/s11914-013-0146-3; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x; Stover DA, 2011, MOL BIOL EVOL, V28, P533, DOI 10.1093/molbev/msq221; Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teofilo JM, 2011, IMPLANT DENT, V20, pE7, DOI 10.1097/ID.0b013e31820fbacf; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; Ting K, 1999, AM J PATHOL, V155, P1993, DOI 10.1016/S0002-9440(10)65518-6; TING K, 1993, J BONE MINER RES, V8, P1377; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x; Trombone AP, 2010, GENES IMMUN, V11, P479, DOI 10.1038/gene.2010.13; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Rodrigues MTV, 2011, J APPL ORAL SCI, V19, P260, DOI 10.1590/S1678-77572011000300015; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Wu YF, 2010, MATRIX BIOL, V29, P701, DOI 10.1016/j.matbio.2010.09.002; Yang XH, 2014, CALCIFIED TISSUE INT, V94, P338, DOI 10.1007/s00223-013-9815-6; Yugoshi Luciana Ibara, 2002, Braz. Dent. J., V13, P92, DOI 10.1590/S0103-64402002000200003	102	73	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128021	10.1371/journal.pone.0128021	http://dx.doi.org/10.1371/journal.pone.0128021			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023920	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400065
J	Hara, T; Kobayashi, T; Ito, S; Zhou, XR; Katafuchi, T; Fujita, H				Hara, Takeshi; Kobayashi, Tatsunori; Ito, Satoshi; Zhou, Xiangrong; Katafuchi, Tetsuro; Fujita, Hiroshi			Quantitative Analysis of Torso FDG-PET Scans by Using Anatomical Standardization of Normal Cases from Thorough Physical Examinations	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BODY; BRAIN; ATLAS; SUV	Understanding of standardized uptake value (SUV) of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) depends on the background accumulations of glucose because the SUV often varies the status of patients. The purpose of this study was to develop a new method for quantitative analysis of SUV of FDG-PET scan images. The method included an anatomical standardization and a statistical comparison with normal cases by using Z-score that are often used in SPM or 3D-SSP approach for brain function analysis. Our scheme consisted of two approaches, which included the construction of a normal model and the determination of the SUV scores as Z-score index for measuring the abnormality of an FDG-PET scan image. To construct the normal torso model, all of the normal images were registered into one shape, which indicated the normal range of SUV at all voxels. The image deformation process consisted of a whole body rigid registration of shoulder to bladder region and liver registration and a non-linear registration of body surface by using the thin-plate spline technique. In order to validate usefulness of our method, we segment suspicious regions on FDG-PET images manually, and obtained the Z-scores of the regions based on the corresponding voxels that stores the mean and the standard deviations from the normal model. We collected 243 (143 males and 100 females) normal cases to construct the normal model. We also extracted 432 abnormal spots from 63 abnormal cases (73 cancer lesions) to validate the Z-scores. The Z-scores of 417 out of 432 abnormal spots were higher than 2.0, which statistically indicated the severity of the spots. In conclusions, the Z-scores obtained by our computerized scheme with anatomical standardization of torso region would be useful for visualization and detection of subtle lesions on FDG-PET scan images even when the SUV may not clearly show an abnormality.	[Hara, Takeshi; Kobayashi, Tatsunori; Zhou, Xiangrong; Fujita, Hiroshi] Gifu Univ, Grad Sch Med, Dept Intelligent Image Informat, Div Regenerat & Adv Med Sci, Gifu, Gifu, Japan; [Kobayashi, Tatsunori] Junshin Gakuen Univ, Fac Hlth Sci, Dept Radiol Sci, Fukuoka, Fukuoka, Japan; [Ito, Satoshi] Daiyukai Gen Hosp, Dept Radiol, Ichinomiya, Aichi, Japan; [Katafuchi, Tetsuro] Gifu Univ Med Sci, Dept Radiol Technol, Seki, Gifu, Japan	Gifu University	Hara, T (corresponding author), Gifu Univ, Grad Sch Med, Dept Intelligent Image Informat, Div Regenerat & Adv Med Sci, Gifu, Gifu, Japan.	takeshi.hara@mac.com	Kobayashi, Tatsunori/AAF-9774-2020		Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government [19500385, 21103004, 10283285, 26108001]	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Academic Research (#19500385, #21103004, #10283285, #26108001) from the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Delbeke D, 2006, J NUCL MED, V47, P885; Engel H, 1996, J NUCL MED, V37, P441; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Huang SC, 2000, NUCL MED BIOL, V27, P643; Ide M, 2005, EUR J NUCL MED MOL I, V32, P339, DOI 10.1007/s00259-005-1774-3; Ishii K, 2009, EUR J NUCL MED MOL I, V36, P831, DOI 10.1007/s00259-008-1051-3; Kamiya N, 2013, IEICE T INF SYST, VE96D, P869, DOI 10.1587/transinf.E96.D.869; KANO A, 1994, MED PHYS, V21, P453, DOI 10.1118/1.597308; KEYES JW, 1995, J NUCL MED, V36, P1836; KIM CK, 1994, J NUCL MED, V35, P164; Minamimoto R, 2007, ANN NUCL MED, V21, P481, DOI 10.1007/s12149-007-0061-8; Minamimoto R, 2011, ANN NUCL MED, V25, P45, DOI 10.1007/s12149-010-0428-0; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; MINOSHIMA S, 1994, J NUCL MED, V35, P949; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Sadik M, 2008, J NUCL MED, V49, P1958, DOI 10.2967/jnumed.108.055061; Shiraishi J, 2007, MED PHYS, V34, P25, DOI 10.1118/1.2401044; Tang BNT, 2004, EUR J NUCL MED MOL I, V31, P1487, DOI 10.1007/s00259-004-1597-7; Visser EP, 2010, J NUCL MED, V51, P173, DOI 10.2967/jnumed.109.068411; Wang YB, 2007, MOL IMAGING BIOL, V9, P83, DOI 10.1007/s11307-006-0075-y; Weckesser M, 2005, EUR J NUCL MED MOL I, V32, P342, DOI 10.1007/s00259-005-1775-2; Yasuda S, 1997, LANCET, V350, P1819, DOI 10.1016/S0140-6736(97)24051-1; Yasuda S, 2000, BRIT J CANCER, V83, P1607, DOI 10.1054/bjoc.2000.1496; Zhou XR, 2014, RADIOL PHYS TECHNOL, V7, P277, DOI 10.1007/s12194-014-0261-6	25	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125713	10.1371/journal.pone.0125713	http://dx.doi.org/10.1371/journal.pone.0125713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020960	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300015
J	Gascoyne, DM; Spearman, H; Lyne, L; Puliyadi, R; Perez-Alcantara, M; Coulton, L; Fisher, SE; Croucher, PI; Banham, AH				Gascoyne, Duncan M.; Spearman, Hayley; Lyne, Linden; Puliyadi, Rathi; Perez-Alcantara, Marta; Coulton, Les; Fisher, Simon E.; Croucher, Peter I.; Banham, Alison H.			The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21(WAF1/CIP1) in 143B Osteosarcoma Cell Growth Arrest	PLOS ONE			English	Article							T-CELLS; OSTEOBLAST DIFFERENTIATION; LANGUAGE DISORDER; DOWN-REGULATION; SEVERE SPEECH; HUMAN BRAIN; GENE; EXPRESSION; MICE; MUTATION	Mutations of the forkhead transcription factor FOXP2 gene have been implicated in inherited speech-and-language disorders, and specific Foxp2 expression patterns in neuronal populations and neuronal phenotypes arising from Foxp2 disruption have been described. However, molecular functions of FOXP2 are not completely understood. Here we report a requirement for FOXP2 in growth arrest of the osteosarcoma cell line 143B. We observed endogenous expression of this transcription factor both transiently in normally developing murine osteoblasts and constitutively in human SAOS-2 osteosarcoma cells blocked in early osteoblast development. Critically, we demonstrate that in 143B osteosarcoma cells with minimal endogenous expression, FOXP2 induced by growth arrest is required for upregulation of p21(WAF1/CIP1). Upon growth factor withdrawal, FOXP2 induction occurs rapidly and precedes p21(WAF1/CIP1) activation. Additionally, FOXP2 expression could be induced by MAPK pathway inhibition in growth-arrested 143B cells, but not in traditional cell line models of osteoblast differentiation (MG-63, C2C12, MC3T3-E1). Our data are consistent with a model in which transient upregulation of Foxp2 in pre-osteoblast mesenchymal cells regulates a p21-dependent growth arrest checkpoint, which may have implications for normal mesenchymal and osteosarcoma biology.	[Gascoyne, Duncan M.; Spearman, Hayley; Lyne, Linden; Perez-Alcantara, Marta; Banham, Alison H.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England; [Puliyadi, Rathi] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Coulton, Les] Univ Sheffield, Dept Human Metab, Acad Unit Bone Biol, Sheffield S10 2RX, S Yorkshire, England; [Fisher, Simon E.] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Fisher, Simon E.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Sheffield; Max Planck Society; Radboud University Nijmegen; Garvan Institute of Medical Research	Banham, AH (corresponding author), Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England.	alison.banham@ndcls.ox.ac.uk	Fisher, Simon E./E-9130-2012	Fisher, Simon E./0000-0002-3132-1996; Croucher, Peter/0000-0002-7102-2413; Banham, Alison/0000-0002-3197-273X; Perez Alcantara, Marta/0000-0002-7767-1940	Specialist Programme Grant from Leukaemia and Lymphoma Research [10044]; Oxford Cancer Research Centre; Wellcome Trust [075491, 080971]; Simons Foundation Autism Research Initiative (SFARI) [137593]; Mrs. Janice Gibson and Ernest Heine Family Foundation	Specialist Programme Grant from Leukaemia and Lymphoma Research; Oxford Cancer Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); Simons Foundation Autism Research Initiative (SFARI); Mrs. Janice Gibson and Ernest Heine Family Foundation	DMG, HS, LL, and AHB were supported by a Specialist Programme Grant (Ref: 10044) from Leukaemia and Lymphoma Research. MPA was supported by a studentship grant from the Oxford Cancer Research Centre. SEF and RP were supported by the Wellcome Trust (grant numbers 075491 and 080971) and the Simons Foundation Autism Research Initiative (SFARI, grant number 137593). PIC is supported by Mrs. Janice Gibson and Ernest Heine Family Foundation.	Marques-Torrejon MA, 2013, CELL STEM CELL, V12, P88, DOI 10.1016/j.stem.2012.12.001; Banham AH, 2001, CANCER RES, V61, P8820; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bellosta P, 2003, J BONE MINER RES, V18, P818, DOI 10.1359/jbmr.2003.18.5.818; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BONEWALD LF, 1992, BONE MINER, V17, P139, DOI 10.1016/0169-6009(92)90725-S; Brown PJ, 2010, OPEN LEUKEMIA J, V3, P16, DOI [10.2174/1876816401003010016, DOI 10.2174/1876816401003010016]; Campbell AJ, 2010, BRIT J HAEMATOL, V149, P221, DOI 10.1111/j.1365-2141.2009.08070.x; Colla S, 2005, LEUKEMIA, V19, P2166, DOI 10.1038/sj.leu.2403976; Denaxa M, 2009, DEV BIOL, V333, P324, DOI 10.1016/j.ydbio.2009.07.001; Di Giorgio E, 2015, MOL CELL BIOL, V35, P1633, DOI 10.1128/MCB.01461-14; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fowler JA, 2011, BONE, V48, P121, DOI 10.1016/j.bone.2010.06.029; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kawashima H, 2013, J IMMUNOL, V191, P3614, DOI 10.4049/jimmunol.1300509; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kurt S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033130; Kurt S, 2009, BRAIN RES, V1289, P30, DOI 10.1016/j.brainres.2009.06.092; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Leishman E, 2013, DEVELOPMENT, V140, P3809, DOI 10.1242/dev.097477; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Ridgway PJ, 1997, VIROLOGY, V237, P404, DOI 10.1006/viro.1997.8782; ROMANO JW, 1989, ONCOGENE, V4, P1483; Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024; Shah R, 2006, INT J DEV BIOL, V50, P435, DOI 10.1387/ijdb.052065rs; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Thomas D, 2004, IEEE SOFTWARE, V21, P12, DOI 10.1109/MS.2004.49; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Zhao H. K., 2014, J BACTERIOL MYCOL, V1, P1, DOI DOI 10.1049/J0E.2013.0129; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002	51	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128513	10.1371/journal.pone.0128513	http://dx.doi.org/10.1371/journal.pone.0128513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26034982	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100035
J	Jisha, V; Dampanaboina, L; Vadassery, J; Mithofer, A; Kappara, S; Ramanan, R				Jisha, V.; Dampanaboina, Lavanya; Vadassery, Jyothilakshmi; Mithoefer, Axel; Kappara, Saivishnupriya; Ramanan, Rajeshwari			Overexpression of an AP2/ERF Type Transcription Factor OsEREBP1 Confers Biotic and Abiotic Stress Tolerance in Rice	PLOS ONE			English	Article							XA21-MEDIATED INNATE IMMUNITY; JASMONIC ACID ACCUMULATION; RESPONSIVE GENE-EXPRESSION; GENOME-WIDE ANALYSIS; ORYZAE PV. ORYZAE; FUNCTIONAL-ANALYSIS; SUBMERGENCE TOLERANCE; DROUGHT TOLERANCE; BACTERIAL-BLIGHT; SALT TOLERANCE	AP2/ERF-type transcription factors regulate important functions of plant growth and development as well as responses to environmental stimuli. A rice AP2/ERF transcription factor, OsEREBP1 is a downstream component of a signal transduction pathway in a specific interaction between rice (Oryza sativa) and its bacterial pathogen, Xoo (Xanthomonas oryzae pv. oryzae). Constitutive expression of OsEREBP1 in rice driven by maize ubiquitin promoter did not affect normal plant growth. Microarray analysis revealed that over expression of OsEREBP1 caused increased expression of lipid metabolism related genes such as lipase and chloroplastic lipoxygenase as well as several genes related to jasmonate and abscisic acid biosynthesis. PR genes, transcription regulators and Aldhs (alcohol dehydrogenases) implicated in abiotic stress and submergence tolerance were also upregulated in transgenic plants. Transgenic plants showed increase in endogenous levels of a-linolenate, several jasmonate derivatives and abscisic acid but not salicylic acid. Soluble modified GFP (SmGFP)-tagged OsEREBP1 was localized to plastid nucleoids. Comparative analysis of non-transgenic and OsEREBP1 overexpressing genotypes revealed that OsEREBP1 attenuates disease caused by Xoo and confers drought and submergence tolerance in transgenic rice. Our results suggest that constitutive expression of OsEREBP1 activates the jasmonate and abscisic acid signalling pathways thereby priming the rice plants for enhanced survival under abiotic or biotic stress conditions. OsEREBP1 is thus, a good candidate gene for engineering plants for multiple stress tolerance.	[Jisha, V.; Dampanaboina, Lavanya; Kappara, Saivishnupriya; Ramanan, Rajeshwari] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Vadassery, Jyothilakshmi; Mithoefer, Axel] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Max Planck Society	Ramanan, R (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	raji@ccmb.res.in		Dampanaboina, Lavanya/0000-0001-6303-6818	Department of Science and Technology (DST) [SR/SO/PS-68/2008]; Council for Scientific and Industrial Research (CSIR), Government of India [9/1/BS/CCMB(4)/2012-13-PPD]	Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by Department of Science and Technology (DST No: SR/SO/PS-68/2008) and Council for Scientific and Industrial Research (CSIR No: 9/1/BS/CCMB(4)/2012-13-PPD), Government of India.	Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Chauvin A, 2013, NEW PHYTOL, V197, P566, DOI 10.1111/nph.12029; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Datta K, 2012, PLANT BIOTECHNOL J, V10, P579, DOI 10.1111/j.1467-7652.2012.00688.x; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fitzgerald HA, 2004, MOL PLANT MICROBE IN, V17, P140, DOI 10.1094/MPMI.2004.17.2.140; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Fujiwara S, 2004, MOL PLANT MICROBE IN, V17, P986, DOI 10.1094/MPMI.2004.17.9.986; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; Griffiths G, 2000, J EXP BOT, V51, P1363, DOI 10.1093/jexbot/51.349.1363; Han MJ, 2006, PLANT CELL PHYSIOL, V47, P1457, DOI 10.1093/pcp/pcl013; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khong GN, 2008, BIOTECHNOL GENET ENG, V25, P381, DOI 10.5661/bger-25-381; Kim CY, 2000, MOL PLANT MICROBE IN, V13, P470, DOI 10.1094/MPMI.2000.13.4.470; Kiribuchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P1042, DOI 10.1271/bbb.69.1042; Koo AJK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00019; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002; Liu F, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00017; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; Melonek J, 2012, PLANT CELL, V24, P3060, DOI 10.1105/tpc.112.099721; Miyamoto K, 2013, PROTOPLASMA, V250, P241, DOI 10.1007/s00709-012-0400-z; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Ohnishi T, 2005, GENES GENET SYST, V80, P135, DOI 10.1266/ggs.80.135; Park CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009262; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Peng Y, 2010, RICE, V3, P36, DOI 10.1007/s12284-010-9039-6; Quan RD, 2010, PLANT BIOTECHNOL J, V8, P476, DOI 10.1111/j.1467-7652.2009.00492.x; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Sun LJ, 2013, PLANT MOL BIOL, V81, P41, DOI 10.1007/s11103-012-9981-3; Taniguchi S, 2014, PLANT CELL ENVIRON, V37, P451, DOI 10.1111/pce.12169; Todaka D, 2012, RICE, V5, DOI 10.1186/1939-8433-5-6; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Vadez V., 2008, QUO VADIS J FOOD LEG, V21, P77; Wagner R, 2006, GENE, V381, P62, DOI 10.1016/j.gene.2006.06.022; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yaish MW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001098; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yan LH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003964; Ye NH, 2012, RICE, V5, DOI 10.1186/1939-8433-5-1; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022	68	105	116	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127831	10.1371/journal.pone.0127831	http://dx.doi.org/10.1371/journal.pone.0127831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035591	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100023
J	Burdelski, C; Bujupi, E; Tsourlakis, MC; Hube-Magg, C; Kluth, M; Melling, N; Lebok, P; Minner, S; Koop, C; Graefen, M; Heinzer, H; Wittmer, C; Sauter, G; Wilczak, W; Simon, R; Schlomm, T; Steurer, S; Krech, T				Burdelski, Christoph; Bujupi, Erzen; Tsourlakis, Maria Christina; Hube-Magg, Claudia; Kluth, Martina; Melling, Nathaniel; Lebok, Patrick; Minner, Sarah; Koop, Christina; Graefen, Markus; Heinzer, Hans; Wittmer, Corinna; Sauter, Guido; Wilczak, Waldemar; Simon, Ronald; Schlomm, Thorsten; Steurer, Stefan; Krech, Till			Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers	PLOS ONE			English	Article							CELLULAR SENESCENCE; INVASION; FUSION; GENES; DIFFERENTIATION; OVEREXPRESSION; TUMORIGENESIS; SUPPRESSION; PROGRESSION; PATHWAY	The transcription factor SOX9 plays a crucial role in normal prostate development and has been suggested to drive prostate carcinogenesis in concert with PTEN inactivation. To evaluate the clinical impact of SOX9 and its relationship with key genomic alterations in prostate cancer, SOX9 expression was analyzed by immunohistochemistry on a tissue microarray containing 11,152 prostate cancers. Data on ERG status and deletions of PTEN, 3p13, 5q21 and 6q15 were available from earlier studies. SOX9 expression levels were comparable in luminal cells of normal prostate glands (50% SOX9 positive) and 3,671 cancers lacking TMPRSS2: ERG fusion (55% SOX9 positive), but was markedly increased in 3,116 ERG-fusion positive cancers (81% SOX9 positive, p<0.0001). While no unequivocal changes in the SOX9 expression levels were found in different stages of ERG-negative cancers, a gradual decrease of SOX9 paralleled progression to advanced stage, high Gleason grade, metastatic growth, and presence of PTEN deletions in ERG-positive cancers (p<0.0001 each). SOX9 levels were unrelated to deletions of 3p, 5q, and 6q. Down-regulation of SOX9 expression was particularly strongly associated with PSA recurrence in ERG-positive tumors harboring PTEN deletions (p=0.001), but had no significant effect in ERG-negative cancers or in tumors with normal PTEN copy numbers. In summary, the results of our study argue against a tumor-promoting role of SOX9 in prostate cancer, but demonstrate that loss of SOX9 expression characterizes a particularly aggressive subset of ERG positive cancers harboring PTEN deletions.	[Burdelski, Christoph; Melling, Nathaniel] Univ Med Ctr Hamburg Eppendorf, Gen Visceral & Thorac Surg Dept & Clin, Hamburg, Germany; [Tsourlakis, Maria Christina; Hube-Magg, Claudia; Kluth, Martina; Lebok, Patrick; Minner, Sarah; Koop, Christina; Wittmer, Corinna; Sauter, Guido; Wilczak, Waldemar; Simon, Ronald; Steurer, Stefan; Krech, Till] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Graefen, Markus; Heinzer, Hans; Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Martini Clin, Prostate Canc Ctr, Hamburg, Germany; [Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Sect Translat Prostate Canc Res, Hamburg, Germany; [Bujupi, Erzen] St Franziskus Hosp, Dept Radiol, Ahlen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Simon, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany.	R.Simon@uke.de		Schlomm, Thorsten/0000-0001-9557-4653				Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Burkhardt L, 2013, CANCER RES, V73, P2795, DOI 10.1158/0008-5472.CAN-12-1342; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Drivdahl R, 2004, ONCOGENE, V23, P4584, DOI 10.1038/sj.onc.1207603; Eble JN, 2004, PATHOLOGY GENETICS T; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Jemal A, 2005, CANCER EPIDEM BIOMAR, V14, P590, DOI 10.1158/1055-9965.EPI-04-0522; Kluth M, 2013, MOD PATHOL; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Koopman P, 2005, TRENDS GENET, V21, P367, DOI 10.1016/j.tig.2005.05.006; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Qin GQ, 2014, ONCOTARGETS THER, V7, P137, DOI 10.2147/OTT.S55432; Ring A, 2014, STEM CELL REV REP, V10, P512, DOI 10.1007/s12015-014-9515-2; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang GC, 2013, NAT GENET, V45, P739, DOI 10.1038/ng.2654; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Zhong WD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-248	38	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128525	10.1371/journal.pone.0128525	http://dx.doi.org/10.1371/journal.pone.0128525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030748	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900165
J	Guo, W; Jin, MX; Miao, ZX; Qu, K; Liu, X; Zhang, PC; Qin, HL; Zhu, HB; Wang, YH				Guo, Wei; Jin, Mengxia; Miao, Zhaoxia; Qu, Kai; Liu, Xia; Zhang, Peicheng; Qin, Hailin; Zhu, Haibo; Wang, Yinghong			Structure Elucidation of the Metabolites of 2 ', 3 ', 5 '-Tri-O-Acetyl-N-6-(3-Hydroxyphenyl) Adenosine in Rat Urine by HPLC-DAD, ESI-MS and Off-Line Microprobe NMR	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; NUCLEAR-MAGNETIC-RESONANCE; HUMAN INTESTINAL BACTERIA; FLIGHT-MASS-SPECTROMETRY; UPLC-Q-TOF/MS; IN-VITRO; LC-NMR; PROBE; IDENTIFICATION; SPECTROSCOPY	2 ', 3 ', 5 '-tri-O-acetyl-N-6-(3-hydroxyphenyl) adenosine (also known as WS070117) is a new adenosine analog that displays anti-hyperlipidemic activity both in vitro and in vivo experiments as shown in many preliminary studies. Due to its new structure, little is known about the metabolism of WS070117. Hence, the in vivo metabolites of WS070117 in rat urine following oral administration were investigated. Identification of the metabolites was conducted using the combination of high-performance liquid chromatography (HPLC) coupled with diode array detector (DAD), ion trap electrospray ionization-mass spectrometry (ESIMS), and off-line microprobe nuclear magnetic resonance (NMR) measurements. Seven metabolites were obtained as pure compounds at the sub-milligram to milligram levels. Results of structure elucidation unambiguously revealed that the phase I metabolite, N-6-(3-hydroxyphenyl) adenosine (M8), was a hydrolysate of WS070117 by hydrolysis on the three ester groups. N-6-(3-hydr-oxyphenyl) adenine (M7), also one of the phase I metabolites, was the derivative of M8 by the loss of ribofuranose. In addition to two phase I metabolites, there were five phase II metabolites of WS070117 found in rat urine. 8-hydroxy-N-6-(3-hydroxy-phenyl) adenosine (M6) was the product of M7 by hydrolysis at position 8. The other four were elucidated to be N-6-(3-O-beta-D-glucuronyphenyl) adenine (M2), N-8-hydroxy-N-6-( 3-O-sulfophenyl) adenine (M3), N-6-(3-O-beta-D-glucuronyphenyl) adenosine (M4), and N-6-(3-O-sulfophenyl) adenosine (M5). Phase II metabolic pathways were proven to consist of hydroxylation, glucuronidation and sulfation. This study provides new and valuable information on the metabolism of WS070117, and also demonstrates the HPLC/MS/off-line microprobe NMR approach as a robust means for rapid identification of metabolites.	[Guo, Wei; Jin, Mengxia; Miao, Zhaoxia; Qu, Kai; Liu, Xia; Zhang, Peicheng; Qin, Hailin; Zhu, Haibo; Wang, Yinghong] Chinese Acad Med Sci, State Key Lab Bioact Substance & Funct Nat Med, Beijing 100730, Peoples R China; [Guo, Wei; Jin, Mengxia; Miao, Zhaoxia; Qu, Kai; Liu, Xia; Zhang, Peicheng; Qin, Hailin; Zhu, Haibo; Wang, Yinghong] Chinese Acad Med Sci, Minist Hlth, Key Lab Biosynth Nat Prod, Beijing 100730, Peoples R China; [Guo, Wei; Jin, Mengxia; Miao, Zhaoxia; Qu, Kai; Liu, Xia; Zhang, Peicheng; Qin, Hailin; Zhu, Haibo; Wang, Yinghong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Qu, Kai; Zhu, Haibo] Chinese Acad Med Sci, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhu, HB (corresponding author), Chinese Acad Med Sci, State Key Lab Bioact Substance & Funct Nat Med, Beijing 100730, Peoples R China.	zhuhaibo@imm.ac.cn; wyh@imm.ac.cn			Natural Sciences Foundation of Beijing, China [7122114]; National High Technology Research and Development Program of China [2014AA021101]; National Natural Sciences Foundation of China (NSFC) [30973527, 81273514]; National Mega-project for Innovative Drugs [2012ZX09301002-002, 91229127/H3104]	Natural Sciences Foundation of Beijing, China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Mega-project for Innovative Drugs	This study was supported by Natural Sciences Foundation of Beijing, China (Grant No: 7122114), National High Technology Research and Development Program of China (Grant No: 2014AA021101), National Natural Sciences Foundation of China (NSFC. Grant No: 30973527 and 81273514) and National Mega-project for Innovative Drugs (Grant No: 2012ZX09301002-002 and 91229127/H3104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; Bahmani M, 2015, J EVID BASED CO 0128; Bhattacharya A, 2010, NATURE, V463, P605, DOI 10.1038/463605a; Ciuffreda P, 2007, MAGN RESON CHEM, V45, P781, DOI 10.1002/mrc.2036; GAGLIARDI L, 1987, J CHROMATOGR, V408, P409, DOI 10.1016/S0021-9673(01)81832-X; Gao D, 2010, ANAL CHEM, V82, P5679, DOI 10.1021/ac101370p; Godejohann M, 2011, J CHROMATOGR A, V1218, P9202, DOI 10.1016/j.chroma.2011.10.051; Griffin JL, 2002, ANALYST, V127, P582, DOI 10.1039/b201207c; Grimes JH, 2011, J BIOMOL NMR, V49, P297, DOI 10.1007/s10858-011-9488-2; Guo P, 2012, LIFE SCI, V90, P1, DOI 10.1016/j.lfs.2011.09.001; Huang LZ, 2015, J LIPID RES; Lian ZQ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-67; Liu CW, 2010, RAPID COMMUN MASS SP, V24, P3413, DOI 10.1002/rcm.4744; Liu Y, 2011, XENOBIOTICA, V41, P549, DOI 10.3109/00498254.2011.573016; Logan TM, 1999, MAGN RESON CHEM, V37, P762, DOI 10.1002/(SICI)1097-458X(199910)37:10<762::AID-MRC584>3.3.CO;2-G; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Novak P, 2005, J SEP SCI, V28, P1442, DOI 10.1002/jssc.200400057; Olson DL, 2004, ANAL CHEM, V76, P2966, DOI 10.1021/ac035426l; OWINO E, 1991, J CHROMATOGR SCI, V29, P450, DOI 10.1093/chromsci/29.10.450; Reo NV, 2002, DRUG CHEM TOXICOL, V25, P375, DOI 10.1081/DCT-120014789; Schlotterbeck G, 2002, ANAL CHEM, V74, P4464, DOI 10.1021/ac025556e; Schmidt B, 2008, ANAL CHEM, V80, P1978, DOI 10.1021/ac702064p; Schroeder FC, 2006, ANGEW CHEM INT EDIT, V45, P7122, DOI 10.1002/anie.200601789; Schutz C, 2011, FITOTERAPIA, V82, P1021, DOI 10.1016/j.fitote.2011.06.005; Serkova NJ, 2009, J CELL MOL MED, V13, P1933, DOI 10.1111/j.1582-4934.2008.00464.x; Simons LA, 2002, AM J CARDIOL, V90, P737, DOI 10.1016/S0002-9149(02)02600-0; Sturm S, 2012, J CHROMATOGR A, V1259, P50, DOI 10.1016/j.chroma.2012.05.032; Wang YX, 2009, TALANTA, V80, P572, DOI 10.1016/j.talanta.2009.07.027; WILSON DM, 1974, BIOCHEM BIOPH RES CO, V56, P828, DOI 10.1016/0006-291X(74)90680-9; Yang J, 2012, J CHROMATOGR B, V898, P95, DOI 10.1016/j.jchromb.2012.04.024; Zhang W, 2014, CHROMATOGRAPHIA, V77, P439, DOI 10.1007/s10337-014-2625-9	32	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127583	10.1371/journal.pone.0127583	http://dx.doi.org/10.1371/journal.pone.0127583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029929	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900064
J	Kong, XQ; Huang, MY; Duan, RY				Kong, Xiaoquan; Huang, Minyi; Duan, Renyan			SDMdata: A Web-Based Software Tool for Collecting Species Occurrence Records	PLOS ONE			English	Article							CLIMATE-CHANGE	It is important to easily and efficiently obtain high quality species distribution data for predicting the potential distribution of species using species distribution models (SDMs). There is a need for a powerful software tool to automatically or semi-automatically assist in identifying and correcting errors. Here, we use Python to develop a web-based software tool (SDMdata) to easily collect occurrence data from the Global Biodiversity Information Facility (GBIF) and check species names and the accuracy of coordinates (latitude and longitude). It is an open source software (GNU Affero General Public License/AGPL licensed) allowing anyone to access and manipulate the source code.	[Kong, Xiaoquan; Huang, Minyi; Duan, Renyan] Anqing Normal Univ, Dept Life Sci, Anqing 246011, Anhui, Peoples R China	Anqing Normal University	Huang, MY (corresponding author), Anqing Normal Univ, Dept Life Sci, Anqing 246011, Anhui, Peoples R China.	huang.m.y@163.com; duanrenyan78@163.com	Kong, Xiaoquan/B-3571-2016	Kong, Xiaoquan/0000-0003-1039-494X	National Natural Science Foundation of China [31100311, 31300342]; China Postdoctoral Science Foundation [2014M561683]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31100311, 31300342) and China Postdoctoral Science Foundation (2014M561683).	Andelman SJ, 2002, CONSERV BIOL, V16, P1352, DOI 10.1046/j.1523-1739.2002.01119.x; [Anonymous], 1997, DATA QUALITY INFORM; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Cantu-Salazar L, 2013, DIVERS DISTRIB, V19, P782, DOI 10.1111/ddi.12034; Chamberlain S., 2014, RGBIF INTERFACE GLOB; Chapman AD., 2005, PRINCIPLES METHODS D; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Eskildsen A, 2013, GLOBAL ECOL BIOGEOGR, V22, P1293, DOI 10.1111/geb.12078; Feeley KJ, 2010, J BIOGEOGR, V37, P733, DOI 10.1111/j.1365-2699.2009.02240.x; Garcia-Rosello E, 2014, METHODS ECOL EVOL, V5, P708, DOI 10.1111/2041-210X.12209; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hijmans R.J., 2014, SPECIES DISTRIBUTION; Lutz M., 2013, LEARNING PYTHON; Munguia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034420; Ochoa-Ochoa LM, 2012, BIOL CONSERV, V150, P94, DOI 10.1016/j.biocon.2012.03.010; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Rose JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100277; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x	19	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128295	10.1371/journal.pone.0128295	http://dx.doi.org/10.1371/journal.pone.0128295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030926	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900135
J	Van Driest, SL; McGregor, TL; Edwards, DRV; Saville, BR; Kitchner, TE; Hebbring, SJ; Brilliant, M; Jouni, H; Kullo, IJ; Creech, CB; Kannankeril, PJ; Vear, SI; Brothers, KB; Bowton, EA; Shaffer, CM; Patel, N; Delaney, JT; Bradford, Y; Wilson, S; Olson, LM; Crawford, DC; Potts, AL; Ho, RH; Roden, DM; Denny, JC				Van Driest, Sara L.; McGregor, Tracy L.; Edwards, Digna R. Velez; Saville, Ben R.; Kitchner, Terrie E.; Hebbring, Scott J.; Brilliant, Murray; Jouni, Hayan; Kullo, Iftikhar J.; Creech, C. Buddy; Kannankeril, Prince J.; Vear, Susan I.; Brothers, Kyle B.; Bowton, Erica A.; Shaffer, Christian M.; Patel, Neelam; Delaney, Jessica T.; Bradford, Yuki; Wilson, Sarah; Olson, Lana M.; Crawford, Dana C.; Potts, Amy L.; Ho, Richard H.; Roden, Dan M.; Denny, Josh C.			Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin Therapy	PLOS ONE			English	Article							KIDNEY-FUNCTION	Vancomycin, a commonly used antibiotic, can be nephrotoxic. Known risk factors such as age, creatinine clearance, vancomycin dose / dosing interval, and concurrent nephrotoxic medications fail to accurately predict nephrotoxicity. To identify potential genomic risk factors, we performed a genome-wide association study (GWAS) of serum creatinine levels while on vancomycin in 489 European American individuals and validated findings in three independent cohorts totaling 439 European American individuals. In primary analyses, the chromosome 6q22.31 locus was associated with increased serum creatinine levels while on vancomycin therapy (most significant variant rs2789047, risk allele A, beta = -0.06, p = 1.1 x 10(-7)). SNPs in this region had consistent directions of effect in the validation cohorts, with a	[Van Driest, Sara L.; McGregor, Tracy L.; Creech, C. Buddy; Kannankeril, Prince J.; Vear, Susan I.; Brothers, Kyle B.; Ho, Richard H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37235 USA; [Van Driest, Sara L.; McGregor, Tracy L.; Creech, C. Buddy; Kannankeril, Prince J.; Vear, Susan I.; Brothers, Kyle B.; Ho, Richard H.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [McGregor, Tracy L.; Edwards, Digna R. Velez; Bradford, Yuki; Wilson, Sarah; Olson, Lana M.; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Dept Obstet & Gynecol, Nashville, TN 37235 USA; [Saville, Ben R.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Kitchner, Terrie E.; Hebbring, Scott J.; Brilliant, Murray] Marshfield Clin Fdn Med Res & Educ, Ctr Human Genet, Marshfield, WI USA; [Jouni, Hayan; Kullo, Iftikhar J.] Mayo Clin, Coll Med, Dept Med, Div Cardiovasc Dis, Rochester, MN USA; [Bowton, Erica A.] Vanderbilt Univ, Inst Clin & Translat Res, Nashville, TN 37235 USA; [Shaffer, Christian M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Patel, Neelam] Vanderbilt Univ, Sch Med, Nashville, TN 37235 USA; [Delaney, Jessica T.; Roden, Dan M.; Denny, Josh C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Potts, Amy L.] Vanderbilt Univ, Dept Pharmaceut Serv, Nashville, TN 37235 USA; [Denny, Josh C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Marshfield Clinic; Mayo Clinic; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Van Driest, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, 221 Kirkland Hall, Nashville, TN 37235 USA.	sara.van.driest@vanderbilt.edu	Denny, Josh/AAL-3359-2021; Roden, Dan/ABD-5412-2021; Crawford, Dana/O-5578-2019; Colace, Susan/ABG-3571-2020	Denny, Josh/0000-0002-3049-7332; Crawford, Dana/0000-0002-6437-6248; Colace, Susan/0000-0003-3868-3655	National Center for Research Resources / National Institutes of Health [UL1-RR024975]; National Human Genome Research Institute / National Institutes of Health [U01-HG04603, 1U01-HG006389, U01-HG04599, U01-HG006379]; National Institute of General Medical Sciences / National Institutes of Health [RC2-GM092618]; National Institute of General Medical Sciences / National Institutes of Health Clinical Pharmacology Training Program [5T32-GM007569]; Early Career Award from the Pharmaceutical Research and Manufacturers of America Foundation; National Institute of Environmental Health Sciences / National Institutes of Health [K12-ES015855]; National Institute of Child Health and Human Development / National Institutes of Health [1K23-HD000001]; National Institute of Child Health and Human Development / National Institutes of Health Building Interdisciplinary Research Careers in Women's Health career development program [2K12-HD043483-11]; Vanderbilt CTSA grant from National Center for Advancing Translational Sciences / National Institutes of Health [UL1-TR000445]; Personalized Medicine Research Project of Marshfield Clinic; National Center for Advancing Translational Sciences / National Institutes of Health [UL1-TR000427]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043483, K23HD000001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006389, U01HG004599, U01HG006379, U01HG006378, U01HG004603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K12ES015855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092618, T32GM007569] Funding Source: NIH RePORTER	National Center for Research Resources / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Human Genome Research Institute / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences / National Institutes of Health Clinical Pharmacology Training Program; Early Career Award from the Pharmaceutical Research and Manufacturers of America Foundation; National Institute of Environmental Health Sciences / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Child Health and Human Development / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Child Health and Human Development / National Institutes of Health Building Interdisciplinary Research Careers in Women's Health career development program; Vanderbilt CTSA grant from National Center for Advancing Translational Sciences / National Institutes of Health; Personalized Medicine Research Project of Marshfield Clinic; National Center for Advancing Translational Sciences / National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Center for Research Resources / National Institutes of Health (http://www.nih.gov/) grant UL1-RR024975, supporting the Vanderbilt Institute for Clinical and Translational Research (VICTR) (SLV, TLM, DRVE, BRS, CBC, PJK, SIV, KBB, EAB, CMS, NP, JTD, YB, SW, SMP, DCC, ALP, RHH, DMR, JCD); National Human Genome Research Institute / National Institutes of Health (http://www.nih.gov/) grant U01-HG04603 (SLV, TLM, DRVE, BRS, CBC, PJK, SIV, KBB, EAB, CMS, NP, JTD, YB, SW, SMP, DCC, ALP, RHH, DMR, JCD); and National Institute of General Medical Sciences / National Institutes of Health (http://www.nih.gov/) RC2-GM092618 (SLV, TLM, DRVE, BRS, CBC, PJK, SIV, KBB, EAB, CMS, NP, JTD, YB, SW, SMP, DCC, ALP, RHH, DMR, JCD). SLV and SIV have been supported by National Institute of General Medical Sciences / National Institutes of Health (http://www.nih.gov/) Clinical Pharmacology Training Program 5T32-GM007569. SLV is supported by an Early Career Award from the Pharmaceutical Research and Manufacturers of America Foundation (http://phrmafoundation.org/). TLM has been supported by National Institute of Environmental Health Sciences / National Institutes of Health (http://www.nih.gov/) grant K12-ES015855 and the National Institute of Child Health and Human Development / National Institutes of Health (http://www.nih.gov/) 1K23-HD000001. DRVE was supported by the National Institute of Child Health and Human Development / National Institutes of Health (http://www.nih.gov/) Building Interdisciplinary Research Careers in Women's Health career development program (2K12-HD043483-11). The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant UL1-TR000445 from National Center for Advancing Translational Sciences / National Institutes of Health (http://www.nih.gov/) (SLV, TLM, DRVE, BRS, CBC, PJK, SIV, KBB, EAB, CMS, NP, JTD, YB, SW, SMP, DCC, ALP, RHH, DMR, JCD); the Personalized Medicine Research Project of Marshfield Clinic which is supported by institutional funding and by National Human Genome Research Institute / National Institutes of Health (http://www.nih.gov/) grant 1U01-HG006389 and from National Center for Advancing Translational Sciences / National Institutes of Health (http://www.nih.gov/) grant UL1-TR000427 (TEK, SJH, MB); and the Mayo eMERGE Network Project which is supported by the National Human Genome Research Institute / National Institutes of Health (http://www.nih.gov/) grants (U01-HG04599 and U01-HG006379) (HJ, IJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adly N, 2014, HUM MUTAT, V35, P36, DOI 10.1002/humu.22477; Bowton E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008604; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Crawford DC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00184; Deck DH, 2015, BASIC CLIN PHARM, P769; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elyasi S, 2012, EUR J CLIN PHARMACOL, V68, P1243, DOI 10.1007/s00228-012-1259-9; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marsot A, 2012, CLIN PHARMACOKINET, V51, P1, DOI 10.2165/11596390-000000000-00000; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Murphy JE, 2006, AM J HEALTH-SYST PH, V63, P2365, DOI 10.2146/ajhp060047; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Toubas J, 2011, AM J PHYSIOL-RENAL, V301, pF24, DOI 10.1152/ajprenal.00255.2010; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong-Beringer A, 2011, INT J ANTIMICROB AG, V37, P95, DOI 10.1016/j.ijantimicag.2010.10.013; Yao JA, 2010, BRIT J PHARMACOL, V160, P2055, DOI 10.1111/j.1476-5381.2010.00860.x; Yaoita E, 2002, AM J PATHOL, V161, P1597, DOI 10.1016/S0002-9440(10)64438-0	30	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127791	10.1371/journal.pone.0127791	http://dx.doi.org/10.1371/journal.pone.0127791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030142	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900081
J	Wibberley, A; Staunton, CA; Feetham, CH; Vereninov, AA; Barrett-Jolley, R				Wibberley, Anna; Staunton, Caroline A.; Feetham, Claire H.; Vereninov, Alexey A.; Barrett-Jolley, Richard			An In Vitro Model of Skeletal Muscle Volume Regulation	PLOS ONE			English	Article							MEDULLOBLASTOMA CELL-LINE; HYPERTONIC SHRINKAGE; DEATH MACHINERY; DECREASE AVD; APOPTOSIS; CHANNELS; TE671; DIFFERENTIATION; PROGRESSION; MECHANISMS	Introduction Hypertonic media causes cells to shrink due to water loss through aquaporin channels. After acute shrinkage, cells either regulate their volume or, alternatively, undergo a number of metabolic changes which ultimately lead to cell death. In many cell types, hypertonic shrinkage is followed by apoptosis. Due to the complex 3D morphology of skeletal muscle and the difficulty in obtaining isolated human tissue, we have begun skeletal muscle volume regulation studies using the human skeletal muscle cell line TE671RD. In this study we investigated whether hypertonic challenge of the human skeletal muscle cell line TE671RD triggered cell death or evoked a cell volume recovery response. Methods The cellular volume of TE671RD cells was calculated from the 2D surface area. Cell death was assessed by both the trypan blue live/dead assay and the TUNEL assay. Results Medium osmolality was increased by addition of up to 200mM sucrose. Addition of 200mM sucrose resulted in mean cell shrinkage of 44 +/- 1% after 30mins. At later time points (2 and 4 hrs) two separate cell subpopulations with differing mean cell volume became apparent. The first subpopulation (15 +/- 2% of the total cell number) continued to shrink whereas the second subpopulation had an increased cell volume. Cell death was observed in a small proportion of cells (approximately 6-8%). Conclusion We have established that a substantial proportion of TE671RD cells respond to hypertonic challenge with RVI, but that these cells are resistant to hypertonicity triggered cell death.	[Wibberley, Anna; Staunton, Caroline A.; Feetham, Claire H.; Barrett-Jolley, Richard] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [Vereninov, Alexey A.] Russian Acad Sci, Inst Cytol, Lab Cell Physiol, St Petersburg 194064, Russia	University of Liverpool; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Barrett-Jolley, R (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England.	RBJ@liv.ac.uk	Barrett-Jolley, Richard/G-7704-2011	Barrett-Jolley, Richard/0000-0003-0449-9972; Staunton, Caroline Amy/0000-0003-0647-3063; Vereninov, Alexey/0000-0002-3602-7059; Feetham, Claire/0000-0002-7712-8825	Russian Foundation for Basic Research [15-04-00776-A]; BBSRC	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AAV was supported by the Russian Foundation for Basic Research, project no. 15-04-00776-A, and CHF was supported by the BBSRC. The funders had no role in the design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Barrett-Jolley R, 1998, BRIT J PHARMACOL, V123, P1103, DOI 10.1038/sj.bjp.0701727; BARRETTJOLLEY R, 1994, PFLUG ARCH EUR J PHY, V428, P492, DOI 10.1007/BF00374570; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; DalL'Asta V, 1999, AM J PHYSIOL-CELL PH, V276, pC865, DOI 10.1152/ajpcell.1999.276.4.C865; Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001; Edwards YS, 1998, AM J PHYSIOL-LUNG C, V275, pL670, DOI 10.1152/ajplung.1998.275.4.L670; FAKLER B, 1990, PFLUG ARCH EUR J PHY, V415, P693, DOI 10.1007/BF02584007; Farrugia ME, 2007, J NEUROIMMUNOL, V185, P136, DOI 10.1016/j.jneuroim.2007.01.010; Feetham CH, 2015, BRIT J PHARMACOL, V172, P1753, DOI 10.1111/bph.13023; Ferenczi EA, 2004, J PHYSIOL-LONDON, V555, P423, DOI 10.1113/jphysiol.2003.058545; Frigeri A, 2004, FASEB J, V18, P905, DOI 10.1096/fj.03-0987fje; Friis MB, 2005, J PHYSIOL-LONDON, V567, P427, DOI 10.1113/jphysiol.2005.087130; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghosh A, 2007, APOPTOSIS, V12, P1281, DOI 10.1007/s10495-007-0054-z; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Lang F, 2013, J PHYSIOL-LONDON, V591, P6119, DOI 10.1113/jphysiol.2013.258632; Lewis R, 2011, J CELL PHYSIOL, V226, P2979, DOI 10.1002/jcp.22646; Lindinger MI, 2011, J PHYSIOL-LONDON, V589, P2887, DOI 10.1113/jphysiol.2011.206730; LUTHER MA, 1989, J NEUROSCI, V9, P1082; Maeno E, 2006, FEBS LETT, V580, P6513, DOI 10.1016/j.febslet.2006.10.074; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Marzetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032829; MCLEAN KA, 1992, AGE AGEING, V21, P56, DOI 10.1093/ageing/21.1.56; Miller TR, 1999, EUR J PHARMACOL, V370, P179, DOI 10.1016/S0014-2999(99)00128-4; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Orlov SN, 2013, J PHYSIOL-LONDON, V591, P6123, DOI 10.1113/jphysiol.2013.258624; PHILLIPS PA, 1991, AM J PHYSIOL, V261, pR166, DOI 10.1152/ajpregu.1991.261.1.R166; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Platonova A, 2012, APOPTOSIS, V17, P429, DOI 10.1007/s10495-011-0694-x; Pollack M, ANN NEW YORK ACAD SC, P93; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Skulachev VP, 2012, BIOCHEMISTRY-MOSCOW+, V77, P689, DOI 10.1134/S0006297912070012; SOTOS JF, 1960, PEDIATRICS, V26, P925; Stachenfeld NS, 1997, AM J PHYSIOL-REG I, V272, pR148, DOI 10.1152/ajpregu.1997.272.1.R148; STRATTON MR, 1989, CARCINOGENESIS, V10, P899, DOI 10.1093/carcin/10.5.899; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Troshin AS, 1966, PROBLEMS OF CELL PER, V26, P30; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yurinskaya VE, 2012, CELL PHYSIOL BIOCHEM, V30, P964, DOI 10.1159/000341473	46	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127889	10.1371/journal.pone.0127889	http://dx.doi.org/10.1371/journal.pone.0127889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029913	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900088
J	Wilder, B; Stanley, KO				Wilder, Bryan; Stanley, Kenneth O.			Altruists Proliferate Even at a Selective Disadvantage within Their Own Niche	PLOS ONE			English	Article							INDIRECT RECIPROCITY; EVOLUTION; COOPERATION; DIVERSIFICATION; POPULATIONS; GENETICS; TRAITS	The evolutionary origin of altruism is a long-standing puzzle. Numerous explanations have been proposed, most prominently based on inclusive fitness or group selection. One possibility that has not yet been considered is that new niches will be created disproportionately often when altruism appears, perhaps by chance, causing altruists to be over-represented in such new niches. This effect is a novel variant of group selection in which altruistic groups benefit by discovering unoccupied niches instead of by competing for the limited resources within a single niche. Both an analytical population genetics model and computational simulations support that altruism systematically arises due to this side effect of increased carrying capacity even when it is strongly selected against within any given niche. In fact, even when selection is very strongly negative and altruism does not develop in most populations, it can still be expected to be observed in a consistent fraction of species. The ecological structure provided by niches thereby may be sufficient for altruists to proliferate even if they are always at a disadvantage within each niche considered individually.	[Wilder, Bryan; Stanley, Kenneth O.] Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Wilder, B (corresponding author), Univ Cent Florida, Dept Elect Engn & Comp Sci, Orlando, FL 32816 USA.	bryan.wilder@knights.ucf.edu						AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Dawkins Richard, 1976, SELFISH GENE; Erwin DH, 2005, SCIENCE, V308, P1752, DOI 10.1126/science.1113416; Ewens WJ., 2004, MATH POPULATION GENE, V27; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Gilpin ME, 1975, GROUP SELECTION PRED, V9; GIVNISH TJ, 2000, MOL EVOLUTION ADAPTI; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, V2; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Houchmandzadeh B, 2014, ARXIV E PRINTS; Lehman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062186; LEVIN BR, 1974, EVOLUTION, V28, P527, DOI 10.1111/j.1558-5646.1974.tb00787.x; MATESSI C, 1976, THEOR POPUL BIOL, V9, P360, DOI 10.1016/0040-5809(76)90053-8; Mohtashemi M, 2003, J THEOR BIOL, V223, P523, DOI 10.1016/S0022-5193(03)00143-7; Morgan AD, 2012, ECOL LETT, V15, P841, DOI 10.1111/j.1461-0248.2012.01805.x; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Odling-Smee F. J., 2003, NICHE CONSTRUCTION N, V37; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; QUELLER DC, 1992, AM NAT, V139, P540, DOI 10.1086/285343; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P1265, DOI 10.1073/pnas.0913626107; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Silva RF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002181; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; WADE MJ, 1978, Q REV BIOL, V53, P101, DOI 10.1086/410450; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; WILSON DS, 1977, AM NAT, V111, P157, DOI 10.1086/283146; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Wright S, 1945, TEMPO MODE EVOLUTION	38	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128654	10.1371/journal.pone.0128654	http://dx.doi.org/10.1371/journal.pone.0128654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030734	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900181
J	Goldinger, A; Shakhbazov, K; Henders, AK; Mcrae, AF; Montgomery, GW; Powell, JE				Goldinger, Anita; Shakhbazov, Konstantin; Henders, Anjali K.; Mcrae, Allan F.; Montgomery, Grant W.; Powell, Joseph E.			Seasonal Effects on Gene Expression	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MESSENGER-RNA; DISORDERS; BLOOD; METABOLITES; DISCOVERY; BEHAVIOR; DISEASE; HUMANS	Many health conditions, ranging from psychiatric disorders to cardiovascular disease, display notable seasonal variation in severity and onset. In order to understand the molecular processes underlying this phenomenon, we have examined seasonal variation in the transcriptome of 606 healthy individuals. We show that 74 transcripts associated with a 12-month seasonal cycle were enriched for processes involved in DNA repair and binding. An additional 94 transcripts demonstrated significant seasonal variability that was largely influenced by blood cell count levels. These transcripts were enriched for immune function, protein production, and specific cellular markers for lymphocytes. Accordingly, cell counts for erythrocytes, platelets, neutrophils, monocytes, and CD19 cells demonstrated significant association with a 12-month seasonal cycle. These results demonstrate that seasonal variation is an important environmental regulator of gene expression and blood cell composition. Notable changes in leukocyte counts and genes involved in immune function indicate that immune cell physiology varies throughout the year in healthy individuals.	[Goldinger, Anita; Shakhbazov, Konstantin; Mcrae, Allan F.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Goldinger, Anita; Henders, Anjali K.; Mcrae, Allan F.; Powell, Joseph E.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Henders, Anjali K.; Mcrae, Allan F.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute	Goldinger, A (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia.	a.goldinger@uq.edu.au	Goldinger, Anita/K-9171-2018; McRae, Allan F/J-2644-2014; Montgomery, Grant W/B-7148-2008; Henders, Anjali/E-3126-2017	Goldinger, Anita/0000-0002-7688-1823; McRae, Allan F/0000-0001-5286-5485; Montgomery, Grant W/0000-0002-4140-8139; Powell, Joseph/0000-0002-5070-4124; Henders, Anjali/0000-0003-3672-1451	Australian National Health and Medical Research Council (NHMRC) [389892, 496667, 613601, 1010374, 1046880]; National Institutes of Health (NIH) [GM057091]; NHMRC; Australia Research Council (ARC); Australian Postgraduate Award	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council (ARC)(Australian Research Council); Australian Postgraduate Award(Australian Government)	This research was supported by Australian National Health and Medical Research Council (NHMRC) grants 389892, 496667, 613601, 1010374, and 1046880 and National Institutes of Health (NIH) grant GM057091. Dr. Montgomery is supported by the NHMRC Fellowship Scheme. Dr. Powell is supported by the Australia Research Council (ARC) Fellowship Scheme. Anita Goldinger is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstadhaug KB, 2005, CEPHALALGIA, V25, P811, DOI 10.1111/j.1468-2982.2005.01018.x; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; Barnett AG, 2008, AUST NZ J PUBL HEAL, V32, P408, DOI 10.1111/j.1753-6405.2008.00270.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Cleveland R.B., 1990, J OFF STAT, V6, P3; Davie A, 2009, CHRONOBIOL INT, V26, P379, DOI 10.1080/07420520902820947; de Jong S, 2014, HUM MOL GENET; De Vriese SR, 2004, PROSTAG LEUKOTR ESS, V71, P13, DOI 10.1016/j.plefa.2003.12.002; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; FAEDDA GL, 1993, ARCH GEN PSYCHIAT, V50, P17; Falconer D. S., 1996, Introduction to quantitative genetics.; Friedman E, 2006, ACTA PSYCHIAT SCAND, V113, P510, DOI 10.1111/j.1600-0447.2005.00701.x; Gallerani M, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-31; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Goldinger A, 2013, GENETICS, V195, P1117, DOI 10.1534/genetics.113.153221; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Iuliano G, 2012, J NEUROL, P1; JUTTMANN JR, 1981, BRIT MED J, V282, P1349, DOI 10.1136/bmj.282.6273.1349; Kao CC, 2005, PEDIAT ALLERG IMM-UK, V16, P408, DOI 10.1111/j.1399-3038.2005.00268.x; KASPER S, 1988, NERVENARZT, V59, P191; KIYOHARA T, 1995, BRAIN RES BULL, V38, P193, DOI 10.1016/0361-9230(95)00093-T; Kristal-Boneh E, 2008, BRIT J HAEMATOL, V85, P603; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; Landi L, 2011, J AGR FOOD CHEM, V59, P6628, DOI 10.1021/jf104297n; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Levis S, 2005, J CLIN ENDOCR METAB, V90, P1557, DOI 10.1210/jc.2004-0746; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; LOSONCZY MF, 1984, PSYCHIAT RES, V12, P79, DOI 10.1016/0165-1781(84)90140-9; Luykx JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030497; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Mikulich SK, 2003, STAT MED, V22, P3195, DOI 10.1002/sim.1560; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Parnell GP, 2014, MULT SCLER J, V20, P675, DOI 10.1177/1352458513507819; Powell JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003502; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; SCRAGG R, 1981, INT J EPIDEMIOL, V10, P337, DOI 10.1093/ije/10.4.337; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; STRYD RP, 1979, J CLIN ENDOCR METAB, V48, P771, DOI 10.1210/jcem-48-5-771; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; Tournier BB, 2007, EUR J NEUROSCI, V25, P1529, DOI 10.1111/j.1460-9568.2007.05421.x; Vogel U, 2002, CARCINOGENESIS, V23, P1505, DOI 10.1093/carcin/23.9.1505; Weinkauf B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039411; Xiao XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004006; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang SH, 2005, TREE PHYSIOL, V25, P1063, DOI 10.1093/treephys/25.8.1063; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	61	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126995	10.1371/journal.pone.0126995	http://dx.doi.org/10.1371/journal.pone.0126995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023781	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400028
J	Hartgerink, CHJ; van Beest, I; Wicherts, JM; Williams, KD				Hartgerink, Chris H. J.; van Beest, Ilja; Wicherts, Jelte M.; Williams, Kipling D.			The Ordinal Effects of Ostracism: A Meta-Analysis of 120 Cyberball Studies	PLOS ONE			English	Article							SOCIAL EXCLUSION; SELF-ESTEEM; REJECTION; PAIN; DICHOTOMIZATION; MODERATORS; NEED; BIAS	We examined 120 Cyberball studies (N = 11,869) to determine the effect size of ostracism and conditions under which the effect may be reversed, eliminated, or small. Our analyses showed that (1) the average ostracism effect is large (d > vertical bar 1.4 vertical bar) and (2) generalizes across structural aspects (number of players, ostracism duration, number of tosses, type of needs scale), sampling aspects (gender, age, country), and types of dependent measure (interpersonal, intrapersonal, fundamental needs). Further, we test Williams's (2009) proposition that the immediate impact of ostracism is resistant to moderation, but that moderation is more likely to be observed in delayed measures. Our findings suggest that (3) both first and last measures are susceptible to moderation and (4) time passed since being ostracized does not predict effect sizes of the last measure. Thus, support for this proposition is tenuous and we suggest modifications to the temporal need-threat model of ostracism.	[Hartgerink, Chris H. J.; Wicherts, Jelte M.] Tilburg Univ, Dept Methodol & Stat, NL-5000 LE Tilburg, Netherlands; [van Beest, Ilja] Tilburg Univ, Dept Social Psychol, NL-5000 LE Tilburg, Netherlands; [Williams, Kipling D.] Purdue Univ, Dept Psychol, W Lafayette, IN 47907 USA	Tilburg University; Tilburg University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	van Beest, I (corresponding author), Tilburg Univ, Dept Social Psychol, NL-5000 LE Tilburg, Netherlands.	i.vanbeest@tilburguniversity.edu	Wicherts, Jelte M./A-2664-2008; van Beest, Ilja/M-3708-2019; Hartgerink, Chris/H-6623-2013	Wicherts, Jelte M./0000-0003-2415-2933; van Beest, Ilja/0000-0003-2855-3638; Hartgerink, Chris/0000-0003-1050-6809	Netherlands Organization for Scientific Research [016-125-385]; National Science Foundation [BCS-1339160]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF))	The preparation of this article was supported by grant number 016-125-385 from the Netherlands Organization for Scientific Research (http://nwo.nl) awarded to Jelte M. Wicherts and by the National Science Foundation (http://nsf.gov) under Grant #BCS-1339160 awarded to Kipling D. Williams.	Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2002, J PERS SOC PSYCHOL, V83, P817, DOI 10.1037//0022-3514.83.4.817; Bernstein MJ, 2012, SOC INFLUENCE, V7, P113, DOI 10.1080/15534510.2012.664326; Blackhart GC, 2009, PERS SOC PSYCHOL REV, V13, P269, DOI 10.1177/1088868309346065; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Carter-Sowell AR, 2008, SOC INFLUENCE, V3, P143, DOI 10.1080/15534510802204868; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRAIGHEAD WE, 1979, J CONSULT CLIN PSYCH, V47, P385, DOI 10.1037/0022-006X.47.2.385; de Waal-Andrews W, 2012, PERS SOC PSYCHOL B, V38, P1367, DOI 10.1177/0146167212450463; DeWall CN, 2010, PSYCHOL SCI, V21, P931, DOI 10.1177/0956797610374741; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerber J, 2009, PERSPECT PSYCHOL SCI, V4, P468, DOI 10.1111/j.1745-6924.2009.01158.x; Gonsalkorale K, 2007, EUR J SOC PSYCHOL, V37, P1176, DOI 10.1002/ejsp.392; Hawes DJ, 2012, EUR J DEV PSYCHOL, V9, P599, DOI 10.1080/17405629.2011.638815; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd, DOI DOI 10.1016/S0005-7967(02)00184-5; HUNTER JE, 1990, J APPL PSYCHOL, V75, P334, DOI 10.1037/0021-9010.75.3.334; Ijzerman H, 2012, ACTA PSYCHOL, V140, P283, DOI 10.1016/j.actpsy.2012.05.002; LAUTENBACHER S, 1994, J PSYCHIAT RES, V28, P109, DOI 10.1016/0022-3956(94)90023-X; Leary MR, 2003, AGGRESSIVE BEHAV, V29, P202, DOI 10.1002/ab.10061; Lebel EP, 2013, PERSPECT PSYCHOL SCI, V8, P424, DOI 10.1177/1745691613491437; Light R.J., 1984, SUMMING SCI REV RES; Lustenberger DE, 2010, HUM PERFORM, V23, P283, DOI 10.1080/08959285.2010.501046; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Nezlek JB, 1997, PERS SOC PSYCHOL B, V23, P1235, DOI 10.1177/01461672972312001; Oaten M, 2008, J SOC CLIN PSYCHOL, V27, P471, DOI 10.1521/jscp.2008.27.5.471; Pharo H, 2011, SOC INFLUENCE, V6, P22, DOI 10.1080/15534510.2010.525852; R Core Team, 2021, R LANGUAGE ENV STAT; Ritter D, 2005, AGGRESSIVE BEHAV, V31, P407, DOI 10.1002/ab.20066; Riva P, 2012, PSYCHOL SCI, V23, P1473, DOI 10.1177/0956797612450894; Rotge J-Y, 2014, SOC COGN AFFECT NEUR, V110; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Smits IAM, 2011, J PERS SOC PSYCHOL, V100, P1124, DOI 10.1037/a0022874; Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P75, DOI 10.1002/0470870168.ch5; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; van Beest I, 2012, GROUP DYN-THEOR RES, V16, P241, DOI 10.1037/a0030104; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Wirth JH, 2010, J RES PERS, V44, P397, DOI 10.1016/j.jrp.2010.03.001; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; Zadro L, 2006, J EXP SOC PSYCHOL, V42, P692, DOI 10.1016/j.jesp.2005.10.007	47	261	264	16	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127002	10.1371/journal.pone.0127002	http://dx.doi.org/10.1371/journal.pone.0127002			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26023925	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400029
J	Kabu, S; Jaffer, H; Petro, M; Dudzinski, D; Stewart, D; Courtney, A; Courtney, M; Labhasetwar, V				Kabu, Shushi; Jaffer, Hayder; Petro, Marianne; Dudzinski, Dave; Stewart, Desiree; Courtney, Amy; Courtney, Michael; Labhasetwar, Vinod			Blast-Associated Shock Waves Result in Increased Brain Vascular Leakage and Elevated ROS Levels in a Rat Model of Traumatic Brain Injury	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; BARRIER DISRUPTION; HUMAN NEURONS; MOUSE MODEL; EDEMA; DEFICITS; DIFFUSE; OVERPRESSURE; BREAKDOWN	Blast-associated shock wave-induced traumatic brain injury (bTBI) remains a persistent risk for armed forces worldwide, yet its detailed pathophysiology remains to be fully investigated. In this study, we have designed and characterized a laboratory-scale shock tube to develop a rodent model of bTBI. Our blast tube, driven by a mixture of oxygen and acetylene, effectively generates blast overpressures of 20-130 psi, with pressure-time profiles similar to those of free-field blast waves. We tested our shock tube for brain injury response to various blast wave conditions in rats. The results show that blast waves cause diffuse vascular brain damage, as determined using a sensitive optical imaging method based on the fluorescence signal of Evans Blue dye extravasation developed in our laboratory. Vascular leakage increased with increasing blast overpressures and mapping of the brain slices for optical signal intensity indicated nonhomogeneous damage to the cerebral vasculature. We confirmed vascular leakage due to disruption in the blood-brain barrier (BBB) integrity following blast exposure. Reactive oxygen species (ROS) levels in the brain also increased with increasing blast pressures and with time post-blast wave exposure. Immunohistochemical analysis of the brain sections analyzed at different time points post blast exposure demonstrated astrocytosis and cell apoptosis, confirming sustained neuronal injury response. The main advantages of our shock-tube design are minimal jet effect and no requirement for specialized equipment or facilities, and effectively generate blast-associated shock waves that are relevant to battle-field conditions. Overall data suggest that increased oxidative stress and BBB disruption could be the crucial factors in the propagation and spread of neuronal degeneration following blast injury. Further studies are required to determine the interplay between increased ROS activity and BBB disruption to develop effective therapeutic strategies that can prevent the resulting cascade of neurodegeneration.	[Kabu, Shushi; Jaffer, Hayder; Petro, Marianne; Stewart, Desiree; Labhasetwar, Vinod] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Dudzinski, Dave] Cleveland Clin, Med Device Solut, Lerner Res Inst, Cleveland, OH 44106 USA; [Courtney, Amy; Courtney, Michael] BTG Res, Colorado Springs, CO USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Labhasetwar, V (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA.	labhasv@ccf.org	Labhasetwar, Vinod/J-9660-2016	Labhasetwar, Vinod/0000-0001-7950-1542; Courtney, Amy/0000-0002-1925-8736				Ahn HY, 2012, J AM CHEM SOC, V134, P4721, DOI 10.1021/ja210315x; Alley M., 2009, THESIS PURDUE U W LA; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Blixt J, 2015, BRAIN RES; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Courtney E, 2014, DEF TECHNOL, V10, P245, DOI 10.1016/j.dt.2014.04.003; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Her H, 2012, QUANTIFYING MOMENTUM; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iffland PH, 2013, NEUROBIOL DIS, V59, P206, DOI 10.1016/j.nbd.2013.07.006; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jaffer H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03117; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Newman AJ, 2015, J NEUROSCI METH, V242, P82, DOI 10.1016/j.jneumeth.2015.01.009; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1; Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singhal A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.362; Stuhmiller J. H., 2008, MILITARY QUANTITATIV, P267; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	64	46	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127971	10.1371/journal.pone.0127971	http://dx.doi.org/10.1371/journal.pone.0127971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024446	gold, Green Published			2022-12-27	WOS:000355319400062
J	Sun, J; Li, FN; Zhao, Y; Zhao, L; Qiao, C; Li, ZY; Guo, QL; Lu, N				Sun, Jie; Li, Fanni; Zhao, Yue; Zhao, Li; Qiao, Chen; Li, Zhiyu; Guo, Qinglong; Lu, Na			LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							PHASE ARREST; CELLS; WOGONIN; TUMOR; EXPRESSION; PROGRESSION; PREVENTION; INDUCTION; ACID	Flavonoids and flavonoid derivatives, which have significant biological and pharmacological activities, including antitumor and anti-inflammatory activities, have been widely used in human healthcare. To design a more effective flavonoid antitumor agent, we altered the flavonoid backbone with substitutions of piperazine and methoxy groups to synthesize a novel flavonoid derivative, LZ-207. The anticancer effect of LZ-207 against HCT116 colon cancer cells and the underlying mechanism of this effect were explored in this study. Specifically, LZ-207 exhibited inhibitory effects on growth and viability in several human colon cancer cell lines and induced apoptosis in HCT116 cells both in vitro and in vivo. LZ-207 treatment also suppressed the nuclear translocation of NF-kappa B and the phosphorylation of I kappa B and IKK alpha/beta in a dose-dependent manner in both HCT116 cells and human acute monocytic leukemia THP-1 cells. Moreover, LZ-207 also reduced the secretion of the pro-inflammatory cytokine interleukin-6 (IL-6) in LPS-induced THP-1 cells, and this effect was confirmed at the transcriptional level. Furthermore, LZ-207 significantly inhibited HCT116 cell proliferation that was elicited by LPS-induced THP-1 cells in a co-culture system. These findings elucidated some potential molecular mechanisms for preventing inflammation-driven colon cancer using the newly synthesized flavonoid LZ-207 and suggested the possibility of further developing novel therapeutic agents derived from flavonoids.	[Sun, Jie; Li, Fanni; Zhao, Yue; Zhao, Li; Qiao, Chen; Guo, Qinglong; Lu, Na] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Li, Zhiyu] China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Guo, QL (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China.	anticancer_drug@163.com; luna555@163.com	sun, jie/H-8312-2018; Sun, Jie/M-9620-2013	Sun, Jie/0000-0002-8368-3091	National Science & Technology Major Project [2012ZX09304-001]; State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303, SKLNMZZJQ201302, G140042]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1193]; National Natural Science Foundation of China [91029744]	National Science & Technology Major Project; State Key Laboratory of Natural Medicines, China Pharmaceutical University; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science & Technology Major Project (No.2012ZX09304-001), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303 and SKLNMZZJQ201302, G140042), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1193), the National Natural Science Foundation of China (No. 91029744).	Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bondar T, 2013, CANCER CELL, V24, P143, DOI 10.1016/j.ccr.2013.07.016; Brard Laurent, 2009, Drug Des Devel Ther, V2, P61; Chen FH, 2010, CANCER LETT, V296, P96, DOI 10.1016/j.canlet.2010.04.004; Chen P, 2011, TOXICOLOGY, V282, P122, DOI 10.1016/j.tox.2011.01.018; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hellstrom I, 2010, CANCER LETT, V296, P43, DOI 10.1016/j.canlet.2010.03.013; Huang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043645; Kanadaswami C, 2005, IN VIVO, V19, P895; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li LW, 2011, EUR J PHARM SCI, V43, P393, DOI 10.1016/j.ejps.2011.06.001; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279; Liu W, 2011, BIOCHEM CELL BIOL, V89, P287, DOI 10.1139/O10-162; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Middleton E, 2000, PHARMACOL REV, V52, P673; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Neuhouser ML, 2004, NUTR CANCER, V50, P1, DOI 10.1207/s15327914nc5001_1; Nguyen IS, 2006, INT C SERIES, P257; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Pan D, 2014, BIOCHEM PHARMACOL, V87, P598, DOI 10.1016/j.bcp.2013.12.010; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Qiang L, 2008, BIOCHEM PHARMACOL, V75, P1083, DOI 10.1016/j.bcp.2007.10.033; Ramasamy K, 2008, CANCER LETT, V269, P352, DOI 10.1016/j.canlet.2008.03.053; Rong JJ, 2009, CANCER LETT, V284, P102, DOI 10.1016/j.canlet.2009.04.011; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vuletic S, 2011, BBA-MOL CELL RES, V1813, P1917, DOI 10.1016/j.bbamcr.2011.06.013; Wang QX, 2009, J CLIN BIOCHEM NUTR, V45, P163, DOI 10.3164/jcbn.09-21; Wei LB, 2010, J CELL BIOCHEM, V111, P1629, DOI 10.1002/jcb.22898; Yang L, 2009, BIOCHEM CELL BIOL, V87, P933, DOI [10.1139/O09-060, 10.1139/o09-060]; Yao J, 2014, MOL CARCINOGEN, V53, P145, DOI 10.1002/mc.21958; Zeng S, 2009, BIOCHEM BIOPH RES CO, V385, P551, DOI 10.1016/j.bbrc.2009.05.099; Zhang HW, 2008, EUR J PHARMACOL, V591, P7, DOI 10.1016/j.ejphar.2008.06.024; Zhang LB, 2011, EUR J PHARMACOL, V651, P33, DOI 10.1016/j.ejphar.2010.10.067; Zhang Y, 2014, ARCH TOXICOL, V88, P97, DOI 10.1007/s00204-013-1085-6; Zhao Q, 2010, TOXICOL LETT, V197, P201, DOI 10.1016/j.toxlet.2010.05.019; Zhou YX, 2013, EUR J PHARM SCI, V49, P649, DOI 10.1016/j.ejps.2013.04.016	45	7	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127282	10.1371/journal.pone.0127282	http://dx.doi.org/10.1371/journal.pone.0127282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023926	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400035
J	Uji, A; Murakami, T; Muraoka, Y; Hosoda, Y; Yoshitake, S; Dodo, Y; Arichika, S; Yoshimura, N				Uji, Akihito; Murakami, Tomoaki; Muraoka, Yuki; Hosoda, Yoshikatsu; Yoshitake, Shin; Dodo, Yoko; Arichika, Shigeta; Yoshimura, Nagahisa			Potential Measurement Errors Due to Image Enlargement in Optical Coherence Tomography Imaging	PLOS ONE			English	Article							HYPERREFLECTIVE FOCI; VISUAL-ACUITY; PARALLELISM; SPEED	The effect of interpolation and super-resolution (SR) algorithms on quantitative and qualitative assessments of enlarged optical coherence tomography (OCT) images was investigated in this report. Spectral-domain OCT images from 30 eyes in 30 consecutive patients with diabetic macular edema (DME) and 20 healthy eyes in 20 consecutive volunteers were analyzed. Original image (OR) resolution was reduced by a factor of four. Images were then magnified by a factor of four with and without application of one of the following algorithms: bilinear (BL), bicubic (BC), Lanczos3 (LA), and SR. Differences in peak signal-to-noise ratio (PSNR), retinal nerve fiber layer (RNFL) thickness, photoreceptor layer status, and parallelism (reflects the complexity of photoreceptor layer alterations) were analyzed in each image type. The order of PSNRs from highest to lowest was SR > LA > BC > BL > non-processed enlarged images (NONE). The PSNR was statistically different in all groups. The NONE, BC, and LA images resulted in significantly thicker RNFL measurements than the OR image. In eyes with DME, the photoreceptor layer, which was hardly identifiable in NONE images, became detectable with algorithm application. However, OCT photoreceptor parameters were still assessed as more undetectable than in OR images. Parallelism was not statistically different in OR and NONE images, but other image groups had significantly higher parallelism than OR images. Our results indicated that interpolation and SR algorithms increased OCT image resolution. However, qualitative and quantitative assessments were influenced by algorithm use. Additionally, each algorithm affected the assessments differently.	[Uji, Akihito; Murakami, Tomoaki; Muraoka, Yuki; Hosoda, Yoshikatsu; Yoshitake, Shin; Dodo, Yoko; Arichika, Shigeta; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan	Kyoto University	Uji, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan.	akihito1@kuhp.kyoto-u.ac.jp		Murakami, Tomoaki/0000-0002-0314-8807	Innovative Techno-Hub for Integrated Medical BioImaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan)	Innovative Techno-Hub for Integrated Medical BioImaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan)	This work was supported in part by the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan) (AU, NY), (http://ckpj.t.kyoto-u.ac.jp/?lang = en). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasil T, 2010, OPHTHALMOLOGY, V117, P2379, DOI 10.1016/j.ophtha.2010.03.051; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; Chen TC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1715, DOI 10.1001/archopht.123.12.1715; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; Forooghian F, 2010, RETINA-J RET VIT DIS, V30, P63, DOI 10.1097/IAE.0b013e3181bd2c5a; Freeman WT, 2000, INT J COMPUT VISION, V40, P25, DOI 10.1023/A:1026501619075; Gonzalez R.C., 2011, DIGITAL IMAGE PROCES; Greenspan H, 2009, COMPUT J, V52, P43, DOI 10.1093/comjnl/bxm075; Hangai M, 2006, CLIN APPL HIGH CONTR; Horii T, 2010, AM J OPHTHALMOL, V150, P840, DOI 10.1016/j.ajo.2010.06.015; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Kitayama T, 2012, HARDWARE ARCHITECTUR, P492; Makwana RR, 2013, INT J SOFT COMPUTING; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480; Park SC, 2003, IEEE SIGNAL PROC MAG, V20, P21, DOI 10.1109/MSP.2003.1203207; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Takayama K, 2012, INVEST OPHTH VIS SCI, V53, P6904, DOI 10.1167/iovs.12-10210; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Uji A, 2014, INVEST OPHTH VIS SCI, V55, P3361, DOI 10.1167/iovs.14-13948; Uji A, 2014, AM J OPHTHALMOL, V157, P227, DOI 10.1016/j.ajo.2013.09.008; Uji A, 2012, AM J OPHTHALMOL, V153, P710, DOI 10.1016/j.ajo.2011.08.041; Yoneda A, 2007, PLANT CELL PHYSIOL, V48, P1393, DOI 10.1093/pcp/pcm120; Zhu TP, 2014, MICROVASC RES, V95, P7, DOI 10.1016/j.mvr.2014.06.007; [No title captured]	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128512	10.1371/journal.pone.0128512	http://dx.doi.org/10.1371/journal.pone.0128512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024236	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400096
J	van der Schans, J; Kotsopoulos, N; Hoekstra, PJ; Hak, E; Postma, MJ				van der Schans, Jurjen; Kotsopoulos, Nikos; Hoekstra, Pieter J.; Hak, Eelko; Postma, Maarten J.			Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; MULTIMODAL TREATMENT; ADHD; EPIDEMIOLOGY; UTILITIES; EFFICACY; PATTERNS; OUTCOMES; LIFE	Background Attention-Deficit/Hyperactivity Disorder (ADHD) is a common psychiatric disorder in children and adolescents. Immediate-release methylphenidate (IR-MPH) is the medical treatment of first choice. The necessity to use several IR-MPH tablets per day and associated potential social stigma at school often leads to reduced compliance, sub-optimal treatment, and therefore economic loss. Replacement of IR-MPH with a single-dose extended release (ER-MPH) formulation may improve drug response and economic efficiency. Objective To evaluate the cost-effectiveness from a societal perspective of a switch from IR-MPH to ER-MPH in patients who are sub-optimally treated. Methods A daily Markov-cycle model covering a time-span of 10 years was developed including four different health states: (1) optimal response, (2) sub-optimal response, (3) discontinued treatment, and (4) natural remission. ER-MPH options included methylphenidate osmotic release oral system (MPH-OROS) and Equasym XL/Medikinet CR. Both direct costs and indirect costs were included in the analysis, and effects were expressed as quality-adjusted life years (QALYs). Univariate, multivariate as well as probabilistic sensitivity analysis were conducted and the main outcomes were incremental cost-effectiveness ratios. Results Switching sub-optimally treated patients from IR-MPH to MPH-OROS or Equasym XL/Medikinet CR led to per-patient cost-savings of sic4200 and sic5400, respectively, over a 10-year treatment span. Sensitivity analysis with plausible variations of input parameters resulted in cost-savings in the vast majority of estimations. Conclusions This study lends economic support to switching patients with ADHD with suboptimal response to short-acting IR-MPH to long-acting ER-MPH regimens.	[van der Schans, Jurjen; Kotsopoulos, Nikos; Hak, Eelko; Postma, Maarten J.] Univ Groningen RUG, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Healthy Aging & HealthcaRE, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Schans, J (corresponding author), Univ Groningen RUG, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	j.van.der.schans@rug.nl; m.j.postma@rug.nl		Postma, Maarten/0000-0002-6306-3653; KOTSOPOULOS, NIKOLAOS/0000-0002-8248-7697	Netherlands Organisation for Health Research and Development (ZonMW) [836011014]	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	All phases of this study were supported by a Netherlands Organisation for Health Research and Development (ZonMW) grant, #836011014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs A, 2006, DECISION MODELING HL; College voor zorgverzekeringen (CVZ), 2006, GUID PHARM RES UPD V; Faber A, 2008, CNS DRUGS, V22, P157, DOI 10.2165/00023210-200822020-00006; Faber A, 2010, EUR CHILD ADOLES PSY, V19, P159, DOI 10.1007/s00787-009-0075-y; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Gau SSF, 2008, J CLIN PSYCHIAT, V69, P131, DOI 10.4088/JCP.v69n0118; Hak E, 2013, ANN ALLERG ASTHMA IM, V111, P102, DOI 10.1016/j.anai.2013.05.023; Hakkaart-van Roijen L, 2007, EUR CHILD ADOLES PSY, V16, P316, DOI 10.1007/s00787-007-0603-6; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 2005, AM J PSYCHIAT, V162, P1628, DOI 10.1176/appi.ajp.162.9.1628; Lage M, 2004, J CHILD ADOL PSYCHOP, V14, P575, DOI 10.1089/cap.2004.14.575; Le HH, 2014, EUR CHILD ADOLES PSY, V23, P587, DOI 10.1007/s00787-013-0477-8; Lloyd A, 2011, PATIENT, V4, P247, DOI 10.2165/11592150-000000000-00000; Maldonado R, 2013, EXPERT OPIN DRUG MET, V9, P1001, DOI 10.1517/17425255.2013.786041; Marcus SC, 2005, ARCH PEDIAT ADOL MED, V159, P572, DOI 10.1001/archpedi.159.6.572; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; Monster TBM, 2002, PHARMACOEPIDEM DR S, V11, P379, DOI 10.1002/pds.722; National Institute for Health and Care Excellence, 2008, DIAGN MAN ADHD CHILD; National institute for health and clinical excellence (NICE), 2006, TECHN APPR 98 METH A; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Rothenberger Aribert, 2011, Eur Child Adolesc Psychiatry, V20 Suppl 2, pS235, DOI 10.1007/s00787-011-0201-5; Rothenberger Aribert, 2011, Eur Child Adolesc Psychiatry, V20 Suppl 2, pS257, DOI 10.1007/s00787-011-0203-3; Secnik K, 2005, MED DECIS MAKING, V25, P56, DOI 10.1177/0272989X04273140; Statistics Netherlands (CBS), 2014, POP KEY FIG; Steele M, 2006, CAN J CLIN PHARM, V13, P50; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; The Health Care Insurance Board (CVZ), 2013, PHARM LIST PRIC; Trip AM, 2009, BRIT J CLIN PHARMACO, V67, P466, DOI 10.1111/j.1365-2125.2009.03373.x; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Wong ICK, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13490	32	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127237	10.1371/journal.pone.0127237	http://dx.doi.org/10.1371/journal.pone.0127237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024479	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400032
J	Xu, YW; Pickering, JG; Nong, ZX; Gibson, E; Arpino, JM; Yin, H; Ward, AD				Xu, Yiwen; Pickering, J. Geoffrey; Nong, Zengxuan; Gibson, Eli; Arpino, John-Michael; Yin, Hao; Ward, Aaron D.			A Method for 3D Histopathology Reconstruction Supporting Mouse Microvasculature Analysis	PLOS ONE			English	Article							VIVO MR-IMAGES; REGISTRATION	Structural abnormalities of the microvasculature can impair perfusion and function. Conventional histology provides good spatial resolution with which to evaluate the microvascular structure but affords no 3-dimensional information; this limitation could lead to misinterpretations of the complex microvessel network in health and disease. The objective of this study was to develop and evaluate an accurate, fully automated 3D histology reconstruction method to visualize the arterioles and venules within the mouse hind-limb. Sections of the tibialis anterior muscle from C57BL/J6 mice (both normal and subjected to femoral artery excision) were reconstructed using pairwise rigid and affine registrations of 5 mu m-thick, paraffin-embedded serial sections digitized at 0.25 mu m/pixel. Low-resolution intensity-based rigid registration was used to initialize the nucleus landmark-based registration, and conventional high-resolution intensity-based registration method. The affine nucleus landmark-based registration was developed in this work and was compared to the conventional affine high-resolution intensity-based registration method. Target registration errors were measured between adjacent tissue sections (pairwise error), as well as with respect to a 3D reference reconstruction (accumulated error, to capture propagation of error through the stack of sections). Accumulated error measures were lower (p<0.01) for the nucleus landmark technique and superior vasculature continuity was observed. These findings indicate that registration based on automatic extraction and correspondence of small, homologous landmarks may support accurate 3D histology reconstruction. This technique avoids the otherwise problematic "banana-into-cylinder" effect observed using conventional methods that optimize the pairwise alignment of salient structures, forcing them to be section-orthogonal. This approach will provide a valuable tool for high-accuracy 3D histology tissue reconstructions for analysis of diseased microvasculature.	[Xu, Yiwen; Pickering, J. Geoffrey; Arpino, John-Michael; Ward, Aaron D.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Xu, Yiwen; Pickering, J. Geoffrey; Nong, Zengxuan; Gibson, Eli; Arpino, John-Michael; Yin, Hao] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Ward, Aaron D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Ward, AD (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	aaron.ward@uwo.ca	Pickering, J. Geoffrey/G-3341-2011; Gibson, Eli/E-2191-2016; Ward, Aaron/B-4950-2015	Pickering, J. Geoffrey/0000-0001-6474-3274; Gibson, Eli/0000-0001-9207-7280; 	Natural Sciences and Engineering Research Council of Canada [418740-2012 RGPIN, CGS M-427711-2012]; Cancer Care Ontario [2011 CCO RGA]; Canadian Institutes of Health Research [FRN-11715]; Canadian Cancer Society [701080]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cancer Care Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by Natural Sciences and Engineering Research Council of Canada, Grant number: 418740-2012 RGPIN, URL: http://www.nserc-crsng.gc.ca; Cancer Care Ontario, Grant number: 2011 CCO RGA, URL: http://www.cancercare.on.ca; Canadian Institutes of Health Research, Grant number: FRN-11715, http://www.cihr-irsc.gc.ca; Canadian Cancer Society, Grant number: #701080, http://www.cancer.ca; Natural Sciences and Engineering Research Council of Canada, Grant number: CGS M-427711-2012, URL: http://www.nserc-crsng.gc.ca. JGP holds the Heart and Stroke Foundation of Ontario/Barnett-Ivey Chair (http://www.heartandstroke.on.ca). ADW holds a Cancer Care Ontario Research Chair in Cancer Imaging (http://www.cancercare.on.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; CAMPBELL MJ, 1988, BRIT MED J, V296, P1454, DOI 10.1136/bmj.296.6634.1454; Cifor A, 2011, NEUROIMAGE, V56, P197, DOI 10.1016/j.neuroimage.2011.01.060; Csernus B, 2008, HISTOPATHOLOGY, V53, P410; ERIKSSON E, 1972, ACTA PHYSIOL SCAND, V86, P211, DOI 10.1111/j.1748-1716.1972.tb05327.x; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Gaffling S, 2011, LANDMARK CONSTRAINED; Gibson E, P SPIE, V86762013; Gibson E, 2012, J MAGN RESON IMAGING, V36, P1402, DOI 10.1002/jmri.23767; Gijtenbeek J. M. M., 2005, Angiogenesis, V8, P297; Gilhuis H. Jacobus, 2006, Angiogenesis, V9, P201, DOI 10.1007/s10456-006-9054-9; Gleeson M., 2008, SCOTT BROWNS OTORHIN, P111; Hughes C, 2013, IEEE T BIO-MED ENG, V60, P281, DOI 10.1109/TBME.2012.2225835; Ichinose E, 2008, ARCH HISTOL CYTOL, V71, P45, DOI 10.1679/aohc.71.45; Janacek J, 2011, MICROVASC RES, V81, P231, DOI 10.1016/j.mvr.2010.11.012; Jirkovska M, 2012, PLACENTA, V33, P343, DOI 10.1016/j.placenta.2012.01.014; Lopez XM, 2014, J AM MED INFORM ASSN; Marieb PW, 2012, HUMAN ANATOMY; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Roberts N, 2012, AM J PATHOL, V180, P1835, DOI 10.1016/j.ajpath.2012.01.033; Ryan TP., 2007, MODERN ENG STAT; Saam T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073513; Schwier Michael, 2013, J Pathol Inform, V4, pS10, DOI 10.4103/2153-3539.109868; Song Yi, 2013, J Pathol Inform, V4, pS7, DOI 10.4103/2153-3539.109864; Steiniger B, 2011, J HISTOCHEM CYTOCHEM, V59, P639, DOI 10.1369/0022155411408315; van der Veer E, 2005, CIRC RES, V97, P25, DOI 10.1161/01.RES.0000173298.38808.27; Walker EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2958; Ward AD, 2012, RADIOLOGY, V263, P856, DOI 10.1148/radiol.12102294; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586	31	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126817	10.1371/journal.pone.0126817	http://dx.doi.org/10.1371/journal.pone.0126817			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024221	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400024
J	Chisti, MJ; Salam, MA; Raqib, R; Banu, S; Shahid, AMSB; Shahunja, KM; Sharmin, L; Ashraf, H; Faruque, AG; Bardhan, PK; Ahmed, T				Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Raqib, Rubhana; Banu, Sayera; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Sharmin, Lazina; Ashraf, Hasan; Faruque, Abu Syed Golam; Bardhan, Pradip Kumar; Ahmed, Tahmeed			Validity of Antibodies in Lymphocyte Supernatant in Diagnosing Tuberculosis in Severely Malnourished Children Presenting with Pneumonia	PLOS ONE			English	Article							INTERFERON-GAMMA; MALNUTRITION; AGE	Background The diagnosis of tuberculosis (TB) in young children can be challenging, especially in severely malnourished children. There is a critical need for improved diagnostics for children. Thus, we sought to evaluate the performance of a technique that measures antibodies in lymphocyte supernatant (ALS) for the diagnosis of TB in severely malnourished children presenting with suspected pneumonia. Methods Children less than 5 years with severe acute malnutrition and radiological features of pneumonia admitted to the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh, were enrolled consecutively following informed written consent. In addition to clinical and radiological assessment, samples taken for TB diagnosis included gastric lavage fluid and induced sputum for microbiological confirmation. ALS was measured from venous blood, and results were evaluated in children classified as "confirmed", "non-confirmed TB" or "not TB". Results Among 224 children who had ALS analysis, 12 (5.4%) children had microbiologically "confirmed TB", a further 41 (18%) had clinically diagnosed "non-confirmed TB" and the remaining 168 (75%) were considered not to have TB. ALS was positive in 89 (40%) and negative in 85 (39%) of children, with a large number (47 or 21%) reported as "borderline". These proportions were similar between the three diagnostic groups. The sensitivity and specificity of ALS when comparing "Confirmed TB" to "Not TB" was only 67% (95% CI: 31-91%) and 51% (95% CI: 42-60%), respectively. Conclusions and Significance Our data suggest that ALS is not sufficiently accurate to improve the diagnosis of TB in children with severe malnutrition.	[Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Raqib, Rubhana; Banu, Sayera; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Sharmin, Lazina; Ashraf, Hasan; Faruque, Abu Syed Golam; Bardhan, Pradip Kumar; Ahmed, Tahmeed] Icddr B, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer] Univ Melbourne, Royal Childrens Hosp, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Chisti, Mohammod Jobayer] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Chisti, MJ (corresponding author), Icddr B, Dhaka, Bangladesh.	chisti@icddrb.org	Chisti, Mohammod J/A-7216-2018; Shahunja, K M/AAR-6229-2020	Shahunja, K M/0000-0002-9345-206X; Banu, Sayera/0000-0002-5121-1962; Raqib, Rubhana/0000-0002-8116-4511	International Centre for Diarrhoeal Disease Research, Bangladesh [Gr- 00233]; Australian Agency for International Development, Government of the People's Republic of Bangladesh; Canadian International Development Agency; Department for International Development, United Kingdom; Swedish International Development Cooperation Agency	International Centre for Diarrhoeal Disease Research, Bangladesh; Australian Agency for International Development, Government of the People's Republic of Bangladesh; Canadian International Development Agency; Department for International Development, United Kingdom; Swedish International Development Cooperation Agency	This research study was funded by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b; grant no Gr- 00233) and its donors, which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aref G H, 1992, J Egypt Public Health Assoc, V67, P655; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chiappini E, 2012, INT J IMMUNOPATH PH, V25, P335, DOI 10.1177/039463201202500203; Chisti MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093776; Holm LL, 2014, PEDIATRICS, V134, pE1568, DOI 10.1542/peds.2014-1570; LLOYD AVC, 1968, BRIT MED J, V3, P529, DOI 10.1136/bmj.3.5617.529; Marais BJ, 2010, INFECT DIS CLIN N AM, V24, P727, DOI 10.1016/j.idc.2010.04.004; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; Punia RS, 2012, TROP DOCT, V42, P46, DOI 10.1258/td.2011.110314; Raqib R, 2003, J INFECT DIS, V188, P364, DOI 10.1086/376511; Raqib R, 2009, CLIN VACCINE IMMUNOL, V16, P521, DOI 10.1128/CVI.00391-08; Rekha RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016425; SUSKIND D, 1990, NESTLE NUTR WORKS SE, V19, P1; Tebruegge M, 2014, J CLIN MICROBIOL, V52, P2694, DOI 10.1128/JCM.00814-14; Thomas T, 2011, THORAX, V66, P727, DOI 10.1136/thx.2010.147363; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Winston CA, 2012, PEDIATRICS, V130, pE1425, DOI 10.1542/peds.2012-1057	18	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126863	10.1371/journal.pone.0126863	http://dx.doi.org/10.1371/journal.pone.0126863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020966	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300027
J	Gudenkauf, BM; Hewson, I				Gudenkauf, Brent M.; Hewson, Ian			Metatranscriptomic Analysis of Pycnopodia helianthoides (Asteroidea) Affected by Sea Star Wasting Disease	PLOS ONE			English	Article							OF-THORNS STARFISH; DIADEMA-ANTILLARUM; MASS MORTALITY	Sea star wasting disease (SSWD) describes a suite of symptoms reported in asteroids of the North American Pacific Coast. We performed a metatranscriptomic survey of asymptomatic and symptomatic sunflower star (Pycnopodia helianthoides) body wall tissues to understand holobiont gene expression in tissues affected by SSWD. Metatranscriptomes were highly variable between replicate libraries, and most differentially expressed genes represented either transcripts of associated microorganisms (particularly Pseudomonasand Vibriorelatives) or low-level echinoderm transcripts of unknown function. However, the pattern of annotated host functional genes reflects enhanced apoptotic and tissue degradation processes and decreased energy metabolism, while signalling of death-related proteins was greater in asymptomatic and symptomatic tissues. Our results suggest that the body wall tissues of SSWD-affected asteroids may undergo structural changes during disease progression, and that they are stimulated to undergo autocatalytic cell death processes.	[Gudenkauf, Brent M.; Hewson, Ian] Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA	Cornell University	Hewson, I (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA.	hewson@cornell.edu			Rapid Response grants [OCE-1401727]; David R. Atkinson Center for Sustainable Futures	Rapid Response grants; David R. Atkinson Center for Sustainable Futures	This work was supported by Rapid Response grants OCE-1401727 ( to IH and B. Miner) and from the David R. Atkinson Center for Sustainable Futures.	Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Eckert G, 1999, SEA STAR DIS POPULAT, P435; Ferguson JC, 1996, BIOL BULL, V191, P431, DOI 10.2307/1543016; Gudenkauf BM, 2014, J GEN VIROL, V95, P652, DOI 10.1099/vir.0.060780-0; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Lessios HA, 2005, CORAL REEFS, V24, P125, DOI 10.1007/s00338-004-0443-5; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; LESSIOS HA, 1995, P ROY SOC B-BIOL SCI, V259, P331, DOI 10.1098/rspb.1995.0049; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pincebourde S, 2013, J EXP BIOL, V216, P2183, DOI 10.1242/jeb.083881; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Pratchett MS, 1999, CORAL REEFS, V18, P272, DOI 10.1007/s003380050192; Scheibling RE, 1997, MAR ECOL PROG SER, V125, P167; ZANN L, 1990, CORAL REEFS, V9, P135, DOI 10.1007/BF00258225	16	17	17	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128150	10.1371/journal.pone.0128150	http://dx.doi.org/10.1371/journal.pone.0128150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020776	gold, Green Published			2022-12-27	WOS:000355187300085
J	Guo, Y; Huang, JY; Shi, Z; Li, HY				Guo, Yan; Huang, Jingyi; Shi, Zhou; Li, Hongyi			Mapping Spatial Variability of Soil Salinity in a Coastal Paddy Field Based on Electromagnetic Sensors	PLOS ONE			English	Article							MULTIPLE LINEAR-REGRESSION; ELECTRICAL-CONDUCTIVITY; INDUCTION TECHNIQUES; INVERSION; PROFILES; PREDICTION; MODELS	In coastal China, there is an urgent need to increase land area for agricultural production and urban development, where there is a rapid growing population. One solution is land reclamation from coastal tidelands, but soil salinization is problematic. As such, it is very important to characterize and map the within-field variability of soil salinity in space and time. Conventional methods are often time-consuming, expensive, labor-intensive, and unpractical. Fortunately, proximal sensing has become an important technology in characterizing within-field spatial variability. In this study, we employed the EM38 to study spatial variability of soil salinity in a coastal paddy field. Significant correlation relationship between ECa and EC1:5 (i.e. r >0.9) allowed us to use EM38 data to characterize the spatial variability of soil salinity. Geostatistical methods were used to determine the horizontal spatio-temporal variability of soil salinity over three consecutive years. The study found that the distribution of salinity was heterogeneous and the leaching of salts was more significant in the edges of the study field. By inverting the EM38 data using a Quasi-3D inversion algorithm, the vertical spatio-temporal variability of soil salinity was determined and the leaching of salts over time was easily identified. The methodology of this study can be used as guidance for researchers interested in understanding soil salinity development as well as land managers aiming for effective soil salinity monitoring and management practices. In order to better characterize the variations in soil salinity to a deeper soil profile, the deeper mode of EM38 (i.e., EM38v) as well as other EMI instruments (e.g. DUALEM-421) can be incorporated to conduct Quasi-3D inversions for deeper soil profiles.	[Guo, Yan; Shi, Zhou] Zhejiang Univ, Coll Environm & Resource Sci, Inst Agr Remote Sensing & Informat Technol Applic, Hangzhou 310003, Zhejiang, Peoples R China; [Guo, Yan] Henan Acad Agr Sci, Inst Agr Econ & Informat, Zhengzhou, Peoples R China; [Huang, Jingyi] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia; [Li, Hongyi] Jiangxi Univ Finance & Econ, Sch Tourism & Urban Management, Nanchang, Peoples R China	Zhejiang University; Henan Academy of Agricultural Sciences; University of New South Wales Sydney; Jiangxi University of Finance & Economics	Shi, Z (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Inst Agr Remote Sensing & Informat Technol Applic, Hangzhou 310003, Zhejiang, Peoples R China.	shizhou@zju.edu.cn	LI, H.Y./B-3427-2014; Huang, Jingyi/ABI-5860-2020; Guo, Yan/GOE-6973-2022; Huang, Jingyi/B-5541-2015; shi, Zhou/M-7845-2019; shi, Zhou/A-2283-2015	Huang, Jingyi/0000-0002-1209-9699; Huang, Jingyi/0000-0002-1209-9699; shi, Zhou/0000-0003-3914-5402; shi, Zhou/0000-0003-3914-5402	National Natural Science Foundation of China [41271234, 41101197]; National High-tech R&D Program of China [2013AA102301]; Key National Projects of High-Resolution Earth Observing System [09-Y30B03-9001-13/15]; Independent Innovative Project of Henan Academy of Agricultural Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Key National Projects of High-Resolution Earth Observing System; Independent Innovative Project of Henan Academy of Agricultural Sciences	This research was supported by National Natural Science Foundation of China (No. 41271234; No. 41101197), the National High-tech R&D Program of China (No. 2013AA102301), the Key National Projects of High-Resolution Earth Observing System (09-Y30B03-9001-13/15) and by the Independent Innovative Project of Henan Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akramkhanov A, 2011, GEODERMA, V163, P55, DOI 10.1016/j.geoderma.2011.04.001; Blackmore S, 2000, COMPUT ELECTRON AGR, V26, P37, DOI 10.1016/S0168-1699(99)00075-7; COOK PG, 1992, SOIL SCI SOC AM J, V56, P1015, DOI 10.2136/sssaj1992.03615995005600040003x; Corwin DL, 2008, BOOKS SOIL PLANT ENV, P17; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P135, DOI 10.1016/j.compag.2004.11.003; Corwin DL, 2003, AGRON J, V95, P352, DOI 10.2134/agronj2003.0455; CORWIN DL, 1984, SOIL SCI SOC AM J, V48, P288, DOI 10.2136/sssaj1984.03615995004800020011x; CORWIN DL, 1982, SOIL SCI SOC AM J, V46, P517, DOI 10.2136/sssaj1982.03615995004600030014x; DEGROOTHEDLIN C, 1990, GEOPHYSICS, V55, P1613, DOI 10.1190/1.1442813; Doolittle JA, 2014, GEODERMA, V223, P33, DOI [10.1016/j.geoderma2014.01.027, 10.1016/j.geoderma.2014.01.027]; GALLICHAND J, 1992, CAN J SOIL SCI, V72, P503, DOI 10.4141/cjss92-042; Hendrickx JMH, 2002, SOIL SCI SOC AM J, V66, P673, DOI 10.2136/sssaj2002.0673; Huang J, 2014, SOIL USE MANAGE, V30, P241, DOI 10.1111/sum.12106; Huang MX, 2008, J COASTAL RES, V24, P170, DOI 10.2112/06-0651.1; LESCH SM, 1995, WATER RESOUR RES, V31, P373, DOI 10.1029/94WR02179; LESCH SM, 1995, WATER RESOUR RES, V31, P387, DOI 10.1029/94WR02180; Li HY, 2015, GEODERMA, V237, P71, DOI 10.1016/j.geoderma.2014.08.008; Li HY, 2013, GEODERMA, V195, P31, DOI 10.1016/j.geoderma.2012.11.005; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; MCNEILL JD, 1980, TN6 GEON LTD, P15; Mester A, 2011, VADOSE ZONE J, V10, P1319, DOI 10.2136/vzj2011.0035; Santos FAM, 2010, J ENVIRON ENG GEOPH, V15, P163, DOI 10.2113/JEEG15.3.163; Santos FAM, 2011, GEOPHYSICS, V76, pB43, DOI 10.1190/1.3537834; Padhi J, 2011, SOIL TILL RES, V117, P93, DOI 10.1016/j.still.2011.09.003; Robinson DA, 2004, SOIL SCI SOC AM J, V68, P339, DOI 10.2136/sssaj2004.3390; SASAKI Y, 1989, GEOPHYSICS, V54, P254, DOI 10.1190/1.1442649; SHEETS KR, 1995, WATER RESOUR RES, V31, P2401, DOI 10.1029/95WR01949; Shi Z, 2005, ENVIRON GEOL, V48, P967, DOI [10.1007/s00254-005-0035-x, 10.1007/s00254-005-1285-3]; Shi Z, 2002, SOIL USE MANAGE, V18, P353, DOI 10.1079/SUM2002144; Shiraz FA, 2013, EXPLOR GEOPHYS, V44, P16, DOI 10.1071/EG12006; Triantafilis J, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0086; Triantafilis J, 2000, SOIL SCI SOC AM J, V64, P1009, DOI 10.2136/sssaj2000.6431009x; Viganotti M, 2013, J APPL GEOPHYS, V92, P110, DOI 10.1016/j.jappgeo.2013.03.001; WEBSTER R, 1992, J SOIL SCI, V43, P177, DOI 10.1111/j.1365-2389.1992.tb00128.x; Webster R., 2007, STAT PRACTICE; Yao RJ, 2010, AGR WATER MANAGE, V97, P1961, DOI 10.1016/j.agwat.2010.02.001; Yu TongHai, 1996, Journal of Zhejiang Agricultural University, V22, P201	37	28	29	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127996	10.1371/journal.pone.0127996	http://dx.doi.org/10.1371/journal.pone.0127996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020969	gold, Green Submitted, Green Published			2022-12-27	WOS:000355187300069
J	Luna-Ramirez, K; Quintero-Hernandez, V; Juarez-Gonzalez, VR; Possani, LD				Luna-Ramirez, Karen; Quintero-Hernandez, Veronica; Juarez-Gonzalez, Victor Rivelino; Possani, Lourival D.			Whole Transcriptome of the Venom Gland from Urodacus yaschenkoi Scorpion	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; MASS-SPECTROMETRY ANALYSIS; PROTEOMIC ANALYSIS; ANTIMICROBIAL PEPTIDES; MOLECULAR DIVERSITY; FUNCTIONAL-CHARACTERIZATION; DISULFIDE BRIDGES; TITYUS-STIGMURUS; TOXIC FRACTIONS; CDNA SEQUENCES	Australian scorpion venoms have been poorly studied, probably because they do not pose an evident threat to humans. In addition, the continent has other medically important venomous animals capable of causing serious health problems. Urodacus yaschenkoi belongs to the most widely distributed family of Australian scorpions (Urodacidae) and it is found all over the continent, making it a useful model system for studying venom composition and evolution. This communication reports the whole set of mRNA transcripts produced by the venom gland. U. yaschenkoi venom is as complex as its overseas counterparts. These transcripts certainly code for several components similar to known scorpion venom components, such as: alpha-KTxs, beta-KTxs, calcins, protease inhibitors, antimicrobial peptides, sodium-channel toxins, toxin-like peptides, allergens, La1-like, hyaluronidases, ribosomal proteins, proteasome components and proteins related to cellular processes. A comparison with the venom gland transcriptome of Centruroides noxius (Buthidae) showed that these two scorpions have similar components related to biological processes, although important differences occur among the venom toxins. In contrast, a comparison with sequences reported for Urodacus manicatus revealed that these two Urodacidae species possess the same subfamily of scorpion toxins. A comparison with sequences of an U. yaschenkoi cDNA library previously reported by our group showed that both techniques are reliable for the description of the venom components, but the whole transcriptome generated with Next Generation Sequencing platform provides sequences of all transcripts expressed. Several of which were identified in the proteome, but many more transcripts were identified including uncommon transcripts. The information reported here constitutes a reference for non-Buthidae scorpion venoms, providing a comprehensive view of genes that are involved in venom production. Further, this work identifies new putative bioactive compounds that could be used to seed research into new pharmacological compounds and increase our understanding of the function of different ion channels.	[Luna-Ramirez, Karen] Univ Melbourne, Dept Pharmacol & Therapeut, Australian Venom Res Unit, Melbourne, Vic 3010, Australia; [Quintero-Hernandez, Veronica; Juarez-Gonzalez, Victor Rivelino; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	University of Melbourne; Universidad Nacional Autonoma de Mexico	Luna-Ramirez, K (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Australian Venom Res Unit, Melbourne, Vic 3010, Australia.	karen.luna@unimelb.edu.au; possani@ibt.unam.mx		Quintero-Hernandez, Veronica/0000-0002-1856-8134; Luna-Ramirez, Karen/0000-0002-1485-2576	Struan Sutherland Fund; Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) [IN200113]; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Struan Sutherland Fund; Direccion General de Asuntos del Personal Academico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Struan Sutherland Fund awarded to the Australian Venom Research Unit (KLR). Partial support came from the grant IN200113 of Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) and Consejo Nacional de Ciencia y Tecnologia (CONACyT) given to LDP.	Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064; ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; Almaaytah A, 2012, PEPTIDES, V35, P291, DOI 10.1016/j.peptides.2012.03.016; Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Alvarenga E.R., 2012, OJGEN, V02, P210, DOI [10.4236/ojgen.2012.24027, DOI 10.4236/OJGEN.2012.24027]; Andreotti N, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P287; Angeloni F, 2011, MOL ECOL RESOUR, V11, P662, DOI 10.1111/j.1755-0998.2011.02990.x; Baek JH, 2013, J ASIA-PAC ENTOMOL, V16, P497, DOI 10.1016/j.aspen.2013.08.003; Barona J, 2006, BBA-PROTEINS PROTEOM, V1764, P76, DOI 10.1016/j.bbapap.2005.08.010; Batista CVF, 2007, COMP BIOCHEM PHYS C, V146, P147, DOI 10.1016/j.cbpc.2006.12.004; Batista CVF, 2006, PROTEOMICS, V6, P3718, DOI 10.1002/pmic.200500525; Batista CVF, 2004, J CHROMATOGR B, V803, P55, DOI 10.1016/j.jchromb.2003.09.002; Bouzid W, 2013, TOXICON, V70, P70, DOI 10.1016/j.toxicon.2013.03.010; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Cahais V, 2012, MOL ECOLOGY RESOURCE; Caliskan F, 2012, TOXICON, V59, P408, DOI 10.1016/j.toxicon.2011.12.013; Caliskan F, 2006, TOXICON, V48, P12, DOI 10.1016/j.toxicon.2006.04.003; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Cao ZJ, 2003, PEPTIDES, V24, P187, DOI 10.1016/S0196-9781(03)00025-1; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; Chen YP, 2012, PLOS ONE, V7; Chen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082288; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Chen ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057529; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Conde R, 1999, FEBS LETT, V460, P447, DOI 10.1016/S0014-5793(99)01392-7; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; de la Vega R.C.R., 2013, HDB BIOL ACT PEPT, P423, DOI [10.1016/B978-0-12-385095-9.00059-2, DOI 10.1016/B978-0-12-385095-9.00059-2]; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2005, TOXICON, V45, P273, DOI 10.1016/j.toxicon.2004.10.014; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; Diego-Garcia E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-295; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; Durban J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-259; Fet V, 2000, CATALOG SCORPIONS WO; Gordon D, 1998, J TOXICOL-TOXIN REV, V17, P131, DOI 10.3109/15569549809009247; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harrison PL, 2014, TOXICON, V88, P115, DOI 10.1016/j.toxicon.2014.06.006; He YW, 2013, J PROTEOMICS, V89, P1, DOI 10.1016/j.jprot.2013.06.007; Heavner ME, 2013, GENE, V526, P195, DOI 10.1016/j.gene.2013.04.080; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; KING TP, 1978, BIOCHEMISTRY-US, V17, P5165, DOI 10.1021/bi00617a016; Koch L.E., 1977, Records W Aust Mus, V5, P83; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Liu ZC, 2012, J PROTEOME RES, V11, P6197, DOI 10.1021/pr300881d; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Lulin H., 2012, PLOS ONE, V7; Luna-Ramirez K, 2014, BIOCHIM BIOPHYS ACTA, V9, P4; Luna-Ramirez K, 2014, MOL PHARMACOL, V86, P28, DOI 10.1124/mol.113.090183; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Matsushita N, 2007, TOXICON, V50, P861, DOI 10.1016/j.toxicon.2007.06.014; Mille BG, 2014, TOXICON, V83, P75, DOI 10.1016/j.toxicon.2014.03.001; Minagawa S, 1997, COMP BIOCHEM PHYS B, V118, P381, DOI 10.1016/S0305-0491(97)00174-0; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; NARASIMHAN L, 1994, NAT STRUCT BIOL, V1, P850, DOI 10.1038/nsb1294-850; Nascimento DG, 2006, TOXICON, V47, P628, DOI 10.1016/j.toxicon.2006.01.015; Newton KA, 2007, RAPID COMMUN MASS SP, V21, P3467, DOI 10.1002/rcm.3240; Ortiz E, 2014, BIOCHIM BIOPHYS ACTA, V6, P19; Oukkache N, 2008, TOXICON, V51, P835, DOI 10.1016/j.toxicon.2007.12.012; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pimenta AMC, 2001, RAPID COMMUN MASS SP, V15, P1562, DOI 10.1002/rcm.415; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; ROCHAT C, 1967, BIOCHEMISTRY-US, V6, P578, DOI 10.1021/bi00854a028; ROCHAT H, 1970, EUR J BIOCHEM, V17, P262, DOI 10.1111/j.1432-1033.1970.tb01162.x; ROCHAT H, 1970, FEBS LETT, V10, P349, DOI 10.1016/0014-5793(70)80470-7; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Schwartz EF, 2008, TOXICON, V51, P1499, DOI 10.1016/j.toxicon.2008.03.029; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Smith JJ, 2013, P NATL ACAD SCI USA, V110, P8906, DOI 10.1073/pnas.1214062110; Smith Jennifer J, 2012, J Venom Res, V3, P7; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Sunagar K, 2013, TOXINS, V5, P2456, DOI 10.3390/toxins5122456; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Valdez-Velazquez LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066486; VALDIVIA HH, 1992, P NATL ACAD SCI USA, V89, P12185, DOI 10.1073/pnas.89.24.12185; Wu WL, 2007, PEPTIDES, V28, P2306, DOI 10.1016/j.peptides.2007.10.009; Xu XB, 2014, J PROTEOMICS, V106, P162, DOI 10.1016/j.jprot.2014.04.032; Zeng XC, 2013, PEPTIDES, V45, P28, DOI 10.1016/j.peptides.2013.03.026; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027548; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452; Zhao ZH, 2012, J BIOL CHEM, V287, P30181, DOI 10.1074/jbc.M112.370312; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1; Zhu SY, 2010, BBA-PROTEINS PROTEOM, V1804, P872, DOI 10.1016/j.bbapap.2009.12.017	103	51	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127883	10.1371/journal.pone.0127883	http://dx.doi.org/10.1371/journal.pone.0127883			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020943	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300062
J	Park, L				Park, Leeyoung			Ancestral Alleles in the Human Genome Based on Population Sequencing Data	PLOS ONE			English	Article							BIASED GENE CONVERSION; GC-CONTENT; SUBSTITUTION RATES; MUTATION-RATES; EVOLUTION; DELETIONS; INSERTIONS; NUCLEOTIDE	Ancestral allele information is useful for genetics studies. Previously, the identification of ancestral alleles was primarily based on sequence alignments between species. Alternative ways to identify ancestral alleles were proposed in this study based on population sequencing data. The methods described here utilized the diversity between haplotypes harboring ancestral and newly emerged alleles. Simulations showed that these methods were reliable for identifying ancestral alleles when the variants had not aged too greatly. Application to the human genome sequencing data suggested the role of indels in maintaining the GC content in the human genome. The deletion-to-insertion ratios and GC proportions were correlated depending on the sizes of insertions and deletions in the direction of increasing GC content. There were GC-biased fixations in single base-pair insertions and AT-biased fixations in single base-pair deletions in the results based on the proposed methods. In the current study, GC-biased gene conversions in nucleotide substitutions were very slight or insignificant. In the variants of several quantitative trait loci (QTLs), slight GC-biased gene conversion was observed in nucleotide substitutions. For the QTL indels, insertions were observed more often than deletions, and deletion-biased fixation was observed, providing new insights into the evolution of functional genes.	Yonsei Univ, Nat Sci Res Inst, Seoul 120749, South Korea	Yonsei University	Park, L (corresponding author), Yonsei Univ, Nat Sci Res Inst, Seoul 120749, South Korea.	lypark@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [353-2009-2-C00061, 2013R1A1A3006685]; Korea Institute of Science and Technology Information (KISTI) [KSC-2011-C2-47]	National Research Foundation of Korea (NRF) - Korean Government (MSIP); Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MSIP) (353-2009-2-C00061 and 2013R1A1A3006685). The key calculations were performed using the supercomputing resource at the Korea Institute of Science and Technology Information (KISTI), which provided support through grant no. KSC-2011-C2-47. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arndt PF, 2005, J MOL EVOL, V60, P748, DOI 10.1007/s00239-004-0222-5; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Chen FC, 2007, GENOME RES, V17, P16, DOI 10.1101/gr.5429606; Chong ZC, 2013, MOL BIOL EVOL, V30, P2699, DOI 10.1093/molbev/mst167; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fry AE, 2006, AM J HUM GENET, V78, P1053, DOI 10.1086/504160; Galtier N, 2001, GENETICS, V159, P907; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Hernandez RD, 2007, MOL BIOL EVOL, V24, P2196, DOI 10.1093/molbev/msm149; Karro JE, 2008, MOL BIOL EVOL, V25, P362, DOI 10.1093/molbev/msm261; Kimura M., 1971, THEORETICAL ASPECTS; Kuo CH, 2009, GENOME BIOL EVOL, V1, P145, DOI 10.1093/gbe/evp016; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Laurie S, 2012, GENOME RES, V22, P478, DOI 10.1101/gr.121897.111; Leushkin EV, 2013, GENOME BIOL EVOL, V5, P514, DOI 10.1093/gbe/evt021; Lin MW, 2010, EUR J HUM GENET, V18, P26, DOI 10.1038/ejhg.2009.135; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2007, THE ORIGINS OF GENOM; Martinez-Cadenas C, 2013, MOL BIOL EVOL, V30, P2654, DOI 10.1093/molbev/mst158; Maruta Y, 2008, CANCER GENET CYTOGEN, V180, P24, DOI 10.1016/j.cancergencyto.2007.09.011; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nei M., 2000, Molecular evolution and phylogenetics.; Park L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046603; Park L, 2009, GENET RES, V91, P293, DOI 10.1017/S0016672309990164; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Tyekucheva S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r76; Wang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026949; WEIR BS, 1980, GENETICS, V95, P477; Weller AM, 2014, GENETICS, V196, P1145, DOI 10.1534/genetics.113.159863; Wright S, 1931, GENETICS, V16, P0097	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128186	10.1371/journal.pone.0128186	http://dx.doi.org/10.1371/journal.pone.0128186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020928	Green Submitted, gold, Green Published			2022-12-27	WOS:000355187300086
J	Prabu, P; Rome, S; Sathishkumar, C; Aravind, S; Mahalingam, B; Shanthirani, CS; Gastebois, C; Villard, A; Mohan, V; Balasubramanyam, M				Prabu, Paramasivam; Rome, Sophie; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Gastebois, Caroline; Villard, Audrey; Mohan, Viswanathan; Balasubramanyam, Muthuswamy			Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; CELL FUNCTION; MICRORNAS; PLASMA; FAT; BRAIN; ASSOCIATIONS; PREVALENCE; MECHANISMS; BIOMARKERS	Several omics technologies are underway worldwide with an aim to unravel the pathophysiology of a complex phenotype such as type 2 diabetes mellitus (T2DM). While recent studies imply a clinically relevant and potential biomarker role of circulatory miRNAs in the etiology of T2DM, there is lack of data on this aspect in Indians-an ethnic population characterized to represent 'Asian Indian phenotype' known to be more prone to develop T2DM and cardiovascular disease than Europeans. We performed global serum miRNA profiling and the validation of candidate miRNAs by qRT-PCR in a cohort of subjects comprised of normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and patients with T2DM. Our study revealed 4 differentially expressed miRNAs (miR-128, miR-130b-3p, miR-374a5p, miR-423-5p) in subjects with IGT and T2DM patients compared to control subjects. They were positively or negatively correlated to cholesterol levels, HbA1C, HOMA-IR and fasting insulin. Interestingly, circulating level of miR-128 and miR-130b-3p were also altered in serum of diet-induced diabetic mice compared to control animals. Among the altered circulating miRNAs, miR-128 had never been described in previous studies/populations and appeared to be a ` New Lead' in Indians. It was positively correlated with cholesterol both in prediabetic subjects and in diet-induced diabetic mice, suggesting that its increased level might be associated with the development of dyslipedemia associated with T2DM. Our findings imply directionality towards biomarker potential of miRNAs in the prevention/diagnosis/treatment outcomes of diabetes.	[Prabu, Paramasivam; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Mohan, Viswanathan; Balasubramanyam, Muthuswamy] Madras Diabet Res Fdn, Madras 600086, Tamil Nadu, India; [Prabu, Paramasivam; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Mohan, Viswanathan; Balasubramanyam, Muthuswamy] WHO, Collaborating Ctr Noncommunicable Dis Prevent & C, Dr Mohans Diabet Special Ctr, Madras 600086, Tamil Nadu, India; [Prabu, Paramasivam; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Mohan, Viswanathan; Balasubramanyam, Muthuswamy] IDF Ctr Educ, Madras 600086, Tamil Nadu, India; [Rome, Sophie; Gastebois, Caroline; Villard, Audrey] Univ Lyon, Fac Med Lyon Sud, INSA, INRA 1397,IMSERM 1060,CarMeN Lab, F-69600 Oullins, France	Madras Diabetes Research Foundation; World Health Organization; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Balasubramanyam, M (corresponding author), Madras Diabet Res Fdn, Madras 600086, Tamil Nadu, India.	diasignal@gmail.com	Paramasivam, Prabu/AAT-4515-2020; Prabu, Paramasivam/V-8323-2018; Chandrakumar, Sathishkumar/AAM-3149-2020	Prabu, Paramasivam/0000-0002-8626-1601; Chandrakumar, Sathishkumar/0000-0003-2320-050X	Department of Biotechnology (DBT), Government of India; French Fondation pour la Recherche Medicale [FRM-20101220456]; French-Indian medical research cooperation program	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); French Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French-Indian medical research cooperation program	Authors acknowledge the financial support from the Department of Biotechnology (DBT), Government of India. This work was also supported by grants from the French Fondation pour la Recherche Medicale (FRM-20101220456) and is supported by the French-Indian medical research cooperation program between INSERM and ICMR. The authors thank the study participants, and the clinical assistants and administrative personnel at the Madras Diabetes Research Foundation, Chennai, India.	Adlakha YK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.46; Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Biessels GJ, 2014, DIABETES, V63, P2244, DOI 10.2337/db14-0348; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Eastwood SV, 2015, OBESITY, V23, P699, DOI 10.1002/oby.20997; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Guay C, 2012, DIABETES OBES METAB, V14, P12, DOI 10.1111/j.1463-1326.2012.01654.x; Gujral UP, 2013, ANN NY ACAD SCI, V1281, P51, DOI 10.1111/j.1749-6632.2012.06838.x; Jacovetti C, 2013, CELL CYCLE, V12, P197, DOI 10.4161/cc.23378; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Lin Q, 2011, NAT NEUROSCI, V14, P1115, DOI 10.1038/nn.2891; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Misra A, 2004, INT J OBESITY, V28, P1217, DOI 10.1038/sj.ijo.0802704; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MOHAN V, 1986, DIABETOLOGIA, V29, P235, DOI 10.1007/BF00454882; Mohan V, 2007, INDIAN J MED RES, V125, P217; Mohan V, 2013, DIABETES TECHNOL THE, V15, P315, DOI 10.1089/dia.2012.0259; Motohashi N, 2013, J CELL SCI, V126, P2678, DOI 10.1242/jcs.119966; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Plaisance V, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/618652; Regazzi R, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/217387; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; SHARP PS, 1987, HORM METAB RES, V19, P84, DOI 10.1055/s-2007-1011745; Sheinerman KS, 2013, AGING-US, V5, P925, DOI 10.18632/aging.100624; Staimez LR, 2013, DIABETES CARE, V36, P2772, DOI 10.2337/dc12-2290; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang YC, 2013, DIABETOLOGIA, V56, P2275, DOI 10.1007/s00125-013-2996-8; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhu HM, 2015, DIABETOLOGIA, V58, P900, DOI 10.1007/s00125-015-3510-2	45	44	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128372	10.1371/journal.pone.0128372	http://dx.doi.org/10.1371/journal.pone.0128372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020947	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300105
J	Bassi, E; Willis, SG; Passilongo, D; Mattioli, L; Apollonio, M				Bassi, Elena; Willis, Stephen G.; Passilongo, Daniela; Mattioli, Luca; Apollonio, Marco			Predicting the Spatial Distribution of Wolf (Canis lupus) Breeding Areas in a Mountainous Region of Central Italy	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; GRAY WOLF; LIVESTOCK DEPREDATION; HABITAT SUITABILITY; RENDEZVOUS SITES; RADIO-TRACKING; HOME RANGES; SAMPLE-SIZE; WILD PREY; WOLVES	Wolves (Canis lupus) in Italy represent a relict west European population. They are classified as vulnerable by IUCN, though have increased in number and expanded their range in recent decades. Here we use 17 years of monitoring data (from 1993 to 2010) collected in a mountainous region of central Italy (Arezzo, Tuscany) in an ecological niche-based model (MaxEnt) to characterize breeding sites (i.e. the areas where pups were raised) within home ranges, as detected from play-back responses. From a suite of variables related to topography, habitat and human disturbance we found that elevation and distance to protected areas were most important in explaining the locality of wolf responses. Rendezvous sites (family play-back response sites) typically occurred between 800 and 1200 m a.s.l., inside protected areas, and were usually located along mountain chains distant from human settlements and roads. In these areas human disturbance is low and the densities of ungulates are typically high. Over recent years, rendezvous sites have occurred closer to urban areas as the wolf population has continued to expand, despite the consequent human disturbance. This suggests that undisturbed landscapes may be reaching their carrying capacity for wolves. This, in turn, may lead to the potential for increased human-wolf interactions in future. Applying our model, both within and beyond the species' current range, we identify sites both within the current range and also further afield, that the species could occupy in future. Our work underlines the importance of the present protected areas network in facilitating the recolonisation by wolves. Our projections of suitability of sites for future establishment as the population continues to expand could inform planning to minimize future wolfhuman conflicts.	[Bassi, Elena; Passilongo, Daniela; Apollonio, Marco] Univ Sassari, Dept Sci Nat & Environm Resources, Sardinia, Italy; [Willis, Stephen G.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Mattioli, Luca] Prov Adm Arezzo, Arezzo, Tuscany, Italy	University of Sassari; Durham University	Willis, SG (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	s.g.willis@durham.ac.uk	Willis, Stephen G/F-8503-2015; Passilongo, Daniela/F-2282-2018	Willis, Stephen G/0000-0002-8656-5808; Passilongo, Daniela/0000-0003-0005-0852	Tuscany Region; Arezzo Province Administrations	Tuscany Region(Regione Toscana); Arezzo Province Administrations	Tuscany Region and Arezzo Province Administrations funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than the contribution of Luca Mattioli (co-author), who facilitated data access and was a local contact for the project.	Allen BL, 2014, ENVIRON SCI POLLUT R, V21, P2178, DOI 10.1007/s11356-013-2118-7; Apollonio M, 2004, BIOL CONSERV, V120, P249, DOI 10.1016/j.biocon.2004.02.021; BALLARD WB, 1983, CAN FIELD NAT, V97, P299; Bisi J, 2007, EUR J WILDLIFE RES, V53, P304, DOI 10.1007/s10344-007-0092-4; BOERTJE RD, 1992, CAN J ZOOL, V70, P2441, DOI 10.1139/z92-328; Boitani L., 2000, ACTION PLAN CONSERVA; Cagnolaro L, 1974, INCHIESTA DISTRIBUZI; Capitani C, 2004, MAMM BIOL, V69, P1, DOI 10.1078/1616-5047-112; Capitani C, 2006, ACTA THERIOL, V51, P395, DOI 10.1007/BF03195186; Carbyn L.N., 1988, WILD FURBEARER MANAG, P359; Ciucci P, 1997, J ZOOL, V243, P803, DOI 10.1111/j.1469-7998.1997.tb01977.x; CIUCCI P, 1992, J MAMMAL, V73, P899, DOI 10.2307/1382214; Corsi F, 1999, CONSERV BIOL, V13, P150, DOI 10.1046/j.1523-1739.1999.97269.x; Cowley MJR, 2000, J APPL ECOL, V37, P60, DOI 10.1046/j.1365-2664.2000.00526.x; Cresswell B., PRACTICAL RADIO TRAC; Davis ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047894; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Fritts Steven H., 2003, P289; FULLER TK, 1989, AM MIDL NAT, V121, P184, DOI 10.2307/2425669; Fuller Todd K., 2003, P161; Gazzola A, 2007, ITAL J ZOOL, V74, P297, DOI 10.1080/11250000701447074; Gazzola A, 2002, ITAL J ZOOL, V69, P157, DOI 10.1080/11250000209356454; Genovesi P., 2002, QUADERNI CONSERVAZIO, V13; Ghering TM, 1995, THESIS U WISCONSIN; Harrington F.H., 1982, P81; HARRINGTON FH, 1982, J WILDLIFE MANAGE, V46, P686, DOI 10.2307/3808560; Harrington Fred H., 2003, P66; HEARD DC, 1992, CAN J ZOOL, V70, P1504, DOI 10.1139/z92-207; HEEZEN KL, 1967, J WILDLIFE MANAGE, V31, P124, DOI 10.2307/3798367; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jedrzejewska B, 1995, ECOLOGICAL STUDIES, V135; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Jedrzejewski W, 2004, DIVERS DISTRIB, V10, P225, DOI 10.1111/j.1366-9516.2004.00073.x; JOSLIN PWB, 1967, AM ZOOL, V7, P279; Kohn BE, 2000, IMPACT US HIGHWAY 53; Kusak J, 2005, EUR J WILDLIFE RES, V51, P254, DOI 10.1007/s10344-005-0111-2; Lucchini V, 2002, MOL ECOL, V11, P857, DOI 10.1046/j.1365-294X.2002.01489.x; Macdonald D.W., 2004, CANIDS FOXES WOLVES; Marucco F, 2010, J APPL ECOL, V47, P789, DOI 10.1111/j.1365-2664.2010.01831.x; Massolo A, 1998, ECOGRAPHY, V21, P97, DOI 10.1111/j.1600-0587.1998.tb00663.x; Mattioli L, 2004, J ZOOL, V264, P249, DOI 10.1017/S095283690400576X; Mattioli L, 2011, EUR J WILDLIFE RES, V57, P909, DOI 10.1007/s10344-011-0503-4; Mech D., 2003, WOLVES BEHAV ECOLOGY; MECH LD, 1995, CONSERV BIOL, V9, P270, DOI 10.1046/j.1523-1739.1995.9020270.x; Mech LD., 1998, WOLVES DENALI; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Merrill SB, 2000, CAN FIELD NAT, V114, P312; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Mladenoff DJ, 1998, J WILDLIFE MANAGE, V62, P1, DOI 10.2307/3802259; MLADENOFF DJ, 1995, CONSERV BIOL, V9, P279, DOI 10.1046/j.1523-1739.1995.9020279.x; Monterroso P, 2009, J ZOOL, V279, P27, DOI 10.1111/j.1469-7998.2009.00585.x; Nores C, 2008, WILDLIFE BIOL, V14, P44, DOI 10.2981/0909-6396(2008)14[44:WBSSMB]2.0.CO;2; Norris DR, 2002, CAN J ZOOL, V80, P866, DOI [10.1139/z02-067, 10.1139/Z02-067]; Okarma H, 1998, J MAMMAL, V79, P842, DOI 10.2307/1383092; OKARMA H, 1995, ACTA THERIOL, V40, P197, DOI 10.4098/AT.arch.95-20; Ordiz A, 2014, BIOL CONSERV, V173, P1, DOI 10.1016/j.biocon.2014.03.006; Packard Jane M., 2003, P35; Passilongo D, 2010, BIOACOUSTICS, V19, P159, DOI 10.1080/09524622.2010.9753622; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peterson Rolf O., 2003, P104; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Promberger C., 1993, WOLVES EUROPE STATUS; Renner IW, 2013, BIOMETRICS, V69, P274, DOI 10.1111/j.1541-0420.2012.01824.x; SALVADOR A, 1987, MAMMALIA, V51, P45, DOI 10.1515/mamm.1987.51.1.45; Scandura M, 2001, MAMM BIOL, V66, P321; Sidorovich VE, 2003, WILDLIFE BIOL, V9, P103, DOI 10.2981/wlb.2003.032; Theuerkauf J, 2003, J WILDLIFE MANAGE, V67, P706, DOI 10.2307/3802677; Theuerkauf J, 2003, CAN J ZOOL, V81, P163, DOI 10.1139/Z02-190; Thiel RP, 1998, CAN FIELD NAT, V112, P340; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Trapp JR, 2008, CAN FIELD NAT, V122, P49, DOI 10.22621/cfn.v122i1.543; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Unger DE, 1999, THESIS U WISCONSIN; VANDYKE FG, 1986, J WILDLIFE MANAGE, V50, P95; VILA C, 1995, ECOLOGY CONSERVATION, P335; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; ZIMEN E, 1975, Zeitschrift fuer Saeugetierkunde, V40, P102	82	33	34	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0124698	10.1371/journal.pone.0124698	http://dx.doi.org/10.1371/journal.pone.0124698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035174	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000355699100004
J	Hao, J; Zhang, YY; Wang, XR; Yan, H; Liu, EW; Gao, XM				Hao, Jia; Zhang, Yingyue; Wang, Xingrui; Yan, Huo; Liu, Erwei; Gao, Xiumei			Interaction between the Natural Components in Danhong Injection (DHI) with Serum Albumin (SA) and the Influence of the Coexisting Multi-Components on the SaB-BSA Binding System: Fluorescence and Molecular Docking Studies	PLOS ONE			English	Article							SPECTROSCOPIC ANALYSIS; BOVINE; CONSTITUENTS; PROTEINS; HEMOGLOBIN; SIMULATION; QUALITY; DRUGS; ACID	Danhong injection (DHI) is a widely used Chinese Materia Medica standardized product for the clinical treatment of ischemic encephalopathy and coronary heart disease. The bindings of eight natural components in DHI between bovine serum albumin (BSA) were studied by fluorescence spectroscopy technology and molecular docking. According to the results, the quenching process of salvianolic acid B and hydroxysafflor yellow A was a static quenching procedure through the analysis of quenching data by the Stern-Volmer equation, the modified Stern-Volmer equation, and the modified Scatchard equation. Meanwhile, syringin (Syr) enhanced the fluorescence of BSA, and the data were analyzed using the Lineweaver-Burk equation. Molecular docking suggested that all of these natural components bind to serum albumin at the site I location. Further competitive experiments of SaB confirmed the result of molecular docking studies duo to the displacement of warfarin by SaB. Base on these studies, we selected SaB as a research target because it presented the strongest binding ability to BSA and investigated the influence of the multi-components coexisting in DHI on the interaction between the components of the SaB-BSA binding system. The participation of these natural components in DHI affected the interaction between the components of the SaB-BSA system. Therefore, when DHI is used in mammals, SaB is released from serum albumin more quickly than it is used alone. This work would provide a new experiment basis for revealing the scientific principle of compatibility for Traditional Chinese Medicine.	[Hao, Jia; Zhang, Yingyue; Gao, Xiumei] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 300193, Peoples R China; [Hao, Jia; Wang, Xingrui; Yan, Huo; Liu, Erwei] Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Phytochem & Pharmaceut Anal, Tianjin 300193, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Liu, EW (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin Key Lab Phytochem & Pharmaceut Anal, Tianjin 300193, Peoples R China.	hastjtcm@126.com			National Key Basic Research Program of China (973 Program); Important Drug Development of MOST, China [2012ZX09304007]; Natural Science Foundation of China [NSFC81125024]; National program for Innovative Research Team in Universities of Tianjin	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Important Drug Development of MOST, China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National program for Innovative Research Team in Universities of Tianjin	The authors acknowledge the support of National Key Basic Research Program of China (973 Program), the Important Drug Development of MOST, China (2012ZX09304007), the Natural Science Foundation of China (NSFC81125024), and the National program for Innovative Research Team in Universities of Tianjin.	Agudelo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043814; Bardhan M, 2012, J PHOTOCH PHOTOBIO B, V106, P113, DOI 10.1016/j.jphotobiol.2011.10.014; BHATTACHARYYA J, 1994, BIOCHEM PHARMACOL, V47, P2049, DOI 10.1016/0006-2952(94)90080-9; Chang YX, 2008, J CHROMATOGR A, V1208, P76, DOI 10.1016/j.chroma.2008.08.054; Chang YX, 2009, CHROMATOGRAPHIA, V69, P319, DOI 10.1365/s10337-008-0876-z; Charbonneau DM, 2010, J PHYS CHEM B, V114, P1148, DOI 10.1021/jp910077h; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Chen TT, 2011, SPECTROCHIM ACTA A, V81, P645, DOI 10.1016/j.saa.2011.06.068; Duman O, 2013, J FLUORESC, V23, P659, DOI 10.1007/s10895-013-1177-y; Fan L, 2009, J CHROMATOGR A, V1216, P2063, DOI 10.1016/j.chroma.2008.03.046; Fani N, 2013, SPECTROCHIM ACTA A, V103, P11, DOI 10.1016/j.saa.2012.11.003; Gao WH, 2010, J MOL STRUCT, V983, P133, DOI 10.1016/j.molstruc.2010.08.042; Ge YS, 2014, SPECTROCHIM ACTA A, V124, P265, DOI 10.1016/j.saa.2014.01.009; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gupta BS, 2013, PROCESS BIOCHEM, V48, P1686, DOI 10.1016/j.procbio.2013.08.018; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; He Y, 2008, J FLUORESC, V18, P433, DOI 10.1007/s10895-007-0283-0; He Y, 2012, J ETHNOPHARMACOL, V144, P387, DOI 10.1016/j.jep.2012.09.025; Hetenyi C, 2006, FEBS LETT, V580, P1447, DOI 10.1016/j.febslet.2006.01.074; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Huang JC, 2009, BIOSENS BIOELECTRON, V25, P320, DOI 10.1016/j.bios.2009.07.012; Kong WJ, 2011, J CHROMATOGR B, V879, P3565, DOI 10.1016/j.jchromb.2011.09.045; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, DOI DOI 10.1007/978-0-387-46312-4; LAKOWICZ JR, 1980, BIOPHYS J, V32, P591, DOI 10.1016/S0006-3495(80)84992-7; Li YS, 2013, J PHOTOCH PHOTOBIO B, V128, P12, DOI 10.1016/j.jphotobiol.2013.07.027; Liao ZX, 2014, SPECTROCHIM ACTA A, V129, P314, DOI 10.1016/j.saa.2014.03.057; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Mahesha HG, 2006, FEBS J, V273, P451, DOI 10.1111/j.1742-4658.2005.05071.x; Mehranfar F, 2013, J PHOTOCH PHOTOBIO B, V127, P100, DOI 10.1016/j.jphotobiol.2013.07.019; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MULLER WE, 1979, PHARMACOLOGY, V19, P59, DOI 10.1159/000137289; Naik KM, 2013, J LUMIN, V143, P484, DOI 10.1016/j.jlumin.2013.05.013; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sekula B, 2013, INT J BIOL MACROMOL, V60, P316, DOI 10.1016/j.ijbiomac.2013.06.004; Singh RB, 2009, PHOTOCH PHOTOBIO SCI, V8, P101, DOI 10.1039/b814050b; Skrt M, 2012, FOOD CHEM, V135, P2418, DOI 10.1016/j.foodchem.2012.06.114; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Sun M, 2009, PHYTOMEDICINE, V16, P683, DOI 10.1016/j.phymed.2009.03.020; Tian FF, 2010, J PHYS CHEM B, V114, P14842, DOI 10.1021/jp105766n; Tian J, 2011, SPECTROSC-BIOMED APP, V26, P195, DOI 10.1155/2011/932060; Uto T, 2012, BIOCHEM BIOPH RES CO, V417, P473, DOI 10.1016/j.bbrc.2011.11.143; Vlasova IM, 2012, RUSS J PHYS CHEM A+, V86, P509, DOI 10.1134/S0036024412030338; Vuignier K, 2010, ANAL BIOANAL CHEM, V398, P53, DOI 10.1007/s00216-010-3737-1; WAGGONER AS, 1971, BIOCHEMISTRY-US, V10, P3250; Yu XY, 2014, SPECTROCHIM ACTA A, V133, P372, DOI 10.1016/j.saa.2014.05.085	46	6	7	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128919	10.1371/journal.pone.0128919	http://dx.doi.org/10.1371/journal.pone.0128919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035712	Green Submitted, gold, Green Published			2022-12-27	WOS:000355699100056
J	Lv, QZ; Guo, KK; Xu, H; Wang, T; Zhang, YM				Lv, Qizhuang; Guo, Kangkang; Xu, Han; Wang, Tao; Zhang, Yanming			Identification of Putative ORF5 Protein of Porcine Circovirus Type 2 and Functional Analysis of GFP-Fused ORF5 Protein	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; ENDOPLASMIC-RETICULUM STRESS; COLOSTRUM-DEPRIVED PIGLETS; VIRUS-INDUCED APOPTOSIS; CYCLIN-A EXPRESSION; FACTOR-KAPPA-B; CELL-CYCLE; S-PHASE; ALVEOLAR MACROPHAGES; MAMMALIAN-CELLS	Porcine circovirus type 2 (PCV2) is the essential infectious agent responsible for causing porcine circovirus-associated diseases in pigs. To date, eleven RNAs and five viral proteins of PCV2 have been detected. Here, we identified a novel viral gene within the PCV2 genome, termed ORF5, that exists at both the transcriptional and translational level during productive infection of PCV2 in porcine alveolar macrophages 3D4/2 (PAMs). Northern blot analysis was used to demonstrate that the ORF5 gene measures 180 bp in length and overlaps completely with ORF1 when read in the same direction. Site-directed mutagenesis was used to show that the ORF5 protein is not essential for PCV2 replication. To investigate the biological functions of the novel protein, we constructed a recombinant eukaryotic expression plasmid capable of expressing PCV2 ORF5. The results show that the GFP-tagged PCV2 ORF5 protein localizes to the endoplasmic reticulum (ER), is degraded via the proteasome, inhibits PAM growth and prolongs the S-phase of the cell cycle. Further studies show that the GFP-tagged PCV2 ORF5 protein induces ER stress and activates NF-kappa B, which was further confirmed by a significant upregulation in IL-6, IL-8 and COX-2 expression. In addition, five cellular proteins (GPNMB, CYP1A1, YWHAB, ZNF511 and SRSF3) were found to interact with ORF5 via yeast two-hybrid assay. These findings provide novel information on the identification and functional analysis of the PCV2 ORF5 protein and are likely to be of benefit in elucidating the molecular mechanisms of PCV2 pathogenicity. However, additional experiments are needed to validate the expression and function of the ORF5 protein during PCV2 infection in vitro before any definitive conclusion can be drawn.	[Lv, Qizhuang; Guo, Kangkang; Xu, Han; Wang, Tao; Zhang, Yanming] Northwest A&F Univ, Coll Vet Med, Lab Vet Publ Hlth & Food Safety, Yangling 712100, Peoples R China	Northwest A&F University - China	Zhang, YM (corresponding author), Northwest A&F Univ, Coll Vet Med, Lab Vet Publ Hlth & Food Safety, Yangling 712100, Peoples R China.	zhangym@nwsuaf.edu.cn			Shaanxi Key Agricultural Science and Technology Popularization [ZDKJ-2014-33]; research fund for Shaanxi Science and Technology Innovative Project [2014KTCQ02-02]; National Natural Science Foundation of China [31472210]	Shaanxi Key Agricultural Science and Technology Popularization; research fund for Shaanxi Science and Technology Innovative Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the grant from Shaanxi Key Agricultural Science and Technology Popularization (Grant number ZDKJ-2014-33) the research fund for Shaanxi Science and Technology Innovative Project (Grant number 2014KTCQ02-02) and the National Natural Science Foundation of China (Grant number 31472210).	Allan GM, 2004, VET MICROBIOL, V98, P165, DOI 10.1016/j.vetmic.2003.10.009; Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; ALLAN GM, 1995, VET MICROBIOL, V44, P49, DOI 10.1016/0378-1135(94)00136-K; Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Bolin SR, 2001, J VET DIAGN INVEST, V13, P185, DOI 10.1177/104063870101300301; Chae C, 2004, VET J, V168, P41, DOI 10.1016/j.tvjl.2003.09.018; Chae C, 2005, VET J, V169, P326, DOI 10.1016/j.tvjl.2004.01.012; Chae C, 2012, VIRUS RES, V164, P107, DOI 10.1016/j.virusres.2011.10.013; Chang HW, 2006, VET MICROBIOL, V115, P311, DOI 10.1016/j.vetmic.2006.03.010; Cheung AK, 2003, VIROLOGY, V313, P452, DOI 10.1016/S0042-6822(03)00373-8; Cheung AK, 2003, VIROLOGY, V310, P41, DOI 10.1016/S0042-6822(03)00096-5; Cheung AK, 2003, VIROLOGY, V305, P168, DOI 10.1006/viro.2002.1733; Choi C, 2000, J COMP PATHOL, V123, P302, DOI 10.1053/jcpa.2000.0421; Darwich L, 2004, ARCH VIROL, V149, P857, DOI 10.1007/s00705-003-0280-9; Finsterbusch T, 2009, VIROLOGY, V386, P122, DOI 10.1016/j.virol.2008.12.039; Gao ZZ, 2014, VIRUS RES, V183, P56, DOI 10.1016/j.virusres.2014.01.024; Gillespie J, 2009, J VET INTERN MED, V23, P1151, DOI 10.1111/j.1939-1676.2009.0389.x; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Guo KK, 2013, J ANIM VET ADV, V12, P234; Guo LJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-273; Hamel AL, 1998, J VIROL, V72, P5262, DOI 10.1128/JVI.72.6.5262-5267.1998; Haqshenas G, 2013, VIRUS RES, V176, P211, DOI 10.1016/j.virusres.2013.06.009; He JL, 2013, J VIROL, V87, P1420, DOI 10.1128/JVI.01443-12; Karuppannan AK, 2009, VIROLOGY, V383, P338, DOI 10.1016/j.virol.2008.10.024; Kennedy S, 2000, J COMP PATHOL, V122, P9, DOI 10.1053/jcpa.1999.0337; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Liu J, 2005, J VIROL, V79, P8262, DOI 10.1128/JVI.79.13.8262-8274.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mankertz A, 2003, J VIROL, V77, P9885, DOI 10.1128/JVI.77.18.9885-9893.2003; Mankertz A, 1998, J GEN VIROL, V79, P381, DOI 10.1099/0022-1317-79-2-381; McGuire K, 2005, VET IMMUNOL IMMUNOP, V105, P259, DOI 10.1016/j.vetimm.2005.02.001; Meehan BM, 1997, J GEN VIROL, V78, P221, DOI 10.1099/0022-1317-78-1-221; Meng XJ, 2013, ANNU REV ANIM BIOSCI, V1, P43, DOI 10.1146/annurev-animal-031412-103720; Nawagitgul P, 2000, J GEN VIROL, V81, P2281, DOI 10.1099/0022-1317-81-9-2281; Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601; Ramamoorthy Sheela, 2009, Animal Health Research Reviews, V10, P1, DOI 10.1017/S1466252308001461; REED L. J., 1938, AMER JOUR HYG, V27, P493; Segales J, 2004, VET MICROBIOL, V98, P137, DOI 10.1016/j.vetmic.2003.10.006; Segales J, 2002, VET QUART, V24, P109, DOI 10.1080/01652176.2002.9695132; Segales J, 1997, VET REC, V141, P600; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Tang QH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-4; Tang QH, 2013, ARCH VIROL, V158, P2553, DOI 10.1007/s00705-013-1785-5; Tang ZhiHui, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P7; Tato CM, 2002, INFECT IMMUN, V70, P3311, DOI 10.1128/IAI.70.7.3311-3317.2002; TISCHER I, 1987, ARCH VIROL, V96, P39, DOI 10.1007/BF01310989; TISCHER I, 1986, ARCH VIROL, V91, P271, DOI 10.1007/BF01314286; Wei L, 2008, VIROLOGY, V378, P177, DOI 10.1016/j.virol.2008.05.013; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Zhang HL, 2013, ARCH VIROL, V158, P2285, DOI 10.1007/s00705-013-1750-3; Zhou JY, 2006, VET RES COMMUN, V30, P205, DOI 10.1007/s11259-006-3203-x	54	35	39	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0127859	10.1371/journal.pone.0127859	http://dx.doi.org/10.1371/journal.pone.0127859			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035722	Green Published, Green Submitted, gold			2022-12-27	WOS:000355699100024
J	Avlas, O; Bragg, A; Fuks, A; Nicholson, JD; Farkash, A; Porat, E; Aravot, D; Levy-Drummer, RS; Cohen, C; Shainberg, A; Arad, M; Hochhauser, E				Avlas, Orna; Bragg, Arieh; Fuks, Avi; Nicholson, James D.; Farkash, Ariel; Porat, Eyal; Aravot, Dan; Levy-Drummer, Rachel S.; Cohen, Cyrille; Shainberg, Asher; Arad, Michael; Hochhauser, Edith			TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass Surgery	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; UP-REGULATION; ISCHEMIA; TOLL-LIKE-RECEPTOR-4; INFLAMMATION; BIOMARKERS; MICRORNAS; INJURY; SHOCK	Introduction Toll-like receptor 4 (TLR4) is an innate immune receptor expressed in immune cells and the heart. Activation of the immune system following myocardial ischemia causes the release of proinflammatory mediators that may negatively influence heart function. Aim The aim of this study is to determine whether TLR4 is activated in peripheral monocytes and heart tissue taken from patients with varying degrees of myocardial dysfunction caused by coronary artery diseases and scheduled for coronary artery bypass graft (CABG) surgery before 12 months following operation. Methods and Results Patients (n = 44) undergoing CABG surgery having left ventricular ejection fraction <= 45% ('reduced EF', n = 20) were compared to patients with preserved EF >45% ('preserved EF' group, n = 24). 'Reduced EF' patients exhibited increased TLR4 expression in monocytes (2.78 +/- 0.49 vs. 1.76 +/- 0.07 rMFI, p = 0.03). Plasma levels of C-reactive protein, microRNA miR-320a, brain natriuretic peptide (pro BNP) and NADPH oxidase (NOX4) were also significantly different between the ` preserved EF' and 'reduced EF'groups. Elevated TLR4 gene expression levels in the right auricle correlated with those of EF (p<0.008), NOX4 (p<0.008) and miR320, (p<0.04). In contrast, no differences were observed in peripheral monocyte TLR2 expression. After CABG surgery, monocyte TLR4 expression decreased in all patients, reaching statistical significance in the ` reduced EF' group. Conclusion TLR4 is activated in peripheral monocytes and heart tissue obtained from patients with ischemic heart disease and reduced left ventricular function. Coronary revascularization decreases TLR4 expression. We therefore propose that TLR4 plays a pathogenic role and may serve as an additional marker of ischemic myocardial dysfunction.	[Avlas, Orna; Bragg, Arieh; Levy-Drummer, Rachel S.; Cohen, Cyrille; Shainberg, Asher] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Fuks, Avi; Nicholson, James D.; Farkash, Ariel; Porat, Eyal; Aravot, Dan; Hochhauser, Edith] Tel Aviv Univ, Rabin Med Ctr, Felsenstein Med Res Ctr, Cardiac Res Lab, Petah Tiqwa, Israel; [Fuks, Avi; Nicholson, James D.; Farkash, Ariel; Porat, Eyal; Aravot, Dan; Hochhauser, Edith] Tel Aviv Univ, Rabin Med Ctr, Felsenstein Med Res Ctr, Dept Cardiothorac Surg, Petah Tiqwa, Israel; [Arad, Michael] Tel Aviv Univ, Sheba Med Ctr, Heart Failure Serv & Leviev Heart Inst, IL-69978 Tel Aviv, Israel; [Arad, Michael] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Bar Ilan University; Rabin Medical Center; Tel Aviv University; Rabin Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Hochhauser, E (corresponding author), Tel Aviv Univ, Rabin Med Ctr, Felsenstein Med Res Ctr, Cardiac Res Lab, Petah Tiqwa, Israel.	hochhaus@post.tau.ac.il			Chief Scientist's Office of the Israeli Ministry of Health	Chief Scientist's Office of the Israeli Ministry of Health	This work was partially supported by The Chief Scientist's Office of the Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Avlas O, 2011, ANTIOXID REDOX SIGN, V15, P1895, DOI 10.1089/ars.2010.3728; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Ben Ari Z, 2012, CELL PHYSIOL BIOCHEM, V29, P41, DOI 10.1159/000337585; Ben Mkaddem S, 2010, CELL DEATH DIFFER, V17, P1474, DOI 10.1038/cdd.2010.26; Birks EJ, 2004, J HEART LUNG TRANSPL, V23, P228, DOI 10.1016/S1053-2498(03)00106-2; Brouwers C, 2013, BIOL PSYCHOL, V92, P220, DOI 10.1016/j.biopsycho.2012.10.002; Cleland JGF, 2003, EUR J HEART FAIL, V5, P295, DOI 10.1016/S1388-9842(03)00056-4; Devaux B, 1997, EUR HEART J, V18, P470; Dixon DL, 2011, CYTOKINE, V56, P593, DOI 10.1016/j.cyto.2011.08.029; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Hochhauser E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073041; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Kolek MJ, 2004, AM HEART J, V148, P1034, DOI 10.1016/j.ahj.2004.05.049; Lepoutre T, 2013, CLIN LAB, V59, P831, DOI 10.7754/Clin.Lab.2012.120418; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Perez AV, 2010, INT J CARDIOL, V141, P39, DOI 10.1016/j.ijcard.2008.11.146; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Satoh M, 2006, INT J CARDIOL, V109, P226, DOI 10.1016/j.ijcard.2005.06.023; Selejan S, 2012, EUR HEART J, V33, P1085, DOI 10.1093/eurheartj/ehr377; Shao L, 2014, HEART VESSELS, V29, P690, DOI 10.1007/s00380-013-0421-3; Suzuki Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00896; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; van de Vrie M, 2011, CARDIOVASC DRUG THER, V25, P161, DOI 10.1007/s10557-011-6291-y; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011	37	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0120175	10.1371/journal.pone.0120175	http://dx.doi.org/10.1371/journal.pone.0120175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030867	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900006
J	Fusco, G; Lesniewska, M; Congiu, L; Bertorelle, G				Fusco, Giuseppe; Lesniewska, Malgorzata; Congiu, Leonardo; Bertorelle, Giorgio			Population Genetic Structure of a Centipede Species with High Levels of Developmental Instability	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; SEGMENTATION; GEOPHILOMORPHA; MITOCHONDRIAL; ANOMALIES; ECOLOGY	European populations of the geophilomorph centipede Haplophilus subterraneus show a high proportion of individuals with morphological anomalies, suggesting high levels of developmental instability. The broad geographic distribution of this phenomenon seems to exclude local environmental causes, but the source of instability is still to be identified. The goal of the present study was to collect quantitative data on the occurrence of phenodeviants in different populations, along with data on the patterns of genetic variation within and between populations, in order to investigate possible association between developmental instability and genetic features. In a sample of 11 populations of H. subterraneus, distributed in western and central Europe, we looked for phenodeviants, in particular with respect to trunk morphology, and studied genetic variation through the genotyping of microsatellite loci. Overall, no support was found to the idea that developmental instability in H. subterraneus is related to a specific patterns of genetic variation, including inbreeding estimates. We identified a major genetic partition that subdivides French populations from the others, and a low divergence among northwestern areas, which are possibly related to the post-glacial recolonization from southern refugia and/or to recent anthropogenic soil displacements. A weak correlation between individual number of leg bearing segments and the occurrence of trunk anomalies seems to support a trade-off between these two developmental traits. These results, complemented by preliminary data on developmental stability in two related species, suggest that the phenomenon has not a simple taxonomic distribution, while it exhibits an apparent localization in central and eastern Europe.	[Fusco, Giuseppe; Congiu, Leonardo] Univ Padua, Dept Biol, Padua, Italy; [Lesniewska, Malgorzata] Adam Mickiewicz Univ, Dept Gen Zool, Poznan, Poland; [Bertorelle, Giorgio] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	University of Padua; Adam Mickiewicz University; University of Ferrara	Congiu, L (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	leonardo.congiu@unipd.it	Bertorelle, Giorgio/AAE-9078-2022	CONGIU, LEONARDO/0000-0002-9293-9837; Bertorelle, Giorgio/0000-0002-2498-2702; Lesniewska, Malgorzata/0000-0001-9526-7389; FUSCO, GIUSEPPE/0000-0002-4690-6049	Italian Ministry of Education, University and Research (MIUR) [60A06-2190/12]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by a grant (60A06-2190/12) from the Italian Ministry of Education, University and Research (MIUR) to GF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata K, 2011, MOL ECOL RESOUR, V11, P586, DOI 10.1111/j.1755-0998.2011.03004.x; Barber A.D., 1988, PROVISIONAL ATLAS CE; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Belkhir K, 2004, GENETIX 4 04 LOGICIE; Berto D, 1997, ENTOMOL SCAND, P61; Bonato L, 2014, CLADISTICS, V30, P485, DOI 10.1111/cla.12060; Brena C, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0058-9; Brena C, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-112; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Edgecombe Gregory D., 2011, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fusco G, 2005, EVOL DEV, V7, P608, DOI 10.1111/j.1525-142X.2005.05064.x; Fusco Giuseppe, 2013, P197; Fusco Giuseppe, 2000, Fragmenta Faunistica (Warsaw), V43, P73; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Graham John H., 2003, P35; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Homburg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061185; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Kuznetsova A., 2014, R PACKAGE VERSION 2; Lesniewska M., 2012, MORPHOLOGICAL ANOMA; Lesniewska Malgorzata, 2009, Soil Organisms, V81, P347; Lesniewska M, 2009, ARTHROPOD STRUCT DEV, V38, P417, DOI 10.1016/j.asd.2009.05.001; Lindner E. Norman, 2007, Schubartiana, V2, P49; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Maruzzo D, 2005, CRUSTACEAN ISS, V16, P215, DOI 10.1201/9781420037548.ch9; Maruzzo Diego, 2013, P149; Minelli A, 2004, TRENDS ECOL EVOL, V19, P423, DOI 10.1016/j.tree.2004.06.007; Moller AP, 1997, ASYMMETRY DEV STABIL; Nijhout H. F., 2003, P3; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; Polak M., 2003, CAUSES CONSEQUENCES; Pritchard JK, 2000, GENETICS, V155, P945; Ruedi M, 2003, MOL ECOL, V12, P1527, DOI 10.1046/j.1365-294X.2003.01828.x; Savriama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-280; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vilaca ST, 2014, J BIOGEOGR, V41, P987, DOI 10.1111/jbi.12268; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x	42	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126245	10.1371/journal.pone.0126245	http://dx.doi.org/10.1371/journal.pone.0126245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029915	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900024
J	Hsieh, CL; Lin, CH; Chen, KC; Peng, CC; Peng, RY				Hsieh, Chiu Lan; Lin, Chien-Hong; Chen, Kuan Chou; Peng, Chiung-Chi; Peng, Robert Y.			The Teratogenicity and the Action Mechanism of Gallic Acid Relating with Brain and Cervical Muscles	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MATRIX METALLOPROTEINASE-2; CELL-DEATH; ANTIOXIDANT; INHIBITION; RADICALS; GALLATE; POLYPHENOLS; ACTIVATION; EXPRESSION	Gallic acid (3,4,5-trihydroxybenzoic acid) (GA) and other flavanoids are extensively used in nutraceuticals because of their antioxidant and antiinflammatory properties. While examining whether GA is effective in alleviating valproic-acid-induced teratogenesis in a chicken embryo model (CEM), we observed embryo hemorrhage and liposis in the musculi longissimus cervicis. We conducted this study to determine whether GA is inherently teratogenic and the extent to which the risk can be transferred to fetuses. A CEM was used to administer GA at 2, 6, 10, and 14 mu M. GA at 2 mu M did not exhibit cytotoxicity. At 6, 10, and 14 mu M, GA caused severe decreases in body and liver weights, causing -5.6%, -21.3%, and -27.5% body weights and 4.0, 3.8, and 3.2-g, liver weights, respectively, in day-1 chicks. The optimal alive birth rate (or damaging rate) reached 33.3%, 39.4%, and 29.2% at 6, 10, and 14 mu M GA, respectively. The damaged tissue was primarily cervical muscle (musculi longissimus cervicis), as evidenced by liposis, Zenker's necrosis, and hemolysis. The erythrocyte, hemoglobin, eosinophil, lymphocyte, and monocyte counts were severely reduced and PPAR-alpha was downregulated, whereas the Ras/Raf/JAK/STAT pathway was upregulated. The GA dose required to induce teratogenesis was >= 6 mu M (1.02 mg/kg), which can be easily consumed by pregnant women in typical teas such as Chinese Pu-'Er and Chinese black teas, indicating a potential risk to human fetuses. GA at doses >= 1.02 mg/kg of body weight potentially causes characteristic cerebral hemolysis and liposis in the musculi longissimus cervicis. The mechanism of action of GA is multidisciplinary: The liposis can be ascribed to downregulation of PPAR-alpha; the erythrocyte hemolysis can be attributed to its unique autooxidative and prooxidant behavior and the inhibition of carbonic anhydrase; and the proliferation and differentiation deficits can be attributed to the upregulation of the Ras/ Raf/JAK/STAT pathway.	[Hsieh, Chiu Lan; Lin, Chien-Hong] Changhua Univ Educ, Grad Inst Biotechnol, Changhua, Taiwan; [Chen, Kuan Chou] Taipei Med Univ, Coll Med, Sch Med, Dept Urol, Taipei, Taiwan; [Chen, Kuan Chou] Taipei Med Univ, Shuang Ho Hosp, Dept Urol, New Taipei City, Taiwan; [Peng, Chiung-Chi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Peng, Robert Y.] Hungkuang Univ, Biotechnol Res Inst, Taichung, Taiwan	National Changhua University of Education; Taipei Medical University; Taipei Medical University; Taipei Medical University; Hungkuang University	Chen, KC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Urol, Taipei, Taiwan.	kc.chen416@msa.hinet.net; misspeng@ms2.hinet.net		Lin, Chein Hong/0000-0001-5135-0340	National Science Council of Taiwan [102-2313-B-018 -001 -MY3, 102-2320-B-038-025]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The authors are grateful for the financial support of the National Science Council of Taiwan (102-2313-B-018 -001 -MY3 and 102-2320-B-038-025). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2006, MOL CANCER THER, V5, P3294, DOI 10.1158/1535-7163.MCT-06-0483; AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; Alanko J, 1999, FREE RADICAL BIO MED, V26, P193, DOI 10.1016/S0891-5849(98)00179-8; ARUOMA OI, 1993, J AGR FOOD CHEM, V41, P1880, DOI 10.1021/jf00035a014; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Boots AW, 2007, TOXICOL APPL PHARM, V222, P89, DOI 10.1016/j.taap.2007.04.004; Bors W, 2000, ARCH BIOCHEM BIOPHYS, V374, P347, DOI 10.1006/abbi.1999.1606; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Cree MG, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-9; de Mejia EG, 2006, FOOD CHEM TOXICOL, V44, P1191, DOI 10.1016/j.fct.2006.01.015; DESESSO JM, 1981, TERATOLOGY, V24, P19, DOI 10.1002/tera.1420240104; DESESSO JM, 1990, REPROD TOXICOL, V4, P145, DOI 10.1016/0890-6238(90)90009-K; Eslami AC, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-15; Fazary AE, 2009, J CHEM ENG DATA, V54, P35, DOI 10.1021/je800441u; Friedman M, 2000, J AGR FOOD CHEM, V48, P2101, DOI 10.1021/jf990489j; Gil-Longo J, 2010, J NUTR BIOCHEM, V21, P304, DOI 10.1016/j.jnutbio.2009.01.003; Haber F, 1932, NATURWISSENSCHAFTEN, V20, P948, DOI 10.1007/BF01504715; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Ho CC, 2009, IN VIVO, V23, P409; Hsieh CL, 2012, TOXICOLOGY, V291, P32, DOI 10.1016/j.tox.2011.10.015; Hsieh CL, 2010, J AGR FOOD CHEM, V58, P9273, DOI 10.1021/jf101580j; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kami K, 2000, J HISTOCHEM CYTOCHEM, V48, P1203, DOI 10.1177/002215540004800904; Kang MK, 2009, ANN NY ACAD SCI, V1171; Ko CH, 2006, INT J MOL MED, V18, P987; Kondo K, 1999, FREE RADICAL BIO MED, V27, P855, DOI 10.1016/S0891-5849(99)00133-1; Labieniec M, 2006, CELL BIOL INT, V30, P761, DOI 10.1016/j.cellbi.2006.05.013; Lee KW, 2005, J AGR FOOD CHEM, V53, P1990, DOI 10.1021/jf0486040; Lin JK, 1998, J AGR FOOD CHEM, V46, P3635, DOI 10.1021/jf980223x; Liu KC, 2011, ONCOL REP, V26, P177, DOI 10.3892/or.2011.1264; Lizarraga D, 2007, FEBS J, V274, P4802, DOI 10.1111/j.1742-4658.2007.06010.x; Lo C, 2011, MELANOMA RES, V21, P267, DOI 10.1097/CMR.0b013e3283414444; Mochizuki M, 2002, BBA-GEN SUBJECTS, V1569, P35, DOI 10.1016/S0304-4165(01)00230-6; Niho N, 2001, FOOD CHEM TOXICOL, V39, P1063, DOI 10.1016/S0278-6915(01)00054-0; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Park W, 2008, TOXICOL IN VITRO, V22, P159, DOI 10.1016/j.tiv.2007.08.010; Peng CC, 2012, MOL NUTR FOOD RES, V56, P1541, DOI 10.1002/mnfr.201200178; Peng CC, 2012, CLIN NUTR, V31, P405, DOI 10.1016/j.clnu.2011.11.003; Qiu XB, 2000, HEART VESSELS, V15, P90, DOI 10.1007/s003800070038; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Sakihama Y, 2002, TOXICOLOGY, V177, P67, DOI 10.1016/S0300-483X(02)00196-8; Sarikaya SBO, 2010, CHEM BIOL DRUG DES, V75, P515, DOI 10.1111/j.1747-0285.2010.00965.x; Severino JF, 2009, FREE RADICAL BIO MED, V46, P1076, DOI 10.1016/j.freeradbiomed.2009.01.004; Simic A, 2007, MOLECULES, V12, P2327, DOI 10.3390/12102327; Supuran CT, 2011, MOL DIVERS, V15, P305, DOI 10.1007/s11030-010-9271-4; Tomas-Barberan FA, 2000, J SCI FOOD AGR, V80, P1024, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1024::AID-JSFA567&gt;3.0.CO;2-S, 10.1002/(SICI)1097-0010(20000515)80:7<1024::AID-JSFA567>3.3.CO;2-J]; WONG SK, 1972, CAN J CHEMISTRY, V50, P3052, DOI 10.1139/v72-484; Yeh RD, 2011, ANTICANCER RES, V31, P2821; Yoshiki Y, 2000, LUMINESCENCE, V15, P183, DOI 10.1002/1522-7243(200005/06)15:3<183::AID-BIO584>3.0.CO;2-V; You BR, 2011, MOL CELL BIOCHEM, V357, P295, DOI 10.1007/s11010-011-0900-8; You BR, 2010, TOXICOL IN VITRO, V24, P1356, DOI 10.1016/j.tiv.2010.04.009; Yuan JH, 2009, POULTRY SCI, V88, P2415, DOI 10.3382/ps.2008-00555	53	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0119516	10.1371/journal.pone.0119516	http://dx.doi.org/10.1371/journal.pone.0119516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030624	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900004
J	Ji, SH; Doumit, ME; Hill, RA				Ji, Shuhan; Doumit, Matthew E.; Hill, Rodney A.			Regulation of Adipogenesis and Key Adipogenic Gene Expression by 1, 25-Dihydroxyvitamin D in 3T3-L1 Cells	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; ADIPOSE CONVERSION; PPAR-GAMMA; METABOLISM; ACID; PREADIPOCYTES; ADD1/SREBP1; PATHWAY	The functions of 1, 25-dihydroxyvitamin D (1, 25-(OH)(2)D-3) in regulating adipogenesis, adipocyte differentiation and key adipogenic gene expression were studied in 3T3-L1 preadipocytes. Five concentrations (0.01, 0.1, 1, 10, 100nM) of 1, 25-(OH)(2)D-3 were studied and lipid accumulation measured by Oil Red O staining and expression of adipogenic genes quantified using quantitative real-time PCR. Adipogenic responses to 1, 25-(OH)(2)D-3 were determined on 6, and 12 h, and days 1-10 after induction of adipogenesis by a hormonal cocktail with or without 1, 25-(OH)(2)D-3. In response to 1, 25-(OH)(2)D-3 (1, 10, and 100 nM), lipid accumulation and the expression of PPAR gamma, C/EBP alpha, FABP4 and SCD-1 were inhibited through day 10, and vitamin D receptor expression was inhibited in the early time points. The greatest inhibitory effect was upon expression of FABP4. Expression of SREBP-1c was only affected on day 2. The lowest concentrations of 1, 25-(OH)(2)D-3 tested did not affect adipocyte differentiation or adipogenic gene expression. The C/EBP alpha promoter activity response to 1, 25-(OH)(2)D-3 was also tested, with no effect detected. These results indicate that 1, 25-(OH)(2)D-3 inhibited adipogenesis via suppressing adipogenic-specific genes, and is invoked either during PPAR gamma activation or immediately up-stream thereof. Gene expression down-stream of PPAR gamma especially FABP4 was strongly inhibited, and we suggest that the role of 1, 25-(OH)(2)D-3 in regulating adipogenesis will be informed by further studies of adipogenic-specific gene promoter activity.	[Ji, Shuhan; Doumit, Matthew E.; Hill, Rodney A.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	Charles Sturt University	Hill, RA (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.	rhill@csu.edu.au	Hill, Rodney A/C-4106-2012	Hill, Rodney A/0000-0001-9990-1113	Idaho Experiment Station; China Scholarship Council	Idaho Experiment Station; China Scholarship Council(China Scholarship Council)	The authors thank the Idaho Experiment Station for support of these studies. The authors also thank the China Scholarship Council for support of Ms. Shuhan Ji.	Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cheguru P, 2012, PFLUG ARCH EUR J PHY, V463, P429, DOI 10.1007/s00424-011-1066-7; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hida Y, 1998, LIFE SCI, V62, pPL205, DOI 10.1016/S0024-3205(98)00059-9; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; KAMEI Y, 1993, BIOCHEM BIOPH RES CO, V193, P948, DOI 10.1006/bbrc.1993.1717; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2622, DOI 10.1210/en.139.5.2622; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Martini LA, 2006, NUTR REV, V64, P479, DOI 10.1111/j.1753-4887.2006.tb00180.x; Matsuo T, 2001, ASIA PAC J CLIN NUTR, V10, P46, DOI 10.1046/j.1440-6047.2001.00196.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; SATO M, 1988, J CELL PHYSIOL, V135, P545, DOI 10.1002/jcp.1041350326; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; van Etten E, 2003, J CELL BIOCHEM, V88, P223, DOI 10.1002/jcb.10329; Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	34	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126142	10.1371/journal.pone.0126142	http://dx.doi.org/10.1371/journal.pone.0126142			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030589	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900020
J	Kim, J; Shin, JY; Lee, J; Song, HJ; Choi, NK; Park, BJ				Kim, Jungmee; Shin, Ju-Young; Lee, Joongyub; Song, Hong-Ji; Choi, Nam-Kyong; Park, Byung-Joo			Comparison of the Prescribing Pattern of Bisphosphonate and Raloxifene in Korean Women with Osteoporosis: From a National Health Insurance Claims Database	PLOS ONE			English	Article							HIP FRACTURE INCIDENCE; POSTMENOPAUSAL WOMEN; BREAST-CANCER; BONE TURNOVER; ALENDRONATE; RISEDRONATE; PREVALENCE; PATIENT; ADULTS; RISK	This study aimed to evaluate the differences of prescribing pattern between bisphosphonate and raloxifene users among Korean women with osteoporosis, focusing on the underlying conditions, concurrent medications, nature of healthcare utilization, and regional disparity. We used the Health Insurance Review and Assessment Service National Patients Sample database of the year 2010. Study subjects were defined as female osteoporosis patients aged over 50 years with both the diagnosis of osteoporosis and prescriptions of bisphosphonate or raloxifene. The frequency and the proportion of bisphosphonate and raloxifene were compared using chi-square test and the trend of the proportion using the Cochran-Armitage test. Medications were quantified as defined daily doses per 1,000 patients per day. The prescription pattern was visualized by using the Quantum Geographic Information Systems program. Of the 1,367,367 people who utilized medical services in 2010, the final number of study subjects was 26,881-26,032 (96.8%) bisphosphonate and 849 (3.2%) raloxifene recipients. Raloxifene users were younger than bisphosphonate users and were more frequently patients with a lipid disorder (16.0% vs. 22.1%, p-value < 0.0001), rheumatic disease (4.0% vs. 6.1%, p-value = 0.0024), hot flash (1.8% vs. 6.1%, p < 0.0001), and coronary artery disease (1.2% vs. 2.8%, p < 0.0001). The proportion of raloxifene users was higher in tertiary care institutions (21.6% vs. 44.7%, p-value < 0.0001). A regional distribution showed that raloxifene use was higher in the Seoul metropolitan area. These differences in demographic and clinical profiles of each recipient may influence prescription decisions.	[Kim, Jungmee; Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Shin, Ju-Young; Park, Byung-Joo] Korea Inst Drug Safety & Risk Management, Seoul, South Korea; [Lee, Joongyub; Choi, Nam-Kyong] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Lee, Joongyub] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Song, Hong-Ji] Hallym Univ, Coll Med, Dept Family Med, Chunchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hallym University	Park, BJ (corresponding author), Korea Inst Drug Safety & Risk Management, Boryung Bldg, Seoul, South Korea.	bjpark@snu.ac.kr		Shin, Ju-Young/0000-0003-1010-7525; Choi, Nam-Kyong/0000-0003-1153-9928				Bachmann G, 2011, MENOPAUSE, V18, P851, DOI 10.1097/gme.0b013e31820b80f1; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Brookhart MA, 2006, J CLIN EPIDEMIOL, V59, P18, DOI 10.1016/j.jclinepi.2005.07.005; Choi HJ, 2012, J BONE MINER METAB, V30, P54, DOI 10.1007/s00774-011-0280-x; Choi YJ, 2012, J BONE MINER RES, V27, P1879, DOI 10.1002/jbmr.1635; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Curtis JR, 2009, OSTEOPOROSIS INT, V20, P973, DOI 10.1007/s00198-008-0772-2; Ferrari S, 2011, J BONE MINER METAB, V29, P561, DOI 10.1007/s00774-010-0249-1; Foster SA, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-15; Foster SA, 2010, CURR MED RES OPIN, V26, P2521, DOI 10.1185/03007995.2010.515456; Foster Shonda A, 2008, BMC Womens Health, V8, P24, DOI 10.1186/1472-6874-8-24; Gadam RK, 2013, ENDOCR PRACT, V19, P780, DOI 10.4158/EP12416.OR; Gehlbach S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082840; Gong HS, 2009, J BONE JOINT SURG AM, V91A, P2376, DOI 10.2106/JBJS.H.01871; Harmankaya N, 2013, ACTA BIOMATER, V9, P7064, DOI 10.1016/j.actbio.2013.02.040; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098043; Kim KH, 2012, BONE, V50, P1039, DOI 10.1016/j.bone.2012.02.007; Kim Logyoung, 2013, [Health Policy and Mangemnet, 보건행정학회지], V23, P152; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lin TC, 2013, J CLIN ENDOCRINOL ME; Park C, 2011, J BONE MINER METAB, V29, P744, DOI 10.1007/s00774-011-0279-3; Pasion EG, 2007, J BONE MINER METAB, V25, P105, DOI 10.1007/s00774-006-0735-7; Recker RR, 2007, BONE, V40, P843, DOI 10.1016/j.bone.2006.11.001; Ro C, 2013, CURR OSTEOPOROS REP, V11, P45, DOI 10.1007/s11914-012-0129-9; Sambrook PN, 2004, J INTERN MED, V255, P503, DOI 10.1111/j.1365-2796.2004.01317.x; Sanad Z, 2011, CLIMACTERIC, V14, P369, DOI 10.3109/13697137.2010.537408; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Shin CS, 2012, J BONE MINER METAB, V30, P183, DOI 10.1007/s00774-011-0300-x	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127970	10.1371/journal.pone.0127970	http://dx.doi.org/10.1371/journal.pone.0127970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030300	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900098
J	Lourenco, FS; Decker, JH; Pedersen, GA; Dellarco, DV; Casey, BJ; Hartley, CA				Lourenco, Frederico S.; Decker, Johannes H.; Pedersen, Gloria A.; Dellarco, Danielle V.; Casey, B. J.; Hartley, Catherine A.			Consider the Source: Adolescents and Adults Similarly Follow Older Adult Advice More than Peer Advice	PLOS ONE			English	Article							DECISION-MAKING; INHIBITORY CONTROL; RISK-TAKING; BEHAVIOR; SUSCEPTIBILITY	Individuals learn which of their actions are likely to be rewarded through trial and error. This form of learning is critical for adapting to new situations, which adolescents frequently encounter. Adolescents are also greatly influenced by their peers. The current study tested the extent to which adolescents rely on peer advice to guide their actions. Adolescent and young adult participants completed a probabilistic learning task in which they chose between four pairs of stimuli with different reinforcement probabilities, with one stimulus in each pair more frequently rewarded. Participants received advice about two of these pairs, once from a similarly aged peer and once from an older adult. Crucially, this advice was inaccurate, enabling the dissociation between experience-based and instruction-based learning. Adolescents and adults learned equally well from experience and no age group difference was evident in the overall influence of advice on choices. Surprisingly, when considering the source of advice, there was no evident influence of peer advice on adolescent choices. However, both adolescents and adults were biased toward choosing the stimulus recommended by the older adult. Contrary to conventional wisdom, these data suggest that adolescents may prioritize the advice of older adults over that of peers in certain decisionmaking contexts.	[Lourenco, Frederico S.; Decker, Johannes H.; Pedersen, Gloria A.; Dellarco, Danielle V.; Casey, B. J.; Hartley, Catherine A.] Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10065 USA	Cornell University	Hartley, CA (corresponding author), Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10065 USA.	cah2031@med.cornell.edu		Pedersen, Gloria/0000-0003-3427-3464	NIGMS NIH HHS [T32 GM007739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2011, NURTURE ASSUMPTION W; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Barkley-Levenson E, 2014, P NATL ACAD SCI USA, V111, P1646, DOI 10.1073/pnas.1319762111; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037/0012-1649.15.6.608; Biele G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001089; Biele G, 2009, COGNITIVE SCI, V33, P206, DOI 10.1111/j.1551-6709.2009.01010.x; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; Boorman ED, 2013, NEURON, V80, P1558, DOI 10.1016/j.neuron.2013.10.024; Brown B., 2004, HDB ADOLESCENT PSYCH, V2nd, P363; Casey B, 2006, ATTENTION PROCESS CH; Chassin L, 2004, HDB ADOLESC PSYCHOL; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Cohen JR, 2010, NAT NEUROSCI, V13, P669, DOI 10.1038/nn.2558; Cohen-Gilbert JE, 2013, CHILD DEV, V84, P1954, DOI 10.1111/cdev.12085; Decker JH, 2015, COGN AFFECT BEHAV NE, V15, P310, DOI 10.3758/s13415-014-0332-5; Doll BB, 2014, COGN AFFECT BEHAV NE, V14, P715, DOI 10.3758/s13415-014-0250-6; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Doll BB, 2009, BRAIN RES, V1299, P74, DOI 10.1016/j.brainres.2009.07.007; Dreyfuss M, 2014, DEV NEUROSCI-BASEL, V36, P220, DOI 10.1159/000357755; Engelmann JB, 2012, SOC COGN AFFECT NEUR, V7, P557, DOI 10.1093/scan/nss050; Engelmann JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004957; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Grose-Fifer J, 2013, ADV COGN PSYCHOL, V9, P81, DOI [10.5709/acp-0134-9, 10.2478/v10053-008-0134-9]; Guyer AE, 2009, CHILD DEV, V80, P1000, DOI 10.1111/j.1467-8624.2009.01313.x; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Jones RM, 2014, COGN AFFECT BEHAV NE, V14, P683, DOI 10.3758/s13415-014-0257-z; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Levinger GK, 1972, ATTRACTION RELATION; Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108; Luan S, 2004, J BEHAV DECIS MAKING, V17, P95, DOI 10.1002/bdm.464; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Meshi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049748; Pfeifer JH, 2011, NEURON, V69, P1029, DOI 10.1016/j.neuron.2011.02.019; Silk JS, 2012, SOC COGN AFFECT NEUR, V7, P93, DOI 10.1093/scan/nsr044; Simons-Morton B, 2005, ACCIDENT ANAL PREV, V37, P973, DOI 10.1016/j.aap.2005.04.014; Somerville LH, 2013, CURR DIR PSYCHOL SCI, V22, P121, DOI 10.1177/0963721413476512; Somerville LH, 2011, J COGNITIVE NEUROSCI, V23, P2123, DOI 10.1162/jocn.2010.21572; Somsen RJM, 2007, DEVELOPMENTAL SCI, V10, P664, DOI 10.1111/j.1467-7687.2007.00613.x; Staudinger MR, 2013, NEUROIMAGE, V76, P125, DOI 10.1016/j.neuroimage.2013.02.074; Suen VYM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087321; Teslovich T, 2014, DEVELOPMENTAL SCI, V17, P59, DOI 10.1111/desc.12092; van den Bos W, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.052.2009; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Wechsler D, 1974, WECHSLER INTELLIGENC; Yaniv I, 2004, CURR DIR PSYCHOL SCI, V13, P75, DOI 10.1111/j.0963-7214.2004.00278.x; Zimring F. E., 2000, AM YOUTH VIOLENCE	51	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128047	10.1371/journal.pone.0128047	http://dx.doi.org/10.1371/journal.pone.0128047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030134	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900105
J	Ridgeway, JA; Timm, AE				Ridgeway, Jaryd A.; Timm, Alicia E.			Reference Gene Selection for Quantitative Real-Time PCR Normalization in Larvae of Three Species of Grapholitini (Lepidoptera: Tortricidae)	PLOS ONE			English	Article							HOUSEKEEPING GENES; EXPRESSION ANALYSIS; CODLING MOTH; VALIDATION; RESISTANCE; QUANTIFICATION; IDENTIFICATION; GRANULOVIRUS; DOMINANT; TISSUES	Despite the agricultural importance of species in the Grapholitini (Lepidoptera: Tortricidae), and the value of gene expression analysis for improved population management, few gene expression studies based on quantitative real-time PCR (qPCR) have been conducted for this tribe. Part of the reason for this lack of information is that suitable reference genes, which are fundamental for accurate normalization of qPCR studies, have not been identified for the tribe. Thus, the expression stability of six potential reference genes (ACT, AK, COI, EF1, ENO and TUB) was assessed in three different tissues (whole body, midgut and cuticle) of Cryptophlebia peltastica (Meyrick), Cydia pomonella (L.) and Thaumatotibia leucotreta (Meyrick). Additionally, these reference genes were tested using T. leucotreta at different temperatures (15 degrees C, 25 degrees C and 35 degrees C) with and without baculovirus infection. Suitable reference genes were identified for the whole body and midgut tissue of all three species, and for cuticle tissue of Cy. pomonella and T. leucotreta. When T. leucotreta was infected with the virus at all temperature conditions ACT, AK and EF1 were found to be the most suitable reference genes for experimental normalization. In general, for all tissue types, species and stress conditions, AK and EF1 were the best-performing reference genes. However, even though the three species analysed were closely related and within the same tribe, each species required varying gene combinations for suitable normalization. This study provides the first reference gene evaluation for the Tortricidae, and paves the way for future qPCR analysis in Tortricidae.	[Ridgeway, Jaryd A.; Timm, Alicia E.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Rhodes University	Timm, AE (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa.	aetimm@gmail.com	Timm, Alicia E/A-1866-2008	Timm, Alicia/0000-0002-5800-5512	Citrus Research International; South African National Research Foundation (NRF); Rhodes University; Alexander von Humboldt Foundation	Citrus Research International; South African National Research Foundation (NRF)(National Research Foundation - South Africa); Rhodes University; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was funded by Citrus Research International, the South African National Research Foundation (NRF), Rhodes University and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asser-Kaiser S, 2007, SCIENCE, V317, P1916, DOI 10.1126/science.1146542; Brits D, 2015, AFRICAN ENTOMOL, V23; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Dyar H.G., 1890, PSYCHE, V5, P420, DOI [DOI 10.1155/1890/23871, 10.1155/1890/23871]; Eberle KE, 2006, J INVERTEBR PATHOL, V93, P201, DOI 10.1016/j.jip.2006.07.001; Fritsch E, 2005, J ENTWICKLUNGSPOLITI, V57, P2, DOI [10.1136/adc.2010.185470, DOI 10.1136/ADC.2010.185470]; Gatehouse HS, 2009, INSECT MOL BIOL, V18, P635, DOI 10.1111/j.1365-2583.2009.00904.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Hunter-Fujita F., 1998, INSECT VIRUS PEST MA; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lee DW, 2007, BIOCHEM BIOPH RES CO, V353, P591, DOI 10.1016/j.bbrc.2006.12.088; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Lynn D, 2002, METHODS CELL SCI, V23, P221; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; MOORE SD, 2002, THESIS RHODES U; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Niu JZ, 2014, J INVERTEBR PATHOL, V115, P76, DOI 10.1016/j.jip.2013.10.011; Opoku-Debrah JK, 2011, THESIS RHODES U; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Pereira-da-Conceicoa LL, 2012, AFR ENTOMOL, V20, P187, DOI 10.4001/003.020.0124; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Reim T, 2013, APIDOLOGIE, V44, P342, DOI 10.1007/s13592-012-0184-3; Ridgeway J.A., 2014, J INSECT SCI, V1, P1, DOI [10.1093/jis/14.1.1, DOI 10.1093/JIS/14.1.1]; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Singh S, 2003, J INVERTEBR PATHOL, V83, P249, DOI 10.1016/S0022-2011(03)00081-8; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Timm AE, 2007, AFR ENTOMOL, V15, P269, DOI 10.4001/1021-3589-15.2.269; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Viscuso R, 2001, TISSUE CELL, V33, P33, DOI 10.1054/tice.2000.0147; Wang C. S., 1994, Plant Molecular Biology Reporter, V12, P132, DOI 10.1007/BF02668374; Xie W, 2012, INT J BIOL SCI, V8, P1142, DOI 10.7150/ijbs.4588; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	41	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129026	10.1371/journal.pone.0129026	http://dx.doi.org/10.1371/journal.pone.0129026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030743	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900205
J	Sun, B; Hu, C; Fang, H; Zhu, LN; Gao, N; Zhu, JC				Sun, Bo; Hu, Chen; Fang, Huan; Zhu, Lina; Gao, Ning; Zhu, Jingci			The Effects of Lactobacillus acidophilus on the Intestinal Smooth Muscle Contraction through PKC/MLCK/MLC Signaling Pathway in TBI Mouse Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN KINASE; INTERSTITIAL-CELLS; PHOSPHORYLATION; RELAXATION; CPI-17; GROWTH; SUPPLEMENTATION; SENSITIZATION	Clinical studies have shown that probiotics influence gastrointestinal motility. However, the molecular mechanisms by which probiotic Lactobacillus modulates intestinal motility in traumatic brain injury (TBI) mouse model have not been explored. In the present study, we provided evidence showing that treatment of TBI mice with Lactobacillus acidophilus significantly improved the terminal ileum villus morphology, restored the impaired interstitial cells of Cajal (ICC) and the disrupted ICC networks after TBI, and prevented TBI-mediated inhibition of contractile activity in intestinal smooth muscle. Mechanistically, the decreased concentration of MLCK, phospho-MLC20 and phospho-MYPT1 and increased concentration of MLCP and PKC were observed after TBI, and these events mediated by TBI were efficiently prevented by Lactobacillus acidophilus application. These findings may provide a novel mechanistic basis for the application of Lactobacillus acidophilus in the treatment of TBI.	[Sun, Bo; Hu, Chen; Fang, Huan; Zhu, Lina; Zhu, Jingci] Third Mil Med Univ, Sch Nursing, Chongqing 400038, Peoples R China; [Gao, Ning] Third Mil Med Univ, Coll Pharm, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Gao, N (corresponding author), Third Mil Med Univ, Coll Pharm, Chongqing 400038, Peoples R China.	gaoning59@163.com; zhujingci2009@163.com			National Natural Science Foundation of China [81272079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China, grant number 81272079, URL: http://www.nsfc.gov.cn/, received by JCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayman S, 2003, BRIT J PHARMACOL, V139, P1532, DOI 10.1038/sj.bjp.0705394; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; BATEUP JM, 1995, APPL ENVIRON MICROB, V61, P1147, DOI 10.1128/AEM.61.3.1147-1149.1995; Biancani P, 1997, AM J MED, V103, p23S, DOI 10.1016/S0002-9343(97)00316-1; Borthakur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075664; Botes M, 2008, ARCH MICROBIOL, V190, P573, DOI 10.1007/s00203-008-0408-0; Bowen Denise M, 2013, J Dent Hyg, V87, P5; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Duan HB, 2013, J SURG RES, V184, P1006, DOI 10.1016/j.jss.2013.03.096; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Ehrmann MA, 2002, J APPL MICROBIOL, V92, P966, DOI 10.1046/j.1365-2672.2002.01608.x; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Gomes AMP, 1999, TRENDS FOOD SCI TECH, V10, P139, DOI 10.1016/S0924-2244(99)00033-3; Hersch E, 2004, AM J PHYSIOL-CELL PH, V287, pC1209, DOI 10.1152/ajpcell.00198.2004; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; IKEBE M, 1985, J BIOL CHEM, V260, P4547; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; Lipp P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004556; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu ZH, 2014, MOL BIOL REP, V41, P8037, DOI 10.1007/s11033-014-3701-9; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Mahavadi S, 2014, CELL BIOCHEM BIOPHYS, V68, P1, DOI 10.1007/s12013-013-9677-6; Massi M, 2006, WORLD J GASTROENTERO, V12, P5987, DOI 10.3748/wjg.v12.i37.5987; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Nalli AD, 2014, J PHARMACOL EXP THER, V350, P89, DOI 10.1124/jpet.113.212522; Nazzaro F, 2012, ANAEROBE, V18, P280, DOI 10.1016/j.anaerobe.2012.03.002; Ojetti V, 2014, J GASTROINTEST LIVER, V23, P387, DOI 10.15403/jgld.2014.1121.234.elr; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Pan Hong, 2014, Fa Yi Xue Za Zhi, V30, P169; Porcher C, 2002, AM J GASTROENTEROL, V97, P118; Rauch S, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.002; Savard P, 2011, INT J FOOD MICROBIOL, V149, P50, DOI 10.1016/j.ijfoodmicro.2010.12.026; Singhi SC, 2008, INDIAN J PEDIATR, V75, P621, DOI 10.1007/s12098-008-0119-1; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Weber LP, 2000, BIOCHEM J, V352, P573, DOI 10.1042/0264-6021:3520573; Ye J, 2006, J CELL MOL MED, V10, P687, DOI 10.1111/j.1582-4934.2006.tb00428.x; Yu QH, 2013, HUM VACC IMMUNOTHER, V9, P805, DOI 10.4161/hv.23302	43	18	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128214	10.1371/journal.pone.0128214	http://dx.doi.org/10.1371/journal.pone.0128214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030918	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900127
J	Funtikova, AN; Gomez, SF; Fito, M; Elosua, R; Bentiez-Arciniega, AA; Schroder, H				Funtikova, Anna N.; Gomez, Santiago F.; Fito, Montserrat; Elosua, Roberto; Bentiez-Arciniega, Alejandra A.; Schroeder, Helmut			Effect of Energy Under-Reporting on Secular Trends of Dietary Patterns in a Mediterranean Population	PLOS ONE			English	Article							BASAL METABOLIC-RATE; PHYSICAL-ACTIVITY QUESTIONNAIRE; BODY-MASS INDEX; GOLDBERG CUTOFF; FOOD PATTERNS; LIFE-STYLE; CLUSTER-ANALYSIS; RISK-FACTORS; MALMO DIET; MEN	Background Diet is an important factor in the prevention of chronic diseases. Analysis of secular trends of dietary patterns can be biased by energy under-reporting. Therefore, the objective of the present study was to analyse the impact of energy under-reporting on dietary patterns and secular trends in dietary patterns defined by cluster analysis. Design and methods Two cross-sectional population-based surveys were conducted in Spain, in 2000 and 2005, with 3058 and 6352 participants, respectively, aged 25 to 74 years. Validated questionnaire was used to collect dietary data. Cluster analysis was run separately for all participants, plausible energy reporters (PER), and energy under-reporters (EUR) to define dietary patterns. Results Three clusters, "healthy", "mixed" and "western", were identified for both surveys. The "mixed" cluster was the predominant cluster in both surveys. Excluding EUR reduced the proportion of the "mixed" cluster up to 6.40% in the 2000 survey; this caused secular trend increase in the prevalence of the "mixed" pattern. Cross-classification analysis of all participants and PER' data showed substantial agreement in cluster assignments: 68.7% in 2000 and 84.4% in 2005. Excluding EUR did not cause meaningful (>= 15%) changes in the "healthy" pattern. It provoked changes in consumption of some food groups in the "mixed" and "western" patterns: mainly decreases of unhealthy foods within the 2000 and increases of unhealthy foods within the 2005 surveys. Secular trend effects of EUR were similar to those within the 2005 survey. Excluding EUR reversed the direction of secular trends in consumption of several food groups in PER in the "mixed" and "western" patterns. Conclusions EUR affected distribution of participants between dietary patterns within and between surveys, secular trends in food group consumption and amount of food consumed in all, but not in the "healthy" pattern. Our findings emphasize threats from energy under-reporting in dietary data analysis.	[Funtikova, Anna N.; Gomez, Santiago F.; Fito, Montserrat; Schroeder, Helmut] Hosp del Mar, Med Res Inst, Cardiovasc Risk & Nutr Res Grp CARIN ULEC, Barcelona, Spain; [Funtikova, Anna N.; Schroeder, Helmut] Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Funtikova, Anna N.] Univ Barcelona, PhD Program Foods & Nutr, Barcelona, Spain; [Gomez, Santiago F.] Fdn THAO, Barcelona, Spain; [Fito, Montserrat] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain; [Elosua, Roberto] Hosp del Mar, Med Res Inst, Cardiovasc Epidemiol & Genet EGEC ULEC, Barcelona, Spain; [Bentiez-Arciniega, Alejandra A.] Autonomous Univ Mexico State, Fac Med, Toluca, Mexico	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universidad Autonoma del Estado de Mexico; Universidad Nacional Autonoma de Mexico	Schroder, H (corresponding author), Hosp del Mar, Med Res Inst, Cardiovasc Risk & Nutr Res Grp CARIN ULEC, Barcelona, Spain.	hschroeder@imim.es	Fito, Montserrat/C-1822-2012; Santos, Santiago Felipe Gómez/H-9478-2017; Schroder, Helmut/G-2586-2015	Fito, Montserrat/0000-0002-1817-483X; Santos, Santiago Felipe Gómez/0000-0003-3352-2510; Schroder, Helmut/0000-0003-2231-5081	Fondo Europeo de Desarrollo Regional (FEDER) [2FD097-0297-CO2-01]; Ministry of Education of Spain [AP2010-3198]; Spain Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III: FEDER) [PI11/01900]; Spain Ministry of Health (Ministerio de Sanidad y Consumo, FEDER) [CB06/02/0029]; Spain Ministry of Health (Ministerio de Sanidad y Consumo, Red Investigacion Cardiovascular, Programa HERACLES) [RD12/0042, RD06/0009]; Instituto de Salud Carlos III [CP03/00115]; Health Department of the Catalan Government (Generalitat de Catalunya) [CP03/00115]; AGAUR [2014 SGR 240]	Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Ministry of Education of Spain(Spanish Government); Spain Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III: FEDER); Spain Ministry of Health (Ministerio de Sanidad y Consumo, FEDER); Spain Ministry of Health (Ministerio de Sanidad y Consumo, Red Investigacion Cardiovascular, Programa HERACLES); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This research was supported by a grant (2FD097-0297-CO2-01) from Fondo Europeo de Desarrollo Regional (FEDER); by a scholarship for PhD formation from the national program of university professors formation, FPU, from Ministry of Education of Spain (AP2010-3198); by portions of grants from Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III: FEDER [PI11/01900], FEDER [CB06/02/0029] and Red Investigacion Cardiovascular, Programa HERACLES [RD12/0042], [RD06/0009]), and by a joint contract (CP03/00115) between the Instituto de Salud Carlos III and the Health Department of the Catalan Government (Generalitat de Catalunya), and AGAUR (2014 SGR 240). The CIBERESP and CIBEROBN are an initiative of the Instituto de Salud Carlos III, Madrid, Spain.	Alberti-Fidanza A, 1999, EUR J CLIN NUTR, V53, P854, DOI 10.1038/sj.ejcn.1600865; Ammerman AS, 2002, PREV MED, V35, P25, DOI 10.1006/pmed.2002.1028; [Anonymous], 2002, PUBLIC HEALTH NUTR, P7; Azizi F, 2005, ASIA PAC J CLIN NUTR, V14, P54; Bailey RL, 2007, J AM DIET ASSOC, V107, P64, DOI 10.1016/j.jada.2006.10.009; Benitez-Arciniega AA, 2011, PUBLIC HEALTH NUTR, V14, P2015, DOI 10.1017/S1368980011001212; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; Cutler GJ, 2009, J NUTR, V139, P323, DOI 10.3945/jn.108.090928; Devlin UM, 2012, P NUTR SOC, V71, P599, DOI 10.1017/S0029665112000729; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Engeset D, 2005, EUR J CLIN NUTR, V59, P675, DOI 10.1038/sj.ejcn.1602129; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Grau M, 2007, EUR J CARDIOV PREV R, V14, P653, DOI 10.1097/HJR.0b013e3281764429; Hearty AP, 2009, BRIT J NUTR, V101, P598, DOI 10.1017/S0007114508014128; Horgan GW, 2003, EUR J CLIN NUTR, V57, P335, DOI 10.1038/sj.ejcn.1601542; JOHNSON RK, 1994, AM J CLIN NUTR, V59, P1286, DOI 10.1093/ajcn/59.6.1286; KrebsSmith SM, 1997, AM J CLIN NUTR, V65, P1264, DOI 10.1093/ajcn/65.4.1264S; Lee S, 2007, J AM DIET ASSOC, V107, P213, DOI 10.1016/j.jada.2006.11.003; Liu E, 2009, BRIT J NUTR, V102, P576, DOI 10.1017/S0007114509220836; Livingstone MBE, 2003, EUR J CLIN NUTR, V57, P455, DOI 10.1038/sj.ejcn.1601563; Lutomski JE, 2011, PUBLIC HEALTH NUTR, V14, P532, DOI 10.1017/S1368980010001801; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Mullaney L, 2015, J PUBLIC HEALTH-UK, V37, P728, DOI 10.1093/pubmed/fdu086; Nielsen BM, 2009, J NUTR, V139, P2337, DOI 10.3945/jn.109.112599; Oliveira A, 2011, J AM DIET ASSOC, V111, P241, DOI 10.1016/j.jada.2010.10.042; Popkin B, 2003, AM J PREV MED, V25, P1, DOI 10.1016/S0749-3797(03)00099-0; Pryer JA, 2001, J EPIDEMIOL COMMUN H, V55, P29, DOI 10.1136/jech.55.1.29; Quatromoni PA, 2002, J EPIDEMIOL COMMUN H, V56, P381, DOI 10.1136/jech.56.5.381; Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300; Schroder H, 2001, CLIN NUTR, V20, P429, DOI 10.1054/clnu.2001.0460; Schroder H, 2004, J NUTR, V134, P3355, DOI 10.1093/jn/134.12.3355; Song Y, 2010, INT J OBESITY, V34, P48, DOI 10.1038/ijo.2009.203; Souza Amanda de Moura, 2011, Rev Bras Epidemiol, V14 Suppl 1, P44, DOI 10.1590/S1415-790X2011000500005; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638; Willett W., 2012, NUTR EPIDEMIOLOGY; Winkvist A, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-12; Wirfalt AKE, 1997, J AM DIET ASSOC, V97, P272, DOI 10.1016/S0002-8223(97)00071-0; Wirfalt E, 2001, AM J EPIDEMIOL, V154, P1150, DOI 10.1093/aje/154.12.1150; Wirfalt E, 2000, PUBLIC HEALTH NUTR, V3, P159, DOI 10.1017/S1368980000000197	45	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127647	10.1371/journal.pone.0127647	http://dx.doi.org/10.1371/journal.pone.0127647			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023775	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400046
J	Wang, N; Rajasekaran, N; Hou, TY; Macaubas, C; Mellins, ED				Wang, Nan; Rajasekaran, Narendiran; Hou, Tieying; Macaubas, Claudia; Mellins, Elizabeth D.			Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; PANCREATIC LYMPH-NODES; TOTAL-BODY IRRADIATION; HEMATOPOIETIC STEM; ADJUVANT IMMUNOTHERAPY; MICE; AUTOIMMUNE; DISEASE; PREVENTION	Type I diabetes (T1D), mediated by autoreactive T cell destruction of insulin-producing islet beta cells, has been treated with bone marrow-derived hematopoietic stem cell (BM-HSC) transplantation. Older non-obese diabetic (NOD) mice recipients (3m, at disease-onset stage) receiving syngeneic BM-HSC progressed more rapidly to end-stage diabetes posttransplantation than younger recipients (4-6w, at disease-initiation stage). FACS analyses showed a higher percentage and absolute number of regulatory T cells (Treg) and lower proportion of proliferating T conventional cells (Tcon) in pancreatic lymph nodes from the resistant mice among the younger recipients compared to the rapid progressors among the older recipients. Treg distribution in spleen, mesenteric lymph nodes (MLN), blood and thymus between the two groups was similar. However, the percentage of thymic Tcon and the proliferation of Tcon in MLN and blood were lower in the young resistants. These results suggest recipient age and associated disease stage as a variable to consider in BM-HSC transplantation for treating T1D.	[Wang, Nan; Rajasekaran, Narendiran; Hou, Tieying; Macaubas, Claudia; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Sch Med, Div Human Gene Therapy,Program Immunol, Stanford, CA 94305 USA	Stanford University	Mellins, ED (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Human Gene Therapy,Program Immunol, Stanford, CA 94305 USA.	mellins@stanford.edu		Mellins, Elizabeth/0000-0003-2577-139X; Rajasekaran, Narendiran/0000-0002-0740-0272	Juvenile Diabetes Research Foundation; Stanford Medical School Child Health Research Institute - Stanford NIH/NCRR CTSA award [UL1 RR025744]; Lucile Packard Foundation for Children's Health; Arthritis Foundation; NIH/NIAID [F32AI089080]; American College of Rheumatology Research and Education Foundation; NIH [AI075253, DK079163]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075253, F32AI089080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK079163] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Stanford Medical School Child Health Research Institute - Stanford NIH/NCRR CTSA award; Lucile Packard Foundation for Children's Health; Arthritis Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American College of Rheumatology Research and Education Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Juvenile Diabetes Research Foundation, Stanford Medical School Child Health Research Institute funded by Stanford NIH/NCRR CTSA award number UL1 RR025744 and by the Lucile Packard Foundation for Children's Health (to N.W.), Arthritis Foundation (to N.R.), NIH/NIAID F32AI089080 for postdoctoral fellows (to T.H.), American College of Rheumatology Research and Education Foundation, the Juvenile Diabetes Research Foundation and NIH AI075253 and DK079163 (to E.D.M.).	Alard P, 2006, DIABETES, V55, P2098, DOI 10.2337/db05-0810; Aribi M, 2007, MED SCI MONITOR, V13, pCR372; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Avanzini MA, 2005, EXP CLIN ENDOCR DIAB, V113, P313, DOI 10.1055/s-2005-865643; Beilhack GF, 2005, DIABETES, V54, P1770, DOI 10.2337/diabetes.54.6.1770; Bonetti F, 1999, J CLIN ONCOL, V17, P3729, DOI 10.1200/JCO.1999.17.12.3729; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Bryson JS, 1997, BONE MARROW TRANSPL, V19, P721, DOI 10.1038/sj.bmt.1700719; Chan J, 2006, J GENE MED, V8, P1281, DOI 10.1002/jgm.968; Chilton PM, 2004, DIABETES, V53, P1995, DOI 10.2337/diabetes.53.8.1995; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Domenick MA, 2001, WORLD J SURG, V25, P474, DOI 10.1007/s002680020340; Edelman Steven V, 2002, Diabetes Technol Ther, V4, P175, DOI 10.1089/15209150260007390; Elkin G, 2004, EXP HEMATOL, V32, P579, DOI 10.1016/j.exphem.2004.03.007; Ferraro A, 2011, DIABETES, V60, P2903, DOI 10.2337/db11-0090; Filippi CM, 2011, EUR J IMMUNOL, V41, P1399, DOI 10.1002/eji.200939841; Filippi CM, 2009, J CLIN INVEST, V119, P1515, DOI 10.1172/JCI38503; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Guo Z, 2013, J IMMUNOL, V190; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; Holland AM, 2012, J CLIN INVEST, V122, P4716, DOI 10.1172/JCI60630; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; JOHNSON FL, 1988, BLOOD, V71, P1277; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Li H, 1996, J IMMUNOL, V156, P380; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Liu Q, 2009, INFECT IMMUN, V77, P5347, DOI 10.1128/IAI.01170-08; Mathieu C, 1997, J IMMUNOL, V158, P1453; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Mellanby RJ, 2007, IMMUNOLOGY, V121, P15, DOI 10.1111/j.1365-2567.2007.02546.x; Miranda SRP, 1997, BLOOD, V90, P444; Nelson JL, 1997, J RHEUMATOL, V24, P23; Nti BK, 2012, CELL MOL IMMUNOL, V9, P455, DOI 10.1038/cmi.2012.36; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Popplewell LL, 2002, BONE MARROW TRANSPL, V29, P277, DOI 10.1038/sj.bmt.1703382; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Rachmiel M, 2011, PEDIATR DIABETES, V12, P596, DOI 10.1111/j.1399-5448.2010.00751.x; Racine J, 2011, DIABETES, V60, P555, DOI 10.2337/db10-0827; Rajasekaran N, 2013, CLIN EXP IMMUNOL, V174, P27, DOI 10.1111/cei.12163; Rinderknecht CH, 2010, INT IMMUNOL, V22, P705, DOI 10.1093/intimm/dxq056; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulz AS, 2011, BLOOD, V117, P4642, DOI 10.1182/blood-2010-06-284349; Snell-Bergeon JK, 2010, J CLIN ENDOCR METAB, V95, P2868, DOI 10.1210/jc.2009-1993; Steptoe RJ, 2003, J CLIN INVEST, V111, P1357, DOI 10.1172/JCI200315995; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tian B, 2009, TRANSPLANTATION, V87, P198, DOI 10.1097/TP.0b013e3181933261; van Bekkum DW, 1999, RHEUMATOLOGY, V38, P757, DOI 10.1093/rheumatology/38.8.757; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Wang J, 2009, MED HYPOTHESES, V72, P36, DOI 10.1016/j.mehy.2008.07.049; Wang N, 2014, STEM CELL RES, V12, P209, DOI 10.1016/j.scr.2013.10.010; Wang N, 2013, EXP HEMATOL, V41, P934, DOI 10.1016/j.exphem.2013.07.002; Wucherpfennig KW, 2003, ANN NY ACAD SCI, V1005, P119, DOI 10.1196/annals.1288.013; Zhang YX, 2012, CURR OPIN ENDOCRINOL, V19, P271, DOI 10.1097/MED.0b013e328355a2d5	60	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128494	10.1371/journal.pone.0128494	http://dx.doi.org/10.1371/journal.pone.0128494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020954	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300117
J	Donnelly, NA; Hickey, A; Burns, A; Murphy, P; Doyle, F				Donnelly, Nora-Ann; Hickey, Anne; Burns, Annette; Murphy, Paul; Doyle, Frank			Systematic Review and Meta-Analysis of the Impact of Carer Stress on Subsequent Institutionalisation of Community-Dwelling Older People	PLOS ONE			English	Review							NURSING-HOME PLACEMENT; CRITICAL-APPRAISAL TOOL; CAREGIVERS; PREDICTORS; DEMENTIA; HEALTH; HOSPITALIZATION; INTERVENTIONS; DISEASE; BURDEN	Background In the caregiving literature there is a common assertion that a higher level of carer stress is a critical determinant of premature ending of homecare. However, this contention has not been systematically assessed. We therefore systematically reviewed and meta-analysed the prospective association between various forms of carer stress and subsequent institutionalisation of community-dwelling older people. Methods Systematic literature search of prospective studies measuring carer stress at baseline and institutionalisation at follow-up. Given substantial interchangeability in the measurement of carer stress, we included a wide number of exposure measures, namely: carer stress, burden, depression, distress, anxiety, burnout, and strain. Institutionalisation included both acute and long-term care utilisation. The standardised mean difference between stressed and non-stressed carers was the primary measure of effect. We assessed study quality with the Crowe Critical Appraisal Tool (CCAT). Pre-planned sensitivity analysis included examination of estimates according to study size; decade published; study quality according to quartiles of CCAT scores; population; follow-up period; study design and impact of adjusted or unadjusted estimates. Results The search yielded 6,963 articles. After exclusions, we analysed data from 54 datasets. The meta-analysis found that while carer stress has a significant effect on subsequent institutionalisation of care recipients, the overall effect size was negligible (SMD=0.05, 95% CI=0.04-0.07). Sensitivity analyses found that, the effect size was higher for measurements of stress than for other measures, though still relatively small (SMD=0.23, 95% CI=0.09-0.38). Thus, whether analysing the association between carer stress, burden, distress, or depression with either acute or long-term care, the effect size remains small to negligible. Concurrently, we found estimates reduce over time and were smaller with larger studies and those of higher quality, according to the CCAT scores. Conclusion Despite strong statements to the contrary, it appears that the effect of carer stress on subsequent care recipient institutionalisation is small to negligible. The current findings point to a biased literature, with significant small study effects. The results suggest a need to reevaluate the degree to which carer stress predicts premature ending of home care. Concurrently, other factors may be more crucial in institutional placement than carer stress and should be investigated.	[Donnelly, Nora-Ann; Hickey, Anne; Burns, Annette; Doyle, Frank] Royal Coll Surgeons Ireland, Dept Psychol, Dublin 2, Ireland; [Murphy, Paul] Royal Coll Surgeons Ireland, Mercer Lib, Dublin 2, Ireland	Royal College of Surgeons - Ireland; University College Dublin; Royal College of Surgeons - Ireland	Donnelly, NA (corresponding author), Royal Coll Surgeons Ireland, Dept Psychol, Dublin 2, Ireland.	noraadonnelly@rcsi.ie	Murphy, Paul/E-2305-2011; Doyle, Frank/C-2750-2012; Burns, Annette/ABF-7763-2020	Murphy, Paul/0000-0001-5056-1971; Doyle, Frank/0000-0002-3785-7433; Burns, Annette/0000-0002-4924-7640; Donnelly, Nora-Ann/0000-0002-8468-8695	Health Research Board (HRB) in Ireland [PHD/2007/16]	Health Research Board (HRB) in Ireland	This work was funded by the Health Research Board (HRB) in Ireland under Grant No. PHD/2007/16. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrieu S, 2002, INT J GERIATR PSYCH, V17, P422, DOI 10.1002/gps.624; Bastawrous M, 2013, INT J NURS STUD, V50, P431, DOI 10.1016/j.ijnurstu.2012.10.005; Bauer ME, 2000, J NEUROIMMUNOL, V103, P84, DOI 10.1016/S0165-5728(99)00228-3; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Bradburn M, 2009, META ANALYSIS IN STA; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; BRODATY H, 1989, BMJ-BRIT MED J, V299, P1375, DOI 10.1136/bmj.299.6712.1375; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; Chou K R, 2000, J Pediatr Nurs, V15, P398, DOI 10.1053/jpdn.2000.16709; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Crowe M, 2012, J CLIN EPIDEMIOL, V65, P375, DOI 10.1016/j.jclinepi.2011.08.006; Crowe M, 2011, INT J NURS STUD, V48, P1505, DOI 10.1016/j.ijnurstu.2011.06.004; Crowe M, 2011, INT J EVID-BASED HEA, V9, P444, DOI 10.1111/j.1744-1609.2011.00237.x; Deeken JF, 2003, J PAIN SYMPTOM MANAG, V26, P922, DOI 10.1016/S0885-3924(03)00327-0; Doyle F, 2014, PSYCHOSOM MED, V76, P44, DOI 10.1097/PSY.0000000000000020; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; Fisher L, 1999, GERONTOLOGIST, V39, P677, DOI 10.1093/geront/39.6.677; Garcia-Perez L, 2011, QJM-INT J MED, V104, P639, DOI 10.1093/qjmed/hcr070; Gaugler JE, 2005, J AM GERIATR SOC, V53, P2098, DOI 10.1111/j.1532-5415.2005.00495.x; Gaugler JE, 2003, GERONTOLOGIST, V43, P219, DOI 10.1093/geront/43.2.219; Gaugler JE, 2006, J CROSS-CULT GERONTO, V21, P139, DOI 10.1007/s10823-006-9029-8; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Harbord R, 2009, METAANALYSIS STATA U; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JETTE AM, 1995, J GERONTOL B-PSYCHOL, V50, pS4, DOI 10.1093/geronb/50B.1.S4; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; Kontopantelis E, 2011, METAEFF STATA MODULE; Kuhberger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105825; Kuzuya M, 2011, AM J GERIAT PSYCHIAT, V19, P382, DOI 10.1097/JGP.0b013e3181e9b98d; Lazarus R. S., 1984, STRESS APPRAISAL AND; Li XH, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1472-1; Livingston G, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18390; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Miller EA, 2000, MED CARE RES REV, V57, P259, DOI 10.1177/107755870005700301; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nobili A, 2004, ALZ DIS ASSOC DIS, V18, P75, DOI 10.1097/01.wad.0000126618.98867.fc; NOLAN MR, 1990, J ADV NURS, V15, P544, DOI 10.1111/j.1365-2648.1990.tb01853.x; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; Schulz R, 2008, AM J NURS, V108, P23, DOI 10.1097/01.NAJ.0000336406.45248.4c; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Sharp S, 2009, METAANALYSIS STATA U; Spillman BC, 2009, INQUIRY-J HEALTH CAR, V46, P140, DOI 10.5034/inquiryjrnl_46.02.140; Steichen T, 2009, METAANALYSIS STATA U; Tak LM, 2010, PSYCHOSOM MED, V72, P253, DOI 10.1097/PSY.0b013e3181d714e1; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yates ME, 1999, J GERONTOL B-PSYCHOL, V54, pP12, DOI 10.1093/geronb/54B.1.P12; Zarit S., 2006, CAREGIVER ASSESSMENT, P12; Zarit Steven H, 2008, Handb Clin Neurol, V89, P101, DOI 10.1016/S0072-9752(07)01209-2	56	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128213	10.1371/journal.pone.0128213	http://dx.doi.org/10.1371/journal.pone.0128213			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26035433	Green Published, gold, Green Submitted			2022-12-27	WOS:000355699100030
J	Eshima, S; Yokoyama, S; Abe, T; Hayakawa, Y; Saiki, I				Eshima, Shizuka; Yokoyama, Satoru; Abe, Takashi; Hayakawa, Yoshihiro; Saiki, Ikuo			Multi-Pathway Cellular Analysis on Crude Natural Drugs/Herbs from Japanese Kampo Formulations	PLOS ONE			English	Article								Kampo formulations comprise a number of crude natural drugs/herbs as constituents. The crude drugs/herbs have been traditionally classified by their traditional classifications or efficacies in Kampo medicines; however, it has been difficult to establish the scientific link between experimental evidence and traditional classifications in Kampo medicine. To clarify such traditional conceptions, we tested 112 crude drugs/herbs that are major components of Kampo formulations, in the multi-pathway analysis of 10 well-studied transcriptional activities including CREB, ERSF, HIF-1 alpha, IRFs, MYC, NF-kappa B, p53, SMAD, SOX2, and TCF/LEF in A549 human lung cancer cells. By clustering the results of multi-pathway analysis with the Spearman rank-correlation coefficient and Ward linkage, three distinct traditional categories were significantly enriched in the major groupings, which are heat-clearing and dampness-drying herbs, acrid and warm exterior-resolving herbs, and acrid and cool exterior-resolving herbs. These results indicate that these crude drugs/herbs have similar effects on intracellular signaling and further imply that the traditional classifications of those enriched crude drugs/herbs can be supported by such experimental evidence. Collectively, our new in vitro multi-pathway analysis may be useful to clarify the mechanism of action of crude drugs/herbs and Kampo formulations.	[Eshima, Shizuka; Yokoyama, Satoru; Hayakawa, Yoshihiro; Saiki, Ikuo] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan; [Abe, Takashi] Niigata Univ, Grad Sch Sci & Technol, Niigata 9518510, Japan	University of Toyama; Niigata University	Yokoyama, S (corresponding author), Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan.	yokoyama@inm.u-toyama.ac.jp	Yokoyama, Satoru/AAT-3254-2021	Yokoyama, Satoru/0000-0001-8336-486X	Ministry of Education, Culture, Sports, Science, and Technology, Japan [24700971, 24659348, 15K08902]; Uehara Memorial Foundation; Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine), Institute of Natural Medicine, University of Toyama	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine), Institute of Natural Medicine, University of Toyama	This work was supported in part by a Grant-in-Aid for Young Scientists (B) 24700971 (SY), by a Grant-in-Aid for Challenging Exploratory Research 24659348 (IS), by a Grant-in-Aid for Scientific Research (B) 15K08902 (IS) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by The Uehara Memorial Foundation (SY), and by a Grant-in-Aid for the Cooperative Research Project (TA, IS, and SY) from the Joint Usage/Research Center (Joint Usage/Research Center for Science-Based Natural Medicine), Institute of Natural Medicine, University of Toyama, in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRASIER AR, 1992, METHOD ENZYMOL, V216, P386; Fallahi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115517; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hijikata Y, 2006, EXPERT REV NEUROTHER, V6, P795, DOI 10.1586/14737175.6.5.795; Yz S, 2005, INTRO KAMPO JAPANESE, Vxvi	5	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128872	10.1371/journal.pone.0128872	http://dx.doi.org/10.1371/journal.pone.0128872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035432	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100054
J	Zhang, LW; Yuan, MH; Tao, AF; Xu, JT; Lin, LH; Fang, PP; Qi, JM				Zhang, Liwu; Yuan, Minhang; Tao, Aifen; Xu, Jiantang; Lin, Lihui; Fang, Pingping; Qi, Jianmin			Genetic Structure and Relationship Analysis of an Association Population in Jute (Corchorus spp.) Evaluated by SSR Markers	PLOS ONE			English	Article							DIVERSITY; TRAITS; L.	Population structure and relationship analysis is of great importance in the germplasm utilization and association mapping. Jute, comprised of white jute (C. capsularis L) and dark jute (C. olitorius L), is second to cotton in its commercial significance in the world. Here, we assessed the genetic structure and relationship in a panel of 159 jute accessions from 11 countries and regions using 63 SSRs. The structure analysis divided the 159 jute accessions from white and dark jute into Co and Cc group, further into Co1, Co2, Cc1 and Cc2 subgroups. Out of Cc1 subgroup, 81 accessions were from China and the remaining 10 accessions were from India (2), Japan (5), Thailand, Vietnam (2) and Pakistan (1). Out of Cc2 subgroup, 35 accessions were from China, and the remaining 3 accessions were from India, Pakistan and Thailand respectively. It can be inferred that the genetic background of these jute accessions was not always correlative with their geographical regions. Similar results were found in Co1 and Co2 subgroups. Analysis of molecular variance revealed 81% molecular variation between groups but it was low (19%) within subgroups, which further confirmed the genetic differentiation between the two groups. The genetic relationship analysis showed that the most diverse genotypes were Maliyeshengchangguo and Changguozhongyueyin in dark jute, BZ-2-2, Aidianyehuangma, Yangjuchiyuanguo, Zijinhuangma and Jute 179 in white jute, which could be used as the potential parents in breeding programs for jute improvement. These results would be very useful for association studies and breeding in jute.	[Zhang, Liwu; Yuan, Minhang; Tao, Aifen; Xu, Jiantang; Lin, Lihui; Fang, Pingping; Qi, Jianmin] Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab Minist Educ Genet Breeding & Multiple Uti, Fuzhou 350002, Peoples R China	Fujian Agriculture & Forestry University	Zhang, LW (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab Minist Educ Genet Breeding & Multiple Uti, Fuzhou 350002, Peoples R China.	zhang_liwu@hotmail.com; qijm863@163.com		Zhang, Liwu/0000-0001-8465-2476; Yuan, Minhang/0000-0001-6184-2998	Doctoral Program of Higher Education of China [20133515120002]; Introduction Breeding and Varieties Demonstration of Featured Crops between China and Benin [2015I0001]; National AgriIndustry Technology Research System for Crops of Bast and Leaf Fiber, China [nycytx-19-E05]; Introduction Program of International Advanced Agricultural Science and Technology of Ministr of Agriculture, China [2013Z70]; Construction of Germplasm Resources Platform of Bast Fiber Crops in Fujian, China	Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Introduction Breeding and Varieties Demonstration of Featured Crops between China and Benin; National AgriIndustry Technology Research System for Crops of Bast and Leaf Fiber, China; Introduction Program of International Advanced Agricultural Science and Technology of Ministr of Agriculture, China; Construction of Germplasm Resources Platform of Bast Fiber Crops in Fujian, China	This work was supported by The Doctoral Program of Higher Education of China (20133515120002), http://www.cutech.edu.cn/; Introduction Breeding and Varieties Demonstration of Featured Crops between China and Benin (2015I0001), http://xmgl.fjkjt.gov.cn/; National AgriIndustry Technology Research System for Crops of Bast and Leaf Fiber, China (nycytx-19-E05), http://119.253.58.231/; The Introduction Program of International Advanced Agricultural Science and Technology of Ministr of Agriculture, China (2013Z70), http://www.moa.gov.cn/; Construction of Germplasm Resources Platform of Bast Fiber Crops in Fujian, China, http://xmgl.fjkjt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter J, 2008, AUST J CROP SCI, V1, P97; Basu A, 2004, CROP SCI, V44, P678, DOI 10.2135/cropsci2004.0678; Das M, 2012, J GENET, V91, P21, DOI 10.1007/s12041-012-0151-9; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ghosh R. K., 2014, Kasetsart Journal, Natural Science, V48, P83; Huq S, 2009, BANGL J BOT, V38, P153; Kundu A, 2013, J PLANT BIOCHEM BIOT, V22, P372, DOI 10.1007/s13562-012-0165-7; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mir RR, 2008, EUPHYTICA, V161, P413, DOI 10.1007/s10681-007-9597-x; Mir RR, 2009, CROP SCI, V49, P1687, DOI 10.2135/cropsci2008.10.0599; Palit P, 1996, EUPHYTICA, V90, P49; Patel G. I., 1960, EUPHYTICA, V9, P89; Pritchard JK, 2000, GENETICS, V155, P945; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Roy A, 2006, PLANT BREEDING, V125, P292, DOI 10.1111/j.1439-0523.2006.01208.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sumana Banerjee, 2012, Molecular Plant Breeding, V2012, P11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Xiong H., 2008, BREEDING SCI BAST LE; Zhang L, 2014, ACTA AGRONOMICA SINI, V40, P1028	21	12	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128195	10.1371/journal.pone.0128195	http://dx.doi.org/10.1371/journal.pone.0128195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035301	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100029
J	Alves-De-Souza, C; Pecqueur, D; Le Floc'h, E; Mas, S; Roques, C; Mostajir, B; Vidussi, F; Velo-Suarez, L; Sourisseau, M; Fouilland, E; Guillou, L				Alves-de-Souza, Catharina; Pecqueur, David; Le Floc'h, Emilie; Mas, Sebastien; Roques, Cecile; Mostajir, Behzad; Vidussi, Franscesca; Velo-Suarez, Lourdes; Sourisseau, Marc; Fouilland, Eric; Guillou, Laure			Significance of Plankton Community Structure and Nutrient Availability for the Control of Dinoflagellate Blooms by Parasites: A Modeling Approach	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; ROTIFER BRACHIONUS-PLICATILIS; PHYTOPLANKTON COMMUNITIES; DISEASE RISK; THAU LAGOON; GENERATION TIME; COASTAL LAGOON; AMOEBOPHRYA SP; GROWTH-RATES; RED-TIDE	Dinoflagellate blooms are frequently observed under temporary eutrophication of coastal waters after heavy rains. Growth of these opportunistic microalgae is believed to be promoted by sudden input of nutrients and the absence or inefficiency of their natural enemies, such as grazers and parasites. Here, numerical simulations indicate that increasing nutrient availability not only promotes the formation of dinoflagellate blooms but can also stimulate their control by protozoan parasites. Moreover, high abundance of phytoplankton other than dinoflagellate hosts might have a significant dilution effect on the control of dinoflagellate blooms by parasites, either by resource competition with dinoflagellates (thus limiting the number of hosts available for infection) or by affecting numerical-functional responses of grazers that consume free-living parasite stages. These outcomes indicate that although both dinoflagellates and their protozoan parasites are directly affected by nutrient availability, the efficacy of the parasitic control of dinoflagellate blooms under temporary eutrophication depends strongly on the structure of the plankton community as a whole.	[Alves-de-Souza, Catharina] Univ Fed Rio de Janeiro, Museu Nacl, Dept Bot, Lab Ficol, Rio De Janeiro, RJ, Brazil; [Pecqueur, David; Le Floc'h, Emilie; Roques, Cecile; Mostajir, Behzad; Vidussi, Franscesca] Univ Montpellier, CNRS, IFREMER,IRD,UM,CC 093, UMR MARBEC Ctr Marine Biodivers Exploitat & Conse, F-34059 Montpellier, France; [Le Floc'h, Emilie; Mas, Sebastien] CNRS, SMEL, IRD, UM,UMS OSU OREME MEDIMEER 3282, Sete, France; [Le Floc'h, Emilie; Fouilland, Eric] CNRS, UMR MARBEC Ctr Marine Biodivers Exploitat & Conse, IFREMER, UM,IRD,SMEL, Sete, France; [Velo-Suarez, Lourdes; Sourisseau, Marc] IFREMER, DYNECO PELAGOS, Plouzane, France; [Guillou, Laure] CNRS, UMR 7144, Roscoff, France; [Guillou, Laure] Univ Paris 06, Stn Biol Roscoff, Roscoff, France	Universidade Federal do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Alves-De-Souza, C (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Bot, Lab Ficol, Quinta Boa Vista S N, Rio De Janeiro, RJ, Brazil.	cathsouza@gmail.com	Fouilland, Eric/R-1415-2017; Alves-de-Souza, Catharina/G-3286-2014; Velo-Suárez, Lourdes/C-2664-2009	Fouilland, Eric/0000-0001-9633-8847; Alves-de-Souza, Catharina/0000-0001-9577-8090; sourisseau, marc/0000-0002-0778-0076	French National Research Agency (ANR); Marie Curie International Outgoing Fellowship (IOF) [MOHAB PIOF-GA-252260]; "ECosphere Continentale et Cotiere" (EC2CO) French National Program; national French EC2CO program PARALEX	French National Research Agency (ANR)(French National Research Agency (ANR)); Marie Curie International Outgoing Fellowship (IOF); "ECosphere Continentale et Cotiere" (EC2CO) French National Program(French National Research Agency (ANR)); national French EC2CO program PARALEX	This research was part of the projects "Paralex", funded by the French National Research Agency (ANR), and "Impact des eaux de crue sur le reseau microbien de la lagune de Thau (RESTHAU)", funded by the "ECosphere Continentale et Cotiere" (EC2CO) French National Program. The modeling part was supported by the national French EC2CO program PARALEX (2009-2011) coordinated by L. Guillou. L. Velo-Suarez was supported by a Marie Curie International Outgoing Fellowship (IOF; grant agreement: MOHAB PIOF-GA-252260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; ANDERSON R M, 1981, PHILOS T R SOC B, V210, P658; Bachvaroff TR, APPL ENV MI IN PRESS; Burkholder JM, 2008, HARMFUL ALGAE, V8, P77, DOI 10.1016/j.hal.2008.08.010; Buskey EJ, 2008, HARMFUL ALGAE, V8, P152, DOI 10.1016/j.hal.2008.08.009; Cachon J., 1964, Annales des Sciences Naturelles (12), V6, P1; Calbet A, 2003, MAR ECOL PROG SER, V259, P303, DOI 10.3354/meps259303; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; Chan LL, 2004, PROTEOMICS, V4, P3214, DOI 10.1002/pmic.200300838; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Collos Y, 2004, J PHYCOL, V40, P96, DOI 10.1046/j.1529-8817.2004.03034.x; Collos Y, 1997, ESTUAR COAST SHELF S, V44, P369, DOI 10.1006/ecss.1996.0121; FURNAS MJ, 1982, MAR BIOL, V70, P105, DOI 10.1007/BF00397301; Graneli E, 2008, HARMFUL ALGAE, V8, P94, DOI 10.1016/j.hal.2008.08.011; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hansen B, 1997, J EXP MAR BIOL ECOL, V215, P217, DOI 10.1016/S0022-0981(97)00053-1; Hatcher MJ, 2012, FRONT ECOL ENVIRON, V10, P186, DOI 10.1890/110016; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Jeong HJ, 2002, AQUAT MICROB ECOL, V28, P289, DOI 10.3354/ame028289; Johansson M, 2002, AQUAT MICROB ECOL, V28, P69, DOI 10.3354/ame028069; Johnson PTJ, 2010, J EXP BIOL, V213, P961, DOI 10.1242/jeb.037721; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Laanaia N, 2013, HARMFUL ALGAE, V28, P31, DOI 10.1016/j.hal.2013.05.016; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Montagnes DJS, 2008, AQUAT MICROB ECOL, V53, P211, DOI 10.3354/ame01245; MONTAGNES DJS, 1994, LIMNOL OCEANOGR, V39, P1044, DOI 10.4319/lo.1994.39.5.1044; Montagnes DJS, 2001, MAR BIOL, V139, P975; Orlofske SA, 2014, FRESHWATER BIOL, V59, P1064, DOI 10.1111/fwb.12329; Ornolfsdottir EB, 2004, J PLANKTON RES, V26, P325, DOI 10.1093/plankt/fbh035; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Park MG, 2004, J EUKARYOT MICROBIOL, V51, P145, DOI 10.1111/j.1550-7408.2004.tb00539.x; Rosetta CH, 2003, HARMFUL ALGAE, V2, P109, DOI 10.1016/S1568-9883(03)00019-2; Salomon PS, 2010, MAR ECOL PROG SER, V419, P1, DOI 10.3354/meps08839; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Seeyave S., 2009, NITROGEN NUTR HARMFU; Sherr EB, 2009, AQUAT MICROB ECOL, V57, P253, DOI 10.3354/ame01358; Smayda TJ, 2008, HARMFUL ALGAE, V8, P140, DOI 10.1016/j.hal.2008.08.018; Sobol I.M., 1990, MAT MODEL, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Strom SL, 1998, J PLANKTON RES, V20, P571, DOI 10.1093/plankt/20.3.571; Teegarden GJ, 1996, J EXP MAR BIOL ECOL, V196, P145, DOI 10.1016/0022-0981(95)00128-X; Thieltges DW, 2008, PARASITOLOGY, V135, P407, DOI 10.1017/S0031182007000248; Tournoud MG, 2006, ECOL MODEL, V193, P19, DOI 10.1016/j.ecolmodel.2005.07.038; VERITY PG, 1991, J PROTOZOOL, V38, P69, DOI 10.1111/j.1550-7408.1991.tb04804.x; Walsh JJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002813; Warrick JA, 2005, ESTUAR COAST SHELF S, V62, P559, DOI 10.1016/j.ecss.2004.09.033; Yih W, 2000, J EUKARYOT MICROBIOL, V47, P504, DOI 10.1111/j.1550-7408.2000.tb00082.x; Zheng-Fang W, 1995, CHIN J OCEANOL LIMN, V13, P338	54	11	11	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127623	10.1371/journal.pone.0127623	http://dx.doi.org/10.1371/journal.pone.0127623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030411	Green Published, gold			2022-12-27	WOS:000356630900067
J	Barkho, S; Pierce, LCT; Li, S; Adams, JA; Jennings, PA				Barkho, Sulyman; Pierce, Levi C. T.; Li, Sheng; Adams, Joseph A.; Jennings, Patricia A.			Theoretical Insights Reveal Novel Motions in Csk's SH3 Domain That Control Kinase Activation	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; TERMINAL SRC KINASE; EXCHANGE MASS-SPECTROMETRY; FAMILY KINASES; C-SRC; CATALYTIC DOMAINS; STRUCTURAL BASIS; IDENTIFICATION; MECHANISM; DYNAMICS	The Src family of tyrosine kinases (SFKs) regulate numerous aspects of cell growth and differentiation and are under the principal control of the C-terminal Src Kinase (Csk). Although Csk and SFKs share conserved kinase, SH2 and SH3 domains, they differ considerably in three-dimensional structure, regulatory mechanism, and the intrinsic kinase activities. Although the SH2 and SH3 domains are known to up-or down-regulate tyrosine kinase function, little is known about the global motions in the full-length kinase that govern these catalytic variations. We use a combination of accelerated Molecular Dynamics (aMD) simulations and experimental methods to provide a new view of functional motions in the Csk scaffold. These computational studies suggest that high frequency vibrations in the SH2 domain are coupled through the N-terminal lobe of the kinase domain to motions in the SH3 domain. The effects of these reflexive movements on the kinase domain can be viewed using both Deuterium Exchange Mass Spectrometry (DXMS) and steady-state kinetic methods. Removal of several contacts, including a crystallographically unobserved N-terminal segment, between the SH3 and kinase domains short-circuit these coupled motions leading to reduced catalytic efficiency and stability of N-lobe motifs within the kinase domain. The data expands the model of Csk's activation whereby separate domains productively interact with two diametrically opposed surfaces of the kinase domain. Such reversible transitions may organize the active structure of the tyrosine kinase domain of Csk.	[Barkho, Sulyman; Pierce, Levi C. T.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pajennings@ucsd.edu			National Institutes of Health (NIH) [AI081982, AI101436, GM020501]; NIH [GM101467]; NSF [PHY-1212312]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101436, R01AI081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098528, T32GM008326, R01GM101467, R01GM067969] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SL is supported by National Institutes of Health (NIH) grants AI081982, AI101436, GM020501. PAJ is supported by NIH Grant GM101467 and NSF Grant PHY-1212312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayrapetov MK, 2005, J BIOL CHEM, V280, P25780, DOI 10.1074/jbc.M504022200; Barkho S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003188; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; de Oliveira CAF, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002178; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Huang KZ, 2009, J MOL BIOL, V386, P1066, DOI 10.1016/j.jmb.2009.01.012; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jamros MA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002695; Jamros MA, 2010, J BIOL CHEM, V285, P36121, DOI 10.1074/jbc.M110.116947; Jankowski W, 2012, NAT CHEM BIOL, V8, P590, DOI [10.1038/NCHEMBIO.954, 10.1038/nchembio.954]; Lee S, 2003, P NATL ACAD SCI USA, V100, P14707, DOI 10.1073/pnas.2534493100; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Lieser SA, 2006, J BIOL CHEM, V281, P38004, DOI 10.1074/jbc.M607824200; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mikkola ET, 2010, J MOL BIOL, V399, P618, DOI 10.1016/j.jmb.2010.04.045; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Safari F, 2011, P NATL ACAD SCI USA, V108, P14938, DOI 10.1073/pnas.1107740108; SEIDELDUGAN C, 1992, MOL CELL BIOL, V12, P1835, DOI 10.1128/MCB.12.4.1835; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Sun GQ, 1999, ARCH BIOCHEM BIOPHYS, V367, P167, DOI 10.1006/abbi.1999.1253; Tanaka H, 2013, J BIOL CHEM, V288, P15240, DOI 10.1074/jbc.M112.439075; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wereszczynski J, 2012, P NATL ACAD SCI USA, V109, P7759, DOI 10.1073/pnas.1117441109; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; Xu B, 1996, MOL CELL BIOCHEM, V158, P57; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1	44	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127724	10.1371/journal.pone.0127724	http://dx.doi.org/10.1371/journal.pone.0127724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030592	Green Published, gold			2022-12-27	WOS:000356630900076
J	Dehmer, M; Kurt, Z; Emmert-Streib, F; Them, C; Schulc, E; Hofer, S				Dehmer, Matthias; Kurt, Zeyneb; Emmert-Streib, Frank; Them, Christa; Schulc, Eva; Hofer, Sabine			Structural Analysis of Treatment Cycles Representing Transitions between Nursing Organizational Units Inferred from Diabetes	PLOS ONE			English	Article							NETWORK ANALYSIS	In this paper, we investigate treatment cycles inferred from diabetes data by means of graph theory. We define the term treatment cycles graph-theoretically and perform a descriptive as well as quantitative analysis thereof. Also, we interpret our findings in terms of nursing and clinical management.	[Dehmer, Matthias] Univ Bundeswehr Munchen, Dept Comp Sci, D-85577 Neubiberg, Germany; [Dehmer, Matthias] UMIT, Dept Biomed Comp Sci & Mechatron, A-6060 Hall In Tirol, Austria; [Kurt, Zeyneb] Yildiz Tech Univ, Dept Comp Engn, TR-34220 Istanbul, Turkey; [Emmert-Streib, Frank] Tampere Univ Technol, FI-33720 Tampere, Finland; [Them, Christa; Schulc, Eva] UMIT, Inst Nursing Sci, Dept Nursing Sci & Gerontol, A-6060 Hall In Tirol, Austria; [Hofer, Sabine] Med Univ Innsbruck, Dept Pediat, A-6020 Innsbruck, Austria	Bundeswehr University Munich; Yildiz Technical University; Tampere University; Medical University of Innsbruck	Dehmer, M (corresponding author), Univ Bundeswehr Munchen, Dept Comp Sci, Werner Heisenberg Weg 39, D-85577 Neubiberg, Germany.	matthias.dehmer@umit.at	Kurt, Zeyneb/D-2661-2017; Emmert-Streib, Frank/AAF-2878-2020; Emmert-Streib, Frank/G-8099-2011	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641; Kurt, Zeyneb/0000-0003-3186-8091	Tiroler Wissenschaftsfond [GZ. 0404/1443]	Tiroler Wissenschaftsfond	Matthias Dehmer, Christa Them, Eva Schulc, and Zeyneb Kurt thank the Tiroler Wissenschaftsfond for supporting this work (project GZ. 0404/1443).	Anderson C, 2011, NURS RES, V60, P378, DOI 10.1097/NNR.0b013e3182337d97; Anderson R. A., 2008, EDGE NURSING AGE COM, P73; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Benham-Hutchins MM, 2010, INT J MED INFORM, V79, P252, DOI 10.1016/j.ijmedinf.2009.12.005; Bunke H., 1983, Bulletin of the European Association for Theoretical Computer Science, P35; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cott C, 1997, SOC SCI MED, V45, P1411, DOI 10.1016/S0277-9536(97)00066-X; Dehmer M., 2013, ADV NETWORK COMPLEXI; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094985; Dehmer M, 2013, INT J NURS KNOWL, V24, P150, DOI 10.1111/j.2047-3095.2013.01246.x; Dehmer M, 2013, ADV COMPUT MATH, V39, P311, DOI 10.1007/s10444-012-9281-0; Devillers J., 1999, TOPOLOGICAL INDICES; Dowsland KA, 2000, J OPER RES SOC, V51, P825, DOI 10.2307/253963; Effken JA, 2013, CIN-COMPUT INFORM NU, V31, P36, DOI 10.1097/NXN.0b013e3182701082; Effken JA, 2012, CIN-COMPUT INFORM NU, V30, P620, DOI 10.1097/NXN.0b013e318261f1bb; Emmert-Streib F, 2011, IET SYST BIOL, V5, P185, DOI 10.1049/iet-syb.2010.0025; Gambiano M. L., 2008, EDGE NURSING AGE COM, P49; Hamzeh A, 2014, MATCH-COMMUN MATH CO, V72, P807; Harary F., 1969, GRAPH THEORY; HERSHEY JC, 1981, OPER RES, V29, P1, DOI 10.1287/opre.29.1.1; Knor M, 2014, MATCH-COMMUN MATH CO, V72, P321; Kraus V, 2014, INFORM SCIENCES, V288, P220, DOI 10.1016/j.ins.2014.07.018; Li XL, 2008, MATCH-COMMUN MATH CO, V59, P127; Merrill J, 2012, FRONT PHSSR, V1, P1; Merrill J, 2010, J PUBLIC HEALTH MAN, V16, P564, DOI 10.1097/PHH.0b013e3181e31cee; Patterson CC, 2009, EURODIAB STUDY GROUP, V373, P2017; Pesut D. J., 2008, EDGE NURSING AGE COM, P211; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Schober E, 2009, J PEDIATR-US, V155, P190, DOI 10.1016/j.jpeds.2009.03.010; Schutte M, 2014, J MATH CHEM, V52, P805, DOI 10.1007/s10910-013-0294-9; Sommerfeld E., 1994, KNOWLEDGE STRUCTURES, P146, DOI [DOI 10.1007/978-3-642-52064-8_5, 10.1007/978-3-642-52064-8_5]; Todeschini R., 2002, HDB MOL DESCRIPTORS; Tsang SS, 2012, J NURS RES, V20, P9, DOI 10.1097/JNR.0b013e318247bf11; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Zelinka A, 1975, CASOPIS PEST MAT, V100, P371, DOI DOI 10.21136/CPM.1975.117890	36	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127152	10.1371/journal.pone.0127152	http://dx.doi.org/10.1371/journal.pone.0127152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030296	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900042
J	Guo, RR; Cao, LF; Kong, XM; Liu, XS; Xue, HY; Shen, LJ; Li, XL				Guo, Ruru; Cao, Lanfang; Kong, Xianming; Liu, Xuesong; Xue, Haiyan; Shen, Lijuan; Li, Xiaoli			Fever as an Initial Manifestation of Enthesitis-Related Arthritis Subtype of Juvenile Idiopathic Arthritis: Retrospective Study	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; DISEASE-ACTIVITY; COHORT; CRITERIA; CHILDREN; CLASSIFICATION; CATEGORIES	Objective We wished to determine the prevalence of fever as one of the first symptoms of the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis. Also, we wished to ascertain if ERA patients with fever at disease onset differed from those without fever. Methods Consecutive cases of ERA were diagnosed and followed in a retrospective observational study from 1998 to 2013. Information about clinical/laboratory data, medications, magnetic resonance imaging (MRI), and disease activity during the study period was also recorded. Results A total of 146 consecutive ERA patients were assessed. Among them, 52 patients (35.6%) had fever as one of the first symptoms at disease onset. Compared with ERA patients without fever at disease onset, patients with fever had significantly more painful joints (3.5 vs. 2.8), more swollen joints (1.1 vs. 0.8), and more enthesitis (1.0 vs. 0.4) (p<0.05 for all comparisons). Patients with fever had significantly higher mean values of erythrocyte sedimentation rate, C-reactive protein, platelet count, and child health assessment questionnaire (CHAQ) scores (40.8 vs. 26.4 mm/h; 20.7 vs. 9.7 mg/dL; 353.2x10(9)/L vs. 275.6x109/L; 1.0 vs. 0.8, respectively; all p<0.05). During two-year follow-up, CHAQ score, number of flares, as well as the number of patients treated with oral non-steroidal anti-inflammatory drugs, corticosteroids and combination therapy with disease-modifying anti-rheumatic drugs, were significantly higher in ERA patients with fever. Conclusions Fever was a frequent manifestation of ERA. ERA patients with fever had more active disease at disease onset and poorer outcomes than ERA patients without fever.	[Guo, Ruru; Cao, Lanfang; Kong, Xianming; Xue, Haiyan; Shen, Lijuan; Li, Xiaoli] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Pediat, Shanghai 200030, Peoples R China; [Liu, Xuesong] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Ultrasound, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Cao, LF (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Pediat, Shanghai 200030, Peoples R China.	proclf@163.com	Li, Xiaoli/GYQ-7384-2022		Second Major Research Project of the Three Years' Shanghai Traditional Chinese Medicine Career Development Action Plan of Shanghai Health Bureau [ZYSNXD-CC-ZDYJ030]	Second Major Research Project of the Three Years' Shanghai Traditional Chinese Medicine Career Development Action Plan of Shanghai Health Bureau	The work was supported by a grant from the Second Major Research Project of the Three Years' Shanghai Traditional Chinese Medicine Career Development Action Plan of Shanghai Health Bureau (Project Number: ZYSNXD-CC-ZDYJ030).	Alvarez-Madrid C, 2009, CLIN EXP RHEUMATOL, V27, P691; Armon K, 2014, PAED CHILD HLTH CAN, V24, P64; Burgos-Vargas R, 2002, BEST PRACT RES CL RH, V16, P551, DOI 10.1053/berh.2002.0247; Burgos-Vargas R, 2012, TXB CLIN PEDIAT, P1601, DOI [10.1007/978-3-642-02202-9_155, DOI 10.1007/978-3-642-02202-9_155]; Chorus AMJ, 2003, ANN RHEUM DIS, V62, P1178, DOI 10.1136/ard.2002.004861; Colbert RA, 2010, NAT REV RHEUMATOL, V6, P477, DOI 10.1038/nrrheum.2010.103; Elewaut D, 2009, RHEUMATOLOGY, V48, P1029, DOI 10.1093/rheumatology/kep146; Fisher C, 2012, ANN PAEDIAT RHEUM, V1, P8, DOI DOI 10.5455/APR.011520120733; Flato B, 2006, ARTHRITIS RHEUM-US, V54, P3573, DOI 10.1002/art.22181; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Gutiurrez-SuuYrez, 2010, INT J CLIN RHEUMATOL, V5, P229, DOI [10.2217/ijr.10.12, DOI 10.2217/IJR.10.12]; Heiligenhaus A, 2007, RHEUMATOLOGY, V46, P1015, DOI 10.1093/rheumatology/kem053; Hyrich KL, 2010, RHEUMATOLOGY, V49, P116, DOI 10.1093/rheumatology/kep352; Jousse-Joulin S, 2011, ARTHRIT CARE RES, V63, P849, DOI 10.1002/acr.20444; Kan JH, 2013, PEDIATR RADIOL, V43, pS172, DOI 10.1007/s00247-012-2586-9; Lee T-L, 2010, HONG KONG B RHEUM DI, V10, P15; Maas T, 2014, PRIM CARE RESP J, V23, P14, DOI 10.4104/pcrj.2013.00108; Nordal E, 2011, ARTHRITIS RHEUM-US, V63, P2809, DOI 10.1002/art.30426; Ogoina Dimie, 2011, J Infect Public Health, V4, P108, DOI 10.1016/j.jiph.2011.05.002; Pagnini I, 2010, J RHEUMATOL, V37, P2395, DOI 10.3899/jrheum.100090; Pruunsild C, 2007, SCAND J RHEUMATOL, V36, P7, DOI 10.1080/03009740601089259; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS91; Saurenmann RK, 2007, ARTHRITIS RHEUM, V56, P1974, DOI 10.1002/art.22709; Shen CC, 2013, J MICROBIOL IMMUNOL, V46, P288, DOI 10.1016/j.jmii.2012.03.006; Sieper J, 2009, ANN RHEUM DIS, V68, P784, DOI 10.1136/ard.2008.101501; von Bubnoff D, 2010, J ALLERGY CLIN IMMUN, V125, P60, DOI 10.1016/j.jaci.2009.11.020; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Weiss PF, 2012, ADOLESC HEALTH MED T, V3, P67, DOI 10.2147/AHMT.S25872; Weiss PF, 2011, ARTHRIT CARE RES, V63, P1307, DOI 10.1002/acr.20508; Windschall D, 2015, CLIN RHEUMATOL, V34, P61, DOI 10.1007/s10067-014-2744-6	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128979	10.1371/journal.pone.0128979	http://dx.doi.org/10.1371/journal.pone.0128979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030261	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900202
J	Kanda, E; Bieber, BA; Pisoni, RL; Robinson, BM; Fuller, DS				Kanda, Eiichiro; Bieber, Brian A.; Pisoni, Ronald L.; Robinson, Bruce M.; Fuller, Douglas S.			Importance of Simultaneous Evaluation of Multiple Risk Factors for Hemodialysis Patients' Mortality and Development of a Novel Index: Dialysis Outcomes and Practice Patterns Study	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; NUTRITIONAL-STATUS; SERUM-ALBUMIN; PROTEIN; PHOSPHORUS; PREDICTOR; CALCIUM	Background For hemodialysis (HD) patients, many risk factors for death are associated with each other intricately. However, they are often considered separately in clinical settings. We evaluated the maintenance HD patients' risk of death within one year from multiple risk factors simultaneously considering their interrelationships using a novel index (survival index, SI) for HD patients in the United States developed using data from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Methods We analyzed data from 3899 and 3765 patients to develop and validate SI, respectively. To predict death within one year, candidate models were developed using logistic regression models. The final model was determined by comparing the accuracy among the models for the prediction of deaths. Results The model included age; body mass index; serum creatinine, albumin, total cholesterol and phosphorus levels; history of cardiovascular diseases; and arteriovenous fistula use. SI showed a higher accuracy in predicting death (c-statistic, 0.739) than geriatric nutritional risk index (0.647) and serum albumin level (0.637). The probability of death predicted on the basis of SI matched the observed number of deaths. Cox proportional hazard models for time-dependent SI showed that patients with low SI had a higher risk of death than patients with high SI [reference, Group 4 (26.1 <= SI)]; Group 1 (SI<12.7), adjusted hazard ratio, 7.97 (95% CI, 5.02, 12.65); Group 2 (12.7 <= SI<19.0), 3.18 (95% CI, 1.96, 5.16); Group 3 (19.0 <= SI<26.1), 2.20 (95% CI, 1.33, 3.66). Conclusion Results of this study suggest that the simultaneous evaluation of multiple risk factors can more accurately assess patients' prognosis and identify patients at an increased risk of death than single factors.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro] Tokyo Med & Dent Univ, Life Sci & Bioeth Ctr, Bunkyo Ku, Tokyo, Japan; [Bieber, Brian A.; Pisoni, Ronald L.; Robinson, Bruce M.; Fuller, Douglas S.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Robinson, Bruce M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Tokyo Medical & Dental University (TMDU); Arbor Research Collaborative for Health; University of Michigan System; University of Michigan	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com		Bieber, Brian/0000-0001-8505-0979; Robinson, Bruce/0000-0003-0749-1714	Amgen; Kyowa Hakko Kirin (Japan); Sanofi Renal; AbbVie; Baxter; Vifor Fresenius Renal Pharma	Amgen(Amgen); Kyowa Hakko Kirin (Japan); Sanofi Renal; AbbVie(AbbVie); Baxter; Vifor Fresenius Renal Pharma	The DOPPS is administered by Arbor Research Collaborative for Health. The DOPPS Program has been supported by scientific research grants from Amgen (since 1996), Kyowa Hakko Kirin (since 1999, in Japan), Sanofi Renal (since 2009), AbbVie (since 2009), Baxter (since 2011), and Vifor Fresenius Renal Pharma (since 2011), with the shared mission of providing a strong scientific basis for the identification of dialysis and CKD practices that are most associated with improved patient survival and quality of life. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. All support has been provided without restrictions on publications.	Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Beddhu S, 2004, J AM SOC NEPHROL, V15, P733, DOI 10.1097/01.ASN.0000113319.57131.28; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; CANAUD B, 1995, NEPHROL DIAL TRANSPL, V10, P1405; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chua HR, 2014, BLOOD PURIFICAT, V37, P85, DOI 10.1159/000357640; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Mutsert R, 2008, NEPHROL DIAL TRANSPL, V23, P2957, DOI 10.1093/ndt/gfn167; Depner TA, 1996, J AM SOC NEPHROL, V7, P780; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Fouque D, 2013, NEPHROL DIAL TRANSPL, V28, P360, DOI 10.1093/ndt/gfs404; Gama-Axelsson T, 2012, CLIN J AM SOC NEPHRO, V7, P1446, DOI 10.2215/CJN.10251011; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Herselman M, 2010, J RENAL NUTR, V20, P281, DOI 10.1053/j.jrn.2010.03.010; Hoogeveen EK, 2012, CLIN J AM SOC NEPHRO, V7, P280, DOI 10.2215/CJN.05700611; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kalantar-Zadeh K, 2010, CLIN J AM SOC NEPHRO, V5, P519, DOI 10.2215/CJN.06080809; KESHAVIAH PR, 1994, J AM SOC NEPHROL, V4, P1475; Kobayashi I, 2010, NEPHROL DIAL TRANSPL, V25, P3361, DOI 10.1093/ndt/gfq211; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Lopes AA, 2010, J RENAL NUTR, V20, P224, DOI 10.1053/j.jrn.2009.10.002; Lynch KE, 2011, CLIN J AM SOC NEPHRO, V6, P620, DOI 10.2215/CJN.04620510; Miskulin D, 2009, CLIN J AM SOC NEPHRO, V4, P1818, DOI 10.2215/CJN.00640109; Moss AH, 2008, CLIN J AM SOC NEPHRO, V3, P1379, DOI 10.2215/CJN.00940208; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Plantinga LC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-5; Rocco MV, 2006, ANN INTERN MED, V145, P512, DOI 10.7326/0003-4819-145-7-200610030-00009; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Takahashi R, 2012, AM J NEPHROL, V36, P136, DOI 10.1159/000339940; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; WILLIFORD WO, 1991, NEW ENGL J MED, V325, P525; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x	39	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128652	10.1371/journal.pone.0128652	http://dx.doi.org/10.1371/journal.pone.0128652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030526	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900180
J	Kok, M; Kietselaer, BLJH; Mihl, C; Altintas, S; Nijssen, EC; Wildberger, JE; Das, M				Kok, Madeleine; Kietselaer, Bas L. J. H.; Mihl, Casper; Altintas, Sibel; Nijssen, Estelle C.; Wildberger, Joachim E.; Das, Marco			Contrast Enhancement of the Right Ventricle during Coronary CT Angiography - Is It Necessary?	PLOS ONE			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; DUAL-SOURCE CT; WORKING GROUP; RIGHT HEART; MASS; ECHOCARDIOGRAPHY; REPRODUCIBILITY; QUANTIFICATION; OPTIMIZATION; MANAGEMENT	Purpose It is unclear if prolonged contrast media injection, to improve right ventricular visualization during coronary CT angiography, leads to increased detection of right ventricle pathology. The purpose of this study was to evaluate right ventricle enhancement and subsequent detection of right ventricle disease during coronary CT angiography. Materials and Methods 472 consecutive patients referred for screening coronary CT angiography were retrospectively evaluated. Every patient underwent multidetector-row CT of the coronary arteries: 128x0.6mm coll., 100-120kV, rot. time 0.28s, ref. mAs 350 and received an individualized (P3T) contrast bolus injection of iodinated contrast medium (300 mgI/ml). Patient data were analyzed to assess right ventricle enhancement (HU) and right ventricle pathology. Image quality was defined good when right ventricle enhancement >200HU, moderate when 140-200HU and poor when <140HU. Results Good image quality was found in 372 patients, moderate in 80 patients and poor in 20 patients. Mean enhancement of the right ventricle cavity was 268HU +/- 102. Patients received an average bolus of 108 +/- 24 ml at an average peak flow rate of 6.1 +/- 2.2 ml/s. In only three out of 472 patients (0.63%) pathology of the right ventricle was found (dilatation) No other right ventricle pathology was detected. Conclusion Right ventricle pathology was detected in three out of 472 patients; the dilatation observed in these three cases may have been picked up even without dedicated enhancement of the right ventricle. Based on our findings, right ventricle enhancement can be omitted during screening coronary CT angiography.	[Kok, Madeleine; Kietselaer, Bas L. J. H.; Mihl, Casper; Nijssen, Estelle C.; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands; [Kok, Madeleine; Kietselaer, Bas L. J. H.; Mihl, Casper; Altintas, Sibel; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, CARIM, Cardio Vasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Kietselaer, Bas L. J. H.; Altintas, Sibel] Maastricht Univ, Med Ctr, Dept Cardiol, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Kok, M (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands.	madeleine.kok@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854	Siemens AG; Bayer Healthcare; GE Healthcare; Philips Healthcare	Siemens AG(Siemens AG); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); GE Healthcare(General ElectricGE Healthcare); Philips Healthcare	JEW MD received general institutional funding from Siemens AG, Bayer Healthcare, GE Healthcare and Philips Healthcare without any correlation to this specific work. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Annuar BR, 2008, EUR J RADIOL, V65, P112, DOI 10.1016/j.ejrad.2007.03.008; Becker CR, 2003, INVEST RADIOL, V38, P690, DOI 10.1097/01.rli.0000084886.44676.e4; Beygui F, 2004, INT J CARDIOVAS IMAG, V20, P509, DOI 10.1007/s10554-004-1097-7; Braunwald E, 2002, CIRCULATION, V106, P1312, DOI 10.1161/01.CIR.0000030314.11999.6A; Buechel ERV, 2012, EUR HEART J, V33, P949, DOI 10.1093/eurheartj/ehr490; Burazor I, 2014, CLIN CARDIOL, V37, P582, DOI 10.1002/clc.22295; Cademartiri F, 2004, EUR RADIOL, V14, P178, DOI 10.1007/s00330-003-2188-x; Castillo JG, 2010, SEMIN CARDIOTHORAC V, V14, P6, DOI 10.1177/1089253210362596; Davidson C, 2006, AM J CARDIOL, V98, p42K, DOI 10.1016/j.amjcard.2006.01.023; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Funabashi N, 2007, INT J CARDIOL, V114, P265, DOI 10.1016/j.ijcard.2005.11.066; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Johnson TRC, 2006, EUR RADIOL, V16, P1409, DOI 10.1007/s00330-006-0298-y; Kerl JM, 2008, RADIOLOGY, V247, P356, DOI 10.1148/radiol.2472070856; LAM KY, 1993, ARCH PATHOL LAB MED, V117, P1027; Nance JW, 2012, INVEST RADIOL, V47, P78, DOI 10.1097/RLI.0b013e31821a2142; OLDERSHAW P, 1992, BRIT HEART J, V68, P12; Puesken M, 2008, EUR RADIOL, V18, P2087, DOI 10.1007/s00330-008-0982-1; Quiroz R, 2004, CIRCULATION, V109, P2401, DOI 10.1161/01.CIR.0000129302.90476.BC; Remy-Jardin M, 2006, AM J ROENTGENOL, V187, P1605, DOI 10.2214/AJR.05.1194; Rist C, 2006, INVEST RADIOL, V41, P460, DOI 10.1097/01.rli.0000208239.34723.5d; Seifarth H, 2009, EUR RADIOL, V19, P2373, DOI 10.1007/s00330-009-1421-7; Takx RAP, 2012, EUR J RADIOL, V81, pE598, DOI 10.1016/j.ejrad.2011.07.001; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208	27	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128625	10.1371/journal.pone.0128625	http://dx.doi.org/10.1371/journal.pone.0128625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029905	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900176
J	Sheffield, CL; Crippen, TL; Byrd, JA; Beier, RC; Yeater, K				Sheffield, Cynthia L.; Crippen, Tawni L.; Byrd, J. Allen; Beier, Ross C.; Yeater, Kathleen			Canonical Discrimination of the Effect of a New Broiler Production Facility on Soil Chemical Profiles as Related to Current Management Practices	PLOS ONE			English	Article							GENETIC-VARIATION; PHOSPHORUS; EXTRACTANT; POTASSIUM; MANGANESE; NITROGEN; QUALITY; ZINC	The effect dirt-floored broiler houses have on the underlying native soil, and the potential for contamination of the ground water by leaching under the foundation, is an understudied area. This study examines alterations in fifteen quantitative soil parameters (Ca, Cu, electrical conductivity, Fe, K, Mg, Mn, Na, NO3, organic matter, P, pH, S, soil moisture and Zn) in the underlayment of a newly constructed dirt-floored broiler house over the first two years of production (Native through Flock 11). The experiment was conducted near NW Robertson County, Texas, where the native soil is a fine, smectitic thermic Udertic Paleustalfs and the slopes range from zero to three percent. Multiple samples were collected from under each of three water and three feed lines the length of the house, in a longitudinal study during February 2008 through August 2010. To better define the relationship between the soil parameters and sampling times, a canonical discriminant analysis approach was used. The soil profiles assembled into five distinctive clusters corresponding to time and management practices. Results of this work revealed that the majority of parameters increased over time. The management practices of partial and total house clean-outs markedly altered soil profiles the house underlayment, thus reducing the risk of infiltration into the ground water near the farm. This is important as most broiler farms consist of several houses within a small area, so the cumulative ecological impact could be substantial if not properly managed.	[Sheffield, Cynthia L.; Crippen, Tawni L.; Byrd, J. Allen; Beier, Ross C.] ARS, USDA, Food & Feed Safety Res Unit, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA; [Yeater, Kathleen] ARS, USDA, Plains Area, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sheffield, CL (corresponding author), ARS, USDA, Food & Feed Safety Res Unit, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA.	cindy.sheffield@ars.usda.gov		Crippen, Tawni/0000-0001-5129-2371	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	The authors extend their thanks to our commercial partner for allowing us to work in cooperation with their producers. We also gratefully recognize Andrew Herndon, Denise Caldwell, Charles Hernandez, Laura Ripley and Bob Droleskey for their invaluable help in both the field and laboratory. This project was funded by the United States Department of Agriculture. There is no commercial or financial conflict of interest. Mention of trade name, proprietary product, or specific equipment does not constitute a guarantee or warranty by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable.	Arshad MA, 2002, AGR ECOSYST ENVIRON, V88, P153, DOI 10.1016/S0167-8809(01)00252-3; Batjes N, 1995, GLOBAL DATA SET SOIL; CRUZCASTILLO JG, 1994, HORTSCIENCE, V29, P1115, DOI 10.21273/HORTSCI.29.10.1115; EPA, 2013, 820R13002 EPA; EPA U. S. E. P. A, 2012, FACTS NUTR POLL; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Kachurina OM, 2000, COMMUN SOIL SCI PLAN, V31, P893, DOI 10.1080/00103620009370485; Keeney D.R, 1982, AGRON MONOGR, P643; Kratz S, 2004, J ENVIRON QUAL, V33, P1662, DOI 10.2134/jeq2004.1662; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Lomax K. M., 1997, Applied Engineering in Agriculture, V13, P773; Mallin MA, 1997, J ENVIRON QUAL, V26, P1622, DOI 10.2134/jeq1997.00472425002600060023x; Mathews K, 2012, LDPM219 USDAERS; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; MEHLICH A, 1978, COMMUN SOIL SCI PLAN, V9, P477, DOI 10.1080/00103627809366824; Miles DM, 2013, POULTRY SCI, V92, P1693, DOI 10.3382/ps.2012-02809; National Chicken Council, 2010, TOP BROIL PROD STAT; Rhoades J.D., 1982, METHODS SOIL ANAL, V1, P149, DOI DOI 10.1016/J.JHAZMAT.2009.04.097; SCHOFIELD R. K., 1955, SOIL SCI SOC AMER PROC, V19, P164; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Sims JT, 2005, SOIL USE MANAGE, V21, P141, DOI 10.1079/SUM2005301; Smith PM, 2012, GEOFORUM, V43, P35, DOI 10.1016/j.geoforum.2011.07.008; Soil Survey Staff, 2013, OFF SOIL SER DESCR; Turan MA, 2013, J FOOD AGRIC ENVIRON, V11, P572; Vaylay R, 2002, CROP SCI, V42, P534, DOI 10.2135/cropsci2002.0534; Wang DL, 1998, COMMUN SOIL SCI PLAN, V29, P15, DOI 10.1080/00103629809369925; Yeater KM, 2015, AGRON J, V107, P799, DOI 10.2134/agronj14.0017; Yeater KM, 2004, CROP SCI, V44, P185, DOI 10.2135/cropsci2004.0185; Zhu J, 2002, T ASAE, V45, P1971	29	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128179	10.1371/journal.pone.0128179	http://dx.doi.org/10.1371/journal.pone.0128179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029909	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900120
J	Shimizu, T; Cheng, Z; Matsuura, K; Masuda, S; Bauer, CE				Shimizu, Takayuki; Cheng, Zhuo; Matsuura, Katsumi; Masuda, Shinji; Bauer, Carl E.			Evidence that Altered Cis Element Spacing Affects PpsR Mediated Redox Control of Photosynthesis Gene Expression in Rubrivivax gelatinosus	PLOS ONE			English	Article							RHODOBACTER-CAPSULATUS; PURPLE BACTERIA; HORIZONTAL TRANSFER; LIGHT; BACTERIOCHLOROPHYLL; REGULATOR; CRTJ; SPHAEROIDES; REPRESSOR; BIOSYNTHESIS	PpsR is a major regulator of photosynthesis gene expression among all characterized purple photosynthetic bacteria. This transcription regulator has been extensively characterized in Rhodobacter (Rba.) capsulatus and Rba. sphaeroides which are members of the a-proteobacteria lineage. In this study, we have investigated the biochemical properties and mutational effects of a ppsR deletion strain in the beta-proteobacterium Rubrivivax (Rvi.) gelatinosus in order to reveal phylogenetically conserved mechanisms and species-specific characteristics. A deletion of the ppsR gene resulted in de-repression of photosystem synthesis showing that PpsR functions as a repressor of photosynthesis genes in this species. We also constructed a Rvi. gelatinosus PpsR mutant in which a conserved cysteine at position 436 was changed to an alanine to examine whether or not this residue is important for sensing redox, as reported in Rhodobacter species. Surprisingly, the Cys436 Ala mutant retained the ability to repress photosynthesis gene expression under aerobic conditions, suggesting that PpsR from Rvi. gelatinosus has different redox-responding characteristics. Furthermore, biochemical analyses demonstrated that Rvi. gelatinosus PpsR only shows redox-dependent binding to promoters with 9-bp spacing, but not 8-bp spacing, between two PpsR-recognition sequences. These results indicate that redox-dependent binding of PpsR requires appropriate cis configuration of PpsR target sequences in Rvi. gelatinosus. These results also indicate that PpsR homologs from different species regulate photosynthesis genes with altered biochemical properties.	[Shimizu, Takayuki] Tokyo Inst Technol, Dept Biol Sci, Kanagawa 2268501, Japan; [Cheng, Zhuo; Bauer, Carl E.] Indiana Univ, Dept Mol & Cellar Biochem, Bloomington, IN 47405 USA; [Matsuura, Katsumi] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Tokyo 1920397, Japan; [Masuda, Shinji] Tokyo Inst Technol, Ctr Biol Resources & Informat, Kanagawa 2268501, Japan; [Masuda, Shinji] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo 1528551, Japan	Tokyo Institute of Technology; Indiana University System; Indiana University Bloomington; Tokyo Metropolitan University; Tokyo Institute of Technology; Tokyo Institute of Technology	Bauer, CE (corresponding author), Indiana Univ, Dept Mol & Cellar Biochem, Bloomington, IN 47405 USA.	bauer@indiana.edu	Shimizu, Takayuki/ABP-2394-2022; Masuda, Shinji/A-2703-2014	Shimizu, Takayuki/0000-0002-2956-9386; Masuda, Shinji/0000-0002-5349-4927	National Institute of Health [GM040941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040941, R29GM040941, R37GM040941] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grant GM040941 to CB by the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer C, 2003, PHILOS T R SOC B, V358, P147, DOI 10.1098/rstb.2002.1189; Cheng Z, 2014, MOL MICROBIOL, V91, P649, DOI 10.1111/mmi.12491; Cheng Z, 2012, MOL MICROBIOL, V85, P734, DOI 10.1111/j.1365-2958.2012.08135.x; Cho SH, 2004, MICROBIOL-SGM, V150, P697, DOI 10.1099/mic.0.26777-0; Elsen S, 2005, MOL MICROBIOL, V57, P17, DOI 10.1111/j.1365-2958.2005.04655.x; HIRAYAMA O, 1994, LIPIDS, V29, P149, DOI 10.1007/BF02537155; HOSHINO Y, 1985, AGR BIOL CHEM TOKYO, V49, P3331, DOI 10.1080/00021369.1985.10867265; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; Jaubert M, 2004, J BIOL CHEM, V279, P44407, DOI 10.1074/jbc.M408039200; Kovacs AT, 2005, RES MICROBIOL, V156, P619, DOI 10.1016/j.resmic.2005.02.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; Masuda S, 2007, J MOL BIOL, V368, P1223, DOI 10.1016/j.jmb.2007.02.087; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Ohmine M, 2009, BIOCHEMISTRY-US, V48, P9132, DOI 10.1021/bi901202m; PENFOLD RJ, 1991, CURR MICROBIOL, V23, P259, DOI 10.1007/BF02092027; PONNAMPALAM SN, 1995, J BACTERIOL, V177, P2990, DOI 10.1128/jb.177.11.2990-2997.1995; Ponnampalam SN, 1997, J BIOL CHEM, V272, P18391, DOI 10.1074/jbc.272.29.18391; Steunou AS, 2004, J BACTERIOL, V186, P3143, DOI 10.1128/JB.186.10.3143-3152.2004; Steunou AS, 2004, J BACTERIOL, V186, P3133, DOI 10.1128/JB.186.10.3133-3142.2004; Swem LR, 2001, J MOL BIOL, V309, P121, DOI 10.1006/jmbi.2001.4652; Wilson DO, 2001, ELECTROPHORESIS, V22, P1979, DOI 10.1002/1522-2683(200106)22:10<1979::AID-ELPS1979>3.0.CO;2-A; Yin L, 2012, J BIOL CHEM, V287, P13850, DOI 10.1074/jbc.M112.346494; Yindeeyoungyeon W, 2000, BIOTECHNIQUES, V29, P1034, DOI 10.2144/00295st05; Zeilstra-Ryalls JH, 2004, CELL MOL LIFE SCI, V61, P417, DOI 10.1007/s00018-003-3242-1	27	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128446	10.1371/journal.pone.0128446	http://dx.doi.org/10.1371/journal.pone.0128446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030916	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900151
J	van der Velde, J; Swart, M; van Rijn, S; van der Meer, L; Wunderink, L; Wiersma, D; Krabbendam, L; Bruggeman, R; Aleman, A				van der Velde, Jorien; Swart, Marte; van Rijn, Sophie; van der Meer, Lisette; Wunderink, Lex; Wiersma, Durk; Krabbendam, Lydia; Bruggeman, Richard; Aleman, Andre			Cognitive Alexithymia Is Associated with the Degree of Risk for Psychosis	PLOS ONE			English	Article							HELP-SEEKING POPULATION; ULTRA-HIGH RISK; SCHIZOPHRENIA; DIMENSIONS; SCHIZOTYPY; SAMPLE; SCALE; QUESTIONNAIRE; METAANALYSIS; RELIABILITY	Alexithymia is a personality construct denoting emotion processing problems. It has been suggested to encompass two dimensions: a cognitive and affective dimension. The cognitive dimension is characterized by difficulties in identifying, verbalizing and analyzing emotions, while the affective dimension reflects the level of emotional arousal and imagination. Alexithymia has been previously proposed as a risk factor for developing psychosis. More specifically, the two alexithymia dimensions might be differentially related to the vulnerability for psychosis. Therefore, we examined the two dimensions of alexithymia, measured with the BVAQ in 94 siblings of patients with schizophrenia, 52 subjects at ultra-high risk (UHR) for developing psychosis, 38 patients with schizophrenia and 109 healthy controls. The results revealed that siblings and patients had higher levels of cognitive alexithymia compared to controls. In addition, subjects at UHR for psychosis had even higher levels of cognitive alexithymia compared to the siblings. The levels of affective alexithymia in siblings and patients were equal to controls. However, UHR individuals had significantly lower levels of affective alexithymia (i.e. higher levels of emotional arousal and fantasizing) compared to controls. Alexithymia was further related to subclinical levels of negative and depressive symptoms. These findings indicate that alexithymia varies parametrically with the degree of risk for psychosis. More specifically, a type-II alexithymia pattern, with high levels of cognitive alexithymia and normal or low levels of affective alexithymia, might be a vulnerability factor for psychosis.	[van der Velde, Jorien; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [van der Velde, Jorien] Hanze Univ Apllied Sci, Acad Sociale Studies, Groningen, Netherlands; [Swart, Marte; van der Meer, Lisette] Ctr Mental Healthcare, Lentis, Groningen, Netherlands; [van Rijn, Sophie] Leiden Univ, Clin Child & Adolescent Studies, Leiden, Netherlands; [Wunderink, Lex] Mental Hlth Care Friesland, Dept Psychosis Studies, Leeuwarden, Netherlands; [Swart, Marte; Wiersma, Durk; Krabbendam, Lydia] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands; [Bruggeman, Richard] Vrije Univ Amsterdam, Fac Psychol & Educ, Dept Educ Neurosci, Amsterdam, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC; University of Groningen; Vrije Universiteit Amsterdam	van der Velde, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.	jorien.van.der.velde@umcg.nl	Krabbendam, Lydia/F-9163-2010; Wunderink, Lex/H-8235-2019	Krabbendam, Lydia/0000-0003-4074-5149; Wunderink, Lex/0000-0002-4150-4681; van rijn, sophie/0000-0002-9179-7515; Bruggeman, Richard/0000-0002-3238-8471	Vici grant from Dutch organization for scientific research (NWO) [435-11-004]; Vici grant from NWO [435-11-006]; Netherlands organization for health research and development (ZonMw) [10.000.1002]	Vici grant from Dutch organization for scientific research (NWO); Vici grant from NWO; Netherlands organization for health research and development (ZonMw)(Netherlands Organization for Health Research and Development)	AA is supported in part by a Vici grant from the Dutch organization for scientific research (NWO, grant number: 435-11-004). LK is supported in part by a Vici grant from NWO (grant number 435-11-006). The GROUP project is supported by a grant from The Netherlands organization for health research and development (ZonMw), within the Mental Health program (project number 10.000.1002). ZonMw is a non-profit organisation working for the Ministry of Health, Welfare and Sport (VWS) and the NWO. The authors would like to thank Paula M. Gromann, Roeline Nieboer, Esther M. Opmeer and Edith J. Liemburg for their assistance in collecting the data.	Achim AM, 2011, SCHIZOPHRENIA BULL, V37, P811, DOI 10.1093/schbul/sbp148; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; Amminger GP, 2012, SCHIZOPHRENIA BULL, V38, P1030, DOI 10.1093/schbul/sbr015; Bagby RM, 2009, PERS INDIV DIFFER, V47, P413, DOI 10.1016/j.paid.2009.04.012; Bailey PE, 2007, PSYCHIAT RES, V150, P13, DOI 10.1016/j.psychres.2006.05.024; Bekker MHJ, 2007, J CLIN PSYCHOL, V63, P507, DOI 10.1002/jclp.20363; Bermond B, 2007, COGNITION EMOTION, V21, P1125, DOI 10.1080/02699930601056989; Berthoz S., 2000, EUROPEAN REV APPL PS, V50, P359; Cedro A, 2001, PSYCHOL REP, V89, P95, DOI 10.2466/pr0.2001.89.1.95; Fogley R, 2014, PSYCHIAT RE IN PRESS; Henry JD, 2010, J CLIN EXP NEUROPSYC, V32, P890, DOI 10.1080/13803391003596462; Horan WP, 2008, SCHIZOPHRENIA BULL, V34, P856, DOI 10.1093/schbul/sbn083; Ising HK, 2012, SCHIZOPHRENIA BULL, V38, P1288, DOI 10.1093/schbul/sbs068; Johnstone EC, 2005, BRIT J PSYCHIAT, V186, P18, DOI 10.1192/bjp.186.1.18; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kohler CG, 2014, PSYCHIAT RES, V216, P206, DOI 10.1016/j.psychres.2014.01.023; KOREEN AR, 1993, AM J PSYCHIAT, V150, P1643; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Kubota M, 2012, SCHIZOPHR RES, V141, P137, DOI 10.1016/j.schres.2012.08.026; Kubota M, 2011, NEUROSCI RES, V70, P206, DOI 10.1016/j.neures.2011.01.019; Laroi F, 2008, J NERV MENT DIS, V196, P927, DOI 10.1097/NMD.0b013e31818eeca4; Mattila AK, 2007, PSYCHOSOMATICS, V48, P523, DOI 10.1176/appi.psy.48.6.523; Meganck R, 2012, PSYCHOL REP, V111, P393, DOI 10.2466/02.08.15.PR0.111.5.393-404; Montebarocci O, 2006, Eat Weight Disord, V11, P14; Moormann P., 2008, EMOTION REGULATION C, P27, DOI [10.1007/978-0-387-29986-0_3, DOI 10.1007/978-0-387-29986-0_3]; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; Parker JDA, 2010, PSYCHOL ASSESSMENT, V22, P798, DOI 10.1037/a0020256; Picardi A, 2012, PSYCHOPATHOLOGY, V45, P159, DOI 10.1159/000330261; Rietdijk J, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-30; Seghers JP, 2011, J NERV MENT DIS, V199, P117, DOI 10.1097/NMD.0b013e3182083bc4; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Taylor G.J., 1997, DISORDERS AFFECT REG; Todarello O, 2005, PSYCHOPATHOLOGY, V38, P310, DOI 10.1159/000088919; van der Meer L, 2013, SCHIZOPHRENIA BULL, V39, P1352, DOI 10.1093/schbul/sbs122; van der Meer L, 2009, PSYCHIAT RES, V170, P108, DOI 10.1016/j.psychres.2009.07.010; van der Velde J, 2014, CORTEX, V54, P190, DOI 10.1016/j.cortex.2014.02.017; van Nierop M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076690; van Rijn S, 2011, PSYCHIAT RES, V187, P100, DOI 10.1016/j.psychres.2010.10.007; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Yu SH, 2011, PSYCHOPATHOLOGY, V44, P371, DOI 10.1159/000325168; Yung AR, 2007, SCHIZOPHRENIA BULL, V33, P673, DOI 10.1093/schbul/sbm015; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353	46	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0124803	10.1371/journal.pone.0124803	http://dx.doi.org/10.1371/journal.pone.0124803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030357	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900011
J	Trachet, B; Fraga-Silva, RA; Londono, FJ; Swillens, A; Stergiopulos, N; Segers, P				Trachet, Bram; Fraga-Silva, Rodrigo A.; Londono, Francisco J.; Swillens, Abigail; Stergiopulos, Nikolaos; Segers, Patrick			Performance Comparison of Ultrasound-Based Methods to Assess Aortic Diameter and Stiffness in Normal and Aneurysmal Mice	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; NONINVASIVE TECHNIQUE; PROGRESSION; MODEL; QUANTIFICATION; VALIDATION; ALGORITHMS; ARTERIES; RUPTURE; STRAIN	Objective Several ultrasound-based methods are currently used to assess aortic diameter, circumferential strain and stiffness in mice, but none of them is flawless and a gold standard is lacking. We aimed to assess the validity and sensitivity of these methods in control animals and animals developing dissecting abdominal aortic aneurysm. Methods and Results We first compared systolic and diastolic diameters as well as local circumferential strains obtained in 47 Angiotensin II-infused ApoE(-/-) mice with three different techniques (BMode, short axis MMode, long axis MMode), at two different abdominal aortic locations (supraceliac and paravisceral), and at three different time points of abdominal aneurysm formation (baseline, 14 days and 28 days). We found that short axis BMode was preferred to assess diameters, but should be avoided for strains. Short axis MMode gave good results for diameters but high standard deviations for strains. Long axis MMode should be avoided for diameters, and was comparable to short axis MMode for strains. We then compared pulse wave velocity measurements using global, ultrasound-based transit time or regional, pressure-based transit time in 10 control and 20 angiotensin II-infused, anti-TGF-Beta injected C57BL/6 mice. Both transit-time methods poorly correlated and were not able to detect a significant difference in PWV between controls and aneurysms. However, a combination of invasive pressure and MMode diameter, based on radio-frequency data, detected a highly significant difference in local aortic stiffness between controls and aneurysms, with low standard deviation. Conclusions In small animal ultrasound the short axis view is preferred over the long axis view to measure aortic diameters, local methods are preferred over transit-time methods to measure aortic stiffness, invasive pressure-diameter data are preferred over non-invasive strains to measure local aortic stiffness, and the use of radiofrequency data improves the accuracy of diameter, strain as well as stiffness measurements.	[Trachet, Bram; Londono, Francisco J.; Swillens, Abigail; Segers, Patrick] Univ Ghent, IMinds Med IT, IBiTech BioMMeda, B-9000 Ghent, Belgium; [Trachet, Bram; Fraga-Silva, Rodrigo A.; Stergiopulos, Nikolaos] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland	Ghent University; IMEC; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Trachet, B (corresponding author), Univ Ghent, IMinds Med IT, IBiTech BioMMeda, B-9000 Ghent, Belgium.	Bram.Trachet@ugent.be	Segers, Patrick/AAA-7844-2020; Trachet, Bram/R-4272-2017	Segers, Patrick/0000-0003-3870-3409; Trachet, Bram/0000-0003-4863-8399; Stergiopulos, Nikolaos/0000-0002-0519-0160	Ghent University; Flemish Fund for Scientific Research; Novartis Consumer Health Foundation	Ghent University(Ghent University); Flemish Fund for Scientific Research(FWO); Novartis Consumer Health Foundation	This research was funded by the Special Research Fund of Ghent University. B.T. received a travel grant and A.S. a post-doctoral grant of the Flemish Fund for Scientific Research, and R.A. F-S. received a grant of the Novartis Consumer Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma J, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/252141; Barisione C, 2006, ARTERIOSCL THROM VAS, V26, pE73; Basu R, 2012, J BIOL CHEM, V287, P44083, DOI 10.1074/jbc.M112.425652; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Cao RY, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00009; Casteleyn C, 2010, J ANAT, V216, P563, DOI 10.1111/j.1469-7580.2010.01220.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Di Lascio N, 2014, ATHEROSCLEROSIS, V237, P31, DOI 10.1016/j.atherosclerosis.2014.08.033; Donato AJ, 2013, AGING CELL, V12, P772, DOI 10.1111/acel.12103; Eagleton MJ, 2010, J VASC SURG, V51, P951, DOI 10.1016/j.jvs.2009.11.075; Favreau JT, 2012, J VASC SURG, V56, P462, DOI 10.1016/j.jvs.2012.01.056; Feintuch A, 2007, AM J PHYSIOL-HEART C, V292, pH884, DOI 10.1152/ajpheart.00796.2006; Fujikura K, 2007, ULTRASONIC IMAGING, V29, P137, DOI 10.1177/016173460702900301; Gaddum NR, 2013, ANN BIOMED ENG, V41, P2617, DOI 10.1007/s10439-013-0854-y; Gavish L, 2014, LASER SURG MED, V46, P781, DOI 10.1002/lsm.22306; Gavish L, 2009, CARDIOVASC RES, V83, P785, DOI 10.1093/cvr/cvp149; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Gitlin JM, 2007, CARDIOVASC RES, V73, P227, DOI 10.1016/j.cardiores.2006.10.015; Goergen CJ, 2011, ARTERIOSCL THROM VAS, V31, P270, DOI 10.1161/ATVBAHA.110.216481; Goergen CJ, 2010, J MAGN RESON IMAGING, V32, P847, DOI 10.1002/jmri.22331; Hartley CJ, 1997, AM J PHYSIOL-HEART C, V273, pH494, DOI 10.1152/ajpheart.1997.273.1.H494; Hartley CJ, 2011, AM J PHYSIOL-HEART C, V301, pH269, DOI 10.1152/ajpheart.00320.2011; Haskett Darren, 2013, Biomatter, V3, DOI 10.4161/biom.24648; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Humphrey JD, 2004, INTRO BIOMECHANICS S, P631; Huybrechts SAM, 2011, J HYPERTENS, V29, P1577, DOI 10.1097/HJH.0b013e3283487841; Iida Y, 2013, ARTERIOSCL THROM VAS, V33, P718, DOI 10.1161/ATVBAHA.112.300329; Jung SM, 2013, AM J PHYSIOL-HEART C, V305, pH803, DOI 10.1152/ajpheart.00103.2013; Klink A, 2011, J AM COLL CARDIOL, V58, P2522, DOI 10.1016/j.jacc.2011.09.017; Knipp BS, 2003, J SURG RES, V112, P97, DOI 10.1016/S0022-4804(03)00114-8; Krishna SM, 2012, AM J PATHOL, V181, P706, DOI 10.1016/j.ajpath.2012.04.015; Leloup AJA, 2014, HYPERTENSION, V64, P195, DOI 10.1161/HYPERTENSIONAHA.114.03312; Luo JW, 2009, IEEE T MED IMAGING, V28, P477, DOI 10.1109/TMI.2008.928179; Martin-McNulty B, 2005, ULTRASOUND MED BIOL, V31, P745, DOI 10.1016/j.ultrasmedbio.2005.02.012; Mirault T, 2013, EUR HEART J, V34, DOI [10.1093/eurheartj/eht308.P2527, DOI 10.1093/EURHEARTJ/EHT308.P2527]; Nandlall SD, 2014, ULTRASOUND MED BIOL, V40, P2404, DOI 10.1016/j.ultrasmedbio.2014.04.013; Prins PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084517; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; References Xu Q, 2006, HDB MOUSE MODELS CAR; Rouer M, 2014, EUR J VASC ENDOVASC, V47, P493, DOI 10.1016/j.ejvs.2014.02.006; Sampson UK, 2011, J ULTRAS MED, V30, P773, DOI 10.7863/jum.2011.30.6.773; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Spin JM, 2011, PHYSIOL GENOMICS, V43, P993, DOI 10.1152/physiolgenomics.00044.2011; Takahashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072558; Trachet B, 2015, CARDIOVASC RES, V105, P213, DOI 10.1093/cvr/cvu257; Turner GH, 2008, CIRC-CARDIOVASC IMAG, V1, P220, DOI 10.1161/CIRCIMAGING.108.787358; Vandeghinste B, 2011, MOL IMAGING BIOL, V13, P78, DOI 10.1007/s11307-010-0335-8; Vardoulis O, 2013, AM J PHYSIOL-HEART C, V304, pH1558, DOI 10.1152/ajpheart.00963.2012; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Weisbrod RM, 2013, HYPERTENSION, V62, P1105, DOI 10.1161/HYPERTENSIONAHA.113.01744; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Xie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046411; Zhao XD, 2009, J MAGN RESON IMAGING, V30, P286, DOI 10.1002/jmri.21846	54	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0129007	10.1371/journal.pone.0129007	http://dx.doi.org/10.1371/journal.pone.0129007			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023786	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400106
J	Wang, L; Gu, ZY; Zhai, RR; Zhao, SS; Luo, L; Li, DD; Zhao, XL; Wei, HP; Pang, ZX; Wang, LL; Liu, DH; Wang, QS; Gao, CJ				Wang, Li; Gu, Zhenyang; Zhai, Ruiren; Zhao, Shasha; Luo, Lan; Li, Dandan; Zhao, Xiaoli; Wei, Huaping; Pang, Zhaoxia; Wang, Lili; Liu, Daihong; Wang, Quanshun; Gao, Chunji			Efficacy of Oral Cryotherapy on Oral Mucositis Prevention in Patients with Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							HIGH-DOSE MELPHALAN; REDUCES MUCOSITIS; MULTIPLE-MYELOMA; MANAGEMENT; CANCER; CHEMOTHERAPY; METHOTREXATE; PROPHYLAXIS; SEVERITY	Objectives Controversy exists regarding whether oral cryotherapy can prevent oral mucositis (OM) in patients with hematological malignancies undergoing hematopoietic stem cell transplantation (HSCT). The aim of the present meta-analysis was to evaluate the efficacy of oral cryotherapy for OM prevention in patients with hematological malignancies undergoing HSCT. Methods PubMed and the Cochrane Library were searched through October 2014. Randomized controlled trials (RCTs) comparing the effect of oral cryotherapy with no treatment or with other interventions for OM in patients undergoing HSCT were included. The primary outcomes were the incidence, severity, and duration of OM. The secondary outcomes included length of analgesic use, total parenteral nutrition (TPN) use, and length of hospital stay. Results Seven RCTs involving eight articles analyzing 458 patients were included. Oral cryotherapy significantly decreased the incidence of severe OM (RR = 0.52, 95% CI = 0.27 to 0.99) and OM severity (SMD = -2.07, 95% CI = -3.90 to -0.25). In addition, the duration of TPN use and the length of hospitalization were markedly reduced (SMD = -0.56, 95% CI = -0.92 to -0.19; SMD = -0.44, 95% CI = -0.76 to -0.13; respectively). However, the pooled results were uncertain for the duration of OM and analgesic use (SMD = -0.13, 95% CI = -0.41 to 0.15; SMD = -1.15, 95% CI = -2.57 to 0.27; respectively). Conclusions Oral cryotherapy is a readily applicable and cost-effective prophylaxis for OM in patients undergoing HSCT.	[Wang, Li; Gu, Zhenyang; Zhao, Shasha; Luo, Lan; Li, Dandan; Zhao, Xiaoli; Wei, Huaping; Wang, Lili; Liu, Daihong; Wang, Quanshun; Gao, Chunji] Chinese Peoples Liberat Army PLA Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Wang, Li; Zhai, Ruiren; Pang, Zhaoxia] Chinese PLA 401 Hosp, Laoshan Branch, Dept Hematol & Oncol, Qingdao, Peoples R China		Gao, CJ (corresponding author), Chinese Peoples Liberat Army PLA Gen Hosp, Dept Hematol, Beijing, Peoples R China.	gaochunji@hotmail.com	wang, lili/HDL-7210-2022	Wang, Li/0000-0002-4706-2482	National Natural Science Foundation of China [81270642]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (No. 81270642). CjG obtained funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisa Y, 2005, SUPPORT CARE CANCER, V13, P266, DOI 10.1007/s00520-004-0726-y; Batlle M, 2014, EUR J HAEMATOL, V93, P487, DOI 10.1111/ejh.12386; Baydar M, 2005, J NATL MED ASSOC, V97, P1161; Bhatt Valkal, 2010, J Oncol Pharm Pract, V16, P195, DOI 10.1177/1078155209348721; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Cutler C, 2005, BIOL BLOOD MARROW TR, V11, P383, DOI 10.1016/j.bbmt.2005.02.006; DUMONTET C, 1994, BONE MARROW TRANSPL, V14, P492; Eduardo FD, 2015, HEMATOL ONCOL, V33, P152, DOI 10.1002/hon.2133; Gori E, 2007, BONE MARROW TRANSPL, V39, P347, DOI 10.1038/sj.bmt.1705590; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Kanuga S, 2013, J AM DENT ASSOC, V144, P928, DOI 10.14219/jada.archive.2013.0211; Karagozoglu S, 2005, J CLIN NURS, V14, P754, DOI 10.1111/j.1365-2702.2005.01128.x; Katranci N, 2012, EUR J ONCOL NURS, V16, P339, DOI 10.1016/j.ejon.2011.07.008; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Lilleby K, 2006, BONE MARROW TRANSPL, V37, P1031, DOI 10.1038/sj.bmt.1705384; Lu Y, 2013, BLOOD, DOI [10.1038/sj.bmt.1705590, DOI 10.1038/SJ.BMT.1705590]; Mori T, 2006, BONE MARROW TRANSPL, V38, P637, DOI 10.1038/sj.bmt.1705494; Ohbayashi Y, 2008, ANN HEMATOL, V87, P837, DOI 10.1007/s00277-008-0508-6; Peterson DE, 2013, SUPPORT CARE CANCER, V21, P327, DOI 10.1007/s00520-012-1562-0; Salvador P, 2012, J PAIN SYMPTOM MANAG, V44, P64, DOI 10.1016/j.jpainsymman.2011.08.012; Sato A, 2006, TOHOKU J EXP MED, V210, P315, DOI 10.1620/tjem.210.315; Svanberg A, 2007, SUPPORT CARE CANCER, V15, P1155, DOI 10.1007/s00520-007-0245-8; Svanberg A, 2010, J CLIN NURS, V19, P2146, DOI 10.1111/j.1365-2702.2010.03255.x; Toro JJ, 2014, BIOL BLOOD MARROW TR, V20, pS204, DOI 10.1016/j.bbmt.2013.12.340; Vokurka S, 2014, EUR J ONCOL NURS, V18, P228, DOI 10.1016/j.ejon.2013.11.001; Worthington HV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000978.pub5	26	22	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128763	10.1371/journal.pone.0128763	http://dx.doi.org/10.1371/journal.pone.0128763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024220	gold, Green Submitted, Green Published			2022-12-27	WOS:000355319400102
J	Puetz, TW; Youngstedt, SD; Herring, MP				Puetz, Timothy W.; Youngstedt, Shawn D.; Herring, Matthew P.			Effects of Pharmacotherapy on Combat-Related PTSD, Anxiety, and Depression: A Systematic Review and Meta-Regression Analysis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; OF-VETERANS-AFFAIRS; SYMPTOMS; EXERCISE; PREVALENCE; EFFICACY; QUALITY	The efficacy of pharmacotherapy for PTSD, anxiety, and depression among combat veterans is not well-established. Objectives To estimate the effect of pharmacotherapy on PTSD, anxiety, and depression among combat veterans; to determine whether the effects varied according to patient and intervention characteristics; and to examine differential effects of pharmacotherapy on outcomes. Materials and Methods Google Scholar, PILOTS, PsycINFO, PubMed, and Web of Science databases were searched through November 2014. Searches resulted in eighteen double-blind, placebo controlled trials of 773 combat veterans diagnosed with PTSD and included only validated pre- and post-intervention PTSD and anxiety or depression measures. Authors extracted data on effect sizes, moderators, and study quality. Hedges' d effect sizes were computed and random effects models estimated sampling error and population variance. The Johnson-Neyman procedure identified the critical points in significant interactions to define regions of significance. Results Pharmacotherapy significantly reduced (Delta, 95% CI) PTSD (0.38, 0.23-0.52), anxiety (0.42, 0.30-0.54), and depressive symptoms (0.52, 0.35-0.70). The effects of SSRIs and tricyclic antidepressants on PTSD were greater than other medications independent of treatment duration. The effect of SSRIs and tricyclic antidepressants were greater than other medications up to 5.2 and 13.6 weeks for anxiety and depression, respectively. The magnitude of the effect of pharmacotherapy on concurrently-measured PTSD, anxiety, and depression did not significantly differ. Conclusions Pharmacotherapy reduced PTSD, anxiety, and depressive symptoms in combat veterans. The effects of SSRIs and tricyclic antidepressants were greater for PTSD and occurred quicker for anxiety and depression than other medications.	[Puetz, Timothy W.] NIH, Ctr Clin, Off Director, Bethesda, MD 20892 USA; [Youngstedt, Shawn D.] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA; [Youngstedt, Shawn D.] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [Youngstedt, Shawn D.] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Herring, Matthew P.] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Arizona State University; Arizona State University-Downtown Phoenix; Arizona State University; Arizona State University-Downtown Phoenix; University of Limerick	Herring, MP (corresponding author), Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland.	matthew.herring@ul.ie	Herring, Matthew P/O-2265-2014; youngstedt, shawn/AAA-3361-2021	Herring, Matthew P/0000-0002-6835-5321; 	National Institutes of Health [R01 HL095799]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by the National Institutes of Health under grant R01 HL095799. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn EP, 2011, INT CLIN PSYCHOPHARM, V26, P193, DOI 10.1097/YIC.0b013e3283473738; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asnis GM, 2004, DRUGS, V64, P383, DOI 10.2165/00003495-200464040-00004; Baldwin D, 2001, BMJ-BRIT MED J, V342, pd1199; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berger W, 2009, PROG NEURO-PSYCHOPH, V33, P169, DOI 10.1016/j.pnpbp.2008.12.004; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Celik C, 2011, KLIN PSIKOFARMAKOL B, V21, P179, DOI 10.5455/bcp.20110627111141; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Defense Manpower Data Center Department of Defense, 2012, CONT TRACK SYST DEPL; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2013, AN VA HLTH CAR UT OP; Erickson DJ, 2001, J CONSULT CLIN PSYCH, V69, P41, DOI 10.1037/0022-006X.69.1.41; Gleser L.J., 1994, HDB RES SYNTHESIS, P339, DOI DOI 10.7758/9781610448864.16; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530; Hidalgo RB, 2000, J PSYCHOPHARMACOL, V14, P70, DOI 10.1177/026988110001400110; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IOM (Institute of Medicine), 2014, TREATM POSTTR STRESS; Ipser JC, 2012, INT J NEUROPSYCHOPH, V15, P825, DOI 10.1017/S1461145711001209; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Lazar AA, 2011, J EDUC BEHAV STAT, V36, P699, DOI 10.3102/1076998610396889; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Mohamed S, 2008, J CLIN PSYCHIAT, V69, P959, DOI 10.4088/JCP.v69n0611; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Monnelly EP, 2003, J CLIN PSYCHOPHARM, V23, P193, DOI 10.1097/00004714-200304000-00012; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Puetz TW, 2013, JAMA INTERN MED, V173, P960, DOI 10.1001/jamainternmed.2013.836; Puetz TW, 2012, AM J PREV MED, V43, pE1, DOI 10.1016/j.amepre.2012.04.027; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rosenthal R, 1991, METAANALYTIC PROCEDU; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Steckler T, 2012, NEUROPHARMACOLOGY, V62, P617, DOI 10.1016/j.neuropharm.2011.06.012; Stein DJ, 2009, CNS SPECTRUMS, V14, P25; Stein MB, 2002, AM J PSYCHIAT, V159, P1777, DOI 10.1176/appi.ajp.159.10.1777; Stewart CL, 2009, MIL MED, V174, P460, DOI 10.7205/MILMED-D-04-1507; United States Census Bureau, 2012, VET STAT 2012 AM COM	45	40	42	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126529	10.1371/journal.pone.0126529	http://dx.doi.org/10.1371/journal.pone.0126529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020791	gold, Green Published			2022-12-27	WOS:000355187300025
J	Krishnamoorthy, R; Kim, CG; Subramanian, P; Kim, KY; Selvakumar, G; Sa, TM				Krishnamoorthy, Ramasamy; Kim, Chang-Gi; Subramanian, Parthiban; Kim, Ki-Yoon; Selvakumar, Gopal; Sa, Tong-Min			Arbuscular Mycorrhizal Fungi Community Structure, Abundance and Species Richness Changes in Soil by Different Levels of Heavy Metal and Metalloid Concentration	PLOS ONE			English	Article							MOLECULAR DIVERSITY; T-RFLP; ROOTS; PHYLUM; BIOAVAILABILITY; GLOMEROMYCOTA; TOLERANCE; RESPONSES; SPORES; STRESS	Arbuscular Mycorrhizal Fungi (AMF) play major roles in ecosystem functioning such as carbon sequestration, nutrient cycling, and plant growth promotion. It is important to know how this ecologically important soil microbial player is affected by soil abiotic factors particularly heavy metal and metalloid (HMM). The objective of this study was to understand the impact of soil HMM concentration on AMF abundance and community structure in the contaminated sites of South Korea. Soil samples were collected from the vicinity of an abandoned smelter and the samples were subjected to three complementary methods such as spore morphology, terminal restriction fragment length polymorphism (T-RFLP) and denaturing gradient gel electrophoresis (DGGE) for diversity analysis. Spore density was found to be significantly higher in highly contaminated soil compared to less contaminated soil. Spore morphological study revealed that Glomeraceae family was more abundant followed by Acaulosporaceae and Gigasporaceae in the vicinity of the smelter. T-RFLP and DGGE analysis confirmed the dominance of Funneliformis mosseae and Rhizophagus intraradices in all the study sites. Claroideoglomus claroideum, Funneliformis caledonium, Rhizophagus clarus and Funneliformis constrictum were found to be sensitive to high concentration of soil HMM. Richness and diversity of Glomeraceae family increased with significant increase in soil arsenic, cadmium and zinc concentrations. Our results revealed that the soil HMM has a vital impact on AMF community structure, especially with Glomeraceae family abundance, richness and diversity.	[Krishnamoorthy, Ramasamy; Subramanian, Parthiban; Kim, Ki-Yoon; Selvakumar, Gopal; Sa, Tong-Min] Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju, Chungbuk, South Korea; [Kim, Chang-Gi] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongwon, South Korea	Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Sa, TM (corresponding author), Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju, Chungbuk, South Korea.	tomsa@chungbuk.ac.kr	Subramanian, Parthiban/CAJ-0756-2022; Kim, Chang-Gi/M-2984-2013	Subramanian, Parthiban/0000-0002-4797-5791; Kim, Chang-Gi/0000-0002-2588-8259; Ramasamy, Krishnamoorthy/0000-0002-1233-0897; Gopal, Selvakumar/0000-0001-7575-7022	National Research Foundation (NRF) - Ministry of Education, Science and Technology [2012R1A2A1A01005294]; Indian Council of Agricultural Research (ICAR), New Delhi, India; ICAR-IF	National Research Foundation (NRF) - Ministry of Education, Science and Technology; Indian Council of Agricultural Research (ICAR), New Delhi, India(Indian Council of Agricultural Research (ICAR)); ICAR-IF	This work was supported by Basic Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (2012R1A2A1A01005294). RK is pleased to acknowledge the Indian Council of Agricultural Research (ICAR), New Delhi, India for their International Fellowship (IF) to precede doctoral research program. RK tuition fees and other expenses were only met from his ICAR-IF.	Aguilera P, 2014, AGR ECOSYST ENVIRON, V186, P178, DOI 10.1016/j.agee.2014.01.029; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ferreira PAA, 2015, APPL SOIL ECOL, V91, P37, DOI 10.1016/j.apsoil.2015.02.008; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Cornejo P, 2004, FEMS MICROBIOL LETT, V241, P265, DOI 10.1016/j.femsle.2004.10.030; Courtney KC, 2012, J MICROBIOL METH, V88, P14, DOI 10.1016/j.mimet.2011.09.016; Del Val C, 1999, APPL ENVIRON MICROB, V65, P718; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Garcia-Sanchez M, 2014, J PLANT PHYSIOL, V171, P421, DOI 10.1016/j.jplph.2013.10.023; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Gohre V, 2006, PLANTA, V223, P1115, DOI 10.1007/s00425-006-0225-0; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; Gonzalez-Chavez C, 2002, NEW PHYTOL, V155, P163, DOI 10.1046/j.1469-8137.2002.00430.x; Gonzalez-Chavez MC, 2009, J HAZARD MATER, V161, P1288, DOI 10.1016/j.jhazmat.2008.04.110; Hassan SED, 2011, MOL ECOL, V20, P3469, DOI 10.1111/j.1365-294X.2011.05142.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Holland TC, 2014, BIOL FERT SOILS, V50, P667, DOI 10.1007/s00374-013-0887-2; Hossain Mohammad Anwar, 2010, Physiology and Molecular Biology of Plants, V16, P19, DOI 10.1007/s12298-010-0003-0; Jacobson KM, 1997, J ARID ENVIRON, V35, P59, DOI 10.1006/jare.1995.0140; Jiao H, 2011, MYCORRHIZA, V21, P681, DOI 10.1007/s00572-011-0377-z; Khade SW, 2009, WATER AIR SOIL POLL, V202, P45, DOI 10.1007/s11270-008-9957-8; Kim KW, 2012, GEOCHEM J, V46, pE17; Krishnamoorthy R, 2014, SOIL BIOL BIOCHEM, V72, P1, DOI 10.1016/j.soilbio.2014.01.017; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lee W., 2009, ASKING CORPORATE RES; Li PZ, 2015, ECOTOX ENVIRON SAFE, V113, P391, DOI 10.1016/j.ecoenv.2014.12.025; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Liu H, 2015, APPL SOIL ECOL, V89, P44, DOI 10.1016/j.apsoil.2015.01.006; Long LK, 2010, EUR J SOIL BIOL, V46, P288, DOI 10.1016/j.ejsobi.2010.06.003; Magalhaes DD, 2015, ENVIRON CHEM LETT, V13, P69, DOI 10.1007/s10311-015-0491-9; Oehl F, 2011, IMA FUNGUS, V2, P191, DOI 10.5598/imafungus.2011.02.02.10; Ortega-Larrocea MP, 2001, APPL SOIL ECOL, V16, P149, DOI 10.1016/S0929-1393(00)00105-0; Pawlowska TE, 2004, APPL ENVIRON MICROB, V70, P6643, DOI 10.1128/AEM.70.11.6643-6649.2004; Pereira CMR, 2014, AGR ECOSYST ENVIRON, V185, P245, DOI 10.1016/j.agee.2014.01.005; Redecker D, 2003, FOLIA GEOBOT, V38, P113, DOI 10.1007/BF02803144; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Renker C, 2005, ENVIRON POLLUT, V135, P255, DOI 10.1016/j.envpol.2004.11.002; Scallan U, 2008, MOL ECOL RESOUR, V8, P95, DOI 10.1111/j.1471-8286.2007.01901.x; Schneider J, 2013, J HAZARD MATER, V262, P1105, DOI 10.1016/j.jhazmat.2012.09.063; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; SCHUSSLER A, 2010, THE GLOMEROMYCOTA A; Schwarzott D, 2001, MYCORRHIZA, V10, P203, DOI 10.1007/PL00009996; SHETTY KG, 1994, ENVIRON POLLUT, V86, P181, DOI 10.1016/0269-7491(94)90189-9; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stutz JC, 1996, CAN J BOT, V74, P1883, DOI 10.1139/b96-225; Tan FX, 2011, SOIL BIOL BIOCHEM, V43, P2473, DOI 10.1016/j.soilbio.2011.08.014; Tipayno S, 2012, APPL SOIL ECOL, V61, P137, DOI 10.1016/j.apsoil.2012.06.001; Tullio M, 2003, BIOL FERT SOILS, V37, P211, DOI 10.1007/s00374-003-0580-y; Utobo E.B., 2011, LIBYAN AGR RES CTR J, P68; Vallino M, 2006, ENVIRON MICROBIOL, V8, P971, DOI 10.1111/j.1462-2920.2006.00980.x; Verbruggen E, 2012, MOL ECOL, V21, P2341, DOI 10.1111/j.1365-294X.2012.05534.x; Wei Y, 2015, J ENVIRON SCI, V29, P18, DOI 10.1016/j.jes.2014.10.002; WEISSENHORN I, 1995, BIOL FERT SOILS, V19, P22, DOI 10.1007/BF00336342; Wu FY, 2010, APPL SOIL ECOL, V44, P213, DOI 10.1016/j.apsoil.2009.12.008; Xu PL, 2008, ENVIRON POLLUT, V156, P215, DOI 10.1016/j.envpol.2008.01.003; Xun FF, 2015, ENVIRON SCI POLLUT R, V22, P598, DOI 10.1007/s11356-014-3396-4; Yeo SJ, 1997, J MINER SOC KOREA, V10, P139; Zarei M, 2008, ENVIRON POLLUT, V156, P1277, DOI 10.1016/j.envpol.2008.03.006; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017; Zhang HQ, 2010, PLANT SOIL, V326, P415, DOI 10.1007/s11104-009-0022-1	62	39	40	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0128784	10.1371/journal.pone.0128784	http://dx.doi.org/10.1371/journal.pone.0128784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7SJ	26035444	gold, Green Published, Green Submitted			2022-12-27	WOS:000355699100046
J	Acevedo, MA; Prosper, O; Lopiano, K; Ruktanonchai, N; Caughlin, TT; Martcheva, M; Osenberg, CW; Smith, DL				Acevedo, Miguel A.; Prosper, Olivia; Lopiano, Kenneth; Ruktanonchai, Nick; Caughlin, T. Trevor; Martcheva, Maia; Osenberg, Craig W.; Smith, David L.			Spatial Heterogeneity, Host Movement and Mosquito-Borne Disease Transmission	PLOS ONE			English	Article							ANOPHELES-ALBIMANUS DIPTERA; PLASMODIUM-FALCIPARUM; POPULATION-DYNAMICS; INFECTIOUS-DISEASES; GLOBAL DISTRIBUTION; MALARIA; VECTOR; MODELS; PERSISTENCE; DEFINITION	Mosquito-borne diseases are a global health priority disproportionately affecting low-income populations in tropical and sub-tropical countries. These pathogens live in mosquitoes and hosts that interact in spatially heterogeneous environments where hosts move between regions of varying transmission intensity. Although there is increasing interest in the implications of spatial processes for mosquito-borne disease dynamics, most of our understanding derives from models that assume spatially homogeneous transmission. Spatial variation in contact rates can influence transmission and the risk of epidemics, yet the interaction between spatial heterogeneity and movement of hosts remains relatively unexplored. Here we explore, analytically and through numerical simulations, how human mobility connects spatially heterogeneous mosquito populations, thereby influencing disease persistence (determined by the basic reproduction number R-0), prevalence and their relationship. We show that, when local transmission rates are highly heterogeneous, R-0 declines asymptotically as human mobility increases, but infection prevalence peaks at low to intermediate rates of movement and decreases asymptotically after this peak. Movement can reduce heterogeneity in exposure to mosquito biting. As a result, if biting intensity is high but uneven, infection prevalence increases with mobility despite reductions in R-0. This increase in prevalence decreases with further increase in mobility because individuals do not spend enough time in high transmission patches, hence decreasing the number of new infections and overall prevalence. These results provide a better basis for understanding the interplay between spatial transmission heterogeneity and human mobility, and their combined influence on prevalence and R-0.	[Acevedo, Miguel A.] Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00931 USA; [Prosper, Olivia] Dartmouth Coll, Dept Math, Hanover, NH 03755 USA; [Lopiano, Kenneth] Stat & Appl Math Sci Inst, Durham, NC USA; [Ruktanonchai, Nick; Caughlin, T. Trevor] Univ Florida, Dept Biol, Gainesville, FL USA; [Martcheva, Maia] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Osenberg, Craig W.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; Dartmouth College; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Georgia; University of Georgia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Acevedo, MA (corresponding author), Univ Puerto Rico Rio Piedras, Dept Biol, San Juan, PR 00931 USA.	miguel.acevedo7@upr.edu	Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Caughlin, T. Trevor/0000-0001-6752-2055; Prosper, Olivia/0000-0002-8042-0616; Osenberg, Craig/0000-0003-1918-7904	National Science Foundation (NSF) Quantitative Spatial Ecology, Evolution, and Environment (QSE3) Integrative Graduate Education and Research Traineeship Program [0801544]; NSF Doctoral Dissertation Improvement Grant [DEB-1110441]	National Science Foundation (NSF) Quantitative Spatial Ecology, Evolution, and Environment (QSE3) Integrative Graduate Education and Research Traineeship Program; NSF Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) Quantitative Spatial Ecology, Evolution, and Environment (QSE3) Integrative Graduate Education and Research Traineeship Program Grant 0801544, and NSF Doctoral Dissertation Improvement Grant (DEB-1110441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; ANDERSON R M, 1991; Auger P, 2008, MATH BIOSCI, V216, P123, DOI 10.1016/j.mbs.2008.08.010; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; BEIER JC, 1991, AM J TROP MED HYG, V44, P564, DOI 10.4269/ajtmh.1991.44.564; BEKESSY A, 1976, B WORLD HEALTH ORGAN, V54, P685; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chiyaka C, 2013, SCIENCE, V339, P909, DOI 10.1126/science.1229509; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Collins WE, 2003, AM J TROP MED HYG, V68, P366, DOI 10.4269/ajtmh.2003.68.366; COLLINS WE, 1977, J PARASITOL, V63, P57, DOI 10.2307/3280103; Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dietz K., 1988, P1091; Dietz K., 1980, Lecture Notes in Biomathematics, V39, P264; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Formont E, 2003, J THEOR BIOL, V223, P465, DOI [10.1016/S0022-5193(03)00122-X, DOI 10.1016/S0022-5193(03)00122-X]; FREEDMAN HI, 1990, P AM MATH SOC, V109, P1025, DOI 10.2307/2048133; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; GRAVES PM, 1990, J APPL ECOL, V27, P134, DOI 10.2307/2403573; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Gurarie D, 2009, J R SOC INTERFACE, V6, P495, DOI 10.1098/rsif.2008.0265; HASIBEDER G, 1988, THEOR POPUL BIOL, V33, P31, DOI 10.1016/0040-5809(88)90003-2; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hernandez-Avila JE, 2006, SALUD PUBLICA MEXICO, V48, P405, DOI 10.1590/S0036-36342006000500007; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Jansen VAA, 2000, J MATH BIOL, V41, P232, DOI 10.1007/s002850000048; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Lambrechts L, 2009, TROP MED INT HEALTH, V14, P1505, DOI 10.1111/j.1365-3156.2009.02401.x; LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921; LOYOLA EG, 1993, J MED ENTOMOL, V30, P518, DOI 10.1093/jmedent/30.3.518; Maude RJ, 2010, INT HEALTH, V2, P239, DOI 10.1016/j.inhe.2010.09.005; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McCallum H, 2006, CONNECTIVITY CONSERV, P479; McKenzie FE, 2000, PARASITOL TODAY, V16, P511, DOI 10.1016/S0169-4758(00)01789-0; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Miranda-Franco R, 1997, REV PANAM SALUD PUBL, V2, P146, DOI [10.1590/S1020-49891997000800015, DOI 10.1590/S1020-49891997000800015]; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Prosper O, 2012, J THEOR BIOL, V303, P1, DOI 10.1016/j.jtbi.2012.02.010; Qiu ZP, 2013, J MATH ANAL APPL, V405, P12, DOI 10.1016/j.jmaa.2013.03.042; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Rodriguez DJ, 2001, B MATH BIOL, V63, P547, DOI 10.1006/bulm.2001.0231; RODRIGUEZ MH, 1992, J MED ENTOMOL, V29, P395, DOI 10.1093/jmedent/29.3.395; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Smith DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0145; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Stratton L, 2008, SOC SCI MED, V67, P854, DOI 10.1016/j.socscimed.2008.05.013; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; THIEME HR, 1993, SIAM J MATH ANAL, V24, P407, DOI 10.1137/0524026; Torres-Sorando L, 1997, ECOL MODEL, V104, P231, DOI 10.1016/S0304-3800(97)00135-X; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	74	25	27	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127552	10.1371/journal.pone.0127552	http://dx.doi.org/10.1371/journal.pone.0127552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030769	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900061
J	Schartum-Hansen, H; Loland, KH; Svingen, GFT; Seifert, R; Pedersen, ER; Nordrehaug, JE; Bleie, O; Ebbing, M; Berge, C; Nilsen, DWT; Nygard, O				Schartum-Hansen, Hall; Loland, Kjetil H.; Svingen, Gard F. T.; Seifert, Reinhard; Pedersen, Eva R.; Nordrehaug, Jan E.; Bleie, Oyvind; Ebbing, Marta; Berge, Christ; Nilsen, Dennis W. T.; Nygard, Ottar			Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching	PLOS ONE			Unspecified	Article							OUTCOMES; THERAPY; HOSPITALIZATION; FIBRILLATION; IMPACT; OLDER; RISK	Background Loop diuretics are widely used in patients with heart and renal failure, as well as to treat hypertension and peripheral edema. However, there are no randomized, controlled trials (RCT) evaluating their long term safety, and several observational reports have indicated adverse effects. We sought to evaluate the impact of loop diuretics on long term survival in patients with suspected coronary artery disease, but without clinical heart failure, reduced left ventricular ejection fraction or impaired renal function. Method and Findings From 3101 patients undergoing coronary angiography for suspected stable angina pectoris, subjects taking loop diuretics (n = 109) were matched with controls (n = 198) in an attempted 1: 2 ratio, using propensity scores based on 59 baseline variables. During median follow-up of 10.1 years, 37.6% in the loop diuretics group and 23.7% in the control group died (logrank p-value 0.005). Treatment with loop diuretics was associated with a hazard ratio (95% confidence interval) of 1.82 (1.20, 2.76), and the number needed to harm was 7.2 (4.1, 30.3). Inclusion of all 3101 patients using propensity score weighting and adjustment for numerous covariates provided similar estimates. The main limitation is the potential of confounding from unmeasured patient characteristics. Conclusions The use of loop diuretics in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment, is associated with increased risk of all-cause mortality. Considering the lack of randomized controlled trials to evaluate long term safety of loop diuretics, our data suggest caution when prescribing these drugs to patients without a clear indication.	[Schartum-Hansen, Hall; Seifert, Reinhard; Bleie, Oyvind; Berge, Christ; Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Loland, Kjetil H.; Svingen, Gard F. T.; Pedersen, Eva R.; Nordrehaug, Jan E.; Nilsen, Dennis W. T.; Nygard, Ottar] Univ Bergen, Dept Clin Sci, Cardiol Sect, Bergen, Norway; [Ebbing, Marta] Norwegian Inst Publ Hlth, Bergen, Norway; [Nilsen, Dennis W. T.] Stavanger Univ Hosp, Stavanger, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH); Stavanger University Hospital	Schartum-Hansen, H (corresponding author), Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway.	hall.schartum-hansen@helse-bergen.no	Nilsen, Dennis/AAM-4344-2020					Ahmed A, 2008, INT J CARDIOL, V125, P246, DOI 10.1016/j.ijcard.2007.05.032; Ahmed A, 2006, EUR HEART J, V27, P1431, DOI 10.1093/eurheartj/ehi890; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bagshaw Sean M, 2007, Crit Care Resusc, V9, P60; BAYLISS J, 1987, BRIT HEART J, V57, P17; BERGENDAL L, 1995, PHARM WORLD SCI, V17, P152, DOI 10.1007/BF01879709; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; BURR M L, 1977, Age and Ageing, V6, P38; Carlsson AC, 2014, HYPERTENS RES, V37, P553, DOI 10.1038/hr.2014.32; Chiong JR, 2010, CLIN CARDIOL, V33, P345, DOI 10.1002/clc.20771; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; Dini FL, 2013, INT J CLIN PRACT, V67, P656, DOI 10.1111/ijcp.12144; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Faris R, 2002, INT J CARDIOL, V82, P149, DOI 10.1016/S0167-5273(01)00600-3; Felker GM, 2012, HEART FAIL REV, V17, P305, DOI 10.1007/s10741-011-9245-3; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Grossman E, 1999, AM J CARDIOL, V83, P1090; Hamaguchi S, 2012, CIRC J, V76, P1920, DOI 10.1253/circj.CJ-11-1196; Harjai KJ, 1999, INT J CARDIOL, V71, P219, DOI 10.1016/S0167-5273(99)00129-1; Hasselblad V, 2007, EUR J HEART FAIL, V9, P1064, DOI 10.1016/j.ejheart.2007.07.011; Ho D., 2007, J STAT SOFTWARE; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Jentzer JC, 2010, J AM COLL CARDIOL, V56, P1527, DOI 10.1016/j.jacc.2010.06.034; Leonard CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102279; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mondal SC, 2012, FUND CLIN PHARMACOL, V26, P383, DOI 10.1111/j.1472-8206.2011.00927.x; Murray MD, 1997, PHARMACOTHERAPY, V17, P98; Musini VM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003825.pub3; Myers M G, 1982, Age Ageing, V11, P213, DOI 10.1093/ageing/11.4.213; NORDREHAUG JE, 1983, BRIT HEART J, V50, P525; Palazzuoli A, 2014, CRIT CARE, V18, DOI 10.1186/cc13952; Peacock WF, 2009, CARDIOLOGY, V113, P12, DOI 10.1159/000164149; Rokutan H, 2012, INT J CARDIOL, V160, P20, DOI 10.1016/j.ijcard.2011.03.005; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; SHERMAN LG, 1986, CLIN PHARMACOL THER, V40, P587, DOI 10.1038/clpt.1986.228; Tveitevag Svingen GF, 2013, ARTERIOSCL THROM VAS, V33, P2041, DOI 10.1161/ATVBAHA.113.301714; van Kraaij DJW, 2000, AM J CARDIOL, V85, P1461, DOI 10.1016/S0002-9149(00)00795-5; van Kraaij DJW, 1998, EUR J CLIN PHARMACOL, V54, P323, DOI 10.1007/s002280050467; Wehling M, 2013, J AM MED DIR ASSOC, V14, P437, DOI 10.1016/j.jamda.2013.02.002; Yancy CW, 2013, J AM COLL CARDIOL; Yilmaz MB, 2011, EUR J HEART FAIL, V13, P1244, DOI 10.1093/eurjhf/hfr121	43	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0124611	10.1371/journal.pone.0124611	http://dx.doi.org/10.1371/journal.pone.0124611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030195	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900010
J	Shlensky, D; Mirrielees, JA; Zhao, ZB; Wang, L; Mahajan, A; Yu, MG; Sherer, NM; Wilke, LG; Xu, W				Shlensky, David; Mirrielees, Jennifer A.; Zhao, Zibo; Wang, Lu; Mahajan, Aparna; Yu, Menggang; Sherer, Nathan M.; Wilke, Lee G.; Xu, Wei			Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors	PLOS ONE			English	Article							PROTEIN ARGININE METHYLATION; ESTROGEN-RECEPTOR; METHYLTRANSFERASE 1; CANCER; REGULATOR; GROWTH	Purpose Coactivator-associated arginine methyltransferase 1 (CARM1) is a coactivator for ER alpha and cancer-relevant transcription factors, and can methylate diverse cellular targets including histones. CARM1 is expressed in one of two alternative splice isoforms, full-length CARM1 (CARM1FL) and truncated CARM1 (CARM1 Delta E15). CARM1FL and CARM1 Delta E15 function differently in transcriptional regulation, protein methylation, and mediation of pre-mRNA splicing in cellular models. Methods To investigate the functional roles and the prognosis potential of CARM1 alternative spliced isoforms in breast cancer, we used recently developed antibodies to detect differential CARM1 isoform expression in subcellular compartments and among malignant and benign breast tumors. Results Immunofluorescence in MDA-MB-231 and BG-1 cell lines demonstrated that CARM1 Delta E15 is the dominant isoform expressed in the cytoplasm, and CARM1FL is more nuclear localized. CARM1 Delta E15 was found to be more sensitive to Hsp90 inhibition than CARM1FL, indicating that the truncated isoform may be the oncogenic form. Clinical cancer samples did not have significantly higher expression of CARM1FL or CARM1 Delta E15 than benign breast samples at the level of mRNA or histology. Furthermore neither CARM1FL nor CARM1 Delta E15 expression correlated with breast cancer molecular subtypes, tumor size, or lymph node involvement. Conclusions The analysis presented here lends new insights into the possible oncogenic role of CARM1 Delta E15. This study also demonstrates no obvious association of CARM1 isoform expression and clinical correlates in breast cancer. Recent studies, however, have shown that CARM1 expression correlates with poor prognosis, indicating a need for further studies of both CARM1 isoforms in a large cohort of breast cancer specimens.	[Shlensky, David; Mirrielees, Jennifer A.; Wilke, Lee G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA; [Zhao, Zibo; Wang, Lu; Sherer, Nathan M.; Xu, Wei] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, Madison, WI 53706 USA; [Mahajan, Aparna] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA; [Yu, Menggang] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Xu, W (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, Madison, WI 53706 USA.	wxu@oncology.wisc.edu	Zhao, Zibo/GWQ-3444-2022		U.S. Department of Defense (DOD) [W81XWYH-11-1-023]; National Institutes of Health [T35 DK062709-09, P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062709] Funding Source: NIH RePORTER	U.S. Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by the U.S. Department of Defense (DOD W81XWYH-11-1-023; awarded to WX; http://cdmrp.army.mil/funding/bcrp.shtml). DS was supported by a training grant sponsored by the National Institutes of Health (T35 DK062709-09; http://www.nih.gov/) and administered by the University of Wisconsin School of Medicine and Public Health Department of Surgery Shapiro summer research experience program under the direction of Dr. Herbert Chen. The UWCCC BioBank is funded by the National Institutes of Health (P30 CA014520; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dhaheri M, 2011, CANCER RES, V71, P2118, DOI 10.1158/0008-5472.CAN-10-2426; Badve S, 2009, J CLIN PATHOL, V62, P6, DOI 10.1136/jcp.2008.059899; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheng HX, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-129; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Davis MB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-40; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Elakoum R, 2014, BIOCHIMIE, V97, P210, DOI 10.1016/j.biochi.2013.10.021; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Habashy HO, 2013, BREAST CANCER RES TR, V140, P307, DOI 10.1007/s10549-013-2614-y; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Kim YR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-197; Kuhn P, 2009, PROG MOL BIOL TRANSL, V87, P299, DOI 10.1016/S1877-1173(09)87009-9; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Mann M, 2013, CARCINOGENESIS, V34, P1468, DOI 10.1093/carcin/bgt091; MCGUIRE WL, 1991, MOL ENDOCRINOL, V5, P1571, DOI 10.1210/mend-5-11-1571; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Osada S, 2013, ONCOL REP, V30, P1669, DOI 10.3892/or.2013.2651; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wang L, 2013, NUCLEIC ACIDS RES, V41, P6870, DOI 10.1093/nar/gkt415; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Zanotti L, 2014, TUMOUR BIOL	27	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128143	10.1371/journal.pone.0128143	http://dx.doi.org/10.1371/journal.pone.0128143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030442	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900115
J	van Alphen, P; Hellingwerf, KJ				van Alphen, Pascal; Hellingwerf, Klaas J.			Sustained Circadian Rhythms in Continuous Light in Synechocystis sp PCC6803 Growing in a Well-Controlled Photobioreactor	PLOS ONE			English	Article							SP STRAIN PCC-6803; PCC 6803; SYNECHOCOCCUS-ELONGATUS; GENE-EXPRESSION; CYANOBACTERIA; GROWTH; CLOCK; OSCILLATIONS; PROKARYOTES; DYNAMICS	The cyanobacterial circadian clock has been well-studied and shown to be both robust and a dominant factor in the control of gene expression in Synechococcus elongatus PCC7942. In Synechocystis sp. PCC6803, the circadian clock is assumed to function similarly, yet appears to control transcription to a far lesser extent and its circadian rhythm was reported to not be sustained, or at least rapidly damped, under continuous illumination. One of the feedback loops that governs the clock in S. elongatus in addition to the core oscillator, i.e., the transcriptional-translation regulation loop hinging on KaiC-dependent expression of kaiBC, appears to be missing in Synechocystis, which would account for this difference. Here, we show that the clock in Synechocystis fulfills all criteria of a circadian clock: 1) a free-running period of approximately 24 h, 2) temperature compensation, and 3) being able to be entrained. A remarkably stable rhythm is generated despite the fact that the organism grows with a doubling time of less than 24 h in a photobioreactor run in turbidostat mode. No damping of the free-running circadian oscillation was observed in 2 weeks, suggesting that the clock in individual cells stays synchronized within a culture despite the apparent lack of a transcriptional-translation regulation loop. Furthermore, the dependence of chlorophyll synthesis on the presence of O-2 was demonstrated.	[van Alphen, Pascal; Hellingwerf, Klaas J.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Microbial Physiol Grp, Amsterdam, Netherlands; [Hellingwerf, Klaas J.] Photanol BV, Amsterdam, Netherlands	University of Amsterdam	Hellingwerf, KJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Mol Microbial Physiol Grp, Amsterdam, Netherlands.	K.J.Hellingwerf@uva.nl			Dutch Ministry of Economic Affairs [FOM24]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This project was carried out within the research programme of BioSolar Cells, co-financed by the Dutch Ministry of Economic Affairs, through grant FOM24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdaoud M, 2007, P NATL ACAD SCI USA, V104, P7051, DOI 10.1073/pnas.0609315104; ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; Angermayr SA, 2012, APPL ENVIRON MICROB, V78, P7098, DOI 10.1128/AEM.01587-12; Aoki S, 1997, J BACTERIOL, V179, P5751, DOI 10.1128/jb.179.18.5751-5755.1997; AOKI S, 1995, J BACTERIOL, V177, P5606, DOI 10.1128/jb.177.19.5606-5611.1995; Aoki Setsuyuki, 2009, P259, DOI 10.1007/978-3-540-88431-6_15; Axmann IM, 2014, MARINE GENOMICS; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Beck C, 2014, APPL ENVIRON MICROB, V80, P5195, DOI 10.1128/AEM.01086-14; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; Dorrich AK, 2014, MICROBIOL-SGM, V160, P2538, DOI 10.1099/mic.0.081695-0; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Ikeuchi M, 2001, PHOTOSYNTH RES, V70, P73, DOI 10.1023/A:1013887908680; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kondo T, 1999, TRENDS PLANT SCI, V4, P171, DOI 10.1016/S1360-1385(99)01410-7; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Kopf M, 2014, DNA RES, V21, P527, DOI 10.1093/dnares/dsu018; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Min HT, 2005, FEBS LETT, V579, P808, DOI 10.1016/j.febslet.2005.01.003; Mori T, 2001, SEMIN CELL DEV BIOL, V12, P271, DOI 10.1006/scdb.2001.0254; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nedbal L, 2008, BIOTECHNOL BIOENG, V100, P902, DOI 10.1002/bit.21833; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Sinetova MA, 2012, J BIOTECHNOL, V162, P148, DOI 10.1016/j.jbiotec.2012.04.009; Skolnick S, 2007, BBA-BIOENERGETICS, V1767, P814, DOI 10.1016/j.bbabio.2006.11.015; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Teng SW, 2013, SCIENCE, V340, P737, DOI 10.1126/science.1230996; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; van Thor JJ, 1999, THESIS U AMSTERDAM; Wiegard A, 2013, MICROBIOL-SGM, V159, P948, DOI 10.1099/mic.0.065425-0; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	37	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127715	10.1371/journal.pone.0127715	http://dx.doi.org/10.1371/journal.pone.0127715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030367	Green Submitted, Green Published, gold			2022-12-27	WOS:000356630900075
J	Zajmi, A; Hashim, NM; Noordin, MI; Khalifa, SAM; Ramli, F; Ali, HM; El-Seedi, HR				Zajmi, Asdren; Hashim, Najihah Mohd; Noordin, Mohamed Ibrahim; Khalifa, Shaden A. M.; Ramli, Faiqah; Ali, Hapipah Mohd; El-Seedi, Hesham R.			Ultrastructural Study on the Antibacterial Activity of Artonin E versus Streptomycin against Staphylococcus aureus Strains	PLOS ONE			English	Article							PROTEINS	Staphylococci are facultative anaerobes, perfectly spherical un-encapsulated cocci, with a diameter not exceeding 1 micrometer in diameter. Staphylococcus aureus are generally harmless and remain confined to the skin unless they burrow deep into the body, causing life-threatening infections in bones, joints, bloodstream, heart valves and lungs. Among the 20 medically important staphylococci species, Staphylococcus aureus is one of the emerging human pathogens. Streptomycin had its highest potency against Staphylococcus infections despite the likelihood of getting a resistant type of staphylococcus strains. Methicillin-resistant S. aureus (MRSA) is the persister type of Staphylococcus aureus and was evolved after decades of antibiotic misuse. Inadequate penetration of the antibiotic is one of the principal factors related to success/failure of the therapy. The active drug needs to reach the bacteria at concentrations necessary to kill or suppress the pathogen's growth. In turn the effectiveness of the treatment relied on the physical properties of Staphylococcus aureus. Thus understanding the cell integrity, shape and roughness is crucial to the overall influence of the therapeutic agent on S. aureus of different origins. Hence our experiments were designed to clarify ultrastructural changes of S. aureus treated with streptomycin (synthetic compound) in comparison to artonin E (natural compound). In addition to the standard in vitro microbial techniques, we used transmission electron microscopy to study the disrupted cell architecture under antibacterial regimen and we correlate this with scanning electron microscopy (SEM) to compare results of both techniques.	[Zajmi, Asdren; Hashim, Najihah Mohd; Noordin, Mohamed Ibrahim; Ramli, Faiqah] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur 50603, Malaysia; [Zajmi, Asdren] Management & Sci Univ, Fac Hlth & Life Sci, Dept Hlth Sci, Shah Alam 40100, Malaysia; [Hashim, Najihah Mohd] Univ Malaya, Fac Sci, Dept Chem, Ctr Nat Prod & Drug Discovery CENAR, Kuala Lumpur 50603, Malaysia; [Khalifa, Shaden A. M.] Karolinska Univ Hosp, Dept Expt Hematol, SE-14186 Stockholm, Sweden; [Ali, Hapipah Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia; [El-Seedi, Hesham R.] Uppsala Univ, Dept Med Chem, Div Pharmacognosy, SE-75123 Uppsala, Sweden	Universiti Malaya; Management Science University; Universiti Malaya; Karolinska Institutet; Karolinska University Hospital; Universiti Malaya; Uppsala University	Zajmi, A (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur 50603, Malaysia.	asza22@yahoo.com; najihahmh@gmail.com	Hashim, Najihah Mohd/J-5508-2015; El-Seedi, Hesham R./C-8627-2018; Zajmi, Asdren/A-1033-2011; Noordin, Mohamed/AAK-4152-2021	Hashim, Najihah Mohd/0000-0003-1133-7998; Zajmi, Asdren/0000-0002-7755-7718; Noordin, Mohamed Ibrahim/0000-0002-9424-8925	University of Malaya Research Grant UMRG [FL001E-13B10]; High Impact Research Grant (UM-MOHE) from Ministry of Higher Education of Malaysia [UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya Research Grant UMRG; High Impact Research Grant (UM-MOHE) from Ministry of Higher Education of Malaysia	University of Malaya Research Grant UMRG (FL001E-13B10) was received by NMH. High Impact Research Grant (UM-MOHE UM.C/625/1/HIR/MOHE/SC/09) from the Ministry of Higher Education of Malaysia was received by HMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, GUIDELINES PERFORMAN; Atkin KE, 2014, FEBS LETT, V588, P1869, DOI 10.1016/j.febslet.2014.04.002; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Blazquez B, 2014, BIOCHEMISTRY-US, V53, P1548, DOI 10.1021/bi500074w; El-Seedi H., 2012, Current Topics in Phytochemistry, Volume 11, P27; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Khalifa SAM, 2006, PARASITE, V13, P51, DOI 10.1051/parasite/2006131051; Khalifa SAM, 2003, HEARING RES, V185, P35, DOI 10.1016/S0378-5955(03)00228-4; Kuete V, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-42; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lorian V., 2005, ANTIBIOTICS LAB MED; Omar B, 2007, ANN MICROSCOPY, V7, P109; Price-Whelan A, 2013, MBIO, V4, DOI [10.1128/mBio.00407-13, DOI 10.1128/MBI0.00407-13]; Proctor RA, 2014, FRONTIERS CELLULAR I, V4, DOI [10.3389/fcimb.2014.00004, DOI 10.3389/FCIMB.2014.00004]; SMITH JA, 1965, LANCET, V2, P772; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	16	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128157	10.1371/journal.pone.0128157	http://dx.doi.org/10.1371/journal.pone.0128157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030925	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900119
J	Adams, RI; Bhangar, S; Pasut, W; Arens, EA; Taylor, JW; Lindow, SE; Nazaroff, WW; Bruns, TD				Adams, Rachel I.; Bhangar, Seema; Pasut, Wilmer; Arens, Edward A.; Taylor, John W.; Lindow, Steven E.; Nazaroff, William W.; Bruns, Thomas D.			Chamber Bioaerosol Study: Outdoor Air and Human Occupants as Sources of Indoor Airborne Microbes	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; SPORE CONCENTRATIONS; FUNGAL; DIVERSITY; BUILDINGS; PARTICLES; SEQUENCES; MARKERS; DUST	Human occupants are an important source of microbes in indoor environments. In this study, we used DNA sequencing of filter samples to assess the fungal and bacterial composition of air in an environmental chamber under different levels of occupancy, activity, and exposed or covered carpeting. In this office-like, mechanically ventilated environment, results showed a strong influence of outdoor-derived particles, with the indoor microbial composition tracking that of outdoor air for the 2-hour sampling periods. The number of occupants and their activity played a significant but smaller role influencing the composition of indoor bioaerosols. Human-associated taxa were observed but were not particularly abundant, except in the case of one fungus that appeared to be transported into the chamber on the clothing of a study participant. Overall, this study revealed a smaller signature of human body-associated taxa than had been expected based on recent studies of indoor microbiomes, suggesting that occupants may not exert a strong influence on bioaerosol microbial composition in a space that, like many offices, is well ventilated with air that is moderately filtered and moderately occupied.	[Adams, Rachel I.; Taylor, John W.; Lindow, Steven E.; Bruns, Thomas D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Bhangar, Seema; Nazaroff, William W.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Pasut, Wilmer; Arens, Edward A.] Univ Calif Berkeley, Ctr Built Environm, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Adams, RI (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	adamsri@berkeley.edu	Nazaroff, William/AAJ-7352-2021; Nazaroff, William W/C-4106-2008	Nazaroff, William/0000-0001-5645-3357; Nazaroff, William W/0000-0001-5645-3357; Adams, Rachel/0000-0003-4499-5743; Pasut, Wilmer/0000-0001-6284-4442	Alfred P. Sloan Foundation [88391]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Funding was provided by the Alfred P. Sloan Foundation (http://www.sloan.org) to TDB, grant # 88391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; [Anonymous], 1991, INDOOR AIR, DOI [DOI 10.1111/J.1600-0668.1991.05-13.X, 10.1111/j.1600-0668.1991.05-13.x]; ASHRAE, 2013, 6212013 ANSIASHRAE; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Bennett D., 2011, CEC5002011043; Bhangar S, INDOOR AIR, DOI [10.1111/12195, DOI 10.1111/12195]; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Flannigan B, 2011, MICROORGANISMS IN HOME AND INDOOR WORK ENVIRONMENTS: DIVERSITY, HEALTH IMPACTS, INVESTIGATION AND CONTROL, 2ND EDITION; Fox A, 2003, J ENVIRON MONITOR, V5, P246, DOI 10.1039/b212341j; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hospodsky D, 2015, INDOOR AIR, V25, P641, DOI 10.1111/ina.12172; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huse SM, 2013, SCI APPL MICROBIAL G, P188; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Layton DW, 2009, ENVIRON SCI TECHNOL, V43, P8199, DOI 10.1021/es9003735; LEHTONEN M, 1993, INT BIODETER BIODEGR, V31, P25, DOI 10.1016/0964-8305(93)90012-Q; Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindsley WG, 2006, J ENVIRON MONITOR, V8, P1136, DOI 10.1039/b609083d; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marples M. J., 1965, ECOLOGY HUMAN SKIN; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McDonagh A, 2014, J AEROSOL SCI, V75, P94, DOI 10.1016/j.jaerosci.2014.05.007; McDonagh A, 2014, J ENVIRON RADIOACTIV, V127, P119, DOI 10.1016/j.jenvrad.2013.10.012; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Meadow JF, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-7; MILLER JD, 1982, WOOD FIBER SCI, V14, P54; Millington WM, 2005, AEROBIOLOGIA, V21, P105, DOI 10.1007/s10453-005-4180-1; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; PASANEN AL, 1989, AM IND HYG ASSOC J, V50, P631, DOI 10.1202/0002-8894(1989)050&lt;0631:FCFFWI&gt;2.0.CO;2; Peccia J, 2011, ATMOS ENVIRON, V45, P1896, DOI 10.1016/j.atmosenv.2010.11.037; Persily AK, 2006, BUILD RES INF, V34, P459, DOI 10.1080/09613210600809128; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramos T, 2014, BUILD ENVIRON, V81, P243, DOI 10.1016/j.buildenv.2014.07.004; Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Walsh T J, 1993, Curr Top Med Mycol, V5, P79; Wirth Fernanda, 2012, Interdiscip Perspect Infect Dis, V2012, P465717, DOI 10.1155/2012/465717; Wu XM, 2012, ENVIRON SCI TECHNOL, V46, P12355, DOI 10.1021/es302140h; Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z	61	121	125	5	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128022	10.1371/journal.pone.0128022	http://dx.doi.org/10.1371/journal.pone.0128022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024222	Green Published, gold			2022-12-27	WOS:000355319400066
J	Li, XZ; Park, BK; Shin, JS; Choi, SH; Smith, SB; Yan, CG				Li, Xiang Z.; Park, Byung K.; Shin, Jong S.; Choi, Seong H.; Smith, Stephen B.; Yan, Chang G.			Effects of Dietary Linseed Oil and Propionate Precursors on Ruminal Microbial Community, Composition, and Diversity in Yanbian Yellow Cattle	PLOS ONE			English	Article							RUMEN BACTERIAL DIVERSITY; UNSATURATED FATTY-ACIDS; METHANE PRODUCTION; FERMENTATION CHARACTERISTICS; BUTYRIVIBRIO-FIBRISOLVENS; ORGANIC-ACIDS; LINOLEIC-ACID; MALATE; FUMARATE; ASSOCIATION	The rumen microbial ecosystem is a complex system where rumen fermentation processes involve interactions among microorganisms. There are important relationships between diet and the ruminal bacterial composition. Thus, we investigated the ruminal fermentation characteristics and compared ruminal bacterial communities using tag amplicon pyrosequencing analysis in Yanbian yellow steers, which were fed linseed oil (LO) and propionate precursors. We used eight ruminally cannulated Yanbian yellow steers (510 +/- 5.8 kg) in a replicated 4 x 4 Latin square design with four dietary treatments. Steers were fed a basal diet that comprised 80% concentrate and 20% rice straw (DM basis, CON). The CON diet was supplemented with LO at 4%. The LO diet was also supplemented with 2% DL-malate or 2% fumarate as ruminal precursors of propionate. Dietary supplementation with LO and propionate precursors increased ruminal pH, total volatile fatty acid concentrations, and the molar proportion of propionate. The most abundant bacterial operational taxonomic units in the rumen were related to dietary treatments. Bacteroidetes dominated the ruminal bacterial community and the genus Prevotella was highly represented when steers were fed LO plus propionate precursors. However, with the CON and LO diet plus malate or fumarate, Firmicutes was the most abundant phylum and the genus Ruminococcus was predominant. In summary, supplementing the diets of ruminants with a moderate level of LO plus propionate precursors modified the ruminal fermentation pattern. The most positive responses to LO and propionate precursors supplementation were in the phyla Bacteriodetes and Firmicutes, and in the genus Ruminococcus and Prevotella. Thus, diets containing LO plus malate or fumarate have significant effects on the composition of the rumen microbial community.	[Li, Xiang Z.; Yan, Chang G.] Yanbian Univ, Dept Anim Sci, Yanji 133002, Kagawa, Peoples R China; [Park, Byung K.] Nonghyup Feed Co Ltd, Feed Res Inst, Seoul 134763, South Korea; [Shin, Jong S.] Kangwon Natl Univ, Dept Anim Life Sci, Chunchoen 200701, South Korea; [Choi, Seong H.] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, Chungbuk, South Korea; [Smith, Stephen B.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Yanbian University; Kangwon National University; Chungbuk National University; Texas A&M University System; Texas A&M University College Station	Yan, CG (corresponding author), Yanbian Univ, Dept Anim Sci, Yanji 133002, Kagawa, Peoples R China.	ycg@ybu.edu.cn			Education Department of Jinlin Province [612013002]; Science and Technology Department of Jilin Province, China [201105109]; Cooperative Research Program for Agriculture Science & Technology Development: Rural Development Administration, Republic of Korea [PJ009482]	Education Department of Jinlin Province; Science and Technology Department of Jilin Province, China; Cooperative Research Program for Agriculture Science & Technology Development: Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was partially supported by the Education Department of Jinlin Province (No: 612013002) and the Science and Technology Department of Jilin Province (No: 201105109), China and the Cooperative Research Program for Agriculture Science & Technology Development (Project No: PJ009482): Rural Development Administration, Republic of Korea.	AOAC, 1995, OFFICIAL METHODS ANA, V16th; Asanuma N, 1999, J DAIRY SCI, V82, P780, DOI 10.3168/jds.S0022-0302(99)75296-3; BRYANT MP, 1959, BACTERIOL REV, V23, P125, DOI 10.1128/MMBR.23.3.125-153.1959; BRYANT MP, 1970, AM J CLIN NUTR, V23, P1440; Callaway TR, 1996, J ANIM SCI, V74, P1982; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carro MD, 2003, BRIT J NUTR, V90, P617, DOI 10.1079/BJN2003935; Castillo C, 2004, ANIM FEED SCI TECH, V115, P101, DOI 10.1016/j.anifeedsci.2004.02.001; Clarke R. T. J., 1977, Microbial ecology of the gut., P251; DEMEYER DI, 1995, ARCH ANIM NUTR, V48, P119, DOI 10.1080/17450399509381834; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; FAWCETT JK, 1960, J CLIN PATHOL, V13, P156, DOI 10.1136/jcp.13.2.156; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Khampa S, 2006, ASIAN AUSTRAL J ANIM, V19, P837, DOI 10.5713/ajas.2006.837; Kim YJ, 2000, APPL ENVIRON MICROB, V66, P5226, DOI 10.1128/AEM.66.12.5226-5230.2000; Kocherginskaya SA, 2001, ANAEROBE, V7, P119, DOI 10.1006/anae.2001.0378; Leaflet AS, 2008, USE PREVOTELLA BRYAN; Li XZ, 2010, ANIM FEED SCI TECH, V155, P132, DOI 10.1016/j.anifeedsci.2009.11.002; Li XZ, 2009, ASIAN AUSTRAL J ANIM, V22, P819, DOI 10.5713/ajas.2009.80682; Li XZ, 2009, ASIAN AUSTRAL J ANIM, V22, P82, DOI 10.5713/ajas.2009.80413; Maia MRG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-52; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marounek M, 1999, LETT APPL MICROBIOL, V29, P429, DOI 10.1046/j.1472-765X.1999.00671.x; Martin SA, 1998, J ANIM SCI, V76, P3123; MARTIN SA, 1995, J ANIM SCI, V73, P2141; Mitsumori M, 2002, LETT APPL MICROBIOL, V35, P251, DOI 10.1046/j.1472-765X.2002.01172.x; Mitsumori M, 2008, ASIAN AUSTRAL J ANIM, V21, P144, DOI 10.5713/ajas.2008.r01; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; NISBET DJ, 1993, CURR MICROBIOL, V26, P133, DOI 10.1007/BF01577366; POLAN CE, 1964, J BACTERIOL, V88, P1056, DOI 10.1128/JB.88.4.1056-1064.1964; RODE LM, 1981, APPL ENVIRON MICROB, V42, P20, DOI 10.1128/AEM.42.1.20-22.1981; *SAS INC, 1985, SAS US GUID STAT AN; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VanNevel CJ, 1996, ENVIRON MONIT ASSESS, V42, P73, DOI 10.1007/BF00394043; Wolin M.J., 1997, RUMEN MICROBIAL ECOS, P467, DOI [10.1007/978-94-009-1453-7_11, DOI 10.1007/978-94-009-1453-7_11]	40	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126473	10.1371/journal.pone.0126473	http://dx.doi.org/10.1371/journal.pone.0126473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024491	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400014
J	Shiba, K; Nishimoto, M; Sugimoto, M; Ishikawa, Y				Shiba, Koichiro; Nishimoto, Masahiro; Sugimoto, Minami; Ishikawa, Yoshiki			The Association between Meditation Practice and Job Performance: A Cross-Sectional Study	PLOS ONE			English	Article							BODY-MASS INDEX; WORK ENGAGEMENT; PHYSICAL-ACTIVITY; MINDFULNESS; HEALTH; STRESS; QUESTIONNAIRE; VALIDATION; WORKPLACE	Many previous studies have shown that meditation practice has a positive impact on cognitive and non-cognitive functioning, which are related to job performance. Thus, the aims of this study were to (1) estimate the prevalence of meditation practice, (2) identify the characteristics of individuals who practice meditation, and (3) examine the association between meditation practice and job performance. Two population-based, cross-sectional surveys were conducted. In study 1, we examined the prevalence of meditation practice and the characteristics of the persons practicing meditation; in Study 2, we examined the association between meditation practice and job performance. The outcome variables included work engagement, subjective job performance, and job satisfaction. The Utrecht Work Engagement Scale was used to assess work engagement, the World Health Organization Health and Work Performance Questionnaire (HPQ) was used to measure subjective job performance, and a scale developed by the Japanese government was used to assess job satisfaction. Hierarchical multiple regression analyses were used in Study 2. Demographic characteristics and behavioral risk factors were included as covariates in the analyses. The results of Study 1 indicated that 3.9% of persons surveyed (n = 30,665) practiced meditation; these individuals were younger and had a higher education, higher household income, higher stress level, and lower body mass index than those who did not practice meditation. The results of Study 2 (n = 1,470) indicated that meditation practice was significantly predictive of work engagement (beta = 0.112, p < .001), subjective job performance (beta = 0.116, p < .001), and job satisfaction (beta = 0.079, p = .002), even after adjusting for covariates (beta = 0.083, p < .001; beta = 0.104, p < .001; beta = 0.060, p = .015, respectively). The results indicate that meditation practice may positively influence job performance, including job satisfaction, subjective job performance, and work engagement.	[Shiba, Koichiro; Ishikawa, Yoshiki] Univ Tokyo, Dept Hlth & Social Behav Hlth Educ & Hlth Sociol, Sch Publ Hlth, Tokyo, Japan; [Nishimoto, Masahiro; Ishikawa, Yoshiki] H Inc, Tokyo, Japan; [Sugimoto, Minami] Univ Tokyo, Dept Social & Prevent Epidemiol, Sch Publ Hlth, Tokyo, Japan	University of Tokyo; University of Tokyo	Shiba, K (corresponding author), Univ Tokyo, Dept Hlth & Social Behav Hlth Educ & Hlth Sociol, Sch Publ Hlth, Tokyo, Japan.	shibakoichiro@gmail.com		Shiba, Koichiro/0000-0001-7956-6485; Sugimoto, Minami/0000-0002-3692-2707	Campus for H., Inc.	Campus for H., Inc.	This study was funded by Campus for H., Inc.. Authors MN and YI were employees of Campus for H., Inc. at the time of the study; they were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Babcock-Roberson ME, 2010, J PSYCHOL, V144, P313, DOI 10.1080/00223981003648336; Bouchard C, 1994, PHYS ACTIVITY FITNES, P551; Cabinet Office Government of Japan, 2008, KOK SEIK SENK CHOUS; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; Creswell JD, 2014, PSYCHONEUROENDOCRINO, V44, P1, DOI 10.1016/j.psyneuen.2014.02.007; Gates DM, 2008, J OCCUP ENVIRON MED, V50, P39, DOI 10.1097/JOM.0b013e31815d8db2; Goetzel RZ, 2010, J OCCUP ENVIRON MED, V52, pS52, DOI 10.1097/JOM.0b013e3181c95b84; Gotlib IH, 1998, ANXIETY DEPRESSION D, P131; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Johansson G, 2008, INT J OBESITY, V32, P1031, DOI 10.1038/ijo.2008.42; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51; Koopmans L, 2011, J OCCUP ENVIRON MED, V53, P856, DOI 10.1097/JOM.0b013e318226a763; Kozasa EH, 2012, NEUROIMAGE, V59, P745, DOI 10.1016/j.neuroimage.2011.06.088; Liu XC, 2000, PSYCHIAT RES, V93, P1, DOI 10.1016/S0165-1781(99)00119-5; Marchand WR, 2014, WORLD J RADIOL, V6, P471, DOI 10.4329/wjr.v6.i7.471; Ministry of Health, 2012, LABOUR AND WELFARE N; [Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology], 2002, ETH GUID EP RES; Nye CD, 2012, PERSPECT PSYCHOL SCI, V7, P384, DOI 10.1177/1745691612449021; O'Boyle EH, 2011, J ORGAN BEHAV, V32, P788, DOI 10.1002/job.714; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Schmidt FL, 2014, PERSPECT PSYCHOL SCI, V9, P211, DOI 10.1177/1745691613518074; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Shimomitsu T., 1998, REPORT RES GRANT PRE, P107; Stults-Kolehmainen MA, 2014, SPORTS MED, V44, P81, DOI 10.1007/s40279-013-0090-5; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; The Ministry of Health Labour and Welfare, 2000, ACT SURV HLTH WELF; Tsutsumi A, 2005, J OCCUP HEALTH, V47, P226, DOI 10.1539/joh.47.226; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Weinstein N, 2009, J RES PERS, V43, P374, DOI 10.1016/j.jrp.2008.12.008; Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014; Zhou J, 2003, LEADERSHIP QUART, V14, P545, DOI 10.1016/S1048-9843(03)00051-1	34	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128287	10.1371/journal.pone.0128287	http://dx.doi.org/10.1371/journal.pone.0128287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024382	Green Submitted, gold, Green Published			2022-12-27	WOS:000355319400079
J	Chen, JH; Kellner, Y; Zagrebelsky, M; Grunwald, M; Korte, M; Walla, PJ				Chen, Jian-Hua; Kellner, Yves; Zagrebelsky, Marta; Grunwald, Matthias; Korte, Martin; Walla, Peter Jomo			Two-Photon Correlation Spectroscopy in Single Dendritic Spines Reveals Fast Actin Filament Reorganization during Activity-Dependent Growth	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FLUORESCENCE CORRELATION SPECTROSCOPY; DYNAMICS; PLASTICITY; FUSION	Two-photon fluorescence correlation spectroscopy (2P-FCS) within single dendritic spines of living hippocampal pyramidal neurons was used to resolve various subpopulations of mobile F-actin during activity-dependent structural changes such as potentiation induced spine head growth. Two major classes of mobile F-actin were discovered: very dynamic and about a hundred times less dynamic F-actin. Spine head enlargement upon application of Tetraethylammonium (TEA), a protocol previously used for the chemical induction of long-term potentiation (cLTP) strictly correlated to changes in the dynamics and filament numbers in the different actin filament fractions. Our observations suggest that spine enlargement is governed by a mechanism in which longer filaments are first cut into smaller filaments that cooperate with the second, increasingly dynamic shorter actin filament population to quickly reorganize and expand the actin cytoskeleton within the spine head. This process would allow a fast and efficient spine head enlargement using a major fraction of the actin filament population that was already present before spine head growth.	[Chen, Jian-Hua; Grunwald, Matthias; Walla, Peter Jomo] Max Planck Inst Biophys Chem, AG Biomol Spect & Single Mol Detect, D-37077 Gottingen, Germany; [Kellner, Yves; Zagrebelsky, Marta; Korte, Martin] TU Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany; [Korte, Martin] AG NIND, HZI, D-38124 Braunschweig, Germany; [Walla, Peter Jomo] TU Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany	Max Planck Society; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Korte, M (corresponding author), TU Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany.	m.korte@tu-braunschweig.de; pwalla@gwdg.de		Zagrebelsky, Marta/0000-0003-1083-7413	German Research Foundation [DFG-ZA554/2-1]	German Research Foundation(German Research Foundation (DFG))	This work was partially supported by the German Research Foundation to MK and MZ (DFG-ZA554/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Michaelsen-Preusse K, 2014, NEUROMETHODS, V87, P189, DOI 10.1007/978-1-4939-0381-8_9; Roth-Alpermann C, 2006, P NATL ACAD SCI USA, V103, P11039, DOI 10.1073/pnas.0600894103; ROUSE PE, 1953, J CHEM PHYS, V21, P1272, DOI 10.1063/1.1699180; RUDDIES R, 1993, EUR BIOPHYS J BIOPHY, V22, P309, DOI 10.1007/BF00213554; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stewart MG, 2005, EUR J NEUROSCI, V21, P3368, DOI 10.1111/j.1460-9568.2005.04174.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	24	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128241	10.1371/journal.pone.0128241	http://dx.doi.org/10.1371/journal.pone.0128241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020927	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300092
J	Makarova, OV; Makarov, EM				Makarova, Olga V.; Makarov, Evgeny M.			The 35S U5 snRNP Is Generated from the Activated Spliceosome during In vitro Splicing	PLOS ONE			English	Article							CATALYTIC ACTIVATION; PROTEIN-COMPOSITION; TRI-SNRNP; COMPLEXES; DESIGN; CORE; STEP	Primary gene transcripts of eukaryotes contain introns, which are removed during processing by splicing machinery. Biochemical studies In vitro have identified a specific pathway in which introns are recognised and spliced out. This occurs by progressive formation of spliceosomal complexes designated as E, A, B, and C. The composition and structure of these spliceosomal conformations have been characterised in many detail. In contrast, transitions between the complexes and the intermediates of these reactions are currently less clear. We have previously isolated a novel 35S U5 snRNP from HeLa nuclear extracts. The protein composition of this particle differed from the canonical 20S U5 snRNPs but was remarkably similar to the activated B* spliceosomes. Based on this observation we have proposed a hypothesis that 35S U5 snRNPs represent a dissociation product of the spliceosome after both transesterification reactions are completed. Here we provide experimental evidence that 35S U5 snRNPs are generated from the activated B* spliceosomes during In vitro splicing.	[Makarova, Olga V.; Makarov, Evgeny M.] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Makarova, Olga V.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Makarov, Evgeny M.] Brunel Univ London, Coll Hlth & Life Sci, Div Biosci, Uxbridge, Middx, England	Max Planck Society; University of Leicester; Brunel University	Makarov, EM (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany.	evgeny.makarov@brunel.ac.uk		Makarov, Evgeny/0000-0003-2543-9637				Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarov EM, 2012, NUCLEIC ACIDS RES, V40, P2639, DOI 10.1093/nar/gkr1056; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480	16	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128430	10.1371/journal.pone.0128430	http://dx.doi.org/10.1371/journal.pone.0128430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020933	Green Published, gold			2022-12-27	WOS:000355187300110
J	Eichinger, M; Titze, S; Haditsch, B; Dorner, TE; Stronegger, WJ				Eichinger, Michael; Titze, Sylvia; Haditsch, Bernd; Dorner, Thomas E.; Stronegger, Willibald J.			How Are Physical Activity Behaviors and Cardiovascular Risk Factors Associated with Characteristics of the Built and Social Residential Environment?	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; UNITED-STATES; HEALTH; ADULTS; QUESTIONNAIRE; POPULATION; MORTALITY; VALIDITY; WOMEN	Background The aim of our study was to identify perceptions of built and social residential characteristics and their association with behaviors such as physical activity (PA), nutrition and smoking and with cardiovascular risk factors (elevated BMI and fasting blood glucose). Methods Among participants of a preventive medical checkup at an Austrian District Health Insurance Fund (n=904, response rate = 82.2%, 42% women, 18-91 years) self-reported and measured data were collected. Results Total PA was positively associated with the presence of trees along the streets and high levels of pro-physical activity social modeling (SM) and it was negatively related to perceived safety from crime. More leisure-time PA was associated with higher levels of cycling/walking infrastructure and high levels of SM. PA for transportation was positively related to high levels of connectivity and high levels of SM. Better behavioral cardiovascular risk factor profiles (smoking and nutrition) were associated with high levels of SM and high levels of total PA. Lower BMI values were associated with high levels of infrastructure and high levels of SM. Conclusions Both built and social residential characteristics are important correlates of PA as well as of major cardiovascular risk factors besides PA.	[Eichinger, Michael] Med Univ Graz, Inst Social Med & Epidemiol, A-8010 Graz, Austria; [Titze, Sylvia] Graz Univ, Inst Sport Sci, A-8010 Graz, Austria; [Haditsch, Bernd] Styrian Dist Hlth Insurance Fund, A-8010 Graz, Austria; [Dorner, Thomas E.] Med Univ Vienna, Inst Social Med, A-1090 Vienna, Austria; [Stronegger, Willibald J.] Med Univ Graz, Inst Social Med & Epidemiol, A-8010 Graz, Austria	Medical University of Graz; University of Graz; Medical University of Vienna; Medical University of Graz	Eichinger, M (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Univ Str 6, A-8010 Graz, Austria.	michael.e.eichinger@gmail.com	Stronegger, Willibald J./C-2425-2018	Stronegger, Willibald J./0000-0003-3496-1208; Eichinger, Michael/0000-0003-0064-7640; Dorner, Thomas Ernst/0000-0002-5218-1160	Medical University of Graz	Medical University of Graz	Funding for this study was provided by the Medical University of Graz through an advancement scholarship awarded to ME. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CARD DIS; Brunner-Ziegler S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1138; Bucksch J, 2011, J PUBLIC HEALTH-HEID, V19, P417, DOI 10.1007/s10389-011-0416-4; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; De Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P886, DOI 10.1079/PHN2005735; Do DP, 2008, AM J EPIDEMIOL, V168, P611, DOI 10.1093/aje/kwn182; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Garrett N, 2007, DIS MANAGE, V10, P51, DOI 10.1089/dis.2006.630; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Grossschadl F, 2012, WIEN KLIN WOCHENSCHR, V124, P363, DOI 10.1007/s00508-012-0175-4; HOVELL MF, 1989, PREV MED, V18, P856, DOI 10.1016/0091-7435(89)90021-2; IPAQ Research Committee, GUID DAT PROC AN INT; King AC, 2000, HEALTH PSYCHOL, V19, P354, DOI 10.1037//0278-6133.19.4.354; Li FZ, 2008, AM J PREV MED, V35, P38, DOI 10.1016/j.amepre.2008.03.021; Messer LC, 2007, AM J EPIDEMIOL, V165, P868, DOI 10.1093/aje/kwm038; Moore JB, 2013, PREV MED, V56, P145, DOI 10.1016/j.ypmed.2012.11.019; Moran Andrew, 2008, BMC Public Health, V8, P394, DOI 10.1186/1471-2458-8-394; Mujahid MS, 2008, EPIDEMIOLOGY, V19, P590, DOI 10.1097/EDE.0b013e3181772cb2; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; Rosengren A, 2001, EUR HEART J, V22, P136, DOI 10.1053/euhj.2000.2179; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Spittaels H, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-48; Spittaels H, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-39; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stein KV, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-59; Stronegger WJ, 2010, HEALTH PLACE, V16, P736, DOI 10.1016/j.healthplace.2010.03.005; Sugiyama T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.064287; Titze S, 2003, PROMOTION HLTH ENHAN; Titze Sylvia, 2007, J Phys Act Health, V4, P66; Titze S, 2010, J PHYS ACT HEALTH, V7, P423, DOI 10.1123/jpah.7.4.423; WHO, 2010, GLOB STAT REP NONC D; Wood L, 2010, SOC SCI MED, V70, P1381, DOI 10.1016/j.socscimed.2010.01.021; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007	39	21	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2015	10	6							e0126010	10.1371/journal.pone.0126010	http://dx.doi.org/10.1371/journal.pone.0126010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7SJ	26035294	Green Submitted, Green Published, gold			2022-12-27	WOS:000355699100005
J	Chain, B; Arnold, J; Akthar, S; Brandt, M; Davis, D; Noursadeghi, M; Lapp, T; Ji, CH; Sankuratri, S; Zhang, YJ; Govada, L; Saridakis, E; Chayen, N				Chain, Benny; Arnold, Jack; Akthar, Samia; Brandt, Michael; Davis, David; Noursadeghi, Mahdad; Lapp, Thabo; Ji, Changhua; Sankuratri, Surya; Zhang, Yanjing; Govada, Lata; Saridakis, Emmanuel; Chayen, Naomi			A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; T-CELL EPITOPES; MONOCLONAL-ANTIBODIES; HIV-1 INFECTION; CHEMOKINE; RECEPTOR; IMMUNIZATION; CORECEPTOR; INDUCTION; PEPTIDE	The CCR5 receptor plays a role in several key physiological and pathological processes and is an important therapeutic target. Inhibition of the CCR5 axis by passive or active immunisation offers one very selective strategy for intervention. In this study we define a new linear epitope within the extracellular domain of CCR5 recognised by two independently produced monoclonal antibodies. A short peptide encoding the linear epitope can induce antibodies which recognise the intact receptor when administered colinear with a tetanus toxoid helper T cell epitope. The monoclonal antibody RoAb 13 is shown to bind to both cells and peptide with moderate to high affinity (6x10 boolean AND 8 and 1.2x10(7) M-1 respectively), and binding to the peptide is enhanced by sulfation of tyrosines at positions 10 and 14. RoAb13, which has previously been shown to block HIV infection, also blocks migration of monocytes in response to CCR5 binding chemokines and to inflammatory macrophage conditioned medium. A Fab fragment of RoAb13 has been crystallised and a structure of the antibody is reported to 2.1 angstrom resolution.	[Chain, Benny; Arnold, Jack; Akthar, Samia; Noursadeghi, Mahdad; Lapp, Thabo; Zhang, Yanjing] UCL, Div Infect & Immun, London, England; [Brandt, Michael; Ji, Changhua; Sankuratri, Surya] Roche Nutley, Virol Discovery & Translat Area, Nutley, NJ 07110 USA; [Davis, David] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [Govada, Lata; Chayen, Naomi] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Computat & Syst Med, London, England; [Saridakis, Emmanuel] Natl Ctr Sci Res Demokritos, Dept Phys Chem, Lab Struct & Supramol Chem, Athens, Greece	University of London; University College London; Imperial College London; National Centre of Scientific Research "Demokritos"	Chain, B (corresponding author), UCL, Div Infect & Immun, Gower St, London, England.	b.chain@ucl.ac.uk	Saridakis, Emmanuel/AAC-7172-2020	Saridakis, Emmanuel/0000-0003-1500-0874; Govada, Lata/0000-0002-8077-0480; Noursadeghi, Mahdad/0000-0002-4774-0853; Chayen, Naomi/0000-0003-2861-2458; Chain, Benny/0000-0002-7417-3970; Lapp, Thabo/0000-0001-7097-7587; Arnold, Jack/0000-0002-6574-2043	Gertrud-Kusen-Foundation fellowship; Rosetrees Trust; NIHR Biomedical Research Centre funding to University College London Hospitals and UCL; Bill and Melinda Gates Foundation; Wellcome Trust; UK Engineering and Physical Sciences Research Council (EPSRC) [EP/G027005]; Roche Pharma; Engineering and Physical Sciences Research Council [EP/G027005/1] Funding Source: researchfish; EPSRC [EP/G027005/1] Funding Source: UKRI	Gertrud-Kusen-Foundation fellowship; Rosetrees Trust(Rosetrees Trust); NIHR Biomedical Research Centre funding to University College London Hospitals and UCL; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Roche Pharma; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by a Gertrud-Kusen-Foundation fellowship (TL), the Rosetrees Trust, NIHR Biomedical Research Centre funding to University College London Hospitals and UCL, the Bill and Melinda Gates Foundation and the Wellcome Trust. NEC thanks the UK Engineering and Physical Sciences Research Council (EPSRC) Grant EP/G027005 for financial support. Roche Pharma provided support in the form of salaries for authors MB, CJ and SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Bogers WMJM, 2004, VACCINE, V22, P2974, DOI 10.1016/j.vaccine.2004.02.050; Brower ET, 2009, BIOCHEMISTRY-US, V48, P779, DOI 10.1021/bi8021476; Chain BM, 2008, VACCINE, V26, P5752, DOI 10.1016/j.vaccine.2008.08.025; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; DYSON HJ, 1988, ANNU REV BIOPHYS BIO, V17, P305; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; HO PC, 1990, EUR J IMMUNOL, V20, P477, DOI 10.1002/eji.1830200304; Hunter Z, 2009, VACCINE, V28, P403, DOI 10.1016/j.vaccine.2009.10.035; IVERSON GM, 1972, EUR J IMMUNOL, V2, P195, DOI 10.1002/eji.1830020302; Ji CH, 2007, ANTIVIR RES, V74, P125, DOI 10.1016/j.antiviral.2006.11.003; Ji C, 2007, MOL PHARMACOL, V72, P18, DOI 10.1124/mol.107.035055; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Khurana S, 2005, J VIROL, V79, P6791, DOI 10.1128/JVI.79.11.6791-6800.2005; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Leslie AGW, 2002, ACTA CRYSTALLOGR D, V58, P1924, DOI 10.1107/S0907444902016864; Li L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008439.pub3; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; Misumi S, 2006, J IMMUNOL, V176, P463, DOI 10.4049/jimmunol.176.1.463; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noursadeghi M, J IMMUNOL METHODS, V329, P194; OHARA O, 1989, P NATL ACAD SCI USA, V86, P5673, DOI 10.1073/pnas.86.15.5673; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Pastori C, 2014, J VIROL, V88, P3623, DOI 10.1128/JVI.03663-13; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Tamamis P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05447; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Rompay KKA, 2014, J VIROL, V88, P2011, DOI 10.1128/JVI.02447-13; Weitzenfeld P, 2014, CANCER LETT, V352, P36, DOI 10.1016/j.canlet.2013.10.006; Wu KT, 2006, PROTEIN EXPRES PURIF, V49, P108, DOI 10.1016/j.pep.2006.02.020	39	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128381	10.1371/journal.pone.0128381	http://dx.doi.org/10.1371/journal.pone.0128381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030924	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900143
J	Ghasemi-Kasman, M; Hajikaram, M; Baharvand, H; Javan, M				Ghasemi-Kasman, Maryam; Hajikaram, Maryam; Baharvand, Hossein; Javan, Mohammad			MicroRNA-Mediated In Vitro and In Vivo Direct Conversion of Astrocytes to Neuroblasts	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL-NEURONS; HUMAN FIBROBLASTS; MOUSE FIBROBLASTS; ADULT BRAIN; GENERATION; PLURIPOTENCY; EXPRESSION; INDUCTION	Background The conversion of astrocytes to neuroblasts holds great promise for treatment of neurodegenerative and traumatic brain diseases. Methodology and Principal Findings Here we have shown that adult human astrocytes could be reprogrammed to neuroblasts by miR-302/367, both in vivo and in vitro. However, the reprogramming of adult mouse astrocytes to neuroblasts required valproic acid (VPA), a histone deacetylase inhibitor. Following induction of astrocytes toward neurons the expression of pluripotency markers were not detected, which suggested direct cell conversion. We did not observed tumor formation during two months follow up. Conclusions and Significance These results show that neuroblasts can be generated directly from adult human and mouse astrocytes by miR-302/367-driven induction. This approach seems promising for converting glial scar cells into neuroblasts in a wide range of neurological diseases.	[Ghasemi-Kasman, Maryam; Javan, Mohammad] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Hajikaram, Maryam; Baharvand, Hossein; Javan, Mohammad] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran	Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Javan, M (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.	mjavan@modares.ac.ir	Ghasemi-Kasman, Maryam/Q-7989-2016; Javan, Mohammad/C-6758-2008	Ghasemi-Kasman, Maryam/0000-0002-5014-5166; Javan, Mohammad/0000-0003-2045-6171	Iranian Council for Cognitive Sciences and Technologies; Iran National Science Foundation; Tarbiat Modares University; Royan Institute	Iranian Council for Cognitive Sciences and Technologies; Iran National Science Foundation(Iran National Science Foundation (INSF)); Tarbiat Modares University; Royan Institute	This work was supported by grants from the Iranian Council for Cognitive Sciences and Technologies, Iran National Science Foundation, Tarbiat Modares University and Royan Institute.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Corti S, 2012, EXP CELL RES, V318, P1528, DOI 10.1016/j.yexcr.2012.02.040; Grande A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3373; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kuo CH, 2013, J CELL BIOCHEM, V114, P275, DOI 10.1002/jcb.24385; Lee MR, 2013, STEM CELLS, V31, P666, DOI 10.1002/stem.1302; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, STEM CELLS, V29, P1645, DOI 10.1002/stem.744; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lu J, 2014, BIOCHEM BIOPH RES CO, V453, P405, DOI 10.1016/j.bbrc.2014.09.095; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; MARSON A, CELL, V134, P521; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Smetana K, 2010, FOLIA BIOL-PRAGUE, V56, P201; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu S, 2014, CELL RES, V24, P126, DOI 10.1038/cr.2013.156	36	40	45	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127878	10.1371/journal.pone.0127878	http://dx.doi.org/10.1371/journal.pone.0127878			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030913	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900087
J	Hill, JE; Paladino, FV; Spotila, JR; Tomillo, PS				Hill, Jacob E.; Paladino, Frank V.; Spotila, James R.; Tomillo, Pilar Santidrian			Shading and Watering as a Tool to Mitigate the Impacts of Climate Change in Sea Turtle Nests	PLOS ONE			English	Article							LEATHERBACK TURTLES; INCUBATION-TEMPERATURE; MANAGEMENT STRATEGIES; LEPIDOCHELYS-OLIVACEA; SAND TEMPERATURE; PLAYA-GRANDE; EGGS; PERFORMANCE; HATCHLINGS; POPULATION	Increasing sand temperatures resulting from climate change may negatively impact sea turtle nests by altering sex ratios and decreasing reproductive output. We analyzed the effect of nest shading and watering on sand temperatures as climate mitigation strategies in a beach hatchery at Playa Grande, Costa Rica. We set up plots and placed thermocouples at depths of 45cm and 75cm. Half of the plots were shaded and half were exposed to the sun. Within these exposure treatments, we applied three watering treatments over one month, replicating local climatic conditions experienced in this area. We also examined gravimetric water content of sand by collecting sand samples the day before watering began, the day after watering was complete, and one month after completion. Shading had the largest impact on sand temperature, followed by watering and depth. All watering treatments lowered sand temperature, but the effect varied with depth. Temperatures in plots that received water returned to control levels within 10 days after watering stopped. Water content increased at both depths in the two highest water treatments, and 30 days after the end of water application remained higher than plots with low water. While the impacts of watering on sand temperature dissipate rapidly after the end of application, the impacts on water content are much more lasting. Although less effective at lowering sand temperatures than shading, watering may benefit sea turtle clutches by offsetting negative impacts of low levels of rain in particularly dry areas. Prior to implementing such strategies, the natural conditions at the location of interest (e.g. clutch depth, environmental conditions, and beach characteristics) and natural hatchling sex ratios should be taken into consideration. These results provide insight into the effectiveness of nest shading and watering as climate mitigation techniques and illustrate important points of consideration in the crafting of such strategies.	[Hill, Jacob E.; Paladino, Frank V.] Indiana Univ Purdue Univ, Coll Arts & Sci, Dept Biol, Ft Wayne, IN 46805 USA; [Spotila, James R.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Tomillo, Pilar Santidrian] IMEDEA CSIC UIB, Inst Mediterrani Estudis Avancats, Populat Ecol Grp, Mallorca, Spain	Purdue University System; Indiana University Purdue University Fort Wayne; Drexel University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Hill, JE (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS 39762 USA.	jearl.hill98@gmail.com	Santidrián Tomillo, Pilar/N-5406-2014	Santidrián Tomillo, Pilar/0000-0002-6895-7218; Paladino, Frank V./0000-0002-6452-0086; Hill, Jacob/0000-0003-2761-8786	Earthwatch to Frank Paladino at Indiana University Purdue University at Fort Wayne (IPFW); Schrey Chair in Biology at IPFW; Betz Chair of Environmental Science at Drexel University	Earthwatch to Frank Paladino at Indiana University Purdue University at Fort Wayne (IPFW); Schrey Chair in Biology at IPFW; Betz Chair of Environmental Science at Drexel University	This study was funded by a grant from Earthwatch to Frank Paladino at Indiana University Purdue University at Fort Wayne (IPFW), by the Schrey Chair in Biology at IPFW, and by the Betz Chair of Environmental Science at Drexel University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Ralph A., 1997, P83; Binckley CA, 1998, COPEIA, P291; Booth DT, 2006, PHYSIOL BIOCHEM ZOOL, V79, P274, DOI 10.1086/499988; Burgess EA, 2006, CORAL REEFS, V25, P341, DOI 10.1007/s00338-006-0116-7; Chevalier J, 1999, ANN SCI NAT ZOOL, V20, P147, DOI 10.1016/S0003-4339(00)88882-6; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Dornfeld TC, 2014, MAR BIOL, V162, P1; Fuentes MMPB, 2012, MITIG ADAPT STRAT GL, V17, P51, DOI 10.1007/s11027-011-9308-8; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Fuentes M. M. P. B., 2009, Endangered Species Research, V9, P33, DOI 10.3354/esr00224; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; GUTZKE WHN, 1987, PHYSIOL ZOOL, V60, P9, DOI 10.1086/physzool.60.1.30158624; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hays GC, 2001, OIKOS, V93, P87, DOI 10.1034/j.1600-0706.2001.930109.x; Hays GC, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00043; Houghton JDR, 2007, J EXP MAR BIOL ECOL, V345, P71, DOI 10.1016/j.jembe.2007.02.001; IBM, 2011, IBM SPSS STAT WIND; Ischer T, 2009, MAR BIOL, V156, P1399, DOI 10.1007/s00227-009-1180-7; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Janzen FJ, 1995, FUNCT ECOL, V9, P913, DOI 10.2307/2389990; JANZEN FJ, 1993, ECOLOGY, V74, P332, DOI 10.2307/1939296; Jourdan J, 2013, MITIG ADAPT STRAT GL, V20, P1; Katselidis KA, 2012, ANIM CONSERV, V15, P508, DOI 10.1111/j.1469-1795.2012.00543.x; Laloe JO, 2014, NAT CLIM CHANGE, V4, P513, DOI 10.1038/NCLIMATE2236; Leslie Alison J., 1996, Chelonian Conservation and Biology, V2, P159; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; MCGEHEE MA, 1990, HERPETOLOGICA, V46, P251; Micheli-Campbell MA, 2011, J ZOOL, V285, P266, DOI 10.1111/j.1469-7998.2011.00840.x; Mickelson LE, 2010, CAN J ZOOL, V88, P359, DOI 10.1139/Z10-007; MILLER K, 1987, J EXP BIOL, V127, P401; MORREALE SJ, 1982, SCIENCE, V216, P1245, DOI 10.1126/science.7079758; Nordmoe ED, 2004, ANIM BEHAV, V68, P387, DOI 10.1016/j.anbehav.2003.07.015; PACKARD GC, 1988, J COMP PHYSIOL B, V158, P117, DOI 10.1007/BF00692735; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Patino-Martinez J, 2012, GLOBAL CHANGE BIOL, V18, P401, DOI 10.1111/j.1365-2486.2011.02532.x; Pike DA, 2014, GLOBAL CHANGE BIOL, V20, P7, DOI 10.1111/gcb.12397; Ralph CR, 2005, AUST J ZOOL, V53, P289, DOI 10.1071/ZO04062; Robinson NJ, 2014, ENDANGER SPECIES RES, V24, P197, DOI 10.3354/esr00604; Saba VS, 2012, NAT CLIM CHANGE, V2, P814, DOI 10.1038/NCLIMATE1582; Santidrian Tomillo P, GLOB CHANG IN PRESS; Segura LN, 2010, HERPETOL CONSERV BIO, V5, P196; SPOTILA JR, 1987, HERPETOLOGICA, V43, P74; STANDORA EA, 1985, COPEIA, P711, DOI 10.2307/1444765; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; Valverde Roldan A., 2010, Endangered Species Research, V12, P77, DOI 10.3354/esr00296; Wallace BP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P423, DOI 10.1086/420951; Waylen PR, 1996, J CLIMATE, V9, P2606, DOI 10.1175/1520-0442(1996)009<2606:IVOMPI>2.0.CO;2; Wibbels T, 2003, CRC MAR BIOL SER, P103; Wibbels T, 1998, COPEIA, P1086; Wood A, 2014, J EXP MAR BIOL ECOL, V451, P105, DOI 10.1016/j.jembe.2013.11.005	54	44	46	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129528	10.1371/journal.pone.0129528	http://dx.doi.org/10.1371/journal.pone.0129528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030883	Green Published, gold, Green Submitted			2022-12-27	WOS:000356630900222
J	Jezequel, C; Laine, F; Laviolle, B; Kiani, A; Bardou-Jacquet, E; Deugnier, Y				Jezequel, Caroline; Laine, Fabrice; Laviolle, Bruno; Kiani, Anita; Bardou-Jacquet, Edouard; Deugnier, Yves			Both Hepatic and Body Iron Stores Are Increased in Dysmetabolic Iron Overload Syndrome. A Case-Control Study	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATION; PHLEBOTOMY	Background & Aims Hepatic iron is increased in dysmetabolic iron overload syndrome (DIOS). Whether this reflects elevated body iron stores is still debated. The study was aimed at assessing body iron stores in DIOS patients by calculating the amount of mobilized iron (AMI). Methods We conducted a prospective case-control study comparing AMI in 12 DIOS patients and 12 overweight normoferritinemic subjects matched on BMI and age. All participants were phlebotomized until serum ferritin dropped <= 50 mu g/L. Results The two groups were comparable with respect to metabolic abnormalities and differed according to serum ferritin levels only. AMI was significantly (p<0.0001) higher in DIOS (2.5g +/- 0.7) than in controls (0.8g +/- 0.3). No side effects were related to phlebotomies.	[Jezequel, Caroline; Laine, Fabrice; Bardou-Jacquet, Edouard; Deugnier, Yves] CHU Rennes, Liver Unit, F-35033 Rennes, France; [Jezequel, Caroline; Laine, Fabrice; Laviolle, Bruno; Kiani, Anita; Bardou-Jacquet, Edouard; Deugnier, Yves] INSERM, CIC 1414, F-35033 Rennes, France; [Laviolle, Bruno; Deugnier, Yves] Univ Rennes 1, Fac Med, F-35043 Rennes, France; [Kiani, Anita] CHU Rennes, Dept Radiol, F-35033 Rennes, France; [Bardou-Jacquet, Edouard] INSERM, U991, F-35033 Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jezequel, C (corresponding author), CHU Rennes, Liver Unit, F-35033 Rennes, France.	caroline.jezequel@chu-rennes.fr	Bardou-Jacquet, Edouard/E-6701-2013	Bardou-Jacquet, Edouard/0000-0002-0784-0710; laine, fabrice/0000-0001-6405-2211	SNFGE (French National Gastroenterology Society)	SNFGE (French National Gastroenterology Society)	Financial support was obtained by the SNFGE (French National Gastroenterology Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaton MD, 2013, ALIMENT PHARM THER, V37, P720, DOI 10.1111/apt.12255; Beaton MD, 2014, ANN HEPATOL, V13, P353, DOI 10.1016/S1665-2681(19)30864-6; Bozzini C, 2005, DIABETES CARE, V28, P2061, DOI 10.2337/diacare.28.8.2061; Brudevold R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003547; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; Moreno-Navarrete JM, 2014, DIABETES CARE, V37, P1092, DOI 10.2337/dc13-1602; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; OLSSON KS, 1972, ACTA MED SCAND, V192, P401; Sirlin CB, 2010, MAGN RESON IMAGING C, V18, P359, DOI 10.1016/j.mric.2010.08.014; Turlin B, 2001, AM J CLIN PATHOL, V116, P263; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Yanoff LB, 2007, INT J OBESITY, V31, P1412, DOI 10.1038/sj.ijo.0803625	13	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128530	10.1371/journal.pone.0128530	http://dx.doi.org/10.1371/journal.pone.0128530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26030828	Green Submitted, gold, Green Published			2022-12-27	WOS:000356630900166
J	Russell, AE; Ford, T; Russell, G				Russell, Abigail Emma; Ford, Tamsin; Russell, Ginny			Socioeconomic Associations with ADHD: Findings from a Mediation Analysis	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; MATERNAL DEPRESSION; EARLY-CHILDHOOD; DRUG-USE; HEALTH; CHILDREN; BEHAVIOR; SYMPTOMS; SMOKING	Background Children from disadvantaged socioeconomic backgrounds are at greater risk of a range of negative outcomes throughout their life course than their peers; however the specific mechanisms by which socioeconomic status relates to different health outcomes in childhood are as yet unclear. Aims The current study investigates the relationship between socioeconomic disadvantage in childhood and attention deficit/hyperactivity disorder (ADHD), and investigates putative mediators of this association in a longitudinal population-based birth cohort in the UK. Methods Data from the Avon Longitudinal Study of Parents and Children was used (n = 8,132) to explore the relationship between different measures of socioeconomic status at birth-3 years and their association with a diagnosis of ADHD at age 7. A multiple mediation model was utilised to examine factors occurring between these ages that may mediate the association. Results Financial difficulties, housing tenure, maternal age at birth of child and marital status were significantly associated with an outcome of ADHD, such that families either living in financial difficulty, living in council housing, with younger or single mothers' were more likely to have a child with a research diagnosis of ADHD at age 7. Financial difficulties was the strongest predictor of ADHD (OR 2.23 95% CI 1.57-3.16). In the multiple mediation model, involvement in parenting at age 6 and presence of adversity at age 2-4 mediated 27.8% of the association. Conclusions Socioeconomic disadvantage, conceptualised as reported difficulty in affording basic necessities (e.g. heating, food) has both direct and indirect impacts on a child's risk of ADHD. Lower levels of parent involvement mediates this association, as does presence of adversity; with children exposed to adversity and those with less involved parents being at an increased risk of having ADHD. This study highlights the importance of home and environmental factors as small but important contributors toward the aetiology of ADHD.	[Russell, Abigail Emma; Ford, Tamsin; Russell, Ginny] Univ Exeter, Sch Med, Inst Hlth Res, Exeter, Devon, England; [Russell, Ginny] Univ Exeter, Sch Med, ESRC Ctr Genom Soc Egenis, Exeter, Devon, England	University of Exeter; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of Exeter	Russell, AE (corresponding author), Univ Exeter, Sch Med, Inst Hlth Res, Exeter, Devon, England.	A.E.Russell@exeter.ac.uk	Ford, Tamsin/V-5908-2019	Ford, Tamsin/0000-0001-5295-4904; Russell, Abigail/0000-0002-2903-6264; Russell, Ginny/0000-0002-6440-1167	UK Medical Research Council; ESRC Secondary Data Analysis Initiative [ES/K003356/1]; Wellcome Trust [092731]; University of Exeter Medical School; Economic and Social Research Council [ES/K003356/1] Funding Source: researchfish; Medical Research Council [MC_PC_15018] Funding Source: researchfish; ESRC [ES/K003356/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC Secondary Data Analysis Initiative(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Exeter Medical School; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provided core support for ALSPAC. This publication is the work of the authors and Abigail Russell, Tamsin Ford and Ginny Russell will serve as guarantors for the contents of this paper. This research was specifically funded by the University of Exeter Medical School and the ESRC Secondary Data Analysis Initiative, Grant Number ES/K003356/1.	Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5; Avon Longitudinal Study of Parents and Children, 2014, ALSPAC DAT DICT; Barnard M, 2004, ADDICTION, V99, P552, DOI 10.1111/j.1360-0443.2003.00664.x; Bernfort L, 2008, ACTA PAEDIATR, V97, P239, DOI 10.1111/j.1651-2227.2007.00611.x; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; Boe T, 2012, SOC PSYCH PSYCH EPID, V47, P1557, DOI 10.1007/s00127-011-0462-9; Boyd A, 2012, INT J EPIDEMIOL; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brion MJ, 2010, PEDIATRICS, V126, pE57, DOI 10.1542/peds.2009-2754; Burgess SM, 2004, CSE085 LSE STICERD; Counts CA, 2005, J AM ACAD CHILD PSY, V44, P690, DOI 10.1097/01.chi.0000162582.87710.66; Crittenden P. M., 2007, TIDSSKRIFT NORSK PSY, V44, P1220; CUMMINGS EM, 1994, J CHILD PSYCHOL PSYC, V35, P73, DOI 10.1111/j.1469-7610.1994.tb01133.x; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Ford T, 2007, BRIT J PSYCHIAT, V190, P319, DOI 10.1192/bjp.bp.106.025023; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gonzalez-DeHass AR, 2005, EDUC PSYCHOL REV, V17, P95, DOI 10.1007/s10648-005-3949-7; Goodman A, COHABITATION MARRIAG; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1996, J CHILD PSYCHOL PSYC, V37, P369, DOI 10.1111/j.1469-7610.1996.tb01418.x; Graham H, 2002, SOC SCI MED, V55, P2005, DOI 10.1016/S0277-9536(01)00343-4; HAUSER RM, 1994, CHILD DEV, V65, P1541, DOI 10.2307/1131279; Johnston C, 2001, CLIN CHILD FAM PSYCH, V4, P183, DOI 10.1023/A:1017592030434; Kalff AC, 2001, J EPIDEMIOL COMMUN H, V55, P246, DOI 10.1136/jech.55.4.246; Keyes KM, 2012, IMPLICATIONS TOBACCO; Kiernan K, 2003, UNMARRIED PARENTHOOD, P26; Kiernan KE, 2009, J SOC POLICY, V38, P569, DOI 10.1017/S0047279409003250; Kim-Cohen J, 2005, ARCH GEN PSYCHIAT, V62, P173, DOI 10.1001/archpsyc.62.2.173; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Kollins SH, 2005, ARCH GEN PSYCHIAT, V62, P1142, DOI 10.1001/archpsyc.62.10.1142; Kvist AP, 2013, SOC SCI MED, V88, P30, DOI 10.1016/j.socscimed.2013.04.001; Lemery-Chalfant K, 2013, DEV PSYCHOPATHOL, V25, P51, DOI 10.1017/S0954579412000892; Lingineni RK, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-50; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Mick E, 2002, J AM ACAD CHILD PSY, V41, P378, DOI 10.1097/00004583-200204000-00009; Miech RA, 2001, ANN EPIDEMIOL, V11, P75, DOI 10.1016/S1047-2797(00)00079-X; Ouyang LJ, 2008, J PEDIATR-US, V153, P851, DOI 10.1016/j.jpeds.2008.06.002; Petrill SA, 2004, INTELLIGENCE, V32, P445, DOI 10.1016/j.intell.2004.06.010; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reiss F, 2013, SOCIOECONOMIC INEQUA; Romirowsky A, 2013, PATERNAL ADHD SYMPTO; Russell G, 2013, J CHILD PSYCHOL PSYC; Rutter M, 1977, ECOLOGICAL FACTORS H, P173; Sagiv SK, 2013, J ATTEN DISORD, V17, P47, DOI 10.1177/1087054711427563; Schmiedeler S, 2014, EUR J PSYCHOL EDUC, V29, P467, DOI 10.1007/s10212-013-0208-z; Schneider H, 2006, PEDIATRICS, V117, pE601, DOI 10.1542/peds.2005-1308; Schneiders J, 2003, J EPIDEMIOL COMMUN H, V57, P699, DOI 10.1136/jech.57.9.699; Selig JP, 2009, RES HUM DEV, V6, P144, DOI 10.1080/15427600902911247; Shah PJ, 2013, BRIT J PSYCHIAT, V203, P317, DOI 10.1192/bjp.bp.113.126474; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Spencer N, 2018, POVERTY CHILD HLTH, DOI [10.1201/9781315385297, DOI 10.1201/9781315385297]; StataCorp, 2013, STATA STAT SOFTW REL; Steer C, 2004, 3 C EP LONG STUD EUR; Tarver J, 2014, ATTENTION DEFICIT HY; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Van Batenburg-Eddes T, 2013, J CHILD PSYCHOL PSYC, V54, P591, DOI 10.1111/jcpp.12023; Webb E, 2013, ARCH DIS CHILD, V98, P397, DOI 10.1136/archdischild-2012-303578; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751; Wray JD, POPULATION PRESSURE	67	76	76	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128248	10.1371/journal.pone.0128248	http://dx.doi.org/10.1371/journal.pone.0128248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL0KF	26030626	gold, Green Published, Green Submitted			2022-12-27	WOS:000356630900132
J	Chen, L; Mu, ZC; Zhang, BQ; Zhang, Y				Chen, Long; Mu, Zhichun; Zhang, Baoqing; Zhang, Yi			Ear Recognition from One Sample Per Person	PLOS ONE			English	Article							SPARSE REPRESENTATION; FACE RECOGNITION; SHRINKAGE; IMAGE	Biometrics has the advantages of efficiency and convenience in identity authentication. As one of the most promising biometric-based methods, ear recognition has received broad attention and research. Previous studies have achieved remarkable performance with multiple samples per person (MSPP) in the gallery. However, most conventional methods are insufficient when there is only one sample per person (OSPP) available in the gallery. To solve the OSPP problem by maximizing the use of a single sample, this paper proposes a hybrid multi-keypoint descriptor sparse representation-based classification (MKD-SRC) ear recognition approach based on 2D and 3D information. Because most 3D sensors capture 3D data accessorizing the corresponding 2D data, it is sensible to use both types of information. First, the ear region is extracted from the profile. Second, keypoints are detected and described for both the 2D texture image and 3D range image. Then, the hybrid MKD-SRC algorithm is used to complete the recognition with only OSPP in the gallery. Experimental results on a benchmark dataset have demonstrated the feasibility and effectiveness of the proposed method in resolving the OSPP problem. A Rank-one recognition rate of 96.4% is achieved for a gallery of 415 subjects, and the time involved in the computation is satisfactory compared to conventional methods.	[Chen, Long; Mu, Zhichun; Zhang, Yi] Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Beijing 100083, Peoples R China; [Zhang, Baoqing] Second Acad CASIC, Inst 208, Beijing, Peoples R China	University of Science & Technology Beijing; China Aerospace Science & Industry Corporation (CASIC)	Mu, ZC (corresponding author), Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Beijing 100083, Peoples R China.	mu@ies.ustb.edu.cn			National Natural Science Foundation of China [61170116, 61472031, 61375010, 61300075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This article is supported by the National Natural Science Foundation of China (Grant No. 61170116), the National Natural Science Foundation of China (Grant No. 61472031), the National Natural Science Foundation of China (Grant No. 61375010) and the National Natural Science Foundation of China (Grant No. 61300075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431221; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Chang K, 2003, IEEE T PATTERN ANAL, V25, P1160, DOI 10.1109/TPAMI.2003.1227990; Chen H, 2009, IEEE T PATTERN ANAL, V31, P172, DOI 10.1109/TPAMI.2008.176; Chen H, 2007, IEEE T PATTERN ANAL, V29, P718, DOI 10.1109/TPAMI.2007.1005; Dewi K, 2006, P COMP INT, P253; Donoho DL, 2008, IEEE T INFORM THEORY, V54, P4789, DOI 10.1109/TIT.2008.929958; Hoffman DD, 1997, COGNITION, V63, P29, DOI 10.1016/S0010-0277(96)00791-3; Islam SMS, 2011, INT J COMPUT VISION, V95, P52, DOI 10.1007/s11263-011-0436-0; Jain AK, 2004, IEEE T CIRC SYST VID, V14, P4, DOI 10.1109/TCSVT.2003.818349; Jain Anil K., 2007, HDB BIOMETRICS; Kisku Dakshina R., 2009, 2009 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P60, DOI 10.1109/CVPR.2009.5204298; Kisku DR, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTATIONAL TOOLS FOR ENGINEERING APPLICATIONS, P380, DOI 10.1109/ACTEA.2009.5227958; Kittler J., 2005, 2005 IEEE COMPUTER S, V00, P114, DOI DOI 10.1109/CVPR.2005.377; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Kumar A, 2013, PATTERN RECOGN, V46, P73, DOI 10.1016/j.patcog.2012.06.020; Liao SC, 2013, IEEE T PATTERN ANAL, V35, P1193, DOI 10.1109/TPAMI.2012.191; Liu LZ, 2011, ADV MATER RES-SWITZ, V143-144, P287, DOI 10.4028/www.scientific.net/AMR.143-144.287; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lu L, 2006, ICICIC 2006: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE COMPUTING, INFORMATION AND CONTROL, VOL 3, PROCEEDINGS, P353; Moreno B., 1999, Proceedings IEEE 33rd Annual 1999 International Carnahan Conference on Security Technology (Cat. No.99CH36303), P469, DOI 10.1109/CCST.1999.797956; Mu Z., 2005, ADV BIOMETRIC PERSON, V3338, P663; Naseem I, 2008, LECT NOTES COMPUT SC, V5359, P336, DOI 10.1007/978-3-540-89646-3_33; Park U, 2008, P SPIE DEF SEC S; Rattani A., 2007, 2007 1 IEEE INT C BI, P1, DOI DOI 10.1109/BTAS.2007.4401919; Rivera A R, 2014, LETTERS, V51, P94; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Tuytelaars T, 2007, FOUND TRENDS COMPUT, V3, P177, DOI 10.1561/0600000017; Unar JA, 2014, PATTERN RECOGN, V47, P2673, DOI 10.1016/j.patcog.2014.01.016; Victor B, 2002, INT C PATT RECOG, P429, DOI 10.1109/ICPR.2002.1044746; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Yan P., 2005, 2005 IEEE COMP SOC C, P121; Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761; Yuan L, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-6, P2414, DOI 10.1109/ICMLC.2009.5212166; Yuizono T, 2002, IEEE C EVOL COMPUTAT, P237, DOI 10.1109/CEC.2002.1006240; Zhang BQ, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.6.061702; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100120; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095506; Zhang XX, 2007, NEUROCOMPUTING, V70, P842, DOI 10.1016/j.neucom.2006.10.016; Zhao H, 2009, CHINESE J SCI INSTRU, V11	46	33	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0129505	10.1371/journal.pone.0129505	http://dx.doi.org/10.1371/journal.pone.0129505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024226	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400108
J	Martin, L; Schmitz, S; De Santis, R; Doemming, S; Haase, H; Hoeger, J; Heinbockel, L; Brandenburg, K; Marx, G; Schuerholz, T				Martin, Lukas; Schmitz, Susanne; De Santis, Rebecca; Doemming, Sabine; Haase, Hajo; Hoeger, Janine; Heinbockel, Lena; Brandenburg, Klaus; Marx, Gernot; Schuerholz, Tobias			Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflammation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum	PLOS ONE			English	Article							MODEL	Myocardial dysfunction in sepsis has been linked to inflammation caused by pathogen-associated molecular patterns (PAMPs) as well as by host danger-associated molecular patterns (DAMPs). These include soluble heparan sulfate (HS), which triggers the devastating consequences of the pro-inflammatory cascades in severe sepsis and septic shock. Thus, there is increasing interest in the development of anti-infective agents, with effectiveness against both PAMPs and DAMPs. We hypothesized that a synthetic antimicrobial peptide (peptide 19-2.5) inhibits inflammatory response in murine cardiomyocytes (HL-1 cells) stimulated with PAMPs, DAMPs or serum from patients with septic shock by reduction and/or neutralization of soluble HS. In the current study, our data indicate that the treatment with peptide 19-2.5 decreases the inflammatory response in HL-1 cells stimulated with either PAMPs or DAMPs. Furthermore, our work shows that soluble HS in serum from patients with Gram-negative or Gram-positive septic shock induces a strong pro-inflammatory response in HL-1 cells, which can be effectively blocked by peptide 19-2.5. Based on these findings, peptide 19-2.5 is a novel anti-inflammatory agent interacting with both PAMPs and DAMPs, suggesting peptide 19-2.5 may have the potential for further development as a broad-spectrum anti-inflammatory agent in sepsis-induced myocardial inflammation and dysfunction.	[Martin, Lukas; Schmitz, Susanne; De Santis, Rebecca; Doemming, Sabine; Marx, Gernot; Schuerholz, Tobias] Univ Hosp, Dept Intens Care & Intermediate Care, Aachen, Germany; [Haase, Hajo] Berlin Inst Technol, Dept Food Chem & Toxicol, Berlin, Germany; [Hoeger, Janine] Rhein Westfal TH Aachen, Fac Med, Inst Immunol, Aachen, Germany; [Heinbockel, Lena; Brandenburg, Klaus] Forschungszentrum, Div Biophys, Borstel, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Technical University of Berlin; RWTH Aachen University	Schuerholz, T (corresponding author), Univ Hosp, Dept Intens Care & Intermediate Care, Aachen, Germany.	tschuerholz@ukaachen.de	Martin, Lukas/Q-8917-2019; van Griensven, Martijn/F-5808-2012; Haase, Hajo/B-9280-2009; Schuerholz, Tobias/E-8071-2011	Martin, Lukas/0000-0001-8650-5090; van Griensven, Martijn/0000-0001-5104-9881; Haase, Hajo/0000-0002-1622-8718; Schuerholz, Tobias/0000-0003-3830-3499	RWTH centralized Biomaterial Database (RWTH cBMB) of the University Hospital RWTH Aachen; Brandenburg Antiinfektiva GmbH.; Astellas Pharma; Bayer Vital; Astra-Zeneca; B. Braun Melsungen; Edwards Life Sciences; Serumwerke Bernburg; Hutchinson Technology; Baxter	RWTH centralized Biomaterial Database (RWTH cBMB) of the University Hospital RWTH Aachen; Brandenburg Antiinfektiva GmbH.; Astellas Pharma(Astellas Pharmaceuticals); Bayer Vital(Bayer AG); Astra-Zeneca(AstraZeneca); B. Braun Melsungen; Edwards Life Sciences; Serumwerke Bernburg; Hutchinson Technology; Baxter	This work was supported by the RWTH centralized Biomaterial Database (RWTH cBMB) of the University Hospital RWTH Aachen. Brandenburg Antiinfektiva GmbH., Astellas Pharma, Bayer Vital, Astra-Zeneca, B. Braun Melsungen, Edwards Life Sciences, Serumwerke Bernburg, Hutchinson Technology, Baxter, provided support in the form of salaries for authors (TS, GM) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarshahi H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-219; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Brennan TV, 2012, BLOOD, V120, P2899, DOI 10.1182/blood-2011-07-368720; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Campo GM, 2009, ARCH BIOCHEM BIOPHYS, V491, P7, DOI 10.1016/j.abb.2009.09.017; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; CUNNION RE, 1986, CIRCULATION, V73, P637, DOI 10.1161/01.CIR.73.4.637; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; Galdiero S, 2013, J PEPT SCI, V19, P148, DOI 10.1002/psc.2489; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Gutsmann T, 2010, ANTIMICROB AGENTS CH, V54, P3817, DOI 10.1128/AAC.00534-10; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Henrich M, 2010, THESCIENTIFICWORLDJO, V10, P917, DOI 10.1100/tsw.2010.88; Hu ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085765; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Konno S, 2005, J INTERF CYTOK RES, V25, P277, DOI 10.1089/jir.2005.25.277; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; Li JP, 2009, THROMB HAEMOSTASIS, V102, P823, DOI 10.1160/TH09-02-0091; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Nelson A, 2014, ACTA ANAESTH SCAND, V58, P36, DOI 10.1111/aas.12223; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Pathak E, 2012, J PHARMACOL EXP THER, V340, P192, DOI 10.1124/jpet.111.183756; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P316, DOI 10.1111/j.1399-6576.2011.02578.x; Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220; Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920; Spirig R, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/181394; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Teng LP, 2015, CARBOHYD POLYM, V115, P643, DOI 10.1016/j.carbpol.2014.08.119; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Zhang LJ, 2006, EXPERT OPIN PHARMACO, V7, P653, DOI 10.1517/14656566.7.6.653	40	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127584	10.1371/journal.pone.0127584	http://dx.doi.org/10.1371/journal.pone.0127584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024383	Green Submitted, Green Published, gold			2022-12-27	WOS:000355319400043
J	Remold, SK; Purdy-Gibson, ME; France, MT; Hundley, TC				Remold, Susanna K.; Purdy-Gibson, Megan E.; France, Michael T.; Hundley, Thomas C.			Pseudomonas putida and Pseudomonas fluorescens Species Group Recovery from Human Homes Varies Seasonally and by Environment	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; BACTERIAL COMMUNITY; GROWTH; AERUGINOSA; DIVERSITY; SOIL; TEMPERATURE; IDENTIFICATION; BIOGEOGRAPHY; HOUSEHOLDS	By shedding light on variation in time as well as in space, long-term biogeographic studies can help us define organisms' distribution patterns and understand their underlying drivers. Here we examine distributions of Pseudomonas in and around 15 human homes, focusing on the P. putida and P. fluorescens species groups. We describe recovery from 10,941 samples collected during up to 8 visits per home, occurring on average 2.6 times per year. We collected a mean of 141 samples per visit, from sites in most rooms of the house, from the surrounding yards, and from human and pet occupants. We recovered Pseudomonas in 9.7% of samples, with the majority of isolates being from the P. putida and P. fluorescens species groups (approximately 62% and 23% of Pseudomonas samples recovered respectively). Although representatives of both groups were recovered from every season, every house, and every type of environment sampled, recovery was highly variable across houses and samplings. Whereas recovery of P. putida group was higher in summer and fall than in winter and spring, P. fluorescens group isolates were most often recovered in spring. P. putida group recovery from soils was substantially higher than its recovery from all other environment types, while higher P. fluorescens group recovery from soils than from other sites was much less pronounced. Both species groups were recovered from skin and upper respiratory tract samples from healthy humans and pets, although this occurred infrequently. This study indicates that even species that are able to survive under a broad range of conditions can be rare and variable in their distributions in space and in time. For such groups, determining patterns and causes of stochastic and seasonal variability may be more important for understanding the processes driving their biogeography than the identity of the types of environments in which they can be found.	[Remold, Susanna K.; Purdy-Gibson, Megan E.; France, Michael T.; Hundley, Thomas C.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA	University of Louisville	Remold, SK (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	susanna.remold@louisville.edu			National Science Foundation [DEB-0950361]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, DEB-0950361 to SKR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Alouache S, 2012, MICROBES ENVIRON, V27, P80, DOI 10.1264/jsme2.ME11266; [Anonymous], 2010, HDB MICROBIOLOGICAL, DOI DOI 10.1201/EBK1439804063; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; BLAZEVIC DJ, 1973, APPL MICROBIOL, V25, P107, DOI 10.1128/AEM.25.1.107-110.1973; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; CLARKE PH, 1982, A VAN LEEUW J MICROB, V48, P105, DOI 10.1007/BF00405197; Croce O, 2010, J MICROBIOL BIOCH TE, V2, DOI 10.4172/1948-5948.1000029; Dimartino M, 2011, J PLANT PATHOL, V93, P79; Doulgeraki AI, 2013, FOOD MICROBIOL, V34, P62, DOI 10.1016/j.fm.2012.11.017; Dunn R.R., 2013, PLOS ONE, V8; Frankel M, 2012, APPL ENVIRON MICROB, V78, P8289, DOI 10.1128/AEM.02069-12; Ghyselinck J, 2013, MICROBIOL-SGM, V159, P2097, DOI 10.1099/mic.0.068031-0; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Guillou C, 1996, APPL ENVIRON MICROB, V62, P3319, DOI 10.1128/AEM.62.9.3319-3324.1996; Igbinosa IH, 2012, INT J ENV RES PUB HE, V9, P2537, DOI 10.3390/ijerph9072537; INGRAHAM JL, 1958, J BACTERIOL, V76, P75, DOI 10.1128/JB.76.1.75-80.1958; Jacquier H, 2011, EUR J CLIN MICROBIOL, V30, P1579, DOI 10.1007/s10096-011-1263-5; Jasser I, 2013, J MICROBIOL BIOTECHN, V23, P739, DOI 10.4014/jmb.1208.08002; Knezevic P, 2011, J APPL MICROBIOL, V111, P245, DOI 10.1111/j.1365-2672.2011.05043.x; Lemke MJ, 1999, MICROB ECOL, V38, P234, DOI 10.1007/s002489900173; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Marinho PR, 2009, MEM I OSWALDO CRUZ, V104, P678, DOI 10.1590/S0074-02762009000500002; Molina L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081604; Moschandreas DJ, 2003, AEROSOL SCI TECH, V37, P899, DOI 10.1080/02786820300935; Negi YK, 2011, J PLANT GROWTH REGUL, V30, P128, DOI 10.1007/s00344-010-9175-7; Ojima M, 2002, INT J ENVIRON HEAL R, V12, P41, DOI 10.1080/09603120120110040; Purdy-Gibson ME, 2015, J CYST FIBROS, V14, P341, DOI 10.1016/j.jcf.2014.10.008; Regnath T, 2004, INT J HYG ENVIR HEAL, V207, P585, DOI 10.1078/1438-4639-00331; Remold SK, 2011, MICROB ECOL, V62, P505, DOI 10.1007/s00248-011-9844-5; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Schelstraete P, 2008, EUR RESPIR J, V31, P822, DOI 10.1183/09031936.00088907; Shaburova OV, 2009, RUSS J GENET+, V45, P161, DOI 10.1134/S1022795409020057; Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-79; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Southwood T, 1977, J ANIM ECOL, P337; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; TSUJI A, 1982, MICROBIOL IMMUNOL, V26, P15, DOI 10.1111/j.1348-0421.1982.tb00149.x; Vullo DL, 2005, ENVIRON MONIT ASSESS, V105, P81, DOI 10.1007/s10661-005-3157-4; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wong V, 2011, J CLIN MICROBIOL, V49, P2093, DOI 10.1128/JCM.02559-10; Wu Z, 2012, APPL BIOCHEM MICRO+, V48, P363, DOI 10.1134/S0003683812040138	48	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127704	10.1371/journal.pone.0127704	http://dx.doi.org/10.1371/journal.pone.0127704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023929	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400047
J	Liu, YX; Pang, CK; Liu, Y; Sun, XB; Li, XX; Jiang, SW; Xue, FZ				Liu, Yun-Xia; Pang, Chun-Kun; Liu, Yanxun; Sun, Xiu-Bin; Li, Xin-Xu; Jiang, Shi-Wen; Xue, Fuzhong			Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling	PLOS ONE			English	Article							DRUG-RESISTANCE; PREVALENCE; PLS	Background Multidrug-resistant tuberculosis (MDR-TB) resulting from various factors has raised serious public health concerns worldwide. Identifying the ecological risk factors associated with MDR-TB is critical to its prevention and control. This study aimed to explore the association between the development of MDR-TB and the risk factors at the group-level (ecological risk factors) in China. Methods Data on MDR-TB in 120 counties were obtained from the National Tuberculosis Information Management System, and data on risk-factor variables were extracted from the Health Statistical Yearbook, provincial databases, and the meteorological bureau of each province (municipality). Partial Least Square Path Modeling was used to detect the associations. Results The median proportion of MDR-TB in new TB cases was 3.96% (range, 0-39.39%). Six latent factors were extracted from the ecological risk factors, which explained 27.60% of the total variance overall in the prevalence of MDR-TB. Based on the results of PLS-PM, TB prevention, health resources, health services, TB treatment, TB detection, geography and climate factors were all associated with the risk of MDR-TB, but socioeconomic factors were not significant. Conclusions The development of MDR-TB was influenced by TB prevention, health resources, health services, TB treatment, TB detection, geography and climate factors. Such information may help us to establish appropriate public health intervention strategies to prevent and control MDR-TB and yield benefits to the entire public health system in China.	[Liu, Yun-Xia; Liu, Yanxun; Sun, Xiu-Bin; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China; [Pang, Chun-Kun] Shandong Acad Med Sci, Inst Off, Jinan, Peoples R China; [Li, Xin-Xu; Jiang, Shi-Wen] Chinese Ctr Dis Control & Prevent, Inst TB Control & Prevent, Beijing, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Chinese Center for Disease Control & Prevention	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81001292]; National Special Science and Technology Major Projects [2008ZX10003-007]; China postdoctoral Science Foundation [2013M531619]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Science and Technology Major Projects; China postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by grants from the National Natural Science Foundation of China (no. 81001292), the National Special Science and Technology Major Projects (no. 2008ZX10003-007), and the China postdoctoral Science Foundation (2013M531619).	Amin MN, 2009, IBRAHIM MED COLL J, V3, P29, DOI DOI 10.3329/imcj.v3i1.2917; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chen K, 2007, EPIDEMIOLOGY DESCRIP; Cohen T, 2014, DRUG RESIST UPDATE, V17, P105, DOI 10.1016/j.drup.2014.10.001; Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Farazi A, 2013, CASP J INTERN MED, V4, P785; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; FRANCIS DJ, 1988, J CLIN EXP NEUROPSYC, V10, P623, DOI 10.1080/01688638808402800; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gaude Gajanan S, 2014, Niger Med J, V55, P327, DOI 10.4103/0300-1652.137194; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Horna-Campos OJ, 2010, INT J TUBERC LUNG D, V14, P714; Huang F., 2011, CHINA DIGIT MED, V6, P97, DOI [10.3969/j.issn.1673-7571.2011.10.032, DOI 10.3969/J.ISSN.1673-7571.2011.10.032]; Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Liu Q, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1171; Liu YX, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-50; Hang NTL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071867; Norris M, 2010, J AUTISM DEV DISORD, V40, P8, DOI 10.1007/s10803-009-0816-2; Pritchard AJ, 2003, EPIDEMIOL INFECT, V130, P481, DOI 10.1017/S0950268803008367; Rifat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105214; Skrahina A, 2013, B WORLD HEALTH ORGAN, V91, P36, DOI 10.2471/BLT.12.104588; Tanrikulu AC, 2008, TROP DOCT, V38, P91, DOI 10.1258/td.2007.070131; Tanrikulu AC, 2010, MED SCI MONITOR, V16, pPH57; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Tenenhaus M, 2008, TOTAL QUAL MANAG BUS, V19, P871, DOI 10.1080/14783360802159543; Terlikbayeva A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-262; Ulmasova DJ, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.42.20609; Vashakidze L, 2009, INT J TUBERC LUNG D, V13, P1148; Wardani DWSR, 2014, OPEN J EPIDEMIOLOGY, V4, P76, DOI DOI 10.4236/OJEPI.2014.420; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; WHO, 1998, INT J TUBERC LUNG D, V2, P71; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; World Health Organization, DRUG RES TB SURV R S; World Health Organization, 1994, 1 WHO; Zhang JF, 2002, MED MULTIVARIATE STA; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	39	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128298	10.1371/journal.pone.0128298	http://dx.doi.org/10.1371/journal.pone.0128298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020921	gold, Green Submitted, Green Published			2022-12-27	WOS:000355187300098
J	Tornevi, A; Barregard, L; Forsberg, B				Tornevi, Andreas; Barregard, Lars; Forsberg, Bertil			Precipitation and Primary Health Care Visits for Gastrointestinal Illness in Gothenburg, Sweden	PLOS ONE			English	Article							DRINKING-WATER TURBIDITY; EXTREME PRECIPITATION; UNITED-STATES; ASSOCIATION; OUTBREAKS; RAINFALL; DISEASE	Background The river Gota Alv is a source of freshwater for the City of Gothenburg, Sweden, and we recently identified a clear influence of upstream precipitation on concentrations of indicator bacteria in the river water, as well as an association with the daily number of phone calls to the nurse advice line related to acute gastrointestinal illnesses (AGI calls). This study aimed to examine visits to primary health-care centers owing to similar symptoms (AGI visits) in the same area, to explore associations with precipitation, and to compare variability in AGI visits and AGI calls. Methods We obtained data covering six years (2007-2012) of daily AGI visits and studied their association with prior precipitation (0-28 days) using a distributed lag nonlinear Poisson regression model, adjusting for seasonal patterns and covariates. In addition, we studied the effects of prolonged wet and dry weather on AGI visits. We analyzed lagged short-term relations between AGI visits and AGI calls, and we studied differences in their seasonal patterns using a binomial regression model. Results The study period saw a total of 17,030 AGI visits, and the number of daily visits decreased on days when precipitation occurred. However, prolonged wet weather was associated with an elevated number of AGI visits. Differences in seasonality patterns were observed between AGI visits and AGI calls, as visits were relatively less frequent during winter and relatively more frequent in August, and only weak short-term relations were found. Conclusion AGI visits and AGI calls seems to partly reflect different types of AGI illnesses, and the patients' choice of medical contact (in-person visits versus phone calls) appears to depend on current weather conditions. An association between prolonged wet weather and increased AGI visits supports the hypothesis that the drinking water is related to an increased risk of AGI illnesses.	[Tornevi, Andreas; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Div Occupat & Environm Med, Umea, Sweden; [Barregard, Lars] Univ Gothenburg, Dept Publ Hlth & Community Med, Div Occupat & Environm Med, Gothenburg, Sweden	Umea University; University of Gothenburg	Tornevi, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Div Occupat & Environm Med, Umea, Sweden.	andreas.tornevi@envmed.umu.se			Swedish Water & Wastewater Association; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	Swedish Water & Wastewater Association; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	The Swedish Water & Wastewater Association; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramini J, 2000, Can Commun Dis Rep, V26, P211; Bush KF, 2014, ENVIRON HEALTH PERSP, V122, P249, DOI 10.1289/ehp.1306807; Chui KKH, 2011, AM J PUBLIC HEALTH, V101, P2082, DOI 10.2105/AJPH.2010.300096; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Mendel V., 2005, THESIS CHALMERS U TE; Morris RD, 1996, AM J PUBLIC HEALTH, V86, P237, DOI 10.2105/AJPH.86.2.237; Naumova Elena N., 2005, Journal of Water and Health, V3, P185; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; Swedish Commission on Climate and Vulnerability, 2007, SWED GOV OFF REP, VSOU 2007:60; Team R, 2007, R LANG ENV STAT COMP; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Toljander J., 2012, Journal of Public Health and Epidemiology, V4, P30; Tornevi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098546; Tornevi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069918; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	22	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128487	10.1371/journal.pone.0128487	http://dx.doi.org/10.1371/journal.pone.0128487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0SC	26020929	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300116
J	Yang, XJ; Wu, QP; Zhang, JM; Huang, JH; Guo, WP; Cai, SZ				Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen			Prevalence and Characterization of Monophasic Salmonella Serovar (1) under bar,4,[5], 12: i:-of Food Origin in China	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; MOLECULAR CHARACTERIZATION; PHENOTYPIC CHARACTERISTICS; INFECTIONS; RESISTANCE; STRAINS; VARIANT; SURVEILLANCE; EMERGENCE; EVOLUTION	Salmonella enterica subsp. enterica serovar (1) under bar,4,[5], 12:i:-is a monophasic variant of Salmonella Typhimurium, which has recently been recognized as an emerging cause of infection worldwide. This bacterium has also ranked among the four most frequent serovars causing human salmonellosis in China. However, there are no reports on its contamination in Chinese food. Serotyping, polymerase chain reaction, antibiotic resistance, virulotyping, and multilocus sequence typing (MLST) assays were used to investigate the prevalence of this serological variant in food products in China, and to determine phenotypic and genotypic difference of monophasic isolates and Salmonella Typhimurium isolated over the same period. Salmonella (1) under bar,4,[5], 12:i:-was prevalent in various food sources, including beef, pork, chicken, and pigeon. The study also confirmed the high prevalence (53.8%) of resistance to ampicillin, streptomycin, sulfonamides, and tetracycline in Salmonella (1) under bar,4,[5], 12:i:-, which was higher than that in Salmonella Typhimurium. Moreover, Salmonella (1) under bar,4,[5], 12:i:-isolates in our study were different from Salmonella Typhimurium isolates by the absence of three plasmid-borne genes (spvC, pefA, and rck) and the presence of gipA in all isolates. All Salmonella (1) under bar,4,[5], 12:i:-isolates demonstrated MLST pattern ST34. Genomic deletions within the fljBA operon and surrounding genes were only found in Salmonella (1) under bar,4,[5], 12:i:isolates, with all isolates containing a deletion of fljB. However, hin and iroB were identified in all Salmonella (1) under bar,4,[5], 12:i:-isolates. Three different deletion profiles were observed and two of them were different from the reported Salmonella (1) under bar,4,[5], 12:i:-clones from Spain, America, and Italy, which provided some new evidence on the independent evolution of the multiple successful monophasic clones from Salmonella Typhimurium ancestors. This study is the first report of Salmonella (1) under bar,4,[5], 12:i:-in food products from China. The data are more comprehensive and representative, providing valuable information for epidemiological studies, risk management, and public health strategies.	[Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China; [Yang, Xiaojuan; Wu, Qingping; Zhang, Jumei; Huang, Jiahui; Guo, Weipeng; Cai, Shuzhen] Guangdong Open Lab Appl Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Wu, QP (corresponding author), Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou, Guangdong, Peoples R China.	wuqp203@163.com	Gu, Yan/AFQ-1163-2022		Science and Technology Projects of Guangdong [2013B050800026, 2014A040401055]; Science and Technology Projects of Guangzhou [201300000074]	Science and Technology Projects of Guangdong; Science and Technology Projects of Guangzhou	The authors' study was supported by the Science and Technology Projects of Guangdong (2013B050800026, JMZ; 2014A040401055, XJY) and the Science and Technology Projects of Guangzhou (201300000074, JMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amavisit P, 2005, J CLIN MICROBIOL, V43, P2736, DOI 10.1128/JCM.43.6.2736-2740.2005; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1826; Antunes P, 2011, J ANTIMICROB CHEMOTH, V66, P2028, DOI 10.1093/jac/dkr228; Barco L, 2012, ZOONOSES PUBLIC HLTH, V59, P505, DOI 10.1111/j.1863-2378.2012.01487.x; Barco L, 2014, FOODBORNE PATHOG DIS, V11, P138, DOI 10.1089/fpd.2013.1626; Boland C, 2014, VET MICROBIOL, V168, P447, DOI 10.1016/j.vetmic.2013.11.040; Bone A, 2010, EUROSURVEILLANCE, V15, P2; Capuano F, 2013, FOODBORNE PATHOG DIS, V10, P963, DOI 10.1089/fpd.2013.1511; Centers for Disease Control and Prevention [CDC], 2006, EM ANT RES SALM SER; Chiou CS, 2006, DIAGN MICR INFEC DIS, V54, P315, DOI 10.1016/j.diagmicrobio.2005.10.009; Clinical and Laboratory Standards Institute, 2014, CLSI DOC; de la Torre E, 2003, J CLIN MICROBIOL, V41, P2395, DOI 10.1128/JCM.41.6.2395-2400.2003; Deng XL, 2012, FOODBORNE PATHOG DIS, V9, P305, DOI 10.1089/fpd.2011.1008; Dionisi AM, 2009, FOODBORNE PATHOG DIS, V6, P711, DOI 10.1089/fpd.2008.0240; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Gallati C, 2013, FOODBORNE PATHOG DIS, V10, P549, DOI 10.1089/fpd.2012.1407; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; Garcia P, 2013, J CLIN MICROBIOL, V51, P973, DOI 10.1128/JCM.02777-12; Grimont PAD, 2007, ANTIGENIC FORMULAE F; Guerra B, 2000, FEMS MICROBIOL LETT, V190, P341, DOI 10.1016/S0378-1097(00)00359-1; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Hopkins K L, 2010, Euro Surveill, V15, P19580; Hopkins KL, 2010, 2 ANT RES ZOON BACT, P13; Huehn S, 2010, FOODBORNE PATHOG DIS, V7, P523, DOI 10.1089/fpd.2009.0447; Kurosawa A, 2012, VET MICROBIOL, V160, P264, DOI 10.1016/j.vetmic.2012.05.023; Laorden L, 2010, J CLIN MICROBIOL, V48, P4563, DOI 10.1128/JCM.00337-10; Liang ZM, 2013, S CHINA J PREVENTIVE, V39, P27; Lucarelli C, 2012, J ANTIMICROB CHEMOTH, V67, P111, DOI 10.1093/jac/dkr391; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mossong J, 2007, Euro Surveill, V12, pE11; Mulvey MR, 2013, J ANTIMICROB CHEMOTH, V68, P1982, DOI 10.1093/jac/dkt149; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; Wasyl D, 2012, FOODBORNE PATHOG DIS, V9, P1037, DOI 10.1089/fpd.2012.1154; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1	36	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2015	10	9							e0137967	10.1371/journal.pone.0137967	http://dx.doi.org/10.1371/journal.pone.0137967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CR0WB	26360603	Green Submitted, Green Published, gold			2022-12-27	WOS:000361043100104
J	Liu, ZG; Patil, IY; Jiang, TY; Sancheti, H; Walsh, JP; Stiles, BL; Yin, F; Cadenas, E				Liu, Zhigang; Patil, Ishan Y.; Jiang, Tianyi; Sancheti, Harsh; Walsh, John P.; Stiles, Bangyan L.; Yin, Fei; Cadenas, Enrique			High-Fat Diet Induces Hepatic Insulin Resistance and Impairment of Synaptic Plasticity	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DIABETES-MELLITUS; ENERGY-METABOLISM; INDUCED OBESITY; LIVER-DISEASE; ER STRESS; BRAIN; PHOSPHORYLATION; MECHANISMS; ROLES	High-fat diet (HFD)-induced obesity is associated with insulin resistance, which may affect brain synaptic plasticity through impairment of insulin-sensitive processes underlying neuronal survival, learning, and memory. The experimental model consisted of 3 month-old C57BL/6J mice fed either a normal chow diet (control group) or a HFD (60% of calorie from fat; HFD group) for 12 weeks. This model was characterized as a function of time in terms of body weight, fasting blood glucose and insulin levels, HOMA-IR values, and plasma triglycerides. IRS-1/Akt pathway was assessed in primary hepatocytes and brain homogenates. The effect of HFD in brain was assessed by electrophysiology, input/output responses and long-term potentiation. HFD-fed mice exhibited a significant increase in body weight, higher fasting glucose-and insulin levels in plasma, lower glucose tolerance, and higher HOMA-IR values. In liver, HFD elicited (a) a significant decrease of insulin receptor substrate (IRS-1) phosphorylation on Tyr608 and increase of Ser307 phosphorylation, indicative of IRS-1 inactivation; (b) these changes were accompanied by inflammatory responses in terms of increases in the expression of NF kappa B and iNOS and activation of the MAP kinases p38 and JNK; (c) primary hepatocytes from mice fed a HFD showed decreased cellular oxygen consumption rates (indicative of mitochondrial functional impairment); this can be ascribed partly to a decreased expression of PGC1 alpha and mitochondrial biogenesis. In brain, HFD feeding elicited (a) an inactivation of the IRS-1 and, consequentially, (b) a decreased expression and plasma membrane localization of the insulin-sensitive neuronal glucose transporters GLUT3/GLUT4; (c) a suppression of the ERK/CREB pathway, and (d) a substantial decrease in long-term potentiation in the CA1 region of hippocampus (indicative of impaired synaptic plasticity). It may be surmised that 12 weeks fed with HFD induce a systemic insulin resistance that impacts profoundly on brain activity, i.e., synaptic plasticity.	[Liu, Zhigang; Patil, Ishan Y.; Jiang, Tianyi; Sancheti, Harsh; Stiles, Bangyan L.; Yin, Fei; Cadenas, Enrique] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Liu, Zhigang] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China; [Walsh, John P.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Walsh, John P.] Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; Northwest A&F University - China; University of Southern California; University of Southern California	Cadenas, E (corresponding author), Univ So Calif, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	cadenas@usc.edu	Liu, Zhigang/H-4818-2016; Walsh, John/GQI-2785-2022; Liu, Z/H-7536-2012	Liu, Zhigang/0000-0002-6863-6561; Yin, Fei/0000-0002-5996-2410; Liu, Z/0000-0002-0086-5659	National Institutes of Health [RO1AG016718, R01CA154986-01A1]; NATIONAL CANCER INSTITUTE [R01CA154986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health RO1AG016718 and R01CA154986-01A1.	Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Bocarsly ME, 2013, NEUROSCIENCE, V248, P61, DOI 10.1016/j.neuroscience.2013.05.046; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Calvo-Ochoa E, 2014, J CEREB BLOOD FLOW M, P1, DOI [10.1038/jcbfm.2014.180, DOI 10.1038/JCBFM.2014.180]; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Chen L, 2007, J NEUROPHYSIOL, V98, P1538, DOI 10.1152/jn.01151.2006; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727; de la Monte SM, 2009, CURR OPIN INVEST DR, V10, P1049; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Ha SK, 2010, EXP ANIM TOKYO, V59, P595, DOI 10.1538/expanim.59.595; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jiang TY, 2013, AGING CELL, V12, P1021, DOI 10.1111/acel.12127; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Karpac J, 2009, TRENDS ENDOCRIN MET, V20, P100, DOI 10.1016/j.tem.2008.11.004; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Mielke JG, 2005, J NEUROCHEM, V93, P1568, DOI 10.1111/j.1471-4159.2005.03155.x; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x; Saberi B, 2014, HEPATOLOGY, V59, P1543, DOI 10.1002/hep.26625; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sancheti H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069830; Storlien LH, 2000, BRIT J NUTR, V83, pS85; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Win S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.522; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yang KT, 2014, DIABETOLOGIA, V57, P352, DOI 10.1007/s00125-013-3085-8; Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774; Yin F, 2013, BIOCHEM SOC T, V41, P101, DOI 10.1042/BST20120260; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004	58	151	156	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128274	10.1371/journal.pone.0128274	http://dx.doi.org/10.1371/journal.pone.0128274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26465959	gold, Green Published, Green Submitted			2022-12-27	WOS:000355319400077
J	Lee, SY; Ryan, ME; Hamlet, AF; Palen, WJ; Lawler, JJ; Halabisky, M				Lee, Se-Yeun; Ryan, Maureen E.; Hamlet, Alan F.; Palen, Wendy J.; Lawler, Joshua J.; Halabisky, Meghan			Projecting the Hydrologic Impacts of Climate Change on Montane Wetlands	PLOS ONE			English	Article							NORTHERN PRAIRIE WETLANDS; WATER; MODEL; TRENDS; SIZE; RESTORATION; ECOSYSTEMS; AMPHIBIANS; STREAMFLOW; RESOURCES	Wetlands are globally important ecosystems that provide critical services for natural communities and human society. Montane wetland ecosystems are expected to be among the most sensitive to changing climate, as their persistence depends on factors directly influenced by climate (e.g. precipitation, snowpack, evaporation). Despite their importance and climate sensitivity, wetlands tend to be understudied due to a lack of tools and data relative to what is available for other ecosystem types. Here, we develop and demonstrate a new method for projecting climate-induced hydrologic changes in montane wetlands. Using observed wetland water levels and soil moisture simulated by the physically based Variable Infiltration Capacity (VIC) hydrologic model, we developed site-specific regression models relating soil moisture to observed wetland water levels to simulate the hydrologic behavior of four types of montane wetlands (ephemeral, intermediate, perennial, permanent wetlands) in the U.S. Pacific Northwest. The hybrid models captured observed wetland dynamics in many cases, though were less robust in others. We then used these models to a) hindcast historical wetland behavior in response to observed climate variability (1916-2010 or later) and classify wetland types, and b) project the impacts of climate change on montane wetlands using global climate model scenarios for the 2040s and 2080s (A1B emissions scenario). These future projections show that climate-induced changes to key driving variables (reduced snowpack, higher evapotranspiration, extended summer drought) will result in earlier and faster drawdown in Pacific Northwest montane wetlands, leading to systematic reductions in water levels, shortened wetland hydroperiods, and increased probability of drying. Intermediate hydroperiod wetlands are projected to experience the greatest changes. For the 2080s scenario, widespread conversion of intermediate wetlands to fastdrying ephemeral wetlands will likely reduce wetland habitat availability for many species.	[Lee, Se-Yeun; Hamlet, Alan F.] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA; [Ryan, Maureen E.; Lawler, Joshua J.; Halabisky, Meghan] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Ryan, Maureen E.; Palen, Wendy J.] Simon Fraser Univ, Dept Biol, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Hamlet, Alan F.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Simon Fraser University; University of Notre Dame	Ryan, ME (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	mo@csp-inc.org			David H. Smith Conservation Research Fellowship Program; North Pacific Landscape Conservation Cooperative [F11AC00080]; Northwest Climate Science Center [GS276A-A]; Canada Research Chairs Program; Grants-in-Aid for Scientific Research [14F04070] Funding Source: KAKEN	David H. Smith Conservation Research Fellowship Program; North Pacific Landscape Conservation Cooperative; Northwest Climate Science Center; Canada Research Chairs Program(Canada Research Chairs); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The David H. Smith Conservation Research Fellowship Program funded MER's salary and field research (no grant number; smithfellows.org). The North Pacific Landscape Conservation Cooperative funded SL's salary, a workshop to share results, and equipment (USFWS grant #F11AC00080; http://www.northpacificlcc.org/). The Northwest Climate Science Center provided salary support for SL, MER, AFH, JJL, and MH and funding for field research (USGS grant #GS276A-A; http://www.doi.gov/csc/Northwest/index.cfm). The Canada Research Chairs Program provided salary for WJP (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Burkett V, 2000, J AM WATER RESOUR AS, V36, P313, DOI 10.1111/j.1752-1688.2000.tb04270.x; CARPENTER SR, 1992, ANNU REV ECOL SYST, V23, P119, DOI 10.1146/annurev.es.23.110192.001003; Cherkauer KA, 2003, GLOBAL PLANET CHANGE, V38, P151, DOI 10.1016/S0921-8181(03)00025-0; Dahl T., 1990, WETLANDS LOSSES US 1; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Davidson C, 2004, ECOL APPL, V14, P1892, DOI 10.1890/03-5224; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Epanchin PN, 2010, ECOLOGY, V91, P2406, DOI 10.1890/09-1974.1; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Garwood J, COMMUNICATION; Garwood JM, 2007, ECOLOGY CASCADES FRO; GIRDNER SF, 1995, J PLANKTON RES, V17, P1731, DOI 10.1093/plankt/17.9.1731; Halabisky M, 2013, WETL SCI PRAC, V30, P12; Halabisky M, USING LIDAR OBJECT B; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; Hamlet AF, 2003, ATMOS OCEAN, V51, P392; Hamlet AF, 2007, J CLIMATE, V20, P1468, DOI 10.1175/JCLI4051.1; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hruby T, 2006, STATE DEP ECOLOGY PU; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Johnson AC, 2009, SCI TOTAL ENVIRON, V407, P4787, DOI 10.1016/j.scitotenv.2009.05.018; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Knapp RA, 2007, BIOL CONSERV, V135, P11, DOI 10.1016/j.biocon.2006.09.013; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Littell J. S., 2011, 09JV11015600039 USDA, P1; Metz B, 2007, P 8 SESS WORK GROUP; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING WE, P68; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; O'Regan SM, 2014, ECOLOGY, V95, P845, DOI 10.1890/13-0916.1; Payne JT, 2004, CLIMATIC CHANGE, V62, P233, DOI 10.1023/B:CLIM.0000013694.18154.d6; Pearl C, COMMUNICATION; Piovia-Scott J, 2011, BIOL CONSERV, V144, P2913, DOI 10.1016/j.biocon.2011.08.008; Poiani KA, 1996, LIMNOL OCEANOGR, V41, P871, DOI 10.4319/lo.1996.41.5.0871; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; R Core Team, 2015, R LANG ENV STAT COMP; Ryan ME, 2014, FRONT ECOL ENVIRON, V12, P232, DOI 10.1890/130145; Safeeq M, 2014, J HYDROMETEOROL, V15, P2501, DOI 10.1175/JHM-D-13-0198.1; Salathe EP, 2013, UNCERTAINTY EXTREME; Salathe EP, 2010, CLIMATIC CHANGE, V102, P51, DOI 10.1007/s10584-010-9849-y; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Tarr M, 2008, IMPORTANCE HYDROPERI, VAvailable; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Tohver IM, 2014, J AM WATER RESOUR AS, V50, P1461, DOI 10.1111/jawr.12199; Walls SC, 2013, WETLANDS, V33, P345, DOI 10.1007/s13157-013-0391-3; Washington Department of Natural Resources, 2011, STAT WASH NAT HER PL; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wenger SJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008839; Werner BA, 2013, ECOL EVOL, V3, P3471, DOI 10.1002/ece3.731; Zambrano-Bigiarini M, 2014, PACKAGE HYDROGOF GOO; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	62	133	140	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136385	10.1371/journal.pone.0136385	http://dx.doi.org/10.1371/journal.pone.0136385			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331850	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800054
J	Yang, X; Zhu, CF; Gu, Y				Yang, Xue; Zhu, Chenfang; Gu, Yan			The Prognosis of Breast Cancer Patients after Mastectomy and Immediate Breast Reconstruction: A Meta-Analysis	PLOS ONE			English	Article							SKIN-SPARING MASTECTOMY; POSTMASTECTOMY RECONSTRUCTION; ONCOLOGICAL SAFETY; ADJUVANT CHEMOTHERAPY; LOCAL RECURRENCE; FOLLOW-UP; SURVIVAL; IMPACT; CONSERVATION; REVIEWS	Background An increasing number of patients with breast cancer are being offered immediate breast reconstruction (IBR). The aim of this study was to analyze the impact of IBR on the prognosis of patients with breast cancer. Methods We searched the electronic databases of Medline (Pubmed), ISI Web of Knowledge, Embase, and Google Scholar databases for studies reporting the overall recurrence, disease- free survival (DFS), and overall survival (OS) of patients after mastectomy only and mastectomy with IBR. With these data, we conducted a meta-analysis of the clinical outcomes. Results Fourteen studies, including 3641 cases and 9462 controls, matched our criteria. Relevant information was extracted from these 14 studies. There was no significant heterogeneity (P for Q-statistic > 0.10 and I-2 < 25%). Patients who underwent IBR showed no increased risk of overall recurrence of breast cancer (RR = 0.89; 95% confidence interval [CI]: 0.75, 1.04; P = 0.14). Furthermore, patients receiving IBR had similar DFS (RR = 1.04; 95% CI: 0.99, 1.08); P = 0.10) and OS (RR = 1.02; 95% CI: 0.99, 1.05; P = 0.24)) as those of control patients. Conclusion This meta-analysis provides evidence that IBR does not have an adverse effect on prognosis. These data suggest that IBR is an appropriate and safe choice for patients with breast cancer.	[Yang, Xue; Zhu, Chenfang; Gu, Yan] Shanghai Jiao Tong Univ, Shanghai Ninth Hosp, Sch Med, Dept Gen Surg, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Gu, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ninth Hosp, Sch Med, Dept Gen Surg, Shanghai 200011, Peoples R China.	guyan_8@hotmail.com	Gu, Yan/AFQ-1163-2022					Agarwal J, 2012, BREAST J, V18, P226, DOI 10.1111/j.1524-4741.2012.01235.x; Agarwal S, 2010, BREAST J, V16, P503, DOI 10.1111/j.1524-4741.2010.00958.x; Alderman AK, 2002, PLAST RECONSTR SURG, V109, P2265, DOI 10.1097/00006534-200206000-00015; Barry PN, 2014, AM J CLIN ONCOL-CANC, V37, P575, DOI 10.1097/COC.0b013e318280d79f; Bezuhly M, 2009, CANCER, V115, P4648, DOI 10.1002/cncr.24511; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eriksen C, 2011, BREAST CANCER RES TR, V127, P439, DOI 10.1007/s10549-011-1437-y; Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f; Gieni M, 2012, BREAST, V21, P230, DOI 10.1016/j.breast.2011.12.013; Goktas SB, 2011, TURK KLIN TIP BILIM, V31, P664, DOI 10.5336/medsci.2009-15488; Gomez SL, 2010, J CLIN ONCOL, V28, pE155, DOI 10.1200/JCO.2009.26.1032; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; Hoshaw SJ, 2001, PLAST RECONSTR SURG, V107, P1393, DOI 10.1097/00006534-200105000-00012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson A, 2000, BREAST CANCER RES TR, V60, P201, DOI 10.1023/A:1006441018271; Joslyn SA, 2005, PLAST RECONSTR SURG, V115, P1289, DOI 10.1097/01.PRS.0000156974.69184.5E; Kim MK, 2014, EUROPEAN J SURG ONCO; Kontos M, 2010, EJSO-EUR J SURG ONC, V36, P745, DOI 10.1016/j.ejso.2010.06.013; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee TJ, 2012, ARCH PLAST SURG-APS, V39, P376, DOI 10.5999/aps.2012.39.4.376; Lim W, 2010, J SURG ONCOL, V102, P39, DOI 10.1002/jso.21573; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; McCarthy CM, 2008, PLAST RECONSTR SURG, V121, P381, DOI 10.1097/01.prs.0000298316.74743.dd; McGuire KP, 2009, ANN SURG ONCOL, V16, P2682, DOI 10.1245/s10434-009-0635-x; Min SY, 2010, BREAST J, V16, P356, DOI 10.1111/j.1524-4741.2010.00941.x; Morrow M, 2001, J AM COLL SURGEONS, V192, P1, DOI 10.1016/S1072-7515(00)00747-X; Murphy RX, 2003, ANN PLAS SURG, V50, P333, DOI 10.1097/01.SAP.0000041488.88950.A2; Nedumpara T, 2011, BREAST, V20, P437, DOI 10.1016/j.breast.2011.04.006; Neyt MJ, 2005, BRIT J PLAST SURG, V58, P493, DOI 10.1016/j.bjps.2004.12.002; Nguyen TJ, 2012, ANN SURG, V256, P326, DOI 10.1097/SLA.0b013e3182602bb7; NOGUCHI M, 1992, J SURG ONCOL, V50, P241, DOI 10.1002/jso.2930500409; Ota D, 2014, CLIN BREAST CANCER, V14, P339, DOI 10.1016/j.clbc.2013.12.014; Petit JY, 2008, BREAST CANCER RES TR, V112, P545, DOI 10.1007/s10549-008-9891-x; Reddy S, 2011, ANN PLAS SURG, V66, P466, DOI 10.1097/SAP.0b013e318214e575; Roder D, 2013, BREAST, V22, P1220, DOI 10.1016/j.breast.2013.09.011; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ueda S, 2008, SURGERY, V143, P414, DOI 10.1016/j.surg.2007.10.006; Viera AJ, 2005, FAM MED, V37, P360; Yoshimura, 1996, Breast Cancer, V3, P47, DOI 10.1007/BF02966962	43	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125655	10.1371/journal.pone.0125655	http://dx.doi.org/10.1371/journal.pone.0125655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26360603	Green Published, gold, Green Submitted			2022-12-27	WOS:000355319400008
J	Labree, W; Van de Mheen, D; Rutten, F; Rodenburg, G; Koopmans, G; Foets, M				Labree, Wim; Van de Mheen, Dike; Rutten, Frans; Rodenburg, Gerda; Koopmans, Gerrit; Foets, Marleen			Differences in Overweight and Obesity among Children from Migrant and Native Origin: The Role of Physical Activity, Dietary Intake, and Sleep Duration	PLOS ONE			English	Article							CHILDHOOD OBESITY; VEGETABLE INTAKE; ADOLESCENTS; PREVENTION; WEIGHT; REPRODUCIBILITY; ACCULTURATION; QUESTIONNAIRE; ASSOCIATION; ENVIRONMENT	A cross-sectional survey was performed to examine to what degree differences in overweight and obesity between native Dutch and migrant primary school children could be explained by differences in physical activity, dietary intake, and sleep duration among these children. Subjects (n= 1943) were primary school children around the age of 8-9 years old and their primary caregivers: native Dutch children (n = 1546), Turkish children (n = 93), Moroccan children (n = 66), other non-western children (n = 105), and other western children (n = 133). Multivariate regressions and logistic regressions were used to examine the relationship between migrant status, child's behavior, and BMI or prevalence of overweight, including obesity (logistic). Main explanatory variables were physical activity, dietary intake, and sleep duration. We controlled for age, sex, parental educational level, and parental BMI. Although sleep duration, dietary intake of fruit, and dietary intake of energy-dense snacks were associated with BMI, ethnic differences in sleep duration and dietary intake did not have a large impact on ethnic differences in overweight and obesity among children from migrant and native origin. It is suggested that future preventive strategies to reduce overweight and obesity, in general, consider the role of sleep duration. Also, cross-cultural variation in preparation of food among specific migrant groups, focusing on fat, sugar, and salt, deserves more attention. In order to examine which other variables may clarify ethnic differences in overweight and obesity, future research is needed.	[Labree, Wim; Rutten, Frans; Koopmans, Gerrit; Foets, Marleen] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [Van de Mheen, Dike; Rodenburg, Gerda] Res Inst Addict, Rotterdam, Netherlands; [Van de Mheen, Dike; Rodenburg, Gerda] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Van de Mheen, Dike] Maastricht Univ, Dept Hlth Promot, NL-6200 MD Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Maastricht University	Labree, W (corresponding author), POB 1738, NL-3000 DR Rotterdam, Netherlands.	labree@bmg.eur.nl	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900; Rutten, Gemma/0000-0001-9552-4605	Netherlands Organization for Health Research and Development [115100004]; Institute of Health Policy and Management, a department of the Erasmus University Rotterdam	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Institute of Health Policy and Management, a department of the Erasmus University Rotterdam	This research was made possible by a grant of the Netherlands Organization for Health Research and Development (115100004) and financial support from the Institute of Health Policy and Management, a department of the Erasmus University Rotterdam.	Aranceta J, 2009, NUTR REV, V67, pS83, DOI 10.1111/j.1753-4887.2009.00166.x; Beccuti G, 2011, CURR OPIN CLIN NUTR, V14, P402, DOI 10.1097/MCO.0b013e3283479109; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Booth KM, 2005, J AM DIET ASSOC, V105, pS110, DOI 10.1016/j.jada.2005.02.045; Burrows TL, 2013, CLIN NUTR, V32, P613, DOI 10.1016/j.clnu.2012.11.006; Cattaneo A, 2010, OBES REV, V11, P389, DOI 10.1111/j.1467-789X.2009.00639.x; CBS (Statistics Netherlands), 2000, STAND ALL; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; de Wilde JA, 2014, ARCH DIS CHILD, V99, P46, DOI 10.1136/archdischild-2013-304222; de Wilde JA, 2009, ARCH DIS CHILD, V94, P795, DOI 10.1136/adc.2009.163709; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; GGD (Municipal Health Services), 2009, STANDD BEW MON JEUGD; Gilbert PA, 2008, NUTR REV, V66, P203, DOI 10.1111/j.1753-4887.2008.00025.x; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Guo XF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-120; Haraldsdottir J, 2005, ANN NUTR METAB, V49, P221, DOI 10.1159/000087276; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; James WPT, 2008, J INTERN MED, V263, P336, DOI 10.1111/j.1365-2796.2008.01922.x; John J, 2010, CURR OPIN CLIN NUTR, V13, P305, DOI 10.1097/MCO.0b013e328337fe18; Knutson KL, 2012, AM J HUM BIOL, V24, P361, DOI 10.1002/ajhb.22219; Labree LJW, 2011, OBES REV, V12, pe535, DOI 10.1111/j.1467-789X.2010.00839.x; Labree LJW, 2014, J PUBLIC HEALTH-HEID, V22, P415, DOI 10.1007/s10389-014-0637-4; Liu JH, 2012, J SPEC PEDIATR NURS, V17, P193, DOI 10.1111/j.1744-6155.2012.00332.x; Lytle LA, 2009, AM J COMMUN PSYCHOL, V44, P338, DOI 10.1007/s10464-009-9269-1; Mejean C, 2009, PUBLIC HEALTH NUTR, V12, P832, DOI 10.1017/S1368980008003285; Meng LP, 2012, BIOMED ENVIRON SCI, V25, P133, DOI 10.3967/0895-3988.2012.02.002; Nicolaou M, 2009, J NUTR EDUC BEHAV, V41, P232, DOI 10.1016/j.jneb.2008.05.011; Rauner A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-19; Renzaho AMN, 2010, PUBLIC HEALTH NUTR, V13, P438, DOI 10.1017/S136898000999111X; SALLIS JF, 1991, J SCHOOL HEALTH, V61, P215, DOI 10.1111/j.1746-1561.1991.tb06017.x; Steinbeck K S, 2001, Obes Rev, V2, P117, DOI 10.1046/j.1467-789x.2001.00033.x; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Toselli S, 2014, ENDOCRINE, V24, pE1; van der Horst K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-142; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788	37	54	54	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0123672	10.1371/journal.pone.0123672	http://dx.doi.org/10.1371/journal.pone.0123672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26406985	Green Published, Green Submitted, gold			2022-12-27	WOS:000356630900009
J	Lee, S				Lee, Sean			A Sketch of Language History in the Korean Peninsula	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HOMOGENEITY; BARRIERS; MODEL	Among 7100 languages spoken on Earth, the Koreanic language is the 13th largest, with about 77 million speakers in and around the Korean Peninsula. In comparison to other languages of similar size, however, surprisingly little is known about the evolution of the Koreanic language. This is mainly due to two reasons. The first reason is that the genealogical relationship of the Koreanic to other neighboring languages remains uncertain, and thus inference from the linguistic comparative method provides only provisional evidence. The second reason is that, as the ancestral Koreanic speakers lacked their own writing system until around 500 years ago, there are scant historical materials to peer into the past, except for those preserved in Sinitic characters that we have no straightforward way of interpreting. Here I attempt to overcome these disadvantages and shed some light on the linguistic history of the Korean Peninsula, by analyzing the internal variation of the Koreanic language with methods adopted from evolutionary biology. The preliminary results presented here suggest that the evolutionary history of the Koreanic language is characterized by a weak hierarchical structure, and intensive gene/culture flows within the Korean Peninsula seem to have promoted linguistic homogeneity among the Koreanic variants. Despite the gene/culture flows, however, there are still three detectable linguistic barriers in the Korean Peninsula that appear to have been shaped by geographical features such as mountains, elevated areas, and ocean. I discuss these findings in an inclusive manner to lay the groundwork for future studies.	Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan	University of Tokyo	Lee, S (corresponding author), Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan.	seanlee@darwin.c.u-tokyo.ac.jp			 [2604070]; Grants-in-Aid for Scientific Research [14F04070] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (2604070). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikhenvald AY, 2006, AREAL DIFFUSION AND; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2014, ETHNOLOGUE LANGUAGES; [Anonymous], 2006, LANGUAGE KOREAN CULT; [Anonymous], [No title captured], DOI DOI 10.1075/DIA.23.1.04HAM; Axelsen JB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3029; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Blust R., 2013, THE AUSTRONESIAN LAN; Bouckaert R., 2014, DENSITREE 2 SEEING T, DOI [10.1101/012401, DOI 10.1101/012401]; Bowern C, 2012, P ROY SOC B-BIOL SCI, V279, P4590, DOI 10.1098/rspb.2012.1842; Brassel K.E., 1979, GEOGR ANAL, V325, P31, DOI [10.1111/j.1538-4632.1979.tb00695.x, DOI 10.1111/J.1538-4632.1979.TB00695.X]; Crowley T, 2010, AN INTRODUCTION TO H; Dixon RMW, 1997, THE RISE AND FALL OF; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunn Michael., 2015, ROUTLEDGE HDB HIST L, P190; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2013, STRUNGMANN FORUM REP, P285; Greenhill S. J., 2015, ROUTLEDGE HDB HIST L, P557; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Holden Clare, 2006, PHYLOGENETIC METHODS, P19; Hong SB, 2014, GENES GENOM, V36, P583, DOI 10.1007/s13258-014-0194-9; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hymes D, 1974, PIDGINIZATION AND CR; Jin HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004210; Kim SH, 2010, INT J LEGAL MED, V124, P653, DOI 10.1007/s00414-010-0501-1; Kim YJ, 2013, GENES GENOM, V35, P355, DOI 10.1007/s13258-013-0082-8; Lee KM, 2011, HISTORY OF THE KOREAN LANGUAGE, P1, DOI 10.1017/CBO9780511974045; Lee S, 2014, J EVOLUTION BIOL, V27, P1905, DOI 10.1111/jeb.12442; Lee SH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041009; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062243; Lee S, 2011, P ROY SOC B-BIOL SCI, V278, P3662, DOI 10.1098/rspb.2011.0518; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MARTIN SE, 1966, LANGUAGE, V42, P185, DOI 10.2307/411687; Mayr E., 1998, THIS IS BIOLOGY; Monmonier MS, 1973, GEOGRAPHICAL ANALYSI; Nam K., 2014, KYOHAKKOE SACEN A MI; Nanmal ohwi chongbo chori yonguso, 2010, URIMAL PANGEN SACEN; Ogura S, 1944, CHOSENGO HOGEN NO KE; Ogura S, 1940, THE OUTLINE OF THE K; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R A LANGUAGE AND ENV; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Simpson A., 2007, LANGUAGE AND NATIONA; Sohn H-M, 2001, THE KOREAN LANGUAGE; Starostin S, 2003, LANGUAGES OF THE WOR; Starostin SA, 2003, ETYMOLOGICAL DICTION; Trudgill Peter, 2004, LINGUIST TYPOL, V8, P305, DOI DOI 10.1515/LITY.2004.8.3.305; Voronoi G, 1908, J REINE ANGEW MATH, V134, P198, DOI 10.1515/crll.1908.134.198; Vovin A, 2010, KOREA JAPONICA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	59	133	140	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128448	10.1371/journal.pone.0128448	http://dx.doi.org/10.1371/journal.pone.0128448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CJ2MQ	26331850	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400091
J	Rutten, G; Ensslin, A; Hemp, A; Fischer, M				Rutten, Gemma; Ensslin, Andreas; Hemp, Andreas; Fischer, Markus			Vertical and Horizontal Vegetation Structure across Natural and Modified Habitat Types at Mount Kilimanjaro	PLOS ONE			English	Article							SPECIES-DIVERSITY; TROPICAL FOREST; CLIMATE-CHANGE; LAND-USE; MONTANE FORESTS; TREE DIVERSITY; BIOMASS; CONSERVATION; BIODIVERSITY; GRADIENTS	In most habitats, vegetation provides the main structure of the environment. This complexity can facilitate biodiversity and ecosystem services. Therefore, measures of vegetation structure can serve as indicators in ecosystem management. However, many structural measures are laborious and require expert knowledge. Here, we used consistent and convenient measures to assess vegetation structure over an exceptionally broad elevation gradient of 866-4550m above sea level at Mount Kilimanjaro, Tanzania. Additionally, we compared (human)-modified habitats, including maize fields, traditionally managed home gardens, grasslands, commercial coffee farms and logged and burned forests with natural habitats along this elevation gradient. We distinguished vertical and horizontal vegetation structure to account for habitat complexity and heterogeneity. Vertical vegetation structure (assessed as number, width and density of vegetation layers, maximum canopy height, leaf area index and vegetation cover) displayed a unimodal elevation pattern, peaking at intermediate elevations in montane forests, whereas horizontal structure (assessed as coefficient of variation of number, width and density of vegetation layers, maximum canopy height, leaf area index and vegetation cover) was lowest at intermediate altitudes. Overall, vertical structure was consistently lower in modified than in natural habitat types, whereas horizontal structure was inconsistently different in modified than in natural habitat types, depending on the specific structural measure and habitat type. Our study shows how vertical and horizontal vegetation structure can be assessed efficiently in various habitat types in tropical mountain regions, and we suggest to apply this as a tool for informing future biodiversity and ecosystem service studies.	[Rutten, Gemma; Ensslin, Andreas; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Rutten, Gemma] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland; [Rutten, Gemma; Ensslin, Andreas; Fischer, Markus] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Hemp, Andreas] Univ Bayreuth, Dept Plant Systemat, Bayreuth, Germany; [Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Fischer, Markus] Biodivers & Climate Res Ctr BiK F, Senckenberg Gesell Naturforschung, Frankfurt, Germany	University of Bern; University of Bern; University of Bayreuth; University of Bern; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Rutten, G (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	ggpmrutten@gmail.com	Fischer, Markus/C-6411-2008	Fischer, Markus/0000-0002-5589-5900; Rutten, Gemma/0000-0001-9552-4605	Swiss National Science Foundation (SNSF) of Research-Unit of the German Research Foundation (DFG) [1246]	Swiss National Science Foundation (SNSF) of Research-Unit of the German Research Foundation (DFG)	Funding: This study was supported by the Swiss National Science Foundation (SNSF) in the context of Research-Unit 1246 of the German Research Foundation (DFG). Prof. Dr. Markus Fischer, Dr. Andreas Hemp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawala S, 2003, DEV CLIMATE CHANGE T; Appelhans T, 2014, MONTHLY ANN CLIMATE; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; BELSKY AJ, 1994, BIOSCIENCE, V44, P77, DOI 10.2307/1312205; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Dean WRJ, 1999, J ARID ENVIRON, V41, P61, DOI 10.1006/jare.1998.0455; Dickinson MB, 2000, FOREST ECOL MANAG, V134, P137, DOI 10.1016/S0378-1127(99)00252-2; Ensslin A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00492.1; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; HATLEY CL, 1980, ENVIRON ENTOMOL, V9, P632, DOI 10.1093/ee/9.5.632; Helbig-Bonitz M, 2013, AFRICAN J ECOLOGY; Hemp A, 2005, GLOBAL CHANGE BIOL, V11, P1013, DOI 10.1111/j.1365-2486.2005.00968.x; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Hemp A, 2006, PLANT ECOL, V184, P27, DOI 10.1007/s11258-005-9049-4; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; Herve BD, 2008, BIODIVERS CONSERV, V17, P1821, DOI 10.1007/s10531-007-9276-1; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; JENSEN M, 1993, AGROFOREST SYST, V24, P171, DOI 10.1007/BF00706890; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kessler M, 2005, BIODIVERS CONSERV, V14, P547, DOI 10.1007/s10531-004-3914-7; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lambrechts C., 2002, AERIAL SURVEY THREAT; Lopez-Gomez AA, 2008, AGR ECOSYST ENVIRON, V124, P160, DOI 10.1016/j.agee.2007.09.008; Lovett JC, 2006, AFR J ECOL, V44, P478, DOI 10.1111/j.1365-2028.2006.00660.x; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Moser G, 2007, ECOSYSTEMS, V10, P924, DOI 10.1007/s10021-007-9063-6; Paletto A, 2009, EUR J FOREST RES, V128, P265, DOI 10.1007/s10342-009-0262-x; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Reich RM, 2010, PLANT ECOL, V210, P67, DOI 10.1007/s11258-010-9738-5; Rhoades CC, 1996, AGROFOREST SYST, V35, P71, DOI 10.1007/BF02345330; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Ruiz-Jaen MC, 2005, FOREST ECOL MANAG, V218, P159, DOI 10.1016/j.foreco.2005.07.008; Rutten G, 2015, FOREST ECOL MANAG, V337, P61, DOI 10.1016/j.foreco.2014.10.036; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Stumpf K., 1993, SOC AM FOR NAT CONV; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tylianakis JM, 2005, ECOLOGY, V86, P3296, DOI 10.1890/05-0371; Van Gemerden BS, 2003, BIODIVERS CONSERV, V12, P1553, DOI 10.1023/A:1023603813163; Williams-Linera G, 2013, PLANT ECOL, P1; Wilson JB, 2011, J VEG SCI, V22, P197, DOI 10.1111/j.1654-1103.2010.01238.x	53	54	54	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2015	10	9							e0138822	10.1371/journal.pone.0138822	http://dx.doi.org/10.1371/journal.pone.0138822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS1CR	26406985	Green Published, Green Submitted, gold			2022-12-27	WOS:000361800700103
